PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ghorpade, DS; Ozcan, L; Zheng, Z; Nicoloro, SM; Shen, YF; Hen, EC; Bluher, M; Czech, MP; Tabas, I				Ghorpade, Devram S.; Ozcan, Lale; Zheng, Ze; Nicoloro, Sarah M.; Shen, Yuefei; Hen, Emily C.; Blueher, Matthias; Czech, Michael P.; Tabas, Ira			Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance	NATURE			English	Article							DIPEPTIDYL PEPTIDASE-4 INHIBITOR; BODY-MASS INDEX; GLYCEMIC CONTROL; LINKING OBESITY; EXPRESSION; TISSUE; MACROPHAGES; SITAGLIPTIN; EFFICACY; SAFETY	Obesity-induced metabolic disease involves functional integration among several organs via circulating factors, but little is known about crosstalk between liver and visceral adipose tissue (VAT)(1). In obesity, VAT becomes populated with inflammatory adipose tissue macrophages (ATMs)(2,3). In obese humans, there is a close correlation between adipose tissue inflammation and insulin resistance4,5, and in obese mice, blocking systemic or ATM inflammation improves insulin sensitivity(6-8). However, processes that promote pathological adipose tissue inflammation in obesity are incompletely understood. Here we show that obesity in mice stimulates hepatocytes to synthesize and secrete dipeptidyl peptidase 4 (DPP4), which acts with plasma factor Xa to inflame ATMs. Silencing expression of DPP4 in hepatocytes suppresses inflammation of VAT and insulin resistance; however, a similar effect is not seen with the orally administered DPP4 inhibitor sitagliptin. Inflammation and insulin resistance are also suppressed by silencing expression of caveolin-1 or PAR2 in ATMs; these proteins mediate the actions of DPP4 and factor Xa, respectively. Thus, hepatocyte DPP4 promotes VAT inflammation and insulin resistance in obesity, and targeting this pathway may have metabolic benefits that are distinct from those observed with oral DPP4 inhibitors.	[Ghorpade, Devram S.; Ozcan, Lale; Zheng, Ze; Tabas, Ira] Columbia Univ, Dept Med, Med Ctr, New York, NY 10032 USA; [Nicoloro, Sarah M.; Shen, Yuefei; Czech, Michael P.] Univ Massachusetts, Program Mol Med, Sch Med, Worcester, MA 01605 USA; [Hen, Emily C.] Columbia Univ, Prote Shared Resource Herbert Irving Comprehens C, Med Ctr, New York, NY 10032 USA; [Hen, Emily C.] Columbia Univ, Herbert Irving Comprehens Canc Ctr Prote Shared R, Med Ctr, New York, NY 10032 USA; [Blueher, Matthias] Univ Leipzig, Dept Med, D-04103 Leipzig, Germany; [Tabas, Ira] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10032 USA; [Tabas, Ira] Columbia Univ, Dept Physiol, Med Ctr, New York, NY 10032 USA	Columbia University; University of Massachusetts System; University of Massachusetts Worcester; Columbia University; Columbia University; Leipzig University; Columbia University; Columbia University	Ozcan, L; Tabas, I (corresponding author), Columbia Univ, Dept Med, Med Ctr, New York, NY 10032 USA.; Tabas, I (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10032 USA.; Tabas, I (corresponding author), Columbia Univ, Dept Physiol, Med Ctr, New York, NY 10032 USA.	lo2192@columbia.edu; iat1@columbia.edu		Ozcan, Lale/0000-0002-2710-7057; Nicoloro, Sarah/0000-0002-8638-4556; Zheng, Ze/0000-0002-4453-224X	NATIONAL CANCER INSTITUTE [P30CA013696] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075662, R01HL140554, T32HL007343, P01HL087123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103047, P30DK063608, R01DK106045] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA013696] Funding Source: Medline; NHLBI NIH HHS [R01 HL140554, P01 HL087123, R01 HL075662, T32 HL007343] Funding Source: Medline; NIDDK NIH HHS [R01 DK106045, P30 DK063608, R01 DK103047] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aouadi M, 2013, P NATL ACAD SCI USA, V110, P8278, DOI 10.1073/pnas.1300492110; Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Aschner P, 2006, DIABETES CARE, V29, P2632, DOI 10.2337/dc06-0703; Bluher M, 2016, CLIN SCI, V130, P1603, DOI 10.1042/CS20160005; Boonacker E, 2003, EUR J CELL BIOL, V82, P53, DOI 10.1078/0171-9335-00302; Busch G, 2005, ARTERIOSCL THROM VAS, V25, P461, DOI 10.1161/01.ATV.0000151279.35780.2d; Cohen JL, 2016, MOL PHARMACEUT, V13, P964, DOI 10.1021/acs.molpharmaceut.5b00831; Dasgupta S, 2010, BIOCHEM J, V429, P451, DOI 10.1042/BJ20100330; Dobrian AD, 2011, AM J PHYSIOL-ENDOC M, V300, pE410, DOI 10.1152/ajpendo.00463.2010; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Ebert SM, 2012, J BIOL CHEM, V287, P27290, DOI 10.1074/jbc.M112.374777; Fitzgerald K, 2017, NEW ENGL J MED, V376, P41, DOI 10.1056/NEJMoa1609243; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hardy OT, 2011, SURG OBES RELAT DIS, V7, P60, DOI 10.1016/j.soard.2010.05.013; Hasty A. H, 2013, JOVE-J VIS EXP, V22; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jung CH, 2015, DIABETES-METAB RES, V31, P295, DOI 10.1002/dmrr.2613; Kadowaki T, 2013, DIABETES OBES METAB, V15, P810, DOI 10.1111/dom.12092; Kirino Y, 2012, ENDOCR J, V59, P949, DOI 10.1507/endocrj.EJ12-0158; Kutoh E, 2012, ENDOCRINE, V41, P435, DOI 10.1007/s12020-012-9596-0; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; Lisowski L, 2014, NATURE, V506, P382, DOI 10.1038/nature12875; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; MCGEE MP, 1989, BLOOD, V74, P1583; Mu X, 2015, J CLIN INVEST, V125, P3891, DOI 10.1172/JCI77995; Mulvihill EE, 2017, CELL METAB, V25, P152, DOI 10.1016/j.cmet.2016.10.007; Nazarian A, 2014, MOL CELL PROTEOMICS, V13, P3082, DOI 10.1074/mcp.M114.038836; Ohnuma K, 2005, MOL CELL BIOL, V25, P7743, DOI 10.1128/MCB.25.17.7743-7757.2005; Ozcan L, 2016, CELL REP, V15, P2214, DOI 10.1016/j.celrep.2016.05.006; Ozcan L, 2013, CELL METAB, V18, P803, DOI 10.1016/j.cmet.2013.10.011; Ozcan L, 2012, CELL METAB, V15, P739, DOI 10.1016/j.cmet.2012.03.002; Pedersen DJ, 2015, MOL METAB, V4, P507, DOI 10.1016/j.molmet.2015.04.003; Raz I, 2006, DIABETOLOGIA, V49, P2564, DOI 10.1007/s00125-006-0416-z; Ristic S, 2005, DIABETES OBES METAB, V7, P692, DOI 10.1111/j.1463-1326.2005.00539.x; Senden NHM, 1998, J IMMUNOL, V161, P4318; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zuo PF, 2015, AM J TRANSL RES, V7, P2326	39	153	160	9	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2018	555	7698					673	+		10.1038/nature26138	http://dx.doi.org/10.1038/nature26138			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8UX	29562231	Green Accepted, Green Published			2022-12-28	WOS:000428617600052
J	Tansarli, GS; Mylonakis, E				Tansarli, Giannoula S.; Mylonakis, Eleftherios			Fecal transplant by oral capsule was noninferior to delivery by colonoscopy for C difficile recurrence	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Tansarli, Giannoula S.; Mylonakis, Eleftherios] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University	Tansarli, GS (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.							Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4	1	1	1	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2018	168	6					JC31	JC31		10.7326/ACPJC-2018-168-6-031	http://dx.doi.org/10.7326/ACPJC-2018-168-6-031			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ8AM	29554669				2022-12-28	WOS:000427827400008
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Why do we ignore uncertainty?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Flynn M., 2015, SERIOUS CASE REV JAM; Inquest, 2018, INQ PREM DEATH R HAN	2	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2018	360								k1164	10.1136/bmj.k1164	http://dx.doi.org/10.1136/bmj.k1164			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB1KM	29555818	Bronze, Green Published			2022-12-28	WOS:000428809700001
J	Mossialos, E; McGuire, A; Anderson, M; Pitchforth, E; James, A; Horton, R				Mossialos, Elias; McGuire, Alistair; Anderson, Michael; Pitchforth, Emma; James, Astrid; Horton, Richard			The future of the NHS: no longer the envy of the world?	LANCET			English	Editorial Material									[Mossialos, Elias; McGuire, Alistair; Anderson, Michael; Pitchforth, Emma] London Sch Econ & Polit Sci, Dept Hlth Policy, London WC2A 2AE, England; [Pitchforth, Emma] Univ Exeter, Sch Med, Primary Care Res Grp, Exeter, Devon, England; [James, Astrid; Horton, Richard] The Lancet, London, England	University of London; London School Economics & Political Science; University of Exeter	Mossialos, E (corresponding author), London Sch Econ & Polit Sci, Dept Hlth Policy, London WC2A 2AE, England.	e.a.mossialos@lse.ac.uk	Mossialos, Elias/ABE-1301-2021	Pitchforth, Emma/0000-0001-9055-9331				Abel-Smith B., 1992, INT SOCIAL SECURITY, V45, P6, DOI DOI 10.1111/J.1468-246X.1992.TB00900.X; Bojke C, 2018, HEALTH ECON, V27, pe26, DOI 10.1002/hec.3525; CHESTER TE, 1956, PUBLIC ADMIN, V34, P199, DOI 10.1111/j.1467-9299.1956.tb01489.x; Esping-Andersen G., 1990, 3 WORLDS WELFARE CAP; Ham C., 2009, HLTH POLICY BRITAIN, V6th; Kings Fund, 2015, NHS COAL GOV 1; Klein R., 2018, NATL HLTH SERVICE NH, DOI [10.1017/S17441331170003541-10, DOI 10.1017/S17441331170003541-10]; Kutzin J, 2002, FUNDING HLTH CARE OP; Mossialos E, 2000, BMJ-BRIT MED J, V320, P197, DOI 10.1136/bmj.320.7229.197; NHS England, 2013, PRINC VAL NHS ENGL; NHS England, 2014, 5 YEAR FORW VIEW; TIMMINS N, 1995, 5 GIANTS BIOGRAPHY W; Titmuss, 1958, ESSAYS WELFARE STATE; Townsend P., 1982, INEQUALITIES HLTH BL; Wanless D, 2004, WANLESS REPORT SECUR; Webster C., 1991, A BEVAN NATL HLTH SE; Wenzl M, 2015, BRIT MED BULL, V115, P5, DOI 10.1093/bmb/ldv031; [No title captured]	18	7	7	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2018	391	10125					1001	1003		10.1016/S0140-6736(18)30574-9	http://dx.doi.org/10.1016/S0140-6736(18)30574-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ4TP	29565005	Green Accepted			2022-12-28	WOS:000427585100006
J	Bailey, JN; de Nijs, L; Bai, D; Suzuki, T; Miyamoto, H; Tanaka, M; Patterson, C; Lin, YC; Medina, MT; Alonso, ME; Serratosa, JM; Duron, RM; Nguyen, VH; Wight, JE; Martinez-Juarez, IE; Ochoa, A; Jara-Prado, A; Guilhoto, L; Molina, Y; Yacubian, EM; Lopez-Ruiz, M; Inoue, Y; Kaneko, S; Hirose, S; Osawa, M; Oguni, H; Fujimoto, S; Grisar, TM; Stern, JM; Yamakawa, K; Lakaye, B; Delgado-Escueta, AV				Bailey, J. N.; de Nijs, L.; Bai, D.; Suzuki, T.; Miyamoto, H.; Tanaka, M.; Patterson, C.; Lin, Y. -C.; Medina, M. T.; Alonso, M. E.; Serratosa, J. M.; Duron, R. M.; Nguyen, V. H.; Wight, J. E.; Martinez-Juarez, I. E.; Ochoa, A.; Jara-Prado, A.; Guilhoto, L.; Molina, Y.; Yacubian, E. M.; Lopez-Ruiz, M.; Inoue, Y.; Kaneko, S.; Hirose, S.; Osawa, M.; Oguni, H.; Fujimoto, S.; Grisar, T. M.; Stern, J. M.; Yamakawa, K.; Lakaye, B.; Delgado-Escueta, A. V.			Variant Intestinal-Cell Kinase in Juvenile Myoclonic Epilepsy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEQUENCE VARIANTS; GENETIC-VARIATION; GUIDELINES; CAUSALITY; EFHC1; PROLIFERATION; ACTIVATION; DISEASE; FAMILY; ICK	BACKGROUND In juvenile myoclonic epilepsy, data are limited on the genetic basis of networks promoting convulsions with diffuse polyspikes on electroencephalography (EEG) and the subtle microscopic brain dysplasia called microdysgenesis. METHODS Using Sanger sequencing, we sequenced the exomes of six members of a large family affected with juvenile myoclonic epilepsy and confirmed cosegregation in all 37 family members. We screened an additional 310 patients with this disorder for variants on DNA melting-curve analysis and targeted real-time DNA sequencing of the gene encoding intestinal-cell kinase (ICK). We calculated Bayesian logarithm of the odds (LOD) scores for cosegregating variants, odds ratios in case-control associations, and allele frequencies in the Genome Aggregation Database. We performed functional tests of the effects of variants on mitosis, apoptosis, and radial neuroblast migration in vitro and conducted video-EEG studies in mice lacking a copy of Ick. RESULTS A variant, K305T (c.914A -> C), cosegregated with epilepsy or polyspikes on EEG in 12 members of the family affected with juvenile myoclonic epilepsy. We identified 21 pathogenic ICK variants in 22 of 310 additional patients (7%). Four strongly linked variants (K220E, K305T, A615T, and R632X) impaired mitosis, cell-cycle exit, and radial neuroblast migration while promoting apoptosis. Tonic-clonic convulsions and polyspikes on EEG resembling seizures in human juvenile myoclonic epilepsy occurred more often in knockout heterozygous mice than in wildtype mice (P = 0.02) during light sleep with isoflurane anesthesia. CONCLUSIONS Our data provide evidence that heterozygous variants in ICK caused juvenile myoclonic epilepsy in 7% of the patients included in our analysis. Variant ICK affects cell processes that help explain microdysgenesis and polyspike networks observed on EEG in juvenile myoclonic epilepsy.	[Bailey, J. N.; Bai, D.; Tanaka, M.; Patterson, C.; Lin, Y. -C.; Serratosa, J. M.; Stern, J. M.; Delgado-Escueta, A. V.] Univ Calif Los Angeles, David Geffen Sch Med, Vet Affairs Greater Angeles Healthcare Syst, Neurol & Res Serv,Epilepsy Genet Genom Lab, Los Angeles, CA 90095 USA; [Bai, D.; Tanaka, M.; Serratosa, J. M.; Stern, J. M.; Delgado-Escueta, A. V.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Bailey, J. N.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA; [Nguyen, V. H.] Chapman Univ, Irvine, CA USA; [de Nijs, L.; Grisar, T. M.; Lakaye, B.] Univ Liege, Grp Interdisciplinaire Genoproteom Appl Neurosci, Liege, Belgium; [Suzuki, T.; Miyamoto, H.; Yamakawa, K.] RIKEN, Brain Sci Inst, Saitama, Japan; [Inoue, Y.] Shizuoka Inst Epilepsy & Neurol Disorders, Shizuoka, Japan; [Kaneko, S.] Hirosaki Univ, Grad Sch Med, Hirosaki, Aomori, Japan; [Hirose, S.] Fukuoka Univ, Fukuoka, Japan; [Osawa, M.; Oguni, H.] Tokyo Womens Med Univ, Tokyo, Japan; [Fujimoto, S.] Nagoya City Univ, Nagoya, Aichi, Japan; [Fujimoto, S.] Tsutsujigaoka Childrens Clin, Nagoya, Aichi, Japan; [Medina, M. T.; Molina, Y.] Natl Autonomous Univ Honduras, Tegucigalpa, Honduras; [Duron, R. M.] Univ Tecnol Ctr Amer, Tegucigalpa, Honduras; [Alonso, M. E.; Martinez-Juarez, I. E.; Ochoa, A.; Jara-Prado, A.] Natl Inst Neurol & Neurosurg Manuel Velasco Suare, Mexico City, DF, Mexico; [Lopez-Ruiz, M.] Gen Hosp Mexico, Mexico City, DF, Mexico; [Guilhoto, L.; Yacubian, E. M.] Univ Fed Sao Paulo, Sao Paulo, SP, Brazil; [Serratosa, J. M.] Autonomous Univ Madrid, Inst Invest Sanit, Fdn Jimenez Diaz, Madrid, Spain; [Serratosa, J. M.] Biomed Res Network Ctr Rare Dis, Madrid, Spain	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Chapman University System; Chapman University; University of Liege; RIKEN; Hirosaki University; Fukuoka University; Tokyo Women's Medical University; Nagoya City University; Universidad Nacional Autonoma de Honduras; Universidade Federal de Sao Paulo (UNIFESP); Autonomous University of Madrid; Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Delgado-Escueta, AV (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Epilepsy Ctr 127B, VA GLAHS, Rm 3049,Bldg 500,11301 Wilshire Blvd, Los Angeles, CA 90073 USA.; Lakaye, B (corresponding author), Univ Liege, GIGA Neurosci, 15 Ave Hippocrate, B-4000 Liege, Belgium.; Yamakawa, K (corresponding author), RIKEN, Brain Sci Inst, Lab Neurogenet, 2-1 Wako Shi, Saitama, Japan.	yamakawa@brain.riken.jp; b.lakaye@ulg.ac.be; aescueta@mednet.ucla.edu	Ochoa, Adriana/AAU-2918-2020; Yamakawa, Kazuhiro/N-5050-2015; Jara-Prado, Aurelio/AAU-3017-2020; Durón, Reyna M./AAX-4407-2020; Martinez-Juarez, Iris E/S-5351-2017; Iris E. Martínez-Juárez, MSc/AAZ-9428-2020	Ochoa, Adriana/0000-0003-1084-2984; Yamakawa, Kazuhiro/0000-0002-1478-4390; Iris E. Martínez-Juárez, MSc/0000-0001-6512-5312; HIROSE, Shinichi/0000-0001-6796-3790; Jara-Prado, Aurelio/0000-0001-8985-3744; Duron, Reyna M./0000-0002-9425-2289; Stern, John/0000-0002-3549-1642; Medina, Marco Tulio/0000-0003-0469-054X; Suzuki, Toshimitsu/0000-0003-0585-5692; Serratosa, Jose/0000-0003-2239-8948; Guilhoto, Laura/0000-0001-6398-8632	National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055057] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15H02548, 25253073] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funded by the National Institutes of Health and others.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Bailey JN, 2017, GENET MED, V19, P144, DOI 10.1038/gim.2016.86; Berger I, 2012, EPILEPSIA, V53, P1436, DOI 10.1111/j.1528-1167.2012.03536.x; Camfield CS, 2013, EPILEPSY BEHAV, V28, pS15, DOI 10.1016/j.yebeh.2012.06.024; Chaya T, 2014, EMBO J, V33, P1227, DOI 10.1002/embj.201488175; Crespel A, 2013, EPILEPSY BEHAV, V28, pS81, DOI 10.1016/j.yebeh.2013.01.001; de Nijs L, 2012, HUM MOL GENET, V21, P5106, DOI 10.1093/hmg/dds356; Delgado-Escueta AV, 2013, EPILEPSY BEHAV, V28, pS52, DOI 10.1016/j.yebeh.2012.06.033; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; Fisher RS, 2017, EPILEPSIA, V58, P522, DOI 10.1111/epi.13670; Fredericks S, 2005, ANN CLIN BIOCHEM, V42, P376, DOI 10.1258/0004563054889927; Fu Z, 2005, MOL CELL BIOL, V25, P6047, DOI 10.1128/MCB.25.14.6047-6064.2005; Fu Z, 2009, AM J PHYSIOL-GASTR L, V297, pG632, DOI 10.1152/ajpgi.00066.2009; Glusman G, 2011, BIOINFORMATICS, V27, P3216, DOI 10.1093/bioinformatics/btr540; Hauser W, 1990, EPILEPSY FREQUENCY C; KOMATSU H, 1987, ANESTHESIOLOGY, V67, P771, DOI 10.1097/00000542-198711000-00022; Lahiry P, 2009, AM J HUM GENET, V84, P134, DOI 10.1016/j.ajhg.2008.12.017; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lindner TH, 2005, BIOINFORMATICS, V21, P405, DOI 10.1093/bioinformatics/bti009; Liu XM, 2016, HUM MUTAT, V37, P235, DOI 10.1002/humu.22932; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Martinez-Juarez IE, 2006, BRAIN, V129, P1269, DOI 10.1093/brain/awl048; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meencke H J, 1999, Adv Neurol, V79, P123; Mehrotra DV, 2003, BIOMETRICS, V59, P441, DOI 10.1111/1541-0420.00051; Moon H, 2014, P NATL ACAD SCI USA, V111, P8541, DOI 10.1073/pnas.1323161111; Neligan Aidan, 2012, Handb Clin Neurol, V107, P113, DOI 10.1016/B978-0-444-52898-8.00006-9; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Thompson D, 2003, AM J HUM GENET, V73, P652, DOI 10.1086/378100; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wu D, 2012, J BIOL CHEM, V287, P12510, DOI 10.1074/jbc.M111.302117; Yoon D, 2009, EPILEPSIA, V50, P2186, DOI 10.1111/j.1528-1167.2009.02159.x	38	24	24	1	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2018	378	11					1018	1028		10.1056/NEJMoa1700175	http://dx.doi.org/10.1056/NEJMoa1700175			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ2HT	29539279	Bronze, Green Published			2022-12-28	WOS:000427399000007
J	Molloy, SF; Kanyama, C; Heyderman, RS; Loyse, A; Kouanfack, C; Chanda, D; Mfinanga, S; Temfack, E; Lakhi, S; Lesikari, S; Chan, AK; Stone, N; Kalata, N; Karunaharan, N; Gaskell, K; Peirse, M; Ellis, J; Chawinga, C; Lontsi, S; Ndong, JG; Bright, P; Lupiya, D; Chen, T; Bradley, J; Adams, J; Van der Horst, C; van Oosterhout, JJ; Sini, V; Mapoure, YN; Mwaba, P; Bicanic, T; Lalloo, DG; Wang, D; Hosseinipour, MC; Lortholary, O; Jaffar, S; Harrison, TS				Molloy, S. F.; Kanyama, C.; Heyderman, R. S.; Loyse, A.; Kouanfack, C.; Chanda, D.; Mfinanga, S.; Temfack, E.; Lakhi, S.; Lesikari, S.; Chan, A. K.; Stone, N.; Kalata, N.; Karunaharan, N.; Gaskell, K.; Peirse, M.; Ellis, J.; Chawinga, C.; Lontsi, S.; Ndong, J. -G.; Bright, P.; Lupiya, D.; Chen, T.; Bradley, J.; Adams, J.; Van der Horst, Charles; van Oosterhout, J. J.; Sini, V.; Mapoure, Y. N.; Mwaba, P.; Bicanic, T.; Lalloo, D. G.; Wang, D.; Hosseinipour, M. C.; Lortholary, O.; Jaffar, S.; Harrison, T. S.		ACTA Trial Study Team	Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-DOSE FLUCONAZOLE; COURSE AMPHOTERICIN-B; COMBINED COHORT; GLOBAL BURDEN; FLUCYTOSINE; THERAPY; DISEASE; TRIAL	BACKGROUND Cryptococcal meningitis accounts for more than 100,000 human immunodeficiency virus (HIV)-related deaths per year. We tested two treatment strategies that could be more sustainable in Africa than the standard of 2 weeks of amphotericin B plus flucytosine and more effective than the widely used fluconazole monotherapy. METHODS We randomly assigned HIV-infected adults with cryptococcal meningitis to receive an oral regimen (fluconazole [1200 mg per day] plus flucytosine [100 mg per kilogram of body weight per day] for 2 weeks), 1 week of amphotericin B (1 mg per kilogram per day), or 2 weeks of amphotericin B (1 mg per kilogram per day). Each patient assigned to receive amphotericin B was also randomly assigned to receive fluconazole or flucytosine as a partner drug. After induction treatment, all the patients received fluconazole consolidation therapy and were followed to 10 weeks. RESULTS A total of 721 patients underwent randomization. Mortality in the oral-regimen, 1-week amphotericin B, and 2-week amphotericin B groups was 18.2% (41 of 225), 21.9% (49 of 224), and 21.4% (49 of 229), respectively, at 2 weeks and was 35.1% (79 of 225), 36.2% (81 of 224), and 39.7% (91 of 229), respectively, at 10 weeks. The upper limit of the one-sided 97.5% confidence interval for the difference in 2-week mortality was 4.2 percentage points for the oral-regimen group versus the 2-week amphotericin B groups and 8.1 percentage points for the 1-week amphotericin B groups versus the 2-week amphotericin B groups, both of which were below the predefined 10-percentage-point noninferiority margin. As a partner drug with amphotericin B, flucytosine was superior to fluconazole (71 deaths [31.1%] vs. 101 deaths [45.0%]; hazard ratio for death at 10 weeks, 0.62; 95% confidence interval [CI], 0.45 to 0.84; P = 0.002). One week of amphotericin B plus flucytosine was associated with the lowest 10-week mortality (24.2%; 95% CI, 16.2 to 32.1). Side effects, such as severe anemia, were more frequent with 2 weeks than with 1 week of amphotericin B or with the oral regimen. CONCLUSIONS One week of amphotericin B plus flucytosine and 2 weeks of fluconazole plus flucytosine were effective as induction therapy for cryptococcal meningitis in resourcelimited settings.	[Molloy, S. F.; Loyse, A.; Stone, N.; Karunaharan, N.; Adams, J.; Bicanic, T.; Harrison, T. S.] St Georges Univ London, Inst Infect & Immun, Ctr Global Hlth, London, England; [Heyderman, R. S.] UCL, London, England; [Bradley, J.] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London, England; [Chen, T.; Lalloo, D. G.; Wang, D.; Jaffar, S.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Kanyama, C.; Chawinga, C.; Van der Horst, Charles; Hosseinipour, M. C.; Harrison, T. S.] Univ North Carolina Project, Kamuzu Cent Hosp, Lilongwe, Malawi; [Heyderman, R. S.; Kalata, N.; Gaskell, K.; Peirse, M.; Ellis, J.] Liverpool Wellcome Trust Clin Res Programm, Liverpool, Merseyside, England; [Heyderman, R. S.; Kalata, N.; Gaskell, K.; Peirse, M.; Ellis, J.] Univ Malawi, Coll Med, Blantyre, Malawi; [Chan, A. K.; Bright, P.; Lupiya, D.; van Oosterhout, J. J.] Zomba Cent Hosp, Dignitas Int, Zomba, Malawi; [Kouanfack, C.] Univ Dschang, Dschang, Cameroon; [Kouanfack, C.; Lontsi, S.; Ndong, J. -G.; Sini, V.] Agence Natl Rech Sida, Hop Cent Yaounde Site, Yaounde, Cameroon; [Temfack, E.; Mapoure, Y. N.] Douala Gen Hosp, Douala, Cameroon; [Chanda, D.; Stone, N.; Karunaharan, N.; Bright, P.] Inst Med Res & Training, Lusaka, Zambia; [Chanda, D.; Lakhi, S.; Stone, N.; Karunaharan, N.; Bright, P.] Univ Teaching Hosp, Lusaka, Zambia; [Mwaba, P.] Lusaka Apex Med Univ, Dept Internal Med, Lusaka, Zambia; [Mwaba, P.] Lusaka Apex Med Univ, Directorate Res & Postgrad Studies, Lusaka, Zambia; [Mfinanga, S.; Lesikari, S.] Natl Inst Med Res, Muhimbili Med Res Ctr, Dar Es Salaam, Tanzania; [Temfack, E.; Lortholary, O.] Inst Pasteur, Mol Mycol Unit, Paris, France; [Lortholary, O.] Paris Descartes Univ, Necker Pasteur Ctr Infect Dis & Trop Med, AP HP, IHU Imagine, Paris, France; [Chan, A. K.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med, Div Infect Dis, Toronto, ON, Canada; [Van der Horst, Charles; Hosseinipour, M. C.] Univ N Carolina, Chapel Hill, NC USA	St Georges University London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; Liverpool School of Tropical Medicine; University of Malawi; University of Zambia; National Institute of Medical Research; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of North Carolina; University of North Carolina Chapel Hill	Harrison, TS (corresponding author), Univ North Carolina Project, Kamuzu Cent Hosp, Lilongwe, Malawi.	tharriso@sgul.ac.uk	Temfack, Elvis/R-1717-2016; Mwaba, Peter/V-6017-2019; Kalata, Newton/N-7071-2019; Chanda, Duncan/N-1045-2019	Temfack, Elvis/0000-0001-8189-6555; Kalata, Newton/0000-0003-1715-8093; Molloy, Sile/0000-0001-8847-2325; Bicanic, Tihana/0000-0002-2676-838X; Ellis, Jayne/0000-0002-7009-9144; Jaffar, Shabbar/0000-0002-9615-1588; Loyse, Angela/0000-0001-7853-1344; Bright, Philip/0000-0002-7373-5038; Harrison, Thomas/0000-0003-3619-4348; Lalloo, David/0000-0001-7680-2200; Gaskell, Katherine M/0000-0003-4691-6359; Bradley, John/0000-0002-9449-4608; Heyderman, Robert/0000-0003-4573-449X; Kivuyo, Sokoine Lesikari/0000-0003-2257-5254; Wang, Duolao/0000-0003-2788-2464	Medical Research Council, United Kingdom [100504]; French Agency for Research on AIDS and Viral Hepatitis (ANRS) [ANRS12275]; Wellcome Trust UK; the National Institute of Allergy and Infectious Diseases, National Institutes of Health [2 P30-AI50410-14]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER; MRC [G1100814] Funding Source: UKRI	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); French Agency for Research on AIDS and Viral Hepatitis (ANRS)(ANRSFrench National Research Agency (ANR)); Wellcome Trust UK(Wellcome Trust); the National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by grants from the Medical Research Council, United Kingdom (100504) and the French Agency for Research on AIDS and Viral Hepatitis (ANRS) (ANRS12275), a strategic award from the Wellcome Trust UK (to the Malawi-Liverpool-Wellcome Clinical Research Programme), and a grant from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (2 P30-AI50410-14 to the University of North Carolina Center for AIDS Research, with support to Dr. van der Horst). Some of the diagnostic lateral-flow cryptococcal antigen tests used in the trial were donated by IMMY.	Beardsley J, 2016, NEW ENGL J MED, V374, P542, DOI 10.1056/NEJMoa1509024; Bicanic T, 2015, ANTIMICROB AGENTS CH, V59, P7224, DOI 10.1128/AAC.01698-15; Bicanic T, 2009, CLIN INFECT DIS, V49, P702, DOI 10.1086/604716; Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0; Day JN, 2013, NEW ENGL J MED, V368, P2522, DOI [10.1056/NEJMc1305981, 10.1056/NEJMoa1110404]; Durski KN, 2013, JAIDS-J ACQ IMM DEF, V63, pE101, DOI 10.1097/QAI.0b013e31828e1e56; Gaskell KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110285; Harsanyi A, 2017, ORG PROCESS RES DEV, V21, P273, DOI 10.1021/acs.oprd.6b00420; Jackson AT, 2012, AIDS, V26, P1363, DOI 10.1097/QAD.0b013e328354b419; Jarvis J. N., 2017, C RETR OPP INF SEATT; Jarvis JN, 2014, CLIN INFECT DIS, V58, P736, DOI 10.1093/cid/cit794; Jarvis JN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-67; Leeme T., 2017, P C RETROVIRUSES OPP; Lestner J, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00090-17, 10.1128/aac.00090-17]; Livermore J, 2014, MBIO, V5, DOI 10.1128/mBio.00725-13; Longley N, 2008, CLIN INFECT DIS, V47, P1556, DOI 10.1086/593194; Loyse A, 2013, J ANTIMICROB CHEMOTH, V68, P2435, DOI 10.1093/jac/dkt221; Loyse A, 2013, LANCET INFECT DIS, V13, P629, DOI 10.1016/S1473-3099(13)70078-1; Molloy SF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005575; Muzoora CK, 2012, J INFECTION, V64, P76, DOI 10.1016/j.jinf.2011.10.014; Nussbaum JC, 2010, CLIN INFECT DIS, V50, P338, DOI 10.1086/649861; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Rajasingham R, 2017, LANCET INFECT DIS, V17, P873, DOI [10.1016/S1473-3099(17)30243-8, 10.1016/s1473-3099(17)30243-8]; Siddiqi OK, 2014, CLIN INFECT DIS, V58, P1771, DOI 10.1093/cid/ciu191; Tenforde MW, 2017, CLIN INFECT DIS, V65, P779, DOI 10.1093/cid/cix430; TURNIDGE JD, 1994, J ANTIMICROB CHEMOTH, V34, P83, DOI 10.1093/jac/34.1.83; Wall EC, 2014, CLIN INFECT DIS, V58, pE137, DOI 10.1093/cid/ciu057; World Health Organization, 2011, RAP ADV DIAGN PREV M	29	180	187	5	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2018	378	11					1004	1017		10.1056/NEJMoa1710922	http://dx.doi.org/10.1056/NEJMoa1710922			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ2HT	29539274	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000427399000006
J	Roybal, KT				Roybal, Kole T.			Refining cell therapy	SCIENCE			English	Editorial Material							SYNTHETIC NOTCH RECEPTORS; T-CELLS		[Roybal, Kole T.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Roybal, KT (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	kole.roybal@ucsf.edu						Morsut L, 2016, CELL, V164, P780, DOI 10.1016/j.cell.2016.01.012; Roybal KT, 2016, CELL, V167, P419, DOI 10.1016/j.cell.2016.09.011; Roybal KT, 2016, CELL, V164, P770, DOI 10.1016/j.cell.2016.01.011	3	4	4	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2018	359	6380					1112	1113		10.1126/science.aat0962	http://dx.doi.org/10.1126/science.aat0962			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY4ZM	29590036				2022-12-28	WOS:000426835900033
J	Pinto-Teixeira, F; Koo, C; Rossi, AM; Neriec, N; Bertet, C; Li, X; Del-Valle-Rodriguez, A; Desplan, C				Pinto-Teixeira, Filipe; Koo, Clara; Rossi, Anthony Michael; Neriec, Nathalie; Bertet, Claire; Li, Xin; Del-Valle-Rodriguez, Alberto; Desplan, Claude			Development of Concurrent Retinotopic Maps in the Fly Motion Detection Circuit	CELL			English	Article							NEURONAL CELL FATE; OPTIC LOBE; DROSOPHILA-MELANOGASTER; ASYMMETRIC SEGREGATION; NEUROBLAST LINEAGES; NERVOUS-SYSTEM; DAUGHTER CELL; SELF-RENEWAL; NOTCH; PROSPERO	Understanding how complex brain wiring is produced during development is a daunting challenge. In Drosophila, information from 800 retinal ommatidia is processed in distinct brain neuropiles, each subdivided into 800 matching retinotopic columns. The lobula plate comprises four T4 and four T5 neuronal subtypes. T4 neurons respond to bright edge motion, whereas T5 neurons respond to dark edge motion. Each is tuned to motion in one of the four cardinal directions, effectively establishing eight concurrent retinotopic maps to support wide-field motion. We discovered a mode of neurogenesis where two sequential Notch-dependent divisions of either a horizontal or a vertical progenitor produce matching sets of two T4 and two T5 neurons retinotopically coincident with pairwise opposite direction selectivity. We show that retinotopy is an emergent characteristic of this neurogenic program and derives directly from neuronal birth order. Our work illustrates how simple developmental rules can implement complex neural organization.	[Pinto-Teixeira, Filipe; Neriec, Nathalie; Del-Valle-Rodriguez, Alberto; Desplan, Claude] New York Univ Abu Dhabi, Ctr Genom & Syst Biol, Abu Dhabi, U Arab Emirates; [Pinto-Teixeira, Filipe; Koo, Clara; Rossi, Anthony Michael; Bertet, Claire; Li, Xin; Desplan, Claude] NYU, Dept Biol, New York, NY 10003 USA; [Bertet, Claire] CNRS, IBDM, Campus Luminy, F-13288 Marseille 9, France; [Li, Xin] Univ Illinois, Coll Liberal Arts & Sci, Sch MCB, Urbana, IL 61820 USA	New York University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Illinois System; University of Illinois Urbana-Champaign	Desplan, C (corresponding author), New York Univ Abu Dhabi, Ctr Genom & Syst Biol, Abu Dhabi, U Arab Emirates.; Desplan, C (corresponding author), NYU, Dept Biol, New York, NY 10003 USA.	cd38@nyu.edu	; Li, Xin/D-3421-2013	Desplan, Claude/0000-0002-6914-1413; Rossi, Anthony/0000-0001-9345-7939; Sousa, Filipe/0000-0002-9960-0035; Li, Xin/0000-0002-3428-3569	Center for Genomics and Systems Biology of NYU Abu Dhabi; NIH [R01 EY017916]; CGSB at NYUAD; EMBO [ALTF 680-2009]; HFSPO [LT000077/2010-L]; NATIONAL EYE INSTITUTE [R01EY017916, P30EY013079] Funding Source: NIH RePORTER	Center for Genomics and Systems Biology of NYU Abu Dhabi; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CGSB at NYUAD; EMBO(European Molecular Biology Organization (EMBO)); HFSPO(Human Frontier Science Program); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We would like to dedicate this manuscript to the memory of Jean-Philippe Grossier with whom we had extensive discussions on the establishment of retinotopy. We would like to acknowledge Laura Quintana-Rio for help in building the 3D model of the developing optic lobe; Chris Doe and Cheng-Yu Lee for sharing reagents and suggestions for improving the antibody staining protocol; and Sarah Bennert for help with the elaboration of the illustrations. We also thank the fly community, especially the Doe lab and Janelia for gifts of antibodies and fly stocks and the Desplan laboratory members for essential discussion and support. This work was supported by the Center for Genomics and Systems Biology of NYU Abu Dhabi and an NIH grant (R01 EY017916 to C.D.). F. P.-T., N.N., and A.D.-V.-R. were supported by the CGSB at NYUAD, and C.B. was supported by fellowships from EMBO (ALTF 680-2009) and HFSPO (LT000077/2010-L).	Almeida MS, 2005, MECH DEVELOP, V122, P1282, DOI 10.1016/j.mod.2005.08.004; Apitz H., 2018, BIORXIV; Apitz H, 2015, NAT NEUROSCI, V18, P46, DOI 10.1038/nn.3896; BAUSENWEIN B, 1992, CELL TISSUE RES, V267, P17, DOI 10.1007/BF00318687; Behnia R, 2014, NATURE, V512, P427, DOI 10.1038/nature13427; Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5; Bertet C, 2014, CELL, V158, P1173, DOI 10.1016/j.cell.2014.07.045; Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Buescher M, 1998, GENE DEV, V12, P1858, DOI 10.1101/gad.12.12.1858; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; Clark DA, 2011, NEURON, V70, P1165, DOI 10.1016/j.neuron.2011.05.023; Doe CQ, 2017, ANNU REV CELL DEV BI, V33, P219, DOI 10.1146/annurev-cellbio-111315-125210; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; Egger B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-1; Egger B, 2010, DEVELOPMENT, V137, P2981, DOI 10.1242/dev.051250; Eichner H, 2011, NEURON, V70, P1155, DOI 10.1016/j.neuron.2011.03.028; Endo K, 2007, NAT NEUROSCI, V10, P153, DOI 10.1038/nn1832; Erclik T, 2017, NATURE, V541, P365, DOI 10.1038/nature20794; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Fisher YE, 2015, NEURON, V88, P390, DOI 10.1016/j.neuron.2015.09.033; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; Haag J, 2017, ELIFE, V6, DOI 10.7554/eLife.29044; Hassan BA, 2015, CELL, V163, P285, DOI 10.1016/j.cell.2015.09.031; Hiesinger PR, 2006, CURR BIOL, V16, P1835, DOI 10.1016/j.cub.2006.07.047; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; HOFBAUER A, 1990, ROUX ARCH DEV BIOL, V198, P264, DOI 10.1007/BF00377393; Homem CCF, 2012, DEVELOPMENT, V139, P4297, DOI 10.1242/dev.080515; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Joesch M, 2013, J NEUROSCI, V33, P902, DOI 10.1523/JNEUROSCI.3374-12.2013; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; Karcavich R, 2005, J COMP NEUROL, V481, P240, DOI 10.1002/cne.20371; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Kohwi M, 2013, NAT REV NEUROSCI, V14, P823, DOI 10.1038/nrn3618; Kolodkin AL, 2017, CURR OPIN NEUROBIOL, V42, P128, DOI 10.1016/j.conb.2016.12.006; Lai SL, 2014, ELIFE, V3, DOI 10.7554/eLife.03363; Langen M, 2015, CELL, V162, P120, DOI 10.1016/j.cell.2015.05.055; Leong JCS, 2016, J NEUROSCI, V36, P8078, DOI 10.1523/JNEUROSCI.1272-16.2016; Li X, 2013, CURR TOP DEV BIOL, V105, P69, DOI 10.1016/B978-0-12-396968-2.00003-8; Li X, 2013, NATURE, V498, P456, DOI 10.1038/nature12319; Maisak MS, 2013, NATURE, V500, P212, DOI 10.1038/nature12320; Mauss AS, 2015, CELL, V162, P351, DOI 10.1016/j.cell.2015.06.035; Mauss AS, 2014, J NEUROSCI, V34, P2254, DOI 10.1523/JNEUROSCI.3938-13.2014; Mora N, 2018, DEV CELL, V45, P53, DOI 10.1016/j.devcel.2018.02.023; Morante J, 2004, SEMIN CELL DEV BIOL, V15, P137, DOI 10.1016/j.semcdb.2003.09.007; Morante J, 2008, CURR BIOL, V18, P553, DOI 10.1016/j.cub.2008.02.075; Nassif C, 2003, J COMP NEUROL, V455, P417, DOI 10.1002/cne.10482; Nern A, 2015, P NATL ACAD SCI USA, V112, pE2967, DOI 10.1073/pnas.1506763112; Ngo KT, 2017, DEV BIOL, V428, P1, DOI 10.1016/j.ydbio.2017.05.008; Ngo KT, 2010, DEV BIOL, V346, P284, DOI 10.1016/j.ydbio.2010.07.036; Oliva C, 2014, NEURAL DEV, V9, DOI 10.1186/1749-8104-9-4; Reddy BVVG, 2010, DEVELOPMENT, V137, P2397, DOI 10.1242/dev.050013; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Rossi AM, 2017, CURR OPIN NEUROBIOL, V42, P84, DOI 10.1016/j.conb.2016.11.010; Sato M, 2016, P NATL ACAD SCI USA, V113, pE5153, DOI 10.1073/pnas.1602739113; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; Silies M, 2013, NEURON, V79, P111, DOI 10.1016/j.neuron.2013.04.029; Southall TD, 2009, EMBO J, V28, P3799, DOI 10.1038/emboj.2009.309; Strother JA, 2017, NEURON, V94, P168, DOI 10.1016/j.neuron.2017.03.010; Takemura SY, 2008, J COMP NEUROL, V509, P493, DOI 10.1002/cne.21757; Takemura SY, 2017, ELIFE, V6, DOI 10.7554/eLife.24394; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Truman JW, 2010, DEVELOPMENT, V137, P53, DOI 10.1242/dev.041749; Ulvklo C, 2012, DEVELOPMENT, V139, P678, DOI 10.1242/dev.074500; Wan Y, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1694-9; Wang HY, 2007, NATURE, V449, P96, DOI 10.1038/nature06056; Yu HH, 2009, NAT NEUROSCI, V12, P947, DOI 10.1038/nn.2345; Zacharioudaki E, 2014, METHODS, V68, P173, DOI 10.1016/j.ymeth.2014.03.029	71	38	38	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 5	2018	173	2					485	+	498.e1	10.1016/j.cell.2018.02.053	http://dx.doi.org/10.1016/j.cell.2018.02.053			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GB8IS	29576455	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000429320200020
J	Gunsalus, CK; Marcus, AR; Oransky, I				Gunsalus, C. K.; Marcus, Adam R.; Oransky, Ivan			Institutional Research Misconduct Reports NeedMore Credibility	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gunsalus, C. K.] Univ Illinois, Natl Ctr Profess & Res Eth, Champaign, IL USA; [Marcus, Adam R.; Oransky, Ivan] Ctr Sci Integr, New York, NY USA; [Oransky, Ivan] NYU, Arthur Carter Journalism Inst, 20 Cooper Sq,Sixth Floor, New York, NY 10003 USA	University of Illinois System; University of Illinois Urbana-Champaign; New York University	Oransky, I (corresponding author), NYU, Arthur Carter Journalism Inst, 20 Cooper Sq,Sixth Floor, New York, NY 10003 USA.	oransi01@nyu.edu	Gunsalus, C.K./R-2381-2019; Oransky, Ivan/J-9412-2019	Gunsalus, C.K./0000-0003-4018-533X; Oransky, Ivan/0000-0002-0746-9288				Davidoff F, 2010, JAMA-J AM MED ASSOC, V304, P206, DOI 10.1001/jama.2010.972; Hornyak T., 2016, NAT INDEX; Institute of Medicine, 2012, EVOLUTION TRANSLATIO, P122; National Academies of Sciences Engineering and Medicine, 2017, FOST INT RES; U.S. Department of Health and Human Services (HHS), 2005, Fed Regist, V70, P28369; Valdesolo P, 2007, PSYCHOL SCI, V18, P689, DOI 10.1111/j.1467-9280.2007.01961.x	6	24	24	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2018	319	13					1315	1316		10.1001/jama.2018.0358	http://dx.doi.org/10.1001/jama.2018.0358			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB4NC	29532069				2022-12-28	WOS:000429035900009
J	White, WB; Saag, KG; Becker, MA; Borer, JS; Gorelick, PB; Whelton, A; Hunt, B; Castillo, M; Gunawardhana, L				White, William B.; Saag, Kenneth G.; Becker, Michael A.; Borer, Jeffrey S.; Gorelick, Philip B.; Whelton, Andrew; Hunt, Barbara; Castillo, Majin; Gunawardhana, Lhanoo		CARES Investigators	Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							XANTHINE-OXIDASE INHIBITION; CLINICAL-TRIALS; HEART-FAILURE; HYPERURICEMIA; MORTALITY; DISEASE; EVENTS; IMPACT; URATE; RISK	BACKGROUND Cardiovascular risk is increased in patients with gout. We compared cardiovascular outcomes associated with febuxostat, a nonpurine xanthine oxidase inhibitor, with those associated with allopurinol, a purine base analogue xanthine oxidase inhibitor, in patients with gout and cardiovascular disease. METHODS We conducted a multicenter, double-blind, noninferiority trial involving patients with gout and cardiovascular disease; patients were randomly assigned to receive febuxostat or allopurinol and were stratified according to kidney function. The trial had a prespecified noninferiority margin of 1.3 for the hazard ratio for the primary end point (a composite of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, or unstable angina with urgent revascularization). RESULTS In total, 6190 patients underwent randomization, received febuxostat or allopurinol, and were followed for a median of 32 months (maximum, 85 months). The trial regimen was discontinued in 56.6% of patients, and 45.0% discontinued follow-up. In the modified intention-to-treat analysis, a primary end-point event occurred in 335 patients (10.8%) in the febuxostat group and in 321 patients (10.4%) in the allopurinol group (hazard ratio, 1.03; upper limit of the one-sided 98.5% confidence interval [CI], 1.23; P = 0.002 for noninferiority). All-cause and cardiovascular mortality were higher in the febuxostat group than in the allopurinol group (hazard ratio for death from any cause, 1.22 [95% CI, 1.01 to 1.47]; hazard ratio for cardiovascular death, 1.34 [95% CI, 1.03 to 1.73]). The results with regard to the primary end point and all-cause and cardiovascular mortality in the analysis of events that occurred while patients were being treated were similar to the results in the modified intention-to-treat analysis. CONCLUSIONS In patients with gout and major cardiovascular coexisting conditions, febuxostat was noninferior to allopurinol with respect to rates of adverse cardiovascular events. Allcause mortality and cardiovascular mortality were higher with febuxostat than with allopurinol. (Funded by Takeda Development Center Americas; CARES ClinicalTrials. gov number, NCT01101035.)	[White, William B.] Univ Connecticut, Sch Med, Farmington, CT 06032 USA; [Saag, Kenneth G.] Univ Alabama Birmingham, Birmingham, AL USA; [Becker, Michael A.] Univ Chicago Med, Chicago, IL USA; [Hunt, Barbara; Castillo, Majin; Gunawardhana, Lhanoo] Takeda Dev Ctr Amer, Deerfield, IL USA; [Borer, Jeffrey S.] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA; [Gorelick, Philip B.] Michigan State Univ, Coll Human Med, Grand Rapids, MI USA; [Whelton, Andrew] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	University of Connecticut; University of Alabama System; University of Alabama Birmingham; Takeda Pharmaceutical Company Ltd; Takeda Development Center Americas, Inc.; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Michigan State University; Michigan State University College of Human Medicine; Johns Hopkins University	White, WB (corresponding author), Univ Connecticut, Sch Med, Calhoun Cardiol Ctr, 263 Farmington Ave, Farmington, CT 06032 USA.	wwhite@uchc.edu		Abud-Mendoza, Carlos/0000-0002-3749-5831; Esquivel-Valerio, Jorge/0000-0002-3124-0395	Takeda Development Center Americas	Takeda Development Center Americas	Funded by Takeda Development Center Americas	[Anonymous], 2008, FDA ANN NEW REC EV C; Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; Choi HK, 2007, CIRCULATION, V116, P894, DOI 10.1161/CIRCULATIONAHA.107.703389; Foody J, 2017, AM HEALTH DRUG BENEF, V10, P393; Grewal HK, 2014, EXPERT OPIN DRUG MET, V10, P747, DOI 10.1517/17425255.2014.904285; Hicks KA, 2015, CIRCULATION, V132, P302, DOI 10.1161/CIR.0000000000000156; Hou MX, 2006, J CARDIOVASC PHARM, V48, P255, DOI 10.1097/01.fjc.0000249961.61451.da; Khanna D, 2012, ARTHRIT CARE RES, V64, P1447, DOI 10.1002/acr.21773; Kiltz U, 2017, ANN RHEUM DIS, V76, DOI 10.1136/annrheumdis-2016-209467; Krishnan E, 2008, ARCH INTERN MED, V168, P1104, DOI 10.1001/archinte.168.10.1104; Krishnan E, 2010, RHEUMATOLOGY, V49, P1229, DOI 10.1093/rheumatology/keq037; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Roddy E, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3199; Sanchez-Lozada LG, 2008, AM J PHYSIOL-RENAL, V294, pF710, DOI 10.1152/ajprenal.00454.2007; Schumacher HR, 2009, RHEUMATOLOGY, V48, P188, DOI 10.1093/rheumatology/ken457; Schumacher HR, 2008, ARTHRIT RHEUM-ARTHR, V59, P1540, DOI 10.1002/art.24209; Singh JA, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0513-6; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; Wei L, 2011, BRIT J CLIN PHARMACO, V71, P600, DOI 10.1111/j.1365-2125.2010.03887.x; White WB, 2012, AM HEART J, V164, P14, DOI 10.1016/j.ahj.2012.04.011; Xu X, 2008, J CARD FAIL, V14, P746, DOI 10.1016/j.cardfail.2008.06.006; Zhao L, 2008, LIFE SCI, V82, P495, DOI 10.1016/j.lfs.2007.12.010	22	401	442	18	78	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2018	378	13					1200	1210		10.1056/NEJMoa1710895	http://dx.doi.org/10.1056/NEJMoa1710895			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GA8HN	29527974	Bronze			2022-12-28	WOS:000428580500006
J	Breeze, JD; Salvadori, E; Sathian, J; Alford, NM; Kay, CWM				Breeze, Jonathan D.; Salvadori, Enrico; Sathian, Juna; Alford, Neil McN.; Kay, Christopher W. M.			Continuous-wave room-temperature diamond maser	NATURE			English	Article							ELECTRON-SPIN-RESONANCE; SOLID-STATE MASER; NITROGEN; CENTERS	The maser-the microwave progenitor of the optical laser-has been confined to relative obscurity owing to its reliance on cryogenic refrigeration and high-vacuum systems. Despite this, it has found application in deep-space communications and radio astronomy owing to its unparalleled performance as a low-noise amplifier and oscillator. The recent demonstration of a room-temperature solid-state maser that utilizes polarized electron populations within the triplet states of photo-excited pentacene molecules in a p-terphenyl host(1-3) paves the way for a new class of maser. However,p-terphenyl has poor thermal and mechanical properties, and the decay rates of the triplet sublevel of pentacene mean that only pulsed maser operation has been observed in this system. Alternative materials are therefore required to achieve continuous emission: inorganic materials that contain spin defects, such as diamond(4-6) and silicon carbide(7), have been proposed. Here we report a continuous-wave room-temperature maser oscillator using optically pumped nitrogen-vacancy defect centres in diamond. This demonstration highlights the potential of room-temperature solid-state masers for use in a new generation of microwave devices that could find application in medicine, security, sensing and quantum technologies.	[Breeze, Jonathan D.; Sathian, Juna; Alford, Neil McN.] Imperial Coll London, Dept Mat, Exhibit Rd, London SW7 2AZ, England; [Breeze, Jonathan D.; Alford, Neil McN.] Imperial Coll London, London Ctr Nanotechnol, Exhibit Rd, London SW7 2AZ, England; [Salvadori, Enrico; Kay, Christopher W. M.] UCL, Inst Struct & Mol Biol, Gower St, London WC1E 8BT, England; [Salvadori, Enrico; Kay, Christopher W. M.] London Ctr Nanotechnol, 17-19 Gordon St, London WC1H 0AH, England; [Salvadori, Enrico] Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England; [Kay, Christopher W. M.] Univ Saarland, Dept Chem, D-66123 Saarbrucken, Germany	Imperial College London; Imperial College London; University of London; University College London; University of London; Birkbeck University London; University College London; University of London; University College London; University of London; Queen Mary University London; Saarland University	Breeze, JD (corresponding author), Imperial Coll London, Dept Mat, Exhibit Rd, London SW7 2AZ, England.; Breeze, JD (corresponding author), Imperial Coll London, London Ctr Nanotechnol, Exhibit Rd, London SW7 2AZ, England.	jonathan.breeze@imperial.ac.uk	Kay, Christopher William Michael/C-2467-2008	Kay, Christopher William Michael/0000-0002-5200-6004; Breeze, Jonathan/0000-0002-3962-270X; Salvadori, Enrico/0000-0003-4394-9438; Sathian, Juna/0000-0002-6746-7110	UK Engineering and Physical Sciences Research Council [EP/K011987/1, EP/K011804/1]; Henry Royce Institute; Engineering and Physical Sciences Research Council [EP/K011804/1] Funding Source: researchfish; EPSRC [EP/P02520X/1, EP/K011987/1, EP/S000798/1, EP/F067828/1, EP/M020398/1, EP/K011804/1] Funding Source: UKRI	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Henry Royce Institute; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank J. Hall and M. Markham (Element 6 Ltd) for supplying the diamond samples, P. French and R. Taylor (Photonics Group at Imperial College London) for lending us their continuous-wave laser, and E. Bauch (Harvard University) for discussions. We also thank M. Lennon (IC), D. Halpin and D. Farquharson (UCL) for manufacturing the cavity components. This work was supported by the UK Engineering and Physical Sciences Research Council through grants EP/K011987/1 (IC) and EP/K011804/1 (UCL). We also acknowledge support from the Henry Royce Institute.	Aslam N, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/013064; Breeze J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7215; Breeze JD, 2017, NPJ QUANTUM INFORM, V3, DOI 10.1038/s41534-017-0041-3; Carmichael H. J., 2003, STAT METHODS QUANTUM; Childress L, 2006, SCIENCE, V314, P281, DOI 10.1126/science.1131871; Dimer F, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.013804; Doherty MW, 2013, PHYS REP, V528, P1, DOI 10.1016/j.physrep.2013.02.001; Gruber A, 1997, SCIENCE, V276, P2012, DOI 10.1126/science.276.5321.2012; Jarmola A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.197601; Jin L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9251; Kajfez D., 1964, DIELECTRIC RESONATOR; Kraus H, 2014, NAT PHYS, V10, P157, DOI [10.1038/NPHYS2826, 10.1038/nphys2826]; LOUBSER J, 1978, REP PROG PHYS, V41, P1201, DOI 10.1088/0034-4885/41/8/002; Manson NB, 2005, DIAM RELAT MATER, V14, P1705, DOI 10.1016/j.diamond.2005.06.027; Maze JR, 2008, NATURE, V455, P644, DOI 10.1038/nature07279; Oxborrow M, 2012, NATURE, V488, P353, DOI 10.1038/nature11339; Poklonski NA, 2007, CHINESE PHYS LETT, V24, P2088, DOI 10.1088/0256-307X/24/7/083; Poklonski NA, 2004, JETP LETT+, V80, P748, DOI 10.1134/1.1868799; Robledo L, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/025013; Salvadori E, 2017, SCI REP-UK, V7, DOI 10.1038/srep41836; SCHAWLOW AL, 1958, PHYS REV, V112, P1940, DOI 10.1103/PhysRev.112.1940; Siegman A., 1964, MICROWAVE SOLID STAT; SMITH WV, 1959, PHYS REV, V115, P1546, DOI 10.1103/PhysRev.115.1546; SOROKIN PP, 1960, PHYS REV, V118, P939, DOI 10.1103/PhysRev.118.939; Takahashi S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.047601; TAVIS M, 1968, PHYS REV, V170, P379, DOI 10.1103/PhysRev.170.379; Taylor J.M., 2008, NAT PHYS, V7, P270; Wee TL, 2007, J PHYS CHEM A, V111, P9379, DOI 10.1021/jp073938o; Yavkin BV, 2016, J MAGN RESON, V262, P15, DOI 10.1016/j.jmr.2015.11.005	29	80	82	12	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2018	555	7697					493	+		10.1038/nature25970	http://dx.doi.org/10.1038/nature25970			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ9NF	29565362	Green Submitted, Green Accepted			2022-12-28	WOS:000427937900047
J	Devi, G				Devi, Gayatri			Alzheimer's Disease in Physicians - Assessing Professional Competence and Tempering Stigma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Devi, Gayatri] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA; [Devi, Gayatri] Lenox Hill Hosp, Dept Neurol, New York, NY 10021 USA; [Devi, Gayatri] Lenox Hill Hosp, Dept Psychiat, New York, NY 10021 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Northwell Health; Northwell Health	Devi, G (corresponding author), Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA.; Devi, G (corresponding author), Lenox Hill Hosp, Dept Neurol, New York, NY 10021 USA.; Devi, G (corresponding author), Lenox Hill Hosp, Dept Psychiat, New York, NY 10021 USA.							Ferreira D, 2017, SCI REP-UK, V7, DOI 10.1038/srep46263; Katz MJ, 2012, ALZ DIS ASSOC DIS, V26, P335, DOI 10.1097/WAD.0b013e31823dbcfc; Morris JC, 2012, ARCH NEUROL-CHICAGO, V69, P700, DOI 10.1001/archneurol.2011.3152; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Turnbull J, 2006, ACAD MED, V81, P915, DOI 10.1097/01.ACM.0000238194.55648.b2	5	10	10	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2018	378	12					1073	1075		10.1056/NEJMp1716381	http://dx.doi.org/10.1056/NEJMp1716381			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ9OV	29562159				2022-12-28	WOS:000427942300001
J	Haydel, M				Haydel, Micelle			In acute headache, the Ottawa Subarachnoid Hemorrhage rule had 100% sensitivity and 14% specificity	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Haydel, Micelle] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Haydel, M (corresponding author), Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA 70112 USA.							Carpenter CR, 2016, ACAD EMERG MED, V23, P963, DOI 10.1111/acem.12984; Finnerty NM, 2015, ACAD EMERG MED, V22, P1406, DOI 10.1111/acem.12828; Sayer D, 2015, ACAD EMERG MED, V22, P1267, DOI 10.1111/acem.12811	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2018	168	6					JC35	JC35		10.7326/ACPJC-2018-168-6-035	http://dx.doi.org/10.7326/ACPJC-2018-168-6-035			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ8AM	29554673				2022-12-28	WOS:000427827400012
J	Clark, H				Clark, Helen			Report card shows gender is missing in global health	LANCET			English	Editorial Material									[Clark, Helen] Helen Clark Fdn, POB 56014,Dominion Rd, Auckland 1446, New Zealand		Clark, H (corresponding author), Helen Clark Fdn, POB 56014,Dominion Rd, Auckland 1446, New Zealand.	helenclark.invites@gmail.com			Global Health 50/50	Global Health 50/50	I am a member of the Advisory Council of Global Health 50/50, and was supported by Global Health 50/50 in the preparation of this Comment. I declare no other competing interests.	Global Health 50/50, 2018, GLOB HLTH 50 50 REP; *GOV IC, 2018, NEW IC LAW EQ PAY CE; Hawkes S, 2013, LANCET, V381, P1783, DOI 10.1016/S0140-6736(13)60253-6; Payne S., 2006, HLTH MEN WOMEN; *UN, INT C POP DEV 1994 P; WHO, 2018, LEG BAC LIM COUNTR; World Economic Forum, GLOB GEND PAY GAP RE; World Health Statistics, 2017, WORLD HLTH STAT 2017	8	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 10	2018	391	10124					918	920		10.1016/S0140-6736(18)30428-8	http://dx.doi.org/10.1016/S0140-6736(18)30428-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ1UN	29525408				2022-12-28	WOS:000427363100009
J	Al-Butmeh, S; Al-Khataib, N				Al-Butmeh, Suha; Al-Khataib, Njah			Mental health and quality of life of elderly people in the Bethlehem district: a cross-sectional study	LANCET			English	Meeting Abstract	8th Lancet-Palestinian-Health-Alliance (LPHA) Conference	MAR 15-16, 2017	Birzeit Univ, Birzeit, PALESTINE	Inst Community & Publ Hlth, Lancet Palestinian Hlth Alliance	Birzeit Univ				[Al-Butmeh, Suha] Al Quds Univ, Med Technol Dept, Fac Hlth Profess, Jerusalem, Israel; [Al-Khataib, Njah] Al Quds Univ, Fac Publ Hlth, Community Mental Hlth Dept, Jerusalem, Israel			salbutmeh@staff.alquds.edu							0	8	10	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 21	2018	391			2			46	46						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	FY0BD	29553446				2022-12-28	WOS:000426474000047
J	Wilson, ML; Fleming, KA; Kuti, MA; Looi, LM; Lago, N; Ru, K				Wilson, Michael L.; Fleming, Kenneth A.; Kuti, Modupe A.; Looi, Lai Meng; Lago, Nestor; Ru, Kun			Pathology and laboratory medicine in low-income and middle-income countries 1: Access to pathology and laboratory medicine services: a crucial gap	LANCET			English	Article							FECAL OCCULT BLOOD; CERVICAL-CANCER; COST-EFFECTIVENESS; HEALTH SYSTEMS; GLOBAL HEALTH; QUALITY; AFRICA; DNA; DISEASE; ACCREDITATION	As global efforts accelerate to implement the Sustainable Development Goals and, in particular, universal health coverage, access to high-quality and timely pathology and laboratory medicine (PALM) services will be needed to support health-care systems that are tasked with achieving these goals. This access will be most challenging to achieve in low-income and middle-income countries (LMICs), which have a disproportionately large share of the global burden of disease but a disproportionately low share of global health-care resources, particularly PALM services. In this first in a Series of three papers on PALM in LMICs, we describe the crucial and central roles of PALM services in the accurate diagnosis and detection of disease, informing prognosis and guiding treatment, contributing to disease screening, public health surveillance and disease registries, and supporting medical-legal systems. We also describe how, even though data are sparse, these services are of both insufficient scope and inadequate quality to play their key role in health-care systems in LMICs. Lastly, we identify four key barriers to the provision of optimal PALM services in resource-limited settings: insufficient human resources or workforce capacity, inadequate education and training, inadequate infrastructure, and insufficient quality, standards, and accreditation.	[Wilson, Michael L.] Denver Hlth, Dept Pathol & Lab Serv, Denver, CO 80204 USA; [Wilson, Michael L.] Univ Colorado, Dept Pathol, Sch Med, Aurora, CO USA; [Fleming, Kenneth A.] NCI, Ctr Global Hlth, Rockville, MD USA; [Fleming, Kenneth A.] Univ Oxford, Green Templeton Coll, Oxford, England; [Kuti, Modupe A.] Univ Ibadan, Dept Chem Pathol, Coll Med, Univ Coll Hosp, Ibadan, Nigeria; [Looi, Lai Meng] Univ Malaya, Dept Pathol, Fac Med, Kuala Lumpur, Malaysia; [Lago, Nestor] Univ Buenos Aires, Dept Pathol, Buenos Aires, DF, Argentina; [Ru, Kun] Chinese Acad Med Sci, Dept Pathol & Lab Med, Inst Hematol, Tianjin, Peoples R China	Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oxford; University of Ibadan; University College Hospital, Ibadan; Universiti Malaya; University of Buenos Aires; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS	Wilson, ML (corresponding author), Denver Hlth, Dept Pathol & Lab Serv, Denver, CO 80204 USA.	michael.wilson@dhha.org	Looi, Lai Meng/AAB-9403-2019; Looi, Lai Meng/A-3382-2009	Looi, Lai Meng/0000-0001-8325-0117; Looi, Lai Meng/0000-0001-8325-0117; Fleming, Kenneth/0000-0002-3200-1302; Kuti, Modupe/0000-0001-7574-1450; Quinn, James/0000-0002-3694-2118	National Cancer Institute, National Institutes of Health; National Cancer Institute	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors gratefully acknowledge the assistance of Nick Wolf, Shannon Silkensen, and Bill Cherniak at the Center for Global Health, National Cancer Institute, National Institutes of Health, and the authors of the second and third papers in this Series for their thoughtful comments and suggestions. Funding for the initial writing meeting in January, 2017, in Oxford, UK, was provided by the National Cancer Institute, National Institutes of Health. Funding for the meeting with Dr Sabine Kleinert and the three reviewers in September, 2017, in Washington, DC, USA was also provided by the National Cancer Institute.	Alemnji GA, 2012, GLOB PUBLIC HEALTH, V7, P648, DOI 10.1080/17441692.2012.670861; Ali M, 2013, PLOS ONE, V8; American Board of Pathology, 2015, MAINTENANCE OF CERTI; American Board of Pathology, 2015, TO BECOME CERTIFIED; Amin M, 2005, SCAND J UROL NEPHROL, V39, P20, DOI 10.1080/03008880510030923; Amukele TK, 2015, AM J CLIN PATHOL, V143, P50, DOI 10.1309/AJCPCYA54DWZQPQT; [Anonymous], 2017, LANCET GLOB HEALTH, V5, pE115, DOI 10.1016/S2214-109X(17)30009-8; Arbyn M, 2016, J CLIN VIROL, V76, pS14, DOI 10.1016/j.jcv.2015.09.014; Association of American Medical Colleges, 2015, ACTIVE PHYSICIANS IN; Balajee SA, 2016, HEALTH SECUR, V14, P424, DOI 10.1089/hs.2015.0062; Branca M, 2015, ACTA CYTOL, V59, P361, DOI 10.1159/000441515; Brierley James D, 2013, Healthc Q, V16, P27; Broadhurst MJ, 2016, CLIN MICROBIOL REV, V29, P773, DOI 10.1128/CMR.00003-16; Canadian Resident Matching Service, 2016, 2016 R 1 MAIN RESIDE; Carozzi FM, 2016, J CLIN VIROL, V76, pS22, DOI 10.1016/j.jcv.2015.10.025; Carter JY, 2017, BIOCHEM MEDICA, V27, P97, DOI 10.11613/BM.2017.013; Carter JY, 2012, AFR J LAB MED, V1, DOI 10.4102/ajlm.v1i1.8; Centers for Disease Control and Prevention, 2014, FACTS ABOUT THE LABO; Centers for Medicare and Medicaid Services, 2017, CLIN LAB; Centre for International Economics, 2016, THE ECONOMIC VALUE O; Chan KCA, 2017, NEW ENGL J MED, V377, P513, DOI [10.1056/NEJMoa1701717, 10.1056/nejmoa1701717]; Chen C, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-4; Cox JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033685; Cross A, 2017, LANCET INFECT DIS, V17, P1005, DOI 10.1016/S1473-3099(17)30491-7; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; Dasgupta P, 2016, THE SHAMEFUL FRAILTY; Dawood S, 2010, J CLIN ONCOL, V28, P92, DOI 10.1200/JCO.2008.19.9844; Diabetes Collaborative Registry, 2017, TRANSFORMING THE FUT; Dzau V, 2017, NEW ENGL J MED, V377, P1292, DOI 10.1056/NEJMsr1707974; Ellis DW, 2016, VIRCHOWS ARCH, V468, P51, DOI 10.1007/s00428-015-1834-4; Fonjungo PN, 2012, J PUBLIC HEALTH POL, V33, P34, DOI 10.1057/jphp.2011.57; Fung MK, 2014, TECHNICAL MANUAL, V18th; General Medical Council, 2016, THE STATE OF MEDICAL; Gershy-Damet GM, 2010, AM J CLIN PATHOL, V134, P393, DOI 10.1309/AJCPTUUC2V1WJQBM; Gopal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070361; Hernandez B, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-38; Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x; Horton S, 2018, LANCET; Hsu CY, 2011, J FORMOS MED ASSOC, V110, P78, DOI 10.1016/S0929-6646(11)60013-2; Imperiale TF, 2004, NEW ENGL J MED, V351, P2704, DOI 10.1056/NEJMoa033403; Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI 10.1056/NEJMoa1311194; Institute of Medicine, 2015, IMPROVING DIAGNOSIS; International Standards Organization, 2014, MEDICAL LABORATORIES; Islam SMS, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/s12992-014-0081-9; Jamison DT, 2006, COST EFFECTIVE STRAT; Jin XW, 2016, J GEN INTERN MED, V31, P1338, DOI 10.1007/s11606-016-3772-5; Joint Commission International, 2016, ACCREDITATION STANDA; Kasvosve I, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-46; Kenya Accreditation Service, 2017, MEDICAL LABORATORIES; Khoury T, 2009, MODERN PATHOL, V22, P1457, DOI 10.1038/modpathol.2009.117; Kralievits Katherine E, 2015, Lancet, V385 Suppl 2, pS28, DOI 10.1016/S0140-6736(15)60823-6; Kuijpers CCHJ, 2014, J CLIN PATHOL, V67, P512, DOI 10.1136/jclinpath-2013-202122; Lee EY, 2016, ARCH PATHOL LAB MED, V140, P394, DOI 10.5858/arpa.2015-0381-ED; Lin JS, 2016, EVIDENCE SYNTHESIS, V135; Looi Lai-Meng, 2008, Malays J Pathol, V30, P1; Malaysian National Specialist Register, 2013, ANATOMICAL PATHOLOGY; McCaw-Binns A, 2015, J CLIN EPIDEMIOL, V68, P979, DOI 10.1016/j.jclinepi.2014.11.026; Meggiolaro A, 2016, CLIN TER, V167, P124, DOI 10.7417/CT.2016.1942; Ministry of Health Federal Democratic Republic of Ethiopia, 2005, NATIONAL BLOOD TRANS; Mullan F, 2011, LANCET, V377, P1113, DOI 10.1016/S0140-6736(10)61961-7; Musicha P, 2017, LANCET INFECT DIS, V17, P1042, DOI 10.1016/S1473-3099(17)30394-8; Mwaikambo L., 2013, Knowledge Management for Development Journal, V9, P63; National Institutes of Health, 2016, NIH CLINICAL RESEARC; National Resident Matching Program, 2017, RESULTS AND DATA 201; Ndihokubwayo JB, 2010, STRENGTHENING PUBLIC; Ndihokubwayo JB, 2016, AFR J LAB MED, V5, DOI 10.4102/ajlm.v5i1.280; Nelson AM, 2016, J CLIN ONCOL, V34, P20, DOI 10.1200/JCO.2015.61.9767; Ngatu NR, 2017, J EPIDEMIOL, V27, P455, DOI 10.1016/j.je.2016.09.010; Olson B, 2016, INT J GYNECOL OBSTET, V134, P239, DOI 10.1016/j.ijgo.2016.03.011; Petersen LR, 2013, EPIDEMIOL INFECT, V141, P591, DOI 10.1017/S0950268812001070; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Pien BC, 2010, AM J MED, V123, P819, DOI 10.1016/j.amjmed.2010.03.021; Polage CR, 2006, AM J TROP MED HYG, V75, P526, DOI 10.4269/ajtmh.2006.75.526; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Robboy SJ, 2015, ARCH PATHOL LAB MED, V139, P1413, DOI 10.5858/arpa.2014-0559-OA; Rohr UP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149856; Royal College of Pathologists, 2017, SPECIALIST REGISTRAT; Royal College of Pathologists, 2017, CONTINUING PROFESSIO; Royal College of Pathologists, 2017, THE REGULATORY LANDS; Royal College of Pathologists, 2015, FIRST ANNUAL MEDICAL; Sawai Takashi, 2010, J Pathol Inform, V1, DOI 10.4103/2153-3539.68327; Sayed S, 2018, LANCET; Srigley J, 2013, J ONCOL PRACT, V9, pE255, DOI 10.1200/JOP.2012.000818; United Nations, 2015, TRANSF OUR WORLD 203; US Preventive Services Task Force, 2016, COLORECTAL CANCER SC; van Ingen J, 2017, LANCET INFECT DIS, V17, P1033, DOI 10.1016/S1473-3099(17)30324-9; van Rosmalen J, 2012, BJOG-INT J OBSTET GY, V119, P699, DOI 10.1111/j.1471-0528.2011.03228.x; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wattanasri N, 2010, AM J CLIN PATHOL, V134, P534, DOI 10.1309/AJCPZYY19WMKMAZT; Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2015, WORLDWIDE COUNTRY SI; WHO, 2017, IN VITRO DIAGNOSTICS; WHO, 2013, TRANSFORMING AND SCA; WHO, 2016, GLOBAL HEALTH ESTIMA; WHO Country Office for Ethiopia, 2015, BLOOD SAFETY PROGRES; WHO Global Health Workforce Alliance, 2013, GLOBAL HLTH WORKFORC; WHO Regional Office for Africa, 2017, POLICY MAKERS IN ETH; Wilson Michael L, 2014, Evid Based Med, V19, P233, DOI 10.1136/ebmed-2014-110069; Wiredu EK, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-159; World Bank, 2017, 2017 WORLD DEVELOPME; World Health Organization, 2014, ANTIMICROBIAL RESIST, VVolume 61, P383, DOI 10.1007/s13312-014-0374-3	102	150	153	21	136	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2018	391	10133					1927	1938		10.1016/S0140-6736(18)30458-6	http://dx.doi.org/10.1016/S0140-6736(18)30458-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF3NC	29550029				2022-12-28	WOS:000431861800028
J	Kobayashi, K; Jomaa, A; Lee, JH; Chandrasekar, S; Boehringer, D; Shan, SO; Ban, N				Kobayashi, Kan; Jomaa, Ahmad; Lee, Jae Ho; Chandrasekar, Sowmya; Boehringer, Daniel; Shan, Shu-ou; Ban, Nenad			Structure of a prehandover mammalian ribosomal SRP.SRP receptor targeting complex	SCIENCE			English	Article							SIGNAL-RECOGNITION PARTICLE; ENDOPLASMIC-RETICULUM MEMBRANE; PROTEIN TRANSLOCATION; BETA-SUBUNIT; ALPHA-SUBUNIT; SRP RNA; GTPASE ACTIVATION; SECRETORY PROTEIN; DOMAIN; BINDING	Signal recognition particle (SRP) targets proteins to the endoplasmic reticulum (ER). SRP recognizes the ribosome synthesizing a signal sequence and delivers it to the SRP receptor (SR) on the ER membrane followed by the transfer of the signal sequence to the translocon. Here, we present the cryo-electron microscopy structure of the mammalian translating ribosome in complex with SRP and SR in a conformation preceding signal sequence handover. The structure visualizes all eukaryotic-specific SRP and SR proteins and reveals their roles in stabilizing this conformation by forming a large protein assembly at the distal site of SRP RNA. We provide biochemical evidence that the guanosine triphosphate hydrolysis of SRP.SR is delayed at this stage, possibly to provide a time window for signal sequence handover to the translocon.	[Kobayashi, Kan; Jomaa, Ahmad; Boehringer, Daniel; Ban, Nenad] Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Dept Biol, Otto Stern Weg 5, CH-8093 Zurich, Switzerland; [Lee, Jae Ho; Chandrasekar, Sowmya; Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; California Institute of Technology	Ban, N (corresponding author), Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Dept Biol, Otto Stern Weg 5, CH-8093 Zurich, Switzerland.	ban@mol.biol.ethz.ch		Jomaa, Ahmad/0000-0002-5543-7942; Jomaa, Ahmad/0000-0002-4786-934X	Toyobo Biotechnology Foundation; European Molecular Biology Organization (EMBO) [ALTF 660-2015]; Swiss National Science Foundation (SNSF) [310030B_163478]; National Center of Excellence in Research (NCCR) RNA & Disease Program of the SNSF [51NF40_141735]; NIH [GM107368]; Gordon and Betty Moore Foundation [GBMF2939]; Weston Havens Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078024, R01GM107368] Funding Source: NIH RePORTER	Toyobo Biotechnology Foundation; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); National Center of Excellence in Research (NCCR) RNA & Disease Program of the SNSF; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Weston Havens Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	K.K. was supported by Long-Term Fellowships from Toyobo Biotechnology Foundation and European Molecular Biology Organization (EMBO) (ALTF 660-2015). This study was supported by the Swiss National Science Foundation (SNSF) (grant number 310030B_163478), National Center of Excellence in Research (NCCR) RNA & Disease Program of the SNSF (grant number 51NF40_141735) (to N.B.), NIH grant GM107368, Gordon and Betty Moore Foundation grant GBMF2939, and a fellowship from the Weston Havens Foundation (to S.-o.S.).	Ataide SF, 2011, SCIENCE, V331, P881, DOI 10.1126/science.1196473; Bacher G, 1999, J CELL BIOL, V146, P723, DOI 10.1083/jcb.146.4.723; Bacher G, 1996, NATURE, V381, P248, DOI 10.1038/381248a0; Becker MMM, 2017, NUCLEIC ACIDS RES, V45, P470, DOI 10.1093/nar/gkw1124; Chartron JW, 2016, NATURE, V536, P224, DOI 10.1038/nature19309; Cheng ZL, 2006, NAT STRUCT MOL BIOL, V13, P930, DOI 10.1038/nsmb1146; Fulga TA, 2001, EMBO J, V20, P2338, DOI 10.1093/emboj/20.9.2338; GILMORE R, 1982, J CELL BIOL, V95, P470, DOI 10.1083/jcb.95.2.470; Grotwinkel JT, 2014, SCIENCE, V344, P101, DOI 10.1126/science.1249094; Halic M, 2006, SCIENCE, V312, P745, DOI 10.1126/science.1124864; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Jomaa A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15470; Jomaa A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10471; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; Legate KR, 2000, J BIOL CHEM, V275, P27439; LUTCKE H, 1992, EMBO J, V11, P1543, DOI 10.1002/j.1460-2075.1992.tb05199.x; Mandon EC, 2003, J CELL BIOL, V162, P575, DOI 10.1083/jcb.200303143; Mandon EC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013342; MEYER DI, 1982, NATURE, V297, P647, DOI 10.1038/297647a0; MILLER JD, 1995, J CELL BIOL, V128, P273, DOI 10.1083/jcb.128.3.273; Nyathi Y, 2013, BBA-MOL CELL RES, V1833, P2392, DOI 10.1016/j.bbamcr.2013.02.021; Rapiejko PJ, 1997, CELL, V89, P703, DOI 10.1016/S0092-8674(00)80253-6; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schlenker O, 2006, J BIOL CHEM, V281, P8898, DOI 10.1074/jbc.M512415200; Schwartz T, 2003, CELL, V112, P793, DOI 10.1016/S0092-8674(03)00161-2; Shen K, 2012, NATURE, V492, P271, DOI 10.1038/nature11726; SIEGEL V, 1988, CELL, V52, P39, DOI 10.1016/0092-8674(88)90529-6; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; TAJIMA S, 1986, J CELL BIOL, V103, P1167, DOI 10.1083/jcb.103.4.1167; Utz PJ, 1998, J BIOL CHEM, V273, P35362, DOI 10.1074/jbc.273.52.35362; Voigts-Hoffmann F, 2013, MOL CELL, V52, P643, DOI 10.1016/j.molcel.2013.10.005; Voorhees RM, 2016, CURR OPIN CELL BIOL, V41, P91, DOI 10.1016/j.ceb.2016.04.009; Voorhees RM, 2015, ELIFE, V4, DOI 10.7554/eLife.07975; WALTER P, 1980, P NATL ACAD SCI-BIOL, V77, P7112, DOI 10.1073/pnas.77.12.7112; WALTER P, 1981, J CELL BIOL, V91, P545, DOI 10.1083/jcb.91.2.545; WALTER P, 1982, NATURE, V299, P691, DOI 10.1038/299691a0; Wild K, 2016, J MOL BIOL, V428, P2880, DOI 10.1016/j.jmb.2016.05.015; YOUNG JC, 1995, J BIOL CHEM, V270, P15650, DOI 10.1074/jbc.270.26.15650	38	34	35	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2018	360	6386					323	326		10.1126/science.aar7924	http://dx.doi.org/10.1126/science.aar7924			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD3IC	29567807	Green Accepted			2022-12-28	WOS:000430396600046
J	Hajdinjak, M; Fu, QM; Hubner, A; Petr, M; Mafessoni, F; Grote, S; Skoglund, P; Narasimham, V; Rougier, H; Crevecoeur, I; Semal, P; Soressi, M; Talamo, S; Hublin, JJ; Gusic, I; Kucan, Z; Rudan, P; Golovanova, LV; Doronichev, VB; Posth, C; Krause, J; Korlevic, P; Nagel, S; Nickel, B; Slatkin, M; Patterson, N; Reich, D; Prufer, K; Meyer, M; Paabo, S; Kelso, J				Hajdinjak, Mateja; Fu, Qiaomei; Huebner, Alexander; Petr, Martin; Mafessoni, Fabrizio; Grote, Steffi; Skoglund, Pontus; Narasimham, Vagheesh; Rougier, Helene; Crevecoeur, Isabelle; Semal, Patrick; Soressi, Marie; Talamo, Sahra; Hublin, Jean-Jacques; Gusic, Ivan; Kucan, Zeljko; Rudan, Pavao; Golovanova, Liubov V.; Doronichev, Vladimir B.; Posth, Cosimo; Krause, Johannes; Korlevic, Petra; Nagel, Sarah; Nickel, Birgit; Slatkin, Montgomery; Patterson, Nick; Reich, David; Pruefer, Kay; Meyer, Matthias; Paeaebo, Svante; Kelso, Janet			Reconstructing the genetic history of late Neanderthals	NATURE			English	Article							MITOCHONDRIAL GENOME SEQUENCE; DNA-SEQUENCES; DENISOVA CAVE; MODERN HUMANS; ANCIENT; HOMININ; CONTAMINATION; ALIGNMENT; SYSTEMS; FLOW	Although it has previously been shown that Neanderthals contributed DNA to modern humans(1,2), not much is known about the genetic diversity of Neanderthals or the relationship between late Neanderthal populations at the time at which their last interactions with early modern humans occurred and before they eventually disappeared. Our ability to retrieve DNA from a larger number of Neanderthal individuals has been limited by poor preservation of endogenous DNA(3) and contamination of Neanderthal skeletal remains by large amounts of microbial and present-day human DNA(3-5). Here we use hypochlorite treatment(6) of as little as 9 mg of bone or tooth powder to generate between 1- and 2.7-fold genomic coverage of five Neanderthals who lived around 39,000 to 47,000 years ago (that is, late Neanderthals), thereby doubling the number of Neanderthals for which genome sequences are available. Genetic similarity among late Neanderthals is well predicted by their geographical location, and comparison to the genome of an older Neanderthal from the Caucasus(2,7) indicates that a population turnover is likely to have occurred, either in the Caucasus or throughout Europe, towards the end of Neanderthal history. We find that the bulk of Neanderthal gene flow into early modern humans originated from one or more source populations that diverged from the Neanderthals that were studied here at least 70,000 years ago, but after they split from a previously sequenced Neanderthal from Siberia(2) around 150,000 years ago. Although four of the Neanderthals studied here post-date the putative arrival of early modern humans into Europe, we do not detect any recent gene flow from early modern humans in their ancestry.	[Hajdinjak, Mateja; Huebner, Alexander; Petr, Martin; Mafessoni, Fabrizio; Grote, Steffi; Korlevic, Petra; Nagel, Sarah; Nickel, Birgit; Pruefer, Kay; Meyer, Matthias; Paeaebo, Svante; Kelso, Janet] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Fu, Qiaomei] Chinese Acad Sci, Key Lab Vertebrate Evolut & Human Origins Chinese, IVPP, Beijing 100044, Peoples R China; [Fu, Qiaomei] CAS Ctr Excellence Life & Paleoenvironm, Beijing 100044, Peoples R China; [Fu, Qiaomei] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Skoglund, Pontus; Narasimham, Vagheesh; Patterson, Nick; Reich, David] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Rougier, Helene] Calif State Univ Northridge, Dept Anthropol, Northridge, CA 91330 USA; [Crevecoeur, Isabelle] Univ Bordeaux, CNRS, UMR PACEA 5199, F-33615 Pessac, France; [Semal, Patrick] Royal Belgian Inst Nat Sci, B-1000 Brussels, Belgium; [Soressi, Marie] Leiden Univ, Fac Archaeol, NL-2300 RA Leiden, Netherlands; [Soressi, Marie; Talamo, Sahra; Hublin, Jean-Jacques] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Gusic, Ivan; Kucan, Zeljko; Rudan, Pavao] Croatian Acad Sci & Arts, HR-10000 Zagreb, Croatia; [Golovanova, Liubov V.; Doronichev, Vladimir B.] ANO Lab Prehist, 14 Linia 3 11, St Petersburg 199034, Russia; [Posth, Cosimo; Krause, Johannes] Max Planck Inst Sci Human Hist, D-07745 Jena, Germany; [Posth, Cosimo; Krause, Johannes] Univ Tubingen, Inst Archaeol Sci, Rumelin Str 23, D-72070 Tubingen, Germany; [Slatkin, Montgomery] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Patterson, Nick; Reich, David] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Reich, David] Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA	Max Planck Society; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Harvard University; Harvard Medical School; California State University System; California State University Northridge; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; Royal Belgian Institute of Natural Sciences; Leiden University; Leiden University - Excl LUMC; Max Planck Society; Croatian Academy of Sciences & Arts; Eberhard Karls University of Tubingen; University of California System; University of California Berkeley; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Hajdinjak, M; Paabo, S; Kelso, J (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany.	mateja_hajdinjak@eva.mpg.de; paabo@eva.mpg.de; kelso@eva.mpg.de	Talamo, Sahra/AAD-1774-2022; Posth, Cosimo/AAL-6219-2021; mafessoni, fabrizio/AAD-9425-2022; Krause, Johannes/AFP-2642-2022; Kelso, Janet/N-1812-2019; Liubov, Golovanova V./Q-2995-2016; SORESSI, Marie/N-7728-2015	Talamo, Sahra/0000-0002-2406-3132; Krause, Johannes/0000-0001-9144-3920; Kelso, Janet/0000-0002-3618-322X; Golovanova, Liubov/0000-0002-6099-4081; SORESSI, Marie/0000-0003-1733-7745; Korlevic, Petra/0000-0002-5418-5587; Skoglund, Pontus/0000-0002-3021-5913; Hajdinjak, Mateja/0000-0002-4064-0331; Petr, Martin/0000-0003-4879-8421; Hubner, Alexander/0000-0003-3572-9996; Rougier, Helene/0000-0003-0358-0285; Semal, Patrick/0000-0002-4048-7728; Doronichev, Vladimir/0000-0003-0198-0250	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040282] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Brown S, 2016, SCI REP-UK, V6, DOI 10.1038/srep23559; Busing FMTA, 1999, STAT COMPUT, V9, P3, DOI 10.1023/A:1008800423698; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Dabney J, 2012, BIOTECHNIQUES, V52, P87, DOI 10.2144/000113809; Dalen L, 2012, MOL BIOL EVOL, V29, P1893, DOI 10.1093/molbev/mss074; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Ermini L, 2008, CURR BIOL, V18, P1687, DOI 10.1016/j.cub.2008.09.028; Fu QM, 2016, NATURE, V534, P200, DOI 10.1038/nature17993; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Gansauge MT, 2014, GENOME RES, V24, P1543, DOI 10.1101/gr.174201.114; Gansauge MT, 2013, NAT PROTOC, V8, P737, DOI 10.1038/nprot.2013.038; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gilbert MTP, 2008, SCIENCE, V320, P1787, DOI 10.1126/science.1159750; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Higham T, 2014, NATURE, V512, P306, DOI 10.1038/nature13621; HORAI S, 1992, J MOL EVOL, V35, P32, DOI 10.1007/BF00160258; Hublin JJ, 2015, QUATERNARY SCI REV, V118, P194, DOI 10.1016/j.quascirev.2014.08.011; Hublin JJ, 2009, CR PALEVOL, V8, P503, DOI 10.1016/j.crpv.2009.04.001; Karmin M, 2015, GENOME RES, V25, P459, DOI 10.1101/gr.186684.114; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Korlevic P, 2015, BIOTECHNIQUES, V59, P87, DOI 10.2144/000114320; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Kuhlwilm M, 2016, NATURE, V530, P429, DOI 10.1038/nature16544; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; Mendez FL, 2016, AM J HUM GENET, V98, P728, DOI 10.1016/j.ajhg.2016.02.023; Meyer M, 2016, NATURE, V531, P504, DOI 10.1038/nature17405; Meyer M, 2014, NATURE, V505, P403, DOI 10.1038/nature12788; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Moorjani P, 2016, P NATL ACAD SCI USA, V113, P5652, DOI 10.1073/pnas.1514696113; Muller UC, 2011, QUATERNARY SCI REV, V30, P273, DOI 10.1016/j.quascirev.2010.11.016; Overmann KA, 2013, J ANTHROPOL SCI, V91, P91, DOI [10.4436/JASS.91021, 10.4436/jass.91021]; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Paten B, 2008, GENOME RES, V18, P1829, DOI 10.1101/gr.076521.108; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pinhasi R, 2011, P NATL ACAD SCI USA, V108, P8611, DOI 10.1073/pnas.1018938108; Posth C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16046; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Prufer K, 2017, SCIENCE, V358, P655, DOI 10.1126/science.aao1887; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Renaud G, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku699; Renaud G, 2013, BIOINFORMATICS, V29, P1208, DOI 10.1093/bioinformatics/btt117; Rougier H, 2016, SCI REP-UK, V6, DOI 10.1038/srep29005; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sawyer S, 2015, P NATL ACAD SCI USA, V112, P15696, DOI 10.1073/pnas.1519905112; Sawyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034131; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Semal P, 2009, AM J PHYS ANTHROPOL, V138, P421, DOI 10.1002/ajpa.20954; Skoglund P, 2014, P NATL ACAD SCI USA, V111, P2229, DOI 10.1073/pnas.1318934111; Soressi M., 2010, MEMOIRE, V38, P221; Svensson A, 2008, CLIM PAST, V4, P47, DOI 10.5194/cp-4-47-2008; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Welker F, 2016, P NATL ACAD SCI USA, V113, P11162, DOI 10.1073/pnas.1605834113	77	113	120	9	127	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 29	2018	555	7698					652	+		10.1038/nature26151	http://dx.doi.org/10.1038/nature26151			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8UX	29562232	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000428617600048
J	Slomski, A				Slomski, Anita			Exercise Remodels Heart in Middle Age	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2018	319	12					1190	1190		10.1001/jama.2018.2786	http://dx.doi.org/10.1001/jama.2018.2786			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HI0BD	29584839				2022-12-28	WOS:000456106200005
J	Olalde, I; Brace, S; Allentoft, ME; Armit, I; Kristiansen, K; Booth, T; Rohland, N; MaHick, S; Szecsenyi-Nagy, A; Mittnik, A; Altena, E; Lipson, M; Lazaridis, I; Harper, TK; Patterson, N; Broomandkhoshbacht, N; Diekmann, Y; Faltyskova, Z; Fernandes, D; Ferry, M; Harney, E; de Knijff, P; Michel, M; Oppenheimer, J; Stewardson, K; Barclay, A; Alt, KW; Liesau, C; Rios, P; Blasco, C; Miguel, JV; Garcia, RM; Fernandez, AA; Banffy, E; Bernabo-Brea, M; Billoin, D; Bonsall, C; Bonsall, L; Allen, T; Buster, L; Carver, S; Navarro, LC; Craig, OE; Cook, GT; Cunliffe, B; Denaire, A; Dinwiddy, KE; Dodwell, N; Ernee, M; Evans, C; Kucharik, M; Farre, JF; Fowler, C; Gazenbeek, M; Pena, RG; Haber, M; Haduch, UF; Hey, G; Jowett, N; Knowles, T; Massy, K; Pfrengle, S; Lefranc, P; Lemercier, O; Lefebvre, A; Martinez, CH; Olmo, VG; Ramirez, AB; Maurandi, JL; Majo, T; McKinley, JI; McSweeney, K; Mende, BG; Mod, A; Kulcsar, G; Kiss, V; Czene, A; Patay, R; Endrodi, A; Kohler, K; Hajdu, T; Szeniczey, T; Dani, J; Bernert, Z; Hoole, M; Cheronet, O; Keating, D; Veleminsky, P; Dobes, M; Candilio, F; Brown, F; Fernandez, RF; Herrero-Corral, AM; Tusa, S; Carnieri, E; Lentini, L; Valenti, A; Zanini, A; Waddington, C; Delibes, G; Guerra-Doce, E; Neil, B; Brittain, M; Luke, M; Mortimer, R; Desideri, J; Besse, M; Brucken, G; Furmanek, M; Haluszko, A; Mackiewicz, M; Rapinski, A; Leach, S; Soriano, I; Lillios, KT; Cardoso, JL; Pearson, MP; Wlodarczak, P; Price, TD; Prieto, P; Rey, PJ; Risch, R; Guerra, MAR; Schmitt, A; Serralongue, J; Silva, AM; Smrcka, V; Vergnaud, L; Zilhao, J; Caramelli, D; Highann, T; Thomas, MG; Kennett, DJ; Fokkens, H; Heyd, V; Sheridan, A; Sjogren, KG; Stockhamrner, PW; Krause, J; Pinhasi, R; Haak, W; Barnes, I; Fox, CL; Reich, D				Olalde, Inigo; Brace, Selina; Allentoft, Morten E.; Armit, Ian; Kristiansen, Kristian; Booth, Thomas; Rohland, Nadin; MaHick, Swapan; Szecsenyi-Nagy, Anna; Mittnik, Alissa; Altena, Eveline; Lipson, Mark; Lazaridis, Iosif; Harper, Thomas K.; Patterson, Nick; Broomandkhoshbacht, Nasreen; Diekmann, Yoan; Faltyskova, Zuzana; Fernandes, Daniel; Ferry, Matthew; Harney, Eadaoin; de Knijff, Peter; Michel, Megan; Oppenheimer, Jonas; Stewardson, Kristin; Barclay, Alistair; Alt, Kurt Werner; Liesau, Carina; Rios, Patricia; Blasco, Concepcion; Miguel, Jorge Vega; Garcia, Roberto Menduilia; Fernandez, Azucena Aviles; Banffy, Eszter; Bernabo-Brea, Maria; Billoin, David; Bonsall, Clive; Bonsall, Laura; Allen, Tim; Buster, Lindsey; Carver, Sophie; Navarro, Laura Castells; Craig, Oliver E.; Cook, Gordon T.; Cunliffe, Barry; Denaire, Anthony; Dinwiddy, Kirsten Egging; Dodwell, Natasha; Ernee, Michal; Evans, Christopher; Kucharik, Milan; Farre, Joan Frances; Fowler, Chris; Gazenbeek, Michiel; Pena, Rafael Garrido; Haber, Maria; Haduch, Uriarte Flzbieta; Hey, Gill; Jowett, Nick; Knowles, Timothy; Massy, Ken; Pfrengle, Saskia; Lefranc, Philippe; Lemercier, Olivier; Lefebvre, Arnaud; Martinez, Cesar Heras; Olmo, Virginia Galera; Ramirez, Ana Bastida; Maurandi, Joaquin Lomba; Majo, Tana; McKinley, Jacqueline I.; McSweeney, Kathleen; Mende, Balazs Gusztav; Mod, Alessandra; Kulcsar, Gabriella; Kiss, Viktoria; Czene, Andras; Patay, Robert; Endrodi, Anna; Kohler, Kitti; Hajdu, Tamas; Szeniczey, Tamas; Dani, Janos; Bernert, Zsolt; Hoole, Maya; Cheronet, Olivia; Keating, Denise; Veleminsky, Petr; Dobes, Miroslav; Candilio, Francesca; Brown, Fraser; Fernandez, Radl Flores; Herrero-Corral, Ana Mercedes; Tusa, Sebastian; Carnieri, Emiliano; Lentini, Luigi; Valenti, Antonella; Zanini, Alessandro; Waddington, Clive; Delibes, German; Guerra-Doce, Elisa; Neil, Benjamin; Brittain, Marcus; Luke, Mike; Mortimer, Richard; Desideri, Jocelyne; Besse, Marie; Brucken, Gunter; Furmanek, Miroslaw; Haluszko, Agata; Mackiewicz, Maksym; Rapinski, Artur; Leach, Stephany; Soriano, Ignacio; Lillios, Katina T.; Cardoso, Joao Luis; Pearson, Michael Parker; Wlodarczak, Piotr; Price, T. Douglas; Prieto, Pilar; Rey, Pierre Jerome; Risch, Roberto; Guerra, Manuel A. Rojo; Schmitt, Aurore; Serralongue, Joel; Silva, Ana Maria; Smrcka, Vaclav; Vergnaud, Luc; Zilhao, Joao; Caramelli, David; Highann, Thomas; Thomas, Mark G.; Kennett, Douglas J.; Fokkens, Harry; Heyd, Volker; Sheridan, Alison; Sjogren, Karl Guran; Stockhamrner, Philipp W.; Krause, Johannes; Pinhasi, Ron; Haak, Wolfgang; Barnes, Ian; Fox, Caries Lalueza; Reich, David			The Beaker phenomenon and the genomic transformation of northwest Europe (vol 555, pg 190, 2018)	NATURE			English	Correction													Silva, Ana Maria/E-6281-2015; Candilio, Francesca/C-8634-2019; Guerra-Doce, Elisa/P-3332-2019; Smrcka, Vaclav/V-4764-2017; Risch, Roberto/L-4115-2014; Barnes, Ian C/B-8081-2008; Szeniczey, Tamas/K-4843-2017; Zilhão, João/L-5670-2014; Krause, Johannes/AFP-2642-2022; de Knijff, Peter/Y-2519-2018; Hałuszko, Agata/HGE-9968-2022; Dobes, Miroslav/H-6681-2014; Thomas, Mark G/A-2219-2012; Ernee, Michal/H-7159-2014; Kiss, Viktória/GLT-7205-2022; Rojo-Guerra, Manuel Ángel/AAB-6968-2019; Bonsall, Clive/AAU-6154-2020; Risch, Roberto/ABG-9562-2020; Olalde, Iñigo/N-6928-2018; Hajdu, Tamas/C-8856-2013	Silva, Ana Maria/0000-0002-1912-6581; Candilio, Francesca/0000-0002-4668-1361; Guerra-Doce, Elisa/0000-0002-8411-5133; Smrcka, Vaclav/0000-0001-8286-511X; Risch, Roberto/0000-0001-8534-5806; Barnes, Ian C/0000-0001-8322-6918; Szeniczey, Tamas/0000-0003-1546-7140; Zilhão, João/0000-0001-5937-3061; Krause, Johannes/0000-0001-9144-3920; de Knijff, Peter/0000-0002-0899-771X; Hałuszko, Agata/0000-0001-8312-3222; Thomas, Mark G/0000-0002-2452-981X; Kiss, Viktória/0000-0002-6577-9081; Rojo-Guerra, Manuel Ángel/0000-0002-9317-8654; Bonsall, Clive/0000-0003-0243-3232; Risch, Roberto/0000-0001-8534-5806; Olalde, Iñigo/0000-0002-2660-6807; Harney, Eadaoin/0000-0001-9385-7297; Besse, Marie/0000-0002-4752-9070; LEMERCIER, Olivier/0000-0002-8445-6261; Hajdu, Tamas/0000-0002-3604-1125				Olalde I, 2018, NATURE, V555, P190, DOI 10.1038/nature25738	1	4	4	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2018	555	7697								10.1038/nature26164	http://dx.doi.org/10.1038/nature26164			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ9NF	29565364	Bronze			2022-12-28	WOS:000427937900060
J	Goel, A				Goel, Anupam			Intensive weight management in primary care improved weight loss and remission of type 2 diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Goel, Anupam] Advocate Hlth Care, Clarendon Hills, IL 60515 USA		Goel, A (corresponding author), Advocate Hlth Care, Clarendon Hills, IL 60515 USA.							Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Kodama S, 2014, OBES REV, V15, P202, DOI 10.1111/obr.12129; Muller-Stich BP, 2015, ANN SURG, V261, P421, DOI 10.1097/SLA.0000000000001014; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914	4	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2018	168	6					JC30	JC30		10.7326/ACPJC-2018-168-6-030	http://dx.doi.org/10.7326/ACPJC-2018-168-6-030			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ8AM	29554668				2022-12-28	WOS:000427827400007
J	Maddox, KEJ				Maddox, Karen E. Joynt			Financial Incentives and Vulnerable Populations - Will Alternative Payment Models Help or Hurt?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Maddox, Karen E. Joynt] Washington Univ, Sch Med, Dept Med, Cardiovasc Div, St Louis, MO 63110 USA	Washington University (WUSTL)	Maddox, KEJ (corresponding author), Washington Univ, Sch Med, Dept Med, Cardiovasc Div, St Louis, MO 63110 USA.							Colla CH, 2012, JAMA-J AM MED ASSOC, V308, P1015, DOI 10.1001/2012.jama.10812; Department of IIealth and IIuman Services Office of the Assistant Secretary for Planning and Evaluation, 2016, REP C SOC RISK FACT; Hannan EL, 2013, J INTERV CARDIOL, V26, P470, DOI 10.1111/joic.12059; McWilliams JM, 2017, HEALTH AFFAIR, V36, P2085, DOI 10.1377/hlthaff.2017.0814; Song ZR, 2017, HEALTH AFFAIR, V36, P74, DOI 10.1377/hlthaff.2016.0682	5	41	41	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2018	378	11					977	979		10.1056/NEJMp1715455	http://dx.doi.org/10.1056/NEJMp1715455			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ2HT	29539282	Green Published			2022-12-28	WOS:000427399000001
J	Yarchoan, R; Uldrick, TS				Yarchoan, Robert; Uldrick, Thomas S.			HIV-Associated Cancers and Related Diseases	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SARCOMA-ASSOCIATED-HERPESVIRUS; MULTICENTRIC CASTLEMAN-DISEASE; HUMAN-IMMUNODEFICIENCY-VIRUS; PEGYLATED-LIPOSOMAL DOXORUBICIN; HUMAN-PAPILLOMAVIRUS INFECTION; ACTIVE ANTIRETROVIRAL THERAPY; CLASSICAL HODGKIN LYMPHOMA; NERVOUS-SYSTEM LYMPHOMA; EPSTEIN-BARR-VIRUS; B-CELL LYMPHOMA		[Yarchoan, Robert; Uldrick, Thomas S.] NCI, HIV & AIDS Malignancy Branch, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yarchoan, R (corresponding author), NCI, 10 Ctr Dr,Rm 6N106,MSC1868, Bethesda, MD 20892 USA.	robert.yarchoan@nih.gov			NATIONAL CANCER INSTITUTE [ZIABC010885, ZIABC010888] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 CA999999, ZIA BC010888-11, ZIA BC010885-11] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		AIDS info, 2016, GUID PREV TREATM OPP; Alvarnas JC, 2016, BLOOD, V128, P1050, DOI 10.1182/blood-2015-08-664706; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Antinori A, 1999, J CLIN ONCOL, V17, P554, DOI 10.1200/JCO.1999.17.2.554; Aoki Y, 2001, BLOOD, V97, P2526, DOI 10.1182/blood.V97.8.2526; Barta SK, 2013, BLOOD, V122, P3251, DOI 10.1182/blood-2013-04-498964; Beaver JA, 2017, NEW ENGL J MED, V376, P1504, DOI 10.1056/NEJMp1615879; BERAL V, 1990, LANCET, V335, P123, DOI 10.1016/0140-6736(90)90001-L; Bower M, 2010, BLOOD, V116, P4415, DOI 10.1182/blood-2010-07-290213; Bower M, 2009, AIDS, V23, P1701, DOI 10.1097/QAD.0b013e32832d080d; Butler LM, 2009, J INFECT DIS, V200, P430, DOI 10.1086/600103; Casper C, 2007, J INFECT DIS, V195, P30, DOI 10.1086/509621; Centers for Disease Control (CDC), 1981, MMWR Morb Mortal Wkly Rep, V30, P305; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Chalya Phillipo L, 2015, BMC Res Notes, V8, P440, DOI 10.1186/s13104-015-1348-9; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chinula L, 2017, CURR OPIN HIV AIDS, V12, P89, DOI 10.1097/COH.0000000000000329; Cianfrocca M, 2010, CANCER-AM CANCER SOC, V116, P3969, DOI 10.1002/cncr.25362; Coutinho R, 2014, AIDS, V28, P689, DOI 10.1097/QAD.0000000000000133; D'Souza G, 2014, JAIDS-J ACQ IMM DEF, V65, P603, DOI 10.1097/QAI.0000000000000083; de Martel C, 2015, AIDS, V29, P2173, DOI 10.1097/QAD.0000000000000808; Delecluse HJ, 1997, BLOOD, V89, P1413, DOI 10.1182/blood.V89.4.1413; Denny L, 2010, JNCI-J NATL CANCER I, V102, P1557, DOI 10.1093/jnci/djq342; Dunleavy K, 2013, NEW ENGL J MED, V369, P1915, DOI 10.1056/NEJMoa1308392; Dunleavy K, 2010, BLOOD, V115, P3017, DOI 10.1182/blood-2009-11-253039; Duprez R, 2007, JNCI-J NATL CANCER I, V99, P1086, DOI 10.1093/jnci/djm045; Eltom MA, 2002, J NATL CANCER I, V94, P1204, DOI 10.1093/jnci/94.16.1204; Gao SJ, 1996, NAT MED, V2, P925, DOI 10.1038/nm0896-925; Gerard L, 2007, J CLIN ONCOL, V25, P3350, DOI 10.1200/JCO.2007.10.6732; GILL PS, 1989, ANN INTERN MED, V110, P937, DOI 10.7326/0003-4819-110-11-937; Goncalves PH, 2015, 15 INT C MAL AIDS OT; Goncalves PH, 2016, SEMIN ONCOL, V43, P173, DOI 10.1053/j.seminoncol.2015.09.011; Guillet S, 2016, AM J HEMATOL, V91, P233, DOI 10.1002/ajh.24251; Haque M, 2003, J VIROL, V77, P6761, DOI 10.1128/JVI.77.12.6761-6768.2003; Hegde U, 2005, BLOOD, V105, P496, DOI 10.1182/blood-2004-05-1982; Hernandez-Ramirez RU, 2017, LANCET HIV, V4, pE495, DOI 10.1016/S2352-3018(17)30125-X; Hulbert A, 2014, J THORAC ONCOL, V9, P752, DOI 10.1097/JTO.0000000000000161; Hwang JP, 2015, J ONCOL PRACT, V11, P384, DOI 10.1200/JOP.2015.005116; Krown SE, 1997, J CLIN ONCOL, V15, P3085, DOI 10.1200/JCO.1997.15.9.3085; KROWN SE, 1989, J CLIN ONCOL, V7, P1201, DOI 10.1200/JCO.1989.7.9.1201; Letang E, 2013, AIDS, V27, P1603, DOI 10.1097/QAD.0b013e328360a5a1; Lowy DR, 2006, J CLIN INVEST, V116, P1167, DOI 10.1172/JCI28607; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; MACMAHON EME, 1991, LANCET, V338, P969, DOI 10.1016/0140-6736(91)91837-K; Martin-Carbonero L, 2004, AIDS, V18, P1737, DOI 10.1097/01.aids.0000131385.60974.b9; Martinez-Maza O, 2002, CURR OPIN ONCOL, V14, P528, DOI 10.1097/00001622-200209000-00009; Maskew M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064392; Maurer T, 2007, NEW ENGL J MED, V357, P1352, DOI 10.1056/NEJMc070508; Minkoff H, 2010, J INFECT DIS, V201, P681, DOI 10.1086/650467; Montaner S, 2006, CANCER RES, V66, P168, DOI 10.1158/0008-5472.CAN-05-1026; Montoto S, 2012, J CLIN ONCOL, V30, P4111, DOI 10.1200/JCO.2011.41.4193; Moore PS, 1996, SCIENCE, V274, P1739, DOI 10.1126/science.274.5293.1739; Morlat P, 2014, AIDS, V28, P1181, DOI 10.1097/QAD.0000000000000222; National Comprehensive Cancer Network, 2017, NCCN CLIN PRACT GUID; Northfelt DW, 1998, J CLIN ONCOL, V16, P2445, DOI 10.1200/JCO.1998.16.7.2445; Noy A, 2016, LEUKEMIA LYMPHOMA, V57, P1731, DOI 10.3109/10428194.2015.1113281; Oksenhendler E, 2000, BLOOD, V96, P2069, DOI 10.1182/blood.V96.6.2069.h8002069_2069_2073; Oksenhendler E, 1996, AIDS, V10, P61, DOI 10.1097/00002030-199601000-00009; Osmond DH, 2002, JAMA-J AM MED ASSOC, V287, P221, DOI 10.1001/jama.287.2.221; Persad GC, 2008, J CLIN ONCOL, V26, P1027, DOI 10.1200/JCO.2007.14.5532; Phillips AM, 2008, SEX TRANSM DIS, V35, P1011, DOI 10.1097/OLQ.0b013e318182c91f; Picard A, 2016, AIDS, V30, P1257, DOI 10.1097/QAD.0000000000001030; Polizzotto MN, 2016, J CLIN ONCOL, V34, P4125, DOI 10.1200/JCO.2016.69.3812; Polizzotto MN, 2016, CLIN INFECT DIS, V62, P730, DOI 10.1093/cid/civ996; Polizzotto MN, 2013, BLOOD, V122, P4189, DOI 10.1182/blood-2013-08-519959; RABKIN CS, 1995, CLIN CANCER RES, V1, P257; Robbins HA, 2015, JNCI-J NATL CANCER I, V107, P107, DOI DOI 10.1093/JNCI/DJU503.PRINT; Royse KE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182750; Rudek MA, 2011, LANCET ONCOL, V12, P905, DOI 10.1016/S1470-2045(11)70056-0; Sanchez-Martin D, 2017, JNCI-J NATL CANCER I, V109, P109; Shebl FM, 2010, JAIDS-J ACQ IMM DEF, V55, P375, DOI 10.1097/QAI.0b013e3181eef4f7; Shiels MS, 2011, J NATL CANCER I, V103, P753, DOI 10.1093/jnci/djr076; Shimabukuro K., 2017, 16 INT C MAL HIV AID; Silverberg MJ, 2015, ANN INTERN MED, V163, P507, DOI 10.7326/M14-2768; Silverberg MJ, 2013, JNCI-J NATL CANCER I, V105, P350, DOI 10.1093/jnci/djs529; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Uldrick TS, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.73.7338; Uldrick TS, 2015, BLOOD, V125, P1226, DOI 10.1182/blood-2014-08-551598; Uldrick TS, 2014, BLOOD, V124, P3544, DOI 10.1182/blood-2014-07-586800; Uldrick TS, 2014, AIDS, V28, P397, DOI 10.1097/QAD.0000000000000030; Uldrick TS, 2011, BLOOD, V117, P6977, DOI 10.1182/blood-2010-11-317610; Uldrick TS, 2010, CLIN INFECT DIS, V51, P350, DOI 10.1086/654798; Uldrick TS, 2012, 54 AM SOC HEM ANN M; Valera A, 2010, AM J SURG PATHOL, V34, P1686, DOI 10.1097/PAS.0b013e3181f3e29f; Waterston A, 2004, ACTA ONCOL, V43, P698, DOI 10.1080/02841860410002752; Welles L, 1998, J CLIN ONCOL, V16, P1112, DOI 10.1200/JCO.1998.16.3.1112; Wilkin T, 2010, J INFECT DIS, V202, P1246, DOI 10.1086/656320; WILLIAMS AB, 1994, OBSTET GYNECOL, V83, P205	88	179	186	8	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2018	378	11					1029	1041		10.1056/NEJMra1615896	http://dx.doi.org/10.1056/NEJMra1615896			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ2HT	29539283	Green Accepted			2022-12-28	WOS:000427399000008
J	Thompson, AJ; Baranzini, SE; Geurts, J; Hemmer, B; Ciccarelli, O				Thompson, Alan J.; Baranzini, Sergio E.; Geurts, Jeroen; Hemmer, Bernhard; Ciccarelli, Olga			Multiple sclerosis	LANCET			English	Review							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; MAGNIMS CONSENSUS GUIDELINES; CLINICALLY ISOLATED SYNDROME; GENETIC RISK BURDEN; DOUBLE-BLIND; FOLLOW-UP; PHARMACOLOGICAL MANAGEMENT; RETROSPECTIVE ANALYSIS; COGNITIVE IMPAIRMENT; CONTROLLED-TRIAL	Multiple sclerosis continues to be a challenging and disabling condition but there is now greater understanding of the underlying genetic and environmental factors that drive the condition, including low vitamin D levels, cigarette smoking, and obesity. Early and accurate diagnosis is crucial and is supported by diagnostic criteria, incorporating imaging and spinal fluid abnormalities for those presenting with a clinically isolated syndrome. Importantly, there is an extensive therapeutic armamentarium, both oral and by infusion, for those with the relapsing remitting form of the disease. Careful consideration is required when choosing the correct treatment, balancing the side-effect profile with efficacy and escalating as clinically appropriate. This move towards more personalised medicine is supported by a clinical guideline published in 2018. Finally, a comprehensive management programme is strongly recommended for all patients with multiple sclerosis, enhancing health-related quality of life through advocating wellness, addressing aggravating factors, and managing comorbidities. The greatest remaining challenge for multiple sclerosis is the development of treatments incorporating neuroprotection and remyelination to treat and ultimately prevent the disabling, progressive forms of the condition.	[Thompson, Alan J.; Ciccarelli, Olga] UCL Inst Neurol, Queen Sq MS Ctr, London WC1N 3BG, England; [Thompson, Alan J.; Ciccarelli, Olga] NIHR Univ Coll London Hosp Biomed Res Ctr, London, England; [Baranzini, Sergio E.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Geurts, Jeroen] Vrije Univ Amsterdam, Med Ctr, Dept Anat & Neurosci, Amsterdam, Netherlands; [Hemmer, Bernhard] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, Munich, Germany; [Hemmer, Bernhard] Munich Cluster Syst Neurol SyNergy, Munich, Germany	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of California System; University of California San Francisco; Vrije Universiteit Amsterdam; Technical University of Munich; University of Munich	Thompson, AJ (corresponding author), UCL Inst Neurol, Queen Sq MS Ctr, London WC1N 3BG, England.	alan.thompson@ucl.ac.uk	Hemmer, Bernhard/AAT-8388-2021; Ciccarelli, Olga/AAY-3328-2020; Hemmer, Bernhard/GPX-8451-2022; Thompson, Alan J/C-2654-2008	Hemmer, Bernhard/0000-0001-5985-6784; Thompson, Alan J/0000-0002-4333-8496; Ciccarelli, Olga/0000-0001-7485-1367; Baranzini, Sergio/0000-0003-0067-194X	UK National Institute for Health Research University College London Hospitals Biomedical Research Centre	UK National Institute for Health Research University College London Hospitals Biomedical Research Centre	AJT and OC acknowledge the support of the UK National Institute for Health Research University College London Hospitals Biomedical Research Centre. We thank Arman Eshaghi, Carmen Tur, and Marcello Moccia (UCL Institute of Neurology, London, UK) and Gavin Giovannoni (Queen Mary University of London, London, UK) for providing the figures and help with the tables and references.	Amato MP, 2013, J NEUROL, V260, P1452, DOI 10.1007/s00415-012-6678-0; Antel J, 2012, ACTA NEUROPATHOL, V123, P627, DOI 10.1007/s00401-012-0953-0; Ascherio A, 2008, SEMIN NEUROL, V28, P17, DOI 10.1055/s-2007-1019126; Ascherio A, 2016, SEMIN NEUROL, V36, P103, DOI 10.1055/s-0036-1579693; Ascherio A, 2014, JAMA NEUROL, V71, P306, DOI 10.1001/jamaneurol.2013.5993; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bermel RA, 2010, MULT SCLER, V16, P1335, DOI 10.1177/1352458510377334; Bloomgren G, 2012, NEW ENGL J MED, V366, P1870, DOI 10.1056/NEJMoa1107829; Boesen F, 2018, MULT SCLER J, V24, P340, DOI 10.1177/1352458517735188; Bogosian A, 2017, PSYCHOL HEALTH, V32, P343, DOI 10.1080/08870446.2016.1268691; Briken S, 2014, MULT SCLER J, V20, P382, DOI 10.1177/1352458513507358; Brosseau MSG, 2016, NEUROLOGY, V86, P484, DOI 10.1212/WNL.0000000000002330; Browne P, 2014, NEUROLOGY, V83, P1022, DOI 10.1212/WNL.0000000000000768; Brownlee WJ, 2017, LANCET, V389, P1336, DOI 10.1016/S0140-6736(16)30959-X; Brownlee WJ, 2015, J NEUROL NEUROSUR PS, V86, P584, DOI 10.1136/jnnp-2014-308675; Burton Erik V, 2011, Pathophysiology, V18, P81, DOI 10.1016/j.pathophys.2010.04.009; Charvet LE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177177; Chataway J, 2014, LANCET, V383, P2213, DOI 10.1016/S0140-6736(13)62242-4; Ciccarelli O, 2015, MULT SCLER J, V21, P37, DOI 10.1177/1352458514559866; Ciccarelli O, 2014, LANCET NEUROL, V13, P807, DOI 10.1016/S1474-4422(14)70101-2; Coetzee T, 2018, NAT REV NEUROL, V14, P191, DOI 10.1038/nrneurol.2017.184; Cohen J, 2015, JAMA NEUROL, V72, P1433, DOI 10.1001/jamaneurol.2015.2154; Cree BAC, 2016, ANN NEUROL, V80, P499, DOI 10.1002/ana.24747; Dalgas U, 2009, NEUROLOGY, V73, P1478, DOI 10.1212/WNL.0b013e3181bf98b4; De Jager PL, 2009, LANCET NEUROL, V8, P1111, DOI 10.1016/S1474-4422(09)70275-3; De Stefano N, 2018, MULT SCLER J, V24, P214, DOI 10.1177/1352458517717808; DEAN G, 1971, BMJ-BRIT MED J, V3, P725, DOI 10.1136/bmj.3.5777.725; Ehler J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134583; Enzinger C, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.194; Eshaghi A, 2018, ANN NEUROL, V83, P210, DOI 10.1002/ana.25145; Filli L, 2017, NEUROLOGY, V88, P832, DOI 10.1212/WNL.0000000000003656; Fisniku LK, 2008, BRAIN, V131, P808, DOI 10.1093/brain/awm329; Fox RJ, 2017, SPRINT MS NN 102 PHA; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Gafson A, 2017, MULT SCLER J, V23, P362, DOI 10.1177/1352458516672017; Gay FW, 1997, BRAIN, V120, P1461, DOI 10.1093/brain/120.8.1461; Giovannoni G, 2017, MULT SCLER, V24, P1594, DOI [DOI 10.1177/1352458517727603, 10.1177/1352458517727603]; Giovannoni G, 2010, NEW ENGL J MED, V362, P416, DOI 10.1056/NEJMoa0902533; Goodman AD, 2010, ANN NEUROL, V68, P494, DOI 10.1002/ana.22240; Gourraud PA, 2011, ANN NEUROL, V69, P65, DOI 10.1002/ana.22323; Goverover Y, 2018, ARCH PHYS MED REHAB, V99, P390, DOI 10.1016/j.apmr.2017.07.021; Green AJ, 2017, LANCET, V390, P2481, DOI 10.1016/S0140-6736(17)32346-2; Gunn H, 2015, ARCH PHYS MED REHAB, V96, P1898, DOI 10.1016/j.apmr.2015.05.018; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Haines JL, 1998, HUM MOL GENET, V7, P1229, DOI 10.1093/hmg/7.8.1229; Hammond SR, 2000, BRAIN, V123, P968, DOI 10.1093/brain/123.5.968; Hartung DM, 2015, NEUROLOGY, V84, P2185, DOI 10.1212/WNL.0000000000001608; Haselkorn JK, 2015, NEUROLOGY, V85, P1896, DOI 10.1212/WNL.0000000000002146; Hauser SL, 2017, NEW ENGL J MED, V376, P221, DOI 10.1056/NEJMoa1601277; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Havrdova E, 2009, LANCET NEUROL, V8, P254, DOI 10.1016/S1474-4422(09)70021-3; Hemmer B, 2015, LANCET NEUROL, V14, P406, DOI 10.1016/S1474-4422(14)70305-9; Hempel S, 2017, MULT SCLER J, V23, P513, DOI 10.1177/1352458517690271; Henderson APD, 2011, ANN NEUROL, V70, P955, DOI 10.1002/ana.22554; Ho PR, 2017, LANCET NEUROL, V16, P925, DOI 10.1016/S1474-4422(17)30282-X; Hohlfeld R, 2016, LANCET NEUROL, V15, P198, DOI 10.1016/S1474-4422(15)00334-8; Howell OW, 2011, BRAIN, V134, P2755, DOI 10.1093/brain/awr182; Iaffaldano P, 2017, ANN NEUROL, V81, P729, DOI 10.1002/ana.24938; Irvine KA, 2008, BRAIN, V131, P1464, DOI 10.1093/brain/awn080; Isobe N, 2016, JAMA NEUROL, V73, P795, DOI 10.1001/jamaneurol.2016.0980; Jenkins TM, 2010, ANN NEUROL, V67, P99, DOI 10.1002/ana.21823; JERSILD C, 1972, LANCET, V1, P1240; Jokubaitis VG, 2016, ANN NEUROL, V80, P89, DOI 10.1002/ana.24682; Kalincik T, 2017, LANCET NEUROL, V16, P271, DOI 10.1016/S1474-4422(17)30007-8; Kalincik T, 2015, ANN NEUROL, V77, P425, DOI 10.1002/ana.24339; Kalincik T, 2013, BRAIN, V136, P3609, DOI 10.1093/brain/awt281; Kantarci OH, 2016, ANN NEUROL, V79, P288, DOI 10.1002/ana.24564; Kappos L, 2018, LANCET, V391, P1263, DOI 10.1016/S0140-6736(18)30475-6; Kappos L, 2016, NEUROLOGY, V87, P978, DOI 10.1212/WNL.0000000000003078; Kobelt G, 2017, MULT SCLER J, V23, P1123, DOI 10.1177/1352458517694432; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Krupp LB, 2013, MULT SCLER J, V19, P1261, DOI 10.1177/1352458513484547; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Labiano-Fontcuberta A, 2016, MULT SCLER J, V22, P1514, DOI 10.1177/1352458516653666; Laroni A, 2017, NEUROLOGY, V89, P2222, DOI 10.1212/WNL.0000000000004686; Lassmann H, 2012, NAT REV NEUROL, V8, P647, DOI 10.1038/nrneurol.2012.168; Laursen JH, 2015, MULT SCLER J, V21, P1376, DOI 10.1177/1352458515603802; Le Page E, 2015, LANCET, V386, P974, DOI 10.1016/S0140-6736(15)61137-0; Leist TP, 2014, LANCET NEUROL, V13, P257, DOI 10.1016/S1474-4422(14)70005-5; Levin LI, 2005, JAMA-J AM MED ASSOC, V293, P2496, DOI 10.1001/jama.293.20.2496; Lorscheider J, 2017, NEUROLOGY, V89, P1050, DOI 10.1212/WNL.0000000000004330; Lorscheider J, 2016, BRAIN, V139, P2395, DOI 10.1093/brain/aww173; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Lublin FD, 2014, NEUROLOGY, V83, P278, DOI 10.1212/WNL.0000000000000560; Lucio AC, 2014, MULT SCLER J, V20, P1761, DOI 10.1177/1352458514531520; Lunde HMB, 2017, J NEUROL NEUROSUR PS, V88, P621, DOI 10.1136/jnnp-2016-315238; Marrie RA, 2004, LANCET NEUROL, V3, P709, DOI 10.1016/S1474-4422(04)00933-0; Marrie RA, 2017, NAT REV NEUROL, V13, P375, DOI 10.1038/nrneurol.2017.33; McCauley JL, 2010, HUM MOL GENET, V19, P953, DOI 10.1093/hmg/ddp542; Meijer KA, 2017, NEUROLOGY, V88, P2107, DOI 10.1212/WNL.0000000000003982; Melendez-Torres GJ, 2017, HEALTH TECHNOL ASSES, V21, pI, DOI 10.3310/hta21520; Metz LM, 2017, NEW ENGL J MED, V376, P2122, DOI 10.1056/NEJMoa1608889; Miller D, 2005, LANCET NEUROL, V4, P281, DOI 10.1016/S1474-4422(05)70071-5; Miller DH, 2007, LANCET NEUROL, V6, P903, DOI 10.1016/S1474-4422(07)70243-0; Montalban X, 2017, NEW ENGL J MED, V376, P209, DOI 10.1056/NEJMoa1606468; Montalban X, 2018, MULT SCLER J, V24, P96, DOI 10.1177/1352458517751049; Motl RW, 2017, LANCET NEUROL, V16, P848, DOI 10.1016/S1474-4422(17)30281-8; Muhlau M, 2016, JAMA NEUROL, V73, P1500, DOI 10.1001/jamaneurol.2016.4329; Nash RA, 2017, NEUROLOGY, V88, P842, DOI 10.1212/WNL.0000000000003660; NICE, 2014, MULT SCLER AD MAN; Okuda DT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090509; Oliveria SF, 2017, LANCET NEUROL, V16, P691, DOI 10.1016/S1474-4422(17)30166-7; Olsson T, 2017, NAT REV NEUROL, V13, P25, DOI 10.1038/nrneurol.2016.187; Orton SM, 2006, LANCET NEUROL, V5, P932, DOI 10.1016/S1474-4422(06)70581-6; Otero-Romero S, 2016, MULT SCLER J, V22, P1386, DOI 10.1177/1352458516643600; Pakpoor J, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000158; Patsopoulos N, 2018, BIORXIV, DOI 10.1101/143933; Patsopoulos NA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003926; Peyro Saint Paul L, 2016, J NEUROL SCI, V363, P69; Phe V, 2016, NAT REV UROL, V13, P275, DOI 10.1038/nrurol.2016.53; Plavina T, 2014, ANN NEUROL, V76, P802, DOI 10.1002/ana.24286; Ploughman M, 2017, LANCET NEUROL, V16, P768, DOI 10.1016/S1474-4422(17)30301-0; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Rademakers R, 2012, NAT GENET, V44, P200, DOI 10.1038/ng.1027; Raftopoulos R, 2016, LANCET NEUROL, V15, P259, DOI 10.1016/S1474-4422(16)00004-1; Ramanujam R, 2015, JAMA NEUROL, V72, P1117, DOI 10.1001/jamaneurol.2015.1788; Rocca MA, 2017, BRAIN, V140, P2814, DOI 10.1093/brain/awx250; Rosenkranz T, 2015, NEW ENGL J MED, V372, P1476, DOI 10.1056/NEJMc1415408; Rovira A, 2015, NAT REV NEUROL, V11, P471, DOI 10.1038/nrneurol.2015.106; Sanai SA, 2016, MULT SCLER J, V22, P717, DOI 10.1177/1352458516634871; Sawcer S, 2014, LANCET NEUROL, V13, P700, DOI 10.1016/S1474-4422(14)70041-9; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schirmer L, 2014, MULT SCLER J, V20, P271, DOI 10.1177/1352458514522104; Schreiner B, 2015, CELL REP, V12, P1377, DOI 10.1016/j.celrep.2015.07.051; Scolding NJ, 2017, BRAIN, V140, P2776, DOI 10.1093/brain/awx154; Shiina T, 2004, TISSUE ANTIGENS, V64, P631, DOI 10.1111/j.1399-0039.2004.00327.x; Solomon AJ, 2016, NEUROLOGY, V87, P1393, DOI 10.1212/WNL.0000000000003152; Sombekke MH, 2013, NEUROLOGY, V80, P69, DOI 10.1212/WNL.0b013e31827b1a67; Sorensen PS, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.224; Stoppe M, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0927-x; Thompson AJ, 2018, LANCET NEUROL, V17, P162, DOI 10.1016/S1474-4422(17)30470-2; Thompson AJ, 2010, LANCET NEUROL, V9, P1182, DOI 10.1016/S1474-4422(10)70249-0; Tintore M, 2015, BRAIN, V138, P1863, DOI 10.1093/brain/awv105; Tomassini V, 2012, NAT REV NEUROL, V8, P635, DOI 10.1038/nrneurol.2012.179; Tourbah A, 2016, MULT SCLER J, V22, P1719, DOI 10.1177/1352458516667568; Trapp BD, 2009, LANCET NEUROL, V8, P280, DOI 10.1016/S1474-4422(09)70043-2; Trebst C, 2009, BLOOD PURIFICAT, V28, P108, DOI 10.1159/000224630; Ueda P, 2014, ANN NEUROL, V76, P338, DOI 10.1002/ana.24210; US Food and Drug Administration, 2015, FDA DRUG SAF COMM FD; Van der Walt A, 2012, NEUROLOGY, V79, P92, DOI 10.1212/WNL.0b013e31825dcdd9; van Horssen J, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-156; Ventura RE, 2017, MULT SCLER J, V23, P1554, DOI 10.1177/1352458516679894; Wattjes MP, 2015, NAT REV NEUROL, V11, P597, DOI 10.1038/nrneurol.2015.157; Wattjes MP, 2014, CURR OPIN NEUROL, V27, P260, DOI 10.1097/WCO.0000000000000099; WEINSHENKER BG, 1991, BRAIN, V114, P1045, DOI 10.1093/brain/114.2.1045; Weiss S, 2014, NEUROSCI BIOBEHAV R, V43, P88, DOI 10.1016/j.neubiorev.2014.03.023; Wiendl H, 2017, NEUROLOGY, V89, P1098, DOI 10.1212/WNL.0000000000004381; Youssef NA, 2017, BJU INT, V119, P515, DOI 10.1111/bju.13759	149	810	825	18	242	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2018	391	10130					1622	1636		10.1016/S0140-6736(18)30481-1	http://dx.doi.org/10.1016/S0140-6736(18)30481-1			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD5JG	29576504				2022-12-28	WOS:000430542700031
J	Brown, AF; Liang, LJ; Vassar, SD; Escarce, JJ; Merkin, SS; Cheng, E; Richards, A; Seeman, T; Longstreth, WT				Brown, Arleen F.; Liang, Li-Jung; Vassar, Stefanie D.; Escarce, Jose J.; Merkin, Sharon Stein; Cheng, Eric; Richards, Adam; Seeman, Teresa; Longstreth, W. T., Jr.			Trends in Racial/Ethnic and Nativity Disparities in Cardiovascular Health Among Adults Without Prevalent Cardiovascular Disease in the United States, 1988 to 2014	ANNALS OF INTERNAL MEDICINE			English	Article							AMERICAN-HEART-ASSOCIATION; BODY-MASS INDEX; LIFES SIMPLE 7; RISK-FACTORS; PHYSICAL-ACTIVITY; US ADULTS; MYOCARDIAL-INFARCTION; NORTHERN MANHATTAN; ETHNIC DISPARITIES; LATINOS HCHS/SOL	Background: Trends in cardiovascular disparities are poorly understood, even as diversity increases in the United States. Objective: To examine U.S. trends in racial/ethnic and nativity disparities in cardiovascular health. Design: Repeated cross-sectional study. Setting: NHANES (National Health and Nutrition Examination Survey), 1988 to 2014. Participants: Adults aged 25 years or older who did not report cardiovascular disease. Measurements: Racial/ethnic, nativity, and period differences in Life's Simple 7 (LS7) health factors and behaviors (blood pressure, cholesterol, hemoglobin A1c, body mass index, physical activity, diet, and smoking) and optimal composite scores for cardiovascular health (LS7 score >= 10). Results: Rates of optimal cardiovascular health remain below 40% among whites, 25% among Mexican Americans, and 15% among African Americans. Disparities in optimal cardiovascular health between whites and African Americans persisted but decreased over time. In 1988 to 1994, the percentage of African Americans with optimal LS7 scores was 22.8 percentage points (95% CI, 19.3 to 26.4 percentage points) lower than that of whites in persons aged 25 to 44 years and 8.0 percentage points (CI, 6.4 to 9.7 percentage points) lower in those aged 65 years or older. By 2011 to 2014, differences decreased to 10.6 percentage points (CI, 7.4 to 13.9 percentage points) and 3.8 percentage points (CI, 2.5 to 5.0 percentage points), respectively. Disparities in optimal LS7 scores between whites and Mexican Americans were smaller but also decreased. These decreases were due to reductions in optimal cardiovascular health among whites over all age groups and periods: Between 1988 to 1994 and 2011 to 2014, the percentage of whites with optimal cardiovascular health decreased 15.3 percentage points (CI, 11.1 to 19.4 percentage points) for those aged 25 to 44 years and 4.6 percentage points (CI, 2.7 to 6.5 percentage points) for those aged 65 years or older. Limitation: Only whites, African Americans, and Mexican Americans were studied. Conclusion: Cardiovascular health has declined in the United States, racial/ethnic and nativity disparities persist, and decreased disparities seem to be due to worsening cardiovascular health among whites rather than gains among African Americans and Mexican Americans. Multifaceted interventions are needed to address declining population health and persistent health disparities. Primary Funding Source: National Institute of Neurological Disorders and Stroke and National Center for Advancing Translational Sciences of the National Institutes of Health.	[Brown, Arleen F.; Liang, Li-Jung; Vassar, Stefanie D.; Escarce, Jose J.; Richards, Adam] Univ Calif Los Angeles, Dept Med, Div Gen Internal Med, Box 951736,911 Broxton Ave, Los Angeles, CA 90095 USA; [Brown, Arleen F.; Liang, Li-Jung; Vassar, Stefanie D.; Escarce, Jose J.; Richards, Adam] Univ Calif Los Angeles, Dept Med, Hlth Serv Res, Box 951736,911 Broxton Ave, Los Angeles, CA 90095 USA; [Merkin, Sharon Stein; Seeman, Teresa] Univ Calif Los Angeles, Dept Med, Div Geriatr, Box 951687,2339 PVUB, Los Angeles, CA USA; [Cheng, Eric] Univ Calif Los Angeles, Neurol, Box 957250,Oppenheimer Tower,10880 Wilshire Blvd, Los Angeles, CA 90095 USA; [Longstreth, W. T., Jr.] Harborview Med Ctr, Dept Neurol, Box 359775,325 Ninth Ave, Seattle, WA 98104 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Harborview Medical Center	Brown, AF (corresponding author), Univ Calif Los Angeles, Dept Med, Div Gen Internal Med, Box 951736,911 Broxton Ave, Los Angeles, CA 90095 USA.; Brown, AF (corresponding author), Univ Calif Los Angeles, Dept Med, Hlth Serv Res, Box 951736,911 Broxton Ave, Los Angeles, CA 90095 USA.	ABrown@mednet.ucla.edu	richards, adam/ABF-8189-2021	richards, adam/0000-0002-7098-0513; Brown, Arleen/0000-0001-9948-8955	National Institute of Neurological Disorders and Stroke of the National Institutes of Health [U54NS081764]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR001881]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS081764] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	By award U54NS081764 from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health and grant UL1TR001881 from the National Center for Advancing Translational Sciences of the National Institutes of Health to the University of California, Los Angeles, Clinical and Translational Science Institute.	Aadahl M, 2003, MED SCI SPORT EXER, V35, P1196, DOI 10.1249/01.MSS.0000074446.02192.14; Bartolome Rowena E, 2016, Perm J, V20, P53, DOI 10.7812/TPP/15-052; Berglund P, 2014, MULTIPLE IMPUTATION; Caleyachetty R, 2015, INT J CARDIOL, V191, P296, DOI 10.1016/j.ijcard.2015.05.007; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Centers for Disease Control and Prevention, 1996, 1988 1994 NHANES HOU; Centers for Disease Control and Prevention, 2011, AN NOT REG 2007 2010; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P524; Centers for Disease Control and Prevention; National Center forHealth Statistics, 2018, NAT HLTH NUTR EX SUR; Cohen MG, 2010, CIRCULATION, V121, P2294, DOI 10.1161/CIRCULATIONAHA.109.922286; Colby SL, 2015, PROJECTIONS SIZE COM; Crimmins EM, 2007, AM J PUBLIC HEALTH, V97, P1305, DOI 10.2105/AJPH.2006.091892; Daviglus ML, 2014, PROG CARDIOVASC DIS, V57, P230, DOI 10.1016/j.pcad.2014.07.006; Daviglus ML, 2012, JAMA-J AM MED ASSOC, V308, P1775, DOI 10.1001/jama.2012.14517; Djousse L, 2015, PREV MED, V74, P111, DOI 10.1016/j.ypmed.2015.02.006; Dominguez K, 2015, MMWR-MORBID MORTAL W, V64, P469; Dong CH, 2012, CIRCULATION, V125, P2975, DOI 10.1161/CIRCULATIONAHA.111.081083; Ellrodt AG, 2013, CIRCULATION, V128, P2447, DOI 10.1161/01.cir.0000435779.48007.5c; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Folsom AR, 2015, AM J MED, V128, P970, DOI 10.1016/j.amjmed.2015.03.027; Folsom AR, 2011, J AM COLL CARDIOL, V57, P1690, DOI 10.1016/j.jacc.2010.11.041; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Ford ES, 2012, CIRCULATION, V125, P987, DOI 10.1161/CIRCULATIONAHA.111.049122; Fretts AM, 2014, DIABETES CARE, V37, P2240, DOI 10.2337/dc13-2267; Fryar Cheryl D, 2012, NCHS Data Brief, P1; Galea S, 2010, INT J EPIDEMIOL, V39, P97, DOI 10.1093/ije/dyp296; Gonzalez-Barrera A., 2005, MORE MEXICANS LEAVIN; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Guo FJ, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003619; Gutierrez-Fisac JL, 2002, OBES RES, V10, P270, DOI 10.1038/oby.2002.37; He XXZ, 2004, AM J PUBLIC HEALTH, V94, P1567, DOI 10.2105/AJPH.94.9.1567; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Institute of Medicine, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Jaffe MG, 2013, JAMA-J AM MED ASSOC, V310, P699, DOI 10.1001/jama.2013.108769; Kanjilal S, 2006, ARCH INTERN MED, V166, P2348, DOI 10.1001/archinte.166.21.2348; Kershaw KN, 2016, PREV MED, V89, P84, DOI 10.1016/j.ypmed.2016.05.013; Kershaw KN, 2012, PREV MED, V55, P597, DOI 10.1016/j.ypmed.2012.09.019; Kindig DA, 2015, HLTH AFFAIRS BLOG, DOI 10.1377/hblog20150406.046151/full/; Koenig W, 1997, CIRCULATION, V95, P335; Koh HK, 2010, NEW ENGL J MED, V362, P1653, DOI 10.1056/NEJMp1001601; Kolenikov S, 2010, STATA J, V10, P165, DOI 10.1177/1536867X1001000201; Kronish IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052771; Krueger PM, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0666-6; Kulshreshtha A, 2013, STROKE, V44, P1909, DOI 10.1161/STROKEAHA.111.000352; Kurian AK, 2007, ETHNIC DIS, V17, P143; Kypridemos C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123112; Lackland DT, 2014, STROKE, V45, P315, DOI 10.1161/01.str.0000437068.30550.cf; LaVeist TA, 2011, INT J HEALTH SERV, V41, P231, DOI 10.2190/HS.41.2.c; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Muntner P, 2013, J AM SOC NEPHROL, V24, P1159, DOI 10.1681/ASN.2012070642; Murillo R, 2015, AM J HEALTH PROMOT, V30, P50, DOI 10.4278/ajhp.140128-QUAN-49; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ogunmoroti O, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005180; Pearson-Stuttard J, 2016, CIRCULATION, V133, P967, DOI 10.1161/CIRCULATIONAHA.115.019904; RAUH MJD, 1992, INT J EPIDEMIOL, V21, P966, DOI 10.1093/ije/21.5.966; Rodriguez CJ, 2014, CIRCULATION, V130, P593, DOI 10.1161/CIR.0000000000000071; Sacco RL, 2001, STROKE, V32, P1725, DOI 10.1161/01.STR.32.8.1725; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Saydah S, 2014, OBESITY, V22, P1888, DOI 10.1002/oby.20761; Selvin E, 2014, ANN INTERN MED, V160, P517, DOI 10.7326/M13-2411; Sequist TD, 2014, NEW ENGL J MED, V371, P2148, DOI 10.1056/NEJMp1408457; Sharma S, 2004, ETHNIC DIS, V14, P43; Shay CM, 2015, PROG CARDIOVASC DIS, V58, P41, DOI 10.1016/j.pcad.2015.05.003; Thacker EL, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000635; Tynan M., 2011, Morbidity and Mortality Weekly Report, V60, P472; United States Department of Health and Human Services, 2010, END TOB EP TOB CONTR; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339	70	61	61	1	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2018	168	8					541	+		10.7326/M17-0996	http://dx.doi.org/10.7326/M17-0996			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GC8XZ	29554692	Green Accepted			2022-12-28	WOS:000430083100014
J	Kahi, CJ; Pohl, H; Myers, LJ; Mobarek, D; Robertson, DJ; Imperiale, TF				Kahi, Charles J.; Pohl, Heiko; Myers, Laura J.; Mobarek, Dalia; Robertson, Douglas J.; Imperiale, Thomas F.			Colonoscopy and Colorectal Cancer Mortality in the Veterans Affairs Health Care System A Case-Control Study	ANNALS OF INTERNAL MEDICINE			English	Article							NEGATIVE COLONOSCOPY; SCREENING COLONOSCOPY; LOWER ENDOSCOPY; UNITED-STATES; RISK; ASSOCIATION; PREDICTORS; PROTECTION; RATIONALE; SPECIALTY	Background: Colonoscopy is widely used in the Veterans Affairs (VA) health care system for colorectal cancer (CRC) prevention, but its effect on CRC mortality is unknown. Objective: To determine whether colonoscopy is associated with decreased CRC mortality in veterans and whether its effect differs by anatomical location of CRC. Design: Case-control study. Setting: VA-Medicare administrative data. Participants: Case patients were veterans aged 52 years or older who were diagnosed with CRC between 2002 and 2008 and died of the disease by the end of 2010. Case patients were matched to 4 control patients without prior CRC on the basis of age, sex, and facility. Conditional logistic regression was performed to calculate odds ratios (ORs) for exposure to colonoscopy, with adjustment for race, Charlson Comorbidity Index score, selected chronic conditions, nonsteroidal anti-inflammatory drug use, and family history of CRC. Measurements: Exposure to colonoscopy was determined from 1997 to 6 months before CRC diagnosis in case patients and to a corresponding date in control patients. Subgroup analysis was performed for patients who had undergone screening colonoscopy. Results: A total of 4964 case patients and 19 856 control patients were identified. Case patients were significantly less likely to have undergone any colonoscopy (OR, 0.39 [95% CI, 0.35 to 0.43]). Colonoscopy was associated with reduced mortality for left-sided cancer (OR, 0.28 [CI, 0.24 to 0.32]) and right-sided cancer (OR, 0.54[CI, 0.47 to 0.63]). The results were similar for patients who had undergone screening colonoscopy (overall OR, 0.30 [CI, 0.24 to 0.38]). Sensitivity analyses that varied the interval between CRC diagnosis and colonoscopy exposure did not affect the primary findings. Limitation: Unmeasured confounding. Conclusion: In this study using national VA-Medicare data, colonoscopy was associated with significant reductions in CRC mortality among veterans and was associated with greater benefit for left-sided cancer than right-sided cancer.	[Kahi, Charles J.] Indiana Univ Sch Med, Clin Med, Gastroenterol Sect Chief, Roudebush VA Med Ctr, 1481 West 10th St,111G, Indianapolis, IN 46202 USA; [Pohl, Heiko] White River Junct VA Med Ctr, Dept Hepatol & Gastroenterol, 215 North Main St, White River Jct, VT 05009 USA; [Myers, Laura J.] Roudebush VA Med Ctr, HSR&D Ctr Excellence, 1481 West 10th St, Indianapolis, IN 46202 USA; [Mobarek, Dalia] Vet Affairs Med Ctr, 50 Irving St NW,Suite 2C North 128, Washington, DC USA; [Robertson, Douglas J.] White River Junct VA Med Ctr, Dept Med 111E, Div Gastroenterol, 215 North Main St, White River Jct, VT 05009 USA; [Imperiale, Thomas F.] Indiana Univ, Regenstrief Inst Inc, 1101 West 10th St, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc	Kahi, CJ (corresponding author), Indiana Univ Sch Med, Clin Med, Gastroenterol Sect Chief, Roudebush VA Med Ctr, 1481 West 10th St,111G, Indianapolis, IN 46202 USA.	ckahi2@iu.edu		Imperiale, Thomas/0000-0001-7586-1073	VA Clinical Science Research Development [1 I01 CX000589-01A2]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development, VA Information Resource Center [SDR 02-237, SDR 98-004]	VA Clinical Science Research Development; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development, VA Information Resource Center(US Department of Veterans Affairs)	By a VA Clinical Science Research & Development Grant (1 I01 CX000589-01A2) to Drs. Kahi and Pohl. Support for VACMS data is provided by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development, VA Information Resource Center (project numbers SDR 02-237 and 98-004). This work was also supported using resources and facilities at the VA Informatics and Computing Infrastructure, VA HSR RES 13-457.	Baxter NN, 2012, J CLIN ONCOL, V30, P2664, DOI 10.1200/JCO.2011.40.4772; Baxter NN, 2011, GASTROENTEROLOGY, V140, P65, DOI 10.1053/j.gastro.2010.09.006; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Brenner H, 2014, GASTROENTEROLOGY, V146, P709, DOI 10.1053/j.gastro.2013.09.001; Brenner H, 2012, GUT, V61, P1576, DOI 10.1136/gutjnl-2011-301531; Brenner H, 2011, J CLIN ONCOL, V29, P3761, DOI 10.1200/JCO.2011.35.9307; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Brenner H, 2010, GASTROENTEROLOGY, V138, P870, DOI 10.1053/j.gastro.2009.10.054; Brenner H, 2010, J NATL CANCER I, V102, P89, DOI 10.1093/jnci/djp436; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Department of Veterans Affairs, 2014, COL CANC SCREEN VHA; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dominitz JA, 2017, AM J GASTROENTEROL, V112, P1736, DOI 10.1038/ajg.2017.286; Doubeni CA, 2018, GUT, V67, P291, DOI 10.1136/gutjnl-2016-312712; El-Serag HB, 2006, ARCH INTERN MED, V166, P2202, DOI 10.1001/archinte.166.20.2202; Hewett David G, 2015, Gastrointest Endosc Clin N Am, V25, P403, DOI 10.1016/j.giec.2014.12.002; Kahi CJ, 2014, GASTROENTEROLOGY, V146, P718, DOI 10.1053/j.gastro.2013.11.050; Kahi CJ, 2009, CLIN GASTROENTEROL H, V7, P770, DOI 10.1016/j.cgh.2008.12.030; Kaminski MF, 2012, ENDOSCOPY, V44, P695, DOI 10.1055/s-0032-1306895; Klabunde CN, 2013, MMWR-MORBID MORTAL W, V62, P881; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Mulder SA, 2010, EUR J GASTROEN HEPAT, V22, P437, DOI 10.1097/MEG.0b013e328333fc6a; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Park LS, 2014, J AIDS CLIN RES, V5, DOI DOI 10.1038/NCOMMS6318; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]; Rabeneck L, 2010, CLIN GASTROENTEROL H, V8, P275, DOI 10.1016/j.cgh.2009.10.022; Rutter MD, 2016, ENDOSCOPY, V48, P81, DOI 10.1055/s-0035-1569580; Seeff LC, 2004, GASTROENTEROLOGY, V127, P1670, DOI 10.1053/j.gastro.2004.09.051; Singh H, 2010, AM J GASTROENTEROL, V105, P2588, DOI 10.1038/ajg.2010.390; Singh H, 2010, GASTROENTEROLOGY, V139, P1128, DOI 10.1053/j.gastro.2010.06.052; Singh H, 2010, AM J GASTROENTEROL, V105, P663, DOI 10.1038/ajg.2009.650; Trivedi AN, 2011, MED CARE, V49, P76, DOI 10.1097/MLR.0b013e3181f53575	34	35	35	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2018	168	7					481	+		10.7326/M17-0723	http://dx.doi.org/10.7326/M17-0723			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB4AB	29532085	Green Submitted			2022-12-28	WOS:000429000900006
J	Kappos, L; Bar-Or, A; Cree, BAC; Fox, RJ; Giovannoni, G; Gold, R; Vermersch, P; Arnold, DL; Arnould, S; Scherz, T; Wolf, C; Wallstrom, E; Dahlke, F				Kappos, Ludwig; Bar-Or, Amit; Cree, Bruce A. C.; Fox, Robert J.; Giovannoni, Gavin; Gold, Ralf; Vermersch, Patrick; Arnold, Douglas L.; Arnould, Sophie; Scherz, Tatiana; Wolf, Christian; Wallstroem, Erik; Dahlke, Frank		EXPAND Clinical Investigators	Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study	LANCET			English	Article							INTERFERON BETA-1B; CLINICAL-TRIALS; DISABILITY; MS; FINGOLIMOD	Background No treatment has consistently shown efficacy in slowing disability progression in patients with secondary progressive multiple sclerosis (SPMS). We assessed the effect of siponimod, a selective sphingosine 1-phosphate (S1P) receptor 1,5 modulator, on disability progression in patients with SPMS. Methods This event-driven and exposure-driven, double-blind, phase 3 trial was done at 292 hospital clinics and specialised multiple sclerosis centres in 31 countries. Using interactive response technology to assign numbers linked to treatment arms, patients (age 18-60 years) with SPMS and an Expanded Disability Status Scale score of 3.0-6.5 were randomly assigned (2: 1) to once daily oral siponimod 2 mg or placebo for up to 3 years or until the occurrence of a prespecified number of confirmed disability progression (CDP) events. The primary endpoint was time to 3-month CDP. Efficacy was assessed for the full analysis set (ie, all randomly assigned and treated patients); safety was assessed for the safety set. This trial is registered with ClinicalTrials. gov, number NCT01665144. Findings 1651 patients were randomly assigned between Feb 5, 2013, and June 2, 2015 (1105 to the siponimod group, and 546 to the placebo group). One patient did not sign the consent form, and five patients did not receive study drug, all of whom were in the siponimod group. 1645 patients were included in the analyses (1099 in the siponimod group and 546 in the placebo). At baseline, the mean time since first multiple sclerosis symptoms was 16.8 years (SD 8.3), and the mean time since conversion to SPMS was 3.8 years (SD 3.5); 1055 (64%) patients had not relapsed in the previous 2 years, and 918 (56%) of 1651 needed walking assistance. 903 (82%) patients receiving siponimod and 424 (78%) patients receiving placebo completed the study. 288 (26%) of 1096 patients receiving siponimod and 173 (32%) of 545 patients receiving placebo had 3-month CDP (hazard ratio 0.79, 95% CI 0.65-0.95; relative risk reduction 21%; p=0.013). Adverse events occurred in 975 (89%) of 1099 patients receiving siponimod versus 445 (82%) of 546 patients receiving placebo; serious adverse events were reported for 197 (18%) patients in the siponimod group versus 83 (15%) patients in the placebo group. Lymphopenia, increased liver transaminase concentration, bradycardia and bradyarrhythmia at treatment initiation, macular oedema, hypertension, varicella zoster reactivation, and convulsions occurred more frequently with siponimod than with placebo. Initial dose titration mitigated cardiac first-dose effects. Frequencies of infections, malignancies, and fatalities did not differ between groups. Interpretation Siponimod reduced the risk of disability progression with a safety profile similar to that of other S1P modulators and is likely to be a useful treatment for SPMS.	[Kappos, Ludwig] Univ Basel, Univ Hosp, Dept Med, Neurol Clin & Policlin, CH-4031 Basel, Switzerland; [Kappos, Ludwig] Univ Basel, Univ Hosp, Dept Clin Res, Neurol Clin & Policlin, CH-4031 Basel, Switzerland; [Kappos, Ludwig] Univ Basel, Univ Hosp, Dept Biomed, Neurol Clin & Policlin, CH-4031 Basel, Switzerland; [Kappos, Ludwig] Univ Basel, Univ Hosp, Dept Biomed Engn, Neurol Clin & Policlin, CH-4031 Basel, Switzerland; [Bar-Or, Amit] Univ Penn, Perelman Sch Med, Ctr Neuroinflammat & Neurotherapeut, Philadelphia, PA 19104 USA; [Bar-Or, Amit] Univ Penn, Perelman Sch Med, Multiple Sclerosis Div, Dept Neurol, Philadelphia, PA 19104 USA; [Bar-Or, Amit] McGill Univ, Montreal Neurol Inst & Hosp, Neuroimmunol Unit, Montreal, PQ, Canada; [Cree, Bruce A. C.] Univ Calif San Francisco, Dept Neurol, UCSF Weill Inst Neurosci, San Francisco, CA USA; [Fox, Robert J.] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Neurol Inst, Cleveland, OH 44106 USA; [Giovannoni, Gavin] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England; [Gold, Ralf] Ruhr Univ Bochum, Dept Neurol, St Josef Hosp, Bochum, Germany; [Vermersch, Patrick] Univ Lille, CHU Lille, LIRIC INSERM U995, Lille, France; [Arnold, Douglas L.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Arnold, Douglas L.] NeuroRx Res, Montreal, PQ, Canada; [Arnould, Sophie; Scherz, Tatiana; Wallstroem, Erik; Dahlke, Frank] Novartis Pharma AG, Basel, Switzerland; [Wolf, Christian] Lycalis, Brussels, Belgium	University of Basel; University of Basel; University of Basel; University of Basel; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; McGill University; University of California System; University of California San Francisco; Cleveland Clinic Foundation; University of London; Queen Mary University London; Ruhr University Bochum; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; McGill University; Novartis	Kappos, L (corresponding author), Univ Basel, Univ Hosp, Dept Med, Neurol Clin & Policlin, CH-4031 Basel, Switzerland.; Kappos, L (corresponding author), Univ Basel, Univ Hosp, Dept Clin Res, Neurol Clin & Policlin, CH-4031 Basel, Switzerland.; Kappos, L (corresponding author), Univ Basel, Univ Hosp, Dept Biomed, Neurol Clin & Policlin, CH-4031 Basel, Switzerland.; Kappos, L (corresponding author), Univ Basel, Univ Hosp, Dept Biomed Engn, Neurol Clin & Policlin, CH-4031 Basel, Switzerland.	ludwig.kappos@usb.ch	Centonze, Diego/J-7767-2016; Brola, Waldemar/D-8813-2014; Bar-Or, Amit/AIC-1416-2022; Hardiman, Orla/Y-3441-2019; van Oosten, Bob/I-7152-2012; Montalban, Xavier/J-5938-2016; Cerqueira, Joao J/B-4579-2008; Nakahara, Jin/M-4427-2013; Siva, Aksel/A-5132-2016; Weissert, Robert/B-2585-2009; Cree, Bruce C/AAV-6109-2020; Odinak, Miroslav/I-6024-2016; UCCELLI, Antonio/E-7343-2012; Dubois, Benedicte/A-4338-2019	Centonze, Diego/0000-0002-8390-8545; Brola, Waldemar/0000-0002-7955-3454; Hardiman, Orla/0000-0003-2610-1291; van Oosten, Bob/0000-0003-4536-6201; Montalban, Xavier/0000-0002-0098-9918; Cerqueira, Joao J/0000-0003-3155-2775; Siva, Aksel/0000-0002-8340-6641; Weissert, Robert/0000-0002-1295-1271; Cree, Bruce C/0000-0001-7689-2533; Odinak, Miroslav/0000-0002-7314-7711; UCCELLI, Antonio/0000-0002-2008-6038; Simu, Mihaela/0000-0001-9676-1282; Chan, Andrew/0000-0003-3434-7283; Laureys, Guy/0000-0002-1708-4373; Dubois, Benedicte/0000-0003-0604-8702; Sazonov, Denis/0000-0003-4127-0704; Sidorenko, Tatiana/0000-0003-4262-7293; MARTINEZ YELAMOS, SERGIO/0000-0001-9889-2040; antel, jack/0000-0002-5148-0636; Wiendl, Heinz/0000-0003-4310-3432; Roshanisefat, Homayoun/0000-0002-3019-8826; Nakahara, Jin/0000-0002-5858-0998; Wolf, Christian/0000-0002-4683-0507; Jasinska, Elzbieta/0000-0003-0016-9896; Hua, Le/0000-0002-0535-3978; Maeurer, Markus/0000-0002-8436-8077; Derfuss, Tobias/0000-0001-8656-4250; MIRABELLA, Massimiliano/0000-0002-7783-114X; Willekens, Barbara/0000-0002-5212-8837; Toomsoo, Toomas/0000-0002-8364-0438; Selmaj, Krzysztof/0000-0003-1213-7218; Stolarov, Igor'/0000-0001-8154-9107; Walter, Silke/0000-0002-1176-2911; Boz, Cavit/0000-0003-0956-3304; Martins da Silva, Ana/0000-0002-1409-0831; Kozubski, Wojciech/0000-0003-2777-261X; Ziemssen, Tjalf/0000-0001-8799-8202; Czlonkowska, Anna/0000-0002-1956-1866; Krastev, Georgi/0000-0002-2904-3317; Arnold, Douglas/0000-0003-4266-0106; Butzkueven, Helmut/0000-0003-3940-8727; Shchukin, Ivan/0000-0002-6308-9706; Boyko, Alexei/0000-0003-3306-9541; Turcani, Peter/0000-0002-4868-6836; Wiertlewki, Sandrine/0000-0002-8678-3661	Novartis Pharma AG; Novartis Pharma AG (Basel, Switzerland); Novartis Pharma; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI144298] Funding Source: NIH RePORTER	Novartis Pharma AG; Novartis Pharma AG (Basel, Switzerland); Novartis Pharma; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Novartis Pharma AG.; The study investigators and Novartis are grateful to all of the patients in EXPAND for their participation in and commitment to the study. We thank Tobias Derfuss, Jens Kuhle, Davorka Tomic, and David Leppert for advice during the project. Davorka Tomic, Goril Karlsson, Nicolas Rouyrre, Harald Pohlmann, Tobias Derfuss, and Jens Kuhle provided input and help in the assessment, analysis, and interpretation of the data. This research was funded by Novartis Pharma AG (Basel, Switzerland). Ludwig Kappos, Christian Wolf, and Frank Dahlke wrote the first draft of this manuscript. Medical writing assistance was provided by Mark Rolfe and Kim Wager (Oxford PharmaGenesis, Oxford, UK), with input from all authors. Jane Francis (Oxford PharmaGenesis, Oxford, UK) copyedited and styled the manuscript as per the journal requirements. Their services were paid for by Novartis Pharma. Frauke Treppke (University Hospital Basel) provided secretarial assistance.	Aslanis V, 2012, MULT SCLER S, V18, P279; Bennett Susan E, 2017, Int J MS Care, V19, P247, DOI 10.7224/1537-2073.2015-006; Brinkmann V, 2009, BRIT J PHARMACOL, V158, P1173, DOI 10.1111/j.1476-5381.2009.00451.x; D'Souza M, 2017, MULT SCLER J, V23, P597, DOI 10.1177/1352458516657439; Ebers GC, 2008, NEUROLOGY, V71, P624, DOI 10.1212/01.wnl.0000313034.46883.16; Gentile A, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0686-4; Gergely P, 2012, BRIT J PHARMACOL, V167, P1035, DOI 10.1111/j.1476-5381.2012.02061.x; Jackson SJ, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-76; Kappos L, 1998, LANCET, V352, P1491, DOI 10.1016/S0140-6736(98)10039-9; Kappos L, 2004, NEUROLOGY, V63, P1779, DOI 10.1212/01.WNL.0000145561.08973.4F; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Lublin FD, 2014, NEUROLOGY, V83, P278, DOI 10.1212/WNL.0000000000000560; Montalban X, 2017, NEW ENGL J MED, V376, P209, DOI 10.1056/NEJMoa1606468; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Panitch H, 2004, NEUROLOGY, V63, P1788; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Rovaris M, 2006, LANCET NEUROL, V5, P343, DOI 10.1016/S1474-4422(06)70410-0; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Scalfari A, 2014, J NEUROL NEUROSUR PS, V85, P67, DOI 10.1136/jnnp-2012-304333; Selmaj K, 2013, LANCET NEUROL, V12, P756, DOI 10.1016/S1474-4422(13)70102-9; Shirani A, THERAPEUTIC ADV FUTU; Steiner D, 2016, NEUROLOGY, V87, pE22; Tanigawa Makoto, 2017, Mult Scler J Exp Transl Clin, V3, p2055217316688930, DOI 10.1177/2055217316688930; Tremlett H, 2008, MULT SCLER J, V14, P314, DOI 10.1177/1352458507084264	26	441	461	2	70	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 31	2018	391	10127					1263	1273		10.1016/S0140-6736(18)30475-6	http://dx.doi.org/10.1016/S0140-6736(18)30475-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB1DR	29576505				2022-12-28	WOS:000428791600025
J	Citron, RI; Manga, M; Hemingway, DJ				Citron, Robert I.; Manga, Michael; Hemingway, Douglas J.			Timing of oceans on Mars from shoreline deformation	NATURE			English	Article							DEPENDENT ROTATIONAL STABILITY; NORTHERN LOWLANDS; DYNAMIC PLANETS; ANCIENT OCEANS; TOPOGRAPHY; TIME; THARSIS; DICHOTOMY; EVOLUTION; TERRAIN	Widespread evidence points to the existence of an ancient Martian ocean(1-8). Most compelling are the putative ancient shorelines in the northern plains(2,7). However, these shorelines fail to follow an equipotential surface, and this has been used to challenge the notion that they formed via an early ocean(9) and hence to question the existence of such an ocean. The shorelines' deviation from a constant elevation can be explained by true polar wander occurring after the formation of Tharsis(10), a volcanic province that dominates the gravity and topography of Mars. However, surface loading from the oceans can drive polar wander only if Tharsis formed far from the equator(10), and most evidence indicates that Tharsis formed near the equator(11-15), meaning that there is no current explanation for the shorelines' deviation from an equipotential that is consistent with our geophysical understanding of Mars. Here we show that variations in shoreline topography can be explained by deformation caused by the emplacement of Tharsis. We find that the shorelines must have formed before and during the emplacement of Tharsis, instead of afterwards, as previously assumed. Our results imply that oceans on Mars formed early, concurrent with the valley networks(15), and point to a close relationship between the evolution of oceans on Mars and the initiation and decline of Tharsis volcanism, with broad implications for the geology, hydrological cycle and climate of early Mars.	[Citron, Robert I.; Manga, Michael; Hemingway, Douglas J.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Citron, Robert I.; Manga, Michael; Hemingway, Douglas J.] Univ Calif Berkeley, Ctr Integrat Planetary Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Citron, RI (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.; Citron, RI (corresponding author), Univ Calif Berkeley, Ctr Integrat Planetary Sci, Berkeley, CA 94720 USA.	ricitron@berkeley.edu	Manga, Michael/D-3847-2013; Hemingway, Douglas/F-6332-2014	Manga, Michael/0000-0003-3286-4682; Citron, Robert/0000-0001-8920-0356; Hemingway, Douglas/0000-0001-5617-207X				Anderson RC, 2001, J GEOPHYS RES-PLANET, V106, P20563, DOI 10.1029/2000JE001278; [Anonymous], 2003, MGSMMOLA5MEGDRL3V10; Arkani-Hamed J, 1998, J GEOPHYS RES-PLANET, V103, P3709, DOI 10.1029/97JE02815; BAKER VR, 1991, NATURE, V352, P589, DOI 10.1038/352589a0; Bouley S, 2016, NATURE, V531, P344, DOI 10.1038/nature17171; CARR MH, 2003, J GEOPHYS RES-PLANET, V108, DOI [DOI 10.1029/2002JE001963, 10.1029/2002je001963]; Chan NH, 2014, J GEOPHYS RES-PLANET, V119, P169, DOI 10.1002/2013JE004466; Clifford SM, 2001, ICARUS, V154, P40, DOI 10.1006/icar.2001.6671; Costard F, 2017, J GEOPHYS RES-PLANET, V122, P633, DOI 10.1002/2016JE005230; Daradich A, 2008, ICARUS, V194, P463, DOI 10.1016/j.icarus.2007.10.017; Davila AF, 2013, GEOLOGY, V41, P755, DOI 10.1130/G34201.1; Di Achille G, 2010, NAT GEOSCI, V3, P459, DOI 10.1038/NGEO891; Dohm J.M., 2007, SUPERPLUMES PLATE TE, P523; Edgett KS, 1997, GEOPHYS RES LETT, V24, P2897, DOI 10.1029/97GL02840; Fairen AG, 2010, ICARUS, V208, P165, DOI 10.1016/j.icarus.2010.01.006; Grott M, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003456; Halevy I, 2007, SCIENCE, V318, P1903, DOI 10.1126/science.1147039; Halevy I, 2014, NAT GEOSCI, V7, P865, DOI 10.1038/NGEO2293; Harada Y, 2012, ICARUS, V220, P449, DOI 10.1016/j.icarus.2012.05.024; Head JW, 1999, SCIENCE, V286, P2134, DOI 10.1126/science.286.5447.2134; Hu H, 2017, J GEOPHYS RES-PLANET, V122, P2745, DOI 10.1002/2017JE005365; Ivanov MA, 2017, PLANET SPACE SCI, V144, P49, DOI 10.1016/j.pss.2017.05.012; Kite ES, 2017, NAT GEOSCI, V10, P737, DOI 10.1038/NGEO3033; Kite ES, 2009, EARTH PLANET SC LETT, V280, P254, DOI 10.1016/j.epsl.2009.01.040; Malin MC, 1999, GEOPHYS RES LETT, V26, P3049, DOI 10.1029/1999GL002342; Matsuyama I, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2010JE003686; McGowan EM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024170; Moore KM, 2017, ICARUS, V289, P34, DOI 10.1016/j.icarus.2017.01.036; Pan L, 2017, J GEOPHYS RES-PLANET, V122, P1824, DOI 10.1002/2017JE005276; PARKER TJ, 1989, ICARUS, V82, P111, DOI 10.1016/0019-1035(89)90027-4; PARKER TJ, 1993, J GEOPHYS RES-PLANET, V98, P11061, DOI 10.1029/93JE00618; Perron JT, 2007, NATURE, V447, P840, DOI 10.1038/nature05873; Roberts JH, 2007, ICARUS, V190, P24, DOI 10.1016/j.icarus.2007.03.002; Roberts JH, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002226; Rodriguez JAP, 2016, SCI REP-UK, V6, DOI 10.1038/srep25106; Rouby H, 2008, EARTH PLANET SC LETT, V272, P212, DOI 10.1016/j.epsl.2008.04.044; Ruiz J, 2004, PLANET SPACE SCI, V52, P1297, DOI 10.1016/j.pss.2004.06.003; Ruiz J., 2006, SPACE SCI NEW RES, P141; Searls ML, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002666; SJOGREN WL, 1979, SCIENCE, V203, P1006, DOI 10.1126/science.203.4384.1006; Spada G, 2008, COMPUT GEOSCI-UK, V34, P667, DOI 10.1016/j.cageo.2007.12.001; Tanaka KL, 2014, PLANET SPACE SCI, V95, P11, DOI 10.1016/j.pss.2013.03.006; Tian F, 2010, EARTH PLANET SC LETT, V295, P412, DOI 10.1016/j.epsl.2010.04.016; Werner SC, 2011, ICARUS, V215, P603, DOI 10.1016/j.icarus.2011.07.024; WILLEMANN RJ, 1984, ICARUS, V60, P701, DOI 10.1016/0019-1035(84)90174-X; Zuber MT, 2000, SCIENCE, V287, P1788, DOI 10.1126/science.287.5459.1788	46	58	59	7	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2018	555	7698					643	+		10.1038/nature26144	http://dx.doi.org/10.1038/nature26144			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8UX	29555993	Green Submitted			2022-12-28	WOS:000428617600046
J	Riddle, MR; Aspiras, AC; Gaudenz, K; Peuss, R; Sung, JY; Martineau, B; Peavey, M; Box, AC; Tabin, JA; McGaugh, S; Borowsky, R; Tabin, CJ; Rohner, N				Riddle, Misty R.; Aspiras, Ariel C.; Gaudenz, Karin; Peuss, Robert; Sung, Jenny Y.; Martineau, Brian; Peavey, Megan; Box, Andrew C.; Tabin, Julius A.; McGaugh, Suzanne; Borowsky, Richard; Tabin, Clifford J.; Rohner, Nicolas			Insulin resistance in cavefish as an adaptation to a nutrient-limited environment	NATURE			English	Article							GLYCATION END-PRODUCTS; BLIND CAVEFISH; RECEPTOR; POPULATIONS; METABOLISM; MUTATIONS; INSIGHTS; DISEASE; GLUCOSE; FISH	Periodic food shortages are a major challenge faced by organisms in natural habitats. Cave-dwelling animals must withstand long periods of nutrient deprivation, as-in the absence of photosynthesis-caves depend on external energy sources such as seasonal floods(1). Here we show that cave-adapted populations of the Mexican tetra, Astyanax mexicanus, have dysregulated blood glucose homeostasis and are insulin-resistant compared to river-adapted populations. We found that multiple cave populations carry a mutation in the insulin receptor that leads to decreased insulin binding in vitro and contributes to hyperglycaemia. Hybrid fish from surface-cave crosses carrying this mutation weigh more than non-carriers, and zebrafish genetically engineered to carry the mutation have increased body weight and insulin resistance. Higher body weight may be advantageous in caves as a strategy to cope with an infrequent food supply. In humans, the identical mutation in the insulin receptor leads to a severe form of insulin resistance and reduced lifespan. However, cavefish have a similar lifespan to surface fish and do not accumulate the advanced glycation end-products in the blood that are typically associated with the progression of diabetes-associated pathologies. Our findings suggest that diminished insulin signalling is beneficial in a nutrient-limited environment and that cavefish may have acquired compensatory mechanisms that enable them to circumvent the typical negative effects associated with failure to regulate blood glucose levels.	[Riddle, Misty R.; Aspiras, Ariel C.; Martineau, Brian; Peavey, Megan; Tabin, Julius A.; Tabin, Clifford J.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Gaudenz, Karin; Peuss, Robert; Sung, Jenny Y.; Box, Andrew C.; Rohner, Nicolas] Stowers Inst Med Res, Kansas City, MO 64110 USA; [McGaugh, Suzanne] Univ Minnesota, Coll Biomed Sci, St Paul, MN 55108 USA; [Borowsky, Richard] NYU, Dept Biol, New York, NY 10003 USA; [Rohner, Nicolas] Univ Kansas, Dept Mol & Integrat Physiol, Med Ctr, Kansas City, KS 66160 USA	Harvard University; Harvard Medical School; Stowers Institute for Medical Research; University of Minnesota System; University of Minnesota Twin Cities; New York University; University of Kansas; University of Kansas Medical Center	Tabin, CJ (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Rohner, N (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.; Rohner, N (corresponding author), Univ Kansas, Dept Mol & Integrat Physiol, Med Ctr, Kansas City, KS 66160 USA.	tabin@genetics.med.harvard.edu; nro@stowers.org	Tabin, Julius A/J-8361-2015	Rohner, Nicolas/0000-0003-3248-2772; Tabin, Julius/0000-0002-3591-6620; Peuss, Robert/0000-0002-9716-6650	NICHD NIH HHS [R01 HD089934] Funding Source: Medline; NIDDK NIH HHS [F32 DK108495] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD089934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK108495] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albadri S, 2017, METHODS, V121, P77, DOI 10.1016/j.ymeth.2017.03.005; Aspiras AC, 2015, P NATL ACAD SCI USA, V112, P9668, DOI 10.1073/pnas.1510802112; Atray A, 2013, J DIABETOL, V2, P2; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borowsky R, 2008, CURR BIOL, V18, pR23, DOI 10.1016/j.cub.2007.11.023; Bradic M, 2013, MOL BIOL EVOL, V30, P2383, DOI 10.1093/molbev/mst136; Bradic M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-9; CARRERA P, 1993, HUM MOL GENET, V2, P1437, DOI 10.1093/hmg/2.9.1437; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; Elipot Y, 2014, ZEBRAFISH, V11, P291, DOI 10.1089/zeb.2014.1005; Fariello MI, 2013, GENETICS, V193, P929, DOI 10.1534/genetics.112.147231; Gross JB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-105; Hayes AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075787; Horst Wilkens U. S, 2017, US EVOLUTION DARK DA; HUPPOP K, 1986, ENVIRON BIOL FISH, V17, P299, DOI 10.1007/BF00001496; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lizcano JM, 2002, CURR BIOL, V12, pR236, DOI 10.1016/S0960-9822(02)00777-7; Martin M, 2011, EMBNET J, V17; McGaugh SE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6307; Moran D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107877; MURPHY RF, 1982, CYTOMETRY, V2, P402; Navarro I, 2002, FISH PHYSIOL BIOCHEM, V27, P205, DOI 10.1023/B:FISH.0000032726.78074.04; Prasad A, 2012, CARDIOL REV, V20, P177, DOI 10.1097/CRD.0b013e318244e57c; R Development Core Team, 2016, LANG ENV STAT COMP; Rines AK, 2016, NAT REV DRUG DISCOV, V15, P786, DOI 10.1038/nrd.2016.151; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Savage DB, 2010, CURR OPIN LIPIDOL, V21, P329, DOI 10.1097/MOL.0b013e32833b7782; Simon V, 2017, EVODEVO, V8, DOI 10.1186/s13227-017-0086-6; Suzuki N, 2016, ENDOCRINE, V54, P575, DOI 10.1007/s12020-016-1153-9; TAYLOR SI, 1990, DIABETES CARE, V13, P257, DOI 10.2337/diacare.13.3.257; Tomomori-Sato C, 2004, J BIOL CHEM, V279, P5846, DOI 10.1074/jbc.M312523200; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yan SF, 2008, NAT CLIN PRACT ENDOC, V4, P285, DOI 10.1038/ncpendmet0786	36	107	109	18	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2018	555	7698					647	+		10.1038/nature26136	http://dx.doi.org/10.1038/nature26136			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8UX	29562229	Green Submitted, Green Accepted			2022-12-28	WOS:000428617600047
J	Mitra, S; Florez, ID; Tamayo, ME; Mbuagbaw, L; Vanniyasingam, T; Veroniki, AA; Zea, AM; Zhang, Y; Sadeghirad, B; Thabane, L				Mitra, Souvik; Florez, Ivan D.; Tamayo, Maria E.; Mbuagbaw, Lawrence; Vanniyasingam, Thuva; Veroniki, Areti Angeliki; Zea, Adriana M.; Zhang, Yuan; Sadeghirad, Behnam; Thabane, Lehana			Association of Placebo, Indomethacin, Ibuprofen, and Acetaminophen With Closure of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Infants A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							BIRTH-WEIGHT INFANTS; HIGH-DOSE IBUPROFEN; PREMATURE-INFANTS; ORAL IBUPROFEN; DOUBLE-BLIND; CONTROLLED-TRIAL; BLOOD-FLOW; BRONCHOPULMONARY DYSPLASIA; NECROTIZING ENTEROCOLITIS; INTRAVENOUS INDOMETHACIN	IMPORTANCE Despite increasing emphasis on conservative management of patent ductus arteriosus (PDA) in preterm infants, different pharmacotherapeutic interventions are used to treat those developing a hemodynamically significant PDA. OBJECTIVES To estimate the relative likelihood of hemodynamically significant PDA closure with common pharmacotherapeutic interventions and to compare adverse event rates. DATA SOURCES AND STUDY SELECTION The databases of MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials were searched from inception until August 15, 2015, and updated on December 31, 2017, along with conference proceedings up to December 2017. Randomized clinical trials that enrolled preterm infants with a gestational age younger than 37 weeks treated with intravenous or oral indomethacin, ibuprofen, or acetaminophen vs each other, placebo, or no treatment for a clinically or echocardiographically diagnosed hemodynamically significant PDA. DATA EXTRACTION AND SYNTHESIS Data were independently extracted in pairs by 6 reviewers and synthesized with Bayesian random-effects network meta-analyses. MAIN OUTCOMES AND MEASURES Primary outcome: hemodynamically significant PDA closure; secondary: included surgical closure, mortality, necrotizing enterocolitis, and intraventricular hemorrhage. RESULTS In 68 randomized clinical trials of 4802 infants, 14 different variations of indomethacin, ibuprofen, or acetaminophen were used as treatment modalities. The overall PDA closure rate was 67.4%(2867 of 4256 infants). A high dose of oral ibuprofen was associated with a significantly higher odds of PDA closure vs a standard dose of intravenous ibuprofen (odds ratio [OR], 3.59; 95% credible interval [CrI], 1.64-8.17; absolute risk difference, 199 [95% CrI, 95-258] more per 1000 infants) and a standard dose of intravenous indomethacin (OR, 2.35 [95% CrI, 1.08-5.31]; absolute risk difference, 124 [95% CrI, 14-188] more per 1000 infants). Based on the ranking statistics, a high dose of oral ibuprofen ranked as the best pharmacotherapeutic option for PDA closure (mean surface under the cumulative ranking [SUCRA] curve, 0.89 [SD, 0.12]) and to prevent surgical PDA ligation (mean SUCRA, 0.98 [SD, 0.08]). There was no significant difference in the odds of mortality, necrotizing enterocolitis, or intraventricular hemorrhage with use of placebo or no treatment compared with any of the other treatment modalities. CONCLUSIONS AND RELEVANCE A high dose of oral ibuprofen was associated with a higher likelihood of hemodynamically significant PDA closure vs standard doses of intravenous ibuprofen or intravenous indomethacin; placebo or no treatment did not significantly change the likelihood of mortality, necrotizing enterocolitis, or intraventricular hemorrhage.	[Mitra, Souvik] Dalhousie Univ, Dept Pediat, Div Neonatal Perinatal Med, Halifax, NS, Canada; [Mitra, Souvik] IWK Hlth Ctr, G-2214,5850-5980 Univ Ave, Halifax, NS B3K 6R8, Canada; [Mitra, Souvik; Florez, Ivan D.; Mbuagbaw, Lawrence; Vanniyasingam, Thuva; Zea, Adriana M.; Zhang, Yuan; Sadeghirad, Behnam; Thabane, Lehana] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Florez, Ivan D.; Tamayo, Maria E.] Univ Antioquia, Dept Pediat, Medellin, Colombia; [Mbuagbaw, Lawrence; Vanniyasingam, Thuva] St Josephs Healthcare Hamilton, Father Sean OSullivan Res Ctr, Biostat Unit, Hamilton, ON, Canada; [Veroniki, Areti Angeliki] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Sadeghirad, Behnam] Kerman Univ Med Sci, HIV STI Surveillance Res Ctr, Kerman, Iran; [Sadeghirad, Behnam] Kerman Univ Med Sci, WHO Collaborating Ctr HIV Surveillance, Kerman, Iran; [Sadeghirad, Behnam] Kerman Univ Med Sci, Inst Futures Studies Hlth, Kerman, Iran; [Sadeghirad, Behnam] McMaster Univ, Michael G DeGroote Inst Pain Res & Care, Hamilton, ON, Canada; [Thabane, Lehana] McMaster Univ, Dept Pediat & Anesthesia, Hamilton, ON, Canada	Dalhousie University; Dalhousie University; McMaster University; Universidad de Antioquia; McMaster University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Kerman University of Medical Sciences; Kerman University of Medical Sciences; World Health Organization; Kerman University of Medical Sciences; McMaster University; McMaster University	Mitra, S (corresponding author), Dalhousie Univ, Dept Pediat, G-2214,5850-5980 Univ Ave, Halifax, NS B3K 6R8, Canada.; Mitra, S (corresponding author), IWK Hlth Ctr, G-2214,5850-5980 Univ Ave, Halifax, NS B3K 6R8, Canada.	souvik.mitra@iwk.nshealth.ca	Florez, Ivan D./K-3536-2015; Sadeghirad, Behnam/A-1772-2009; Mbuagbaw, Lawrence/D-9381-2015	Florez, Ivan D./0000-0002-0751-8932; Sadeghirad, Behnam/0000-0001-9422-5232; Mbuagbaw, Lawrence/0000-0001-5855-5461; /0000-0001-6388-4825; Vanniyasingam, Thuva/0000-0002-4662-0083				Adamska Ewa, 2005, Med Wieku Rozwoj, V9, P335; Akisu Mete, 2001, Cocuk Sagligi ve Hastaliklari Dergisi, V44, P56; Akl EA, 2012, J CLIN EPIDEMIOL, V65, P262, DOI 10.1016/j.jclinepi.2011.04.015; Aly H, 2007, AM J PERINAT, V24, P267, DOI 10.1055/s-2007-976550; Aranda JV, 2009, AM J PERINAT, V26, P235, DOI 10.1055/s-0028-1103515; Baenziger O, 1999, KLIN PADIATR, V211, P438, DOI 10.1055/s-2008-1043829; Bagheri MM, 2016, IRAN J PEDIATR, V26, DOI 10.5812/ijp.3975; Bagnoli F, 2013, J MATERN-FETAL NEO M, V26, P423, DOI 10.3109/14767058.2012.733775; Baker Stuart G, 2002, BMC Med Res Methodol, V2, P13, DOI 10.1186/1471-2288-2-13; Barzilay B, 2012, ARCH DIS CHILD-FETAL, V97, pF116, DOI 10.1136/adc.2011.215160; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; BETKERUR MV, 1981, PEDIATRICS, V68, P99; BROWN ER, 1979, J PEDIATR-US, V95, P865, DOI 10.1016/S0022-3476(79)80454-0; Brown S, 2014, SYST REV, V3, DOI 10.1186/2046-4053-3-110; Cherif A, 2008, PEDIATRICS, V122, pE1256, DOI 10.1542/peds.2008-1780; Chotigeat Uraiwan, 2003, J Med Assoc Thai, V86 Suppl 3, pS563; Christmann V, 2002, ACTA PAEDIATR, V91, P440, DOI 10.1080/080352502317371698; Cipriani A, 2013, ANN INTERN MED, V159, P130, DOI 10.7326/0003-4819-159-2-201307160-00008; Clyman RI, 2012, SEMIN PERINATOL, V36, P123, DOI 10.1053/j.semperi.2011.09.022; Dang D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077888; Dani C, 2012, CLIN PHARMACOL THER, V91, P590, DOI 10.1038/clpt.2011.284; Dash SK, 2015, INDIAN PEDIATR, V52, P573, DOI 10.1007/s13312-015-0677-z; Desfrere L, 2005, J CLIN PHARM THER, V30, P121, DOI 10.1111/j.1365-2710.2005.00630.x; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Ding YJ, 2014, EUR REV MED PHARMACO, V18, P2596; Dollberg S, 2005, J PEDIATR GASTR NUTR, V40, P184, DOI 10.1097/00005176-200502000-00019; Dornelles LV, 2016, J PEDIAT-BRAZIL, V92, P314, DOI 10.1016/j.jped.2015.09.009; Erdeve O, 2012, ARCH DIS CHILD-FETAL, V97, pF279, DOI 10.1136/archdischild-2011-300532; Fakhraee Saed Hossein, 2007, Zhongguo Dang Dai Er Ke Za Zhi, V9, P399; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; GERSONY WM, 1983, J PEDIATR-US, V102, P895, DOI 10.1016/S0022-3476(83)80022-5; Ghanem S, 2010, J SAUDI HEART ASSOC, V22, P7, DOI 10.1016/j.jsha.2010.03.002; Gimeno Navarro A, 2005, An Pediatr (Barc), V63, P212; Gokmen T, 2011, J PEDIATR-US, V158, P549, DOI 10.1016/j.jpeds.2010.10.008; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; HAMMERMAN C, 1990, J PEDIATR-US, V117, P771, DOI 10.1016/S0022-3476(05)83342-6; HAMMERMAN C, 1995, PEDIATRICS, V95, P244; Hammerman C, 2008, PEDIATR RES, V64, P291, DOI 10.1203/PDR.0b013e31817d9bb0; Herrera C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003480.pub3; Higgins JPT, COCHRANE HDB SYSTEMA, P4; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hirt D, 2008, BRIT J CLIN PHARMACO, V65, P629, DOI 10.1111/j.1365-2125.2008.03118.x; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Isayama T, 2016, JAMA-J AM MED ASSOC, V316, P611, DOI 10.1001/jama.2016.10708; Jansen JP, 2008, VALUE HEALTH, V11, P956, DOI 10.1111/j.1524-4733.2008.00347.x; Jansen JP, 2014, VALUE HEALTH, V17, P157, DOI 10.1016/j.jval.2014.01.004; Jegatheesan P, 2008, J PEDIATR, V153, P183, DOI 10.1016/j.jpeds.2008.01.031; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Jones LJ, 2011, ARCH DIS CHILD-FETAL, V96, pF45, DOI 10.1136/adc.2009.168682; Kluckow M, 2014, ARCH DIS CHILD-FETAL, V99, pF99, DOI 10.1136/archdischild-2013-304695; KRAUSS AN, 1989, AM J DIS CHILD, V143, P78, DOI 10.1001/archpedi.1989.02150130088021; Lago P, 2002, EUR J PEDIATR, V161, P202, DOI 10.1007/s00431-002-0915-y; Lago P, 2014, NEONATOLOGY, V105, P46, DOI 10.1159/000355679; Lee J, 2003, PEDIATRICS, V112, P345, DOI 10.1542/peds.112.2.345; Letshwiti JB, 2017, EARLY HUM DEV, V104, P45, DOI 10.1016/j.earlhumdev.2016.12.008; Lin Xin-Zhu, 2012, Zhongguo Dang Dai Er Ke Za Zhi, V14, P502; Lin YJ, 2017, NEONATOLOGY, V111, P195, DOI 10.1159/000450822; LIPMAN B, 1982, PEDIATRICS, V69, P778; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mercanti I, 2012, CURR PHARM DESIGN, V18, P3007, DOI 10.2174/1381612811209023007; Mercanti I, 2009, J MATERN-FETAL NEO M, V22, P14, DOI 10.1080/14767050903198132; MERRITT TA, 1981, J PEDIATR-US, V99, P281, DOI 10.1016/S0022-3476(81)80479-9; Mills EJ, 2012, JAMA-J AM MED ASSOC, V308, P1246, DOI 10.1001/2012.jama.11228; Mitra S, SYSTEMATIC REV NETWO; Mitra S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011271; Mitra S, 2013, CONGENIT HEART DIS, V8, P500, DOI 10.1111/chd.12143; MONSETCOUCHARD M, 1983, PEDIATRIE, V38, P365; Mosca F, 1997, J PEDIATR-US, V131, P549, DOI 10.1016/S0022-3476(97)70060-X; MULLETT MD, 1982, CLIN PEDIATR, V21, P217, DOI 10.1177/000992288202100404; NESTRUD RM, 1980, DEV PHARMACOL THERAP, V1, P125, DOI 10.1159/000455530; NEU J, 1981, PEDIATR PHARMACOL, V1, P245; Ohlsson A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010061.pub2; Ohlsson A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003481.pub6; Oncel MY, 2014, J PEDIATR-US, V164, P510, DOI 10.1016/j.jpeds.2013.11.008; Osborn DA, 2003, ARCH DIS CHILD-FETAL, V88, pF477, DOI 10.1136/fn.88.6.F477; Pacifici GM, CLIN PHARM IBUPROFEN; Palmer T, 2016, METAANALYSIS STATA U, V2; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Patel J, 2000, PEDIATR RES, V47, P36, DOI 10.1203/00006450-200001000-00009; Pezzati M, 1999, J PEDIATR-US, V135, P733, DOI 10.1016/S0022-3476(99)70093-4; Pistulli E, 2014, IRAN J PEDIATR, V24, P42; Pourarian Sh, 2008, East Mediterr Health J, V14, P360; Pourarian S, 2015, AM J PERINAT, V32, P1158, DOI 10.1055/s-0035-1551671; Puhan MA, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5630; RENNIE JM, 1991, ARCH DIS CHILD-FETAL, V66, P55, DOI 10.1136/adc.66.1_Spec_No.55; RHODES PG, 1988, EUR J PEDIATR, V147, P481, DOI 10.1007/BF00441971; Romagnoli C, 1997, CLIN PHARMACOL THER, V62, P181, DOI 10.1016/S0009-9236(97)90066-7; RUDD P, 1983, ARCH DIS CHILD, V58, P267, DOI 10.1136/adc.58.4.267; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Sangtawesin Chaisit, 2008, J Med Assoc Thai, V91 Suppl 3, pS28; Sedagat, 2012, TEHRAN U MED J, V70, P488; Sosenko IRS, 2012, J PEDIATR-US, V160, DOI 10.1016/j.jpeds.2011.12.031; Su BH, 2008, ARCH DIS CHILD-FETAL, V93, pF94, DOI 10.1136/adc.2007.120584; Su BH, 1999, ARCH DIS CHILD-FETAL, V81, pF197, DOI 10.1136/fn.81.3.F197; Su PH, 2003, PEDIATR INT, V45, P665, DOI 10.1111/j.1442-200X.2003.01797.x; Supapannachart Sarayut, 2002, Journal of the Medical Association of Thailand, V85, pS1252; Tammela O, 1999, J PEDIATR-US, V134, P552, DOI 10.1016/S0022-3476(99)70239-8; Tatli MM, 2004, ACTA PAEDIATR, V93, P999, DOI 10.1111/j.1651-2227.2004.tb02702.x; Van Overmeire B, 2000, NEW ENGL J MED, V343, P674, DOI 10.1056/NEJM200009073431001; Van Overmeire B, 2001, CLIN PHARMACOL THER, V70, P336, DOI 10.1067/mcp.2001.118453; Van Overmeire B, 2001, J PEDIATR-US, V138, P205, DOI 10.1067/mpd.2001.110528; van Valkenhoef G, 2012, RES SYNTH METHODS, V3, P285, DOI 10.1002/jrsm.1054; Vanhaesebrouck S, 2007, ARCH DIS CHILD-FETAL, V92, P244; VANOVERMEIRE B, 1995, PEDIATR RES, V38, P886; VanOvermeire B, 1997, ARCH DIS CHILD-FETAL, V76, pF179, DOI 10.1136/fn.76.3.F179; Veroniki AA, 2013, INT J EPIDEMIOL, V42, P332, DOI 10.1093/ije/dys222; White IR, 2012, RES SYNTH METHODS, V3, P111, DOI 10.1002/jrsm.1045; Yadav S, 2014, PEDIATR CARDIOL, V35, P824, DOI 10.1007/s00246-014-0861-2; YANAGI RM, 1981, PEDIATRICS, V67, P647; Yang B, 2016, EXP THER MED, V12, P2531, DOI 10.3892/etm.2016.3676; YEH TF, 1982, J PEDIATR-US, V101, P433, DOI 10.1016/S0022-3476(82)80079-6; YEH TF, 1981, J PEDIATR-US, V98, P137, DOI 10.1016/S0022-3476(81)80560-4; Zanardo V, 2005, FETAL DIAGN THER, V20, P534, DOI 10.1159/000088046; 이수진, 2008, Clinical and Experimental Pediatrics, V51, P956	115	135	136	5	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2018	319	12					1221	1238		10.1001/jama.2018.1896	http://dx.doi.org/10.1001/jama.2018.1896			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GA5VW	29584842	Green Published, Bronze			2022-12-28	WOS:000428403000015
J	Song, S; Gleeson, JG				Song, Saera; Gleeson, Joseph G.			Early life experience shapes neural genome	SCIENCE			English	Editorial Material							L1 RETROTRANSPOSITION; SOMATIC MOSAICISM; HUMAN BRAIN; CELLS		[Song, Saera] Columbia Univ, Inst Genom Med, Med Ctr, New York, NY 10032 USA; [Gleeson, Joseph G.] Univ Calif San Diego, Lab Pediat Brain Dis, Howard Hughes Med Inst, Rady Childrens Inst Genom Med, San Diego, CA 92093 USA	Columbia University; Howard Hughes Medical Institute; University of California System; University of California San Diego	Gleeson, JG (corresponding author), Univ Calif San Diego, Lab Pediat Brain Dis, Howard Hughes Med Inst, Rady Childrens Inst Genom Med, San Diego, CA 92093 USA.	jogleeson@ucsd.edu						Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Beck CR, 2011, ANNU REV GENOM HUM G, V12, P187, DOI 10.1146/annurev-genom-082509-141802; Bedrosian TA, 2018, SCIENCE, V359, P1395, DOI 10.1126/science.aah3378; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Di Segni M., 2017, SEMIN CELL DEV BIOL; Evrony GD, 2016, ELIFE, V5, DOI 10.7554/eLife.12966; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Goodier JL, 2001, GENOME RES, V11, P1677, DOI 10.1101/gr.198301; McConnell MJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal1641; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Richardson SR, 2014, ANNU REV GENET, V48, P1, DOI 10.1146/annurev-genet-120213-092412; Upton KR, 2015, CELL, V161, P228, DOI 10.1016/j.cell.2015.03.026; Weaver ICG, 2006, P NATL ACAD SCI USA, V103, P3480, DOI 10.1073/pnas.0507526103	14	9	9	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2018	359	6382			SI		1330	1331		10.1126/science.aat3977	http://dx.doi.org/10.1126/science.aat3977			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA0ZG	29567692				2022-12-28	WOS:000428043600022
J	Capper, D; Jones, DTW; Sill, M; Hovestadt, V; Schrimpf, D; Sturm, D; Koelsche, C; Sahm, F; Chavez, L; Reuss, DE; Kratz, A; Wefers, AK; Huang, K; Pajtler, KW; Schweizer, L; Stichel, D; Olar, A; Engel, NW; Lindenberg, K; Harter, PN; Braczynski, AK; Plate, KH; Dohmen, H; Garvalov, BK; Coras, R; Holsken, A; Hewer, E; Bewerunge-Hudler, M; Schick, M; Fischer, R; Beschorner, R; Schittenhelm, J; Staszewski, O; Wani, K; Varlet, P; Pages, M; Temming, P; Lohmann, D; Selt, F; Witt, H; Milde, T; Witt, O; Aronica, E; Giangaspero, F; Rushing, E; Scheurlen, W; Geisenberger, C; Rodriguez, FJ; Becker, A; Preusser, M; Haberler, C; Bjerkvig, R; Cryan, J; Farrell, M; Deckert, M; Hench, J; Frank, S; Serrano, J; Kannan, K; Tsirigos, A; Bruck, W; Hofer, S; Brehmer, S; Seiz-Rosenhagen, M; Hanggi, D; Hans, V; Rozsnoki, S; Hansford, JR; Kohlhof, P; Kristensen, BW; Lechner, M; Lopes, B; Mawrin, C; Ketter, R; Kulozik, A; Khatib, Z; Heppner, F; Koch, A; Jouvet, A; Keohane, C; Muhleisen, H; Mueller, W; Poh, U; Prinz, M; Benner, A; Zapatka, M; Gottardo, NG; Driever, PH; Kramm, CM; Muller, HL; Rutkowski, S; von Hoff, K; Fruhwald, MC; Gnekow, A; Fleischhack, G; Tippelt, S; Calaminus, G; Monoranu, CM; Perry, A; Jones, C; Jacques, TS; Radlwimmer, B; Gessi, M; Pietsch, T; Schramm, J; Schackert, G; Westphal, M; Reifenberger, G; Wesseling, P; Weller, M; Collins, VP; Blumcke, I; Bendszus, M; Debus, J; Huang, A; Jabado, N; Northcott, PA; Paulus, W; Gajjar, A; Robinson, GW; Taylor, MD; Jaunmuktane, Z; Ryzhova, M; Platten, M; Unterberg, A; Wick, W; Karajannis, MA; Mittelbronn, M; Acker, T; Hartmann, C; Aldape, K; Schuller, U; Buslei, R; Lichter, P; Kool, M; Herold-Mende, C; Ellison, DW; Hasselblatt, M; Snuder, M; Brandner, S; Korshunov, A; von Deimling, A; Pfister, SM				Capper, David; Jones, David T. W.; Sill, Martin; Hovestadt, Volker; Schrimpf, Daniel; Sturm, Dominik; Koelsche, Christian; Sahm, Felix; Chavez, Lukas; Reuss, David E.; Kratz, Annekathrin; Wefers, Annika K.; Huang, Kristin; Pajtler, Kristian W.; Schweizer, Leonille; Stichel, Damian; Olar, Adriana; Engel, Nils W.; Lindenberg, Kerstin; Harter, Patrick N.; Braczynski, Anne K.; Plate, Karl H.; Dohmen, Hildegard; Garvalov, Boyan K.; Coras, Roland; Hoelsken, Annett; Hewer, Ekkehard; Bewerunge-Hudler, Melanie; Schick, Matthias; Fischer, Roger; Beschorner, Rudi; Schittenhelm, Jens; Staszewski, Ori; Wani, Khalida; Varlet, Pascale; Pages, Melanie; Temming, Petra; Lohmann, Dietmar; Selt, Florian; Witt, Hendrik; Milde, Till; Witt, Olaf; Aronica, Eleonora; Giangaspero, Felice; Rushing, Elisabeth; Scheurlen, Wolfram; Geisenberger, Christoph; Rodriguez, Fausto J.; Becker, Albert; Preusser, Matthias; Haberler, Christine; Bjerkvig, Rolf; Cryan, Jane; Farrell, Michael; Deckert, Martina; Hench, Juergen; Frank, Stephan; Serrano, Jonathan; Kannan, Kasthuri; Tsirigos, Aristotelis; Brueck, Wolfgang; Hofer, Silvia; Brehmer, Stefanie; Seiz-Rosenhagen, Marcel; Haenggi, Daniel; Hans, Volkmar; Rozsnoki, Stephanie; Hansford, Jordan R.; Kohlhof, Patricia; Kristensen, Bjarne W.; Lechner, Matt; Lopes, Beatriz; Mawrin, Christian; Ketter, Ralf; Kulozik, Andreas; Khatib, Ziad; Heppner, Frank; Koch, Arend; Jouvet, Anne; Keohane, Catherine; Muehleisen, Helmut; Mueller, Wolf; Pohl, Ute; Prinz, Marco; Benner, Axel; Zapatka, Marc; Gottardo, Nicholas G.; Driever, Pablo Hernaiz; Kramm, Christof M.; Mueller, Hermann L.; Rutkowski, Stefan; von Hoff, Katja; Fruehwald, Michael C.; Gnekow, Astrid; Fleischhack, Gudrun; Tippelt, Stephan; Calaminus, Gabriele; Monoranu, Camelia-Maria; Perry, Arie; Jones, Chris; Jacques, Thomas S.; Radlwimmer, Bernhard; Gessi, Marco; Pietsch, Torsten; Schramm, Johannes; Schackert, Gabriele; Westphal, Manfred; Reifenberger, Guido; Wesseling, Pieter; Weller, Michael; Collins, Vincent Peter; Bluemcke, Ingmar; Bendszus, Martin; Debus, Juergen; Huang, Annie; Jabado, Nada; Northcott, Paul A.; Paulus, Werner; Gajjar, Amar; Robinson, Giles W.; Taylor, Michael D.; Jaunmuktane, Zane; Ryzhova, Marina; Platten, Michael; Unterberg, Andreas; Wick, Wolfgang; Karajannis, Matthias A.; Mittelbronn, Michel; Acker, Till; Hartmann, Christian; Aldape, Kenneth; Schueller, Ulrich; Buslei, Rolf; Lichter, Peter; Kool, Marcel; Herold-Mende, Christel; Ellison, David W.; Hasselblatt, Martin; Snuderl, Matija; Brandner, Sebastian; Korshunov, Andrey; von Deimling, Andreas; Pfister, Stefan M.			DNA methylation-based classification of central nervous system tumours	NATURE			English	Article							CLASS PROBABILITY ESTIMATION; MOLECULAR CLASSIFICATION; MEDULLOBLASTOMA; MULTICENTER; EXPRESSION; SUBGROUPS; COMPRISE; SUBSETS; GLIOMAS	Accurate pathological diagnosis is crucial for optimal management of patients with cancer. For the approximately 100 known tumour types of the central nervous system, standardization of the diagnostic process has been shown to be particularly challengingwith substantial inter-observer variability in the histopathological diagnosis of many tumour types. Here we present a comprehensive approach for the DNA methylation-based classification of central nervous system tumours across all entities and age groups, and demonstrate its application in a routine diagnostic setting. We show that the availability of this method may have a substantial impact on diagnostic precision compared to standard methods, resulting in a change of diagnosis in up to 12% of prospective cases. For broader accessibility, we have designed a free online classifier tool, the use of which does not require any additional onsite data processing. Our results provide a blueprint for the generation of machine-learning-based tumour classifiers across other cancer entities, with the potential to fundamentally transform tumour pathology.	[Capper, David; Schrimpf, Daniel; Koelsche, Christian; Sahm, Felix; Reuss, David E.; Kratz, Annekathrin; Wefers, Annika K.; Huang, Kristin; Schweizer, Leonille; Stichel, Damian; Korshunov, Andrey; von Deimling, Andreas] Univ Hosp Heidelberg, Dept Neuropathol, Heidelberg, Germany; [Capper, David; Schrimpf, Daniel; Koelsche, Christian; Sahm, Felix; Reuss, David E.; Kratz, Annekathrin; Wefers, Annika K.; Huang, Kristin; Stichel, Damian; Lindenberg, Kerstin; Korshunov, Andrey; von Deimling, Andreas] German Canc Res Ctr, German Canc Consortium DKTK, Clin Cooperat Unit Neuropathol, Heidelberg, Germany; [Capper, David; Heppner, Frank; Koch, Arend] Charite, Humboldt Univ Berlin, Freie Univ Berlin, Berlin, Germany; [Capper, David; Schweizer, Leonille; Heppner, Frank; Koch, Arend] Berlin Inst Hlth, Dept Neuropathol, Berlin, Germany; [Capper, David] German Canc Res Ctr, German Canc Consortium DKTK, Partner Site Berlin, Heidelberg, Germany; [Jones, David T. W.; Sill, Martin; Sturm, Dominik; Chavez, Lukas; Pajtler, Kristian W.; Selt, Florian; Witt, Hendrik; Milde, Till; Witt, Olaf; Kulozik, Andreas; Kool, Marcel; Pfister, Stefan M.] NCT Heidelberg KiTZ, Hopp Childrens Canc Ctr, Heidelberg, Germany; [Jones, David T. W.; Sill, Martin; Sturm, Dominik; Chavez, Lukas; Pajtler, Kristian W.; Witt, Hendrik; Kool, Marcel; Pfister, Stefan M.] German Canc Res Ctr, Div Pediat Neurooncol, German Canc Consortium DKTK, Heidelberg, Germany; [Sill, Martin; Benner, Axel] German Canc Res Ctr, Div Biostat, Heidelberg, Germany; [Hovestadt, Volker; Zapatka, Marc; Radlwimmer, Bernhard; Lichter, Peter] German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany; [Sturm, Dominik; Pajtler, Kristian W.; Selt, Florian; Witt, Hendrik; Milde, Till; Witt, Olaf; Kulozik, Andreas; Pfister, Stefan M.] Univ Hosp Heidelberg, Dept Pediat Oncol Hematol & Immunol, Heidelberg, Germany; [Olar, Adriana] Med Univ South Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; [Olar, Adriana] Med Univ South Carolina, Dept Neurosurg, Charleston, SC 29425 USA; [Olar, Adriana] Hollings Canc Ctr, Charleston, SC 29425 USA; [Engel, Nils W.] Univ Med Ctr Hamburg, Dept Oncol & Hematol, Sect Bone Marrow Transplant & Pneumol, Hubertus Wald Tumorzentrum,Univ Canc Ctr Hamburg, Hamburg, Germany; [Engel, Nils W.; Schueller, Ulrich] Ludwig Maximilians Univ Munchen, Ctr Neuropathol & Prion Res, Munich, Germany; [Harter, Patrick N.; Braczynski, Anne K.; Plate, Karl H.; Mittelbronn, Michel] Goethe Univ Frankfurt Main, Inst Neurol, Edinger Inst, Frankfurt, Germany; [Harter, Patrick N.; Braczynski, Anne K.; Plate, Karl H.; Mittelbronn, Michel] German Canc Res Ctr, Partner Site Frankfurt Mainz, German Canc Consortium DKTK, Heidelberg, Germany; [Dohmen, Hildegard; Garvalov, Boyan K.; Acker, Till] Univ Giessen, Inst Neuropathol, Giessen, Germany; [Coras, Roland; Hoelsken, Annett; Bluemcke, Ingmar; Buslei, Rolf] Friedrich Alexander Univ Erlangen Nuremberg, Univ Hosp Erlangen, Neuropathol Inst, Erlangen, Germany; [Hewer, Ekkehard] Univ Bern, Inst Pathol, Bern, Switzerland; [Bewerunge-Hudler, Melanie; Schick, Matthias; Fischer, Roger] German Canc Res Ctr, Genom & Prote Core Facil, Heidelberg, Germany; [Beschorner, Rudi; Schittenhelm, Jens] Univ Hosp Tubingen, Dept Neuropathol, Inst Pathol & Neuropathol, Tubingen, Germany; [Staszewski, Ori; Prinz, Marco] Univ Freiburg, Med Ctr, Inst Neuropathol, Fac Med, Freiburg, Germany; [Wani, Khalida] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Varlet, Pascale; Pages, Melanie] Univ Paris, Ctr Hosp St Anne, Dept Neuropathol, Paris, France; [Temming, Petra; Fleischhack, Gudrun; Tippelt, Stephan] Univ Hosp Essen, Pediat 3, Pediat Oncol & Hematol, Essen, Germany; [Lohmann, Dietmar] Univ Duisburg Essen, Eye Canc Res Grp, Fac Med, Essen, Germany; [Selt, Florian; Milde, Till; Witt, Olaf] German Canc Res Ctr, CCU Pediat Oncol G340, Heidelberg, Germany; [Selt, Florian; Milde, Till; Witt, Olaf] German Canc Consortium DKTK, Heidelberg, Germany; [Aronica, Eleonora] Univ Amsterdam, Dept Neuropathol, AMC, Amsterdam, Netherlands; [Aronica, Eleonora] Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, Amsterdam, Netherlands; [Aronica, Eleonora] SEIN, Amsterdam, Netherlands; [Giangaspero, Felice] Sapienza Univ, Dept Radiol Oncol & Anatomopathol Sci, Rome, Italy; [Giangaspero, Felice] IRCCS Neuromed, Pozzilli, Italy; [Rushing, Elisabeth] Univ Hosp Zurich, Dept Neuropathol, Zurich, Switzerland; [Scheurlen, Wolfram] Cnopfsche Kinderklin Nuremberg, Nurnberg, Germany; [Geisenberger, Christoph; Unterberg, Andreas; Herold-Mende, Christel] Heidelberg Univ Hosp, Dept Neurosurg, Heidelberg, Germany; [Geisenberger, Christoph] Hubrecht Inst KNAW Royal Netherlands Acad Arts &, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands; [Rodriguez, Fausto J.] Johns Hopkins Univ, Sch Med, Div Neuropathol, Baltimore, MD USA; [Becker, Albert; Gessi, Marco; Pietsch, Torsten] Univ Bonn, Dept Neuropathol, Bonn, Germany; [Preusser, Matthias] Med Univ Vienna, Dept Med 1, Comprehens Canc Ctr Vienna, CNS Unit CCC CNS, Vienna, Austria; [Haberler, Christine] Med Univ Vienna, Inst Neurol, Vienna, Austria; [Bjerkvig, Rolf] Univ Bergen, Dept Biomed, Bergen, Norway; [Bjerkvig, Rolf] Luxembourg Inst Hlth, Dept Oncol, NORLUX Neurooncol Lab, Luxembourg, Luxembourg; [Cryan, Jane; Farrell, Michael] Beaumont Hosp, Dept Neuropathol, Dublin, Ireland; [Deckert, Martina] Univ Hosp Cologne, Dept Neuropathol, Cologne, Germany; [Hench, Juergen; Frank, Stephan] Basel Univ Hosp, Inst Pathol, Dept Neuropathol, Basel, Switzerland; [Serrano, Jonathan; Kannan, Kasthuri; Tsirigos, Aristotelis] NYU, Langone Med Ctr, New York, NY USA; [Brueck, Wolfgang] Univ Med Ctr Gottingen, Inst Neuropathol, Gottingen, Germany; [Hofer, Silvia] Luzerner Kantonsspital, Div Oncol, Luzern, Switzerland; [Brehmer, Stefanie; Seiz-Rosenhagen, Marcel; Haenggi, Daniel] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Neurosurg, Mannheim, Germany; [Hans, Volkmar] Evangelisches Krankenhaus Bielefeld gGmbH, Inst Neuropathol, Bielefeld, Germany; [Hans, Volkmar] Univ Kinikum Essen, Inst Neuropathol, Essen, Germany; [Rozsnoki, Stephanie; Paulus, Werner; Hasselblatt, Martin] Univ Hosp Munster, Inst Neuropathol, Munster, Germany; [Hansford, Jordan R.] Univ Melbourne, Royal Childrens Hosp, Childrens Canc Ctr, Melbourne, Vic, Australia; [Hansford, Jordan R.] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Hansford, Jordan R.] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Kohlhof, Patricia] Katharinen Hosp, Inst Pathol, Stuttgart, Germany; [Kristensen, Bjarne W.] Univ Southern Denmark, Dept Clin Res, Odense Univ Hosp, Dept Pathol, Odense, Denmark; [Lechner, Matt] UCL, Canc Inst, London, England; [Lechner, Matt] Univ Coll London Hosp, London, England; [Lopes, Beatriz] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Mawrin, Christian] Otto Von Guericke Univ, Inst Nephrol, Magdeburg, Germany; [Ketter, Ralf] Univ Hosp Saarland, Dept Neurosurg, Homburg, Saar, Germany; [Khatib, Ziad] Nicklaus Childrens Hosp Brain Inst, Miami, FL 33155 USA; [Heppner, Frank] NeuroCure, Cluster Excellence, Berlin, Germany; [Heppner, Frank] BIH, Berlin, Germany; [Jouvet, Anne] Hosp Civils Lyon, Dept Pathol & Neuropathol, Hop Neurol, Lyon, France; [Keohane, Catherine] Cork Univ Hosp, Dept Neuropathol, Cork, Ireland; [Muehleisen, Helmut] Ludwigsburg Hosp, Dept Pathol, Ludwigsburg, Germany; [Mueller, Wolf] Univ Leipzig, Dept Neuropathol, Leipzig, Germany; [Pohl, Ute] Queens Hosp, Dept Cellular Pathol, Romford, Essex, England; [Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany; [Gottardo, Nicholas G.] Princess Margaret Hosp Children, Dept Pediat Oncol & Haematol, GPO Box D184, Perth, WA 6840, Australia; [Gottardo, Nicholas G.] Univ Western Australia, Telethon Kids Inst, POB 855, Perth, WA 6872, Australia; [Gottardo, Nicholas G.] Univ Western Australia, Sch Paediat & Child Hlth, GPO Box D184, Perth, WA 6840, Australia; [Driever, Pablo Hernaiz; von Hoff, Katja] Charite, Dept Pediat Oncol Hematol, Berlin, Germany; [Kramm, Christof M.] Univ Med Ctr Gottingen, Div Pediat Hematol & Oncol, Gottingen, Germany; [Mueller, Hermann L.] Carl von Ossietzky Univ Oldenburg, Klinikum Oldenburg AOR, Dept Pediat & Pediat Hematol Oncol, Med Campus, D-26133 Oldenburg, Germany; [Rutkowski, Stefan; von Hoff, Katja] Univ Hosp Hamburg Eppendort, Dept Pediat Hematol & Oncol, Hamburg, Germany; [Fruehwald, Michael C.; Gnekow, Astrid] Childrens Hosp Augsburg, Swabian Childrens Canc Ctr, Augsburg, Germany; [Calaminus, Gabriele] Univ Bonn, Dept Pediat Hematol Oncol, Med Ctr, Bonn, Germany; [Monoranu, Camelia-Maria] Univ Wurzburg, Dept Neuropathol, Comprehens Canc Ctr CCC Mainfranken, Inst Pathol, Wurzburg, Germany; [Perry, Arie] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Jones, Chris] Inst Canc Res, Div Mol Pathol, London, England; [Jacques, Thomas S.] Great Ormond St Hosp Children NHS Fdn Trust, UCL Great Ormond St Inst Child Hlth & Histopatho, Dev Biol & Canc Programme, London, England; [Schramm, Johannes] Univ Bonn, Med Fac, Med Sch, Bonn, Germany; [Schackert, Gabriele] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Neurosurg, Dresden, Germany; [Westphal, Manfred] Univ Hosp Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany; [Reifenberger, Guido] Heinrich Heine Univ Dusseldorf, Dept Neuropathol, Dusseldorf, Germany; [Reifenberger, Guido] German Canc Res Ctr, German Canc Consortium DKTK, Partner Site Essen Dusseldorf, Heidelberg, Germany; [Wesseling, Pieter] Princess Maxima Ctr Pediat Oncol, Dept Pathol, Utrecht, Netherlands; [Wesseling, Pieter] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Wesseling, Pieter] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Weller, Michael] Univ Hosp, Dept Neurol, Zurich, Switzerland; [Weller, Michael] Univ Zurich, Zurich, Switzerland; [Collins, Vincent Peter] Univ Cambridge, Div Mol Histopathol, Dept Pathol, Cambridge, England; [Bendszus, Martin] Heidelberg Univ Hosp, Dept Neuroradiol, Heidelberg, Germany; [Debus, Juergen] Heidelberg Univ Hosp, Dept Radiat Oncol, Heidelberg, Germany; [Huang, Annie] Univ Toronto, Dept Pediat, Lab Med & Pathobiol, Toronto, ON, Canada; [Jabado, Nada] McGill Univ, Div Hematol Oncol, Montreal, PQ, Canada; [Northcott, Paul A.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Gajjar, Amar; Robinson, Giles W.] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Taylor, Michael D.] Univ Toronto, Hosp Sick Children, Div Neurosurg, Arthur & Sonia Labatt Brain Tumor Res Ctr, Toronto, ON, Canada; [Jaunmuktane, Zane; Brandner, Sebastian] UCL, Inst Neurol, UCL Hosp, Div Neuropathol, Queen Sq, London WC1N 3BG, England; [Jaunmuktane, Zane] UCL, Inst Neurol, Dept Mol Neurosci, Queen Sq, London WC1N 3BG, England; [Jaunmuktane, Zane; Brandner, Sebastian] UCL, Inst Neurol, Dept Neurodegenerat, Queen Sq, London WC1N 3BG, England; [Ryzhova, Marina] NN Burdenko Inst Neurosurg, Moscow, Russia; [Platten, Michael] Heidelberg Univ, Med Fac Mannheim, Univ Med Mannheim, Dept Neurol, Mannheim, Germany; [Wick, Wolfgang] Heidelberg Univ Hosp, Dept Neurol, Heidelberg, Germany; [Karajannis, Matthias A.] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA; [Mittelbronn, Michel] LIH, NORLUX Neurooncol Lab, Luxembourg, Luxembourg; [Mittelbronn, Michel] Univ Luxembourg, LCSB, Luxembourg, Luxembourg; [Mittelbronn, Michel] LNS, Dudelange, Luxembourg; [Mittelbronn, Michel] Luxembourg Ctr Neuropathol LCNP, Luxembourg, Luxembourg; [Hartmann, Christian] Hannover Med Sch, Dept Neuropathol, Hannover, Germany; [Aldape, Kenneth] Univ Toronto, Dept Pathol, Toronto, ON, Canada; [Schueller, Ulrich] Univ Med Ctr, Inst Neuropathol, Hamburg, Germany; [Schueller, Ulrich] Childrens Canc Ctr, Res Inst, Hamburg, Germany; [Schueller, Ulrich] Univ Med Ctr, Dept Pediat Hematol & Oncol, Hamburg, Germany; [Buslei, Rolf] Klinikum Bruderwald, Sozialstiftung Bamberg, Inst Pathol, Sect Neuropathol, Bamberg, Germany; [Ellison, David W.] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Snuderl, Matija] NYU, Dept Pathol, Div Neuropathol, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Hovestadt, Volker] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Hovestadt, Volker] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Hovestadt, Volker] Broad Inst MIT & Harvard, Cambridge, MA USA	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Medical University of South Carolina; Medical University of South Carolina; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ); Justus Liebig University Giessen; University of Erlangen Nuremberg; University of Bern; Helmholtz Association; German Cancer Research Center (DKFZ); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Freiburg; University of Texas System; UTMD Anderson Cancer Center; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; University of Duisburg Essen; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Sapienza University Rome; IRCCS Neuromed; University of Zurich; University Zurich Hospital; Ruprecht Karls University Heidelberg; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Johns Hopkins University; University of Bonn; Medical University of Vienna; Medical University of Vienna; University of Bergen; Luxembourg Institute of Health; University of Cologne; University of Basel; New York University; NYU Langone Medical Center; University of Gottingen; Lucerne Cantonal Hospital; Ruprecht Karls University Heidelberg; University of Munster; Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; Klinikum Stuttgart; University of Southern Denmark; Odense University Hospital; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Virginia; Otto von Guericke University; Universitatsklinikum des Saarlandes; Berlin Institute of Health; CHU Lyon; University College Cork; Leipzig University; University of Freiburg; Telethon Kids Institute; University of Western Australia; University of Western Australia; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Gottingen; Carl von Ossietzky Universitat Oldenburg; Klinikum Oldenburg; University of Bonn; University of Wurzburg; University of California System; University of California San Francisco; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Bonn; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Heine University Dusseldorf; Helmholtz Association; German Cancer Research Center (DKFZ); Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Zurich; University Zurich Hospital; University of Zurich; University of Cambridge; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Toronto; McGill University; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; University College London; Russian Academy of Medical Sciences; N.N.Burdenko National Medical Research Center of Neurosurgery; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Memorial Sloan Kettering Cancer Center; Luxembourg Institute of Health; University of Luxembourg; Hannover Medical School; University of Toronto; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; St Jude Children's Research Hospital; New York University; NYU Langone Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	von Deimling, A (corresponding author), Univ Hosp Heidelberg, Dept Neuropathol, Heidelberg, Germany.; von Deimling, A (corresponding author), German Canc Res Ctr, German Canc Consortium DKTK, Clin Cooperat Unit Neuropathol, Heidelberg, Germany.; Pfister, SM (corresponding author), NCT Heidelberg KiTZ, Hopp Childrens Canc Ctr, Heidelberg, Germany.; Pfister, SM (corresponding author), German Canc Res Ctr, Div Pediat Neurooncol, German Canc Consortium DKTK, Heidelberg, Germany.; Pfister, SM (corresponding author), Univ Hosp Heidelberg, Dept Pediat Oncol Hematol & Immunol, Heidelberg, Germany.	Andreas.vonDeimling@med.uni-heidelberg.de; s.pfister@dkfz.de	Kölsche, Christian/Q-8854-2019; Ellison, David/N-4806-2018; Jabado, Nada/AAN-4026-2020; Giangaspero, Felice/Z-4961-2019; Milde, Till/AAR-4528-2021; Kristensen, Bjarne Winther/A-6690-2012; Kulozik, Andreas/AAO-2432-2020; Hewer, Ekkehard/W-8670-2019; Jones, Chris/ABE-6059-2021; Karajannis, Matthias A/H-8845-2019; Reifenberger, Guido/AAE-3599-2019; Pfister, Stefan M/F-6860-2013; Ryzhova, Marina/G-4178-2014; Hansford, Jordan/V-4036-2019; Northcott, Paul A/N-4022-2018; Heppner, Frank/ABH-8393-2020; Gajjar, Amar/N-8059-2018; Jaunmuktane, Zane/ABC-9039-2020; Jones, David TW/G-9588-2013; Jones, David T. W./Z-1963-2019; Wick, Wolfgang/AAA-2545-2020; Brandner, Sebastian/J-4562-2014; Wefers, Annika K./ABF-3832-2020; Radlwimmer, Bernhard F/I-3229-2013; Sturm, Dominik/AAL-3689-2020; Preusser, Matthias/C-8530-2011; Platten, Michael/F-2902-2013; müller, Hermann l/AAC-1637-2020; Pajtler, Kristian/AAN-9029-2020; von Deimling, Andreas/F-7774-2013; Ketteler, Petra/M-4743-2016; Giangaspero, Felice/AAH-9253-2020; Capper, David/I-8500-2014; Kristensen, Bjarne Winther/AAX-5491-2020; Sahm, Felix/GQY-8202-2022; Lohmann, Dietmar R./X-4895-2019; Gessi, Marco/K-2572-2018; Robinson, Giles W/N-8095-2018; Pages, Melanie/S-1875-2019; Becker, Albert J/F-6248-2012; Hartmann, Christian/D-1882-2010; Garvalov, Boyan K./AAF-6414-2020; Zapatka, Marc/G-9896-2013	Giangaspero, Felice/0000-0001-5382-2380; Milde, Till/0000-0002-7267-1052; Kristensen, Bjarne Winther/0000-0002-6352-0826; Hewer, Ekkehard/0000-0002-9128-0364; Jones, Chris/0000-0001-8118-2296; Karajannis, Matthias A/0000-0002-7151-6528; Pfister, Stefan M/0000-0002-5447-5322; Ryzhova, Marina/0000-0001-7206-6365; Northcott, Paul A/0000-0002-1220-5252; Heppner, Frank/0000-0001-9816-8917; Jaunmuktane, Zane/0000-0001-7738-8881; Jones, David TW/0000-0002-2036-5141; Wick, Wolfgang/0000-0002-6171-634X; Brandner, Sebastian/0000-0002-9821-0342; Wefers, Annika K./0000-0001-9394-8519; Radlwimmer, Bernhard F/0000-0002-4553-7800; Sturm, Dominik/0000-0003-0250-1696; Preusser, Matthias/0000-0003-3541-2315; Platten, Michael/0000-0002-4746-887X; von Deimling, Andreas/0000-0002-5863-540X; Ketteler, Petra/0000-0002-8138-0441; Giangaspero, Felice/0000-0001-5382-2380; Capper, David/0000-0003-1945-497X; Kristensen, Bjarne Winther/0000-0002-6352-0826; Sahm, Felix/0000-0001-5441-1962; Lohmann, Dietmar R./0000-0002-2624-9889; Robinson, Giles W/0000-0001-7441-9486; Garvalov, Boyan K./0000-0003-0013-9064; Zapatka, Marc/0000-0001-8287-5967; Korshunov, Andrey/0000-0002-5257-3623; Koelsche, Christian/0000-0001-8763-8864; Weller, Michael/0000-0002-1748-174X; Taylor, Michael/0000-0001-7009-3466; Hansford, Jordan/0000-0001-7733-383X; Tsirigos, Aristotelis/0000-0002-7512-8477; Mittelbronn, Michel/0000-0002-2998-052X; Staszewski, Ori/0000-0002-0579-6701; Chavez, Lukas/0000-0002-8718-8848; Gottardo, Nicholas/0000-0002-1082-6776; von Hoff, Katja/0000-0002-5669-8546; Engel, Nils/0000-0002-3514-5686; Kannan, Kasthuri/0000-0002-8479-0657; Aronica, Eleonora/0000-0002-3542-3770; Sill, Martin/0000-0001-7616-7665; Snuderl, Matija/0000-0003-0752-0917; Hernaiz Driever, Pablo/0000-0003-3135-3872; Pajtler, Kristian W./0000-0002-3562-6121; Schweizer, Leonille/0000-0002-4649-2587	DKFZ-Heidelberg Center for Personalized Oncology [DKFZ-HIPO_036]; German Childhood Cancer Foundation, an Illumina Medical Research Grant [DKS 2015.01]; DKTK joint funding project 'Next Generation Molecular Diagnostics of Malignant Gliomas'; A Kids' Brain Tumour Cure (PLGA) Foundation; Brain Tumour Charity (UK); Friedberg Charitable Foundation; Sohn Conference Foundation; RKA-Forderpool Project [37]; Stichting Kinderen Kankervrij; Stichting AMC Foundation; NIH/ NCI [5T32CA163185]; NIH/NCI Cancer Center Support Grant [P30 CA008748]; Luxembourg National Research Fond (FNR PEARL) [P16/BM/11192868]; National Institute of Health Research (NIHR) UCLH/UCL Biomedical Research Centre; MRC [MR/N004272/1, G1100578, G0701018] Funding Source: UKRI; Russian Science Foundation [18-45-06012] Funding Source: Russian Science Foundation; Cancer Research UK [13982, 23536] Funding Source: researchfish; The Brain Tumour Charity [8/152, GN-000382, 16/193, 8/197] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [W1097] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [T32CA163185, P30CA021765, P30CA008748] Funding Source: NIH RePORTER	DKFZ-Heidelberg Center for Personalized Oncology; German Childhood Cancer Foundation, an Illumina Medical Research Grant; DKTK joint funding project 'Next Generation Molecular Diagnostics of Malignant Gliomas'; A Kids' Brain Tumour Cure (PLGA) Foundation; Brain Tumour Charity (UK); Friedberg Charitable Foundation; Sohn Conference Foundation; RKA-Forderpool Project; Stichting Kinderen Kankervrij; Stichting AMC Foundation; NIH/ NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCI Cancer Center Support Grant; Luxembourg National Research Fond (FNR PEARL); National Institute of Health Research (NIHR) UCLH/UCL Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Russian Science Foundation(Russian Science Foundation (RSF)); Cancer Research UK(Cancer Research UK); The Brain Tumour Charity; Great Ormond Street Hospital Childrens Charity; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank U. Lass, A. Habel, I. Oezen for technical and administrative support, the Microarray unit of the Genomics and Proteomics Core Facility (DKFZ) for methylation services, the German Glioma Network and the Neuroonkologische Arbeitsgemeinschaft for sharing their data. This research was supported by the DKFZ-Heidelberg Center for Personalized Oncology (DKFZ-HIPO_036), the German Childhood Cancer Foundation (DKS 2015.01), an Illumina Medical Research Grant, the DKTK joint funding project 'Next Generation Molecular Diagnostics of Malignant Gliomas', the A Kids' Brain Tumour Cure (PLGA) Foundation, the Brain Tumour Charity (UK) for the Everest Centre for Paediatric Low-Grade Brain Tumour Research, the Friedberg Charitable Foundation and the Sohn Conference Foundation (to M. Snuderl and M. Karajannis), the RKA-Forderpool (Project 37) and Stichting Kinderen Kankervrij and Stichting AMC Foundation (to E. Aronica), NIH/ NCI 5T32CA163185 (to A.O.), NIH/NCI Cancer Center Support Grant P30 CA008748 to MSKCC, the Luxembourg National Research Fond (FNR PEARL P16/BM/11192868 to M.M.) and the National Institute of Health Research (NIHR) UCLH/UCL Biomedical Research Centre (S. Bra.).	Appel IJ, 2011, BIOINFORMATICS, V27, P2563, DOI 10.1093/bioinformatics/btr434; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Bady P, 2016, J MOL DIAGN, V18, P350, DOI 10.1016/j.jmoldx.2015.11.009; Bostrom H, 2008, SEVENTH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS, PROCEEDINGS, P121, DOI 10.1109/ICMLA.2008.107; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 1984, CLASSIFICATION REGRE; Brier G.W., 1950, MON WEATHER REV, V78, P1, DOI [10.1175/1520-0493(1950)0782.0.CO,2, DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2, 10.1175/1520-0493(1950)0782.0.CO;2]; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Chen C., 2004, TECHNICAL REPORT; Ellison DW, 2011, J NEGAT RESULTS BIOM, V10, DOI 10.1186/1477-5751-10-7; Fernandez AF, 2012, GENOME RES, V22, P407, DOI 10.1101/gr.119867.110; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Hand DJ, 2001, MACH LEARN, V45, P171, DOI 10.1023/A:1010920819831; Heim S, 2016, BRAIN PATHOL, V26, P199, DOI 10.1111/bpa.12282; Holsken A, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0287-6; Hovestadt V., 2015, CONUMEE ENHANCED COP; Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268; Hovestadt V, 2013, ACTA NEUROPATHOL, V125, P913, DOI 10.1007/s00401-013-1126-5; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; Johann PD, 2016, CANCER CELL, V29, P379, DOI 10.1016/j.ccell.2016.02.001; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kim KI, 2014, BIOMETRICAL J, V56, P256, DOI 10.1002/bimj.201300083; Koelsche C, 2015, BRAIN PATHOL, V25, P202, DOI 10.1111/bpa.12228; Korshunov A, 2016, ACTA NEUROPATHOL, V131, P137, DOI 10.1007/s00401-015-1493-1; Korshunov A, 2014, ACTA NEUROPATHOL, V128, P279, DOI 10.1007/s00401-013-1228-0; Lambert SR, 2013, ACTA NEUROPATHOL, V126, P291, DOI 10.1007/s00401-013-1124-7; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Leek JT, 2008, P NATL ACAD SCI USA, V105, P18718, DOI 10.1073/pnas.0808709105; Louis DN., 2016, WHO CLASSIFICATION T; Mack SC, 2014, NATURE, V506, P445, DOI 10.1038/nature13108; Moran S, 2016, LANCET ONCOL, V17, P1386, DOI 10.1016/S1470-2045(16)30297-2; Pajtler KW, 2015, CANCER CELL, V27, P728, DOI 10.1016/j.ccell.2015.04.002; Pietsch T, 2014, ACTA NEUROPATHOL, V128, P137, DOI 10.1007/s00401-014-1276-0; R Development Core Team, 2009, R LANG ENV STAT COMP; Reuss DE, 2015, ACTA NEUROPATHOL, V130, P407, DOI 10.1007/s00401-015-1454-8; Sahm F, 2016, ACTA NEUROPATHOL, V131, P903, DOI 10.1007/s00401-015-1519-8; Simon R, 2014, BIOMETRICAL J, V56, P597, DOI 10.1002/bimj.201300296; Smola A.J., 2000, ADV LARGE MARGIN CLA; Sokolova M, 2009, INFORM PROCESS MANAG, V45, P427, DOI 10.1016/j.ipm.2009.03.002; Sturm D, 2016, CELL, V164, P1060, DOI 10.1016/j.cell.2016.01.015; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Thomas C, 2016, NEURO-ONCOLOGY, V18, P790, DOI 10.1093/neuonc/nov322; van den Bent MJ, 2010, ACTA NEUROPATHOL, V120, P297, DOI 10.1007/s00401-010-0725-7; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Weller M, 2015, ACTA NEUROPATHOL, V129, P679, DOI 10.1007/s00401-015-1409-0; Wiestler B, 2014, ACTA NEUROPATHOL, V128, P561, DOI 10.1007/s00401-014-1315-x	49	1169	1180	9	341	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 22	2018	555	7697					469	+		10.1038/nature26000	http://dx.doi.org/10.1038/nature26000			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ9NF	29539639	Green Accepted, Green Submitted			2022-12-28	WOS:000427937900043
J	Rey, FA; Lok, SM				Rey, Felix A.; Lok, Shee-Mei			Common Features of Enveloped Viruses and Implications for Immunogen Design for Next-Generation Vaccines	CELL			English	Review							BROADLY NEUTRALIZING ANTIBODIES; RESPIRATORY SYNCYTIAL VIRUS; CORONAVIRUS SPIKE PROTEIN; II FUSION PROTEIN; CRYO-EM STRUCTURE; MEMBRANE-FUSION; DENGUE VIRUS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; INFLUENZA-VIRUS	Enveloped viruses enter cells by inducing fusion of viral and cellular membranes, a process catalyzed by a specialized membrane-fusion protein expressed on their surface. This review focuses on recent structural studies of viral fusion proteins with an emphasis on their metastable prefusion form and on interactions with neutralizing antibodies. The fusion glycoproteins have been difficult to study because they are present in a labile, metastable form at the surface of infectious virions. Such metastability is a functional requirement, allowing these proteins to refold into a lower energy conformation while transferring the difference in energy to catalyze the membrane fusion reaction. Structural studies have shown that stable immunogens presenting the same antigenic sites as the labile wild-type proteins efficiently elicit potently neutralizing antibodies, providing a framework with which to engineer the antigens for stability, as well as identifying key vulnerability sites that can be used in next-generation subunit vaccine design.	[Rey, Felix A.] Inst Pasteur, CNRS, UMR3569, Struct Virol Unit, 25-28 Rue Dr Roux, F-75015 Paris, France; [Lok, Shee-Mei] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore; [Lok, Shee-Mei] Duke NUS Med Sch, 8 Coll Rd, Singapore 169857, Singapore	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National University of Singapore; National University of Singapore	Rey, FA (corresponding author), Inst Pasteur, CNRS, UMR3569, Struct Virol Unit, 25-28 Rue Dr Roux, F-75015 Paris, France.; Lok, SM (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.; Lok, SM (corresponding author), Duke NUS Med Sch, 8 Coll Rd, Singapore 169857, Singapore.	felix.rey@pasteur.fr; sheemei.lok@duke-nus.edu.sg		Rey, Felix/0000-0002-9953-7988; Lok, Shee-Mei/0000-0003-4631-8041	Institut Pasteur; CNRS; ERC [UE 340371]; European Infect-ERA [ANR 15 IFEC]; "Integrative Biology of Emerging Infectious Diseases'' Labex (Laboratoire d'Excellence) [ANR-10-LABX-62-IBEID]; Zoonoses Anticipation and Preparedness Initiative (ZAPI project) [115760]; Singapore Ministry of Education Tier 3 [MOE2012-T3-1-008]; National Research Foundation Investigatorship award [NRF-NRFI2016-01]; National Research Foundation competitive Research Project grant [NRF2015NRF-CRP001-063];  [ANR-13-ISV8-0002-01]	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); ERC(European Research Council (ERC)European Commission); European Infect-ERA; "Integrative Biology of Emerging Infectious Diseases'' Labex (Laboratoire d'Excellence); Zoonoses Anticipation and Preparedness Initiative (ZAPI project); Singapore Ministry of Education Tier 3(Ministry of Education, Singapore); National Research Foundation Investigatorship award; National Research Foundation competitive Research Project grant; 	F.A.R. was funded by Institut Pasteur, the CNRS, the ERC Advanced grant "Celcelfus'' (Grant UE 340371), the ANR-13-ISV8-0002-01 grant "Flavistem,'' the European Infect-ERA "HantaHunt'' Project (Grant ANR 15 IFEC), from the "Integrative Biology of Emerging Infectious Diseases'' Labex (Laboratoire d'Excellence) grant ANR-10-LABX-62-IBEID. Part of the research was performed as part of the Zoonoses Anticipation and Preparedness Initiative (ZAPI project; IMI Grant Agreement no 115760). S.-M.L. acknowledges support by the Singapore Ministry of Education Tier 3 grant (MOE2012-T3-1-008), the National Research Foundation Investigatorship award (NRF-NRFI2016-01) and the National Research Foundation competitive Research Project grant (NRF2015NRF-CRP001-063). Given the focus of this Review, we have not attempted to be comprehensive and only aselection of recent primary literature has been cited.	Altamura LA, 2007, J VIROL, V81, P6632, DOI 10.1128/JVI.02730-06; Andrabi R, 2017, IMMUNITY, V47, P524, DOI 10.1016/j.immuni.2017.08.006; Baquero E, 2015, CURR OPIN STRUC BIOL, V33, P52, DOI 10.1016/j.sbi.2015.07.011; Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Bose S, 2015, VIROLOGY, V479, P518, DOI 10.1016/j.virol.2015.02.037; Burkard C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004502; Burri DJ, 2012, VIRUSES-BASEL, V4, P2162, DOI 10.3390/v4102162; Burton DR, 2001, CURR TOP MICROBIOL, V260, P109; Chen L, 2001, STRUCTURE, V9, P255, DOI 10.1016/S0969-2126(01)00581-0; de la Pena AT, 2017, CELL REP, V20, P1805, DOI 10.1016/j.celrep.2017.07.077; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058; Dessau M, 2013, P NATL ACAD SCI USA, V110, P1696, DOI 10.1073/pnas.1217780110; Doms RW, 2017, CELL, V168, P755, DOI 10.1016/j.cell.2017.02.012; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; El Omari K, 2013, CELL REP, V3, P30, DOI 10.1016/j.celrep.2012.12.001; Elliott R., 2013, BUNYAVIRIDAE, V1; Escolano A, 2016, CELL, V166, P1445, DOI 10.1016/j.cell.2016.07.030; Fedry J, 2017, CELL, V168, P904, DOI 10.1016/j.cell.2017.01.024; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Fox JM, 2015, CELL, V163, P1095, DOI 10.1016/j.cell.2015.10.050; Guardado-Calvo P, 2017, SCIENCE, V358, P663, DOI 10.1126/science.aal2712; Guardado-Calvo P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005813; Halldorsson S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02789-2; Halldorsson S, 2016, P NATL ACAD SCI USA, V113, P7154, DOI 10.1073/pnas.1603827113; Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043; Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8; Hastie KM, 2017, SCIENCE, V356, P923, DOI 10.1126/science.aam7260; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Hoffmann B, 2015, NEW ENGL J MED, V373, P154, DOI 10.1056/NEJMoa1415627; Jae LT, 2015, TRENDS MICROBIOL, V23, P392, DOI 10.1016/j.tim.2015.04.006; Joyce MG, 2017, CELL REP, V21, P2992, DOI 10.1016/j.celrep.2017.11.016; Kadam RU, 2017, SCIENCE, V358, P496, DOI 10.1126/science.aan0516; Kadlec J, 2008, NAT STRUCT MOL BIOL, V15, P1024, DOI 10.1038/nsmb.1484; Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836; Key T, 2015, BBA-BIOMEMBRANES, V1848, P408, DOI 10.1016/j.bbamem.2014.10.020; Khan AG, 2014, NATURE, V509, P381, DOI 10.1038/nature13117; Kirchdoerfer RN, 2016, NATURE, V531, P118, DOI 10.1038/nature17200; Kong L, 2013, SCIENCE, V342, P1090, DOI 10.1126/science.1243876; Krarup A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9143; Kuhn R., 2013, TOGAVIRIDAE, V1; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Kulp DW, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01549-6; Landais E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005369; Lauber C, 2017, CELL HOST MICROBE, V22, P387, DOI 10.1016/j.chom.2017.07.019; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; Li KJ, 2008, J VIROL, V82, P7135, DOI 10.1128/JVI.00448-08; Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263; Li L, 2010, NATURE, V468, P705, DOI 10.1038/nature09546; Li S, 2016, CELL REP, V16, P278, DOI 10.1016/j.celrep.2016.06.039; Li S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005418; Libersou S, 2010, J CELL BIOL, V191, P199, DOI 10.1083/jcb.201006116; Lindenbach B., 2013, FLAVIVIRIDAE, V1; Lok SM, 2016, TRENDS MICROBIOL, V24, P284, DOI 10.1016/j.tim.2015.12.004; Long F, 2015, P NATL ACAD SCI USA, V112, P13898, DOI 10.1073/pnas.1515558112; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; Medina-Ramirez M, 2017, J EXP MED, V214, P2573, DOI 10.1084/jem.20161160; Medina-Ramirez M, 2017, CURR OPIN HIV AIDS, V12, P241, DOI 10.1097/COH.0000000000000363; Moss B, 2016, SEMIN CELL DEV BIOL, V60, P89, DOI 10.1016/j.semcdb.2016.07.015; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; Ngwuta JO, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4241; Nikolaus J, 2011, CURR TOP MEMBR, V68, P1, DOI 10.1016/B978-0-12-385891-7.00001-5; Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114; Pancera M, 2017, CURR OPIN HIV AIDS, V12, P229, DOI 10.1097/COH.0000000000000360; Peng RC, 2017, P NATL ACAD SCI USA, V114, pE8905, DOI 10.1073/pnas.1706125114; Perez-Vargas J, 2014, CELL, V157, P407, DOI 10.1016/j.cell.2014.02.020; Prasad VM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006377; Qiao H, 1998, J CELL BIOL, V141, P1335, DOI 10.1083/jcb.141.6.1335; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Roche S, 2007, SCIENCE, V315, P843, DOI 10.1126/science.1135710; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; Rouvinski A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15411; Salanueva IJ, 2003, J VIROL, V77, P1368, DOI 10.1128/JVI.77.2.1368-1381.2003; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Saunders KO, 2017, CELL REP, V21, P3681, DOI 10.1016/j.celrep.2017.12.028; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Seitz S, 2016, CELL HOST MICROBE, V20, P25, DOI 10.1016/j.chom.2016.05.013; Steichen JM, 2016, IMMUNITY, V45, P483, DOI 10.1016/j.immuni.2016.08.016; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Stewart-Jones GBE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128779; Sun SY, 2013, ELIFE, V2, DOI 10.7554/eLife.00435; Swanson KA, 2011, P NATL ACAD SCI USA, V108, P9619, DOI 10.1073/pnas.1106536108; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108; Vaney MC, 2013, CURR OPIN VIROL, V3, P151, DOI 10.1016/j.coviro.2013.04.003; Vaney MC, 2011, CELL MICROBIOL, V13, P1451, DOI 10.1111/j.1462-5822.2011.01653.x; Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555; Walls AC, 2017, P NATL ACAD SCI USA, V114, P11157, DOI 10.1073/pnas.1708727114; Walls AC, 2016, NAT STRUCT MOL BIOL, V23, P899, DOI 10.1038/nsmb.3293; Walls AC, 2016, NATURE, V531, P114, DOI 10.1038/nature16988; Ward AB, 2017, IMMUNOL REV, V275, P21, DOI 10.1111/imr.12507; White JM, 2016, TRAFFIC, V17, P593, DOI 10.1111/tra.12389; Willensky S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005948; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wu Y, 2017, P NATL ACAD SCI USA, V114, pE7564, DOI 10.1073/pnas.1705176114; Yamauchi Y, 2013, J CELL SCI, V126, P1289, DOI 10.1242/jcs.119685; Yang ZN, 1999, J STRUCT BIOL, V126, P131, DOI 10.1006/jsbi.1999.4116; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322; Yin HS, 2005, P NATL ACAD SCI USA, V102, P9288, DOI 10.1073/pnas.0503989102; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; Zhang R, 2011, EMBO J, V30, P3854, DOI 10.1038/emboj.2011.261; Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463; Zhao YG, 2016, NATURE, V535, P169, DOI 10.1038/nature18615; Zhu Y., 2017, J VIROL, V92, P92	111	114	115	3	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 8	2018	172	6					1319	1334		10.1016/j.cell.2018.02.054	http://dx.doi.org/10.1016/j.cell.2018.02.054			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FZ3IX	29522750	Green Published, Bronze			2022-12-28	WOS:000427482100031
J	Sorondo, MMS; Sorondo, S; Ramanathan, V				Sanchez Sorondo, Monsignor Marcelo; Sorondo, Sanchez; Ramanathan, Veerabhadran			Health, Faith, and Science on a Warming Planet	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CLIMATE-CHANGE		[Sanchez Sorondo, Monsignor Marcelo] Pontifical Acad Sci, Vatican City, Vatican; [Ramanathan, Veerabhadran] Univ Washington, Sch Publ Hlth, Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; Univ Calif San Diego, Scripps Inst Oceanog, Atmospher & Climate Sci, San Diego, CA 92103 USA	University of Washington; University of Washington Seattle; University of California System; University of California San Diego; Scripps Institution of Oceanography	Sorondo, S (corresponding author), Univ Washington, Sch Publ Hlth, Hlth Sci Ctr, Environm & Occupat Hlth Sci, 1959 NE Pacific St,POB 354695, Seattle, WA 98195 USA.	frumkin@uw.edu		Frumkin, Howard/0000-0001-7079-3534				Cantore E., 1977, SCI MAN HUMANISTIC S; Gibbons ED, 2014, HEALTH HUM RIGHTS, V16, P19; Kaelin WG, 2017, JAMA-J AM MED ASSOC, V318, P611, DOI 10.1001/jama.2017.6999; Leichenko R, 2014, WIRES CLIM CHANGE, V5, P539, DOI 10.1002/wcc.287; Pope Francis, 2013, EVANGELII GAUDIURN; Ramanathan V, 2017, FINAL DECLARATION OU; World Health Organization, 2012, BURD DIS JOINT EFF H	7	7	7	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2018	319	16					1651	1652		10.1001/jama.2018.2779	http://dx.doi.org/10.1001/jama.2018.2779			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD7RF	29543969	Green Published			2022-12-28	WOS:000430709300014
J	Hawkes, N				Hawkes, Nigel			The BMJ Awards 2018: Dermatology	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com			LEO Pharma	LEO Pharma(LEO Pharma)	The Dermatology Team of the Year award is sponsored by LEO Pharma. The awards ceremony takes place on 10 May at the Park Plaza Hotel, Westminster. To find out more go to thebmjawards.bmj.com		0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2018	360								k1338	10.1136/bmj.k1338	http://dx.doi.org/10.1136/bmj.k1338			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB5MP	29581145				2022-12-28	WOS:000429109200005
J	Ryan, A; Heath, S; Cook, P				Ryan, Aidan; Heath, Simon; Cook, Paul			Managing dyslipidaemia for the primary prevention of cardiovascular disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DENSITY-LIPOPROTEIN CHOLESTEROL; STATIN THERAPY; GUIDELINES; RISK; HYPERCHOLESTEROLEMIA; MANAGEMENT; SAFETY		[Ryan, Aidan] Univ Hosp Southampton, Dept Lab Med, Metab Med, Southampton, Hants, England; [Cook, Paul] Univ Hosp Southampton, Dept Lab Med, Metab Med, Chem Pathol & Metab Med, Southampton, Hants, England; [Heath, Simon] Hazelwood Grp Practice, Gen Practice, Coleshill, Warwick, England		Ryan, A (corresponding author), Univ Hosp Southampton, Dept Lab Med, Metab Med, Southampton, Hants, England.	aidan.ryan@uhs.nhs.uk	Ryan, Aidan/GWQ-9352-2022					Anderson TJ, 2016, CAN J CARDIOL, V32, P1263, DOI 10.1016/j.cjca.2016.07.510; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; [Anonymous], BMJ; Authors/Task Force Members:, 2016, Atherosclerosis, V253, P281, DOI 10.1016/j.atherosclerosis.2016.08.018; Bays H, 2014, J CLIN LIPIDOL, V8, pS47, DOI 10.1016/j.jacl.2014.02.011; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P1997, DOI 10.1001/jama.2016.15450; Catapano AL, 2016, ATHEROSCLEROSIS, V253, P281, DOI 10.1016/j.atherosclerosis.2016.08.018; Ference BA, 2017, EUR HEART J, V38, P2459, DOI 10.1093/eurheartj/ehx144; Ford I, 2016, CIRCULATION, V133, P1073, DOI 10.1161/CIRCULATIONAHA.115.019014; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Landmesser U, 2017, EUR HEART J, V38, P2245, DOI 10.1093/eurheartj/ehw480; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Mozaffarian D, 2016, CIRCULATION, V133, P187, DOI 10.1161/CIRCULATIONAHA.115.018585; Navar-Boggan AM, 2015, CIRCULATION, V131, P451, DOI 10.1161/CIRCULATIONAHA.114.012477; Nordestgaard BG, 2017, J AM COLL CARDIOL, V70, P1637, DOI 10.1016/j.jacc.2017.08.006; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Quispe R, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0852-2; Ridker PM, 2015, J AM COLL CARDIOL, V65, P942, DOI 10.1016/j.jacc.2014.12.028; Soran H, 2017, EUR J PREV CARDIOL, V24, P76, DOI 10.1177/2047487316667785; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Stroes ES, 2015, EUR HEART J, V36, P1012, DOI 10.1093/eurheartj/ehv043; Thanassoulis G, 2016, CIRCULATION, V133, P1574, DOI 10.1161/CIRCULATIONAHA.115.018383; Thompson PD, 2016, J AM COLL CARDIOL, V67, P2395, DOI 10.1016/j.jacc.2016.02.071; Ueda P, 2017, BRIT J GEN PRACT, V67, pE598, DOI 10.3399/bjgp17X692141	24	3	3	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2018	360								k946	10.1136/bmj.k946	http://dx.doi.org/10.1136/bmj.k946			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB1LW	29572251	Green Accepted			2022-12-28	WOS:000428813300015
J	Schlesinger, WH				Schlesinger, William H.			Are wood pellets a green fuel?	SCIENCE			English	Editorial Material							SOUTHEASTERN UNITED-STATES; POLICY		[Schlesinger, William H.] Cary Inst Ecosyst Studies, Post Off Box AB, Millbrook, NY 12545 USA	Cary Institute of Ecosystem Studies	Schlesinger, WH (corresponding author), Cary Inst Ecosyst Studies, Post Off Box AB, Millbrook, NY 12545 USA.	schlesingerw@caryinstitute.org						Dwivedi P, 2015, GCB BIOENERGY, V7, P945, DOI 10.1111/gcbb.12199; Erb KH, 2018, NATURE, V553, P73, DOI 10.1038/nature25138; Galik CS, 2016, GCB BIOENERGY, V8, P658, DOI 10.1111/gcbb.12273; Hanssen SV, 2017, GCB BIOENERGY, V9, P1406, DOI 10.1111/gcbb.12426; Jonker JGG, 2014, GCB BIOENERGY, V6, P371, DOI 10.1111/gcbb.12056; Kanemoto K, 2016, ENVIRON SCI TECHNOL, V50, P10512, DOI 10.1021/acs.est.6b03227; Kelsey Katharine C, 2014, Carbon Balance Manag, V9, P6, DOI 10.1186/s13021-014-0006-1; Martinuzzi S, 2015, ECOL APPL, V25, P160, DOI 10.1890/13-2078.1; Ocko IB, 2017, SCIENCE, V356, P492, DOI 10.1126/science.aaj2350; SCHIFFMAN PM, 1989, CAN J FOREST RES, V19, P69, DOI 10.1139/x89-010; Schlesinger W.H., 2013, BIOGEOCHEMISTRY; Shoemaker JK, 2013, SCIENCE, V342, P1323, DOI 10.1126/science.1240162; Stephenson A.L., 2014, LIFE CYCLE IMPACTS B; Sterman JD, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aaa512; Ter-Mikaelian MT, 2015, J FOREST, V113, P57, DOI 10.5849/jof.14-016	15	36	36	9	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2018	359	6382			SI		1328	1329		10.1126/science.aat2305	http://dx.doi.org/10.1126/science.aat2305			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA0ZG	29567691				2022-12-28	WOS:000428043600021
J	Friedrich, MJ				Friedrich, M. J.			NTDs Added to African Leaders Malaria Alliance Scorecard	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2018	319	11					1085	1085		10.1001/jama.2018.2365	http://dx.doi.org/10.1001/jama.2018.2365			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HI0BJ	29558560				2022-12-28	WOS:000456106800002
J	Grossman, DC; Curry, SJ; Owens, DK; Barry, MJ; Caughey, AB; Davidson, KW; Doubeni, CA; Epling, JW; Kemper, AR; Krist, AH; Kubik, M; Landefeld, S; Mangione, CM; Silverstein, M; Simon, MA; Tseng, CW				Grossman, David C.; Curry, Susan J.; Owens, Douglas K.; Barry, Michael J.; Caughey, Aaron B.; Davidson, Karina W.; Doubeni, Chyke A.; Epling, John W., Jr.; Kemper, Alex R.; Krist, Alex H.; Kubik, Martha; Landefeld, Seth; Mangione, Carol M.; Silverstein, Michael; Simon, Melissa A.; Tseng, Chien-Wen		US Preventive Serv Task Force	Behavioral Counseling to Prevent Skin Cancer US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED CONTROLLED-TRIAL; SUN PROTECTION BEHAVIORS; ULTRAVIOLET-RADIATION; SELF-EXAMINATION; MELANOMA RISK; INTERVENTION; CHILDREN; EXPOSURE; SUNSCREEN; CELL	IMPORTANCE Skin cancer is the most common type of cancer in the United States. Although invasive melanoma accounts for only 2% of all skin cancer cases, it is responsible for 80% of skin cancer deaths. Basal and squamous cell carcinoma, the 2 predominant types of nonmelanoma skin cancer, represent the vast majority of skin cancer cases. OBJECTIVE To update the 2012 US Preventive Services Task Force (USPSTF) recommendation on behavioral counseling for the primary prevention of skin cancer and the 2009 recommendation on screening for skin cancer with skin self-examination. EVIDENCE REVIEW The USPSTF reviewed the evidence on whether counseling patients about sun protection reduces intermediate outcomes (eg, sunburn or precursor skin lesions) or skin cancer; the link between counseling and behavior change, the link between behavior change and skin cancer incidence, and the harms of counseling or changes in sun protection behavior; and the link between counseling patients to perform skin self-examination and skin cancer outcomes, as well as the harms of skin self-examination. FINDINGS The USPSTF determined that behavioral counseling interventions are of moderate benefit in increasing sun protection behaviors in children, adolescents, and young adults with fair skin types. The USPSTF found adequate evidence that behavioral counseling interventions result in a small increase in sun protection behaviors in adults older than 24 years with fair skin types. The USPSTF found inadequate evidence on the benefits and harms of counseling adults about skin self-examination to prevent skin cancer. CONCLUSIONS AND RECOMMENDATION The USPSTF recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to UV radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer. (B recommendation) The USPSTF recommends that clinicians selectively offer counseling to adults older than 24 years with fair skin types about minimizing their exposure to UV radiation to reduce risk of skin cancer. Existing evidence indicates that the net benefit of counseling all adults older than 24 years is small. In determining whether this service is appropriate in individual cases, patients and clinicians should consider the presence of risk factors for skin cancer. (C recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer. (I statement)	[Grossman, David C.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA 98101 USA; [Curry, Susan J.] Univ Iowa, Iowa City, IA USA; [Owens, Douglas K.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Owens, Douglas K.] Stanford Univ, Stanford, CA 94305 USA; [Barry, Michael J.] Harvard Med Sch, Boston, MA USA; [Caughey, Aaron B.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Davidson, Karina W.] Columbia Univ, New York, NY USA; [Doubeni, Chyke A.] Univ Penn, Philadelphia, PA 19104 USA; [Epling, John W., Jr.] Virginia Tech Caril Sch Med, Roanoke, VA USA; [Kemper, Alex R.] Nationwide Childrens Hosp, Columbus, OH USA; [Krist, Alex H.] Fairfax Family Practice Residency, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA USA; [Kubik, Martha] Temple Univ, Philadelphia, PA 19122 USA; [Landefeld, Seth] Univ Alabama Birmingham, Birmingham, AL USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Silverstein, Michael] Boston Univ, Boston, MA 02215 USA; [Simon, Melissa A.] Northwestern Univ, Evanston, IL USA; [Tseng, Chien-Wen] Univ Hawaii, Honolulu, HI 96822 USA; [Tseng, Chien-Wen] Pacific Hlth Res & Educ Inst, Honolulu, HI USA	Kaiser Permanente; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Harvard University; Harvard Medical School; Oregon Health & Science University; Columbia University; University of Pennsylvania; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Virginia Commonwealth University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; Boston University; Northwestern University; University of Hawaii System; Pacific Health Research & Education Institute	Grossman, DC (corresponding author), Kaiser Permanente Washington Hlth Res Inst, Seattle, WA 98101 USA.	chair@uspstf.net	Davidson, Karina/AAG-2388-2019; Epling, John W/J-1097-2019; Davidson, Karina/GWC-0996-2022	Davidson, Karina/0000-0002-9162-477X; Epling, John W/0000-0001-9445-8669; Davidson, Karina/0000-0002-9162-477X; Kemper, Alex/0000-0001-5491-3997	Agency for Healthcare Research and Quality (AHRQ); NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.	Abhishek Kumar, 2015, J Cutan Aesthet Surg, V8, P239, DOI 10.4103/0974-2077.172206; American Academy of Dermatology, SKIN CANC; American Cancer Society, 2017, CANC FACTS FIG 2015; American Cancer Society, SKIN CANC PREV EARL; American Cancer Society, BAS SQAM CELL SKIN C; [Anonymous], 2015, Obstet Gynecol, V125, P752, DOI 10.1097/01.AOG.0000461764.54910.a8; [Anonymous], MEL SKIN CANC; Balk SJ, 2011, PEDIATRICS, V127, P588, DOI 10.1542/peds.2010-3501; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P429, DOI 10.1001/jama.2016.8465; Boniol M, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4757; Calonge N, 2009, ANN INTERN MED, V150, P188, DOI 10.7326/0003-4819-150-3-200902030-00020; Centers for Disease Control, SKIN CANC WHAT AR RI; Community Preventive Services Task Force, 2016, Am J Prev Med, V51, P540, DOI 10.1016/j.amepre.2016.03.019; Crane LA, 2006, PREV MED, V42, P162, DOI 10.1016/j.ypmed.2005.11.007; Crane LA, 2012, AM J PREV MED, V43, P399, DOI 10.1016/j.amepre.2012.06.022; FDA, 2021, SUNSCR HELP PROT YOU; Ferrucci LM, 2014, J AM ACAD DERMATOL, V71, P882, DOI 10.1016/j.jaad.2014.06.046; Glanz K, 2013, J HEALTH COMMUN, V18, P1368, DOI 10.1080/10810730.2013.778361; Glasser A, 2010, AM J HEALTH BEHAV, V34, P500, DOI 10.5993/AJHB.34.4.11; Green A, 1999, LANCET, V354, P723, DOI 10.1016/S0140-6736(98)12168-2; Green AC, 2011, J CLIN ONCOL, V29, P257, DOI 10.1200/JCO.2010.28.7078; Gritz ER, 2013, CANCER EPIDEM BIOMAR, V22, P1813, DOI 10.1158/1055-9965.EPI-13-0249; Heckman CJ, 2016, AM J PREV MED, V51, P1, DOI 10.1016/j.amepre.2015.11.008; Henrikson NB, 2018, BEHAV COUNSELING SKI; Henrikson NB, 2018, JAMA-J AM MED ASSOC, V319, P1143, DOI 10.1001/jama.2017.21630; Hillhouse J, 2008, CANCER-AM CANCER SOC, V113, P3257, DOI 10.1002/cncr.23922; IARC, 2012, IARC MON EV CARC RIS, V100; International Agency for Research on Cancer, 2001, IARC HDB CANC PREV, V5; Koster B, 2010, SCAND J PUBLIC HEALT, V38, P548, DOI 10.1177/1403494810371250; Lazovich D, 2011, CANCER EPIDEM BIOMAR, V20, P2583, DOI 10.1158/1055-9965.EPI-11-0705; Lin SW, 2012, INT J CANCER, V131, pE1015, DOI 10.1002/ijc.27619; Linos E, 2011, CANCER CAUSE CONTROL, V22, P1067, DOI 10.1007/s10552-011-9780-1; Mahler HIM, 2007, HEALTH PSYCHOL, V26, P350, DOI 10.1037/0278-6133.26.3.350; Milne E, 2007, AM J PUBLIC HEALTH, V97, P306, DOI 10.2105/AJPH.2005.080499; Moyer VA, 2012, ANN INTERN MED, V157, P59, DOI 10.7326/0003-4819-157-1-201207030-00442; National Cancer Institute, CANC STAT FACTS MEL; Norman GJ, 2007, ARCH PEDIAT ADOL MED, V161, P146, DOI 10.1001/archpedi.161.2.146; Paddock LE, 2016, MELANOMA RES, V26, P401, DOI 10.1097/CMR.0000000000000255; Skin Cancer Foundation, EARL DET SELF EX; The Royal Australian College of General Practitioners, 2012, GUID PREV ACT GEN PR; U.S. Food and Drug Administration, IND TANN RISKS ULTR; United States Environmental Protection Agency, SUN SAF; US Department of Health and Human Services, 2014, SURG GEN CALL ACT PR; Veierod MB, 2014, INT J CANCER, V135, P413, DOI 10.1002/ijc.28657; Veierod MB, 2010, CANCER EPIDEM BIOMAR, V19, P111, DOI 10.1158/1055-9965.EPI-09-0567; Wehner MR, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5909; Weinstock MA, 2017, BRIT J DERMATOL, V176, P949, DOI 10.1111/bjd.15077; Weinstock MA, 2007, AM J PREV MED, V32, P517, DOI 10.1016/j.amepre.2007.02.024	48	85	86	5	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2018	319	11					1134	1142		10.1001/jama.2018.1623	http://dx.doi.org/10.1001/jama.2018.1623			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ8LL	29558558	Bronze			2022-12-28	WOS:000427860200018
J	Holbrook, AM				Holbrook, Anne M.			Review: Multilevel and patient-level implementation strategies reduce BP more than usual care in hypertension	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Holbrook, Anne M.] McMaster Univ, Hamilton, ON, Canada	McMaster University	Holbrook, AM (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Carey RM, 2018, ANN INTERN MED, V168, P359, DOI 10.7326/M18-0025; Tucker KL, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002389	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2018	168	6					JC29	JC29		10.7326/ACPJC-2018-168-6-029	http://dx.doi.org/10.7326/ACPJC-2018-168-6-029			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ8AM	29554667				2022-12-28	WOS:000427827400006
J	Rehfeld, K; Unch, TM; Ho, SL; Laepple, T				Rehfeld, Kira; Unch, Thomas M.; Ho, Sze Ling; Laepple, Thomas			Global patterns of declining temperature variability from the Last Glacial Maximum to the Holocene (vol 554, pg 356, 2018)	NATURE			English	Correction													Rehfeld, Kira/O-1781-2019	Rehfeld, Kira/0000-0002-9442-5362				Rehfeld K, 2018, NATURE, V554, P356, DOI 10.1038/nature25454	1	0	0	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2018	555	7696								10.1038/nature25998	http://dx.doi.org/10.1038/nature25998			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ3HG	29542691	Bronze			2022-12-28	WOS:000427477100045
J	Myat, A; Song, KJ; Rea, T				Myat, Aung; Song, Kyoung-Jun; Rea, Thomas			Out-of-hospital cardiac arrest: current concepts	LANCET			English	Review							ASSISTED CARDIOPULMONARY-RESUSCITATION; CHRONIC HEALTH CONDITIONS; LONG-TERM OUTCOMES; SOCIOECONOMIC-STATUS; VENTRICULAR-FIBRILLATION; MYOCARDIAL-INFARCTION; POPULATION-DENSITY; REGIONAL-VARIATION; CARE COMMITTEE; SURVIVAL RATES	Out-of-hospital cardiac arrest (OHCA) is a leading cause of global mortality. Regional variations in reporting frameworks and survival mean the exact burden of OHCA to public health is unknown. Nevertheless, overall prognosis and neurological outcome are relatively poor following OHCA and have remained almost static for the past three decades. In this Series paper, we explore the aetiology of OHCA. Coronary artery disease remains the predominant cause, but there is a diverse range of other potential cardiac and non-cardiac causes to be aware of. Additionally, we describe how investigators and key stakeholders in resuscitation science have formulated specific Utstein data element domains in an attempt to standardise the definitions and outcomes reported in OHCA research so that management pathways can be improved. Finally, we identify the predictors of survival after OHCA and what primary and secondary prevention strategies can be instigated to mitigate the devastating sequelae of this growing public health issue.	[Myat, Aung] Brighton & Sussex Univ Hosp NHS Trust, Sussex Cardiac Ctr, Brighton BN2 5BE, E Sussex, England; [Myat, Aung] Brighton & Sussex Med Sch, Div Clin & Expt Med, Brighton, E Sussex, England; [Song, Kyoung-Jun] Seoul Natl Univ, Dept Emergency Med, Coll Med & Hosp, Seoul, South Korea; [Song, Kyoung-Jun] Seoul Natl Univ Hosp, Lab Emergency Med Serv, Biomed Res Inst, Seoul, South Korea; [Rea, Thomas] Univ Washington, Harborview Med Ctr, Div Gen Internal Med, 325 9th Ave, Seattle, WA 98104 USA	Brighton and Sussex University Hospitals NHS Trust; University of Brighton; University of Brighton; University of Sussex; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Harborview Medical Center; University of Washington; University of Washington Seattle	Myat, A (corresponding author), Brighton & Sussex Univ Hosp NHS Trust, Sussex Cardiac Ctr, Brighton BN2 5BE, E Sussex, England.	aung.myat@bsuh.nhs.uk	Lee, Jae Hyuk/W-5616-2018	Lee, Jae Hyuk/0000-0003-2429-4085	American Heart Association; Laerdal Foundation; Life Sciences Foundation; Medtronic Philanthropy; National Institutes of Health; Philips Healthcare; PhysioControl	American Heart Association(American Heart Association); Laerdal Foundation; Life Sciences Foundation; Medtronic Philanthropy; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philips Healthcare; PhysioControl	AM and K-JS declare no competing interests. TR has received research grants from the American Heart Association, the Laerdal Foundation, the Life Sciences Foundation, Medtronic Philanthropy, National Institutes of Health, Philips Healthcare, and PhysioControl, which were administered by the University of Washington (Seattle, WA, USA).	Ahn KO, 2011, RESUSCITATION, V82, P270, DOI 10.1016/j.resuscitation.2010.10.023; ALKHATIB SM, 2018, HEART RHYTHM, V15, pE19, DOI DOI 10.1016/J.HRTHM.2017.10.035; Andrew E, 2017, RESUSCITATION, V110, P42, DOI 10.1016/j.resuscitation.2016.10.018; Anyfantakis ZA, 2009, AM HEART J, V157, P312, DOI 10.1016/j.ahj.2008.09.016; Atwood C, 2005, RESUSCITATION, V67, P75, DOI 10.1016/j.resuscitation.2005.03.021; Bagnall RD, 2016, NEW ENGL J MED, V374, P2441, DOI 10.1056/NEJMoa1510687; Becker L, 2008, RESUSCITATION, V79, P22, DOI 10.1016/j.resuscitation.2008.06.019; Beesems SG, 2015, RESUSCITATION, V94, P33, DOI 10.1016/j.resuscitation.2015.06.017; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Blewer AL, 2012, CRIT CARE MED, V40, P787, DOI 10.1097/CCM.0b013e318236f2ca; Bobrow BJ, 2016, JAMA CARDIOL, V1, P294, DOI 10.1001/jamacardio.2016.0251; Bobrow BJ, 2010, JAMA-J AM MED ASSOC, V304, P1447, DOI 10.1001/jama.2010.1392; Bunch TJ, 2003, NEW ENGL J MED, V348, P2626, DOI 10.1056/NEJMoa023053; Carew HT, 2007, HEART, V93, P728, DOI 10.1136/hrt.2006.103895; Cave DM, 2011, CIRCULATION, V123, P691, DOI 10.1161/CIR.0b013e31820b5328; Chiang WC, 2014, RESUSCITATION, V85, P53, DOI 10.1016/j.resuscitation.2013.07.033; Clarke SO, 2005, ACAD EMERG MED, V12, P941, DOI 10.1197/j.aem.2005.05.031; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; CUMMINS RO, 1991, ANN EMERG MED, V20, P861; Curry LA, 2011, ANN INTERN MED, V154, P384, DOI 10.7326/0003-4819-154-6-201103150-00003; D'Silva A, 2017, HEART, V103, P463, DOI 10.1136/heartjnl-2016-309435; Dainty KN, 2013, RESUSCITATION; DAVIES MJ, 1984, NEW ENGL J MED, V310, P1137, DOI 10.1056/NEJM198405033101801; Dumas F, 2017, RESUSCITATION, V120, P71, DOI 10.1016/j.resuscitation.2017.08.239; Dumas F, 2010, CIRC-CARDIOVASC INTE, V3, P200, DOI 10.1161/CIRCINTERVENTIONS.109.913665; Engdahl J, 1997, NEW ENGL J MED, V336, P1629; FARB A, 1995, CIRCULATION, V92, P1701, DOI 10.1161/01.CIR.92.7.1701; Friesen J, 2015, PREHOSP DISASTER MED, V30, P97, DOI 10.1017/S1049023X14001265; Girotra S, 2016, CIRCULATION, V133, P2159, DOI 10.1161/CIRCULATIONAHA.115.018175; Grasner JT, 2016, RESUSCITATION, V105, P188, DOI 10.1016/j.resuscitation.2016.06.004; Hallstrom AP, 1996, CIRCULATION, V93, P2019, DOI 10.1161/01.CIR.93.11.2019; Hawkes C, 2017, RESUSCITATION, V110, P133, DOI 10.1016/j.resuscitation.2016.10.030; Hazinski MF, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006552; Institute of Medicine of the National Academies, 2015, STRAT IMPR CARD ARR; Iwami T, 2012, CIRCULATION, V126, P2844, DOI 10.1161/CIRCULATIONAHA.112.109504; Iwami T, 2009, CIRCULATION, V119, P728, DOI 10.1161/CIRCULATIONAHA.108.802058; Kragholm K, 2017, NEW ENGL J MED, V376, P1737, DOI 10.1056/NEJMoa1601891; Landry CH, 2017, NEW ENGL J MED, V377, P1943, DOI 10.1056/NEJMoa1615710; Lee CC, 2011, EMERG MED J, V28, P432, DOI 10.1136/emj.2009.087593; Lerner EB, 2012, CIRCULATION, V125, P648, DOI 10.1161/CIR.0b013e31823ee5fc; Lund-Kordahl I, 2010, RESUSCITATION, V81, P422, DOI 10.1016/j.resuscitation.2009.12.020; Luo SY, 2017, RESUSCITATION, V121, P1, DOI 10.1016/j.resuscitation.2017.09.014; Lurie KG, 2005, ACAD EMERG MED, V12, P79, DOI 10.1197/j.aem.2004.11.010; Marijon E, 2016, ANN INTERN MED, V164, P23, DOI 10.7326/M14-2342; Moriwaki Yoshihiro, 2013, J Emerg Trauma Shock, V6, P87, DOI 10.4103/0974-2700.110752; Muller D, 2006, CIRCULATION, V114, P1146, DOI 10.1161/CIRCULATIONAHA.106.616318; Nehme Z, 2014, MED J AUSTRALIA, V200, P471, DOI 10.5694/mja13.10856; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Nichol G, 2010, CIRCULATION, V121, P709, DOI 10.1161/CIR.0b013e3181cdb7db; Olasveengen TM, 2017, RESUSCITATION, V121, P201, DOI 10.1016/j.resuscitation.2017.10.021; Ong MEH, 2015, RESUSCITATION, V96, P100, DOI 10.1016/j.resuscitation.2015.07.026; Perkins GD, 2015, CIRCULATION, V132, P1286, DOI 10.1161/CIR.0000000000000144; Pottenger BC, 2008, ANN EMERG MED, V52, P677, DOI 10.1016/j.annemergmed.2008.06.004; Priori SG, 2015, EUR HEART J, V36, P2793, DOI 10.1093/eurheartj/ehv316; Rajan S, 2017, RESUSCITATION, V114, P157, DOI 10.1016/j.resuscitation.2016.12.021; Rea TD, 2004, RESUSCITATION, V63, P17, DOI 10.1016/j.resuscitation.2004.03.025; Rea TD, 2001, CIRCULATION, V104, P2513, DOI 10.1161/hc4601.099468; Rea TD, 2010, ANN EMERG MED, V55, P249, DOI 10.1016/j.annemergmed.2009.09.018; Reinier K, 2006, RESUSCITATION, V70, P186, DOI 10.1016/j.resuscitation.2005.11.018; Resuscitation Academy, 2017, 10 STEPS IMPR SURV S; Ringh M, 2015, NEW ENGL J MED, V372, P2316, DOI 10.1056/NEJMoa1406038; Ro YS, 2017, ANN EMERG MED, V69, P52, DOI 10.1016/j.annemergmed.2016.07.028; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Soreide E, 2013, RESUSCITATION, V84, P1487, DOI 10.1016/j.resuscitation.2013.07.020; Starks MA, 2017, JAMA CARDIOL, V2, P1110, DOI 10.1001/jamacardio.2017.2671; Stecker EC, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001160; Stromsoe A, 2011, RESUSCITATION, V82, P1307, DOI 10.1016/j.resuscitation.2011.04.025; Tanaka Y, 2012, RESUSCITATION, V83, P1235, DOI 10.1016/j.resuscitation.2012.02.013; Terman SW, 2015, RESUSCITATION, V89, P169, DOI 10.1016/j.resuscitation.2015.01.006; Tranberg T, 2017, EUR HEART J, V38, P1645, DOI 10.1093/eurheartj/ehx104; Vaillancourt C, 2008, RESUSCITATION, V79, P417, DOI 10.1016/j.resuscitation.2008.07.012; Van de Voorde P, 2014, RESUSCITATION, V85, P602, DOI 10.1016/j.resuscitation.2014.01.032; van Diepen S, 2017, J AM HEART ASS; Wallace SK, 2013, CIRC-CARDIOVASC QUAL, V6, P148, DOI 10.1161/CIRCOUTCOMES.111.000041; Wells DM, 2016, ANN EPIDEMIOL, V26, P418, DOI 10.1016/j.annepidem.2016.04.001; Wissenberg M, 2013, JAMA-J AM MED ASSOC, V310, P1377, DOI 10.1001/jama.2013.278483; Zhang S, 2015, EUROPACE, V17, P1720, DOI 10.1093/europace/euv103; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334; Zive D, 2011, RESUSCITATION, V82, P277, DOI 10.1016/j.resuscitation.2010.10.022	79	193	206	1	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 10	2018	391	10124					970	979		10.1016/S0140-6736(18)30472-0	http://dx.doi.org/10.1016/S0140-6736(18)30472-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ1UN	29536861				2022-12-28	WOS:000427363100030
J	Clark, S; Horton, R				Clark, Stephanie; Horton, Richard			Low back pain: a major global challenge	LANCET			English	Editorial Material									[Clark, Stephanie; Horton, Richard] The Lancet, London EC2Y 5AS, England		Clark, S (corresponding author), The Lancet, London EC2Y 5AS, England.	stephanie.clark@lancet.com						Buchbinder R, 2018, LANCET, V391, P2384, DOI 10.1016/S0140-6736(18)30488-4; Foster NE, 2018, LANCET, V391, P2368, DOI 10.1016/S0140-6736(18)30489-6; Hartvigsen J, 2018, LANCET, V391, P2356, DOI 10.1016/S0140-6736(18)30480-X; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2	4	118	133	2	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 9	2018	391	10137					2302	2302		10.1016/S0140-6736(18)30725-6	http://dx.doi.org/10.1016/S0140-6736(18)30725-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GI6WF	29573869				2022-12-28	WOS:000434643200008
J	Horton, S; Sullivan, R; Flanigan, J; Fleming, KA; Kuti, MA; Looi, LM; Pai, SA; Lawler, M				Horton, Susan; Sullivan, Richard; Flanigan, John; Fleming, Kenneth A.; Kuti, Modupe A.; Looi, Lai Meng; Pai, Sanjay A.; Lawler, Mark			Pathology and laboratory medicine in low-income and middle-income countries 3: Delivering modern, high-quality, affordable pathology and laboratory medicine to low-income and middle-income countries: a call to action	LANCET			English	Article							CERVICAL-CANCER; POINT; COSTS; SURGERY; TECHNOLOGIES; GENERATION; MALARIA; NEED; ERA	Modern, affordable pathology and laboratory medicine (PALM) systems are essential to achieve the 2030 Sustainable Development Goals for health in low-income and middle-income countries (LMICs). In this last in a Series of three papers about PALM in LMICs, we discuss the policy environment and emphasise three crucial high-level actions that are needed to deliver universal health coverage. First, nations need national strategic laboratory plans; second, these plans require adequate financing for implementation; and last, pathologists themselves need to take on leadership roles to advocate for the centrality of PALM to achieve the Sustainable Development Goals for health. The national strategic laboratory plan should deliver a tiered, networked laboratory system as a central element. Appropriate financing should be provided, at a level of at least 4% of health expenditure. Financing of new technologies such as molecular diagnostics is challenging for LMICs, even though many of these tests are cost-effective. Point-of-care testing can substantially reduce test-reporting time, but this benefit must be balanced with higher costs. Our research analysis highlights a considerable deficiency in advocacy for PALM; pathologists have been invisible in national and international health discourse and leadership. Embedding PALM in LMICs can only be achieved if pathologists advocate for these services, and undertake leadership roles, both nationally and internationally. We articulate eight key recommendations to address the current barriers identified in this Series and issue a call to action for all stakeholders to come together in a global alliance to ensure the effective provision of PALM services in resource-limited settings.	[Horton, Susan] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON N2L 3G1, Canada; [Sullivan, Richard] Kings Coll London, Inst Canc Policy, London, England; [Flanigan, John; Fleming, Kenneth A.] NCI, Ctr Global Hlth, NIH, Bethesda, MD 20892 USA; [Fleming, Kenneth A.] Univ Oxford, Green Templeton Coll, Oxford, England; [Kuti, Modupe A.] Univ Ibadan, Dept Chem Pathol, Coll Med, Ibadan, Nigeria; [Kuti, Modupe A.] Univ Hosp, Ibadan, Nigeria; [Looi, Lai Meng] Univ Malaya, Dept Pathol, Fac Med, Kuala Lumpur, Malaysia; [Pai, Sanjay A.] Columbia Asia Referral Hosp, Bangalore, Karnataka, India; [Lawler, Mark] Queens Univ, Fac Med Hlth & Life Sci, Belfast, Antrim, North Ireland; [Lawler, Mark] Queens Univ, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland	University of Waterloo; University of London; King's College London; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oxford; University of Ibadan; Universiti Malaya; Queens University Belfast; Queens University Belfast	Horton, S (corresponding author), Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON N2L 3G1, Canada.	sehorton@uwaterloo.ca	Looi, Lai Meng/AAB-9403-2019; Looi, Lai Meng/A-3382-2009	Looi, Lai Meng/0000-0001-8325-0117; Looi, Lai Meng/0000-0001-8325-0117; Sullivan, Richard/0000-0002-6435-1825; Fleming, Kenneth/0000-0002-3200-1302; Kuti, Modupe/0000-0001-7574-1450	NCI	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Nick Wolf (Center for Global Health, National Cancer Institute [NCI], National Institutes of Health, MD, USA) for assistance in searching for relevant literature, Michael L Wilson (Denver Health, CO, USA) and Zohir Moloo (Aga Khan University Hospital, Nairobi, Kenya) for providing some of the data, and Shannon Silkensen (Center for Global Health, NCI) for excellent support of the Series. Funding for the initial writing meeting in January, 2017, in Oxford, UK, was provided by the NCI. Funding for the meeting with Sabine Kleinert (London, UK) and the three reviewers in September, 2017, in Washington, DC, also was provided by the NCI. Funding for development of the figures was provided by Michael L Wilson. The NCI had no role in the analysis and interpretation of the evidence or in writing the paper and the decision to submit for publication.	Ali M, 2013, PLOS ONE, V8; Amukele TK, 2015, AM J CLIN PATHOL, V143, P50, DOI 10.1309/AJCPCYA54DWZQPQT; Anim J T, 2015, Ghana Med J, V49, P112, DOI 10.4314/gmj.v49i2.9; [Anonymous], LANCET; Avivar Cristobal, 2012, Open Virol J, V6, P115, DOI 10.2174/1874357901206010115; Bannister B, 2009, LANCET INFECT DIS, V9, P45, DOI 10.1016/S1473-3099(08)70304-9; Boddie C, 2015, HEALTH SECUR, V13, P186, DOI 10.1089/hs.2015.0017; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Cabutti N V, 1995, J Int Fed Clin Chem, V7, P29; CADTH, 2010, CADTH TECHNOL OVERV, V1, pe0102; Carter JY, 2012, AFR J LAB MED, V1, DOI 10.4102/ajlm.v1i1.8; Carter P., 2008, REPORT 2 PHASE REV N; Centre for International Economics, 2016, EC VAL PATH ACH BETT; Chalkidou K, 2014, LANCET ONCOL, V15, pE119, DOI 10.1016/S1470-2045(13)70547-3; Cheah PL, 2018, AM J CLIN PATHOL, V149, P1, DOI [10.1093/ajcp/aqx088, 10.1093/AJCP/AQX088]; Ciaranello AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117751; Cordray MS, 2012, AM J TROP MED HYG, V87, P223, DOI 10.4269/ajtmh.2012.11-0685; Cunnama L, 2016, HEALTH ECON, V25, P53, DOI 10.1002/hec.3295; Denny L, 2017, LANCET, V389, P861, DOI 10.1016/S0140-6736(16)31795-0; Doble B, 2016, LANCET, V387, P433, DOI 10.1016/S0140-6736(16)00176-8; Ethiopian Health and Nutrition Research Institute, 2009, MAST PLAN PUBL HLTH; Fleming KA, 2017, AM J CLIN PATHOL, V147, P15, DOI [10.1093/AJCP/AQW143, 10.1093/ajcp/aqw143]; France NC, 2003, HEALTH POLICY, V64, P131, DOI 10.1016/S0168-8510(02)00162-8; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Gu J, 2014, APPL IMMUNOHISTO M M, V22, P1, DOI 10.1097/PAI.0000000000000022; Harvey Jennifer A, 2009, J Am Coll Radiol, V6, P26, DOI 10.1016/j.jacr.2008.07.010; He JA, 2015, INT J HEALTH CARE Q, V28, P394, DOI 10.1108/IJHCQA-09-2014-0096; Hedges JP, 2010, WORLD J SURG, V34, P2003, DOI 10.1007/s00268-010-0610-5; Heffernan A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158303; Holmes K, 2017, MAJOR INFECT DISEASE, V6; Hsiang MS, 2014, J INFECT DIS, V210, P1167, DOI 10.1093/infdis/jiu253; King S., 2006, PINK RIBBONS INC BRE; Lewandrowski K, 2017, UTILIZATION MANAGEME, P72; Lewison G, 2010, EUR J CANCER, V46, P912, DOI 10.1016/j.ejca.2009.12.020; Looi Lai-Meng, 2008, Malays J Pathol, V30, P1; Maitland K, 2016, NEW ENGL J MED, V375, P2416, DOI 10.1056/NEJMp1613528; Morgan C, 2018, J Cancer Policy, V17, P38, DOI 10.1016/j.jcpo.2017.03.012; Mugambi ML, 2017, DIAGNOSTICS, V7, DOI 10.3390/diagnostics7010008; Musarurwa C, 2012, Cent Afr J Med, V58, P33; Mvundura M, 2014, INT J GYNECOL OBSTET, V126, P151, DOI 10.1016/j.ijgo.2014.02.012; Okebukola PO, 2016, INT Q COMMUNITY HEAL, V36, P241, DOI 10.1177/0272684X16657451; Ondoa P, 2017, AFR J LAB MED, V6, DOI 10.4102/ajlm.v6i1.578; Park SM, 2005, WORLD J GASTROENTERO, V11, P1587, DOI 10.3748/wjg.v11.i11.1587; Park Seung, 2013, J Pathol Inform, V4, P7, DOI 10.4103/2153-3539.112689; Perkins MD, 2017, LANCET, V390, P2111, DOI 10.1016/S0140-6736(17)31224-2; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Pillay TS, 2013, SAMJ S AFR MED J, V103, P24, DOI [10.7196/SAMJ.6383, 10.7196/samj.6383]; Pretorius C, 2007, SAMJ S AFR MED J, V97, P51; Reich M R, 1995, J Int Dev, V7, P489, DOI 10.1002/jid.3380070310; Ritchie AV, 2014, J CLIN MICROBIOL, V52, P3377, DOI 10.1128/JCM.00593-14; Sayed S, 2018, LANCET; Schroeder LF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134578; Shawar YR, 2015, LANCET GLOB HEALTH, V3, pE487, DOI 10.1016/S2214-109X(15)00098-4; Sullivan R, 2015, LANCET ONCOL, V16, P1193, DOI 10.1016/S1470-2045(15)00223-5; The Global Fund, 2015, 34 BOARD M GEN SWITZ; van den Tweel JG, 2010, VIRCHOWS ARCH, V457, P3, DOI 10.1007/s00428-010-0934-4; Vashist SK, 2015, TRENDS BIOTECHNOL, V33, P692, DOI 10.1016/j.tibtech.2015.09.001; Wagar EA, 2008, LABMEDICINE, V39, P560, DOI 10.1309/9R9Y0V68Y3BA0KDN; Webster P, 2017, LANCET, V390, P15, DOI 10.1016/S0140-6736(17)31722-1; WHO, 2017, WHO DEV ESS DIAGN LI; WHO. Regional Committee for Africa, 2008, AFRRD586 WHO; WHO Regional Office for Africa and Centers for Disease Control and Prevention, 2008, GUID DEV NAT LAB STR; Wilson ML, 2018, LANCET; Yadavar S., WHY ARENT DIAGNOSTIC; Zang X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167308	65	57	58	2	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2018	391	10133					1953	1964		10.1016/S0140-6736(18)30460-4	http://dx.doi.org/10.1016/S0140-6736(18)30460-4			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF3NC	29550030				2022-12-28	WOS:000431861800030
J	van de Loosdrecht, M; Bouzouggar, A; Humphrey, L; Posth, C; Barton, N; Aximu-Petri, A; Nickel, B; Nagel, S; Talbi, EH; El Hajraoui, MA; Amzazi, S; Hublin, JJ; Paabo, S; Schiffels, S; Meyer, M; Haak, W; Jeong, C; Krause, J				van de Loosdrecht, Marieke; Bouzouggar, Abdeljalil; Humphrey, Louise; Posth, Cosimo; Barton, Nick; Aximu-Petri, Ayinuer; Nickel, Birgit; Nagel, Sarah; Talbi, El Hassan; El Hajraoui, Mohammed Abdeljalil; Amzazi, Saaid; Hublin, Jean-Jacques; Paeaebo, Svante; Schiffels, Stephan; Meyer, Matthias; Haak, Wolfgang; Jeong, Choongwon; Krause, Johannes			Pleistocene North African genomes link Near Eastern and sub-Saharan African human populations	SCIENCE			English	Article							MIGRATION; ADMIXTURE; EUROPE; ORIGIN; CAVE	North Africa is a key region for understanding human history, but the genetic history of its people is largely unknown. We present genomic data from seven 15,000-year-old modern humans, attributed to the Iberomaurusian culture, from Morocco. We find a genetic affinity with early Holocene Near Easterners, best represented by Levantine Natufians, suggesting a pre-agricultural connection between Africa and the Near East. We do not find evidence for gene flow from Paleolithic Europeans to Late Pleistocene North Africans. The Taforalt individuals derive one-third of their ancestry from sub-Saharan Africans, best approximated by a mixture of genetic components preserved in present-day West and East Africans. Thus, we provide direct evidence for genetic interactions between modern humans across Africa and Eurasia in the Pleistocene.	[van de Loosdrecht, Marieke; Posth, Cosimo; Schiffels, Stephan; Haak, Wolfgang; Jeong, Choongwon; Krause, Johannes] MPI SHH, Dept Archaeogenet, Kahla Str 10, D-07745 Jena, Germany; [Bouzouggar, Abdeljalil; El Hajraoui, Mohammed Abdeljalil] Inst Natl Sci Archeol & Patrimoine, Origin & Evolut Homosapiens Morocco Res Grp, Angle Rues 5&7, Rabat 10000, Morocco; [Bouzouggar, Abdeljalil; Hublin, Jean-Jacques] Max Planck Inst Evolutionary Anthropol MPI EVA, Dept Human Evolut, Deutsch Pl 6, D-04103 Leipzig, Germany; [Humphrey, Louise] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Barton, Nick] Univ Oxford, Inst Archaeol, 36 Beaumont St, Oxford OX1 2PG, England; [Aximu-Petri, Ayinuer; Nickel, Birgit; Nagel, Sarah; Paeaebo, Svante; Meyer, Matthias] Max Planck Inst Evolutionary Anthropol MPI EVA, Dept Evolutionary Genet, Deutsch Pl 6, D-04103 Leipzig, Germany; [Talbi, El Hassan] Univ Mohammed Premier, Fac Sci, Campus Al Qods,BP 717, Oujda, Morocco; [Amzazi, Saaid] Mohammed V Univ, Ave Ibn Batouta, Rabat, Morocco	Max Planck Society; Natural History Museum London; University of Oxford; Max Planck Society; Mohammed First University of Oujda; Mohammed V University in Rabat	Jeong, C; Krause, J (corresponding author), MPI SHH, Dept Archaeogenet, Kahla Str 10, D-07745 Jena, Germany.; Bouzouggar, A (corresponding author), Inst Natl Sci Archeol & Patrimoine, Origin & Evolut Homosapiens Morocco Res Grp, Angle Rues 5&7, Rabat 10000, Morocco.; Bouzouggar, A (corresponding author), Max Planck Inst Evolutionary Anthropol MPI EVA, Dept Human Evolut, Deutsch Pl 6, D-04103 Leipzig, Germany.	bouzouggar@eva.mpg.de; jeong@shh.mpg.de; krause@shh.mpg.de	Posth, Cosimo/AAL-6219-2021; Bouzouggar, Abdeljalil/AAD-3608-2022; Krause, Johannes/AFP-2642-2022; Schiffels, Stephan/D-5675-2018; Haak, Wolfgang/Z-4947-2019	Krause, Johannes/0000-0001-9144-3920; Schiffels, Stephan/0000-0002-1017-9150; Haak, Wolfgang/0000-0003-2475-2007; Barton, Nick/0000-0003-4717-8175; Talbi, El Hassan/0000-0002-7057-1752; Van de Loosdrecht, Marieke/0000-0002-5606-093X; Bouzouggar, Abdeljalil/0000-0002-4332-4385; Jeong, Choongwon/0000-0003-3049-2352	Max Planck Society; Institut National des Sciences de l'Archeologie et du Patrimoine [P32/09-CNRST]; Natural Environment Research Council [EFCHED NER/T/S/2002/00700, RESET NE/E015670/1]; Leverhulme Trust [F/08735/F]; British Academy, Oxford University(Fell Fund, Boise and Meyerstein); Natural History Museum (Human Origins Research Fund); Calleva Foundation	Max Planck Society(Max Planck SocietyFoundation CELLEX); Institut National des Sciences de l'Archeologie et du Patrimoine; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Leverhulme Trust(Leverhulme Trust); British Academy, Oxford University(Fell Fund, Boise and Meyerstein); Natural History Museum (Human Origins Research Fund); Calleva Foundation	This work was supported by the Max Planck Society, Institut National des Sciences de l'Archeologie et du Patrimoine (Protars grant P32/09-CNRST), the Natural Environment Research Council (grants EFCHED NER/T/S/2002/00700 and RESET NE/E015670/1), the Leverhulme Trust (grant F/08735/F), the British Academy, Oxford University (Fell Fund, Boise and Meyerstein), the Natural History Museum (Human Origins Research Fund), and the Calleva Foundation.	Barton RNE, 2013, J HUM EVOL, V65, P266, DOI 10.1016/j.jhevol.2013.06.003; Camps G., 1974, CIVILISATIONS PREHIS; Castaneda IS, 2009, P NATL ACAD SCI USA, V106, P20159, DOI 10.1073/pnas.0905771106; Cruciani F, 2007, MOL BIOL EVOL, V24, P1300, DOI 10.1093/molbev/msm049; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fu QM, 2016, NATURE, V534, P200, DOI 10.1038/nature17993; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Gansauge MT, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx033; Gonzalez AM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-223; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Hervella M, 2016, SCI REP-UK, V6, DOI 10.1038/srep25501; Hogue JT, 2016, QUATERN INT, V413, P62, DOI 10.1016/j.quaint.2015.11.144; Humphrey L, 2012, J HUM EVOL, V62, P261, DOI 10.1016/j.jhevol.2011.11.003; Jones ER, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9912; Lazaridis I, 2016, NATURE, V536, P419, DOI 10.1038/nature19310; Llorente MG, 2015, SCIENCE, V350, P820, DOI 10.1126/science.aad2879; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Pallary P., 1909, MEMOIRES SOC HIST AL, V3; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pennarun E, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-234; Posth C, 2016, CURR BIOL, V26, P827, DOI 10.1016/j.cub.2016.01.037; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Schuenemann VJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15694; Sehlebusch CM, 2017, SCIENCE, V358, P652, DOI 10.1126/science.aao6266; Skoglund P, 2017, CELL, V171, P59, DOI 10.1016/j.cell.2017.08.049	27	78	80	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2018	360	6388					548	+		10.1126/science.aar8380	http://dx.doi.org/10.1126/science.aar8380			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6PM	29545507				2022-12-28	WOS:000431351500049
J	Ma, S; Cahalan, S; LaMonte, G; Grubaugh, ND; Zeng, WZ; Murthy, SE; Paytas, E; Gamini, R; Lukacs, V; Whitwam, T; Loud, M; Lohia, R; Berry, L; Khan, SM; Janse, CJ; Bandell, M; Schmedt, C; Wengelnik, K; Su, AI; Honore, E; Winzeler, EA; Andersen, KG; Patapoutian, A				Ma, Shang; Cahalan, Stuart; LaMonte, Gregory; Grubaugh, Nathan D.; Zeng, Weizheng; Murthy, Swetha E.; Paytas, Emma; Gamini, Ramya; Lukacs, Viktor; Whitwam, Tess; Loud, Meaghan; Lohia, Rakhee; Berry, Laurence; Khan, Shahid M.; Janse, Chris J.; Bandell, Michael; Schmedt, Christian; Wengelnik, Kai; Su, Andrew I.; Honore, Eric; Winzeler, Elizabeth A.; Andersen, Kristian G.; Patapoutian, Ardem			Common PIEZO1 Allele in African Populations Causes RBCDehydration and Attenuates Plasmodium Infection	CELL			English	Article							HUMAN MALARIA PARASITES; CD8(+) T-CELLS; MECHANICAL FORCES; NATURAL-SELECTION; HUMAN GENOME; CHANNEL; GENE; PATHOGENESIS; XEROCYTOSIS; MACROPHAGES	Hereditary xerocytosis is thought to be a rare genetic condition characterized by red blood cell (RBC) dehydration with mild hemolysis. RBC dehydration is linked to reduced Plasmodium infection in vitro; however, the role of RBC dehydration in protection against malaria in vivo is unknown. Most cases of hereditary xerocytosis are associated with gain-of-function mutations in PIEZO1, a mechanically activated ion channel. We engineered a mouse model of hereditary xerocytosis and show that Plasmodium infection fails to cause experimental cerebral malaria in these mice due to the action of Piezo1 in RBCs and in T cells. Remarkably, we identified a novel human gain-of-function PIEZO1 allele, E756del, present in a third of the African population. RBCs from individuals carrying this allele are dehydrated and display reduced Plasmodiuminfection in vitro. The existence of a gain-of-function PIEZO1 at such high frequencies is surprising and suggests an association with malaria resistance.	[Ma, Shang; Cahalan, Stuart; Zeng, Weizheng; Murthy, Swetha E.; Lukacs, Viktor; Whitwam, Tess; Loud, Meaghan; Patapoutian, Ardem] Howard Hughes Med Inst, Scripps Res Inst, Dept Neurosci, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [LaMonte, Gregory; Paytas, Emma; Winzeler, Elizabeth A.] Univ Calif San Diego, Dept Pediat, Div Host Microbe Syst & Therapeut, San Diego, CA 92103 USA; [Grubaugh, Nathan D.; Andersen, Kristian G.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Gamini, Ramya; Su, Andrew I.; Andersen, Kristian G.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Lohia, Rakhee; Berry, Laurence; Wengelnik, Kai] Univ Montpellier, CNRS, DIMNP, INSERM, Montpellier, France; [Khan, Shahid M.; Janse, Chris J.] LUMC, Dept Parasitol, Leiden Malaria Res Grp, NL-2333 ZA Leiden, Netherlands; [Bandell, Michael; Schmedt, Christian] Novartis Res Fdn, Genom Inst, La Jolla, CA USA; [Honore, Eric] Univ Cote dAzur, CNRS, Paris, France; [Honore, Eric] Inst Pharmacol Mol & Cellulaire, Labex ICST, Valbonne, France; [Cahalan, Stuart] Vertex Pharmaceut, 11010 Torreyana Rd, San Diego, CA 92121 USA	Howard Hughes Medical Institute; Scripps Research Institute; University of California System; University of California San Diego; Scripps Research Institute; Scripps Research Institute; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Leiden University; Leiden University Medical Center (LUMC); Novartis; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Vertex Pharmaceuticals	Patapoutian, A (corresponding author), Howard Hughes Med Inst, Scripps Res Inst, Dept Neurosci, Dorris Neurosci Ctr, La Jolla, CA 92037 USA.	ardem@scripps.edu	Winzeler, Elizabeth/AAP-6752-2020	Winzeler, Elizabeth/0000-0002-4049-2113; Murthy, Swetha/0000-0001-9580-3380; Berry, laurence/0000-0002-8150-7860; Lohia, Rakhee/0000-0001-5041-3776; Lukacs, Viktor/0000-0003-3652-5469; Wengelnik, Kai/0000-0002-4547-4205; Khan, Shahid/0000-0002-0533-4670; Su, Andrew I./0000-0002-9859-4104; Janse, Chris J/0000-0002-6410-6205; Grubaugh, Nathan/0000-0003-2031-1933	NIH [R01 DE022358, AI090141, AI103058]; Calibr-GHDDI Gates postdoctoral fellowship; A.P. Giannini postdoctoral fellowship; NIH NCATS CTSA [UL1TR001114]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007244, R01AI103058, R01AI090141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022358] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Calibr-GHDDI Gates postdoctoral fellowship; A.P. Giannini postdoctoral fellowship; NIH NCATS CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Ali Torkamani for advice on genomics, Dominic Kwiatkowski and Ilya Shlyakhter for discussions, and Lisa Stowers for reading the manuscript. This work was partly supported by NIH grants R01 DE022358 to A.P. and AI090141 and AI103058 to E.A.W. S.M. is supported by a Calibr-GHDDI Gates postdoctoral fellowship. G.L. is supported by an A.P. Giannini postdoctoral fellowship. K.G.A. is a Pew Biomedical Scholar and is supported by NIH NCATS CTSA UL1TR001114. A.P. is an investigator of the Howard Hughes Medical Institute.	Albuisson J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2899; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Archer NM, 2014, AM J HEMATOL, V89, P1142, DOI 10.1002/ajh.23799; Bae C, 2013, P NATL ACAD SCI USA, V110, pE1162, DOI 10.1073/pnas.1219777110; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Brugnara C, 1995, Curr Opin Hematol, V2, P132; Cahalan SM, 2015, ELIFE, V4, DOI 10.7554/eLife.07370; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chesler AT, 2016, NEW ENGL J MED, V375, P1355, DOI 10.1056/NEJMoa1602812; Chong SS, 2000, BLOOD, V95, P360; Chua CLL, 2013, TRENDS PARASITOL, V29, P26, DOI 10.1016/j.pt.2012.10.002; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; de Oca Marcela Montes, 2013, Methods Mol Biol, V1031, P203, DOI 10.1007/978-1-62703-481-4_23; de Souza JB, 2010, PARASITOLOGY, V137, P755, DOI 10.1017/S0031182009991715; Delaunay J, 2004, SEMIN HEMATOL, V41, P165, DOI 10.1053/j.seminhematol.2004.02.005; Dubin AE, 2017, NEURON, V94, P266, DOI 10.1016/j.neuron.2017.03.039; Dunst J, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00324; ELIAS JM, 1979, AM J CLIN PATHOL, V71, P109; Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836; Feng ZL, 2004, MATH BIOSCI, V189, P1, DOI 10.1016/j.mbs.2004.01.005; Ferreira A, 2011, CELL, V145, P398, DOI 10.1016/j.cell.2011.03.049; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Glogowska E, 2017, BLOOD, V130, P1845, DOI 10.1182/blood-2017-05-786004; Hafalla JCR, 2006, PARASITE IMMUNOL, V28, P15, DOI 10.1111/j.1365-3024.2006.00777.x; Hedrick P, 2004, J EVOLUTION BIOL, V17, P221, DOI 10.1046/j.1420-9101.2003.00635.x; Howland SW, 2015, SEMIN IMMUNOPATHOL, V37, P221, DOI 10.1007/s00281-015-0476-6; Hunt NH, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00113; Hunt NH, 2010, TRENDS PARASITOL, V26, P272, DOI 10.1016/j.pt.2010.03.006; Huse M, 2017, NAT REV IMMUNOL, V17, P679, DOI 10.1038/nri.2017.74; Johnson JD, 2007, ANTIMICROB AGENTS CH, V51, P1926, DOI 10.1128/AAC.01607-06; Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449; KAPLAN NM, 1994, LANCET, V344, P450, DOI 10.1016/S0140-6736(94)91774-4; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Leffler EM, 2017, SCIENCE, V356, DOI 10.1126/science.aam6393; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; Loy DE, 2017, INT J PARASITOL, V47, P87, DOI 10.1016/j.ijpara.2016.05.008; Lukacs V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9329; Maher AD, 2003, INT J BIOCHEM CELL B, V35, P1182, DOI 10.1016/S1357-2725(02)00310-2; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Murthy SE, 2017, NAT REV MOL CELL BIO, V18, P771, DOI 10.1038/nrm.2017.92; Nacer A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004528; PHILLIPS RE, 1992, BAILLIERE CLIN HAEM, V5, P315, DOI 10.1016/S0950-3536(11)80022-3; Ranade SS, 2015, NEURON, V87, P1162, DOI 10.1016/j.neuron.2015.08.032; Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980; Ranade SS, 2014, P NATL ACAD SCI USA, V111, P10347, DOI 10.1073/pnas.1409233111; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Retailleau K, 2015, CELL REP, V13, P1161, DOI 10.1016/j.celrep.2015.09.072; Rockett KA, 2014, NAT GENET, V46, P1197, DOI 10.1038/ng.3107; Rode B, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00429-3; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Syeda R, 2015, ELIFE, V4, DOI 10.7554/eLife.07369; Tiffert T, 2005, BLOOD, V105, P4853, DOI 10.1182/blood-2004-12-4948; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vacchio MS, 2014, NAT IMMUNOL, V15, P947, DOI 10.1038/ni.2960; Vitti JJ, 2013, ANNU REV GENET, V47, P97, DOI 10.1146/annurev-genet-111212-133526; Wang SP, 2016, J CLIN INVEST, V126, P4527, DOI 10.1172/JCI87343; Woo SH, 2015, NAT NEUROSCI, V18, P1756, DOI 10.1038/nn.4162; Woo SH, 2014, NATURE, V509, P622, DOI 10.1038/nature13251; Yanez DM, 1996, J IMMUNOL, V157, P1620; Zarychanski R, 2012, BLOOD, V120, P1908, DOI 10.1182/blood-2012-04-422253	67	103	105	2	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 5	2018	173	2					443	+	455.e1	10.1016/j.cell.2018.02.047	http://dx.doi.org/10.1016/j.cell.2018.02.047			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GB8IS	29576450	Green Published, Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000429320200017
J	Zhang, T; Niinemets, U; Sheffield, J; Lichstein, JW				Zhang, Tao; Niinemets, Uelo; Sheffield, Justin; Lichstein, Jeremy W.			Shifts in tree functional composition amplify the response of forest biomass to climate	NATURE			English	Article							EASTERN UNITED-STATES; AUTOREGRESSIVE MODELS; CHANGE IMPACTS; DROUGHT; BIODIVERSITY; MORTALITY; TOLERANCE; DYNAMICS; EXTREMES; FORCINGS	Forests have a key role in global ecosystems, hosting much of the world's terrestrial biodiversity and acting as a net sink for atmospheric carbon(1). These and other ecosystem services that are provided by forests may be sensitive to climate change as well as climate variability on shorter time scales (for example, annual to decadal)(2-4). Previous studies have documented responses of forest ecosystems to climate change and climate variability(2-4), including drought-induced increases in tree mortality rates(5). However, relationships between forest biomass, tree species composition and climate variability have not been quantified across a large region using systematically sampled data. Here we use systematic forest inventories from the 1980s and 2000s across the eastern USA to show that forest biomass responds to decadal-scale changes in water deficit, and that this biomass response is amplified by concurrent changes in community-mean drought tolerance, a functionally important aspect of tree species composition. The amplification of the direct effects of water stress on biomass occurs because water stress tends to induce a shift in tree species composition towards species that are more tolerant to drought but are slower growing. These results demonstrate concurrent changes in forest species composition and biomass carbon storage across a large, systematically sampled region, and highlight the potential for climate-induced changes in forest ecosystems across the world, resulting from both direct effects of climate on forest biomass and indirect effects mediated by shifts in species composition.	[Zhang, Tao; Lichstein, Jeremy W.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Niinemets, Uelo] Estonian Univ Life Sci, Inst Agr & Environm Sci, Tartu, Estonia; [Sheffield, Justin] Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA; [Sheffield, Justin] Univ Southampton, Geog & Environm, Southampton, Hants, England	State University System of Florida; University of Florida; Estonian University of Life Sciences; Princeton University; University of Southampton	Zhang, T; Lichstein, JW (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.	t.zhang05@outlook.com; jlichstein@ufl.edu	Zhang, Tao/AAQ-5214-2021; Niinemets, Ülo/A-3816-2008; Lichstein, Jeremy/GMW-6555-2022	Zhang, Tao/0000-0001-7135-1762; Niinemets, Ülo/0000-0002-3078-2192; Sheffield, Justin/0000-0003-2400-0630	US Department of Agriculture Forest Service [11-JV-11242306-059, 16-JV-11242306-050]; European Regional Development Fund (Centre of Excellence EcolChange); Estonian Ministry of Science and Education [IUT-8-3]	US Department of Agriculture Forest Service(United States Department of Agriculture (USDA)United States Forest Service); European Regional Development Fund (Centre of Excellence EcolChange); Estonian Ministry of Science and Education(Ministry of Education and Research, Estonia)	Funding was provided by US Department of Agriculture Forest Service agreements 11-JV-11242306-059 and 16-JV-11242306-050 to J.W.L., and by the European Regional Development Fund (Centre of Excellence EcolChange) and the Estonian Ministry of Science and Education (institutional grant IUT-8-3) to U.N.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderegg WRL, 2013, NAT CLIM CHANGE, V3, P30, DOI 10.1038/nclimate1635; [Anonymous], 2012, FOR INV AN NAT COR F, V1; Bechtold W.A., 2005, GTRSRS080; Bivand R, 2013, GEOGR ANAL, V45, P150, DOI 10.1111/gean.12008; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Clark JS, 2016, GLOBAL CHANGE BIOL, V22, P2329, DOI 10.1111/gcb.13160; Cornwell WK, 2003, OIKOS, V100, P417, DOI 10.1034/j.1600-0706.2003.11697.x; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Dornelas M, 2014, SCIENCE, V344, P296, DOI 10.1126/science.1248484; Farrior CE, 2013, AM NAT, V181, P314, DOI 10.1086/669153; Fei SL, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603055; Field CB, 2012, SPECIAL REPORT WORKI; Frank D, 2015, GLOBAL CHANGE BIOL, V21, P2861, DOI 10.1111/gcb.12916; Grace JB., 2015, STRUCTURAL EQUATION; Hanewinkel M, 2013, NAT CLIM CHANGE, V3, P203, DOI [10.1038/nclimate1687, 10.1038/NCLIMATE1687]; Hicke JA, 2012, GLOBAL CHANGE BIOL, V18, P7, DOI 10.1111/j.1365-2486.2011.02543.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Isbell F, 2015, NATURE, V526, P574, DOI 10.1038/nature15374; Jenkins JC, 2003, FOREST SCI, V49, P12; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Niinemets U, 2006, ECOL MONOGR, V76, P521, DOI 10.1890/0012-9615(2006)076[0521:TTSDAW]2.0.CO;2; Nowacki GJ, 2015, GLOBAL CHANGE BIOL, V21, P314, DOI 10.1111/gcb.12663; O'Connell B.M., 2013, FOREST INVENTORY ANA; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Peng CH, 2011, NAT CLIM CHANGE, V1, P467, DOI 10.1038/NCLIMATE1293; Peters MP, 2015, FOREST ECOL MANAG, V345, P56, DOI 10.1016/j.foreco.2015.02.022; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Pinder RW, 2012, P NATL ACAD SCI USA, V109, P7671, DOI 10.1073/pnas.1114243109; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Ruiz-Benito P, 2017, GLOBAL CHANGE BIOL, V23, P4162, DOI 10.1111/gcb.13728; Sakschewski B, 2016, NAT CLIM CHANGE, V6, P1032, DOI [10.1038/nclimate3109, 10.1038/NCLIMATE3109]; Sheffield J, 2006, J CLIMATE, V19, P3088, DOI 10.1175/JCLI3790.1; Sheffield J, 2012, NATURE, V491, P435, DOI 10.1038/nature11575; Vanderwel MC, 2013, GLOBAL CHANGE BIOL, V19, P1504, DOI 10.1111/gcb.12152	39	68	68	7	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2018	556	7699					99	+		10.1038/nature26152	http://dx.doi.org/10.1038/nature26152			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5KP	29562235	Green Accepted			2022-12-28	WOS:000429103300042
J	Spencer, K; Parrish, R; Barton, R; Henry, A				Spencer, Katie; Parrish, Rhona; Barton, Rachael; Henry, Ann			Palliative radiotherapy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SPINAL-CORD COMPRESSION; DIAGNOSED BRAIN METASTASES; PAINFUL BONE METASTASES; RADIATION-THERAPY; RANDOMIZED-TRIAL; PHASE-III; SURGICAL RESECTION; DOUBLE-BLIND; 8 GY; HYPOFRACTIONATED RADIOTHERAPY		[Spencer, Katie; Henry, Ann] Univ Leeds, Leeds Inst Canc & Pathol, Leeds LS2 9NL, W Yorkshire, England; [Parrish, Rhona] Garforth Med Ctr, Leeds LS25 1HB, W Yorkshire, England; [Barton, Rachael] Castle Hill Hosp, Queens Ctr Oncol & Haematol, Cottingham HU16 5JQ, England	University of Leeds; University of Hull	Spencer, K (corresponding author), Univ Leeds, Leeds Inst Canc & Pathol, Leeds LS2 9NL, W Yorkshire, England.	KSpencerkatie.spencer1@nhs.net		Henry, Ann/0000-0002-5379-6618; Spencer, Katie/0000-0002-6846-4341	Medical Research Council on a Clinical Research Training Fellowship [MR/N021339/1]; MRC [MR/N021339/1] Funding Source: UKRI	Medical Research Council on a Clinical Research Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	While undertaking this work KS was funded by the Medical Research Council on a Clinical Research Training Fellowship (MR/N021339/1).	Adderley UJ, 2014, COCHRANE DB SYST REV, V1; Andrews DW, 2004, LANCET, V363, P1665, DOI 10.1016/S0140-6736(04)16250-8; Andreyev HJN, 2012, GUT, V61, P179, DOI 10.1136/gutjnl-2011-300563; [Anonymous], 2018, WHOS CANC PAIN LADD; Ashton A, 1999, RADIOTHER ONCOL, V52, P111; Baker S, 2016, LUNG CANCER-TARGETS, V7, P119, DOI 10.2147/LCTT.S96443; Barnes EA, 2010, CLIN ONCOL-UK, V22, P844, DOI 10.1016/j.clon.2010.07.014; Braam P, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1178-7; Cameron MG, 2016, ACTA ONCOL, V55, P1400, DOI 10.1080/0284186X.2016.1191666; Cameron MG, 2014, RADIOTHER ONCOL, V110, P55, DOI 10.1016/j.radonc.2013.08.008; Cancer Research UK, 2016, LOC CANC STAT; Cancer Research UK, 2015, LUNG CANC INC STAT; Chang EL, 2009, LANCET ONCOL, V10, P1037, DOI 10.1016/S1470-2045(09)70263-3; Chow E, 2012, CLIN ONCOL-UK, V24, P112, DOI 10.1016/j.clon.2011.11.004; Chow E, 2015, LANCET ONCOL, V16, P1463, DOI 10.1016/S1470-2045(15)00199-0; Chow E, 2014, LANCET ONCOL, V15, P164, DOI 10.1016/S1470-2045(13)70556-4; Clarkson JE, 2010, COCHRANE DB SYST REV, V1; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Corry J, 2005, RADIOTHER ONCOL, V77, P137, DOI 10.1016/j.radonc.2005.10.008; Cramp F, 2012, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD006145.PUB3; Dai YX, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005048.pub4; Delaney G, 2005, CANCER-AM CANCER SOC, V104, P1129, DOI 10.1002/cncr.21324; Department of Health, 2012, RAD SERV ENGL 2012; Duchesne GM, 2000, INT J RADIAT ONCOL, V47, P379, DOI 10.1016/S0360-3016(00)00430-2; Fairchild A, 2008, J CLIN ONCOL, V26, P4001, DOI 10.1200/JCO.2007.15.3312; Feyer PC, 2011, SUPPORT CARE CANCER, V19, pS5, DOI 10.1007/s00520-010-0950-6; Gaspar L, 1997, INT J RADIAT ONCOL, V37, P745, DOI 10.1016/S0360-3016(96)00619-0; George R, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006716.pub3; Halkett GKB, 2014, FAM PRACT, V31, P60, DOI 10.1093/fampra/cmt068; Hamilton K, 2015, SUPPORT CARE CANCER, V23, P95, DOI 10.1007/s00520-014-2335-8; Health & Social Care Information Centre, 2016, GEN PRACT TRENDS UK; HELLMAN S, 1995, J CLIN ONCOL, V13, P8, DOI 10.1200/JCO.1995.13.1.8; Hoskin PJ, 2013, CLIN ONCOL-UK, V25, P531, DOI 10.1016/j.clon.2013.04.006; Hoskin P, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv197; Huang J, 2001, J CLIN ONCOL, V19, P137, DOI 10.1200/JCO.2001.19.1.137; Independent Cancer Taskforce, 2015, ACH WORLD CLASS CANC; Javed Amit, 2012, J Gastrointest Cancer, V43, P63, DOI 10.1007/s12029-010-9206-4; Joiner Michael, 2009, BASIC CLIN RADIOBIOL, DOI DOI 10.1201/B15450; Kalkanis SN, 2010, J NEURO-ONCOL, V96, P33, DOI 10.1007/s11060-009-0061-8; Kancherla KN, 2011, CLIN ONCOL-UK, V23, P141, DOI 10.1016/j.clon.2010.09.006; Kane CM, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h315; Kassam Z, 2008, CLIN ONCOL-UK, V20, P53, DOI 10.1016/j.clon.2007.10.003; Kedge EM, 2009, RADIOGRAPHY, V15, P247, DOI 10.1016/j.radi.2008.08.002; Kerr CW, 2012, J PAIN SYMPTOM MANAG, V43, P68, DOI 10.1016/j.jpainsymman.2011.03.026; Kirkpatrick JP, 2010, INT J RADIAT ONCOL, V76, pS42, DOI 10.1016/j.ijrobp.2009.04.095; Kocher M, 2011, J CLIN ONCOL, V29, P134, DOI 10.1200/JCO.2010.30.1655; Koswig S, 1999, STRAHLENTHER ONKOL, V175, P500, DOI 10.1007/s000660050061; Kramer GWPM, 2005, J CLIN ONCOL, V23, P2962, DOI 10.1200/JCO.2005.01.685; Kumar S, 2010, J MED IMAG RADIAT ON, V54, P264, DOI 10.1111/j.1754-9485.2010.02170.x; Lalla RV, 2014, CANCER-AM CANCER SOC, V120, P1453, DOI 10.1002/cncr.28592; Lawrence D.P., 2004, J NATL CANC I MONOGR, V32, P40, DOI [DOI 10.1093/JNCIM0N0GRAPHS/LGH027, DOI 10.1093/JNCIMONOGRAPHS/LGH027]; Leeds Teaching Hospitals NHS Trust, 2017, RAD BLADD; Linskey ME, 2010, J NEURO-ONCOL, V96, P45, DOI 10.1007/s11060-009-0073-4; Loblaw DA, 2007, SUPPORT CARE CANCER, V15, P451, DOI 10.1007/s00520-006-0166-y; Lutz S, 2004, J CLIN ONCOL, V22, P3581, DOI 10.1200/JCO.2004.11.151; Lutz ST, 2014, J CLIN ONCOL, V32, P2913, DOI 10.1200/JCO.2014.55.1143; Macbeth F R, 1996, Clin Oncol (R Coll Radiol), V8, P167, DOI 10.1016/S0936-6555(96)80041-0; Macmillan Cancer Support, CHANG APP BOD IM DEA; Maranzano E, 2005, J CLIN ONCOL, V23, P3358, DOI 10.1200/JCO.2005.08.193; Maranzano E, 2009, RADIOTHER ONCOL, V93, P174, DOI 10.1016/j.radonc.2009.05.012; McQuestion Maurene, 2011, Semin Oncol Nurs, V27, pe1, DOI 10.1016/j.soncn.2011.02.009; MIRELS H, 1989, CLIN ORTHOP RELAT R, P256; Molassiotis A, 2015, COCHRANE DB SYST REV, V5; Moraska AR, 2010, J CLIN ONCOL, V28, P3673, DOI 10.1200/JCO.2010.28.1444; Mucke M, 2015, COCHRANE DB SYST REV, V1; Mulvenna P, 2016, LANCET, V388, P2004, DOI 10.1016/S0140-6736(16)30825-X; Murphy JD, 2013, J ONCOL PRACT, V9, pE220, DOI 10.1200/JOP.2012.000835; National Institute for Health and Care Excellence, BRIT NAT FORM MED GU; National Institute for Health and Care Excellence, MET SPIN CORD COMPR; NCRI, 2016, CTRAD ID OPP PROM PR; NHS Choices, 2017, CANC AND HAIR LOSS; NHS Quality Improvement Scotland, 2010, SKINC PAT REC RAD; Northern Ireland Cancer Network, 2015, NICAN AC ONC CLIN GU; Palma DA, 2014, NAT REV CLIN ONCOL, V11, P549, DOI 10.1038/nrclinonc.2014.96; Palma DA, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-305; Parker C, 2013, NEW ENGL J MED, V369, P213, DOI 10.1056/NEJMoa1213755; Patchell RA, 2005, LANCET, V366, P643, DOI 10.1016/S0140-6736(05)66954-1; Patil CG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006121.pub3; Peterson DE, 2011, ANN ONCOL, V22, pvi78, DOI 10.1093/annonc/mdr391; Porceddu SV, 2007, RADIOTHER ONCOL, V85, P456, DOI 10.1016/j.radonc.2007.10.020; Princess Royal Radiotherapy Review Team, 2011, MAN RAD IND SKIN REA; Radbruch L, 2008, PALLIATIVE MED, V22, P13, DOI 10.1177/0269216307085183; Rades D, 2016, J CLIN ONCOL, V34, P597, DOI 10.1200/JCO.2015.64.0862; Rades D, 2011, INT J RADIAT ONCOL, V79, P1503, DOI 10.1016/j.ijrobp.2010.01.024; Rades D, 2010, CANCER-AM CANCER SOC, V116, P3670, DOI 10.1002/cncr.25223; Roos DE, 2005, RADIOTHER ONCOL, V75, P54, DOI 10.1016/j.radonc.2004.09.017; Rosenblatt E, 2010, RADIOTHER ONCOL, V97, P488, DOI 10.1016/j.radonc.2010.09.001; Round CE, 2013, CLIN ONCOL-UK, V25, P522, DOI 10.1016/j.clon.2013.05.005; Royal College of Radiologists, 2016, RAD DOS FRACT; Salvo N, 2012, INT J RADIAT ONCOL, V82, P408, DOI 10.1016/j.ijrobp.2010.08.060; Samant RS, 2007, ACTA ONCOL, V46, P659, DOI 10.1080/02841860600979005; Samant RS, 2006, RADIOTHER ONCOL, V78, P101, DOI 10.1016/j.radonc.2005.11.008; Sourati A, 2017, ACUTE SIDE EFFECTS R, P47, DOI [10.1007/978-3-319-55950-6_5, DOI 10.1007/978-3-319-55950-6_5]; Spencer K, 2015, RADIOTHER ONCOL, V115, P264, DOI 10.1016/j.radonc.2015.03.023; Sperduto PW, 2008, INT J RADIAT ONCOL, V70, P510, DOI 10.1016/j.ijrobp.2007.06.074; Spratt DE, 2014, J CLIN ONCOL, V32, P3144, DOI 10.1200/JCO.2014.55.4634; Steenland E, 1999, RADIOTHER ONCOL, V52, P101, DOI 10.1016/S0167-8140(99)00110-3; Stevens R, 2015, COCHRANE DB SYST REV, P1, DOI 10.1002/14651858.CD002143.pub4; Sundstrom S, 2004, J CLIN ONCOL, V22, P801, DOI 10.1200/JCO.2004.06.123; Sze WM, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004721; Tey J, 2017, ONCOTARGET, V8, P25797, DOI 10.18632/oncotarget.15554; Tokuhashi Y, 2005, SPINE, V30, P2186, DOI 10.1097/01.brs.0000180401.06919.a5; TOWNSEND PW, 1995, INT J RADIAT ONCOL, V31, P43, DOI 10.1016/0360-3016(94)E0310-G; Tsao MN, 2012, COCHRANE DB SYST REV, V1; UKOMiC, 2015, MOUTH CAR GUID SUPP; van der Velden JM, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2947-0; van Lonkhuijzen L, 2011, RADIOTHER ONCOL, V98, P287, DOI 10.1016/j.radonc.2011.01.009; Walters S, 2013, THORAX, V68, P551, DOI 10.1136/thoraxjnl-2012-202297; Williams M, 2013, CLIN ONCOL-UK, V25, P668, DOI 10.1016/j.clon.2013.06.003; Wong CYB, 2014, INT J DERMATOL, V53, P56, DOI 10.1111/j.1365-4632.2012.05635.x; Worthington HV, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000978.pub2; Yan J, 2011, CLIN ONCOL-UK, V23, P476, DOI 10.1016/j.clon.2011.01.001	112	54	55	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2018	360								k821	10.1136/bmj.k821	http://dx.doi.org/10.1136/bmj.k821			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB1LW	29572337	Green Published, hybrid			2022-12-28	WOS:000428813300013
J	McQuaid, JB; Kustka, AB; Obornik, M; Horak, A; McCrow, JR; Karas, BJ; Zheng, H; Kindeberg, T; Andersson, AJ; Barbeau, KA; Allen, AE				McQuaid, Jeffrey B.; Kustka, Adam B.; Obornik, Miroslav; Horak, Ales; McCrow, John R.; Karas, Bogumil J.; Zheng, Hong; Kindeberg, Theodor; Andersson, Andreas J.; Barbeau, Katherine A.; Allen, Andrew E.			Carbonate-sensitive phytotransferrin controls high-affinity iron uptake in diatoms	NATURE			English	Article							MARINE-PHYTOPLANKTON; PHAEODACTYLUM-TRICORNUTUM; OCEAN ACIDIFICATION; SEQUENCE ALIGNMENT; ALGA DUNALIELLA; SIGNAL PEPTIDES; PLASMA-MEMBRANE; REPORTER GENES; TRANSFERRIN; EVOLUTION	In vast areas of the ocean, the scarcity of iron controls the growth and productivity of phytoplankton(1,2). Although most dissolved iron in the marine environment is complexed with organic molecules(3), picomolar amounts of labile inorganic iron species (labile iron) are maintained within the euphotic zone(4) and serve as an important source of iron for eukaryotic phytoplankton and particularly for diatoms(5). Genome-enabled studies of labile iron utilization by diatoms have previously revealed novel iron responsive transcripts(6,7), including the ferric iron-concentrating protein ISIP2A(8), but the mechanism behind the acquisition of picomolar labile iron remains unknown. Here we show that ISIP2A is a phytotransferrin that independently and convergently evolved carbonate ion-coordinated ferric iron binding. Deletion of ISIP2A disrupts high-affinity iron uptake in the diatom Phaeodactylum tricornutum, and uptake is restored by complementation with human transferrin. ISIP2A is internalized by endocytosis, and manipulation of the seawater carbonic acid system reveals a second order dependence on the concentrations of labile iron and carbonate ions. In P. tricornutum, the synergistic interaction of labile iron and carbonate ions occurs at environmentally relevant concentrations, revealing that carbonate availability co-limits iron uptake. Phytotransferrin sequences have a broad taxonomic distribution(8) and are abundant in marine environmental genomic datasets(9,10), suggesting that acidification-driven declines in the concentration of seawater carbonate ions will have a negative effect on this globally important eukaryotic iron acquisition mechanism.	[McQuaid, Jeffrey B.; McCrow, John R.; Karas, Bogumil J.; Zheng, Hong; Allen, Andrew E.] J Craig Venter Inst, Microbial & Environm Genom, La Jolla, CA 92037 USA; [McQuaid, Jeffrey B.; Kindeberg, Theodor; Andersson, Andreas J.; Barbeau, Katherine A.; Allen, Andrew E.] Univ Calif La Jolla, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Kustka, Adam B.] Rutgers State Univ, Earth & Environm Sci, Newark, NJ 07102 USA; [Obornik, Miroslav; Horak, Ales] Inst Parasitol, Biol Ctr CAS, Branisovska 31, Ceske Budejovice 37005, Czech Republic; [Obornik, Miroslav; Horak, Ales] Univ South Bohemia, Fac Sci, Branisovska 31, Ceske Budejovice 37005, Czech Republic; [Karas, Bogumil J.] Designer Microbes Inc, London, ON N6G4X8, Canada	J. Craig Venter Institute; University of California System; University of California San Diego; Scripps Institution of Oceanography; Rutgers State University Newark; Rutgers State University New Brunswick; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Allen, AE (corresponding author), J Craig Venter Inst, Microbial & Environm Genom, La Jolla, CA 92037 USA.; Allen, AE (corresponding author), Univ Calif La Jolla, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	aallen@jcvi.org	Kindeberg, Theodor/E-5017-2019; Horak, Ales/H-6723-2012; Obornik, Miroslav/G-9350-2014; Kindeberg, Theodor/P-7219-2019; Allen, Andrew E/C-4896-2012	Kindeberg, Theodor/0000-0001-8151-8423; Horak, Ales/0000-0002-3364-7383; Kindeberg, Theodor/0000-0001-8151-8423; Allen, Andrew E/0000-0001-5911-6081; McCrow, John/0000-0002-7014-5040; McQuaid, Jeff/0000-0002-2646-9283; Barbeau, Katherine/0000-0002-2132-7219	National Science Foundation [NSF-MCB-1024913, NSF-ANT-1043671, NSF-OCE-0727997]; United States Department of Energy Genomics Science program [DE-SC00006719, DE-SC0008593]; Gordon and Betty Moore Foundation [GBMF3828]; Czech Science Foundation [15-17643S];  [NSF-1557928]; Division Of Integrative Organismal Systems [1557928] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); United States Department of Energy Genomics Science program; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Czech Science Foundation(Grant Agency of the Czech Republic); ; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank J. Badger for early contributions to phylogenetic analyses, A. Dickson for pH analysis, K. Forsch for CSV measurements and E. Bertrand for trace-metal clean techniques. This study was supported by the National Science Foundation (NSF-MCB-1024913, NSF-ANT-1043671 and NSF-OCE-0727997), United States Department of Energy Genomics Science program (DE-SC00006719 and DE-SC0008593), and the Gordon and Betty Moore Foundation grant GBMF3828 (A.E.A.); NSF-1557928 (A.B.K.); and the Czech Science Foundation, project 15-17643S (M.O. and A.H.).	AISEN P, 1978, J BIOL CHEM, V253, P1930; Allen AE, 2008, P NATL ACAD SCI USA, V105, P10438, DOI 10.1073/pnas.0711370105; Allen MD, 2007, EUKARYOT CELL, V6, P1841, DOI 10.1128/EC.00205-07; ANDERSON MA, 1982, LIMNOL OCEANOGR, V27, P789, DOI 10.4319/lo.1982.27.5.0789; [Anonymous], 2014, R LANG ENV STAT COMP; Baker HM, 2003, P NATL ACAD SCI USA, V100, P3579, DOI 10.1073/pnas.0637295100; Barbeau K, 2001, NATURE, V413, P409, DOI 10.1038/35096545; Berney C, 2006, P ROY SOC B-BIOL SCI, V273, P1867, DOI 10.1098/rspb.2006.3537; Bertrand EM, 2015, P NATL ACAD SCI USA, V112, P9938, DOI 10.1073/pnas.1501615112; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Bruns CM, 1997, NAT STRUCT BIOL, V4, P919, DOI 10.1038/nsb1197-919; Caron DA, 2017, NAT REV MICROBIOL, V15, P6, DOI 10.1038/nrmicro.2016.160; Carter BR, 2013, LIMNOL OCEANOGR-METH, V11, P16, DOI 10.4319/lom.2013.11.16; Dickson A.G., 2007, GUIDE BEST PRACTICES, V3; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dutta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045799; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Falciatore A, 1999, MAR BIOTECHNOL, V1, P239, DOI 10.1007/PL00011773; Fisher M, 1997, J BIOL CHEM, V272, P1565, DOI 10.1074/jbc.272.3.1565; Fisher M, 1998, J BIOL CHEM, V273, P17553, DOI 10.1074/jbc.273.28.17553; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gledhill M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00069; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Halbrooks PJ, 2004, J MOL BIOL, V339, P217, DOI 10.1016/j.jmb.2004.03.049; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; HUDSON RJM, 1989, LIMNOL OCEANOGR, V34, P1113, DOI 10.4319/lo.1989.34.6.1113; Karas BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7925; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kustka AB, 2007, J PHYCOL, V43, P715, DOI 10.1111/j.1529-8817.2007.00359.x; Lambert LA, 2005, COMP BIOCHEM PHYS B, V142, P129, DOI 10.1016/j.cbpb.2005.07.007; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lewis E., 1998, PROGRAM DEV CO2 SYST; Lis H, 2015, ISME J, V9, P1003, DOI 10.1038/ismej.2014.199; Lommer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r66; Marchetti A, 2012, P NATL ACAD SCI USA, V109, pE317, DOI 10.1073/pnas.1118408109; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/NGEO1765, 10.1038/ngeo1765]; Morel FMM, 2008, LIMNOL OCEANOGR, V53, P400, DOI 10.4319/lo.2008.53.1.0400; Morrissey J, 2015, CURR BIOL, V25, P364, DOI 10.1016/j.cub.2014.12.004; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Och LM, 2012, EARTH-SCI REV, V110, P26, DOI 10.1016/j.earscirev.2011.09.004; Parfrey LW, 2011, P NATL ACAD SCI USA, V108, P13624, DOI 10.1073/pnas.1110633108; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; Poulsen N, 2005, FEBS J, V272, P3413, DOI 10.1111/j.1742-4658.2005.04760.x; Saito MA, 2008, LIMNOL OCEANOGR, V53, P276, DOI 10.4319/lo.2008.53.1.0276; Sasaki T, 1998, PLANT CELL PHYSIOL, V39, P131, DOI 10.1093/oxfordjournals.pcp.a029349; SCHLABACH MR, 1975, J BIOL CHEM, V250, P2182; Shi DL, 2010, SCIENCE, V327, P676, DOI 10.1126/science.1183517; Slinker BK, 1998, J MOL CELL CARDIOL, V30, P723, DOI 10.1006/jmcc.1998.0655; Smith SR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006490; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sunda W, 2003, MAR CHEM, V84, P35, DOI 10.1016/S0304-4203(03)00101-4; Sunda W.G., 2005, ALGAE CULTURING TECH, V4, P35, DOI [10.1016/b978-012088426-1/50005-6, DOI 10.1016/B978-012088426-1/50005-6]; Weyman PD, 2015, PLANT BIOTECHNOL J, V13, P460, DOI 10.1111/pbi.12254; Zaslavskaia LA, 2000, J PHYCOL, V36, P379, DOI 10.1046/j.1529-8817.2000.99164.x	57	63	64	4	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2018	555	7697					534	+		10.1038/nature25982	http://dx.doi.org/10.1038/nature25982			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ9NF	29539640				2022-12-28	WOS:000427937900056
J	Zhu, B; Liu, JZ; Cauley, SF; Rosen, BR; Rosen, MS				Zhu, Bo; Liu, Jeremiah Z.; Cauley, Stephen F.; Rosen, Bruce R.; Rosen, Matthew S.			Image reconstruction by domain-transform manifold learning	NATURE			English	Article							NEURAL-NETWORK; APPROXIMATION; MRI; SIGNAL; MODEL; CT	Image reconstruction is essential for imaging applications across the physical and life sciences, including optical and radar systems, magnetic resonance imaging, X-ray computed tomography, positron emission tomography, ultrasound imaging and radio astronomy(1-3). During image acquisition, the sensor encodes an intermediate representation of an object in the sensor domain, which is subsequently reconstructed into an image by an inversion of the encoding function. Image reconstruction is challenging because analytic knowledge of the exact inverse transform may not exist a priori, especially in the presence of sensor non-idealities and noise. Thus, the standard reconstruction approach involves approximating the inverse function with multiple ad hoc stages in a signal processing chain(4,5), the composition of which depends on the details of each acquisition strategy, and often requires expert parameter tuning to optimize reconstructionperformance. Here we present a unified framework for image reconstruction-automated transform by manifold approximation (AUTOMAP)-which recasts image reconstruction as a data-driven supervised learning task that allows a mapping between the sensor and the image domain to emerge from an appropriate corpus of training data. We implement AUTOMAP with a deep neural network and exhibit its flexibility in learning reconstruction transforms for various magnetic resonance imaging acquisition strategies, using the same network architecture and hyperparameters. We further demonstrate that manifold learning during training results in sparse representations of domain transforms along low-dimensional data manifolds, and observe superior immunity to noise and a reduction in reconstruction artefacts compared with conventional handcrafted reconstruction methods. In addition to improving the reconstruction performance of existing acquisition methodologies, we anticipate that AUTOMAP and other learned reconstruction approaches will accelerate the development of new acquisition strategies across imaging modalities.	[Zhu, Bo; Cauley, Stephen F.; Rosen, Bruce R.; Rosen, Matthew S.] Massachusetts Gen Hosp, AA Martinos Ctr Biomed Imaging, Boston, MA 02114 USA; [Zhu, Bo; Cauley, Stephen F.; Rosen, Bruce R.; Rosen, Matthew S.] Harvard Med Sch, Boston, MA 02115 USA; [Zhu, Bo; Rosen, Matthew S.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Liu, Jeremiah Z.] Harvard Univ, Dept Biostat, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University	Rosen, MS (corresponding author), Massachusetts Gen Hosp, AA Martinos Ctr Biomed Imaging, Boston, MA 02114 USA.; Rosen, MS (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Rosen, MS (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	mrosen@cfa.harvard.edu		Rosen, Matthew/0000-0002-7194-002X	MGH Department of Radiology; BWH Department of Radiology; NVIDIA; National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering [EB022390]; HCP; MGH-USC Consortium [U01MH093765]; NIH Blueprint Initiative for Neuroscience Research grant; National Institutes of Health [P41EB015896];  [S10RR023043];  [1S10RR023401];  [1S10RR019307]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH093765] Funding Source: NIH RePORTER	MGH Department of Radiology; BWH Department of Radiology; NVIDIA; National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); HCP; MGH-USC Consortium; NIH Blueprint Initiative for Neuroscience Research grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We acknowledge M. Michalski and the computational resources and assistance provided by the Massachusetts General Hospital (MGH) and the Brigham and Women's Hospital (BWH) Center for Clinical Data Science (CCDS). The CCDS is supported by MGH, BWH, the MGH Department of Radiology, the BWH Department of Radiology, and through industry partnership with NVIDIA. We also acknowledge the Center for Machine Learning at Martinos. We also thank J. Stockmann, J. Polimeni, D. E. J. Waddington and R. L. Walsworth for their comments on this manuscript, and B. Bilgic and C. Liao for their assistance in human subject data acquisition. We acknowledge C. Catana for providing raw PET data and for filtered back projection and OSEM reconstructions. We also thank M. Haskell for providing the MRI motion encoding model. B.Z. was supported by the National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering F32 Fellowship (EB022390). Data were provided in part by the HCP, MGH-USC Consortium (Principal Investigators: Bruce R. Rosen, Arthur W. Toga and Van Wedeen; U01MH093765), which was funded by the NIH Blueprint Initiative for Neuroscience Research grant; the National Institutes of Health grant P41EB015896; and the Instrumentation Grants S10RR023043, 1S10RR023401, 1S10RR019307.	Abadi M, 2016, PREPRINT; Addy NO, 2012, MAGN RESON MED, V68, P120, DOI 10.1002/mrm.23217; Anderes E., 2012, PREPRINT; BARRON AR, 1994, MACH LEARN, V14, P115, DOI 10.1007/BF00993164; Bernstein A, 2015, LECT NOTES ARTIF INT, V9047, P414, DOI 10.1007/978-3-319-17091-6_36; Brown MJ., 2017, ICML, V33, P384; Brown RW, 2014, MAGNETIC RESONANCE I, DOI 10.1002/9781118633953.ch18; Cauley SF, 2015, MAGN RESON MED, V73, P1034, DOI 10.1002/mrm.25222; Comtat C, 2004, IEEE NUCL SCI CONF R, P3492; Cybenko G., 1989, Mathematics of Control, Signals, and Systems, V2, P303, DOI 10.1007/BF02551274; Daigle O, 2012, PROC SPIE, V8453, DOI 10.1117/12.926385; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Di Carli M. F., 2007, CARDIAC PET PET CT; Duyn JH, 1998, J MAGN RESON, V132, P150, DOI 10.1006/jmre.1998.1396; Fan QY, 2016, NEUROIMAGE, V124, P1108, DOI 10.1016/j.neuroimage.2015.08.075; Fessler JA, 2005, IEEE T SIGNAL PROCES, V53, P3393, DOI 10.1109/TSP.2005.853152; Fessler JA, 2003, IEEE T SIGNAL PROCES, V51, P560, DOI 10.1109/TSP.2002.807005; FLOYD CE, 1991, IEEE T MED IMAGING, V10, P485, DOI 10.1109/42.97600; Getis A., 2010, HDB APPL SPATIAL ANA, P255, DOI [10.1007/978-3-642-03647-7_14, DOI 10.1007/978-3-642-03647-7_14, 10.1007/978-3-642-03647-7]; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Girard JN, 2015, J INSTRUM, V10, DOI 10.1088/1748-0221/10/08/C08013; Gold J, 1999, NATURE, V402, P176, DOI 10.1038/46027; Goodfellow I, 2020, COMMUN ACM, V63, P139, DOI 10.1145/3422622; Grangeat P., 2013, TOMOGRAPHY; GULL SF, 1978, NATURE, V272, P686, DOI 10.1038/272686a0; Hammernik K, 2018, MAGN RESON MED, V79, P3055, DOI 10.1002/mrm.26977; Han H, 2010, CONCEPT MAGN RESON A, V36A, P349, DOI 10.1002/cmr.a.20194; Han S., 2015, PREPRINT; Haskell M., 2018, IEEE T MED IMAGING, P99; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; HOOLE SRH, 1993, IEEE T MAGN, V29, P1931, DOI 10.1109/20.250786; HORNIK K, 1991, NEURAL NETWORKS, V4, P251, DOI 10.1016/0893-6080(91)90009-T; HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8; Hu H., 2016, PREPRINT; Irie B., 1988, IEEE INT C NEURAL NE, V1, P641; Izquierdo-Garcia D, 2014, J NUCL MED, V55, P1825, DOI 10.2967/jnumed.113.136341; Jin KH, 2017, IEEE T IMAGE PROCESS, V26, P4509, DOI 10.1109/TIP.2017.2713099; Kim DH, 2003, MAGNET RESON MED, V50, P214, DOI 10.1002/mrm.10493; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Kubo T, 2008, AM J ROENTGENOL, V190, P335, DOI 10.2214/AJR.07.2556; Lebed E, 2010, OPT EXPRESS, V18, P21003, DOI 10.1364/OE.18.021003; Lu ZL, 2011, NEUROBIOL LEARN MEM, V95, P145, DOI 10.1016/j.nlm.2010.09.010; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Makhzani A., 2015, ADV NEURAL INFORM PR, P2791; Mordvintsev A., 2015, DEEPDREAM CODE EXAMP; Ogawa T, 1998, IEEE WORLD CONGRESS ON COMPUTATIONAL INTELLIGENCE, P2471, DOI 10.1109/IJCNN.1998.687250; Pelt DM, 2013, IEEE T IMAGE PROCESS, V22, P5238, DOI 10.1109/TIP.2013.2283142; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Pruessmann KP, 2001, MAGNET RESON MED, V46, P638, DOI 10.1002/mrm.1241; Reeder SB, 2005, MAGNET RESON MED, V54, P748, DOI 10.1002/mrm.20636; SAAD Y, 1986, SIAM J SCI STAT COMP, V7, P856, DOI 10.1137/0907058; Schiller H, 1999, INT J REMOTE SENS, V20, P1735, DOI 10.1080/014311699212443; Uecker M., 2015, P INT SOC MAGN RES M, V2486; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vincent P., 2008, P 25 INT C MACH LEAR, DOI 10.1145/1390156.1390294; Virtue P., 2016, PREPRINT; Weller DS, 2014, IEEE T MED IMAGING, V33, P351, DOI 10.1109/TMI.2013.2285046; Wright J, 2010, P IEEE, V98, P1031, DOI 10.1109/JPROC.2010.2044470; Xi YZ, 2014, SIAM J MATRIX ANAL A, V35, P44, DOI 10.1137/120895755; Xia JL, 2010, NUMER LINEAR ALGEBR, V17, P953, DOI 10.1002/nla.691; Yang ZL, 2014, J MAGN RESON, V242, P126, DOI 10.1016/j.jmr.2014.01.016; Yu Kai, 2010, ICML, P1215; Yu Z, 2011, IEEE T IMAGE PROCESS, V20, P161, DOI 10.1109/TIP.2010.2058811; Zeng GL, 2010, MEDICAL IMAGE RECONSTRUCTION: A CONCEPTUAL TUTORIAL, P1, DOI 10.1007/978-3-642-05368-9; Zhang Miaomiao, 2013, Inf Process Med Imaging, V23, P37, DOI 10.1007/978-3-642-38868-2_4; Zhao B, 2016, IEEE T MED IMAGING, V35, P1812, DOI 10.1109/TMI.2016.2531640	67	719	731	44	474	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2018	555	7697					487	+		10.1038/nature25988	http://dx.doi.org/10.1038/nature25988			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ9NF	29565357	Green Submitted			2022-12-28	WOS:000427937900046
J	Hawkes, N				Hawkes, Nigel			The BMJ Awards 2018: Anaesthesia and Perioperative Medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com			Royal College of Anaesthetists	Royal College of Anaesthetists	The Anaesthesia and Perioperative Medicine Team of the Year award is sponsored by the Royal College of Anaesthetists. The awards ceremony takes place on 10 May at the Park Plaza Hotel, Westminster. To find out more go to thebmjawards.bmj.com		0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 21	2018	360								k1250	10.1136/bmj.k1250	http://dx.doi.org/10.1136/bmj.k1250			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB1LG	29563087				2022-12-28	WOS:000428811700005
J	Ramachandran, SM; Liu, LY; Perkins, SH				Ramachandran, Sarika M.; Liu, Lucy Y.; Perkins, Sara H.			Peristomal Nodule in a Patient With Ovarian Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CUTANEOUS METASTASES; MANAGEMENT; CARCINOMA; TUMORS		[Ramachandran, Sarika M.; Perkins, Sara H.] Yale Sch Med, Dept Dermatol, New Haven, CT 06511 USA; [Liu, Lucy Y.] Yale Sch Med, New Haven, CT 06511 USA	Yale University; Yale University	Ramachandran, SM (corresponding author), Yale Sch Med, Dept Med, 333 Cedar St,LCI 501,POB 208059, New Haven, CT 06511 USA.	sarika.ramachandran@yale.edu		Liu, Lucy/0000-0002-7846-9373				Berretta R, 2009, EUR J GYNAECOL ONCOL, V30, P300; Cormio G, 2003, GYNECOL ONCOL, V90, P682, DOI 10.1016/S0090-8258(03)00400-1; Huang KG, 2003, AM J OBSTET GYNECOL, V189, P16, DOI 10.1067/mob.2003.330; LOOKINGBILL DP, 1993, J AM ACAD DERMATOL, V29, P228, DOI 10.1016/0190-9622(93)70173-Q; Nashan D, 2009, J CANCER RES CLIN, V135, P1, DOI 10.1007/s00432-008-0432-0; van Dam PA, 1999, AM J OBSTET GYNECOL, V181, P536, DOI 10.1016/S0002-9378(99)70489-8; Wiechert AC, 2012, GYNECOL ONCOL CASE R, V2, P324	7	1	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2018	319	11					1158	1159		10.1001/jama.2018.0770	http://dx.doi.org/10.1001/jama.2018.0770			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ8LL	29558535				2022-12-28	WOS:000427860200020
J	Winkler, F; Wick, W				Winkler, Frank; Wick, Wolfgang			Harmful networks in the brain and beyond	SCIENCE			English	Editorial Material							TUNNELING NANOTUBES; IN-VIVO; CELLS; TRANSPORT; GLIOMAS		[Winkler, Frank] Univ Med Ctr, Neurol Clin, Heidelberg, Germany; German Canc Res Ctr, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Winkler, F (corresponding author), Univ Med Ctr, Neurol Clin, Heidelberg, Germany.	frank.winkler@med.uni-heidelberg.de	Wick, Wolfgang/AAA-2545-2020	Wick, Wolfgang/0000-0002-6171-634X; Winkler, Frank/0000-0003-4892-6104				Ariazi J, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00333; Inaba M, 2015, NATURE, V523, P329, DOI 10.1038/nature14602; Jung E, 2017, J NEUROSCI, V37, P6837, DOI 10.1523/JNEUROSCI.3532-16.2017; Lou E, 2017, TRENDS CANCER, V3, P678, DOI 10.1016/j.trecan.2017.08.001; Lou E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033093; Nakagaki T, 2000, NATURE, V407, P470, DOI 10.1038/35035159; Osswald M, 2016, NEURO-ONCOLOGY, V18, P479, DOI 10.1093/neuonc/now014; Osswald M, 2015, NATURE, V528, P93, DOI 10.1038/nature16071; Polak R, 2015, BLOOD, V126, P2404, DOI 10.1182/blood-2015-03-634238; Rehberg M, 2016, SMALL, V12, P1882, DOI 10.1002/smll.201503606; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; te Boekhorst V, 2016, ANNU REV CELL DEV BI, V32, P491, DOI 10.1146/annurev-cellbio-111315-125201; Wang X, 2015, CELL DEATH DIFFER, V22, P1181, DOI 10.1038/cdd.2014.211; Weil S, 2017, NEURO-ONCOLOGY, V19, P1316, DOI 10.1093/neuonc/nox070; ZUBER MX, 1989, SCIENCE, V244, P1193, DOI 10.1126/science.2658062	15	27	27	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2018	359	6380					1100	1101		10.1126/science.aar5555	http://dx.doi.org/10.1126/science.aar5555			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY4ZM	29590028				2022-12-28	WOS:000426835900023
J	Sobieraj, DM; Weeda, ER; Nguyen, E; Coleman, CI; White, M; Lazarus, SC; Blake, KV; Lang, JE; Baker, WL				Sobieraj, Diana M.; Weeda, Erin R.; Nguyen, Elaine; Coleman, Craig I.; White, Michael; Lazarus, Stephen C.; Blake, Kathryn V.; Lang, Jason E.; Baker, William L.			Association of Inhaled Corticosteroids and Long-Acting beta-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							OF-LIFE QUESTIONNAIRE; RANDOMIZED CONTROLLED-TRIAL; BUDESONIDE/FORMOTEROL MAINTENANCE; SINGLE INHALER; DOUBLE-BLIND; COST-EFFECTIVENESS; PLUS FORMOTEROL; BUDESONIDE; COMBINATION; EFFICACY	IMPORTANCE Combined use of inhaled corticosteroids and long-acting beta-agonists (LABAs) as the controller and the quick relief therapy termed single maintenance and reliever therapy (SMART) is a potential therapeutic regimen for the management of persistent asthma. OBJECTIVE To conduct a systematic review and meta-analysis of the effects of SMART in patients with persistent asthma. DATA SOURCES AND STUDY SELECTION The databases of MEDLINE via OVID, EMBASE, the Cochrane Central Register of Controlled Trials, and the Cochrane Database of Systematic Reviews were searched from database inception through August 2016 and updated through November 28, 2017. Two reviewers selected randomized clinical trials or observational studies evaluating SMART vs inhaled corticosteroids with or without a LABA used as the controller therapy and short-acting beta-agonists as the relief therapy for patients aged 5 years or older with persistent asthma and reporting on an outcome of interest. DATA EXTRACTION AND SYNTHESIS Meta-analyses were conducted using a random-effects model to calculate risk ratios (RRs), risk differences (RDs), and mean differences with corresponding 95% CIs. Citation screening, data abstraction, risk assessment, and strength of evidence grading were completed by 2 independent reviewers. MAIN OUTCOMES AND MEASURES Asthma exacerbations. RESULTS The analyses included 16 randomized clinical trials (N = 22 748 patients), 15 of which evaluated SMART as a combination therapy with budesonide and formoterol in a dry-powder inhaler. Among patients aged 12 years or older (n = 22 524; mean age, 42 years; 14 634 [65%] were female), SMART was associated with a reduced risk of asthma exacerbations compared with the same dose of inhaled corticosteroids and LABA as the controller therapy (RR, 0.68 [95% Cl, 0.58 to 0.80]; RD,-6.4% [95% Cl,-10.2% to-2.6%]) and a higher dose of inhaled corticosteroids and LABA as the controller therapy (RR, 0.77 [95% Cl, 0.60 to 0.98]; RD, -2.8% [95% Cl,-5.2% to-0.3%]). Similar results were seen when SMART was compared with inhaled corticosteroids alone as the controller therapy. Among patients aged 4 to 11 years (n = 341; median age, 8 [range, 4-11] years; 69 [31%] were female), SMART was associated with a reduced risk of asthma exacerbations compared with a higher dose of inhaled corticosteroids as the controller therapy (RR, 0.55 [95% Cl, 0.32 to 0.94]; RD,-12.0% [95% Cl,-22.5% to-1.5%]) or the same dose of inhaled corticosteroids and LABA as the controller therapy (RR, 0.38 [95% Cl, 0.23 to 0.63]; RD,-23.2% [95% Cl,-33.6% to-12.1%]). CONCLUSIONS AND RELEVANCE In this meta-analysis of patients with persistent asthma, the use of single maintenance and reliever therapy compared with inhaled corticosteroids as the controller therapy (with or without a long-acting P-agonist) and short-acting P-agonists as the relief therapy was associated with a lower risk of asthma exacerbations. Evidence for patients aged 4 to 11 years was limited.	[Sobieraj, Diana M.; Weeda, Erin R.; Nguyen, Elaine; Coleman, Craig I.; White, Michael; Baker, William L.] Univ Connecticut, Sch Pharm, Dept Pharm Practice, Storrs, CT 06269 USA; [Lazarus, Stephen C.] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Blake, Kathryn V.] Nemours Childrens Specialty Care, Ctr Pharmacogen & Translat Res, Jacksonville, FL USA; [Lang, Jason E.] Duke Univ, Sch Med, Duke Childrens Hosp & Hlth Ctr, Div Allergy Immunol & Pulm Med, Durham, NC USA	University of Connecticut; University of California System; University of California San Francisco; Duke University	Baker, WL (corresponding author), Univ Connecticut, Sch Pharm, 69 N Eagleville Rd,Unit 3092, Storrs, CT 06269 USA.	william.baker_Jr@uconn.edu	Nguyen, Elaine/ABG-6132-2021	Nguyen, Elaine/0000-0001-6695-3187; Baker, William/0000-0003-2172-0931; Coleman, Craig/0000-0003-4868-7158; Sobieraj, Diana/0000-0002-5227-0681; Weeda, Erin/0000-0001-7876-5802	Agency for Healthcare Research and Quality, US Department of Health and Human Services [HHSA290201500012I]	Agency for Healthcare Research and Quality, US Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This review was funded under contract No. HHSA290201500012I from the Agency for Healthcare Research and Quality, US Department of Health and Human Services.	Agency for Healthcare Research and Quality, SYST REV INT INH COR; Atienza T, 2013, RESPIROLOGY, V18, P354, DOI 10.1111/resp.12009; Bateman ED, 2015, J ALLERGY CLIN IMMUN, V136, P914, DOI 10.1016/j.jaci.2015.03.023; Bateman ED, 2010, J ALLERGY CLIN IMMUN, V125, P600, DOI 10.1016/j.jaci.2009.11.033; Berkman ND, 2013, GRADING STRENGTH BOD, DOI DOI 10.1080/08897077.2015.1080208; Bisgaard H, 2006, CHEST, V130, P1733, DOI 10.1378/chest.130.6.1733; Bousquet J, 2007, RESP MED, V101, P2437, DOI 10.1016/j.rmed.2007.07.014; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; European Medicines Agency, DUORESP SPIROM; FDA Drug Safety Communication, FDA REV FINDS NO SIG; Fuhlbrigge A, 2012, J ALLERGY CLIN IMMUN, V129, pS34, DOI 10.1016/j.jaci.2011.12.983; Global Initiative for Asthma, 2017, GLOB STRAT ASTHM MAN; Hartung J, 2001, STAT MED, V20, P3875, DOI 10.1002/sim.1009; Hartung J, 2001, STAT MED, V20, P1771, DOI 10.1002/sim.791; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hozawa S, 2014, PULM PHARMACOL THER, V27, P190, DOI 10.1016/j.pupt.2013.12.003; Jackson D, 2017, STAT MED, V36, P3923, DOI 10.1002/sim.7411; Juniper EF, 2010, EUR RESPIR J, V36, P1410, DOI 10.1183/09031936.00117509; Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008; JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1; Juniper EF, 1999, CHEST, V115, P1265, DOI 10.1378/chest.115.5.1265; Kuna P, 2007, INT J CLIN PRACT, V61, P725, DOI 10.1111/j.1742-1241.2007.01338.x; Lundborg M, 2006, CURR MED RES OPIN, V22, P809, DOI 10.1185/030079906X100212; Morice AH, 2007, INT J CLIN PRACT, V61, P1874, DOI 10.1111/j.1742-1241.2007.01574.x; National Asthma Education and Prevention Program, 2007, 3 NAT HEART LUNG BLO; National Heart Lung and Blood Advisory Council Asthma Expert Working Group, 2007, 3 NAT HEART LUNG BLO; O'Byrne PM, 2005, AM J RESP CRIT CARE, V171, P129, DOI 10.1164/rccm.200407-884OC; Palmqvist M, 1997, EUR RESPIR J, V10, P2484, DOI 10.1183/09031936.97.10112489; Papi A, 2013, LANCET RESP MED, V1, P23, DOI 10.1016/S2213-2600(13)70012-2; Patel M, 2013, LANCET RESP MED, V1, P32, DOI 10.1016/S2213-2600(13)70007-9; Pavord ID, 2009, J ALLERGY CLIN IMMUN, V123, P1083, DOI 10.1016/j.jaci.2009.02.034; Peters SP, 2016, NEW ENGL J MED, V375, P850, DOI 10.1056/NEJMoa1511190; Rabe KF, 2006, CHEST, V129, P246, DOI 10.1378/chest.129.2.246; Rabe KF, 2006, LANCET, V368, P744, DOI 10.1016/S0140-6736(06)69284-2; Santanello NC, 1999, EUR RESPIR J, V14, P23, DOI 10.1034/j.1399-3003.1999.14a06.x; Schatz M, 2009, J ALLERGY CLIN IMMUN, V124; Scicchitano R, 2004, CURR MED RES OPIN, V20, P1403, DOI 10.1185/030079904X2051; Sobieraj DM, INTERMITTENT INHALED; Sovani MP, 2008, BRIT J GEN PRACT, V58, P37, DOI 10.3399/bjgp08X263802; Stallberg B, 2008, RESP MED, V102, P1360, DOI 10.1016/j.rmed.2008.06.017; Stempel DA, 2016, NEW ENGL J MED, V375, P840, DOI 10.1056/NEJMoa1606356; Stempel DA, 2016, NEW ENGL J MED, V374, P1822, DOI 10.1056/NEJMoa1511049; Takeyama K, 2014, ALLERGY ASTHMA PROC, V35, P141, DOI 10.2500/aap.2014.35.3729; Vogelmeier C, 2012, CLIN DRUG INVEST, V32, P439, DOI 10.2165/11598840-000000000-00000; Wiksten A, 2016, STAT MED, V35, P2503, DOI 10.1002/sim.6879	48	163	166	1	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 10	2018	319	14					1485	1496		10.1001/jama.2018.2769	http://dx.doi.org/10.1001/jama.2018.2769			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GC2CR	29554195	Green Published, Bronze			2022-12-28	WOS:000429590200017
J	Brooks, AS; Yellen, JE; Potts, R; Behrensmeyer, AK; Deino, AL; Leslie, DE; Ambrose, SH; Ferguson, JR; d'Errico, F; Zipkin, AM; Whittaker, S; Post, J; Veatch, EG; Foecke, K; Clark, JB				Brooks, Alison S.; Yellen, John E.; Potts, Richard; Behrensmeyer, Anna K.; Deino, Alan L.; Leslie, David E.; Ambrose, Stanley H.; Ferguson, Jeffrey R.; d'Errico, Francesco; Zipkin, Andrew M.; Whittaker, Scott; Post, Jeffrey; Veatch, Elizabeth G.; Foecke, Kimberly; Clark, Jennifer B.			Long-distance stone transport and pigment use in the earliest Middle Stone Age	SCIENCE			English	Article							MODERN HUMAN-BEHAVIOR; SOUTH-AFRICA; KAPTHURIN FORMATION; BLOMBOS CAVE; JEBEL IRHOUD; HOMO-SAPIENS; SHELL BEADS; KENYA; ORIGINS; PLEISTOCENE	Previous research suggests that the complex symbolic, technological, and socioeconomic behaviors that typify Homo sapiens had roots in the middle Pleistocene <200,000 years ago, but data bearing on human behavioral origins are limited. We present a series of excavated Middle Stone Age sites from the Olorgesailie basin, southern Kenya, dating from a 295,000 to similar to 320,000 years ago by argon-40/argon-39 and uranium-series methods. Hominins at these sites made prepared cores and points, exploited iron-rich rocks to obtain red pigment, and procured stone tool materials from >= 25- to 50-kilometer distances. Associated fauna suggests a broad resource strategy that included large and small prey. These practices imply notable changes in how individuals and groups related to the landscape and to one another and provide documentation relevant to human social and cognitive evolution.	[Brooks, Alison S.; Foecke, Kimberly] George Washington Univ, Dept Anthropol, Ctr Adv Study Human Paleobiol, Washington, DC 20052 USA; [Brooks, Alison S.; Yellen, John E.; Potts, Richard; Clark, Jennifer B.] Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20013 USA; [Yellen, John E.] Natl Sci Fdn, Archaeol Program, Alexandria, VA 22314 USA; [Potts, Richard] Natl Museums Kenya, Dept Earth Sci, POB 40658-00100, Nairobi, Kenya; [Behrensmeyer, Anna K.] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA; [Deino, Alan L.] Berkeley Geochronol Ctr, Ridge Rd, Berkeley, CA 94709 USA; [Leslie, David E.] Univ Connecticut, Dept Anthropol, Storrs, CT 06269 USA; [Ambrose, Stanley H.; Zipkin, Andrew M.] Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA; [Ferguson, Jeffrey R.] Univ Missouri, Res Reactor Ctr, Columbia, MO 65211 USA; [d'Errico, Francesco] Univ Bordeaux, CNRS, UMR 5199, PACEA, F-33615 Pessac, France; [d'Errico, Francesco] Univ Bergen, Ctr Early Sapiens Behav SapienCE, SFF, Postboks 7805, N-5020 Bergen, Norway; [Whittaker, Scott] Smithsonian Inst, Natl Museum Nat Hist, Lab Analyt Biol, Washington, DC 20013 USA; [Post, Jeffrey] Smithsonian Inst, Natl Museum Nat Hist, Dept Mineral Sci, Washington, DC 20013 USA; [Veatch, Elizabeth G.] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA	George Washington University; Smithsonian Institution; Smithsonian National Museum of Natural History; National Science Foundation (NSF); Smithsonian Institution; Smithsonian National Museum of Natural History; Berkeley Geochronolgy Center; University of Connecticut; University of Illinois System; University of Illinois Urbana-Champaign; University of Missouri System; University of Missouri Columbia; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; University of Bergen; Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Museum of Natural History; Emory University	Brooks, AS (corresponding author), George Washington Univ, Dept Anthropol, Ctr Adv Study Human Paleobiol, Washington, DC 20052 USA.; Brooks, AS; Potts, R (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20013 USA.; Potts, R (corresponding author), Natl Museums Kenya, Dept Earth Sci, POB 40658-00100, Nairobi, Kenya.	abrooks@gwu.edu; pottsr@si.edu	d'Errico, Francesco/P-1043-2016; Veatch, Elizabeth/ABA-3706-2020; Zipkin, Andrew M/AAI-9285-2020	d'Errico, Francesco/0000-0002-2422-3079; Veatch, Elizabeth/0000-0002-6952-7666; Zipkin, Andrew M/0000-0002-3813-8051; whittaker, scott/0000-0003-4490-4469; Leslie, David/0000-0003-2518-8639	Peter Buck Fund for Human Origins research (Smithsonian Institution); NSF Human Origins: Moving in New Directions (HOMINID) [BCS-0218511]; NSF Graduate Research Fellowship [2011116368]; NSF Doctoral Dissertation Research Improvement Grant [BCS-1240694]; NSF Integrative Graduate Education and Research Traineeship (IGERT) [DGE-0801634]; Wenner-Gren Foundation Dissertation Fieldwork Grant [8623]; NSF [EAR-1322017, BCS-0802757, BCS-0814304]; Research Council of Norway (SFF Centre SapienCE) [262618]; Universite de Bordeaux LaScArBx research program [ANR-10-LABX-52]; NSF; Smithsonian Institution Olorgesailie project	Peter Buck Fund for Human Origins research (Smithsonian Institution); NSF Human Origins: Moving in New Directions (HOMINID); NSF Graduate Research Fellowship(National Science Foundation (NSF)); NSF Doctoral Dissertation Research Improvement Grant; NSF Integrative Graduate Education and Research Traineeship (IGERT)(National Science Foundation (NSF)); Wenner-Gren Foundation Dissertation Fieldwork Grant; NSF(National Science Foundation (NSF)); Research Council of Norway (SFF Centre SapienCE); Universite de Bordeaux LaScArBx research program; NSF(National Science Foundation (NSF)); Smithsonian Institution Olorgesailie project	Kenya field and Kenya and U.S. laboratory work were supported by the Peter Buck Fund for Human Origins research (Smithsonian Institution) (R.P.) and by NSF Human Origins: Moving in New Directions (HOMINID) award BCS-0218511 (R.P.). Field and laboratory work by A.M.Z. on obsidian and ochre sourcing was supported by NSF Graduate Research Fellowship 2011116368 (A.M.Z.), NSF Doctoral Dissertation Research Improvement Grant BCS-1240694 (A.S.B. and A.M.Z.), NSF Integrative Graduate Education and Research Traineeship (IGERT) award DGE-0801634 to George Washington University, and Wenner-Gren Foundation Dissertation Fieldwork Grant 8623 (A.M.Z). Laboratory analyses on dating samples were funded by NSF grant EAR-1322017 to A.L.D. Field and laboratory research on Kenya obsidian sourcing was funded by NSF awards to the University of Missouri Research Reactor Center (BCS-0802757) and to J.R.F. and S.H.A. for the Kenya obsidian project (BCS-0814304). Laboratory work on the ochre by F.d'E. was funded by the Research Council of Norway (SFF Centre SapienCE), project number 262618, and the Universite de Bordeaux LaScArBx research program (ANR-10-LABX-52). J.E.Y. was supported by the NSF and by the Smithsonian Institution Olorgesailie project.	Barham LS, 2000, MIDDLE STONE AGE ZAM; Behrensmeyer A. K., 2018, GSA B, DOI [10.1130/B31853.1, DOI 10.1130/B31853.1]; Blegen N, 2017, J HUM EVOL, V103, P1, DOI 10.1016/j.jhevol.2016.11.002; Bouzouggar A, 2007, P NATL ACAD SCI USA, V104, P9964, DOI 10.1073/pnas.0703877104; Brooks AS, 2006, INTERD CONTRIB ARCH, P233, DOI 10.1007/0-387-24661-4_13; BROOKS AS, 1995, SCIENCE, V268, P548, DOI 10.1126/science.7725099; Brown KS, 2009, SCIENCE, V325, P859, DOI 10.1126/science.1175028; Clark J. D., 2001, KALAMBA FALLS PREHIS, V3, P234; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; DEINO A, 1990, J GEOPHYS RES-SOLID, V95, P8453, DOI 10.1029/JB095iB06p08453; Deino AL, 2002, J HUM EVOL, V42, P185, DOI 10.1006/jhev.2001.0517; Deino AL, 2018, SCIENCE, V360, P95, DOI 10.1126/science.aao2216; Dunbar RIM, 2003, ANNU REV ANTHROPOL, V32, P163, DOI 10.1146/annurev.anthro.32.061002.093158; Henshilwood CS, 2011, SCIENCE, V334, P219, DOI 10.1126/science.1211535; Henshilwood CS, 2001, J HUM EVOL, V41, P631, DOI 10.1006/jhev.2001.0515; Henshilwood CS, 2002, SCIENCE, V295, P1278, DOI 10.1126/science.1067575; Hublin JJ, 2017, NATURE, V546, P289, DOI 10.1038/nature22336; Kuman K, 1999, J ARCHAEOL SCI, V26, P1409, DOI 10.1006/jasc.1999.0439; Leslie DE, 2016, PALAEOGEOGR PALAEOCL, V449, P27, DOI 10.1016/j.palaeo.2016.02.010; Lombard M, 2012, CAMB ARCHAEOL J, V22, P237, DOI 10.1017/S095977431200025X; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McBrearty S., 2006, TRANSITIONS TRANSITI; Porat N, 2010, J ARCHAEOL SCI, V37, P269, DOI 10.1016/j.jas.2009.09.038; Potts R, 2018, SCIENCE, V360, P86, DOI 10.1126/science.aao2200; Potts R, 2013, QUATERNARY SCI REV, V73, P1, DOI 10.1016/j.quascirev.2013.04.003; Richter D, 2017, NATURE, V546, P293, DOI 10.1038/nature22335; Sahle Y, 2014, QUATERN INT, V331, P6, DOI 10.1016/j.quaint.2013.03.010; Scerri EML, 2013, QUATERN INT, V300, P111, DOI 10.1016/j.quaint.2012.09.008; Shea JJ, 2008, J HUM EVOL, V55, P448, DOI 10.1016/j.jhevol.2008.05.014; Texier PJ, 2013, J ARCHAEOL SCI, V40, P3412, DOI 10.1016/j.jas.2013.02.021; Tryon C. A., CURR ANTH, V54, pS234; Tryon CA, 2006, QUATERNARY RES, V65, P492, DOI 10.1016/j.yqres.2006.01.008; Watts I, 2016, CURR ANTHROPOL, V57, P287, DOI 10.1086/686484; Wiessner P., 1982, POLITICS HIST BAND S, P61; Wurz S, 2013, CURR ANTHROPOL, V54, pS305, DOI 10.1086/673283; YELLEN J, 1972, WORLD ARCHAEOL, V4, P244, DOI 10.1080/00438243.1972.9979535; Zipkin AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112560	39	138	137	3	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2018	360	6384					90	94		10.1126/science.aao2646	http://dx.doi.org/10.1126/science.aao2646			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB7OE	29545508				2022-12-28	WOS:000429263100052
J	Kuehn, B				Kuehn, Bridget			Drug-Resistant Infections from Raw Milk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2018	319	12					1191	1191		10.1001/jama.2018.2363	http://dx.doi.org/10.1001/jama.2018.2363			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GA5VW	29584851				2022-12-28	WOS:000428403000005
J	Clery, D				Clery, Daniel			Stephen Hawking, betting man	SCIENCE			English	News Item														Clery, Daniel/0000-0002-8742-3596					0	0	0	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2018	359	6382			SI		1317	1317		10.1126/science.359.6382.1317	http://dx.doi.org/10.1126/science.359.6382.1317			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA0ZG	29567687				2022-12-28	WOS:000428043600017
J	Bartel, DP				Bartel, David P.			Metazoan MicroRNAs	CELL			English	Review							MESSENGER-RNA DECAY; GENE-EXPRESSION; TARGETED DELETION; MAMMALIAN MICRORNAS; STRUCTURAL BASIS; NUCLEAR EXPORT; NONCODING RNA; C-ELEGANS; TRANSLATIONAL REPRESSION; CAENORHABDITIS-ELEGANS	MicroRNAs (miRNAs) are similar to 22 nt RNAs that direct posttranscriptional repression of mRNA targets in diverse eukaryotic lineages. In humans and other mammals, these small RNAs help sculpt the expression of most mRNAs. This article reviews advances in our understanding of the defining features of metazoan miRNAs and their biogenesis, genomics, and evolution. It then reviews how metazoan miRNAs are regulated, how they recognize and cause repression of their targets, and the biological functions of this repression, with a compilation of knockout phenotypes that shows that important biological functions have been identified for most of the broadly conserved miRNAs of mammals.	[Bartel, David P.] Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Bartel, David P.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Bartel, David P.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Bartel, DP (corresponding author), Howard Hughes Med Inst, Cambridge, MA 02139 USA.; Bartel, DP (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Bartel, DP (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dbartel@wi.mit.edu			NIGMS of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118135] Funding Source: NIH RePORTER	NIGMS of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I thank current and former members of the lab as well as many other colleagues for stimulating discussions over the years, and I apologize to many whose work I did not adequately describe or cite due to space constraints. I am an HHMI investigator and our work on miRNAs is supported by NIGMS of the National Institutes of Health.	Agarwal A., 2017, BIORXIV; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Agudo J, 2014, NAT IMMUNOL, V15, P54, DOI 10.1038/ni.2767; Ahmed K, 2017, J CLIN INVEST, V127, P1061, DOI 10.1172/JCI90031; Alvarez-Saavedra E, 2010, CURR BIOL, V20, P367, DOI 10.1016/j.cub.2009.12.051; Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Amin ND, 2015, SCIENCE, V350, P1525, DOI 10.1126/science.aad2509; Andersson MG, 2005, J VIROL, V79, P9556, DOI 10.1128/JVI.79.15.9556-9565.2005; Andolina D, 2016, NEUROPHARMACOLOGY, V107, P305, DOI 10.1016/j.neuropharm.2016.03.044; Aurora AB, 2012, J CLIN INVEST, V122, P1222, DOI 10.1172/JCI59327; Auyeung VC, 2013, CELL, V152, P844, DOI 10.1016/j.cell.2013.01.031; Avesson L, 2012, RNA, V18, P1771, DOI 10.1261/rna.033175.112; Azevedo-Pouly ACP, 2017, FUNCT INTEGR GENOMIC, V17, P203, DOI 10.1007/s10142-016-0512-1; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bail S, 2010, RNA, V16, P1032, DOI 10.1261/rna.1851510; Ballarino M, 2009, MOL CELL BIOL, V29, P5632, DOI 10.1128/MCB.00664-09; Barbato S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17331-z; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Bellutti F, 2015, J VIROL, V89, P1608, DOI 10.1128/JVI.02336-14; Bender W, 2008, GENE DEV, V22, P14, DOI 10.1101/gad.1614208; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bethune J, 2012, EMBO REP, V13, P716, DOI 10.1038/embor.2012.82; Bezman NA, 2011, J EXP MED, V208, P2717, DOI 10.1084/jem.20111386; Bluhm B, 2017, DEVELOPMENT, V144, P3562, DOI 10.1242/dev.148429; Bobbin ML, 2016, ANNU REV PHARMACOL, V56, P103, DOI 10.1146/annurev-pharmtox-010715-103633; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Bortolamiol-Becet D, 2015, MOL CELL, V59, P217, DOI 10.1016/j.molcel.2015.05.034; Boulias K, 2012, CELL METAB, V15, P439, DOI 10.1016/j.cmet.2012.02.014; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brenner JL, 2010, CURR BIOL, V20, P1321, DOI 10.1016/j.cub.2010.05.062; Burke SL, 2015, GENETICS, V200, P1201, DOI 10.1534/genetics.115.179184; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Cao HJ, 2013, DEVELOPMENT, V140, P3348, DOI 10.1242/dev.089193; Carrer M, 2012, P NATL ACAD SCI USA, V109, P15330, DOI 10.1073/pnas.1207605109; Cassidy JJ, 2016, GENETICS, V202, P675, DOI 10.1534/genetics.115.183822; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Chandradoss SD, 2015, CELL, V162, P96, DOI 10.1016/j.cell.2015.06.032; Chang HM, 2013, NATURE, V497, P244, DOI 10.1038/nature12119; Chapnik E, 2014, ELIFE, V3, DOI 10.7554/eLife.01964; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chen CYA, 2011, WIRES RNA, V2, P167, DOI 10.1002/wrna.40; Chen X., 2018, FASEB J; Chen YW, 2014, DEV CELL, V31, P784, DOI 10.1016/j.devcel.2014.11.029; CHENG L, 2017, CELL DEATH DIS, V8; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chiang DY, 2014, CIRC-ARRHYTHMIA ELEC, V7, P1214, DOI 10.1161/CIRCEP.114.001973; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Choi Sik-Won, 2015, Bone Rep, V3, P5, DOI 10.1016/j.bonr.2015.06.003; Chowdhary V, 2017, AM J PATHOL, V187, P2758, DOI 10.1016/j.ajpath.2017.08.026; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Chun SK, 2017, NAT MED, V23, P39, DOI 10.1038/nm.4240; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Cioffi M, 2015, CELL REP, V12, P1594, DOI 10.1016/j.celrep.2015.08.006; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Crowley JJ, 2015, BIOL PSYCHIAT, V77, pE5, DOI 10.1016/j.biopsych.2014.05.022; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; de la Mata M, 2015, EMBO REP, V16, P500, DOI 10.15252/embr.201540078; de Lencastre A, 2010, CURR BIOL, V20, P2159, DOI 10.1016/j.cub.2010.11.015; de Pontual L, 2011, NAT GENET, V43, P1026, DOI 10.1038/ng.915; Denzler R, 2016, MOL CELL, V64, P565, DOI 10.1016/j.molcel.2016.09.027; Denzler R, 2014, MOL CELL, V54, P766, DOI 10.1016/j.molcel.2014.03.045; Deshpande SD, 2013, DIABETES, V62, P3151, DOI 10.2337/db13-0305; Diebel KW, 2010, RNA, V16, P170, DOI 10.1261/rna.1873910; Ding L, 2005, MOL CELL, V19, P437, DOI 10.1016/j.molcel.2005.07.013; Ding L, 2018, ONCOGENE, V37, P1293, DOI 10.1038/s41388-017-0055-5; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Dooley J, 2016, DIABETES, V65, P53, DOI 10.2337/db15-0770; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Drexel T, 2016, GENE DEV, V30, P2042, DOI 10.1101/gad.287904.116; Du P, 2015, CELL, V162, P885, DOI 10.1016/j.cell.2015.07.008; Dunand-Sauthier I, 2011, BLOOD, V117, P4490, DOI 10.1182/blood-2010-09-308064; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Ecsedi M, 2015, DEV CELL, V32, P335, DOI 10.1016/j.devcel.2014.12.018; Eichhorn SW, 2014, MOL CELL, V56, P104, DOI 10.1016/j.molcel.2014.08.028; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Fang WW, 2015, MOL CELL, V60, P131, DOI 10.1016/j.molcel.2015.08.015; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Farmer DT, 2017, DEV BIOL, V427, P12, DOI 10.1016/j.ydbio.2017.05.012; Farmer DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076634; Fededa JP, 2016, EMBO J, V35, P2386, DOI 10.15252/embj.201694056; Fiori E, 2015, BEHAV GENET, V45, P547, DOI 10.1007/s10519-015-9724-8; Fragoso R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002855; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Golden RJ, 2017, NATURE, V542, P197, DOI 10.1038/nature21025; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grosswendt S, 2014, MOL CELL, V54, P1042, DOI 10.1016/j.molcel.2014.03.049; Gu S, 2012, CELL, V151, P900, DOI 10.1016/j.cell.2012.09.042; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Gurha P, 2012, CIRCULATION, V125, P2751, DOI 10.1161/CIRCULATIONAHA.111.044354; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Han YC, 2015, NAT GENET, V47, P766, DOI 10.1038/ng.3321; Hansen KF, 2016, LEARN MEMORY, V23, P61, DOI 10.1101/lm.039578.115; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; Hasuwa H, 2013, SCIENCE, V341, P71, DOI 10.1126/science.1237999; Heestand BN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003651; Heidersbach A, 2013, ELIFE, V2, DOI 10.7554/eLife.01323; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Henao-Mejia J, 2013, IMMUNITY, V38, P984, DOI 10.1016/j.immuni.2013.02.021; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Henique C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01885-7; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2012, CELL, V151, P521, DOI 10.1016/j.cell.2012.09.022; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hernandez-Rapp J, 2015, BEHAV BRAIN RES, V287, P15, DOI 10.1016/j.bbr.2015.03.032; Hoover AR, 2016, J BIOL CHEM, V291, P23237, DOI 10.1074/jbc.M116.744508; Horie T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3883; Horie T, 2010, P NATL ACAD SCI USA, V107, P17321, DOI 10.1073/pnas.1008499107; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Hsu SH, 2016, HEPATOLOGY, V64, P599, DOI 10.1002/hep.28573; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Hu CY, 2017, SCI REP-UK, V7, DOI 10.1038/srep45582; Hu WH, 2015, BLOOD, V125, P2206, DOI 10.1182/blood-2014-06-585273; Huang ZP, 2013, CIRC RES, V112, P1234, DOI 10.1161/CIRCRESAHA.112.300682; Huberdeau MQ, 2017, EMBO J, V36, P2088, DOI 10.15252/embj.201696386; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Iwasaki S, 2010, MOL CELL, V39, P292, DOI 10.1016/j.molcel.2010.05.015; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Jee D, 2018, MOL CELL, V69, P265, DOI 10.1016/j.molcel.2017.12.027; Jo S, 2018, DIABETES, V67, P256, DOI 10.2337/db17-0506; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kamenska A, 2016, NUCLEIC ACIDS RES, V44, P6318, DOI 10.1093/nar/gkw565; Kamenska A, 2014, NUCLEIC ACIDS RES, V42, P3298, DOI 10.1093/nar/gkt1265; Kasper DM, 2017, DEV CELL, V40, P552, DOI 10.1016/j.devcel.2017.02.021; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kawamata T, 2010, TRENDS BIOCHEM SCI, V35, P368, DOI 10.1016/j.tibs.2010.03.009; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kiessling S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176547; Kim D, 2016, NAT GENET, V48, P1517, DOI 10.1038/ng.3694; Kim J, 2015, J NEUROSCI, V35, P14717, DOI 10.1523/JNEUROSCI.2053-15.2015; Kim JC, 2016, CANCER RES, V76, P6424, DOI 10.1158/0008-5472.CAN-16-1571; Kim YK, 2016, P NATL ACAD SCI USA, V113, pE1881, DOI 10.1073/pnas.1602532113; Kleaveland B., 2018, BIORXIV; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Klum SM, 2018, EMBO J, V37, P75, DOI 10.15252/embj.201796474; Kohlhaas S, 2009, J IMMUNOL, V182, P2578, DOI 10.4049/jimmunol.0803162; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kramer NJ, 2015, BLOOD, V125, P3720, DOI 10.1182/blood-2014-10-603951; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krzeszinski JY, 2014, NATURE, V512, P431, DOI 10.1038/nature13375; Kuhn S, 2011, P NATL ACAD SCI USA, V108, P2355, DOI 10.1073/pnas.1016646108; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; Kumarswamy R, 2014, EUR HEART J, V35, P3224, DOI 10.1093/eurheartj/ehu344; Kurkewich J. L., 2017, EXP HEMATOL, P30906; Kurkewich JL, 2016, J LEUKOCYTE BIOL, V100, P665, DOI 10.1189/jlb.1HI0915-398RR; Labialle S, 2014, EMBO J, V33, P2216, DOI 10.15252/embj.201387038; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Latreille M, 2014, J CLIN INVEST, V124, P2722, DOI 10.1172/JCI73066; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE A, 2017, SCI REP, V7; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee S, 2013, CELL HOST MICROBE, V13, P678, DOI 10.1016/j.chom.2013.05.007; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Li CJ, 2015, J CLIN INVEST, V125, P1509, DOI 10.1172/JCI77716; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Li X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01003-z; Li YF, 2016, IMMUNOLOGY, V148, P140, DOI 10.1111/imm.12592; Libri V, 2012, P NATL ACAD SCI USA, V109, P279, DOI 10.1073/pnas.1114204109; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu N, 2012, J CLIN INVEST, V122, P2054, DOI 10.1172/JCI62656; Liu N, 2011, J CLIN INVEST, V121, P3258, DOI 10.1172/JCI46267; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Liu ZY, 2017, BIOCHEM BIOPH RES CO, V490, P62, DOI 10.1016/j.bbrc.2017.06.012; Llobet-Navas D, 2014, GENE DEV, V28, P765, DOI 10.1101/gad.237404.114; Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002; Lovat F, 2015, P NATL ACAD SCI USA, V112, P11636, DOI 10.1073/pnas.1514954112; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Lu LF, 2015, IMMUNITY, V43, P52, DOI 10.1016/j.immuni.2015.04.022; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Lu TX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059397; Lu TX, 2013, J IMMUNOL, V190, P1576, DOI 10.4049/jimmunol.1202897; Lu W, 2015, NAT IMMUNOL, V16, P1185, DOI 10.1038/ni.3292; Lumayag S, 2013, P NATL ACAD SCI USA, V110, pE507, DOI 10.1073/pnas.1212655110; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Lykken EA, 2016, J BIOL CHEM, V291, P23532, DOI 10.1074/jbc.M116.741264; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Ma XD, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.5; Ma YC, 2017, BIOCHEM BIOPH RES CO, V494, P120, DOI 10.1016/j.bbrc.2017.10.069; Madison BB, 2013, GENE DEV, V27, P2233, DOI 10.1101/gad.224659.113; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Mao RR, 2015, INT J BIOCHEM CELL B, V69, P153, DOI 10.1016/j.biocel.2015.10.008; Marcinowski L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002510; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Marty V, 2016, HUM MOL GENET, V25, P728, DOI 10.1093/hmg/ddv510; Marzi MJ, 2016, GENOME RES, V26, P554, DOI 10.1101/gr.198788.115; Mazziotti R, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15488; McJunkin K, 2017, GENE DEV, V31, P422, DOI 10.1101/gad.290155.116; Medeiros LA, 2011, P NATL ACAD SCI USA, V108, P14163, DOI 10.1073/pnas.1111241108; Medrano S, 2014, AM J PATHOL, V184, P3226, DOI 10.1016/j.ajpath.2014.08.012; Mehta A, 2015, IMMUNITY, V42, P1021, DOI 10.1016/j.immuni.2015.05.017; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Mendoza-Viveros L, 2017, CELL REP, V19, P505, DOI 10.1016/j.celrep.2017.03.057; Mildner A, 2017, EUR J IMMUNOL, V47, P1142, DOI 10.1002/eji.201746987; Mildner A, 2013, BLOOD, V121, P1016, DOI 10.1182/blood-2012-07-445999; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Miyaki S, 2010, GENE DEV, V24, P1173, DOI 10.1101/gad.1915510; Moffett HF, 2017, NAT IMMUNOL, V18, P791, DOI 10.1038/ni.3755; Mohammed J, 2018, GENOME RES, V28, P52, DOI 10.1101/gr.226068.117; Mok YT, 2013, J IMMUNOL, V191, P3037, DOI 10.4049/jimmunol.1301289; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Moon HG, 2014, J IMMUNOL, V193, P4558, DOI 10.4049/jimmunol.1401372; Moran Y, 2014, GENOME RES, V24, P651, DOI 10.1101/gr.162503.113; Mori M, 2014, CELL, V156, P893, DOI 10.1016/j.cell.2013.12.043; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Muraleedharan CK, 2016, INVEST OPHTH VIS SCI, V57, P1506, DOI 10.1167/iovs.16-19134; Nagosa S, 2017, STEM CELL REP, V9, P1991, DOI 10.1016/j.stemcr.2017.10.030; Nakamura Y, 2011, MOL CELL BIOL, V31, P3019, DOI 10.1128/MCB.05178-11; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Nehammer C, 2015, SCI REP-UK, V5, DOI 10.1038/srep08866; Nishiga M, 2017, CIRC RES, V120, P835, DOI 10.1161/CIRCRESAHA.116.309528; Nishimura T, 2015, CELL REP, V11, P1425, DOI 10.1016/j.celrep.2015.04.065; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Ozgur S, 2015, CELL REP, V13, P703, DOI 10.1016/j.celrep.2015.09.033; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Paikari A, 2017, DEVELOPMENT, V144, P3731, DOI 10.1242/dev.151654; Papadopoulou AS, 2015, NEUROBIOL DIS, V73, P275, DOI 10.1016/j.nbd.2014.10.006; Papadopoulou AS, 2012, NAT IMMUNOL, V13, P181, DOI 10.1038/ni.2193; Parchem RJ, 2015, CELL REP, V12, P760, DOI 10.1016/j.celrep.2015.06.074; Park CY, 2012, CELL REP, V1, P385, DOI 10.1016/j.celrep.2012.02.008; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Patrick DM, 2010, GENE DEV, V24, P1614, DOI 10.1101/gad.1942810; Pedersen ME, 2013, SCIENCE, V341, P1404, DOI 10.1126/science.1242528; Peng L, 2016, EBIOMEDICINE, V14, P83, DOI 10.1016/j.ebiom.2016.10.041; Penzkofer D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101153; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Piwecka M, 2017, SCIENCE, V357, DOI 10.1126/science.aam8526; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Pua HH, 2016, IMMUNITY, V44, P821, DOI 10.1016/j.immuni.2016.01.003; Qayum AA, 2016, J IMMUNOL, V196, P4457, DOI 10.4049/jimmunol.1502240; Radzikinas K, 2011, J NEUROSCI, V31, P15407, DOI 10.1523/JNEUROSCI.2745-11.2011; Rakoczy J, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.107607; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Reimao-Pinto MM, 2015, MOL CELL, V59, P203, DOI 10.1016/j.molcel.2015.05.033; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Remenyi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062509; Riemondy K, 2015, ELIFE, V4, DOI 10.7554/eLife.07004; Rissland OS, 2011, MOL CELL, V43, P993, DOI 10.1016/j.molcel.2011.08.021; Rivkin N, 2017, HAEMATOLOGICA, V102, P676, DOI 10.3324/haematol.2016.156109; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rodriguez-Barrueco R, 2017, GENE DEV, V31, P553, DOI 10.1101/gad.292318.116; Rowe RG, 2016, J EXP MED, V213, P1497, DOI 10.1084/jem.20151912; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sachdeva M, 2014, J CLIN INVEST, V124, P4305, DOI 10.1172/JCI77116; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Salunkhe VA, 2015, ACTA PHYSIOL, V213, P882, DOI 10.1111/apha.12460; Sanuki R, 2011, NAT NEUROSCI, V14, P1125, DOI 10.1038/nn.2897; Sarkies P, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002061; Sassi Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01737-4; Schirle NT, 2015, ELIFE, V4, DOI 10.7554/eLife.07646; Schirle NT, 2014, SCIENCE, V346, P608, DOI 10.1126/science.1258040; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Schmiedel JM, 2015, SCIENCE, V348, P128, DOI 10.1126/science.aaa1738; Schnall-Levin M, 2010, P NATL ACAD SCI USA, V107, P15751, DOI 10.1073/pnas.1006172107; Schober A, 2014, NAT MED, V20, P368, DOI 10.1038/nm.3487; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Shibata M, 2011, J NEUROSCI, V31, P3407, DOI 10.1523/JNEUROSCI.5085-10.2011; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Simion P, 2017, CURR BIOL, V27, P958, DOI 10.1016/j.cub.2017.02.031; Smith KM, 2012, J IMMUNOL, V189, P1567, DOI 10.4049/jimmunol.1103171; Smith NL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16399; Song R, 2014, NATURE, V510, P115, DOI 10.1038/nature13413; Stadthagen G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003913; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stark A, 2007, GENOME RES, V17, P1865, DOI 10.1101/gr.6593807; Stark A, 2008, GENE DEV, V22, P8, DOI 10.1101/gad.1613108; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Subtelny AO, 2014, NATURE, V508, P66, DOI 10.1038/nature13007; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Sullivan RP, 2015, J IMMUNOL, V195, P2806, DOI 10.4049/jimmunol.1500949; Sun YP, 2015, J CLIN INVEST, V125, P2825, DOI 10.1172/JCI78753; Suzuki HI, 2015, NAT STRUCT MOL BIOL, V22, P512, DOI 10.1038/nsmb.3050; Tan CL, 2013, SCIENCE, V342, P1254, DOI 10.1126/science.1244193; Tao C, 2016, ONCOTARGET, V7, P67796, DOI 10.18632/oncotarget.12080; Tatsumi N, 2016, ONCOGENE, V35, P1003, DOI 10.1038/onc.2015.154; Tattikota SG, 2014, CELL METAB, V19, P122, DOI 10.1016/j.cmet.2013.11.015; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Treiber T, 2017, MOL CELL, V66, P270, DOI 10.1016/j.molcel.2017.03.014; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; Tsujimura K, 2015, CELL REP, V12, P1887, DOI 10.1016/j.celrep.2015.08.028; Nguyen TA, 2015, CELL, V161, P1374, DOI 10.1016/j.cell.2015.05.010; Tuschl T, 2002, NAT BIOTECHNOL, V20, P446, DOI 10.1038/nbt0502-446; Tyler DM, 2008, GENE DEV, V22, P26, DOI 10.1101/gad.1615208; Ustianenko D, 2013, RNA, V19, P1632, DOI 10.1261/rna.040055.113; van Nieuwenhuijze A, 2017, CELL MOL LIFE SCI, V74, P2095, DOI 10.1007/s00018-017-2456-6; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Vickers KC, 2014, P NATL ACAD SCI USA, V111, P14518, DOI 10.1073/pnas.1215767111; Wang DM, 2013, NAT CELL BIOL, V15, P1153, DOI 10.1038/ncb2827; Wang HB, 2017, DEV CELL, V40, P566, DOI 10.1016/j.devcel.2017.03.001; Wang HP, 2014, NAT IMMUNOL, V15, P393, DOI 10.1038/ni.2846; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115855; Watanabe T, 2008, DEV DYNAM, V237, P3738, DOI 10.1002/dvdy.21787; Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036; Wei YS, 2014, CELL RES, V24, P278, DOI 10.1038/cr.2014.12; Wen JY, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004441; White K, 2015, EMBO MOL MED, V7, P695, DOI 10.15252/emmm.201404511; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Wong SFL, 2015, P NATL ACAD SCI USA, V112, pE4884, DOI 10.1073/pnas.1512655112; Wu JW, 2014, P NATL ACAD SCI USA, V111, pE2851, DOI 10.1073/pnas.1407777111; Wu LW, 2015, ELIFE, V4, DOI 10.7554/eLife.09431; Wystub K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003793; Xiang L, 2017, P NATL ACAD SCI USA, V114, P6376, DOI 10.1073/pnas.1618757114; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xie MY, 2013, CELL, V155, P1568, DOI 10.1016/j.cell.2013.11.027; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Yamada Y, 2014, BIOCHEM BIOPH RES CO, V443, P980, DOI 10.1016/j.bbrc.2013.12.078; Yang JS, 2010, P NATL ACAD SCI USA, V107, P15163, DOI 10.1073/pnas.1006432107; Yang K, 2017, AUTOPHAGY, V13, P1679, DOI 10.1080/15548627.2017.1353841; Yang RQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep36434; Yang SZ, 2013, FASEB J, V27, P2382, DOI 10.1096/fj.12-219493; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yao Y., 2015, NAT COMMUN, V6; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yoda M, 2013, CELL REP, V5, P715, DOI 10.1016/j.celrep.2013.09.029; Yoo KH, 2014, DEV BIOL, V395, P245, DOI 10.1016/j.ydbio.2014.09.012; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zamudio JR, 2014, CELL, V156, P920, DOI 10.1016/j.cell.2014.01.041; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zeng Y, 2005, J BIOL CHEM, V280, P27595, DOI 10.1074/jbc.M504714200; Zhang BJ, 2016, IMMUNITY, V44, P568, DOI 10.1016/j.immuni.2016.01.007; Zhang D, 2016, CELL REP, V16, P757, DOI 10.1016/j.celrep.2016.06.040; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang LY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8639; Zhao JL, 2013, ELIFE, V2, DOI 10.7554/eLife.00537; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507; Zheng QH, 2012, J IMMUNOL, V188, P2118, DOI 10.4049/jimmunol.1103342; Zhuang GQ, 2012, CIRCULATION, V125, P2892, DOI 10.1161/CIRCULATIONAHA.111.087817; Zietara N, 2013, P NATL ACAD SCI USA, V110, P7407, DOI 10.1073/pnas.1221984110; Zisoulis DG, 2012, NATURE, V486, P541, DOI 10.1038/nature11134; Zou FY, 2016, FEBS J, V283, P1438, DOI 10.1111/febs.13678	390	1662	1704	22	189	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 22	2018	173	1					20	51		10.1016/j.cell.2018.03.006	http://dx.doi.org/10.1016/j.cell.2018.03.006			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GA3MT	29570994	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000428234200006
J	Cyranoski, D				Cyranoski, David			The cells that sparked a revolution	NATURE			English	News Item							EMBRYONIC STEM-CELLS; LINES; DIFFERENTIATION											da Cruz L., 2018, NATURE BIOTECHNOL; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Eiges R, 2007, CELL STEM CELL, V1, P568, DOI 10.1016/j.stem.2007.09.001; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Sagi I, 2016, NATURE, V532, P107, DOI 10.1038/nature17408; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Verlinsky Y, 2005, REPROD BIOMED ONLINE, V10, P105, DOI 10.1016/S1472-6483(10)60810-3; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	15	15	16	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2018	555	7697					428	430		10.1038/d41586-018-03268-4	http://dx.doi.org/10.1038/d41586-018-03268-4			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ9NF	29565377	Bronze			2022-12-28	WOS:000427937900024
J	Vernot, B; Paabo, S				Vernot, Benjamin; Paeaebo, Svante			The Predecessors Within . . .	CELL			English	Editorial Material							HISTORY; EAST	By examining the genomes of present-day people from Asia, researchers show that modern humans met and interbred with Denisovans, distant relatives to Neanderthals, on at least two occasions. As a result, people today carry DNA from two different Denisovan populations.	[Vernot, Benjamin; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany	Max Planck Society	Vernot, B; Paabo, S (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany.	benjamin_vernot@eva.mpg.de; paabo@eva.mpg.de	Vernot, Benjamin/ABH-1495-2021	Vernot, Benjamin/0000-0002-6820-2181				Browning SR, 2018, CELL, V173, P53, DOI 10.1016/j.cell.2018.02.031; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Lazaridis I, 2016, NATURE, V536, P419, DOI 10.1038/nature19310; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Sankararaman S, 2016, CURR BIOL, V26, P1241, DOI 10.1016/j.cub.2016.03.037; Vernot B, 2015, AM J HUM GENET, V96, P448, DOI 10.1016/j.ajhg.2015.01.006; Wall JD, 2013, GENETICS, V194, P199, DOI 10.1534/genetics.112.148213	8	7	7	8	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 22	2018	173	1					6	7		10.1016/j.cell.2018.03.023	http://dx.doi.org/10.1016/j.cell.2018.03.023			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GA3MT	29570998	Bronze			2022-12-28	WOS:000428234200003
J	Zhong, SJ; Zhang, S; Fan, XY; Wu, Q; Yan, LY; Dong, J; Zhang, HF; Li, L; Sun, L; Pan, N; Xu, XH; Tang, FC; Zhang, J; Qiao, J; Wang, XQ				Zhong, Suijuan; Zhang, Shu; Fan, Xiaoying; Wu, Qian; Yan, Liying; Dong, Ji; Zhang, Haofeng; Li, Long; Sun, Le; Pan, Na; Xu, Xiaohui; Tang, Fuchou; Zhang, Jun; Qiao, Jie; Wang, Xiaoqun			A single-cell RNA-seq survey of the developmental landscape of the human prefrontal cortex	NATURE			English	Article							EVOLUTION; PROGENITORS; MICROGLIA; DIVERSITY; NEURONS; GENES; BRAIN	The mammalian prefrontal cortex comprises a set of highly specialized brain areas containing billions of cells and serves as the centre of the highest-order cognitive functions, such as memory, cognitive ability, decision-making and social behaviour(1,2). Although neural circuits are formed in the late stages of human embryonic development and even after birth, diverse classes of functional cells are generated and migrate to the appropriate locations earlier in development. Dysfunction of the prefrontal cortex contributes to cognitive deficits and the majority of neurodevelopmental disorders; there is therefore a need for detailed knowledge of the development of the prefrontal cortex. However, it is still difficult to identify cell types in the developing human prefrontal cortex and to distinguish their developmental features. Here we analyse more than 2,300 single cells in the developing human prefrontal cortex from gestational weeks 8 to 26 using RNA sequencing. We identify 35 subtypes of cells in six main classes and trace the developmental trajectories of these cells. Detailed analysis of neural progenitor cells highlights new marker genes and unique developmental features of intermediate progenitor cells. We also map the timeline of neurogenesis of excitatory neurons in the prefrontal cortex and detect the presence of interneuron progenitors in early developing prefrontal cortex. Moreover, we reveal the intrinsic development dependent signals that regulate neuron generation and circuit formation using single-cell transcriptomic data analysis. Our screening and characterization approach provides a blueprint for understanding the development of the human prefrontal cortex in the early and mid-gestational stages in order to systematically dissect the cellular basis and molecular regulation of prefrontal cortex function in humans.	[Zhong, Suijuan; Wu, Qian; Li, Long; Sun, Le; Pan, Na; Wang, Xiaoqun] Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing, Peoples R China; [Zhong, Suijuan; Wu, Qian; Li, Long; Wang, Xiaoqun] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhang, Shu; Fan, Xiaoying; Yan, Liying; Dong, Ji; Tang, Fuchou; Qiao, Jie] Peking Univ, Hosp 3, Beijing Adv Innovat Ctr Gen, Coll Life Sci,Dept Obstet & Gynecol, Beijing 100871, Peoples R China; [Zhang, Haofeng; Xu, Xiaohui; Zhang, Jun] Capital Med Univ, Beijing Anzhen Hosp, Med Ctr Severe Cardiovasc, Obstet & Gynecol, Beijing, Peoples R China; [Tang, Fuchou; Qiao, Jie] Biomed Inst Pioneering Invest, Via Convergence, Beijing, Peoples R China; [Tang, Fuchou; Qiao, Jie] Minist Educ, Ctr Reprod Med, Key Lab Cell Proliferat & Differentiat, Beijing, Peoples R China; [Tang, Fuchou; Qiao, Jie] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Wang, Xiaoqun] Beijing Inst Brain Disorders, Beijing 100069, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University; Capital Medical University; Peking University	Wang, XQ (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing, Peoples R China.; Wang, XQ (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Tang, FC; Qiao, J (corresponding author), Peking Univ, Hosp 3, Beijing Adv Innovat Ctr Gen, Coll Life Sci,Dept Obstet & Gynecol, Beijing 100871, Peoples R China.; Zhang, J (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Med Ctr Severe Cardiovasc, Obstet & Gynecol, Beijing, Peoples R China.; Tang, FC; Qiao, J (corresponding author), Biomed Inst Pioneering Invest, Via Convergence, Beijing, Peoples R China.; Tang, FC; Qiao, J (corresponding author), Minist Educ, Ctr Reprod Med, Key Lab Cell Proliferat & Differentiat, Beijing, Peoples R China.; Tang, FC; Qiao, J (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.; Wang, XQ (corresponding author), Beijing Inst Brain Disorders, Beijing 100069, Peoples R China.	tangfuchou@pku.edu.cn; drzhangj@outlook.com; jie.qiao@263.net; xiaoqunwang@ibp.ac.cn	Wu, Qian/AAI-2915-2020	Dong, Ji/0000-0002-8953-5284; Zhang, Shu/0000-0003-2543-5943; Li, Long/0000-0002-1354-8468; Tang, Fuchou/0000-0002-8625-7717	National Basic Research Program of China [2014CB964600]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA16020601]; National Natural Science Foundation of China (NSFC) [91732301, 31371100, 31771140]; National Key Research and Development Program of China [2017YFA0103303, 2017YFA0102601]; Shanghai Brain-Intelligence Project from STCSM [16JC1420500]; Newton Advanced Fellowship [NA140246]; Youth Innovation Promotion Association CAS	National Basic Research Program of China(National Basic Research Program of China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Shanghai Brain-Intelligence Project from STCSM; Newton Advanced Fellowship; Youth Innovation Promotion Association CAS	We thank members of the Wang and Tang laboratories for discussions. This work was supported by National Basic Research Program of China (2014CB964600), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA16020601), the National Natural Science Foundation of China (NSFC) (91732301, 31371100, 31771140), National Key Research and Development Program of China (2017YFA0103303, 2017YFA0102601), Shanghai Brain-Intelligence Project from STCSM (16JC1420500), Newton Advanced Fellowship (NA140246) to X.W. and Youth Innovation Promotion Association CAS to Q.W.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bandler RC, 2017, CURR OPIN NEUROBIOL, V42, P17, DOI 10.1016/j.conb.2016.10.003; Bicks LK, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01805; Canitano R, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00069; Guo F, 2015, CELL, V161, P1437, DOI 10.1016/j.cell.2015.05.015; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Homem CCF, 2015, NAT REV NEUROSCI, V16, P647, DOI 10.1038/nrn4021; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; Lake BB, 2016, SCIENCE, V352, P1586, DOI 10.1126/science.aaf1204; Lewitus E, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00424; Li L, 2017, CELL STEM CELL, V20, P891, DOI 10.1016/j.stem.2017.05.009; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Ma T, 2013, NAT NEUROSCI, V16, P1588, DOI 10.1038/nn.3536; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Masserdotti G, 2016, DEVELOPMENT, V143, P2494, DOI 10.1242/dev.092163; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2007, ARCH NEUROL-CHICAGO, V64, P639, DOI 10.1001/archneur.64.5.639; O'Rahilly R, 2008, ANN ANAT, V190, P105, DOI 10.1016/j.aanat.2008.01.001; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Palop JJ, 2011, METHODS MOL BIOL, V670, P207, DOI 10.1007/978-1-60761-744-0_15; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Qiu XJ, 2017, NAT METHODS, V14, P309, DOI [10.1038/NMETH.4150, 10.1038/nmeth.4150]; Radonjic NV, 2014, CELL REP, V9, P2139, DOI 10.1016/j.celrep.2014.11.026; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Roth G, 2012, PROG BRAIN RES, V195, P413, DOI 10.1016/B978-0-444-53860-4.00020-9; Sandberg M, 2016, NEURON, V91, P1260, DOI 10.1016/j.neuron.2016.08.020; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Shi GX, 2005, J BIOL CHEM, V280, P37599, DOI 10.1074/jbc.M507364200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283; Vasistha NA, 2015, CEREB CORTEX, V25, P3290, DOI 10.1093/cercor/bhu125	45	290	305	9	211	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 22	2018	555	7697					524	+		10.1038/nature25980	http://dx.doi.org/10.1038/nature25980			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ9NF	29539641				2022-12-28	WOS:000427937900054
J	Armstrong, S				Armstrong, Stephen			Data deadlines loom large for the NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												stephen.armstrong@me.com						[Anonymous], 2016, MAKING IT WORK HARNE; Baldwin C, 2014, COMPUT WKLY     0226; Donnelly L., 2014, DAILY TELEGRAPH; Hughes O, 2018, DIGITAL HLTH; Information Commissioner's Office, GUID GEN DAT PROT RE; National Data Guardian for Health and Care, 2016, REV DAT SEC CONS OPT; NHS Digital, NAT DAT OPT OUT PROG; Stevens L, 2017, DIGITAL HLTH	8	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 21	2018	360								k1215	10.1136/bmj.k1215	http://dx.doi.org/10.1136/bmj.k1215			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB1LG	29563084				2022-12-28	WOS:000428811700003
J	Hawkes, N				Hawkes, Nigel			The BMJ Awards 2018: Cancer Care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com			Macmillan	Macmillan	The Cancer Care Team of the Year award is sponsored by Macmillan. The awards ceremony takes place on 10 May at the Park Plaza Hotel, Westminster. To find out more go to thebmjawards.bmj.com.		0	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2018	360								k1244	10.1136/bmj.k1244	http://dx.doi.org/10.1136/bmj.k1244			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB1KM	29555654				2022-12-28	WOS:000428809700004
J	Ball, P				Ball, Philip			Giving meaning to art in hospital care	LANCET			English	Editorial Material																			0	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2018	391	10125					1016	1017		10.1016/S0140-6736(18)30557-9	http://dx.doi.org/10.1016/S0140-6736(18)30557-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ4TP	29565010				2022-12-28	WOS:000427585100014
J	Kinoshita, S; Koizumi, N; Ueno, M; Okumura, N; Imai, K; Tanaka, H; Yamamoto, Y; Nakamura, T; Inatomi, T; Bush, J; Toda, M; Hagiya, M; Yokota, I; Teramukai, S; Sotozono, C; Hamuro, J				Kinoshita, Shigeru; Koizumi, Noriko; Ueno, Morio; Okumura, Naoki; Imai, Kojiro; Tanaka, Hiroshi; Yamamoto, Yuji; Nakamura, Takahiro; Inatomi, Tsutomu; Bush, John; Toda, Munetoyo; Hagiya, Michio; Yokota, Isao; Teramukai, Satoshi; Sotozono, Chie; Hamuro, Junji			Injection of Cultured Cells with a ROCK Inhibitor for Bullous Keratopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORNEAL ENDOTHELIAL-CELLS; KINASE INHIBITOR; RABBIT MODEL; TRANSPLANTATION; KERATOPLASTY; MEMBRANE; THERAPY; SHEET	BACKGROUND Corneal endothelial cell (CEC) disorders, such as Fuchs's endothelial corneal dystrophy, induce abnormal corneal hydration and result in corneal haziness and vision loss known as bullous keratopathy. We investigated whether injection of cultured human CECs supplemented with a rho-associated protein kinase (ROCK) inhibitor into the anterior chamber could increase CEC density. METHODS We performed an uncontrolled, single-group study involving 11 persons who had received a diagnosis of bullous keratopathy and had no detectable CECs. Human CECs were cultured from a donor cornea; a total of 1x10(6) passaged cells were supplemented with a ROCK inhibitor (final volume, 300 mu l) and injected into the anterior chamber of the eye that was selected for treatment. After the procedure, patients were placed in a prone position for 3 hours. The primary outcome was restoration of corneal transparency, with a CEC density of more than 500 cells per square millimeter at the central cornea at 24 weeks after cell injection. Secondary outcomes were a corneal thickness of less than 630 mu m and an improvement in best corrected visual acuity equivalent to two lines or more on a Landolt C eye chart at 24 weeks after cell injection. RESULTS At 24 weeks after cell injection, we recorded a CEC density of more than 500 cells per square millimeter (range, 947 to 2833) in 11 of the 11 treated eyes (100%; 95% confidence interval [CI], 72 to 100), of which 10 had a CEC density exceeding 1000 cells per square millimeter. A corneal thickness of less than 630 mu m (range, 489 to 640) was attained in 10 of the 11 treated eyes (91%; 95% CI, 59 to 100), and an improvement in best corrected visual acuity of two lines or more was recorded in 9 of the 11 treated eyes (82%; 95% CI, 48 to 98). CONCLUSIONS Injection of human CECs supplemented with a ROCK inhibitor was followed by an increase in CEC density after 24 weeks in 11 persons with bullous keratopathy.	[Kinoshita, Shigeru; Nakamura, Takahiro; Toda, Munetoyo; Hagiya, Michio] Kyoto Prefectural Univ Med, Dept Frontier Med Sci & Technol Ophthalmol, Kyoto, Japan; [Ueno, Morio; Imai, Kojiro; Tanaka, Hiroshi; Yamamoto, Yuji; Inatomi, Tsutomu; Bush, John; Sotozono, Chie; Hamuro, Junji] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Yokota, Isao; Teramukai, Satoshi] Kyoto Prefectural Univ Med, Dept Biostat, Kyoto, Japan; [Koizumi, Noriko; Okumura, Naoki] Doshisha Univ, Dept Biomed Engn, Kyoto, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Doshisha University	Kinoshita, S (corresponding author), Kyoto Prefectural Univ Med, Dept Frontier Med Sci & Technol Ophthalmol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6020841, Japan.	shigeruk@koto.kpu-m.ac.jp	Teramukai, Satoshi/I-2249-2019; Yokota, Isao/AAB-2910-2021	Teramukai, Satoshi/0000-0003-2184-0597; Yokota, Isao/0000-0001-6254-2225	Highway Program for Realization of Regenerative Medicine of the Japan Agency for Medical Research and Development; Research Project for Practical Applications of Regenerative Medicine of the Japanese Ministry of Health, Labor, and Welfare; Funding Program for Next- Generation World-Leading Researchers (NEXT Program) of the Japan Society for the Promotion of Science; Program for the Strategic Research Foundation at Private Universities of the Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research [17K11487] Funding Source: KAKEN	Highway Program for Realization of Regenerative Medicine of the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Research Project for Practical Applications of Regenerative Medicine of the Japanese Ministry of Health, Labor, and Welfare; Funding Program for Next- Generation World-Leading Researchers (NEXT Program) of the Japan Society for the Promotion of Science; Program for the Strategic Research Foundation at Private Universities of the Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Supported by a grant from the Highway Program for Realization of Regenerative Medicine of the Japan Agency for Medical Research and Development (to Drs. Kinoshita and Koizumi), a grant from the Research Project for Practical Applications of Regenerative Medicine of the Japanese Ministry of Health, Labor, and Welfare (to Dr. Kinoshita), a grant from the Funding Program for Next- Generation World-Leading Researchers (NEXT Program) of the Japan Society for the Promotion of Science (to Dr. Koizumi), and a grant from the Program for the Strategic Research Foundation at Private Universities of the Ministry of Education, Culture, Sports, Science, and Technology (to Dr. Koizumi).	[Anonymous], 2016, 2015 EYE BANK STAT R; Borkar DS, 2016, CORNEA, V35, P1267, DOI 10.1097/ICO.0000000000000915; Bourne W M, 1998, Trans Am Ophthalmol Soc, V96, P229; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Dawson DG., 2011, ADLERS PHYSL EYE, P71; ENGELMANN K, 1989, IN VITRO CELL DEV B, V25, P1065; Gain P, 2016, JAMA OPHTHALMOL, V134, P167, DOI 10.1001/jamaophthalmol.2015.4776; Hamuro J, 2016, INVEST OPHTH VIS SCI, V57, P4749, DOI 10.1167/iovs.16-19770; Holladay JT, 2004, J CATARACT REFR SURG, V30, P287, DOI 10.1016/j.jcrs.2004.01.014; Hongo A, 2017, INVEST OPHTH VIS SCI, V58, P3325, DOI 10.1167/iovs.16-21170; Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016; Joyce Nancy C, 2004, Cornea, V23, pS8, DOI 10.1097/01.ico.0000136666.63870.18; Koizumi N, 2007, INVEST OPHTH VIS SCI, V48, P4519, DOI 10.1167/iovs.07-0567; Konomi K, 2005, INVEST OPHTH VIS SCI, V46, P4086, DOI 10.1167/iovs.05-0245; Melles GRJ, 2008, AM J OPHTHALMOL, V145, P222, DOI 10.1016/j.ajo.2007.09.021; Mimura T, 2005, INVEST OPHTH VIS SCI, V46, P3128, DOI 10.1167/iovs.05-0251; Mimura T, 2005, EXP EYE RES, V80, P149, DOI 10.1016/j.exer.2004.08.021; Mimura T, 2004, INVEST OPHTH VIS SCI, V45, P2992, DOI 10.1167/iovs.03-1174; Okumura N, 2016, SCI REP-UK, V6, DOI 10.1038/srep26113; Okumura N, 2013, INVEST OPHTH VIS SCI, V54, P2493, DOI 10.1167/iovs.12-11320; Okumura N, 2012, AM J PATHOL, V181, P268, DOI 10.1016/j.ajpath.2012.03.033; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; Peh GSL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028310; Price MO, 2009, OPHTHALMOLOGY, V116, P2361, DOI 10.1016/j.ophtha.2009.07.010; Sawai S, 2005, NATURE, V433, P323, DOI 10.1038/nature03228; Schlogl A, 2016, AM J OPHTHALMOL, V169, P218, DOI 10.1016/j.ajo.2016.07.002; Schmedt T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051427; Streilein JW, 2003, NAT REV IMMUNOL, V3, P879, DOI 10.1038/nri1224; Tan DTH, 2012, LANCET, V379, P1749, DOI 10.1016/S0140-6736(12)60437-1; Toda M, 2017, INVEST OPHTH VIS SCI, V58, P2011, DOI 10.1167/iovs.16-20703; Wacker K, 2016, OPHTHALMOLOGY, V123, P154, DOI 10.1016/j.ophtha.2015.09.023; Yamada J, 2016, INVEST OPHTH VIS SCI, V57, P4572, DOI 10.1167/iovs.15-19020; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814	33	239	244	2	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2018	378	11					995	1003		10.1056/NEJMoa1712770	http://dx.doi.org/10.1056/NEJMoa1712770			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ2HT	29539291	Bronze			2022-12-28	WOS:000427399000005
J	Cornwall, W				Cornwall, Warren			LOOKING FOR LOVE	SCIENCE			English	Editorial Material															Pulitzer Center on Crisis Reporting	Pulitzer Center on Crisis Reporting	This project was supported with a grant from the Pulitzer Center on Crisis Reporting.		0	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2018	359	6380					1086	1089		10.1126/science.359.6380.1086	http://dx.doi.org/10.1126/science.359.6380.1086			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY4ZM	29590023				2022-12-28	WOS:000426835900018
J	Sobieraj, DM; Baker, WL; Nguyen, E; Weeda, ER; Coleman, CI; White, CM; Lazarus, SC; Blake, KV; Lang, JE				Sobieraj, Diana M.; Baker, William L.; Nguyen, Elaine; Weeda, Erin R.; Coleman, Craig I.; White, C. Michael; Lazarus, Stephen C.; Blake, Kathryn V.; Lang, Jason E.			Association of Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists With Asthma Control in Patients With Uncontrolled, Persistent Asthma A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CONTROL QUESTIONNAIRE; TIOTROPIUM; VALIDATION; DOXOFYLLINE; MONTELUKAST; COMBINATION; BUDESONIDE; ADULTS; SCORES	IMPORTANCE Long-acting muscarinic antagonists (LAMAs) are a potential adjunct therapy to inhaled corticosteroids in the management of persistent asthma. OBJECTIVE To conduct a systematic review and meta-analysis of the effects associated with LAMA vs placebo or vs other controllers as an add-on therapy to inhaled corticosteroids and the use of a LAMA as add-on therapy to inhaled corticosteroids and long-acting beta-agonists (LABAs; hereafter referred to as triple therapy) vs inhaled corticosteroids and LABA in patients with uncontrolled, persistent asthma. DATA SOURCES MEDLINE, EMBASE, Cochrane databases, and clinical trial registries date through November 28, 2017). STUDY SELECTION Two reviewers selected randomized clinical trials or observational studies evaluating a LAMA vs placebo or vs another controller as an add-on therapy to inhaled corticosteroids or triple therapy vs inhaled corticosteroids and LABA in patients with uncontrolled, persistent asthma reporting on an outcome of interest. DATA EXTRACTION AND SYNTHESIS Meta-analyses using a random-effects model was conducted to calculate risk ratios (RR5), risk differences (RD5), and mean differences (MDs) with corresponding 95% Cls. Citation screening, data abstraction, risk assessment, and strength-of-evidence grading were completed by 2 independent reviewers. MAIN OUTCOMES AND MEASURES Asthma exacerbations. RESULTS Of 1326 records identified, 15 randomized clinical trials (N = 7122 patients) were included. Most trials assessed adding LAMA vs placebo or LAMA vs LABA to inhaled corticosteroids. Adding LAMA vs placebo to inhaled corticosteroids was associated with a significantly reduced risk of exacerbation requiring systemic corticosteroids (RR, 0.67 [95% Cl, 0.48 to 0.92]; RD,-0.02 [95% Cl,-0.04 to 0.00]). Compared with adding LABA, adding LAMA to inhaled corticosteroids was not associated with significant improvements in exacerbation risk (RR, 0.87 [95% Cl, 0.53 to 142]; RD, 0.00 [95% Cl,-0.02 to 0.02]), or any other outcomes of interest. Triple therapy was not significantly associated with improved exacerbation risk vs inhaled corticosteroids and LABA (RR, 0.84 [95% Cl, 037 to 1.22]; RD,-0.01 [95% Cl,-0.08 to 0.07]). CONCLUSIONS AND RELEVANCE In this systematic review and meta-analysis, the use of LAMA compared with placebo as add-on therapy to inhaled corticosteroids was associated with a lower risk of asthma exacerbations; however, the association of LAMA with benefit may not be greater than that with LABA. Triple therapy was not associated with a lower risk of exacerbations.	[Sobieraj, Diana M.; Baker, William L.; Nguyen, Elaine; Weeda, Erin R.; Coleman, Craig I.; White, C. Michael] Univ Connecticut, Sch Pharm, Dept Pharm Practice, Storrs, CT 06269 USA; [Lazarus, Stephen C.] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Blake, Kathryn V.] Nemours Childrens Specialty Care, Ctr Pharmacogen & Translat Res, Jacksonville, FL USA; [Lang, Jason E.] Duke Univ, Sch Med, Duke Childrens Hosp & Hlth Ctr, Div Allergy Immunol & Pulm Med, Durham, NC USA	University of Connecticut; University of California System; University of California San Francisco; Duke University	Sobieraj, DM (corresponding author), Univ Connecticut, Sch Pharm, 69 N Eagleville Rd,Unit 3092, Storrs, CT 06269 USA.	diana.sobieraj@uconn.edu	Nguyen, Elaine/ABG-6132-2021	Nguyen, Elaine/0000-0001-6695-3187; Weeda, Erin/0000-0001-7876-5802; Coleman, Craig/0000-0003-4868-7158; Baker, William/0000-0003-2172-0931; Sobieraj, Diana/0000-0002-5227-0681	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA290201500012I]	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services	This systematic review was funded under contract HHSA290201500012I from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services.	Agency for Healthcare Research and Quality, SYST REV INT INH COR; [Anonymous], 2016, SPIR RESP PACK INS; Bateman ED, 2015, J ALLERGY CLIN IMMUN, V136, P914, DOI 10.1016/j.jaci.2015.03.023; Bateman ED, 2011, J ALLERGY CLIN IMMUN, V128, P315, DOI 10.1016/j.jaci.2011.06.004; Berkman N, 2011, AHRQ PUBLICATION, V11-E006; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Cloutier MM, 2012, J ALLERGY CLIN IMMUN, V129, pS24, DOI 10.1016/j.jaci.2011.12.980; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Hamelmann E, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01100-2016; Hamelmann E, 2016, J ALLERGY CLIN IMMUN, V138, P441, DOI 10.1016/j.jaci.2016.01.011; Hartung J, 2001, STAT MED, V20, P3875, DOI 10.1002/sim.1009; Hartung J, 2001, STAT MED, V20, P1771, DOI 10.1002/sim.791; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Juniper EF, 2010, EUR RESPIR J, V36, P1410, DOI 10.1183/09031936.00117509; Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008; Juniper EF, 1999, EUR RESPIR J, V14, P32, DOI 10.1034/j.1399-3003.1999.14a08.x; JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1; Juniper EF, 1999, CHEST, V115, P1265, DOI 10.1378/chest.115.5.1265; Juniper Elizabeth F, 2005, Health Qual Life Outcomes, V3, P58, DOI 10.1186/1477-7525-3-58; Kerstjens HAM, 2015, LANCET RESP MED, V3, P367, DOI 10.1016/S2213-2600(15)00031-4; Kerstjens HAM, 2012, NEW ENGL J MED, V367, P1198, DOI 10.1056/NEJMoa1208606; Lee LA, 2015, RESP MED, V109, P54, DOI 10.1016/j.rmed.2014.09.012; National Heart Lung and Blood Advisory Council Asthma Expert Working Group, 2015, 3 NAT HEART LUNG BLO; National Heart Lung and Blood Institute, 2007, 3 NAT HEART LUNG BLO; Ohta K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124109; Paggiaro P, 2016, J ALLERGY CLIN IMMUN, V4; Peters SP, 2010, NEW ENGL J MED, V363, P1715, DOI 10.1056/NEJMoa1008770; Rajanandh MG, 2014, CLIN THER, V36, P526, DOI 10.1016/j.clinthera.2014.02.006; Rajanandh MG, 2015, CLIN THER, V37, P418, DOI 10.1016/j.clinthera.2014.12.008; Santanello NC, 1999, EUR RESPIR J, V14, P23, DOI 10.1034/j.1399-3003.1999.14a06.x; Sobieraj DM, INTERMITTENT INHALED; Tepper RS, 2012, J ALLERGY CLIN IMMUN, V129, pS65, DOI 10.1016/j.jaci.2011.12.986; Wang K, 2015, INT J CLIN EXP MED, V8, P19476; Wechsler ME, 2015, JAMA-J AM MED ASSOC, V314, P1720, DOI 10.1001/jama.2015.13277; Wyrwich KW, 2011, QUAL LIFE RES, V20, P903, DOI 10.1007/s11136-010-9821-3	37	58	58	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 10	2018	319	14					1473	1484		10.1001/jama.2018.2757	http://dx.doi.org/10.1001/jama.2018.2757			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GC2CR	29554174	Green Published			2022-12-28	WOS:000429590200016
J	Hartmann, M; Zeier, T; Bernsdorff, F; Reichel-Deland, V; Kim, D; Hohmann, M; Scholten, N; Schuck, S; Brautigam, A; Holzel, T; Ganter, C; Zeier, J				Hartmann, Michael; Zeier, Tatyana; Bernsdorff, Friederike; Reichel-Deland, Vanessa; Kim, Denis; Hohmann, Michele; Scholten, Nicola; Schuck, Stefan; Braeutigam, Andrea; Hoelzel, Torsten; Ganter, Christian; Zeier, Juergen			Flavin Monooxygenase-Generated N-Hydroxypipecolic Acid Is a Critical Element of Plant Systemic Immunity	CELL			English	Article							ACQUIRED-RESISTANCE; SALICYLIC-ACID; DEPENDENT MONOOXYGENASE; BIOSYNTHESIS PATHWAY; ARABIDOPSIS-THALIANA; DEFENSE RESPONSES; PIPECOLIC ACID; CELL-DEATH; ACTIVATION; CATALYZES	Following a previous microbial inoculation, plants can induce broad-spectrum immunity to pathogen infection, a phenomenon known as systemic acquired resistance (SAR). SAR establishment in Arabidopsis thaliana is regulated by the Lys catabolite pipecolic acid (Pip) and flavin-dependent-monooxygenase1 (FMO1). Here, we show that elevated Pip is sufficient to induce an FMO1-dependent transcriptional reprogramming of leaves that is reminiscent of SAR. In planta and in vitro analyses demonstrate that FMO1 functions as a pipecolate N-hydroxylase, catalyzing the biochemical conversion of Pip to N-hydroxypipecolic acid (NHP). NHP-systemically accumulates in plants after microbial attack. When exogenously applied, it overrides the defect of NHP-deficient fmo1 in acquired resistance and acts as a potent inducer of plant immunity to bacterial and oomycete infection. Our work has identified a pathogen-inducible L-Lys catabolic pathway in plants that generates the N-hydroxylated amino acid NHP as a critical regulator of systemic acquired resistance to pathogen infection.	[Hartmann, Michael; Zeier, Tatyana; Bernsdorff, Friederike; Reichel-Deland, Vanessa; Kim, Denis; Hohmann, Michele; Scholten, Nicola; Schuck, Stefan; Zeier, Juergen] Heinrich Heine Univ, Dept Biol, Inst Mol Ecophysiol Plants, Univ Str 1, D-40225 Dusseldorf, Germany; [Schuck, Stefan; Braeutigam, Andrea; Zeier, Juergen] Heinrich Heine Univ, Cluster Excellence Plant Sci CEPLAS, Univ Str 1, D-40225 Dusseldorf, Germany; [Braeutigam, Andrea] Heinrich Heine Univ, Dept Biol, Inst Plant Biochem, Univ Str 1, D-40225 Dusseldorf, Germany; [Hoelzel, Torsten; Ganter, Christian] Heinrich Heine Univ, Dept Chem, Inst Inorgan & Struct Chem, Univ Str 1, D-40225 Dusseldorf, Germany; [Braeutigam, Andrea] Univ Bielefeld, Computat Biol, Fac Biol, Univ Str 27, D-33615 Bielefeld, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Cologne; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Bielefeld	Zeier, J (corresponding author), Heinrich Heine Univ, Dept Biol, Inst Mol Ecophysiol Plants, Univ Str 1, D-40225 Dusseldorf, Germany.; Zeier, J (corresponding author), Heinrich Heine Univ, Cluster Excellence Plant Sci CEPLAS, Univ Str 1, D-40225 Dusseldorf, Germany.	juergen.zeier@hhu.de		Reichel-Deland, Vanessa/0000-0003-2449-6402; Brautigam, Andrea/0000-0002-5309-0527; Schuck, Stefan/0000-0002-3959-4884; Bernsdorff, Friederike/0000-0003-3457-2034; Hartmann, Michael/0000-0003-4828-958X	German Research Foundation (DFG) [ZE467/6-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	We thank Jane Parker for providing the Hpa Noco2 strain, Steffen Kohler (Center for Advanced Imaging, HHU Dusseldorf) for support with respect to the acquisition of leaf overview images, and Laura Rose for proofreading the manuscript. This work was supported by the German Research Foundation (DFG grant ZE467/6-1).	Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernsdorff F, 2016, PLANT CELL, V28, P102, DOI 10.1105/tpc.15.00496; Bunsupa S, 2012, PLANT CELL, V24, P1202, DOI 10.1105/tpc.112.095885; Cecchini NM, 2015, MOL PLANT MICROBE IN, V28, P455, DOI 10.1094/MPMI-06-14-0187-R; Ding PT, 2016, PLANT CELL, V28, P2603, DOI 10.1105/tpc.16.00486; Dubiella U, 2013, P NATL ACAD SCI USA, V110, P8744, DOI 10.1073/pnas.1221294110; Fan J, 2008, PLANT J, V53, P393, DOI 10.1111/j.1365-313X.2007.03303.x; Galili G, 2001, CURR OPIN PLANT BIOL, V4, P261, DOI 10.1016/S1369-5266(00)00170-9; Gruner K, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00252; HOLUB EB, 1994, MOL PLANT MICROBE IN, V7, P223, DOI 10.1094/MPMI-7-0223; Jing BB, 2011, PLANT PHYSIOL, V157, P973, DOI 10.1104/pp.111.182089; Jung HW, 2009, SCIENCE, V324, P89, DOI 10.1126/science.1170025; Koch M, 2006, PLANT J, V47, P629, DOI 10.1111/j.1365-313X.2006.02813.x; Li J, 2008, PLANT PHYSIOL, V148, P1721, DOI 10.1104/pp.108.125757; Liu PP, 2011, PLANT PHYSIOL, V157, P2216, DOI 10.1104/pp.111.187773; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; Mishina TE, 2006, PLANT PHYSIOL, V141, P1666, DOI 10.1104/pp.106.081257; MURAHASHI SI, 1987, TETRAHEDRON LETT, V28, P6469, DOI 10.1016/S0040-4039(00)96890-4; Naumann C, 2002, P NATL ACAD SCI USA, V99, P6085, DOI 10.1073/pnas.082674499; Navarova H, 2012, PLANT CELL, V24, P5123, DOI 10.1105/tpc.112.103564; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Olszak B, 2006, PLANT SCI, V170, P614, DOI 10.1016/j.plantsci.2005.10.016; Rossner R, 2017, J BIOL CHEM, V292, P11138, DOI 10.1074/jbc.R117.779678; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shah J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00030; Sharma S, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-182; Song JT, 2004, PLANT J, V40, P200, DOI 10.1111/j.1365-313X.2004.02200.x; Sun TJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10159; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; Wang CX, 2014, CELL REP, V7, P348, DOI 10.1016/j.celrep.2014.03.032; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Wittstock U, 2000, J BIOL CHEM, V275, P14659, DOI 10.1074/jbc.275.19.14659; Yoshimoto N, 2015, PLANT J, V83, P941, DOI 10.1111/tpj.12954; Zeier J, 2004, PLANTA, V219, P673, DOI 10.1007/s00425-004-1272-z; Zeier J, 2013, PLANT CELL ENVIRON, V36, P2085, DOI 10.1111/pce.12122; Zhang ZG, 2008, MOL PLANT, V1, P510, DOI 10.1093/mp/ssn011	38	196	199	8	88	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 5	2018	173	2					456	+	469.e1	10.1016/j.cell.2018.02.049	http://dx.doi.org/10.1016/j.cell.2018.02.049			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GB8IS	29576453	Bronze, Green Published			2022-12-28	WOS:000429320200018
J	Byerley, JS				Byerley, Julie Story			Mentoring in the Era of #MeToo	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Byerley, Julie Story] Univ N Carolina, Dept Pediat, Sch Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Byerley, JS (corresponding author), Univ N Carolina, Sch Med, 4068 Bondurant Hall,CB 7000, Chapel Hill, NC 27514 USA.	Julie_byerley@med.unc.edu							0	40	40	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2018	319	12					1199	1200		10.1001/jama.2018.2128	http://dx.doi.org/10.1001/jama.2018.2128			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GA5VW	29584847				2022-12-28	WOS:000428403000009
J	[Anonymous]				[Anonymous]			Legislation for Increased Rank for Medical Officers (Reprint from JAMA vol 70, pg 926, 1918)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		REILING J, 1918, JAMA-J AM MED ASSOC, V70, P926	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2018	319	12					1283	1283		10.1001/jama.2017.12303	http://dx.doi.org/10.1001/jama.2017.12303			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GA5VW	29584831				2022-12-28	WOS:000428403000028
J	Dayan, M				Dayan, Mark			Long division: summing up Brexit and the NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Dayan, Mark] Nuffield Trust, London, England		Dayan, M (corresponding author), Nuffield Trust, London, England.	Mark.Dayan@nuffieldtrust.org.uk						Dayan M, 2018, END STATE NHS; Dayan M, 2016, FACT CHECK MIGRATION; De Lyon J, 2018, LSE BLOGS       0315; European Commission, 2018, INT EU27 PREP DISC F; Lintern S, 2017, HLTH SERVICE J; Local Government Association, 2017, AD SOC CAR FUND STAT; May T, 2018, PM SPEECH OUR FUTURE; Morrow G, 2012, IMPACT WORKING TIME; NHS Digital, JOIN NHS 31 DEC 2015; NHS Digital, JOIN LEAV NHS; NHS Improvement, Q PERF NHS PROV SECT; Nursing and Midwifery Council, 2017, REP EU NURS MIDW; Virginia Department of Health Professions, 2020, VIRG LIC CLIN SOC WO	13	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2018	360								k1320	10.1136/bmj.k1320	http://dx.doi.org/10.1136/bmj.k1320			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB5MP	29581159				2022-12-28	WOS:000429109200004
J	Lai, ZW; Kelly, R; Winans, T; Marchena, I; Shadakshari, A; Yu, J; Dawood, M; Garcia, R; Tily, H; Francis, L; Faraone, SV; Phillips, PE; Perl, A				Lai, Zhi-Wei; Kelly, Ryan; Winans, Thomas; Marchena, Ivan; Shadakshari, Ashwini; Yu, Julie; Dawood, Maha; Garcia, Ricardo; Tily, Hajra; Francis, Lisa; Faraone, Stephen V.; Phillips, Paul E.; Perl, Andras			Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial	LANCET			English	Article							REDUCES DISEASE-ACTIVITY; T-CELLS; MAMMALIAN TARGET; REVISED CRITERIA; ACTIVITY INDEX; RAPAMYCIN; ACTIVATION; CLASSIFICATION; INHIBITION; MECHANISMS	Background Patients with systemic lupus erythematosus have T-cell dysfunction that has been attributed to the activation of the mammalian target of rapamycin (mTOR). Rapamycin inhibits antigen-induced T-cell proliferation and has been developed as a medication under the generic designation of sirolimus. We assessed safety, tolerance, and efficacy of sirolimus in a prospective, biomarker-driven, open-label clinical trial. Methods We did a single-arm, open-label, phase 1/2 trial of sirolimus in patients with active systemic lupus erythematosus disease unresponsive to, or intolerant of, conventional medications at the State University of New York Upstate Medical University (Syracuse, NY, USA). Eligible participants (aged >= 18 years) had active systemic lupus erythematosus fulfilling four or more of 11 diagnostic criteria defined by the American College of Rheumatology. We excluded patients with allergy or intolerance to sirolimus, patients with life-threatening manifestations of systemic lupus erythematosus, proteinuria, a urine protein to creatinine ratio higher than 0.5, anaemia, leucopenia, or thrombocytopenia. Patients received oral sirolimus at a starting dose of 2 mg per day, with dose adjusted according to tolerance and to maintain a therapeutic range of 6-15 ng/mL. Patients were treated with sirolimus for 12 months. Safety outcomes included tolerance as assessed by the occurrence of common side-effects. The primary efficacy endpoint was decrease in disease activity, assessed using the British Isles Lupus Assessment Group (BILAG) index and the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI). Blood samples of 56 matched healthy individuals were obtained as controls for immunobiological outcomes monitored at each visit. The primary efficacy endpoint was assessed in all patients who completed 12 months of treatment, and all patients who received at least one dose of treatment were included in the safety analyses. This trial is registered with ClinicalTrials.gov, number NCT00779194. Findings Between March 9, 2009, and Dec 8, 2014, 43 patients were enrolled, three of whom did not meet eligibility criteria. 11 of the 40 eligible patients discontinued study treatment because of intolerance (n=2) or non-compliance (n=9). SLEDAI and BILAG disease activity scores were reduced during 12 months of treatment in 16 (55%) of 29 patients who completed treatment. Mean SLEDAI score decreased from 10.2 (SD 5.6) at enrolment to 4.8 (4.5) after 12 months of treatment (p<0.001) and the mean total BILAG index score decreased from 28.4 (12.4) at enrolment to 17.4 (10.7) after 12 months of treatment (p<0.001). The mean daily dose of prednisone required to control disease activity decreased from 23.7 mg (SD 9.6) to 7.2 mg (2.3; p<0.001) after 12 months of treatment. Sirolimus expanded CD4(+)CD25(+)FoxP3(+) regulatory T cells and CD8(+) memory T-cell populations and inhibited interleukin-4 and interleukin-17 production by CD4(+) and CD4(-)CD8(-) double-negative T cells after 12 months. CD8+ memory T cells were selectively expanded in SRI-responders. Patient liver function and lymphocyte counts were unchanged. Although HDL-cholesterol (Z=-2.50, p=0.012), neutrophil counts (Z=-1.92, p=0.054), and haemoglobin (Z=-2.83, p=0.005) were moderately reduced during treatment, all changes occurred within a range that was considered safe. Platelet counts were slightly elevated during treatment (Z=2.06, p=0.0400). Interpretation These data show that a progressive improvement in disease activity is associated with correction of pro-inflammatory T-cell lineage specification in patients with active systemic lupus erythematosus during 12 months of sirolimus treatment. Follow-up placebo-controlled clinical trials in diverse patient populations are warranted to further define the role of mTOR blockade in treatment of systemic lupus erythematosus. Funding Pfizer, the National Institutes of Health, and the Central New York Community Foundation.	[Lai, Zhi-Wei; Kelly, Ryan; Winans, Thomas; Marchena, Ivan; Shadakshari, Ashwini; Yu, Julie; Dawood, Maha; Garcia, Ricardo; Tily, Hajra; Francis, Lisa; Phillips, Paul E.; Perl, Andras] SUNY Upstate Med Univ, Div Rheumatol, Syracuse, NY 13210 USA; [Faraone, Stephen V.] SUNY Upstate Med Univ, Dept Psychiat, Syracuse, NY 13210 USA; [Lai, Zhi-Wei; Kelly, Ryan; Winans, Thomas; Marchena, Ivan; Shadakshari, Ashwini; Yu, Julie; Dawood, Maha; Garcia, Ricardo; Tily, Hajra; Francis, Lisa; Phillips, Paul E.; Perl, Andras] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA; [Perl, Andras] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA; [Perl, Andras] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Perl, A (corresponding author), SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.	perla@upstate.edu	Faraone, Stephen/AAE-7334-2019; Faraone, Stephen V/O-7239-2018	Faraone, Stephen/0000-0002-9217-3982; Faraone, Stephen V/0000-0002-9217-3982	Pfizer; National Institutes of Health; Central New York Community Foundation; Pfizer [P0468X1-4470/WS1234172]; National Institutes of Health [AI 048079, AI 072648, AI 122176]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072648, R01AI048079, R56AI048079, R01AI122176] Funding Source: NIH RePORTER	Pfizer(Pfizer); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Central New York Community Foundation; Pfizer(Pfizer); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Pfizer, the National Institutes of Health, and the Central New York Community Foundation.; This work was supported in part by an investigator-initiated research grant from Pfizer (P0468X1-4470/WS1234172) and grants from the National Institutes of Health (AI 048079, AI 072648, and AI 122176) and the Central New York Community Foundation. We thank Melissa Reale for dispensing the study drug and excellent record keeping.	Bettencourt IA, 2017, J IMMUNOL, V198, P999, DOI 10.4049/jimmunol.1601318; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Brunner HI, 2010, ARTHRIT CARE RES, V62, P950, DOI 10.1002/acr.20154; Canaud G, 2014, NEW ENGL J MED, V371, P303, DOI 10.1056/NEJMoa1312890; Caza TN, 2014, ANN RHEUM DIS, V73, P1888, DOI 10.1136/annrheumdis-2013-203794; Champion L, 2006, ANN INTERN MED, V144, P505, DOI 10.7326/0003-4819-144-7-200604040-00009; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; COLLIER DS, 1990, TRANSPLANT P, V22, P1674; Comte D, 2017, ARTHRITIS RHEUMATOL, V69, P1035, DOI 10.1002/art.40038; El-Chemaly S, 2017, CHEST, V151, P1302, DOI 10.1016/j.chest.2017.01.033; Fernandez D, 2006, ARTHRITIS RHEUM-US, V54, P2983, DOI 10.1002/art.22085; Fernandez DR, 2009, J IMMUNOL, V182, P2063, DOI 10.4049/jimmunol.0803600; Francis L, 2009, EXPERT OPIN PHARMACO, V10, P1481, DOI 10.1517/14656560902971003; Furie RA, 2009, ARTHRIT RHEUM-ARTHR, V61, P1143, DOI 10.1002/art.24698; Gergely P, 2002, ARTHRITIS RHEUM-US, V46, P175, DOI 10.1002/1529-0131(200201)46:1<175::AID-ART10015>3.0.CO;2-H; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Isenberg DA, 2005, RHEUMATOLOGY, V44, P902, DOI 10.1093/rheumatology/keh624; Kirou KA, 2005, ARTHRITIS RHEUM-US, V52, P1491, DOI 10.1002/art.21031; Lai ZW, 2013, J IMMUNOL, V191, P2236, DOI 10.4049/jimmunol.1301005; Lai ZW, 2012, ARTHRITIS RHEUM-US, V64, P2937, DOI 10.1002/art.34502; Lockshin MD, 2003, NEW ENGL J MED, V349, P1177, DOI 10.1056/NEJMe038131; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Morel L, 2017, NAT REV RHEUMATOL, V13, P280, DOI 10.1038/nrrheum.2017.43; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; Oaks Z, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0622-8; Oaks Z, 2016, ARTHRITIS RHEUMATOL, V68, P2728, DOI 10.1002/art.39791; Perl A, 1999, ANN RHEUM DIS, V58, P454, DOI 10.1136/ard.58.8.454; Perl A, 2016, NAT REV RHEUMATOL, V12, P169, DOI 10.1038/nrrheum.2015.172; Perl A, 2015, METABOLOMICS, V11, P1157, DOI 10.1007/s11306-015-0772-0; Perl A, 2013, NAT REV RHEUMATOL, V9, P674, DOI 10.1038/nrrheum.2013.147; Pons-Estel GJ, 2010, SEMIN ARTHRITIS RHEU, V39, P257, DOI 10.1016/j.semarthrit.2008.10.007; Ponticelli C, 2014, EXPERT REV CLIN IMMU, V10, P295, DOI 10.1586/1744666X.2014.872562; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SEHGAL SN, 1993, ANN NY ACAD SCI, V685, P58, DOI 10.1111/j.1749-6632.1993.tb35852.x; Strand V, 2011, EXPERT REV PHARM OUT, V11, P455, DOI [10.1586/erp.11.38, 10.1586/ERP.11.38]; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tselios K, 2016, SEMIN ARTHRITIS RHEU, V45, P604, DOI 10.1016/j.semarthrit.2015.10.010; *US DEP HHS, GUID IND SYST LUP ER; VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721; WARNER LM, 1994, ARTHRITIS RHEUM, V37, P289, DOI 10.1002/art.1780370219; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Yee CS, 2011, RHEUMATOLOGY, V50, P982, DOI 10.1093/rheumatology/keq376	43	216	224	0	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2018	391	10126					1186	1196		10.1016/S0140-6736(18)30485-9	http://dx.doi.org/10.1016/S0140-6736(18)30485-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GA2MF	29551338	Green Accepted			2022-12-28	WOS:000428156100030
J	Stringhini, S; Carmeli, C; Jokela, M; Avendano, M; McCrory, C; d'Errico, A; Bochud, M; Barros, H; Costa, G; Chadeau-Hyam, M; Delpierre, C; Gandini, M; Fraga, S; Goldberg, M; Giles, GG; Lassale, C; Kenny, RA; Kelly-Irving, M; Paccaud, F; Layte, R; Muennig, P; Marmot, MG; Ribeiro, AI; Severi, G; Steptoe, A; Shipley, MJ; Zins, M; Mackenbach, JP; Vineis, P; Kivimaki, M				Stringhini, Silvia; Carmeli, Cristian; Jokela, Markus; Avendano, Mauricio; McCrory, Cathal; d'Errico, Angelo; Bochud, Murielle; Barros, Henrique; Costa, Giuseppe; Chadeau-Hyam, Marc; Delpierre, Cyrille; Gandini, Martina; Fraga, Silvia; Goldberg, Marcel; Giles, Graham G.; Lassale, Camille; Kenny, Rose Anne; Kelly-Irving, Michelle; Paccaud, Fred; Layte, Richard; Muennig, Peter; Marmot, Michael G.; Ribeiro, Ana Isabel; Severi, Gianluca; Steptoe, Andrew; Shipley, Martin J.; Zins, Marie; Mackenbach, Johan P.; Vineis, Paolo; Kivimaki, Mika		LIFEPATH Consortium	Socioeconomic status, non-communicable disease risk factors, and walking speed in older adults: multi-cohort population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GAIT SPEED; PHYSICAL-ACTIVITY; WHITEHALL II; ELDERLY-PEOPLE; UNITED-STATES; MORTALITY; MIDLIFE; LIFE; AGE; ASSOCIATION	OBJECTIVE To assess the association of low socioeconomic status and risk factors for non-communicable diseases (diabetes, high alcohol intake, high blood pressure, obesity, physical inactivity, smoking) with loss of physical functioning at older ages. DESIGN Multi-cohort population based study. SETTING 37 cohort studies from 24 countries in Europe, the United States, Latin America, Africa, and Asia, 1990-2017. PARTICIPANTS 109 107 men and women aged 45-90 years. MAIN OUTCOME MEASURE Physical functioning assessed using the walking speed test, a valid index of overall functional capacity. Years of functioning lost was computed as a metric to quantify the difference in walking speed between those exposed and unexposed to low socioeconomic status and risk factors. RESULTS According to mixed model estimations, men aged 60 and of low socioeconomic status had the same walking speed as men aged 66.6 of high socioeconomic status (years of functioning lost 6.6 years, 95% confidence interval 5.0 to 9.4). The years of functioning lost for women were 4.6 (3.6 to 6.2). In men and women, respectively, 5.7 (4.4 to 8.1) and 5.4 (4.3 to 7.3) years of functioning were lost by age 60 due to insufficient physical activity, 5.1 (3.9 to 7.0) and 7.5 (6.1 to 9.5) due to obesity, 2.3 (1.6 to 3.4) and 3.0 (2.3 to 4.0) due to hypertension, 5.6 (4.2 to 8.0) and 6.3 (4.9 to 8.4) due to diabetes, and 3.0 (2.2 to 4.3) and 0.7 (0.1 to 1.5) due to tobacco use. In analyses restricted to high income countries, the number of years of functioning lost attributable to low socioeconomic status by age 60 was 8.0 (5.7 to 13.1) for men and 5.4 (4.0 to 8.0) for women, whereas in low and middle income countries it was 2.6 (0.2 to 6.8) for men and 2.7 (1.0 to 5.5) for women. Within high income countries, the number of years of functioning lost attributable to low socioeconomic status by age 60 was greater in the United States than in Europe. Physical functioning continued to decline as a function of unfavourable risk factors between ages 60 and 85. Years of functioning lost were greater than years of life lost due to low socioeconomic status and non-communicable disease risk factors. CONCLUSIONS The independent association between socioeconomic status and physical functioning in old age is comparable in strength and consistency with those for established non-communicable disease risk factors. The results of this study suggest that tackling all these risk factors might substantially increase life years spent in good physical functioning.	[Stringhini, Silvia; Carmeli, Cristian; Bochud, Murielle; Paccaud, Fred] Lausanne Univ Hosp, Inst Social & Prevent Med, Biopole 2 Route Corniche 10, CH-1010 Lausanne, Switzerland; [Jokela, Markus] Univ Helsinki, Dept Psychol & Logoped, Fac Med, Helsinki, Finland; [Avendano, Mauricio] Kings Coll London, Dept Global Hlth & Social Med, London, England; [Avendano, Mauricio] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [McCrory, Cathal; Kenny, Rose Anne] Trinity Coll Dublin, Irish Longitudinal Study Ageing TILDA, Dublin, Ireland; [d'Errico, Angelo; Costa, Giuseppe; Gandini, Martina] ASL TO3 Piedmont Reg, Epidemiol Unit, Grugliasco, TO, Italy; [Barros, Henrique; Fraga, Silvia; Ribeiro, Ana Isabel] Univ Porto, Inst Publ Hlth, EPIUnit, Porto, Portugal; [Barros, Henrique] Univ Porto, Sch Med, Dept Clin Epidemiol Predict Med & Publ Hlth, Porto, Portugal; [Chadeau-Hyam, Marc; Vineis, Paolo] Imperial Coll London, Dept Epidemiol & Biostat, Sch Publ Hlth, MRC PHE Ctr Environm & Hlth, London, England; [Delpierre, Cyrille; Kelly-Irving, Michelle] INSERM, UMR1027, Toulouse, France; [Delpierre, Cyrille; Kelly-Irving, Michelle] Univ Toulouse III Paul Sabatier, Toulouse, France; [Goldberg, Marcel; Zins, Marie] INSERM, UMS 11, Populat Based Epidemiol Cohorts Unit, Villejuif, France; [Goldberg, Marcel; Zins, Marie] Paris Descartes Univ, Paris, France; [Giles, Graham G.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [Lassale, Camille; Marmot, Michael G.; Steptoe, Andrew; Shipley, Martin J.; Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Layte, Richard] Trinity Coll Dublin, Dept Sociol, Dublin, Ireland; [Muennig, Peter; Severi, Gianluca] Columbia Univ, Global Res Analyt Populat Hlth Hlth Policy & Mana, New York, NY USA; [Severi, Gianluca] Univ Paris Saclay, INSERM, U1018, CESP, Villejuif, France; [Severi, Gianluca] Human Genet Fdn HuGeF, Turin, Italy; [Mackenbach, Johan P.] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Kivimaki, Mika] Univ Helsinki, Fac Med, Clinicum, Helsinki, Finland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Helsinki; University of London; King's College London; Harvard University; Harvard T.H. Chan School of Public Health; Trinity College Dublin; Universidade do Porto; Universidade do Porto; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Cancer Council Victoria; University of London; University College London; Trinity College Dublin; Columbia University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Erasmus University Rotterdam; Erasmus MC; University of Helsinki	Stringhini, S (corresponding author), Lausanne Univ Hosp, Inst Social & Prevent Med, Biopole 2 Route Corniche 10, CH-1010 Lausanne, Switzerland.	silvia.stringhini@chuv.ch	d'Errico, Angelo/AAB-8993-2019; Kelly Irving, Michelle/AAA-5052-2022; Lassale, Camille/ABE-7813-2020; Gandini, Martina/GOE-5251-2022; Barros, Henrique/A-5488-2008; Severi, Gianluca/H-3774-2018; Goldberg, Marcel/I-7834-2012; paccaud, fred/M-7516-2019; costa, giuseppe/K-2526-2016; Steptoe, Andrew/Y-2440-2019; Zins, Marie/AAX-6551-2021; McCrory, Cathal/Q-5937-2019; Chadeau, Marc/AAN-7586-2021; Kelly-Irving, Michelle/G-3151-2010; Kivimaki, Mika/B-3607-2012; Marmot, M G/Y-3920-2019; d'Errico, Angelo/K-5547-2018; Ribeiro, Ana Isabel/AAH-8373-2019; Barros, Henrique/Q-8609-2019; Severi, Gianluca/Q-1824-2019; Jokela, Markus/A-4669-2009; Avendano, Mauricio/C-9658-2018	Kelly Irving, Michelle/0000-0001-5749-4791; Lassale, Camille/0000-0002-9340-2708; Gandini, Martina/0000-0002-2484-5783; Severi, Gianluca/0000-0001-7157-419X; Goldberg, Marcel/0000-0002-6161-5880; McCrory, Cathal/0000-0001-6575-2367; Chadeau, Marc/0000-0001-8341-5436; Kelly-Irving, Michelle/0000-0001-5749-4791; Kivimaki, Mika/0000-0002-4699-5627; Marmot, M G/0000-0002-2431-6419; Ribeiro, Ana Isabel/0000-0001-8880-6962; Barros, Henrique/0000-0003-4699-6571; Severi, Gianluca/0000-0001-7157-419X; delpierre, cyrille/0000-0002-0831-080X; Carmeli, Cristian/0000-0002-1463-4587; Jokela, Markus/0000-0003-0117-0012; Kenny, Rose Anne/0000-0002-9336-8124; Fraga, Silvia/0000-0002-5268-7751; Avendano, Mauricio/0000-0002-7295-2911; COSTA, Giuseppe/0000-0003-3187-4889; d'Errico, Angelo/0000-0003-3171-413X	European Commission [633666]; Swiss State Secretariat for Education, Research and Innovation SERI; Ambizione grant from the Swiss National Science Foundation [PZ00P3_167732]; Portuguese Foundation for Science and Technology [SFRH/BPD/97015/2013]; UK Medical Research Council [K013351]; NordForsk; Nordic Programme on Health and Welfare; Academy of Finland [311492]; Finnish Work Environment Fund; Medical Research Council [MR/K013351/1] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [P01AG020166, U19AG051426] Funding Source: NIH RePORTER; MRC [MR/K013351/1] Funding Source: UKRI	European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss State Secretariat for Education, Research and Innovation SERI; Ambizione grant from the Swiss National Science Foundation; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NordForsk; Nordic Programme on Health and Welfare; Academy of Finland(Academy of Finland); Finnish Work Environment Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the European Commission (Horizon 2020 grant No 633666) and the Swiss State Secretariat for Education, Research and Innovation SERI. SS was supported by an Ambizione grant (PZ00P3_167732) from the Swiss National Science Foundation. Silvia Fraga is supported by the Portuguese Foundation for Science and Technology (SFRH/BPD/97015/2013). Various sources have supported recruitment, follow-up, and measurements in the 48 cohort studies contributing to this collaborative analysis. MK is supported by the UK Medical Research Council (K013351), NordForsk, the Nordic Programme on Health and Welfare, the Academy of Finland (311492), and the Finnish Work Environment Fund. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of this manuscript.	Artaud F, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4240; Bell JA, 2017, INT J OBESITY, V41, P866, DOI 10.1038/ijo.2017.51; BENDALL MJ, 1989, AGE AGEING, V18, P327, DOI 10.1093/ageing/18.5.327; Birnie K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015564; Brunner E, 2009, J GERONTOL A-BIOL, V64, P1082, DOI 10.1093/gerona/glp078; Brunner EJ, 2011, HYPERTENSION, V57, P1003, DOI 10.1161/HYPERTENSIONAHA.110.168864; Buracchio T, 2010, ARCH NEUROL-CHICAGO, V67, P980, DOI 10.1001/archneurol.2010.159; Cesari M, 2006, GERONTOLOGY, V52, P24, DOI 10.1159/000089822; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Cesari M, 2004, J GERONTOL A-BIOL, V59, P242; Chiles NS, 2014, J DIABETES COMPLICAT, V28, P91, DOI 10.1016/j.jdiacomp.2013.08.007; Clark DJ, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00217; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Cooper R, 2011, AM J PREV MED, V41, P376, DOI 10.1016/j.amepre.2011.06.035; d'Errico A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178071; Elbaz A, 2005, STROKE, V36, P2198, DOI 10.1161/01.STR.0000181752.16915.5c; Elbaz A, 2014, INT J CARDIOL, V172, P96, DOI 10.1016/j.ijcard.2013.12.051; Elbaz A, 2013, AGE, V35, P943, DOI 10.1007/s11357-012-9387-9; Heckman JJ, 2006, SCIENCE, V312, P1900, DOI 10.1126/science.1128898; Hornyak V, 2012, TOP GERIATR REHABIL, V28, P27, DOI 10.1097/TGR.0b013e318233e75b; Hosseinpoor AR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-912; Institute for Social and Economic Research, EUR SOC CLASS; Ko SU, 2010, J BIOMECH, V43, P1104, DOI 10.1016/j.jbiomech.2009.12.004; Kontis V, 2017, LANCET, V389, P1323, DOI 10.1016/S0140-6736(16)32381-9; LACROIX AZ, 1993, AM J EPIDEMIOL, V137, P858, DOI 10.1093/oxfordjournals.aje.a116747; Lang IA, 2008, J AM GERIATR SOC, V56, P1474, DOI 10.1111/j.1532-5415.2008.01813.x; Lleras-Muney A, 2005, REV ECON STUD, V72, P189, DOI 10.1111/0034-6527.00329; Marmot M, 2010, MARMOT REV; McCrory C, 2018, J GERONTOL B-PSYCHOL, V73, P279, DOI 10.1093/geronb/gbv084; Middleton A, 2015, J AGING PHYS ACTIV, V23, P314, DOI 10.1123/japa.2013-0236; Morris JS, 2002, STAT PROBABIL LETT, V56, P425, DOI 10.1016/S0167-7152(02)00041-X; Muennig P, 2010, AM J PUBLIC HEALTH, V100, P1758, DOI 10.2105/AJPH.2009.165019; Odden MC, 2012, ARCH INTERN MED, V172, P1162, DOI 10.1001/archinternmed.2012.2555; Pahor M, 2014, JAMA-J AM MED ASSOC, V311, P2387, DOI 10.1001/jama.2014.5616; Rose D, 2007, EUR SOC, V9, P459, DOI 10.1080/14616690701336518; Sabia S, 2014, J AM GERIATR SOC, V62, P1860, DOI 10.1111/jgs.13071; Seeman T, 2002, J GERONTOL B-PSYCHOL, V57, pS135, DOI 10.1093/geronb/57.3.S135; Stenholm S, 2016, J GERONTOL A-BIOL, V71, P496, DOI 10.1093/gerona/glv111; Stringhini S, 2017, LANCET, V389, P1229, DOI 10.1016/S0140-6736(16)32380-7; Stringhini S, 2013, INT J CARDIOL, V168, P1201, DOI 10.1016/j.ijcard.2012.11.064; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; United Nations, 2015, WORLD POP PROSP; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; Vineis P, 2017, LONGITUD LIFE COURSE, V8, P417, DOI 10.14301/llcs.v8i4.448; Wang YD, 1998, J ROY STAT SOC B, V60, P159, DOI 10.1111/1467-9868.00115; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; World Health Organization, 2013, GLOB ACT PLAN PREV C; Zaninotto P, 2013, J GERONTOL A-BIOL, V68, P1525, DOI 10.1093/gerona/glt058	49	65	68	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2018	360								k1046	10.1136/bmj.k1046	http://dx.doi.org/10.1136/bmj.k1046			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GB1LW	29572376	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000428813300001
J	Asadi, M; Sayahpour, B; Abbasi, P; Ngo, AT; Karis, K; Jokisaari, JR; Liu, C; Narayanan, B; Gerard, M; Yasaei, P; Hu, X; Mukherjee, A; Lau, KC; Assary, RS; Khalili-Araghi, F; Klie, RF; Curtiss, LA; Salehi-Khojin, A				Asadi, Mohammad; Sayahpour, Baharak; Abbasi, Pedram; Ngo, Anh T.; Karis, Klas; Jokisaari, Jacob R.; Liu, Cong; Narayanan, Badri; Gerard, Marc; Yasaei, Poya; Hu, Xuan; Mukherjee, Arijita; Lau, Kah Chun; Assary, Rajeev S.; Khalili-Araghi, Fatemeh; Klie, Robert F.; Curtiss, Larry A.; Salehi-Khojin, Amin			A lithium-oxygen battery with a long cycle life in an air-like atmosphere	NATURE			English	Article							SOLID-ELECTROLYTE INTERPHASE; MOLECULAR-DYNAMICS; DIFFUSION MECHANISMS; STABILITY; LI2CO3; SOLVENTS; CATHODE; ANODE; WATER; LIO2	Lithium-air batteries are considered to be a potential alternative to lithium-ion batteries for transportation applications, owing to their high theoretical specific energy(1). So far, however, such systems have been largely restricted to pure oxygen environments (lithium oxygen batteries) and have a limited cycle life owing to side reactions involving the cathode, anode and electrolyte(2-5). In the presence of nitrogen, carbon dioxide and water vapour, these side reactions can become even more complex(6-11). Moreover, because of the need to store oxygen, the volumetric energy densities of lithium-oxygen systems may be too small for practical applications(12). Here we report a system comprising a lithium carbonate-based protected anode, a molybdenum disulfide cathode(2) and an ionic liquid/di methyl sulfoxide electrolyte that operates as a lithium-air battery in a simulated air atmosphere with a long cycle life of up to 700 cycles. We perform computational studies to provide insight into the operation of the system in this environment. This demonstration of a lithium-oxygen battery with a long cycle life in an air-like atmosphere is an important step towards the development of this field beyond lithium-ion technology, with a possibility to obtain much higher specific energy densities than for conventional lithium ion batteries.	[Asadi, Mohammad; Sayahpour, Baharak; Abbasi, Pedram; Gerard, Marc; Yasaei, Poya; Salehi-Khojin, Amin] Univ Illinois, Dept Mech & Ind Engn, Chicago, IL 60607 USA; [Asadi, Mohammad] IIT, Dept Chem & Biol Engn, Chicago, IL 60616 USA; [Ngo, Anh T.; Narayanan, Badri; Assary, Rajeev S.; Curtiss, Larry A.] Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA; [Karis, Klas; Jokisaari, Jacob R.; Hu, Xuan; Mukherjee, Arijita; Khalili-Araghi, Fatemeh; Klie, Robert F.] Univ Illinois, Dept Phys, Chicago, IL 60607 USA; [Liu, Cong] Argonne Natl Lab, Div Chem Sci, Argonne, IL 60439 USA; [Lau, Kah Chun] Calif State Univ Northridge, Dept Phys & Astron, Northridge, CA 91330 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Illinois Institute of Technology; United States Department of Energy (DOE); Argonne National Laboratory; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; United States Department of Energy (DOE); Argonne National Laboratory; California State University System; California State University Northridge	Salehi-Khojin, A (corresponding author), Univ Illinois, Dept Mech & Ind Engn, Chicago, IL 60607 USA.; Curtiss, LA (corresponding author), Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA.	curtiss@anl.gov; salehikh@uic.edu	Abbasi, Pedram/K-2669-2019; Asadi, Mohammad/AAF-6564-2020; Hu, Xuan/ABC-7555-2020; Asadi, Mohammad/ABA-9701-2021; Liu, Cong/A-6297-2014	Narayanan, Badri/0000-0001-8147-1047; Klie, Robert/0000-0003-4773-6667; Khalili-Araghi, Fatemeh/0000-0002-0756-5560; Liu, Cong/0000-0002-2145-5034; , Klas/0000-0003-1699-7776; Sayahpour, Baharak/0000-0003-0200-6636	National Science Foundation (NSF-DMREF) [1729420]; Joint Center for Energy Storage Research (JCESR), an Energy Innovation Hub - US Department of Energy, Office of Science, Basic Energy Sciences; Center for Electrical Energy Storage: Tailored Interfaces, an Energy Frontier Research Center - US Department of Energy, Office of Science, Office of Basic Energy Sciences; University of Illinois at Chicago start-up fund; programme development funds by Chemical Sciences and Engineering division at Argonne National Laboratory; MRSEC Materials Preparation and Measurement Laboratory at the University of Chicago [NSFDMR-1420709]; MRSEC program (NSF) at the Materials Research Center [DMR-1121262]; Nanoscale Science and Engineering Center (NSF) at the Materials Research Center [EEC-0647560]; Nanoscale Science and Engineering Center (NSF) at the International Institute for Nanotechnology [EEC-0647560]; State of Illinois through International Institute for Nanotechnology; Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource (NSF) [NNCI-1542205]; MRI-R2 grant from National Science Foundation [DMR-0959470]; DOE Office of Science User Facility [DE-AC02-06CH11357]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	National Science Foundation (NSF-DMREF); Joint Center for Energy Storage Research (JCESR), an Energy Innovation Hub - US Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); Center for Electrical Energy Storage: Tailored Interfaces, an Energy Frontier Research Center - US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); University of Illinois at Chicago start-up fund; programme development funds by Chemical Sciences and Engineering division at Argonne National Laboratory; MRSEC Materials Preparation and Measurement Laboratory at the University of Chicago; MRSEC program (NSF) at the Materials Research Center(National Science Foundation (NSF)); Nanoscale Science and Engineering Center (NSF) at the Materials Research Center; Nanoscale Science and Engineering Center (NSF) at the International Institute for Nanotechnology; State of Illinois through International Institute for Nanotechnology; Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource (NSF); MRI-R2 grant from National Science Foundation; DOE Office of Science User Facility(United States Department of Energy (DOE)); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	The work of A.S.-K., M. A., B. S. and P. A. was supported by the National Science Foundation (NSF-DMREF Award #1729420). Work by B.N., K.C.L., R.S.A., L.A.C., R.F.K., A.M., X.H. and J.R.J. was supported by the Joint Center for Energy Storage Research (JCESR), an Energy Innovation Hub funded by the US Department of Energy, Office of Science, Basic Energy Sciences. Work by A.N. and C.L. was supported by the Center for Electrical Energy Storage: Tailored Interfaces, an Energy Frontier Research Center funded by the US Department of Energy, Office of Science, Office of Basic Energy Sciences. The work of F.K.A. and K.K. was supported by a University of Illinois at Chicago start-up fund. C.L. was also supported by programme development funds provided by the Chemical Sciences and Engineering division at Argonne National Laboratory. We acknowledge the MRSEC Materials Preparation and Measurement Laboratory shared user facility at the University of Chicago (NSFDMR-1420709); the EPIC facility (NUANCE Center, Northwestern University), which has received support from the MRSEC program (NSF DMR-1121262) at the Materials Research Center; the Nanoscale Science and Engineering Center (NSF EEC-0647560) at the International Institute for Nanotechnology; and the State of Illinois, through the International Institute for Nanotechnology. This work also made use of the Integrated Molecular Structure Education and Research Center at Northwestern University, which has received support from the Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource (NSF NNCI-1542205). The acquisition of the UIC JEOL JEM ARM200CF was supported by an MRI-R<SUP>2</SUP> grant from the National Science Foundation (DMR-0959470). The use of instrumentation at University of Illinois at Chicago Research Resources Center (RRC-East) is acknowledged. A. Nicholls at UIC's Electron Microscopy Service is also acknowledged for help and support. This research used high performance computing resources of the Argonne Leadership Computing Facility, which is a DOE Office of Science User Facility supported under Contract DE-AC02-06CH11357. Use of the Center for Nanoscale Materials, an Office of Science user facility, was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357. F.K.A. acknowledges the use of the University of Illinois at Chicago High Performance Computing Cluster to perform molecular dynamics simulations. We thank K. Gallagher, P. Redfern, H.-H. Wang, J. Jureller and X. Chen.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adams BD, 2013, ENERG ENVIRON SCI, V6, P1772, DOI 10.1039/c3ee40697k; Asadi M, 2016, ACS NANO, V10, P2167, DOI 10.1021/acsnano.5b06672; Assary RS, 2013, CHEMSUSCHEM, V6, P51, DOI 10.1002/cssc.201200810; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bi YJ, 2016, RSC ADV, V6, P19233, DOI 10.1039/c6ra00648e; Bruce PG, 2012, NAT MATER, V11, P19, DOI [10.1038/nmat3191, 10.1038/NMAT3191]; Cheng L, 2017, J ELECTROCHEM SOC, V164, pE3696, DOI 10.1149/2.0721711jes; Christensen J, 2012, J ELECTROCHEM SOC, V159, pR1, DOI 10.1149/2.086202jes; Das S. K., 2016, J MAT SCI CHEM ENG, V4, P74, DOI DOI 10.4236/msce.2016.41012; Du P, 2013, PHYS CHEM CHEM PHYS, V15, P5572, DOI 10.1039/c3cp50500f; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Gallagher KG, 2014, ENERG ENVIRON SCI, V7, P1555, DOI 10.1039/c3ee43870h; Garcia-Araez N, 2013, J SOLID STATE ELECTR, V17, P1793, DOI 10.1007/s10008-013-1999-1; Geng DS, 2016, ADV ENERGY MATER, V6, DOI 10.1002/aenm.201502164; Horta BAC, 2016, J CHEM THEORY COMPUT, V12, P3825, DOI 10.1021/acs.jctc.6b00187; Iddir H, 2010, J PHYS CHEM C, V114, P20903, DOI 10.1021/jp1086569; Imanishi N., 2014, LITHIUM AIR BATTERY; Johnson L, 2014, NAT CHEM, V6, P1091, DOI [10.1038/nchem.2101, 10.1038/NCHEM.2101]; Jung HG, 2012, NAT CHEM, V4, P579, DOI [10.1038/nchem.1376, 10.1038/NCHEM.1376]; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Lau KC, 2011, J PHYS CHEM C, V115, P23625, DOI 10.1021/jp206796h; Leung K, 2016, J PHYS CHEM C, V120, P6302, DOI 10.1021/acs.jpcc.5b11719; Lu J, 2016, NATURE, V529, P377, DOI 10.1038/nature16484; Lu J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3383; Lu YC, 2012, SCI REP-UK, V2, DOI 10.1038/srep00715; Mark P, 2002, J COMPUT CHEM, V23, P1211, DOI 10.1002/jcc.10117; Mark P, 2001, J PHYS CHEM A, V105, P9954, DOI 10.1021/jp003020w; McCloskey BD, 2011, J PHYS CHEM LETT, V2, P1161, DOI 10.1021/jz200352v; Pasierb P, 2001, J MOL STRUCT, V596, P151, DOI 10.1016/S0022-2860(01)00703-7; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Shi SQ, 2013, J PHYS CHEM C, V117, P8579, DOI 10.1021/jp310591u; Sina M, 2015, J PHYS CHEM C, V119, P9762, DOI 10.1021/acs.jpcc.5b02058; Welland MJ, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4936410; Wu SC, 2016, ADV FUNCT MATER, V26, P3291, DOI 10.1002/adfm.201505420; Xiao DD, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201400664; Zhang T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2855	41	286	292	58	843	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2018	555	7697					502	+		10.1038/nature25984	http://dx.doi.org/10.1038/nature25984			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ9NF	29565358	Green Submitted			2022-12-28	WOS:000427937900049
J	Galluzzi, L; Vanpouille-Box, C; Bakhoum, SF; Demaria, S				Galluzzi, Lorenzo; Vanpouille-Box, Claire; Bakhoum, Samuel F.; Demaria, Sandra			SnapShot: cGAS-STING Signaling	CELL			English	Editorial Material							INNATE		[Galluzzi, Lorenzo; Vanpouille-Box, Claire; Demaria, Sandra] Weill Cornell Med Coll, Dept Radiat Oncol, New York, NY 10065 USA; [Galluzzi, Lorenzo; Bakhoum, Samuel F.; Demaria, Sandra] Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA; [Galluzzi, Lorenzo] Univ Paris Descartes Paris V, Paris, France; [Bakhoum, Samuel F.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA; [Demaria, Sandra] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA	Cornell University; UDICE-French Research Universities; Universite Paris Cite; Memorial Sloan Kettering Cancer Center; Cornell University	Galluzzi, L (corresponding author), Weill Cornell Med Coll, Dept Radiat Oncol, New York, NY 10065 USA.; Galluzzi, L (corresponding author), Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA.; Galluzzi, L (corresponding author), Univ Paris Descartes Paris V, Paris, France.		Vanpouille-Box, Claire/AAO-5355-2021; Demaria, Sandra/AAA-5816-2020; Galluzzi, Lorenzo/AAG-6294-2019; Galluzzi, Lorenzo/AAH-3286-2021; Galluzzi, Lorenzo/AAG-6432-2019	Demaria, Sandra/0000-0003-4426-0499; Vanpouille-Box, Claire/0000-0001-7213-0670				Bakhoum SF, 2018, NATURE, V553, P467, DOI 10.1038/nature25432; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Galluzzi L, 2017, NAT REV IMMUNOL, V17, P97, DOI 10.1038/nri.2016.107; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Vanpouille-Box C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15618; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156	9	71	72	6	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 22	2018	173	1								10.1016/j.cell.2018.03.015	http://dx.doi.org/10.1016/j.cell.2018.03.015			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GA3MT	29570996	Bronze			2022-12-28	WOS:000428234200025
J	Mustoe, AM; Busan, S; Rice, GM; Hajdin, CE; Peterson, BK; Ruda, VM; Kubica, N; Nutiu, R; Baryza, JL; Weeks, KM				Mustoe, Anthony M.; Busan, Steven; Rice, Greggory M.; Hajdin, Christine E.; Peterson, Brant K.; Ruda, Vera M.; Kubica, Neil; Nutiu, Razvan; Baryza, Jeremy L.; Weeks, Kevin M.			Pervasive Regulatory Functions of mRNA Structure Revealed by High-Resolution SHAPE Probing	CELL			English	Article							RIBOSOMAL-PROTEIN S20; ESCHERICHIA-COLI K-12; SECONDARY STRUCTURE; IN-VIVO; POSTTRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; NONCODING RNA; SOLUBLE-RNAS; TRANSLATIONAL EFFICIENCY; SEQUENCE DETERMINANTS	mRNAs can fold into complex structures that regulate gene expression. Resolving such structures de novo has remained challenging and has limited our understanding of the prevalence and functions of mRNA structure. We use SHAPE-MaP experiments in living E. coli cells to derive quantitative, nucleotide-resolution structure models for 194 endogenous transcripts encompassing approximately 400 genes. Individual mRNAs have exceptionally diverse architectures, and most contain well-defined structures. Active translation destabilizes mRNA structure in cells. Nevertheless, mRNA structure remains similar between in-cell and cell-free environments, indicating broad potential for structure-mediated gene regulation. We find that the translation efficiency of endogenous genes is regulated by unfolding kinetics of structures overlapping the ribosome binding site. We discover conserved structured elements in 35% of UTRs, several of which we validate as novel protein binding motifs. RNA structure regulates every gene studied here in a meaningful way, implying that most functional structures remain to be discovered.	[Mustoe, Anthony M.; Busan, Steven; Rice, Greggory M.; Weeks, Kevin M.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Rice, Greggory M.; Hajdin, Christine E.; Peterson, Brant K.; Ruda, Vera M.; Kubica, Neil; Nutiu, Razvan; Baryza, Jeremy L.] Novartis Inst Biomed Res Inc, Cambridge, MA USA	University of North Carolina; University of North Carolina Chapel Hill; Novartis	Mustoe, AM; Weeks, KM (corresponding author), Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA.	amustoe@unc.edu; weeks@unc.edu		Rice, Greggory/0000-0003-2638-9301; Peterson, Brant/0000-0002-0433-3035	NIH [R35 GM122532]; NSF [MCB-1121024]; NIBR; Arnold and Mabel Beckman Foundation; UNC Lineberger NIH training fellowship [T32-CA009156]; NATIONAL CANCER INSTITUTE [T32CA009156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122532] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NIBR; Arnold and Mabel Beckman Foundation; UNC Lineberger NIH training fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIH (R35 GM122532) and the NSF (MCB-1121024) to K.M.W. and NIBR internal funding. A.M.M. is supported by a postdoctoral fellowship from the Arnold and Mabel Beckman Foundation and was supported by the UNC Lineberger NIH training fellowship (T32-CA009156). We are indebted to D. Mathews (University of Rochester) for helpful discussions; M. Smola (UNC) for sharing his DSHAPE analysis framework; and P. Irving (UNC), S. Gowrisankar (NIBR), A. Ho (NIBR), O. Iartchouk (NIBR), and B. Jones (NIBR) for assistance.	Angelini S, 2008, J BIOL CHEM, V283, P14084, DOI 10.1074/jbc.M709405200; Aseev LV, 2008, RNA, V14, P1882, DOI 10.1261/rna.1099108; Aseev LV, 2016, J BACTERIOL, V198, P2494, DOI 10.1128/JB.00187-16; Aseev LV, 2015, RNA, V21, P851, DOI 10.1261/rna.047381.114; BARRY G, 1980, P NATL ACAD SCI-BIOL, V77, P3331, DOI 10.1073/pnas.77.6.3331; Bentele K, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.32; BIN H, 1993, J BACTERIOL, V175, P3598, DOI 10.1128/jb.175.11.3598-3606.1993; Boel G, 2016, NATURE, V529, P358, DOI 10.1038/nature16509; Borujeni AE, 2017, NUCLEIC ACIDS RES, V45, P5437, DOI 10.1093/nar/gkx061; Borujeni AE, 2014, NUCLEIC ACIDS RES, V42, P2646, DOI 10.1093/nar/gkt1139; Burkhardt DH, 2017, ELIFE, V6, DOI [10.7554/elife.22037, 10.7554/eLife.22037]; BURTON ZF, 1983, CELL, V32, P335, DOI 10.1016/0092-8674(83)90453-1; BYSTROM AS, 1989, J MOL BIOL, V208, P575, DOI 10.1016/0022-2836(89)90149-6; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Chiaruttini C, 1996, EMBO J, V15, P4402, DOI 10.1002/j.1460-2075.1996.tb00813.x; CHRISTENSEN T, 1984, EMBO J, V3, P1609, DOI 10.1002/j.1460-2075.1984.tb02018.x; CHUNG TW, 1993, J BACTERIOL, V175, P4572, DOI 10.1128/JB.175.14.4572-4575.1993; CLIMIE SC, 1988, J BIOL CHEM, V263, P15166; Conway T, 2014, MBIO, V5, DOI 10.1128/mBio.01442-14; de Smit MH, 2003, J MOL BIOL, V331, P737, DOI 10.1016/S0022-2836(03)00809-X; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Del Campo C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005613; DENNIS PP, 1984, J BIOL CHEM, V259, P3202; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; Desnoyers G, 2009, EMBO J, V28, P1551, DOI 10.1038/emboj.2009.116; Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756; DONLY BC, 1988, NUCLEIC ACIDS RES, V16, P997, DOI 10.1093/nar/16.3.997; DOWNING WL, 1987, J MOL BIOL, V194, P609, DOI 10.1016/0022-2836(87)90238-5; Dubey AK, 2005, RNA, V11, P1579, DOI 10.1261/rna.2990205; Dykxhoorn DM, 1996, MOL MICROBIOL, V19, P483, DOI 10.1046/j.1365-2958.1996.384913.x; Dykxhoorn DM, 1997, NUCLEIC ACIDS RES, V25, P4209, DOI 10.1093/nar/25.21.4209; Eddy SR, 2014, ANNU REV BIOPHYS, V43, P433, DOI 10.1146/annurev-biophys-051013-022950; Fu Y, 2014, RNA, V20, P168, DOI 10.1261/rna.041285.113; Fu Y, 2013, NUCLEIC ACIDS RES, V41, P3491, DOI 10.1093/nar/gkt055; Giuliodori AM, 2010, MOL CELL, V37, P21, DOI 10.1016/j.molcel.2009.11.033; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Guillier M, 2005, MOL MICROBIOL, V56, P1441, DOI 10.1111/j.1365-2958.2005.04644.x; Guimaraes JC, 2014, NUCLEIC ACIDS RES, V42, P4791, DOI 10.1093/nar/gku126; Hannon G. J., 2011, RNA A LABORATORY MAN; HANSEN FG, 1982, EMBO J, V1, P1043, DOI 10.1002/j.1460-2075.1982.tb01294.x; HANSEN FG, 1985, GENE, V38, P85, DOI 10.1016/0378-1119(85)90206-9; Hemm MR, 2008, MOL MICROBIOL, V70, P1487, DOI 10.1111/j.1365-2958.2008.06495.x; Higashi K, 2008, J BIOL CHEM, V283, P32989, DOI 10.1074/jbc.M806027200; Hollands K, 2014, P NATL ACAD SCI USA, V111, pE1999, DOI 10.1073/pnas.1319193111; Holmqvist E, 2016, EMBO J, V35, P991, DOI 10.15252/embj.201593360; Iben JR, 2008, BIOCHEMISTRY-US, V47, P2721, DOI 10.1021/bi701838y; James ES, 2004, J BIOL CHEM, V279, P2520, DOI 10.1074/jbc.M311584200; KAKUDA H, 1994, J BIOCHEM-TOKYO, V116, P916, DOI 10.1093/oxfordjournals.jbchem.a124616; Kalamorz F, 2007, MOL MICROBIOL, V65, P1518, DOI 10.1111/j.1365-2958.2007.05888.x; Kamiyama D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11046; Kawano M, 2005, NUCLEIC ACIDS RES, V33, P1040, DOI 10.1093/nar/gki256; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee JH, 2002, NUCLEIC ACIDS RES, V30, P5360, DOI 10.1093/nar/gkf694; LESAGE P, 1992, J MOL BIOL, V228, P366, DOI 10.1016/0022-2836(92)90827-7; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Livny J, 2006, NUCLEIC ACIDS RES, V34, P3484, DOI 10.1093/nar/gkl453; Livny J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003197; Lu ZP, 2016, CELL, V165, P1267, DOI 10.1016/j.cell.2016.04.028; MACKIE GA, 1983, J BIOL CHEM, V258, P7840; Maguire BA, 1997, J BACTERIOL, V179, P2486, DOI 10.1128/jb.179.8.2486-2493.1997; Matelska D, 2013, RNA, V19, P1341, DOI 10.1261/rna.038794.113; MATSUMOTO Y, 1986, J BACTERIOL, V166, P945, DOI 10.1128/jb.166.3.945-958.1986; MATTHEAKIS LC, 1988, J BACTERIOL, V170, P4484, DOI 10.1128/jb.170.10.4484-4492.1988; Mauger DM, 2015, P NATL ACAD SCI USA, V112, P3692, DOI 10.1073/pnas.1416266112; MCDOWALL KJ, 1994, J BIOL CHEM, V269, P10790; McGinnis JL, 2015, P NATL ACAD SCI USA, V112, P2425, DOI 10.1073/pnas.1411514112; Meades G, 2010, NUCLEIC ACIDS RES, V38, P1217, DOI 10.1093/nar/gkp1079; Morita M, 1999, J BACTERIOL, V181, P401, DOI 10.1128/JB.181.2.401-410.1999; My L, 2015, J BACTERIOL, V197, P1862, DOI 10.1128/JB.00064-15; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; Ott A, 2012, NUCLEIC ACIDS RES, V40, pD205, DOI 10.1093/nar/gkr807; Pannuri A, 2016, J BACTERIOL, V198, P3000, DOI 10.1128/JB.00454-16; PARSONS GD, 1983, J BACTERIOL, V154, P152, DOI 10.1128/JB.154.1.152-160.1983; PARSONS GD, 1988, J BACTERIOL, V170, P2485, DOI 10.1128/jb.170.6.2485-2492.1988; PASSADOR L, 1989, J BACTERIOL, V171, P6234, DOI 10.1128/jb.171.11.6234-6242.1989; PASSADOR L, 1992, J BACTERIOL, V174, P7174, DOI 10.1128/jb.174.22.7174-7179.1992; PEACOCK S, 1985, GENE, V33, P227, DOI 10.1016/0378-1119(85)90097-6; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pelechano V, 2015, CELL, V161, P1400, DOI 10.1016/j.cell.2015.05.008; Peng Y, 2014, P NATL ACAD SCI USA, V111, P17134, DOI 10.1073/pnas.1410114111; Peng Y, 2014, J MOL BIOL, V426, P275, DOI 10.1016/j.jmb.2013.08.026; Peters JM, 2011, J MOL BIOL, V412, P793, DOI 10.1016/j.jmb.2011.03.036; Peters JM, 2009, P NATL ACAD SCI USA, V106, P15406, DOI 10.1073/pnas.0903846106; Pichon C, 2012, NUCLEIC ACIDS RES, V40, P2846, DOI 10.1093/nar/gkr1141; PODKOVYROV S, 1995, FEBS LETT, V368, P429, DOI 10.1016/0014-5793(95)00702-B; POST DA, 1993, J GEN MICROBIOL, V139, P259, DOI 10.1099/00221287-139-2-259; POWELL BS, 1995, J BIOL CHEM, V270, P4822, DOI 10.1074/jbc.270.9.4822; Pulvermacher SC, 2008, FEMS MICROBIOL LETT, V281, P42, DOI 10.1111/j.1574-6968.2008.01068.x; Ramani V, 2015, NAT BIOTECHNOL, V33, P980, DOI 10.1038/nbt.3289; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Rivas E, 2001, CURR BIOL, V11, P1369, DOI 10.1016/S0960-9822(01)00401-8; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; RIVERALEON R, 1995, J BACTERIOL, V177, P2564, DOI 10.1128/jb.177.9.2564-2566.1995; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; Ryder Sean P., 2008, V488, P99, DOI 10.1007/978-1-60327-475-3_7; SAITO K, 1994, J MOL BIOL, V235, P125, DOI 10.1016/S0022-2836(05)80021-X; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Salim NN, 2012, NUCLEIC ACIDS RES, V40, P8021, DOI 10.1093/nar/gks392; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Salvail H, 2010, P NATL ACAD SCI USA, V107, P15223, DOI 10.1073/pnas.1007805107; Sevostyanova A, 2015, P NATL ACAD SCI USA, V112, pE6835, DOI 10.1073/pnas.1515383112; Sharma CM, 2007, GENE DEV, V21, P2804, DOI 10.1101/gad.447207; SHEN P, 1988, NUCLEIC ACIDS RES, V16, P8905, DOI 10.1093/nar/16.18.8905; Siegfried NA, 2014, NAT METHODS, V11, P959, DOI [10.1038/nmeth.3029, 10.1038/NMETH.3029]; Slinger BL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-657; Smola MJ, 2015, NAT PROTOC, V10, P1643, DOI 10.1038/nprot.2015.103; Spitale RC, 2015, NATURE, V519, P486, DOI 10.1038/nature14263; Steen K.-A., 2011, PROTOC EXCH; STEWARD KL, 1992, NUCLEIC ACIDS RES, V20, P4773, DOI 10.1093/nar/20.18.4773; Studer SM, 2006, MOL CELL, V22, P105, DOI 10.1016/j.molcel.2006.02.014; Sugimoto Y, 2015, NATURE, V519, P491, DOI 10.1038/nature14280; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Tatusova T, 2014, NUCLEIC ACIDS RES, V42, pD553, DOI 10.1093/nar/gkt1274; THOMAS MS, 1987, J MOL BIOL, V196, P333, DOI 10.1016/0022-2836(87)90694-2; Tran TT, 2009, BIOINFORMATICS, V25, P2897, DOI 10.1093/bioinformatics/btp537; TSUI HCT, 1994, BIOCHIMIE, V76, P1168, DOI 10.1016/0300-9084(94)90046-9; Tsui HCT, 1996, J BACTERIOL, V178, P5719, DOI 10.1128/jb.178.19.5719-5731.1996; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Turnbough CL, 2008, MICROBIOL MOL BIOL R, V72, P266, DOI 10.1128/MMBR.00001-08; Tyrrell J, 2013, BIOCHEMISTRY-US, V52, P8777, DOI 10.1021/bi401207q; Urban JH, 2008, PLOS BIOL, V6, P631, DOI 10.1371/journal.pbio.0060064; Wan Y, 2014, NATURE, V505, P706, DOI 10.1038/nature12946; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Watters KE, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv879; Weeks KM, 2015, BIOPOLYMERS, V103, P438, DOI 10.1002/bip.22601; Weinberg Z, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-3; WIKSTROM PM, 1988, J MOL BIOL, V203, P141, DOI 10.1016/0022-2836(88)90098-8; Wilson LA, 2006, MOL BIOL EVOL, V23, P1156, DOI 10.1093/molbev/msj125; WIRTH R, 1982, MOL GEN GENET, V188, P164, DOI 10.1007/BF00333013; YAJNIK V, 1993, J BIOL CHEM, V268, P13253; Yakhnin H, 2011, MOL MICROBIOL, V81, P689, DOI 10.1111/j.1365-2958.2011.07723.x; Yao Z, 2007, PLOS COMPUT BIOL, V3, P1212, DOI 10.1371/journal.pcbi.0030126; Zengel JM, 1996, J BACTERIOL, V178, P2383, DOI 10.1128/jb.178.8.2383-2387.1996; Zhang YQ, 2015, NAT STRUCT MOL BIOL, V22, P906, DOI 10.1038/nsmb.3103	140	133	134	3	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 22	2018	173	1					181	+		10.1016/j.cell.2018.02.034	http://dx.doi.org/10.1016/j.cell.2018.02.034			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GA3MT	29551268	Bronze, Green Accepted			2022-12-28	WOS:000428234200017
J	Voelker, R				Voelker, Rebecca			Domestically Produced Radioisotope	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2018	319	11					1086	1086		10.1001/jama.2018.1807	http://dx.doi.org/10.1001/jama.2018.1807			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ8LL	29558539				2022-12-28	WOS:000427860200006
J	Muinonen-Martin, AJ; O'Shea, SJ; Newton-Bishop, J				Muinonen-Martin, Andy J.; O'Shea, Sally Jane; Newton-Bishop, Julia			Amelanotic melanoma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CUTANEOUS MELANOMA		[Muinonen-Martin, Andy J.] York Teaching Hosp NHS Fdn Trust, York, N Yorkshire, England; [Muinonen-Martin, Andy J.; O'Shea, Sally Jane] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England; [Muinonen-Martin, Andy J.; O'Shea, Sally Jane; Newton-Bishop, Julia] Univ Leeds, Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England	University of Leeds; University of Leeds	O'Shea, SJ (corresponding author), Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England.; O'Shea, SJ (corresponding author), Univ Leeds, Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England.	S.J.O'Shea@leeds.ac.uk		Newton-Bishop, Julia/0000-0001-9147-6802	Cancer Research UK [C588/A19167]	Cancer Research UK(Cancer Research UK)	JN-B is funded by Cancer Research UK (Programme grant C588/A19167).	Abbasi NR, 2004, JAMA-J AM MED ASSOC, V292, P2771, DOI 10.1001/jama.292.22.2771; Haenssle HA, 2010, J AM ACAD DERMATOL, V62, P785, DOI 10.1016/j.jaad.2009.08.049; Macbeth F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3708; Marsden JR, 2010, BRIT J DERMATOL, V163, P238, DOI [10.1111/j.1365-2133.2010.09883.x, 10.1016/j.bjps.2010.07.006]; Thomas NE, 2014, JAMA DERMATOL, V150, P1306, DOI 10.1001/jamadermatol.2014.1348; Tsao H, 2015, J AM ACAD DERMATOL, V72, P717, DOI 10.1016/j.jaad.2015.01.025; Whited JD, 1998, JAMA-J AM MED ASSOC, V279, P696, DOI 10.1001/jama.279.9.696	7	7	8	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2018	360								k826	10.1136/bmj.k826	http://dx.doi.org/10.1136/bmj.k826			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ9GD	29545447				2022-12-28	WOS:000427917100008
J	Thenappan, T; Ormiston, ML; Ryan, JJ; Archer, SL				Thenappan, Thenappan; Ormiston, Mark L.; Ryan, John J.; Archer, Stephen L.			Pulmonary arterial hypertension: pathogenesis and clinical management	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RIGHT-VENTRICULAR FUNCTION; CALCIUM-CHANNEL BLOCKERS; CONTINUOUS INTRAVENOUS EPOPROSTENOL; MUSCLE-CELL PROLIFERATION; CAPILLARY WEDGE PRESSURE; LONG-TERM RESPONSE; ACTIVATED T-CELLS; GATED K+ CHANNELS; HEART-FAILURE; SEX-DIFFERENCES	Pulmonary hypertension is defined as a resting mean pulmonary artery pressure of 25 mm Hg or above. This review deals with pulmonary arterial hypertension (PAH), a type of pulmonary hypertension that primarily affects the pulmonary vasculature. In PAH, the pulmonary vasculature is dynamically obstructed by vasoconstriction, structurally obstructed by adverse vascular remodeling, and pathologically non-compliant as a result of vascular fibrosis and stiffening. Many cell types are abnormal in PAH, including vascular cells (endothelial cells, smooth muscle cells, and fibroblasts) and inflammatory cells. Progress has been made in identifying the causes of PAH and approving new drug therapies. A cancerlike increase in cell proliferation and resistance to apoptosis reflects acquired abnormalities of mitochondrial metabolism and dynamics. Mutations in the type II bone morphogenetic protein receptor (BMPR2) gene dramatically increase the risk of developing heritable PAH. Epigenetic dysregulation of DNA methylation, histone acetylation, and microRNAs also contributes to disease pathogenesis. Aberrant bone morphogenetic protein signaling and epigenetic dysregulation in PAH promote cell proliferation in part through induction of a Warburg mitochondrial-metabolic state of uncoupled glycolysis. Complex changes in cytokines (interleukins and tumor necrosis factor), cellular immunity (T lymphocytes, natural killer cells, macrophages), and autoantibodies suggest that PAH is, in part, an autoimmune, inflammatory disease. Obstructive pulmonary vascular remodeling in PAH increases right ventricular afterload causing right ventricular hypertrophy. In some patients, maladaptive changes in the right ventricle, including ischemia and fibrosis, reduce right ventricular function and cause right ventricular failure. Patients with PAH have dyspnea, reduced exercise capacity, exertional syncope, and premature death from right ventricular failure. PAH targeted therapies (prostaglandins, phosphodiesterase-5 inhibitors, endothelin receptor antagonists, and soluble guanylate cyclase stimulators), used alone or in combination, improve functional capacity and hemodynamics and reduce hospital admissions. However, these vasodilators do not target key features of PAH pathogenesis and have not been shown to reduce mortality, which remains about 50% at five years. This review summarizes the epidemiology, pathogenesis, diagnosis, and treatment of PAH.	[Thenappan, Thenappan] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Ormiston, Mark L.; Archer, Stephen L.] Queens Univ, Dept Med, Kingston, ON, Canada; [Ryan, John J.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA	University of Minnesota System; University of Minnesota Twin Cities; Queens University - Canada; Utah System of Higher Education; University of Utah	Archer, SL (corresponding author), Queens Univ, Dept Med, Kingston, ON, Canada.	stephen.archer@queensu.ca		Ormiston, Mark/0000-0003-0907-1940; Thenappan, Thenappan/0000-0002-6210-0467	Canada Foundation for Innovation [229252, 33012]; NIH [R01 HL113003, R01 HL071115]; Tier 1 Canada research chair in mitochondrial dynamics and translational medicine [950-229252]; William J Henderson Foundation; AHA scientist development grant [15SDG25560048]; CIHR [PJT-152916]; Tier 2 Canada research chair; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071115, R01HL113003] Funding Source: NIH RePORTER	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tier 1 Canada research chair in mitochondrial dynamics and translational medicine; William J Henderson Foundation; AHA scientist development grant(American Heart Association); CIHR(Canadian Institutes of Health Research (CIHR)); Tier 2 Canada research chair(Canada Research Chairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SLA is supported by Canada Foundation for Innovation (229252 and 33012), NIH R01s HL113003 and HL071115, a Tier 1 Canada research chair in mitochondrial dynamics and translational medicine (950-229252), and a grant from the William J Henderson Foundation. TT is funded by AHA scientist development grant 15SDG25560048. MLO is supported by a CIHR project grant (PJT-152916) and a Tier 2 Canada research chair.	Abdelmalak M, 2013, MOL GENET METAB, V109, P139, DOI 10.1016/j.ymgme.2013.03.019; Abe K, 2016, CARDIOVASC RES, V111, P16, DOI 10.1093/cvr/cvw070; Addetia K, 2014, CIRC-CARDIOVASC IMAG, V7, P115, DOI 10.1161/CIRCIMAGING.113.000932; Aldred MA, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9398; Aldred MA, 2010, AM J RESP CRIT CARE, V182, P1153, DOI 10.1164/rccm.201003-0491OC; Anand V, 2016, JAMA CARDIOL, V1, P1021, DOI 10.1001/jamacardio.2016.3591; Anavekar NS, 2007, ECHOCARDIOGR-J CARD, V24, P452, DOI 10.1111/j.1540-8175.2007.00424.x; Archer SL, 1998, J CLIN INVEST, V101, P2319, DOI 10.1172/JCI333; Archer SL, 2008, AM J PHYSIOL-HEART C, V294, pH570, DOI 10.1152/ajpheart.01324.2007; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Archer SL, 2010, CIRCULATION, V121, P2661, DOI 10.1161/CIRCULATIONAHA.109.916098; Archer SL, 2009, NEW ENGL J MED, V361, P1864, DOI 10.1056/NEJMct0904473; Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Austin ED, 2012, CIRC-CARDIOVASC GENE, V5, P336, DOI 10.1161/CIRCGENETICS.111.961888; Badesch DB, 2007, CHEST, V131, P1917, DOI 10.1378/chest.06-2674; Badesch DB, 2010, CHEST, V137, P376, DOI 10.1378/chest.09-1140; Badesch DB, 2000, ANN INTERN MED, V132, P425, DOI 10.7326/0003-4819-132-6-200003210-00002; Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504; Benza RL, 2013, J HEART LUNG TRANSPL, V32, P889, DOI 10.1016/j.healun.2013.06.008; Benza RL, 2010, CIRCULATION, V122, P164, DOI 10.1161/CIRCULATIONAHA.109.898122; Benza RL, 2009, PREDICTING SURVIVAL, DOI [10.1164/ajrccm-conference.2009.179.1_MeetingAbstracts.A2651, DOI 10.1164/AJRCCM-CONFERENCE.2009.179.1_MEETINGABSTRACTS.A2651]; Best DH, 2014, CHEST, V145, P231, DOI 10.1378/chest.13-2366; Bhave NM, 2013, J AM SOC ECHOCARDIOG, V26, P860, DOI 10.1016/j.echo.2013.05.007; Bian XM, 1998, AM J PHYSIOL-HEART C, V275, pH169, DOI 10.1152/ajpheart.1998.275.1.H169; Bogaard HJ, 2011, AM J RESP CRIT CARE, V183, P1402, DOI 10.1164/rccm.201007-1106OC; Bogaard HJ, 2010, AM J RESP CRIT CARE, V182, P652, DOI 10.1164/rccm.201003-0335OC; Bonnet S, 2007, P NATL ACAD SCI USA, V104, P11418, DOI 10.1073/pnas.0610467104; Bonnet S, 2006, CIRCULATION, V113, P2630, DOI 10.1161/CIRCULATIONAHA.105.609008; Borlaug BA, 2010, CIRC-HEART FAIL, V3, P588, DOI 10.1161/CIRCHEARTFAILURE.109.930701; BRISTOW MR, 1992, J CLIN INVEST, V89, P803, DOI 10.1172/JCI115659; Brittain EL, 2016, CIRCULATION, V133, P1936, DOI 10.1161/CIRCULATIONAHA.115.019351; Brock M, 2009, CIRC RES, V104, P1184, DOI 10.1161/CIRCRESAHA.109.197491; Califf RM, 1997, AM HEART J, V134, P44, DOI 10.1016/S0002-8703(97)70105-4; Caruso P, 2017, CIRCULATION, V136, P2451, DOI 10.1161/CIRCULATIONAHA.117.028034; Caruso P, 2012, CIRC RES, V111, P290, DOI 10.1161/CIRCRESAHA.112.267591; Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028; Cavasin MA, 2015, PULM CIRC, V5, P63, DOI 10.1086/679700; Cavasin MA, 2012, CIRC RES, V110, P739, DOI 10.1161/CIRCRESAHA.111.258426; Chaouat A, 2005, AM J RESP CRIT CARE, V172, P189, DOI 10.1164/rccm.200401-006OC; Chaouat A, 2004, THORAX, V59, P446, DOI 10.1136/thx.2003.11890; Chaouat A, 2009, CHEST, V136, P678, DOI 10.1378/chest.08-2420; Cho YK, 2010, CIRC J, V74, P760, DOI 10.1253/circj.CJ-09-0580; Chua S, 2009, EUR J ECHOCARDIOGR, V10, P619, DOI 10.1093/ejechocard/jep013; Chugh SS, 2003, CARDIOVASC RES, V57, P477, DOI 10.1016/S0008-6363(02)00703-4; Cogan JD, 2005, GENET MED, V7, P169, DOI 10.1097/01.GIM.0000156525.09595.E9; Cogan JD, 2006, AM J RESP CRIT CARE, V174, P590, DOI 10.1164/rccm.200602-165OC; Colvin KL, 2013, AM J RESP CRIT CARE, V188, P1126, DOI 10.1164/rccm.201302-0403OC; Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812; Dasgupta A, 2015, CLIN PHARMACOL THER, V97, P88, DOI 10.1002/cpt.10; Deano RC, 2013, JAMA INTERN MED, V173, P887, DOI 10.1001/jamainternmed.2013.319; Decoene C, 2001, CAN J ANAESTH, V48, P584, DOI 10.1007/BF03016836; Diebold I, 2015, CELL METAB, V21, P596, DOI 10.1016/j.cmet.2015.03.010; Dorfmuller P, 2002, AM J RESP CRIT CARE, V165, P534, DOI 10.1164/rccm.2012112; Drake KM, 2013, AM J RESP CELL MOL, V49, P403, DOI 10.1165/rcmb.2013-0100OC; Drake KM, 2011, AM J RESP CRIT CARE, V184, P1400, DOI 10.1164/rccm.201106-1130OC; Edwards AL, 2013, RESPIROLOGY, V18, P1271, DOI 10.1111/resp.12152; El Kasmi KC, 2014, J IMMUNOL, V193, P597, DOI 10.4049/jimmunol.1303048; Ernande L, 2013, J AM SOC ECHOCARDIOG, V26, P297, DOI 10.1016/j.echo.2012.11.011; Esfandiari S, 2017, MED SCI SPORT EXER, V49, P1293, DOI 10.1249/MSS.0000000000001227; Evans JDW, 2016, LANCET RESP MED, V4, P129, DOI 10.1016/S2213-2600(15)00544-5; Eyries M, 2014, NAT GENET, V46, P65, DOI 10.1038/ng.2844; Fang YH, 2012, J MOL MED, V90, P31, DOI 10.1007/s00109-011-0804-9; Farha S, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.95240; Fijalkowska I, 2010, AM J PATHOL, V176, P1130, DOI 10.2353/ajpath.2010.090832; Foderaro A, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-016-0689-7; Forfia PR, 2006, AM J RESP CRIT CARE, V174, P1034, DOI 10.1164/rccm.200604-547OC; Frank H, 1997, CHEST, V112, P714, DOI 10.1378/chest.112.3.714; Freed BH, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-11; Frid MG, 2006, AM J PATHOL, V168, P659, DOI 10.2353/ajpath.2006.050599; FUSTER V, 1984, CIRCULATION, V70, P580, DOI 10.1161/01.CIR.70.4.580; Galie N, 2008, LANCET, V371, P2093, DOI 10.1016/S0140-6736(08)60919-8; Galie N, 2015, NEW ENGL J MED, V373, P834, DOI 10.1056/NEJMoa1413687; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Galie N, 2008, CIRCULATION, V117, P3010, DOI 10.1161/CIRCULATIONAHA.107.742510; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Galie N, 2009, CIRCULATION, V119, P2894, DOI 10.1161/CIRCULATIONAHA.108.839274; Georgianos PI, 2015, AM J HYPERTENS, V28, P958, DOI 10.1093/ajh/hpv004; Ghio S, 2011, AM J CARDIOL, V107, P628, DOI 10.1016/j.amjcard.2010.10.027; Ghofrani HA, 2013, NEW ENGL J MED, V369, P319, DOI 10.1056/NEJMoa1209657; Gotthardt D, 2016, CANCER DISCOV, V6, P414, DOI 10.1158/2159-8290.CD-15-0732; Graham BB, 2010, CHEST, V137, p20S, DOI 10.1378/chest.10-0048; Guignabert C, 2009, FASEB J, V23, P4135, DOI 10.1096/fj.09-131664; Gupta S, 2008, EUR J ECHOCARDIOGR, V9, P766, DOI 10.1093/ejechocard/jen147; Gutierrez G, 2007, CRIT CARE, V11, DOI 10.1186/cc5739; Halpern SD, 2009, CHEST, V136, P37, DOI 10.1378/chest.08-2784; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Hardziyenka M, 2006, J AM SOC ECHOCARDIOG, V19, P1272, DOI 10.1016/j.echo.2006.04.036; Harrison RE, 2003, J MED GENET, V40, P865, DOI 10.1136/jmg.40.12.865; Hashimoto-Kataoka T, 2015, P NATL ACAD SCI USA, V112, pE2677, DOI 10.1073/pnas.1424774112; Hatton N, 2014, CHEST, V145, P1184, DOI 10.1378/chest.13-3061; HEATH D, 1991, J CLIN PATHOL, V44, P1003, DOI 10.1136/jcp.44.12.1003; Hemnes AR, 2016, AM J RESP CRIT CARE, V194, P464, DOI 10.1164/rccm.201508-1678OC; Hemnes AR, 2015, PULM CIRC, V5, P435, DOI 10.1086/682230; Hemnes AR, 2015, CIRCULATION, V131, P401, DOI 10.1161/CIRCULATIONAHA.114.013317; Hoeper MM, 2016, EUR RESPIR J, V48, DOI 10.1183/13993003.congress-2016.OA263; Hoeper MM, 2013, J AM COLL CARDIOL, V62, pD42, DOI 10.1016/j.jacc.2013.10.032; Hoeper MM, 2013, INT J CARDIOL, V168, P871, DOI 10.1016/j.ijcard.2012.10.026; Hong ZG, 2017, AM J RESP CRIT CARE, V195, P515, DOI 10.1164/rccm.201604-0814OC; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; HUMBERT M, 1995, AM J RESP CRIT CARE, V151, P1628, DOI 10.1164/ajrccm.151.5.7735624; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Hurst LA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14079; Jacobs W, 2014, CHEST, V145, P1230, DOI 10.1378/chest.13-1291; Jais X, 2012, EUR RESPIR J, V40, P881, DOI 10.1183/09031936.00141211; Jiang R, 2015, HYPERTENS RES, V38, P539, DOI 10.1038/hr.2015.33; Jing ZC, 2007, CHEST, V132, P373, DOI 10.1378/chest.06-2913; Jing ZC, 2013, CIRCULATION, V127, P624, DOI 10.1161/CIRCULATIONAHA.112.124388; Kane GC, 2011, CHEST, V139, P1285, DOI 10.1378/chest.10-1293; Kang K, 2013, J BIOL CHEM, V288, P25414, DOI 10.1074/jbc.M113.460287; Kawut SM, 2011, CIRCULATION, V123, P2542, DOI 10.1161/CIRCULATIONAHA.110.985515; Kim J, 2015, CIRCULATION, V131, P190, DOI 10.1161/CIRCULATIONAHA.114.013339; Kim J, 2013, NAT MED, V19, P74, DOI 10.1038/nm.3040; Koehler R, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.023101; Lahm T, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00983-2017; Larkin EK, 2012, AM J RESP CRIT CARE, V186, P892, DOI 10.1164/rccm.201205-0886OC; Lavoie JR, 2014, CIRCULATION, V129, P2125, DOI 10.1161/CIRCULATIONAHA.114.008777; Leather HA, 2006, AM J PHYSIOL-HEART C, V290, pH2369, DOI 10.1152/ajpheart.01211.2004; Lee SL, 2014, CIRC J, V78, P962, DOI 10.1253/circj.CJ-13-1234; Li M, 2016, CIRCULATION, V134, P1105, DOI 10.1161/CIRCULATIONAHA.116.023171; Li M, 2011, J IMMUNOL, V187, P2711, DOI 10.4049/jimmunol.1100479; Lindqvist P, 2005, ECHOCARDIOGR-J CARD, V22, P305, DOI 10.1111/j.1540-8175.2005.04023.x; Ling Y, 2012, AM J RESP CRIT CARE, V186, P790, DOI 10.1164/rccm.201203-0383OC; Long L, 2015, NAT MED, V21, P777, DOI 10.1038/nm.3877; Long L, 2013, CIRC RES, V112, P1159, DOI 10.1161/CIRCRESAHA.111.300483; Ma L, 2013, NEW ENGL J MED, V369, P351, DOI 10.1056/NEJMoa1211097; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Machuca TN, 2015, CIRCULATION, V132, P526, DOI 10.1161/CIRCULATIONAHA.114.012593; Mair KM, 2014, BRIT J PHARMACOL, V171, P567, DOI 10.1111/bph.12281; Marcus FI, 2010, CIRCULATION, V121, P1533, DOI 10.1161/CIRCULATIONAHA.108.840827; Maresca A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00090; Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848; Marsboom G, 2012, AM J RESP CRIT CARE, V185, P670, DOI 10.1164/rccm.201108-1562OC; Mathai SC, 2015, CHEST, V147, P188, DOI 10.1378/chest.14-0263; McLaughlin V, 2015, EUR RESPIR J, V46, P405, DOI 10.1183/13993003.02044-2014; McLaughlin VV, 2015, J AM COLL CARDIOL, V65, pA1538, DOI 10.1016/S0735-1097(15)61538-8; McLaughlin VV, 2010, J AM COLL CARDIOL, V55, P1915, DOI 10.1016/j.jacc.2010.01.027; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; McMurtry MS, 2007, AM J PHYSIOL-LUNG C, V292, pL872, DOI 10.1152/ajplung.00309.2006; McMurtry MS, 2004, CIRC RES, V95, P830, DOI 10.1161/01.RES.0000145360.16770.9f; Meluzin J, 2001, EUR HEART J, V22, P340, DOI 10.1053/euhj.2000.2296; Michelakis ED, 2003, CIRCULATION, V108, P2066, DOI 10.1161/01.CIR.0000099502.17776.C2; Michelakis ED, 2002, CIRCULATION, V105, P244, DOI 10.1161/hc0202.101974; Michelakis ED, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4583; Miyata M, 2000, INT ARCH ALLERGY IMM, V121, P246, DOI 10.1159/000024324; Momparler RL, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00019; MONCADA S, 1985, J PHARMACOL-PARIS, V16, P71; Montani D, 2017, LANCET RESP MED, V5, P125, DOI 10.1016/S2213-2600(16)30438-6; Montani D, 2010, EUR HEART J, V31, P1898, DOI 10.1093/eurheartj/ehq170; Morisaki H, 2004, HUM MUTAT, V23, P632, DOI 10.1002/humu.9251; Mukerji B, 2000, SOUTHERN MED J, V93, P673; Nagata Y, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.116.005384; Nagendran J, 2007, CIRCULATION, V116, P238, DOI 10.1161/CIRCULATIONAHA.106.655266; Nahar K, 2014, MOL PHARMACEUT, V11, P4374, DOI 10.1021/mp500456k; NOOTENS M, 1995, J AM COLL CARDIOL, V26, P1581, DOI 10.1016/0735-1097(95)00399-1; Oikawa M, 2005, J AM COLL CARDIOL, V45, P1849, DOI 10.1016/j.jacc.2005.02.065; Oka M, 2007, CIRC RES, V100, P923, DOI 10.1161/01.RES.0000261658.12024.18; Olsson KM, 2014, CIRCULATION, V129, P57, DOI 10.1161/CIRCULATIONAHA.113.004526; Opotowsky AR, 2012, CIRC-CARDIOVASC IMAG, V5, P765, DOI 10.1161/CIRCIMAGING.112.976654; Ormiston ML, 2012, CIRCULATION, V126, P1099, DOI 10.1161/CIRCULATIONAHA.112.110619; Overbeek MJ, 2008, EUR RESPIR J, V31, P1160, DOI 10.1183/09031936.00135407; Pandey A, 2015, CIRC-HEART FAIL, V8, P1032, DOI 10.1161/CIRCHEARTFAILURE.115.002130; Parikh VN, 2012, CIRCULATION, V125, P1520, DOI 10.1161/CIRCULATIONAHA.111.060269; Paul GA, 2005, BRIT J CLIN PHARMACO, V60, P107, DOI 10.1111/j.1365-2125.2005.02383.x; Peacock AJ, 2007, EUR RESPIR J, V30, P104, DOI 10.1183/09031936.00092306; Perros F, 2007, EUR RESPIR J, V29, P937, DOI 10.1183/09031936.00104706; Perros F, 2007, EUR RESPIR J, V29, P462, DOI 10.1183/09031936.00094706; Perros F, 2012, AM J RESP CRIT CARE, V185, P311, DOI 10.1164/rccm.201105-0927OC; Piao L, 2012, CIRCULATION, V126, P2859, DOI 10.1161/CIRCULATIONAHA.112.109868; Piao L, 2010, J MOL MED, V88, P47, DOI 10.1007/s00109-009-0524-6; Pozeg ZI, 2003, CIRCULATION, V107, P2037, DOI 10.1161/01.CIR.0000062688.76508.B3; Preston IR, 2015, CIRCULATION, V132, P2403, DOI 10.1161/CIRCULATIONAHA.115.018435; Prins KW, 2017, PULM CIRC, V7, P145, DOI 10.1086/690017; Pulido T, 2013, NEW ENGL J MED, V369, P809, DOI 10.1056/NEJMoa1213917; Pullamsetti SS, 2012, AM J RESP CRIT CARE, V185, P409, DOI 10.1164/rccm.201106-1093OC; Qian J, 2015, HYPERTENSION, V66, P1227, DOI 10.1161/HYPERTENSIONAHA.115.06370; Rabinovitch M, 2014, CIRC RES, V115, P165, DOI 10.1161/CIRCRESAHA.113.301141; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Raymond RJ, 2002, J AM COLL CARDIOL, V39, P1214, DOI 10.1016/S0735-1097(02)01744-8; Redfield MM, 2013, JAMA-J AM MED ASSOC, V309, P1268, DOI 10.1001/jama.2013.2024; Rexhaj E, 2011, AM J PHYSIOL-HEART C, V301, pH247, DOI 10.1152/ajpheart.01309.2010; Reynolds AM, 2007, AM J PHYSIOL-LUNG C, V292, pL1182, DOI 10.1152/ajplung.00020.2006; Rhodes CJ, 2013, AM J RESP CRIT CARE, V187, P294, DOI 10.1164/rccm.201205-0839OC; Rich JD, 2011, CHEST, V139, P988, DOI 10.1378/chest.10-1269; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; Rich S, 1998, CHEST, V114, P787, DOI 10.1378/chest.114.3.787; RICH S, 1992, NEW ENGL J MED, V327, P76, DOI 10.1056/NEJM199207093270203; Rich S, 2010, CHEST, V138, P1234, DOI 10.1378/chest.09-2815; Robbins IM, 2014, CIRC-HEART FAIL, V7, P116, DOI 10.1161/CIRCHEARTFAILURE.113.000468; Romberg E., 1891, DTSCH ARCH KLIN MED, V48, P197; Rothman AMK, 2016, J CLIN INVEST, V126, P2495, DOI 10.1172/JCI83361; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Ryan JJ, 2015, CIRCULATION, V131, P1691, DOI 10.1161/CIRCULATIONAHA.114.006979; Ryan JJ, 2013, AM J RESP CRIT CARE, V187, P865, DOI 10.1164/rccm.201209-1687OC; Ryan JJ, 2012, AM HEART J, V163, P589, DOI 10.1016/j.ahj.2012.01.024; Sachdev A, 2011, CHEST, V139, P1299, DOI 10.1378/chest.10-2015; Sanchez O, 2007, AM J RESP CRIT CARE, V176, P1041, DOI 10.1164/rccm.200610-1559OC; Sarkar J, 2010, AM J PHYSIOL-LUNG C, V299, pL861, DOI 10.1152/ajplung.00201.2010; Schlosser K, 2013, AM J RESP CRIT CARE, V188, P1472, DOI 10.1164/rccm.201308-1403LE; Scourzic L, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0134-6; Seeger W, 2013, J AM COLL CARDIOL, V62, pD109, DOI 10.1016/j.jacc.2013.10.036; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Shapiro S, 2012, CHEST, V141, P363, DOI 10.1378/chest.10-3114; Sharma S, 2004, AM J PHYSIOL-HEART C, V286, pH1185, DOI 10.1152/ajpheart.00916.2003; Shehata ML, 2011, AM J ROENTGENOL, V196, P87, DOI 10.2214/AJR.09.4114; Simonneau G, 2002, AM J RESP CRIT CARE, V165, P800, DOI 10.1164/ajrccm.165.6.2106079; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Sitbon O, 2005, CIRCULATION, V111, P3105, DOI 10.1161/CIRCULATIONAHA.104.488486; Sitbon O, 2015, NEW ENGL J MED, V373, P2522, DOI 10.1056/NEJMoa1503184; Sitbon O, 2014, EUR RESPIR J, V43, P1691, DOI 10.1183/09031936.00116313; Sobolewski A, 2008, HUM MOL GENET, V17, P3180, DOI 10.1093/hmg/ddn214; Soon E, 2010, CIRCULATION, V122, P921, DOI 10.1161/CIRCULATIONAHA.109.933762; Spiekerkoetter E, 2013, J CLIN INVEST, V123, P3600, DOI 10.1172/JCI65592; Strange G, 2012, HEART, V98, P1805, DOI 10.1136/heartjnl-2012-301992; Sutendra G, 2014, CELL, V158, P84, DOI 10.1016/j.cell.2014.04.046; Syrris P, 2006, AM J HUM GENET, V79, P978, DOI 10.1086/509122; Taichman DB, 2014, CHEST, V146, P449, DOI 10.1378/chest.14-0793; Tamosiuniene R, 2011, CIRC RES, V109, P867, DOI 10.1161/CIRCRESAHA.110.236927; Tapson VF, 2013, CHEST, V144, P952, DOI 10.1378/chest.12-2875; Tei C, 1996, J Am Soc Echocardiogr, V9, P838, DOI 10.1016/S0894-7317(96)90476-9; Thenappan T, 2007, EUR RESPIR J, V30, P1103, DOI 10.1183/09031936.00042107; Thenappan T, 2010, EUR RESPIR J, V35, P1079, DOI 10.1183/09031936.00072709; Thenappan T, 2011, CIRC-HEART FAIL, V4, P257, DOI 10.1161/CIRCHEARTFAILURE.110.958801; Torbicki A, 2003, CIRCULATION, V108, P844, DOI 10.1161/01.CIR.0000084544.54513.E2; Trembath RC, 2001, NEW ENGL J MED, V345, P325, DOI 10.1056/NEJM200108023450503; Tuder RM, 2007, CLIN CHEST MED, V28, P23, DOI 10.1016/j.ccm.2006.11.010; Tuder RM, 2013, J AM COLL CARDIOL, V62, pD4, DOI 10.1016/j.jacc.2013.10.025; Tunariu N, 2007, J NUCL MED, V48, P680, DOI 10.2967/jnumed.106.039438; Ulrich S, 2017, EUR HEART J, V38, P1159, DOI 10.1093/eurheartj/ehx099; van Campen JSJA, 2016, EUR RESPIR J, V48, P787, DOI 10.1183/13993003.00090-2016; van de Veerdonk MC, 2011, J AM COLL CARDIOL, V58, P2511, DOI 10.1016/j.jacc.2011.06.068; van Wolferen SA, 2007, EUR HEART J, V28, P1250, DOI 10.1093/eurheartj/ehl477; Wang DR, 2014, CIRC RES, V114, P67, DOI 10.1161/CIRCRESAHA.114.301633; Wang G, 2013, AM J PHYSIOL-HEART C, V305, pH1451, DOI 10.1152/ajpheart.00238.2013; Waxman AB, 2017, CHEST; Wei AH, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003896; White K, 2014, HYPERTENSION, V64, P185, DOI 10.1161/HYPERTENSIONAHA.113.03037; Xu XF, 2010, J HYPERTENS, V28, P2227, DOI 10.1097/HJH.0b013e32833e08f1; Yu Y, 2009, CIRCULATION, V119, P2313, DOI 10.1161/CIRCULATIONAHA.108.782458; Yuan JXJ, 1998, CIRCULATION, V98, P1400, DOI 10.1161/01.CIR.98.14.1400; Zhang HR, 2017, ARTERIOSCL THROM VAS, V37, P2000, DOI 10.1161/ATVBAHA.117.309195; Zhang R, 2011, CHEST, V140, P301, DOI 10.1378/chest.10-2327; Zhao L, 2012, CIRCULATION, V126, P455, DOI 10.1161/CIRCULATIONAHA.112.103176	242	380	403	21	205	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 14	2018	360								j5492	10.1136/bmj.j5492	http://dx.doi.org/10.1136/bmj.j5492			27	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ9FZ	29540357	Green Published			2022-12-28	WOS:000427916700001
J	Kuehn, B				Kuehn, Bridget			Suicide: The Leading Cause of Violent Death	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2018	319	10					973	973		10.1001/jama.2018.1699	http://dx.doi.org/10.1001/jama.2018.1699			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ0HS	29536105				2022-12-28	WOS:000427249700007
J	Das, P				Das, Pamela			Peter Sands: charting a new course for The Global Fund	LANCET			English	Biographical-Item																		SANDS P, PUBLICATION LISTS	1	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 10	2018	391	10124					927	927		10.1016/S0140-6736(18)30550-6	http://dx.doi.org/10.1016/S0140-6736(18)30550-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ1UN	29536849				2022-12-28	WOS:000427363100015
J	Lazer, DMJ; Baum, MA; Benkler, Y; Berinsky, AJ; Greenhill, KM; Menczer, F; Metzger, MJ; Nyhan, B; Pennycook, G; Rothschild, D; Schudson, M; Sloman, SA; Sunstein, CR; Thorson, EA; Watts, DJ; Zittrain, JL				Lazer, David M. J.; Baum, Matthew A.; Benkler, Yochai; Berinsky, Adam J.; Greenhill, Kelly M.; Menczer, Filippo; Metzger, Miriam J.; Nyhan, Brendan; Pennycook, Gordon; Rothschild, David; Schudson, Michael; Sloman, Steven A.; Sunstein, Cass R.; Thorson, Emily A.; Watts, Duncan J.; Zittrain, Jonathan L.			The science of fake news	SCIENCE			English	Editorial Material									[Lazer, David M. J.] Northeastern Univ, Network Science Inst, Boston, MA 02115 USA; [Lazer, David M. J.] Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA; [Baum, Matthew A.; Greenhill, Kelly M.] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA; [Benkler, Yochai; Sunstein, Cass R.; Zittrain, Jonathan L.] Harvard Univ, Harvard Law Sch, Cambridge, MA 02138 USA; [Benkler, Yochai; Zittrain, Jonathan L.] Berkman Klein Ctr Internet & Soc, Cambridge, MA 02138 USA; [Berinsky, Adam J.] MIT, Dept Polit Sci, Cambridge, MA 02139 USA; [Greenhill, Kelly M.] Tufts Univ, Dept Polit Sci, Medford, MA 02155 USA; [Menczer, Filippo] Indiana Univ, Sch Informat Comp & Engn, Bloomington, IN 47405 USA; [Metzger, Miriam J.] Univ Calif Santa Barbara, Dept Commun, Santa Barbara, CA 93106 USA; [Nyhan, Brendan] Dartmouth Coll, Dept Govt, Hanover, NH 03755 USA; [Pennycook, Gordon] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Rothschild, David; Watts, Duncan J.] Microsoft Res, New York, NY 10011 USA; [Schudson, Michael] Columbia Univ, Grad Sch Jouralism, New York, NY 10027 USA; [Sloman, Steven A.] Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA; [Thorson, Emily A.] Boston Coll, Dept Polit Sci, Chestnut Hill, MA 02467 USA	Northeastern University; Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Tufts University; Indiana University System; Indiana University Bloomington; University of California System; University of California Santa Barbara; Dartmouth College; Yale University; Microsoft; Columbia University; Brown University; Boston College	Lazer, DMJ (corresponding author), Northeastern Univ, Network Science Inst, Boston, MA 02115 USA.; Lazer, DMJ (corresponding author), Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA.	d.lazer@northeastern.edu	Pennycook, Gordon/AAD-6631-2019; Sunstein, Cass/AAV-8196-2020	Pennycook, Gordon/0000-0003-1344-6143; 	Shorenstein Center at the Harvard Kennedy School; NULab for Texts, Maps, and Networks at Northeastern University; Economic and Social Research Council [ES/N012283/1]; National Endowment for the Humanities; ESRC [ES/N012283/1] Funding Source: UKRI	Shorenstein Center at the Harvard Kennedy School; NULab for Texts, Maps, and Networks at Northeastern University; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Endowment for the Humanities; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	We acknowledge support from the Shorenstein Center at the Harvard Kennedy School and the NULab for Texts, Maps, and Networks at Northeastern University. D.M. J.L. acknowledges support by the Economic and Social Research Council ES/N012283/1. D.M. J.L. and M.A.B. contributed equally to this article. Y.B. is on the advisory board of the Open Science Foundation. C.R.S. has consulted for Facebook. K.M.G. acknowledges support by the National Endowment for the Humanities.	Allcott Hunt, 2017, J ECON PERSPECT, V31, P211, DOI DOI 10.1257/JEP.31.2.211; Bakshy E, 2015, SCIENCE, V348, P1130, DOI 10.1126/science.aaa1160; Crowell, 2017, OUR APPROACH BOTS MI; Ecker UKH, 2017, J APPL RES MEM COGN, V6, P185, DOI 10.1016/j.jarmac.2017.01.014; Ferrara E., 2017, 1 MONDAY, V22, P2017; Gottfried E. Shearer, 2017, NEWS USE SOCIAL MEDI; Jones C., 2017, BILL WOULD HELP CALI; Kalla JL, 2018, AM POLIT SCI REV, V112, P148, DOI 10.1017/S0003055417000363; Swift A., 2016, AM TRUST MASS MEDIA; Swire B, 2017, J EXP PSYCHOL LEARN, V43, P1948, DOI 10.1037/xlm0000422; Varol O., 2017, P INT AAAI C WEB SOC; Vosoughi S, 2018, SCIENCE, V359, P1146, DOI 10.1126/science.aap9559; Wardle C., 2017, DGI201709 COUNC EUR; Watts C, 2017, EXTREMIST CONTENT RU; Weedon J., 2017, FACEBOOK	15	1293	1320	82	735	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2018	359	6380					1094	1096		10.1126/science.aao2998	http://dx.doi.org/10.1126/science.aao2998			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY4ZM	29590025				2022-12-28	WOS:000426835900020
J	Konermann, S; Lotfy, P; Brideau, NJ; Oki, J; Shokhirev, MN; Hsu, PD				Konermann, Silvana; Lotfy, Peter; Brideau, Nicholas J.; Oki, Jennifer; Shokhirev, Maxim N.; Hsu, Patrick D.			Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors	CELL			English	Article							FRONTOTEMPORAL DEMENTIA; DNA; COMPLEX; ENDONUCLEASE; PERFORMANCE; ALIGNMENT; PROTEINS; IMMUNITY; CLEAVAGE; MODELS	Class 2 CRISPR-Cas systems endow microbes with diverse mechanisms for adaptive immunity. Here, we analyzed prokaryotic genome and metagenome sequences to identify an uncharacterized family of RNA-guided, RNA-targeting CRISPR systems that we classify as type VI-D. Biochemical characterization and protein engineering of seven distinct orthologs generated a ribonuclease effector derived from Ruminococcus flavefaciens XPD3002 (CasRx) with robust activity in human cells. CasRx-mediated knockdown exhibits high efficiency and specificity relative to RNA interference across diverse endogenous transcripts. As one of the most compact single-effector Cas enzymes, CasRx can also be flexibly packaged into adeno-associated virus. We target virally encoded, catalytically inactive CasRx to cis elements of pre-mRNA to manipulate alternative splicing, alleviating dysregulated tau isoform ratios in a neuronal model of frontotemporal dementia. Our results present CasRx as a programmable RNA-binding module for efficient targeting of cellular RNA, enabling a general platform for transcriptome engineering and future therapeutic development.	[Konermann, Silvana; Lotfy, Peter; Brideau, Nicholas J.; Oki, Jennifer; Hsu, Patrick D.] Salk Inst Biol Studies, Lab Mol & Cell Biol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Konermann, Silvana; Lotfy, Peter; Brideau, Nicholas J.; Oki, Jennifer; Hsu, Patrick D.] Salk Inst Biol Studies, Helmsley Ctr Genom Med, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Shokhirev, Maxim N.] Salk Inst Biol Studies, Razavi Newman Integrat Genom & Bioinformat Core, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	Salk Institute; Salk Institute; Salk Institute	Hsu, PD (corresponding author), Salk Inst Biol Studies, Lab Mol & Cell Biol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Hsu, PD (corresponding author), Salk Inst Biol Studies, Helmsley Ctr Genom Med, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	patrick@salk.edu	Hsu, Patrick/ABD-5749-2021; Lotfy, Peter/AAC-5900-2019; Lotfy, Peter/AGR-6999-2022	Lotfy, Peter/0000-0003-0809-7073; Lotfy, Peter/0000-0003-0809-7073; Hsu, Patrick/0000-0002-9380-2648; Oki, Jennifer/0000-0003-0147-0269	Waitt Advanced Biophotonics Core Facility of the Salk Institute; NIH-NCI CCSG [P30 014195]; NINDS Neuroscience Core Grant [NS072031]; Waitt Foundation; Stem Cell; NGS; Razavi Newman Integrative Genomics and Bioinformatics; Flow Cytometry Core Facilities of the Salk Institute; Helmsley Trust; NIH-NCI [CCSG P30 014195]; Chapman Foundation; Catharina Foundation Fellowship; Howard Hughes Medical Institute Hanna H. Gray Fellows program; Salk Women AMP; Science Special Award; NIH through the Office of the Director [5 DP5 OD021369-02]; National Institutes on Aging [5 R21 AG056811-02]; Helmsley Charitable Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS072031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG056811] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD021369] Funding Source: NIH RePORTER	Waitt Advanced Biophotonics Core Facility of the Salk Institute; NIH-NCI CCSG(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS Neuroscience Core Grant; Waitt Foundation; Stem Cell; NGS; Razavi Newman Integrative Genomics and Bioinformatics; Flow Cytometry Core Facilities of the Salk Institute; Helmsley Trust; NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Chapman Foundation; Catharina Foundation Fellowship; Howard Hughes Medical Institute Hanna H. Gray Fellows program; Salk Women AMP; Science Special Award; NIH through the Office of the Director; National Institutes on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Helmsley Charitable Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the entire Hsu laboratory for support and advice; T. Hunter and W. Eckhart for helpful comments; F. Gao for the gift of FTDP-17 patient-derived and control iPSC lines; A. Hsu for assistance with data analysis; S. Tyagi for guidance with protein purification; S. Schafer for the gift of Neurogenin- 2 plasmid; F. Zhang for the gift of His-MBP-TEV plasmid; J. Karlseder, M. Montminy, J. Ayres, and D. Lyumkis for instrument access; C. Pourcel for CRISPRFinder source code; and K. Reilly, S. Leahy, P. Kougias, P. Weimer, F. Farquharson, J. Dore, and F. Levenez for gifts of genomic DNA samples from Ruminococcus flavefaciens XPD3002, Rum. albus, Rum. bicirculans, Rum. sp. CAG: 57, Rum. flavefaciens FD1, and anaerobic digester metagenomes. This work was additionally supported by the Waitt Advanced Biophotonics Core Facility of the Salk Institute with funding from NIH-NCI CCSG P30 014195, NINDS Neuroscience Core Grant NS072031, and the Waitt Foundation; the Stem Cell, NGS, Razavi Newman Integrative Genomics and Bioinformatics, and Flow Cytometry Core Facilities of the Salk Institute with funding from the Helmsley Trust; NIH-NCI CCSG P30 014195; and the Chapman Foundation. S. K. is supported by a Catharina Foundation Fellowship, the Howard Hughes Medical Institute Hanna H. Gray Fellows program, and a Salk Women & Science Special Award. P. D. H. is supported by the NIH through the Office of the Director (5 DP5 OD021369-02), the National Institutes on Aging (5 R21 AG056811-02), and the Helmsley Charitable Trust. Plasmids described in this study will be conveniently distributed to the academic community through the nonprofit repository Addgene.	Abudayyeh OO, 2017, NATURE, V550, P280, DOI 10.1038/nature24049; Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Almeida S, 2012, CELL REP, V2, P789, DOI 10.1016/j.celrep.2012.09.007; Anantharaman V, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-15; Andronescu M, 2007, BIOINFORMATICS, V23, pI19, DOI 10.1093/bioinformatics/btm223; Batra R, 2017, CELL, V170, P899, DOI 10.1016/j.cell.2017.07.010; Biswas MHU, 2016, STEM CELL REP, V7, P316, DOI 10.1016/j.stemcr.2016.08.006; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Boeve BF, 2008, ARCH NEUROL-CHICAGO, V65, P460, DOI 10.1001/archneur.65.4.460; Cheong CG, 2006, P NATL ACAD SCI USA, V103, P13635, DOI 10.1073/pnas.0606294103; Chiriboga CA, 2016, NEUROLOGY, V86, P890, DOI 10.1212/WNL.0000000000002445; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Du YC, 2006, MOL CELL PROTEOMICS, V5, P1033, DOI 10.1074/mcp.M500327-MCP200; East-Seletsky A, 2017, MOL CELL, V66, P373, DOI 10.1016/j.molcel.2017.04.008; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Edgar RC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-18; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Gasiunas Giedrius, 2012, Proc Natl Acad Sci U S A, V109, pE2579; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hammond SM, 2011, TRENDS GENET, V27, P196, DOI 10.1016/j.tig.2011.02.004; Heidrich Nadja, 2015, Methods Mol Biol, V1311, P1, DOI 10.1007/978-1-4939-2687-9_1; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kar A, 2005, ALZ DIS ASSOC DIS, V19, pS29, DOI 10.1097/01.wad.0000183082.76820.81; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kim E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14500; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liu L, 2017, CELL, V168, P121, DOI 10.1016/j.cell.2016.12.031; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Matera AG, 2014, NAT REV MOL CELL BIO, V15, P108, DOI 10.1038/nrm3742; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Orengo JP, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl967; PEABODY DS, 1993, EMBO J, V12, P595, DOI 10.1002/j.1460-2075.1993.tb05691.x; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schoch KM, 2016, NEURON, V90, P941, DOI 10.1016/j.neuron.2016.04.042; Shendure J, 2017, NATURE, V550, P345, DOI 10.1038/nature24286; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sigoillot FD, 2012, NAT METHODS, V9, P363, DOI [10.1038/NMETH.1898, 10.1038/nmeth.1898]; Smargon AA, 2017, MOL CELL, V65, P618, DOI 10.1016/j.molcel.2016.12.023; Smith I, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003213; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Treu L, 2016, BIORESOURCE TECHNOL, V216, P260, DOI 10.1016/j.biortech.2016.05.081; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Wang Y, 2015, BIOMED REP, V3, P152, DOI 10.3892/br.2014.407; Wright AV, 2016, NAT STRUCT MOL BIOL, V23, P876, DOI 10.1038/nsmb.3289; Yang XL, 2010, J PROTEOME RES, V9, P1402, DOI 10.1021/pr900932y; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zetsche B, 2017, BIORXIV, DOI [10.1101/134015, DOI 10.1101/134015]; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029	64	450	481	30	147	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2018	173	3					665	+		10.1016/j.cell.2018.02.033	http://dx.doi.org/10.1016/j.cell.2018.02.033			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GD7GB	29551272	Bronze, Green Accepted			2022-12-28	WOS:000430677400016
J	Miller, DP; Denizard-Thompson, N; Weaver, KE; Case, LD; Troyer, JL; Spangler, JG; Lawler, D; Pignone, MP				Miller, David P., Jr.; Denizard-Thompson, Nancy; Weaver, Kathryn E.; Case, L. Doug; Troyer, Jennifer L.; Spangler, John G.; Lawler, Donna; Pignone, Michael P.			Effect of a Digital Health Intervention on Receipt of Colorectal Cancer Screening in Vulnerable Patients A Randomized Controlled Trial	ANNALS OF INTERNAL MEDICINE			English	Article							COST-EFFECTIVENESS; REPORTED BARRIERS; DECISION AID; PRIMARY-CARE; TASK-FORCE; LITERACY; PREFERENCES; COLONOSCOPY; RECOMMENDATIONS; FACILITATORS	Background: Screening for colorectal cancer (CRC) reduces mortality, yet more than one third of age-eligible Americans are unscreened. Objective: To examine the effect of a digital health intervention, Mobile Patient Technology for Health-CRC (mPATH-CRC), on rates of CRC screening. Design: Randomized clinical trial. (ClinicalTrials.gov: NCT02088333) Setting: 6 community-based primary care practices. Participants: 450 patients (223 in the mPATH-CRC group and 227 in usual care) scheduled for a primary care visit and due for routine CRC screening. Intervention: An iPad application that displays a CRC screening decision aid, lets patients order their own screening tests, and sends automated follow-up electronic messages to support patients. Measurements: The primary outcome was chart-verified completion of CRC screening within 24 weeks. Secondary outcomes were ability to state a screening preference, intention to receive screening, screening discussions, and orders for screening tests. All outcome assessors were blinded to randomization. Results: Baseline characteristics were similar between groups; 37% of participants had limited health literacy, and 53% had annual incomes less than $20 000. Screening was completed by 30% of mPATH-CRC participants and 15% of those receiving usual care (logistic regression odds ratio, 2.5 [95% CI, 1.6 to 4.0]). Compared with usual care, more mPATH-CRC participants could state a screening preference, planned to be screened within 6 months, discussed screening with their provider, and had a screening test ordered. Half of mPATH-CRC participants (53%; 118 of 223) "self-ordered" a test via the program. Limitation: Participants were English speakers in a single health care system. Conclusion: A digital health intervention that allows patients to self-order tests can increase CRC screening. Future research should identify methods for implementing similar interventions in clinical care. Primary Funding Source: National Cancer Institute.	[Miller, David P., Jr.; Denizard-Thompson, Nancy] Wake Forest Sch Med, Dept Internal Med, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Weaver, Kathryn E.; Lawler, Donna] Wake Forest Sch Med, Dept Social Sci & Hlth Policy, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Case, L. Doug] Wake Forest Sch Med, Dept Biostat Sci, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Troyer, Jennifer L.] Univ N Carolina, Belk Coll Business, 9201 Univ City Blvd, Charlotte, NC 28223 USA; [Spangler, John G.] Wake Forest Sch Med, Dept Family & Community Med, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Pignone, Michael P.] Univ Texas Austin, Dell Med Sch, 1501 Red River St, Austin, TX 78712 USA	Wake Forest University; Wake Forest University; Wake Forest University; University of North Carolina; University of North Carolina Charlotte; Wake Forest University; University of Texas System; University of Texas Austin	Miller, DP (corresponding author), Wake Forest Sch Med, Dept Internal Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	dmiller@wakehealth.edu	Weaver, Kathryn E/W-3258-2019	Weaver, Kathryn E/0000-0001-9006-4064	National Cancer Institute [R01CA178941]; Wake Forest Clinical and Translational Science Institute [UL1TR001420]; Wake Forest Comprehensive Cancer Center [P30CA012197]; NATIONAL CANCER INSTITUTE [R01CA178941, P30CA012197] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001420] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wake Forest Clinical and Translational Science Institute; Wake Forest Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	By award R01CA178941 from the National Cancer Institute. The study also received support from the shared resources of the Wake Forest Clinical and Translational Science Institute (UL1TR001420) and the Wake Forest Comprehensive Cancer Center (P30CA012197).	American Cancer Society, 2018, AM CANC SOC REC COL; American Cancer Society, 2017, CANC FACTS FIG 2017; Arnold CL, 2012, J HEALTH COMMUN, V17, P252, DOI 10.1080/10810730.2012.713441; Ayres CG, 2007, AM J MANAG CARE, V13, P150; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Berkowitz Z, 2008, J AM GERIATR SOC, V56, P307, DOI 10.1111/j.1532-5415.2007.01547.x; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V315, P2564, DOI 10.1001/jama.2016.5989; Bromley EG, 2015, PREV MED, V71, P40, DOI 10.1016/j.ypmed.2014.11.022; Centers for Disease Control and Prevention, 2009, FIND BAL; Chew LD, 2008, J GEN INTERN MED, V23, P561, DOI 10.1007/s11606-008-0520-5; DeBourcy AC, 2008, J GEN INTERN MED, V23, P169, DOI 10.1007/s11606-007-0480-1; Guessous I, 2010, PREV MED, V50, P3, DOI 10.1016/j.ypmed.2009.12.005; Hawley S, 2014, AM J MANAG CARE, V20, P555; Hawley ST, 2012, CANCER-AM CANCER SOC, V118, P2726, DOI 10.1002/cncr.26551; Holden DJ, 2010, ANN INTERN MED, V152, P668, DOI 10.7326/0003-4819-152-10-201005180-00239; Inadomi JM, 2017, NEW ENGL J MED, V376, P149, DOI 10.1056/NEJMcp1512286; Inadomi JM, 2012, ARCH INTERN MED, V172, P575, DOI 10.1001/archinternmed.2012.332; Jones RM, 2010, AM J PREV MED, V38, P508, DOI 10.1016/j.amepre.2010.01.021; Katz MG, 2007, J GEN INTERN MED, V22, P782, DOI 10.1007/s11606-007-0184-6; Klabunde CN, 2009, AM J PREV MED, V37, P8, DOI 10.1016/j.amepre.2009.03.008; Lafata JE, 2011, AM J PREV MED, V41, P480, DOI 10.1016/j.amepre.2011.07.018; Lin JS, 2016, 1405203EF1 AG HEALTH; McLachlan SA, 2012, PATIENT EDUC COUNS, V86, P137, DOI 10.1016/j.pec.2011.04.010; Miller DP, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.7268; Miller DP, 2011, AM J PREV MED, V40, P608, DOI 10.1016/j.amepre.2011.02.019; Nielsen-Bohlman L, 2004, HLTH LITERACY PRESCR; Ostbye T, 2005, ANN FAM MED, V3, P209, DOI 10.1370/afm.310; Paasche-Orlow MK, 2005, J GEN INTERN MED, V20, P175, DOI 10.1111/j.1525-1497.2005.40245.x; Patel SS, 2015, CANCER CONTROL, V22, P248, DOI 10.1177/107327481502200219; Pew Research Center, 2017, MOB FACT SHEET; Reuland DS, 2017, JAMA INTERN MED, V177, P967, DOI 10.1001/jamainternmed.2017.1294; Rex DK, 2017, AM J GASTROENTEROL, V112, P1016, DOI 10.1038/ajg.2017.174; Shapiro JA, 2012, CANCER EPIDEM BIOMAR, V21, P895, DOI 10.1158/1055-9965.EPI-12-0192; Sharaf RN, 2013, AM J GASTROENTEROL, V108, P120, DOI 10.1038/ajg.2012.380; Steinwachs D, 2010, ANN INTERN MED, V152, P663, DOI 10.7326/0003-4819-152-10-201005180-00237; The Office of the National Coordinator for Health Information Technology, 2017, CONN HLTH CAR NAT SH; Tinmouth J, 2015, GUT, V64, P1327, DOI 10.1136/gutjnl-2014-308074; United States Department of Agriculture, 2017, RUR URB CONT COD; Volk RJ, 2016, AM J PREV MED, V51, P779, DOI 10.1016/j.amepre.2016.06.022; von Wagner C, 2009, PATIENT EDUC COUNS, V75, P352, DOI 10.1016/j.pec.2009.03.015; White A, 2017, MMWR-MORBID MORTAL W, V66, P1, DOI 10.15585/mmwr.mm6608a1; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635	42	34	34	0	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2018	168	8					550	+		10.7326/M17-2315	http://dx.doi.org/10.7326/M17-2315			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GC8XZ	29532054	Green Accepted			2022-12-28	WOS:000430083100015
J	Potts, R; Behrensmeyer, AK; Faith, JT; Tryon, CA; Brooks, AS; Yellen, JE; Deino, ML; Kinyanjui, R; Clark, JB; Haradon, CM; Levin, NE; Meijer, HJM; Veatch, EG; Owen, RB; Renaut, RW				Potts, Richard; Behrensmeyer, Anna K.; Faith, J. Tyler; Tryon, Christian A.; Brooks, Alison S.; Yellen, John E.; Deino, Man L.; Kinyanjui, Rahab; Clark, Jennifer B.; Haradon, Catherine M.; Levin, Naomi E.; Meijer, Hanneke J. M.; Veatch, Elizabeth G.; Owen, R. Bernhart; Renaut, Robin W.			Environmental dynamics during the onset of the Middle Stone Age in eastern Africa	SCIENCE			English	Article							LARGE MAMMAL FAUNAS; JEBEL IRHOUD; CLIMATE; ORIGIN; KENYA; VARIABILITY; MOROCCO; FOSSILS; BASIN	Development of the African Middle Stone Age (MSA) before 300,000 years ago raises the question of how environmental change influenced the evolution of behaviors characteristic of early Homo sapiens. We used temporally well-constrained sedimentological and paleoenvironmental data to investigate environmental dynamics before and after the appearance of the early MSA in the Olorgesailie basin, Kenya. In contrast to the Acheulean archeological record in the same basin, MSA sites are associated with a markedly different faunal community, more pronounced erosion-deposition cycles, tectonic activity, and enhanced wet-dry variability. Aspects of Acheulean technology in this region imply that, as early as 615,000 years ago, greater stone material selectivity and wider resource procurement coincided with an increased pace of land-lake fluctuation, potentially anticipating the adaptability of MSA hominins.	[Potts, Richard; Behrensmeyer, Anna K.; Brooks, Alison S.; Yellen, John E.; Clark, Jennifer B.; Meijer, Hanneke J. M.] Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20013 USA; [Potts, Richard; Kinyanjui, Rahab] Natl Museums Kenya, Dept Earth Sci, POB 40658-00100, Nairobi, Kenya; [Behrensmeyer, Anna K.] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA; [Faith, J. Tyler] Univ Utah, Nat Hist Museum Utah, Salt Lake City, UT 84108 USA; [Faith, J. Tyler] Univ Utah, Dept Anthropol, Salt Lake City, UT 84108 USA; [Tryon, Christian A.] Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA; [Brooks, Alison S.] George Washington Univ, Dept Anthropol, Washington, DC 20052 USA; [Yellen, John E.] Natl Sci Fdn, Archaeol Program, Alexandria, VA 22314 USA; [Deino, Man L.] Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; [Haradon, Catherine M.] Santa Monica Coll, Dept Earth Sci, Santa Monica, CA 90405 USA; [Levin, Naomi E.] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA; [Meijer, Hanneke J. M.] Univ Bergen, Dept Nat Hist, Univ Museum, Bergen, Norway; [Veatch, Elizabeth G.] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA; [Owen, R. Bernhart] Hong Kong Baptist Univ, Dept Geog, Kowloon Tong, Hong Kong, Peoples R China; [Renaut, Robin W.] Univ Saskatchewan, Dept Geol Sci, Saskatoon, SK S7N 5E2, Canada	Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Museum of Natural History; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Harvard University; George Washington University; National Science Foundation (NSF); Berkeley Geochronolgy Center; Santa Monica College; University of Michigan System; University of Michigan; University of Bergen; Emory University; Hong Kong Baptist University; University of Saskatchewan	Potts, R (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20013 USA.; Potts, R (corresponding author), Natl Museums Kenya, Dept Earth Sci, POB 40658-00100, Nairobi, Kenya.	pottsr@si.edu	Levin, Naomi E/B-4124-2010; Meijer, Hanneke J.M./A-1912-2013; Veatch, Elizabeth/ABA-3706-2020	Levin, Naomi E/0000-0001-5703-3717; Meijer, Hanneke J.M./0000-0001-7066-6869; Veatch, Elizabeth/0000-0002-6952-7666; Clark, Jennifer B./0000-0002-7529-2656; Tryon, Christian/0000-0002-2354-3273; Faith, J. Tyler/0000-0002-1101-7161; Owen, Richard Bernhart/0000-0001-5267-5366	Peter Buck Fund for Human Origins Research, Smithsonian Institution; NSF HOMINID Program [BCS-0218511]; NSF Archaeometry [EAR-1322017]	Peter Buck Fund for Human Origins Research, Smithsonian Institution; NSF HOMINID Program; NSF Archaeometry	Supported by the Peter Buck Fund for Human Origins Research, Smithsonian Institution (R.P.), NSF HOMINID Program grant BCS-0218511 (R.P.), and NSF Archaeometry grant EAR-1322017 (A.L.D.).	Alemseged Z, 2003, J HUM EVOL, V44, P451, DOI 10.1016/S0047-2484(03)00012-5; Behrensmeyer A. K., 2018, GEOL SOC AM BULL, DOI [10.1130/B31853.1, DOI 10.1130/B31853.1]; Behrensmeyer A. K., 2002, SEPM SPECIAL PUBLICA, V73, P97; Behrensmeyer AK, 1997, SCIENCE, V278, P1589, DOI 10.1126/science.278.5343.1589; Brooks AS, 2018, SCIENCE, V360, P90, DOI 10.1126/science.aao2646; Cerling TE, 2011, NATURE, V476, P51, DOI 10.1038/nature10306; de Ruiter DJ, 2008, J HUM EVOL, V55, P1015, DOI 10.1016/j.jhevol.2008.06.003; DEINO A, 1990, J GEOPHYS RES-SOLID, V95, P8453, DOI 10.1029/JB095iB06p08453; Deino AL, 2018, SCIENCE, V360, P95, DOI 10.1126/science.aao2216; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; deMenocal PB, 2011, SCIENCE, V331, P540, DOI 10.1126/science.1190683; Dibble E., 1995, DEFINITION INTERPRET, P41; DYSONHUDSON R, 1978, AM ANTHROPOL, V80, P21, DOI 10.1525/aa.1978.80.1.02a00020; Faith JT, 2012, PALAEOGEOGR PALAEOCL, V361, P84, DOI 10.1016/j.palaeo.2012.08.005; Guth A., 2013, GEOLOGY MAGADI AREA; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hublin JJ, 2017, NATURE, V546, P289, DOI 10.1038/nature22336; Isaac G.L., 1977, OLORGESAILIE ARCHEOL; Kelly Robert L, 2013, LIFEWAYS HUNTER GATH; Levin NE, 2013, COMPILATION E AFRICA; Lorenzen ED, 2012, MOL ECOL, V21, P3656, DOI 10.1111/j.1365-294X.2012.05650.x; Marsden M., 1979, THESIS; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McDougall I, 2008, J HUM EVOL, V55, P409, DOI 10.1016/j.jhevol.2008.05.012; Melson WG, 2002, J ARCHAEOL SCI, V29, P307, DOI 10.1006/jasc.2001.0695; Noll M. P., 2000, THESIS; Potts R, 1996, SCIENCE, V273, P922, DOI 10.1126/science.273.5277.922; POTTS R, 1995, QUATERNARY RES, V43, P106, DOI 10.1006/qres.1995.1010; Potts R, 2015, J HUM EVOL, V87, P5, DOI 10.1016/j.jhevol.2015.06.014; Richter D, 2017, NATURE, V546, P293, DOI 10.1038/nature22335; Siepielski AM, 2017, SCIENCE, V355, P959, DOI 10.1126/science.aag2773; Trauth MH, 2005, SCIENCE, V309, P2051, DOI 10.1126/science.1112964; Tryon CA, 2013, CURR ANTHROPOL, V54, pS234, DOI 10.1086/673752; Vazquez DP, 2017, BIOL REV, V92, P22, DOI 10.1111/brv.12216; Vrba E.S., 1980, P247; WINTERHALDER B, 1986, J ANTHROPOL ARCHAEOL, V5, P369, DOI 10.1016/0278-4165(86)90017-6; YELLEN J, 1972, WORLD ARCHAEOL, V4, P244, DOI 10.1080/00438243.1972.9979535	37	90	91	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2018	360	6384					86	+		10.1126/science.aao2200	http://dx.doi.org/10.1126/science.aao2200			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB7OE	29545506				2022-12-28	WOS:000429263100051
J	Topalidou, I				Topalidou, Irini			The freedom of choice	SCIENCE			English	Editorial Material								A postdoc friend recently called me to discuss his career options. He didn't want to run his own lab, he said. Instead, he wanted to become a research scientist, mainly working at the bench-like me. I sensed that his mind was already made up, but he needed validation about pursuing a path that is not generally thought of as a professional success. Our conversation got me thinking about my own decision to become a research scientist-and about other career choices I made that went against the norm.	[Topalidou, Irini] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Topalidou, I (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.		Idnurm, Alexander/GPX-9055-2022; Idnurm, Alexander/K-8558-2013; Topalidou, Irini/ABG-2833-2020	Idnurm, Alexander/0000-0001-5995-7040; Idnurm, Alexander/0000-0001-5995-7040; 					0	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2018	359	6382			SI		1434	1434		10.1126/science.359.6382.1434	http://dx.doi.org/10.1126/science.359.6382.1434			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA0ZG	29567717				2022-12-28	WOS:000428043600050
J	Choi, IJ; Kook, MC; Kim, YI; Cho, SJ; Lee, JY; Kim, CG; Park, B; Nam, BH				Choi, Il Ju; Kook, Myeong-Cherl; Kim, Young-Il; Cho, Soo-Jeong; Lee, Jong Yeul; Kim, Chan Gyoo; Park, Boram; Nam, Byung-Ho			Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOSCOPIC RESECTION; ERADICATION; INFECTION; RISK; CLASSIFICATION; CARCINOMA; TUMORS; KOREA	BACKGROUND Patients with early gastric cancers that are limited to gastric mucosa or submucosa usually have an advanced loss of mucosal glandular tissue (glandular atrophy) and are at high risk for subsequent (metachronous) development of new gastric cancer. The long-term effects of treatment to eradicate Helicobacter pylori on histologic improvement and the prevention of metachronous gastric cancer remain unclear. METHODS In this prospective, double-blind, placebo-controlled, randomized trial, we assigned 470 patients who had undergone endoscopic resection of early gastric cancer or high-grade adenoma to receive either H. pylori eradication therapy with antibiotics or placebo. Two primary outcomes were the incidence of metachronous gastric cancer detected on endoscopy performed at the 1-year follow-up or later and improvement from baseline in the grade of glandular atrophy in the gastric corpus lesser curvature at the 3-year follow-up. RESULTS A total of 396 patients were included in the modified intention-to-treat analysis population (194 in the treatment group and 202 in placebo group). During a median follow-up of 5.9 years, metachronous gastric cancer developed in 14 patients (7.2%) in the treatment group and in 27 patients (13.4%) in the placebo group (hazard ratio in the treatment group, 0.50; 95% confidence interval, 0.26 to 0.94; P = 0.03). Among the 327 patients in the subgroup that underwent histologic analysis, improvement from baseline in the atrophy grade at the gastric corpus lesser curvature was observed in 48.4% of the patients in the treatment group and in 15.0% of those in the placebo group (P<0.001). There were no serious adverse events; mild adverse events were more common in the treatment group (42.0% vs. 10.2%, P<0.001). CONCLUSIONS Patients with early gastric cancer who received H. pylori treatment had lower rates of metachronous gastric cancer and more improvement from baseline in the grade of gastric corpus atrophy than patients who received placebo.	[Choi, Il Ju; Kook, Myeong-Cherl; Kim, Young-Il; Cho, Soo-Jeong; Lee, Jong Yeul; Kim, Chan Gyoo] Natl Canc Ctr, Ctr Gastr Canc, 323 Ilsan Ro, Goyang 10408, South Korea; [Park, Boram; Nam, Byung-Ho] Natl Canc Ctr, Res Inst, Biometr Res Branch, Goyang, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Choi, IJ (corresponding author), Natl Canc Ctr, Ctr Gastr Canc, 323 Ilsan Ro, Goyang 10408, South Korea.	cij1224@ncc.re.kr	Choi, Il Ju/P-8654-2018	Choi, Il Ju/0000-0002-8339-9824; Park, Boram/0000-0003-2683-8795; CHO, SOO-JEONG/0000-0001-7144-0589	National Cancer Center, South Korea	National Cancer Center, South Korea	Funded by the National Cancer Center, South Korea.	Ajani JA, 2016, J NATL COMPR CANC NE, V14, P1286, DOI 10.6004/jnccn.2016.0137; [Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V61, P1; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Asada K, 2015, GUT, V64, P388, DOI 10.1136/gutjnl-2014-307094; Asaka M, 2010, INTERNAL MED, V49, P633, DOI 10.2169/internalmedicine.49.3470; Chey WD, 2017, AM J GASTROENTEROL, V112, P212, DOI 10.1038/ajg.2016.563; Chiba T, 2012, GASTROENTEROLOGY, V143, P550, DOI 10.1053/j.gastro.2012.07.009; Cho SJ, 2013, ALIMENT PHARM THER, V38, P1292, DOI 10.1111/apt.12515; Choi J, 2014, CLIN GASTROENTEROL H, V12, P793, DOI 10.1016/j.cgh.2013.09.057; Chon Ilyoung, 2013, Korean J Gastroenterol, V61, P307; CORREA P, 1995, AM J SURG PATHOL, V19, pS37; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Ford AC, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3174; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Hamilton SR, 2000, WHO CLASSIFICATION T; Japanese Gastr Canc Assoc, 2021, GASTRIC CANCER, V24, P1, DOI [10.1007/s10120-020-01042-y, 10.1007/s10120-016-0622-4]; Jun JK, 2017, GASTROENTEROLOGY, V152, P1319, DOI 10.1053/j.gastro.2017.01.029; Kim YI, 2016, CANCER RES TREAT, V48, P1020, DOI 10.4143/crt.2015.264; Kong YJ, 2014, WORLD J GASTROENTERO, V20, P5903, DOI 10.3748/wjg.v20.i19.5903; Lee JH, 2014, J GASTRIC CANCER, V14, P87, DOI [10.5230/jgc.2014.14.2.87, 10.7583/JKGS.2014.14.5.87]; Lee SE, 2012, J GASTRIC CANCER, V12, P81, DOI [10.5230/jgc.2012.12.2.81, 10.5230/jgc.2012.12.2.88]; Lee SW, 2015, J KOREAN MED SCI, V30, P1001, DOI 10.3346/jkms.2015.30.8.1001; Lee YC, 2016, GASTROENTEROLOGY, V150, P1113, DOI 10.1053/j.gastro.2016.01.028; Li WQ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju116; Ma JL, 2012, J NATL CANCER I, V104, P488, DOI 10.1093/jnci/djs003; Maehata Y, 2012, GASTROINTEST ENDOSC, V75, P39, DOI 10.1016/j.gie.2011.08.030; Malfertheiner P, 2017, GUT, V66, P6, DOI 10.1136/gutjnl-2016-312288; Mori G, 2016, GASTRIC CANCER, V19, P911, DOI 10.1007/s10120-015-0544-6; Murakami K, 2012, CLIN J GASTROENTEROL, V5, P247, DOI 10.1007/s12328-012-0317-2; NOMURA A, 1991, NEW ENGL J MED, V325, P1132, DOI 10.1056/NEJM199110173251604; Pan KF, 2016, GUT, V65, P9, DOI 10.1136/gutjnl-2015-309197; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Rokkas T, 2007, HELICOBACTER, V12, P32, DOI 10.1111/j.1523-5378.2007.00563.x; Schlemper RJ, 2000, GUT, V47, P251, DOI 10.1136/gut.47.2.251; Shimizu N, 2000, CANCER RES, V60, P1512; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Uemura N, 1997, CANCER EPIDEM BIOMAR, V6, P639; Wong BCY, 2004, JAMA-J AM MED ASSOC, V291, P187, DOI 10.1001/jama.291.2.187; Yoon SB, 2014, HELICOBACTER, V19, P243, DOI 10.1111/hel.12146	39	323	355	6	98	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2018	378	12					1085	1095		10.1056/NEJMoa1708423	http://dx.doi.org/10.1056/NEJMoa1708423			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ9OV	29562147	Bronze			2022-12-28	WOS:000427942300005
J	Dodgson, SE				Dodgson, Stacie E.			There Will Be Blood Tests	CELL			English	Editorial Material														Dodgson, Stacie/0000-0002-6622-5507				Cohen JD, 2018, SCIENCE, V359, P926, DOI 10.1126/science.aar3247; Nakamura A, 2018, NATURE, V554, P249, DOI 10.1038/nature25456	2	4	4	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 22	2018	173	1					1	3		10.1016/j.cell.2018.03.012	http://dx.doi.org/10.1016/j.cell.2018.03.012			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GA3MT	29570990	Bronze			2022-12-28	WOS:000428234200001
J	Kneeland, PP; Burden, M				Kneeland, Patrick P.; Burden, Marisha			Inpatient Notes: Patient Experience as a Health Care Value Domain in Hospitals	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kneeland, Patrick P.] Univ Colorado Hosp, Aurora, CO USA; [Burden, Marisha] Denver Hlth, Denver, CO USA	University of Colorado System; University of Colorado Hospital; Denver Health Medical Center	Kneeland, PP (corresponding author), Univ Colorado Hlth, Anschutz Inpatient Pavil,12605 East 16th Ave, Aurora, CO 80045 USA.	patrick.kneeland@ucdenver.edu	Burden, Marisha/AAN-5555-2021	Burden, Marisha/0000-0002-8262-3994				Boissy A, 2016, J GEN INTERN MED, V31, P755, DOI 10.1007/s11606-016-3597-2; Doyle C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001570; Rudolph MA, 2016, THE HOSPITALIST  JAN; Wolf JA, 2014, PATIENT EXPERIENCE J, V1	4	4	4	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2018	168	6					HO2	HO3		10.7326/M18-0231	http://dx.doi.org/10.7326/M18-0231			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ8AM	29554686				2022-12-28	WOS:000427827400001
J	Olszewski, TM				Olszewski, Todd M.			Lost in Translation: Linking Biomedical Research and Clinical Practice at the National Institutes of Health, 1977 to 2013	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CONSENSUS DEVELOPMENT PROGRAM; INFANT HEARING IMPAIRMENT; CONFERENCES		[Olszewski, Todd M.] Providence Coll, 1 Cunningham Sq, Providence, RI 02918 USA	Providence College	Olszewski, TM (corresponding author), Providence Coll, 1 Cunningham Sq, Providence, RI 02918 USA.	tolszews@providence.edu	Olszewski, Todd/AAC-6514-2021					[Anonymous], 2017, Obstet Gynecol, V130, pe1, DOI 10.1097/AOG.0000000000002158; [Anonymous], 1997, NIH Consens Statement, V15, P1; [Anonymous], 1990, CONVULSIVE THER, V6, P85; [Anonymous], 1993, NIH Consens Statement, V11, P1; [Anonymous], 1977, RESP NAT I HLTH HLTH; [Anonymous], 1997, WASH POST, pA10; [Anonymous], 2010, BODIES KNOWLEDGE SEX; [Anonymous], 2012, OMAR ASS ODP, V64, P5; [Anonymous], 1982, NY TIMES, pA30; [Anonymous], 1984, NIH CONSENSUS STATE, V5, P1; Baumol, 2012, COST DIS; BESS FH, 1994, PEDIATRICS, V93, P330; Boffey Philip, 1984, NY TIMES        0828, pA1; Epstein Steven., 1996, IMPURE SCI; Ferguson JH, 1996, INT J TECHNOL ASSESS, V12, P460; FERGUSON JH, 1993, ANN NY ACAD SCI, V703, P180, DOI 10.1111/j.1749-6632.1993.tb26348.x; Fredrickson DS, 1975, PURPOSES NATL I HLTH; Institute of Medicine, 1990, CONS DEV NIH IMPR PR; JACOBY I, 1983, KNOWLEDGE, V5, P245, DOI 10.1177/107554708300500206; Kalichman S., 1997, AIDS BEHAV, V1, P203; Kanouse DE, 1989, CHANGING MED PRACTIC; KOSECOFF J, 1987, JAMA-J AM MED ASSOC, V258, P2708, DOI 10.1001/jama.258.19.2708; MARKLE GE, 1987, MILBANK Q, V65, P1, DOI 10.2307/3350011; MAY WE, 1985, JAMA-J AM MED ASSOC, V254, P1077, DOI 10.1001/jama.254.8.1077; National Institutes of Health, 2017, CONS DEV PROGR; National Institutes of Health, 1985, NIH CONSENSUS STATE, V5, P1; Olszewski TM, 2015, J HIST MED ALL SCI, V70, P218, DOI 10.1093/jhmas/jru001; Public Health Service; National Institutes of Health, 1978, FR              1013, V43, P47285; Reverby Susan M., 2009, EXAMINING TUSKEGEE I; Rogal D., 1984, LAY PRESS CONSENSUS; Rothman D., 1991, STRANGERS BEDSIDE HI, DOI DOI 10.4324/9781315130286; Sadowsky J., 2016, ELECTROCONVULSIVE TH; SchmeckJr HM, 1988, NEW YORK TIMES  0505; Solomon M., 2015, MAKING MED KNOWLEDGE; Squire S., 1987, NY TIMES, pSM78; Starr P, 1982, SOCIAL TRANSFORMATIO; Timmermans S, 2003, GOLD STANDARD CHALLE; Tone A., 2001, DEVICES DESIRES HIST; Weisz G, 2007, MILBANK Q, V85, P691, DOI 10.1111/j.1468-0009.2007.00505.x; Whelton PK, 2018, J AM COLL CARDIOL, V71, pE127, DOI 10.1016/j.jacc.2017.11.006; WHITE KR, 1995, INT J PEDIATR OTORHI, V32, P201, DOI 10.1016/0165-5876(95)01165-8; Working Group of the Advisory Committee to the Director to Review the Office of Medical Applications of Research, 1999, REP WORK GROUP ADV C; WORTMAN PM, 1988, J HEALTH POLIT POLIC, V13, P469, DOI 10.1215/03616878-13-3-469; Ziegler J., 1984, ULTRASOUND SAFE UNSA	44	0	0	3	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2018	168	6					431	+		10.7326/M17-2418	http://dx.doi.org/10.7326/M17-2418			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ8AM	29554683				2022-12-28	WOS:000427827400018
J	Voelker, R				Voelker, Rebecca			Smart Watch Detects Seizures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	3	3	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2018	319	11					1086	1086		10.1001/jama.2018.1809	http://dx.doi.org/10.1001/jama.2018.1809			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HI0BJ	29558540				2022-12-28	WOS:000456106800005
J	Dwyer-Lindgren, L; Bertozzi-Villa, A; Stubbs, RW; Morozoff, C; Shirude, S; Unutzer, J; Naghavi, M; Mokdad, AH; Murray, CJL				Dwyer-Lindgren, Laura; Bertozzi-Villa, Amelia; Stubbs, Rebecca W.; Morozoff, Chloe; Shirude, Shreya; Unutzer, Jurgen; Naghavi, Mohsen; Mokdad, Ali H.; Murray, Christopher J. L.			Trends and Patterns of Geographic Variation in Mortality From Substance Use Disorders and Intentional Injuries Among US Counties, 1980-2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; RATES; ACCESS; LEVEL; DEATH; DRUG	IMPORTANCE Substance use disorders, including alcohol use disorders and drug use disorders, and intentional injuries, including self-harm and interpersonal violence, are important causes of early death and disability in the United States. OBJECTIVE To estimate age-standardized mortality rates by county from alcohol use disorders, drug use disorders, self-harm, and interpersonal violence in the United States. DESIGN AND SETTING Validated small-area estimation models were applied to deidentified death records from the National Center for Health Statistics (NCHS) and population counts from the US Census Bureau, NCHS, and the Human Mortality Database to estimate county-level mortality rates from 1980 to 2014 for alcohol use disorders, drug use disorders, self-harm, and interpersonal violence. EXPOSURES County of residence. MAIN OUTCOMES AND MEASURES Age-standardized mortality rates by US county (N = 3110), year, sex, and cause. RESULTS Between 1980 and 2014, there were 2 848 768 deaths due to substance use disorders and intentional injuries recorded in the United States. Mortality rates from alcohol use disorders (n = 256 432), drug use disorders (n = 542 501), self-harm (n = 1 289 086), and interpersonal violence (n = 760 749) varied widely among counties. Mortality rates decreased for alcohol use disorders, self-harm, and interpersonal violence at the national level between 1980 and 2014; however, over the same period, the percentage of counties in which mortality rates increased for these causes was 65.4% for alcohol use disorders, 74.6% for self-harm, and 6.6% for interpersonal violence. Mortality rates from drug use disorders increased nationally and in every county between 1980 and 2014, but the relative increase varied from 8.2% to 8369.7%. Relative and absolute geographic inequalities in mortality, as measured by comparing the 90th and 10th percentile among counties, decreased for alcohol use disorders and interpersonal violence but increased substantially for drug use disorders and self-harm between 1980 and 2014. CONCLUSIONS AND RELEVANCE Mortality due to alcohol use disorders, drug use disorders, self-harm, and interpersonal violence varied widely among US counties, both in terms of levels of mortality and trends. These estimates may be useful to inform efforts to target prevention, diagnosis, and treatment to improve health and reduce inequalities.	[Dwyer-Lindgren, Laura; Bertozzi-Villa, Amelia; Stubbs, Rebecca W.; Morozoff, Chloe; Shirude, Shreya; Naghavi, Mohsen; Mokdad, Ali H.; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, 2301 Fifth Ave,Ste 600, Seattle, WA 98121 USA; [Unutzer, Jurgen] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98121 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 Fifth Ave,Ste 600, Seattle, WA 98121 USA.	cjlm@uw.edu	Mokdad, Ali H./AAD-1232-2022; Unutzer, Jurgen/N-4048-2018	Mokdad, Ali H./0000-0002-4994-3339; Dwyer-Lindgren, Laura/0000-0002-3872-6451	NATIONAL INSTITUTE ON AGING [P30AG047845] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BAKER SP, 1988, J TRAUMA, V28, P741, DOI 10.1097/00005373-198806000-00003; Case A, BROOKINGS PAPERS EC; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Devine OJ, 1991, INJURY MORTALITY ATL; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr7103a1, 10.1001/jama.2016.1464]; Dwyer-Lindgren L, 2016, JAMA-J AM MED ASSOC, V316, P2385, DOI 10.1001/jama.2016.13645; FIENBERG SE, 1970, ANN MATH STAT, V41, P907, DOI 10.1214/aoms/1177696968; Fingerhut LA, 1998, JAMA-J AM MED ASSOC, V280, P423, DOI 10.1001/jama.280.5.423; GBD 2015 Risk Factors Collaborators, 2016, Lancet, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Institute for Health Metrics and Evaluation University ofWashington, US HLTH MAP; Kim D, 2009, AM J PUBLIC HEALTH, V99, P402, DOI 10.2105/AJPH.2008.136937; Knorr-Held L, 2000, STAT MED, V19, P2555, DOI 10.1002/1097-0258(20000915/30)19:17/18<2555::AID-SIM587>3.0.CO;2-#; Kristensen K, 2016, J STAT SOFTW, V70, P1; Lang M, 2013, HEALTH ECON, V22, P73, DOI 10.1002/hec.1816; Leroux B, 2000, STAT MODELS EPIDEMIO, DOI [10.1007/978-1-4612-1284-3_4, DOI 10.1007/978-1-4612-1284-3_4]; Mokdad AH, 2017, JAMA-J AM MED ASSOC, V317, P388, DOI 10.1001/jama.2016.20324; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; National Center for Health Statistics, 2012, BRIDG RAC INT EST RE; National Center for Health Statistics, 2015, VINT 2014 POSTC EST; National Center for Health Statistics, 2004, BRIDG RAC INT EST RE; National Vital Statistics System, MULT CAUS DEATH DAT; Nkhoma Ella T, 2004, Int J Health Geogr, V3, P25, DOI 10.1186/1476-072X-3-25; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Pickle LW, 1996, AMERICAN STATISTICAL ASSOCIATION - 1996 PROCEEDINGS OF THE SECTION ON STATISTICAL GRAPHICS, P40; Rossen LM, 2013, AM J PREV MED, V45, pE19, DOI 10.1016/j.amepre.2013.07.012; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; Sarchiapone M, 2011, INT J ENV RES PUB HE, V8, P4550, DOI 10.3390/ijerph8124550; United States Census Bureau, 2009, INT COUNT EST AG SEX; University of California Berkeley Max Planck Institute for Demographic Research, HUM MORTALITY DATAB; US Department of Health and Human Services Office of the Surgeon General, 2016, SURG GEN REPORT ALCO; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Yip PSF, 2012, LANCET, V379, P2393, DOI 10.1016/S0140-6736(12)60521-2	32	64	64	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2018	319	10					1013	1023		10.1001/jama.2018.0900	http://dx.doi.org/10.1001/jama.2018.0900			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ0HS	29536097	Green Published, Bronze			2022-12-28	WOS:000427249700018
J	Metz, LM; Liu, WQ				Metz, Luanne M.; Liu, Wei-Qiao			Effective treatment of progressive MS remains elusive	LANCET			English	Editorial Material							MULTIPLE-SCLEROSIS; TRIAL DESIGN; PATHOLOGY		[Metz, Luanne M.] Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 2T9, Canada; Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 2T9, Canada	University of Calgary; University of Calgary	Metz, LM (corresponding author), Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 2T9, Canada.	lmetz@ucalgary.ca			Roche; Biogen Idec; EMD Serono; Novartis	Roche(Roche Holding); Biogen Idec(Biogen); EMD Serono; Novartis(Novartis)	LMM has received grants from Roche and Biogen Idec, and personal fees from EMD Serono. LMM was a back-up treating neurologist for this clinical trial. WQL has received personal fees from Novartis, and personal fees and grants from EMD Serono. WQL served as a back-up EDSS examiner for this trial at the University of Calgary site.	Auricchio F, 2017, EXPERT OPIN DRUG SAF, V16, P1359, DOI 10.1080/14740338.2017.1388371; Dutta R, 2014, CURR OPIN NEUROL, V27, P271, DOI 10.1097/WCO.0000000000000094; Fox RJ, 2017, MULT SCLER J, V23, P1573, DOI 10.1177/1352458517729768; Fox RJ, 2012, MULT SCLER J, V18, P1534, DOI 10.1177/1352458512458169; Hobart J, 2013, NEUROLOGY, V80, P1509, DOI 10.1212/WNL.0b013e31828cf7f3; Kappos L, 2018, LANCET; Lassmann H, 2012, NAT REV NEUROL, V8, P647, DOI 10.1038/nrneurol.2012.168; Lublin F, 2016, LANCET, V387, P1075, DOI 10.1016/S0140-6736(15)01314-8; Ontaneda D, 2017, LANCET, V389, P1357, DOI 10.1016/S0140-6736(16)31320-4; Ontaneda D, 2015, LANCET NEUROL, V14, P208, DOI 10.1016/S1474-4422(14)70264-9; Pardini M, 2017, MULT SCLER J, V23, P1642, DOI 10.1177/1352458517729461	11	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 31	2018	391	10127					1239	1240		10.1016/S0140-6736(18)30426-4	http://dx.doi.org/10.1016/S0140-6736(18)30426-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GB1DR	29576503				2022-12-28	WOS:000428791600004
J	Apte, RS				Apte, Rajendra S.			Gene Therapy for Retinal Degeneration	CELL			English	Editorial Material								Biallelic mutations in the RPE65 gene are associated with inherited retinal degenerations/dystrophies (IRD) and disrupt the visual cycle, leading to loss of vision. A new adenoviral vector-based gene therapy surgically delivered to retinal cells provides normal human RPE65 protein that can restore the visual cycle and some vision.	[Apte, Rajendra S.] Washington Univ, Sch Med, 660 South Euclid Ave,Box 8096, St Louis, MO 63110 USA	Washington University (WUSTL)	Apte, RS (corresponding author), Washington Univ, Sch Med, 660 South Euclid Ave,Box 8096, St Louis, MO 63110 USA.	apte@wustl.edu							0	42	44	3	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 22	2018	173	1					5	5		10.1016/j.cell.2018.03.021	http://dx.doi.org/10.1016/j.cell.2018.03.021			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GA3MT	29570997	Bronze			2022-12-28	WOS:000428234200002
J	Cusanovich, DA; Reddington, JP; Garfield, DA; Daza, RM; Aghamirzaie, D; Marco-Ferreres, R; Pliner, HA; Christiansen, L; Qiu, XJ; Steemers, FJ; Trapnell, C; Shendure, J; Furlong, EEM				Cusanovich, Darren A.; Reddington, James P.; Garfield, David A.; Daza, Riza M.; Aghamirzaie, Delasa; Marco-Ferreres, Raquel; Pliner, Hannah A.; Christiansen, Lena; Qiu, Xiaojie; Steemers, Frank J.; Trapnell, Cole; Shendure, Jay; Furlong, Eileen E. M.			The cis-regulatory dynamics of embryonic development at single-cell resolution	NATURE			English	Article							GATA FACTOR SERPENT; DROSOPHILA MESODERM; READ ALIGNMENT; T-SNE; CHROMATIN; EXPRESSION; GENE; TRANSPOSITION; MESENDODERM; ENDODERM	Understanding how gene regulatory networks control the progressive restriction of cell fates is a long-standing challenge. Recent advances in measuring gene expression in single cells are providing new insights into lineage commitment. However, the regulatory events underlying these changes remain unclear. Here we investigate the dynamics of chromatin regulatory landscapes during embryogenesis at single-cell resolution. Using single cell combinatorial indexing assay for transposase accessible chromatin with sequencing (sci-ATAC-seq)(1), we profiled chromatin accessibility in over 20,000 single nuclei from fixed Drosophila melanogaster embryos spanning three landmark embryonic stages: 2-4 h after egg laying (predominantly stage 5 blastoderm nuclei), when each embryo comprises around 6,000 multipotent cells; 6-8 h after egg laying (predominantly stage 10-11), to capture a midpoint in embryonic development when major lineages in the mesoderm and ectoderm are specified; and 10-12 h after egg laying (predominantly stage 13), when each of the embryo's more than 20,000 cells are undergoing terminal differentiation. Our results show that there is spatial heterogeneity in the accessibility of the regulatory genome before gastrulation, a feature that aligns with future cell fate, and that nuclei can be temporally ordered along developmental trajectories. During mid-embryogenesis, tissue granularity emerges such that individual cell types can be inferred by their chromatin accessibility while maintaining a signature of their germ layer of origin. Analysis of the data reveals overlapping usage of regulatory elements between cells of the endoderm and non-myogenic mesoderm, suggesting a common developmental program that is reminiscent of the mesendoderm lineage in other species(2-4). We identify 30,075 distal regulatory elements that exhibit tissue-specific accessibility. We validated the germ-layer specificity of a subset of these predicted enhancers in transgenic embryos, achieving an accuracy of 90%. Overall, our results demonstrate the power of shotgun single-cell profiling of embryos to resolve dynamic changes in the chromatin landscape during development, and to uncover the cis-regulatory programs of metazoan germ layers and cell types.	[Cusanovich, Darren A.; Daza, Riza M.; Aghamirzaie, Delasa; Pliner, Hannah A.; Qiu, Xiaojie; Trapnell, Cole; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Reddington, James P.; Garfield, David A.; Marco-Ferreres, Raquel; Furlong, Eileen E. M.] EMBL, Genome Biol Unit, Heidelberg, Germany; [Christiansen, Lena; Steemers, Frank J.] Illumina, San Diego, CA USA; [Shendure, Jay] Howard Hughes Med Inst, Seattle, WA USA; [Garfield, David A.] Humboldt Univ, IRI Life Sci, Berlin, Germany	University of Washington; University of Washington Seattle; European Molecular Biology Laboratory (EMBL); Illumina; Howard Hughes Medical Institute; Humboldt University of Berlin	Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.; Furlong, EEM (corresponding author), EMBL, Genome Biol Unit, Heidelberg, Germany.	shendure@uw.edu; furlong@embl.de	Shendure, Jay/AAU-3684-2021; Bagher, Saeed/U-1068-2019; Daza, Riza M./HCH-4047-2022; Horwitz, Marshall/AAE-8376-2021; Garfield, David/AAG-1524-2020; Pliner, Hannah Andersen/F-3608-2015	Marco-Ferreres, Raquel/0000-0002-6109-3840; Reddington, James/0000-0001-5317-4600; Cusanovich, Darren/0000-0001-6889-0095; Furlong, Eileen/0000-0002-9544-8339; Pliner, Hannah Andersen/0000-0003-1484-6501	BMBF (TransDiag-2) funds; NIH [DP1HG007811, R01HG006283]; Paul G. Allen Family Foundation; National Heart, Lung, and Blood Institute [T32HL007828]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007828] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006283, DP1HG007811] Funding Source: NIH RePORTER	BMBF (TransDiag-2) funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul G. Allen Family Foundation; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was technically supported by the EMBL Advanced Light Microscopy, Genomics and Flow Cytometry Facilities. We thank D. Prunkard and L. Gitari in the UW-Pathology Flow Cytometry Facility for their assistance with sorting, and all members of the Furlong and Shendure laboratories for discussions and comments. This work was financially supported by BMBF (TransDiag-2) funds to E.E.M.F., and NIH (DP1HG007811 and R01HG006283) and the Paul G. Allen Family Foundation funds to J.S. D.A.C. was partly supported by T32HL007828 from the National Heart, Lung, and Blood Institute. J.S. is a Howard Hughes Medical Institute Investigator.	Amini S, 2014, NAT GENET, V46, P1343, DOI 10.1038/ng.3119; Beiman M, 1996, GENE DEV, V10, P2993, DOI 10.1101/gad.10.23.2993; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bonn S, 2012, NAT PROTOC, V7, P978, DOI 10.1038/nprot.2012.049; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cannavo E, 2017, NATURE, V541, P402, DOI 10.1038/nature20802; Cao JY, 2017, SCIENCE, V357, P661, DOI 10.1126/science.aam8940; Ciglar L, 2009, CURR OPIN CELL BIOL, V21, P754, DOI 10.1016/j.ceb.2009.10.001; CLARK HF, 1995, GENE DEV, V9, P1530, DOI 10.1101/gad.9.12.1530; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; Doe CQ, 2017, ANNU REV CELL DEV BI, V33, P219, DOI 10.1146/annurev-cellbio-111315-125210; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Fraley C, 2012, 597 U WASH; Frieda KL, 2017, NATURE, V541, P107, DOI 10.1038/nature20777; Frise E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.102; Furlong EEM, 2001, SCIENCE, V293, P1629, DOI 10.1126/science.1062660; Gallo SM, 2011, NUCLEIC ACIDS RES, V39, pD118, DOI 10.1093/nar/gkq999; Ghandi M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003711; Girardot C, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1284-2; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Hammonds AS, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r140; Karaiskos N, 2017, SCIENCE, V358, P194, DOI 10.1126/science.aan3235; Krijthe J.H., 2015, RTSNE T DISTRIBUTED; Kvon EZ, 2014, NATURE, V512, P91, DOI 10.1038/nature13395; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lecuit T, 2002, DEV CELL, V2, P425, DOI 10.1016/S1534-5807(02)00141-7; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maduro MF, 2001, MOL CELL, V7, P475, DOI 10.1016/S1097-2765(01)00195-2; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Okumura T, 2005, DEV BIOL, V278, P576, DOI 10.1016/j.ydbio.2004.11.021; Pliner H., 2017, PREPRINT; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raj B., 2017, PREPRINT; REUTER R, 1994, DEVELOPMENT, V120, P1123; Rodaway A, 2001, CELL, V105, P169, DOI 10.1016/S0092-8674(01)00307-5; Rodriguez A, 2014, SCIENCE, V344, P1492, DOI 10.1126/science.1242072; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sandmann T, 2006, NAT PROTOC, V1, P2839, DOI 10.1038/nprot.2006.383; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sethi AJ, 2012, SCIENCE, V335, P590, DOI 10.1126/science.1212867; Setty M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004271; SIMCOX AA, 1983, DEV BIOL, V97, P212, DOI 10.1016/0012-1606(83)90078-7; Spahn P, 2014, DEV BIOL, V386, P272, DOI 10.1016/j.ydbio.2013.12.012; Thomas S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r43; Tingvall TO, 2001, P NATL ACAD SCI USA, V98, P3884, DOI 10.1073/pnas.061230198; Tomancak P, 2002, GENOME BIOL, V3, P88, DOI 10.1186/gb-2002-3-12-research0088; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; van der Maaten L, 2014, J MACH LEARN RES, V15, P3221; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	53	168	170	5	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2018	555	7697					538	+		10.1038/nature25981	http://dx.doi.org/10.1038/nature25981			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ9NF	29539636	Green Accepted, Green Submitted			2022-12-28	WOS:000427937900057
J	Vicinanza, C; Aquila, I; Cianflone, E; Scalise, M; Marino, F; Mancuso, T; Fumagalli, F; Giovannone, ED; Cristiano, F; Iaccino, E; Marotta, P; Torella, A; Latini, R; Agosti, V; Veltri, P; Urbanek, K; Isidori, AM; Saur, D; Indolfi, C; Nadal-Ginard, B; Torella, D				Vicinanza, Carla; Aquila, Iolanda; Cianflone, Eleonora; Scalise, Mariangela; Marino, Fabiola; Mancuso, Teresa; Fumagalli, Francesca; Giovannone, Emilia Dora; Cristiano, Francesca; Iaccino, Enrico; Marotta, Pina; Torella, Annalaura; Latini, Roberto; Agosti, Valter; Veltri, Pierangelo; Urbanek, Konrad; Isidori, Andrea M.; Saur, Dieter; Indolfi, Ciro; Nadal-Ginard, Bernardo; Torella, Daniele			Kit(cre) knock-in mice fail to fate-map cardiac stem cells	NATURE			English	Letter							C-KIT(+) CELLS; KIT; SUFFICIENT; EXPRESSION; MOUSE		[Vicinanza, Carla; Aquila, Iolanda; Cianflone, Eleonora; Scalise, Mariangela; Marino, Fabiola; Mancuso, Teresa; Iaccino, Enrico; Marotta, Pina; Indolfi, Ciro; Nadal-Ginard, Bernardo; Torella, Daniele] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Mol & Cellular Cardiol, I-88100 Catanzaro, Italy; [Fumagalli, Francesca; Latini, Roberto] IRCCS, Ist Ric Farmacol Mario Negri, I-20156 Milan, Italy; [Giovannone, Emilia Dora; Agosti, Valter] Magna Graecia Univ Catanzaro, CIS Genom & Mol Pathol, I-88100 Catanzaro, Italy; [Cristiano, Francesca; Veltri, Pierangelo] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Bioinformat, I-88100 Catanzaro, Italy; [Torella, Annalaura] Univ Campania L Vanvitelli, Dept Biochem Biophys & Gen Pathol, I-80121 Naples, Italy; [Urbanek, Konrad] Univ Campania L Vanvitelli, Dept Expt Med, Sect Pharmacol, I-80121 Naples, Italy; [Isidori, Andrea M.] Univ Roma La Sapienza, Dept Expt Med, I-00161 Rome, Italy; [Saur, Dieter] German Canc Res Ctr, Div Translat Canc Res, D-69120 Heidelberg, Germany; [Saur, Dieter] German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Saur, Dieter] Tech Univ Munich, Klinikum Rechts Isar, Chair Translat Canc Res, Sch Med, D-81675 Munich, Germany; [Saur, Dieter] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 2, Sch Med, D-81675 Munich, Germany	Magna Graecia University of Catanzaro; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Sapienza University Rome; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Technical University of Munich; Technical University of Munich	Nadal-Ginard, B (corresponding author), Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Mol & Cellular Cardiol, I-88100 Catanzaro, Italy.	bernardo.nadalginard@gmail.com; dtorella@unicz.it	Aquila, Iolanda/AAC-2417-2022; Marotta, Pina/W-5262-2019; Isidori, Andrea/AAL-3249-2020; Latini, Roberto/AAB-1410-2020; Marotta, Pina e/K-5785-2018; Saur, Dieter/O-8355-2015; Mancuso, Teresa/ABB-2306-2021; Isidori, Andrea M./F-3062-2010; VICINANZA, CARLA/ABF-9921-2020; Fumagalli, Francesca/AAC-5078-2022; marino, fabiola/AAC-6873-2022; Scalise, Mariangela/ABD-1521-2021; Cianflone, Eleonora/AAC-6733-2022	Aquila, Iolanda/0000-0001-5096-9424; Marotta, Pina/0000-0001-6857-8325; Isidori, Andrea/0000-0002-9037-5417; Latini, Roberto/0000-0002-3729-4650; Marotta, Pina e/0000-0001-6857-8325; Saur, Dieter/0000-0001-5874-0210; Isidori, Andrea M./0000-0002-9037-5417; VICINANZA, CARLA/0000-0001-8660-6668; Fumagalli, Francesca/0000-0002-9749-4478; marino, fabiola/0000-0001-9043-6032; VELTRI, Pierangelo/0000-0003-2494-0294; Torella, Annalaura/0000-0003-2479-6018; Scalise, Mariangela/0000-0002-4417-9570; Cianflone, Eleonora/0000-0002-1675-2093; AGOSTI, Valter/0000-0001-6785-093X	CARE-MI FP7, large-scale collaborative project, M.I.U.R. [Health-F5-2010-242038]; FIRB-Futuro-in-Ricerca [RBFR12I3KA]; M.I.U.R. [2015ZTT5KB_004]; Italian Ministry of Health [GR-2010-2318945]	CARE-MI FP7, large-scale collaborative project, M.I.U.R.; FIRB-Futuro-in-Ricerca(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); M.I.U.R.(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by grants from CARE-MI FP7 (Health-F5-2010-242038) large-scale collaborative project, M.I.U.R. FIRB-Futuro-in-Ricerca (RBFR12I3KA), M.I.U.R. PRIN2015 (2015ZTT5KB_004), and the Italian Ministry of Health (GR-2010-2318945).	Aquila I, 2018, PHARMACOL RES, V127, P116, DOI 10.1016/j.phrs.2017.06.012; Bernex F, 1996, DEVELOPMENT, V122, P3023; Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039; Hatzistergos KE, 2015, P NATL ACAD SCI USA, V112, P13051, DOI 10.1073/pnas.1517201112; Heger K, 2014, EUR J IMMUNOL, V44, P296, DOI 10.1002/eji.201343731; Jensen Patricia, 2014, Methods Mol Biol, V1092, P437, DOI 10.1007/978-1-60327-292-6_26; Klein S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2626; Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011; Liu QZ, 2016, CELL RES, V26, P119, DOI 10.1038/cr.2015.143; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nadal-Ginard B, 2014, CIRC RES, V115, P415, DOI 10.1161/CIRCRESAHA.114.304676; Smith AJ, 2014, NAT PROTOC, V9, P1662, DOI 10.1038/nprot.2014.113; Sultana N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9701; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; Vicinanza C, 2017, CELL DEATH DIFFER, V24, P2101, DOI 10.1038/cdd.2017.130	15	56	57	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2018	555	7697					E1	E17		10.1038/nature25771	http://dx.doi.org/10.1038/nature25771			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ9NF	29565363				2022-12-28	WOS:000427937900001
J	Cuneo, CN				Cuneo, C. Nicholas			Collateral Damage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NEONATAL ABSTINENCE SYNDROME		[Cuneo, C. Nicholas] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Cuneo, C. Nicholas] Boston Childrens Hosp, Dept Med, Boston, MA USA; [Cuneo, C. Nicholas] Boston Med Ctr, Dept Pediat, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Boston Medical Center	Cuneo, CN (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	cncuneo@bwh.harvard.edu		Cuneo, Charles/0000-0002-5824-2243				Brown JD, 2016, JAMA PEDIATR, V170, P1110, DOI 10.1001/jamapediatrics.2016.2150; Oei JL, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2651; Uebel H, 2015, PEDIATRICS, V136, pE811, DOI 10.1542/peds.2014-2767	3	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2018	319	11					1093	1093		10.1001/jama.2018.2183	http://dx.doi.org/10.1001/jama.2018.2183			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ8LL	29558555				2022-12-28	WOS:000427860200010
J	Doshi, P				Doshi, Peter			EMA recommendation on hydroxyethyl starch solutions obscured controversy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRIAL; CHEST					pdoshi@bmj.com						Annane D, 2018, LANCET, V391, P736, DOI 10.1016/S0140-6736(18)30254-X; [Anonymous], 2016, N Engl J Med, V374, P1298, DOI 10.1056/NEJMx160007; Doshi P, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3552; Doshi P, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1571; Doshi P, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1027; European Medicines Agency, 2018, PRAC REC SUSP HYDR S; European Medicines Agency, 2013, HYDR STARCH SOL HES; FDA, 2013, FDA SAF COMM BOX WAR; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; Patel A, 2017, NEW ENGL J MED, V377, P298, DOI 10.1056/NEJMc1703337; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Roberts I, 2018, LANCET, V391, P736, DOI 10.1016/S0140-6736(18)30255-1	12	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2018	360								k1287	10.1136/bmj.k1287	http://dx.doi.org/10.1136/bmj.k1287			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB1KT	29559433				2022-12-28	WOS:000428810400008
J	Friedrich, MJ				Friedrich, M. J.			Surgical Outcomes Are Worse in African Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2018	319	11					1085	1085		10.1001/jama.2018.1791	http://dx.doi.org/10.1001/jama.2018.1791			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ8LL	29558559				2022-12-28	WOS:000427860200005
J	Vize, R				Vize, Richard			NHS The big devolution deal-or no deal?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												richard.vize@gmail.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2018	360								k1217	10.1136/bmj.k1217	http://dx.doi.org/10.1136/bmj.k1217			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB1KM	29555829				2022-12-28	WOS:000428809700002
J	Telenti, A; Steinhubl, SR; Topol, EJ				Telenti, Amalio; Steinhubl, Steven R.; Topol, Eric J.			Rethinking the medical record	LANCET			English	Editorial Material									[Telenti, Amalio; Steinhubl, Steven R.; Topol, Eric J.] Scripps Res Inst, Scripps Translat Sci Inst, La Jolla, CA 92037 USA	Scripps Research Institute	Telenti, A (corresponding author), Scripps Res Inst, Scripps Translat Sci Inst, La Jolla, CA 92037 USA.	atelenti@scripps.edu	Telenti, Amalio/AAY-1674-2021		US National Institutes of Health/National Center for Advancing Translational Sciences [UL1TR001114]; Qualcomm Foundation	US National Institutes of Health/National Center for Advancing Translational Sciences; Qualcomm Foundation	SRS and EJT are supported by the US National Institutes of Health/National Center for Advancing Translational Sciences grant UL1TR001114 and a grant from the Qualcomm Foundation	Bouayad L, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.8073; Davis S, 2017, STUD HEALTH TECHNOL, V234, P75, DOI 10.3233/978-1-61499-742-9-75; Demiris G, 2016, Yearb Med Inform, VSuppl 1, pS42, DOI 10.15265/IYS-2016-s005	3	5	5	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2018	391	10125					1013	1013		10.1016/S0140-6736(18)30538-5	http://dx.doi.org/10.1016/S0140-6736(18)30538-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ4TP	29565009				2022-12-28	WOS:000427585100013
J	McKellar, S				McKellar, Shelley			The promissory nature of artificial hearts	LANCET			English	Editorial Material									[McKellar, Shelley] Western Univ, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada	Western University (University of Western Ontario)	McKellar, S (corresponding author), Western Univ, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada.	smckell@uwo.ca						ANNAS GJ, 1983, HASTINGS CENT REP, V13, P20; DEVRIES WC, 1988, JAMA-J AM MED ASSOC, V259, P849, DOI 10.1001/jama.259.6.849; Fox R. C., 1992, SPARE PARTS ORGAN RE; Johnson K E, 1992, ASAIO J, V38, pM486, DOI 10.1097/00002480-199207000-00082; McKellar Shelley., 2018, ARTIFICIAL HEARTS AL; Rothman D., 1997, BEGINNINGS COUNT TEC	6	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 10	2018	391	10124					930	931		10.1016/S0140-6736(18)30540-3	http://dx.doi.org/10.1016/S0140-6736(18)30540-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ1UN	29536850				2022-12-28	WOS:000427363100016
J	Apelberg, BJ; Feirman, SP; Salazar, E; Corey, CG; Ambrose, BK; Paredes, A; Richman, E; Verzi, SJ; Vugrin, ED; Brodsky, NS; Rostron, BL				Apelberg, Benjamin J.; Feirman, Shari P.; Salazar, Esther; Corey, Catherine G.; Ambrose, Bridget K.; Paredes, Antonio; Richman, Elise; Verzi, Stephen J.; Vugrin, Eric D.; Brodsky, Nancy S.; Rostron, Brian L.			Potential Public Health Effects of Reducing Nicotine Levels in Cigarettes in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SMOKING-CESSATION; TOXICANT EXPOSURE; RANDOMIZED-TRIAL; MORTALITY; TOBACCO; BEHAVIOR; DEPENDENCE; REDUCTION; MEN		[Apelberg, Benjamin J.; Feirman, Shari P.; Salazar, Esther; Corey, Catherine G.; Ambrose, Bridget K.; Paredes, Antonio; Richman, Elise; Rostron, Brian L.] US FDA, Ctr Tobacco Prod, Silver Spring, MD 20993 USA; [Verzi, Stephen J.; Vugrin, Eric D.; Brodsky, Nancy S.] Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA	US Food & Drug Administration (FDA); FDA Center for Tobacco Products (CTP); United States Department of Energy (DOE); Sandia National Laboratories	Apelberg, BJ (corresponding author), US FDA, Ctr Tobacco Prod, Silver Spring, MD 20993 USA.		Verzi, Stephen/AAA-8442-2022	Verzi, Stephen/0000-0003-2152-851X	Center for Tobacco Products of the FDA	Center for Tobacco Products of the FDA	Supported by the Center for Tobacco Products of the FDA.	[Anonymous], SEL CHAR NAT FOR BOR; [Anonymous], 2014, RES 2013 NAT SURV DR; [Anonymous], 2017, ANN EST RES POP SING; Becker KM, 2008, NICOTINE TOB RES, V10, P1139, DOI 10.1080/14622200802123294; Benowitz NL, 2007, CANCER EPIDEM BIOMAR, V16, P2479, DOI 10.1158/1055-9965.EPI-07-0393; Benowitz NL, 2015, ADDICTION, V110, P1667, DOI 10.1111/add.12978; Benowitz NL, 2012, CANCER EPIDEM BIOMAR, V21, P761, DOI 10.1158/1055-9965.EPI-11-0644; Benowitz NL, 2010, NEW ENGL J MED, V362, P2295, DOI 10.1056/NEJMra0809890; BRESLAU N, 1993, DRUG ALCOHOL DEPEN, V33, P129, DOI 10.1016/0376-8716(93)90054-T; Chen J, 1998, Health Rep, V9, P39; Department of Health and Human Services, 2010, TOB SMOK CAUS DIS BI; Department of Health and Human Services, 2014, HLTH CONSMOK 50 YE; Department of Health and Human Services (US) Atlanta, 2012, PREV TOB US YOUTH YO; Dermody SS, 2015, TOB CONTROL, V24, P536, DOI 10.1136/tobaccocontrol-2014-051797; Ding YS, 2014, INT J ENV RES PUB HE, V11, P11898, DOI 10.3390/ijerph111111898; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Donny EC, 2015, NEW ENGL J MED, V373, P1340, DOI 10.1056/NEJMsa1502403; Donny EC, 2009, DRUG ALCOHOL DEPEN, V104, P23, DOI 10.1016/j.drugalcdep.2009.01.021; Enstrom JE, 1999, EPIDEMIOLOGY, V10, P500, DOI 10.1097/00001648-199909000-00007; Gottlieb S, 2017, NEW ENGL J MED, V377, P1111, DOI 10.1056/NEJMp1707409; Hatsukami DK, 2017, ADDICTION, V112, P156, DOI 10.1111/add.13603; Hatsukami DK, 2015, CANCER EPIDEM BIOMAR, V24, P472, DOI 10.1158/1055-9965.EPI-14-0739; Hatsukami DK, 2010, TOB CONTROL, V19, DOI 10.1136/tc.2009.035584; Hatsukami DK, 2010, ADDICTION, V105, P343, DOI 10.1111/j.1360-0443.2009.02780.x; Henley SJ, 2007, TOB CONTROL, V16, P22, DOI 10.1136/tc.2006.018069; Henley SJ, 2005, CANCER CAUSE CONTROL, V16, P347, DOI 10.1007/s10552-004-5519-6; Henningfield JE, 1998, TOB CONTROL, V7, P281, DOI 10.1136/tc.7.3.281; Hyndman R. J., 2007, AUTOMATIC TIME SERIE; Institute of Medicine, 2007, ENDING TOBACCO PROBL; LEE RD, 1992, J AM STAT ASSOC, V87, P659, DOI 10.2307/2290201; Levy David T, 2002, Health Care Manag Sci, V5, P113, DOI 10.1023/A:1014476916361; McRobbie H, 2016, NICOTINE TOB RES, V18, P1134, DOI 10.1093/ntr/ntv122; National Research Council, 2015, UND US ILL TOB MARK; Preston S., 2000, DEMOGRAPHY MEASURING; Scherer G, 1999, PSYCHOPHARMACOLOGY, V145, P1, DOI 10.1007/s002130051027; TAIOLI E, 1991, NEW ENGL J MED, V325, P968; Tam J, BMJ OPEN IN PRESS; Tengs TO, 2005, PREV MED, V40, P170, DOI 10.1016/j.ypmed.2004.05.017; Tidey JW, 2017, NICOTINE TOB RES, V19, P59, DOI 10.1093/ntr/ntw199; U.S. Food and Drug Administration, 2017, FDA ANN COMPR REG PL; Vugrin ED, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121008; Walker N, 2015, TOB CONTROL, V24, pE251, DOI 10.1136/tobaccocontrol-2014-051801; Walker N, 2012, ADDICTION, V107, P1857, DOI 10.1111/j.1360-0443.2012.03906.x	44	97	97	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2018	378	18					1725	1733		10.1056/NEJMsr1714617	http://dx.doi.org/10.1056/NEJMsr1714617			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GE4WO	29543114	Bronze			2022-12-28	WOS:000431218600014
J	Motovska, Z; Bhatt, DL				Motovska, Zuzana; Bhatt, Deepak L.			12 months of DAPT after acute coronary syndrome still beats 6 months	LANCET			English	Editorial Material							BLEEDING COMPLICATIONS; ANTIPLATELET TREATMENT; OUTCOMES; THERAPY; TRIAL; RISK; ACS; PCI		[Motovska, Zuzana] Charles Univ Prague, Div Acute Cardiol Cardioctr, Fac Med 3, Univ Hosp Kralovske Vinohrady, Prague 10034, Czech Republic; [Bhatt, Deepak L.] Harvard Med Sch, Brigham & Womens Hosp, Heart & Vasc Ctr, Boston, MA USA	Charles University Prague; University Hospital Vinohrady; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Motovska, Z (corresponding author), Charles Univ Prague, Div Acute Cardiol Cardioctr, Fac Med 3, Univ Hosp Kralovske Vinohrady, Prague 10034, Czech Republic.	motovska.zuzana@gmail.com	Motovska, Zuzana/J-1122-2016	Motovska, Zuzana/0000-0002-5319-473X				Bhatt DL, 2007, NEW ENGL J MED, V357, P2078, DOI 10.1056/NEJMe0706859; Connolly SJ, 2018, LANCET, V391, P205, DOI 10.1016/S0140-6736(17)32458-3; Costa F, 2017, LANCET, V389, P1025, DOI 10.1016/S0140-6736(17)30397-5; Cuisset T, 2017, EUR HEART J, V38, P3070, DOI 10.1093/eurheartj/ehx175; Giustino G, 2017, J AM COLL CARDIOL, V70, P1846, DOI 10.1016/j.jacc.2017.08.018; Hahn J. Y., 2018, LANCET; Levine GN, 2014, NAT REV CARDIOL, V11, P597, DOI 10.1038/nrcardio.2014.104; Mak KH, 2009, AM HEART J, V157, P658, DOI 10.1016/j.ahj.2008.08.031; Mehran R, 2013, LANCET, V382, P1714, DOI 10.1016/S0140-6736(13)61720-1; Motovska Z, 2018, J AM COLL CARDIOL, V71, P371, DOI 10.1016/j.jacc.2017.11.008; Sibbing D, 2017, LANCET, V390, P1747, DOI 10.1016/S0140-6736(17)32155-4; Varenhorst C, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007174	12	7	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 31	2018	391	10127					1240	1242		10.1016/S0140-6736(18)30612-3	http://dx.doi.org/10.1016/S0140-6736(18)30612-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GB1DR	29544700				2022-12-28	WOS:000428791600005
J	Cho, A				Cho, Adrian			Hawking's bid to save quantum theory from black holes He struggled to explain why black holes don't destroy information, a puzzle that may be his greatest legacy	SCIENCE			English	News Item																			0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2018	359	6382			SI		1316	1317		10.1126/science.359.6382.1316	http://dx.doi.org/10.1126/science.359.6382.1316			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA0ZG	29567686				2022-12-28	WOS:000428043600016
J	Merten, M				Merten, Martina			The forgotten ones: the misery for millions growing old in India	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												info@martina-merten.de			European Journalism Centre; Bill and Melinda Gates Foundation	European Journalism Centre; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the European Journalism Centre and the Bill and Melinda Gates Foundation. See https://health-de.journalismgrants.org/projects/the-impact-of-rising-ncds-on-elderly-and-dementia-care-in-india and www.dementiacareindia.com	Government of India, 2016, ELD IND PROF PROGR; HelpAge India, 2016, SEN CIT GUID	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2018	360								k1040	10.1136/bmj.k1040	http://dx.doi.org/10.1136/bmj.k1040			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ9GG	29549078				2022-12-28	WOS:000427917400002
J	Ott, PA; Hu, ZT; Keskin, DB; Shukla, SA; Sun, J; Bozym, DJ; Zhang, WD; Luoma, A; Giobbie-Hurder, A; Peter, L; Hen, CC; Olive, O; Arter, TAC; Li, SQ; Lieb, DJ; Eisenhaure, T; Gjini, E; Stevens, J; Lane, WJ; Javeri, I; Nellaiappan, K; Salazar, AM; Daley, H; Seaman, M; Buchbinder, EI; Yoon, CH; Harden, M; Lennon, N; Gabriel, S; Rodig, SJ; Barouch, DH; Aster, JC; Getz, G; Wucherpfennig, K; Neuberg, D; Ritz, J; Lander, ES; Fritsch, EF; Acohen, NH; Wu, CJ				Ott, Patrick A.; Hu, Zhuting; Keskin, Derin B.; Shukla, Sachet A.; Sun, Jing; Bozym, David J.; Zhang, Wandi; Luoma, Adrienne; Giobbie-Hurder, Anita; Peter, Lauren; Hen, Christina C.; Olive, Oriol; Arter, Todd A. C.; Li, Shuqiang; Lieb, David J.; Eisenhaure, Thomas; Gjini, Evisa; Stevens, Jonathan; Lane, William J.; Javeri, Indu; Nellaiappan, Kaliappanadar; Salazar, Andres M.; Daley, Heather; Seaman, Michael; Buchbinder, Elizabeth I.; Yoon, Charles H.; Harden, Maegan; Lennon, Niall; Gabriel, Stacey; Rodig, Scott J.; Barouch, Dan H.; Aster, Jon C.; Getz, Gad; Wucherpfennig, Kai; Neuberg, Donna; Ritz, Jerome; Lander, Eric S.; Fritsch, Edward F.; Acohen, Nir H.; Wu, Catherine J.			An immunogenic personal neoantigen vaccine for patients with melanoma (vol 547, pg 217, 2017)	NATURE			English	Correction													Giobbie-Hurder, Anita/AAU-6193-2021; Ritz, Jerome/C-7929-2009	Ritz, Jerome/0000-0001-5526-4669	NCI NIH HHS [R50 CA211482] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R50CA211482] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ott PA, 2017, NATURE, V547, P217, DOI 10.1038/nature22991	1	13	14	3	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2018	555	7696					402	402		10.1038/nature25145	http://dx.doi.org/10.1038/nature25145			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ3HG	29542692	Green Accepted, Bronze			2022-12-28	WOS:000427477100043
J	Horton, R				Horton, Richard			Offline: The health of our societies is in peril	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 10	2018	391	10124					922	922		10.1016/S0140-6736(18)30611-1	http://dx.doi.org/10.1016/S0140-6736(18)30611-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ1UN	29536845				2022-12-28	WOS:000427363100011
J	Sampaziotis, F				Sampaziotis, Fotios			Building better bile ducts	SCIENCE			English	Editorial Material							PLURIPOTENT STEM-CELLS		[Sampaziotis, Fotios] Univ Cambridge, Dept Med, Cambridge CB2 1TN, England	University of Cambridge	Sampaziotis, F (corresponding author), Univ Cambridge, Dept Med, Cambridge CB2 1TN, England.	fs347@cam.ac.uk						Sampaziotis F, 2017, NAT MED, V23, P954, DOI 10.1038/nm.4360; Sampaziotis F, 2017, NAT PROTOC, V12, P814, DOI 10.1038/nprot.2017.011; Sampaziotis F, 2015, NAT BIOTECHNOL, V33, P845, DOI 10.1038/nbt.3275	3	3	3	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2018	359	6380								10.1126/science.aat0964	http://dx.doi.org/10.1126/science.aat0964			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY4ZM	29590038				2022-12-28	WOS:000426835900035
J	Calonge, BN; Gayle, HD				Calonge, Bruce N.; Gayle, Helene D.			The Safety and Quality of Abortion Services in the United States: What Does the Evidence Indicate?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Calonge, Bruce N.] Univ Colorado, Sch Med, Denver, CO 80202 USA; [Calonge, Bruce N.] Univ Colorado, Sch Publ Hlth, 1600 Sherman St, Denver, CO 80203 USA; [Gayle, Helene D.] Chicago Community Trust, Chicago, IL USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Colorado School of Public Health; University of Colorado System; University of Colorado Denver	Calonge, BN (corresponding author), Univ Colorado, Sch Publ Hlth, 1600 Sherman St, Denver, CO 80203 USA.; Calonge, BN (corresponding author), Univ Colorado, Sch Med, Family Med & Epidemiol, 1600 Sherman St, Denver, CO 80203 USA.							Finer LB, 2003, PERSPECT SEX REPRO H, V35, P6, DOI 10.1111/j.1931-2393.2003.tb00079.x; Guttmacher Institute, 2017, FACT SHEET IND AB US; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI [10.17226/10027, DOI 10.17226/10027]; Institute of Medicine, 1975, LEG AB PUBL HLTH; Jatlaoui TC, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6512a1; Jones RK, 2017, PERSPECT SEX REPRO H, V49, P17, DOI 10.1363/psrh.12015; National Academies of Sciences Engineering and Medicine, 2018, SAF QUAL AB CAR US; U. S. Food and Drug Administration, 2016, HIGHL PRESCR INF	8	4	4	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2018	168	12					878	+		10.7326/M18-0662	http://dx.doi.org/10.7326/M18-0662			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GK1TE	29554694				2022-12-28	WOS:000435903500019
J	Hartvigsen, J; Hancock, MJ; Kongsted, A; Louw, Q; Ferreira, ML; Genevay, S; Hoy, D; Karppinen, J; Pransky, G; Sieper, J; Smeets, RJ; Underwood, M				Hartvigsen, Jan; Hancock, Mark J.; Kongsted, Alice; Louw, Quinette; Ferreira, Manuela L.; Genevay, Stephane; Hoy, Damian; Karppinen, Jaro; Pransky, Glenn; Sieper, Joachim; Smeets, Rob J.; Underwood, Martin		Lancet Low Back Pain Series Workin	What low back pain is and why we need to pay attention	LANCET			English	Article							PRIMARY-CARE; AXIAL SPONDYLOARTHRITIS; GLOBAL BURDEN; MUSCULOSKELETAL CONDITIONS; CLINICAL-FEATURES; PHYSICAL-ACTIVITY; PROGNOSTIC-FACTOR; OLDER-ADULTS; FACET JOINT; PREVALENCE	Low back pain is a very common symptom. It occurs in high-income, middle-income, and low-income countries and all age groups from children to the elderly population. Globally, years lived with disability caused by low back pain increased by 54% between 1990 and 2015, mainly because of population increase and ageing, with the biggest increase seen in low-income and middle-income countries. Low back pain is now the leading cause of disability worldwide. For nearly all people with low back pain, it is not possible to identify a specific nociceptive cause. Only a small proportion of people have a well understood pathological cause-eg, a vertebral fracture, malignancy, or infection. People with physically demanding jobs, physical and mental comorbidities, smokers, and obese individuals are at greatest risk of reporting low back pain. Disabling low back pain is over-represented among people with low socioeconomic status. Most people with new episodes of low back pain recover quickly; however, recurrence is common and in a small proportion of people, low back pain becomes persistent and disabling. Initial high pain intensity, psychological distress, and accompanying pain at multiple body sites increases the risk of persistent disabling low back pain. Increasing evidence shows that central pain-modulating mechanisms and pain cognitions have important roles in the development of persistent disabling low back pain. Cost, health-care use, and disability from low back pain vary substantially between countries and are influenced by local culture and social systems, as well as by beliefs about cause and effect. Disability and costs attributed to low back pain are projected to increase in coming decades, in particular in low-income and middle-income countries, where health and other systems are often fragile and not equipped to cope with this growing burden. Intensified research efforts and global initiatives are clearly needed to address the burden of low back pain as a public health problem.	[Hartvigsen, Jan; Kongsted, Alice] Univ Southern Denmark, Dept Sports Sci & Clin Biomechan, Odense, Denmark; [Hartvigsen, Jan; Kongsted, Alice] Nord Inst Chiropract & Clin Biomechan, Odense, Denmark; [Hancock, Mark J.] Macquarie Univ, Fac Med & Hlth Sci, Dept Hlth Profess, Sydney, NSW, Australia; [Louw, Quinette] Univ Stellenbosch, Fac Med & Hlth Sci, Dept Hlth & Rehabil Sci, Stellenbosch, South Africa; [Louw, Quinette] Univ Stellenbosch, Fac Med & Hlth Sci, Dept Hlth & Rehabil, Physiotherapy Div, Tygerberg, South Africa; [Ferreira, Manuela L.] Univ Sydney, Sydney Med Sch, Inst Bone & Joint Res, Sydney, NSW, Australia; [Genevay, Stephane] Univ Hosp Geneva, Div Rheumatol, Geneva, Switzerland; [Hoy, Damian] Univ Sydney, Sydney, NSW, Australia; [Karppinen, Jaro] Univ Oulu, Univ Hosp, Res Ctr Oulu, Oulu, Finland; [Pransky, Glenn] Univ Massachusetts, Med Sch, Dept Family Med & Community Hlth, Worcester, MA USA; [Sieper, Joachim] Dept Rheumatol, Charite, Campus Benjamin Franklin, Berlin, Germany; [Smeets, Rob J.] Maastricht Univ, Dept Rehabil Med, Maastricht, Netherlands; [Smeets, Rob J.] Libra Rehabil & Audiol, Eindhoven, Netherlands; [Underwood, Martin] Univ Warwick, Warwick Med Sch, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England	University of Southern Denmark; Macquarie University; Stellenbosch University; Stellenbosch University; University of Sydney; University of Geneva; University of Sydney; University of Oulu; University of Massachusetts System; University of Massachusetts Worcester; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Maastricht University; University of Warwick	Underwood, M (corresponding author), Univ Warwick, Warwick Med Sch, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England.	m.underwood@warwick.ac.uk	Maher, Christopher/AAC-6267-2019; Underwood, Martin/D-6364-2015; genevay, stephane/AAI-9560-2021; Kongsted, Alice/H-2811-2019; Smeets, Rob JEM/D-1522-2011; Costa, Luciola Menezes/B-4844-2013; genevay, stephane/AAF-2018-2020; Ferreira, Manuela/AAQ-5446-2020; Gross, Douglas P./AAF-6997-2020; Koes, Bart/K-4614-2016	Maher, Christopher/0000-0002-1628-7857; Underwood, Martin/0000-0002-0309-1708; genevay, stephane/0000-0003-4752-3186; Kongsted, Alice/0000-0001-5537-6038; Smeets, Rob JEM/0000-0002-9503-366X; Costa, Luciola Menezes/0000-0003-1859-2799; genevay, stephane/0000-0003-4752-3186; Ferreira, Manuela/0000-0002-3479-0683; Gross, Douglas P./0000-0002-2427-6277; Koes, Bart/0000-0002-0450-9969; Foster, Nadine/0000-0003-4429-9756; van Tulder, Maurits/0000-0002-7589-8471; Hartvigsen, Jan/0000-0002-5876-7410				Abrahm JL, 2004, J SUPPORT ONCOL, V2, P88; Akiyama T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002412; American Academy of Family Physicians, IM LOW BACK PAIN 201; Anema JR, 2009, J OCCUP REHABIL, V19, P419, DOI 10.1007/s10926-009-9202-3; Arnbak B, 2016, SCAND J RHEUMATOL, V45, P321, DOI 10.3109/03009742.2015.1105289; Bernstein IA, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6748; Bevan S, 2009, FIT WORK MUSCULOSKEL; Brinjikji W, 2015, AM J NEURORADIOL, V36, P2394, DOI 10.3174/ajnr.A4498; Brinjikji W, 2015, AM J NEURORADIOL, V36, P811, DOI 10.3174/ajnr.A4173; Buchbinder R, 2018, LANCET, V391, P2384, DOI 10.1016/S0140-6736(18)30488-4; Calvo-Munoz I, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-14; Campbell P, 2013, PAIN, V154, P1783, DOI 10.1016/j.pain.2013.05.035; Chad DA, 2007, NEUROL CLIN, V25, P407, DOI 10.1016/j.ncl.2007.01.003; Chiu CC, 2015, CLIN REHABIL, V29, P184, DOI 10.1177/0269215514540919; Chou R, 2010, JAMA-J AM MED ASSOC, V303, P1295, DOI 10.1001/jama.2010.344; Crombez G, 2012, CLIN J PAIN, V28, P475, DOI 10.1097/AJP.0b013e3182385392; Currie SR, 2005, PSYCHOL MED, V35, P1275, DOI 10.1017/S0033291705004952; da Silva T, 2017, J ORTHOP SPORT PHYS, V47, P305, DOI 10.2519/jospt.2017.7415; Deyo RA, 2009, J AM BOARD FAM MED, V22, P62, DOI 10.3122/jabfm.2009.01.080102; Dionne CE, 2001, J EPIDEMIOL COMMUN H, V55, P455, DOI 10.1136/jech.55.7.455; Dionne CE, 2008, SPINE, V33, P95, DOI 10.1097/BRS.0b013e31815e7f94; Downie A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7095; Dubois JD, 2014, J ELECTROMYOGR KINES, V24, P550, DOI 10.1016/j.jelekin.2014.04.012; Dudli S, 2016, EUR SPINE J, V25, P3723, DOI 10.1007/s00586-016-4459-7; Dudli S, 2016, J ORTHOP RES, V34, P1447, DOI 10.1002/jor.23265; Dunn KM, 2013, BEST PRACT RES CL RH, V27, P591, DOI 10.1016/j.berh.2013.09.007; Fabunmi A A, 2005, Afr J Med Med Sci, V34, P259; Fantoni M, 2012, EUR REV MED PHARMACO, V16, P2; Ferreira PH, 2013, EUR J PAIN, V17, P957, DOI 10.1002/j.1532-2149.2012.00277.x; Foster NE, 2018, LANCET, V391, P2368, DOI 10.1016/S0140-6736(18)30489-6; FROST H, 1995, BRIT MED J, V310, P151, DOI 10.1136/bmj.310.6973.151; Froud R, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-50; Galukande Moses, 2005, Afr Health Sci, V5, P164; Garcia JBS, 2014, PAIN PHYSICIAN, V17, P379; Goubert D, 2016, PAIN PHYSICIAN, V19, pE985; Hancock MJ, 2007, EUR SPINE J, V16, P1539, DOI 10.1007/s00586-007-0391-1; Hansson TH, 2000, SPINE, V25, P3055, DOI 10.1097/00007632-200012010-00013; Hartvigsen J, 2003, EUR SPINE J, V12, P528, DOI 10.1007/s00586-003-0542-y; Hartvigsen J, 2013, BEST PRACT RES CL RH, V27, P613, DOI 10.1016/j.berh.2013.09.008; Hartvigsen J, 2009, ARTHRIT CARE RES, V61, P1343, DOI 10.1002/art.24607; Hashemi L, 1998, J OCCUP ENVIRON MED, V40, P1110; Hendrick P, 2011, EUR SPINE J, V20, P464, DOI 10.1007/s00586-010-1616-2; Heneweer H, 2011, EUR SPINE J, V20, P826, DOI 10.1007/s00586-010-1680-7; Henschke N, 2009, ARTHRITIS RHEUM-US, V60, P3072, DOI 10.1002/art.24853; Hodges PW, 1996, SPINE, V21, P2640, DOI 10.1097/00007632-199611150-00014; Hondras M, 2016, J REHABIL MED, V48, P449, DOI 10.2340/16501977-2083; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Hoy D, 2010, BEST PRACT RES CL RH, V24, P155, DOI 10.1016/j.berh.2009.11.002; Hoy DG, 2015, ANN RHEUM DIS, V74, P4, DOI 10.1136/annrheumdis-2014-205393; Ihlebaek C, 2006, SCAND J PUBLIC HEALT, V34, P555, DOI 10.1080/14034940600552051; Itz CJ, 2013, EUR J PAIN, V17, P5, DOI 10.1002/j.1532-2149.2012.00170.x; Jackson T, 2014, J PAIN, V15, P800, DOI 10.1016/j.jpain.2014.05.002; Jackson T, 2016, ANESTH ANALG, V123, P739, DOI 10.1213/ANE.0000000000001389; Jarvik JG, 2015, JAMA-J AM MED ASSOC, V313, P1143, DOI 10.1001/jama.2015.1871; Jelsma J, 2002, DISABIL REHABIL, V24, P851, DOI 10.1080/09638280210129766; Jordan KP, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-144; Kalichman L, 2008, SPINE, V33, P2560, DOI 10.1097/BRS.0b013e318184ef95; Kamper SJ, 2016, BRAZ J PHYS THER, V16, P10; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; Kehrer M, 2014, J INFECTION, V68, P313, DOI 10.1016/j.jinf.2013.11.011; Kent PM, 2008, MANUAL THER, V13, P12, DOI 10.1016/j.math.2007.05.009; Kongsted A, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1071-2; Kongsted A, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-171; Kregel J, 2015, SEMIN ARTHRITIS RHEU, V45, P229, DOI 10.1016/j.semarthrit.2015.05.002; Kwon BK, 2011, OCCUP MED-OXFORD, V61, P541, DOI 10.1093/occmed/kqr092; Lacey RJ, 2013, EUR J PUBLIC HEALTH, V23, P534, DOI 10.1093/eurpub/cks056; Lambeek LC, 2011, SPINE, V36, P1050, DOI 10.1097/BRS.0b013e3181e70488; Lavy C, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b936; Lee H, 2015, PAIN, V156, P988, DOI 10.1097/j.pain.0000000000000146; Lemeunier N, 2012, CHIROPR MAN THER, V20, DOI 10.1186/2045-709X-20-33; Lewandrowski KU, 2011, ROTHMAN SIMEONE SPIN, P1480; Lin CWC, 2014, EUR J PAIN, V18, P455, DOI 10.1002/j.1532-2149.2013.00384.x; Louw QA, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-105; Lucchini RG, 2014, ANN GLOB HEALTH, V80, P251, DOI 10.1016/j.aogh.2014.09.006; Maas ET, 2017, EUR J PAIN, V21, P403, DOI 10.1002/ejp.963; Maas ET, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008572.pub2; Maatta JH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003495; MacNeela P, 2015, HEALTH PSYCHOL REV, V9, P63, DOI 10.1080/17437199.2013.840951; Maher C, 2017, LANCET, V389, P736, DOI 10.1016/S0140-6736(16)30970-9; Maniadakis N, 2000, PAIN, V84, P95, DOI 10.1016/S0304-3959(99)00187-6; Mash B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032358; Costa LDM, 2012, CAN MED ASSOC J, V184, pE613, DOI 10.1503/cmaj.111271; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Oncu J, 2016, J BACK MUSCULOSKELET, V29, P135, DOI 10.3233/BMR-150609; Pinheiro MB, 2016, SPINE J, V16, P105, DOI 10.1016/j.spinee.2015.10.037; Poddubnyy D, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2015-208553; Power C, 2001, AM J PUBLIC HEALTH, V91, P1671, DOI 10.2105/AJPH.91.10.1671; Qaseem A, 2017, ANN INTERN MED, V166, P514, DOI 10.7326/M16-2367; Roussel NA, 2013, CLIN J PAIN, V29, P625, DOI 10.1097/AJP.0b013e31826f9a71; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P777, DOI 10.1136/ard.2009.108233; Schoenfeld AJ, 2015, SPINE J, V15, P249, DOI 10.1016/j.spinee.2014.09.003; Schofield D, 2012, PAIN, V153, P203, DOI 10.1016/j.pain.2011.10.018; Schousboe JT, 2016, J CLIN DENSITOM, V19, P8, DOI 10.1016/j.jocd.2015.08.004; Shiri R, 2017, BRIT J SPORT MED, V51, P1410, DOI 10.1136/bjsports-2016-097352; Shiri Rahman, 2010, Am J Med, V123, DOI 10.1016/j.amjmed.2009.05.028; Shiri R, 2010, AM J EPIDEMIOL, V171, P135, DOI 10.1093/aje/kwp356; Shmagel A, 2016, ARTHRIT CARE RES, V68, P1688, DOI 10.1002/acr.22890; Sieper J, 2013, ARTHRITIS RHEUM-US, V65, P543, DOI 10.1002/art.37803; Sions JM, 2017, J ORTHOP SPORT PHYS, V47, P173, DOI 10.2519/jospt.2017.7002; Steffens D, 2014, EUR J PAIN, V18, P755, DOI 10.1002/j.1532-2149.2013.00427.x; Steffens D, 2015, ARTHRIT CARE RES, V67, P403, DOI 10.1002/acr.22533; Stochkendahl MJ, 2018, EUR SPINE J, V27, P60, DOI 10.1007/s00586-017-5099-2; Stolwijk C, 2016, ARTHRIT CARE RES, V68, P1320, DOI 10.1002/acr.22831; Taylor JB, 2014, SPINE J, V14, P2299, DOI 10.1016/j.spinee.2014.01.026; Tomkins-Lane C, 2016, SPINE, V41, P1239, DOI 10.1097/BRS.0000000000001476; Trecarichi EM, 2012, EUR REV MED PHARMACO, V16, P58; Underwood M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7432; United States Bone and Joint Initiative, 2014, BURDEN MUSCULOSKELET; van Hoeven L, 2014, ARTHRIT CARE RES, V66, P446, DOI 10.1002/acr.22180; Verwoerd AJH, 2016, EUR SPINE J, V25, P1389, DOI 10.1007/s00586-016-4393-8; Volinn E, 2005, SPINE, V30, P697, DOI 10.1097/01.brs.0000155404.32725.f8; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; Wertli MM, 2014, SPINE J, V14, P2639, DOI 10.1016/j.spinee.2014.03.003; Wertli MM, 2014, SPINE J, V14, P816, DOI 10.1016/j.spinee.2013.09.036; Wolsko P, 2000, J ALTERN COMPLEM MED, V6, P321, DOI 10.1089/10755530050120682; Wolsko PM, 2003, SPINE, V28, P292, DOI 10.1097/00007632-200302010-00018; Wong JJ, 2017, EUR J PAIN, V21, P201, DOI 10.1002/ejp.931; Zhang TT, 2018, CLIN SPINE SURG, V31, P22, DOI 10.1097/BSD.0000000000000468	119	1407	1476	33	261	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 9	2018	391	10137					2356	2367		10.1016/S0140-6736(18)30480-X	http://dx.doi.org/10.1016/S0140-6736(18)30480-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GI6WF	29573870	Green Published, Green Submitted			2022-12-28	WOS:000434643200032
J	Rigotti, NA; Chang, YC; Tindle, HA; Kalkhoran, SM; Levy, DE; Regan, S; Kelley, JHK; Davis, EM; Singer, DE				Rigotti, Nancy A.; Chang, Yuchiao; Tindle, Hilary A.; Kalkhoran, Sara M.; Levy, Douglas E.; Regan, Susan; Kelley, Jennifer H. K.; Davis, Esa M.; Singer, Daniel E.			Association of E-Cigarette Use With Smoking Cessation Among Smokers Who Plan to Quit After a Hospitalization A Prospective Study	ANNALS OF INTERNAL MEDICINE			English	Article							ELECTRONIC CIGARETTES; ADULTS	Background: Many smokers report using e-cigarettes to help them quit smoking, but whether e-cigarettes aid cessation efforts is uncertain. Objective: To determine whether e-cigarette use after hospital discharge is associated with subsequent tobacco abstinence among smokers who plan to quit and are advised to use evidence-based treatment. Design: Secondary data analysis of a randomized controlled trial. (ClinicalTrials.gov:NCT01714323 [parent trial]) Setting: 3 hospitals. Participants: 1357 hospitalized adult cigarette smokers who planned to stop smoking, received tobacco cessation counseling in the hospital, and were randomly assigned at discharge to a tobacco treatment recommendation (control) or free tobacco treatment (intervention). Measurements: Self-reported e-cigarette use (exposure) was assessed 1 and 3 months after discharge; biochemically validated tobacco abstinence (outcome) was assessed 6 months after discharge. Results: Twenty-eight percent of participants used an e-cigarette within 3 months after discharge. In an analysis of 237 propensity score-matched pairs, e-cigarette users were less likely than nonusers to abstain from tobacco use at 6 months (10.1% vs. 26.6%; risk difference, -16.5% [95% CI, -23.3% to -9.6%]). The association between e-cigarette use and quitting varied between intervention patients, who were given easy access to conventional treatment (7.7% vs. 29.8%; risk difference, -22.1% [CI, -32.3% to -11.9%]), and control patients, who received only treatment recommendations (12.0% vs. 24.1%; risk difference, -12.0% [CI, -21.2% to 2.9%]) (P for interaction = 0.143). Limitations: Patients self-selected e-cigarette use. Unmeasured confounding is possible in an observational study. Conclusion: During 3 months after hospital discharge, more than a quarter of smokers attempting to quit used e-cigarettes, mostly to aid cessation, but few used them regularly. This pattern of use was associated with less tobacco abstinence at 6 months than among smokers who did not use e-cigarettes. Additional study is needed to determine whether regular use of e-cigarettes aids or hinders smoking cessation.	[Rigotti, Nancy A.; Chang, Yuchiao; Kalkhoran, Sara M.; Levy, Douglas E.; Regan, Susan; Kelley, Jennifer H. K.; Singer, Daniel E.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Tindle, Hilary A.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Davis, Esa M.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Rigotti, Nancy A.; Chang, Yuchiao; Kalkhoran, Sara M.; Levy, Douglas E.; Kelley, Jennifer H. K.; Singer, Daniel E.] Massachusetts Gen Hosp, Div Gen Internal Med, 100 Cambridge St,Suite 1600, Boston, MA 02114 USA; [Tindle, Hilary A.] Vanderbilt Div Gen Internal Med & Publ Hlth, 2525 West End Ave,Suite 370, Nashville, TN 37203 USA; [Davis, Esa M.] Univ Pittsburgh, Med Ctr, 230 McKee Pl,Suite 600, Pittsburgh, PA 15213 USA	Harvard University; Massachusetts General Hospital; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Massachusetts General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rigotti, NA (corresponding author), Massachusetts Gen Hosp, Div Gen Internal Med, Tobacco Res & Treatment Ctr, 100 Cambridge St,Suite 1600, Boston, MA 02114 USA.; Rigotti, NA (corresponding author), Massachusetts Gen Hosp, Div Gen Internal Med, 100 Cambridge St,Suite 1600, Boston, MA 02114 USA.	nrigotti@partners.org	Levy, Douglas/W-1516-2019	Levy, Douglas/0000-0001-9446-7899	National Heart, Lung, and Blood Institute; National Heart, Lung, and Blood Institute of the National Institutes of Health [R01-HL11821]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111821] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung, and Blood Institute.; By grant R01-HL11821 from the National Heart, Lung, and Blood Institute of the National Institutes of Health.	Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Ayers JW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170702; Bhatnagar A, 2014, CIRCULATION, V130, P1418, DOI 10.1161/CIR.0000000000000107; Biener L, 2015, NICOTINE TOB RES, V17, P127, DOI 10.1093/ntr/ntu200; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Corey C, 2013, MMWR-MORBID MORTAL W, V62, P729; Delnevo CD, 2016, NICOTINE TOB RES, V18, P715, DOI 10.1093/ntr/ntv237; El Dib R, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012680; Fiore MC, 2008, TREATING TOBACCO USE; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; Hajek Peter, 2016, Lancet Respir Med, V4, pe23, DOI 10.1016/S2213-2600(16)30024-8; Hajek P, 2014, ADDICTION, V109, P1801, DOI 10.1111/add.12659; Hartmann-Boyce J, 2016, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD010216.pub3, 10.1002/14651858.CD010216.pub4]; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hitchman SC, 2015, NICOTINE TOB RES, V17, P1187, DOI 10.1093/ntr/ntv078; Hughes JR, 2003, NICOTINE TOB RES, V5, P13, DOI 10.1080/1462220031000070552; Kalkhoran S, 2016, LANCET RESP MED, V4, P116, DOI 10.1016/S2213-2600(15)00521-4; King BA, 2015, NICOTINE TOB RES, V17, P219, DOI 10.1093/ntr/ntu191; Levy DT, 2018, TOB CONTROL, V27, P18, DOI 10.1136/tobaccocontrol-2017-053759; Malas M, 2016, NICOTINE TOB RES, V18, P1926, DOI 10.1093/ntr/ntw119; Mathur MB, 2018, EPIDEMIOLOGY, V29, pE45, DOI 10.1097/EDE.0000000000000864; McNeill A., 2015, REPORT COMMISSIONED; MELCHIOR LA, 1993, EDUC PSYCHOL MEAS, V53, P1117, DOI 10.1177/0013164493053004024; Reid ZZ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1484-0; Rigotti NA, 2016, AM J PREV MED, V51, P597, DOI 10.1016/j.amepre.2016.04.005; Siu AL, 2015, ANN INTERN MED, V163, P622, DOI 10.7326/M15-2023; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581; Substance Abuse and Mental Health Services Administration (US) and Office of the Surgeon General (US), 2020, SMOK CESS REP SURG G; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Zawertailo L, 2017, NICOTINE TOB RES, V19, P183, DOI 10.1093/ntr/ntw218; Zhuang YL, 2016, TOB CONTROL, V25, pi90, DOI 10.1136/tobaccocontrol-2016-053096	31	36	36	1	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2018	168	9					613	+		10.7326/M17-2048	http://dx.doi.org/10.7326/M17-2048			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3BZ	29582077	Green Accepted			2022-12-28	WOS:000434247300003
J	She, J; Guo, JT; Chen, QF; Zeng, WZ; Jiang, YX; Bai, XC				She, Ji; Guo, Jiangtao; Chen, Qingfeng; Zeng, Weizhong; Jiang, Youxing; Bai, Xiao-chen			Structural insights into the voltage and phospholipid activation of the mammalian TPC1 channel	NATURE			English	Article							2-PORE CHANNELS; GATED SODIUM; NAADP; CA2+; CALCIUM; VALIDATION	The organellar two-pore channel (TPC) functions as a homodimer, in which each subunit contains two homologous Shaker-like six-transmembrane (6-TM)-domain repeats(1). TPCs belong to the voltage-gated ion channel superfamily(2) and are ubiquitously expressed in animals and plants(3,4). Mammalian TPC1 and TPC2 are localized at the endolysosomal membrane, and have critical roles in regulating the physiological functions of these acidic organelles(5-7). Here we present electron cryo-microscopy structures of mouse TPC1 (MmTPC1)-a voltage-dependent, phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5) P-2)-activated Na+-selective channelin both the apo closed state and ligand-bound open state. Combined with functional analysis, these structures provide comprehensive structural insights into the selectivity and gating mechanisms of mammalian TPC channels. The channel has a coin-slot-shaped ion pathway in the filter that defines the selectivity of mammalian TPCs. Only the voltage-sensing domain from the second 6-TM domain confers voltage dependence on MmTPC1. Endolysosome-specific PtdIns(3,5) P2 binds to the first 6-TM domain and activates the channel under conditions of depolarizing membrane potential. Structural comparisons between the apo and PtdIns(3,5) P-2-bound structures show the interplay between voltage and ligand in channel activation. These MmTPC1 structures reveal lipid binding and regulation in a 6-TM voltage-gated channel, which is of interest in light of the emerging recognition of the importance of phosphoinositide regulation of ion channels.	[She, Ji; Chen, Qingfeng; Zeng, Weizhong; Jiang, Youxing] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [She, Ji; Chen, Qingfeng; Zeng, Weizhong; Jiang, Youxing; Bai, Xiao-chen] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Guo, Jiangtao] Zhejiang Univ, Sch Med, Dept Biophys, Hangzhou 310058, Zhejiang, Peoples R China; [Chen, Qingfeng; Zeng, Weizhong; Jiang, Youxing] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Bai, Xiao-chen] Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Zhejiang University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Jiang, YX (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.; Jiang, YX; Bai, XC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA.; Jiang, YX (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.; Bai, XC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	youxing.jiang@utsouthwestern.edu; xiaochen.bai@utsouthwestern.edu	chen, qingfeng/J-6844-2017; She, Ji/AAW-6150-2021; Bai, Xiao-chen/HGV-1244-2022	Bai, Xiao-chen/0000-0002-4234-5686	CPRIT; Howard Hughes Medical Institute; National Institute of Health [GM079179]; Welch Foundation [I-1578]; Cancer Prevention and Research Initiative of Texas; Virginia Murchison Linthicum Scholar in Medical Research fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079179] Funding Source: NIH RePORTER	CPRIT; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Cancer Prevention and Research Initiative of Texas; Virginia Murchison Linthicum Scholar in Medical Research fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Nguyen for manuscript preparation and M. X. Zhu for providing clones of animal TPC genes. Single particle cryo-EM data were collected at the University of Texas Southwestern Medical Center (UTSW) Cryo-Electron Microscopy Facility that is funded by the CPRIT Core Facility Support Award . We thank D. Nicastro and Z. Chen for facility access and data acquisition. Negatively stained sample screening was RP170644 performed at UTSW Electron Microscopy core. This work was supported in part by the Howard Hughes Medical Institute (Y.J.) and by grants from the National Institute of Health (GM079179 to Y.J.) and the Welch Foundation (Grant I-1578 to Y.J.). X.B. is supported by the Cancer Prevention and Research Initiative of Texas and Virginia Murchison Linthicum Scholar in Medical Research fund.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ambrosio AL, 2016, P NATL ACAD SCI USA, V113, P5622, DOI 10.1073/pnas.1600108113; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Arndt L, 2014, MOL BIOL CELL, V25, P948, DOI 10.1091/mbc.E13-09-0523; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Bellono NW, 2016, SCI REP-UK, V6, DOI 10.1038/srep26570; Brailoiu E, 2010, J BIOL CHEM, V285, P38511, DOI 10.1074/jbc.M110.162073; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cang CL, 2014, NAT CHEM BIOL, V10, P463, DOI 10.1038/nchembio.1522; Cang CL, 2013, CELL, V152, P778, DOI 10.1016/j.cell.2013.01.023; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DiMaio F, 2013, PROTEIN SCI, V22, P865, DOI 10.1002/pro.2267; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Favia A, 2014, P NATL ACAD SCI USA, V111, pE4706, DOI 10.1073/pnas.1406029111; Fernandez B, 2016, AUTOPHAGY, V12, P1487, DOI 10.1080/15548627.2016.1190072; Furuichi T, 2001, PLANT CELL PHYSIOL, V42, P900, DOI 10.1093/pcp/pce145; Grimm C, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00045; Grimm C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5699; Guo JT, 2017, P NATL ACAD SCI USA, V114, P1009, DOI 10.1073/pnas.1616191114; Guo JT, 2016, NATURE, V531, P196, DOI 10.1038/nature16446; Hedrich R, 2011, MOL PLANT, V4, P428, DOI 10.1093/mp/ssr017; Hooper R, 2011, J BIOL CHEM, V286, P9141, DOI 10.1074/jbc.M110.189985; Ishibashi K, 2000, BIOCHEM BIOPH RES CO, V270, P370, DOI 10.1006/bbrc.2000.2435; Jha A, 2014, EMBO J, V33, P501, DOI 10.1002/embj.201387035; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Kintzer AF, 2016, NATURE, V531, P258, DOI 10.1038/nature17194; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Morales-Perez CL, 2016, STRUCTURE, V24, P797, DOI 10.1016/j.str.2016.03.004; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Patel S, 2017, CELL CALCIUM, V68, P1, DOI 10.1016/j.ceca.2017.09.003; Patel S, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3314; Pereira GJS, 2011, J BIOL CHEM, V286, P27875, DOI 10.1074/jbc.C110.216580; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rahman T, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005450; Rybalchenko V, 2012, J BIOL CHEM, V287, P20407, DOI 10.1074/jbc.M112.359612; Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schrodinger LLC, 2015, JYMOL MOL GRAPH DEV; Sulem P, 2008, NAT GENET, V40, P835, DOI 10.1038/ng.160; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; Yu Frank H, 2004, Sci STKE, V2004, pre15, DOI 10.1126/stke.2532004re15; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	47	106	108	8	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2018	556	7699					130	+		10.1038/nature26139	http://dx.doi.org/10.1038/nature26139			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5KP	29562233	Green Accepted			2022-12-28	WOS:000429103300049
J	Beam, AL; Kohane, IS				Beam, Andrew L.; Kohane, Isaac S.			Big Data and Machine Learning in Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Beam, Andrew L.; Kohane, Isaac S.] Harvard Med Sch, Dept Biomed Informat, 10 Shattuck St, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Beam, AL (corresponding author), Harvard Med Sch, Dept Biomed Informat, 10 Shattuck St, Boston, MA 02115 USA.	Andrew_Beam@hms.harvard.edu						BRAND RJ, 1976, CIRCULATION, V53, P348, DOI 10.1161/01.CIR.53.2.348; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Weber GM, 2014, JAMA-J AM MED ASSOC, V311, P2479, DOI 10.1001/jama.2014.4228	3	579	585	7	129	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2018	319	13					1317	1318		10.1001/jama.2017.18391	http://dx.doi.org/10.1001/jama.2017.18391			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB4NC	29532063				2022-12-28	WOS:000429035900010
J	Maier, L; Pruteanu, M; Kuhn, M; Zeller, G; Telzerow, A; Anderson, EE; Brochado, AR; Fernandez, KC; Dose, H; Mori, H; Patil, KR; Bork, P; Typas, A				Maier, Lisa; Pruteanu, Mihaela; Kuhn, Michael; Zeller, Georg; Telzerow, Anja; Anderson, Exene Erin; Brochado, Ana Rita; Fernandez, Keith Conrad; Dose, Hitomi; Mori, Hirotada; Patil, Kiran Raosaheb; Bork, Peer; Typas, Athanasios			Extensive impact of non-antibiotic drugs on human gut bacteria	NATURE			English	Article							ESCHERICHIA-COLI; MICROBIOME; SUSCEPTIBILITY; IDENTIFICATION; INHIBITORS; METFORMIN; PROTEIN; ANNOTATION; RESISTANCE; INTESTINE	A few commonly used non-antibiotic drugs have recently been associated with changes in gut microbiome composition, but the extent of this phenomenon is unknown. Here, we screened more than 1,000 marketed drugs against 40 representative gut bacterial strains, and found that 24% of the drugs with human targets, including members of all therapeutic classes, inhibited the growth of at least one strain in vitro. Particular classes, such as the chemically diverse antipsychotics, were overrepresented in this group. The effects of human-targeted drugs on gut bacteria are reflected on their antibiotic-like side effects in humans and are concordant with existing human cohort studies. Susceptibility to antibiotics and human-targeted drugs correlates across bacterial species, suggesting common resistance mechanisms, which we verified for some drugs. The potential risk of non-antibiotics promoting antibiotic resistance warrants further exploration. Our results provide a resource for future research on drug-microbiome interactions, opening new paths for side effect control and drug repurposing, and broadening our view of antibiotic resistance.	[Maier, Lisa; Pruteanu, Mihaela; Telzerow, Anja; Anderson, Exene Erin; Brochado, Ana Rita; Fernandez, Keith Conrad; Typas, Athanasios] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany; [Kuhn, Michael; Zeller, Georg; Patil, Kiran Raosaheb; Bork, Peer; Typas, Athanasios] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Dose, Hitomi; Mori, Hirotada] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma 6300101, Japan; [Bork, Peer] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Bork, Peer] Mol Med Partnership Unit, D-69120 Heidelberg, Germany; [Bork, Peer] Univ Wurzburg, Dept Bioinformat, Bioctr, D-97024 Wurzburg, Germany; [Pruteanu, Mihaela] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Nara Institute of Science & Technology; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Wurzburg; Humboldt University of Berlin	Typas, A (corresponding author), European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany.; Zeller, G; Patil, KR; Bork, P; Typas, A (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany.; Bork, P (corresponding author), Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany.; Bork, P (corresponding author), Mol Med Partnership Unit, D-69120 Heidelberg, Germany.; Bork, P (corresponding author), Univ Wurzburg, Dept Bioinformat, Bioctr, D-97024 Wurzburg, Germany.	zeller@embl.de; patil@embl.de; bork@embl.de; typas@embl.de	Bork, Peer/F-1813-2013; Maier, Lisa/ABH-1893-2021; Patil, Kiran R/B-9709-2009; Kuhn, Michael/D-4978-2009; Zeller, Georg/M-6484-2013	Bork, Peer/0000-0002-2627-833X; Maier, Lisa/0000-0002-6473-4762; Patil, Kiran R/0000-0002-6166-8640; Typas, Athanasios/0000-0002-0797-9018; Kuhn, Michael/0000-0002-2841-872X; Fernandez, Keith Conrad/0000-0003-3757-8271; Telzerow, Anja/0000-0001-9855-0809; Zeller, Georg/0000-0003-1429-7485; Pruteanu, Mihaela/0000-0003-0484-8503; Brochado, Ana Rita/0000-0003-1703-383X	European Research Council [669830] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		ARIZA RR, 1995, J BACTERIOL, V177, P1655, DOI 10.1128/jb.177.7.1655-1661.1995; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bailey CJ, 2008, DIABETOLOGIA, V51, P1552, DOI 10.1007/s00125-008-1053-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blaser MJ, 2016, SCIENCE, V352, P544, DOI 10.1126/science.aad9358; BODET CA, 1985, ANTIMICROB AGENTS CH, V28, P437, DOI 10.1128/AAC.28.3.437; Cacace Elisabetta, 2017, Curr Opin Syst Biol, V4, P35, DOI 10.1016/j.coisb.2017.05.020; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Clemente JC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500183; Deghou S, 2016, BIOINFORMATICS, V32, P2869, DOI 10.1093/bioinformatics/btw233; Roldan M, 2008, FEMS MICROBIOL REV, V32, P474, DOI 10.1111/j.1574-6976.2008.00107.x; Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552; Ejim L, 2011, NAT CHEM BIOL, V7, P348, DOI [10.1038/NCHEMBIO.559, 10.1038/nchembio.559]; Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503; Farha MA, 2015, P NATL ACAD SCI USA, V112, P11048, DOI 10.1073/pnas.1511751112; Flowers SA, 2017, PHARMACOTHERAPY, V37, P261, DOI 10.1002/phar.1890; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Gustafsson C, 1998, J BACTERIOL, V180, P359, DOI 10.1128/JB.180.2.359-365.1998; Harbut MB, 2015, P NATL ACAD SCI USA, V112, P4453, DOI 10.1073/pnas.1504022112; Hens B, 2016, J PHARM SCI-US, V105, P2677, DOI 10.1002/jps.24690; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Imhann F, 2016, GUT, V65, P740, DOI 10.1136/gutjnl-2015-310376; Jackson MA, 2016, GUT, V65, P749, DOI 10.1136/gutjnl-2015-310861; Kahrstrom CT, 2016, NATURE, V535, P47, DOI 10.1038/535047a; Kim ER, 2012, J NEUROGASTROENTEROL, V18, P94, DOI 10.5056/jnm.2012.18.1.94; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Kritikos G, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.14; Kruschke JK, 2013, J EXP PSYCHOL GEN, V142, P573, DOI 10.1037/a0029146; Kuhn M, 2016, NUCLEIC ACIDS RES, V44, pD1075, DOI 10.1093/nar/gkv1075; Kuhn M, 2014, NUCLEIC ACIDS RES, V42, pD401, DOI 10.1093/nar/gkt1207; Kultima JR, 2016, BIOINFORMATICS, V32, P2520, DOI 10.1093/bioinformatics/btw183; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Li XZ, 2015, CLIN MICROBIOL REV, V28, P337, DOI 10.1128/CMR.00117-14; MATTHEWS DA, 1977, SCIENCE, V197, P452, DOI 10.1126/science.17920; Mende DR, 2013, NAT METHODS, V10, P881, DOI [10.1038/NMETH.2575, 10.1038/nmeth.2575]; Morgan AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115225; Mori H, 2015, METHOD MOL BIOL, P45; Morita Y, 1998, ANTIMICROB AGENTS CH, V42, P1778, DOI 10.1128/AAC.42.7.1778; Mudie DM, 2014, MOL PHARMACEUT, V11, P3039, DOI 10.1021/mp500210c; Nagy E, 2011, CLIN MICROBIOL INFEC, V17, P371, DOI 10.1111/j.1469-0691.2010.03256.x; Nasie I, 2012, J BACTERIOL, V194, P6766, DOI 10.1128/JB.01318-12; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Otsuka Y, 2015, NUCLEIC ACIDS RES, V43, pD606, DOI 10.1093/nar/gku1164; Pasolli E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004977; Pritchard SE, 2014, NEUROGASTROENT MOTIL, V26, P124, DOI 10.1111/nmo.12243; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rani N, 2013, MINI-REV MED CHEM, V13, P1812; Rettedal EA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5714; Rogers M. A., 2016, CLIN MICROBIOL INFEC, V22, P171; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Sharma S, 2011, EXPERT OPIN INV DRUG, V20, P1665, DOI 10.1517/13543784.2011.628657; Spanogiannopoulos P, 2016, NAT REV MICROBIOL, V14, P273, DOI 10.1038/nrmicro.2016.17; Steinbeck C, 2006, CURR PHARM DESIGN, V12, P2111, DOI 10.2174/138161206777585274; Stringer AM, 2009, CURR DRUG METAB, V10, P79, DOI 10.2174/138920009787048419; Sulavik MC, 2001, ANTIMICROB AGENTS CH, V45, P1126, DOI 10.1128/AAC.45.4.1126-1136.2001; TABER HW, 1987, MICROBIOL REV, V51, P439, DOI 10.1128/MMBR.51.4.439-457.1987; Tramontano M, 2018, NAT MICROBIOL; Turnidge J, 2007, CLIN MICROBIOL REV, V20, P391, DOI 10.1128/CMR.00047-06; Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345	63	842	868	31	431	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2018	555	7698					623	+		10.1038/nature25979	http://dx.doi.org/10.1038/nature25979			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8UX	29555994	Green Accepted			2022-12-28	WOS:000428617600042
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Medicine must do better on gender	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							REASSIGNMENT SURGERY; COMPLICATIONS					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Caspian J, FREE SPEECH MATTERS; Creighton S, 2001, J ROY SOC MED, V94, P218, DOI 10.1177/014107680109400505; Dhejne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016885; Dreher PC, 2018, CLIN ANAT, V31, P191, DOI 10.1002/ca.23001; Hess J, 2014, DTSCH ARZTEBL INT, V111, P795, DOI 10.3238/arztebl.2014.0795; Korte A, 2008, DTSCH ARZTEBL INT, V105, P834, DOI 10.3238/arztebl.2008.0834; Office for National Statistics, 2017, QUAL RES GEND ID PHA; Raigosa M, 2015, J SEX MED, V12, P1837, DOI 10.1111/jsm.12936; Tait R, 2007, GUARDIAN; Wallien MSC, 2008, J AM ACAD CHILD PSY, V47, P1413, DOI 10.1097/CHI.0b013e31818956b9	10	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2018	360								k1312	10.1136/bmj.k1312	http://dx.doi.org/10.1136/bmj.k1312			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB5MP	29581382	Bronze, Green Published			2022-12-28	WOS:000429109200002
J	Kenney, GE; Dassama, LMK; Pandelia, ME; Gizzi, AS; Martinie, RJ; Gao, P; DeHart, CJ; Schachner, LF; Skinner, OS; Ro, SY; Zhu, X; Sadek, M; Thomas, PM; Almo, SC; Bollinger, JM; Krebs, C; Kelleher, NL; Rosenzweig, AC				Kenney, Grace E.; Dassama, Laura M. K.; Pandelia, Maria-Eirini; Gizzi, Anthony S.; Martinie, Ryan J.; Gao, Peng; DeHart, Caroline J.; Schachner, Luis F.; Skinner, Owen S.; Ro, Soo Y.; Zhu, Xiao; Sadek, Monica; Thomas, Paul M.; Almo, Steven C.; Bollinger, J. Martin, Jr.; Krebs, Carsten; Kelleher, Neil L.; Rosenzweig, Amy C.			The biosynthesis of methanobactin	SCIENCE			English	Article							METHYLOSINUS-TRICHOSPORIUM OB3B; METHANE-OXIDIZING BACTERIA; DIOXYGEN ACTIVATION; ESCHERICHIA-COLI; IRON; ENZYMES; COPPER; ACQUISITION; METAL; METALLOPHORE	Metal homeostasis poses a major challenge to microbes, which must acquire scarce elements for core metabolic processes. Methanobactin, an extensively modified copper-chelating peptide, was one of the earliest natural products shown to enable microbial acquisition of a metal other than iron. We describe the core biosynthetic machinery responsible for the characteristic posttranslational modifications that grant methanobactin its specificity and affinity for copper. A heterodimer comprising MbnB, a DUF692 family iron enzyme, and MbnC, a protein from a previously unknown family, performs a dioxygen-dependent four-electron oxidation of the precursor peptide (MbnA) to install an oxazolone and an adjacent thioamide, the characteristic methanobactin bidentate copper ligands. MbnB and MbnC homologs are encoded together and separately in many bacterial genomes, suggesting functions beyond their roles in methanobactin biosynthesis.	[Kenney, Grace E.; Dassama, Laura M. K.; Gao, Peng; DeHart, Caroline J.; Schachner, Luis F.; Skinner, Owen S.; Ro, Soo Y.; Zhu, Xiao; Sadek, Monica; Thomas, Paul M.; Kelleher, Neil L.; Rosenzweig, Amy C.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Kenney, Grace E.; Dassama, Laura M. K.; Gao, Peng; DeHart, Caroline J.; Schachner, Luis F.; Skinner, Owen S.; Ro, Soo Y.; Zhu, Xiao; Sadek, Monica; Thomas, Paul M.; Kelleher, Neil L.; Rosenzweig, Amy C.] Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA; [Pandelia, Maria-Eirini] Brandeis Univ, Dept Biochem, Waltham, MA 02453 USA; [Gizzi, Anthony S.; Almo, Steven C.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Martinie, Ryan J.; Bollinger, J. Martin, Jr.; Krebs, Carsten] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Martinie, Ryan J.; Bollinger, J. Martin, Jr.; Krebs, Carsten] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Northwestern University; Northwestern University; Brandeis University; Yeshiva University; Albert Einstein College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Rosenzweig, AC (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.; Rosenzweig, AC (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	amyr@northwestern.edu	Thomas, Paul M/A-6233-2011; Krebs, Carsten/D-4773-2009	Thomas, Paul M/0000-0003-2887-4765; Krebs, Carsten/0000-0002-3302-7053; Pandelia, Maria-Eirini/0000-0002-6750-1948; Dassama, Laura/0000-0002-0851-6373; Kenney, Grace/0000-0002-9579-3351; Martinie, Ryan/0000-0003-1257-2850; Skinner, Owen/0000-0002-5023-0029	NIH [GM118035, R01AT009143, U54-GM094662, U54 GM093342, P01 GM118303, R00GM111978, F32GM110934, T32GM105538]; NSF [MCB0842366, MCB1330784, DGE1255832]; Price Foundation; American Heart Association [14PRE20460104]; Postdoctoral Enrichment Program grant from the Burroughs Wellcome Fund; Howard Hughes Medical Institute Gilliam Fellowship; NSF GRFP grant [2014171659]; NASA Ames Research Center [NNA06CB93G]; National Resource for Translational and Developmental Proteomics under NIH [P41 GM108569]; National Cancer Institute (NCI) [CCSG P30 CA060553]; Northwestern University; State of Illinois; International Institute for Nanotechnology; Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource (NSF) [NNCI-1542205]; NCI Cancer Center Support Grant [CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT009143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM110934, U54GM094662, P41GM108569, R35GM118035, T32GM105538, U54GM093342, P01GM118303, R00GM111978] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Price Foundation; American Heart Association(American Heart Association); Postdoctoral Enrichment Program grant from the Burroughs Wellcome Fund; Howard Hughes Medical Institute Gilliam Fellowship(Howard Hughes Medical Institute); NSF GRFP grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); NASA Ames Research Center(National Aeronautics & Space Administration (NASA)); National Resource for Translational and Developmental Proteomics under NIH; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Northwestern University; State of Illinois; International Institute for Nanotechnology; Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource (NSF); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grants GM118035 (A.C.R.), R01AT009143 (N.L.K.), U54-GM094662, U54 GM093342, P01 GM118303 (S.C.A.), R00GM111978 (M.-E.P.), and F32GM110934 (L.M.K.D.), as well as NSF grants MCB0842366 (A.C.R.) and MCB1330784 (J.M.B. and C.K.) and the Price Foundation (S.C.A.). G.E.K. was supported by American Heart Association grant 14PRE20460104. L.M.K.D. was additionally funded by a Postdoctoral Enrichment Program grant from the Burroughs Wellcome Fund. L.F.S. was supported by NIH grant T32GM105538 and a Howard Hughes Medical Institute Gilliam Fellowship. O.S.S. was supported by NSF GRFP grant 2014171659 and R.J.M. under NSF grant DGE1255832. At Northwestern University, the Quantitative Bio-element Imaging Center is supported by NASA Ames Research Center grant NNA06CB93G, the Proteomics Center for Excellence is supported by National Resource for Translational and Developmental Proteomics under NIH grant P41 GM108569 and National Cancer Institute (NCI) grant CCSG P30 CA060553, the Integrated Molecular Structure Education and Research Center is supported by Northwestern University and the State of Illinois, the International Institute for Nanotechnology, and the Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource (NSF grant NNCI-1542205), and the Keck Biophysics Facility is supported in part by NCI Cancer Center Support Grant CA060553. Some work was performed at the Albert Einstein Anaerobic Structural and Functional Genomics Resource. All authors declare no conflicts of interest. All data are presented in the supplementary materials.	Ala A, 2007, LANCET, V369, P397, DOI 10.1016/S0140-6736(07)60196-2; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Behling LA, 2008, J AM CHEM SOC, V130, P12604, DOI 10.1021/ja804747d; Behnken S, 2012, APPL MICROBIOL BIOT, V96, P61, DOI 10.1007/s00253-012-4285-8; BROWN CA, 1995, INORG CHEM, V34, P688, DOI 10.1021/ic00107a024; Burkhart BJ, 2015, NAT CHEM BIOL, V11, P564, DOI 10.1038/nchembio.1856; Butler A, 1998, SCIENCE, V281, P207, DOI 10.1126/science.281.5374.207; Chaturvedi KS, 2012, NAT CHEM BIOL, V8, P731, DOI [10.1038/NCHEMBIO.1020, 10.1038/nchembio.1020]; Cherrier MV, 2008, BIOCHEMISTRY-US, V47, P9937, DOI 10.1021/bi801051y; Chivers PT, 2012, METALLOMICS, V4, P1043, DOI 10.1039/c2mt20139a; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Dassama LMK, 2017, METALLOMICS, V9, P7, DOI 10.1039/c6mt00208k; El Ghazouani A, 2012, P NATL ACAD SCI USA, V109, P8400, DOI 10.1073/pnas.1112921109; Ghssein G, 2016, SCIENCE, V352, P1105, DOI 10.1126/science.aaf1018; Izawa M, 2013, APPL ENVIRON MICROB, V79, P7110, DOI 10.1128/AEM.01978-13; Johnston CW, 2013, NAT CHEM BIOL, V9, P241, DOI [10.1038/NCHEMBIO.1179, 10.1038/nchembio.1179]; Johnstone TC, 2015, DALTON T, V44, P6320, DOI 10.1039/c4dt03559c; Kenney GE, 2016, J AM CHEM SOC, V138, P11124, DOI 10.1021/jacs.6b06821; Kenney GE, 2016, METALLOMICS, V8, P931, DOI 10.1039/c5mt00289c; Kenney GE, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-17; Kim HJ, 2004, SCIENCE, V305, P1612, DOI 10.1126/science.1098322; Kim HJ, 2005, BIOCHEMISTRY-US, V44, P5140, DOI 10.1021/bi047367r; Krentz BD, 2010, BIOCHEMISTRY-US, V49, P10117, DOI 10.1021/bi1014375; Lichtmannegger J, 2016, J CLIN INVEST, V126, P2721, DOI 10.1172/JCI85226; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Nairz M, 2010, CELL MICROBIOL, V12, P1691, DOI 10.1111/j.1462-5822.2010.01529.x; Nayak DD, 2017, ELIFE, V6, DOI 10.7554/eLife.29218; Palmer LD, 2016, ANNU REV GENET, V50, P67, DOI 10.1146/annurev-genet-120215-035146; Peck SC, 2017, J AM CHEM SOC, V139, P2045, DOI 10.1021/jacs.6b12147; Rix U, 2004, J AM CHEM SOC, V126, P4496, DOI 10.1021/ja031724o; Sardar D, 2015, CHEM BIOL, V22, P907, DOI 10.1016/j.chembiol.2015.06.014; Semrau JD, 2013, ENVIRON MICROBIOL, V15, P3077, DOI 10.1111/1462-2920.12150; Summer KH, 2011, J TRACE ELEM MED BIO, V25, P36, DOI 10.1016/j.jtemb.2010.12.002; Tamanaha E, 2016, J AM CHEM SOC, V138, P8862, DOI 10.1021/jacs.6b04065; Tolia NH, 2006, NAT METHODS, V3, P55, DOI 10.1038/nmeth0106-55; Trehoux A, 2016, COORDIN CHEM REV, V322, P142, DOI 10.1016/j.ccr.2016.05.014; van Heel AJ, 2013, ACS SYNTH BIOL, V2, P397, DOI 10.1021/sb3001084; Wallar BJ, 1996, CHEM REV, V96, P2625, DOI 10.1021/cr9500489; Worsdorfer B, 2013, P NATL ACAD SCI USA, V110, P18874, DOI 10.1073/pnas.1315927110; Xing G, 2006, P NATL ACAD SCI USA, V103, P6130, DOI 10.1073/pnas.0508473103	41	60	60	7	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2018	359	6382			SI		1411	+		10.1126/science.aap9437	http://dx.doi.org/10.1126/science.aap9437			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA0ZG	29567715	Green Accepted			2022-12-28	WOS:000428043600048
J	Hoehener, C; Hug, I; Nowacki, M				Hoehener, Cristina; Hug, Iris; Nowacki, Mariusz			Dicer-like Enzymes with Sequence Cleavage Preferences	CELL			English	Article							SMALL RNAS; RIBONUCLEASE-III; STRUCTURAL BASIS; INTERFERENCE; PROTEINS; TRANSPOSONS; RECOGNITION; NUCLEOTIDE; MACHINERY; COMPLEX	Dicer proteins are known to produce small RNAs (sRNAs) from long double-stranded RNA (dsRNA) templates. These sRNAs are bound by Argonaute proteins, which select the guide strand, often with a 5' end sequence bias. However, Dicer proteins have never been shown to have sequence cleavage preferences. In Paramecium development, two classes of sRNAs that are required for DNA elimination are produced by three Dicer-like enzymes: Dcl2, Dcl3, and Dcl5. Through in vitro cleavage assays, we demonstrate that Dcl2 has a strict size preference for 25 nt and a sequence preference for 5' U and 5' AGA, while Dcl3 has a sequence preference for 5' UNG. Dcl5, however, has cleavage preferences for 5' UAG and 3' CUAC/UN, which leads to the production of RNAs precisely matching short excised DNA elements with corresponding end base preferences. Thus, we characterize three Dicer-like enzymes that are involved in Paramecium development and propose a biological role for their sequence-biased cleavage products.	[Hoehener, Cristina; Hug, Iris; Nowacki, Mariusz] Univ Bern, Inst Cell Biol, Baltzerstr 4, CH-3012 Bern, Switzerland	University of Bern	Nowacki, M (corresponding author), Univ Bern, Inst Cell Biol, Baltzerstr 4, CH-3012 Bern, Switzerland.	mariusz.nowacki@izb.unibe.ch	Nowacki, Mariusz/E-4485-2011	Nowacki, Mariusz/0000-0003-4894-2905	European Research Council (ERC) [260358, 681178]; Swiss National Science Foundation [31003A_146257, 31003A_166407]; National Center of Competence in Research (NCCR) RNA and Disease	European Research Council (ERC)(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research (NCCR) RNA and Disease(Swiss National Science Foundation (SNSF))	We thank Nasikhat Stahlberger for technical support and the group of Ramesh Pillai for technical help with the immunoprecipitation. We also thank Stefanie Jonas and Sarah Allen for fruitful discussions. This research was supported by grants from the European Research Council (ERC) (260358 "EPIGENOME" and 681178 "G-EDIT"), the Swiss National Science Foundation (31003A_146257 and 31003A_166407), and from the National Center of Competence in Research (NCCR) RNA and Disease.	Allen SE, 2017, CELL, V168, P990, DOI 10.1016/j.cell.2017.02.020; Allen SE, 2017, TRENDS GENET, V33, P197, DOI 10.1016/j.tig.2017.01.005; Arnaiz O, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002984; Calin-Jageman I, 2003, NUCLEIC ACIDS RES, V31, P2381, DOI 10.1093/nar/gkg329; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Cora E, 2014, RNA, V20, P773, DOI 10.1261/rna.044701.114; Coyne RS, 2012, BIOL CELL, V104, P309, DOI 10.1111/boc.201100057; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Glow D, 2015, NUCLEIC ACIDS RES, V43, P2864, DOI 10.1093/nar/gkv009; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lepere G, 2009, NUCLEIC ACIDS RES, V37, P903, DOI 10.1093/nar/gkn1018; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Masliah G, 2013, CELL MOL LIFE SCI, V70, P1875, DOI 10.1007/s00018-012-1119-x; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Provost P, 2002, P NATL ACAD SCI USA, V99, P16648, DOI 10.1073/pnas.212633199; Reuter M, 2009, NAT STRUCT MOL BIOL, V16, P639, DOI 10.1038/nsmb.1615; Sandoval PY, 2014, DEV CELL, V28, P174, DOI 10.1016/j.devcel.2013.12.010; Skouri F, 1997, MOL BIOL CELL, V8, P1063; Stefl R, 2010, CELL, V143, P225, DOI 10.1016/j.cell.2010.09.026; Swart EC, 2014, NUCLEIC ACIDS RES, V42, P8970, DOI 10.1093/nar/gku619; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582; Zhang KJ, 1997, P NATL ACAD SCI USA, V94, P13437, DOI 10.1073/pnas.94.25.13437	30	30	32	2	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 22	2018	173	1					234	+		10.1016/j.cell.2018.02.029	http://dx.doi.org/10.1016/j.cell.2018.02.029			21	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GA3MT	29551264	hybrid, Green Published			2022-12-28	WOS:000428234200021
J	Braithwaite, J; Hibbert, PD; Jaffe, A; White, L; Cowell, CT; Harris, MF; Runciman, WB; Hallahan, AR; Wheaton, G; Williams, HM; Murphy, E; Molloy, CJ; Wiles, LK; Ramanathan, S; Arnolda, G; Ting, HP; Hooper, TD; Szabo, N; Wakefield, JG; Hughes, CF; Schmiede, A; Dalton, C; Dalton, S; Holt, J; Donaldson, L; Kelley, E; Lilford, R; Lachman, P; Muething, S				Braithwaite, Jeffrey; Hibbert, Peter D.; Jaffe, Adam; White, Les; Cowell, Christopher T.; Harris, Mark F.; Runciman, William B.; Hallahan, Andrew R.; Wheaton, Gavin; Williams, Helena M.; Murphy, Elisabeth; Molloy, Charlotte J.; Wiles, Louise K.; Ramanathan, Shanthi; Arnolda, Gaston; Ting, Hsuen P.; Hooper, Tamara D.; Szabo, Natalie; Wakefield, John G.; Hughes, Clifford F.; Schmiede, Annette; Dalton, Chris; Dalton, Sarah; Holt, Joanna; Donaldson, Liam; Kelley, Ed; Lilford, Richard; Lachman, Peter; Muething, Stephen			Quality of Health Care for Children in Australia, 2012-2013	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PEDIATRIC RESEARCH NETWORK; UNITED-STATES; GUIDELINES; DELIVERY; ASTHMA	IMPORTANCE The quality of routine care for children is rarely assessed, and then usually in single settings or for single clinical conditions. OBJECTIVE To estimate the quality of health care for children in Australia in inpatient and ambulatory health care settings. DESIGN, SETTING, AND PARTICIPANTS Multistage stratified sample with medical record review to assess adherence with quality indicators extracted from clinical practice guidelines for 17 common, high-burden clinical conditions (noncommunicable [n = 5], mental health [n = 4], acute infection [n = 7], and injury [n = 1]), such as asthma, attention-deficit/hyperactivity disorder, tonsillitis, and head injury. For these 17 conditions, 479 quality indicators were identified, with the number varying by condition, ranging from 9 for eczema to 54 for head injury. Four hundred medical records were targeted for sampling for each of 15 conditions while 267 records were targeted for anxiety and 133 for depression. Within each selected medical record, all visits for the 17 targeted conditions were identified, and separate quality assessments made for each. Care was evaluated for 6689 children 15 years of age and younger who had 15 240 visits to emergency departments, for inpatient admissions, or to pediatricians and general practitioners in selected urban and rural locations in 3 Australian states. These visits generated 160 202 quality indicator assessments. EXPOSURES Quality indicators were identified through a systematic search of local and international guidelines. Individual indicators were extracted from guidelines and assessed using a 2-stage Delphi process. MAIN OUTCOMES AND MEASURES Quality of care for each clinical condition and overall. RESULTS Of 6689 children with surveyed medical records, 53.6% were aged 0 to 4 years and 55.5% were male. Adherence to quality of care indicators was estimated at 59.8% (95% CI, 57.5%-62.0%; n = 160 202) across the 17 conditions, ranging from a high of 88.8% (95% CI, 83.0%-93.1%; n = 2638) for autism to a low of 43.5% (95% CI, 36.8%-50.4%; n = 2354) for tonsillitis. The mean adherence by condition category was estimated as 60.5% (95% CI, 57.2%-63.8%; n = 41265) for noncommunicable conditions (range, 52.8%-75.8%); 82.4% (95% CI, 79.0%-85.5%; n = 14 622) for mental health conditions (range, 71.5%-88.8%), 56.3% (95% CI, 53.2%-59.4%; n = 94 037) for acute infections (range, 43.5%-69.8%); and 78.3% (95% CI, 75.1%-81.2%; n = 10 278) for injury. CONCLUSIONS AND RELEVANCE Among a sample of children receiving care in Australia in 2012-2013, the overall prevalence of adherence to quality of care indicators for important conditions was not high. For many of these conditions, the quality of care may be inadequate.	[Braithwaite, Jeffrey; Hibbert, Peter D.; White, Les; Runciman, William B.; Molloy, Charlotte J.; Wiles, Louise K.; Ramanathan, Shanthi; Arnolda, Gaston; Ting, Hsuen P.; Hooper, Tamara D.; Szabo, Natalie; Hughes, Clifford F.; Holt, Joanna] Macquarie Univ, Australian Inst Hlth Innovat, Ctr Healthcare Resilience & Implementat Sci, Sydney, NSW, Australia; [Hibbert, Peter D.; Runciman, William B.; Molloy, Charlotte J.; Wiles, Louise K.; Ramanathan, Shanthi; Hooper, Tamara D.; Szabo, Natalie] Univ South Australia, Sansom Inst Hlth Res, Ctr Populat Hlth Res, Adelaide, SA, Australia; [Hibbert, Peter D.; Runciman, William B.] Australian Patient Safety Fdn, Adelaide, SA, Australia; [Jaffe, Adam] Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Jaffe, Adam] Sydney Childrens Hosp Network, Sydney Childrens Hosp, Dept Resp Med, Randwick, NSW, Australia; [White, Les] Univ New South Wales, Sch Womens & Childrens Hlth, Discipline Paediat, Sydney, NSW, Australia; [White, Les; Dalton, Sarah] Sydney Childrens Hosp Network, Sydney Childrens Hosp, Randwick, NSW, Australia; [Cowell, Christopher T.] Sydney Childrens Hosp Network, Kids Res Inst, Westmead, NSW, Australia; [Cowell, Christopher T.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Harris, Mark F.] Univ New South Wales, Ctr Primary Hlth Care & Equity, Fac Med, Sydney, NSW, Australia; [Hallahan, Andrew R.] Childrens Hlth Queensland Hosp & Hlth Serv, Herston, Qld, Australia; [Wheaton, Gavin] Womens & Childrens Hosp, Div Paediat Med, Adelaide, SA, Australia; [Williams, Helena M.] Russell Clin, Blackwood, SA, Australia; [Williams, Helena M.] Australian Commiss Safety & Qual Hlth Care, Sydney, NSW, Australia; [Williams, Helena M.] Southern Adelaide Local Hlth Network, Bedford Pk, SA, Australia; [Murphy, Elisabeth] New South Wales Minist Hlth, Sydney, NSW, Australia; [Wakefield, John G.] Queensland Dept Hlth, Clin Excellence Div, Brisbane, Qld, Australia; [Hughes, Clifford F.; Lachman, Peter] Int Soc Qual Hlth Care, Dublin, Ireland; [Schmiede, Annette; Dalton, Chris] Bupa Hlth Fdn Australia, Sydney, NSW, Australia; [Dalton, Sarah] New South Wales Agcy Clin Innovat, Chatswood, NSW, Australia; [Dalton, Sarah] Clin Excellence Commiss, Sydney, NSW, Australia; [Donaldson, Liam] London Sch Hyg & Trop Med, London, England; [Donaldson, Liam; Kelley, Ed] WHO, Geneva, Switzerland; [Lilford, Richard] Univ Warwick, Coventry, W Midlands, England; [Muething, Stephen] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA	Macquarie University; University of South Australia; University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney; University of New South Wales Sydney; Womens & Childrens Hospital Australia; Queensland Health; University of London; London School of Hygiene & Tropical Medicine; World Health Organization; University of Warwick; Cincinnati Children's Hospital Medical Center	Braithwaite, J (corresponding author), Macquarie Univ, Fac Med & Hlth Sci, Australian Inst Hlth Innovat, Level 6,75 Talavera Rd, Sydney, NSW 2109, Australia.	jeffrey.braithwaite@mq.edu.au	Lachman, Peter/ABD-4054-2020; Hibbert, Peter/T-7981-2019; Braithwaite, Jeffrey/AAN-1467-2020; Arnolda, Gaston R/D-8528-2017; Harris, Mark F/I-2793-2019; Runciman, William (Bill)/F-3202-2013; Wiles, Louise/I-3014-2015	Lachman, Peter/0000-0001-5120-5776; Braithwaite, Jeffrey/0000-0003-0296-4957; Arnolda, Gaston R/0000-0003-4948-7633; Harris, Mark F/0000-0002-0705-8913; Hooper, Tamara/0000-0001-9808-7973; Molloy, Charlotte/0000-0001-7451-9751; Jaffe, Adam/0000-0002-1963-5415; Ramanathan, Shanthi/0000-0003-1374-5565; Runciman, William (Bill)/0000-0001-8489-0693; Lilford, Richard/0000-0002-0634-984X; Wiles, Louise/0000-0002-6557-6196	Australian National Health and Medical Research partnership grant [APP1065898]; National Health and Medical Research Council; Bupa Health Foundation; Sydney Children's Hospital Network; Children's Health Queensland; South Australian Department of Health (SA Health); New South Wales Kids and Families	Australian National Health and Medical Research partnership grant; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Bupa Health Foundation; Sydney Children's Hospital Network; Children's Health Queensland; South Australian Department of Health (SA Health); New South Wales Kids and Families	The research was funded as an Australian National Health and Medical Research partnership grant (APP1065898), with contributions by the National Health and Medical Research Council, Bupa Health Foundation, Sydney Children's Hospital Network, New South Wales Kids and Families, Children's Health Queensland, and the South Australian Department of Health (SA Health).	[Anonymous], 2013, GEN PRACTICE ACTIVIT; Asher I, 2014, INT J TUBERC LUNG D, V18, P1269, DOI 10.5588/ijtld.14.0170; Australian Bureau of Statistics, 2011, AUSTR STAT GEOGR STA, V5; Australian Bureau of Statistics, 2016, TIM SER SPREADSH TAB; Australian Bureau of Statistics, 32180 REG POP GROWTH; Australian Institute of Health and Welfare, PRINC DIAGN DAT CUB; Australian Institute of Health and Welfare, 2014, AUSTR HOSP STAT 2012; Australian Institute of Health andWelfare, AUSTR HOSP STAT 2012; Australian Institute of Health andWelfare, PICT AUSTR CHILDR 20; Australian Institute of Health andWelfare; Commonwealth Department of Health and Family Services, 1 REP NAT HLTH PRIOR; Begg S, 2007, BURDEN DIS INJURY AU; Boulkedid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020476; Chung Erica Y, 2013, Hosp Pediatr, V3, P16; Doherty S, 2007, J PAEDIATR CHILD H, V43, P611, DOI 10.1111/j.1440-1754.2007.01151.x; Fitch K., 2001, RAND UCLA APPROPRIAT; Hasson F, 2011, TECHNOL FORECAST SOC, V78, P1695, DOI 10.1016/j.techfore.2011.04.005; Hathorn C, 2014, J AUTISM DEV DISORD, V44, P1859, DOI 10.1007/s10803-014-2057-2; Hiscock H, 2017, J PAEDIATR CHILD H, V53, P55, DOI 10.1111/jpc.13280; Hiscock H, 2011, MED J AUSTRALIA, V194, P392, DOI 10.5694/j.1326-5377.2011.tb03028.x; Hooper TD, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007749; Mangione-Smith R, 2007, NEW ENGL J MED, V357, P1515, DOI 10.1056/NEJMsa064637; Marks G, ASTHMA AUSTR 2011; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; National Asthma Council Australia, AUSTR ASTHM HDB; National Health and Medical Research Council, 2012, GUID DEV CONFL INT I; NICE, 2014, QUALITY STANDARDS IN; Runciman WB, 2012, MED J AUSTRALIA, V197, P100, DOI 10.5694/mja12.10510; Runciman WB, 2012, MED J AUSTRALIA, V197, P78, DOI 10.5694/mja12.10799; Wiles LK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007748; Zemek RL, 2008, ARCH PEDIAT ADOL MED, V162, P157, DOI 10.1001/archpediatrics.2007.34	30	54	55	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2018	319	11					1113	1124		10.1001/jama.2018.0162	http://dx.doi.org/10.1001/jama.2018.0162			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ8LL	29558552	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000427860200016
J	Oliver, D				Oliver, David			David Oliver: What's wrong with acute "zero day admissions"?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						British Geriatrics Society, 2012, QUAL CAR OLD PEOPL U; Mason S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3579; National Audit Office, 2018, RED EM ADM; NHS Acute Frailty Network, CAS STUD; NHS Bristol Cardiff University University of Bristol, 2012, INT RED UNPL HOSP AD; O'Dowd A, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k1022; Society for Acute Medicine, 2016, SAMBA 16 SAM BENCHM; Sun BC, 2013, ANN EMERG MED, V61, P605, DOI 10.1016/j.annemergmed.2012.10.026; Williams D., 2018, HLTH SERV J, V26	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2018	360								k1241	10.1136/bmj.k1241	http://dx.doi.org/10.1136/bmj.k1241			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB1KT	29559432	Green Published, Bronze			2022-12-28	WOS:000428810400004
J	Char, DS; Shah, NH; Magnus, D				Char, Danton S.; Shah, Nigam H.; Magnus, David			Implementing Machine Learning in Health Care - Addressing Ethical Challenges	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Char, Danton S.] Stanford Univ, Sch Med, Dept Anesthesiol, Div Pediat Cardiac Anesthesia, Stanford, CA 94305 USA; [Char, Danton S.; Magnus, David] Stanford Univ, Sch Med, Ctr Biomed Eth, Stanford, CA 94305 USA; [Shah, Nigam H.] Stanford Univ, Sch Med, Ctr Biomed Informat Res, Stanford, CA USA	Stanford University; Stanford University; Stanford University	Char, DS (corresponding author), Stanford Univ, Sch Med, Dept Anesthesiol, Div Pediat Cardiac Anesthesia, Stanford, CA 94305 USA.; Char, DS (corresponding author), Stanford Univ, Sch Med, Ctr Biomed Eth, Stanford, CA 94305 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K01HG008498] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Angwin J., 2016, MACHINE BIAS; Gijsberts CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132321; Longhurst CA, 2014, HEALTH AFFAIR, V33, P1229, DOI 10.1377/hlthaff.2014.0099; Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181; SIEGLER M, 1982, NEW ENGL J MED, V307, P1518, DOI 10.1056/NEJM198212093072411	5	356	361	10	92	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2018	378	11					981	983		10.1056/NEJMp1714229	http://dx.doi.org/10.1056/NEJMp1714229			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ2HT	29539284	Green Accepted			2022-12-28	WOS:000427399000003
J	Jacobson, A				Jacobson, Anne			The Cicada Season	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Jacobson, Anne] Hektoen Int Journal Med Humanities, 2240 W Ogden Ave, Chicago, IL 60612 USA		Jacobson, A (corresponding author), Hektoen Int Journal Med Humanities, 2240 W Ogden Ave, Chicago, IL 60612 USA.	anne.jacobson@hektoen.org							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2018	319	10					979	980		10.1001/jama.2018.1338	http://dx.doi.org/10.1001/jama.2018.1338			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ0HS	29536100				2022-12-28	WOS:000427249700010
J	Cauldwell, M; Dos Santos, F; Steer, PJ; Swan, L; Gatzoulis, M; Johnson, MR				Cauldwell, Matthew; Dos Santos, Francois; Steer, Philip J.; Swan, Lorna; Gatzoulis, Michael; Johnson, Mark R.			Pregnancy in women with congenital heart disease	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FETAL COMPLICATIONS; EUROPEAN-SOCIETY; POSTPARTUM; MEDICATION; MANAGEMENT; REGISTRY; RISK; MALFORMATIONS; PRECONCEPTION; RECURRENCE		[Cauldwell, Matthew; Dos Santos, Francois; Steer, Philip J.; Johnson, Mark R.] Chelsea & Westminster Hosp, Acad Dept Obstet & Gynaecol, London, England; [Dos Santos, Francois; Swan, Lorna; Gatzoulis, Michael] Royal Brompton Hosp, Dept Adult Congenital Heart Dis, London, England	Imperial College London; Royal Brompton Hospital	Cauldwell, M (corresponding author), Chelsea & Westminster Hosp, Acad Dept Obstet & Gynaecol, London, England.	matthew.cauldwell@imperial.ac.uk						[Anonymous], 2015, MONTGOMERY APPELLANT; [Anonymous], 2016, SAVING LIVES IMPROVI; Assenza GE, 2013, INT J CARDIOL, V168, P1847, DOI 10.1016/j.ijcard.2012.12.071; Atzei A, 2005, ULTRASOUND OBST GYN, V26, P154, DOI 10.1002/uog.1936; Balint OH, 2010, HEART, V96, P1656, DOI 10.1136/hrt.2010.202838; Bartalena L, 2001, J ENDOCRINOL INVEST, V24, P116, DOI 10.1007/BF03343825; Beauchesne LM, 2001, J AM COLL CARDIOL, V38, P1728, DOI 10.1016/S0735-1097(01)01617-5; Bhattacharya Susmita, 2013, J Anaesthesiol Clin Pharmacol, V29, P32, DOI 10.4103/0970-9185.105790; Bowater SE, 2013, CONGENIT HEART DIS, V8, P302, DOI 10.1111/chd.12001; Bullo M, 2012, HYPERTENSION, V60, P444, DOI 10.1161/HYPERTENSIONAHA.112.196352; Burn J, 1998, LANCET, V351, P311, DOI 10.1016/S0140-6736(97)06486-6; Canobbio MM, 2017, CIRCULATION, V135, pE50, DOI 10.1161/CIR.0000000000000458; Cauldwell M, 2017, BJOG-INT J OBSTET GY, V124, P1307, DOI 10.1111/1471-0528.14547; Cauldwell M, 2017, INT J CARDIOL, V240, P374, DOI 10.1016/j.ijcard.2017.03.092; Cauldwell M, 2017, HEART, DOI [10.1093/eurheartj/ehx502.969.28954835, DOI 10.1093/EURHEARTJ/EHX502.969.28954835]; Cauldwell M, 2018, HEART, V104, P401, DOI 10.1136/heartjnl-2017-311763; Cauldwell M, 2017, HEART, V103, P945, DOI 10.1136/heartjnl-2016-310607; Cauldwell M, 2017, AM HEART J, V187, P29, DOI 10.1016/j.ahj.2017.02.007; Cauldwell M, 2016, INT J CARDIOL, V218, P285, DOI 10.1016/j.ijcard.2016.05.068; Cauldwell M, 2016, HEART, V102, P534, DOI 10.1136/heartjnl-2015-308788; Chow T, 1998, AM J CARDIOL, V82, p58I, DOI 10.1016/S0002-9149(98)00473-1; D'Souza R, 2016, SEMIN THROMB HEMOST, V42, P798, DOI 10.1055/s-0036-1593418; Dyer RA, 2011, CURR OPIN ANESTHESIO, V24, P255, DOI 10.1097/ACO.0b013e328345331c; Ertekin E, 2016, INT J CARDIOL, V220, P131, DOI 10.1016/j.ijcard.2016.06.061; Gelson E, 2011, OBSTET GYNECOL, V117, P886, DOI 10.1097/AOG.0b013e31820cab69; Gill HK, 2003, J AM COLL CARDIOL, V42, P923, DOI 10.1016/S0735-1097(03)00853-2; GLADSTONE GR, 1975, J PEDIATR-US, V86, P962, DOI 10.1016/S0022-3476(75)80236-8; Greutmann M, 2013, EUR HEART J, V34, P634, DOI 10.1093/eurheartj/ehs335; Gynaecologists RCoOa, 2011, GOOD PRACT GUID NUMB; Hassouna A, 2014, INTERACT CARDIOV TH, V18, P797, DOI 10.1093/icvts/ivu009; HECKER A, 1980, ACTA ENDOCRINOL-COP, V95, P540, DOI 10.1530/acta.0.0950540; James PR, 2004, HEART, V90, P1499, DOI 10.1136/hrt.2004.035444; Kampman MAM, 2016, HEART, V102, P1302, DOI 10.1136/heartjnl-2015-308946; Kampman MAM, 2015, AM HEART J, V169, P298, DOI 10.1016/j.ahj.2014.11.010; Knight M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-55; Mahendru AA, 2014, J HYPERTENS, V32, P849, DOI 10.1097/HJH.0000000000000090; Mandalenakis Z, 2017, JAMA INTERN MED, V177, P224, DOI 10.1001/jamainternmed.2016.7765; Nakhai-Pour HR, 2010, BIRTH DEFECTS RES B, V89, P147, DOI 10.1002/bdrb.20238; Norgard B, 2005, AM J OBSTET GYNECOL, V192, P922, DOI 10.1016/j.ajog.2004.10.598; PERKIN RM, 1980, J PEDIATR-US, V96, P721, DOI 10.1016/S0022-3476(80)80753-0; Pieper PG, 2015, NAT REV CARDIOL, V12, P718, DOI 10.1038/nrcardio.2015.172; PRENDIVILLE WJ, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000007, DOI 10.1002/14651858.CD000007]; PRESBITERO P, 1994, CIRCULATION, V89, P2673, DOI 10.1161/01.CIR.89.6.2673; Ramzy J, 2015, INT J CARDIOL, V198, P154, DOI 10.1016/j.ijcard.2015.06.106; Regitz-Zagrosek V., 2012, Revista Espanola de Cardiologia, V65, P171, DOI 10.1016/j.rec.2011.11.005; Roos-Hesselink JW, 2013, EUR HEART J, V34, P657, DOI 10.1093/eurheartj/ehs270; Ruys TPE, 2015, HEART, V101, P530, DOI 10.1136/heartjnl-2014-306497; Ruys TPE, 2014, INT J CARDIOL, V177, P124, DOI 10.1016/j.ijcard.2014.09.013; Ruys TPE, 2014, HEART, V100, P231, DOI 10.1136/heartjnl-2013-304888; Svanstrom MC, 2008, BRIT J ANAESTH, V100, P683, DOI 10.1093/bja/aen071; Uebing A, 2010, INT J CARDIOL, V139, P50, DOI 10.1016/j.ijcard.2008.09.001; van Hagen IM, 2017, HEART, V103, P159, DOI 10.1136/heartjnl-2015-308285; van Hagen IM, 2017, HEART, V103, P1610, DOI 10.1136/heartjnl-2016-310644; Vitale N, 1999, J AM COLL CARDIOL, V33, P1637, DOI 10.1016/S0735-1097(99)00044-3; WAGNER X, 1990, AM HEART J, V119, P700, DOI 10.1016/S0002-8703(05)80306-0; Weber-Schoendorfer C, 2008, REPROD TOXICOL, V26, P24, DOI 10.1016/j.reprotox.2008.05.065; WIDERHORN J, 1991, AM HEART J, V122, P1162, DOI 10.1016/0002-8703(91)90489-5; Yakoob MY, 2013, HYPERTENSION, V62, P375, DOI 10.1161/HYPERTENSIONAHA.111.00833	58	16	17	3	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2018	360								k478	10.1136/bmj.k478	http://dx.doi.org/10.1136/bmj.k478			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ1ZU	29523513	Green Submitted			2022-12-28	WOS:000427376900002
J	Service, RF				Service, Robert F.			ELECTROCHEMISTRY Lithium-sulfur batteries poised for leap	SCIENCE			English	News Item																			0	73	75	17	249	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2018	359	6380					1080	1081		10.1126/science.359.6380.1080	http://dx.doi.org/10.1126/science.359.6380.1080			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4ZM	29590017				2022-12-28	WOS:000426835900012
J	Watts, G				Watts, Geoff			Profile Kenneth Fleming: making the global case for pathology	LANCET			English	Biographical-Item																			0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2018	391	10133					1889	1889		10.1016/S0140-6736(18)30623-8	http://dx.doi.org/10.1016/S0140-6736(18)30623-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF3NC	29550032				2022-12-28	WOS:000431861800016
J	Sheu-Gruttadauria, J; MacRae, IJ				Sheu-Gruttadauria, Jessica; MacRae, Ian J.			Phase Transitions in the Assembly and Function of Human miRISC	CELL			English	Article							MESSENGER-RNA DEADENYLATION; STRUCTURAL BASIS; CCR4-NOT DEADENYLASE; LIQUID DROPLETS; P-BODIES; GW182; ARGONAUTE; BINDING; PROTEIN; COMPLEX	miRISC is a multi-protein assembly that uses microRNAs (miRNAs) to identify mRNAs targeted for repression. Dozens of miRISC-associated proteins have been identified, and interactions between many factors have been examined in detail. However, the physical nature of the complex remains unknown. Here, we show that two core protein components of human miRISC, Argonaute2 (Ago2) and TNRC6B, condense into phase-separated droplets in vitro and in live cells. Phase separation is promoted by multivalent interactions between the glycine/tryptophan (GW)-rich domain of TNRC6B and three evenly spaced tryptophan-binding pockets in the Ago2 PIWI domain. miRISC droplets formed in vitro recruit deadenylation factors and sequester target RNAs from the bulk solution. The condensation of miRISC is accompanied by accelerated deadenylation of target RNAs bound to Ago2. The combined results may explain how miRISC silences mRNAs of varying size and structure and provide experimental evidence that protein-mediated phase separation can facilitate an RNA processing reaction.	[Sheu-Gruttadauria, Jessica; MacRae, Ian J.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA	Scripps Research Institute	MacRae, IJ (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.	macrae@scripps.edu	MacRae, Ian/CAF-5564-2022		Abrams Charitable Trust Award; NIH [GM104475, GM115649]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104475, R01GM115649] Funding Source: NIH RePORTER	Abrams Charitable Trust Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to L.F.R. Gebert and other members of the MacRae lab for assistance and insights, W.B. Kiosses for microscopy assistance, N.S. MacRae for advice generating movie files, and Y. Tomari for providing the 8xlet7 template. Diffraction data were collected at beam line 12-2 at the Stanford Synchrotron Radiation Lightsource. J.S.-G. is a pre-doctoral is fellow of the American Heart Association and an Abrams Charitable Trust Award recipient. I.J.M. and this research were supported by NIH (GM104475 and GM115649).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Annunziata O, 2002, P NATL ACAD SCI USA, V99, P14165, DOI 10.1073/pnas.212507199; Baillat D, 2009, MOL CELL BIOL, V29, P4144, DOI 10.1128/MCB.00380-09; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Berry J, 2015, P NATL ACAD SCI USA, V112, pE5237, DOI 10.1073/pnas.1509317112; Boland A, 2013, NAT STRUCT MOL BIOL, V20, P1289, DOI 10.1038/nsmb.2681; Brangwynne CP, 2013, J CELL BIOL, V203, P875, DOI 10.1083/jcb.201308087; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Bridge KS, 2017, CELL REP, V20, P173, DOI 10.1016/j.celrep.2017.06.027; Calabretta S, 2015, TRENDS BIOCHEM SCI, V40, P662, DOI 10.1016/j.tibs.2015.08.012; Chekulaeva M, 2011, NAT STRUCT MOL BIOL, V18, P1218, DOI 10.1038/nsmb.2166; Chekulaeva M, 2009, RNA, V15, P794, DOI 10.1261/rna.1364909; Chen CYA, 2009, NAT STRUCT MOL BIOL, V16, P1160, DOI 10.1038/nsmb.1709; Chen Y, 2014, MOL CELL, V54, P737, DOI 10.1016/j.molcel.2014.03.034; Chivukula RR, 2014, CELL, V157, P1104, DOI 10.1016/j.cell.2014.03.055; Christie M, 2013, MOL CELL, V51, P360, DOI 10.1016/j.molcel.2013.07.011; Cougot N, 2008, J NEUROSCI, V28, P13793, DOI 10.1523/JNEUROSCI.4155-08.2008; De N, 2013, MOL CELL, V50, P344, DOI 10.1016/j.molcel.2013.04.001; Ding L, 2005, MOL CELL, V19, P437, DOI 10.1016/j.molcel.2005.07.013; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Elkayam E, 2017, MOL CELL, V67, P646, DOI 10.1016/j.molcel.2017.07.007; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eulalio A, 2009, RNA, V15, P1067, DOI 10.1261/rna.1605509; Eystathioy T, 2003, RNA, V9, P1171, DOI 10.1261/rna.5810203; Eystathioy T, 2002, MOL BIOL CELL, V13, P1338, DOI 10.1091/mbc.01-11-0544; Fabian MR, 2011, NAT STRUCT MOL BIOL, V18, P1211, DOI 10.1038/nsmb.2149; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Flores-Jasso CF, 2013, RNA, V19, P271, DOI 10.1261/rna.036921.112; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fromm B, 2015, ANNU REV GENET, V49, P213, DOI 10.1146/annurev-genet-120213-092023; Fromm SA, 2014, ANGEW CHEM INT EDIT, V53, P7354, DOI 10.1002/anie.201402885; Fukaya T, 2012, MOL CELL, V48, P825, DOI 10.1016/j.molcel.2012.09.024; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; He XJ, 2009, CELL, V137, P498, DOI 10.1016/j.cell.2009.04.028; Huang LF, 2009, NAT STRUCT MOL BIOL, V16, P91, DOI 10.1038/nsmb.1539; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Jannot G, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006484; Jinek M, 2010, NAT STRUCT MOL BIOL, V17, P238, DOI 10.1038/nsmb.1768; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Jonas S, 2014, NAT STRUCT MOL BIOL, V21, P599, DOI 10.1038/nsmb.2837; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kozlov G, 2010, J BIOL CHEM, V285, P13599, DOI 10.1074/jbc.M109.089540; Kuzuoglu-Ozturk D, 2016, EMBO J, V35, P1186, DOI 10.15252/embj.201592901; Li C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000044; Lian SL, 2009, RNA, V15, P804, DOI 10.1261/rna.1229409; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Mathys H, 2014, MOL CELL, V54, P751, DOI 10.1016/j.molcel.2014.03.036; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nishi K, 2013, RNA, V19, P17, DOI 10.1261/rna.034769.112; Petit AP, 2012, NUCLEIC ACIDS RES, V40, P11058, DOI 10.1093/nar/gks883; Petrie VJ, 2005, MOL CELL BIOL, V25, P2331, DOI 10.1128/MCB.25.6.2331-2346.2005; Pfaff J, 2013, P NATL ACAD SCI USA, V110, pE3770, DOI 10.1073/pnas.1308510110; Rao BS, 2017, P NATL ACAD SCI USA, V114, pE9569, DOI 10.1073/pnas.1712396114; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Schafer IB, 2014, NAT STRUCT MOL BIOL, V21, P591, DOI 10.1038/nsmb.2834; Schirle NT, 2014, SCIENCE, V346, P608, DOI 10.1126/science.1258040; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Strzelecka M, 2010, NAT STRUCT MOL BIOL, V17, P403, DOI 10.1038/nsmb.1783; Takimoto K, 2009, RNA, V15, P1078, DOI 10.1261/rna.1363109; Till S, 2007, NAT STRUCT MOL BIOL, V14, P897, DOI 10.1038/nsmb1302; Vourekas A, 2016, NATURE, V531, P390, DOI 10.1038/nature17150; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wolf J, 2014, EMBO J, V33, P1514, DOI 10.15252/embj.201488373; Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619; Yang Z, 2004, J CELL SCI, V117, P5567, DOI 10.1242/jcs.01477; Ying Y, 2017, CELL, V170, P312, DOI 10.1016/j.cell.2017.06.022	80	123	125	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 3	2018	173	4					946	+		10.1016/j.cell.2018.02.051	http://dx.doi.org/10.1016/j.cell.2018.02.051			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GG1TU	29576456	Green Accepted, Bronze			2022-12-28	WOS:000432471100016
J	Van Meter, KJ; Van Cappellen, P; Basu, NB				Van Meter, K. J.; Van Cappellen, P.; Basu, N. B.			Legacy nitrogen may prevent achievement of water quality goals in the Gulf of Mexico	SCIENCE			English	Article							MISSISSIPPI RIVER-BASIN; UNITED-STATES; PHOSPHORUS; MANAGEMENT; HYPOXIA; INPUTS; AREA	In August 2017, the Gulf of Mexico's hypoxic zone was declared to be the largest ever measured. It has been estimated that a 60% decrease in watershed nitrogen (N) loading may be necessary to adequately reduce eutrophication in the Gulf. However, to date there has been no rigorous assessment of the effect of N legacies on achieving water quality goals. In this study, we show that even if agricultural N use became 100% efficient, it would take decades to meet target N loads due to legacy N within the Mississippi River basin. Our results suggest that both long-term commitment and large-scale changes in agricultural management practices will be necessary to decrease Mississippi N loads and to meet current goals for reducing the size of the Gulf hypoxic zone.	[Van Meter, K. J.; Van Cappellen, P.; Basu, N. B.] Univ Waterloo, Dept Earth & Environm Sci, Waterloo, ON N2L 3G1, Canada; [Van Meter, K. J.; Van Cappellen, P.] Univ Waterloo, Ecohydrol Res Grp, Waterloo, ON N2L 3G1, Canada; [Van Cappellen, P.; Basu, N. B.] Univ Waterloo, Water Inst, Waterloo, ON N2L 3G1, Canada; [Basu, N. B.] Univ Waterloo, Dept Civil & Environm Engn, Waterloo, ON N2L 3G1, Canada	University of Waterloo; University of Waterloo; University of Waterloo; University of Waterloo	Basu, NB (corresponding author), Univ Waterloo, Dept Earth & Environm Sci, Waterloo, ON N2L 3G1, Canada.; Basu, NB (corresponding author), Univ Waterloo, Water Inst, Waterloo, ON N2L 3G1, Canada.; Basu, NB (corresponding author), Univ Waterloo, Dept Civil & Environm Engn, Waterloo, ON N2L 3G1, Canada.	nandita.basu@uwaterloo.ca	Van Cappellen, Philippe/A-2906-2013	Van Cappellen, Philippe/0000-0001-5476-0820; B. Basu, Nandidta/0000-0002-8867-8523; Van Meter, Kimberly/0000-0002-3698-7850	Natural Sciences and Engineering Research Council of Canada funds through the Water Joint Programming Initiative; Canada Excellence Research Chair program; Ontario Early Researcher Award; NSF Coupled Natural and Human Systems program [1114978]	Natural Sciences and Engineering Research Council of Canada funds through the Water Joint Programming Initiative; Canada Excellence Research Chair program; Ontario Early Researcher Award(Ministry of Research and Innovation, Ontario); NSF Coupled Natural and Human Systems program	The present work was financially supported by Natural Sciences and Engineering Research Council of Canada funds provided through the Water Joint Programming Initiative to N.B.B. and P.V.C., by the Canada Excellence Research Chair program (P.V.C.), and also by an Ontario Early Researcher Award to N.B.B. This work grew directly out of research funded through the NSF Coupled Natural and Human Systems program (grant 1114978).	Alexander RB, 2008, ENVIRON SCI TECHNOL, V42, P822, DOI 10.1021/es0716103; Arnold JG, 1998, J AM WATER RESOUR AS, V34, P73, DOI 10.1111/j.1752-1688.1998.tb05961.x; Basu NB, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045168; Bouwman L, 2013, P NATL ACAD SCI USA, V110, P20882, DOI 10.1073/pnas.1012878108; Brown DG, 2005, ECOL APPL, V15, P1851, DOI 10.1890/03-5220; David MB, 2010, J ENVIRON QUAL, V39, P1657, DOI 10.2134/jeq2010.0115; EU Nitrogen Expert Panel, 2015, NITR US EFF NUE IND; Gustafson E. J., LANDSC ECOL, V28, P1429; Hong BG, 2013, ENVIRON SCI TECHNOL, V47, P5199, DOI 10.1021/es303437c; Mayorga E, 2010, ENVIRON MODELL SOFTW, V25, P837, DOI 10.1016/j.envsoft.2010.01.007; McCrackin ML, 2017, BIOGEOCHEMISTRY, V133, P263, DOI 10.1007/s10533-017-0331-z; McIsaac GF, 2016, J ENVIRON QUAL, V45, P1268, DOI 10.2134/jeq2015.10.0531; McIsaac GF, 2010, J ENVIRON QUAL, V39, P1790, DOI 10.2134/jeq2009.0497; Mississippi River/Gulf of Mexico Watershed Nutrient Task Force, 2015, 2015 REP C; Murphy J. C., 20135169 US GEOL SUR; Obenour DR, 2013, ENVIRON SCI TECHNOL, V47, P9808, DOI 10.1021/es400983g; Patterson JJ, 2013, J ENVIRON MANAGE, V128, P441, DOI 10.1016/j.jenvman.2013.05.033; Puckett LJ, 2011, ENVIRON SCI TECHNOL, V45, P839, DOI 10.1021/es1038358; Rabalais NN, 2004, MAR POLLUT BULL, V49, P537, DOI 10.1016/j.marpolbul.2004.03.017; Rabalais NN, 2002, BIOSCIENCE, V52, P129, DOI 10.1641/0006-3568(2002)052[0129:BSIPGO]2.0.CO;2; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; Scavia D, 2017, P NATL ACAD SCI USA, V114, P8823, DOI 10.1073/pnas.1705293114; Sinha E, 2017, SCIENCE, V357, P405, DOI 10.1126/science.aan2409; Sinha E, 2016, ENVIRON SCI TECHNOL, V50, P12874, DOI 10.1021/acs.est.6b04455; U.S. Environmental Protection Agency, 2001, ACT PLAN RED MIT CON; Van Meter KJ, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa7bf4; Van Meter KJ, 2017, GLOBAL BIOGEOCHEM CY, V31, P2, DOI 10.1002/2016GB005498; Van Meter KJ, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/3/035014; Van Meter KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125971; Vero SE, 2018, HYDROGEOL J, V26, P7, DOI 10.1007/s10040-017-1650-9	30	178	179	28	208	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2018	360	6387					427	+		10.1126/science.aar4462	http://dx.doi.org/10.1126/science.aar4462			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1AR	29567808				2022-12-28	WOS:000430949600040
J	Zenker, J; White, MD; Gasnier, M; Alvarez, YD; Lim, HYG; Bissiere, S; Biro, M; Plachta, N				Zenker, Jennifer; White, Melanie D.; Gasnier, Maxime; Alvarez, Yanina D.; Lim, Hui Yi Grace; Bissiere, Stephanie; Biro, Mate; Plachta, Nicolas			Expanding Actin Rings Zipper the Mouse Embryo for Blastocyst Formation	CELL			English	Article							EPITHELIAL ZONULA ADHERENS; EARLY MAMMALIAN EMBRYO; INNER CELL MASS; TISSUE MORPHOGENESIS; TIGHT JUNCTIONS; E-CADHERIN; PRIMITIVE ENDODERM; CORTICAL TENSION; ALPHA-CATENIN; ANIMAL-CELLS	Transformation from morula to blastocyst is a defining event of preimplantation embryo development. During this transition, the embryo must establish a paracellular permeability barrier to enable expansion of the blastocyst cavity. Here, using live imaging of mouse embryos, we reveal an actin-zippering mechanism driving this embryo sealing. Preceding blastocyst stage, a cortical F-actin ring assembles at the apical pole of the embryo's outer cells. The ring structure forms when cortical actin flows encounter a network of polar microtubules that exclude F-actin. Unlike stereotypical actin rings, the actin rings of the mouse embryo are not contractile, but instead, they expand to the cell-cell junctions. Here, they couple to the junctions by recruiting and stabilizing adherens and tight junction components. Coupling of the actin rings triggers localized myosin II accumulation, and it initiates a tension-dependent zippering mechanism along the junctions that is required to seal the embryo for blastocyst formation.	[Zenker, Jennifer; White, Melanie D.; Gasnier, Maxime; Alvarez, Yanina D.; Lim, Hui Yi Grace; Bissiere, Stephanie; Plachta, Nicolas] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Alvarez, Yanina D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, CONICET, Buenos Aires, DF, Argentina; [Biro, Mate] Univ New South Wales, Sch Med Sci, Single Mol Sci Node, EMBL Australia, Sydney, NSW, Australia; [Biro, Mate] Univ New South Wales, ARC Ctr Excellence Adv Mol Imaging, Sydney, NSW, Australia; [Plachta, Nicolas] Natl Univ Singapore, Dept Biochem, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; European Molecular Biology Laboratory (EMBL); University of New South Wales Sydney; University of New South Wales Sydney; National University of Singapore	Plachta, N (corresponding author), ASTAR, Inst Mol & Cell Biol, Singapore, Singapore.; Biro, M (corresponding author), Univ New South Wales, Sch Med Sci, Single Mol Sci Node, EMBL Australia, Sydney, NSW, Australia.; Biro, M (corresponding author), Univ New South Wales, ARC Ctr Excellence Adv Mol Imaging, Sydney, NSW, Australia.; Plachta, N (corresponding author), Natl Univ Singapore, Dept Biochem, Singapore, Singapore.	m.biro@unsw.edu.au; plachtan@imcb.a-star.edu.sg	White, Melanie/J-5565-2019; Biro, Mate/H-6292-2014	White, Melanie/0000-0002-7399-8348; Biro, Mate/0000-0001-5852-3726; Lim, Hui Yi Grace/0000-0002-3241-9952	DFG [ZE997/1-1]; SNF [PBLAP3-145877]; HFSP [LT000164/2015]; EMBL Australia; A*STAR [2013APP005]; EMBO; HHMI-Wellcome Trust	DFG(German Research Foundation (DFG)); SNF; HFSP(Human Frontier Science Program); EMBL Australia; A*STAR(Agency for Science Technology & Research (A*STAR)); EMBO(European Molecular Biology Organization (EMBO)); HHMI-Wellcome Trust	This work was supported by funds from the DFG (ZE997/1-1), SNF (PBLAP3-145877), and HFSP (LT000164/2015) to J.Z.; EMBL Australia to M.B.; and A*STAR (2013APP005), EMBO, and HHMI-Wellcome Trust to N.P. H.Y. G.L. is a member of the Graduate School for Integrative Sciences and Engineering, NUS. We thank O. Thorn-Seshold, M. Govendir, A. Masedunskas, P. Gunning, R. Zaidel-Bar, O. Campas, and O. Hamant for sharing reagents and advice.	Alarcon VB, 2010, BIOL REPROD, V83, P347, DOI 10.1095/biolreprod.110.084400; Anani S, 2014, DEVELOPMENT, V141, P2813, DOI 10.1242/dev.107276; Arnold TR, 2017, EXP CELL RES, V358, P20, DOI 10.1016/j.yexcr.2017.03.053; Arora R, 2016, DEVELOPMENT, V143, P4749, DOI 10.1242/dev.144386; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Biro M, 2013, CYTOSKELETON, V70, P741, DOI 10.1002/cm.21142; Borowiak M, 2015, CELL, V162, P403, DOI 10.1016/j.cell.2015.06.049; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Canman JC, 1997, J CELL SCI, V110, P1907; Cassimeris L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059812; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Choi WS, 2011, MOL BIOL CELL, V22, P2010, DOI 10.1091/mbc.E10-12-1014; Clift D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8217; Conduit PT, 2015, NAT REV MOL CELL BIO, V16, P611, DOI 10.1038/nrm4062; Dard N, 2001, DEV BIOL, V233, P161, DOI 10.1006/dbio.2001.0192; David DJV, 2010, DEVELOPMENT, V137, P1645, DOI 10.1242/dev.044107; Diz-Munoz A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000544; DUCIBELLA T, 1975, DEV BIOL, V45, P231, DOI 10.1016/0012-1606(75)90063-9; Eckert JJ, 2008, BBA-BIOMEMBRANES, V1778, P717, DOI 10.1016/j.bbamem.2007.09.031; Fanning AS, 2012, MOL BIOL CELL, V23, P577, DOI 10.1091/mbc.E11-09-0791; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Fierro-Gonzalez JC, 2013, NAT CELL BIOL, V15, P1424, DOI 10.1038/ncb2875; Galea GL, 2017, P NATL ACAD SCI USA, V114, pE5177, DOI 10.1073/pnas.1700934114; Hashimoto H, 2015, DEV CELL, V32, P241, DOI 10.1016/j.devcel.2014.12.017; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Hirate Y, 2015, DEV GROWTH DIFFER, V57, P544, DOI 10.1111/dgd.12235; Howe K, 2013, CELL CYCLE, V12, P1616, DOI 10.4161/cc.24755; Jesudason E. C., 2015, EMBRYO DEV CELL, V34, P435; JOHNSON MH, 1984, J EMBRYOL EXP MORPH, V82, P97; Kaur G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2657; Kepiro M, 2012, P NATL ACAD SCI USA, V109, P9402, DOI 10.1073/pnas.1202786109; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; Kim JH, 2015, DEV CELL, V32, P561, DOI 10.1016/j.devcel.2015.01.005; Lecuit T, 2015, NAT CELL BIOL, V17, P533, DOI 10.1038/ncb3136; Lecuit T, 2011, ANNU REV CELL DEV BI, V27, P157, DOI 10.1146/annurev-cellbio-100109-104027; Leung CY, 2016, CURR TOP DEV BIOL, V120, P203, DOI 10.1016/bs.ctdb.2016.04.008; Maiers JL, 2013, J CELL SCI, V126, P3904, DOI 10.1242/jcs.126565; Maitre JL, 2016, NATURE, V536, P344, DOI 10.1038/nature18958; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; MCLAREN A, 1977, NATURE, V267, P351, DOI 10.1038/267351a0; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Montembault E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00337-6; Moriwaki K, 2007, DEV BIOL, V312, P509, DOI 10.1016/j.ydbio.2007.09.049; Morris SA, 2010, P NATL ACAD SCI USA, V107, P6364, DOI 10.1073/pnas.0915063107; Plachta N, 2011, NAT CELL BIOL, V13, P117, DOI 10.1038/ncb2154; Priya R, 2013, DIFFERENTIATION, V86, P133, DOI 10.1016/j.diff.2013.01.002; Rauzi M, 2011, CURR TOP DEV BIOL, V95, P93, DOI 10.1016/B978-0-12-385065-2.00004-9; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Reymann AC, 2016, ELIFE, V5, DOI 10.7554/eLife.17807; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Samarage C. R., 2015, CELL, V34, P435; Schwayer C, 2016, DEV CELL, V37, P493, DOI 10.1016/j.devcel.2016.05.024; Sedzinski J, 2011, NATURE, V476, P462, DOI 10.1038/nature10286; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; Stephenson RO, 2010, DEVELOPMENT, V137, P3383, DOI 10.1242/dev.050195; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Tornavaca O, 2015, J CELL BIOL, V208, P821, DOI 10.1083/jcb.201404140; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Watanabe T, 2014, DEVELOPMENT, V141, P2279, DOI 10.1242/dev.103267; Watson AJ, 2001, FRONT BIOSCI-LANDMRK, V6, pD708, DOI 10.2741/Watson; WHITE JG, 1983, J THEOR BIOL, V101, P289, DOI 10.1016/0022-5193(83)90342-9; White MD, 2017, CURR OPIN CELL BIOL, V44, P7, DOI 10.1016/j.ceb.2016.11.002; Wolff J, 2009, BBA-BIOMEMBRANES, V1788, P1415, DOI 10.1016/j.bbamem.2009.03.013; WOLPERT L, 1960, INT REV CYTOL, V10, P163; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Yamanaka Y, 2010, DEVELOPMENT, V137, P715, DOI 10.1242/dev.043471; Yamashita N, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.10.101206; Yap AS, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028761; YONEMURA S, 1995, J CELL SCI, V108, P127; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zenker J, 2017, SCIENCE, V357, P925, DOI 10.1126/science.aam9335; Zhu M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00977-8; Zihni C, 2016, NAT REV MOL CELL BIO, V17, P564, DOI 10.1038/nrm.2016.80	75	71	71	3	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2018	173	3					776	+		10.1016/j.cell.2018.02.035	http://dx.doi.org/10.1016/j.cell.2018.02.035			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GD7GB	29576449	Bronze, Green Published			2022-12-28	WOS:000430677400024
J	O'Dowd, A				O'Dowd, Adrian			MEDICINE AND THE MEDIA New drugs: patient hope or harm?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												adrianodowd@hotmail.com						Department of Health and Social Care, 2018, COST EFF METH VACC P; Lay K, UK CANC GUIDELINES; Pallari E, 2018, ESMO OPEN, V3, DOI 10.1136/esmoopen-2017-000258; Smyth C, TIMES; University of York, 2013, METH EST NICE COST E	5	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2018	360								k1373	10.1136/bmj.k1373	http://dx.doi.org/10.1136/bmj.k1373			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB5MP	29581152				2022-12-28	WOS:000429109200006
J	Riccio, A				Riccio, Antonella			RNA targeting and translation in axons	SCIENCE			English	Editorial Material							MESSENGER-RNA; GROWTH; TRANSCRIPTOME; LOCALIZATION		[Riccio, Antonella] UCL, MRC, Lab Mol Cell Biol, London, England	University of London; University College London	Riccio, A (corresponding author), UCL, MRC, Lab Mol Cell Biol, London, England.	a.riccio@ucl.ac.uk						Andreassi C, 2010, NAT NEUROSCI, V13, P291, DOI 10.1038/nn.2486; Ben-Yaakov K, 2012, EMBO J, V31, P1350, DOI 10.1038/emboj.2011.494; Berkovits BD, 2015, NATURE, V522, P363, DOI 10.1038/nature14321; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Costa CJ, 2018, DEV NEUROBIOL, V78, P209, DOI 10.1002/dneu.22555; Court FA, 2008, J NEUROSCI, V28, P11024, DOI 10.1523/JNEUROSCI.2429-08.2008; Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111; Holt CE, 2013, NEURON, V80, P648, DOI 10.1016/j.neuron.2013.10.036; Kosker K. E., 2016, NAT NEUROSCI, V19, P690; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Rishal I, 2014, NAT REV NEUROSCI, V15, P32, DOI 10.1038/nrn3609; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Terenzio M, 2018, SCIENCE, V359, P1416, DOI 10.1126/science.aan1053; Willis DE, 2007, J CELL BIOL, V178, P965, DOI 10.1083/jcb.200703209; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9	15	5	5	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2018	359	6382			SI		1331	1332		10.1126/science.aat1498	http://dx.doi.org/10.1126/science.aat1498			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA0ZG	29567693	Green Submitted			2022-12-28	WOS:000428043600023
J	Terenzio, M; Koley, S; Samra, N; Rishal, I; Zhao, Q; Sahoo, PK; Urisman, A; Marvaldi, L; Oses-Prieto, JA; Forester, C; Gomes, C; Kalinski, AL; Di Pizio, A; Doron-Mandel, E; Perry, RBT; Koppel, I; Twiss, JL; Burlingame, AL; Fainzilber, M				Terenzio, Marco; Koley, Sandip; Samra, Nitzan; Rishal, Ida; Zhao, Qian; Sahoo, Pabitra K.; Urisman, Anatoly; Marvaldi, Letizia; Oses-Prieto, Juan A.; Forester, Craig; Gomes, Cynthia; Kalinski, Ashley L.; Di Pizio, Agostina; Doron-Mandel, Ella; Perry, Rotem Ben-Tov; Koppel, Indrek; Twiss, Jeffery L.; Burlingame, Alma L.; Fainzilber, Mike			Locally translated mTOR controls axonal local translation in nerve injury	SCIENCE			English	Article							MESSENGER-RNA; PROTEIN-SYNTHESIS; REGENERATION; LOCALIZATION; GROWTH; ACTIVATION; NEURONS; MODES	How is protein synthesis initiated locally in neurons? We found that mTOR (mechanistic target of rapamycin) was activated and then up-regulated in injured axons, owing to local translation of mTOR messenger RNA (mRNA). This mRNA was transported into axons by the cell size-regulating RNA-binding protein nucleolin. Furthermore, mTOR controlled local translation in injured axons. This included regulation of its own translation and that of retrograde injury signaling molecules such as importin beta 1 and STAT3 (signal transducer and activator of transcription 3). Deletion of the mTOR 3' untranslated region (3'UTR) in mice reduced mTOR in axons and decreased local translation after nerve injury. Both pharmacological inhibition of mTOR in axons and deletion of the mTOR 3'UTR decreased proprioceptive neuronal survival after nerve injury. Thus, mRNA localization enables spatiotemporal control of mTOR pathways regulating local translation and long-range intracellular signaling.	[Terenzio, Marco; Koley, Sandip; Samra, Nitzan; Rishal, Ida; Marvaldi, Letizia; Di Pizio, Agostina; Doron-Mandel, Ella; Perry, Rotem Ben-Tov; Koppel, Indrek; Fainzilber, Mike] Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel; [Zhao, Qian; Urisman, Anatoly; Oses-Prieto, Juan A.; Burlingame, Alma L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Sahoo, Pabitra K.; Gomes, Cynthia; Kalinski, Ashley L.; Twiss, Jeffery L.] Univ South Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Forester, Craig] Univ Calif San Francisco, Div Pediat Allergy Immunol & Bone Marrow Transpla, San Francisco, CA 94158 USA; [Twiss, Jeffery L.] Drexel Univ, Dept Neurobiol & Anat, Coll Med, Philadelphia, PA 19129 USA; [Zhao, Qian] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China; [Gomes, Cynthia] Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40202 USA; [Kalinski, Ashley L.] Univ Michigan, Dept Cell & Dev Biol, Sch Med, 109 Zina Pitcher Pl, Ann Arbor, MI 48188 USA	Weizmann Institute of Science; University of California System; University of California San Francisco; University of South Carolina System; University of South Carolina Columbia; University of California System; University of California San Francisco; Drexel University; Hong Kong Polytechnic University; University of Louisville; University of Michigan System; University of Michigan	Fainzilber, M (corresponding author), Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel.	mike.fainzilber@weizmann.ac.il	Sahoo, Pabitra/J-1426-2019; Forester, Craig/HCI-4174-2022; Marvaldi, Letizia/P-1795-2014	Sahoo, Pabitra/0000-0002-1076-9409; Marvaldi, Letizia/0000-0002-2021-3949; Kalinski, Ashley/0000-0001-7611-0810; FORESTER, CRAIG/0000-0002-1868-5760; Zhao, Qian/0000-0003-2244-6516; Oses-Prieto, Juan/0000-0003-4759-2341; Koppel, Indrek/0000-0002-9338-8889; Rishal, Ida/0000-0002-8778-1369; Terenzio, Marco/0000-0002-4480-5746; Urisman, Anatoly/0000-0001-8364-5303; Fainzilber, Mike/0000-0001-8173-8557	European Research Council; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Minerva Foundation; Israel Science Foundation [1284/13]; Department of Defense Congressionally Mandated Research Program [W81XWH-2013-1-308 OR120042]; National Institutes of Health [R01-NS041596, GM103481]; Company of Biologists; Koshland senior postdoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041596, R01NS089633] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Minerva Foundation; Israel Science Foundation(Israel Science Foundation); Department of Defense Congressionally Mandated Research Program(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Company of Biologists; Koshland senior postdoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funding from the European Research Council (Neurogrowth, to M.F.), the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (to M.F., J.L.T., and A.L.B.), the Minerva Foundation (to M.F.), the Israel Science Foundation (1284/13 to M.F.), the Department of Defense Congressionally Mandated Research Program (W81XWH-2013-1-308 OR120042 to J.L.T. and M.F.), the National Institutes of Health (R01-NS041596 to J.L.T. and GM103481 to A.L.B.), and the Company of Biologists (Journal of Cell Science travel grants to I.K. and N.S.). M.T. was supported by a Koshland senior postdoctoral fellowship. M.F. is the incumbent of the Chaya Professorial Chair in Molecular Neuroscience at the Weizmann Institute of Science. J.L.T. is the incumbent of the SmartState Chair in Childhood Neurotherapeutics at the University of South Carolina.	Abe N, 2010, J BIOL CHEM, V285, P28034, DOI 10.1074/jbc.M110.125336; Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Ben-Yaakov K, 2012, EMBO J, V31, P1350, DOI 10.1038/emboj.2011.494; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Chen WT, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0358-16.2016; Donnelly CJ, 2011, EMBO J, V30, P4665, DOI 10.1038/emboj.2011.347; Duan X, 2015, NEURON, V85, P1244, DOI 10.1016/j.neuron.2015.02.017; Ebner M, 2017, J CELL BIOL, V216, P343, DOI 10.1083/jcb.201610060; Ebrahimi-Fakhari D, 2016, CELL REP, V17, P1053, DOI [10.1016/j.celrep.2016.09.054, 10.1016/j.celrep.2016.10.051]; Fonseca BD, 2014, SEMIN CELL DEV BIOL, V36, P102, DOI 10.1016/j.semcdb.2014.09.014; Forester CM, 2018, P NATL ACAD SCI USA, V115, P2353, DOI 10.1073/pnas.1707514115; Gandin V, 2016, GENOME RES, V26, P636, DOI 10.1101/gr.197566.115; Gracias NG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4506; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Kobayashi M, 2012, GENE DEV, V26, P1527, DOI 10.1101/gad.190157.112; Kye MJ, 2014, HUM MOL GENET, V23, P6318, DOI 10.1093/hmg/ddu350; Meyuhas O, 2015, INT REV CEL MOL BIO, V320, P41, DOI 10.1016/bs.ircmb.2015.07.006; Meyuhas O, 2015, BBA-GENE REGUL MECH, V1849, P801, DOI 10.1016/j.bbagrm.2014.08.015; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Perry RB, 2016, CELL REP, V16, P1664, DOI 10.1016/j.celrep.2016.07.005; Perry RB, 2012, NEURON, V75, P294, DOI 10.1016/j.neuron.2012.05.033; Raab-Graham KF, 2006, SCIENCE, V314, P144, DOI 10.1126/science.1131693; Rangaraju V, 2017, EMBO REP, V18, P693, DOI 10.15252/embr.201744045; Rishal I, 2014, NAT REV NEUROSCI, V15, P32, DOI 10.1038/nrn3609; Rishal I, 2010, DEV NEUROBIOL, V70, P126, DOI 10.1002/dneu.20755; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Smith DS, 1997, J NEUROSCI, V17, P646; Sosanya NM, 2013, J CELL BIOL, V202, P53, DOI 10.1083/jcb.201212089; Terenzio M, 2017, NEURON, V96, P667, DOI 10.1016/j.neuron.2017.10.015; Younts TJ, 2016, NEURON, V92, P479, DOI 10.1016/j.neuron.2016.09.040; Yudin D, 2008, NEURON, V59, P241, DOI 10.1016/j.neuron.2008.05.029; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001	33	130	131	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2018	359	6382			SI		1416	1421		10.1126/science.aan1053	http://dx.doi.org/10.1126/science.aan1053			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA0ZG	29567716	Green Accepted			2022-12-28	WOS:000428043600049
J	Browning, SR; Browning, BL; Zhou, Y; Tucci, S; Akey, JM				Browning, Sharon R.; Browning, Brian L.; Zhou, Ying; Tucci, Serena; Akey, Joshua M.			Analysis of Human Sequence Data Reveals Two Pulses of Archaic Denisovan Admixture	CELL			English	Article							HUMAN-POPULATION GROWTH; WHOLE-GENOME SEQUENCES; NEANDERTHAL ANCESTRY; EVOLUTIONARY HISTORY; IMMUNE-SYSTEM; INTROGRESSION; ADAPTATION; INDIVIDUALS; CHEMOKINE; SELECTION	Anatomically modern humans interbred with Neanderthals and with a related archaic population known as Denisovans. Genomes of several Neanderthals and one Denisovan have been sequenced, and these reference genomes have been used to detect intro-gressed genetic material in present-day human genomes. Segments of introgression also can be detected without use of reference genomes, and doing so can be advantageous for finding intro-gressed segments that are less closely related to the sequenced archaic genomes. We apply a new reference-free method for detecting archaic introgression to 5,639 whole-genome sequences from Eurasia and Oceania. We find Denisovan ancestry in populations from East and South Asia and Papuans. Denisovan ancestry comprises two components with differing similarity to the sequenced Altai Denisovan individual. This indicates that at least two distinct instances of Denisovan admixture into modern humans occurred, involving Denisovan populations that had different levels of relatedness to the sequenced Altai Denisovan.	[Browning, Sharon R.; Zhou, Ying] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Browning, Brian L.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Tucci, Serena; Akey, Joshua M.] Princeton Univ, Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Akey, Joshua M.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Princeton University; Princeton University	Browning, SR (corresponding author), Univ Washington, Dept Biostat, Seattle, WA 98195 USA.	sguy@uw.edu	Tucci, Serena/AAU-4728-2021; Zhou, Ying/AAT-2949-2020; Browning, Sharon/B-1530-2008; Browning, Brian L/A-1178-2010; Browning, Brian/ABC-4543-2021	Zhou, Ying/0000-0002-8107-3927; Browning, Sharon/0000-0001-7251-9715; Browning, Brian L/0000-0001-6454-6633; Akey, Joshua/0000-0002-4411-1330	National Institute of General Medical Sciences of the NIH [R01GM110068]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110068] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institute of General Medical Sciences of the NIH under Award Number R01GM110068. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Deschamps M, 2016, AM J HUM GENET, V98, P5, DOI 10.1016/j.ajhg.2015.11.014; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Gazave E, 2014, P NATL ACAD SCI USA, V111, P757, DOI 10.1073/pnas.1310398110; Gittelman RM, 2016, CURR BIOL, V26, P3375, DOI 10.1016/j.cub.2016.10.041; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hammer MF, 2011, P NATL ACAD SCI USA, V108, P15123, DOI 10.1073/pnas.1109300108; Hsieh P, 2016, GENOME RES, V26, P291, DOI 10.1101/gr.196634.115; Huerta-Sanchez E, 2014, NATURE, V512, P194, DOI 10.1038/nature13408; Juric I, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006340; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Kelleher J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004842; Kim BY, 2015, AM J HUM GENET, V96, P454, DOI 10.1016/j.ajhg.2014.12.029; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Lachance J, 2012, CELL, V150, P457, DOI 10.1016/j.cell.2012.07.009; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Papadakis KA, 2000, J IMMUNOL, V165, P5069, DOI 10.4049/jimmunol.165.9.5069; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Plagnol V, 2006, PLOS GENET, V2, P972, DOI 10.1371/journal.pgen.0020105; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Prufer K, 2017, SCIENCE, V358, P655, DOI 10.1126/science.aao1887; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Qin PF, 2015, MOL BIOL EVOL, V32, P2665, DOI 10.1093/molbev/msv141; Quach H, 2016, CELL, V167, P643, DOI 10.1016/j.cell.2016.09.024; Racimo F, 2015, NAT REV GENET, V16, P359, DOI 10.1038/nrg3936; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Sankararaman S, 2016, CURR BIOL, V26, P1241, DOI 10.1016/j.cub.2016.03.037; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; Siepel A, 2006, LECT NOTES COMPUT SC, V3909, P190; Sikora M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004353; Simonti CN, 2016, SCIENCE, V351, P737, DOI 10.1126/science.aad2149; Skoglund P, 2011, P NATL ACAD SCI USA, V108, P18301, DOI 10.1073/pnas.1108181108; Vernot B, 2016, SCIENCE, V352, P235, DOI 10.1126/science.aad9416; Vernot B, 2015, AM J HUM GENET, V96, P448, DOI 10.1016/j.ajhg.2015.01.006; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; Wall JD, 2013, GENETICS, V194, P199, DOI 10.1534/genetics.112.148213; Wall JD, 2009, MOL BIOL EVOL, V26, P1823, DOI 10.1093/molbev/msp096; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	49	138	141	4	88	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 22	2018	173	1					53	+		10.1016/j.cell.2018.02.031	http://dx.doi.org/10.1016/j.cell.2018.02.031			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GA3MT	29551270	Bronze, Green Accepted			2022-12-28	WOS:000428234200007
J	Pastuzyn, ED; Day, CE; Kearns, RB; Kyrke-Smith, M; Taibi, AV; McCormick, J; Yoder, N; Belnap, DM; Erlendsson, S; Morado, DR; Briggs, JAG; Feschotte, C; Shepherd, JD				Pastuzyn, Elissa D.; Day, Cameron E.; Kearns, Rachel B.; Kyrke-Smith, Madeleine; Taibi, Andrew V.; McCormick, John; Yoder, Nathan; Belnap, David M.; Erlendsson, Simon; Morado, Dustin R.; Briggs, John A. G.; Feschotte, Cedric; Shepherd, Jason D.			The Neuronal Gene Arc Encodes a Repurposed Retrotransposon Gag Protein that Mediates Intercellular RNA Transfer (vol 172, pg 275, 2018)	CELL			English	Correction												jason.shepherd@neuro.utah.edu	Shepherd, Jason/N-8555-2018	Shepherd, Jason/0000-0001-7384-8289	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH112766] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH112766] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abrusan G, 2013, NUCLEIC ACIDS RES, V41, P3190, DOI 10.1093/nar/gkt011; Ashley J, 2018, CELL, V172, P262, DOI 10.1016/j.cell.2017.12.022; Pastuzyn ED, 2018, CELL, V172, P275, DOI 10.1016/j.cell.2017.12.024	3	25	26	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 22	2018	173	1					275	275		10.1016/j.cell.2018.03.024	http://dx.doi.org/10.1016/j.cell.2018.03.024			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GA3MT	29570995	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000428234200024
J	Pawar, AS; Kattah, AG				Pawar, Aditya S.; Kattah, Andrea G.			Lithium-Induced Nephropathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Pawar, Aditya S.; Kattah, Andrea G.] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Pawar, AS (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	pawar.aditya@mayo.edu	Pawar, Aditya/T-4504-2019	Pawar, Aditya/0000-0002-9178-4386					0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2018	378	11					1042	1042		10.1056/NEJMicm1709438	http://dx.doi.org/10.1056/NEJMicm1709438			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ2HT	29539276				2022-12-28	WOS:000427399000009
J	Naik, S				Naik, Shruti			The healing power of painful memories	SCIENCE			English	Editorial Material							MODEL		[Naik, Shruti] Rockefeller Univ, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA	Rockefeller University	Naik, S (corresponding author), Rockefeller Univ, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	snaik@rockefeller.edu						Alcolea MP, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015206; Beerman I, 2015, CELL STEM CELL, V16, P613, DOI 10.1016/j.stem.2015.05.009; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Blanpain C, 2014, SCIENCE, V344, P1243, DOI 10.1126/science.1242281; DeYoung KL, 1997, ONCOGENE, V15, P453, DOI 10.1038/sj.onc.1201206; Flutter B, 2013, EUR J IMMUNOL, V43, P3138, DOI 10.1002/eji.201343801; Keyes BE, 2016, CELL, V167, P1323, DOI 10.1016/j.cell.2016.10.052; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Naik S, 2017, NATURE, V550, P475, DOI 10.1038/nature24271; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999	11	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2018	359	6380								10.1126/science.aat0963	http://dx.doi.org/10.1126/science.aat0963			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY4ZM	29590037				2022-12-28	WOS:000426835900034
J	Deino, AL; Behrensmeyer, AK; Brooks, AS; Yellen, JE; Sharp, WD; Potts, R				Deino, Alan L.; Behrensmeyer, Anna K.; Brooks, Alison S.; Yellen, John E.; Sharp, Watten D.; Potts, Richard			Chronology of the Acheulean to Middle Stone Age transition in eastern Africa	SCIENCE			English	Article							HOMO-SAPIENS; OLORGESAILIE FORMATION; KAPTHURIN FORMATION; JEBEL IRHOUD; AWASH VALLEY; KENYA RIFT; ETHIOPIA; GEOCHRONOLOGY; ASSEMBLAGES; ARCHAEOLOGY	The origin of the Middle Stone Age (MSA) marks the transition from a highly persistent mode of stone toolmaking, the Acheulean, to a period of increasing technological innovation and cultural indicators associated with the evolution of Homo sapiens. We used argon-40/argon-39 and uranium-series dating to calibrate the chronology of Acheulean and early MSA artifact-rich sedimentary deposits in the Olorgesailie basin, southern Kenya rift. We determined the age of late Acheulean tool assemblages from 615,000 to 499,000 years ago, after which a large technological and faunal transition occurred, with a definitive MSA lacking Acheulean elements beginning most likely by similar to 320,000 years ago, but at least by 305,000 years ago. These results establish the oldest repository of MSA artifacts in eastern Africa.	[Deino, Alan L.; Sharp, Watten D.] Berkeley Geochronol Ctr, Ridge Rd, Berkeley, CA 94709 USA; [Behrensmeyer, Anna K.] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA; [Brooks, Alison S.] George Washington Univ, Dept Anthropol, Washington, DC 20052 USA; [Brooks, Alison S.; Yellen, John E.; Potts, Richard] Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20013 USA; [Yellen, John E.] Natl Sci Fdn, Archaeol Program, Alexandria, VA 22314 USA; [Potts, Richard] Natl Museums Kenya, Dept Earth Sci, POB 40658-00100, Nairobi, Kenya	Berkeley Geochronolgy Center; Smithsonian Institution; Smithsonian National Museum of Natural History; George Washington University; Smithsonian Institution; Smithsonian National Museum of Natural History; National Science Foundation (NSF)	Deino, AL (corresponding author), Berkeley Geochronol Ctr, Ridge Rd, Berkeley, CA 94709 USA.; Potts, R (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20013 USA.; Potts, R (corresponding author), Natl Museums Kenya, Dept Earth Sci, POB 40658-00100, Nairobi, Kenya.	adeino@bgc.org; pottsr@si.edu			National Science Foundation [EAR-1322017]; Peter Buck Fund for Human Origins Research; Human Origins Program (Smithsonian); NSF HOMINID program [BCS-0218511]	National Science Foundation(National Science Foundation (NSF)); Peter Buck Fund for Human Origins Research; Human Origins Program (Smithsonian); NSF HOMINID program	Laboratory analyses were supported by National Science Foundation grant EAR-1322017 (A.L.D.). Fieldwork was funded by the Peter Buck Fund for Human Origins Research, the Human Origins Program (Smithsonian), and NSF HOMINID program grant BCS-0218511 (R.P.).	BAKER BH, 1971, TECTONOPHYSICS, V11, P191, DOI 10.1016/0040-1951(71)90030-8; Behrensmeyer A. K., 2018, GEOL SOC AM BULL, DOI [10.1130/B31853.1, DOI 10.1130/B31853.1]; Behrensmeyer A. K., 2002, SEPM SPECIAL PUBLICA, V73, P97; Benito-Calvo A, 2014, J HUM EVOL, V76, P26, DOI 10.1016/j.jhevol.2014.08.013; Blegen N, 2017, J HUM EVOL, V103, P1, DOI 10.1016/j.jhevol.2016.11.002; Bridge J.S., 2003, RIVERS FLOODPLAINS F; Brooks AS, 2018, SCIENCE, V360, P90, DOI 10.1126/science.aao2646; CLARK JD, 1994, SCIENCE, V264, P1907, DOI 10.1126/science.8009220; Clark JD, 2003, NATURE, V423, P747, DOI 10.1038/nature01670; DEINO A, 1990, J GEOPHYS RES-SOLID, V95, P8453, DOI 10.1029/JB095iB06p08453; Deino AL, 2002, J HUM EVOL, V42, P185, DOI 10.1006/jhev.2001.0517; Eren MI, 2014, QUATERN INT, V322, P292, DOI 10.1016/j.quaint2013.12.042; Goodwin A., 1928, S AFR J SCI, V25, P410; Guth A., 2013, GEOLOGICAL SOC AM DI; Hublin JJ, 2017, NATURE, V546, P289, DOI 10.1038/nature22336; Isaac GL., 1975, AUSTRALOPITHECINES, P875; KALB JE, 1982, J ARCHAEOL SCI, V9, P349, DOI 10.1016/0305-4403(82)90040-1; Kuiper KF, 2008, SCIENCE, V320, P500, DOI 10.1126/science.1154339; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Manega P, 1993, THESIS U COLORADO BO; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; Min KW, 2000, GEOCHIM COSMOCHIM AC, V64, P73, DOI 10.1016/S0016-7037(99)00204-5; Morgan LE, 2008, GEOLOGY, V36, P967, DOI 10.1130/G25213A.1; Niespolo EM, 2017, QUAT GEOCHRONOL, V39, P205, DOI 10.1016/j.quageo.2016.09.004; Potts R, 1999, J HUM EVOL, V37, P747, DOI 10.1006/jhev.1999.0344; Potts R, 2004, SCIENCE, V305, P75, DOI 10.1126/science.1097661; POTTS R, 1995, QUATERNARY RES, V43, P106, DOI 10.1006/qres.1995.1010; Potts R, 2018, SCIENCE, V360, P86, DOI 10.1126/science.aao2200; Richter D, 2017, NATURE, V546, P293, DOI 10.1038/nature22335; Sahle Y, 2014, QUATERN INT, V331, P6, DOI 10.1016/j.quaint.2013.03.010; Shea JJ, 2008, J HUM EVOL, V55, P448, DOI 10.1016/j.jhevol.2008.05.014; Tryon CA, 2006, CURR ANTHROPOL, V47, P367, DOI 10.1086/503066	32	50	50	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2018	360	6384					95	98		10.1126/science.aao2216	http://dx.doi.org/10.1126/science.aao2216			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB7OE	29545510				2022-12-28	WOS:000429263100053
J	Victor, RG; Lynch, K; Li, N; Blyler, C; Muhammad, E; Handler, J; Brettler, J; Rashid, M; Hsu, B; Foxx-Drew, D; Moy, N; Reid, AE; Elashoff, RM				Victor, Ronald G.; Lynch, Kathleen; Li, Ning; Blyler, Ciantel; Muhammad, Eric; Handler, Joel; Brettler, Jeffrey; Rashid, Mohamad; Hsu, Brent; Foxx-Drew, Davontae; Moy, Norma; Reid, Anthony E.; Elashoff, Robert M.			A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYPERTENSION CONTROL; AFRICAN-AMERICANS; OFFICE VISITS; UNITED-STATES; CARE; HEALTH; INTERVENTIONS; COMMUNITY; INDAPAMIDE	BACKGROUND Uncontrolled hypertension is a major problem among non-Hispanic black men, who are underrepresented in pharmacist intervention trials in traditional health care settings. METHODS We enrolled a cohort of 319 black male patrons with systolic blood pressure of 140 mm Hg or more from 52 black-owned barbershops (nontraditional health care setting) in a cluster-randomized trial in which barbershops were assigned to a pharmacist-led intervention (in which barbers encouraged meetings in barbershops with specialty-trained pharmacists who prescribed drug therapy under a collaborative practice agreement with the participants' doctors) or to an active control approach (in which barbers encouraged lifestyle modification and doctor appointments). The primary outcome was reduction in systolic blood pressure at 6 months. RESULTS At baseline, the mean systolic blood pressure was 152.8 mm Hg in the intervention group and 154.6 mm Hg in the control group. At 6 months, the mean systolic blood pressure fell by 27.0 mm Hg (to 125.8 mm Hg) in the intervention group and by 9.3 mm Hg (to 145.4 mm Hg) in the control group; the mean reduction was 21.6 mm Hg greater with the intervention (95% confidence interval, 14.7 to 28.4; P<0.001). A blood-pressure level of less than 130/80 mm Hg was achieved among 63.6% of the participants in the intervention group versus 11.7% of the participants in the control group (P<0.001). In the intervention group, the rate of cohort retention was 95%, and there were few adverse events (three cases of acute kidney injury). CONCLUSIONS Among black male barbershop patrons with uncontrolled hypertension, health promotion by barbers resulted in larger blood-pressure reduction when coupled with medication management in barbershops by specialty-trained pharmacists.	[Victor, Ronald G.; Lynch, Kathleen; Blyler, Ciantel; Muhammad, Eric; Rashid, Mohamad; Hsu, Brent; Foxx-Drew, Davontae; Moy, Norma; Reid, Anthony E.] Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA 90048 USA; [Li, Ning; Elashoff, Robert M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA; [Handler, Joel; Brettler, Jeffrey] Kaiser Permanente, Los Angeles, CA USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Kaiser Permanente	Victor, RG (corresponding author), Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA 90048 USA.	ronald.victor@cshs.org	Rashid, Mohamad A./ABB-1390-2020	Rashid, Mohamad A./0000-0002-1256-9478	National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [R01HL117983]; NIH National Center for Advancing Translational Sciences UCLA Clinical and Translational Science Institute [UL1TR001881]; California Endowment [20131872, 20162257]; Lincy Foundation; Harriet and Steven Nichols Foundation; Burns and Allen Chair in Cardiology Research at the Smidt Heart Institute; Division of Community Relations and Development at Cedars-Sinai Medical Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001881] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117983] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Center for Advancing Translational Sciences UCLA Clinical and Translational Science Institute; California Endowment; Lincy Foundation; Harriet and Steven Nichols Foundation; Burns and Allen Chair in Cardiology Research at the Smidt Heart Institute; Division of Community Relations and Development at Cedars-Sinai Medical Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (R01HL117983), the NIH National Center for Advancing Translational Sciences UCLA Clinical and Translational Science Institute (UL1TR001881), the California Endowment (grant numbers 20131872 and 20162257), the Lincy Foundation, the Harriet and Steven Nichols Foundation, the Burns and Allen Chair in Cardiology Research at the Smidt Heart Institute, and the Division of Community Relations and Development at Cedars-Sinai Medical Center.	Anderegg MD, 2016, HYPERTENSION, V68, P1314, DOI 10.1161/HYPERTENSIONAHA.116.08043; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Anwar, 1997, Blood Press Monit, V2, P105; Carnethon MR, 2017, CIRCULATION, V136, pE393, DOI 10.1161/CIR.0000000000000534; Carter BL, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004432; Carter BL, 2016, PHARMACOTHERAPY, V36, P363, DOI 10.1002/phar.1732; Cheema E, 2014, BRIT J CLIN PHARMACO, V78, P1238, DOI 10.1111/bcp.12452; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dashevsky M, 2017, WEST J EMERG MED, V18, P403, DOI 10.5811/westjem.2017.1.30532; Elashoff RM, JOINT MODELING LONGI; Eldridge Sandra M, 2004, Clin Trials, V1, P80, DOI 10.1191/1740774504cn006rr; Everitt BS, 2011, CLUSTER ANAL, DOI [10.1002/9780470977811, DOI 10.1002/9780470977811]; Fontil V, 2014, J GEN INTERN MED, V29, P468, DOI 10.1007/s11606-013-2683-y; Franklin SS, 2017, EUR HEART J, V38, P1112, DOI 10.1093/eurheartj/ehw502; Glasgow RE, 2005, MED CARE, V43, P436, DOI 10.1097/01.mlr.0000160375.47920.8c; Hayes RJ, 2009, CLUSTER RAN DOMISED; Hess PL, 2007, HYPERTENSION, V49, P1040, DOI 10.1161/HYPERTENSIONAHA.106.080432; Jaffe MG, 2013, JAMA-J AM MED ASSOC, V310, P699, DOI 10.1001/jama.2013.108769; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kaplan NM, 2015, HYPERTENSION, V65, P983, DOI 10.1161/HYPERTENSIONAHA.115.05138; Khanna RR, 2012, ARCH INTERN MED, V172, P1344, DOI 10.1001/archinternmed.2012.2749; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Merzel C, 2003, AM J PUBLIC HEALTH, V93, P557, DOI 10.2105/AJPH.93.4.557; Pavlik VN, 2015, CURR HYPERTENS REV, V11, P123, DOI 10.2174/1573402111666150325234503; Rader F, 2013, AM J CARDIOL, V112, P1421, DOI 10.1016/j.amjcard.2013.07.004; Roush GC, 2015, HYPERTENSION, V65, P1041, DOI 10.1161/HYPERTENSIONAHA.114.05021; Santschi V, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000718; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18]; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Svarstad BL, 2013, J AM PHARM ASSOC, V53, P520, DOI 10.1331/JAPhA.2013.12246; Tsuyuki RT, 2015, CIRCULATION, V132, P93, DOI 10.1161/CIRCULATIONAHA.115.015464; Victor RG, 2008, ARCH INTERN MED, V168, P1285, DOI 10.1001/archinte.168.12.1285; Victor RG, 2011, ARCH INTERN MED, V171, P342, DOI 10.1001/archinternmed.2010.390; Whelton PK, 2016, HYPERTENSION, V68, P1066, DOI 10.1161/HYPERTENSIONAHA.116.07905; Whelton PK, 2017, HYPERTENSION, DOI 10.1016/j.jacc.2017.11.006; Zullig LL, 2014, J CLIN HYPERTENS, V16, P827, DOI 10.1111/jch.12423	37	256	258	2	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 5	2018	378	14					1291	1301		10.1056/NEJMoa1717250	http://dx.doi.org/10.1056/NEJMoa1717250			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB5LN	29527973	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000429105700005
J	Sargis, RM; Davis, AM				Sargis, Robert M.; Davis, Andrew M.			Evaluation and Treatment of Male Hypogonadism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OLDER MEN; TESTOSTERONE		[Sargis, Robert M.] Univ Illinois, Chicago, IL USA; [Davis, Andrew M.] Univ Chicago, Chicago, IL 60637 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago	Davis, AM (corresponding author), Univ Chicago, Sect Gen Internal Med, 5841 S Maryland, Chicago, IL 60637 USA.	amd@uchicago.edu						Bhasin S, 2018, TESTOSTERONE THERAPY; Budoff MJ, 2017, JAMA-J AM MED ASSOC, V317, P708, DOI 10.1001/jama.2016.21043; Handelsman DJ, 2017, JAMA-J AM MED ASSOC, V317, P699, DOI 10.1001/jama.2017.0129; Layton JB, 2017, JAMA-J AM MED ASSOC, V317, P1159, DOI 10.1001/jama.2016.21041; Layton JB, 2014, J CLIN ENDOCR METAB, V99, P835, DOI 10.1210/jc.2013-3570; Martinez C, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5968; Roy CN, 2017, JAMA INTERN MED, V177, P480, DOI 10.1001/jamainternmed.2016.9540; Snyder PJ, 2016, NEW ENGL J MED, V374, P611, DOI 10.1056/NEJMoa1506119; Snyder PJ, 2017, JAMA INTERN MED, V177, P471, DOI 10.1001/jamainternmed.2016.9539	9	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2018	319	13					1375	+		10.1001/jama.2018.3182	http://dx.doi.org/10.1001/jama.2018.3182			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB4NC	29550857				2022-12-28	WOS:000429035900021
J	Frakt, AB				Frakt, Austin B.			How the Economy Affects Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Frakt, Austin B.] Vet Hlth Adm, Partnered Evidence Based Policy Resource Ctr, Boston, MA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA)	Frakt, AB (corresponding author), Vet Hlth Adm, Partnered Evidence Based Policy Resource Ctr, Boston, MA USA.	afrakt@gmail.com		Frakt, Austin/0000-0002-0795-5462					0	3	3	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2018	319	12					1187	1188		10.1001/jama.2018.1739	http://dx.doi.org/10.1001/jama.2018.1739			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GA5VW	29584830	Bronze			2022-12-28	WOS:000428403000002
J	Fernandez, DR; Crow, MK				Fernandez, David R.; Crow, Mary K.			CD8 T cells and mTOR: new concepts and targets for systemic lupus erythematosus	LANCET			English	Editorial Material							DIFFERENTIATION; INTERFERON; METABOLISM; ANTIBODY; DISEASE		[Fernandez, David R.; Crow, Mary K.] Hosp Special Surg, Mary Kirkland Ctr Lupus Res, 535 E 70th St, New York, NY 10021 USA; [Fernandez, David R.; Crow, Mary K.] Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA	Cornell University	Crow, MK (corresponding author), Hosp Special Surg, Mary Kirkland Ctr Lupus Res, 535 E 70th St, New York, NY 10021 USA.; Crow, MK (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA.	crowm@hss.edu	Crow, Mary/R-8480-2019		AstraZeneca; Bristol-Myers Squibb; Eli Lilly; Janssen; MedImmune; Neovacs	AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); Eli Lilly(Eli Lilly); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); MedImmune(AstraZenecaMedimmune); Neovacs	MKC reports personal fees from AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Janssen, MedImmune, and Neovacs, related to the development of therapeutics for systemic lupus erythematous. DRF declares no competing interests.	Brouard S, 2010, AM J TRANSPLANT, V10, P2604, DOI 10.1111/j.1600-6143.2010.03302.x; Crow MK, 2014, J IMMUNOL, V192, P5459, DOI 10.4049/jimmunol.1002795; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Furie R, 2017, ARTHRITIS RHEUMATOL, V69, P376, DOI 10.1002/art.39962; Lai Z-W, 2018, LANCET; Oaks Z, 2016, ARTHRITIS RHEUMATOL, V68, P2728, DOI 10.1002/art.39791; Pollizzi KN, 2015, J CLIN INVEST, V125, P2090, DOI 10.1172/JCI77746; Reddy PS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2541; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Stohl W, 2012, ARTHRITIS RHEUM-US, V64, P2328, DOI 10.1002/art.34400; Youngblood B, 2017, NATURE, V552, P404, DOI 10.1038/nature25144; Zeng H, 2016, IMMUNITY, V45, P540, DOI 10.1016/j.immuni.2016.08.017	12	9	10	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2018	391	10126					1126	1127		10.1016/S0140-6736(18)30544-0	http://dx.doi.org/10.1016/S0140-6736(18)30544-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GA2MF	29551336				2022-12-28	WOS:000428156100008
J	Jabbour, S; Gate, M; Sabouni, A; al-Batal, S				Jabbour, Samer; Gate, Marvin; Sabouni, Ammar; al-Batal, Saeed			Rehumanising the Syrian conflict: photographs of war, health, and life in Syria	LANCET			English	Editorial Material									[Jabbour, Samer; Sabouni, Ammar] Amer Univ Beirut, Fac Hlth Sci, Beirut 11072020, Lebanon; [Jabbour, Samer; Sabouni, Ammar] Lancet Amer Univ Beirut Commiss Syria, Beirut, Lebanon; [Gate, Marvin; al-Batal, Saeed] Humans Syria Network, Mhardeh, Syria	American University of Beirut	Jabbour, S (corresponding author), Amer Univ Beirut, Fac Hlth Sci, Beirut 11072020, Lebanon.; Jabbour, S (corresponding author), Lancet Amer Univ Beirut Commiss Syria, Beirut, Lebanon.	sj22@aub.edu.lb	Jabbour, Samer/Y-6860-2018	Jabbour, Samer/0000-0002-7150-6856	International Development Research Center (Canada)	International Development Research Center (Canada)	We thank Mohammad Ali Atassi, Director of Bidayyat for Audiovisual Arts, Beirut, Lebanon, for his support and constructive comments. This work has been supported by International Development Research Center (Canada).		0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2018	391	10126					1140	1156		10.1016/S0140-6736(18)30662-7	http://dx.doi.org/10.1016/S0140-6736(18)30662-7			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GA2MF	29550023				2022-12-28	WOS:000428156100017
J	Brown, M; Assen, FP; Leithner, A; Abe, J; Schachner, H; Asfour, G; Bago-Horvath, Z; Stein, JV; Uhrin, P; Sixt, M; Kerjaschki, D				Brown, M.; Assen, F. P.; Leithner, A.; Abe, J.; Schachner, H.; Asfour, G.; Bago-Horvath, Z.; Stein, J. V.; Uhrin, P.; Sixt, M.; Kerjaschki, D.			Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice	SCIENCE			English	Article							BREAST-CANCER; PREMENOPAUSAL WOMEN; DISTANT METASTASES; LYMPHANGIOGENESIS; RADIOTHERAPY; VASCULATURE; IRRADIATION; INVOLVEMENT; INVASION; MAMMARY	During metastasis, malignant cells escape the primary tumor, intravasate lymphatic vessels, and reach draining sentinel lymph nodes before they colonize distant organs via the blood circulation. Although lymph node metastasis in cancer patients correlates with poor prognosis, evidence is lacking as to whether and how tumor cells enter the bloodstream via lymph nodes. To investigate this question, we delivered carcinoma cells into the lymph nodes of mice by microinfusing the cells into afferent lymphatic vessels. We found that tumor cells rapidly infiltrated the lymph node parenchyma, invaded blood vessels, and seeded lung metastases without involvement of the thoracic duct. These results suggest that the lymph node blood vessels can serve as an exit route for systemic dissemination of cancer cells in experimental mouse models. Whether this form of tumor cell spreading occurs in cancer patients remains to be determined.	[Brown, M.; Schachner, H.; Asfour, G.; Bago-Horvath, Z.; Kerjaschki, D.] Med Univ Vienna, Clin Inst Pathol, A-1090 Vienna, Austria; [Brown, M.; Assen, F. P.; Leithner, A.; Sixt, M.] IST Austria, A-3400 Klosterneuburg, Austria; [Abe, J.; Stein, J. V.] Univ Bern, Theodor Kocher Inst, CH-3012 Bern, Switzerland; [Uhrin, P.] Med Univ Vienna, Inst Vasc Biol, A-1090 Vienna, Austria	Medical University of Vienna; Institute of Science & Technology - Austria; University of Bern; Medical University of Vienna	Kerjaschki, D (corresponding author), Med Univ Vienna, Clin Inst Pathol, A-1090 Vienna, Austria.; Sixt, M (corresponding author), IST Austria, A-3400 Klosterneuburg, Austria.	michael.sixt@ist.ac.at; dontscho.kerjaschki@meduniwien.ac.at		Abe, Jun/0000-0001-7511-4502; Stein, Jens V/0000-0002-8199-9586; Sixt, Michael/0000-0002-6620-9179; Leithner, Alexander/0000-0002-1073-744X; Uhrin, Pavel/0000-0002-9792-3420; Assen, Frank/0000-0003-3470-6119	Cell Communication in Health and Disease graduate study program of the Austrian Science Fund (FWF); Medical University of Vienna; European Research Council [ERC GA 281556]; FWF START award	Cell Communication in Health and Disease graduate study program of the Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical University of Vienna; European Research Council(European Research Council (ERC)European Commission); FWF START award	M.B. was supported by the Cell Communication in Health and Disease graduate study program of the Austrian Science Fund (FWF) and the Medical University of Vienna. M.S. was supported by the European Research Council (grant ERC GA 281556) and an FWF START award.	Abe O, 2005, LANCET, V366, P2087; Alitalo A, 2012, ONCOGENE, V31, P4499, DOI 10.1038/onc.2011.602; Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; BURN JI, 1962, BRIT J CANCER, V16, P608, DOI 10.1038/bjc.1962.71; Burton JB, 2008, CANCER RES, V68, P7828, DOI 10.1158/0008-5472.CAN-08-1488; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen ZT, 2005, CANCER RES, V65, P9004, DOI 10.1158/0008-5472.CAN-05-0885; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Das S, 2013, J EXP MED, V210, P1509, DOI 10.1084/jem.20111627; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; HELLMAN S, 1994, J CLIN ONCOL, V12, P2229, DOI 10.1200/JCO.1994.12.10.2229; Jatoi I, 1999, J CLIN ONCOL, V17, P2334, DOI 10.1200/JCO.1999.17.8.2334; Kawada K, 2011, CANCER RES, V71, P1214, DOI 10.1158/0008-5472.CAN-10-3277; Mohammed RAA, 2007, AM J SURG PATHOL, V31, P1825, DOI 10.1097/PAS.0b013e31806841f6; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nathanson SD, 2015, SEMIN CELL DEV BIOL, V38, P106, DOI 10.1016/j.semcdb.2014.10.002; Nathanson SD, 2009, ANN SURG ONCOL, V16, P3396, DOI 10.1245/s10434-009-0659-2; Naxerova K, 2017, SCIENCE, V357, P55, DOI 10.1126/science.aai8515; Overgaard M, 1997, NEW ENGL J MED, V337, P949, DOI 10.1056/NEJM199710023371401; Pereira ER, 2018, SCIENCE, V359, P1403, DOI 10.1126/science.aal3622; Podgrabinska S, 2014, MICROVASC RES, V95, P46, DOI 10.1016/j.mvr.2014.07.004; Poortmans PM, 2015, NEW ENGL J MED, V373, P317, DOI 10.1056/NEJMoa1415369; Ragaz J, 1997, NEW ENGL J MED, V337, P956, DOI 10.1056/NEJM199710023371402; Roberts N, 2006, CANCER RES, V66, P2650, DOI 10.1158/0008-5472.CAN-05-1843; Turner RR, 1997, ANN SURG, V226, P271, DOI 10.1097/00000658-199709000-00006; Van den Eynden GG, 2007, CLIN CANCER RES, V13, P5391, DOI 10.1158/1078-0432.CCR-07-1230; Whelan TJ, 2015, NEW ENGL J MED, V373, P307, DOI 10.1056/NEJMoa1415340	29	221	228	8	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2018	359	6382			SI		1408	+		10.1126/science.aal3662	http://dx.doi.org/10.1126/science.aal3662			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA0ZG	29567714				2022-12-28	WOS:000428043600047
J	Rabesandratana, T				Rabesandratana, Tania			Accounting rules hobble Spanish institutes Staff at centers for solar energy research and oceanography raise alarm	SCIENCE			English	News Item																			0	0	0	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2018	359	6382			SI		1315	1316		10.1126/science.359.6382.1315	http://dx.doi.org/10.1126/science.359.6382.1315			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA0ZG	29567685				2022-12-28	WOS:000428043600015
J	Patel, A; Yang, P; Tinkham, M; Pradhan, M; Sun, MA; Wang, YX; Hoang, D; Wolf, G; Horton, JR; Zhang, X; Macfarlan, T; Cheng, XD				Patel, Anamika; Yang, Peng; Tinkham, Matthew; Pradhan, Mihika; Sun, Ming-An; Wang, Yixuan; Hoang, Don; Wolf, Gernot; Horton, John R.; Zhang, Xing; Macfarlan, Todd; Cheng, Xiaodong			DNA Conformation Induces Adaptable Binding by Tandem Zinc Finger Proteins	CELL			English	Article							STRUCTURAL BASIS; HISTONE H3; RECOGNITION; METHYLATION; SYSTEM; MODEL; GENE; CONTRIBUTES; CHROMATIN; RESIDUES	Tandem zinc finger (ZF) proteins are the largest and most rapidly diverging family of DNA-binding transcription regulators in mammals. ZFP568 represses a transcript of placental-specific insulin like growth factor 2 (Igf2-P0) in mice. ZFP568 binds a 24-base pair sequence-specific element upstream of Igf2-P0 via the eleven-ZF array. Both DNA and protein conformations deviate from the conventional one finger-three bases recognition, with individual ZFs contacting 2, 3, or 4 bases and recognizing thymine on the opposite strand. These interactions arise from a shortened minor groove caused by an AT-rich stretch, suggesting adaptability of ZF arrays to sequence variations. Despite conservation in mammals, mutations at Igf2 and ZFP568 reduce their binding affinity in chimpanzee and humans. Our studies provide important insights into the evolutionary and structural dynamics of ZF-DNA interactions that play a key role in mammalian development and evolution.	[Patel, Anamika; Pradhan, Mihika; Cheng, Xiaodong] Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA; [Yang, Peng; Tinkham, Matthew; Sun, Ming-An; Wang, Yixuan; Hoang, Don; Wolf, Gernot; Macfarlan, Todd] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA; [Horton, John R.; Zhang, Xing; Cheng, Xiaodong] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Yang, Peng; Wang, Yixuan] Tongji Univ, Shanghai Matern & Infant Hosp 1, Shanghai Key Lab Signaling & Dis Res, Clin & Translat Res Ctr,Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Emory University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Texas System; UTMD Anderson Cancer Center; Tongji University	Cheng, XD (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.; Macfarlan, T (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA.; Cheng, XD (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	todd.macfarlan@nih.gov; xcheng5@mdanderson.org	Horton, John R/ABB-4770-2020; Yang, Peng/AAU-9276-2020; Sun, Mingan/D-7141-2019; wang, yixuan/GXW-2866-2022; Macfarlan, Todd/S-3750-2017; Wang, Yin/HCI-9352-2022; Wang, Yijun/GXW-1763-2022; Wang, Yixuan/GZK-6559-2022; wang, yi/GVT-8516-2022; Yang, Peng/AAV-8362-2020	Sun, Mingan/0000-0002-4661-3027; Macfarlan, Todd/0000-0003-2495-9809; Yang, Peng/0000-0002-9724-7936; Wolf, Gernot/0000-0002-3943-8662; Horton, John/0000-0001-9749-8068	NIH [GM049245-24, 1ZIAHD008933]; Cancer Prevention Research Institute of Texas [RR160029]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049245] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C.K.-James Shen for providing human ZNF568 constructs and helpful discussion and B. Baker of New England Biolabs for synthesizing the oligonucleotides. The Department of Biochemistry of Emory University School of Medicine supported the use of SER-CAT beamlines. This work was supported by grants from the NIH (GM049245-24 to X.Z. and X.C. and 1ZIAHD008933 to T.M.), and Cancer Prevention Research Institute of Texas (RR160029) to X.C.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Castro-Diaz N, 2014, GENE DEV, V28, P1397, DOI 10.1101/gad.241661.114; Chien HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047481; Choo Y, 1997, CURR OPIN STRUC BIOL, V7, P117, DOI 10.1016/S0959-440X(97)80015-2; Constancia M, 2000, NAT GENET, V26, P203, DOI 10.1038/79930; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Davies B, 2016, NATURE, V530, P171, DOI 10.1038/nature16931; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; El Hassan MA, 1998, J MOL BIOL, V282, P331, DOI 10.1006/jmbi.1998.1994; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Hashimoto H, 2017, MOL CELL, V66, P711, DOI 10.1016/j.molcel.2017.05.004; Horowitz S, 2012, J BIOL CHEM, V287, P41576, DOI 10.1074/jbc.R112.418574; Horton JR, 2005, CELL, V121, P349, DOI 10.1016/j.cell.2005.02.021; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; Imbeault M, 2017, NATURE, V543, P550, DOI 10.1038/nature21683; Iyengar S, 2011, MOL CELL BIOL, V31, P1833, DOI 10.1128/MCB.01331-10; Jacobs FMJ, 2014, NATURE, V516, P242, DOI 10.1038/nature13760; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Krebs CJ, 2012, MOL CELL BIOL, V32, P3732, DOI 10.1128/MCB.00615-12; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Liu YW, 2013, TRENDS BIOCHEM SCI, V38, P177, DOI 10.1016/j.tibs.2012.12.005; Liu YW, 2012, GENE DEV, V26, P2374, DOI 10.1101/gad.202200.112; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Mackay DJG, 2008, NAT GENET, V40, P949, DOI 10.1038/ng.187; Meylan S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-378; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; Najafabadi HS, 2015, NAT BIOTECHNOL, V33, P555, DOI 10.1038/nbt.3128; O'Geen H, 2010, METHODS MOL BIOL, V649, P437, DOI 10.1007/978-1-60761-753-2_27; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Patel A, 2016, METHOD ENZYMOL, V573, P387, DOI 10.1016/bs.mie.2016.01.019; Patel A, 2017, J BIOL CHEM, V292, P15994, DOI 10.1074/jbc.M117.805754; Patel A, 2016, GENE DEV, V30, P257, DOI 10.1101/gad.274928.115; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Peng HZ, 2000, J MOL BIOL, V295, P1139, DOI 10.1006/jmbi.1999.3402; Persikov AV, 2015, NUCLEIC ACIDS RES, V43, P1965, DOI 10.1093/nar/gku1395; Persikov AV, 2014, NUCLEIC ACIDS RES, V42, P97, DOI 10.1093/nar/gkt890; Quenneville S, 2012, CELL REP, V2, P766, DOI 10.1016/j.celrep.2012.08.043; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Schmitges FW, 2016, GENOME RES, V26, P1742, DOI 10.1101/gr.209643.116; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Segal DJ, 2006, J MOL BIOL, V363, P405, DOI 10.1016/j.jmb.2006.08.016; Shibata M, 2011, DEVELOPMENT, V138, P5333, DOI 10.1242/dev.072546; Shibata M, 2011, DEV BIOL, V349, P331, DOI 10.1016/j.ydbio.2010.11.015; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Thomas JH, 2011, GENOME RES, V21, P1800, DOI 10.1101/gr.121749.111; Vanamee ES, 2005, EMBO J, V24, P4198, DOI 10.1038/sj.emboj.7600880; Wolf G, 2015, GENE DEV, V29, P538, DOI 10.1101/gad.252767.114; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Xu B, 2013, MOL BIOL EVOL, V30, P2723, DOI 10.1093/molbev/mst179; Yang P, 2017, SCIENCE, V356, P757, DOI 10.1126/science.aah6895; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zandarashvili L, 2015, P NATL ACAD SCI USA, V112, pE5142, DOI 10.1073/pnas.1507726112	64	27	27	2	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 22	2018	173	1					221	+		10.1016/j.cell.2018.02.058	http://dx.doi.org/10.1016/j.cell.2018.02.058			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GA3MT	29551271	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000428234200020
J	Seymour, JF; Kipps, TJ; Eichhorst, B; Hillmen, P; D'Rozario, J; Assouline, S; Owen, C; Gerecitano, J; Robak, T; De la Serna, J; Jaeger, U; Cartron, G; Montillo, M; Humerickhouse, R; Punnoose, EA; Li, Y; Boyer, M; Humphrey, K; Mobasher, M; Kater, AP				Seymour, J. F.; Kipps, T. J.; Eichhorst, B.; Hillmen, P.; D'Rozario, J.; Assouline, S.; Owen, C.; Gerecitano, J.; Robak, T.; De la Serna, J.; Jaeger, U.; Cartron, G.; Montillo, M.; Humerickhouse, R.; Punnoose, E. A.; Li, Y.; Boyer, M.; Humphrey, K.; Mobasher, M.; Kater, A. P.			Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MINIMAL RESIDUAL DISEASE; INDEPENDENT PREDICTOR; PROGRESSION-FREE; PLUS RITUXIMAB; TARGETING BCL2; TP53 MUTATION; 17P DELETION; OPEN-LABEL; SURVIVAL; TRIAL	BACKGROUND Venetoclax inhibits BCL2, an antiapoptotic protein that is pathologically overexpressed and that is central to the survival of chronic lymphocytic leukemia cells. We evaluated the efficacy of venetoclax in combination with rituximab in patients with relapsed or refractory chronic lymphocytic leukemia. METHODS In this randomized, open-label, phase 3 trial, we randomly assigned 389 patients to receive venetoclax for up to 2 years (from day 1 of cycle 1) plus rituximab for the first 6 months (venetoclax-rituximab group) or bendamustine plus rituximab for 6 months (bendamustine-rituximab group). The trial design did not include crossover to venetoclax plus rituximab for patients in the bendamustine-rituximab group in whom progression occurred. The primary end point was investigator-assessed progression-free survival. RESULTS After a median follow-up period of 23.8 months, the rate of investigator-assessed progression-free survival was significantly higher in the venetoclax-rituximab group (32 events of progression or death in 194 patients) than in the bendamustine-rituximab group (114 events in 195 patients); the 2-year rates of progression-free survival were 84.9% and 36.3%, respectively (hazard ratio for progression or death, 0.17; 95% confidence interval [CI], 0.11 to 0.25; P<0.001 by the stratified log-rank test). The benefit was maintained across all clinical and biologic subgroups, including the subgroup of patients with chromosome 17p deletion; the 2-year rate of progression-free survival among patients with chromosome 17p deletion was 81.5% in the venetoclax-rituximab group versus 27.8% in the bendamustine-rituximab group (hazard ratio, 0.13; 95% CI, 0.05 to 0.29), and the 2-year rate among those without chromosome 17p deletion was 85.9% versus 41.0% (hazard ratio, 0.19; 95% CI, 0.12 to 0.32). The benefit of venetoclax plus rituximab over bendamustine plus rituximab was confirmed by an independent review committee assessment of progression-free survival and other secondary efficacy end points. The rate of grade 3 or 4 neutropenia was higher in the venetoclax-rituximab group than in the bendamustine-rituximab group, but the rates of grade 3 or 4 febrile neutropenia and infections or infestations were lower with venetoclax than with bendamustine. The rate of grade 3 or 4 tumor lysis syndrome in the venetoclax-rituximab group was 3.1% (6 of 194 patients). CONCLUSIONS Among patients with relapsed or refractory chronic lymphocytic leukemia, venetoclax plus rituximab resulted in significantly higher rates of progression-free survival than bendamustine plus rituximab.	[Seymour, J. F.] Royal Melbourne Hosp, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Seymour, J. F.] Univ Melbourne, Melbourne, Vic, Australia; [D'Rozario, J.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT, Australia; [Kipps, T. J.] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; [Punnoose, E. A.; Li, Y.; Mobasher, M.] Genentech Inc, San Francisco, CA USA; [Eichhorst, B.] Univ Hosp Cologne, Cologne, Germany; [Eichhorst, B.] Ctr Integrated Oncol Cologne Bonn, Cologne, Germany; [Hillmen, P.] St James Univ Hosp, Leeds, W Yorkshire, England; [Boyer, M.; Humphrey, K.] F Hofmann La Roche, Welwyn Garden City, Herts, England; [Assouline, S.] Jewish Gen Hosp, Lady Davis Inst, Segal Canc Ctr, Montreal, PQ, Canada; [Owen, C.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Owen, C.] Univ Calgary, Dept Oncol, Calgary, AB, Canada; [Gerecitano, J.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Robak, T.] Med Univ Lodz, Dept Hematol, Lodz, Poland; [Robak, T.] Copernicus Mem Hosp, Lodz, Poland; [De la Serna, J.] Hosp Univ 12 Octubre, Madrid, Spain; [Jaeger, U.] Med Univ Vienna, Dept Med 1, Div Hematol & Hemostaseol, Vienna, Austria; [Cartron, G.] CHU Montpellier, Dept Hematol, Montpellier, France; [Montillo, M.] Osped Niguarda Ca Granda, Niguarda Canc Ctr, Dept Oncohematol, Div Hematol, Milan, Italy; [Humerickhouse, R.] AbbVie, N Chicago, IL USA; [Kater, A. P.] Acad Med Ctr, Canc Ctr Amsterdam, Dept Hematol, Amsterdam, Netherlands	Peter Maccallum Cancer Center; Royal Melbourne Hospital; University of Melbourne; Australian National University; John Curtin School of Medical Research; University of California System; University of California San Diego; Roche Holding; Genentech; University of Cologne; University of Cologne; Saint James's University Hospital; Lady Davis Institute; McGill University; University of Calgary; University of Calgary; Memorial Sloan Kettering Cancer Center; Medical University Lodz; Hospital Universitario 12 de Octubre; Medical University of Vienna; Universite de Montpellier; CHU de Montpellier; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; AbbVie; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Seymour, JF (corresponding author), Peter MacCallum Canc Ctr, Dept Haematol, Melbourne, Vic 3000, Australia.	john.seymour@petermac.org	Robak, Tadeusz/ABA-5496-2020; Seymour, John/K-7326-2019; DE LA SERNA, JAVIER/B-1735-2012; Robak, Tadeusz/AAW-7365-2021	Seymour, John/0000-0003-2188-6835; DE LA SERNA, JAVIER/0000-0003-3904-1101; Robak, Tadeusz/0000-0002-3411-6357	Genentech; AbbVie	Genentech(Roche HoldingGenentech); AbbVie(AbbVie)	Funded by Genentech and AbbVie.	Anderson MA, 2016, BLOOD, V127, P3215, DOI 10.1182/blood-2016-01-688796; [Anonymous], 1997, Int Dig Health Legis, V48, P231; Bottcher S, 2012, J CLIN ONCOL, V30, P980, DOI 10.1200/JCO.2011.36.9348; Burger JA, 2014, LANCET ONCOL, V15, P1090, DOI 10.1016/S1470-2045(14)70335-3; Byrd JC, 2014, NEW ENGL J MED, V371, P213, DOI 10.1056/NEJMoa1400376; Byrd JC, 2003, BLOOD, V101, P6, DOI 10.1182/blood-2002-04-1258; Byrd JC, 2016, NEW ENGL J MED, V374, P323, DOI 10.1056/NEJMoa1509981; Chanan-Khan A, 2016, LANCET ONCOL, V17, P200, DOI 10.1016/S1470-2045(15)00465-9; Cheson BD, 2010, CL LYMPH MYELOM LEUK, V10, P21, DOI 10.3816/CLML.2010.n.002; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cory S, 2016, TRENDS CANCER, V2, P443, DOI 10.1016/j.trecan.2016.07.001; Davids MS, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.7528; Dimier N, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.720.720; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Eichhorst B, 2015, ANN ONCOL, V26, pV78, DOI 10.1093/annonc/mdv303; Ferrajoli A, 2011, CANCER-AM CANCER SOC, V117, P3182, DOI 10.1002/cncr.25853; Fischer K, 2011, J CLIN ONCOL, V29, P3559, DOI 10.1200/JCO.2010.33.8061; Furman RR, 2014, NEW ENGL J MED, V370, P997, DOI 10.1056/NEJMoa1315226; Hallek M, 2010, LANCET, V376, P1164, DOI 10.1016/S0140-6736(10)61381-5; Hallek M., 2017, 17 INT WORKSH CHRON; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Kovacs G, 2016, J CLIN ONCOL, V34, P3758, DOI 10.1200/JCO.2016.67.1305; Kwok M, 2016, BLOOD, V128, P2770, DOI 10.1182/blood-2016-05-714162; Leverson JD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4642; Moore VD, 2007, J CLIN INVEST, V117, P112, DOI 10.1172/JCI28281; National Comprehensive Cancer Network, 2017, NCCN GUID CHRON LYMP; Pospisilova S, 2012, LEUKEMIA, V26, P1458, DOI 10.1038/leu.2012.25; Robak T, 2010, J CLIN ONCOL, V28, P1756, DOI 10.1200/JCO.2009.26.4556; Roberts AW, 2016, NEW ENGL J MED, V374, P311, DOI 10.1056/NEJMoa1513257; Robertson LE, 1996, LEUKEMIA, V10, P456; Seymour JF, 2017, LANCET ONCOL, V18, P230, DOI 10.1016/S1470-2045(17)30012-8; Shanafelt Tait D, 2009, Hematology Am Soc Hematol Educ Program, P421, DOI 10.1182/asheducation-2009.1.421; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Stilgenbauer S, 2016, LANCET ONCOL, V17, P768, DOI 10.1016/S1470-2045(16)30019-5; Tam CS, 2015, LEUKEMIA LYMPHOMA, V56, P587, DOI 10.3109/10428194.2015.1011641; Thijssen R, 2015, HAEMATOLOGICA, V100, pE302, DOI 10.3324/haematol.2015.124560; Westfall PH, 2001, J STAT PLAN INFER, V99, P25, DOI 10.1016/S0378-3758(01)00077-5; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Zelenetz AD, 2017, LANCET ONCOL, V18, P297, DOI 10.1016/S1470-2045(16)30671-4	39	511	527	1	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2018	378	12					1107	1120		10.1056/NEJMoa1713976	http://dx.doi.org/10.1056/NEJMoa1713976			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ9OV	29562156	Bronze, Green Published			2022-12-28	WOS:000427942300007
J	Zhang, SL; Yue, ZF; Arnold, DM; Artiushin, G; Sehgal, A				Zhang, Shirley L.; Yue, Zhifeng; Arnold, Denice M.; Artiushin, Gregory; Sehgal, Amita			A Circadian Clock in the Blood-Brain Barrier Regulates Xenobiotic Efflux	CELL			English	Article							P-GLYCOPROTEIN; ANTIEPILEPTIC DRUGS; DIURNAL-VARIATION; DROSOPHILA; BEHAVIOR; CELLS; GAP; INNEXINS; TRANSPORTERS; MECHANISMS	Endogenous circadian rhythms are thought to modulate responses to external factors, but mechanisms that confer time-of-day differences in organismal responses to environmental insults/therapeutic treatments are poorly understood. Using a xenobiotic, we find that permeability of the Drosophila "blood''-brain barrier (BBB) is higher at night. The permeability rhythm is driven by circadian regulation of efflux and depends on a molecular clock in the perineurial glia of the BBB, although efflux transporters are restricted to subperineurial glia (SPG). We show that transmission of circadian signals across the layers requires cyclically expressed gap junctions. Specifically, during nighttime, gap junctions reduce intracellular magnesium ([Mg2+]i), a positive regulator of efflux, in SPG. Consistent with lower nighttime efflux, nighttime administration of the anti-epileptic phenytoin is more effective at treating a Drosophila seizure model. These findings identify a novel mechanism of circadian regulation and have therapeutic implications for drugs targeted to the central nervous system.	[Zhang, Shirley L.; Sehgal, Amita] Univ Penn, Perelman Sch Med, Ctr Sleep & Circadian Neurobiol, Philadelphia, PA 19104 USA; [Zhang, Shirley L.; Yue, Zhifeng; Arnold, Denice M.; Artiushin, Gregory; Sehgal, Amita] Univ Penn, Perelman Sch Med, Chronobiol Program Penn, Philadelphia, PA 19104 USA; [Zhang, Shirley L.; Yue, Zhifeng; Arnold, Denice M.; Artiushin, Gregory; Sehgal, Amita] Univ Penn, Perelman Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; University of Pennsylvania; Pennsylvania Medicine	Sehgal, A (corresponding author), Univ Penn, Perelman Sch Med, Ctr Sleep & Circadian Neurobiol, Philadelphia, PA 19104 USA.; Sehgal, A (corresponding author), Univ Penn, Perelman Sch Med, Chronobiol Program Penn, Philadelphia, PA 19104 USA.; Sehgal, A (corresponding author), Univ Penn, Perelman Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.	amita@pennmedicine.upenn.edu	Zhang, Shirley/AAL-7187-2021	Zhang, Shirley/0000-0002-6672-2044	NIH [T32HL07713, R37NS048471]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH060490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS048471] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the NIH (T32HL07713) (to S.L.Z.) and R37NS048471 (to A.S.) and by the Howard Hughes Medical Institute (to A.S.). We thank Dr. John Hogenesch for assistance with statistical analysis and Dr. Annika Barber for assistance with visual representation of data.	Abbott NJ, 2013, J INHERIT METAB DIS, V36, P437, DOI 10.1007/s10545-013-9608-0; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Antoch MP, 2005, CELL CYCLE, V4, P901, DOI 10.4161/cc.4.7.1792; Bainton RJ, 2005, CELL, V123, P145, DOI 10.1016/j.cell.2005.07.029; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; BENZER S, 1971, J AMER MED ASSOC, V218, P1015, DOI 10.1001/jama.218.7.1015; Booth CL, 2000, BIOCHEMISTRY-US, V39, P5518, DOI 10.1021/bi992931x; Brancaccio M, 2017, NEURON, V93, P1420, DOI 10.1016/j.neuron.2017.02.030; Chatterjee A, 2016, RES PERSPECT END INT, P71, DOI 10.1007/978-3-319-27069-2_8; CURTIN KD, 1995, NEURON, V14, P365, DOI 10.1016/0896-6273(95)90292-9; Dallmann R, 2016, TRENDS MOL MED, V22, P430, DOI 10.1016/j.molmed.2016.03.004; Dallmann R, 2014, ANNU REV PHARMACOL, V54, P339, DOI 10.1146/annurev-pharmtox-011613-135923; Damulewicz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073690; DeSalvo MK, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00346; Desalvo MK, 2011, GLIA, V59, P1322, DOI 10.1002/glia.21147; Deshpande SA, 2014, NAT METHODS, V11, P535, DOI [10.1038/NMETH.2899, 10.1038/nmeth.2899]; Feeney KA, 2016, NATURE, V532, P375, DOI 10.1038/nature17407; Feng YF, 2004, J NEUROGENET, V18, P377, DOI 10.1080/01677060490894522; Garbe DS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003749; Guo F, 2014, ELIFE, V3, DOI 10.7554/eLife.02780; Hindle SJ, 2017, CELL REP, V21, P1304, DOI 10.1016/j.celrep.2017.10.026; Holcroft CE, 2013, J CELL SCI, V126, P3823, DOI 10.1242/jcs.117994; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Ito C, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00008; Jackson FR, 2015, METHOD ENZYMOL, V552, P45, DOI 10.1016/bs.mie.2014.10.016; Kaur G, 2016, PHARMACEUTICS, V8, DOI 10.3390/pharmaceutics8020013; Kervezee L, 2014, AAPS J, V16, P1029, DOI 10.1208/s12248-014-9625-4; Liang XT, 2017, NEURON, V94, P1173, DOI 10.1016/j.neuron.2017.05.007; Liang XJ, 2000, BIOSCIENCE REP, V20, P129, DOI 10.1023/A:1005530501137; Limmer S, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00365; Loscher W, 2011, CURR PHARM DESIGN, V17, P2808, DOI 10.2174/138161211797440212; Masuyama K, 2012, J NEUROGENET, V26, P89, DOI 10.3109/01677063.2011.642910; Mayer F, 2009, J NEUROSCI, V29, P3538, DOI 10.1523/JNEUROSCI.5564-08.2009; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Pan WH, 2002, J APPL PHYSIOL, V92, P1357, DOI 10.1152/japplphysiol.00915.2001; Pan WH, 2001, LIFE SCI, V68, P2705, DOI 10.1016/S0024-3205(01)01085-2; Peschel N, 2011, FEBS LETT, V585, P1435, DOI 10.1016/j.febslet.2011.02.028; Phelan P, 2001, BIOESSAYS, V23, P388, DOI 10.1002/bies.1057; Pinsonneault RL, 2011, METHODS MOL BIOL, V686, P357, DOI 10.1007/978-1-60761-938-3_17; Reynolds ER, 2004, J NEUROBIOL, V58, P503, DOI 10.1002/neu.10297; SHAPIRO AB, 1994, J BIOL CHEM, V269, P3745; Skerrett IM, 2017, DEV NEUROBIOL, V77, P522, DOI 10.1002/dneu.22447; Smendziuk CM, 2015, DEVELOPMENT, V142, P2598, DOI 10.1242/dev.123448; Speder P, 2014, DEV CELL, V30, P309, DOI 10.1016/j.devcel.2014.05.021; Stork T, 2008, J NEUROSCI, V28, P587, DOI 10.1523/JNEUROSCI.4367-07.2008; Thews O, 2006, NEOPLASIA, V8, P143, DOI 10.1593/neo.05697; Tso CF, 2017, CURR BIOL, V27, P1055, DOI 10.1016/j.cub.2017.02.037; Volkenhoff A, 2015, CELL METAB, V22, P437, DOI 10.1016/j.cmet.2015.07.006; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Yegnanarayan R, 2006, CHRONOBIOL INT, V23, P1035, DOI 10.1080/07420520600921112; Yoon SS, 2012, BIOMOL THER, V20, P245, DOI 10.4062/biomolther.2012.20.3.245; ZENG HK, 1994, EMBO J, V13, P3590, DOI 10.1002/j.1460-2075.1994.tb06666.x	54	100	101	3	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 22	2018	173	1					130	+		10.1016/j.cell.2018.02.017	http://dx.doi.org/10.1016/j.cell.2018.02.017			20	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GA3MT	29526461	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000428234200013
J	Daniels, AR; Hunt, B; Teo, M; Kurian, KM				Daniels, Aled R.; Hunt, Becky; Teo, Mario; Kurian, Kathreena M.			Progressive blurred vision in a 44 year old woman	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MENINGIOMA		[Daniels, Aled R.] Southmead Hosp, Dept Neuropathol, Bristol, RI USA; [Hunt, Becky; Teo, Mario; Kurian, Kathreena M.] Inst Clin Neurosci, Bristol, Avon, England		Daniels, AR (corresponding author), Southmead Hosp, Dept Neuropathol, Bristol, RI USA.	aleddaniels@gmail.com	Teo, Mario/AAE-5804-2020	Teo, Mario/0000-0002-0051-3303; Kurian, Kathreena/0000-0003-0303-3716; Daniels, Aled/0000-0001-6794-3036				Bienfang D., OVERVIEW DIFFERENTIA; Ellison D., 2013, NEUROPATHOLOGY REFER, V3rd ed., P305; Friedman D I, 2001, Ophthalmol Clin North Am, V14, P129; Goldbrunner R, 2016, LANCET ONCOL, V17, pE383, DOI 10.1016/S1470-2045(16)30321-7; Louise DN, 2016, WHO CLASSIFICATION T, V1; Rapalino O, 2016, HAND CLINIC, V135, P275, DOI 10.1016/B978-0-444-53485-9.00015-5; Sahm F, 2017, LANCET ONCOL, V18, P682, DOI 10.1016/S1470-2045(17)30155-9; Smith AB, 2014, RADIOGRAPHICS, V34, P295, DOI 10.1148/rg.342130075; Wiemels J, 2010, J NEURO-ONCOL, V99, P307, DOI 10.1007/s11060-010-0386-3	9	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2018	360								k579	10.1136/bmj.k579	http://dx.doi.org/10.1136/bmj.k579			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ9GD	29545357				2022-12-28	WOS:000427917100006
J	Exarchakou, A; Rachet, B; Belot, A; Maringe, C; Coleman, MP				Exarchakou, Aimilia; Rachet, Bernard; Belot, Aurelien; Maringe, Camille; Coleman, Michel P.			Impact of national cancer policies on cancer survival trends and socioeconomic inequalities in England, 1996-2013: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BREAST-CANCER; LUNG-CANCER; CONSULTATION PATTERNS; NET SURVIVAL; STAGE; DIAGNOSIS; WALES; UK; AUSTRALIA; MORTALITY	OBJECTIVE To assess the effectiveness of the NHS Cancer Plan (2000) and subsequent national cancer policy initiatives in improving cancer survival and reducing socioeconomic inequalities in survival in England. DESIGN Population based cohort study. SETTING England. POPULATION More than 3.5 million registered patients aged 15-99 with a diagnosis of one of the 24 most common primary, malignant, invasive neoplasms between 1996 and 2013. MAIN OUTCOME MEASURES Age standardised net survival estimates by cancer, sex, year, and deprivation group. These estimates were modelled using regression model with splines to explore changes in the cancer survival trends and in the socioeconomic inequalities in survival. RESULTS One year net survival improved steadily from 1996 for 26 of 41 sex-cancer combinations studied, and only from 2001 or 2006 for four cancers. Trends in survival accelerated after 2006 for five cancers. The deprivation gap observed for all 41 sex-cancer combinations among patients with a diagnosis in 1996 persisted until 2013. However, the gap slightly decreased for six cancers among men for which one year survival was more than 65% in 1996, and for cervical and uterine cancers, for which survival was more than 75% in 1996. The deprivation gap widened notably for brain tumours in men and for lung cancer in women. CONCLUSIONS Little evidence was found of a direct impact of national cancer strategies on one year survival, and no evidence for a reduction in socioeconomic inequalities in cancer survival. These findings emphasise that socioeconomic inequalities in survival remain a major public health problem for a healthcare system founded on equity.	[Exarchakou, Aimilia; Rachet, Bernard; Belot, Aurelien; Maringe, Camille; Coleman, Michel P.] London Sch Hyg & Trop Med, Canc Survival Grp, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Exarchakou, A (corresponding author), London Sch Hyg & Trop Med, Canc Survival Grp, London WC1E 7HT, England.	Aimilia.Exarchakou@lshtm.ac.uk	Coleman, Michel/AAA-9543-2020	Coleman, Michel/0000-0001-8940-3807; Rachet, Bernard/0000-0001-5837-7773; Belot, Aurelien/0000-0003-1410-5172; Exarchakou, Aimilia/0000-0003-4881-6183	Cancer Research UK [C7923/A18525]	Cancer Research UK(Cancer Research UK)	Cancer Research UK (grant No C7923/A18525). Cancer Research UK had no involvement in any of the study steps.	Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; [Anonymous], 2009, NATL AWARENESS EARLY; Berrino F, 1995, IARC SCI PUBLICATION, V132; Cancer Survival Group, 2004, LIF TABL ENGL WAL SE; Clerc-Urmes I, 2014, STATA J, V14, P87, DOI 10.1177/1536867X1401400107; Coleman MP, 2004, BRIT J CANCER, V90, P1367, DOI 10.1038/sj.bjc.6601696; Coleman MP, 1999, STUDIES MED POPULATI, V61; Corazziari I, 2004, EUR J CANCER, V40, P2307, DOI 10.1016/j.ejca.2004.07.002; Crane LMA, 2007, EUR J CANCER, V43, P1445, DOI 10.1016/j.ejca.2007.03.024; De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1; Department of Health, 2007, CANC REF STRAT EQ IM; Department of Health, 2011, CLOUD COMP OPP CHALL, P1; Department of Health, 2000, NHS CANC PLAN PLAN I; Department of Health, 2010, EQ EXC LIB NHS; Ellis L, 2012, EUR J CANCER, V48, P270, DOI 10.1016/j.ejca.2011.10.008; Expert Advisory Group on Cancer, 1995, POL FRAM COMM CANC S; Forbes LJL, 2013, BRIT J CANCER, V108, P292, DOI 10.1038/bjc.2012.542; Ito Y, 2014, ACTA ONCOL, V53, P1423, DOI 10.3109/0284186X.2014.912350; Jeffreys M, 2009, CANCER EPIDEM BIOMAR, V18, P915, DOI 10.1158/1055-9965.EPI-08-0685; Karim-Kos HE, 2008, EUR J CANCER, V44, P1345, DOI 10.1016/j.ejca.2007.12.015; KOGEVINAS M, 1991, J EPIDEMIOL COMMUN H, V45, P216, DOI 10.1136/jech.45.3.216; Kogevinas M, 1997, IARC SCI PUBL, V138, P177; Landy R, 2016, BRIT J CANCER, V115, P1140, DOI 10.1038/bjc.2016.290; Lau KKW, 2013, J THORAC ONCOL, V8, P68, DOI 10.1097/JTO.0b013e3182762315; Li RR, 2016, EUR J EPIDEMIOL, V31, P603, DOI 10.1007/s10654-016-0155-5; Li RR, 2014, CANCER EPIDEMIOL, V38, P314, DOI 10.1016/j.canep.2014.02.013; Linchtenberg FR, 2010, W16051 NBER; Luchtenborg M, 2013, J CLIN ONCOL, V31, P3141, DOI 10.1200/JCO.2013.49.0219; Maringe C, 2013, ACTA ONCOL, V52, P919, DOI 10.3109/0284186X.2013.764008; Maringe C, 2012, GYNECOL ONCOL, V127, P75, DOI 10.1016/j.ygyno.2012.06.033; Moller H, 2011, BRIT J CANCER, V105, P170, DOI 10.1038/bjc.2011.168; Morris M, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3129-4; National Cancer Intelligence Network, 2010, EV MARCH 2010 CANC I; National Cancer Intelligence Network, 2010, NAT CANC EQ IN; Neighbourhood Renewal Unit, 2004, ENGLISH INDICES DEPR; Niksic M, 2016, BRIT J CANCER, V115, P876, DOI 10.1038/bjc.2016.246; Office for National Statistics, 2017, CANC REG STAT ENGL 2; Office for National Statistics, 2015, CANC SURV STAT B QUA; Percy C., 1990, INT CLASSIFICATION D; Perme MP, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2967-9; Perme MP, 2012, BIOMETRICS, V68, P113, DOI 10.1111/j.1541-0420.2011.01640.x; Public Health England, 2015, ROUT DIAGN 2015 UPD; Public Health England, 2015, ROUT DIAGN 2006 2013; Quaresma M, 2015, LANCET, V385, P1206, DOI 10.1016/S0140-6736(14)61396-9; Rachet B, 2008, BRIT J CANCER, V99, pS2, DOI 10.1038/sj.bjc.6604571; Rachet B, 2010, BRIT J CANCER, V103, P446, DOI 10.1038/sj.bjc.6605752; Rachet B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2534-3; Rachet B, 2009, LANCET ONCOL, V10, P351, DOI 10.1016/S1470-2045(09)70028-2; Renzi C, 2016, BRIT J CANCER, V115, P866, DOI 10.1038/bjc.2016.250; Riaz SP, 2012, THORAX, V67, P811, DOI 10.1136/thoraxjnl-2012-201768; Riaz SP, 2012, EUR J CANCER, V48, P54, DOI 10.1016/j.ejca.2011.07.012; Robb K, 2009, BRIT J CANCER, V101, pS18, DOI 10.1038/sj.bjc.6605386; Royal College of Physicians, 2017, NAT EARL WARN SCOR N, P1, DOI [10.1097/JTO.0b013e3182762315, DOI 10.1097/JTO.0B013E3182762315]; Royston P, 2007, STATA J, V7, P45, DOI 10.1177/1536867X0700700103; Shack LG, 2007, BRIT J CANCER, V97, P999, DOI 10.1038/sj.bjc.6603980; Shah A, 2008, BRIT J CANCER, V99, pS86, DOI 10.1038/sj.bjc.6604599; Stata Corp, 2015, STAT STAT SOFTW REL; Walters S, 2013, BRIT J CANCER, V108, P1195, DOI 10.1038/bjc.2013.6; Walters S, 2015, BRIT J CANCER, V113, P848, DOI 10.1038/bjc.2015.265; Walters S, 2013, THORAX, V68, P551, DOI 10.1136/thoraxjnl-2012-202297; Woods LM, 2016, INT J CANCER, V138, P2396, DOI 10.1002/ijc.29983; Woods LM, 2006, ANN ONCOL, V17, P5, DOI 10.1093/annonc/mdj007; World Health Organization, 1994, INT STAT CLASS DIS R	63	65	65	2	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 14	2018	360								k764	10.1136/bmj.k764	http://dx.doi.org/10.1136/bmj.k764			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ9FZ	29540358	Green Submitted, Green Published, hybrid, Green Accepted			2022-12-28	WOS:000427916700013
J	Short, PJ; Mcrae, JF; Gallone, G; Sifrim, A; Won, H; Geschwind, DH; Wright, CF; Firth, HV; FitzPatrick, DR; Barrett, JC; Hurles, ME				Short, Patrick J.; McRae, Jeremy F.; Gallone, Giuseppe; Sifrim, Alejandro; Won, Hyejung; Geschwind, Daniel H.; Wright, Caroline F.; Firth, Helen V.; FitzPatrick, David R.; Barrett, Jeffrey C.; Hurles, Matthew E.			De novo mutations in regulatory elements in neurodevelopmental disorders	NATURE			English	Article							HUMAN-DISEASE; DEVELOPMENTAL DISORDERS; GENETIC-VARIATION; ENHANCER; IDENTIFICATION; DISRUPTION; FRAMEWORK; VARIANTS; DNA; ASSOCIATION	We previously estimated that 42% of patients with severe developmental disorders carry pathogenic de novo mutations in coding sequences. The role of de novo mutations in regulatory elements affecting genes associated with developmental disorders, or other genes, has been essentially unexplored. We identified de novo mutations in three classes of putative regulatory elements in almost 8,000 patients with developmental disorders. Here we show that de novo mutations in highly evolutionarily conserved fetal brain-active elements are significantly and specifically enriched in neurodevelopmental disorders. We identified a significant twofold enrichment of recurrently mutated elements. We estimate that, genome-wide, 1-3% of patients without a diagnostic coding variant carry pathogenic de novo mutations in fetal brain-active regulatory elements and that only 0.15% of all possible mutations within highly conserved fetal brain-active elements cause neurodevelopmental disorders with a dominant mechanism. Our findings represent a robust estimate of the contribution of de novo mutations in regulatory elements to this genetically heterogeneous set of disorders, and emphasize the importance of combining functional and evolutionary evidence to identify regulatory causes of genetic disorders.	[Short, Patrick J.; McRae, Jeremy F.; Gallone, Giuseppe; Sifrim, Alejandro; Wright, Caroline F.; Firth, Helen V.; FitzPatrick, David R.; Barrett, Jeffrey C.; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England; [Won, Hyejung; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Program Neurobehav Genet, Ctr Autism Res & Treatment,Semel Inst, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Wright, Caroline F.] Univ Exeter, Inst Biomed & Clin Sci, Med Sch, Royal Devon & Exeter Hosp, RILD Level 4,Barrack Rd, Exeter EX2 5DW, Devon, England; [Firth, Helen V.] Cambridge Univ Hosp NHS Fdn Trust, East Anglian Med Genet Serv, Box 134,Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [FitzPatrick, David R.] Univ Edinburgh, Western Gen Hosp, MRC Human Genet Unit, MRC IGMM, Edinburgh EH4 2XU, Midlothian, Scotland	Wellcome Trust Sanger Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Exeter; University of Cambridge; University of Edinburgh	Hurles, ME (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	meh@sanger.ac.uk	Sifrim, Alejandro/AAY-2019-2021	Sifrim, Alejandro/0000-0001-8247-4020; FitzPatrick, David R./0000-0003-4861-969X; Short, Patrick/0000-0002-7626-6177; Wright, Caroline/0000-0003-2958-5076	Medical Research Council [MC_UU_00007/3] Funding Source: Medline; NIMH NIH HHS [K99 MH113823, R00 MH113823, U01 MH105666, R01 MH110927] Funding Source: Medline; Wellcome Trust [098051] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH110927, K99MH113823, U01MH105666] Funding Source: NIH RePORTER; MRC [MC_UU_00007/3] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akawi N, 2015, NAT GENET, V47, P1363, DOI 10.1038/ng.3410; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Benko S, 2011, J MED GENET, V48, P825, DOI 10.1136/jmedgenet-2011-100255; Bhatia S, 2013, AM J HUM GENET, V93, P1126, DOI 10.1016/j.ajhg.2013.10.028; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Carlson J, 2017, EXTREMELY RARE VARIA; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Gao TS, 2016, BIOINFORMATICS, V32, P3543, DOI 10.1093/bioinformatics/btw495; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hill RE, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0357; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Jeong Y, 2008, NAT GENET, V40, P1348, DOI 10.1038/ng.230; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kohler S, 2017, NUCLEIC ACIDS RES, V45, pD865, DOI 10.1093/nar/gkw1039; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Koren A, 2014, CELL, V159, P1015, DOI 10.1016/j.cell.2014.10.025; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Mathelier A, 2015, TRENDS GENET, V31, P67, DOI 10.1016/j.tig.2014.12.003; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; May D, 2012, NAT GENET, V44, P89, DOI 10.1038/ng.1006; McLeay RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-165; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Naville M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7904; Noonan JP, 2010, ANNU REV GENOM HUM G, V11, P1, DOI 10.1146/annurev-genom-082509-141651; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Ramu A, 2013, NAT METHODS, V10, P985, DOI 10.1038/nmeth.2611; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Sellick GS, 2004, NAT GENET, V36, P1301, DOI 10.1038/ng1475; Shihab HA, 2015, BIOINFORMATICS, V31, P1536, DOI 10.1093/bioinformatics/btv009; Shooshtari P, 2017, AM J HUM GENET, V101, P75, DOI 10.1016/j.ajhg.2017.06.001; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smedley D, 2016, AM J HUM GENET, V99, P595, DOI 10.1016/j.ajhg.2016.07.005; Spielmann M, 2016, HUM MOL GENET, V25, pR157, DOI 10.1093/hmg/ddw205; Turner TN, 2016, AM J HUM GENET, V98, P58, DOI 10.1016/j.ajhg.2015.11.023; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Weedon MN, 2014, NAT GENET, V46, P61, DOI 10.1038/ng.2826; Whalen S, 2016, NAT GENET, V48, P488, DOI 10.1038/ng.3539; Won HJ, 2016, NATURE, V538, P523, DOI 10.1038/nature19847; Wright CF, 2015, LANCET, V385, P1305, DOI 10.1016/S0140-6736(14)61705-0; Zhang F, 2015, HUM MOL GENET, V24, pR102, DOI 10.1093/hmg/ddv259	50	125	126	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2018	555	7698					611	+		10.1038/nature25983	http://dx.doi.org/10.1038/nature25983			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8UX	29562236	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000428617600040
J	Vandewauw, I; De Clercq, K; Mulier, M; Held, K; Pinto, S; Van Ranst, N; Segal, A; Voet, T; Vennekens, R; Zimmermann, K; Vriens, J; Voets, T				Vandewauw, Ine; De Clercq, Katrien; Mulier, Marie; Held, Katharina; Pinto, Silvia; Van Ranst, Nele; Segal, Andrei; Voet, Thierry; Vennekens, Rudi; Zimmermann, Katharina; Vriens, Joris; Voets, Thomas			A TRP channel trio mediates acute noxious heat sensing	NATURE			English	Article							ION-CHANNEL; NOCICEPTIVE NEURONS; CAPSAICIN RECEPTOR; IN-VITRO; PAIN; SENSOR; THERMOSENSATION; PATHWAY; ACTS; MICE	Acute pain represents a crucial alarm signal to protect us from injury(1). Whereas the nociceptive neurons that convey pain signals were described more than a century ago(2), the molecular sensors that detect noxious thermal or mechanical insults have yet to be fully identified(3-6). Here we show that acute noxious heat sensing in mice depends on a triad of transient receptor potential (TRP) ion channels: TRPM3, TRPV1, and TRPA1. We found that robust somatosensory heat responsiveness at the cellular and behavioural levels is observed only if at least one of these TRP channels is functional. However, combined genetic or pharmacological elimination of all three channels largely and selectively prevents heat responses in both isolated sensory neurons and rapidly firing C and A delta sensory nerve fibres that innervate the skin. Strikingly, Trpv1(-/-)Trpm3(-/-)Trpa1(-/-)triple knockout (TKO) mice lack the acute withdrawal response to noxious heat that is necessary to avoid burn injury, while showing normal nociceptive responses to cold or mechanical stimuli and a preserved preference for moderate temperatures. These findings indicate that the initiation of the acute heat-evoked pain response in sensory nerve endings relies on three functionally redundant TRP channels, representing a fault-tolerant mechanism to avoid burn injury.	[Vandewauw, Ine; De Clercq, Katrien; Mulier, Marie; Held, Katharina; Pinto, Silvia; Van Ranst, Nele; Segal, Andrei; Vennekens, Rudi; Voets, Thomas] Univ Leuven, Dept Cellular & Mol Med, Lab Ion Channel Res, Leuven, Belgium; [Vandewauw, Ine; De Clercq, Katrien; Mulier, Marie; Held, Katharina; Pinto, Silvia; Van Ranst, Nele; Segal, Andrei; Vennekens, Rudi; Voets, Thomas] Univ Leuven, TRP Res Platform Leuven TRPLe, Leuven, Belgium; [Vandewauw, Ine; De Clercq, Katrien; Mulier, Marie; Held, Katharina; Pinto, Silvia; Van Ranst, Nele; Segal, Andrei; Vennekens, Rudi; Voets, Thomas] VIB Ctr Brain & Dis Res, Leuven, Belgium; [De Clercq, Katrien; Held, Katharina; Vriens, Joris] Univ Leuven, Dept Dev & Regenerat, Lab Expt Gynecol & Obstet, Leuven, Belgium; [Voet, Thierry] Univ Leuven, Dept Human Genet, Lab Reprod Genom, Leuven, Belgium; [Zimmermann, Katharina] Univ Erlangen Nurnberg, Dept Anesthesiol, Erlangen, Germany	KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University of Erlangen Nuremberg	Voets, T (corresponding author), Univ Leuven, Dept Cellular & Mol Med, Lab Ion Channel Res, Leuven, Belgium.; Voets, T (corresponding author), Univ Leuven, TRP Res Platform Leuven TRPLe, Leuven, Belgium.; Voets, T (corresponding author), VIB Ctr Brain & Dis Res, Leuven, Belgium.; Vriens, J (corresponding author), Univ Leuven, Dept Dev & Regenerat, Lab Expt Gynecol & Obstet, Leuven, Belgium.	joris.vriens@kuleuven.be; thomas.voets@kuleuven.vib.be	Vennekens, Rudi/AAQ-1664-2020; Voet, Thierry/E-8877-2017; Vriens, Joris/G-9966-2018; Voets, Thomas/AAD-4389-2019; Held, Katharina/AAR-4020-2021; Held, Katharina/AAU-4515-2020; De Clercq, Katrien/R-1962-2017	Vennekens, Rudi/0000-0002-2564-5150; Voet, Thierry/0000-0003-1204-9963; Vriens, Joris/0000-0002-2502-0409; Voets, Thomas/0000-0001-5526-5821; Held, Katharina/0000-0002-1727-9517; De Clercq, Katrien/0000-0002-7439-7587; Segal Stanciu, Andrei/0000-0002-0981-9587				Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Arenas OM, 2017, NAT NEUROSCI, V20, P1686, DOI 10.1038/s41593-017-0005-0; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Brenner DS, 2015, JOVE-J VIS EXP, DOI 10.3791/52640; Caterina MJ, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9040077; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Everaerts W, 2011, CURR BIOL, V21, P316, DOI 10.1016/j.cub.2011.01.031; Geffeney SL, 2012, NEURON, V74, P609, DOI 10.1016/j.neuron.2012.04.023; Grayson M, 2016, NATURE, V535, pS1, DOI 10.1038/535S1a; Huang SM, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-37; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Mishra SK, 2011, EMBO J, V30, P582, DOI 10.1038/emboj.2010.325; Moparthi L, 2016, SCI REP-UK, V6, DOI 10.1038/srep28763; Park U, 2011, J NEUROSCI, V31, P11425, DOI 10.1523/JNEUROSCI.1384-09.2011; Peirs C, 2016, SCIENCE, V354, P578, DOI 10.1126/science.aaf8933; Pogorzala LA, 2013, J NEUROSCI, V33, P5533, DOI 10.1523/JNEUROSCI.5788-12.2013; Sherrington C, 1906, INTEGRATIVE ACTION N; Song K, 2016, SCIENCE, V353, P1393, DOI 10.1126/science.aaf7537; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Tan CL, 2016, CELL, V167, P47, DOI 10.1016/j.cell.2016.08.028; Tan CH, 2016, NATURE, V536, P460, DOI 10.1038/nature19074; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Vriens J, 2014, NAT REV NEUROSCI, V15, P573, DOI 10.1038/nrn3784; Vriens J, 2014, NAT CHEM BIOL, V10, P188, DOI [10.1038/NCHEMBIO.1428, 10.1038/nchembio.1428]; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Zimmermann K, 2009, NAT PROTOC, V4, P174, DOI 10.1038/nprot.2008.223	30	211	215	9	225	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2018	555	7698					662	+		10.1038/nature26137	http://dx.doi.org/10.1038/nature26137			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8UX	29539642				2022-12-28	WOS:000428617600050
J	Kuehn, B				Kuehn, Bridget			Global Outbreaks Threaten US Economy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2018	319	12					1191	1191		10.1001/jama.2018.2595	http://dx.doi.org/10.1001/jama.2018.2595			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HI0BD	29584852				2022-12-28	WOS:000456106200009
J	Patel, A; Gyawali, P				Patel, Amit; Gyawali, Prakash			Gastroesophageal Reflux Monitoring	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DIAGNOSIS; DISEASE; GERD; OUTCOMES; TRIAL		[Patel, Amit] Duke Univ, Sch Med, Div Gastroenterol, 10207 Cerny St,Ste 210, Durham, NC 27617 USA; [Patel, Amit] Durham Vet Affairs Med Ctr, Durham, NC USA; [Gyawali, Prakash] Washington Univ, Sch Med, Div Gastroenterol, St Louis, MO 63110 USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Washington University (WUSTL)	Patel, A (corresponding author), Duke Univ, Sch Med, Div Gastroenterol, 10207 Cerny St,Ste 210, Durham, NC 27617 USA.	amit.patel@duke.edu		Patel, Amit/0000-0001-7214-5901	Medtronic	Medtronic(Medtronic)	Both authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Gyawali reports receipt of a grant from Medtronic and consulting and speakers' bureau relationships with Medtronic and Diversatek. No other disclosures were reported.	Aziz Q, 2016, GASTROENTEROLOGY; Dent J, 2010, GUT, V59, P714, DOI 10.1136/gut.2009.200063; Gyawali CP, 2018, GASTROENTEROLOGY, V154, P302, DOI 10.1053/j.gastro.2017.07.049; Johnston BT, 1996, AM J GASTROENTEROL, V91, P1181; Jonasson C, 2012, ALIMENT PHARM THER, V35, P1290, DOI 10.1111/j.1365-2036.2012.05092.x; Patel A, 2016, NEUROGASTROENT MOTIL, V28, P513, DOI 10.1111/nmo.12745; Patel A, 2015, CLIN GASTROENTEROL H, V13, P884, DOI 10.1016/j.cgh.2014.08.029; Roman S, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.13067; Savarino E, 2017, NAT REV GASTRO HEPAT, V14, P665, DOI 10.1038/nrgastro.2017.130; Weijenborg PW, 2012, NEUROGASTROENT MOTIL, V24, P747, DOI 10.1111/j.1365-2982.2012.01888.x	10	4	7	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2018	319	12					1271	1272		10.1001/jama.2018.1144	http://dx.doi.org/10.1001/jama.2018.1144			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GA5VW	29584823				2022-12-28	WOS:000428403000020
J	Sakulkoo, W; Oses-Ruiz, M; Garcia, EO; Soanes, DM; Littlejohn, GR; Hacker, C; Correia, A; Valent, B; Talbot, NJ				Sakulkoo, Wasin; Oses-Ruiz, Miriam; Garcia, Ely Oliveira; Soanes, Darren M.; Littlejohn, George R.; Hacker, Christian; Correia, Ana; Valent, Barbara; Talbot, Nicholas J.			A single fungal MAP kinase controls plant cell-to-cell invasion by the rice blast fungus	SCIENCE			English	Article							MAGNAPORTHE-ORYZAE; BIOTROPHIC INVASION; PROTEIN-KINASE; INFECTION; GRISEA; PLASMODESMATA; DISEASE	Blast disease destroys up to 30% of the rice crop annually and threatens global food security. The blast fungus Magnaporthe oryzae invades plant tissue with hyphae that proliferate and grow from cell to cell, often through pit fields, where plasmodesmata cluster. We showed that chemical genetic inhibition of a single fungal mitogen-activated protein (MAP) kinase, Pmk1, prevents M. oryzae from infecting adjacent plant cells, leaving the fungus trapped within a single plant cell. Pmk1 regulates expression of secreted fungal effector proteins implicated in suppression of host immune defenses, preventing reactive oxygen species generation and excessive callose deposition at plasmodesmata. Furthermore, Pmk1 controls the hyphal constriction required for fungal growth from one rice cell to the neighboring cell, enabling host tissue colonization and blast disease.	[Sakulkoo, Wasin; Oses-Ruiz, Miriam; Soanes, Darren M.; Littlejohn, George R.; Hacker, Christian; Correia, Ana; Talbot, Nicholas J.] Univ Exeter, Sch Biosci, Exeter EX4 4QD, Devon, England; [Garcia, Ely Oliveira; Valent, Barbara] Kansas State Univ, Dept Plant Pathol, 4024 Throckmorton Plant Sci Ctr, Manhattan, KS 66506 USA; [Littlejohn, George R.] Plymouth Univ, Sch Biol & Marine Sci, Portland Sq Bldg, Plymouth PL4 8AA, Devon, England	University of Exeter; Kansas State University; University of Plymouth	Talbot, NJ (corresponding author), Univ Exeter, Sch Biosci, Exeter EX4 4QD, Devon, England.	n.j.talbot@exeter.ac.uk	Littlejohn, George/AAA-6139-2021; Oses-Ruiz, Miriam/U-8576-2019; Talbot, Nicholas J/I-5618-2019	Littlejohn, George/0000-0002-8768-2598; Oses-Ruiz, Miriam/0000-0002-3989-9071; Talbot, Nicholas J/0000-0001-6434-7757; Oliveira-Garcia, Ely/0000-0003-0322-8716; Zhang, Shi-Hong/0000-0002-4172-7084; Valent, Barbara/0000-0002-5088-3345	Halpin Scholarship for rice blast research; European Research Council (ERC) Advanced Investigator Award under the European Union's Seventh Framework Programme (FP7); ERC [294702 GENBLAST]; Agriculture and Food Research Initiative from the U.S. Department of Agriculture National Institute of Food and Agriculture [2012-67013-19291]; BBSRC [BB/N009959/2, BBS/E/J/000PR9797, BB/N009959/1] Funding Source: UKRI	Halpin Scholarship for rice blast research; European Research Council (ERC) Advanced Investigator Award under the European Union's Seventh Framework Programme (FP7)(European Research Council (ERC)); ERC(European Research Council (ERC)European Commission); Agriculture and Food Research Initiative from the U.S. Department of Agriculture National Institute of Food and Agriculture; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a Halpin Scholarship for rice blast research to W.S., a European Research Council (ERC) Advanced Investigator Award to N.J.T. under the European Union's Seventh Framework Programme (FP7/2007-2013) and ERC grant no. 294702 GENBLAST, and Agriculture and Food Research Initiative Competitive grant no. 2012-67013-19291 to B.V. from the U.S. Department of Agriculture National Institute of Food and Agriculture. This is contribution number 18-174-J from the Kansas Agricultural Experiment Station.	Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bruno KS, 2004, EUKARYOT CELL, V3, P1525, DOI 10.1128/EC.3.6.1525-1532.2004; Cheval C, 2018, NEW PHYTOL, V217, P62, DOI 10.1111/nph.14857; Cui W, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.34, 10.1038/nplants.2016.34]; Dagdas YF, 2012, SCIENCE, V336, P1590, DOI 10.1126/science.1222934; Dixon KP, 1999, PLANT CELL, V11, P2045, DOI 10.1105/tpc.11.10.2045; Faulkner C, 2013, P NATL ACAD SCI USA, V110, P9166, DOI 10.1073/pnas.1203458110; Giraldo MC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2996; Inoue Y, 2017, SCIENCE, V357, P80, DOI 10.1126/science.aam9654; Jones K, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0756-x; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Khang CH, 2010, PLANT CELL, V22, P1388, DOI 10.1105/tpc.109.069666; Li L, 2004, MOL PLANT MICROBE IN, V17, P547, DOI 10.1094/MPMI.2004.17.5.547; Mentlak TA, 2012, PLANT CELL, V24, P322, DOI 10.1105/tpc.111.092957; Mochizuki S, 2015, MICROBIOLOGYOPEN, V4, P952, DOI 10.1002/mbo3.304; Mosquera G, 2009, PLANT CELL, V21, P1273, DOI 10.1105/tpc.107.055228; Ryder LS, 2013, P NATL ACAD SCI USA, V110, P3179, DOI 10.1073/pnas.1217470110; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Xu JR, 1998, P NATL ACAD SCI USA, V95, P12713, DOI 10.1073/pnas.95.21.12713; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696; Zhang X, 2017, ENVIRON MICROBIOL, V19, P4190, DOI 10.1111/1462-2920.13884	22	94	99	21	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2018	359	6382			SI		1399	+		10.1126/science.aaq0892	http://dx.doi.org/10.1126/science.aaq0892			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA0ZG	29567712	Green Submitted			2022-12-28	WOS:000428043600045
J	Andersen, TG; Naseer, S; Ursache, R; Wybouw, B; Smet, W; De Rybel, B; Vermeer, JEM; Geldner, N				Andersen, Tonni Grube; Naseer, Sadaf; Ursache, Robertas; Wybouw, Brecht; Smet, Wouter; De Rybel, Bert; Vermeer, Joop E. M.; Geldner, Niko			Diffusible repression of cytokinin signalling produces endodermal symmetry and passage cells	NATURE			English	Article							TRANSCRIPTION FACTOR; ARABIDOPSIS; ROOTS; AUXIN; DIFFERENTIATION; TRANSDUCTION; MERISTEM; SYSTEM; PHO1	In vascular plants, the root endodermis surrounds the central vasculature as a protective sheath that is analogous to the polarized epithelium in animals, and contains ring-shaped Casparian strips that restrict diffusion(1). After an initial lag phase, individual endodermal cells suberize in an apparently random fashion to produce 'patchy' suberization that eventually generates a zone of continuous suberin deposition(2). Casparian strips and suberin lamellae affect paracellular and transcellular transport, respectively. Most angiosperms maintain some isolated cells in an unsuberized state(3) as so-called 'passage cells', which have previously been suggested to enable uptake across an otherwise impermeable endodermal barrier(3,4). Here we demonstrate that these passage cells are late emanations of a meristematic patterning process that reads out the underlying non-radial symmetry of the vasculature. This process is mediated by the non-cell-autonomous repression of cytokinin signalling in the root meristem, and leads to distinct phloem- and xylem-pole-associated endodermal cells. The latter cells can resist abscisic acid-dependent suberization to produce passage cells. Our data further demonstrate that, during meristematic patterning, xylem-pole-associated endodermal cells can dynamically alter passage-cell numbers in response to nutrient status, and that passage cells express transporters and locally affect the expression of transporters in adjacent cortical cells.	[Andersen, Tonni Grube; Naseer, Sadaf; Ursache, Robertas; Vermeer, Joop E. M.; Geldner, Niko] Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland; [Wybouw, Brecht; Smet, Wouter; De Rybel, Bert] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Wybouw, Brecht; Smet, Wouter; De Rybel, Bert] VIB Ctr Plant Syst Biol, B-9052 Ghent, Belgium; [Smet, Wouter; De Rybel, Bert] Wageningen Univ, Lab Biochem, NL-6708 WE Wageningen, Netherlands; [Vermeer, Joop E. M.] Univ Zurich, Dept Plant & Microbial Biol, CH-8008 Zurich, Switzerland	University of Lausanne; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Wageningen University & Research; University of Zurich	Andersen, TG; Geldner, N (corresponding author), Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland.	tonnigrube.andersen@unil.ch; niko.geldner@unil.ch	Geldner, Niko/Y-2481-2019; Ursache, Robertas/AAA-7700-2022; Vermeer, Joop E.M./J-2232-2014	Vermeer, Joop E.M./0000-0001-8876-5873; De Rybel, Bert/0000-0002-9551-042X; Geldner, Niko/0000-0002-2300-9644; Wybouw, Brecht/0000-0001-8783-4646; Ursache, Robertas/0000-0002-3803-253X; Smet, Wouter/0000-0002-8000-3097	ERC [616228]; SNSF grant [31003A_156261]; IEF Marie Curie fellowship; EMBO Longterm postdoctoral fellowship; Netherlands Organisation for Scientific Research (NWO) [VIDI-864.13.001]; Research Foundation - Flanders (FWO) [G0D0515N]; Central Imaging Facility of the University of Lausanne	ERC(European Research Council (ERC)European Commission); SNSF grant; IEF Marie Curie fellowship; EMBO Longterm postdoctoral fellowship(European Molecular Biology Organization (EMBO)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Research Foundation - Flanders (FWO)(FWO); Central Imaging Facility of the University of Lausanne	This work was supported by funds to N.G. from an ERC Consolidator Grant (GA-No: 616228 - ENDOFUN), an SNSF grant (31003A_156261), an IEF Marie Curie fellowship (T.G.A.) and an EMBO Longterm postdoctoral fellowship (R.U.). B.D.R., W.S. and B.W. were funded by the Netherlands Organisation for Scientific Research (NWO; VIDI-864.13.001) and The Research Foundation - Flanders (FWO; Odysseus II G0D0515N). We thank A. Paradis and the Central Imaging Facility of the University of Lausanne for support; M. Yamazaki for providing constructs; B. Muller, D. Weijers and T. Vernoux for sharing material; A. Bishopp, A. P. Mahonen, D. Weijers, S. Sabatini, V. Grieneisen, Y. Helariutta and Y. Poirier for discussions; and A. Vjestica, C. Drapek, M. Marek and M. Barberon for input to the manuscript.	Auguie B, 2017, GRIDEXTRA MISCELLANE; Barberon M, 2016, CELL, V164, P447, DOI 10.1016/j.cell.2015.12.021; Besnard F, 2014, NATURE, V505, P417, DOI 10.1038/nature12791; Bishopp A, 2011, CURR BIOL, V21, P917, DOI 10.1016/j.cub.2011.04.017; CLARKSON DT, 1968, NATURE, V220, P805, DOI 10.1038/220805a0; De Rybel B, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.6; De Rybel B, 2014, SCIENCE, V345, DOI 10.1126/science.1255215; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Geldner N, 2013, ANNU REV PLANT BIOL, V64, P531, DOI 10.1146/annurev-arplant-050312-120050; Hamburger D, 2002, PLANT CELL, V14, P889, DOI 10.1105/tpc.000745; HARRISONMURRAY RS, 1973, PLANTA, V114, P1, DOI 10.1007/BF00390280; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Karimi M, 2007, PLANT PHYSIOL, V145, P1183, DOI 10.1104/pp.107.110411; Khan GA, 2014, J EXP BOT, V65, P871, DOI 10.1093/jxb/ert444; Kroemer K., 1903, BIBL BOT, V59; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Kurihara D, 2015, DEVELOPMENT, V142, P4168, DOI 10.1242/dev.127613; Lavrekha VV, 2017, PLANT J, V92, P834, DOI 10.1111/tpj.13720; Liao CY, 2015, NAT METHODS, V12, P207, DOI [10.1038/NMETH.3279, 10.1038/nmeth.3279]; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Mason MG, 2005, PLANT CELL, V17, P3007, DOI 10.1105/tpc.105.035451; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Naseer S, 2012, P NATL ACAD SCI USA, V109, P10101, DOI 10.1073/pnas.1205726109; Peterson CA, 1996, PHYSIOL PLANTARUM, V97, P592, DOI 10.1111/j.1399-3054.1996.tb00520.x; Pfister A, 2014, ELIFE, V3, DOI 10.7554/eLife.03115; Roppolo D, 2011, NATURE, V473, P380, DOI 10.1038/nature10070; Sakai H, 2001, SCIENCE, V294, P1519, DOI 10.1126/science.1065201; Sasse J, 2015, CURR BIOL, V25, P647, DOI 10.1016/j.cub.2015.01.015; Siligato R, 2016, PLANT PHYSIOL, V170, P627, DOI 10.1104/pp.15.01246; Ursache R., 2017, PLANT J; Wendrich JR, 2015, METHODS MOL BIOL, V1284, P421, DOI 10.1007/978-1-4939-2444-8_21; Wu HW, 2011, ANN BOT-LONDON, V107, P843, DOI 10.1093/aob/mcr005; Zurcher E, 2013, PLANT PHYSIOL, V161, P1066, DOI 10.1104/pp.112.211763	33	65	67	3	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2018	555	7697					529	+		10.1038/nature25976	http://dx.doi.org/10.1038/nature25976			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ9NF	29539635	Green Accepted			2022-12-28	WOS:000427937900055
J	Khajuria, RK; Munschauer, M; Ulirsch, JC; Fiorini, C; Ludwig, LS; McFarland, SK; Abdulhay, NJ; Specht, H; Keshishian, H; Mani, DR; Jovanovic, M; Ellis, SR; Fulco, CP; Engreitz, JM; Schutz, S; Lian, J; Gripp, KW; Weinberg, OK; Pinkus, GS; Gehrke, L; Regev, A; Lander, ES; Gazda, HT; Lee, WY; Panse, VG; Carr, SA; Sankaran, VG				Khajuria, Rajiv K.; Munschauer, Mathias; Ulirsch, Jacob C.; Fiorini, Claudia; Ludwig, Leif S.; McFarland, Sean K.; Abdulhay, Nour J.; Specht, Harrison; Keshishian, Hasmik; Mani, D. R.; Jovanovic, Marko; Ellis, Steven R.; Fulco, Charles P.; Engreitz, Jesse M.; Schutz, Sabina; Lian, John; Gripp, Karen W.; Weinberg, Olga K.; Pinkus, Geraldine S.; Gehrke, Lee; Regev, Aviv; Lander, Eric S.; Gazda, Hanna T.; Lee, Winston Y.; Panse, Vikram G.; Carr, Steven A.; Sankaran, Vijay G.			Ribosome Levels Selectively Regulate Translation and Lineage Commitment in Human Hematopoiesis	CELL			English	Article							DIAMOND-BLACKFAN ANEMIA; GENETIC-VARIATION; TRANSCRIPTOME ANALYSES; MESSENGER-RNAS; STEM-CELLS; GENOME; GATA1; DIFFERENTIATION; ERYTHROPOIESIS; IDENTIFICATION	Blood cell formation is classically thought to occur through a hierarchical differentiation process, although recent studies have shown that lineage commitment may occur earlier in hematopoietic stem and progenitor cells (HSPCs). The relevance to human blood diseases and the underlying regulation of these refined models remain poorly understood. By studying a genetic blood disorder, Diamond-Blackfan anemia (DBA), where the majority of mutations affect ribosomal proteins and the erythroid lineage is selectively perturbed, we are able to gain mechanistic insight into how lineage commitment is programmed normally and disrupted in disease. We show that in DBA, the pool of available ribosomes is limited, while ribosome composition remains constant. Surprisingly, this global reduction in ribosome levels more profoundly alters translation of a select subset of transcripts. We show how the reduced translation of select transcripts in HSPCs can impair erythroid lineage commitment, illuminating a regulatory role for ribosome levels in cellular differentiation.	[Khajuria, Rajiv K.; Ulirsch, Jacob C.; Fiorini, Claudia; Ludwig, Leif S.; McFarland, Sean K.; Abdulhay, Nour J.; Sankaran, Vijay G.] Harvard Med Sch, Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Khajuria, Rajiv K.; Ulirsch, Jacob C.; Fiorini, Claudia; Ludwig, Leif S.; McFarland, Sean K.; Abdulhay, Nour J.; Sankaran, Vijay G.] Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Khajuria, Rajiv K.; Munschauer, Mathias; Ulirsch, Jacob C.; Fiorini, Claudia; Ludwig, Leif S.; McFarland, Sean K.; Abdulhay, Nour J.; Specht, Harrison; Keshishian, Hasmik; Mani, D. R.; Jovanovic, Marko; Fulco, Charles P.; Engreitz, Jesse M.; Regev, Aviv; Lander, Eric S.; Gazda, Hanna T.; Carr, Steven A.; Sankaran, Vijay G.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Khajuria, Rajiv K.] Charite Univ Med Berlin, Berlin Brandenburg Sch Regenerat, D-13353 Berlin, Germany; [Ellis, Steven R.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40202 USA; [Schutz, Sabina; Panse, Vikram G.] Univ Zurich, Dept Med, Inst Med Microbiol, CH-8006 Zurich, Switzerland; [Lian, John; Gehrke, Lee] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Lian, John; Gehrke, Lee] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Lian, John; Gehrke, Lee] Harvard MIT Program Hlth Sci & Technol, Cambridge, MA 02139 USA; [Gripp, Karen W.] Alfred I DuPont Hosp Children, Div Med Genet, Wilmington, DE 19803 USA; [Weinberg, Olga K.] Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Pinkus, Geraldine S.; Lee, Winston Y.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Pinkus, Geraldine S.; Lee, Winston Y.] Harvard Med Sch, Boston, MA 02115 USA; [Gazda, Hanna T.] Harvard Med Sch, Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Genet & Genom, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Louisville; University of Zurich; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Nemours Alfred I. duPont Hospital for Children; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Sankaran, VG (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.; Sankaran, VG (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.; Sankaran, VG (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	sankaran@broadinstitute.org	Carr, Steven A./AAH-8366-2019; Ludwig, Leif S./A-1913-2015; Munschauer, Mathias/AAK-2789-2020	Ludwig, Leif S./0000-0002-2916-2164; Munschauer, Mathias/0000-0001-6143-4548; Mani, D. R./0000-0003-3914-133X; Ulirsch, Jacob/0000-0002-7947-0827; Panse, Vikram/0000-0001-7950-5746	Boehringer Ingelheim MD Fellowship; NIH [T32 HL007574, R01 DK103794, R33 HL120791]; Swiss National Science Foundation; Novartis Foundation; Olga Mayenfisch Stiftung; European Research Council [EURIBIO260676]; DBA Foundation; March of Dimes Basil O'Connor Scholar Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL120791, T32HL007574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103794] Funding Source: NIH RePORTER	Boehringer Ingelheim MD Fellowship(Boehringer Ingelheim); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation(Novartis); Olga Mayenfisch Stiftung; European Research Council(European Research Council (ERC)European Commission); DBA Foundation; March of Dimes Basil O'Connor Scholar Award(March of Dimes); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Nathan, S. Orkin, L. Zon, K. Patel, S. Eichhorn, Z. Ji, J. Clohessy, A. Bolze, and Sankaran laboratory members for valuable discussions. We are grateful to T. DiCesare for assistance with illustrations. R.K.K received partial support from a Boehringer Ingelheim MD Fellowship. S.K.M. received support from the NIH (T32 HL007574). A.R. is an investigator of the Howard Hughes Medical Institute. V.G.P. received support from the Swiss National Science Foundation, Novartis Foundation, Olga Mayenfisch Stiftung, and the European Research Council (EURIBIO260676). V.G.S. is a Principal Faculty member of the Harvard Stem Cell Institute. This work was supported by the NIH (R01 DK103794 and R33 HL120791), as well as a grant from the DBA Foundation and a March of Dimes Basil O'Connor Scholar Award (to V.G.S.).	An XL, 2014, BLOOD, V123, P3466, DOI 10.1182/blood-2014-01-548305; Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; Bolze A, 2013, SCIENCE, V340, P976, DOI 10.1126/science.1234864; Brooks SS, 2014, GENETICS, V198, P723, DOI 10.1534/genetics.114.168211; Buszczak M, 2014, CELL, V159, P242, DOI 10.1016/j.cell.2014.09.016; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Capellera-Garcia S, 2016, CELL REP, V15, P2550, DOI 10.1016/j.celrep.2016.05.027; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Casanova JL, 2014, J EXP MED, V211, P2137, DOI 10.1084/jem.20140520; Chennupati V., 2018, J CLIN INVEST; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Farrar JE, 2014, AM J HEMATOL, V89, P985, DOI 10.1002/ajh.23807; Gautier EF, 2016, CELL REP, V16, P1470, DOI 10.1016/j.celrep.2016.06.085; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; Giani FC, 2016, CELL STEM CELL, V18, P73, DOI 10.1016/j.stem.2015.09.015; Gripp KW, 2014, AM J MED GENET A, V164, P2240, DOI 10.1002/ajmg.a.36633; Henras AK, 2015, WIRES RNA, V6, P225, DOI 10.1002/wrna.1269; Hinnebusch AG, 2016, SCIENCE, V352, P1413, DOI 10.1126/science.aad9868; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Ingolia NT, 2016, CELL, V165, P22, DOI 10.1016/j.cell.2016.02.066; Iskander D, 2015, BLOOD, V125, P2553, DOI 10.1182/blood-2014-10-608042; Jovanovic M, 2015, SCIENCE, V347, DOI 10.1126/science.1259038; Khatter H, 2015, NATURE, V520, P640, DOI 10.1038/nature14427; Kim AR, 2017, CELL, V168, P1053, DOI 10.1016/j.cell.2017.02.026; Lee WY, 2017, AM J CLIN PATHOL, V147, P420, DOI 10.1093/ajcp/aqx018; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li J, 2014, BLOOD, V124, P3636, DOI 10.1182/blood-2014-07-588806; Ludwig LS, 2014, NAT MED, V20, P748, DOI 10.1038/nm.3557; McCann KL, 2013, SCIENCE, V341, P849, DOI 10.1126/science.1244156; Mills EW, 2016, CELL REP, V17, P1, DOI 10.1016/j.celrep.2016.08.088; Mirabello L, 2017, J MED GENET, V54, P417, DOI 10.1136/jmedgenet-2016-104346; NATHAN DG, 1978, J CLIN INVEST, V61, P489, DOI 10.1172/JCI108960; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; Ohene-Abuakwa Y, 2005, BLOOD, V105, P838, DOI 10.1182/blood-2004-03-1016; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Perie L, 2015, CELL, V163, P1655, DOI 10.1016/j.cell.2015.11.059; Preti M, 2013, NUCLEIC ACIDS RES, V41, P4709, DOI 10.1093/nar/gkt160; Reschke M, 2013, CELL REP, V4, P1276, DOI 10.1016/j.celrep.2013.08.014; Robledo S, 2008, RNA, V14, P1918, DOI 10.1261/rna.1132008; Roepcke S, 2006, GENE, V365, P48, DOI 10.1016/j.gene.2005.09.033; Sankaran VG, 2015, NAT MED, V21, P221, DOI 10.1038/nm.3814; Sankaran VG, 2012, J CLIN INVEST, V122, P2439, DOI 10.1172/JCI63597; Schutz S, 2014, ELIFE, V3, DOI 10.7554/eLife.03473; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shah P, 2013, CELL, V153, P1589, DOI 10.1016/j.cell.2013.05.049; Shi Z, 2017, MOL CELL, V67, P71, DOI 10.1016/j.molcel.2017.05.021; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Srivastava D, 2016, CELL, V166, P1386, DOI 10.1016/j.cell.2016.08.055; Sung MK, 2016, ELIFE, V5, DOI 10.7554/eLife.19105; Tanay A, 2017, NATURE, V541, P331, DOI 10.1038/nature21350; Thompson MK, 2016, ELIFE, V5, DOI 10.7554/eLife.11154; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Ulirsch JC, 2016, CELL, V165, P1530, DOI 10.1016/j.cell.2016.04.048; van Galen P, 2014, NATURE, V510, P268, DOI 10.1038/nature13228; Velten L, 2017, NAT CELL BIOL, V19, P271, DOI 10.1038/ncb3493; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Weiss MJ, 1997, MOL CELL BIOL, V17, P1642, DOI 10.1128/MCB.17.3.1642	59	177	181	3	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 22	2018	173	1					90	+		10.1016/j.cell.2018.02.036	http://dx.doi.org/10.1016/j.cell.2018.02.036			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GA3MT	29551269	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000428234200010
J	Lu, Y; Zhang, K				Lu, Yi; Zhang, Kang			Cellular Reprogramming in the Retina - Seeing the Light	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MULLER GLIA; MICE; REGENERATION; ASCL1		[Lu, Yi] Fudan Univ, Inst Eye, Eye & ENT Hosp, Shanghai, Peoples R China; [Lu, Yi] Fudan Univ, Dept Ophthalmol, Eye & ENT Hosp, Shanghai, Peoples R China; [Zhang, Kang] Univ Calif San Diego, Shiley Eye Inst, Inst Genom Med, La Jolla, CA 92093 USA; [Zhang, Kang] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA; [Zhang, Kang] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Zhang, Kang] Guangzhou Regenerat Med & Hlth Guangdong Lab, Guangzhou, Guangdong, Peoples R China	Fudan University; Fudan University; University of California System; University of California San Diego; University of California System; University of California San Diego; Sun Yat Sen University; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory)	Lu, Y (corresponding author), Fudan Univ, Inst Eye, Eye & ENT Hosp, Shanghai, Peoples R China.; Lu, Y (corresponding author), Fudan Univ, Dept Ophthalmol, Eye & ENT Hosp, Shanghai, Peoples R China.		Zhang, Kang/Y-2740-2019	Zhang, Kang/0000-0002-4549-1697				Jorstad NL, 2017, NATURE, V548, P103, DOI 10.1038/nature23283; Pollak J, 2013, DEVELOPMENT, V140, P2619, DOI 10.1242/dev.091355; Ueki Y, 2015, P NATL ACAD SCI USA, V112, P13717, DOI 10.1073/pnas.1510595112; Yu WH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14716; Zhu J, 2017, CELL RES, V27, P830, DOI 10.1038/cr.2017.57	5	3	3	1	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2018	378	11					1059	1060		10.1056/NEJMcibr1713887	http://dx.doi.org/10.1056/NEJMcibr1713887			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ2HT	29539280				2022-12-28	WOS:000427399000014
J	Oliver, D				Oliver, David			When patients won't leave or families won't let them	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Healthwatch, SAF HOM PEOPL EXP LE; Leppin AL, 2014, JAMA INTERN MED, V174, P1095, DOI 10.1001/jamainternmed.2014.1608; OLIVER D, 2017, BMJ-BRIT MED J, V357, P77428, DOI DOI 10.1136/BMJ.J1523; Oliver D, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4214; Oliver D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4959	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2018	360								k1127	10.1136/bmj.k1127	http://dx.doi.org/10.1136/bmj.k1127			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ9FW	29535118	Bronze, Green Published			2022-12-28	WOS:000427916400003
J	Zhao, EM; Zhang, YF; Mehl, J; Park, H; Lalwani, MA; Toettcher, JE; Avalos, JL				Zhao, Evan M.; Zhang, Yanfei; Mehl, Justin; Park, Helen; Lalwani, Makoto A.; Toettcher, Jared E.; Avalos, Jose L.			Optogenetic regulation of engineered cellular metabolism for microbial chemical production	NATURE			English	Article							GENE-EXPRESSION SYSTEM; SACCHAROMYCES-CEREVISIAE; YEAST; ACID; IMPROVEMENT; DISRUPTION; ACTIVATION; MOLECULES; CASSETTES; PATHWAYS	The optimization of engineered metabolic pathways requires careful control over the levels and timing of metabolic enzyme expression(1-4). Optogenetic tools are ideal for achieving such precise control, as light can be applied and removed instantly without complex media changes. Here we show that light-controlled transcription can be used to enhance the biosynthesis of valuable products in engineered Saccharomyces cerevisiae. We introduce new optogenetic circuits to shift cells from a light-induced growth phase to a darkness-induced production phase, which allows us to control fermentation with only light. Furthermore, optogenetic control of engineered pathways enables a new mode of bioreactor operation using periodic light pulses to tune enzyme expression during the production phase of fermentation to increase yields. Using these advances, we control the mitochondrial isobutanol pathway to produce up to 8.49 +/- 0.31 g l(-1) of isobutanol and 2.38 +/- 0.06 g l(-1) of 2-methyl-1-butanol micro-aerobically from glucose. These results make a compelling case for the application of optogenetics to metabolic engineering for the production of valuable products.	[Zhao, Evan M.; Zhang, Yanfei; Mehl, Justin; Park, Helen; Lalwani, Makoto A.; Avalos, Jose L.] Princeton Univ, Dept Chem & Biol Engn, Hoyt Lab, 25 William St, Princeton, NJ 08544 USA; [Toettcher, Jared E.] Dept Mol Biol, 140 Lewis Thomas Lab,Washington Rd, Princeton, NJ 08544 USA; [Avalos, Jose L.] Princeton Univ, Andlinger Ctr Energy & Environm, 86 Olden St, Princeton, NJ 08544 USA	Princeton University; Princeton University	Avalos, JL (corresponding author), Princeton Univ, Dept Chem & Biol Engn, Hoyt Lab, 25 William St, Princeton, NJ 08544 USA.; Toettcher, JE (corresponding author), Dept Mol Biol, 140 Lewis Thomas Lab,Washington Rd, Princeton, NJ 08544 USA.; Avalos, JL (corresponding author), Princeton Univ, Andlinger Ctr Energy & Environm, 86 Olden St, Princeton, NJ 08544 USA.	toettcher@princeton.edu; javalos@princeton.edu		Avalos, Jose L./0000-0002-7209-4208; Lalwani, Makoto/0000-0003-4629-4131; Zhang, Yanfei/0000-0003-2270-8483	NIBIB NIH HHS [DP2 EB024247] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [DP2EB024247] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Avalos JL, 2013, NAT BIOTECHNOL, V31, P335, DOI 10.1038/nbt.2509; Brockman IM, 2015, METAB ENG, V28, P104, DOI 10.1016/j.ymben.2014.12.005; Chee MK, 2012, G3-GENES GENOM GENET, V2, P515, DOI 10.1534/g3.111.001917; Collart M A, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1312s23; Da Silva NA, 2012, FEMS YEAST RES, V12, P197, DOI 10.1111/j.1567-1364.2011.00769.x; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Gerhardt KP, 2016, SCI REP-UK, V6, DOI 10.1038/srep35363; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gu PF, 2016, SCI REP-UK, V6, DOI 10.1038/srep29745; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hammer SK, 2017, METAB ENG, V44, P302, DOI 10.1016/j.ymben.2017.10.001; Jayaraman P, 2016, NUCLEIC ACIDS RES, V44, P6994, DOI 10.1093/nar/gkw548; Jones E. W., 1982, MOL BIOL YEAST SACCH, P181; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kern SE, 2014, METHODS MOL BIOL, V1149, P311, DOI 10.1007/978-1-4939-0473-0_26; Klein CJL, 1998, MICROBIOL-SGM, V144, P13, DOI 10.1099/00221287-144-1-13; Lee JJ, 2016, J IND MICROBIOL BIOT, V43, P87, DOI 10.1007/s10295-015-1713-7; Lee JY, 2015, BIOTECHNOL BIOENG, V112, P751, DOI 10.1002/bit.25488; Liu X, 2013, J BIOTECHNOL, V164, P188, DOI 10.1016/j.jbiotec.2012.08.008; Milias-Argeitis A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12546; Milias-Argeitis A, 2011, NAT BIOTECHNOL, V29, P1114, DOI 10.1038/nbt.2018; Milne N, 2016, Metab Eng Commun, V3, P39, DOI 10.1016/j.meteno.2016.01.002; Motta-Mena LB, 2014, NAT CHEM BIOL, V10, P196, DOI [10.1038/NCHEMBIO.1430, 10.1038/nchembio.1430]; Nash AI, 2011, P NATL ACAD SCI USA, V108, P9449, DOI 10.1073/pnas.1100262108; Park SH, 2016, APPL MICROBIOL BIOT, V100, P7591, DOI 10.1007/s00253-016-7636-z; Reade A, 2017, DEVELOPMENT, V144, P345, DOI 10.1242/dev.139238; Rivera-Cancel G, 2012, BIOCHEMISTRY-US, V51, P10024, DOI 10.1021/bi301306t; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Salinas F, 2017, APPL MICROBIOL BIOT, V101, P2629, DOI 10.1007/s00253-017-8178-8; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Tan SZ, 2016, ACS SYNTH BIOL, V5, P116, DOI 10.1021/acssynbio.5b00164; Taslimi A, 2016, NAT CHEM BIOL, V12, P425, DOI [10.1038/nchembio.2063, 10.1038/NCHEMBIO.2063]; Toettcher JE, 2011, NAT METHODS, V8, P35, DOI [10.1038/nmeth.f.326, 10.1038/NMETH.F.326]; Usherenko S, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0128-9; van Maris AJA, 2004, APPL ENVIRON MICROB, V70, P159, DOI 10.1128/AEM.70.1.159-166.2004; Woolston BM, 2013, ANNU REV CHEM BIOMOL, V4, P259, DOI 10.1146/annurev-chembioeng-061312-103312; Youk H, 2014, SCIENCE, V343, P628, DOI 10.1126/science.1242782; Yuan JF, 2015, ACS SYNTH BIOL, V4, P23, DOI 10.1021/sb500079f; Zhang YS, 2006, J AM CHEM SOC, V128, P13030, DOI 10.1021/ja0622094; Ziv N., 2013, JOVE-J VIS EXP, V80, P50168; Zoltowski BD, 2013, BIOCHEMISTRY-US, V52, P6653, DOI 10.1021/bi401040m	45	165	181	32	283	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2018	555	7698					683	+		10.1038/nature26141	http://dx.doi.org/10.1038/nature26141			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8UX	29562237	Green Accepted			2022-12-28	WOS:000428617600054
J	Slomski, A				Slomski, Anita			Similar IVF Birth Rates for Frozen and Fresh Embryos	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2018	319	12					1190	1190		10.1001/jama.2018.2150	http://dx.doi.org/10.1001/jama.2018.2150			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GA5VW	29584838				2022-12-28	WOS:000428403000004
J	Ribas, A; Wolchok, JD				Ribas, Antoni; Wolchok, Jedd D.			Cancer immunotherapy using checkpoint blockade	SCIENCE			English	Review							LONG-TERM SURVIVAL; PD-1 BLOCKADE; ACQUIRED-RESISTANCE; CTLA-4 BLOCKADE; ANTITUMOR IMMUNITY; TUMOR RESPONSE; SOLID TUMORS; NIVOLUMAB; PEMBROLIZUMAB; MELANOMA	The release of negative regulators of immune activation (immune checkpoints) that limit antitumor responses has resulted in unprecedented rates of long-lasting tumorresponses in patients with a variety of cancers. This can be achieved by antibodies blocking the cytotoxic T lymphocyte-associated protein 4 (CTLA-4) or the programmed cell death 1 (PD-1) pathway, either alone or in combination. The main premise for inducing an immune response is the preexistence of antitumor T cells that were limited by specific immune checkpoints. Most patients who have tumor responses maintain long-lasting disease control, yet one-third of patients relapse. Mechanisms of acquired resistance are currently poorly understood, but evidence points to alterations that converge on the antigen presentation and interferon-g signaling pathways. New-generation combinatorial therapies may overcome resistance mechanisms to immune checkpoint therapy.	[Ribas, Antoni] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Ribas, Antoni] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Surg, Div Surg Oncol, Los Angeles, CA 90095 USA; [Ribas, Antoni] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Ribas, Antoni] Univ Calif Los Angeles, Parker Inst Canc Immunotherapy, Los Angeles, CA 90095 USA; [Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, Dept Med, New York, NY 10065 USA; [Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Parker Inst Canc Immunotherapy, New York, NY 10065 USA; [Wolchok, Jedd D.] Weill Cornell Med & Grad Coll, New York, NY 10065 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Ribas, A (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA.; Ribas, A (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Surg, Div Surg Oncol, Los Angeles, CA 90095 USA.; Ribas, A (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.; Ribas, A (corresponding author), Univ Calif Los Angeles, Parker Inst Canc Immunotherapy, Los Angeles, CA 90095 USA.; Wolchok, JD (corresponding author), Mem Sloan Kettering Canc Ctr, Ludwig Ctr, Dept Med, New York, NY 10065 USA.; Wolchok, JD (corresponding author), Mem Sloan Kettering Canc Ctr, Parker Inst Canc Immunotherapy, New York, NY 10065 USA.; Wolchok, JD (corresponding author), Weill Cornell Med & Grad Coll, New York, NY 10065 USA.	aribas@mednet.ucla.edu; wolchokj@mskcc.org		Wolchok, Jedd/0000-0001-6718-2222	NIH [R35 CA197633, P01 CA168585, P30 CA016042, R01 CA056821, P30 CA008748]; Ressler Family Fund; Grimaldi Family Fund; Garcia-Corsini Family Fund; Swim Across America; Ludwig Cancer Research; Hazen-Polsky Family Fund; Hogan Family Fund; Live4Life Foundation; Etta Weinheim Fund; NATIONAL CANCER INSTITUTE [P01CA168585, P30CA008748, R35CA197633, P30CA016042, R01CA056821] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ressler Family Fund; Grimaldi Family Fund; Garcia-Corsini Family Fund; Swim Across America; Ludwig Cancer Research; Hazen-Polsky Family Fund; Hogan Family Fund; Live4Life Foundation; Etta Weinheim Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants R35 CA197633, P01 CA168585, and P30 CA016042 (A.R.) and R01 CA056821 and P30 CA008748 (J.D.W.), with additional support from the Ressler Family Fund, the Grimaldi Family Fund, and the Garcia-Corsini Family Fund (A.R.) and Swim Across America, Ludwig Cancer Research, the Hazen-Polsky Family Fund, the Hogan Family Fund, Live4Life Foundation, and the Etta Weinheim Fund (J.D.W.). Both authors are members of the Parker Institute for Cancer Immunotherapy.	Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Baumeister SH, 2016, ANNU REV IMMUNOL, V34, P539, DOI 10.1146/annurev-immunol-032414-112049; Bellmunt J, 2017, NEW ENGL J MED, V376, P1015, DOI 10.1056/NEJMoa1613683; Blank CU, 2016, SCIENCE, V352, P658, DOI 10.1126/science.aaf2834; Carbone DP, 2017, NEW ENGL J MED, V376, P2415, DOI 10.1056/NEJMoa1613493; Carthon BC, 2010, CLIN CANCER RES, V16, P2861, DOI 10.1158/1078-0432.CCR-10-0569; Chambers CA, 2001, ANNU REV IMMUNOL, V19, P565, DOI 10.1146/annurev.immunol.19.1.565; El-Khoueiry AB, 2017, LANCET, V389, P2492, DOI 10.1016/S0140-6736(17)31046-2; Eroglu Z, 2018, NATURE, V553, P347, DOI 10.1038/nature25187; Eroglu Z, 2015, EUR J CANCER, V51, P2689, DOI 10.1016/j.ejca.2015.08.012; Ferris RL, 2016, NEW ENGL J MED, V375, P1856, DOI 10.1056/NEJMoa1602252; Garcia-Diaz A, 2017, CELL REP, V19, P1189, DOI 10.1016/j.celrep.2017.04.031; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Gettinger S, 2017, CANCER DISCOV, V7, P1420, DOI 10.1158/2159-8290.CD-17-0593; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hodi FS, 2003, P NATL ACAD SCI USA, V100, P4712, DOI 10.1073/pnas.0830997100; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Luksza M, 2017, NATURE, V551, P517, DOI 10.1038/nature24473; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; McGranahan N, 2017, CELL, V170, P825, DOI 10.1016/j.cell.2017.08.012; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Nghiem PT, 2016, NEW ENGL J MED, V374, P2542, DOI 10.1056/NEJMoa1603702; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Patel SJ, 2017, NATURE, V548, P537, DOI 10.1038/nature23477; Postow MA, 2018, NEW ENGL J MED, V378, P158, DOI [10.1056/NEJMra1703481, 10.1056/NEJMc1801663]; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Reichel J, 2015, BLOOD, V125, P1061, DOI 10.1182/blood-2014-11-610436; Ribas A, 2005, J CLIN ONCOL, V23, P8968, DOI 10.1200/JCO.2005.01.109; Ribas A, 2016, JAMA-J AM MED ASSOC, V315, P1600, DOI 10.1001/jama.2016.4059; Ribas A, 2015, CANCER DISCOV, V5, P915, DOI 10.1158/2159-8290.CD-15-0563; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Sade-Feldman M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01062-w; Schadendorf D, 2015, J CLIN ONCOL, V33, P1889, DOI 10.1200/JCO.2014.56.2736; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Shin DS, 2017, CANCER DISCOV, V7, P188, DOI 10.1158/2159-8290.CD-16-1223; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Sucker A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15440; SZNOL M, 2010, J CLIN ONCOL S, V28; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Turajlic S, 2017, LANCET ONCOL, V18, P1009, DOI 10.1016/S1470-2045(17)30516-8; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	61	2781	2877	156	1263	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2018	359	6382			SI		1350	+		10.1126/science.aar4060	http://dx.doi.org/10.1126/science.aar4060			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA0ZG	29567705	Green Accepted			2022-12-28	WOS:000428043600036
J	Rose, MR				Rose, Michael R.			SIGECAPS, SSRIs, and Silence - Life as a Depressed Med Student	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rose, Michael R.] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Rose, MR (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.			Rose, Michael/0000-0002-8624-0405				Dyrbye LN, 2017, MAYO CLIN PROC, V92, P1486, DOI 10.1016/j.mayocp.2017.06.020; Rose M., 2017, ND INFORUM      0922; Rosenthal JM, 2005, NEW ENGL J MED, V353, P1085, DOI 10.1056/NEJMp058183; Rotenstein LS, 2016, JAMA-J AM MED ASSOC, V316, P2214, DOI 10.1001/jama.2016.17324; Thayer K., 2017, CHICAGO TRIBUNE	5	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2018	378	12					1081	1083		10.1056/NEJMp1716893	http://dx.doi.org/10.1056/NEJMp1716893			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ9OV	29562146				2022-12-28	WOS:000427942300004
J	Rubio-Cosials, A; Schulz, EC; Lambertsen, L; Smyshlyaev, G; Rojas-Cordova, C; Forslund, K; Karaca, E; Bebel, A; Bork, P; Barabas, O				Rubio-Cosials, Anna; Schulz, Eike C.; Lambertsen, Lotte; Smyshlyaev, Georgy; Rojas-Cordova, Carlos; Forslund, Kristoffer; Karaca, Ezgi; Bebel, Aleksandra; Bork, Peer; Barabas, Orsolya			Transposase-DNA Complex Structures Reveal Mechanisms for Conjugative Transposition of Antibiotic Resistance	CELL			English	Article							SITE-SPECIFIC RECOMBINATION; LAMBDA-INTEGRASE; GENETIC ELEMENTS; TERMINAL DOMAIN; PROTEIN; FEATURES; REQUIREMENTS; PERFORMANCE; INSERTION; CLEAVAGE	Conjugative transposition drives the emergence of multidrug resistance in diverse bacterial pathogens, yet the mechanisms are poorly characterized. The Tn1549 conjugative transposon propagates resistance to the antibiotic vancomycin used for severe drug-resistant infections. Here, we present four high-resolution structures of the conserved Y-transposase of Tn1549 complexed with circular transposon DNA intermediates. The structures reveal individual transposition steps and explain how specific DNA distortion and cleavage mechanisms enable DNA strand exchange with an absolute minimum homology requirement. This appears to uniquely allow Tn916-like conjugative transposons to bypass DNA homology and insert into diverse genomic sites, expanding gene transfer. We further uncover a structural regulatory mechanism that prevents premature cleavage of the transposon DNA before a suitable target DNA is found and generate a peptide antagonist that interferes with the transposase-DNA structure to block transposition. Our results reveal mechanistic principles of conjugative transposition that could help control the spread of antibiotic resistance genes.	[Rubio-Cosials, Anna; Schulz, Eike C.; Lambertsen, Lotte; Smyshlyaev, Georgy; Rojas-Cordova, Carlos; Forslund, Kristoffer; Karaca, Ezgi; Bebel, Aleksandra; Bork, Peer; Barabas, Orsolya] EMBL, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Schulz, Eike C.] European Mol Biol Lab, Hamburg Outstn, D-22603 Hamburg, Germany; [Smyshlyaev, Georgy] EMBL EBI, Hinxton CB10 1SD, England; [Karaca, Ezgi] Izmir Biomed & Genome Ctr IBG, TR-35340 Izmir, Turkey; [Bork, Peer] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Bork, Peer] Mol Med Partnership Unit, D-69120 Heidelberg, Germany; [Bork, Peer] Univ Wurzburg, Bioctr, Dept Bioinformat, D-97074 Wurzburg, Germany; [Schulz, Eike C.] Max Planck Inst Struct & Dynam Matter, Dept Atomically Resolved Dynam, D-22761 Hamburg, Germany; [Bebel, Aleksandra] Univ Chicago, Dept Mol Biol, Chicago, IL 60637 USA	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Wurzburg; Max Planck Society; University of Chicago	Barabas, O (corresponding author), EMBL, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany.	barabas@embl.de	Forslund, Sofia K/Y-2393-2019; Barabas, Orsolya/F-3961-2012; Bork, Peer/F-1813-2013; Karaca, Ezgi/P-1759-2019	Barabas, Orsolya/0000-0002-2873-5872; Bork, Peer/0000-0002-2627-833X; Karaca, Ezgi/0000-0002-4926-7991; Forslund, Sofia K/0000-0003-4285-6993; Rojas Cordova, Carlos Alberto/0000-0002-2959-0919	EMBL; Federal Ministry of Education and Research of Germany (BMBF) under JPIAMR [01KI1706]; EMBL Interdisciplinary Postdoc (EIPOD) programme under Marie-Curie COFUND [291772]; EMBL International PhD Programme; Humboldt Postdoctoral Fellowship	EMBL; Federal Ministry of Education and Research of Germany (BMBF) under JPIAMR(Federal Ministry of Education & Research (BMBF)); EMBL Interdisciplinary Postdoc (EIPOD) programme under Marie-Curie COFUND; EMBL International PhD Programme; Humboldt Postdoctoral Fellowship	The authors thank Fred Dyda, Alison B. Hickman, Kiran R. Patil, Phoebe A. Rice, and members of the Barabas lab for helpful discussions; Matthias Wilmanns for resources and advice to ECS; Martin Beck and Thomas Miller for reading the manuscript; and the Life Science Editors for editing assistance. We thank the Protein Expression and Purification Core Facility, the Crystallization Facilities at EMBL Heidelberg and Hamburg for materials and support, and the 2015 Okinawa-CCP4 school for data-processing help. X-ray data were collected on beamline P13 at PETRA III (DESY, Hamburg) and on beamlines ID29, ID30A-1, ID23-1, and BM29 (BioSAXS) of the European Synchrotron Radiation Facility (ESRF, Grenoble). We thank the staff of ESRF and EMBL for assistance. This work was supported by the EMBL, the Federal Ministry of Education and Research of Germany (BMBF) under JPIAMR 2016 (01KI1706, JumpAR), the EMBL Interdisciplinary Postdoc (EIPOD) programme under Marie-Curie COFUND (291772 to L.L. and G.S.), the EMBL International PhD Programme (to C.R.-C. and A.B.), and the Humboldt Postdoctoral Fellowship (to E.K.).	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agudelo Higuita NI, 2014, ENTEROCOCCAL DIS EPI; Aihara H, 2007, MOL CELL, V27, P901, DOI 10.1016/j.molcel.2007.07.026; Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Ballard SA, 2005, ANTIMICROB AGENTS CH, V49, P1688, DOI 10.1128/AAC.49.5.1688-1694.2005; Bebel A, 2016, ELIFE, V5, DOI 10.7554/eLife.19706; Bi DX, 2012, NUCLEIC ACIDS RES, V40, pD621, DOI 10.1093/nar/gkr846; Bischerour J, 2007, NUCLEIC ACIDS RES, V35, P2584, DOI 10.1093/nar/gkm186; Biswas T, 2005, NATURE, V435, P1059, DOI 10.1038/nature03657; CAPARON MG, 1989, CELL, V59, P1027, DOI 10.1016/0092-8674(89)90759-9; Domingo MC, 2005, J ANTIMICROB CHEMOTH, V55, P466, DOI 10.1093/jac/dki029; Dostal L, 2011, NUCLEIC ACIDS RES, V39, P2658, DOI 10.1093/nar/gkq1137; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; Hickman AB, 1997, CELL, V89, P227, DOI 10.1016/S0092-8674(00)80202-0; Hickman AB, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0034-2014; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holz B, 1998, NUCLEIC ACIDS RES, V26, P1076, DOI 10.1093/nar/26.4.1076; Jayaram M, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0021-2014; JOHNSON RC, 2008, RSC BIOMOL SCI, P176; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kobryn K, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MDNA3-0023-2014; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lambertsen L, 2018, MOL MICROBIOL, V107, P639, DOI 10.1111/mmi.13905; Laprise J, 2010, NUCLEIC ACIDS RES, V38, P958, DOI 10.1093/nar/gkp927; Launay A, 2006, ANTIMICROB AGENTS CH, V50, P1054, DOI 10.1128/AAC.50.3.1054-1062.2006; Lee SY, 2004, P NATL ACAD SCI USA, V101, P2770, DOI 10.1073/pnas.0400135101; Li ZW, 2006, NUCLEIC ACIDS RES, V34, pD277, DOI 10.1093/nar/gkj124; Liu JY, 2016, MICROB PATHOGENESIS, V101, P56, DOI 10.1016/j.micpath.2016.10.028; LU F, 1995, J BACTERIOL, V177, P1938, DOI 10.1128/jb.177.8.1938-1946.1995; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Luscombe NM, 1997, NUCLEIC ACIDS RES, V25, P4940, DOI 10.1093/nar/25.24.4940; Morris ER, 2016, ELIFE, V5, DOI 10.7554/eLife.15537; NUNESDUBY SE, 1989, CELL, V59, P197, DOI 10.1016/0092-8674(89)90881-7; Prieto AMG, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00788; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Roberts AP, 2011, FEMS MICROBIOL REV, V35, P856, DOI 10.1111/j.1574-6976.2011.00283.x; Rubinstein E, 2014, FRONT PUBLIC HLTH, V2, P217, DOI DOI 10.3389/FPUBH.2014.00217; Rudy CK, 1997, J BACTERIOL, V179, P2567, DOI 10.1128/jb.179.8.2567-2572.1997; Sarkar D, 2001, EMBO J, V20, P1203, DOI 10.1093/emboj/20.5.1203; Shi K, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001472; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Taylor KL, 1997, J BACTERIOL, V179, P1117, DOI 10.1128/jb.179.4.1117-1125.1997; Uemura S, 2010, ANTIMICROB AGENTS CH, V54, P3956, DOI 10.1128/AAC.00110-10; van Hal SJ, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000048; van Hoek AHAM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00203; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Warren D, 2005, MOL MICROBIOL, V55, P1104, DOI 10.1111/j.1365-2958.2004.04447.x; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382	57	27	28	5	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 22	2018	173	1					208	+		10.1016/j.cell.2018.02.032	http://dx.doi.org/10.1016/j.cell.2018.02.032			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GA3MT	29551265	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000428234200019
J	Singla, J; McClary, KM; White, KL; Alber, F; Sali, A; Stevens, RC				Singla, Jitin; McClary, Kyle M.; White, Kate L.; Alber, Frank; Sali, Andrej; Stevens, Raymond C.			Opportunities and Challenges in Building a Spatiotemporal Multi-scale Model of the Human Pancreatic beta Cell	CELL			English	Review							METABOLOMIC ANALYSIS; INSULIN; PROTEOMICS; SIMULATIONS; GENERATION; DIFFUSION; FEATURES; SYSTEM; MASS	The construction of a predictive model of an entire eukaryotic cell that describes its dynamic structure from atomic to cellular scales is a grand challenge at the intersection of biology, chemistry, physics, and computer science. Having such a model will open new dimensions in biological research and accelerate healthcare advancements. Developing the necessary experimental and modeling methods presents abundant opportunities for a community effort to realize this goal. Here, we present a vision for creation of a spatiotemporal multi-scale model of the pancreatic beta-cell, a relevant target for understanding and modulating the pathogenesis of diabetes.	[Singla, Jitin; Alber, Frank] Univ Southern Calif, Dept Biol Sci, Mol & Computat Biol, Los Angeles, CA 90089 USA; [Singla, Jitin; White, Kate L.; Alber, Frank; Stevens, Raymond C.] Univ Southern Calif, Dept Biol Sci, Michelson Ctr Convergent Biosci, Bridge Inst, Los Angeles, CA 90089 USA; [McClary, Kyle M.; White, Kate L.; Stevens, Raymond C.] Univ Southern Calif, Dept Chem, Michelson Ctr Convergent Biosci, Bridge Inst, Los Angeles, CA 90089 USA; [Sali, Andrej] Univ Calif San Francisco, Dept Pharmaceut Chem, Calif Inst Quantitat Biosci, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA	University of Southern California; University of Southern California; University of Southern California; University of California System; University of California San Francisco	Alber, F (corresponding author), Univ Southern Calif, Dept Biol Sci, Mol & Computat Biol, Los Angeles, CA 90089 USA.; Alber, F; Stevens, RC (corresponding author), Univ Southern Calif, Dept Biol Sci, Michelson Ctr Convergent Biosci, Bridge Inst, Los Angeles, CA 90089 USA.; Stevens, RC (corresponding author), Univ Southern Calif, Dept Chem, Michelson Ctr Convergent Biosci, Bridge Inst, Los Angeles, CA 90089 USA.; Sali, A (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, Calif Inst Quantitat Biosci, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA.	alber@usc.edu; sali@salilab.org; stevens@usc.edu	Singla, Jitin/AAD-6768-2021; Stevens, Raymond/K-7272-2015	Singla, Jitin/0000-0001-6225-0783; Stevens, Raymond/0000-0002-4522-8725	Bridge Institute, USC Dornsife College of Letters, Arts and Sciences, Provost Fellowship; NIH [R01GM096089, R01 GM083960, P41 GM109824]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096089, R01GM083960, P41GM109824] Funding Source: NIH RePORTER	Bridge Institute, USC Dornsife College of Letters, Arts and Sciences, Provost Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by funding from the Bridge Institute, USC Dornsife College of Letters, Arts and Sciences, Provost Fellowship (J.S.), NIH R01GM096089 (F.A.), and NIH R01 GM083960 and P41 GM109824 (A.S.). The authors would like to thank Angela Walker and Timothy James for feedback on the manuscript, and the entire BISC-599 (2017) class members and faculty guests for discussions on this topic. Authors also thank reviewers and editor for their careful consideration and suggestions to improve the manuscript.	Aguayo-Mazzucato C, 2017, CELL METAB, V25, P898, DOI 10.1016/j.cmet.2017.03.015; Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Ando T, 2011, QTM PROB WHT NOI, V28, P413; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Babtie AC, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0237; Beck M, 2009, NAT METHODS, V6, P817, DOI [10.1038/NMETH.1390, 10.1038/nmeth.1390]; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Betts MJ, 2007, FEBS LETT, V581, P2870, DOI 10.1016/j.febslet.2007.05.062; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Blodgett DM, 2015, DIABETES, V64, P3172, DOI 10.2337/db15-0039; Brackeva B, 2015, DATA BRIEF, V3, P234, DOI 10.1016/j.dib.2015.02.019; Budnik B, 2017, BIORXIV; Burley SK, 2017, STRUCTURE, V25, P1317, DOI 10.1016/j.str.2017.08.001; Cowan AE, 2012, METHOD CELL BIOL, V110, P195, DOI 10.1016/B978-0-12-388403-9.00008-4; Danev R, 2016, ELIFE, V5, DOI 10.7554/eLife.13046; Dekker J, 2017, NATURE, V549, P219, DOI 10.1038/nature23884; Digital Single Market, 2017, DIGITAL SINGLE MARKE; Dlugosz M, 2011, BMC BIOPHYS, V4, DOI 10.1186/2046-1682-4-3; Dorrell C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11756; Ekman AA, 2017, BIOL CELL, V109, P24, DOI 10.1111/boc.201600044; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkz1031, 10.1093/nar/gkx1132]; Feig M, 2015, J MOL GRAPH MODEL, V58, P1, DOI 10.1016/j.jmgm.2015.02.004; Fridlyand LE, 2003, AM J PHYSIOL-ENDOC M, V285, pE138, DOI 10.1152/ajpendo.00194.2002; Fridlyand LE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152869; Golubovskaya V, 2017, CANCERS, V9, DOI 10.3390/cancers9100139; Gooding JR, 2016, ARCH BIOCHEM BIOPHYS, V589, P120, DOI 10.1016/j.abb.2015.06.013; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Gutierrez GD, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00022; Hasnain S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106466; Horwitz R, 2017, SCIENCE, V356, P806, DOI 10.1126/science.aan5955; Horwitz R, 2016, METHODS, V96, P3, DOI 10.1016/j.ymeth.2015.09.007; Huang M, 2012, ISLETS, V4, P210, DOI 10.4161/isl.20141; Hughes AJ, 2014, NAT METHODS, V11, P749, DOI [10.1038/NMETH.2992, 10.1038/nmeth.2992]; Im W, 2016, J MOL BIOL, V428, P2943, DOI 10.1016/j.jmb.2016.05.024; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jiang N, 2007, MAMM GENOME, V18, P508, DOI 10.1007/s00335-007-9011-y; Johnson GT, 2015, NAT METHODS, V12, P85, DOI [10.1038/NMETH.3204, 10.1038/nmeth.3204]; Johnson GT, 2014, FARADAY DISCUSS, V169, P23, DOI 10.1039/c4fd00017j; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; King ZA, 2016, NUCLEIC ACIDS RES, V44, pD515, DOI 10.1093/nar/gkv1049; Komatsu T, 2011, J AM CHEM SOC, V133, P6745, DOI 10.1021/ja200225m; Krogan NJ, 2015, MOL CELL, V58, P690, DOI 10.1016/j.molcel.2015.05.008; Li J, 2016, EMBO REP, V17, P178, DOI 10.15252/embr.201540946; Macklin DN, 2014, CURR OPIN BIOTECH, V28, P111, DOI 10.1016/j.copbio.2014.01.012; McEntyre J, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156658; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; Miao YL, 2015, J COMPUT CHEM, V36, P1536, DOI 10.1002/jcc.23964; Mikuni T, 2016, CELL, V165, P1803, DOI 10.1016/j.cell.2016.04.044; Millman JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11463; Moraru II, 2008, IET SYST BIOL, V2, P352, DOI 10.1049/iet-syb:20080102; Mosca R, 2013, NAT METHODS, V10, P47, DOI [10.1038/NMETH.2289, 10.1038/nmeth.2289]; Murphy RF, 2016, METHODS, V96, P33, DOI 10.1016/j.ymeth.2015.10.011; Murphy RF, 2012, METHOD CELL BIOL, V110, P179, DOI 10.1016/B978-0-12-388403-9.00007-2; Nica AC, 2013, GENOME RES, V23, P1554, DOI 10.1101/gr.150706.112; Nickell S, 2006, NAT REV MOL CELL BIO, V7, P225, DOI 10.1038/nrm1861; Noske AB, 2008, J STRUCT BIOL, V161, P298, DOI 10.1016/j.jsb.2007.09.015; Oates ME, 2013, NUCLEIC ACIDS RES, V41, pD508, DOI 10.1093/nar/gks1226; Pearson GL, 2016, MOL METAB, V5, P404, DOI 10.1016/j.molmet.2016.04.003; Pfeifer CR, 2015, J STRUCT BIOL, V189, P44, DOI 10.1016/j.jsb.2014.10.013; Purcell O, 2013, CHAOS, V23, DOI 10.1063/1.4811182; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Rigort A, 2012, P NATL ACAD SCI USA, V109, P4449, DOI 10.1073/pnas.1201333109; Riz M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003389; Roberts E, 2014, CURR OPIN STRUC BIOL, V25, P86, DOI 10.1016/j.sbi.2014.01.005; Roomp K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176391; Sali A, 2015, STRUCTURE, V23, P1156, DOI 10.1016/j.str.2015.05.013; Sanghvi JC, 2013, NAT METHODS, V10, P1192, DOI [10.1038/NMETH.2724, 10.1038/nmeth.2724]; Schneidman-Duhovny D, 2014, CURR OPIN STRUC BIOL, V28, P96, DOI 10.1016/j.sbi.2014.08.001; Song GJ, 2017, NATURE, V546, P312, DOI 10.1038/nature22378; Stiles JR, 1996, P NATL ACAD SCI USA, V93, P5747, DOI 10.1073/pnas.93.12.5747; Su Y, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600267; TAMURA H, 1992, INTERNAL MED, V31, P380, DOI 10.2169/internalmedicine.31.380; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Tomita M, 1999, BIOINFORMATICS, V15, P72, DOI 10.1093/bioinformatics/15.1.72; Topp B, 2000, J THEOR BIOL, V206, P605, DOI 10.1006/jtbi.2000.2150; Wallace M, 2013, BBA-GEN SUBJECTS, V1830, P2583, DOI 10.1016/j.bbagen.2012.10.025; Ward AB, 2013, SCIENCE, V339, P913, DOI 10.1126/science.1228565; Wilhelm BG, 2014, SCIENCE, V344, P1023, DOI 10.1126/science.1252884; Xu M., 2015, ARXIV151209347; Xu M, 2011, BIOINFORMATICS, V27, pI69, DOI 10.1093/bioinformatics/btr207; Yang LL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8859; Yu I, 2016, ELIFE, V5, DOI 10.7554/eLife.19274; Yuan Z, 2005, PROTEINS, V58, P905, DOI 10.1002/prot.20375; Zheng SQ, 2011, ULTRAMICROSCOPY, V111, P1137, DOI 10.1016/j.ultramic.2011.03.015	87	35	35	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 22	2018	173	1					11	19		10.1016/j.cell.2018.03.014	http://dx.doi.org/10.1016/j.cell.2018.03.014			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GA3MT	29570991	Green Accepted, Bronze			2022-12-28	WOS:000428234200005
J	Thomas, C				Thomas, Carolyn			WHAT YOUR PATIENT IS THINKING What I wish I'd known before my hospital discharge	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 21	2018	360								k1192	10.1136/bmj.k1192	http://dx.doi.org/10.1136/bmj.k1192			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB1LG	29563089	Green Published, Bronze			2022-12-28	WOS:000428811700002
J	Ott, SM				Ott, Susan M.			Guideline: USPSTF recommends against menopausal estrogen for primary prevention of chronic conditions	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HORMONE-THERAPY		[Ott, Susan M.] Univ Washington, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Ott, SM (corresponding author), Univ Washington, Seattle, WA 98195 USA.							Bhupathiraju SN, 2017, AM J EPIDEMIOL, V186, P696, DOI 10.1093/aje/kwx131; Cano A, 2018, MATURITAS, V107, pA1, DOI 10.1016/j.maturitas.2017.09.002; Canonico M, 2016, STROKE, V47, P1734, DOI 10.1161/STROKEAHA.116.013052; Hodis HN, 2016, NEW ENGL J MED, V374, P1221, DOI 10.1056/NEJMoa1505241; Manson JE, 2007, NEW ENGL J MED, V356, P2591, DOI 10.1056/NEJMoa071513; Manson JE, 2017, JAMA-J AM MED ASSOC, V318, P927, DOI 10.1001/jama.2017.11217; Nelson HD, 2002, ARCH INTERN MED, V162, P2278, DOI 10.1001/archinte.162.20.2278	7	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2018	168	6					JC26	JC26		10.7326/ACPJC-2018-168-6-026	http://dx.doi.org/10.7326/ACPJC-2018-168-6-026			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ8AM	29554664				2022-12-28	WOS:000427827400003
J	Gupta, R; Bollyky, TJ; Cohen, M; Ross, JS; Kesselheim, AS				Gupta, Ravi; Bollyky, Thomas J.; Cohen, Matthew; Ross, Joseph S.; Kesselheim, Aaron S.			Affordability and availability of off-patent drugs in the United States-the case for importing from abroad: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PHARMACEUTICALS; ADHERENCE; OUTCOMES; COHORT	OBJECTIVES To evaluate whether off-patent prescription drugs at risk of sudden price increases or shortages in the United States are available from independent manufacturers approved in other well regulated settings around the world. DESIGN Observational study. SETTING Off-patent drugs in the USA and approved by the Food and Drug Administration, up to 10 April 2017. STUDY COHORT Novel tablet or capsule prescription drugs approved by the FDA since 1939 that were no longer protected by patents or other market exclusivity and had up to three generic versions. MAIN OUTCOME MEASURES Number of additional manufacturers that had obtained approval from any of seven non-US regulators with similar standards (European Medicines Agency (European Union), HealthCanada (Canada), Therapeutic Goods Association (Australia), Medsafe (New Zealand), Swissmedic (Switzerland), Medicines Control Council (South Africa), and the Israel Health Ministry). Association with drug characteristics including US orphan drug designation for drugs treating rare diseases, World Health Organization essential medicine designation, treatment area, drug product complexity (that is, with attributes that could complicate establishing bioequivalence or manufacturing), and total Medicaid spending in 2015. RESULTS Of 170 eligible study drugs, more than half (109, 64%) had at least one manufacturer approved by a non-US regulator and 32 (19%) had four or more. Among 44 (26%) drugs with no FDA approved generic versions, 21 (48%) were available from at least one manufacturer approved by one of the seven non-US regulators, and two (5%) by four or more manufacturers. Across all drugs and regulators (including the FDA), 66 (39%) drugs were available from four or more total manufacturers. Of 109 drugs with at least one non-US regulator approved manufacturer, 12 (11%) were approved for patients with rare diseases and 29 (27%) were WHO designated essential medicines; only 12 (11%) were complex products that might be more complicated to import. The highest numbers of drugs were indicated for treating cardiovascular diseases, diabetes, or hyperlipidemia (19, 17%); psychiatric disease (16, 15%); and infectious diseases (15, 14%). In 2015, Medicaid alone spent nearly US$ 700m (508m; pound (sic)570m) on generic drugs without adequate US competition that could have had a manufacturer approved by non-US peer regulatory agencies. CONCLUSION In this study, more than half the off-patent drugs with no generic competition in the USA had at least one independent manufacturer approved by a non-US peer regulatory agency; slightly fewer than half had four or more total manufacturers. Facilitating US patient access to such manufacturers could help sustain affordable access to essential off-patent drugs.	[Gupta, Ravi] Johns Hopkins Univ Hosp, Dept Med, Baltimore, MD 21287 USA; [Gupta, Ravi] Johns Hopkins Sch Med, Baltimore, MD USA; [Bollyky, Thomas J.; Cohen, Matthew] Council Foreign Relat, Global Hlth Econ & Dev, Washington, DC USA; [Ross, Joseph S.] Yale Univ, Sch Med, Dept Med, Sect Gen Internal Med, New Haven, CT 06510 USA; [Ross, Joseph S.] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA; [Ross, Joseph S.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA; [Kesselheim, Aaron S.] Brigham & Womens Hosp, Program Regulat Therapeut & Law PORTAL, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, Boston, MA 02120 USA; [Kesselheim, Aaron S.] Harvard Med Sch, Boston, MA 02120 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Yale University; Yale University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Program Regulat Therapeut & Law PORTAL, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, Boston, MA 02120 USA.; Kesselheim, AS (corresponding author), Harvard Med Sch, Boston, MA 02120 USA.	akesselheim@partners.org		Cohen, Matthew/0000-0001-9087-2678; Ross, Joseph/0000-0002-9218-3320	Laura and John Arnold Foundation; Engelberg Foundation; Harvard Program in Therapeutic Science; Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	Laura and John Arnold Foundation; Engelberg Foundation; Harvard Program in Therapeutic Science; Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Study funded by the Laura and John Arnold Foundation, with additional support from the Engelberg Foundation, Harvard Program in Therapeutic Science, and Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation. The funders were independent from the research development or conduct.	Ashley DD, 2017, NEW ENGL J MED, V377, P1699, DOI 10.1056/NEJMc1711278; Barbui C, 2015, EPIDEMIOL PSYCH SCI, V24, P23, DOI 10.1017/S2045796014000754; Barua B, 2013, CASE MUTUAL RECOGNIT; Bollyky TJ, 2017, CAN DRUG IMPORTATION; Centers for Medicare & Medicaid Services, 2016, MED DRUG SPEND DASHB; Dave CV, 2017, ANN INTERN MED, V167, P145, DOI 10.7326/M16-1432; De Weerdt E, 2017, APPL HEALTH ECON HEA, V15, P441, DOI 10.1007/s40258-016-0264-z; Feldman R, 2017, DATABASE EMPIRICAL E; Freeh S, 2017, REPORT POTENTIAL IMP; Gagne JJ, 2014, ANN INTERN MED, V161, P400, DOI 10.7326/M13-2942; Generic Pharmaceutical Association, 2016, GEN DRUGS CONT DEL B; Generic Pharmaceutical Association, 2015, GEN DRUG SAV US; Greene JA, 2016, JAMA-J AM MED ASSOC, V315, P461, DOI 10.1001/jama.2015.18720; Gupta R, 2016, JAMA INTERN MED, V176, P1391, DOI 10.1001/jamainternmed.2016.3411; Howard P, 2014, HLTH AFFAIRS BLOG; Hussaarts L, 2017, ANN NY ACAD SCI, V1407, P39, DOI 10.1111/nyas.13347; International Trade Administration US Department of Commerce, 2016, TOP MARK REP PHARM; Kaiser Family Foundation, 2016, KAISER HLTH TRACKING; Kesselheim AS, 2016, JAMA-J AM MED ASSOC, V316, P858, DOI 10.1001/jama.2016.11237; Kesselheim AS, 2016, J GEN INTERN MED, V31, P609, DOI 10.1007/s11606-016-3612-7; Kesselheim AS, 2010, DRUGS, V70, P605, DOI 10.2165/10898530-000000000-00000; Labiris G, 2015, SCI CAIRO, V2015, DOI [10.1155/2015/251792/jrn, DOI 10.1155/2015/251792/JRN]; Larochelle M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014582; Lionberger R., 2014, DEV NEW BIOEQUIVALEN; McGinley L, 2017, WASHINGTON POST; Medicaid. gov, 2017, MED CHIP ENR DAT HIG; Pollack A, 2015, NY TIMES, pB2; Ross JS, 2016, JAMA INTERN MED, V176, P776, DOI 10.1001/jamainternmed.2016.2271; Sagonowsky E., 2017, TOP 15 GENERIC DRUGM; Shrank WH, 2006, ARCH INTERN MED, V166, P332, DOI 10.1001/archinte.166.3.332; United States Government Accountability Office, 2016, GEN DRUGS MED D; US Food and Drug Administration, 2017, PRIOR REV OR ANDAS A; US Food and Drug Administration, 2012, TEMP IMP LIP; US Food and Drug Administration, 2017, FDA TAK UNPR STEP MO; US Food and Drug Administration, 2005, FDA AN RET SAL DAT I; US Food and Drug Administration, 2017, REG PROC MAN; US Food and Drug Administration, 2017, DES ORPH PROD DRUGS; US Government Accountability Office, 2016, DRUG SAF FDA HAS IMP; US Government Accountability Office, 2014, DRUG SHORT PUBL HLTH; Ventola C Lee, 2011, P T, V36, P740; Wiske CP, 2015, JAMA-J AM MED ASSOC, V314, P2129, DOI 10.1001/jama.2015.13498; Woodcock J., 2016, IMPLEMENTATION GENER; World Health Organization, 2015, WHO MOD LIST ESS MED; World Health Organization (WHO), 2016, WHO ATC DDD IND 2017	44	12	12	3	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2018	360								k831	10.1136/bmj.k831	http://dx.doi.org/10.1136/bmj.k831			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB1KM	29555641	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000428809700016
J	Feinmann, J				Feinmann, Jane			Low calorie and low carb diets for weight loss in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LOW CARBOHYDRATE-DIET; MANAGEMENT					jane@janefeinmann.com						Davies MJ, 2008, BMJ-BRIT MED J, V336, P491, DOI 10.1136/bmj.39474.922025.BE; Khunti K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2333; Lean MEJ, 2018, LANCET, V391, P541, DOI 10.1016/S0140-6736(17)33102-1; McCartney M, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4226; Meng Y, 2017, DIABETES RES CLIN PR, V131, P124, DOI 10.1016/j.diabres.2017.07.006; NICE, 2017, TYP 2 DIAB AD MAN; Tobias DK, 2015, LANCET DIABETES ENDO, V3, P968, DOI 10.1016/S2213-8587(15)00367-8; Unwin D, 2014, PRACT DIABETES, V31, P76, DOI 10.1002/pdi.1835; Unwin DJ, 2015, DIABESITY PRACTICE, V4, P102; Wermeling M, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-97	10	1	1	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2018	360								k1122	10.1136/bmj.k1122	http://dx.doi.org/10.1136/bmj.k1122			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ9FW	29535083				2022-12-28	WOS:000427916400002
J	Ong, MEH; Perkins, GD; Cariou, A				Ong, Marcus Eng Hock; Perkins, Gavin D.; Cariou, Alain			Out-of-hospital cardiac arrest: prehospital management	LANCET			English	Review							ASSISTED CARDIOPULMONARY-RESUSCITATION; CARDIOVASCULAR CARE SCIENCE; 2015 INTERNATIONAL CONSENSUS; BASIC LIFE-SUPPORT; THERAPEUTIC HYPOTHERMIA; AIRWAY MANAGEMENT; COMATOSE SURVIVORS; CHEST COMPRESSION; ADVISORY STATEMENT; COUNCIL GUIDELINES	Sudden out-of-hospital cardiac arrest is the most time-critical medical emergency. In the second paper of this Series on out-of-hospital cardiac arrest, we considered important issues in the prehospital management of cardiac arrest. Successful resuscitation relies on a strong chain of survival with the community, dispatch centre, ambulance, and hospital working together. Early cardiopulmonary resuscitation and defibrillation has the greatest impact on survival. If the community response does not restart the heart, resuscitation is continued by emergency medical services' staff. However, the best approaches for airway management and the effectiveness of currently used drug treatments are uncertain. Prognostic factors and rules for termination of resuscitation could guide the duration of a resuscitation attempt and decision to transport to hospital. If return of spontaneous circulation is achieved, the focus of treatment shifts to stabilisation, restoration of normal physiological parameters, and transportation to hospital for ongoing care.	[Ong, Marcus Eng Hock] Singapore Gen Hosp, Dept Emergency Med, Singapore 169856, Singapore; [Ong, Marcus Eng Hock] Duke NUS Med Sch, Hlth Serv & Syst Res, Singapore, Singapore; [Perkins, Gavin D.] Univ Warwick, Warwick Med Sch, Warwick Clin Trials Unit, Coventry, W Midlands, England; [Perkins, Gavin D.] Heart England NHS Fdn Trust, Birmingham, W Midlands, England; [Cariou, Alain] Cochin Hosp, AP HP, Med Intens Care Unit, Paris, France; [Cariou, Alain] Paris Descartes Univ, Paris, France	Singapore General Hospital; National University of Singapore; University of Warwick; Heart of England NHS Foundation Trust; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Ong, MEH (corresponding author), Singapore Gen Hosp, Dept Emergency Med, Singapore 169856, Singapore.	marcus.ong.e.h@singhealth.com.sg	Perkins, Gavin/E-7613-2010	Perkins, Gavin/0000-0003-3027-7548	National Institute of Health Research Senior (NIHR) Investigator; NIHR; Bard; AstraZeneca	National Institute of Health Research Senior (NIHR) Investigator(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); Bard(US-Israel Binational Science Foundation); AstraZeneca(AstraZeneca)	MEHO is currently scientific adviser to Global Healthcare SG and TIIM SG, and holds patents related to using heart rate variability and artificial intelligence for medical monitoring. He has no direct conflicts relating to sections written by him. GDP received support as a National Institute of Health Research Senior (NIHR) Investigator and has led studies relating to quality of cardiopulmonary resuscitation (CPR), mechanical CPR, and drugs in cardiac arrest funded by NIHR. He has volunteer roles with the UK and European Resuscitation Councils and the International Committee for Resuscitation. AC received fees for lectures from Bard and AstraZeneca. He has no direct conflicts relating to sections written by him.	[Anonymous], 1959, JAMA-J AM MED ASSOC, V170, P471; Belohlavek J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-163; Berg RA, 2010, CIRCULATION, V122, pS685, DOI 10.1161/CIRCULATIONAHA.110.970939; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bernard SA, 2016, CIRCULATION, V134, P797, DOI 10.1161/CIRCULATIONAHA.116.021989; Bernard SA, 2010, CIRCULATION, V122, P737, DOI 10.1161/CIRCULATIONAHA.109.906859; Bobrow BJ, JAMA, V304, P1447; Bossaert LL, 2015, RESUSCITATION, V95, P302, DOI 10.1016/j.resuscitation.2015.07.033; Boutilier JJ, 2017, CIRCULATION, V135, P2454, DOI 10.1161/CIRCULATIONAHA.116.026318; Camuglia AC, 2014, RESUSCITATION, V85, P1533, DOI 10.1016/j.resuscitation.2014.08.025; Chelly J, 2012, RESUSCITATION, V83, P1444, DOI 10.1016/j.resuscitation.2012.08.321; Cheong RWL, 2016, PREHOSP EMERG CARE, V20, P623, DOI 10.3109/10903127.2016.1162886; Couper K, 2015, CURR OPIN CRIT CARE, V21, P188, DOI 10.1097/MCC.0000000000000200; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; Dami F, 2010, ACAD EMERG MED, V17, P1012, DOI 10.1111/j.1553-2712.2010.00851.x; de Chambrun MP, 2016, INTENS CARE MED, V42, P1999, DOI 10.1007/s00134-016-4541-y; Do Shin S, 2012, RESUSCITATION, V83, P313, DOI 10.1016/j.resuscitation.2011.10.028; Dumas F, 2010, CIRC-CARDIOVASC INTE, V3, P200, DOI 10.1161/CIRCINTERVENTIONS.109.913665; Dyson K, 2014, RESUSCITATION, V85, P1134, DOI 10.1016/j.resuscitation.2014.05.020; Elmer J, 2016, RESUSCITATION, V102, P127, DOI 10.1016/j.resuscitation.2016.01.016; Folke F, 2009, CIRCULATION, V120, P510, DOI 10.1161/CIRCULATIONAHA.108.843755; Fritz Z, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j813; Gates S, 2015, RESUSCITATION, V94, P91, DOI 10.1016/j.resuscitation.2015.07.002; Grunau B, 2016, RESUSCITATION, V101, P50, DOI 10.1016/j.resuscitation.2016.01.021; Hallstrom A, 2000, NEW ENGL J MED, V342, P1546, DOI 10.1056/NEJM200005253422101; Harjanto S, 2016, RESUSCITATION, V102, P85, DOI 10.1016/j.resuscitation.2016.02.014; Hasegawa K, 2013, JAMA-J AM MED ASSOC, V309, P257, DOI 10.1001/jama.2012.187612; Hauff SR, 2003, ANN EMERG MED, V42, P731, DOI 10.1016/S0196-0644(03)00423-2; Hawkes C, 2017, RESUSCITATION, V110, P133, DOI 10.1016/j.resuscitation.2016.10.030; Ho AFW, 2016, RESUSCITATION, V105, P149, DOI 10.1016/j.resuscitation.2016.05.006; Holzer M, 2002, NEW ENGL J MED, V346, P549; Jacobs IG, 2011, RESUSCITATION, V82, P1138, DOI 10.1016/j.resuscitation.2011.06.029; Kamarainen A, 2009, ACTA ANAESTH SCAND, V53, P900, DOI 10.1111/j.1399-6576.2009.02015.x; Kilgannon JH, 2011, CIRCULATION, V123, P2717, DOI 10.1161/CIRCULATIONAHA.110.001016; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; Kim F, 2007, CIRCULATION, V115, P3064, DOI 10.1161/CIRCULATIONAHA.106.655480; Kim F, 2014, JAMA-J AM MED ASSOC, V311, P45, DOI 10.1001/jama.2013.282173; Kitamura T, 2010, NEW ENGL J MED, V362, P994, DOI 10.1056/NEJMoa0906644; Kloeck W, 1997, RESUSCITATION, V34, P109, DOI 10.1016/S0300-9572(97)01100-3; Kragholm K, 2017, NEW ENGL J MED, V376, P1737, DOI 10.1056/NEJMoa1601891; Kudenchuk PJ, 1999, NEW ENGL J MED, V341, P871, DOI 10.1056/NEJM199909163411203; Lamhaut L, 2017, RESUSCITATION, V117, P109, DOI 10.1016/j.resuscitation.2017.04.014; Larabee TM, 2012, RESUSCITATION, V83, P932, DOI 10.1016/j.resuscitation.2012.02.029; Laurent I, 2002, J AM COLL CARDIOL, V40, P2110, DOI 10.1016/S0735-1097(02)02594-9; Lin S, 2014, RESUSCITATION, V85, P732, DOI 10.1016/j.resuscitation.2014.03.008; McMullan J, 2014, RESUSCITATION, V85, P617, DOI 10.1016/j.resuscitation.2014.02.007; Morrison LJ, 2006, NEW ENGL J MED, V355, P478, DOI 10.1056/NEJMoa052620; Morrison LJ, 2009, RESUSCITATION, V80, P324, DOI 10.1016/j.resuscitation.2008.11.014; Nagao K, 2016, CIRCULATION, V133, P1386, DOI 10.1161/CIRCULATIONAHA.115.018788; Nichol G, 1996, ANN EMERG MED, V27, P711, DOI 10.1016/S0196-0644(96)70188-9; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Nichol G, 2015, NEW ENGL J MED, V373, P2203, DOI 10.1056/NEJMoa1509139; Nikolaou NI, 2015, RESUSCITATION, V95, P264, DOI 10.1016/j.resuscitation.2015.07.030; Nolan JP, 2015, INTENS CARE MED, V41, P2039, DOI 10.1007/s00134-015-4051-3; Olasveengen TM, 2017, RESUSCITATION, V121, P201, DOI 10.1016/j.resuscitation.2017.10.021; Olasveengen TM, 2008, CIRCULATION, V118, pS1447; Ong MEH, 2015, RESUSCITATION, V96, P100, DOI 10.1016/j.resuscitation.2015.07.026; Ong MEH, 2013, RESUSCITATION, V84, P508, DOI 10.1016/j.resuscitation.2012.07.033; Ouweneel DM, 2016, INTENS CARE MED, V42, P1922, DOI 10.1007/s00134-016-4536-8; Perkins GD, 2016, RESUSCITATION, V108, P75, DOI 10.1016/j.resuscitation.2016.08.029; Perkins GD, 2015, RESUSCITATION, V95, pE43, DOI 10.1016/j.resuscitation.2015.07.041; Perkins GD., 2016, HLTH SERV DELIV RES, V4, P1, DOI [10.3310/hsdr04110, DOI 10.3310/HSDR04110]; PERKINS GD, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G2435; Rea TD, 2001, CIRCULATION, V104, P2513, DOI 10.1161/hc4601.099468; Reynolds JC, 2016, CIRCULATION, V134, P2084, DOI 10.1161/CIRCULATIONAHA.116.023309; Safar PBN, 1988, CARDIOPULMONARY CERE; Sandroni C, 2014, INTENS CARE MED, V40, P1816, DOI 10.1007/s00134-014-3470-x; Sasson C, 2008, JAMA-J AM MED ASSOC, V300, P1432, DOI 10.1001/jama.300.12.1432; Soar J, 2015, RESUSCITATION, V95, pE71, DOI 10.1016/j.resuscitation.2015.07.042; Spaulding CM, 1997, NEW ENGL J MED, V336, P1629, DOI 10.1056/NEJM199706053362302; Stiell IG, 2004, NEW ENGL J MED, V351, P647, DOI 10.1056/NEJMoa040325; Stiell IG, 1999, ANN EMERG MED, V33, P44, DOI 10.1016/S0196-0644(99)70415-4; Stub D, 2015, CIRCULATION, V131, P2143, DOI 10.1161/CIRCULATIONAHA.114.014494; Tanaka H, 2018, ANN EMERG MED, V71, P608, DOI 10.1016/j.annemergmed.2017.07.484; Taylor J, 2016, RESUSCITATION, V109, P25, DOI 10.1016/j.resuscitation.2016.09.016; Vaillancourt C, 2007, ACAD EMERG MED, V14, P877, DOI 10.1197/j.aem.2007.06.021; Verbeek PR, 2002, ACAD EMERG MED, V9, P671, DOI 10.1197/aemj.9.7.671; Wang HE, 2016, RESUSCITATION, V101, P57, DOI 10.1016/j.resuscitation.2016.01.012; Yannopoulos D, 2017, J AM COLL CARDIOL, V70, P1109, DOI 10.1016/j.jacc.2017.06.059; Zive D, 2011, RESUSCITATION, V82, P277, DOI 10.1016/j.resuscitation.2010.10.022	80	98	102	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 10	2018	391	10124					980	988		10.1016/S0140-6736(18)30316-7	http://dx.doi.org/10.1016/S0140-6736(18)30316-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ1UN	29536862	Green Published			2022-12-28	WOS:000427363100031
J	Singh, S; Song, RG; Johnson, AS; McCray, E; Hall, HI				Singh, Sonia; Song, Ruiguang; Johnson, Anna Satcher; McCray, Eugene; Hall, H. Irene			HIV Incidence, Prevalence, and Undiagnosed Infections in US Men Who Have Sex With Men	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; UNITED-STATES; PREEXPOSURE PROPHYLAXIS; ANTIRETROVIRAL THERAPY; TREATMENT GUIDELINES; COST-EFFECTIVENESS; INJECT DRUGS; VIRAL LOAD; CARE; PREVENTION	Background: HIV infection is a persistent health concern in the United States, and men who have sex with men (MSM) continue to be the most affected population. Objective: To estimate HIV incidence and prevalence and the percentage of undiagnosed HIV infections overall and among MSM. Design: Cross-sectional analysis. Setting: National HIV Surveillance System. Participants: Persons aged 13 years or older with diagnosed HIV infection. Measurements: Data on HIV diagnoses and the first CD4 test result after diagnosis were used to model HIV incidence and prevalence and the percentage of undiagnosed HIV infections from 2008 to 2015 on the basis of a well-characterized CD4 depletion model. Results: Modeled HIV incidence decreased 14.8% overall, from 45 200 infections in 2008 to 38 500 in 2015, and among all transmission risk groups except MSM. The incidence of HIV increased 3.1% (95% CI, 1.6% to 4.5%) per year among Hispanic/Latino MSM (6300 infections in 2008, 7900 in 2015), decreased 2.7% (CI, -3.8% to -1.5%) per year among white MSM (8800 infections in 2008, 7100 in 2015), and remained stable among black MSM at about 10 000 infections. The incidence decreased by 3.0% (CI, -4.2% to -1.8%) per year among MSM aged 13 to 24 years and by 4.7% (CI, -6.2% to -3.1%) per year among those aged 35 to 44 years. Among MSM aged 25 to 34 years, HIV incidence increased 5.7% (CI, 4.4% to 7.0%) per year and among MSM aged 55 years and older, HIV increased 4.1% (CI, 0.8% to 7.4%). The percentage of undiagnosed HIV infections was higher among black, Hispanic/Latino, and younger MSM than white and older MSM, respectively. Limitation: Assumptions of the CD4 depletion model and variability of CD4 values. Conclusion: Expansion of HIV screening to reduce undiagnosed infections and increased access to care and treatment to achieve viral suppression are critical to reduce HIV transmission. Access to prevention methods, such as condoms and preexposure prophylaxis, also is needed, particularly among MSM of color and young MSM.	[Singh, Sonia; Song, Ruiguang; Johnson, Anna Satcher; McCray, Eugene; Hall, H. Irene] Ctr Dis Control & Prevent, 1600 Clifton Rd Northeast,MS E-47, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Singh, S (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd Northeast,MS E-47, Atlanta, GA 30329 USA.	ssingh3@cdc.gov		Satcher Johnson, Anna/0000-0002-8915-6903				Adih William K, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P150, DOI 10.1177/1545109711399805; An Qian, 2012, Morbidity and Mortality Weekly Report, V61, P805; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bradley H, 2014, MMWR-MORBID MORTAL W, V63, P1113; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Centers for Disease Control and Prevention, 2017, HIV SURVEILLANCE S, V22; Centers for Disease Control and Prevention, 2013, HIV TEST TRENDS US 2; Centers for Disease Control and Prevention, DHAP STRAT PLAN; Centers for Disease Control and Prevention, 2016, HIV SURVEILLANCE REP, V27; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cohen SM, 2014, PUBLIC HEALTH REP, V129, P335, DOI 10.1177/003335491412900408; Cooley LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104162; Eaton LA, 2015, AM J PUBLIC HEALTH, V105, pE75, DOI 10.2105/AJPH.2014.302322; Gant Z, 2017, MMWR-MORBID MORTAL W, V66, P1065, DOI 10.15585/mmwr.mm6640a2; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hall H Irene, 2017, JMIR Public Health Surveill, V3, pe8, DOI 10.2196/publichealth.7051; Hall HI, 2015, JAIDS-J ACQ IMM DEF, V69, P248, DOI 10.1097/QAI.0000000000000589; Harrison KM, 2008, PUBLIC HEALTH REP, V123, P618, DOI 10.1177/003335490812300512; Hutchinson AB, 2016, JAIDS-J ACQ IMM DEF, V71, P323, DOI 10.1097/QAI.0000000000000838; Johnson AS, 2014, JAMA-J AM MED ASSOC, V312, P432, DOI 10.1001/jama.2014.8534; Jones CM, 2015, MMWR-MORBID MORTAL W, V64, P719; Juusola JL, 2012, ANN INTERN MED, V156, P541, DOI [10.7326/0003-4819-156-8-201204170-00004, 10.7326/0003-4819-156-8-201204170-00001]; Koethe JR, 2016, JAIDS-J ACQ IMM DEF, V73, P197, DOI 10.1097/QAI.0000000000001035; Koethe JR, 2016, AIDS RES HUM RETROV, V32, P50, DOI 10.1089/aid.2015.0147; Lansky A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133543; Lansky A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097596; Lodi S, 2011, CLIN INFECT DIS, V53, P817, DOI 10.1093/cid/cir494; Mack KA, 2013, MMWR-MORBID MORTAL W, V62, P537; McCree DH, 2017, MMWR-MORBID MORTAL W, V66, P104, DOI 10.15585/mmwr.mm6604a3; Mitsch AJ, 2016, AM J PUBLIC HEALTH, V106, P2194, DOI 10.2105/AJPH.2016.303380; Nwangwu-Ike N, 2015, WOMEN HEALTH ISS, V25, P711, DOI 10.1016/j.whi.2015.07.004; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG AD AD; Peters PJ, 2016, NEW ENGL J MED, V375, P229, DOI 10.1056/NEJMoa1515195; Purcell David W, 2012, Open AIDS J, V6, P98, DOI 10.2174/1874613601206010098; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Singh S, 2017, MMWR-MORBID MORTAL W, V66, P969, DOI 10.15585/mmwr.mm6637a2; Smith DK, 2017, JAIDS-J ACQ IMM DEF, V76, P465, DOI 10.1097/qai.0000000000001532; Smith DK, 2015, MMWR-MORBID MORTAL W, V64, P1291, DOI 10.15585/mmwr.mm6446a4; Song RG, 2017, JAIDS-J ACQ IMM DEF, V74, P3, DOI 10.1097/QAI.0000000000001151; Touloumi G, 2013, CLIN INFECT DIS, V56, P888, DOI 10.1093/cid/cis1000; U. S. Public Health Service, 2014, PREEXP PROPH HIV PRE; United States Census Bureau, 2018, POP HOUS UN EST ENT; Wejnert C, 2016, MMWR-MORBID MORTAL W, V65, P1336, DOI 10.15585/mmwr.mm6547e1; Whiteside YO, 2015, AIDS, V29, P2517, DOI 10.1097/QAD.0000000000000852; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1	48	91	92	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2018	168	10					685	+		10.7326/M17-2082	http://dx.doi.org/10.7326/M17-2082			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GI3DE	29554663				2022-12-28	WOS:000434250700012
J	Judge, AM; Murphy, JA; Hidalgo, J; Macias-Konstantopoulos, W				Judge, Abigail M.; Murphy, Jennifer A.; Hidalgo, Jose; Macias-Konstantopoulos, Wendy			Engaging Survivors of Human Trafficking: Complex Health Care Needs and Scarce Resources	ANNALS OF INTERNAL MEDICINE			English	Article							COMMERCIAL SEXUAL EXPLOITATION; MENTAL-DISORDERS; WOMEN SURVIVORS; TRAUMA; CHILD; VICTIMS; POLICY; GIRLS; PERSPECTIVES; SERVICES	Human trafficking, also known as modern-day slavery, is an egregious human rights violation associated with wide-ranging medical and mental health consequences. Because of the extensive health problems related to trafficking, health care providers play a critical role in identifying survivors and engaging them in ongoing care. Although guidelines for recognizing affected patients and a framework for developing response protocols in health care settings have been described, survivors' ongoing engagement in health care services is very challenging. High rates of disengagement, lost contact, premature termination, and attrition are common outcomes. For interventions to be effective in this marginalized population, challenges in engaging survivors in long-term therapeutic primary and mental health care must be better understood and overcome. This article uses the socio-ecological model of public health to identify barriers to engagement; offers evidence-and practice-based recommendations for overcoming these barriers; and proposes an interdisciplinary call to action for developing more flexible, adaptable models of care.	[Judge, Abigail M.; Murphy, Jennifer A.; Hidalgo, Jose; Macias-Konstantopoulos, Wendy] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Judge, Abigail M.] Massachusetts Gen Hosp, Dept Psychiat, 55 Fruit St, Boston, MA 02114 USA; [Murphy, Jennifer A.] Massachusetts Gen Hosp, LEAP, Children & Law Program, 55 Fruit St, Boston, MA 02114 USA; [Hidalgo, Jose] Massachusetts Gen Hosp, Law & Psychiat Serv, 1 Bowdoin Sq,10 Floor,15 New Chardon St, Boston, MA 02114 USA; [Macias-Konstantopoulos, Wendy] Massachusetts Gen Hosp, Freedom Clin, 55 Fruit St, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Judge, AM (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, 55 Fruit St, Boston, MA 02114 USA.	amjudge@partners.org		Macias-Konstantopoulos, Wendy/0000-0002-5752-2104				Abas M, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-204; Ahn R, 2013, AM J PREV MED, V44, P283, DOI 10.1016/j.amepre.2012.10.025; [Anonymous], 2014, ESTIMATING SIZE STRU; Baker LM, 2004, WOMEN HEALTH, V39, P83, DOI 10.1300/J013v39n02_06; Belser P., 2005, FORCED LABOR HUMAN T; Broudo M, 2012, VACATING CRIMINAL CO; Chisolm-Straker M, 2016, J HEALTH CARE POOR U, V27, P1220, DOI 10.1353/hpu.2016.0131; Chon K., 2016, HUMAN TRAFFICKING OP; Cloitre M, 2011, J TRAUMA STRESS, V24, P615, DOI 10.1002/jts.20697; Contreras PM, 2017, WOMEN THER, V40, P31, DOI 10.1080/02703149.2016.1205908; Courtois CA, 2004, PSYCHOTHERAPY, V41, P412, DOI 10.1037/0033-3204.41.4.412; Evans MA, 2016, HEALTH EXPECT, V19, P62, DOI 10.1111/hex.12330; Gibbs DA, 2015, CHILD YOUTH SERV REV, V54, P1, DOI 10.1016/j.childyouth.2015.04.003; Greenbaum J, 2015, PEDIATRICS, V135, P566, DOI 10.1542/peds.2014-4138; Halter S, 2010, CHILD MALTREATMENT, V15, P152, DOI 10.1177/1077559509355315; Holger-Ambrose B, 2013, J CHILD SEX ABUS, V22, P326, DOI 10.1080/10538712.2013.737443; Hopper E., 2006, INTERCULT HUM RIGHTS, V1, P185; Hossain M, 2010, AM J PUBLIC HEALTH, V100, P2442, DOI 10.2105/AJPH.2009.173229; Johnson SM, 1998, J MARITAL FAM THER, V24, P25, DOI 10.1111/j.1752-0606.1998.tb01061.x; Konstantopoulos WM, 2013, J URBAN HEALTH, V90, P1194, DOI 10.1007/s11524-013-9837-4; Lederer L, 2014, ANN HLTH L, V23, P61; Lutnick A., 2017, DOMESTIC MINOR SEX T; Macias-Konstantopoulos W, 2016, MASSACHUSETTS GEN HO; Macias-Konstantopoulos W., 2016, STIGMA PREJUDICE TOU, P183; Macias-Konstantopoulos W, 2016, ANN INTERN MED, V165, P582, DOI 10.7326/M16-0094; Macias-Konstantopoulos WL, 2015, J APPL RES CHILD, V6; Marcus A, 2012, SEX RES SOC POLICY, V9, P153, DOI 10.1007/s13178-011-0070-1; McDonnell M, 2013, CURR OPIN PSYCHIATR, V26, P1, DOI 10.1097/YCO.0b013e32835aea9d; Muraya DN, 2016, TRAUMA VIOLENCE ABUS, V17, P204, DOI 10.1177/1524838015584356; Musto J, 2016, CONTROL PROTECT COLL; Muzik M, 2013, CHILD ABUSE NEGLECT, V37, P1215, DOI 10.1016/j.chiabu.2013.07.014; Oram S, 2015, LANCET PSYCHIAT, V2, P1084, DOI 10.1016/S2215-0366(15)00290-4; Organization for Security and Co-operation in Europe Office of the Special Representative and Co-ordinator for Combating Traffick-ing in Human Beings, 2013, OCCASIONAL PAPER SER, V5; Ottisova L, 2016, EPIDEMIOL PSYCH SCI, V25, P317, DOI 10.1017/S2045796016000135; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Reid JA, 2016, SEX ABUSE-J RES TR, V28, P491, DOI 10.1177/1079063214544334; Sapiro B, 2016, CHILD ABUSE NEGLECT, V58, P99, DOI 10.1016/j.chiabu.2016.06.019; Stoklosa H., 2017, J HUMAN TRAFFICKING, V3, P182, DOI [10.1080/23322705.2016.1187965, DOI 10.1080/23322705.2016.1187965]; Turner-Moss E, 2014, J IMMIGR MINOR HEALT, V16, P473, DOI 10.1007/s10903-013-9832-6; Valaei E, 2014, ASSESSMENT HARMFUL F; Vijeyarasa R, 2010, JAMA-J AM MED ASSOC, V304, P344, DOI 10.1001/jama.2010.964; West A, 2015, J APPL RES CHILD, V6, P1; Zimmerman C, 2011, SOC SCI MED, V73, P327, DOI 10.1016/j.socscimed.2011.05.028	43	17	17	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2018	168	9					658	663		10.7326/M17-2605	http://dx.doi.org/10.7326/M17-2605			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GI3BZ	29532076				2022-12-28	WOS:000434247300008
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Moral distress in hospital doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Ault R, 2018, STOKE SENTINEL  0113; Baird B, 2017, IS GEN PRACTICE CRIS; Campbell D, 2017, GUARDIAN; Hamric AB, 2012, HEC FORUM, V24, P39, DOI 10.1007/s10730-012-9177-x; Jameton A, 1993, AWHONNS Clin Issues Perinat Womens Health Nurs, V4, P542; Jameton A., 1984, NURSING PRACTICE ETH, DOI 10.1002/chp.4760040110; Kentish B, 2017, INDEPENDENT; Lemaire JB, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3360; Matthews-King Alex, 2018, INDEPENDENT; National Institute for Health Research, 2014, LONG NAT EV SCHWARTZ; NHS Survey Coordination Centre, 2017, 2017 RES; Point of Care Foundation, SCHWARTZ ROUNDS; Point of Care Foundation, WE AR WORK RAD IMPR; Robert G, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014326; Robertson R, 2018, PUBLIC SATISFACTION; Royal College of Paediatrics and Child Health, 2017, ROT COMPL VAC; Smith F, ADVERSE EFFECTS HLTH; West M, 2018, ITS NOT MONEY STAFF; West M.A., 2012, EMPLOYEE ENGAGEMENT	19	17	17	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2018	360								k1333	10.1136/bmj.k1333	http://dx.doi.org/10.1136/bmj.k1333			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB5MV	29588279	Green Published, Bronze			2022-12-28	WOS:000429109900002
J	Li, XR; Carmeliet, P				Li, Xuri; Carmeliet, Peter			Targeting angiogenic metabolism in disease	SCIENCE			English	Editorial Material							ENDOTHELIAL-CELLS; PFKFB3 BLOCKADE; GLYCOLYSIS; NORMALIZATION; VASCULATURE; GLUTAMINE		[Li, Xuri; Carmeliet, Peter] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, 54 South Xianlie Rd, Guangzhou 510060, Guangdong, Peoples R China; [Carmeliet, Peter] Katholieke Univ KU Leuven, Lab Angiogenesis & Vasc Metab, Dept Oncol, B-3000 Leuven, Belgium; [Carmeliet, Peter] VIB, Ctr Canc Biol, Lab Angiogenesis & Vasc Metab, B-3000 Leuven, Belgium	Sun Yat Sen University; KU Leuven; Flanders Institute for Biotechnology (VIB)	Li, XR (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, 54 South Xianlie Rd, Guangzhou 510060, Guangdong, Peoples R China.	lixr6@mail.sysu.edu.cn; peter.carmeliet@kuleuven.vib.be	Carmeliet, Peter/AAQ-5140-2020	Carmeliet, Peter/0000-0001-7961-1821				Cantelmo AR, 2016, CANCER CELL, V30, P968, DOI 10.1016/j.ccell.2016.10.006; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Conradi LC, 2017, ANGIOGENESIS, V20, P599, DOI 10.1007/s10456-017-9573-6; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; Eelen G, 2015, CIRC RES, V116, P1231, DOI 10.1161/CIRCRESAHA.116.302855; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Huang H, 2017, EMBO J, V36, P2334, DOI 10.15252/embj.201695518; Kim B, 2017, EMBO J, V36, P2321, DOI 10.15252/embj.201796436; Schoors S, 2015, NATURE, V520, P192, DOI 10.1038/nature14362; Schoors S, 2014, CELL CYCLE, V13, P16, DOI 10.4161/cc.27519; Schoors S, 2014, CELL METAB, V19, P37, DOI 10.1016/j.cmet.2013.11.008; Wilhelm K, 2016, NATURE, V529, P216, DOI 10.1038/nature16498; Wong BW, 2017, NATURE, V542, P49, DOI 10.1038/nature21028; Yu PC, 2017, NATURE, V545, P224, DOI 10.1038/nature22322	15	21	23	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2018	359	6382			SI		1335	1336		10.1126/science.aar5557	http://dx.doi.org/10.1126/science.aar5557			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA0ZG	29567696				2022-12-28	WOS:000428043600026
J	Pereira, ER; Kedrin, D; Seano, G; Gautier, O; Meijer, EFJ; Jones, D; Chin, SM; Kitahara, S; Bouta, EM; Chang, J; Beech, E; Jeong, HS; Carroll, MC; Taghian, AG; Padera, TP				Pereira, Ethel R.; Kedrin, Dmitriy; Seano, Giorgio; Gautier, Olivia; Meijer, Eelco F. J.; Jones, Dennis; Chin, Shan-Min; Kitahara, Shuji; Bouta, Echoe M.; Chang, Jonathan; Beech, Elizabeth; Jeong, Han-Sin; Carroll, Michael C.; Taghian, Alphonse G.; Padera, Timothy P.			Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice	SCIENCE			English	Article							BREAST-CANCER; SENTINEL-NODE; PREMENOPAUSAL WOMEN; AXILLARY DISSECTION; RADIOTHERAPY; IRRADIATION; CARCINOMA; SURVIVAL; MAMMARY; SURGERY	Lymph node metastases in cancer patients are associated with tumor aggressiveness, poorer prognoses, and the recommendation for systemic therapy. Whether cancer cells in lymph nodes can seed distant metastases has been a subject of considerable debate. We studied mice implanted with cancer cells (mammary carcinoma, squamous cell carcinoma, or melanoma) expressing the photoconvertible protein Dendra2. This technology allowed us to selectively photoconvert metastatic cells in the lymph node and trace their fate. We found that a fraction of these cells invaded lymph node blood vessels, entered the blood circulation, and colonized the lung. Thus, in mouse models, lymph node metastases can be a source of cancer cells for distant metastases. Whether this mode of dissemination occurs in cancer patients remains to be determined.	[Kedrin, Dmitriy] MGH, Div Gastroenterol, Boston, MA 02114 USA; [Kedrin, Dmitriy; Chang, Jonathan; Carroll, Michael C.; Taghian, Alphonse G.] HMS, Boston, MA 02114 USA; [Gautier, Olivia] MIT, Dept Biol Engn, Cambridge, MA 02142 USA; [Chang, Jonathan] HMS, Div Med Sci, Grad Program Immunol, Boston, MA 02115 USA; [Chang, Jonathan; Carroll, Michael C.] Childrens Hosp, Program Cellular & Mol Med, 300 Longwood Ave, Boston, MA 02115 USA; [Jeong, Han-Sin] Sungkyunkwan Univ, Dept Otorhinolaryngol, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Jeong, Han-Sin] Sungkyunkwan Univ, Head & Neck Canc Ctr, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Carroll, Michael C.] Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; [Taghian, Alphonse G.] MGH, Dept Radiat Oncol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Harvard University; Boston Children's Hospital		tpadera@steele.mgh.harvard.edu	Seano, Giorgio/R-6611-2016; Kitahara, Shuji/AAA-4632-2020; Jeong, Han Sin/F-4597-2014; Padera, Timothy/R-2982-2019; Jeong, Han-Sin/C-4884-2011	Seano, Giorgio/0000-0002-7294-302X; Kitahara, Shuji/0000-0002-2904-0319; Padera, Timothy/0000-0002-3453-9384; Jeong, Han-Sin/0000-0003-4652-0573; /0000-0001-6093-7282; Meijer, Eelco/0000-0002-0226-024X; Pereira, Ethel/0000-0003-0562-4536	NIH [DP2OD008780, R01CA214913, R01HL128168, T32 DK007191, P01CA080124, UL1 TR001102]; National Cancer Institute (NCI) Federal Share/MGH Proton Beam Income [C06CA059267]; MGH Executive Committee on Research Interim Support Funding; Susan G. Komen Foundation Fellowship [PDF14301739]; United Negro College Fund-Merck Science Initiative Postdoctoral Fellowship; Burroughs Wellcome Postdoctoral Enrichment Program Award; NIH NCI [F32CA183465]; Korean Ministry of Education, Science, and Technology [NRF-2012R1A1A2040866]; Samsung Biomedical Research Institute [GL1B22912]; Harvard University; M. Vangel and Harvard Catalyst; NATIONAL CANCER INSTITUTE [F32CA183465, R01CA214913, P01CA080124, C06CA059267] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007191] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008780] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI) Federal Share/MGH Proton Beam Income; MGH Executive Committee on Research Interim Support Funding; Susan G. Komen Foundation Fellowship(Susan G. Komen Breast Cancer Foundation); United Negro College Fund-Merck Science Initiative Postdoctoral Fellowship; Burroughs Wellcome Postdoctoral Enrichment Program Award; NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Samsung Biomedical Research Institute(Samsung); Harvard University; M. Vangel and Harvard Catalyst; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants DP2OD008780, R01CA214913, and R01HL128168 (T.P.P.); National Cancer Institute (NCI) Federal Share/MGH Proton Beam Income-C06CA059267 (T.P.P.); MGH Executive Committee on Research Interim Support Funding (T.P.P.); NIH grant T32 DK007191 (D.K.); Susan G. Komen Foundation Fellowship PDF14301739 (G.S.); a United Negro College Fund-Merck Science Initiative Postdoctoral Fellowship (D.J.); a Burroughs Wellcome Postdoctoral Enrichment Program Award (D.J.); NIH NCI grant F32CA183465 (D.J.); Korean Ministry of Education, Science, and Technology grant NRF-2012R1A1A2040866 (H.-S.J.); Samsung Biomedical Research Institute grant GL1B22912 (H.-S.J.); and NIH grant P01CA080124 (T.P.P.). We thank M. Vangel and Harvard Catalyst, the NIH (award UL1 TR001102), and Harvard University for assistance with biostatistical methods and financial contributions.	Abe O, 2005, LANCET, V366, P2087; Brown M, 2018, SCIENCE, V359, P1408, DOI 10.1126/science.aal3662; Cady B, 2007, ANN SURG ONCOL, V14, P1790, DOI 10.1245/s10434-006-9234-2; Cascinelli N, 1998, LANCET, V351, P793, DOI 10.1016/S0140-6736(97)08260-3; Chang JE, 2015, TRENDS IMMUNOL, V36, P30, DOI 10.1016/j.it.2014.11.003; CRILE G, 1971, CANCER, V28, P657, DOI 10.1002/1097-0142(197109)28:3<657::AID-CNCR2820280319>3.0.CO;2-W; Donker M, 2014, LANCET ONCOL, V15, P1303, DOI 10.1016/S1470-2045(14)70460-7; Faries MB, 2017, NEW ENGL J MED, V376, P2211, DOI 10.1056/NEJMoa1613210; Ferris RL, 2012, CLIN EXP METASTAS, V29, P729, DOI 10.1007/s10585-012-9520-2; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Galimberti V, 2013, LANCET ONCOL, V14, P297, DOI 10.1016/S1470-2045(13)70035-4; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Halsted WS, 1907, ANN SURG, V46, P1, DOI 10.1097/00000658-190707000-00001; Jagsi R, 2014, J CLIN ONCOL, V32, P3600, DOI 10.1200/JCO.2014.56.5838; Jatoi I, 1999, J CLIN ONCOL, V17, P2334, DOI 10.1200/JCO.1999.17.8.2334; Jeong HS, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv155; Kawada K, 2011, CANCER RES, V71, P1214, DOI 10.1158/0008-5472.CAN-10-3277; Kerjaschki D, 2011, J CLIN INVEST, V121, P2000, DOI 10.1172/JCI44751; Ly BH, 2010, BREAST CANCER RES TR, V119, P537, DOI 10.1007/s10549-009-0610-z; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; Morton DL, 2014, NEW ENGL J MED, V370, P599, DOI 10.1056/NEJMoa1310460; Nathanson SD, 2015, SEMIN CELL DEV BIOL, V38, P106, DOI 10.1016/j.semcdb.2014.10.002; Nathanson SD, 2009, ANN SURG ONCOL, V16, P3396, DOI 10.1245/s10434-009-0659-2; Naxerova K, 2017, SCIENCE, V357, P55, DOI 10.1126/science.aai8515; Overgaard M, 1997, NEW ENGL J MED, V337, P949, DOI 10.1056/NEJM199710023371401; Pereira ER, 2015, SEMIN CELL DEV BIOL, V38, P98, DOI 10.1016/j.semcdb.2015.01.008; Poortmans PM, 2015, NEW ENGL J MED, V373, P317, DOI 10.1056/NEJMoa1415369; Punglia RS, 2007, NEW ENGL J MED, V356, P2399, DOI 10.1056/NEJMra065241; Ragaz J, 1997, NEW ENGL J MED, V337, P956, DOI 10.1056/NEJM199710023371402; Saksena MA, 2006, EUR J RADIOL, V58, P367, DOI 10.1016/j.ejrad.2005.12.041; Starz H, 2001, CANCER, V91, P2110, DOI 10.1002/1097-0142(20010601)91:11<2110::AID-CNCR1239>3.3.CO;2-H; Stein JV, 2017, J ALLERGY CLIN IMMUN, V139, P12, DOI 10.1016/j.jaci.2016.11.008; Whelan TJ, 2015, NEW ENGL J MED, V373, P307, DOI 10.1056/NEJMoa1415340	34	247	254	17	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2018	359	6382			SI		1403	1407		10.1126/science.aal3622	http://dx.doi.org/10.1126/science.aal3622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA0ZG	29567713	Green Accepted			2022-12-28	WOS:000428043600046
J	Kayatekin, C; Amasino, A; Gaglia, G; Flannick, J; Bonner, JM; Fanning, S; Narayan, P; Barrasa, MI; Pincus, D; Landgraf, D; Nelson, J; Hesse, WR; Costanzo, M; Myers, CL; Boone, C; Florez, JC; Lindquist, S				Kayatekin, Can; Amasino, Audra; Gaglia, Giorgio; Flannick, Jason; Bonner, Julia M.; Fanning, Saranna; Narayan, Priyanka; Barrasa, M. Inmaculada; Pincus, David; Landgraf, Dirk; Nelson, Justin; Hesse, William R.; Costanzo, Michael; Myers, Chad L.; Boone, Charles; Florez, Jose C.; Lindquist, Susan		AMP T2D-GENES Consortium	Translocon Declogger Ste24 Protects against IAPP Oligomer-Induced Proteotoxicity	CELL			English	Article							ISLET-AMYLOID-POLYPEPTIDE; BETA-CELL APOPTOSIS; ENDOPLASMIC-RETICULUM STRESS; HIV PROTEASE INHIBITORS; DIABETES-MELLITUS; ZINC METALLOPROTEINASE; INSULIN-SECRETION; GENE-EXPRESSION; TRANSGENIC MICE; YEAST	Aggregates of human islet amyloid polypeptide (IAPP) in the pancreas of patients with type 2 diabetes (T2D) are thought to contribute to beta cell dysfunction and death. To understand how IAPP harms cells and how this might be overcome, we created a yeast model of IAPP toxicity. Ste24, an evolutionarily conserved protease that was recently reported to degrade peptides stuck within the translocon between the cytoplasm and the endoplasmic reticulum, was the strongest suppressor of IAPP toxicity. By testing variants of the human homolog, ZMPSTE24, with varying activity levels, the rescue of IAPP toxicity proved to be directly proportional to the declogging efficiency. Clinically relevant ZMPSTE24 variants identified in the largest database of exomes sequences derived from T2D patients were characterized using the yeast model, revealing 14 partial loss-of-function variants, which were enriched among diabetes patients over 2-fold. Thus, clogging of the translocon by IAPP oligomers may contribute to beta cell failure.	[Kayatekin, Can; Gaglia, Giorgio; Bonner, Julia M.; Fanning, Saranna; Narayan, Priyanka; Barrasa, M. Inmaculada; Pincus, David; Landgraf, Dirk; Lindquist, Susan] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Amasino, Audra; Hesse, William R.; Lindquist, Susan] MIT, Cambridge, MA 02142 USA; [Flannick, Jason; Florez, Jose C.] Broad Inst & Harvard, Programs Metab & Med & Populat Genet, Cambridge, MA 02142 USA; [Flannick, Jason; Florez, Jose C.] Massachusetts Gen Hosp, Dept Med, Ctr Human Genet Res, Boston, MA 02114 USA; [Nelson, Justin] Univ Minnesota Twin Cities, Bioinformat & Computat Biol Grad Program, Minneapolis, MN 55455 USA; [Costanzo, Michael; Boone, Charles] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Myers, Chad L.] Univ Minnesota Twin Cities, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA; [Florez, Jose C.] Massachusetts Gen Hosp, Dept Med, Diabet Unit, Diabet Res Ctr, Boston, MA 02114 USA; [Florez, Jose C.] Harvard Med Sch, Dept Med, Boston, MA 02114 USA; [Lindquist, Susan] Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; University of Minnesota System; University of Minnesota Twin Cities; University of Toronto; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Kayatekin, C (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	can.kayatekin@gmail.com		Narayan, Priyanka/0000-0002-9328-4959; Kayatekin, Can/0000-0002-4367-9645	Whitehead Institute for Biomedical Research; Picower Institute at MIT; University of Texas, M.D. Anderson Center; Howard Hughes Medical Institute; Glenn Foundation for Medical Research; Eleanor Schwartz Charitable Foundation; Edward N. and Della L. Thome Foundation; JPB Foundation; Robert A. and Renee E. Belfer Foundation; NIH [GM025874, R01HG005084, R01HG005853, R0 CA175744, R21 NS087557]; Canadian Institute of Health Research [FDN-143264]; Department of Defense [W81XWH14-1-0157]; American Italian Cancer Foundation; American Parkinson's Disease Foundation; Helen Hay Whitney Foundation; NATIONAL CANCER INSTITUTE [R01CA175744] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005084, R01HG005853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK110550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025874, R01GM025874, T32GM007287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS087557] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017941] Funding Source: NIH RePORTER	Whitehead Institute for Biomedical Research; Picower Institute at MIT; University of Texas, M.D. Anderson Center; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Glenn Foundation for Medical Research; Eleanor Schwartz Charitable Foundation; Edward N. and Della L. Thome Foundation; JPB Foundation; Robert A. and Renee E. Belfer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Department of Defense(United States Department of Defense); American Italian Cancer Foundation; American Parkinson's Disease Foundation; Helen Hay Whitney Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is dedicated to the memory of our dear friend and mentor, Susan Lindquist, from whom we have learned so much and without whom this work would not have been possible. We thank A. Muthukumar, D. Melton, Y. Freyzon, L. Bayru, L. Clayton, B. Bevis, B.K. Wagner, A. Vetere, A. Haque, E. Hallacli, G. Newby, I. Oderberg, and G. Bell, along with members of the Lindquist, Florez, and Melton laboratories for materials, insightful discussions, and comments. We thank the Schuldiner lab for generously providing ZMPSTE24 plasmids and the El-Samad lab for generously providing plasmids for the estradiol-inducible expression system. This work was supported by grants from the Whitehead Institute for Biomedical Research, the Picower Institute at MIT, the University of Texas, M.D. Anderson Center, the Howard Hughes Medical Institute, the Glenn Foundation for Medical Research, the Eleanor Schwartz Charitable Foundation, the Edward N. and Della L. Thome Foundation, the JPB Foundation, the Robert A. and Renee E. Belfer Foundation, the NIH (GM025874, R01HG005084, R01HG005853), Canadian Institute of Health Research (FDN-143264), and the Department of Defense (W81XWH14-1-0157). G. G. was supported by a fellowship from the American Italian Cancer Foundation and the NIH (R0 CA175744). D. L. was supported by a Fellowship from the American Parkinson's Disease Foundation and the NIH (R21 NS087557). P.N. was supported by a Fellowship from the Helen Hay Whitney Foundation.	Abedini A, 2016, ELIFE, V5, DOI 10.7554/eLife.12977; Agarwal AK, 2003, HUM MOL GENET, V12, P1995, DOI 10.1093/hmg/ddg213; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Aranda-Diaz A, 2017, ACS SYNTH BIOL, V6, P545, DOI 10.1021/acssynbio.6b00251; Ast T, 2016, CELL, V164, P103, DOI 10.1016/j.cell.2015.11.053; Barrowman J, 2012, HUM MOL GENET, V21, P4084, DOI 10.1093/hmg/dds233; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Billings LK, 2010, ANN NY ACAD SCI, V1212, P59, DOI 10.1111/j.1749-6632.2010.05838.x; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Butler AE, 2004, DIABETES, V53, P1509, DOI 10.2337/diabetes.53.6.1509; CLARK A, 1988, DIABETES RES CLIN EX, V9, P151; Clark KM, 2017, PROTEIN SCI, V26, P242, DOI 10.1002/pro.3074; Coffinier C, 2007, P NATL ACAD SCI USA, V104, P13432, DOI 10.1073/pnas.0704212104; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; Costes S, 2011, DIABETES, V60, P227, DOI 10.2337/db10-0522; Couthouis J, 2011, P NATL ACAD SCI USA, V108, P20881, DOI 10.1073/pnas.1109434108; Flannick J, 2016, NAT REV ENDOCRINOL, V12, P394, DOI 10.1038/nrendo.2016.50; Gonsberg A, 2017, J BIOL CHEM, V292, P21383, DOI 10.1074/jbc.M117.788067; Gurlo T, 2010, AM J PATHOL, V176, P861, DOI 10.2353/ajpath.2010.090532; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hu YH, 2007, GENOME RES, V17, P536, DOI 10.1101/gr.6037607; Huang CJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1656, DOI 10.1152/ajpendo.00318.2007; Janson J, 1996, P NATL ACAD SCI USA, V93, P7283, DOI 10.1073/pnas.93.14.7283; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Ju SL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001052; Jurgens CA, 2011, AM J PATHOL, V178, P2632, DOI 10.1016/j.ajpath.2011.02.036; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kayatekin C, 2014, P NATL ACAD SCI USA, V111, P12085, DOI 10.1073/pnas.1412504111; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim HJ, 2014, NAT GENET, V46, P152, DOI 10.1038/ng.2853; Kuzmin E., 2016, COLD SPRING HARB PRO; Landgraf D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163950; Li ZJ, 2011, NAT BIOTECHNOL, V29, P361, DOI 10.1038/nbt.1832; Lin CY, 2007, DIABETES, V56, P1324, DOI 10.2337/db06-1579; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Ma Z, 2001, AMYLOID, V8, P242, DOI 10.3109/13506120108993820; Matveyenko AV, 2009, DIABETES, V58, P906, DOI 10.2337/db08-1464; McIsaac RS, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1313; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Morita S, 2011, J DIABETES INVEST, V2, P287, DOI 10.1111/j.2040-1124.2011.00102.x; Mukherjee A, 2017, J EXP MED, V214, P2591, DOI 10.1084/jem.20161134; Mukherjee A, 2015, TRENDS MOL MED, V21, P439, DOI 10.1016/j.molmed.2015.04.005; Navarro CL, 2004, HUM MOL GENET, V13, P2493, DOI 10.1093/hmg/ddh265; NOVIALS A, 1993, DIABETES, V42, P1514, DOI 10.2337/diabetes.42.10.1514; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Pincus D, 2014, P NATL ACAD SCI USA, V111, P14800, DOI 10.1073/pnas.1409588111; Ripaud L, 2014, P NATL ACAD SCI USA, V111, P18219, DOI 10.1073/pnas.1421313111; Ritzel RA, 2007, DIABETES, V56, P65, DOI 10.2337/db06-0734; Rivera JF, 2014, J CLIN INVEST, V124, P3489, DOI 10.1172/JCI71981; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sakagashira S, 2000, AM J PATHOL, V157, P2101, DOI 10.1016/S0002-9440(10)64848-1; Sakagashira S, 1996, DIABETES, V45, P1279, DOI 10.2337/diabetes.45.9.1279; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; WESTERMARK P, 1972, UPSALA J MED SCI, V77, P91, DOI 10.1517/03009734000000014; Wolfe KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095914; Zhang SP, 2014, FASEB J, V28, P5083, DOI 10.1096/fj.14-251744	57	33	33	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 22	2018	173	1					62	+		10.1016/j.cell.2018.02.026	http://dx.doi.org/10.1016/j.cell.2018.02.026			21	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GA3MT	29526462	Bronze, Green Accepted			2022-12-28	WOS:000428234200008
J	Wood, KE				Wood, Kelly E.			Meconium Ileus in a Neonate with Cystic Fibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wood, Kelly E.] Univ Iowa, Stead Family Childrens Hosp, Iowa City, IA 52242 USA	University of Iowa	Wood, KE (corresponding author), Univ Iowa, Stead Family Childrens Hosp, Iowa City, IA 52242 USA.	kelly-wood@uiowa.edu		Wood, Kelly/0000-0002-8602-5502					0	1	1	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2018	378	12					1142	1142		10.1056/NEJMicm1700400	http://dx.doi.org/10.1056/NEJMicm1700400			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ9OV	29562160				2022-12-28	WOS:000427942300010
J	Carlisle, B; Federico, CA; Kimmelman, J				Carlisle, Benjamin; Federico, Carole A.; Kimmelman, Jonathan			Trials that say "maybe": the disconnect between exploratory and confirmatory testing after drug approval	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL-TRIALS; END-POINTS; PREGABALIN; CANCER; PAIN		[Carlisle, Benjamin; Federico, Carole A.; Kimmelman, Jonathan] McGill Univ, Biomed Eth Unit, Studies Translat Eth & Med STREAM, 3647 Rue Peel, Montreal, PQ H3A 1X1, Canada	McGill University	Kimmelman, J (corresponding author), McGill Univ, Biomed Eth Unit, Studies Translat Eth & Med STREAM, 3647 Rue Peel, Montreal, PQ H3A 1X1, Canada.	jonathan.kimmelman@mcgill.ca	Carlisle, Benjamin/AAD-6332-2020	Carlisle, Benjamin/0000-0001-8975-0649	CIHR; Rabinowitch Fellowship; Louise and Alan Edwards Foundation Studentship in Pain Research	CIHR(Canadian Institutes of Health Research (CIHR)); Rabinowitch Fellowship; Louise and Alan Edwards Foundation Studentship in Pain Research	This work was funded by CIHR, the Rabinowitch Fellowship, and The Louise and Alan Edwards Foundation Studentship in Pain Research.	Boutron I, 2014, J CLIN ONCOL, V32, P4120, DOI 10.1200/JCO.2014.56.7503; Carlisle B, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv292; Doshi P, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1691; Downing NS, 2014, JAMA-J AM MED ASSOC, V311, P368, DOI 10.1001/jama.2013.282034; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Giladi H, 2015, CURR MED RES OPIN, V31, P1403, DOI 10.1185/03007995.2015.1040750; Goodman CW, 2017, NEW ENGL J MED, V377, P411, DOI 10.1056/NEJMp1704633; Halpern SD, 2002, JAMA-J AM MED ASSOC, V288, P358, DOI 10.1001/jama.288.3.358; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Kesselheim AS, 2011, JAMA-J AM MED ASSOC, V305, P2320, DOI 10.1001/jama.2011.769; London AJ, 2007, OXFORD HDB BIOETHICS, P571; Mattina J, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000487; Mullard A, 2014, NAT REV DRUG DISCOV, V13, P401, DOI 10.1038/nrd4338; Naci H, 2017, JAMA-J AM MED ASSOC, V318, P626, DOI 10.1001/jama.2017.9415; Poonacha TK, 2011, J CLIN ONCOL, V29, P186, DOI 10.1200/JCO.2010.31.6414; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; Ratner M, 2009, NAT BIOTECHNOL, V27, P961, DOI 10.1038/nbt1109-961; Shanthanna H, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002369; Vera-Badillo FE, 2013, ANN ONCOL, V24, P1238, DOI 10.1093/annonc/mds636	19	12	12	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2018	360								k959	10.1136/bmj.k959	http://dx.doi.org/10.1136/bmj.k959			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB1KT	29559429	Green Published			2022-12-28	WOS:000428810400015
J	Maki, DG				Maki, Dennis G.			In adults with S aureus bacteremia, adding rifampin to standard antibiotic therapy did not improve outcomes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							COMPLICATIONS		[Maki, Dennis G.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Maki, DG (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA.							Baddour LM, 2015, CIRCULATION, V132, P1435, DOI 10.1161/CIR.0000000000000296; Fowler VG, 2005, CLIN INFECT DIS, V40, P695, DOI 10.1086/427806; van Hal SJ, 2012, CLIN MICROBIOL REV, V25, P362, DOI 10.1128/CMR.05022-11	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2018	168	6					JC32	JC32		10.7326/ACPJC-2018-168-6-032	http://dx.doi.org/10.7326/ACPJC-2018-168-6-032			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ8AM	29554670				2022-12-28	WOS:000427827400009
J	Indiran, V; Jagannathan, D				Indiran, Venkatraman; Jagannathan, Devimeenal			Osgood-Schlatter Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Indiran, Venkatraman] Sree Balaji Med Coll & Hosp, Madras, Tamil Nadu, India; [Jagannathan, Devimeenal] Govt Kilpauk Med Coll, Madras, Tamil Nadu, India	Bharath Institute of Higher Education & Research; Sree Balaji Medical College & Hospital	Indiran, V (corresponding author), Sree Balaji Med Coll & Hosp, Madras, Tamil Nadu, India.	ivraman31@gmail.com	Indiran, Venkatraman/I-4058-2019; Leung, Alexander/AAL-7427-2021	Indiran, Venkatraman/0000-0001-5296-0175; Leung, Alexander/0000-0003-2254-6971					0	5	5	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2018	378	11							e15	10.1056/NEJMicm1711831	http://dx.doi.org/10.1056/NEJMicm1711831			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ2HT	29539285				2022-12-28	WOS:000427399000010
J	Papanicolas, I; Woskie, LR; Jha, AK				Papanicolas, Irene; Woskie, Liana R.; Jha, Ashish K.			Health Care Spending in the United States and Other High-Income Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PRICES	IMPORTANCE Health care spending in the United States is a major concern and is higher than in other high-income countries, but there is little evidence that efforts to reform US health care delivery have had a meaningful influence on controlling health care spending and costs. OBJECTIVE To compare potential drivers of spending, such as structural capacity and utilization, in the United States with those of 10 of the highest-income countries (United Kingdom, Canada, Germany, Australia, Japan, Sweden, France, the Netherlands, Switzerland, and Denmark) to gain insight into what the United States can learn from these nations. EVIDENCE Analysis of data primarily from 2013-2016 from key international organizations including the Organisation for Economic Co-operation and Development (OECD), comparing underlying differences in structural features, types of health care and social spending, and performance between the United States and 10 high-income countries. When data were not available for a given country or more accurate country-level estimates were available from sources other than the OECD, country-specific data sources were used. FINDINGS In 2016, the US spent 17.8% of its gross domestic product on health care, and spending in the other countries ranged from 9.6%(Australia) to 12.4%(Switzerland). The proportion of the population with health insurance was 90% in the US, lower than the other countries (range, 99%-100%), and the US had the highest proportion of private health insurance (55.3%). For some determinants of health such as smoking, the US ranked second lowest of the countries (11.4% of the US population >= 15 years smokes daily; mean of all 11 countries, 16.6%), but the US had the highest percentage of adults who were overweight or obese at 70.1%(range for other countries, 23.8%-63.4%; mean of all 11 countries, 55.6%). Life expectancy in the US was the lowest of the 11 countries at 78.8 years (range for other countries, 80.7-83.9 years; mean of all 11 countries, 81.7 years), and infant mortality was the highest (5.8 deaths per 1000 live births in the US; 3.6 per 1000 for all 11 countries). The US did not differ substantially from the other countries in physician workforce (2.6 physicians per 1000; 43% primary care physicians), or nursing workforce (11.1 nurses per 1000). The US had comparable numbers of hospital beds (2.8 per 1000) but higher utilization of magnetic resonance imaging (118 per 1000) and computed tomography (245 per 1000) vs other countries. The US had similar rates of utilization (US discharges per 100 000 were 192 for acute myocardial infarction, 365 for pneumonia, 230 for chronic obstructive pulmonary disease; procedures per 100 000 were 204 for hip replacement, 226 for knee replacement, and 79 for coronary artery bypass graft surgery). Administrative costs of care (activities relating to planning, regulating, and managing health systems and services) accounted for 8% in the US vs a range of 1% to 3% in the other countries. For pharmaceutical costs, spending per capita was $1443 in the US vs a range of $466 to $939 in other countries. Salaries of physicians and nurses were higher in the US; for example, generalist physicians salaries were $218 173 in the US compared with a range of $86 607 to $154 126 in the other countries. CONCLUSIONS AND RELEVANCE The United States spent approximately twice as much as other high-income countries on medical care, yet utilization rates in the United States were largely similar to those in other nations. Prices of labor and goods, including pharmaceuticals, and administrative costs appeared to be the major drivers of the difference in overall cost between the United States and other high-income countries. As patients, physicians, policy makers, and legislators actively debate the future of the US health system, data such as these are needed to inform policy decisions.	[Papanicolas, Irene; Woskie, Liana R.; Jha, Ashish K.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [Papanicolas, Irene; Woskie, Liana R.; Jha, Ashish K.] Harvard Global Hlth Inst, Cambridge, MA USA; [Papanicolas, Irene; Woskie, Liana R.] London Sch Econ & Polit Sci, Dept Hlth Policy, Houghton St, London WC2A 2AE, England	Harvard University; Harvard T.H. Chan School of Public Health; University of London; London School Economics & Political Science	Papanicolas, I (corresponding author), London Sch Econ & Polit Sci, Dept Hlth Policy, Houghton St, London WC2A 2AE, England.	i.n.papanicolas@lse.ac.uk		Woskie, Liana/0000-0002-7451-6849				Anderson GF, 2003, HEALTH AFFAIR, V22, P89, DOI 10.1377/hlthaff.22.3.89; [Anonymous], 2012, PUBLICS HLTH INVESTI; [Anonymous], 2017, KEY FACTS UN POP; Barber RM, 2017, LANCET, V390, P231, DOI [10.1016/S0140-6736(17)30818-8, 10.1016/s0140-6736(17)30818-8]; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Bradley E., 2013, AM HLTH CARE PARADOX; Bradley EH, 2011, BMJ QUAL SAF, V20, P826, DOI 10.1136/bmjqs.2010.048363; Cylus J., 2016, HLTH SYSTEM EFFICIEN; Daemmrich A, 2009, IS PHARM WORLD INT R; Dieleman JL, 2017, JAMA-J AM MED ASSOC, V318, P1668, DOI 10.1001/jama.2017.15927; Farrell D, 2008, ACCOUNTING COST US H; French E, 2016, FISC STUD, V37, P327, DOI 10.1111/j.1475-5890.2016.12127; Garber AA, 2008, J ECON PERSPECT, V22, P27, DOI 10.1257/jep.22.4.27; General Medical Council, 2016, STAT MED ED PRACT UK; Grabowski HG, 2006, HEALTH AFFAIR, V25, P452, DOI 10.1377/hlthaff.25.2.452; International Federation of Health Plans, 2013, 2013 COMP PRIC REP V; Laugesen MJ, 2011, HEALTH AFFAIR, V30, P1647, DOI 10.1377/hlthaff.2010.0204; Mossialos Elias, 2017, INT PROFILES HLTH CA; Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P717; O'Neill P, INT COMP MED USAGE Q; Obama B, 2016, JAMA-J AM MED ASSOC, V316, P525, DOI 10.1001/jama.2016.9797; OECD, 2017, HLTH GLANC, DOI 10.1787/health_glance-2017-en; Organisation for Economic Co-operation and Development, 2018, SOC EXP DAT; Oroma N., 2016, HLTH SYST POLICY RES, V3, DOI [10.21767/2254-9137.100054, DOI 10.21767/2254-9137.100054]; Rechel B, HLTH CARE WORKFORCE; Reinhardt UE, 2004, HEALTH AFFAIR, V23, P10, DOI 10.1377/hlthaff.23.3.10; Sarnak DO, 2017, PAYING PRESCRIPTION; Schneider EC, 2017, INT COMP REFLECTS FL; Schroeder SA, 2013, NEW ENGL J MED, V368, P2029, DOI 10.1056/NEJMsb1302322; van Ginneken E, 2015, MED CARE RES REV, V72, P496, DOI 10.1177/1077558715579867; Waters HR, 2004, HEALTH POLICY, V69, P339, DOI 10.1016/j.healthpol.2004.01.003; WHO, GLOB HLTH EXP DAT; World Health Organization, 2000, WORLD HLTH REP 2000; Wouters OJ, 2017, MILBANK Q, V95, P554, DOI 10.1111/1468-0009.12279	34	715	718	15	303	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2018	319	10					1024	1039		10.1001/jama.2018.1150	http://dx.doi.org/10.1001/jama.2018.1150			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ0HS	29536101	Green Published			2022-12-28	WOS:000427249700019
J	Stanton, BZ; Chory, EJ; Crabtree, GR				Stanton, Benjamin Z.; Chory, Emma J.; Crabtree, Gerald R.			Chemically induced proximity in biology and medicine	SCIENCE			English	Review							E3 UBIQUITIN LIGASE; BET BROMODOMAIN INHIBITION; ARTIFICIAL DEATH SWITCHES; SMALL-MOLECULE PROTACS; STEM-CELL TRANSPLANT; IN-VIVO; T-CELLS; LIVING CELLS; ENDOPLASMIC-RETICULUM; INDUCED DIMERIZATION	Proximity, or the physical closeness of molecules, is a pervasive regulatory mechanism in biology. For example, most posttranslational modifications such as phosphorylation, methylation, and acetylation promote proximity of molecules to play deterministic roles in cellular processes. To understand the role of proximity in biologic mechanisms, chemical inducers of proximity (CIPs) were developed to synthetically model biologically regulated recruitment. Chemically induced proximity allows for precise temporal control of transcription, signaling cascades, chromatin regulation, protein folding, localization, and degradation, as well as a host of other biologic processes. A systematic analysis of CIPs in basic research, coupled with recent technological advances utilizing CRISPR, distinguishes roles of causality from coincidence and allows for mathematical modeling in synthetic biology. Recently, induced proximity has provided new avenues of gene therapy and emerging advances in cancer treatment.	[Stanton, Benjamin Z.; Chory, Emma J.; Crabtree, Gerald R.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Stanton, Benjamin Z.; Chory, Emma J.; Crabtree, Gerald R.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Stanton, Benjamin Z.] Natl Ctr Adv Translat Sci, Div Preclin Innovat, NIH, Rockville, MD 20850 USA; [Chory, Emma J.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Crabtree, Gerald R.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Stanford University; Howard Hughes Medical Institute; Stanford University	Crabtree, GR (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.; Crabtree, GR (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.; Crabtree, GR (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	crabtree@stanford.edu		Chory, Emma/0000-0001-8541-9289; Stanton, Benjamin/0000-0002-2613-2955; Crabtree, Robert/0000-0002-6639-8707	NSF Graduate Research Fellowship; Ruth L. Kirschstein National Research Service Award [F31 CA203228-02]; Howard Hughes Medical Institute, NIH [5R01CA163915-04]; NIH Javits Neuroscience Investigator Award [R37 NS046789-12]; Congressionally Directed Medical Research Program Breast Cancer Research Breakthrough Award; Simons Foundation Autism Research Initiative; NATIONAL CANCER INSTITUTE [R01CA163915, F31CA203228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS046789] Funding Source: NIH RePORTER	NSF Graduate Research Fellowship(National Science Foundation (NSF)); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute, NIH(Howard Hughes Medical InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Javits Neuroscience Investigator Award; Congressionally Directed Medical Research Program Breast Cancer Research Breakthrough Award; Simons Foundation Autism Research Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We apologize to the many people who have made important contributions to this field whom we were unable to acknowledge because of space constraints. We wish to honor the lasting memory of Joseph P. Calarco, who was a great friend and incisive colleague. E.J.C. was supported by an NSF Graduate Research Fellowship and the Ruth L. Kirschstein National Research Service Award (F31 CA203228-02). G.R.C. active-research funding includes support from the Howard Hughes Medical Institute, NIH 5R01CA163915-04, the NIH Javits Neuroscience Investigator Award R37 NS046789-12, the Congressionally Directed Medical Research Program Breast Cancer Research Breakthrough Award, and the Simons Foundation Autism Research Initiative. The authors declare no competing interests. G.R.C. is an inventor on several patents and patent applications related to chemical inducers of proximity and the uses thereof, filed between 1997 and 2017. These include patent applications WO2017074943A1, WO2013188406A1, US20130158098A1, and WO2002024957A1 submitted by The Board of Trustees of Leland Stanford Junior University, applications US20110160246A1 and US20110003385A1 submitted by G.R.C., patent application US20020173474A1 submitted by the President and Fellows of Harvard College. Patents US8084596B2, US6984635B1, and US6063625A are held by The Board of Trustees of Leland Stanford Junior University and the President and Fellows of Harvard College.	An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Ballister ER, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6475; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bayle JH, 2006, CHEM BIOL, V13, P99, DOI 10.1016/j.chembiol.2005.10.017; Belshaw PJ, 1996, CHEM BIOL, V3, P731, DOI 10.1016/S1074-5521(96)90249-5; Belshaw PJ, 1996, P NATL ACAD SCI USA, V93, P4604, DOI 10.1073/pnas.93.10.4604; Biggar SR, 2000, J BIOL CHEM, V275, P25381, DOI 10.1074/jbc.M002991200; Biggar SR, 2001, EMBO J, V20, P3167, DOI 10.1093/emboj/20.12.3167; Bondeson DP, 2015, NAT CHEM BIOL, V11, P611, DOI [10.1038/NCHEMBIO.1858, 10.1038/nchembio.1858]; Braun SMG, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00644-y; Buckley DL, 2015, ACS CHEM BIOL, V10, P1831, DOI 10.1021/acschembio.5b00442; Buckley DL, 2012, J AM CHEM SOC, V134, P4465, DOI 10.1021/ja209924v; Charbin A, 2014, NUCLEIC ACIDS RES, V42, P340, DOI 10.1093/nar/gkt882; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Conrado RJ, 2007, METAB ENG, V9, P355, DOI 10.1016/j.ymben.2007.05.002; Cruz CRY, 2013, BLOOD, V122, P2965, DOI 10.1182/blood-2013-06-506741; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Diaconu I, 2017, MOL THER, V25, P580, DOI 10.1016/j.ymthe.2017.01.011; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Douglass EF, 2013, J AM CHEM SOC, V135, P6092, DOI 10.1021/ja311795d; Dykhuizen EC, 2013, NATURE, V497, P624, DOI 10.1038/nature12146; Erb MA, 2017, NATURE, V543, P270, DOI 10.1038/nature21688; Fan LF, 1999, HUM GENE THER, V10, P2273, DOI 10.1089/10430349950016924; Fan XC, 2010, P NATL ACAD SCI USA, V107, P17945, DOI 10.1073/pnas.1012674107; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Gao YC, 2016, NAT METHODS, V13, P1043, DOI [10.1038/NMETH.4042, 10.1038/nmeth.4042]; Gestwicki JE, 2004, SCIENCE, V306, P865, DOI 10.1126/science.1101262; Graef IA, 1997, EMBO J, V16, P5618, DOI 10.1093/emboj/16.18.5618; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; Hamilton A, 2012, BLOOD, V119, P1501, DOI 10.1182/blood-2010-12-326843; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; Haruki H, 2008, MOL CELL, V31, P925, DOI 10.1016/j.molcel.2008.07.020; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Ho SN, 1996, NATURE, V382, P822, DOI 10.1038/382822a0; Hodges C, 2012, P NATL ACAD SCI USA, V109, P13296, DOI 10.1073/pnas.1211172109; Holland AJ, 2012, P NATL ACAD SCI USA, V109, pE3350, DOI 10.1073/pnas.1216880109; Holliday MJ, 2017, STRUCTURE, V25, P276, DOI 10.1016/j.str.2016.12.003; HOLSINGER LJ, 1995, P NATL ACAD SCI USA, V92, P9810, DOI 10.1073/pnas.92.21.9810; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Kadoch C, 2017, NAT GENET, V49, P213, DOI 10.1038/ng.3734; KALLEN J, 1991, NATURE, V353, P276, DOI 10.1038/353276a0; Kanke M, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-8; Karpova AY, 2005, NEURON, V48, P727, DOI 10.1016/j.neuron.2005.11.015; KENNISON JA, 1988, P NATL ACAD SCI USA, V85, P8136, DOI 10.1073/pnas.85.21.8136; Klemm JD, 1997, CURR BIOL, V7, P638, DOI 10.1016/S0960-9822(06)00290-9; Ko MA, 2005, NAT GENET, V37, P883, DOI 10.1038/ng1605; Kochenderfer JN, 2013, NAT REV CLIN ONCOL, V10, P267, DOI 10.1038/nrclinonc.2013.46; Kopytek SJ, 2000, CHEM BIOL, V7, P313, DOI 10.1016/S1074-5521(00)00109-5; Lai AC, 2016, ANGEW CHEM INT EDIT, V55, P807, DOI 10.1002/anie.201507634; Lambrus BG, 2015, J CELL BIOL, V210, P63, DOI 10.1083/jcb.201502089; Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002; Liang FS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001449; Liu KJ, 2007, NATURE, V446, P79, DOI 10.1038/nature05557; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luo ZJ, 1996, NATURE, V383, P181, DOI 10.1038/383181a0; MacCorkle RA, 1998, P NATL ACAD SCI USA, V95, P3655, DOI 10.1073/pnas.95.7.3655; Marinec PS, 2009, P NATL ACAD SCI USA, V106, P1336, DOI 10.1073/pnas.0805375106; MICHNICK SW, 1991, SCIENCE, V252, P836, DOI 10.1126/science.1709301; Miller EL, 2017, NAT STRUCT MOL BIOL, V24, P344, DOI 10.1038/nsmb.3384; Miyamoto T, 2012, NAT CHEM BIOL, V8, P465, DOI [10.1038/NCHEMBIO.922, 10.1038/nchembio.922]; Mootz HD, 2003, J AM CHEM SOC, V125, P10561, DOI 10.1021/ja0362813; Morawska M, 2013, YEAST, V30, P341, DOI 10.1002/yea.2967; Morgan SL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15993; Natsume T, 2016, CELL REP, V15, P210, DOI 10.1016/j.celrep.2016.03.001; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Nora EP, 2017, CELL, V169, P930, DOI 10.1016/j.cell.2017.05.004; Ott CJ, 2012, BLOOD, V120, P2843, DOI 10.1182/blood-2012-02-413021; Ou HD, 2017, SCIENCE, V357, DOI 10.1126/science.aag0025; Pajvani UB, 2005, NAT MED, V11, P797, DOI 10.1038/nm1262; Pecot MY, 2004, CELL, V116, P99, DOI 10.1016/S0092-8674(03)01068-7; Penchala SC, 2013, P NATL ACAD SCI USA, V110, P9992, DOI 10.1073/pnas.1300761110; Pruschy M N, 1994, Chem Biol, V1, P163, DOI 10.1016/1074-5521(94)90006-X; Rivera VM, 2005, BLOOD, V105, P1424, DOI 10.1182/blood-2004-06-2501; Rivera VM, 2000, SCIENCE, V287, P826, DOI 10.1126/science.287.5454.826; Rivera VM, 1996, NAT MED, V2, P1028, DOI 10.1038/nm0996-1028; Rosario CO, 2015, ONCOGENE, V34, P3441, DOI 10.1038/onc.2014.275; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Spencer DM, 1996, CURR BIOL, V6, P839, DOI 10.1016/S0960-9822(02)00607-3; SPENCER DM, 1995, P NATL ACAD SCI USA, V92, P9805, DOI 10.1073/pnas.92.21.9805; Stankunas K, 2003, MOL CELL, V12, P1615, DOI 10.1016/S1097-2765(03)00491-X; Stanton BZ, 2017, NAT GENET, V49, P282, DOI 10.1038/ng.3735; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tsuji SY, 2001, BIOCHEMISTRY-US, V40, P2326, DOI 10.1021/bi002463n; Van Albada SB, 2007, PLOS COMPUT BIOL, V3, P1925, DOI 10.1371/journal.pcbi.0030195; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433; Wong KH, 2011, GENE DEV, V25, P2525, DOI 10.1101/gad.179275.111; Ye XH, 1999, SCIENCE, V283, P88, DOI 10.1126/science.283.5398.88; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zhang LY, 2015, DEVELOPMENT, V142, P4374, DOI 10.1242/dev.129635; ZHENG XF, 1995, CELL, V82, P121, DOI 10.1016/0092-8674(95)90058-6; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; Zhou XO, 2015, BLOOD, V125, P4103, DOI 10.1182/blood-2015-02-628354; Zhou XO, 2014, BLOOD, V123, P3895, DOI 10.1182/blood-2014-01-551671	102	146	151	17	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2018	359	6380							eaao5902	10.1126/science.aao5902	http://dx.doi.org/10.1126/science.aao5902			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ3TD	29590011	Green Accepted			2022-12-28	WOS:000435220500001
J	Vogel, G				Vogel, Gretchen			EUROPE Germany's new government makes big promises	SCIENCE			English	News Item																			0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2018	359	6380					1081	1081		10.1126/science.359.6380.1081	http://dx.doi.org/10.1126/science.359.6380.1081			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4ZM	29590018				2022-12-28	WOS:000426835900013
J	Buchbinder, R; van Tulder, M; Oberg, B; Costa, LM; Woolf, A; Schoene, M; Croft, P				Buchbinder, Rachelle; van Tulder, Maurits; Oberg, Birgitta; Costa, Luciola Menezes; Woolf, Anthony; Schoene, Mark; Croft, Peter		Lancet Low Back Pain Series Workin	Low back pain: a call for action	LANCET			English	Editorial Material							DISABILITY; PREVENTION; MANAGEMENT		[Buchbinder, Rachelle] Monash Univ, Cabrini Inst, Monash Cabrini Dept Clin Epidemiol, Malvern, Vic 3144, Australia; [van Tulder, Maurits] Vrije Univ Amsterdam, Fac Sci, Dept Hlth Sci, Amsterdam, Netherlands; [Oberg, Birgitta] Linkoping Univ, Fac Med & Hlth Sci, Dept Med & Hlth Sci, Linkoping, Sweden; [Costa, Luciola Menezes] Univ Cidade Sao Paulo, Sao Paulo, Brazil; [Woolf, Anthony] Univ Exeter, Med Sch, Royal Cornwall Hosp, Truro, England; [Croft, Peter] Keele Univ, Res Inst Primary Care & Hlth Sci, Arthrit Res UK Primary Care Ctr, Keele, Staffs, England	Cabrini Health; Monash University; Vrije Universiteit Amsterdam; Linkoping University; Universidade Cidade de Sao Paulo; Royal Cornwall Hospital; University of Exeter; Keele University	Buchbinder, R (corresponding author), Monash Univ, Cabrini Inst, Monash Cabrini Dept Clin Epidemiol, Malvern, Vic 3144, Australia.	rachelle.buchbinder@monash.edu	Costa, Luciola Menezes/B-4844-2013; Gross, Douglas P./AAF-6997-2020; Maher, Christopher/AAC-6267-2019; Smeets, Rob JEM/D-1522-2011; Kongsted, Alice/H-2811-2019; Buchbinder, Rachelle/G-2952-2011; van Tulder, Maurits/AAB-9785-2022; genevay, stephane/AAI-9560-2021; genevay, stephane/AAF-2018-2020; Koes, Bart/K-4614-2016; Underwood, Martin/D-6364-2015	Costa, Luciola Menezes/0000-0003-1859-2799; Gross, Douglas P./0000-0002-2427-6277; Maher, Christopher/0000-0002-1628-7857; Smeets, Rob JEM/0000-0002-9503-366X; Kongsted, Alice/0000-0001-5537-6038; Buchbinder, Rachelle/0000-0002-0597-0933; van Tulder, Maurits/0000-0002-7589-8471; genevay, stephane/0000-0003-4752-3186; genevay, stephane/0000-0003-4752-3186; Koes, Bart/0000-0002-0450-9969; Foster, Nadine/0000-0003-4429-9756; Hartvigsen, Jan/0000-0002-5876-7410; Underwood, Martin/0000-0002-0309-1708; Hancock, Mark/0000-0002-9277-5377; Chou, Roger/0000-0001-9889-8610	Australian National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship	Australian National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship	There was no funding for this paper. RB is supported by an Australian National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship.	[Anonymous], LANCET; Birhan W, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-39; Blyth FM, 2005, PAIN, V113, P285, DOI 10.1016/j.pain.2004.12.004; Buchbinder R, 2001, BRIT MED J, V322, P1516, DOI 10.1136/bmj.322.7301.1516; Bui QN, 2011, J IMMIGR MINOR HEALT, V13, P194, DOI 10.1007/s10903-010-9371-3; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Hartvigsen J, LANCET; Hoy D, 2014, BEST PRACT RES CL RH, V28, P377, DOI 10.1016/j.berh.2014.07.006; Huber M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010091; Igwesi-Chidobe CN, 2017, DISABIL REHABIL, V39, P779, DOI 10.3109/09638288.2016.1161844; Juch JNS, 2017, JAMA-J AM MED ASSOC, V318, P68, DOI 10.1001/jama.2017.7918; Lin IB, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002654; Linton SJ, 2016, J OCCUP REHABIL, V26, P150, DOI 10.1007/s10926-015-9596-z; Loisel P, 2002, OCCUP ENVIRON MED, V59, P807, DOI 10.1136/oem.59.12.807; MacNeela P, 2015, HEALTH PSYCHOL REV, V9, P63, DOI 10.1080/17437199.2013.840951; Costa LDM, 2013, SPINE, V38, P148, DOI 10.1097/BRS.0b013e318267a92f; Schofield DJ, 2012, SPINE, V37, P1156, DOI 10.1097/BRS.0b013e31824481ee; Steffens D, 2016, JAMA INTERN MED, V176, P199, DOI 10.1001/jamainternmed.2015.7431; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; Werner EL, 2007, OCCUP MED-OXFORD, V57, P590, DOI 10.1093/occmed/kqm094	20	469	484	7	49	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 9	2018	391	10137					2384	2388		10.1016/S0140-6736(18)30488-4	http://dx.doi.org/10.1016/S0140-6736(18)30488-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GI6WF	29573871	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000434643200034
J	Motzer, RJ; Tannir, NM; McDermott, DF; Frontera, OA; Melichar, B; Choueiri, TK; Plimack, ER; Barthelemy, P; Porta, C; George, S; Powles, T; Donskov, F; Neiman, V; Kollmannsberger, CK; Salman, P; Gurney, H; Hawkins, R; Ravaud, A; Grimm, MO; Bracarda, S; Barrios, CH; Tomita, Y; Castellano, D; Rini, BI; Chen, AC; Mekan, S; McHenry, MB; Wind-Rotolo, M; Doan, J; Sharma, P; Hammers, HJ; Escudier, B				Motzer, R. J.; Tannir, N. M.; McDermott, D. F.; Frontera, O. Aren; Melichar, B.; Choueiri, T. K.; Plimack, Elizabeth R.; Barthelemy, P.; Porta, C.; George, S.; Powles, T.; Donskov, F.; Neiman, V.; Kollmannsberger, C. K.; Salman, P.; Gurney, H.; Hawkins, R.; Ravaud, A.; Grimm, M. -O.; Bracarda, S.; Barrios, C. H.; Tomita, Y.; Castellano, D.; Rini, B. I.; Chen, A. C.; Mekan, S.; McHenry, M. B.; Wind-Rotolo, M.; Doan, J.; Sharma, P.; Hammers, H. J.; Escudier, B.		CheckMate 214 Investigators	Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE-III TRIAL; INTERFERON-ALPHA; UNTREATED MELANOMA; 1ST-LINE TREATMENT; SYMPTOM INDEX; KIDNEY CANCER; OPEN-LABEL; PAZOPANIB; THERAPY; MULTICENTER	BACKGROUND Nivolumab plus ipilimumab produced objective responses in patients with advanced renal-cell carcinoma in a pilot study. This phase 3 trial compared nivolumab plus ipilimumab with sunitinib for previously untreated clear-cell advanced renal-cell carcinoma. METHODS We randomly assigned adults in a 1:1 ratio to receive either nivolumab (3 mg per kilogram of body weight) plus ipilimumab (1 mg per kilogram) intravenously every 3 weeks for four doses, followed by nivolumab (3 mg per kilogram) every 2 weeks, or sunitinib (50 mg) orally once daily for 4 weeks (6-week cycle). The coprimary end points were overall survival (alpha level, 0.04), objective response rate (alpha level, 0.001), and progression-free survival (alpha level, 0.009) among patients with intermediate or poor prognostic risk. RESULTS A total of 1096 patients were assigned to receive nivolumab plus ipilimumab (550 patients) or sunitinib (546 patients); 425 and 422, respectively, had intermediate or poor risk. At a median follow-up of 25.2 months in intermediate-and poor-risk patients, the 18-month overall survival rate was 75% (95% confidence interval [CI], 70 to 78) with nivolumab plus ipilimumab and 60% (95% CI, 55 to 65) with sunitinib; the median overall survival was not reached with nivolumab plus ipilimumab versus 26.0 months with sunitinib (hazard ratio for death, 0.63; P<0.001). The objective response rate was 42% versus 27% (P<0.001), and the complete response rate was 9% versus 1%. The median progression-free survival was 11.6 months and 8.4 months, respectively (hazard ratio for disease progression or death, 0.82; P = 0.03, not significant per the prespecified 0.009 threshold). Treatment-related adverse events occurred in 509 of 547 patients (93%) in the nivolumab-plus-ipilimumab group and 521 of 535 patients (97%) in the sunitinib group; grade 3 or 4 events occurred in 250 patients (46%) and 335 patients (63%), respectively. Treatment- related adverse events leading to discontinuation occurred in 22% and 12% of the patients in the respective groups. CONCLUSIONS Overall survival and objective response rates were significantly higher with nivolumab plus ipilimumab than with sunitinib among intermediate-and poor-risk patients with previously untreated advanced renal-cell carcinoma.	[Tannir, N. M.; Sharma, P.] Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Motzer, R. J.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [George, S.] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [McDermott, D. F.] Dana Farber Harvard Canc Ctr, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Choueiri, T. K.] Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA; [Choueiri, T. K.] Harvard Med Sch, Boston, MA USA; [Frontera, O. Aren] Ctr Internac Estudios Clin, Santiago, Chile; [Salman, P.] Fdn Arturo Lopez Perez, Santiago, Chile; [Melichar, B.] Palacky Univ, Olomouc, Czech Republic; [Melichar, B.] Univ Hosp Olomouc, Olomouc, Czech Republic; [Plimack, Elizabeth R.] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Barthelemy, P.] Hop Univ Strasbourg, Strasbourg, France; [Ravaud, A.] Bordeaux Univ Hosp, Hop St Andre, Bordeaux, France; [Escudier, B.] Inst Gustave Roussy, Villejuif, France; [Porta, C.] San Matteo Univ Hosp Fdn, Ist Ricovero & Cura Carattere Sci, Pavia, Italy; [Bracarda, S.] Osped San Donato, Azienda Unita Sanit Locale Toscana Sud Est, Ist Toscano Tumori, Arezzo, Italy; [Powles, T.] Queen Mary Univ London, Barts Canc Inst, Canc Res UK Expt Canc Med Ctr, Royal Free NHS Trust, London, England; [Hawkins, R.] Canc Res UK, London, England; [Donskov, F.] Aarhus Univ Hosp, Aarhus, Denmark; [Neiman, V.] Rabin Med Ctr, Davidoff Canc Ctr, Petah Tiqwa, Israel; [Neiman, V.] Tel Aviv Univ, Tel Aviv, Israel; [Kollmannsberger, C. K.] British Columbia Canc Agcy, Vancouver, BC, Canada; [Gurney, H.] Westmead Hosp, Sydney, NSW, Australia; [Gurney, H.] Macquarie Univ, Sydney, NSW, Australia; [Grimm, M. -O.] Jena Univ Hosp, Jena, Germany; [Barrios, C. H.] Hosp Sao Lucas, Ctr Pesquisa Oncol, Porto Alegre, RS, Brazil; [Tomita, Y.] Niigata Univ, Niigata, Japan; [Castellano, D.] Hosp Univ 12 Octubre, Madrid, Spain; [Rini, B. I.] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA; [Chen, A. C.; Mekan, S.; McHenry, M. B.; Wind-Rotolo, M.; Doan, J.] Bristol Myers Squibb, Princeton, NJ USA; [Hammers, H. J.] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA	University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Roswell Park Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Palacky University Olomouc; University Hospital Olomouc; Fox Chase Cancer Center; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Bordeaux; UNICANCER; Gustave Roussy; IRCCS Policlinico San Donato; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Cancer Research UK; University of London; Queen Mary University London; University College London; Cancer Research UK; Aarhus University; Rabin Medical Center; Tel Aviv University; British Columbia Cancer Agency; University of Sydney; Macquarie University; Friedrich Schiller University of Jena; Niigata University; Hospital Universitario 12 de Octubre; Cleveland Clinic Foundation; Bristol-Myers Squibb; Johns Hopkins University; Johns Hopkins Medicine	Motzer, RJ (corresponding author), Mem Hosp, Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.; Sharma, P (corresponding author), Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA.	motzerr@mskcc.org; padsharma@mdanderson.org	Kimura, Go/Y-7843-2018; de Azevedo, Sergio Jobim/P-5115-2015; Choueiri, Toni/K-5238-2019; Basso, Umberto/F-4229-2014; Recondo, Gonzalo/GNP-1009-2022; Porta, Camillo/AAB-9482-2020; Gurney, Howard/ABF-6924-2020; Gravis, Gwenaelle/CAG-3019-2022	Kimura, Go/0000-0003-0088-9324; Choueiri, Toni/0000-0002-9201-3217; Basso, Umberto/0000-0002-5075-2177; Recondo, Gonzalo/0000-0002-4755-9325; Gurney, Howard/0000-0003-0217-5261; Gravis, Gwenaelle/0000-0002-3127-1554; Zakharia, Yousef/0000-0001-9480-2626; Ravaud, Alain/0000-0001-9455-6744; Bracarda, Sergio/0000-0002-0703-2959; McDermott, Ray/0000-0002-8952-4315; OUDARD, Stephane/0000-0003-0893-285X; DURAN, IGNACIO/0000-0001-8571-7163; Donskov, Frede/0000-0002-8449-863X; Grimm, Marc-Oliver/0000-0003-3084-8654; Hutson, Thomas/0000-0002-4529-4212; Hadaschik, Boris/0000-0002-1052-2692; George, Saby/0000-0002-0444-5870	Bristol-Myers Squibb; Ono Pharmaceutical; Memorial Sloan Kettering Cancer Center [P30 CA008748]; Pfizer; Novartis; Eisai; Exelixis; Genentech/Roche; Epizyme; Mirati Therapeutics; Argos Therapeutics; Nektar; Oncorena; Merck; Array BioPharma; Genentech BioOncology; Prometheus Laboratories; Merck Sharp Dohme; Astellas Pharma; Bayer; AstraZeneca; Genentech; Peloton Therapeutics; Tracon Pharmaceuticals; Cerulean Pharma; Foundation Medicine; GlaxoSmithKline; Corvus Pharmaceuticals; Acceleron Pharma; Aveo Pharmaceuticals; Dendreon; Eli Lilly; Clovis Oncology; Horizon Pharma; Inovio Pharmaceuticals; SynerGene Therapeutics; Ipsen; Sanofi; EUSA Pharma; Janssen; Celldex Therapeutics; Bayer HealthCare; Hexal; Apogepha; Intuitive Surgical; Sanofi-Aventis; Amgen; MedUpdate; Novartger Ingelheim; Taiho Pharmaceutical; Mylan; Merrimack Pharmaceuticals; AbbVie; BioMarin Pharmaceutical; Daiichi Sankyo; Abraxis BioScience; Asana BioSciences; AB Science; Mediis; Boehrinvation; ImClone; LEO Pharma; Millennium Pharmaceuticals; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); Ono Pharmaceutical; Memorial Sloan Kettering Cancer Center; Pfizer(Pfizer); Novartis(Novartis); Eisai(Eisai Co Ltd); Exelixis; Genentech/Roche(Roche HoldingGenentech); Epizyme; Mirati Therapeutics; Argos Therapeutics; Nektar; Oncorena; Merck(Merck & Company); Array BioPharma(Pfizer); Genentech BioOncology; Prometheus Laboratories; Merck Sharp Dohme(Merck & Company); Astellas Pharma(Astellas Pharmaceuticals); Bayer(Bayer AG); AstraZeneca(AstraZeneca); Genentech(Roche HoldingGenentech); Peloton Therapeutics; Tracon Pharmaceuticals; Cerulean Pharma(Dexcel Pharma); Foundation Medicine; GlaxoSmithKline(GlaxoSmithKline); Corvus Pharmaceuticals; Acceleron Pharma; Aveo Pharmaceuticals; Dendreon; Eli Lilly(Eli Lilly); Clovis Oncology; Horizon Pharma; Inovio Pharmaceuticals; SynerGene Therapeutics; Ipsen(Ipsen); Sanofi; EUSA Pharma; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Celldex Therapeutics; Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); Hexal; Apogepha; Intuitive Surgical; Sanofi-Aventis(Sanofi-Aventis); Amgen(Amgen); MedUpdate; Novartger Ingelheim; Taiho Pharmaceutical; Mylan; Merrimack Pharmaceuticals; AbbVie(AbbVie); BioMarin Pharmaceutical(Johnson & Johnson); Daiichi Sankyo(Daiichi Sankyo Company Limited); Abraxis BioScience; Asana BioSciences; AB Science; Mediis; Boehrinvation; ImClone; LEO Pharma(LEO Pharma); Millennium Pharmaceuticals(Takeda Pharmaceutical Company Ltd); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Bristol-Myers Squibb and Ono Pharmaceutical. The authors received no financial support or compensation for publication of this manuscript. Patients treated at the Memorial Sloan Kettering Cancer Center were supported in part by a Memorial Sloan Kettering Cancer Center Support Grant/Core Grant (P30 CA008748).; Dr. Motzer reports receiving grant support and consulting fees from Pfizer, Novartis, Eisai, and Exelixis and grant support from Genentech/Roche; Dr. Tannir, receiving grant support, consulting fees, and honoraria from Bristol-Myers Squibb, receiving grant support from Epizyme and Mirati Therapeutics, receiving grant support, consulting fees, and honoraria from and serving on an advisory board for Exelixis and Novartis, receiving consulting fees and honoraria from Argos Therapeutics and Pfizer, and receiving consulting fees and honoraria from and serving on an advisory board for Eisai, Nektar, and Oncorena; Dr. McDermott, receiving honoraria and consulting fees from Bristol-Myers Squibb, Pfizer, Merck, Novartis, Eisai, Exelixis, Array BioPharma, and Genentech BioOncology and grant support from Prometheus Laboratories; Dr. Melichar, receiving advisory board fees and lecture fees from Bristol-Myers Squibb, Merck, Merck Sharp & Dohme, Roche, Novartis, Astellas Pharma, Pfizer, and Bayer; Dr. Choueiri, receiving grant support, paid to his institution, consulting fees, and advisory fees from AstraZeneca, Bristol-Myers Squibb, Exelixis, Genentech, Merck, Novartis, Peloton Therapeutics, Pfizer, Roche, and Eisai, grant support, paid to his institution, from Tracon Pharmaceuticals, and consulting fees and advisory fees from Bayer, Cerulean Pharma, Foundation Medicine, GlaxoSmithKline, Prometheus Laboratories, and Corvus Pharmaceuticals; Dr. Plimack, receiving grant support, paid to her institution, from Acceleron Pharma, AstraZeneca, Aveo Pharmaceuticals, Bristol-Myers Squibb, Dendreon, Eli Lilly, GlaxoSmithKline, Merck, Peloton Therapeutics, and Pfizer, receiving consulting fees from Acceleron Pharma, Astellas Pharma, AstraZeneca, Bristol-Myers Squibb, Clovis Oncology, Dendreon, Eli Lilly, Exelixis, Genentech/Roche, GlaxoSmithKline, Horizon Pharma, Inovio Pharmaceuticals, Merck, Novartis, Pfizer, and SynerGene Therapeutics, receiving fees for the development of educational presentations from Bristol-Myers Squibb, Merck, Novartis, and Roche, holding a pending patent (14/588,503) on methods for screening patients with muscle-invasive bladder cancer for neoadjuvant chemotherapy responsiveness, and holding a pending patent (15/226,474) on the combination of an immunomodulatory agent with PD-1 or PD-L1 checkpoint inhibitors in the treatment of cancer; Dr. Barthelemy, receiving advisory board fees from Bristol-Myers Squibb, Pfizer, Novartis, Roche, Ipsen, and Sanofi; Dr. Porta, receiving consulting fees and lecture fees from Bristol-Myers Squibb, Novartis, Ipsen, Eisai, and EUSA Pharma, grant support, consulting fees, and lecture fees from Pfizer, and consulting fees from Janssen; Dr. George, receiving consulting fees from AstraZeneca, Exelixis, and Janssen, grant support and consulting fees from Bayer, Bristol-Myers Squibb, Corvus Pharmaceuticals, Novartis, and Pfizer, and grant support from Celldex Therapeutics and Merck; Dr. Powles, receiving grant support and honoraria from AstraZeneca and Roche, grant support from Novartis, and honoraria from Bristol-Myers Squibb, Merck, and Pfizer; Dr. Donskov, receiving grant support from Pfizer and Novartis; Dr. Kollmannsberger, receiving advisory board fees and honoraria from Bristol-Myers Squibb and Pfizer; Dr. Gurney, receiving advisory board fees from Bristol-Myers Squibb, Merck Sharp & Dohme, Roche, and AstraZeneca and grant support and advisory board fees from Pfizer; Dr.; Hawkins, receiving lecture fees from Novartis, Ipsen and Pfizer, lecture fees and travel support from Bristol-Myers Squibb, and royalties for a patent (WO 90/05144) on the phage antibody patent family collectively known as Winter II; Dr. Ravaud, receiving grant support, advisory board fees, and travel support from Pfizer, advisory board fees and travel support from Bristol-Myers Squibb, travel support from Novartis and Merck Sharp & Dohme, and advisory board fees from Roche; Dr. Grimm, receiving grant support, consulting fees, and lecture fees from Novartis and Bristol-Myers Squibb, consulting fees and lecture fees from Pfizer, Bayer HealthCare, and AstraZeneca, lecture fees from Astellas Pharma, Hexal, and Apogepha, and consulting fees from Intuitive Surgical, Sanofi-Aventis, Amgen, Merck Sharp & Dohme, and MedUpdate; Dr. Bracarda, receiving consulting fees, lecture fees, and travel support from Pfizer, Astellas Pharma, Bristol-Myers Squibb, Roche, and Janssen, travel support from Novartis and Bayer, consulting fees and travel support from Ipsen, and consulting fees from EUSA Pharma and Merck Sharp & Dohme; Dr. Barrios, receiving grant support and consulting fees from Novartger Ingelheim, GlaxoSmithKline, Roche, and Pfizer, grant support from Amgen, AstraZeneca, Taiho Pharmaceutical, Eli Lilly, Sanofi, Mylan, Merrimack Pharmaceuticals, Merck, AbbVie, Astellas Pharma, BioMarin Pharmaceutical, Bristol-Myers Squibb, Daiichi Sankyo, Abraxis BioScience, Asana BioSciences, AB Science, Mediis, Boehrinvation, Exelixis, ImClone, LEO Pharma, Millennium Pharmaceuticals, and consulting fees from Eisai; Dr. Tomita, receiving grant support and honoraria from Astellas Pharma and Pfizer, grant support from AstraZeneca, honoraria from Bristol-Myers Squibb, honoraria and consulting fees from Novartis, grant support, honoraria, and consulting fees from Ono Pharmaceutical, and consulting fees from Taiho Pharmaceutical; Dr. Rini, receiving grant support, paid to his institution, and consulting fees from Bristol-Myers Squibb; Dr. Chen, being employed by Bristol-Myers Squibb; Drs. Mekan, McHenry, and Wind-Rotolo and Mr. Doan, being employed by and owning stock in Bristol-Myers Squibb; Dr. Sharma, owning stock in Jounce Therapeutics, Kite Pharma, Constellation Pharmaceuticals, and Neon Therapeutics and receiving consulting fees from Merck and Astellas Pharma; and Dr. Escudier, receiving honoraria from Bayer, Novartis, Pfizer, Exelixis, and Roche. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2017, OPD NIV INJ INTR US; [Anonymous], 2017, YERV IP INJ INTR US; Antonia SJ, 2016, LANCET ONCOL, V17, P883, DOI 10.1016/S1470-2045(16)30098-5; Choueiri TK, 2017, J CLIN ONCOL, V35, P591, DOI 10.1200/JCO.2016.70.7398; Choueiri TK, 2017, NEW ENGL J MED, V376, P354, DOI 10.1056/NEJMra1601333; Choueiri TK, 2015, CLIN CANCER RES, V21, P1071, DOI 10.1158/1078-0432.CCR-14-1993; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Escudier B, 2009, J CLIN ONCOL, V27, P1280, DOI 10.1200/JCO.2008.19.3342; Hammers HJ, 2017, J CLIN ONCOL, V35, P3851, DOI 10.1200/JCO.2016.72.1985; Hellmann MD, 2017, LANCET ONCOL, V18, P31, DOI [10.1016/S1470-2045(16)30624-6, 10.1016/s1470-2045(16)30624-6]; Heng DYC, 2013, LANCET ONCOL, V14, P141, DOI 10.1016/S1470-2045(12)70559-4; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Hodi FS, 2016, LANCET ONCOL, V17, P1558, DOI 10.1016/S1470-2045(16)30366-7; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Kalra S, 2015, ANN ONCOL, V26, P1300, DOI 10.1093/annonc/mdv030; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2017, J NATL COMPR CANC NE, V15, P804, DOI 10.6004/jnccn.2017.0100; Motzer RJ, 2013, NEW ENGL J MED, V369, P722, DOI 10.1056/NEJMoa1303989; National Cancer Institute (U.S.), 2010, COMMON TERMINOLOGY C, DOI DOI 10.1080/00140139.2010.489653; Rao D, 2009, J PAIN SYMPTOM MANAG, V38, P291, DOI 10.1016/j.jpainsymman.2008.08.013; Rini BI, 2008, J CLIN ONCOL, V26, P5422, DOI 10.1200/JCO.2008.16.9847; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Rothrock NE, 2013, VALUE HEALTH, V16, P789, DOI 10.1016/j.jval.2013.04.015; SCHAG CC, 1984, J CLIN ONCOL, V2, P187, DOI 10.1200/JCO.1984.2.3.187; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Yang JC, 2007, J IMMUNOTHER, V30, P825, DOI 10.1097/CJI.0b013e318156e47e	32	2296	2340	7	128	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 5	2018	378	14					1277	1290		10.1056/NEJMoa1712126	http://dx.doi.org/10.1056/NEJMoa1712126			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB5LN	29562145	Green Published, Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000429105700004
J	Arumugam, TV; Kennedy, BK				Arumugam, Thiruma V.; Kennedy, Brian K.			H2S to Mitigate Vascular Aging: A SIRT1 Connection	CELL			English	Editorial Material							HYDROGEN-SULFIDE; GROWTH	H2S is an endogenous gasotransmitter that plays an important role in physiological conditions. In this issue, Das et al. provide evidence that SIRT1-dependent angiogenesis is augmented by H2S-findings reinforced by Longchamp et al., who demonstrate that H2S-dependent angiogenesis is triggered by amino acid deprivation.	[Arumugam, Thiruma V.; Kennedy, Brian K.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, MD9,2 Med Dr, Singapore 117593, Singapore; [Arumugam, Thiruma V.] Sungkyunkwan Univ, Sch Pharm, Suwon 16419, South Korea; [Kennedy, Brian K.] Yong Loo Lin Sch Med, Dept Biochem, MD7,8 Med Dr, Singapore 117596, Singapore; [Kennedy, Brian K.] Buck Inst Res Aging, Novato, CA 94945 USA	National University of Singapore; Sungkyunkwan University (SKKU); National University of Singapore; Buck Institute for Research on Aging	Kennedy, BK (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, MD9,2 Med Dr, Singapore 117593, Singapore.; Kennedy, BK (corresponding author), Yong Loo Lin Sch Med, Dept Biochem, MD7,8 Med Dr, Singapore 117596, Singapore.; Kennedy, BK (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.	bkennedy@nus.edu.sg	Arumugam, Thiruma/AAG-6958-2019	Kennedy, Brian/0000-0002-5754-1874; Arumugam, Thiruma/0000-0002-3377-0939				Bai B, 2016, ONCOTARGET, V7, P39065, DOI 10.18632/oncotarget.9687; Das A, 2018, CELL, V173, P74, DOI 10.1016/j.cell.2018.02.008; Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048; Kanagy NL, 2017, AM J PHYSIOL-CELL PH, V312, pC537, DOI 10.1152/ajpcell.00329.2016; Longchamp A, 2018, CELL, V173, P117, DOI 10.1016/j.cell.2018.03.001; Morland C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15557; Nogueiras R, 2012, PHYSIOL REV, V92, P1479, DOI 10.1152/physrev.00022.2011; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Suo R, 2013, MOL MED REP, V7, P1865, DOI 10.3892/mmr.2013.1417	10	16	16	3	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 22	2018	173	1					8	10		10.1016/j.cell.2018.03.011	http://dx.doi.org/10.1016/j.cell.2018.03.011			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GA3MT	29571000	Bronze			2022-12-28	WOS:000428234200004
J	Beasley, MA; Trujillo, I; Leaman, R; Montes, M				Beasley, Michael A.; Trujillo, Ignacio; Leaman, Ryan; Montes, Mircia			A single population of red globular clusters around the massive compact galaxy NGC 1277	NATURE			English	Article							ELLIPTIC GALAXIES; FORMATION EFFICIENCIES; LUMINOSITY FUNCTION; VIRGO ELLIPTICALS; SIZE EVOLUTION; SYSTEMS; UNIVERSE; DISTRIBUTIONS; SEXTRACTOR	Massive galaxies are thought to form in two phases: an initial collapse of gas and giant burst of central star formation, followed by the later accretion of material that builds up their stellar and dark-matter haloes(1-4). The systems of globular clusters within such galaxies are believed to form in a similar manner. The initial central burst forms metal-rich (spectrally red) clusters, whereas more metal poor (spectrally blue) clusters are brought in by the later accretion of less-massive satellites(5-10). This formation process is thought to result in the multimodal optical colour distributions that are seen in the globular cluster systems of massive galaxies(8,11,12). Here we report optical observations of the massive relic-galaxy candidate NGC 1277-a nearby, un-evolved example of a high-redshift 'red nugget' galaxy(13-17). We find that the optical colour distribution of the cluster system of NGC 1277 is unimodal and entirely red. This finding is in strong contrast to other galaxies of similar and larger stellar mass, the cluster systems of which always exhibit (and are generally dominated by) blue clusters(11). We argue that the colour distribution of the cluster system of NGC 1277 indicates that the galaxy has undergone little (if any) mass accretion after its initial collapse, and use simulations of possible merger histories to show that the stellar mass due to accretion is probably at most ten per cent of the total stellar mass of the galaxy. These results confirm that NGC 1277 is a genuine relic galaxy and demonstrate that blue clusters constitute an accreted population in present-day massive galaxies.	[Beasley, Michael A.; Trujillo, Ignacio] Inst Astrofis Canarias, Calle Via Lactea, San Cristobal la Laguna, Spain; [Beasley, Michael A.; Trujillo, Ignacio] Univ La Laguna, Ave Astrofis Francisco, San Cristobal la Laguna, Spain; [Leaman, Ryan] Max Planck Inst Astron, Konigstuhl 17, D-69117 Heidelberg, Germany; [Montes, Mircia] Yale Univ, Dept Astron, New Haven, CT 06511 USA	Instituto de Astrofisica de Canarias; Universidad de la Laguna; Max Planck Society; Yale University	Beasley, MA (corresponding author), Inst Astrofis Canarias, Calle Via Lactea, San Cristobal la Laguna, Spain.; Beasley, MA (corresponding author), Univ La Laguna, Ave Astrofis Francisco, San Cristobal la Laguna, Spain.	beasley@iac.es	Montes, Mireia/AAH-3277-2019; Leaman, Ryan/AAA-6065-2020; Trujillo, Ignacio/AAD-9756-2019	Montes, Mireia/0000-0001-7847-0393; Leaman, Ryan/0000-0001-6785-9336; Trujillo, Ignacio/0000-0001-8647-2874	Spanish Ministry of Economy and Competitiveness (MINECO) [AYA2016-77237-C3-1-P]; Natural Sciences and Engineering Research Council of Canada PDF award; NASA [NAS 5-26555, HST-GO-4215];  [GO-14215]	Spanish Ministry of Economy and Competitiveness (MINECO); Natural Sciences and Engineering Research Council of Canada PDF award(Natural Sciences and Engineering Research Council of Canada (NSERC)); NASA(National Aeronautics & Space Administration (NASA)); 	We thank C. dalla Vecchia, J. Sanchez Almeida, C. Brook, S. Wellons, M. Fouesneau, A. Vazdekis, B. Dullo, J. Read and G. van de Ven for discussions, and J. Roman and A. Serrano Borlaf for assistance with image alignment. M. A. B. and I. T. acknowledge support from grant AYA2016-77237-C3-1-P from the Spanish Ministry of Economy and Competitiveness (MINECO). R.L. acknowledges funding from a Natural Sciences and Engineering Research Council of Canada PDF award. This research has made use of the NASA/ IPAC Extragalactic Database (NED), which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under contract with NASA, and is based on observations made with the NASA/ESA Hubble Space Telescope, which is operated by the Association of Universities for Research in Astronomy under NASA contract NAS 5-26555. These observations are associated with programme GO-14215. Support for this work was provided by NASA through grant HST-GO-4215 from the Space Telescope Science Institute, operated by AURA under NASA contract NAS 5-26555 This research has made use of NASA's Astrophysics Data System and extensive use of Python and Scipy.	Beasley MA, 2002, MON NOT R ASTRON SOC, V333, P383, DOI 10.1046/j.1365-8711.2002.05402.x; Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; Bertin E, 2011, ASTR SOC P, V442, P435; Blakeslee JP, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/1/88; Bohlin RC, 2016, ASTRON J, V152, DOI 10.3847/0004-6256/152/3/60; Brodie JP, 2006, ANNU REV ASTRON ASTR, V44, P193, DOI 10.1146/annurev.astro.44.051905.092441; Ceverino D, 2015, MON NOT R ASTRON SOC, V447, P3291, DOI 10.1093/mnras/stu2694; Chies-Santos AL, 2012, ASTRON ASTROPHYS, V539, DOI 10.1051/0004-6361/201117169; Cote P, 1998, ASTROPHYS J, V501, P554, DOI 10.1086/305838; Damjanov I, 2015, ASTROPHYS J, V815, DOI 10.1088/0004-637X/815/2/104; Damjanov I, 2009, ASTROPHYS J, V695, P101, DOI 10.1088/0004-637X/695/1/101; Ferrarese L, 2000, ASTROPHYS J SUPPL S, V128, P431, DOI 10.1086/313391; Furlong M, 2017, MON NOT R ASTRON SOC, V465, P722, DOI 10.1093/mnras/stw2740; Georgiev IY, 2010, MON NOT R ASTRON SOC, V406, P1967, DOI 10.1111/j.1365-2966.2010.16802.x; Hargis JR, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/1/62; Harris WE, 2006, ASTROPHYS J, V636, P90, DOI 10.1086/498058; Jordan A, 2007, ASTROPHYS J SUPPL S, V171, P101, DOI 10.1086/516840; Khochfar S, 2006, ASTROPHYS J, V648, pL21, DOI 10.1086/507768; Kruijssen JMD, 2015, MON NOT R ASTRON SOC, V454, P1658, DOI 10.1093/mnras/stv2026; Leauthaud A, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/159; Martin-Navarro I, 2015, MON NOT R ASTRON SOC, V451, P1081, DOI 10.1093/mnras/stv1022; Mieske S, 2010, ASTROPHYS J, V710, P1672, DOI 10.1088/0004-637X/710/2/1672; Muratov AL, 2010, ASTROPHYS J, V718, P1266, DOI 10.1088/0004-637X/718/2/1266; Oser L, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/63; Peng EW, 2008, ASTROPHYS J, V681, P197, DOI 10.1086/587951; Peng EW, 2006, ASTROPHYS J, V639, P95, DOI 10.1086/498210; de Arriba LP, 2016, MON NOT R ASTRON SOC, V461, P156, DOI 10.1093/mnras/stw1240; Poggianti BM, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/2/77; Pota V, 2013, MON NOT R ASTRON SOC, V428, P389, DOI 10.1093/mnras/sts029; Read JI, 2006, MON NOT R ASTRON SOC, V366, P429, DOI 10.1111/j.1365-2966.2005.09861.x; Schlafly EF, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/103; Scott D. W., 1992, MULTIVARIATE DENSITY, P7; SEARLE L, 1978, ASTROPHYS J, V225, P357, DOI 10.1086/156499; SECKER J, 1993, ASTRON J, V105, P1358, DOI 10.1086/116515; Sersic J. L., 1963, B ASOC ARGENTINA AST, V6, P41; Strader J, 2006, ASTRON J, V132, P2333, DOI 10.1086/509124; Stringer M, 2015, MON NOT R ASTRON SOC, V449, P2396, DOI 10.1093/mnras/stv455; Szomoru D, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/2/121; Toft S, 2017, NATURE, V546, P510, DOI 10.1038/nature22388; Tonini C, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/39; Trujillo I, 2014, ASTROPHYS J LETT, V780, DOI 10.1088/2041-8205/780/2/L20; Trujillo I, 2009, ASTROPHYS J LETT, V692, pL118, DOI 10.1088/0004-637X/692/2/L118; Valentinuzzi T, 2010, ASTROPHYS J, V712, P226, DOI 10.1088/0004-637X/712/1/226; van den Bosch RCE, 2012, NATURE, V491, P729, DOI 10.1038/nature11592; van Dokkum PG, 2010, ASTROPHYS J, V709, P1018, DOI 10.1088/0004-637X/709/2/1018; Wellons S, 2016, MON NOT R ASTRON SOC, V456, P1030, DOI 10.1093/mnras/stv2738; Yildirim A, 2017, MON NOT R ASTRON SOC, V468, P4216, DOI 10.1093/mnras/stx732; Yildirim A, 2015, MON NOT R ASTRON SOC, V452, P1792, DOI 10.1093/mnras/stv1381; Yoon SJ, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/150	52	42	42	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2018	555	7697					483	+		10.1038/nature25756	http://dx.doi.org/10.1038/nature25756			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ9NF	29531319	Green Submitted			2022-12-28	WOS:000427937900045
J	Husebye, ES; Anderson, MS; Kampe, O				Husebye, Eystein S.; Anderson, Mark S.; Kampe, Olle			Autoimmune Polyendocrine Syndromes	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CANDIDIASIS-ECTODERMAL DYSTROPHY; CHRONIC MUCOCUTANEOUS CANDIDIASIS; REGULATORY T-CELLS; X-LINKED SYNDROME; SYNDROME TYPE-1; IMMUNE DYSREGULATION; POLYGLANDULAR SYNDROME; GERMLINE MUTATIONS; DIABETES-MELLITUS; AIRE-MUTATIONS		[Husebye, Eystein S.; Kampe, Olle] Univ Bergen, Dept Clin Sci, N-5021 Bergen, Norway; [Husebye, Eystein S.; Kampe, Olle] Univ Bergen, KG Jebsen Ctr Autoimmune Disorders, Bergen, Norway; [Husebye, Eystein S.] Haukeland Hosp, Dept Med, Bergen, Norway; [Husebye, Eystein S.; Kampe, Olle] Karolinska Inst, Dept Med Solna, Stockholm, Sweden; [Anderson, Mark S.] Univ Calif San Francisco, Diabet Ctr, San Francisco, CA USA; [Anderson, Mark S.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; Karolinska Institutet; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Husebye, ES (corresponding author), Univ Bergen, Dept Clin Sci, N-5021 Bergen, Norway.	eystein.husebye@uib.no		Songini, Marco/0000-0003-3524-645X	Novo Nordisk Foundation; Shire; Torsten Foundation; Ragnar Soderberg Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI118688, R37AI097457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK107383] Funding Source: NIH RePORTER	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Shire; Torsten Foundation; Ragnar Soderberg Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Husebye reports receiving grant support from the Novo Nordisk Foundation, provision of drugs from GlaxoSmithKline, and lecture fees and consulting fees from Shire; Dr. Anderson, owning stock in Medtronic; and Dr. Kampe, receiving grant support from the Torsten and Ragnar Soderberg Foundations and Novo Nordisk Foundation, serving as a board member for and being a shareholder in Olink Bioscience, being an unpaid consultant for Shire, and holding a pending patent (PCT/SE2015/051189) on FHL1 autoantibody testing in polymyositis. No other potential conflict of interest relevant to this article was reported.	Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Abbott JK, 2017, J AUTOIMMUN; AHONEN P, 1990, NEW ENGL J MED, V322, P1829, DOI 10.1056/NEJM199006283222601; Alimohammadi M, 2008, NEW ENGL J MED, V358, P1018, DOI 10.1056/NEJMoa0706487; Alimohammadi M, 2009, P NATL ACAD SCI USA, V106, P4396, DOI 10.1073/pnas.0809986106; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; Barzaghi F, 2018, J ALLERGY CLIN IMMUN, V141, P1036, DOI 10.1016/j.jaci.2017.10.041; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bensing S, 2008, CLIN ENDOCRINOL, V69, P697, DOI 10.1111/j.1365-2265.2008.03340.x; Blansfield JA, 2005, J IMMUNOTHER, V28, P593, DOI 10.1097/01.cji.0000178913.41256.06; Bluestone JA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad4134; Boelaert K, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2009.06.030; Bollerslev J, 2015, EUR J ENDOCRINOL, V173, pEG1, DOI 10.1530/EJE-15-0628; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Bruserud O, 2016, CURR OPIN IMMUNOL, V43, P8, DOI 10.1016/j.coi.2016.07.003; Bruserud O, 2016, J CLIN ENDOCR METAB, V101, P2975, DOI 10.1210/jc.2016-1821; Caudy AA, 2007, J ALLERGY CLIN IMMUN, V119, P482, DOI 10.1016/j.jaci.2006.10.007; Cetani F, 2001, J CLIN ENDOCR METAB, V86, P4747, DOI 10.1210/jc.86.10.4747; Chang B, 2006, J AAPOS, V10, P515, DOI 10.1016/j.jaapos.2006.06.018; Cheng MH, 2010, NEW ENGL J MED, V362, P764, DOI 10.1056/NEJMc0909510; CZARNOCKA B, 1985, FEBS LETT, V190, P147, DOI 10.1016/0014-5793(85)80446-4; Dalin F, 2017, J CLIN ENDOCR METAB, V102, P379, DOI 10.1210/jc.2016-2522; Eisenbarth GS, 2004, NEW ENGL J MED, V350, P2068, DOI 10.1056/NEJMra030158; Ekwall O, 1998, LANCET, V352, P279, DOI 10.1016/S0140-6736(97)11050-9; Erichsen MM, 2009, J CLIN ENDOCR METAB, V94, P4882, DOI 10.1210/jc.2009-1368; Eriksson D, 2016, J INTERN MED, V280, P595, DOI 10.1111/joim.12569; Ferre EMN, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88782; Flanagan SE, 2014, NAT GENET, V46, P812, DOI 10.1038/ng.3040; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Grant SFA, 2009, DIABETES, V58, P290, DOI 10.2337/db08-1022; Gutierrez MJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00377; Halonen M, 2002, J CLIN ENDOCR METAB, V87, P2568, DOI 10.1210/jc.87.6.2568; Hippen KL, 2011, AM J TRANSPLANT, V11, P1148, DOI 10.1111/j.1600-6143.2011.03558.x; Hughes J, 2015, DIABETES CARE, V38, pe55, DOI 10.2337/dc14-2349; Husebye ES, 2009, J INTERN MED, V265, P514, DOI 10.1111/j.1365-2796.2009.02090.x; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Lampasona V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078664; Landegren N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9186; Leonard JD, 2017, IMMUNITY, V47, P107, DOI 10.1016/j.immuni.2017.06.015; Li D, 2017, J CLIN ENDOCR METAB, V102, P1726, DOI 10.1210/jc.2016-3836; Lo B, 2015, SCIENCE, V349, P436, DOI 10.1126/science.aaa1663; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; Meager A, 2006, PLOS MED, V3, P1152, DOI 10.1371/journal.pmed.0030289; Milner JD, 2015, BLOOD, V125, P591, DOI 10.1182/blood-2014-09-602763; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Noble JA, 1996, AM J HUM GENET, V59, P1134; Oftedal BE, 2015, IMMUNITY, V42, P1185, DOI 10.1016/j.immuni.2015.04.021; Orlova EM, 2017, J CLIN ENDOCR METAB, V102, P3546, DOI 10.1210/jc.2017-00139; Parent AV, 2013, CELL STEM CELL, V13, P219, DOI 10.1016/j.stem.2013.04.004; Perheentupa J, 2006, J CLIN ENDOCR METAB, V91, P2843, DOI 10.1210/jc.2005-2611; Pollak U, 2009, EUR J PEDIATR, V168, P233, DOI 10.1007/s00431-008-0735-9; Popler J, 2012, PEDIATR PULM, V47, P84, DOI 10.1002/ppul.21520; Postow MA, 2018, NEW ENGL J MED, V378, P158, DOI [10.1056/NEJMra1703481, 10.1056/NEJMc1801663]; POWELL BR, 1982, J PEDIATR-US, V100, P731, DOI 10.1016/S0022-3476(82)80573-8; Proust-Lemoine E, 2010, HORM RES PAEDIAT, V74, P275, DOI 10.1159/000297714; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schmidt MB., 1926, VERH DTSCH GES PATHO, V21, P212; Schubert D, 2014, NAT MED, V20, P1410, DOI 10.1038/nm.3746; Shum AK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006998; Simmonds MJ, 2004, CLIN EXP IMMUNOL, V136, P1, DOI 10.1111/j.1365-2249.2004.02424.x; Soderbergh A, 2004, J CLIN ENDOCR METAB, V89, P557, DOI 10.1210/jc.2003-030279; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; Torino F, 2016, CURR OPIN ONCOL, V28, P278, DOI 10.1097/CCO.0000000000000293; Trainer Harris, 2016, Endocrinol Diabetes Metab Case Rep, V2016; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Walter JE, 2015, J CLIN INVEST, V125, P4135, DOI 10.1172/JCI80477; Ward L, 1999, J CLIN ENDOCR METAB, V84, P844, DOI 10.1210/jc.84.3.844; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; WINQVIST O, 1992, LANCET, V339, P1559, DOI 10.1016/0140-6736(92)91829-W; Wolff ASB, 2007, J CLIN ENDOCR METAB, V92, P595, DOI 10.1210/jc.2006-1873; Wolff ASB, 2014, J IMMUNOL, V193, P3880, DOI 10.4049/jimmunol.1401068	77	166	175	6	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2018	378	12					1132	1141		10.1056/NEJMra1713301	http://dx.doi.org/10.1056/NEJMra1713301			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ9OV	29562162	Green Accepted			2022-12-28	WOS:000427942300009
J	Savitski, MM; Zinn, N; Faelth-Savitski, M; Poeckel, D; Gade, S; Becher, I; Muelbaier, M; Wagner, AJ; Strohmer, K; Werner, T; Melchert, S; Petretich, M; Rutkowska, A; Vappiani, J; Franken, H; Steidel, M; Sweetman, GM; Gilan, O; Lam, EYN; Dawson, MA; Prinjha, RK; Grandi, P; Bergamini, G; Bantscheff, M				Savitski, Mikhail M.; Zinn, Nico; Faelth-Savitski, Maria; Poeckel, Daniel; Gade, Stephan; Becher, Isabelle; Muelbaier, Marcel; Wagner, Anne J.; Strohmer, Katrin; Werner, Thilo; Melchert, Stephanie; Petretich, Massimo; Rutkowska, Anna; Vappiani, Johanna; Franken, Holger; Steidel, Michael; Sweetman, Gavain M.; Gilan, Omer; Lam, Enid Y. N.; Dawson, Mark A.; Prinjha, Rab K.; Grandi, Paola; Bergamini, Giovanna; Bantscheff, Marcus			Multiplexed Proteome Dynamics Profiling Reveals Mechanisms Controlling Protein Homeostasis	CELL			English	Article							ESTROGEN-RECEPTOR; SELECTIVE-INHIBITION; BREAST-CANCER; CELL; DEGRADATION; HSP90; BET; QUANTIFICATION; ACTIVATION; PROTEASOME	Protein degradation plays important roles in biological processes and is tightly regulated. Further, targeted proteolysis is an emerging research tool and therapeutic strategy. However, proteome-wide technologies to investigate the causes and consequences of protein degradation in biological systems are lacking. We developed "multiplexed proteome dynamics profiling'' (mPDP), a mass-spectrometry-based approach combining dynamic-SILAC labeling with isobaric mass tagging for multiplexed analysis of protein degradation and synthesis. In three proof-of-concept studies, we uncover different responses induced by the bromodomain inhibitor JQ1 versus a JQ1 proteolysis targeting chimera; we elucidate distinct modes of action of estrogen receptor modulators; and we comprehensively classify HSP90 clients based on their requirement for HSP90 constitutively or during synthesis, demonstrating that constitutive HSP90 clients have lower thermal stability than non-clients, have higher affinity for the chaperone, vary between cell types, and change upon external stimuli. These findings highlight the potential of mPDP to identify dynamically controlled degradation mechanisms in cellular systems.	[Savitski, Mikhail M.; Zinn, Nico; Faelth-Savitski, Maria; Poeckel, Daniel; Gade, Stephan; Muelbaier, Marcel; Wagner, Anne J.; Strohmer, Katrin; Werner, Thilo; Melchert, Stephanie; Petretich, Massimo; Rutkowska, Anna; Vappiani, Johanna; Franken, Holger; Steidel, Michael; Sweetman, Gavain M.; Grandi, Paola; Bergamini, Giovanna; Bantscheff, Marcus] GlaxoSmithKline, Cellzome GmbH, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Savitski, Mikhail M.; Becher, Isabelle] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany; [Gilan, Omer; Lam, Enid Y. N.; Dawson, Mark A.] Peter MacCallum Canc Ctr, Canc Res Div, East Melbourne, Vic 3002, Australia; [Prinjha, Rab K.] GlaxoSmithKline, Med Res Ctr, Epinova DPU, Immunoinflammat Ctr Excellence Drug Discovery, Gunnels Wood Rd, Stevenage SG1 2NY, Herts, England	GlaxoSmithKline; Cellzome GmbH; European Molecular Biology Laboratory (EMBL); Peter Maccallum Cancer Center; GlaxoSmithKline	Savitski, MM; Bergamini, G; Bantscheff, M (corresponding author), GlaxoSmithKline, Cellzome GmbH, Meyerhofstr 1, D-69117 Heidelberg, Germany.; Savitski, MM (corresponding author), European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany.	mikhail.savitski@embl.de; giovanna.2.bergamini@gsk.com; marcus.x.bantscheff@gsk.com	Dawson, Mark A/B-9317-2017; Bantscheff, Marcus/AAQ-2903-2021	Dawson, Mark A/0000-0002-5464-5029; Bantscheff, Marcus/0000-0002-8343-8977; Bergamini, Giovanna/0000-0002-9662-9502; Becher, Isabelle/0000-0001-7170-2235; Lam, Enid Yi Ni/0000-0001-5843-7836				Ahsan A, 2013, J BIOL CHEM, V288, P26879, DOI 10.1074/jbc.M113.492280; Alarid ET, 1999, MOL ENDOCRINOL, V13, P1522, DOI 10.1210/me.13.9.1522; ARAD G, 1976, CELL, V8, P95, DOI 10.1016/0092-8674(76)90190-2; Arlander SJH, 2006, J BIOL CHEM, V281, P2989, DOI 10.1074/jbc.M508687200; Bae J, 2013, J IMMUNOL, V190, P1360, DOI 10.4049/jimmunol.1200593; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Bartz F, 2009, CELL METAB, V10, P63, DOI 10.1016/j.cmet.2009.05.009; Becher I, 2016, NAT CHEM BIOL, V12, P908, DOI [10.1038/NCHEMBIO.2185, 10.1038/nchembio.2185]; Bhadury J, 2014, P NATL ACAD SCI USA, V111, pE2721, DOI 10.1073/pnas.1406722111; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011429; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; Buckley DL, 2012, J AM CHEM SOC, V134, P4465, DOI 10.1021/ja209924v; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Dayspring T, 2006, METABOLISM, V55, P972, DOI 10.1016/j.metabol.2006.03.005; Deshaies RJ, 2015, NAT CHEM BIOL, V11, P634, DOI 10.1038/nchembio.1887; Doherty MK, 2009, J PROTEOME RES, V8, P104, DOI 10.1021/pr800641v; Echeverria PC, 2010, BBA-MOL CELL RES, V1803, P641, DOI 10.1016/j.bbamcr.2009.11.012; Fierro-Monti I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080425; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fliss AE, 2000, J STEROID BIOCHEM, V72, P223, DOI 10.1016/S0960-0760(00)00037-6; Ghosh MG, 2000, CANCER RES, V60, P6367; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; HARTSON SD, 1994, BIOCHEMISTRY-US, V33, P8912, DOI 10.1021/bi00196a008; Hautbergue GM, 2009, CURR BIOL, V19, P1918, DOI 10.1016/j.cub.2009.09.041; Ho WH, 2012, J PROTEOME RES, V11, P3160, DOI 10.1021/pr201201y; Houry W.A., 2014, MOL CHAPERONES INTER, P133, DOI DOI 10.1007/978-1-4939-1130-1_6; Huang M, 2016, ONCOTARGET, V7, P74917, DOI 10.18632/oncotarget.12493; Jovanovic M, 2015, SCIENCE, V347, DOI 10.1126/science.1259038; Kim DE, 2015, MOL CELLS, V38, P138, DOI 10.14348/molcells.2015.2193; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Lai AC, 2017, NAT REV DRUG DISCOV, V16, P101, DOI 10.1038/nrd.2016.211; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Ma WB, 2011, CELL RES, V21, P1564, DOI 10.1038/cr.2011.84; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; McAlister GC, 2012, ANAL CHEM, V84, P7469, DOI 10.1021/ac301572t; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; Moliterno AR, 2011, CELL RES, V21, P1528, DOI 10.1038/cr.2011.96; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Pallis M, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-32; Pernis AB, 2002, J INTERF CYTOK RES, V22, P111, DOI 10.1089/107999002753452728; Polisetty RV, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013565; Pollex T, 2013, METHODS MOL BIOL, V1042, P13, DOI 10.1007/978-1-62703-526-2_2; Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200; Savitski MM, 2014, SCIENCE, V346, P55, DOI 10.1126/science.1255784; Savitski MM, 2013, J PROTEOME RES, V12, P3586, DOI 10.1021/pr400098r; Schoof N, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-17; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwanhausser B, 2009, PROTEOMICS, V9, P205, DOI 10.1002/pmic.200800275; Siddiqa A, 2001, NATURE, V410, P383, DOI 10.1038/35066602; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Welle KA, 2016, MOL CELL PROTEOMICS, V15, P3551, DOI 10.1074/mcp.M116.063230; Werner T, 2014, ANAL CHEM, V86, P3594, DOI 10.1021/ac500140s; Werner T, 2012, ANAL CHEM, V84, P7188, DOI 10.1021/ac301553x; Whittier JE, 2004, J BIOL CHEM, V279, P46135, DOI 10.1074/jbc.M406048200; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Winter GE, 2017, MOL CELL, V67, P5, DOI 10.1016/j.molcel.2017.06.004; Wu YL, 2005, MOL CELL, V18, P413, DOI 10.1016/j.molcel.2005.04.014; Wu ZX, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016675; Wurz RP, 2018, J MED CHEM, V61, P453, DOI 10.1021/acs.jmedchem.6b01781; Yorgin PD, 2000, J IMMUNOL, V164, P2915, DOI 10.4049/jimmunol.164.6.2915	64	116	116	7	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 22	2018	173	1					260	274		10.1016/j.cell.2018.02.030	http://dx.doi.org/10.1016/j.cell.2018.02.030			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GA3MT	29551266	Green Published, hybrid			2022-12-28	WOS:000428234200023
J	Friedrich, MJ				Friedrich, M. J.			Air Pollution Is Greatest Environmental Threat to Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	10	11	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2018	319	11					1085	1085		10.1001/jama.2018.2366	http://dx.doi.org/10.1001/jama.2018.2366			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HI0BJ	29558561				2022-12-28	WOS:000456106800003
J	Kelly, RG; Sperling, SR				Kelly, Robert G.; Sperling, Silke R.			Diverging roads to the heart	SCIENCE			English	Editorial Material							GENE-EXPRESSION; CELL-TYPES; PROGENITORS; STATES		[Kelly, Robert G.] Aix Marseille Univ, CNRS, UMR 7288, Dev Biol Inst Marseille, Campus Luminy Case 907, Marseille 9, France; [Sperling, Silke R.] Charite, Dept Cardiovasc Genet, Expt & Clin Res Ctr, Berlin, Germany; [Sperling, Silke R.] Free Univ Berlin, Dept Biol Chem & Pharm, Berlin, Germany; [Sperling, Silke R.] Berlin Inst Hlth, Berlin, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Berlin Institute of Health	Kelly, RG (corresponding author), Aix Marseille Univ, CNRS, UMR 7288, Dev Biol Inst Marseille, Campus Luminy Case 907, Marseille 9, France.	robert.kelly@univ-amu.fr	Kelly, Robert G/F-2523-2013	Kelly, Robert G/0000-0003-4357-0073; Rickert-Sperling, Silke/0000-0002-7135-3298				DeLaughter DM, 2016, DEV CELL, V39, P480, DOI 10.1016/j.devcel.2016.10.001; Devine WP, 2014, ELIFE, V3, DOI 10.7554/eLife.03848; Epstein JA, 2010, NEW ENGL J MED, V363, P1638, DOI 10.1056/NEJMra1003941; Lescroart F, 2018, SCIENCE, V359, P1177, DOI 10.1126/science.aao4174; Lescroart F, 2014, NAT CELL BIOL, V16, P829, DOI 10.1038/ncb3024; Li G, 2016, DEV CELL, V39, P491, DOI 10.1016/j.devcel.2016.10.014; Loh KM, 2016, CELL, V166, P451, DOI 10.1016/j.cell.2016.06.011; Moris N, 2016, NAT REV GENET, V17, P693, DOI 10.1038/nrg.2016.98; Peng GD, 2016, DEV CELL, V36, P681, DOI 10.1016/j.devcel.2016.02.020; Razy-Krajka F, 2014, DEV CELL, V29, P263, DOI 10.1016/j.devcel.2014.04.001; Saga Y, 2000, TRENDS CARDIOVAS MED, V10, P345, DOI 10.1016/S1050-1738(01)00069-X; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Scialdone A, 2016, NATURE, V535, P289, DOI 10.1038/nature18633; Trapnell C, 2015, GENOME RES, V25, P1491, DOI 10.1101/gr.190595.115; Waddington C H, 1957, STRATEGY GENES DISCU	15	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2018	359	6380					1098	1099		10.1126/science.aat0230	http://dx.doi.org/10.1126/science.aat0230			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY4ZM	29590027				2022-12-28	WOS:000426835900022
J	Voosen, P				Voosen, Paul			OCEANOGRAPHY Saildrone fleet could help replace aging buoys	SCIENCE			English	News Item																			0	6	6	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2018	359	6380					1082	1083		10.1126/science.359.6380.1082	http://dx.doi.org/10.1126/science.359.6380.1082			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4ZM	29590019				2022-12-28	WOS:000426835900014
J	Sayed, S; Cherniak, W; Lawler, M; Tan, SY; El Sadr, W; Wolf, N; Silkensen, S; Brand, N; Looi, LM; Pai, SA; Wilson, ML; Milner, D; Flanigan, J; Fleming, KA				Sayed, Shahin; Cherniak, William; Lawler, Mark; Tan, Soo Yong; El Sadr, Wafaa; Wolf, Nicholas; Silkensen, Shannon; Brand, Nathan; Looi, Lai Meng; Pai, Sanjay A.; Wilson, Michael L.; Milner, Danny; Flanigan, John; Fleming, Kenneth A.			Pathology and laboratory medicine in low-income and middle-income countries 2: Improving pathology and laboratory medicine in low-income and middle-income countries: roadmap to solutions	LANCET			English	Article							CERVICAL-CANCER; OF-CARE; HEALTH; SERVICES; DIAGNOSIS; EDUCATION; MALARIA; QUALITY; POINT; MANAGEMENT	Insufficient awareness of the centrality of pathology and laboratory medicine (PALM) to a functioning health-care system at policy and governmental level, with the resultant inadequate investment, has meant that efforts to enhance PALM in low-income and middle-income countries have been local, fragmented, and mostly unsustainable. Responding to the four major barriers in PALM service delivery that were identified in the first paper of this Series (workforce, infrastructure, education and training, and quality assurance), this second paper identifies potential solutions that can be applied in low-income and middle-income countries (LMICs). Increasing and retaining a quality PALM workforce requires access to mentorship and continuing professional development, task sharing, and the development of short-term visitor programmes. Opportunities to enhance the training of pathologists and allied PALM personnel by increasing and improving education provision must be explored and implemented. PALM infrastructure must be strengthened by addressing supply chain barriers, and ensuring laboratory information systems are in place. New technologies, including telepathology and point-of-care testing, can have a substantial role in PALM service delivery, if used appropriately. We emphasise the crucial importance of maintaining PALM quality and posit that all laboratories in LMICs should participate in quality assurance and accreditation programmes. A potential role for public-private partnerships in filling PALM services gaps should also be investigated. Finally, to deliver these solutions and ensure equitable access to essential services in LMICs, we propose a PALM package focused on these countries, integrated within a nationally tiered laboratory system, as part of an overarching national laboratory strategic plan.	[Sayed, Shahin] Aga Khan Univ Hosp, Dept Pathol, Nairobi 00100, Kenya; [Cherniak, William; Wolf, Nicholas; Silkensen, Shannon; Flanigan, John; Fleming, Kenneth A.] NCI, Ctr Global Hlth, NIH, Bethesda, MD 20892 USA; [Brand, Nathan] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY USA; [Tan, Soo Yong] Natl Univ Singapore, Dept Pathol, Natl Univ Hosp, Singapore, Singapore; [El Sadr, Wafaa] Columbia Univ, ICAP, Mailman Sch Publ Hlth, New York, NY USA; [Lawler, Mark] Queens Univ, Fac Med Hlth & Life Sci, Belfast, Antrim, North Ireland; [Lawler, Mark] Queens Univ, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Looi, Lai Meng] Univ Malaya, Dept Pathol, Fac Med, Kuala Lumpur, Malaysia; [Pai, Sanjay A.] Columbia Asia Referral Hosp, Bangalore, Karnataka, India; [Wilson, Michael L.] Denver Hlth, Dept Pathol & Lab Serv, Denver, CO USA; [Wilson, Michael L.] Univ Colorado, Dept Pathol, Sch Med, Aurora, CO USA; [Milner, Danny] Amer Soc Clin Pathologists, Chicago, IL USA; [Fleming, Kenneth A.] Univ Oxford, Green Templeton Coll, Oxford, England	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Columbia University; National University of Singapore; Columbia University; Queens University Belfast; Queens University Belfast; Universiti Malaya; Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Oxford	Sayed, S (corresponding author), Aga Khan Univ Hosp, Dept Pathol, Nairobi 00100, Kenya.	shaheen.sayed@aku.edu	Looi, Lai Meng/A-3382-2009; Looi, Lai Meng/AAB-9403-2019; Milner, Danny/K-3568-2019; SAYED, SHAHIN/F-8641-2016	Looi, Lai Meng/0000-0001-8325-0117; Looi, Lai Meng/0000-0001-8325-0117; Fleming, Kenneth/0000-0002-3200-1302; Tan, Soo-Yong/0000-0002-6348-2823				Adesina A, 2013, LANCET ONCOL, V14, pE152, DOI 10.1016/S1470-2045(12)70598-3; Adeyi OA, 2011, ARCH PATHOL LAB MED, V135, P183, DOI 10.1043/2008-0432-CCR.1; Aller R., 1996, CLIN DIAGNOSIS MANAG, P92; Asirwa FC, 2016, J CLIN ONCOL, V34, P36, DOI 10.1200/JCO.2015.63.0152; Basu S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001244; Benediktsson H, 2007, ARCH PATHOL LAB MED, V131, P1636; Bennett Sara, 2013, Educ Health (Abingdon), V26, P183, DOI 10.4103/1357-6283.126001; Birrell I, 2010, GUARDIAN; Blaya JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090110; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Bollyky TJ, 2015, HEALTH AFFAIR, V34, P1464, DOI 10.1377/hlthaff.2015.0343; Carter JY, 2010, NEEDS ASSESSMENT STR; Castaneda Christian, 2015, J Clin Bioinforma, V5, P4, DOI 10.1186/s13336-015-0019-3; Chen J, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-S1-S2; College of Pathologists, 2005, MALAYS J PATHOL, V27, P51; Crook M, 2002, J CLIN PATHOL, V55, P177, DOI 10.1136/jcp.55.3.177; De Cock KM, 2011, JAIDS-J ACQ IMM DEF, V57, pS61, DOI 10.1097/QAI.0b013e3182217f00; De Crignis E, 2010, J VIROL METHODS, V165, P51, DOI 10.1016/j.jviromet.2009.12.017; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Denny L, 2017, LANCET, V389, P861, DOI 10.1016/S0140-6736(16)31795-0; Ethiopian Health and Nutrition Research Institute, 2009, MAST PLAN PUBL HLTH; Fischer MK, 2011, J AM ACAD DERMATOL, V64, P986, DOI 10.1016/j.jaad.2010.05.032; Fleming KA, 2017, AM J CLIN PATHOL, V147, P15, DOI [10.1093/AJCP/AQW143, 10.1093/ajcp/aqw143]; Geissbuhler A, 2007, INT J MED INFORM, V76, P351, DOI 10.1016/j.ijmedinf.2007.01.012; Goel N, 2017, J VIROL METHODS, V244, P39, DOI 10.1016/j.jviromet.2017.03.001; Government of India Ministry of Statistics and Programme Implementation, 574 NSS; Hawkins Robert C, 2007, Clin Biochem Rev, V28, P179; Hernandez-Aguado I, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009342; Hoenecke H, 2011, ARCH PATHOL LAB MED, V135, P173, DOI 10.1043/2008-0450-SOR1.1; Holmes K., 2017, DIS CONTROL PRIORITI; Hsiang MS, 2014, J INFECT DIS, V210, P1167, DOI 10.1093/infdis/jiu253; Hung T, 2011, HUM PATHOL, V42, P802, DOI 10.1016/j.humpath.2010.10.018; Jeon YH, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-182; Jian WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044462; Joloba M, 2016, J INFECT DIS, V213, pS41, DOI 10.1093/infdis/jiw035; Kaindjee-Tjituka F, 2017, AFR J LAB MED, V6, DOI 10.4102/ajlm.v6i1.643; Kamat Sonal, 2011, J Pathol Inform, V2, P42, DOI 10.4103/2153-3539.84279; Kebede Y, 2016, J INFECT DIS, V213, pS59, DOI 10.1093/infdis/jiv576; Knaul F, 2012, CLOSING CANC DIVIDE; Kobusingye OC, 2005, B WORLD HEALTH ORGAN, V83, P626; Kyobe S, 2017, BIOPRESERV BIOBANK, V15, P112, DOI 10.1089/bio.2017.0006; Liverpool School of Tropical Medicine, 2017, AN APPR LAB CAP STRE; Loh LC, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0135-7; Looi Lai-Meng, 2008, Malays J Pathol, V30, P1; Looi LM, 2016, UICC WORLD CANC C PA, p101M; Lowe J., 2013, TELEPATHOLOGY GUIDAN; Manabe YC, 2014, LANCET GLOB HEALTH, V2, pE392, DOI 10.1016/S2214-109X(14)70235-9; McNairy ML, 2015, JAIDS-J ACQ IMM DEF, V70, pE44, DOI 10.1097/QAI.0000000000000745; McNairy ML, 2014, CLIN INFECT DIS, V59, pS12, DOI 10.1093/cid/ciu251; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Middleton L, 2014, ACAD MED, V89, pS24, DOI 10.1097/ACM.0000000000000342; Mir AM, 2013, ASSESSING RETENTION; Mpunga Tharcisse, 2016, J Glob Oncol, V2, P76, DOI 10.1200/JGO.2015.002162; Mpunga T, 2014, AM J CLIN PATHOL, V142, P541, DOI 10.1309/AJCPYPDES6Z8ELEY; Mumtaz Z, 2017, LANCET GLOB HEALTH, V5, pE734, DOI 10.1016/S2214-109X(17)30256-5; Mwai GW, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18586; Nigatu A, 2009, CASE STUDY IMPACT ET; Noble M, TRANSFORMING QUALITY; Okyere E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174631; Oriero EC, 2015, EXPERT REV MOL DIAGN, V15, P1419, DOI 10.1586/14737159.2015.1090878; Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306; Palen J, 2012, JAIDS-J ACQ IMM DEF, V60, pS113, DOI 10.1097/QAI.0b013e31825d28d7; Patel JC, 2014, J INFECT DIS, V210, P1180, DOI 10.1093/infdis/jiu252; Perrone LA, 2016, B WORLD HEALTH ORGAN, V94, P743, DOI 10.2471/BLT.15.163824; Peter T, 2012, BUILDING EFFECTIVE L; Rabkin M, 2017, B WORLD HEALTH ORGAN, V95, P353, DOI [10.2471/BLT.16.180646, 10.2471/blt.16.180646]; Rabkin Miriam, 2012, AIDS, V26 Suppl 1, pS77; Rambau PF, 2011, ARCH PATHOL LAB MED, V135, P191, DOI 10.1043/1543-2165-135.2.191; Riewpaiboon A, 2015, PUBLIC HEALTH, V129, P899, DOI 10.1016/j.puhe.2015.04.016; Ritchie AV, 2014, J CLIN MICROBIOL, V52, P3377, DOI 10.1128/JCM.00593-14; Sankaranarayanan R, 2007, LANCET, V370, P398, DOI 10.1016/S0140-6736(07)61195-7; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Schneider F, 2017, ANN LAB MED, V37, P365, DOI 10.3343/alm.2017.37.5.365; Shaw Julie L V, 2016, Pract Lab Med, V4, P22, DOI 10.1016/j.plabm.2015.12.002; Shrivastava R, 2016, J INFECT DIS, V213, pS35, DOI 10.1093/infdis/jiv574; Skaggs B, 2016, J INFECT DIS, V213, pS47, DOI 10.1093/infdis/jiv544; Snijdewind IJM, 2012, ANTIVIR RES, V93, P309, DOI 10.1016/j.antiviral.2011.12.011; Strasser R, 2016, ANNU REV PUBL HEALTH, V37, P395, DOI 10.1146/annurev-publhealth-032315-021507; Strasser R, 2010, B WORLD HEALTH ORGAN, V88, P777, DOI 10.2471/BLT.09.072462; Strother RM, 2013, J Cancer Policy, V1, pE42, DOI 10.1016/j.jcpo.2013.06.002; Tan D, 2013, LANCET ONCOL, V14, pE548, DOI 10.1016/S1470-2045(13)70450-9; UC Davis Health Newsroom, 2016, TEL PROGR IMPR CANC; UNITAID, 2015, HEP C DIAGN TECHN LA; US President's Emergency Plan for AIDS Relief, 2013, ETH OP PLAN REP 2012; Vashist SK, 2015, TRENDS BIOTECHNOL, V33, P692, DOI 10.1016/j.tibtech.2015.09.001; Vaught Jimmie, 2011, Journal of the National Cancer Institute Monographs, P24, DOI 10.1093/jncimonographs/lgr009; Wagenaar BH, 2016, HEALTH POLICY PLANN, V31, P129, DOI 10.1093/heapol/czv029; Warner LC, 2017, AM J CLIN PATHOL, V147, P8, DOI [10.1093/AJCP/AQW217, 10.1093/ajcp/aqw217]; WHO, 2013, WHO GUID STEPW LAB I; WHO, 2013, SMA PRINT AID EARL I; WHO PATH, 2012, OUTS VACC SUPPL CHAI; WHO Regional Office for Europe, 1985, PRINC QUAL ASS REP W; Wilson ML, 2012, CLIN INFECT DIS, V54, P1637, DOI 10.1093/cid/cis228; Wilson ML, 2018, LANCET; World Association of Societies of Pathology and Laboratory Medicine, WORLD PATH FDN GORD; World Health Organization, 2013, MAN PROC DIAGN REL L; World Health Organization, 2017, WHO M REP TECHN EXP; World Health Organization, 2008, TASK SHIFT RAT RED T; World Health Organization PATH, 2013, OPT SEN REP; World Health Organization (WHO), 2017, HUM RES MED DEV ROL	100	89	90	2	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2018	391	10133					1939	1952		10.1016/S0140-6736(18)30459-8	http://dx.doi.org/10.1016/S0140-6736(18)30459-8			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GF3NC	29550027				2022-12-28	WOS:000431861800029
J	Atabay, KD; LoCascio, SA; de Hoog, T; Reddien, P				Atabay, Kutay Deniz; LoCascio, Samuel A.; de Hoog, Thom; Reddien, PeterW.			Self-organization and progenitor targeting generate stable patterns in planarian regeneration	SCIENCE			English	Article							EYE REGENERATION; STEM-CELLS; MAINTENANCE; WOUNDS	During animal regeneration, cells must organize into discrete and functional systems. We show that self-organization, along with patterning cues, govern progenitor behavior in planarian regeneration. Surgical paradigms allowed the manipulation of planarian eye regeneration in predictable locations and numbers, generating alternative stable neuroanatomical states for wild-type animals with multiple functional ectopic eyes. We used animals with multiple ectopic eyes and eye transplantation to demonstrate that broad progenitor specification, combined with self-organization, allows anatomy maintenance during regeneration. We propose a model for regenerative progenitors involving (i) migratory targeting cues, (ii) self-organization into existing or regenerating eyes, and (iii) a broad zone, associated with coarse progenitor specification, in which eyes can be targeted by progenitors. These three properties help explain how tissues can be organized during regeneration.	[Atabay, Kutay Deniz; LoCascio, Samuel A.; de Hoog, Thom; Reddien, PeterW.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Atabay, Kutay Deniz; LoCascio, Samuel A.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Atabay, Kutay Deniz; LoCascio, Samuel A.; de Hoog, Thom; Reddien, PeterW.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Reddien, PeterW.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Reddien, P (corresponding author), Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.; Reddien, P (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.; Reddien, P (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.	reddien@wi.mit.edu		LoCascio, Samuel/0000-0002-6273-7302; Atabay, Kutay Deniz/0000-0001-6920-5053; /0000-0002-5569-333X	NIH [R01GM080639]; Howard Hughes Medical Institute (HHMI) International Student Research Fellowship; Massachussetts Institute of Technology (MIT) Presidential Fellowship Program; National Defense Science and Engineering Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080639] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI) International Student Research Fellowship; Massachussetts Institute of Technology (MIT) Presidential Fellowship Program; National Defense Science and Engineering Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge NIH (R01GM080639) support. K.D.A. is supported by a Howard Hughes Medical Institute (HHMI) International Student Research Fellowship and the Massachussetts Institute of Technology (MIT) Presidential Fellowship Program. S.A.L. was supported by a National Defense Science and Engineering Graduate Fellowship. P.W.R. is a HHMI Investigator and an associate member of the Broad Institute of Harvard and MIT.	Adler CE, 2014, ELIFE, V3, DOI 10.7554/eLife.02238; Bonabeau E DdRDF, 1999, SWARM INTELLIGENCE N; Camazine S., 2003, SELF ORG BIOL SYSTEM; Cebria F, 2002, NATURE, V419, P620, DOI 10.1038/nature01042; Cebria F, 2007, DEV BIOL, V307, P394, DOI 10.1016/j.ydbio.2007.05.006; Corson F, 2017, SCIENCE, V356, DOI 10.1126/science.aai7407; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Forsthoefel DJ, 2011, DEV BIOL, V356, P445, DOI 10.1016/j.ydbio.2011.05.669; Gurley KA, 2010, DEV BIOL, V347, P24, DOI 10.1016/j.ydbio.2010.08.007; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Harrison S. E., 2017, SCIENCE, V14, P356; Hill EM, 2015, DEVELOPMENT, V142, P4217, DOI 10.1242/dev.123612; Keller EF, 2009, HIST STUD NAT SCI, V39, P1, DOI 10.1525/hsns.2009.39.1.1; Lancaster M. A., 2013, SCIENCE, V345, P374; Lander R, 2016, ELIFE, V5, DOI 10.7554/eLife.12850; Lapan SW, 2012, CELL REP, V2, P294, DOI 10.1016/j.celrep.2012.06.018; Lapan SW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002226; LoCascio SA, 2017, DEV CELL, V40, P381, DOI 10.1016/j.devcel.2017.02.002; Morgan TH, 1898, ARCH ENTW MECH ORG, V7, P364; Nicolis G, 1977, SELF ORG NONEQUILIBR; Oderberg IM, 2017, CURR BIOL, V27, P733, DOI 10.1016/j.cub.2017.01.024; Pellettieri J, 2010, DEV BIOL, V338, P76, DOI 10.1016/j.ydbio.2009.09.015; Petersen CP, 2011, SCIENCE, V332, P852, DOI 10.1126/science.1202143; Sakai F, 2000, ZOOL SCI, V17, P375, DOI 10.2108/jsz.17.375; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Scimone ML, 2016, ELIFE, V5, DOI 10.7554/eLife.12845; Shyer AE, 2017, SCIENCE, V357, P811, DOI 10.1126/science.aai7868; STOCUM DL, 1977, J EXP ZOOL, V201, P451, DOI 10.1002/jez.1402010312; Stuckemann T, 2017, DEV CELL, V40, P248, DOI 10.1016/j.devcel.2016.12.024; Tsiairis CD, 2016, CELL, V164, P656, DOI 10.1016/j.cell.2016.01.028; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983; Witchley JN, 2013, CELL REP, V4, P633, DOI 10.1016/j.celrep.2013.07.022	33	24	25	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2018	360	6387					404	+		10.1126/science.aap8179	http://dx.doi.org/10.1126/science.aap8179			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1AR	29545509	Green Accepted			2022-12-28	WOS:000430949600034
J	Patino, AM; Marsh, RH; Nilles, EJ; Baugh, CW; Rouhani, SA; Kayden, S				Patino, Andres M.; Marsh, Regan H.; Nilles, Eric J.; Baugh, Christopher W.; Rouhani, Shada A.; Kayden, Stephanie			Facing the Shortage of IV Fluids - A Hospital-Based Oral Rehydration Strategy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Patino, Andres M.; Marsh, Regan H.; Nilles, Eric J.; Baugh, Christopher W.; Rouhani, Shada A.; Kayden, Stephanie] Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA; [Patino, Andres M.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Marsh, Regan H.; Rouhani, Shada A.] Partners Hlth, Boston, MA USA; [Nilles, Eric J.; Kayden, Stephanie] Harvard Humanitarian Initiat, Cambridge, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Partners Healthcare System; Harvard University	Patino, AM (corresponding author), Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA.; Patino, AM (corresponding author), Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA.		Nilles, Eric/ABA-4757-2021; Baugh, Christopher William/AAJ-3688-2021	Nilles, Eric/0000-0001-7044-5257; Baugh, Christopher William/0000-0002-2360-1891; Patino, Andres/0000-0002-4599-4016; Rouhani, Shada/0000-0002-2801-192X				[Anonymous], 2014, DRUG SHORT PUBL HLTH; Harting L, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004390.pub2; MAHALANABIS D, 1973, JOHNS HOPKINS MED J, V132, P197; Munos MK, 2010, INT J EPIDEMIOL, V39, P75, DOI 10.1093/ije/dyq025; Saker A, 2018, USA TODAY NETWO 0114	5	13	14	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 19	2018	378	16					1475	1477		10.1056/NEJMp1801772	http://dx.doi.org/10.1056/NEJMp1801772			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GD2EI	29561701	Bronze			2022-12-28	WOS:000430312500003
J	Harris, LH				Harris, Lisa H.			Divisions, New and Old - Conscience and Religious Freedom at HHS	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Harris, Lisa H.] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Harris, Lisa H.] Univ Michigan, Dept Womens Studies, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Harris, LH (corresponding author), Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA.; Harris, LH (corresponding author), Univ Michigan, Dept Womens Studies, Ann Arbor, MI 48109 USA.							Coleman PT, 2014, PSYCHOL TODAY; Department of Health and Human Services, CONSC REL FREED; Gushee DP, 2013, PROLIFE PROCHOICE PR; Martin LA, 2017, SOC SCI MED, V184, P75, DOI 10.1016/j.socscimed.2017.05.001; McLemore MR, 2015, RES NURS HEALTH, V38, P222, DOI 10.1002/nur.21655	5	0	0	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 12	2018	378	15					1369	1371		10.1056/NEJMp1801154	http://dx.doi.org/10.1056/NEJMp1801154			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GC3YA	29537933				2022-12-28	WOS:000429718500001
J	Berwanger, O; Santucci, EV; Silva, PGMDE; Jesuino, ID; Damiani, LP; Barbosa, LM; Santos, RHN; Laranjeira, LN; Egydio, FD; de Oliveira, JAB; Orto, FTCD; de Andrade, PB; Bienert, IRD; Bosso, CE; Mangione, JA; Polanczyk, CA; Sousa, AGDR; Kalil, RAK; Santos, LD; Sposito, AC; Rech, RL; Sousa, ACS; Baldissera, F; Nascimento, BR; Giraldez, RRCV; Cavalcanti, AB; Pereira, SB; Mattos, LA; Armaganijan, LV; Guimaraes, HP; Sousa, JEMR; Alexander, JH; Granger, CB; Lopes, RD				Berwanger, Otavio; Santucci, Eliana Vieira; Melo de Barros e Silva, Pedro Gabriel; Jesuino, Isabella de Andrade; Damiani, Lucas Petri; Barbosa, Lilian Mazza; Nakagawa Santos, Renato Hideo; Laranjeira, Ligia Nasi; Egydio, Flavia de Mattos; Borges de Oliveira, Juliana Aparecida; Campo Dall Orto, Frederico Toledo; de Andrade, Pedro Beraldo; de Castro Bienert, Igor Ribeiro; Bosso, Carlos Eduardo; Mangione, Jose Armando; Polanczyk, Carisi Anne; de Moraes Rego Sousa, Amanda Guerra; Karam Kalil, Renato Abdala; Santos, Luciano de Moura; Sposito, Andrei Carvalho; Rech, Rafael Luiz; Sobral Sousa, Antonio Carlos; Baldissera, Felipe; Nascimento, Bruno Ramos; Correa Veiga Giraldez, Roberto Rocha; Cavalcanti, Alexandre Biasi; Pereira, Sabrina Bernardez; Mattos, Luiz Alberto; Armaganijan, Luciana Vidal; Guimaraes, Helio Penna; Moraes Rego Sousa, Jose Eduardo; Alexander, John Hunter; Granger, Christopher Bull; Lopes, Renato Delascio		SECURE- PCI Investigators	Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome The SECURE-PCI Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ELEVATION MYOCARDIAL-INFARCTION; STATIN THERAPY; METAANALYSIS; EFFICACY; DAMAGE; PRETREATMENT; REDUCTION; IMPACT	IMPORTANCE The effects of loading doses of statins on clinical outcomes in patients with acute coronary syndrome (ACS) and planned invasive management remain uncertain. OBJECTIVE To determine if periprocedural loading doses of atorvastatin decrease 30-day major adverse cardiovascular events (MACE) in patients with ACS and planned invasive management. DESIGN, SETTING, AND PARTICIPANTS Multicenter, double-blind, placebo-controlled, randomized clinical trial conducted at 53 sites in Brazil among 4191 patients with ACS evaluated with coronary angiography to proceed with a percutaneous coronary intervention (PCI) if anatomically feasible. Enrollment occurred between April 18, 2012, and October 6, 2017. Final follow-up for 30-day outcomes was on November 6, 2017. INTERVENTIONS Patients were randomized to receive 2 loading doses of 80 mg of atorvastatin (n = 2087) or matching placebo (n = 2104) before and 24 hours after a planned PCI. All patients received 40 mg of atorvastatin for 30 days starting 24 hours after the second dose of study medication. MAIN OUTCOMES AND MEASURES The primary outcome was MACE, defined as a composite of all-cause mortality, myocardial infarction, stroke, and unplanned coronary revascularization through 30 days RESULTS Among the 4191 patients (mean age, 61.8 [SD, 11.5] years; 1085 women [25.9%]) enrolled, 4163 (99.3%) completed 30-day follow-up. A total of 2710 (64.7%) underwent PCI, 333 (8%) underwent coronary artery bypass graft surgery, and 1144 (27.3%) had exclusively medical management. At 30 days, 130 patients in the atorvastatin group (6.2%) and 149 in the placebo group (7.1%) had a MACE (absolute difference, 0.85%[95% CI, -0.70% to 2.41%]; hazard ratio, 0.88; 95% CI, 0.69-1.11; P =.27). No cases of hepatic failure were reported; 3 cases of rhabdomyolysis were reported in the placebo group (0.1%) and 0 in the atorvastatin group. CONCLUSIONS AND RELEVANCE Among patients with ACS and planned invasive management with PCI, periprocedural loading doses of atorvastatin did not reduce the rate of MACE at 30 days. These findings do not support the routine use of loading doses of atorvastatin among unselected patients with ACS and intended invasive management.	[Berwanger, Otavio; Santucci, Eliana Vieira; Melo de Barros e Silva, Pedro Gabriel; Jesuino, Isabella de Andrade; Damiani, Lucas Petri; Nakagawa Santos, Renato Hideo; Laranjeira, Ligia Nasi; Borges de Oliveira, Juliana Aparecida; Cavalcanti, Alexandre Biasi; Pereira, Sabrina Bernardez; Guimaraes, Helio Penna; Moraes Rego Sousa, Jose Eduardo] Heart Hosp, Res Inst, Abilio Soares St 250,Twelfth Floor, BR-04005000 Sao Paulo, SP, Brazil; [Melo de Barros e Silva, Pedro Gabriel; Barbosa, Lilian Mazza; Egydio, Flavia de Mattos; Armaganijan, Luciana Vidal; Lopes, Renato Delascio] Brazilian Clin Res Inst, Sao Paulo, Brazil; [Campo Dall Orto, Frederico Toledo] Hosp Coracao Pocos de Caldas, Pocos De Caldas, Brazil; [de Andrade, Pedro Beraldo] Santa Casa Marilia, Marilia, Brazil; [de Castro Bienert, Igor Ribeiro] Hosp Clin, Fac Med Marilia, Marilia, Brazil; [Bosso, Carlos Eduardo] Inst Coracao Presidente Prudente, Santa Casa Presidente Prudente, Presidente Prudente, Brazil; [Mangione, Jose Armando] Hosp Sao Francisco de Assis, Braganca Paulista, SP, Brazil; [Polanczyk, Carisi Anne] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [de Moraes Rego Sousa, Amanda Guerra] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil; [Karam Kalil, Renato Abdala] Inst Cardiol Rio Grande do Sul, Porto Alegre, RS, Brazil; [Santos, Luciano de Moura] Inst Cardiol Dist Fed, Brasilia, DF, Brazil; [Sposito, Andrei Carvalho] Univ Estadual Campinas, Fac Ciencias Med, Campinas, Brazil; [Rech, Rafael Luiz] Hosp Univ Canoas, Canoas, Brazil; [Sobral Sousa, Antonio Carlos] Hosp Sao Lucas, Aracaju, Brazil; [Baldissera, Felipe] Inst Pesquisa & Estudos Med Itajai, Itajai, Brazil; [Nascimento, Bruno Ramos] Hosp Univ Ciencias Med, Belo Horizonte, MG, Brazil; [Correa Veiga Giraldez, Roberto Rocha] Inst Coracao, Sao Paulo, Brazil; [Mattos, Luiz Alberto] Rede DOr Sao Luiz, Sao Paulo, Brazil; [Alexander, John Hunter; Granger, Christopher Bull; Lopes, Renato Delascio] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA	Faculdade de Medicina de Marilia; Universidade de Sao Paulo; Instituto Dante Pazzanese de Cardiologia; Fundacao Universitaria de Cardiologia; Universidade Estadual de Campinas; Universidade de Sao Paulo; Duke University	Berwanger, O (corresponding author), Heart Hosp, Res Inst, Abilio Soares St 250,Twelfth Floor, BR-04005000 Sao Paulo, SP, Brazil.	otavioberwanger@gmail.com	Giraldez, Roberto RCV/E-2498-2012; dos Santos, Joao Manoel Theotonio/S-3156-2019; de Barros e Silva, Pedro G M/U-5183-2017; Sposito, Andrei C/G-4116-2013; Nacimento, Bruno Ramos/F-8066-2013; Bosso, Carlos Eduardo C. N./A-6446-2015; Bosso, Cadu/N-3450-2019; de Andrade, Pedro Beraldo/AAQ-6202-2020; Guimaraes, Helio Penna/AAD-8681-2019; Alexander, John/GVS-7271-2022; Damiani, Lucas/F-8576-2015	dos Santos, Joao Manoel Theotonio/0000-0003-2822-0737; de Barros e Silva, Pedro G M/0000-0003-1940-4470; Sposito, Andrei C/0000-0001-7127-2052; Nacimento, Bruno Ramos/0000-0002-5586-774X; Bosso, Cadu/0000-0001-8216-4372; de Andrade, Pedro Beraldo/0000-0003-3511-7375; Alexander, John/0000-0002-1444-2462; Damiani, Lucas/0000-0002-5836-3379; Santos, Luciano/0000-0003-4788-7713; Sobral Sousa, Antonio Carlos/0000-0002-4158-9726; Polanczyk, Carisi/0000-0002-2447-2577	Program to Support Institutional Development of Universal System of the Brazilian Ministry of Health	Program to Support Institutional Development of Universal System of the Brazilian Ministry of Health	This study was funded by and conducted as part of the Program to Support Institutional Development of Universal System of the Brazilian Ministry of Health.	Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P2713, DOI 10.1016/j.jacc.2014.10.011; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Berwanger O, 2018, AM HEART J, V198, P129, DOI 10.1016/j.ahj.2017.12.018; Briguori C, 2009, J AM COLL CARDIOL, V54, P2157, DOI 10.1016/j.jacc.2009.07.005; Cavallini C, 2005, EUR HEART J, V26, P1494, DOI 10.1093/eurheartj/ehi173; Di Sciascio G, 2009, J AM COLL CARDIOL, V54, P558, DOI 10.1016/j.jacc.2009.05.028; Giugliano RP, 2009, NEW ENGL J MED, V360, P2176, DOI 10.1056/NEJMoa0901316; Kim JS, 2010, JACC-CARDIOVASC INTE, V3, P332, DOI 10.1016/j.jcin.2009.11.021; Lansky AJ, 2010, CIRC-CARDIOVASC INTE, V3, P602, DOI 10.1161/CIRCINTERVENTIONS.110.959080; Nohria A, 2009, ATHEROSCLEROSIS, V205, P517, DOI 10.1016/j.atherosclerosis.2008.12.023; O'Gara PT, 2013, J AM COLL CARDIOL, V61, P485, DOI [10.1161/CIR.0b013e3182742c84, 10.1016/j.jacc.2012.11.018]; Pasceri V, 2004, CIRCULATION, V110, P674, DOI 10.1161/01.CIR.0000137828.06205.87; Patti G, 2007, J AM COLL CARDIOL, V49, P1272, DOI 10.1016/j.jacc.2007.02.025; Patti G, 2011, CIRCULATION, V123, P1622, DOI 10.1161/CIRCULATIONAHA.110.002451; R Development Core Team, 2009, R LANG ENV STAT COMP; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Rosenson RS, 1998, JAMA-J AM MED ASSOC, V279, P1643, DOI 10.1001/jama.279.20.1643; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004; Winchester DE, 2010, J AM COLL CARDIOL, V56, P1099, DOI 10.1016/j.jacc.2010.04.023	21	80	82	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2018	319	13					1331	1340		10.1001/jama.2018.2444	http://dx.doi.org/10.1001/jama.2018.2444			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB4NC	29525821	Green Published, Bronze			2022-12-28	WOS:000429035900017
J	Hernan, MA; Scharfstein, D				Hernan, Miguel A.; Scharfstein, Daniel			Cautions as Regulators Move to End Exclusive Reliance on Intention to Treat	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Hernan, Miguel A.] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Hernan, Miguel A.] Harvard Mit Div Hlth Sci & Technol, Boston, MA 02115 USA; [Scharfstein, Daniel] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Hernan, Miguel A.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA; [Scharfstein, Daniel] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, 615 North Wolfe St, Baltimore, MD 21205 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Hernan, MA (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.; Hernan, MA (corresponding author), Harvard Mit Div Hlth Sci & Technol, Boston, MA 02115 USA.; Hernan, MA (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.	miguel_hernan@post.harvard.edu		Hernan, Miguel/0000-0003-1619-8456	National Institutes of Health [UL1TR001079]; Patient-Centered Outcomes Research Institute [ME-1503-28119]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	In part by grant UL1TR001079 from the National Institutes of Health and contract ME-1503-28119 from the Patient-Centered Outcomes Research Institute.	Causey M, 2017, FDA ENDORSES ICH E9; Goetghebeur E, 2002, EPIDEMIOL REV, V24, P85, DOI 10.1093/epirev/24.1.85; Hernan MA, 2017, NEW ENGL J MED, V377, P1391, DOI 10.1056/NEJMsm1605385; Hernan MA, 2013, ANN INTERN MED, V159, P560, DOI 10.7326/0003-4819-159-8-201310150-00709; Hernan MA, 2012, CLIN TRIALS, V9, P48, DOI 10.1177/1740774511420743; International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use, 2017, ICH HARM GUID EST SE; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730	7	19	20	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2018	168	7					515	+		10.7326/M17-3354	http://dx.doi.org/10.7326/M17-3354			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB4AB	29554689				2022-12-28	WOS:000429000900013
J	Hindupur, SK; Colombi, M; Fuhs, SR; Matter, MS; Guri, Y; Adam, K; Cornu, M; Piscuoglio, S; Ng, CKY; Betz, C; Liko, D; Quagliata, L; Moes, S; Jenoe, P; Terracciano, LM; Heim, MH; Hunter, T; Hall, MN				Hindupur, Sravanth K.; Colombi, Marco; Fuhs, Stephen R.; Matter, Matthias S.; Guri, Yakir; Adam, Kevin; Cornu, Marion; Piscuoglio, Salvatore; Ng, Charlotte K. Y.; Betz, Charles; Liko, Dritan; Quagliata, Luca; Moes, Suzette; Jenoe, Paul; Terracciano, Luigi M.; Heim, Markus H.; Hunter, Tony; Hall, Michael N.			The protein histidine phosphatase LHPP is a tumour suppressor	NATURE			English	Article							GENOME-WIDE ASSOCIATION; HEPATOCELLULAR-CARCINOMA; INORGANIC PYROPHOSPHATASE; PHOSPHORYLATION; PHOSPHOHISTIDINE; LIVER; IDENTIFICATION; PLATFORM; KINASE; CANCER	Histidine phosphorylation, the so-called hidden phosphoproteome, is a poorly characterized post-translational modification of proteins(1,2). Here we describe a role of histidine phosphorylation in tumorigenesis. Proteomic analysis of 12 tumours from an mTOR-driven hepatocellular carcinoma mouse model revealed that NME1 and NME2, the only known mammalian histidine kinases, were upregulated. Conversely, expression of the putative histidine phosphatase LHPP was downregulated specifically in the tumours. We demonstrate that LHPP is indeed a protein histidine phosphatase. Consistent with these observations, global histidine phosphorylation was significantly upregulated in the liver tumours. Sustained, hepatic expression of LHPP in the hepatocellular carcinoma mouse model reduced tumour burden and prevented the loss of liver function. Finally, in patients with hepatocellular carcinoma, low expression of LHPP correlated with increased tumour severity and reduced overall survival. Thus, LHPP is a protein histidine phosphatase and tumour suppressor, suggesting that deregulated histidine phosphorylation is oncogenic.	[Hindupur, Sravanth K.; Colombi, Marco; Guri, Yakir; Cornu, Marion; Betz, Charles; Liko, Dritan; Moes, Suzette; Jenoe, Paul; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Fuhs, Stephen R.; Adam, Kevin; Hunter, Tony] Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Matter, Matthias S.; Piscuoglio, Salvatore; Ng, Charlotte K. Y.; Quagliata, Luca; Terracciano, Luigi M.] Univ Hosp Basel, Inst Pathol, CH-4031 Basel, Switzerland; [Heim, Markus H.] Univ Hosp Basel, Dept Biomed, CH-4031 Basel, Switzerland	University of Basel; Salk Institute; University of Basel; University of Basel	Hall, MN (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	m.hall@unibas.ch	Ng, Charlotte K Y/AAA-1670-2020; Betz, Charles/B-7444-2008; Guri, Yakir/Y-1789-2019; Piscuoglio, Salvatore/AAB-4959-2022; Heim, Markus/A-7526-2008; Ng, Charlotte K Y/AAY-3178-2021; Terracciano, Luigi M./AAB-5335-2022; Quagliata, Luca/B-8321-2015	Betz, Charles/0000-0002-9837-6916; Guri, Yakir/0000-0003-4273-4603; Piscuoglio, Salvatore/0000-0003-2686-2939; Heim, Markus/0000-0002-7523-4894; Ng, Charlotte K Y/0000-0002-6100-0026; Terracciano, Luigi M./0000-0002-9393-9660; Quagliata, Luca/0000-0001-8249-9914; Hall, Michael N/0000-0002-2998-0757; Adam, Kevin/0000-0003-0007-0634; Hindupur, Sravanth/0000-0002-8078-4006; Matter, Matthias/0000-0002-2005-5266	NCI NIH HHS [R01 CA082683, R01 CA194584, P30 CA014195, R01 CA080100, CA194584, CA082683, CA080100] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA194584, R01CA082683, R01CA080100] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Attwood PV, 2007, AMINO ACIDS, V32, P145, DOI 10.1007/s00726-006-0443-6; Besant PG, 2009, MOL CELL BIOCHEM, V329, P93, DOI 10.1007/s11010-009-0117-2; Cai N, 2015, NATURE, V523, P588, DOI 10.1038/nature14659; Cai XJ, 2014, MOL BIOL CELL, V25, P1244, DOI 10.1091/mbc.E13-04-0180; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen M, 2015, CANCER RES, V75, P1645, DOI 10.1158/0008-5472.CAN-14-2147; Chong PSY, 2014, CANCER RES, V74, P3043, DOI 10.1158/0008-5472.CAN-13-2321; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dephoure N, 2011, METHODS, V54, P379, DOI 10.1016/j.ymeth.2011.03.008; Ek P, 2002, EUR J BIOCHEM, V269, P5016, DOI 10.1046/j.1432-1033.2002.03206.x; Fuhs SR, 2017, CURR OPIN CELL BIOL, V45, P8, DOI 10.1016/j.ceb.2016.12.010; Fuhs SR, 2015, CELL, V162, P198, DOI 10.1016/j.cell.2015.05.046; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Guri Y, 2017, CANCER CELL, V32, P807, DOI 10.1016/j.ccell.2017.11.011; Hartsough MT, 2002, J BIOL CHEM, V277, P32389, DOI 10.1074/jbc.M203115200; Hiraishi H, 1998, ARCH BIOCHEM BIOPHYS, V349, P381, DOI 10.1006/abbi.1997.0480; Hiraishi H, 1997, ARCH BIOCHEM BIOPHYS, V341, P153, DOI 10.1006/abbi.1997.9935; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Kee JM, 2012, ACS CHEM BIOL, V7, P44, DOI 10.1021/cb200445w; Kee JM, 2010, J AM CHEM SOC, V132, P14327, DOI 10.1021/ja104393t; Kenerson HL, 2013, GASTROENTEROLOGY, V144, P1055, DOI 10.1053/j.gastro.2013.01.053; Klumpp S, 2002, J CEREBR BLOOD F MET, V22, P1420, DOI 10.1097/01.wcb.0000045041.03034.99; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lesseur C, 2016, NAT GENET, V48, P1544, DOI 10.1038/ng.3685; Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]; Lo Re O., 2018, HEPATOLOGY, V67; Makowska Z, 2016, J PATHOL CLIN RES, V2, P80, DOI 10.1002/cjp2.37; Neff CD, 2009, MOL PSYCHIATR, V14, P621, DOI 10.1038/mp.2008.8; Panda S, 2016, MOL CELL, V63, P457, DOI 10.1016/j.molcel.2016.06.021; Park IH, 2002, J BIOL CHEM, V277, P31423, DOI 10.1074/jbc.M204080200; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Riley NM, 2016, ANAL CHEM, V88, P74, DOI 10.1021/acs.analchem.5b04123; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Vijayakrishnan J, 2017, LEUKEMIA, V31, P573, DOI 10.1038/leu.2016.271; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; WAGNER PD, 1995, J BIOL CHEM, V270, P21758, DOI 10.1074/jbc.270.37.21758; Yokoi F, 2003, J BIOCHEM, V133, P607, DOI 10.1093/jb/mvg078	40	109	119	4	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2018	555	7698					678	+		10.1038/nature26140	http://dx.doi.org/10.1038/nature26140			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8UX	29562234	Green Accepted			2022-12-28	WOS:000428617600053
J	Riddell, J; Amico, R; Mayer, KH				Riddell, James; Amico, Rivet; Mayer, Kenneth H.			HIV Preexposure Prophylaxis A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							MULTIDRUG-RESISTANT HIV-1; ANTIRETROVIRAL PROPHYLAXIS; PREVENTION; INFECTION; TENOFOVIR; SAFETY; MEN; TRANSMISSION; CHALLENGES; RISK	IMPORTANCE About 40 000 Americans and 2 million people worldwide are newly infected with HIV each year. The combination antiretroviral regimen, tenofovir disoproxil fumarate (TDF)/emtricitabine, taken as a single pill once daily, has been shown to prevent HIV transmission but is used by fewer than 20% of people who could benefit in the United States. OBSERVATIONS PubMed was searched on February 15, 2018, using the search terms pre-exposure, prophylaxis, HIV, and PrEP to identify English-language articles published between 2010 and 2018. Four placebo-controlled randomized clinical trials have demonstrated that preexposure prophylaxis (PrEP) with daily dosing of TDF/emtricitabine significantly reduces HIV acquisition in men who have sex with men, high-risk heterosexuals, and injection drug users who share injection equipment. The efficacy of daily TDF/emtricitabine exceeds 90% but is highly correlated with degree of adherence. TDF/emtricitabine is safe and well-tolerated. Only 2% of people discontinue PrEP because of adverse effects. Sexually transmitted infections are common among those using PrEP. Resistance to TDF/emtricitabine when used for PrEP is rare (<0.1%) and usually occurs when PrEP is inadvertently prescribed to individuals with undiagnosed acute HIV infection who have false-negative findings on HIV antibody/antigen testing due to HIV infection acquired within 7 to 10 days of testing. Effective methods are needed to identify individuals at high risk for acquiring HIV, ensure their access to PrEP, and maximize medication adherence. CONCLUSIONS AND RELEVANCE TDF/emtricitabine is an effective and safe therapy for preventing HIV transmission. Increasing prescription of TDF/emtricitabine for patients at risk of acquiring HIV has the potential to reduce new HIV infections.	[Riddell, James] Univ Michigan, Med Ctr, Dept Internal Med, Div Infect Dis, Ann Arbor, MI 48109 USA; [Amico, Rivet] Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA; [Mayer, Kenneth H.] Fenway Hlth, Fenway Inst, Boston, MA USA; [Mayer, Kenneth H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA USA; [Mayer, Kenneth H.] Harvard Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Fenway Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Riddell, J (corresponding author), Univ Michigan, Med Ctr, 1500 E Med Ctr Dr,Univ Hosp South F4131, Ann Arbor, MI 48109 USA.	jriddell@umich.edu	/AAE-4700-2020	Amico, K Rivet/0000-0002-4458-6934	GlaxoSmithKline; ViiV Healthcare; University of Michigan from Gilead Sciences for material development; Gilead Sciences	GlaxoSmithKline(GlaxoSmithKline); ViiV Healthcare; University of Michigan from Gilead Sciences for material development; Gilead Sciences(Gilead Sciences)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Riddell reported receiving grant support from GlaxoSmithKline and ViiV Healthcare. Dr Amico reported receiving an educational grant through the University of Michigan from Gilead Sciences for material development for PrEP awareness and serving as an expert in an advisory meeting in May 2017 for Gilead Sciences. Dr Mayer reported receiving unrestricted research grants from Gilead Sciences and ViiV Healthcare.	Adams LM, 2016, AIDS CARE, V28, P1154, DOI 10.1080/09540121.2016.1153595; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Anderson PL, 2017, ANTIMICROB AGENTS CH, V62; [Anonymous], 2017, WORLD HTLH STAT 2017; [Anonymous], 2014, PREEXP PROPH PREV HI; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baeten JM, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002099; Buchbinder SP, 2011, AIDS BEHAV, V15, pS72, DOI 10.1007/s10461-011-9894-1; Cardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101; Centers for Disease Control and Prevention, 2016, TRENDS US HIV DIAGN; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Fonner VA, 2016, AIDS, V30, P1973, DOI 10.1097/QAD.0000000000001145; Garcia-Lerma JG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000391; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grigsby IF, 2010, BIOCHEM BIOPH RES CO, V394, P48, DOI 10.1016/j.bbrc.2010.02.080; Gunawardana M, 2015, ANTIMICROB AGENTS CH, V59, P3913, DOI 10.1128/AAC.00656-15; Hanscom B, 2016, JAIDS-J ACQ IMM DEF, V73, P606, DOI 10.1097/QAI.0000000000001160; Herlitz LC, 2010, KIDNEY INT, V78, P1171, DOI 10.1038/ki.2010.318; Hess K, 2017, HIV SURVEILLANCE REP; Hoornenborg E, 2017, LANCET HIV, V4, pE522, DOI 10.1016/S2352-3018(17)30132-7; Hosek SG, 2017, JAMA PEDIATR, V171, P1063, DOI 10.1001/jamapediatrics.2017.2007; Hosek SG, 2017, JAIDS-J ACQ IMM DEF, V74, P21, DOI 10.1097/QAI.0000000000001179; Hua CK, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01655; Hurt CB, 2011, CLIN INFECT DIS, V53, P1265, DOI 10.1093/cid/cir684; Johnson A, 2014, HIV SURVEILLANCE REP; Kasonde M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090111; Knox DC, 2017, NEW ENGL J MED, V376, P501, DOI 10.1056/NEJMc1611639; Krakower DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132398; Ledgerwood JE, 2015, CLIN EXP IMMUNOL, V182, P289, DOI 10.1111/cei.12692; Liu AY, 2016, JAMA INTERN MED, V176, P75, DOI 10.1001/jamainternmed.2015.4683; Marcus JL, 2016, JAIDS-J ACQ IMM DEF, V73, P540, DOI 10.1097/QAI.0000000000001129; Marcus JL, 2016, CURR HIV-AIDS REP, V13, P116, DOI 10.1007/s11904-016-0308-x; Markowitz M, 2017, JAIDS-J ACQ IMM DEF, V76, pE104, DOI 10.1097/QAI.0000000000001534; Markowitz M, 2017, LANCET HIV, V4, pE331, DOI 10.1016/S2352-3018(17)30068-1; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Matthews LT, 2010, AIDS, V24, P1975, DOI 10.1097/QAD.0b013e32833bedeb; Mayer KH, 2018, JAIDS-J ACQ IMM DEF, V77, P119, DOI 10.1097/QAI.0000000000001579; Mayer KH, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx214; Mayer KH, 2016, JAMA-J AM MED ASSOC, V315, P867, DOI 10.1001/jama.2016.0318; Mayer KH, 2015, CURR OPIN HIV AIDS, V10, P226, DOI 10.1097/COH.0000000000000170; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Medland NA, 2018, INT J STD AIDS, V29, P227, DOI 10.1177/0956462417722133; Mofenson LM, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002133; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Mugwanya K, 2016, J INFECT DIS, V214, P1050, DOI 10.1093/infdis/jiw125; Murnane PM, 2014, AIDS, V28, P1825, DOI 10.1097/QAD.0000000000000290; Nel A, 2016, NEW ENGL J MED, V375, P2133, DOI 10.1056/NEJMoa1602046; Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298; Patterson KB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003174; Puri A, 2017, CRIT REV THER DRUG, V34, P551, DOI 10.1615/CritRevTherDrugCarrierSyst.2017020147; Rodger Alison J, 2016, JAMA, V316, P171, DOI 10.1001/jama.2016.5148; Smith DK, 2015, MMWR-MORBID MORTAL W, V64, P1291, DOI 10.15585/mmwr.mm6446a4; Solomon MM, 2016, JAIDS-J ACQ IMM DEF, V71, P281, DOI 10.1097/QAI.0000000000000857; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Volk JE, 2015, CLIN INFECT DIS, V61, P1601, DOI 10.1093/cid/civ778; Wesolowski L.G, 2014, LAB TEST DIAGN HIV I	58	161	163	7	52	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2018	319	12					1261	1268		10.1001/jama.2018.1917	http://dx.doi.org/10.1001/jama.2018.1917			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GA5VW	29584848				2022-12-28	WOS:000428403000018
J	Abul-Husn, NS; Cheng, X; Li, AH; Xin, Y; Schurmann, C; Stevis, P; Liu, Y; Kozlitina, J; Stender, S; Wood, GC; Stepanchick, AN; Still, MD; McCarthy, S; O'Dushlaine, C; Packer, JS; Balasubramanian, S; Gosalia, N; Esopi, D; Kim, SY; Mukherjee, S; Lopez, AE; Fuller, ED; Penn, J; Chu, X; Luo, JZ; Mirshahi, UL; Carey, DJ; Still, CD; Feldman, MD; Small, A; Damrauer, SM; Rader, DJ; Zambrowicz, B; Olson, W; Murphy, AJ; Borecki, IB; Shuldiner, AR; Reid, JG; Overton, JD; Yancopoulos, GD; Hobbs, HH; Cohen, JC; Gottesman, O; Teslovich, TM; Baras, A; Mirshahi, T; Gromada, J; Dewey, FE				Abul-Husn, N. S.; Cheng, X.; Li, A. H.; Xin, Y.; Schurmann, C.; Stevis, P.; Liu, Y.; Kozlitina, J.; Stender, S.; Wood, G. C.; Stepanchick, A. N.; Still, M. D.; McCarthy, S.; O'Dushlaine, C.; Packer, J. S.; Balasubramanian, S.; Gosalia, N.; Esopi, D.; Kim, S. Y.; Mukherjee, S.; Lopez, A. E.; Fuller, E. D.; Penn, J.; Chu, X.; Luo, J. Z.; Mirshahi, U. L.; Carey, D. J.; Still, C. D.; Feldman, M. D.; Small, A.; Damrauer, S. M.; Rader, D. J.; Zambrowicz, B.; Olson, W.; Murphy, A. J.; Borecki, I. B.; Shuldiner, A. R.; Reid, J. G.; Overton, J. D.; Yancopoulos, G. D.; Hobbs, H. H.; Cohen, J. C.; Gottesman, O.; Teslovich, T. M.; Baras, A.; Mirshahi, T.; Gromada, J.; Dewey, F. E.			A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; UNITED-STATES; CONFERS SUSCEPTIBILITY; GENETIC-VARIATION; PNPLA3; TM6SF2; PREVALENCE; EXPRESSION; SECRETION; RISK	BACKGROUND Elucidation of the genetic factors underlying chronic liver disease may reveal new therapeutic targets. METHODS We used exome sequence data and electronic health records from 46,544 participants in the DiscovEHR human genetics study to identify genetic variants associated with serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Variants that were replicated in three additional cohorts (12,527 persons) were evaluated for association with clinical diagnoses of chronic liver disease in DiscovEHR study participants and two independent cohorts (total of 37,173 persons) and with histopathological severity of liver disease in 2391 human liver samples. RESULTS A splice variant (rs72613567: TA) in HSD17B13, encoding the hepatic lipid droplet protein hydroxysteroid 17-beta dehydrogenase 13, was associated with reduced levels of ALT (P = 4.2x10(-12)) and AST (P = 6.2x10(-10)). Among DiscovEHR study participants, this variant was associated with a reduced risk of alcoholic liver disease (by 42% [95% confidence interval {CI}, 20 to 58] among heterozygotes and by 53% [95% CI, 3 to 77] among homozygotes), nonalcoholic liver disease (by 17% [95% CI, 8 to 25] among heterozygotes and by 30% [95% CI, 13 to 43] among homozygotes), alcoholic cirrhosis (by 42% [95% CI, 14 to 61] among heterozygotes and by 73% [95% CI, 15 to 91] among homozygotes), and nonalcoholic cirrhosis (by 26% [95% CI, 7 to 40] among heterozygotes and by 49% [95% CI, 15 to 69] among homozygotes). Associations were confirmed in two independent cohorts. The rs72613567: TA variant was associated with a reduced risk of nonalcoholic steatohepatitis, but not steatosis, in human liver samples. The rs72613567: TA variant mitigated liver injury associated with the risk-increasing PNPLA3 p.I148M allele and resulted in an unstable and truncated protein with reduced enzymatic activity. CONCLUSIONS A loss-of-function variant in HSD17B13 was associated with a reduced risk of chronic liver disease and of progression from steatosis to steatohepatitis.	[Abul-Husn, N. S.; Li, A. H.; Schurmann, C.; McCarthy, S.; O'Dushlaine, C.; Packer, J. S.; Balasubramanian, S.; Gosalia, N.; Mukherjee, S.; Lopez, A. E.; Fuller, E. D.; Penn, J.; Borecki, I. B.; Shuldiner, A. R.; Reid, J. G.; Overton, J. D.; Gottesman, O.; Teslovich, T. M.; Baras, A.; Dewey, F. E.] Regeneron Genet Ctr, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA; [Cheng, X.; Xin, Y.; Stevis, P.; Liu, Y.; Esopi, D.; Kim, S. Y.; Zambrowicz, B.; Olson, W.; Murphy, A. J.; Yancopoulos, G. D.; Gromada, J.] Regeneron Pharmaceut, Tarrytown, NY USA; [Kozlitina, J.; Stender, S.; Hobbs, H. H.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Wood, G. C.; Stepanchick, A. N.; Still, M. D.; Chu, X.; Luo, J. Z.; Mirshahi, U. L.; Carey, D. J.; Still, C. D.; Mirshahi, T.] Geisinger Hlth Syst, Danville, PA USA; [Still, M. D.; Feldman, M. D.; Small, A.; Damrauer, S. M.; Rader, D. J.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	Regeneron; Regeneron; University of Texas System; University of Texas Southwestern Medical Center Dallas; Geisinger Health System; University of Pennsylvania; Pennsylvania Medicine	Dewey, FE (corresponding author), Regeneron Genet Ctr, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.	frederick.dewey@regeneron.com	Schurmann, Claudia/L-1204-2016; Stender, Stefan/AAC-8258-2019	Schurmann, Claudia/0000-0003-4158-9192; Stender, Stefan/0000-0003-0281-5900; Damrauer, Scott/0000-0001-8009-1632; Packer, Jonathan/0000-0003-4025-0007; Still, Matthew/0000-0002-3862-2425; Kozlitina, Julia/0000-0001-7720-2290; Balasubramanian, Suganthi/0000-0003-2243-5948; Luo, Jonathan/0000-0003-2567-1516; Abul-Husn, Noura/0000-0002-5179-1944; Kim, Sun/0000-0001-8133-865X	Regeneron Pharmaceuticals; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488, R01DK090066] Funding Source: NIH RePORTER	Regeneron Pharmaceuticals(Regeneron); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by Regeneron Pharmaceuticals and others.	BRANTLY M, 1988, AM J MED, V84, P13; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Buch S, 2015, NAT GENET, V47, P1443, DOI 10.1038/ng.3417; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Dewey FE, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6814; Donati B, 2016, HEPATOLOGY, V63, P787, DOI 10.1002/hep.28370; Feitosa MF, 2013, ATHEROSCLEROSIS, V228, P175, DOI 10.1016/j.atherosclerosis.2013.01.038; Huang YC, 2011, J BIOL CHEM, V286, P37085, DOI 10.1074/jbc.M111.290114; Kampf C, 2014, FASEB J, V28, P2901, DOI 10.1096/fj.14-250555; Kitamoto T, 2013, HUM GENET, V132, P783, DOI 10.1007/s00439-013-1294-3; Kochanek Kenneth D, 2016, Natl Vital Stat Rep, V65, P1; Kozlitina J, 2014, NAT GENET, V46, P352, DOI 10.1038/ng.2901; Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448; Li PP, 2015, NAT MED, V21, P239, DOI 10.1038/nm.3800; Liu S, 2007, ACTA BIOCHIM POL, V54, P213, DOI 10.18388/abp.2007_3289; Liu YL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5309; Mahdessian H, 2014, P NATL ACAD SCI USA, V111, P8913, DOI 10.1073/pnas.1323785111; Mancina RM, 2016, GASTROENTEROLOGY, V150, P1219, DOI 10.1053/j.gastro.2016.01.032; Moeller G, 2009, MOL CELL ENDOCRINOL, V301, P7, DOI 10.1016/j.mce.2008.10.040; Pirazzi C, 2012, J HEPATOL, V57, P1276, DOI 10.1016/j.jhep.2012.07.030; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Rotman Y, 2010, HEPATOLOGY, V52, P894, DOI 10.1002/hep.23759; Smagris E, 2016, J BIOL CHEM, V291, P10659, DOI 10.1074/jbc.M116.719955; Sookoian S, 2015, HEPATOLOGY, V61, P515, DOI 10.1002/hep.27556; Sookoian S, 2009, J LIPID RES, V50, P2111, DOI 10.1194/jlr.P900013-JLR200; Su W, 2014, P NATL ACAD SCI USA, V111, P11437, DOI 10.1073/pnas.1410741111; Trepo E, 2016, J HEPATOL, V65, P399, DOI 10.1016/j.jhep.2016.03.011; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Younossi ZM, 2011, CLIN GASTROENTEROL H, V9, P524, DOI 10.1016/j.cgh.2011.03.020	30	364	373	3	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2018	378	12					1096	1106		10.1056/NEJMoa1712191	http://dx.doi.org/10.1056/NEJMoa1712191			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ9OV	29562163	Bronze, Green Accepted			2022-12-28	WOS:000427942300006
J	Honarbakhsh, S; Hunter, L; Chow, A; Hunter, RJ				Honarbakhsh, S.; Hunter, L.; Chow, A.; Hunter, Ross J.			Bradyarrhythmias and pacemakers	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ATRIOVENTRICULAR-BLOCK; ESC GUIDELINES; SOCIETY; DEFIBRILLATOR; DIAGNOSIS; PROGNOSIS; THERAPY; YOUNG		[Honarbakhsh, S.; Chow, A.; Hunter, Ross J.] Barts Hlth NHS Trust, St Bartholomews Hosp, Dept Arrhythmia Serv, Barts Heart Ctr, London EC1A 7BE, England; [Hunter, L.] Rosemead Surg, 8 Ray Pk Ave, Maidenhead SL6 8DS, Berks, England	Barts Health NHS Trust; University of London; Queen Mary University London	Hunter, RJ (corresponding author), Barts Hlth NHS Trust, St Bartholomews Hosp, Dept Arrhythmia Serv, Barts Heart Ctr, London EC1A 7BE, England.	ross.hunter@bartshealth.nhs.uk						Abi Khalil C, 2017, BMJ-BRIT MED J, V358, pj3123, DOI [10.1136/bmj.j312328751495, DOI 10.1136/BMJ.J312328751495]; [Anonymous], 2014, EUR SOC CARD C AUG 3; Blanc JJ, 2014, HEART FAILURE DEVICE; Bradshaw PJ, 2014, OPEN HEART, V1, DOI 10.1136/openhrt-2014-000177; Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150; Chen Lin Y, 2006, Am J Med, V119, DOI 10.1016/j.amjmed.2006.01.029; Barra SNC, 2012, PACE, V35, P1395, DOI 10.1111/j.1540-8159.2012.03489.x; Curtis AB, 2013, NEW ENGL J MED, V368, P1585, DOI 10.1056/NEJMoa1210356; DAVIES M, 1969, BRIT HEART J, V31, P219; Epstein AE, 2013, J AM COLL CARDIOL, V62, P2000, DOI 10.1016/j.jacc.2013.05.086; Ezzat VA, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2014-000198; Gerstenblith G, 2005, CARDIOVASCULAR DIS E, DOI [10.1385/1592599419, DOI 10.1385/1592599419]; HARRIS A, 1969, BRIT HEART J, V31, P206; Kandolin R, 2011, CIRC-ARRHYTHMIA ELEC, V4, P303, DOI 10.1161/CIRCEP.110.959254; Kirkfeldt RE, 2014, EUR HEART J, V35, P1186, DOI 10.1093/eurheartj/eht511; LAMB L E, 1960, Aerosp Med, V31, P973; Mond HG, 2011, PACE, V34, P1013, DOI 10.1111/j.1540-8159.2011.03150.x; Osmonov D, 2012, PACE, V35, P804, DOI 10.1111/j.1540-8159.2012.03410.x; Ozcan KS, 2012, J CARDIOL, V60, P327, DOI 10.1016/j.jjcc.2012.05.012; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Raatikainen MJP, 2015, EUROPACE, V17, pI1, DOI 10.1093/europace/euu300; Reddy VY, 2015, NEW ENGL J MED, V373, P1125, DOI 10.1056/NEJMoa1507192; Reynolds D, 2016, NEW ENGL J MED, V374, P533, DOI 10.1056/NEJMoa1511643; Sheldon RS, 2015, HEART RHYTHM, V12, pE41, DOI 10.1016/j.hrthm.2015.03.029; Shen WK, 2017, HEART RHYTHM, V14, pE155, DOI 10.1016/j.hrthm.2017.03.004; Sweeney MO, 2003, CIRCULATION, V107, P2932, DOI 10.1161/01.CIR.0000072769.17295.B1; Wilkoff BL, 2002, JAMA-J AM MED ASSOC, V288, P3115; Zeltser D, 2004, J AM COLL CARDIOL, V44, P105, DOI 10.1016/j.jacc.2004.03.057; ZOOB M, 1963, Br Med J, V2, P1149	29	4	5	3	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2018	360								k642	10.1136/bmj.k642	http://dx.doi.org/10.1136/bmj.k642			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ9GD	29545242				2022-12-28	WOS:000427917100007
J	Citi, S				Citi, Sandra			Intestinal barriers protect against disease	SCIENCE			English	Editorial Material							TIGHT JUNCTION; CLAUDINS		[Citi, Sandra] Univ Geneva, Fac Sci, Dept Cell Biol, 30 Quai Ernest Ansermet, CH-1205 Geneva, Switzerland; [Citi, Sandra] Univ Geneva, Inst Genet & Genom Geneva iGE3, 30 Quai Ernest Ansermet, CH-1205 Geneva, Switzerland	University of Geneva; University of Geneva	Citi, S (corresponding author), Univ Geneva, Fac Sci, Dept Cell Biol, 30 Quai Ernest Ansermet, CH-1205 Geneva, Switzerland.; Citi, S (corresponding author), Univ Geneva, Inst Genet & Genom Geneva iGE3, 30 Quai Ernest Ansermet, CH-1205 Geneva, Switzerland.	sandra.citi@unige.ch						Buckley A, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029314; Citi Sandra, 2014, Small GTPases, V5, P1, DOI 10.4161/21541248.2014.973760; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; Fanning AS, 2009, ANN NY ACAD SCI, V1165, P113, DOI 10.1111/j.1749-6632.2009.04440.x; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Ivanov AI, 2005, BIOESSAYS, V27, P356, DOI 10.1002/bies.20203; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Krug SM, 2014, SEMIN CELL DEV BIOL, V36, P166, DOI 10.1016/j.semcdb.2014.09.002; Luissint AC, 2016, GASTROENTEROLOGY, V151, P616, DOI 10.1053/j.gastro.2016.07.008; Mohanan V, 2018, SCIENCE, V359, P1161, DOI 10.1126/science.aan0814; Thaiss CA, 2018, SCIENCE, V359, P1376, DOI 10.1126/science.aar3318; Tsukita S, 2000, J CELL BIOL, V149, P13, DOI 10.1083/jcb.149.1.13; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Vieira SM, 2018, SCIENCE, V359, P1156, DOI 10.1126/science.aar7201; Zihni C, 2016, NAT REV MOL CELL BIO, V17, P564, DOI 10.1038/nrm.2016.80	15	97	106	7	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2018	359	6380					1097	1098		10.1126/science.aat0835	http://dx.doi.org/10.1126/science.aat0835			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY4ZM	29590026				2022-12-28	WOS:000426835900021
J	Reese, A				Reese, April			CLIMATE CHANGE Slow coolant phaseout could worsen warming	SCIENCE			English	News Item																			0	7	7	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2018	359	6380					1084	1084		10.1126/science.359.6380.1084	http://dx.doi.org/10.1126/science.359.6380.1084			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4ZM	29590021				2022-12-28	WOS:000426835900016
J	Xiao, G; Chan, LN; Klemm, L; Braas, D; Chen, ZS; Geng, HM; Zhang, QYC; Aghajanirefah, A; Cosgun, KN; Sadras, T; Lee, J; Mirzapoiazova, T; Salgia, R; Ernst, T; Hochhaus, A; Jumaa, H; Jiang, XY; Weinstock, DM; Graeber, TG; Muschen, M				Xiao, Gang; Chan, Lai N.; Klemm, Lars; Braas, Daniel; Chen, Zhengshan; Geng, Huimin; Zhang, Qiuyi Chen; Aghajanirefah, Ali; Cosgun, Kadriye Nehir; Sadras, Teresa; Lee, Jaewoong; Mirzapoiazova, Tamara; Salgia, Ravi; Ernst, Thomas; Hochhaus, Andreas; Jumaa, Hassan; Jiang, Xiaoyan; Weinstock, David M.; Graeber, Thomas G.; Muschen, Markus			B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell Malignancies	CELL			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; PROTEIN PHOSPHATASE 2A; TRANSCRIPTION FACTORS; TUMOR-GROWTH; LUNG-CANCER; PP2A; GENE; MECHANISMS; GLYCOLYSIS; ACTIVATION	Bcell activationduringnormalimmune responsesand oncogenic transformation impose increased metabolic demands on B cells and their ability to retain redox homeostasis. While the serine/threonine-protein phosphatase 2A (PP2A) was identified as a tumor suppressor in multiple types of cancer, our genetic studies revealed an essential role of PP2A in B cell tumors. Thereby, PP2A redirects glucose carbon utilization from glycolysis to the pentose phosphate pathway (PPP) to salvage oxidative stress. This uniquevulnerability reflectsconstitutively lowPPPactivity in B cells and transcriptional repression of G6PD and other key PPP enzymes by theB cell transcription factors PAX5 and IKZF1. Reflecting B-cell-specific transcriptional PPP-repression, glucose carbon utilization inBcells is heavily skewedin favor of glycolysis resulting in lack of PPP-dependent antioxidant protection. These findings reveal a gatekeeper function of the PPP in a broad range of B cell malignancies that can be efficiently targeted by small molecule inhibition of PP2A and G6PD.	[Xiao, Gang; Chan, Lai N.; Klemm, Lars; Chen, Zhengshan; Zhang, Qiuyi Chen; Aghajanirefah, Ali; Cosgun, Kadriye Nehir; Sadras, Teresa; Lee, Jaewoong; Mirzapoiazova, Tamara; Salgia, Ravi; Jumaa, Hassan; Muschen, Markus] Beckman Res Inst, Dept Syst Biol, Monrovia, CA 91016 USA; [Xiao, Gang; Chan, Lai N.; Klemm, Lars; Chen, Zhengshan; Zhang, Qiuyi Chen; Aghajanirefah, Ali; Cosgun, Kadriye Nehir; Sadras, Teresa; Lee, Jaewoong; Mirzapoiazova, Tamara; Salgia, Ravi; Jumaa, Hassan; Muschen, Markus] City Hope Natl Med Ctr, Comprehens Canc Ctr, Monrovia, CA 91016 USA; [Braas, Daniel; Graeber, Thomas G.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, UCLA Metabol Ctr, Los Angeles, CA 90095 USA; [Braas, Daniel; Graeber, Thomas G.] Univ Calif Los Angeles, Crump Inst Mol Imaging, Los Angeles, CA 90095 USA; [Geng, Huimin; Muschen, Markus] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Ernst, Thomas; Hochhaus, Andreas] Univ Klinikum Jena, Klin Innere Med 2, Abt Hamatol Onkol, Jena, Germany; [Jiang, Xiaoyan] Univ British Columbia, Terry Fox Lab, British Columbia Canc Agcy, Vancouver, BC, Canada; [Jiang, Xiaoyan] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Weinstock, David M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Weinstock, David M.] Harvard Med Sch, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Francisco; Friedrich Schiller University of Jena; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Xiao, G; Muschen, M (corresponding author), Beckman Res Inst, Dept Syst Biol, Monrovia, CA 91016 USA.; Xiao, G; Muschen, M (corresponding author), City Hope Natl Med Ctr, Comprehens Canc Ctr, Monrovia, CA 91016 USA.	gaxiao@coh.org; mmuschen@coh.org		Sadras, Teresa/0000-0001-9048-9580; Cosgun, Kadriye/0000-0003-4181-744X; Lee, Jaewoong/0000-0001-7952-5544; Jiang, Xiaoyan/0000-0002-8974-7340; Xiao, Gang/0000-0002-9476-3847	NIH/NCI [R35CA197628, R01CA137060, R01CA157644, R01CA172558, R01CA213138]; Wellcome Trust Senior Investigator Award; Leukemia and Lymphoma Scholar award [WT101880, LLS-1479-11]; Howard Hughes Medical Institute [HHMI-55108547]; Norman and Sadie Lee Foundation for Pediatric Cancer; Dr. Ralph and Marian Falk Medical Research Trust; Cancer Research Institute through a Clinic and Laboratory Integration Program grant; California Institute for Regenerative Medicine (CIRM) [DISC2-10061]; Deutsche Forschungsgemeinschaft [SFB1074, P10]; ERC [694992]; NATIONAL CANCER INSTITUTE [R01CA169458, R01CA139032, R01CA157644, R35CA197628, R01CA213138, R21CA152497, R01CA172558, R01CA137060] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust Senior Investigator Award(Wellcome Trust); Leukemia and Lymphoma Scholar award(Leukemia and Lymphoma Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Norman and Sadie Lee Foundation for Pediatric Cancer; Dr. Ralph and Marian Falk Medical Research Trust; Cancer Research Institute through a Clinic and Laboratory Integration Program grant; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank John S. Kovach (Lixte Biotechnology), Arthur Riggs (Beckman Research Institute), Daniel Hodson (University of Cambridge), David A. Fruman (University of California Irvine), Michael Farrar (University of Minnesota), H. Phillip Koeffler (University of California Los Angeles), and all members of the Muschen laboratory for support and helpful discussions. Research is funded by the NIH/NCI through Outstanding Investigator Award R35CA197628, R01CA137060, R01CA157644, R01CA172558, and R01CA213138 (to M.M.), a Wellcome Trust Senior Investigator Award and a Leukemia and Lymphoma Scholar award (WT101880 and LLS-1479-11 to M.M.), the Howard Hughes Medical Institute (HHMI-55108547 to M.M.), the Norman and Sadie Lee Foundation for Pediatric Cancer (to M.M.), the Dr. Ralph and Marian Falk Medical Research Trust (to M.M.), Cancer Research Institute through a Clinic and Laboratory Integration Program grant (to M.M.), and the California Institute for Regenerative Medicine (CIRM) through DISC2-10061. H.J. is supported by Deutsche Forschungsgemeinschaft (SFB1074, P10) and ERC Advanced Grant 694992. M.M. is a Howard Hughes Medical Institute (HHMI) Faculty Scholar.	Apostolidis SA, 2016, NAT IMMUNOL, V17, P556, DOI 10.1038/ni.3390; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Buchner M, 2015, IMMUNOL REV, V263, P192, DOI 10.1111/imr.12235; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chan LN, 2017, NATURE, V542, P479, DOI 10.1038/nature21076; Chen W, 2005, CANCER RES, V65, P8183, DOI 10.1158/0008-5472.CAN-05-1103; Chen ZS, 2015, NATURE, V521, P357, DOI 10.1038/nature14231; Cheung EC, 2013, DEV CELL, V25, P463, DOI 10.1016/j.devcel.2013.05.001; Chung V, 2017, CLIN CANCER RES, V23, P3277, DOI 10.1158/1078-0432.CCR-16-2299; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Hitosugi T, 2012, CANCER CELL, V22, P585, DOI 10.1016/j.ccr.2012.09.020; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Hochhaus A, 2017, ANN ONCOL, V28, P41, DOI 10.1093/annonc/mdx219; Kanteti R, 2009, LAB INVEST, V89, P301, DOI 10.1038/labinvest.2008.168; Lakhanpal GK, 2010, BLOOD, V116, P428, DOI 10.1182/blood-2009-10-250217; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lin RT, 2015, NAT CELL BIOL, V17, P1484, DOI 10.1038/ncb3255; Liu GJ, 2014, GENE DEV, V28, P1337, DOI 10.1101/gad.240416.114; Lu J, 2009, P NATL ACAD SCI USA, V106, P11697, DOI 10.1073/pnas.0905930106; Muschen M, 2018, NAT REV CANCER, V18, P103, DOI 10.1038/nrc.2017.111; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Ros S, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-8; Rubio MP, 2003, EMBO J, V22, P3514, DOI 10.1093/emboj/cdg363; Ruediger R, 2011, MOL CELL BIOL, V31, P3832, DOI 10.1128/MCB.05744-11; Shojaee S, 2016, NAT MED, V22, P379, DOI 10.1038/nm.4062; Swaminathan S, 2015, NAT IMMUNOL, V16, P766, DOI 10.1038/ni.3160; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Team RC., 2022, LANG ENV STAT COMP; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200; Yusuf I, 2004, BLOOD, V104, P784, DOI 10.1182/blood-2003-09-3071; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	36	65	67	4	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 5	2018	173	2					470	+	484.e1	10.1016/j.cell.2018.02.048	http://dx.doi.org/10.1016/j.cell.2018.02.048			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GB8IS	29551267	Bronze, Green Accepted			2022-12-28	WOS:000429320200019
J	El Bcheraoui, C; Mokdad, AH; Dwyer-Lindgren, L; Bertozzi-Villa, A; Stubbs, RW; Morozoff, C; Shirude, S; Naghavi, M; Murray, CJL				El Bcheraoui, Charbel; Mokdad, Ali H.; Dwyer-Lindgren, Laura; Bertozzi-Villa, Amelia; Stubbs, Rebecca W.; Morozoff, Chloe; Shirude, Shreya; Naghavi, Mohsen; Murray, Christopher J. L.			Trends and Patterns of Differences in Infectious Disease Mortality Among US Counties, 1980-2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; PREVALENCE; CARE	IMPORTANCE Infectious diseases are mostly preventable but still pose a public health threat in the United States, where estimates of infectious diseases mortality are not available at the county level. OBJECTIVE To estimate age-standardized mortality rates and trends by county from 1980 to 2014 from lower respiratory infections, diarrheal diseases, HIV/AIDS, meningitis, hepatitis, and tuberculosis. DESIGN AND SETTING This study used deidentified death records from the National Center for Health Statistics (NCHS) and population counts from the US Census Bureau, NCHS, and the Human Mortality Database. Validated small-area estimation models were applied to these data to estimate county-level infectious disease mortality rates. EXPOSURES County of residence. MAIN OUTCOMES AND MEASURES Age-standardized mortality rates of lower respiratory infections, diarrheal diseases, HIV/AIDS, meningitis, hepatitis, and tuberculosis by county, year, and sex. RESULTS Between 1980 and 2014, there were 4 081 546 deaths due to infectious diseases recorded in the United States. In 2014, a total of 113 650 (95% uncertainty interval [UI], 108 764-117 942) deaths or a rate of 34.10 (95% UI, 32.63-35.38) deaths per 100 000 persons were due to infectious diseases in the United States compared to a total of 72 220 (95% UI, 69 887-74 712) deaths or a rate of 41.95 (95% UI, 40.52-43.42) deaths per 100 000 persons in 1980, an overall decrease of 18.73%(95% UI, 14.95%-23.33%). Lower respiratory infections were the leading cause of infectious diseases mortality in 2014 accounting for 26.87 (95% UI, 25.79-28.05) deaths per 100 000 persons (78.80% of total infectious diseases deaths). There were substantial differences among counties in death rates from all infectious diseases. Lower respiratory infection had the largest absolute mortality inequality among counties (difference between the 10th and 90th percentile of the distribution, 24.5 deaths per 100 000 persons). However, HIV/AIDS had the highest relative mortality inequality between counties (10.0 as the ratio of mortality rate in the 90th and 10th percentile of the distribution). Mortality from meningitis and tuberculosis decreased over the study period in all US counties. However, diarrheal diseases were the only cause of infectious diseases mortality to increase from 2000 to 2014, reaching a rate of 2.41 (95% UI, 0.86-2.67) deaths per 100 000 persons, with many counties of high mortality extending from Missouri to the northeastern region of the United States. CONCLUSIONS AND RELEVANCE Between 1980 and 2014, there were declines in mortality from most categories of infectious diseases, with large differences among US counties. However, over this time there was an increase in mortality for diarrheal diseases.	[El Bcheraoui, Charbel; Mokdad, Ali H.; Dwyer-Lindgren, Laura; Bertozzi-Villa, Amelia; Stubbs, Rebecca W.; Morozoff, Chloe; Shirude, Shreya; Naghavi, Mohsen; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, 2301 Fifth Ave,Ste 600, Seattle, WA 98121 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 Fifth Ave,Ste 600, Seattle, WA 98121 USA.	cjlm@uw.edu	Mokdad, Ali H./AAD-1232-2022	Mokdad, Ali H./0000-0002-4994-3339; Dwyer-Lindgren, Laura/0000-0002-3872-6451	Robert Wood Johnson Foundation [72305]; National Institute on Aging of the National Institutes of Health [5P30AG047845]; NATIONAL INSTITUTE ON AGING [P30AG047845] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported in this publication was supported by the Robert Wood Johnson Foundation (72305), the National Institute on Aging of the National Institutes of Health (5P30AG047845), and John W. Stanton and Theresa E. Gillespie.	[Anonymous], 2021, LANG ENV STAT COMP; Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61; Armstrong GL, 2007, ARCH INTERN MED, V167, P166, DOI 10.1001/archinte.167.2.166; Caliendo AM, 2013, CLIN INFECT DIS, V57, pS139, DOI 10.1093/cid/cit578; Caucci L, 2013, TABLE 2 CHARACTERIST; Caucci L, 2013, TABLE 1 SELECTED CHA; Center for Disease Control and Prevention, 2015, TOD HER EP MOR PEOPL; Centers for Disease Control and Prevention, 2014 NAT STAT HEALTH; Centers for Disease Control and Prevention, 25 YEARS HIV AIDS US; Centers for Disease Control and Prevention, 2013, ANTIBIOTIC RESISTANC, P1; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P621; Collins IJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091004; Dieleman JL, 2016, JAMA-J AM MED ASSOC, V316, P2627, DOI 10.1001/jama.2016.16885; Dwyer-Lindgren L, 2016, JAMA-J AM MED ASSOC, V316, P2385, DOI 10.1001/jama.2016.13645; Dwyer-Lindgren L, 2016, DIABETES CARE, V39, P1556, DOI 10.2337/dc16-0678; Dwyer-Lindgren L, 2015, AM J PUBLIC HEALTH, V105, P1120, DOI 10.2105/AJPH.2014.302313; Dwyer-Lindgren L, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-5; Hedden SL, 2015, SUBSTANCE ABUSE MENT, P1; Jump Robin Lp, 2013, Aging health, V9, P403; Kim WR, 2009, HEPATOLOGY, V49, pS28, DOI 10.1002/hep.22975; Knorr-Held L, 2000, STAT MED, V19, P2555, DOI 10.1002/1097-0258(20000915/30)19:17/18<2555::AID-SIM587>3.0.CO;2-#; Kristensen K, 2016, J STAT SOFTW, V70, P1; Lederberg J., 1992, I MED US COMMITTEE; Leroux BG, 2000, STAT MODELS EPIDEMIO, P179, DOI [10.1007/978-1-4612-1284-3_4, DOI 10.1007/978-1-4612-1284-3]; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; May M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6016; Montoya Ana, 2011, Aging health, V7, P889; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; National Center for Health Statistics, 2012, BRIDG RAC INT EST RE; National Center for Health Statistics, 2015, VINT 2014 POSTC EST; National Vital Statistics System, 1980, MULT CAUS DEATH DAT; Pinner RW, 1996, JAMA-J AM MED ASSOC, V275, P189, DOI 10.1001/jama.275.3.189; Pouget ER, 2012, ADDICTION, V107, P1057, DOI 10.1111/j.1360-0443.2011.03765.x; Riley Elise D, 2007, Curr HIV/AIDS Rep, V4, P181, DOI 10.1007/s11904-007-0026-5; United States Census Bureau, SMALL AR INC POV EST; United States Census Bureau, 2009, COUNT INT EST AG SEX; University of California Berkeley & Max Planck Institute for Demographic Research, HUM MORTALITY DATAB; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Watson JT, 2007, EMERG INFECT DIS, V13, P1, DOI 10.3201/eid1301.060779	40	54	55	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2018	319	12					1248	1260		10.1001/jama.2018.2089	http://dx.doi.org/10.1001/jama.2018.2089			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GA5VW	29584843	Green Published			2022-12-28	WOS:000428403000017
J	Alhadeff, AL; Su, ZW; Hernandez, E; Klima, ML; Phillips, SZ; Holland, RA; Guo, CY; Hantman, AW; De Jonghe, BC; Betley, JN				Alhadeff, Amber L.; Su, Zhenwei; Hernandez, Elen; Klima, Michelle L.; Phillips, Sophie Z.; Holland, Ruby A.; Guo, Caiying; Hantman, Adam W.; De Jonghe, Bart C.; Betley, J. Nicholas			A Neural Circuit for the Suppression of Pain by a Competing Need State	CELL			English	Article							NEUROPEPTIDE-Y; AGRP NEURONS; PARABRACHIAL NUCLEUS; FEEDING-BEHAVIOR; TEACHING SIGNAL; ENERGY-BALANCE; FORMALIN TEST; FOOD-INTAKE; ADULT MICE; RECEPTOR	Hunger and pain are two competing signals that individuals must resolve to ensure survival. However, the neural processes that prioritize conflicting survival needs are poorly understood. We discovered that hunger attenuates behavioral responses and affective properties of inflammatory pain without altering acute nociceptive responses. This effect is centrally controlled, as activity in hunger-sensitive agoutirelated protein (AgRP)-expressing neurons abrogates inflammatory pain. Systematic analysis of AgRP projection subpopulations revealed that the neural processing of hunger and inflammatory pain converge in the hindbrain parabrachial nucleus (PBN). Strikingly, activity in AgRP -> PBN neurons blocked the behavioral response to inflammatory pain as effectively as hunger or analgesics. The anti-nociceptive effect of hunger is mediated by neuropeptide Y(NPY) signaling in the PBN. By investigating the intersection between hunger and pain, we have identified a neural circuit that mediates competing survival needs and uncovered NPY Y1 receptor signaling in the PBN as a target for pain suppression.	[Alhadeff, Amber L.; Su, Zhenwei; Hernandez, Elen; Klima, Michelle L.; Phillips, Sophie Z.; Betley, J. Nicholas] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Holland, Ruby A.; De Jonghe, Bart C.] Univ Penn, Dept Biobehav Hlth Sci, Philadelphia, PA 19104 USA; [Guo, Caiying; Hantman, Adam W.] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA	University of Pennsylvania; University of Pennsylvania; Howard Hughes Medical Institute	Betley, JN (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	jnbetley@sas.upenn.edu		Holland, Ruby/0000-0002-6757-4944	University of Pennsylvania School of Arts and Sciences; American Heart Association (AHA) [17SDG33400158]; Whitehall Foundation; NIH [1R01DK114104, 2T32DK7314-36, F32DK112561-01, R01DK114812]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK112812, F32DK112561, R01DK114104, T32DK007314] Funding Source: NIH RePORTER	University of Pennsylvania School of Arts and Sciences; American Heart Association (AHA)(American Heart Association); Whitehall Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Pulido, B. Jannuzi, O. Park, C. Shin, K. Patel, I. Cogdell, R. Ly, O. Green, and P. Ehmann for experimental assistance and S. Sternson, H. Grill, M. Schmidt, and A. Chen for comments on the manuscript. This research was funded by the University of Pennsylvania School of Arts and Sciences (to J.N.B.), the American Heart Association (AHA) (17SDG33400158 to J.N.B.), the Whitehall Foundation (to J.N.B), and the NIH (1R01DK114104 to J.N.B, 2T32DK7314-36 and F32DK112561-01 to A.L.A., and R01DK114812 to B.C.D.J.).	Alhadeff AL, 2017, J NEUROSCI, V37, P362, DOI [10.1523/JNEUROSCI.2714-16.2017, 10.1523/JNEUROSCI.2714-16.2016]; Alhadeff AL, 2015, AM J PHYSIOL-ENDOC M, V309, pE759, DOI 10.1152/ajpendo.00346.2015; Andermann ML, 2017, NEURON, V95, P757, DOI 10.1016/j.neuron.2017.06.014; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Baulmann J, 2000, NEUROSCIENCE, V95, P813; Betley JN, 2015, NATURE, V521, P180, DOI 10.1038/nature14416; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; Betley JN, 2009, CELL, V139, P161, DOI 10.1016/j.cell.2009.08.027; BODNAR RJ, 1978, PHARMACOL BIOCHEM BE, V8, P661, DOI 10.1016/0091-3057(78)90263-0; BODNAR RJ, 1977, FED PROC, V36, P1010; Burnett CJ, 2016, NEURON, V92, P187, DOI 10.1016/j.neuron.2016.08.032; Campos CA, 2016, CELL METAB, V23, P811, DOI 10.1016/j.cmet.2016.04.006; Carey LM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01062-2; Carter ME, 2013, NATURE, V503, P111, DOI 10.1038/nature12596; CODERRE TJ, 1990, BRAIN RES, V535, P155, DOI 10.1016/0006-8993(90)91835-5; Deyama S, 2007, NEUROSCI RES, V59, P199, DOI 10.1016/j.neures.2007.06.1473; Dietrich MO, 2015, CELL, V160, P1222, DOI 10.1016/j.cell.2015.02.024; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Essner RA, 2017, J NEUROSCI, V37, P8678, DOI 10.1523/JNEUROSCI.0798-17.2017; Grill HJ, 2006, OBESITY, V14, P216, DOI 10.1038/oby.2006.312; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; HAMM RJ, 1984, PHYSIOL BEHAV, V33, P499, DOI 10.1016/0031-9384(84)90176-8; Hargraves WA, 2005, PAIN, V114, P455, DOI 10.1016/j.pain.2005.01.010; Higgs S, 1996, EUR J PHARMACOL, V313, P1, DOI 10.1016/0014-2999(96)00446-3; Hnasko TS, 2010, NEURON, V65, P643, DOI 10.1016/j.neuron.2010.02.012; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Jikomes N, 2016, CURR BIOL, V26, P2500, DOI 10.1016/j.cub.2016.07.019; Johansen JP, 2004, NAT NEUROSCI, V7, P398, DOI 10.1038/nn1207; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; KEYS A, 1946, FED PROC, V5, P55; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; LaGraize SC, 2004, NEUROSCI LETT, V372, P30, DOI 10.1016/j.neulet.2004.09.008; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lerner TN, 2015, CELL, V162, P635, DOI 10.1016/j.cell.2015.07.014; Li HH, 2013, NAT NEUROSCI, V16, P332, DOI 10.1038/nn.3322; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Loeser JD, 2012, CLIN J PAIN, V28, P185, DOI 10.1097/AJP.0b013e318230f6c1; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Mandelblat-Cerf Y, 2015, ELIFE, V4, DOI 10.7554/eLife.07122; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; Miller LR, 2009, J PAIN, V10, P619, DOI 10.1016/j.jpain.2008.12.007; Mu D, 2017, SCIENCE, V357, P695, DOI 10.1126/science.aaf4918; Naveilhan P, 2001, NATURE, V409, P513, DOI 10.1038/35054063; Oliveira MM, 2016, PAIN, V157, P1666, DOI 10.1097/j.pain.0000000000000571; Padilla SL, 2016, NAT NEUROSCI, V19, P734, DOI 10.1038/nn.4274; Pavlov I. P., 1926, SAMMLUNG ARTIKELN BE; Penzo MA, 2015, NATURE, V519, P455, DOI 10.1038/nature13978; Skibicka KP, 2009, ENDOCRINOLOGY, V150, P5351, DOI 10.1210/en.2009-0804; Solway B, 2011, P NATL ACAD SCI USA, V108, P7224, DOI 10.1073/pnas.1017719108; STANLEY BG, 1985, P NATL ACAD SCI USA, V82, P3940, DOI 10.1073/pnas.82.11.3940; Sternson SM, 2017, ANNU REV PHYSIOL, V79, P401, DOI 10.1146/annurev-physiol-021115-104948; Su ZW, 2017, CELL REP, V21, P2724, DOI 10.1016/j.celrep.2017.11.036; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Wang JZ, 2001, BRAIN RES, V893, P264, DOI 10.1016/S0006-8993(00)03279-0; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Zhu H, 2016, GENESIS, V54, P439, DOI 10.1002/dvg.22949	58	94	97	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 22	2018	173	1					140	+		10.1016/j.cell.2018.02.057	http://dx.doi.org/10.1016/j.cell.2018.02.057			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GA3MT	29570993	Green Accepted, Bronze			2022-12-28	WOS:000428234200014
J	Chessman, AW				Chessman, Alexander W.			IV prochlorperazine plus diphenhydramine improved migraine pain relief more than IV hydromorphone in the ED	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Chessman, Alexander W.] Med Univ South Carolina, Charleston, SC 29425 USA	Medical University of South Carolina	Chessman, AW (corresponding author), Med Univ South Carolina, Charleston, SC 29425 USA.							Charles A, 2017, NEW ENGL J MED, V377, P553, DOI 10.1056/NEJMcp1605502; Derry S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008040.pub3; Law S, 2016, COCHRANE DB SYST REV, V4; Loder E, 2013, HEADACHE, V53, P1651, DOI 10.1111/head.12233; Volkow ND, 2017, NEW ENGL J MED, V377, P391, DOI 10.1056/NEJMsr1706626	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2018	168	6					JC28	JC28		10.7326/ACPJC-2018-168-6-028	http://dx.doi.org/10.7326/ACPJC-2018-168-6-028			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ8AM	29554666				2022-12-28	WOS:000427827400005
J	Hoen, B; Schaub, B; Funk, AL; Ardillon, V; Boullard, M; Cabie, A; Callier, C; Carles, G; Cassadou, S; Cesaire, R; Douine, M; Herrmann-Storck, C; Kadhel, P; Laouenan, C; Madec, Y; Monthieux, A; Nacher, M; Najioullah, F; Rousset, D; Ryan, C; Schepers, K; Stegmann-Planchard, S; Tressieres, B; Volumenie, JL; Yassinguezo, S; Janky, E; Fontanet, A				Hoen, Bruno; Schaub, Bruno; Funk, Anna L.; Ardillon, Vanessa; Boullard, Manon; Cabie, Andre; Callier, Caroline; Carles, Gabriel; Cassadou, Sylvie; Cesaire, Raymond; Douine, Maylis; Herrmann-Storck, Cecile; Kadhel, Philippe; Laouenan, Cedric; Madec, Yoann; Monthieux, Alice; Nacher, Mathieu; Najioullah, Fatiha; Rousset, Dominique; Ryan, Catherine; Schepers, Kinda; Stegmann-Planchard, Sofia; Tressieres, Benoit; Volumenie, Jean-Luc; Yassinguezo, Samson; Janky, Eustase; Fontanet, Arnaud			Pregnancy Outcomes after ZIKV Infection in French Territories in the Americas	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VIRUS-INFECTION; BIRTH-DEFECTS; INFANTS; FETUSES	BACKGROUND The risk of congenital neurologic defects related to Zika virus (ZIKV) infection has ranged from 6 to 42% in various reports. The aim of this study was to estimate this risk among pregnant women with symptomatic ZIKV infection in French territories in the Americas. METHODS From March 2016 through November 2016, we enrolled in this prospective cohort study pregnant women with symptomatic ZIKV infection that was confirmed by polymerase-chain-reaction (PCR) assay. The analysis included all data collected up to April 27, 2017, the date of the last delivery in the cohort. RESULTS Among the 555 fetuses and infants in the 546 pregnancies included in the analysis, 28 (5.0%) were not carried to term or were stillborn, and 527 were born alive. Neurologic and ocular defects possibly associated with ZIKV infection were seen in 39 fetuses and infants (7.0%; 95% confidence interval, 5.0 to 9.5); of these, 10 were not carried to term because of termination of pregnancy for medical reasons, 1 was stillborn, and 28 were live-born. Microcephaly (defined as head circumference more than 2 SD below the mean for sex and gestational age) was detected in 32 fetuses and infants (5.8%), of whom 9 (1.6%) had severe microcephaly (more than 3 SD below the mean). Neurologic and ocular defects were more common when ZIKV infection occurred during the first trimester (24 of 189 fetuses and infants [12.7%]) than when it occurred during the second trimester (9 of 252 [3.6%]) or third trimester (6 of 114 [5.3%]) (P = 0.001). CONCLUSIONS Among pregnant women with symptomatic, PCR-confirmed ZIKV infection, birth defects possibly associated with ZIKV infection were present in 7% of fetuses and infants. Defects occurred more frequently in fetuses and infants whose mothers had been infected early in pregnancy. Longer-term follow-up of infants is required to assess any manifestations not detected at birth.	[Hoen, Bruno; Callier, Caroline; Tressieres, Benoit] Ctr Hosp Univ CHU Pointe A Pitre Abymes, INSERM, Ctr Invest Clin 1424, Pointe a Pitre, Guadeloupe, France; [Hoen, Bruno; Schepers, Kinda] Ctr Hosp Univ CHU Pointe A Pitre Abymes, Serv Malad Infect & Trop, Dermatol, Med Interne, Pointe a Pitre, Guadeloupe, France; [Cassadou, Sylvie] Ctr Hosp Univ CHU Pointe A Pitre Abymes, Cellule Intervent Reg CIRE Antilles, Sante Publ France, Pointe a Pitre, Guadeloupe, France; [Herrmann-Storck, Cecile] Ctr Hosp Univ CHU Pointe A Pitre Abymes, Lab Microbiol, Pointe a Pitre, Guadeloupe, France; [Kadhel, Philippe] Ctr Hosp Univ CHU Pointe A Pitre Abymes, Serv Gynecol Obstet, Pointe a Pitre, Guadeloupe, France; [Ryan, Catherine] Ctr Hosp Univ CHU Pointe A Pitre Abymes, Ctr Pluridisciplinaire Diagnost Prenatal, Pointe a Pitre, Guadeloupe, France; [Janky, Eustase] Ctr Hosp Univ CHU Pointe A Pitre Abymes, Pole Parent Enfant, Pointe a Pitre, Guadeloupe, France; [Hoen, Bruno] Univ Antilles Guyane, Fac Med Hyacinthe Bastaraud, Pointe a Pitre, Guadeloupe, France; [Schaub, Bruno] CHU Martinique, Ctr Pluridisciplinaire Diagnost Prenatal, Maison Femme Mere & Enfant, Martinique, France; CHU Martinique, INSERM, Ctr Invest Clin, Martinique, France; CHU Martinique, Ctr Ressources Biol, Martinique, France; [Monthieux, Alice; Volumenie, Jean-Luc] CHU Martinique, Maison Femme Mere & Enfant, Unit Obstet & Gynecol, Martinique, France; [Najioullah, Fatiha] CHU Martinique, Lab Virol, Martinique, France; [Funk, Anna L.; Madec, Yoann; Fontanet, Arnaud] Paris Diderot Univ, Emerging Dis Epidemiol Unit, Paris, France; [Laouenan, Cedric] Paris Diderot Univ, Ctr Global Hlth, Paris, France; [Laouenan, Cedric] Paris Diderot Univ, Inst Pasteur, INSERM, IAME, Paris, France; [Fontanet, Arnaud] Conservatoire Natl Arts & Metiers, Unite Pasteur Cnam Risques Infectieux & Emergents, Paris, France; [Ardillon, Vanessa] CIRE Guyane, Sante Publ France, French Guiana, France; [Carles, Gabriel] Ctr Hosp Ouest Guyanais, Pole Mere Enfant, French Guiana, France; [Douine, Maylis; Nacher, Mathieu] Ctr Hosp Cayenne, INSERM, Ctr Invest Clin 1424, French Guiana, France; [Rousset, Dominique] Ctr Hosp Cayenne, Inst Pasteur Guyane, Lab Virol, French Guiana, France; [Yassinguezo, Samson] Ctr Hosp Cayenne, Serv Gynecol Obstet, French Guiana, France; [Stegmann-Planchard, Sofia] Ctr Hosp Louis Constant Fleming, Unite Malad Infect, St Martin Dheres, France	CHU Guadeloupe; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Guadeloupe; CHU Guadeloupe; Institute of Public Health Surveillance; CHU Guadeloupe; CHU Guadeloupe; CHU Guadeloupe; CHU Guadeloupe; CHU Guadeloupe; Universite des Antilles; CHU Martinique; CHU Martinique; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Martinique; CHU Martinique; CHU Martinique; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Institute of Public Health Surveillance; Institut National de la Sante et de la Recherche Medicale (Inserm)	Hoen, B (corresponding author), Univ Med Ctr Guadeloupe, Dept Infect Dis Dermatol & Internal Med, BP 465, F-97159 Pointe a Pitre, Guadeloupe, France.	bruno.hoen@inserm.fr	Douine, Maylis/AAD-5136-2021; Laouenan, Cedric/E-1157-2019; Rousset, Dominique/S-5400-2019; nacher, mathieu/AAH-4796-2021; TRESSIERES, Benoit/ABH-1085-2020	Laouenan, Cedric/0000-0002-3681-6314; Rousset, Dominique/0000-0002-1473-3147; nacher, mathieu/0000-0001-9397-3204; Cabie, Andre/0000-0003-0117-3061; , arnaud/0000-0002-5239-6110; Douine, Maylis/0000-0003-4616-6690	French Ministry of Health (Soutien Exceptionnel a la Recherche et a l'Innovation); ZIKAlliance consortium (the European Union's Horizon Research and Innovation Program); INSERM; Institut Carnot-Pasteur Maladies Infectieuses through the Pasteur-Paris University International Ph.D. program [ANR 11-CARN 017-01]; Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases project [ANR-10-LABX-62-IBEID]	French Ministry of Health (Soutien Exceptionnel a la Recherche et a l'Innovation); ZIKAlliance consortium (the European Union's Horizon Research and Innovation Program); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Carnot-Pasteur Maladies Infectieuses through the Pasteur-Paris University International Ph.D. program; Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases project	Supported by the French Ministry of Health (Soutien Exceptionnel a la Recherche et a l'Innovation), by a grant (ANR-10-LABX-62-IBEID) from Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases project, by the ZIKAlliance consortium (the European Union's Horizon 2020 Research and Innovation Program), and by INSERM. This study is part of the ZIKAlliance consortium project.r Ms. Funk reports receiving salary from Institut Carnot-Pasteur Maladies Infectieuses (ANR 11-CARN 017-01) through the Pasteur-Paris University International Ph.D. program. No other potential conflict of interest relevant to this article was reported.	[Anonymous], INFECT DIS CLIN PRAC; [Anonymous], 2016, AV REL ACT AV HCSP 2; Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Conseil National Professionnel de Gynecologie et Obstetrique, 2016, VIR ZIK FEMM ENC AG; de Jong EP, 2013, ARCH DIS CHILDHOOD-E, V98, P93, DOI 10.1136/archdischild-2012-303327; Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472; Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006; Mejdoubi M, 2017, NEW ENGL J MED, V377, P1399, DOI 10.1056/NEJMc1612813; Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831; Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982; Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404; Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1; Schaub B, 2017, LANCET CHILD ADOLESC, V1, P45, DOI 10.1016/S2352-4642(17)30001-9; Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]; Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1; van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2; Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425	18	184	189	1	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2018	378	11					985	994		10.1056/NEJMoa1709481	http://dx.doi.org/10.1056/NEJMoa1709481			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ2HT	29539287	Bronze			2022-12-28	WOS:000427399000004
J	Lam, V; Teutsch, S; Fielding, J				Lam, Vanessa; Teutsch, Steven; Fielding, Jonathan			Hip and Knee Replacements A Neglected Potential Savings Opportunity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES		[Lam, Vanessa; Teutsch, Steven; Fielding, Jonathan] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Hlth Policy & Management, UCLA Ctr Hlth Adv, Los Angeles, CA USA	University of California System; University of California Los Angeles	Teutsch, S (corresponding author), 841 Moon Ave, Los Angeles, CA 90065 USA.	teutsch@comcast.net						[Anonymous], HEALTHC COST UT PROJ; Blue Cross Blue Shield, 2015, STUD COST VAR KNEE H; Centers for Medicare & Medicaid Services, 2015, MED PROV UT PAYM DAT; Haas DA, 2017, J ARTHROPLASTY, V32, P347, DOI 10.1016/j.arth.2016.07.030; Losina E, 2012, J BONE JOINT SURG AM, V94A, P201, DOI [10.2106/JBJS.J.01958, 10.2106/JBJS.K.00009, 10.2106/JBJS.J.101958]; Meyer Harris, MODERN HEALTHCARE; Organization for Economic Co-operation and Development, 2017, HLTH GLANC 2017 OECD; Richter DL, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117694352; Riddle DL, 2014, ARTHRITIS RHEUMATOL, V66, P2134, DOI 10.1002/art.38685; Stacey D, 2016, OSTEOARTHR CARTILAGE, V24, P99, DOI 10.1016/j.joca.2015.07.024	10	24	24	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2018	319	10					977	978		10.1001/jama.2018.2310	http://dx.doi.org/10.1001/jama.2018.2310			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ0HS	29536103				2022-12-28	WOS:000427249700009
J	Dzau, VJ; Leshner, AI				Dzau, Victor J.; Leshner, Alan I.			Public Health Research on Gun Violence: Long Overdue	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Dzau, Victor J.] Natl Acad Med, 500 5th St NW, Washington, DC 20001 USA	National Academies of Sciences, Engineering & Medicine	Dzau, VJ (corresponding author), Natl Acad Med, 500 5th St NW, Washington, DC 20001 USA.							Institute of Medicine; National Research Council, 2013, PRIOR RES RED THREAT, DOI [10.17226/18319, DOI 10.17226/18319]	1	12	12	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2018	168	12					876	+		10.7326/M18-0579	http://dx.doi.org/10.7326/M18-0579			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK1TE	29554693				2022-12-28	WOS:000435903500018
J	Lauby-Secretan, B; Vilahur, N; Bianchini, F; Guha, N; Straif, K				Lauby-Secretan, Beatrice; Vilahur, Nadia; Bianchini, Franca; Guha, Neela; Straif, Kurt		Int Agcy Res Canc Handbook Working	The IARC Perspective on Colorectal Cancer Screening	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OCCULT BLOOD-TEST; FLEXIBLE SIGMOIDOSCOPY; CT COLONOGRAPHY; FOLLOW-UP; MORTALITY; COLONOSCOPY; IMPACT; METAANALYSIS; TRIAL; COLON		[Lauby-Secretan, Beatrice; Vilahur, Nadia; Guha, Neela; Straif, Kurt] Int Agcy Res Canc, Lyon, France; [Bianchini, Franca] German Canc Res Ctr, Heidelberg, Germany	World Health Organization; International Agency for Research on Cancer (IARC); Helmholtz Association; German Cancer Research Center (DKFZ)	Lauby-Secretan, B (corresponding author), Int Agcy Res Canc, IARC Handbooks Grp ESC IHB, 150 Cours Albert, F-69372 Lyon 08, France.		Guha, Neela/AAG-3989-2021; Hoffmeister, Michael/T-7187-2019; Bulliard, Jean-Luc/AAA-7481-2021; Garcia, Montse/B-8832-2014; Nagtegaal, Iris D/A-2448-2014; Blom, Johannes/GON-7869-2022	Guha, Neela/0000-0003-3991-4662; Hoffmeister, Michael/0000-0002-8307-3197; Bulliard, Jean-Luc/0000-0001-9750-2709; Garcia, Montse/0000-0002-3437-3185; Nagtegaal, Iris D/0000-0003-0887-4127; Steele, Robert JC/0000-0003-4248-6785; Sasieni, Peter/0000-0003-1509-8744	American Cancer Society; Centers for Disease Control and Prevention; NATIONAL CANCER INSTITUTE [P30CA008748, U01CA199335] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the American Cancer Society and the Centers for Disease Control and Prevention.	Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912; Atkin W, 2017, LANCET, V389, P1299, DOI 10.1016/S0140-6736(17)30396-3; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Bertario L, 1999, EUR J CANCER, V35, P973, DOI 10.1016/S0959-8049(99)00062-3; Bjerrum A, 2016, BMJ OPEN GASTROENTER, V3, DOI 10.1136/bmjgast-2016-000120; Blom J, 2008, CANCER EPIDEM BIOMAR, V17, P1163, DOI 10.1158/1055-9965.EPI-07-2764; Bouvard V, 2015, LANCET ONCOL, V16, P1599, DOI 10.1016/S1470-2045(15)00444-1; Bray Christopher, 2017, WMJ, V116, P27; Brenner H, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2467; Carrozzi G, 2015, EPIDEMIOL PREV, V39, P210; Castells A, 2014, CLIN GASTROENTEROL H, V12, P1708, DOI 10.1016/j.cgh.2014.03.022; Chiu HM, 2015, CANCER-AM CANCER SOC, V121, P3221, DOI 10.1002/cncr.29462; COIN CG, 1983, COMPUT RADIOL, V7, P215; Costantini AS, 2008, JNCI-J NATL CANCER I, V100, P1818, DOI 10.1093/jnci/djn404; Cottet V, 2012, GUT, V61, P1180, DOI 10.1136/gutjnl-2011-300295; Eldridge RC, 2013, J MED SCREEN, V20, P198, DOI 10.1177/0969141313508282; Elmunzer BJ, 2015, GASTROINTEST ENDOSC, V81, P700, DOI 10.1016/j.gie.2014.10.033; Emilsson L, 2017, ALIMENT PHARM THER, V45, P193, DOI 10.1111/apt.13857; Faivre J, 1999, BRIT J CANCER, V79, P680, DOI 10.1038/sj.bjc.6690107; Garcia-Albeniz X, 2017, ANN INTERN MED, V166, P18, DOI 10.7326/M16-0758; Graser A, 2009, GUT, V58, P241, DOI 10.1136/gut.2008.156448; Hamza S, 2014, DIGEST LIVER DIS, V46, P1121, DOI 10.1016/j.dld.2014.08.041; Hassan C, 2012, ALIMENT PHARM THER, V36, P929, DOI 10.1111/apt.12071; Holme O, 2014, JAMA-J AM MED ASSOC, V312, P606, DOI 10.1001/jama.2014.8266; Honein-AbouHaidar GN, 2016, CANCER EPIDEM BIOMAR, V25, P907, DOI 10.1158/1055-9965.EPI-15-0990; Iafrate F, 2013, DIGEST LIVER DIS, V45, P645, DOI 10.1016/j.dld.2013.02.020; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC MONOGR EVAL CAR, V100, P1; IARC- International Agency for Research on Cancer, 2002, WEIGHT CONTR PHYS AC; International Agency for Research on Cancer, 2013, GLOBOCAN 2012 EST CA; Johnson CD, 2008, NEW ENGL J MED, V359, P1207, DOI 10.1056/NEJMoa0800996; Kahi CJ, 2009, CLIN GASTROENTEROL H, V7, P770, DOI 10.1016/j.cgh.2008.12.030; Kim DH, 2007, NEW ENGL J MED, V357, P1403, DOI 10.1056/NEJMoa070543; Knudsen AB, 2016, JAMA-J AM MED ASSOC, V315, P2595, DOI 10.1001/jama.2016.6828; Kronborg O, 2004, SCAND J GASTROENTERO, V39, P846, DOI 10.1080/00365520410003182; Laing SS, 2014, CANCER EPIDEM BIOMAR, V23, P154, DOI 10.1158/1055-9965.EPI-13-0722; Lauby-Secretan B, 2016, NEW ENGL J MED, V375, P794, DOI 10.1056/NEJMsr1606602; Lazovich D, 1995, J Med Screen, V2, P84; Lee JK, 2014, ANN INTERN MED, V160, P171, DOI 10.7326/M13-1484; Libby G, 2012, BRIT J CANCER, V107, P255, DOI 10.1038/bjc.2012.277; Lin JS, 2016, JAMA-J AM MED ASSOC, V315, P2576, DOI 10.1001/jama.2016.3332; Lindholm E, 2008, BRIT J SURG, V95, P1029, DOI 10.1002/bjs.6136; Littlejohn C, 2012, BRIT J SURG, V99, P1488, DOI 10.1002/bjs.8882; Malila N, 2007, ACTA ONCOL, V46, P1103, DOI 10.1080/02841860701442531; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; Manser CN, 2012, GASTROINTEST ENDOSC, V76, P110, DOI 10.1016/j.gie.2012.02.040; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Parker MA, 2002, J MED SCREEN, V9, P7, DOI 10.1136/jms.9.1.7; Patel SS, 2015, CANCER CONTROL, V22, P248, DOI 10.1177/107327481502200219; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Pitkaniemi J, 2015, BMJ OPEN GASTROENTER, V2, DOI 10.1136/bmjgast-2015-000034; Rossi PG, 2015, AM J GASTROENTEROL, V110, P1359, DOI 10.1038/ajg.2015.240; Sali L, 2015, JNCI-J NATL CANCER I, V108, P108; Scheitel SM, 1999, MAYO CLIN PROC, V74, P1207, DOI 10.4065/74.12.1207; Schoen RE, 2012, GASTROINTEST ENDOSC, V75, P612, DOI 10.1016/j.gie.2011.10.024; Scholefield JH, 2012, GUT, V61, P1036, DOI 10.1136/gutjnl-2011-300774; Schreuders EH, 2015, GUT, V64, P1637, DOI 10.1136/gutjnl-2014-309086; Segnan N, 2002, J NATL CANCER I, V94, P1763; SELBY JV, 1993, ANN INTERN MED, V118, P1, DOI 10.7326/0003-4819-118-1-199301010-00001; Shaukat A, 2013, NEW ENGL J MED, V369, P1106, DOI 10.1056/NEJMoa1300720; Stoop EM, 2012, LANCET ONCOL, V13, P55, DOI 10.1016/S1470-2045(11)70283-2; Ventura L, 2014, DIGEST LIVER DIS, V46, P82, DOI 10.1016/j.dld.2013.07.017; WCRF, 2017, DIET NUTR PHYS ACT C; Zappa M, 1997, INT J CANCER, V73, P208, DOI 10.1002/(SICI)1097-0215(19971009)73:2<208::AID-IJC8>3.0.CO;2-#; Zorzi M, 2017, GUT; Zorzi M, 2015, GUT, V64, P784, DOI 10.1136/gutjnl-2014-307508	66	130	141	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2018	378	18					1734	1740		10.1056/NEJMsr1714643	http://dx.doi.org/10.1056/NEJMsr1714643			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GE4WO	29580179	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000431218600015
J	Ou, JX; Ball, JM; Luan, YZ; Zhao, TT; Miyagishima, KJ; Xu, YF; Zhou, HZ; Chen, JG; Merriman, DK; Xie, Z; Mallon, BS; Li, W				Ou, Jingxing; Ball, John M.; Luan, Yizhao; Zhao, Tantai; Miyagishima, Kiyoharu J.; Xu, Yufeng; Zhou, Huizhi; Chen, Jinguo; Merriman, Dana K.; Xie, Zhi; Mallon, Barbara S.; Li, Wei			iPSCs from a Hibernator Provide a Platform for Studying Cold Adaptation and Its Potential Medical Applications	CELL			English	Article							13-LINED GROUND-SQUIRREL; MAMMALIAN HIBERNATION; OXIDATIVE STRESS; METABOLIC SUPPRESSION; NEURONAL PLASTICITY; OXIDIZED PROTEINS; GENE-EXPRESSION; MITOCHONDRIA; HYPOTHERMIA; MICROTUBULES	Hibernating mammals survive hypothermia (<10 degrees C) without injury, a remarkable feat of cellular preservation that bears significance for potential medical applications. However, mechanisms imparting cold resistance, such as cytoskeleton stability, remain elusive. Using the first IPSC line from a hibernating mammal (13-lined ground squirrel), we uncovered cellular pathways critical for cold tolerance. Comparison between human and ground squirrel iPSC-derived neurons revealed differential mitochondria! and protein quality control responses to cold. In human iPSC-neurons, cold triggered mitochondrial stress, resulting in reactive oxygen species overproduction and lysosomal membrane permeabilization, contributing to microtubule destruction. Manipulations of these pathways endowed microtubule cold stability upon human IPSC-neurons and rat (a non-hibernator) retina, preserving its light responsiveness after prolonged cold exposure. Furthermore, these treatments significantly improved microtulzule integrity in cold-stored kidneys, demonstrating the potential for prolonging shelf-life of organ transplants. Thus, ground squirrel iPSCs offer a unique platform for bringing cold-adaptive strategies from hibernators to humans in clinical applications.	[Ou, Jingxing; Ball, John M.; Zhao, Tantai; Miyagishima, Kiyoharu J.; Xu, Yufeng; Li, Wei] NIH, Retinal Neurophysiol Sect, Natl Eye Inst, Bethesda, MD 20892 USA; [Luan, Yizhao; Xie, Zhi] Sun Yat Sen Univ, State Key Lab Ophthalmol, Guangdong Prov Key Lab Ophthalmol & Visual Sci, Zhongshan Ophthalm Ctr, Guangzhou 510060, Guangdong, Peoples R China; [Luan, Yizhao] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Zhao, Tantai] Cent South Univ, Xiang Ya Hosp 2, Dept Ophthalmol, Changsha 410011, Hunan, Peoples R China; [Xu, Yufeng] Zhejiang Univ, Affiliated Hosp 2, Coll Med, Dept Ophthalmol, Hangzhou 310009, Zhejiang, Peoples R China; [Zhou, Huizhi; Chen, Jinguo] NIH, Trans NIH Ctr Human Immunol Autoimmun & Inflammat, Bethesda, MD 20892 USA; [Merriman, Dana K.] Univ Wisconsin, Dept Biol, Oshkosh, WI 54901 USA; [Mallon, Barbara S.] NINDS, NIH Stem Cell Unit, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Sun Yat Sen University; Sun Yat Sen University; Central South University; Zhejiang University; National Institutes of Health (NIH) - USA; University of Wisconsin System; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Li, W (corresponding author), NIH, Retinal Neurophysiol Sect, Natl Eye Inst, Bethesda, MD 20892 USA.	liwei2@nei.nih.gov		Ball, John/0000-0002-8849-6308; Li, Wei/0000-0002-2897-649X; Xie, Zhi/0000-0002-5589-4836; Miyagishima, Kiyoharu/0000-0002-9744-3152; Merriman, Dana/0000-0003-2780-0772	Intramural Research Programs of the National Eye Institute [ZIAEY000488-10]; Joint Research Fund for Overseas Natural Science of China [31528012]; National Institute of Neurological Disorders and Stroke [ZICNS003008-14]; Center for Human Immunology, Autoimmunity and Inflammation; NATIONAL EYE INSTITUTE [ZIAEY000488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI001226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZICNS003008] Funding Source: NIH RePORTER	Intramural Research Programs of the National Eye Institute; Joint Research Fund for Overseas Natural Science of China(National Natural Science Foundation of China (NSFC)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Center for Human Immunology, Autoimmunity and Inflammation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. Robert Balaban, Jeffrey Diamond, Tiansen Li, Antonina Roll-Mecak, Rosa Puertollano, Zuhang Sheng, Yihong Ye, Peter Yuen, and themembers of the Li lab for critical discussions. Special thanks to Dr. Bing Zhou for his generous help and advice. Funding is provided by the Intramural Research Programs of the National Eye Institute ZIAEY000488-10 (W.L.), Joint Research Fund for Overseas Natural Science of China #31528012 (Z.X. and W.L.), National Institute of Neurological Disorders and Stroke ZICNS003008-14 (B.S.M.), and Center for Human Immunology, Autoimmunity and Inflammation (J.C. and H.Z.).	Ali SS, 2010, J BIOL CHEM, V285, P32522, DOI 10.1074/jbc.M110.155432; Andrews MT, 2007, BIOESSAYS, V29, P431, DOI 10.1002/bies.20560; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Arendt T, 2003, J NEUROSCI, V23, P6972, DOI 10.1523/JNEUROSCI.23-18-06972.2003; Arendt T, 2013, AM J PHYSIOL-REG I, V305, pR478, DOI 10.1152/ajpregu.00117.2013; Avior Y, 2016, NAT REV MOL CELL BIO, V17, P170, DOI 10.1038/nrm.2015.27; Azzam NA, 2000, NATURE, V407, P317, DOI 10.1038/35030294; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Ballinger MA, 2017, AM J PHYSIOL-REG I, V312, pR301, DOI 10.1152/ajpregu.00314.2016; BARNES BM, 1989, SCIENCE, V244, P1593, DOI 10.1126/science.2740905; Bastide A, 2017, CURR BIOL, V27, P638, DOI 10.1016/j.cub.2017.01.047; BILLGER M, 1991, J CELL BIOL, V113, P331, DOI 10.1083/jcb.113.2.331; Bosc C, 2003, BIOCHEMISTRY-US, V42, P12125, DOI 10.1021/bi0352163; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boyer BB, 1998, AM J PHYSIOL-REG I, V275, pR1232, DOI 10.1152/ajpregu.1998.275.4.R1232; Breton S, 1998, J AM SOC NEPHROL, V9, P155; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Cooper ST, 2012, AM J PHYSIOL-REG I, V302, pR1202, DOI 10.1152/ajpregu.00018.2012; COTTERILL LA, 1989, TRANSPLANTATION, V48, P745, DOI 10.1097/00007890-198911000-00004; Dave KR, 2012, COMP BIOCHEM PHYS B, V162, P1, DOI 10.1016/j.cbpb.2012.01.008; DEDUKHOVA VI, 1991, FEBS LETT, V295, P51, DOI 10.1016/0014-5793(91)81382-I; DETRICH HW, 1993, CELL MOTIL CYTOSKEL, V24, P156, DOI 10.1002/cm.970240303; Drew KL, 2007, J NEUROCHEM, V102, P1713, DOI 10.1111/j.1471-4159.2007.04675.x; Drew KL, 2011, JOVE-J VIS EXP, DOI 10.3791/2199; Dunlop RA, 2009, IUBMB LIFE, V61, P522, DOI 10.1002/iub.189; Fabre E, 2002, UROL RES, V30, P89, DOI 10.1007/s00240-002-0237-6; Fedorov VB, 2014, MOL ECOL, V23, P5524, DOI 10.1111/mec.12963; Forreider B, 2017, PROG NEUROBIOL, V157, P174, DOI 10.1016/j.pneurobio.2016.03.002; Fukuda T, 2006, ANN NEUROL, V59, P700, DOI 10.1002/ana.20807; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gregersen N, 2010, METHODS MOL BIOL, V648, P3, DOI 10.1007/978-1-60761-756-3_1; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Guillaud L, 1998, J CELL BIOL, V142, P167, DOI 10.1083/jcb.142.1.167; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hampton M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085157; Hindle AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071627; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jain S, 2016, TRANSPLANTATION, V100, P538, DOI 10.1097/TP.0000000000000937; Kapitein LC, 2015, NEURON, V87, P492, DOI 10.1016/j.neuron.2015.05.046; Kiemer L, 2005, BIOINFORMATICS, V21, P1269, DOI 10.1093/bioinformatics/bti130; Laursen WJ, 2015, P NATL ACAD SCI USA, V112, P1607, DOI 10.1073/pnas.1421419112; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maathuis MHJ, 2007, TRANSPLANTATION, V83, P1289, DOI 10.1097/01.tp.0000265586.66475.cc; Mangino MJ, 2008, TRANSPLANTATION, V85, P427, DOI 10.1097/TP.0b013e31815fed17; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Meberg PJ, 2003, METHOD CELL BIOL, V71, P111, DOI 10.1016/S0091-679X(03)01007-0; Mertens J, 2015, CELL STEM CELL, V17, P705, DOI 10.1016/j.stem.2015.09.001; Mitchell T, 2011, J PHARMACOL EXP THER, V336, P682, DOI 10.1124/jpet.110.176743; Morin P, 2009, INT J DEV BIOL, V53, P433, DOI 10.1387/ijdb.082643pm; Nathaniel TI, 2008, INT J STROKE, V3, P98, DOI 10.1111/j.1747-4949.2008.00186.x; Niemann CU, 2015, NEW ENGL J MED, V373, P405, DOI 10.1056/NEJMoa1501969; Penazzi L, 2016, INT REV CEL MOL BIO, V321, P89, DOI 10.1016/bs.ircmb.2015.09.004; Peretti D, 2015, NATURE, V518, P236, DOI 10.1038/nature14142; Qiang XL, 2013, NAT MED, V19, P1489, DOI 10.1038/nm.3368; Quinones QJ, 2014, INTEGR COMP BIOL, V54, P497, DOI 10.1093/icb/icu047; Rauen U, 1998, FREE RADICAL BIO MED, V24, P1316, DOI 10.1016/S0891-5849(97)00456-5; Reinhard K, 2016, INVEST OPHTH VIS SCI, V57, P658, DOI 10.1167/iovs.15-17751; Roberg K, 1998, AM J PATHOL, V152, P1151; Schultheiss M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148616; Shen D, 2011, CELL BIOCHEM BIOPHYS, V60, P173, DOI 10.1007/s12013-010-9138-4; SKULACHEV VP, 1991, FEBS LETT, V294, P158, DOI 10.1016/0014-5793(91)80658-P; Song YY, 2013, NEURON, V78, P109, DOI 10.1016/j.neuron.2013.01.036; Speir ML, 2016, NUCLEIC ACIDS RES, V44, pD717, DOI 10.1093/nar/gkv1275; Staples JF, 2016, COMPR PHYSIOL, V6, P737, DOI 10.1002/cphy.c140064; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Storey KB, 2010, ADV CLIN CHEM, V52, P77, DOI 10.1016/S0065-2423(10)52003-1; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taylor MJ, 2006, ADV BIOPRESERVATION, P15; Tong G, 2013, BRAIN RES, V1504, P74, DOI 10.1016/j.brainres.2013.01.041; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Varemo L, 2013, NUCLEIC ACIDS RES, V41, P4378, DOI 10.1093/nar/gkt111; von der Ohe CG, 2006, J NEUROSCI, V26, P10590, DOI 10.1523/JNEUROSCI.2874-06.2006; WALLIN M, 1995, INT REV CYTOL, V157, P1, DOI 10.1016/S0074-7696(08)62155-5; Wang LK, 2012, NUCLEIC ACIDS RES, V40, pW376, DOI 10.1093/nar/gks437; WEBB BC, 1980, BIOCHEMISTRY-US, V19, P1993, DOI 10.1021/bi00550a041; WEBER K, 1975, P NATL ACAD SCI USA, V72, P459, DOI 10.1073/pnas.72.2.459; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams DR, 2005, PHYSIOL GENOMICS, V24, P13, DOI 10.1152/physiolgenomics.00301.2004; Wilson C, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00381; Yamashita H, 1999, FEBS LETT, V458, P157, DOI 10.1016/S0014-5793(99)01143-6; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174; Zhang T, 2014, DNA CELL BIOL, V33, P477, DOI 10.1089/dna.2014.2452; Zhang YJ, 2014, J PROTEOMICS, V105, P266, DOI 10.1016/j.jprot.2014.01.006; Zhu XZ, 2016, CELL MOL LIFE SCI, V73, P3839, DOI 10.1007/s00018-016-2253-7	89	52	57	4	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 3	2018	173	4					851	+		10.1016/j.cell.2018.03.010	http://dx.doi.org/10.1016/j.cell.2018.03.010			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GG1TU	29576452	Bronze, Green Accepted			2022-12-28	WOS:000432471100009
J	Butala, NM; Kramer, DB; Shen, CY; Strom, JB; Kennedy, KF; Wang, Y; Valsdottir, LR; Wasfy, JH; Yeh, RW				Butala, Neel M.; Kramer, Daniel B.; Shen, Changyu; Strom, Jordan B.; Kennedy, Kevin F.; Wang, Yun; Valsdottir, Linda R.; Wasfy, Jason H.; Yeh, Robert W.			Applicability of Publicly Reported Hospital Readmission Measures to Unreported Conditions and Other Patient Populations A Cross-sectional All-Payer Study	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ADMINISTRATIVE CLAIMS MEASURE; HEART-FAILURE; 30-DAY READMISSIONS; REDUCTION PROGRAM; MEDICARE PATIENTS; OLDER-ADULTS; RATES; RISK; PERFORMANCE	Background: Readmission rates after hospitalizations for heart failure (HF), acute myocardial infarction (AMI), and pneumonia among Medicare beneficiaries are used to assess quality and determine reimbursement. Whether these measures reflect readmission rates for other conditions or insurance groups is unknown. Objective: To investigate whether hospital-level 30-day readmission measures for publicly reported conditions (HF, AMI, and pneumonia) among Medicare patients reflect those for Medicare patients hospitalized for unreported conditions or non-Medicare patients hospitalized with HF, AMI, or pneumonia. Design: Cross-sectional. Setting: Population-based. Participants: Hospitals in the all-payer Nationwide Readmissions Database in 2013 and 2014. Measurements: Hospital-level 30-day all-cause risk-standardized excess readmission ratios (ERRs) were compared for 3 groups of patients: Medicare beneficiaries admitted for HF, AMI, or pneumonia (Medicare reported group); Medicare beneficiaries admitted for other conditions (Medicare unreported group); and non-Medicare beneficiaries admitted for HF, AMI, or pneumonia (non-Medicare group). Results: Within-hospital differences in ERRs varied widely among groups. Medicare reported ratios differed from Medicare unreported ratios by more than 0.1 for 29% of hospitals and from non-Medicare ratios by more than 0.1 for 46% of hospitals. Among hospitals with higher readmission ratios, ERRs for the Medicare reported group tended to overestimate ERRs for the non-Medicare group but underestimate those for the Medicare unreported group. Limitation: Medicare groups and risk adjustment differed slightly from those used by the Centers for Medicare & Medicaid Services. Conclusion: Hospital ERRs, as estimated by Medicare to determine financial penalties, have poor agreement with corresponding measures for populations and conditions not tied to financial penalties. Current publicly reported measures may not be good surrogates for overall hospital quality related to 30-day readmissions.	[Butala, Neel M.; Wasfy, Jason H.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Butala, Neel M.; Kramer, Daniel B.; Shen, Changyu; Strom, Jordan B.; Wasfy, Jason H.; Yeh, Robert W.] Harvard Med Sch, Boston, MA USA; [Kramer, Daniel B.; Shen, Changyu; Strom, Jordan B.; Yeh, Robert W.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Kennedy, Kevin F.] Univ Missouri, St Lukes Mid Amer Heart Inst, 4401 Wornall Rd, Kansas City, MO 64111 USA; [Wang, Yun] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Kramer, Daniel B.; Shen, Changyu; Strom, Jordan B.; Valsdottir, Linda R.; Yeh, Robert W.] Beth Israel Dea coness Med Ctr, Smith Ctr Outcomes Res Cardiol, 375 Longwood Ave,Suite 440, Boston, MA 02215 USA; [Butala, Neel M.; Wasfy, Jason H.] Div Cardiol, GRB 7,55 Fruit St, Boston, MA 02114 USA; [Wang, Yun] 655 Huntington Ave,Bldg 1,Room 451, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Harvard University; Harvard T.H. Chan School of Public Health	Yeh, RW (corresponding author), Beth Israel Dea coness Med Ctr, Smith Ctr Outcomes Res Cardiol, 375 Longwood Ave,Suite 440, Boston, MA 02215 USA.	ryeh@bidmc.harvard.edu	Yeh, Robert/AAJ-3463-2020	Strom, Jordan/0000-0002-6592-6141	Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology	Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology	Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology.	[Anonymous], 2018, HOSP COMP; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boccuti C, 2017, ISSUE BRIEF; Bueno H, 2010, JAMA-J AM MED ASSOC, V303, P2141, DOI 10.1001/jama.2010.748; Campione JR, 2017, AM J MED QUAL, V32, P48, DOI 10.1177/1062860615612158; CDC/ National Center for Health Statistics, 2010, NUMB RAT DISCH SHORT; Center for Health Information and Analysis, 2016, HOSP WID AD ALL PAYE; Centers for Medicare & Medicaid Services, 2013, 2013 MEAS UPD SPEC R; Centers for Medicare & Medicaid Services, 2016, HOSP WID ALL COND 30; Chappidi MR, 2017, J UROLOGY, V197, P296, DOI 10.1016/j.juro.2016.08.082; Dharmarajan K, 2017, J AM GERIATR SOC, V65, P421, DOI 10.1111/jgs.14583; Dharmarajan K, 2014, CURR GERIATR REP, V3, P306, DOI 10.1007/s13670-014-0103-8; Dharmarajan K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h411; Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; Freedman JD, 2016, NEW ENGL J MED, V375, P2215, DOI 10.1056/NEJMp1613276; Hansen LO, 2011, HEALTH SERV RES, V46, P596, DOI 10.1111/j.1475-6773.2010.01204.x; Horwitz LI, 2017, MED CARE, V55, P528, DOI 10.1097/MLR.0000000000000713; Horwitz LI, 2014, ANN INTERN MED, V161, pS66, DOI 10.7326/M13-3000; Horwitz LI, 2012, J HOSP MED, V7, P690, DOI 10.1002/jhm.1965; James J., 2013, HEALTH AFFAIR, V34, P1, DOI [10.1377/hpb20131112.646839, DOI 10.1377/HPB20131112.646839]; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P342, DOI 10.1001/jama.2012.94856; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Koehler BE, 2009, J HOSP MED, V4, P211, DOI 10.1002/jhm.427; Kolte D, 2017, CIRC-CARDIOVASC INTE, V10, DOI 10.1161/CIRCINTERVENTIONS.116.004472; Krumholz HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160492; Krumholz HM, 2011, CIRC-CARDIOVASC QUAL, V4, P243, DOI 10.1161/CIRCOUTCOMES.110.957498; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Lindenauer PK, 2011, J HOSP MED, V6, P142, DOI 10.1002/jhm.890; Lindenauer Peter K, 2010, J Hosp Med, V5, pE12, DOI 10.1002/jhm.822; Linertova R, 2011, J EVAL CLIN PRACT, V17, P1167, DOI 10.1111/j.1365-2753.2010.01493.x; Mayr FB, 2017, JAMA-J AM MED ASSOC, V317, P530, DOI 10.1001/jama.2016.20468; McHugh MD, 2013, MED CARE, V51, P52, DOI [10.1097/MLR.0b013e3182763284, 10.1097/01.NNA.0000435146.46961.d1]; Mellor J, 2017, HEALTH ECON, V26, P1037, DOI 10.1002/hec.3382; Rosen AK, 2016, MED CARE, V54, P155, DOI 10.1097/MLR.0000000000000455; Ross JS, 2010, HEALTH AFFAIR, V29, P2317, DOI 10.1377/hlthaff.2010.0564; Salerno AM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016149; Stranges PM, 2015, AM J MANAG CARE, V21, P106; Strom JB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180767; Thygesen LC, 2015, SCAND J PRIM HEALTH, V33, P65, DOI 10.3109/02813432.2015.1041831; Wasfy JH, 2017, ANN INTERN MED, V166, P324, DOI 10.7326/M16-0185; Zuckerman RB, 2016, NEW ENGL J MED, V374, P1543, DOI 10.1056/NEJMsa1513024	42	7	7	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2018	168	9					631	+		10.7326/M17-1492	http://dx.doi.org/10.7326/M17-1492			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GI3BZ	29582086				2022-12-28	WOS:000434247300005
J	Miller, DP; Denizard-Thompson, N; Weaver, KE; Case, LD; Troyer, JL; Spangler, JG; Lawler, D; Pignone, MP				Miller, D. P., Jr.; Denizard-Thompson, N.; Weaver, K. E.; Case, L. D.; Troyer, J. L.; Spangler, J. G.; Lawler, D.; Pignone, M. P.			A Health App to Promote Colorectal Cancer Screening	ANNALS OF INTERNAL MEDICINE			English	Editorial Material													Weaver, Kathryn E/W-3258-2019	Weaver, Kathryn E/0000-0001-9006-4064					0	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2018	168	8					I16	I16		10.7326/P18-0002	http://dx.doi.org/10.7326/P18-0002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GC8XZ	29532082				2022-12-28	WOS:000430083100002
J	Dodick, DW				Dodick, David W.			Migraine	LANCET			English	Review							CORTICAL SPREADING DEPRESSION; MEDICATION-OVERUSE HEADACHE; VAGUS NERVE-STIMULATION; GENE-RELATED PEPTIDE; QUALITY STANDARDS SUBCOMMITTEE; TRANSCRANIAL MAGNETIC STIMULATION; BRAIN-STEM ACTIVATION; DOUBLE-BLIND; EPISODIC MIGRAINE; AMERICAN-ACADEMY	Migraine is a chronic paroxysmal neurological disorder characterised by multiphase attacks of head pain and a myriad of neurological symptoms. The underlying genetic and biological underpinnings and neural networks involved are coming sharply into focus. This progress in the fundamental understanding of migraine has led to novel, mechanism-based and disease-specific therapeutics. In this Seminar, the clinical features and neurobiology of migraine are reviewed, evidence to support available treatment options is provided, and emerging drug, device, and biological therapies are discussed.	[Dodick, David W.] Mayo Clin, Dept Neurol, Phoenix, AZ 85054 USA	Mayo Clinic; Mayo Clinic Phoenix	Dodick, DW (corresponding author), Mayo Clin, Dept Neurol, Phoenix, AZ 85054 USA.	dodick.david@mayo.edu						Afridi SK, 2005, ARCH NEUROL-CHICAGO, V62, P1270, DOI 10.1001/archneur.62.8.1270; Afridi SK, 2005, BRAIN, V128, P932, DOI 10.1093/brain/awh416; Ambrosini A, 2003, CURR OPIN NEUROL, V16, P327, DOI 10.1097/00019052-200306000-00012; Ambrosini A, 2016, CEPHALALGIA, V37, P1126; Andreou AP, 2016, BRAIN, V139, P2002, DOI 10.1093/brain/aww118; Anttila V, 2013, NAT GENET, V45, P912, DOI 10.1038/ng.2676; Ayata C, 2006, ANN NEUROL, V59, P652, DOI 10.1002/ana.20778; Barbanti P, 2016, CEPHALALGIA, V36, P1334, DOI 10.1177/0333102416630579; Bartsch T, 2003, Curr Pain Headache Rep, V7, P371, DOI 10.1007/s11916-003-0036-y; Becker Werner J, 2015, Continuum (Minneap Minn), V21, P953, DOI 10.1212/CON.0000000000000192; Bigal ME, 2008, NEUROLOGY, V70, P1525, DOI 10.1212/01.wnl.0000310645.31020.b1; Bigal ME, 2008, HEADACHE, V48, P1157, DOI 10.1111/j.1526-4610.2008.01217.x; Bigal ME, 2015, LANCET NEUROL, V14, P1081, DOI 10.1016/S1474-4422(15)00249-5; Bigal ME, 2015, LANCET NEUROL, V14, P1091, DOI 10.1016/S1474-4422(15)00245-8; Bille B, 1997, CEPHALALGIA, V17, P488, DOI 10.1046/j.1468-2982.1997.1704488.x; Blumenfeld AM, 2011, CEPHALALGIA, V31, P301, DOI 10.1177/0333102410381145; Blumenfeld A, 2013, HEADACHE, V53, P437, DOI 10.1111/head.12053; Boulloche N, 2010, J NEUROL NEUROSUR PS, V81, P978, DOI 10.1136/jnnp.2009.190223; Brennan KC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005784; Brighina F, 2009, J HEADACHE PAIN, V10, P77, DOI 10.1007/s10194-008-0095-x; Burstein R, 2004, ANN NEUROL, V55, P19, DOI 10.1002/ana.10786; Burstein R, 2005, J COMP NEUROL, V493, P9, DOI 10.1002/cne.20688; BURSTEIN R, 1987, J NEUROSCI, V7, P4159; Burstein R, 2017, CURR OPIN NEUROL, V30, P263, DOI 10.1097/WCO.0000000000000437; Burstein R, 2015, J NEUROSCI, V35, P6619, DOI 10.1523/JNEUROSCI.0373-15.2015; Buse D, 2012, HEADACHE, V52, P3, DOI 10.1111/j.1526-4610.2011.02046.x; Buse DC, 2016, MAYO CLIN PROC, V91, P596, DOI 10.1016/j.mayocp.2016.02.013; Buse DC, 2012, HEADACHE, V52, P1456, DOI 10.1111/j.1526-4610.2012.02223.x; Calhoun AH, 2010, HEADACHE, V50, P1273, DOI 10.1111/j.1526-4610.2009.01608.x; Cameron C, 2015, HEADACHE, V55, P221, DOI 10.1111/head.12601; Cernuda-Morollon E, 2013, NEUROLOGY, V81, P1191, DOI 10.1212/WNL.0b013e3182a6cb72; Chaparro M, 2011, CURR PHARM BIOTECHNO, V12, P765, DOI 10.2174/138920111795470903; Chiang CC, 2016, CEPHALALGIA, V36, P371, DOI 10.1177/0333102415593088; Chong CD, 2014, CEPHALALGIA, V34, P1115, DOI 10.1177/0333102414531157; Chou DE, 2017, CEPHALALGIA, V37, P323; Coppola G, 2016, CEPHALALGIA, V36, P568, DOI 10.1177/0333102415610873; De Felice M, 2010, BRAIN, V133, P2475, DOI 10.1093/brain/awq159; De Felice M, 2010, ANN NEUROL, V67, P325, DOI 10.1002/ana.21897; Denuelle M, 2011, NEUROLOGY, V76, P213, DOI 10.1212/WNL.0b013e3182074a57; Depre C, 2017, CEPHALALGIA, V37, P340; Detke HC, 2017, CEPHALALGIA, V37, P338; Diener HC, 2007, CEPHALALGIA, V27, P814, DOI 10.1111/j.1468-2982.2007.01326.x; Diener HC, 2009, CEPHALALGIA, V29, P1021, DOI 10.1111/j.1468-2982.2009.01859.x; Diener HC, 2012, NAT REV NEUROL, V8, P162, DOI 10.1038/nrneurol.2012.13; Dilli E, 2015, CEPHALALGIA, V35, P959, DOI 10.1177/0333102414561872; Dodick D, 2004, HEADACHE, V44, P414, DOI 10.1111/j.1526-4610.2004.04078.x; Dodick D W, 2007, Pract Neurol, V7, P383, DOI 10.1136/jnnp.2007.134023; Dodick D, 2006, HEADACHE, V46, pS182, DOI 10.1111/j.1526-4610.2006.00602.x; Dodick DW, 2014, LANCET NEUROL, V13, P885, DOI 10.1016/S1474-4422(14)70128-0; Dodick DW, 2005, HEADACHE, V45, P156, DOI 10.1111/j.1526-4610.2005.05031.x; Eikermann-Haerter K, 2008, CURR OPIN NEUROL, V21, P294, DOI 10.1097/WCO.0b013e3282fc25de; Eross E, 2007, HEADACHE, V47, P213, DOI 10.1111/j.1526-4610.2006.00688.x; Evers S, 2006, EUR J NEUROL, V13, P560, DOI 10.1111/j.1468-1331.2006.01411.x; Evers S, 2011, EUR J NEUROL, V18, P1115, DOI 10.1111/j.1468-1331.2011.03497.x; Feigin VL, 2017, LANCET NEUROL, V16, P877, DOI 10.1016/S1474-4422(17)30299-5; Ferrari MD, 2015, LANCET NEUROL, V14, P65, DOI 10.1016/S1474-4422(14)70220-0; Friedman DI, 2017, HEADACHE, V57, P643, DOI 10.1111/head.13042; Gaul C, 2016, CEPHALALGIA, V36, P534, DOI 10.1177/0333102415607070; Gelfand AA, 2015, CEPHALALGIA, V35, P63, DOI 10.1177/0333102414534326; Giffin NJ, 2016, NEUROLOGY, V87, P309, DOI 10.1212/WNL.0000000000002789; Giffin NJ, 2003, NEUROLOGY, V60, P935, DOI 10.1212/01.WNL.0000052998.58526.A9; Goadsby PJ, 2018, CEPHALALGIA, V38, P959, DOI 10.1177/0333102417744362; Goadsby PJ, 2017, NEW ENGL J MED, V377, P2123, DOI 10.1056/NEJMoa1705848; Goadsby PJ, 2017, PHYSIOL REV, V97, P553, DOI 10.1152/physrev.00034.2015; Goadsby PJ, 1998, ANN NEUROL, V43, P711, DOI 10.1002/ana.410430605; Goldberg SW, 2015, CNS DRUGS, V29, P443, DOI 10.1007/s40263-015-0253-z; Gori S, 2015, FUNCT NEUROL, V30, P119; Gormley P, 2016, NAT GENET, V48, P856, DOI 10.1038/ng.3598; Green AL, 2014, CEPHALALGIA, V34, P594, DOI 10.1177/0333102413515344; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Hadjikhani N, 2013, CEPHALALGIA, V33, P1264, DOI 10.1177/0333102413490344; Hansen JM, 2016, CEPHALALGIA, V36, P216, DOI 10.1177/0333102415584601; Hansen JM, 2012, NEUROLOGY, V79, P2044, DOI 10.1212/WNL.0b013e3182749eed; Hauge AW, 2009, LANCET NEUROL, V8, P718, DOI 10.1016/S1474-4422(09)70135-8; Hepp Z, 2015, CEPHALALGIA, V35, P478, DOI 10.1177/0333102414547138; Hewitt DJ, 2011, CEPHALALGIA, V31, P712, DOI 10.1177/0333102411398399; Ho TW, 2008, LANCET, V372, P2115, DOI 10.1016/S0140-6736(08)61626-8; Holland S, 2012, NEUROLOGY, V78, P1346, DOI 10.1212/WNL.0b013e3182535d0c; Holroyd KA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4871; Karatas H, 2013, SCIENCE, V339, P1092, DOI 10.1126/science.1231897; Karsan N, 2016, J HEADACHE PAIN, V17, DOI 10.1186/s10194-016-0689-7; Kelman L, 2006, CEPHALALGIA, V26, P214, DOI 10.1111/j.1468-2982.2005.01026.x; Kelman L, 2005, HEADACHE, V45, P904, DOI 10.1111/j.1526-4610.2005.05159.x; Kelman L, 2004, CEPHALALGIA, V24, P940, DOI 10.1111/j.1468-2982.2004.00766.x; Kelman L, 2006, HEADACHE, V46, P942, DOI 10.1111/j.1526-4610.2006.00443.x; Kopruszinski CM, 2017, CEPHALALGIA, V37, P560, DOI 10.1177/0333102416650702; Kosaras B, 2009, J COMP NEUROL, V515, P331, DOI 10.1002/cne.22049; Lal D, 2015, LARYNGOSCOPE, V125, P303, DOI 10.1002/lary.24926; Lambert GA, 2011, CEPHALALGIA, V31, P1439, DOI 10.1177/0333102411422383; Lampl C, 2016, J HEADACHE PAIN, V17, DOI 10.1186/s10194-016-0599-8; Lewis D, 2004, NEUROLOGY, V63, P2215, DOI 10.1212/01.WNL.0000147332.41993.90; Lipton RB, 2007, NEUROLOGY, V68, P343, DOI 10.1212/01.wnl.0000252808.97649.21; Lipton RB, 2000, JAMA-J AM MED ASSOC, V284, P2599, DOI 10.1001/jama.284.20.2599; Lipton RB, 2005, HEADACHE, V45, pS3, DOI 10.1111/j.1526-4610.2005.4501001.x; Lipton RB, 2003, NEUROLOGY, V61, P375, DOI 10.1212/01.WNL.0000078940.53438.83; Lipton RB, 2016, CEPHALALGIA, V36, P203, DOI 10.1177/0333102415583982; Lipton RB, 2015, NEUROLOGY, V84, P688, DOI 10.1212/WNL.0000000000001256; Lipton RB, 2015, HEADACHE, V55, P103, DOI 10.1111/head.12505_2; Lipton RB, 2009, NEUROLOGY, V72, pS3, DOI 10.1212/WNL.0b013e3181974b19; Lipton RB, 2013, HEADACHE, V53, P930, DOI 10.1111/head.12128; Lipton RB, 2010, LANCET NEUROL, V9, P373, DOI 10.1016/S1474-4422(10)70054-5; MaassenVanDenBrink A, 2016, TRENDS PHARMACOL SCI, V37, P779, DOI 10.1016/j.tips.2016.06.002; Magis D, 2016, CURR OPIN NEUROL, V29, P320, DOI 10.1097/WCO.0000000000000335; Mainero C, 2011, ANN NEUROL, V70, P838, DOI 10.1002/ana.22537; Maleki N, 2012, CEPHALALGIA, V32, P607, DOI 10.1177/0333102412445622; Malick A, 2000, J NEUROPHYSIOL, V84, P2078, DOI 10.1152/jn.2000.84.4.2078; Manack A, 2011, NEUROLOGY, V76, P711, DOI 10.1212/WNL.0b013e31820d8af2; Maniyar FH, 2015, HEADACHE, V55, P609, DOI 10.1111/head.12572; Maniyar FH, 2014, BRAIN, V137, P232, DOI 10.1093/brain/awt320; Marcus R, 2014, CEPHALALGIA, V34, P114, DOI 10.1177/0333102413500727; Marin JCA, 2010, EXPERT OPIN INV DRUG, V19, P555, DOI 10.1517/13543781003691832; Marmura MJ, 2015, HEADACHE, V55, P3, DOI 10.1111/head.12499; Melo-Carrillo A, 2017, J NEUROSCI, V37, P10587, DOI 10.1523/JNEUROSCI.2211-17.2017; Melo-Carrillo A, 2017, J NEUROSCI, V37, P7149, DOI 10.1523/JNEUROSCI.0576-17.2017; Meng FG, 2013, NEUROLOGY, V81, P1102, DOI 10.1212/01.wnl.0000435063.25330.55; Moskowitz MA, 2007, FUNCT NEUROL, V22, P133; Moulton EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095508; Moulton EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003799; Natoli JL, 2010, CEPHALALGIA, V30, P599, DOI 10.1111/j.1468-2982.2009.01941.x; Nicholson RA, 2011, CURR TREAT OPTION NE, V13, P28, DOI 10.1007/s11940-010-0102-9; Nir RR, 2015, CURR OPIN SUPPORT PA, V9, P131, DOI 10.1097/SPC.0000000000000126; Noseda R, 2013, PAIN, V154, pS44, DOI 10.1016/j.pain.2013.07.021; Noseda R, 2011, J NEUROSCI, V31, P14204, DOI 10.1523/JNEUROSCI.3285-11.2011; Noseda R, 2010, NAT NEUROSCI, V13, P239, DOI 10.1038/nn.2475; Olesen J, 2004, NEW ENGL J MED, V350, P1104, DOI 10.1056/NEJMoa030505; Olesen J, 2018, CEPHALALGIA, V38, P1, DOI 10.1177/0333102417738202; Olesen J, 2009, LANCET NEUROL, V8, P679, DOI 10.1016/S1474-4422(09)70090-0; Orr SL, 2015, CEPHALALGIA, V35, P271, DOI 10.1177/0333102414535997; Palm-Meinders IH, 2012, JAMA-J AM MED ASSOC, V308, P1889, DOI 10.1001/jama.2012.14276; Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646; Penzien DB, 2005, HEADACHE, V45, pS110, DOI 10.1111/j.1526-4610.2005.4502004.x; Petrusic I, 2013, CEPHALALGIA, V33, P861, DOI 10.1177/0333102413476373; Pietrobon D, 2013, ANNU REV PHYSIOL, V75, P365, DOI 10.1146/annurev-physiol-030212-183717; Pringsheim T, 2012, CAN J NEUROL SCI, V39, pS1; Pryse-Phillips WEM, 1998, CAN MED ASSOC J, V159, P47; Quintela E, 2006, CEPHALALGIA, V26, P1051, DOI 10.1111/j.1468-2982.2006.01157.x; Russell MB, 1996, BRAIN, V119, P355, DOI 10.1093/brain/119.2.355; Saper J, 2017, CEPHALALGIA, V37, P337; Saper JR, 2006, HEADACHE, V46, pS212, DOI 10.1111/j.1526-4610.2006.00605.x; Schankin CJ, 2016, BRAIN, V139, P1994, DOI 10.1093/brain/aww096; Schulte LH, 2016, BRAIN, V139, P1987, DOI 10.1093/brain/aww097; Schwedt TJ, 2015, HEADACHE, V55, P762, DOI 10.1111/head.12584; Schwedt TJ, 2014, CEPHALALGIA, V34, P947, DOI 10.1177/0333102414526069; Schwedt T, 2015, LANCET NEUROL, V14, P81, DOI 10.1016/S1474-4422(14)70193-0; SELBY G, 1960, J NEUROL NEUROSUR PS, V23, P23, DOI 10.1136/jnnp.23.1.23; Seng EK, 2014, HEADACHE, V54, P1470, DOI 10.1111/head.12426; Silberstein S, 2008, CEPHALALGIA, V28, P484, DOI 10.1111/j.1468-2982.2008.01555.x; Silberstein S, 2007, CEPHALALGIA, V27, P220, DOI 10.1111/j.1468-2982.2006.01275.x; Silberstein SD, 2012, NEUROLOGY, V78, P1337, DOI 10.1212/WNL.0b013e3182535d20; SILBERSTEIN SD, 1995, HEADACHE, V35, P387, DOI 10.1111/j.1526-4610.1995.hed3507387.x; Silberstein SD, 2017, NEW ENGL J MED, V377, P2113, DOI 10.1056/NEJMoa1709038; Silberstein SD, 2016, HEADACHE, V56, P1317, DOI 10.1111/head.12896; Silberstein SD, 2016, NEUROLOGY, V87, P529, DOI 10.1212/WNL.0000000000002918; Silberstein SD, 2013, J NEUROL SCI, V331, P48, DOI 10.1016/j.jns.2013.05.003; Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7; Simpson DM, 2016, NEUROLOGY, V86, P1818, DOI 10.1212/WNL.0000000000002560; Skljarevski V, 2018, JAMA NEUROL, V75, P187, DOI 10.1001/jamaneurol.2017.3859; Starling AJ, CEPHALALGIA IN PRESS; Stolte B, 2015, CEPHALALGIA, V35, P262, DOI 10.1177/0333102414535113; Straube A, 2010, CEPHALALGIA, V30, P207, DOI 10.1111/j.1468-2982.2009.01906.x; Sun H, 2016, LANCET NEUROL, V15, P382, DOI 10.1016/S1474-4422(16)00019-3; Tang YG, 2017, AM J EMERG MED, V35, P1750, DOI 10.1016/j.ajem.2017.08.027; Tassorelli C, 2017, CEPHALALGIA, V37, P319; Tfelt-Hansen PC, 2014, EXPERT OPIN INV DRUG, V23, P375, DOI 10.1517/13543784.2014.861817; Tolner EA, 2015, PAIN, V156, pS64, DOI 10.1097/01.j.pain.0000460346.00213.16; Varkey E, 2011, CEPHALALGIA, V31, P1428, DOI 10.1177/0333102411419681; Vongvaivanich K, 2015, CEPHALALGIA, V35, P894, DOI 10.1177/0333102414560635; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; Voss T, 2016, CEPHALALGIA, V36, P887, DOI 10.1177/0333102416653233; WEILLER C, 1995, NAT MED, V1, P658, DOI 10.1038/nm0795-658; Westergaard ML, 2014, CEPHALALGIA, V34, P409, DOI 10.1177/0333102413512033; Wietecha LA, 2017, CEPHALALGIA, V37, P367; WOODS RP, 1994, NEW ENGL J MED, V331, P1689, DOI 10.1056/NEJM199412223312505; Worthington I, 2013, CAN J NEUROL SCI, V40, pS1; Yallampalli C, 2002, TRENDS ENDOCRIN MET, V13, P263, DOI 10.1016/S1043-2760(02)00563-5; Yarnitsky D, 2017, NEUROLOGY, V88, P1250, DOI 10.1212/WNL.0000000000003760; Zhang XC, 2010, J NEUROSCI, V30, P8807, DOI 10.1523/JNEUROSCI.0511-10.2010	177	216	234	20	90	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 31	2018	391	10127					1315	1330		10.1016/S0140-6736(18)30478-1	http://dx.doi.org/10.1016/S0140-6736(18)30478-1			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB1DR	29523342				2022-12-28	WOS:000428791600029
J	Das, A; Huang, GX; Bonkowski, MS; Longchamp, A; Li, C; Schultz, MB; Kim, LJ; Osborne, B; Joshi, S; Lu, YC; Trevino-Villarreal, JH; Kang, MJ; Hung, TT; Lee, B; Williams, EO; Igarashi, M; Mitchell, JR; Wu, LE; Turner, N; Arany, Z; Guarente, L; Sinclair, DA				Das, Abhirup; Huang, George X.; Bonkowski, Michael S.; Longchamp, Alban; Li, Catherine; Schultz, Michael B.; Kim, Lynn-Jee; Osborne, Brenna; Joshi, Sanket; Lu, Yuancheng; Trevino-Villarreal, Jose Humberto; Kang, Myung-Jin; Hung, Tzong-tyng; Lee, Brendan; Williams, Eric O.; Igarashi, Masaki; Mitchell, James R.; Wu, Lindsay E.; Turner, Nigel; Arany, Zolt; Guarente, Leonard; Sinclair, David A.			Impairment of an Endothelial NAD(+)-H2S Signaling Network Is a Reversible Cause of Vascular Aging	CELL			English	Article							SKELETAL-MUSCLE CAPILLARIZATION; LIFE-SPAN; NICOTINAMIDE MONONUCLEOTIDE; IMPROVES MITOCHONDRIAL; PREMATURE SENESCENCE; CALORIE RESTRICTION; OXIDATIVE STRESS; AMPK ACTIVATION; SIRT1; EXERCISE	A decline in capillary density and blood flow with age is a major cause of mortality and morbidity. Understanding why this occurs is key to future gains in human health. NAD precursors reverse aspects of aging, in part, by activating sirtuin deacylases (SIRT1-SIRT7) that mediate the benefits of exercise and dietary restriction (DR). We show that SIRT1 in endothelial cells is a key mediator of pro-angiogenic signals secreted from myocytes. Treatment of mice with the NAD(+) booster nicotinamide mononucleotide (NMN) improves blood flow and increases endurance in elderly mice by promoting SIRT1-dependent increases in capillary density, an effect augmented by exercise or increasing the levels of hydrogen sulfide (H2S), a DR mimetic and regulator of endothelial NAD(+) levels. These findings have implications for improving blood flow to organs and tissues, increasing human performance, and reestablishing a virtuous cycle of mobility in the elderly.	[Das, Abhirup; Huang, George X.; Bonkowski, Michael S.; Schultz, Michael B.; Lu, Yuancheng; Sinclair, David A.] Harvard Med Sch, Dept Genet, Paul F Glenn Ctr Biol Mech Aging, Boston, MA 02115 USA; [Das, Abhirup; Li, Catherine; Kim, Lynn-Jee; Kang, Myung-Jin; Wu, Lindsay E.; Sinclair, David A.] Univ New South Wales, Sch Med Sci, Dept Pharmacol, Lab Ageing Res, Sydney, NSW 2052, Australia; [Das, Abhirup; Williams, Eric O.; Igarashi, Masaki; Guarente, Leonard] MIT, Dept Biol, Paul F Glenn Ctr Sci Aging Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Huang, George X.; Arany, Zolt] Univ Penn, Perelman Sch Med, Cardiovasc Inst, 3400 Civ Ctr Blvd,Bldg 421, Philadelphia, PA 19104 USA; [Longchamp, Alban; Trevino-Villarreal, Jose Humberto; Mitchell, James R.] Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA USA; [Osborne, Brenna; Joshi, Sanket; Turner, Nigel] Univ New South Wales, Sch Med Sci, Dept Pharmacol, Mitochondrial Bioenerget Lab, Sydney, NSW 2052, Australia; [Hung, Tzong-tyng; Lee, Brendan] Univ New South Wales, Mark Wainwright Analyt Ctr, Biol Resources Imaging Lab, Sydney, NSW 2052, Australia	Harvard University; Harvard Medical School; University of New South Wales Sydney; Massachusetts Institute of Technology (MIT); University of Pennsylvania; Pennsylvania Medicine; Harvard University; Harvard T.H. Chan School of Public Health; University of New South Wales Sydney; University of New South Wales Sydney	Sinclair, DA (corresponding author), Harvard Med Sch, Dept Genet, Paul F Glenn Ctr Biol Mech Aging, Boston, MA 02115 USA.; Sinclair, DA (corresponding author), Univ New South Wales, Sch Med Sci, Dept Pharmacol, Lab Ageing Res, Sydney, NSW 2052, Australia.; Guarente, L (corresponding author), MIT, Dept Biol, Paul F Glenn Ctr Sci Aging Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Arany, Z (corresponding author), Univ Penn, Perelman Sch Med, Cardiovasc Inst, 3400 Civ Ctr Blvd,Bldg 421, Philadelphia, PA 19104 USA.	zarany@pennmedicine.upenn.edu; leng@mit.edu; david_sinclair@hms.harvard.edu	Das, Abhirup/AAF-5129-2019; Wu, Lindsay/GQI-1179-2022; Turner, Nigel/H-7176-2013; Osborne, Brenna/F-5950-2018; Wu, Lindsay/AAA-1486-2021; Lu, Yuancheng/AAT-5000-2021	Wu, Lindsay/0000-0002-1599-7574; Turner, Nigel/0000-0002-0119-9328; Osborne, Brenna/0000-0002-0197-3010; Wu, Lindsay/0000-0002-1599-7574; Bonkowski, Michael/0000-0003-3416-4612; Sinclair, David/0000-0002-9936-436X; Hung, Tzong/0000-0002-2904-2664; Das, Abhirup/0000-0003-1866-457X; Lu, Yuancheng (Ryan)/0000-0002-5982-3963; Lee, Brendan/0000-0002-0347-2105	Glenn Foundation for Medical Research [RO1 AG028730, RO1 DK100263]; Sinclair Gift Fund; NHMRC [APP1093643]; NIH/NIA [RO1 AG015339]; NIH/NHLBI [RO1 HL094499]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [DP1AG058605, R01AG028730, R37AG028730, R01AG015339, R01AG019719] Funding Source: NIH RePORTER	Glenn Foundation for Medical Research; Sinclair Gift Fund; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Margaret Morris, Edna Hardeman, Doyle Lokitiyakul, Patty Lee, Yi Zhang, Kyle Hoehn, Anthony Kee, Luis A. Rajman, Neil Youngson, Golam Mezbah Uddin, Corrine Fiveash, Ellen Olzomer, Menghan Liu, Nicholas Bentley, National Imaging Facility BMIF-BRIL-BRC (UNSW), and Paul Glenn for support. This work was supported by the Glenn Foundation for Medical Research (RO1 AG028730 and RO1 DK100263), the Sinclair Gift Fund, a gift from Edward Schulak to D.A.S., NHMRC (APP1093643) to L.E.W., NIH/NIA (RO1 AG015339) to L.G., and NIH/NHLBI (RO1 HL094499) to Z.A. This study is dedicated to Vera Ryan, grandmother to D.A.S., who believed the measure of a person is not their status or wealth but their impact.	Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Bai P, 2011, CELL METAB, V13, P450, DOI 10.1016/j.cmet.2011.03.013; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Baltgalvis KA, 2014, AM J PHYSIOL-HEART C, V306, pH1128, DOI 10.1152/ajpheart.00839.2013; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Blanco R, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006569; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; BOOTH FW, 1991, PHYSIOL REV, V71, P541, DOI 10.1152/physrev.1991.71.2.541; Borradaile NM, 2009, AGING CELL, V8, P100, DOI 10.1111/j.1474-9726.2009.00453.x; Camacho-Pereira J, 2016, CELL METAB, V23, P1127, DOI 10.1016/j.cmet.2016.05.006; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cardus A, 2013, CARDIOVASC RES, V97, P571, DOI 10.1093/cvr/cvs352; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; de Picciotto NE, 2016, AGING CELL, V15, P522, DOI 10.1111/acel.12461; Degens H, 1998, ADV EXP MED BIOL, V454, P343; DENIS C, 1986, J PHYSIOLOGY PARIS, V81, P379; Dimmeler S, 2000, CIRC RES, V87, P434; Escudier B, 2011, DRUGS R&D, V11, P113, DOI 10.2165/11591240-000000000-00000; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Frederick DW, 2015, J BIOL CHEM, V290, P1546, DOI 10.1074/jbc.M114.579565; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Groen BBL, 2014, J APPL PHYSIOL, V116, P998, DOI 10.1152/japplphysiol.00919.2013; Guarani V, 2011, NATURE, V473, P234, DOI 10.1038/nature09917; Guarente L, 2013, GENE DEV, V27, P2072, DOI 10.1101/gad.227439.113; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hine C, 2015, EXP GERONTOL, V68, P26, DOI 10.1016/j.exger.2014.12.010; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Hu MZ, 2016, INT HEART J, V57, P477, DOI 10.1536/ihj.15-506; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Hughes-Large JM, 2014, ATHEROSCLEROSIS, V237, P696, DOI 10.1016/j.atherosclerosis.2014.10.090; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Le Couteur DG, 2010, J GERONTOL A-BIOL, V65, P1025, DOI 10.1093/gerona/glq135; Li J, 2017, SCIENCE, V355, P1312, DOI 10.1126/science.aad8242; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Longchamp A, 2018, CELL, V173, P117, DOI 10.1016/j.cell.2018.03.001; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Mersmann N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020336; Miller DL, 2007, P NATL ACAD SCI USA, V104, P20618, DOI 10.1073/pnas.0710191104; Mills KF, 2016, CELL METAB, V24, P795, DOI 10.1016/j.cmet.2016.09.013; Morscher S, 2014, PHOTOACOUSTICS, V2, P103, DOI 10.1016/j.pacs.2014.06.001; Mouchiroud L, 2013, CRIT REV BIOCHEM MOL, V48, P397, DOI 10.3109/10409238.2013.789479; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Noseda M, 2004, MOL CELL BIOL, V24, P8813, DOI 10.1128/MCB.24.20.8813-8822.2004; Olfert IM, 2009, J PHYSIOL-LONDON, V587, P1755, DOI 10.1113/jphysiol.2008.164384; Oommen S, 2011, J BIOL CHEM, V286, P1083, DOI 10.1074/jbc.M110.175158; Ota H, 2007, J MOL CELL CARDIOL, V43, P571, DOI 10.1016/j.yjmcc.2007.08.008; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Prior SJ, 2016, J GERONTOL A-BIOL, V71, P1096, DOI 10.1093/gerona/glw017; Ramsey KM, 2008, AGING CELL, V7, P78, DOI 10.1111/j.1474-9726.2007.00355.x; Respress Jonathan L, 2010, J Vis Exp, DOI 10.3791/1738; Rose P, 2015, METHOD ENZYMOL, V554, P143, DOI 10.1016/bs.mie.2014.11.014; Ross JM, 2011, JOVE-J VIS EXP, V57, P3266; Ryan NA, 2006, J APPL PHYSIOL, V100, P178, DOI 10.1152/japplphysiol.00827.2005; Salminen A, 2013, INT J MOL SCI, V14, P3834, DOI 10.3390/ijms14023834; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Sinclair DA, 2014, ANNU REV PHARMACOL, V54, P363, DOI 10.1146/annurev-pharmtox-010611-134657; Suo R, 2013, MOL MED REP, V7, P1865, DOI 10.3892/mmr.2013.1417; Turner N, 2009, DIABETES, V58, P2547, DOI 10.2337/db09-0784; Uddin GM, 2016, FRONT PHARMACOL, V7, DOI [10.3389/fphar.2016.00258, 10.13389/fphar.2016.00258]; Ungvari Z, 2010, AM J PHYSIOL-HEART C, V299, pH18, DOI 10.1152/ajpheart.00260.2010; van Beijnum JR, 2008, NAT PROTOC, V3, P1085, DOI 10.1038/nprot.2008.71; Wang HJ, 2014, AGING CELL, V13, P254, DOI 10.1111/acel.12169; Wei T, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006114; Wu D, 2015, NITRIC OXIDE-BIOL CH, V46, P204, DOI 10.1016/j.niox.2014.11.006; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693; Zhang Y, 2013, FASEB J, V27, P4041, DOI 10.1096/fj.13-231225; Zheng MH, 2014, MOL CELL BIOCHEM, V393, P59, DOI 10.1007/s11010-014-2046-y; Zu Y, 2010, CIRC RES, V106, P1384, DOI 10.1161/CIRCRESAHA.109.215483	83	209	219	9	159	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 22	2018	173	1					74	+		10.1016/j.cell.2018.02.008	http://dx.doi.org/10.1016/j.cell.2018.02.008			36	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GA3MT	29570999	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000428234200009
J	Schiller, M; Bizzarro, M; Fernandes, VA				Schiller, Martin; Bizzarro, Martin; Fernandes, Vera Assis			Isotopic evolution of the protoplanetary disk and the building blocks of Earth and the Moon	NATURE			English	Article							SOLAR NEBULA; HETEROGENEITY; CHRONOLOGY; ACCRETION; SYSTEMATICS; ORIGIN; DIFFERENTIATION; FRACTIONATION; METEORITES; ANOMALIES	Nucleosynthetic isotope variability among Solar System objects is often used to probe the genetic relationship between meteorite groups and the rocky planets (Mercury, Venus, Earth and Mars), which, in turn, may provide insights into the building blocks of the Earth-Moon system(1-5). Using this approach, it has been inferred that no primitive meteorite matches the terrestrial composition and the protoplanetary disk material from which Earth and the Moon accreted is therefore largely unconstrained. This conclusion, however, is based on the assumption that the observed nucleosynthetic variability of inner-Solar-System objects predominantly reflects spatial heterogeneity. Here we use the isotopic composition of the refractory element calcium to show that the nucleosynthetic variability in the inner Solar System primarily reflects a rapid change in the mass-independent calcium isotope composition of protoplanetary disk solids associated with early mass accretion to the proto-Sun. We measure the mass-independent Ca-48/Ca-44 ratios of samples originating from the parent bodies of ureilite and angrite meteorites, as well as from Vesta, Mars and Earth, and find that they are positively correlated with the masses of their parent asteroids and planets, which are a proxy of their accretion timescales. This correlation implies a secular evolution of the bulk calcium isotope composition of the protoplanetary disk in the terrestrial planet-forming region. Individual chondrules from ordinary chondrites formed within one million years of the collapse of the proto-Sun reveal the full range of inner-Solar-System mass independent Ca-48/Ca-44 ratios, indicating a rapid change in the composition of the material of the protoplanetary disk. We infer that this secular evolution reflects admixing of pristine outer-Solar System material into the thermally processed inner protoplanetary disk associated with the accretion of mass to the proto-Sun. The identical calcium isotope composition of Earth and the Moon reported here is a prediction of our model if the Moon-forming impact involved protoplanets or precursors that completed their accretion near the end of the protoplanetary disk's lifetime.	[Schiller, Martin; Bizzarro, Martin] Univ Copenhagen, Ctr Star & Planet Format, Oster Voldgade 5-7, DK-1350 Copenhagen, Denmark; [Schiller, Martin; Bizzarro, Martin] Univ Copenhagen, Nat Hist Museum Denmark, Oster Voldgade 5-7, DK-1350 Copenhagen, Denmark; [Fernandes, Vera Assis] Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, D-10115 Berlin, Germany; [Fernandes, Vera Assis] Univ Lisbon, Inst Dom Luiz, Fac Ciencias, P-1749016 Lisbon, Portugal	University of Copenhagen; University of Copenhagen; Leibniz Institut fur Evolutions und Biodiversitatsforschung; Universidade de Lisboa	Schiller, M (corresponding author), Univ Copenhagen, Ctr Star & Planet Format, Oster Voldgade 5-7, DK-1350 Copenhagen, Denmark.; Schiller, M (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Oster Voldgade 5-7, DK-1350 Copenhagen, Denmark.	schiller@snm.ku.dk	Bizzarro, Martin/M-7474-2019; Bizzarro, Martin/I-8701-2012; Schiller, Martin/E-8054-2010; Assis Fernandes, Vera/B-4653-2013	Bizzarro, Martin/0000-0001-9966-2124; Bizzarro, Martin/0000-0001-9966-2124; Schiller, Martin/0000-0003-4149-0627; Assis Fernandes, Vera/0000-0003-0848-9229	Danish National Research Foundation [DNRF97]; European Research Council (ERC) [616027-STARDUST2ASTEROIDS]; DFG-Eigenstelle [FE 1523/3-1]; Royal Society [287]	Danish National Research Foundation(Danmarks Grundforskningsfond); European Research Council (ERC)(European Research Council (ERC)European Commission); DFG-Eigenstelle; Royal Society(Royal Society of London)	Financial support for this project was provided to M.B. by the Danish National Research Foundation (DNRF97) and the European Research Council (ERC Consolidator Grant Agreement 616027-STARDUST2ASTEROIDS). V.A.F. acknowledges financial support from a DFG-Eigenstelle FE 1523/3-1 and the Royal Society for the purchase of Dhofar 287. We thank A. Nordlund, A. Johansen and F. Moynier for discussion on the paper, as well as J. Day for comments that helped improve the quality of our paper.	Amsellem E, 2017, EARTH PLANET SC LETT, V474, P527, DOI 10.1016/j.epsl.2017.07.018; Baker JA, 2012, GEOCHIM COSMOCHIM AC, V77, P415, DOI 10.1016/j.gca.2011.10.030; Bollard J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700407; Bollard J, 2015, METEORIT PLANET SCI, V50, P1197, DOI 10.1111/maps.12461; Borg LE, 2016, GEOCHIM COSMOCHIM AC, V175, P150, DOI 10.1016/j.gca.2015.12.002; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; Burkhardt C, 2017, METEORIT PLANET SCI, V52, P807, DOI 10.1111/maps.12834; Canup RM, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0175; Canup RM, 2012, SCIENCE, V338, P1052, DOI 10.1126/science.1226073; Carlson RW, 2007, SCIENCE, V316, P1175, DOI 10.1126/science.1140189; Carrasco-Gonzalez C, 2016, ASTROPHYS J LETT, V821, DOI 10.3847/2041-8205/821/1/L16; Ciesla FJ, 2008, METEORIT PLANET SCI, V43, P639, DOI 10.1111/j.1945-5100.2008.tb00675.x; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.earth.21.1.115; Cuk M, 2012, SCIENCE, V338, P1047, DOI 10.1126/science.1225542; Currie T, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/24; Dauphas N, 2011, NATURE, V473, P489, DOI 10.1038/nature10077; Dauphas N, 2014, EARTH PLANET SC LETT, V407, P96, DOI 10.1016/j.epsl.2014.09.015; Estrada PR, 2016, ASTROPHYS J, V818, DOI 10.3847/0004-637X/818/2/200; Ewing SA, 2008, GEOCHIM COSMOCHIM AC, V72, P1096, DOI 10.1016/j.gca.2007.10.029; Fischer-Godde M, 2015, GEOCHIM COSMOCHIM AC, V168, P151, DOI 10.1016/j.gca.2015.07.032; Gussone N, 2005, GEOCHIM COSMOCHIM AC, V69, P4485, DOI 10.1016/j.gca.2005.06.003; Hans U, 2013, EARTH PLANET SC LETT, V374, P204, DOI 10.1016/j.epsl.2013.05.029; Johansen A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500109; Keil K, 2012, CHEM ERDE-GEOCHEM, V72, P191, DOI 10.1016/j.chemer.2012.06.002; Kleine T, 2009, GEOCHIM COSMOCHIM AC, V73, P5150, DOI 10.1016/j.gca.2008.11.047; Kruijer TS, 2017, P NATL ACAD SCI USA, V114, P6712, DOI 10.1073/pnas.1704461114; Larsen KK, 2011, ASTROPHYS J LETT, V735, DOI 10.1088/2041-8205/735/2/L37; Macke RJ, 2011, METEORIT PLANET SCI, V46, P311, DOI 10.1111/j.1945-5100.2010.01155.x; Magna T, 2015, EARTH PLANET SC LETT, V430, P86, DOI 10.1016/j.epsl.2015.08.016; McSween HY, 2013, METEORIT PLANET SCI, V48, P2090, DOI 10.1111/maps.12108; Meier MMM, 2014, ICARUS, V242, P316, DOI 10.1016/j.icarus.2014.08.003; Moynier F, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/1/45; Paton C, 2013, ASTROPHYS J LETT, V763, DOI 10.1088/2041-8205/763/2/L40; Picogna G, 2015, ASTRON ASTROPHYS, V584, DOI 10.1051/0004-6361/201526921; Qin LP, 2010, GEOCHIM COSMOCHIM AC, V74, P1122, DOI 10.1016/j.gca.2009.11.005; Schiller M, 2015, EARTH PLANET SC LETT, V420, P45, DOI 10.1016/j.epsl.2015.03.028; Schiller M, 2015, GEOCHIM COSMOCHIM AC, V149, P88, DOI 10.1016/j.gca.2014.11.005; Schiller M, 2012, J ANAL ATOM SPECTROM, V27, P38, DOI 10.1039/c1ja10272a; Schiller M, 2011, ASTROPHYS J LETT, V740, DOI 10.1088/2041-8205/740/1/L22; Schiller M, 2010, GEOCHIM COSMOCHIM AC, V74, P4844, DOI 10.1016/j.gca.2010.05.011; Sugiura N, 2014, METEORIT PLANET SCI, V49, P772, DOI 10.1111/maps.12292; Tang H, 2014, EARTH PLANET SC LETT, V390, P264, DOI 10.1016/j.epsl.2014.01.005; Trinquier A, 2007, ASTROPHYS J, V655, P1179, DOI 10.1086/510360; Trinquier A, 2009, SCIENCE, V324, P374, DOI 10.1126/science.1168221; Valdes MC, 2014, EARTH PLANET SC LETT, V394, P135, DOI 10.1016/j.epsl.2014.02.052; van Kooten EMME, 2017, GEOCHIM COSMOCHIM AC, V208, P1, DOI 10.1016/j.gca.2017.03.033; Wilson L, 2012, CHEM ERDE-GEOCHEM, V72, P289, DOI 10.1016/j.chemer.2012.09.002; Wilson L, 2008, GEOCHIM COSMOCHIM AC, V72, P6154, DOI 10.1016/j.gca.2008.09.025; Yamakawa A, 2010, ASTROPHYS J, V720, P150, DOI 10.1088/0004-637X/720/1/150; Young ED, 2016, SCIENCE, V351, P493, DOI 10.1126/science.aad0525; Zhang JJ, 2012, NAT GEOSCI, V5, P251, DOI [10.1038/NGEO1429, 10.1038/ngeo1429]; Zhang JJ, 2011, J ANAL ATOM SPECTROM, V26, P2197, DOI 10.1039/c1ja10181a	59	97	100	7	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2018	555	7697					507	+		10.1038/nature25990	http://dx.doi.org/10.1038/nature25990			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ9NF	29565359	Green Accepted, Green Submitted			2022-12-28	WOS:000427937900050
J	Loscalzo, J; Roy, N; Shah, RV; Tsai, JN; Cahalane, AM; Steiner, J; Stone, JR				Loscalzo, Joseph; Roy, Nathalie; Shah, Ravi V.; Tsai, Joy N.; Cahalane, Alexis M.; Steiner, Johannes; Stone, James R.			Case 8-2018: A 55-Year-Old Woman with Shock and Labile Blood Pressure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EUROPEAN CARDIOVASCULAR PATHOLOGY; TAKOTSUBO CARDIOMYOPATHY; PLASMA METANEPHRINES; CARDIOGENIC-SHOCK; ADRENAL PHEOCHROMOCYTOMA; CONSENSUS STATEMENT; HEART-FAILURE; ASSOCIATION; DIAGNOSIS; RECOVERY		[Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Roy, Nathalie] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Shah, Ravi V.; Tsai, Joy N.; Steiner, Johannes] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Cahalane, Alexis M.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Stone, James R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Loscalzo, Joseph; Shah, Ravi V.; Tsai, Joy N.; Steiner, Johannes] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Roy, Nathalie] Harvard Med Sch, Dept Surg, Boston, MA USA; [Cahalane, Alexis M.] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Stone, James R.] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Loscalzo, J (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.; Loscalzo, J (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.		Loscalzo, Joseph/ABD-8980-2021		MyoKardia; KOL Groups; Amgen; GlaxoSmithKline; USP Labs; Alnylam Pharmaceuticals	MyoKardia; KOL Groups; Amgen(Amgen); GlaxoSmithKline(GlaxoSmithKline); USP Labs; Alnylam Pharmaceuticals	Dr. Shah reports receiving consulting fees from MyoKardia and KOL Groups, advisory-board fees from Amgen, and fees for writing case summaries for Best Doctors, as well as holding a pending patent (62/618,349) on extracellular RNA signatures of cardiac remodeling; and Dr. Stone, receiving consulting fees from GlaxoSmithKline, fees for expert testimony from USP Labs, and lecture fees from Alnylam Pharmaceuticals. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2006, NEW ENGL J MED, V355, P394; Blake MA, 2004, RADIOGRAPHICS, V24, pS87, DOI 10.1148/rg.24si045506; Blake MA, 2010, AM J ROENTGENOL, V194, P1450, DOI 10.2214/AJR.10.4547; BRAVO EL, 1981, NEW ENGL J MED, V305, P623, DOI 10.1056/NEJM198109103051107; Celebi H, 2012, INT J ANGIOL, V21, P63, DOI 10.1055/s-0031-1295564; Chiang YL, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004846; Coupez E, 2014, ARCH CARDIOVASC DIS, V107, P245, DOI 10.1016/j.acvd.2014.04.001; Del Buono MG, 2017, CARDIOVASC PATHOL, V30, P78, DOI 10.1016/j.carpath.2017.06.007; Dhoble A, 2008, CARDIOVASC ULTRASOUN, V6, DOI 10.1186/1476-7120-6-37; Eisenhofer G, 2005, KIDNEY INT, V67, P668, DOI 10.1111/j.1523-1755.2005.67123.x; FERGUSON KL, 1994, AM J EMERG MED, V12, P190, DOI 10.1016/0735-6757(94)90245-3; Guerra F, 2015, INT J CARDIOL, V187, P198, DOI 10.1016/j.ijcard.2015.03.350; Ibrahim Majd, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2014-208683; IGA K, 1989, JPN CIRC J, V53, P813, DOI 10.1253/jcj.53.813; Jacques AET, 2008, EUR RADIOL, V18, P2885, DOI 10.1007/s00330-008-1073-z; Kagiyama N, 2016, EUR HEART J-CARD IMG, V17, P210, DOI 10.1093/ehjci/jev145; Kar B, 2012, CIRCULATION, V125, P1809, DOI 10.1161/CIRCULATIONAHA.111.040220; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; KLINE IK, 1961, AM J PATHOL, V38, P539; Knauf F, 2009, AM J MED SCI, V338, P241, DOI 10.1097/MAJ.0b013e3181a66af1; Kudva YC, 2003, J CLIN ENDOCR METAB, V88, P4533, DOI 10.1210/jc.2003-030720; Leone O, 2012, CARDIOVASC PATHOL, V21, P245, DOI 10.1016/j.carpath.2011.10.001; Lyon AR, 2016, EUR J HEART FAIL, V18, P8, DOI 10.1002/ejhf.424; Madias JE, 2014, EUR HEART J-ACUTE CA, V3, P28, DOI 10.1177/2048872613504311; MARCO J, 1974, ARCH MAL COEUR VAISS, V67, P147; Mohamed HA, 2003, CAN J CARDIOL, V19, P573; Mornex R, 1969, Rev Lyon Med, V18, P563; Nef HM, 2007, EUR HEART J, V28, P2456, DOI 10.1093/eurheartj/ehl570; Nunez-Gil IJ, 2016, EUR HEART J-ACUTE CA, V5, P308, DOI 10.1177/2048872615589512; Olson SW, 2004, ANN INTERN MED, V140, P850, DOI 10.7326/0003-4819-140-10-200405180-00033; Papathomas TG, 2015, MODERN PATHOL, V28, P807, DOI 10.1038/modpathol.2015.41; Pascual Isaac, 2015, Rev Esp Cardiol (Engl Ed), V68, P625, DOI 10.1016/j.rec.2014.08.013; Raber W, 2000, ARCH INTERN MED, V160, P2957, DOI 10.1001/archinte.160.19.2957; RONA G, 1985, J MOL CELL CARDIOL, V17, P291, DOI 10.1016/S0022-2828(85)80130-9; Rossi AP, 2009, ENDOCR PRACT, V15, P560, DOI 10.4158/EP09005.CRR1; SAMUELS MA, 1988, NEW ENGL J MED, V318, P970; Sato H., 1990, CLIN ASPECT MYOCARDI, P56; Sawka AM, 2003, J CLIN ENDOCR METAB, V88, P553, DOI 10.1210/jc.2002-021251; Sawka Anna M, 2004, BMC Endocr Disord, V4, P2, DOI 10.1186/1472-6823-4-2; STENSTROM G, 1988, ACTA MED SCAND, V224, P231; Stone JR, 2015, CARDIOVASC PATHOL, V24, P65, DOI 10.1016/j.carpath.2014.07.010; Stone JR, 2012, CARDIOVASC PATHOL, V21, P2, DOI 10.1016/j.carpath.2011.01.001; VANVLIET PD, 1966, NEW ENGL J MED, V274, P1102, DOI 10.1056/NEJM196605192742002; Y-Hassan S, 2016, AM J CARDIOL, V117, P1836, DOI 10.1016/j.amjcard.2016.03.019	45	8	9	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2018	378	11					1043	1053		10.1056/NEJMcpc1712225	http://dx.doi.org/10.1056/NEJMcpc1712225			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ2HT	29539275				2022-12-28	WOS:000427399000011
J	Kuehn, B				Kuehn, Bridget			Zika-Associated Birth Defects Increasing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2018	319	10					973	973		10.1001/jama.2018.1611	http://dx.doi.org/10.1001/jama.2018.1611			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ0HS	29536104				2022-12-28	WOS:000427249700006
J	Van Nuys, K; Joyce, G; Ribero, R; Goldman, DP				Van Nuys, Karen; Joyce, Geoffrey; Ribero, Rocio; Goldman, Dana P.			Frequency and Magnitude of Co-payments Exceeding Prescription Drug Costs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Van Nuys, Karen; Joyce, Geoffrey; Ribero, Rocio; Goldman, Dana P.] Univ Southern Calif, Leonard D Schaeffer Ctr Hlth Policy & Econ, 635 Downey Way, Los Angeles, CA 90089 USA	University of Southern California	Van Nuys, K (corresponding author), Univ Southern Calif, Leonard D Schaeffer Ctr Hlth Policy & Econ, 635 Downey Way, Los Angeles, CA 90089 USA.	vannuys@usc.edu	Goldman, Dana P/E-7667-2013	Goldman, Dana P/0000-0001-8498-6396	NIA NIH HHS [P01 AG033559] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG033559] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Appleby J., FILLING PRESCRIPTION; Express Scripts, DRUG TREND REP 2016; Goldman DP, 2007, JAMA-J AM MED ASSOC, V298, P61, DOI 10.1001/jama.298.1.61; Hopkins JS, YOURE OVERPAYING DRU; National Community Pharmacists Association, SURV COMM PHARM; The Centers for Medicare & Medicaid Services, METH EST IN PRESS 1	6	6	6	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2018	319	10					1045	1047		10.1001/jama.2018.0102	http://dx.doi.org/10.1001/jama.2018.0102			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ0HS	29536088	Bronze, Green Published			2022-12-28	WOS:000427249700022
J	Smith, LM; Kelleher, NL				Smith, Lloyd M.; Kelleher, Neil L.			Proteoforms as the next proteomics currency	SCIENCE			English	Editorial Material							PROTEIN IDENTIFICATION; MASS-SPECTROMETRY; ISOFORMS		[Smith, Lloyd M.] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA; [Kelleher, Neil L.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Kelleher, Neil L.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Kelleher, Neil L.] Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA	University of Wisconsin System; University of Wisconsin Madison; Northwestern University; Northwestern University; Northwestern University; Feinberg School of Medicine	Smith, LM (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	smith@chem.wisc.edu			Paul G. Allen Family Foundation [11715]; National Institute of General Medical Sciences [1R01GM114292, P41 GM108569]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114292, P41GM108569] Funding Source: NIH RePORTER	Paul G. Allen Family Foundation; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Loo, J. Chamot-Rooke, L. Pasa-Tolic, Y. Ge, and Y. Tsybin for their comments and suggestions and D. Walt for pointing out the potential effects of errors in transcription and translation. The Proteoform Atlas is supported by a grant from the Paul G. Allen Family Foundation (http://repository.topdown-proteomics.org; Award 11715). We thank the National Institute of General Medical Sciences for their support under grants 1R01GM114292 (L.M.S.) and P41 GM108569 (N.L.K.). The authors are members of the Consortium for Top Down Proteomics.	Aebersold R, 2018, NAT CHEM BIOL, V14, P206, DOI [10.1038/NCHEMBIO.2576, 10.1038/nchembio.2576]; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Evans VC, 2012, NAT METHODS, V9, P1207, DOI [10.1038/nmeth.2227, 10.1038/NMETH.2227]; Han XM, 2006, SCIENCE, V314, P109, DOI 10.1126/science.1128868; Li YI, 2016, SCIENCE, V352, P600, DOI 10.1126/science.aad9417; Nesvizhskii AI, 2005, MOL CELL PROTEOMICS, V4, P1419, DOI 10.1074/mcp.R500012-MCP200; Phanstiel D, 2008, P NATL ACAD SCI USA, V105, P4093, DOI 10.1073/pnas.0710515105; Shortreed MR, 2016, J PROTEOME RES, V15, P1213, DOI 10.1021/acs.jproteome.5b01090; Smith LM, 2013, NAT METHODS, V10, P186, DOI 10.1038/nmeth.2369; Tran JC, 2011, NATURE, V480, P254, DOI 10.1038/nature10575; Wang XJ, 2012, J PROTEOME RES, V11, P1009, DOI 10.1021/pr200766z; Yang XP, 2016, CELL, V164, P805, DOI 10.1016/j.cell.2016.01.029; Yuan ZF, 2014, ANNU REV ANAL CHEM, V7, P113, DOI 10.1146/annurev-anchem-071213-015959	14	114	114	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2018	359	6380					1106	1107		10.1126/science.aat1884	http://dx.doi.org/10.1126/science.aat1884			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY4ZM	29590032	Green Accepted			2022-12-28	WOS:000426835900027
J	Feero, WG; Wicklund, CA; Veenstra, D				Feero, W. Gregory; Wicklund, Catherine A.; Veenstra, David			Precision Medicine, Genome Sequencing, and Improved Population Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Feero, W. Gregory] Maine Dartmouth Family Med Residency, Four Sheridan Dr, Fairfield, ME 04937 USA; [Wicklund, Catherine A.] Northwestern Med, Feinberg Sch Med, Chicago, IL USA; [Veenstra, David] Univ Washington, Sch Pharm, Seattle, WA 98195 USA	Northwestern University; Feinberg School of Medicine; University of Washington; University of Washington Seattle	Feero, WG (corresponding author), Maine Dartmouth Family Med Residency, Four Sheridan Dr, Fairfield, ME 04937 USA.	wfeero@mainegeneral.org			National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Veenstra reported receiving grant support from the National Institutes of Health. No other disclosures were reported.	[Anonymous], DIV GEN MED; Joyner MJ, 2015, JAMA-J AM MED ASSOC, V314, P999, DOI 10.1001/jama.2015.7725; MyCode Community Health Initiative, GEIS HLTH	3	29	30	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2018	319	19					1979	1980		10.1001/jama.2018.2925	http://dx.doi.org/10.1001/jama.2018.2925			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF8QV	29547675				2022-12-28	WOS:000432238300011
J	Karki, R; Lee, E; Place, D; Samir, P; Mavuluri, J; Sharma, BR; Balakrishnan, A; Malireddi, RKS; Geiger, R; Zhu, QF; Neale, G; Kanneganti, TD				Karki, Rajendra; Lee, Ein; Place, David; Samir, Parimal; Mavuluri, Jayadev; Sharma, Bhesh Raj; Balakrishnan, Arjun; Malireddi, R. K. Subbarao; Geiger, Rechel; Zhu, Qifan; Neale, Geoffrey; Kanneganti, Thirumala-Devi			IRF8 Regulates Transcription of Naips for NLRC4 Inflammasome Activation	CELL			English	Article							SEQUENCE-BINDING-PROTEIN; INNATE IMMUNE RECOGNITION; BACTERIAL LIGANDS; DIFFERENTIAL ROLES; AIM2 INFLAMMASOME; GENE-EXPRESSION; DENDRITIC CELLS; GASDERMIN D; FACTOR-I; IFN	Inflammasome activation is critical for host defenses against various microbial infections. Activation of the NLRC4 inflammasome requires detection of flagellin or type III secretion system (T3SS) components by NLR family apoptosis inhibitory proteins (NAIPs); yet how this pathway is regulated is unknown. Here, we found that interferon regulatory factor 8 (IRF8) is required for optimal activation of the NLRC4 inflammasome in bone-marrow-derived macrophages infected with Salmonella Typhimurium, Burkholderia thailandensis, or Pseudomonas aeruginosa but is dispensable for activation of the canonical and non-canonical NLRP3, AIM2, and Pyrin inflammasomes. IRF8 governs the transcription of Naips to allow detection of flagellin or T3SS proteins to mediate NLRC4 inflammasome activation. Furthermore, we found that IRF8 confers protection against bacterial infection in vivo, owing to its role in inflammasome-dependent cytokine production and pyroptosis. Altogether, our findings suggest that IRF8 is a critical regulator of NAIPs and NLRC4 inflammasome activation for defense against bacterial infection.	[Karki, Rajendra; Lee, Ein; Place, David; Samir, Parimal; Mavuluri, Jayadev; Sharma, Bhesh Raj; Balakrishnan, Arjun; Malireddi, R. K. Subbarao; Geiger, Rechel; Zhu, Qifan; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Lee, Ein; Zhu, Qifan] Univ Tennessee, Hlth Sci Ctr, Integrated Biomed Sci Program, Memphis, TN 38163 USA; [Neale, Geoffrey] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA.	thirumala-devi.kanneganti@stjude.org	Mavuluri, Jayadev/AAW-6724-2021; Sharma, Bhesh/AAJ-5150-2020; Kanneganti, Thirumala-Devi/Y-2503-2019; Place, David/ABD-6703-2021; Kanneganti, Thirumala-Devi/M-9435-2018; Samir, Parimal/N-4144-2014; Malireddi, RKSubbarao/C-5804-2013; Karki, Rajendra/H-6647-2019; Sharma, Bhesh Raj/H-3782-2014	Sharma, Bhesh/0000-0003-3609-833X; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Place, David/0000-0002-1904-4164; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Samir, Parimal/0000-0001-7655-5713; Malireddi, RKSubbarao/0000-0001-8855-9447; Karki, Rajendra/0000-0003-4436-9128; Sharma, Bhesh Raj/0000-0003-3609-833X; , Arjun Balakrishnan/0000-0002-8845-5741	U.S. NIH [AI101935, AI124346, AR056296, CA163507]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [R01CA163507, R25CA023944, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101935, R01AI124346, R37AI101935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank A. Burton from St. Jude Children's Research Hospital for technical support. We thank members of the Kanneganti laboratory for their comments and suggestions. Work from our laboratory is supported by the U.S. NIH (AI101935, AI124346, AR056296, and CA163507 to T.-D.K.) and the American Lebanese Syrian Associated Charities (to T.-D.K.).	Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; BARBER SA, 1995, INFECT IMMUN, V63, P601, DOI 10.1128/IAI.63.2.601-608.1995; BOVOLENTA C, 1994, P NATL ACAD SCI USA, V91, P5046, DOI 10.1073/pnas.91.11.5046; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Carvalho FA, 2012, MUCOSAL IMMUNOL, V5, P288, DOI 10.1038/mi.2012.8; Crowley SM, 2016, CURR TOP MICROBIOL, V397, P43, DOI 10.1007/978-3-319-41171-2_3; DRIGGERS PH, 1990, P NATL ACAD SCI USA, V87, P3743, DOI 10.1073/pnas.87.10.3743; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eklund EA, 1998, J BIOL CHEM, V273, P13957, DOI 10.1074/jbc.273.22.13957; Fabrega A, 2013, CLIN MICROBIOL REV, V26, P308, DOI 10.1128/CMR.00066-12; Fenner JE, 2006, NAT IMMUNOL, V7, P33, DOI 10.1038/ni1287; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; FUJITA T, 1989, NATURE, V337, P270, DOI 10.1038/337270a0; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Iwata A, 2017, NAT IMMUNOL, V18, P563, DOI 10.1038/ni.3714; Jones CL, 2012, MICROBIOL MOL BIOL R, V76, P383, DOI 10.1128/MMBR.05027-11; Jones JDG, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6395; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kimura T, 1996, GENES CELLS, V1, P115, DOI 10.1046/j.1365-2443.1996.08008.x; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Kuehne SA, 2014, J INFECT DIS, V209, P83, DOI 10.1093/infdis/jit426; Kurotaki D, 2016, J INTERF CYTOK RES, V36, P433, DOI 10.1089/jir.2015.0138; Langlais D, 2016, J EXP MED, V213, P585, DOI 10.1084/jem.20151764; Lehtonen A, 1997, J IMMUNOL, V159, P794; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Liu JG, 2004, J BIOL CHEM, V279, P55609, DOI 10.1074/jbc.M406565200; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Man SM, 2017, SCI REP-UK, V7, DOI 10.1038/srep45126; Man SM, 2015, NAT IMMUNOL, V16, P467, DOI 10.1038/ni.3118; Man SM, 2015, IMMUNOL REV, V265, P6, DOI 10.1111/imr.12296; Man SM, 2014, P NATL ACAD SCI USA, V111, P7403, DOI 10.1073/pnas.1402911111; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; Masumi A, 2002, FEBS LETT, V531, P348, DOI 10.1016/S0014-5793(02)03556-1; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Olsson A, 2016, NATURE, V537, P698, DOI 10.1038/nature19348; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rauch I, 2016, J EXP MED, V213, P657, DOI 10.1084/jem.20151809; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Sellin ME, 2014, CELL HOST MICROBE, V16, P237, DOI 10.1016/j.chom.2014.07.001; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Sichien D, 2016, IMMUNITY, V45, P626, DOI 10.1016/j.immuni.2016.08.013; Storek KM, 2015, IMMUNOL REV, V265, P112, DOI 10.1111/imr.12289; Suthar MS, 2012, IMMUNITY, V37, P235, DOI 10.1016/j.immuni.2012.07.004; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Tailor P, 2007, IMMUNITY, V27, P228, DOI 10.1016/j.immuni.2007.06.009; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Van Gorp H, 2016, P NATL ACAD SCI USA, V113, P14384, DOI 10.1073/pnas.1613156113; VEALS SA, 1992, MOL CELL BIOL, V12, P3315, DOI 10.1128/MCB.12.8.3315; Wang IM, 2000, J IMMUNOL, V165, P271, DOI 10.4049/jimmunol.165.1.271; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Xiong HB, 2003, J BIOL CHEM, V278, P2271, DOI 10.1074/jbc.M209583200; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; Yamagata T, 1996, MOL CELL BIOL, V16, P1283; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang JL, 2013, P NATL ACAD SCI USA, V110, P14408, DOI 10.1073/pnas.1306376110; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao Y, 2016, J EXP MED, V213, P647, DOI 10.1084/jem.20160006; Zhao Y, 2015, IMMUNOL REV, V265, P85, DOI 10.1111/imr.12293; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Zitvogel L, 2015, NAT REV IMMUNOL, V15, P405, DOI 10.1038/nri3845	85	100	107	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 3	2018	173	4					920	+		10.1016/j.cell.2018.02.055	http://dx.doi.org/10.1016/j.cell.2018.02.055			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GG1TU	29576451	Bronze, Green Accepted			2022-12-28	WOS:000432471100014
J	de Boer, IH; Bakris, G; Cannon, CP				de Boer, Ian H.; Bakris, George; Cannon, Christopher P.			Individualizing Blood Pressure Targets for People With Diabetes and Hypertension Comparing the ADA and the ACC/AHA Recommendations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[de Boer, Ian H.] Univ Washington, 325 Ninth Ave,POB 359606, Seattle, WA 98195 USA; [Bakris, George] Univ Chicago Med, Chicago, IL USA; [Cannon, Christopher P.] Harvard Med Sch, Boston, MA USA	University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School	de Boer, IH (corresponding author), Univ Washington, 325 Ninth Ave,POB 359606, Seattle, WA 98195 USA.	deboer@u.washington.edu	de Boer, Ian/GYJ-3282-2022; Cannon, Christopher P/AAY-7644-2020	Cannon, Christopher P/0000-0003-4596-2791				Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS65, DOI 10.2337/dc18-S007; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS86, DOI 10.2337/dc18-S009; Brunstrom M, 2018, JAMA INTERN MED, V178, P28, DOI 10.1001/jamainternmed.2017.6015; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; de Boer IH, 2017, DIABETES CARE, V40, P1273, DOI 10.2337/dci17-0026; Emdin CA, 2015, JAMA-J AM MED ASSOC, V313, P603, DOI 10.1001/jama.2014.18574; Lonn EM, 2016, NEW ENGL J MED, V374, P2009, DOI 10.1056/NEJMoa1600175; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Whelton PK, 2017, HYPERTENSION, DOI 10.1016/j.jacc.2017.11.006	9	34	34	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2018	319	13					1319	1320		10.1001/jama.2018.0642	http://dx.doi.org/10.1001/jama.2018.0642			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB4NC	29543954				2022-12-28	WOS:000429035900011
J	Hahn, JY; Bin Song, Y; Oh, JH; Cho, DK; Lee, JB; Doh, JH; Kim, SH; Jeong, JO; Bae, JH; Kim, BO; Cho, JH; Suh, IW; Kim, DI; Park, HK; Park, JS; Choi, WG; Lee, WS; Kim, J; Choi, KH; Park, TK; Lee, JM; Yang, JH; Choi, JH; Choi, SH; Gwon, HC				Hahn, Joo-Yong; Bin Song, Young; Oh, Ju-Hyeon; Cho, Deok-Kyu; Lee, Jin Bae; Doh, Joon-Hyung; Kim, Sang-Hyun; Jeong, Jin-Ok; Bae, Jang-Ho; Kim, Byung-Ok; Cho, Jang Hyun; Suh, Il-Woo; Kim, Doo-Il; Park, Hoon-Ki; Park, Jong-Seon; Choi, Woong Gil; Lee, Wang Soo; Kim, Jihoon; Choi, Ki Hong; Park, Taek Kyu; Lee, Joo Myung; Yang, Jeong Hoon; Choi, Jin-Ho; Choi, Seung-Hyuk; Gwon, Hyeon-Cheol		SMART-DATE Investigators	6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; ELUTING STENT IMPLANTATION; BARE-METAL STENTS; ST-SEGMENT; FOCUSED UPDATE; DURATION; OUTCOMES; CLOPIDOGREL; TICAGRELOR; ASPIRIN	Background Current guidelines recommend dual antiplatelet therapy (DAPT) of aspirin plus a P2Y12 inhibitor for at least 12 months after implantation of drug-eluting stents (DES) in patients with acute coronary syndrome. However, available data about the optimal duration of DAPT in patients with acute coronary syndrome undergoing percutaneous coronary intervention are scant. We aimed to investigate whether a 6-month duration of DAPT would be non-inferior to the conventional 12-month or longer duration of DAPT in this population. Methods We did a randomised, open-label, non-inferiority trial at 31 centres in South Korea. Patients were eligible if they had unstable angina, non-ST-segment elevation myocardial infarction, or ST-segment elevation myocardial infarction, and underwent percutaneous coronary intervention. Enrolled patients were randomly assigned, via a web-based system by computer-generated block randomisation, to either the 6-month DAPT group or to the 12-month or longer DAPT group, with stratification by site, clinical presentation, and diabetes. Assessors were masked to treatment allocation. The primary endpoint was a composite of all-cause death, myocardial infarction, or stroke at 18 months after the index procedure in the intention-to-treat population. Secondary endpoints were the individual components of the primary endpoint; definite or probable stent thrombosis as defined by the Academic Research Consortium; and Bleeding Academic Research Consortium (BARC) type 2-5 bleeding at 18 months after the index procedure. The primary endpoint was also analysed per protocol. This trial is registered with ClinicalTrials. gov, number NCT01701453. Findings Between Sept 5, 2012, and Dec 31, 2015, we randomly assigned 2712 patients; 1357 to the 6-month DAPT group and 1355 to the 12-month or longer DAPT group. Clopidogrel was used as a P2Y12 inhibitor for DAPT in 1082 (79.7%) patients in the 6-month DAPT group and in 1109 (81.8%) patients in the 12-month or longer DAPT group. The primary endpoint occurred in 63 patients in the 6-month DAPT group and in 56 patients in the 12-month or longer DAPT group (cumulative event rate 4.7% vs 42%; absolute risk difference 0.5%; upper limit of one-sided 95% CI 1.8%; p(non-inferiority) = 0 . 03 with a predefined non-inferiority margin of 2.0%). Although all-cause mortality did not differ significantly between the 6-month DAPT group and the 12-month or longer DAPT group (35 [2.6%] patients vs 39 [2.9%]; hazard ratio [HR] 0.90 [95% CI 0.57-1.42]; p= 0.90) and neither did stroke (11 [0.8%] patients vs 12 [0.9%]; 0.92 [0.41-2.08]; p= 0.84), myocardial infarction occurred more frequently in the 6-month DAPT group than in the 12-month or longer DAPT group (24 [1.8%] patients vs ten [0.8%]; 2.41 [1.15-5.05]; p = 0.02). 15 (1.1%) patients had stent thrombosis in the 6-month DAPT group compared with ten (0.7%) in the 12-month or longer DAPT group (HR 1. [95% CI 0. 68-3.35]; p= 0.32). The rate of BARC type 2-5 bleeding was 2.7% (35 patients) in the 6-month DAPT group and 3.9% (51 patients) in the 12-month or longer DAPT group (HR 0 .69 [95% CI 0. 45-1. 05]; p = 0.09). Results from the per-protocol analysis were similar to those from the intention-to-treat analysis. Interpretation The increased risk of myocardial infarction with 6-month DAPT and the wide non-inferiority margin prevent us from concluding that short-term DAPT is safe in patients with acute coronary syndrome undergoing percutaneous coronary intervention with current-generation DES. Prolonged DAPT in patients with acute coronary syndrome without excessive risk of bleeding should remain the standard of care.	[Hahn, Joo-Yong; Bin Song, Young; Kim, Jihoon; Choi, Ki Hong; Park, Taek Kyu; Lee, Joo Myung; Yang, Jeong Hoon; Choi, Jin-Ho; Choi, Seung-Hyuk; Gwon, Hyeon-Cheol] Sungkyunkwan Univ, Div Cardiol, Dept Med, Samsung Med Ctr,Sch Med, Seoul, South Korea; [Oh, Ju-Hyeon] Sungkyunkwan Univ, Samsung Changwon Hosp, Sch Med, Chang Won, South Korea; [Cho, Deok-Kyu] Myongji Hosp, Goyang, South Korea; [Lee, Jin Bae] Daegu Catholic Univ, Med Ctr, Daegu, South Korea; [Doh, Joon-Hyung] Univ Ilsan Paik Hosp, Goyang, South Korea; [Kim, Sang-Hyun] Seoul Natl Univ, Boramae Med Ctr, Seoul, South Korea; [Jeong, Jin-Ok] Chungnam Natl Univ Hosp, Daejeon, South Korea; [Bae, Jang-Ho] Konyang Univ Hosp, Daejon, South Korea; [Kim, Byung-Ok] Inje Univ Sanggye Paik Hosp, Seoul, South Korea; [Cho, Jang Hyun] St Carollo Gen Hosp, Sunchon, South Korea; [Suh, Il-Woo] SAM Med Ctr, Anyang, South Korea; [Kim, Doo-Il] Inje Univ Haeundae Paik Hosp, Busan, South Korea; [Park, Hoon-Ki] Seoul Vet Hosp, Seoul, South Korea; [Park, Jong-Seon] Yeungnam Univ Hosp, Daegu, South Korea; [Choi, Woong Gil] Chungju Konkuk Univ, Med Ctr, Chungju, South Korea; [Lee, Wang Soo] Chung Ang Univ Hosp, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Myongji Hospital; Catholic University of Daegu; Seoul National University (SNU); Seoul National University Hospital; Chungnam National University; Chungnam National University Hospital; Konyang University; Konyang University Hospital; Inje University; Inje University; Seoul Veterans Hospital; Yeungnam University; Yeungnam University Hospital; Chung Ang University; Chung Ang University Hospital	Gwon, HC (corresponding author), Sungkyunkwan Univ, Heart Vasc Stroke Inst, Samsung Med Ctr, Heart Vasc Stroke Inst,Sch Med, Seoul 06351, South Korea.	hcgwon@naver.com	Lee, Wang-Soo/AAS-1477-2021; Hahn, Joo-Yong/AAU-7250-2020	Lee, Wang-Soo/0000-0002-8264-0866; Hahn, Joo-Yong/0000-0002-4412-377X; Kim, Sang-Hyun/0000-0001-8026-1582; Jeong, Myung Ho/0000-0003-2424-810X; Choi, Jaewoong/0000-0002-2456-923X; Lee, Joo Myung/0000-0002-2178-4014; Choi, Ki Hong/0000-0001-7511-9581; Rha, Seung-Woon/0000-0001-9456-9852; Jeong, Jin-Ok/0000-0003-0763-4754	Abbott Vascular Korea; Medtronic Vascular Korea; Biosensors Inc; Dong-A ST	Abbott Vascular Korea; Medtronic Vascular Korea; Biosensors Inc; Dong-A ST	Abbott Vascular Korea, Medtronic Vascular Korea, Biosensors Inc, and Dong-A ST.	Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Costa F, 2015, EUR HEART J, V36, P1242, DOI 10.1093/eurheartj/ehv038; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; Giustino G, 2015, J AM COLL CARDIOL, V65, P1298, DOI 10.1016/j.jacc.2015.01.039; Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; Hong MK, 2004, CIRCULATION, V110, P928, DOI 10.1161/01.CIR.0000139858.69915.2E; Kedhi E, 2017, BEHALF DAPT STEMI IN; Kim C, 2017, KOREAN CIRC J, V47, P888, DOI 10.4070/kcj.2017.0072; Kukreja N, 2009, JACC-CARDIOVASC INTE, V2, P534, DOI 10.1016/j.jcin.2009.04.003; Lee JM, 2016, AM HEART J, V182, P1, DOI 10.1016/j.ahj.2016.07.022; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Loh JP, 2014, AM J CARDIOL, V113, P1794, DOI 10.1016/j.amjcard.2014.03.007; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Natsuaki M, 2016, CARDIOVASC INTERV TH, V31, P196, DOI 10.1007/s12928-015-0366-9; Palmerini T, 2017, EUR HEART J, V38, P1034, DOI 10.1093/eurheartj/ehw627; Palmerini T, 2015, J AM COLL CARDIOL, V65, P2496, DOI 10.1016/j.jacc.2015.04.017; Park SJ, 2011, NEW ENGL J MED, V364, P1718, DOI 10.1056/NEJMoa1100452; Sabate M, 2014, JACC-CARDIOVASC INTE, V7, P55, DOI 10.1016/j.jcin.2013.07.012; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Song PS, 2015, EUR J INTERN MED, V26, P521, DOI 10.1016/j.ejim.2015.06.014; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Suryapranata H, 2017, BEHALF REDUCE TRIAL; Urban P, 2015, NEW ENGL J MED, V373, P2038, DOI 10.1056/NEJMoa1503943; Valgimigli M, 2018, EUR HEART J, V39, P213, DOI 10.1093/eurheartj/ehx419; Varenhorst C, 2014, EUR HEART J, V35, P969, DOI 10.1093/eurheartj/eht438; Varenne O, 2018, LANCET, V391, P41, DOI 10.1016/S0140-6736(17)32713-7; Yang JH, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6650	31	180	186	1	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 31	2018	391	10127					1274	1284		10.1016/S0140-6736(18)30493-8	http://dx.doi.org/10.1016/S0140-6736(18)30493-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB1DR	29544699				2022-12-28	WOS:000428791600026
J	Davies, R				Davies, Rachael			Leo Martinez: striving to end childhood tuberculosis	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2018	391	10126					1139	1139		10.1016/S0140-6736(18)30680-9	http://dx.doi.org/10.1016/S0140-6736(18)30680-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GA2MF	29573868				2022-12-28	WOS:000428156100016
J	Joo, Y; Agarkar, V; Sung, SH; Savoie, BM; Boudouris, BW				Joo, Yongho; Agarkar, Varad; Sung, Seung Hyun; Savoie, Brett M.; Boudouris, Bryan W.			A nonconjugated radical polymer glass with high electrical conductivity	SCIENCE			English	Article							ORGANIC ELECTRONIC DEVICES; STATE CHARGE-TRANSPORT; SOLID-STATE; MACROMOLECULES; MECHANISMS; STABILITY	Solid-state conducting polymers usually have highly conjugated macromolecular backbones and require intentional doping in order to achieve high electrical conductivities. Conversely, single-component, charge-neutral macromolecules could be synthetically simpler and have improved processibility and ambient stability. We show that poly(4-glycidyloxy-2,2,6,6-tetramethylpiperidine-1-oxyl), a nonconjugated radical polymer with a subambient glass transition temperature, underwent rapid solid-state charge transfer reactions and had an electrical conductivity of up to 28 siemens per meter over channel lengths up to 0.6 micrometers. The charge transport through the radical polymer film was enabled with thermal annealing at 80 degrees C, which allowed for the formation of a percolating network of open-shell sites in electronic communication with one another. The electrical conductivity was not enhanced by intentional doping, and thin films of this material showed high optical transparency.	[Joo, Yongho; Sung, Seung Hyun; Savoie, Brett M.; Boudouris, Bryan W.] Purdue Univ, Charles D Davidson Sch Chem Engn, 480 Stadium Mall Dr, W Lafayette, IN 47906 USA; [Agarkar, Varad; Boudouris, Bryan W.] Purdue Univ, Dept Chem, 560 Oval Dr, W Lafayette, IN 47906 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Savoie, BM; Boudouris, BW (corresponding author), Purdue Univ, Charles D Davidson Sch Chem Engn, 480 Stadium Mall Dr, W Lafayette, IN 47906 USA.; Boudouris, BW (corresponding author), Purdue Univ, Dept Chem, 560 Oval Dr, W Lafayette, IN 47906 USA.	bsavoie@purdue.edu; boudouris@purdue.edu	Joo, Yongho/AAQ-7326-2021; Savoie, Brett/O-5976-2019	Joo, Yongho/0000-0002-1149-9105; Savoie, Brett/0000-0002-7039-4039; Agarkar, Varad Vinayak/0000-0003-0621-2090; Boudouris, Bryan/0000-0003-0428-631X; Sung, Seunghyun/0000-0002-7515-1183	NSF through the CAREER Award in the Polymers Program [1554957]; Air Force Office of Scientific Research through the Organic Materials Chemistry Program [FA9550-15-1-0449]	NSF through the CAREER Award in the Polymers Program; Air Force Office of Scientific Research through the Organic Materials Chemistry Program	The molecular design and characterization work was supported by the NSF through the CAREER Award in the Polymers Program (award 1554957; program manager, A. Lovinger), and the advanced microelectronic device fabrication was supported by the Air Force Office of Scientific Research through the Organic Materials Chemistry Program (grant FA9550-15-1-0449; program manager, K. Caster).	Baradwaj AG, 2016, MACROMOLECULES, V49, P4784, DOI 10.1021/acs.macromol.6b00730; Baradwaj AG, 2016, MACROMOL CHEM PHYS, V217, P477, DOI 10.1002/macp.201500272; Baradwaj AG, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4880118; Boudouris BW, 2013, CURR OPIN CHEM ENG, V2, P294, DOI 10.1016/j.coche.2013.07.002; Chang C, 2010, POLYMER, V51, P1947, DOI 10.1016/j.polymer.2010.03.001; Friebe C, 2017, TOPICS CURR CHEM, V375, DOI 10.1007/s41061-017-0103-1; Hay ME, 2017, J POLYM SCI POL PHYS, V55, P1516, DOI 10.1002/polb.24406; Muench S, 2016, CHEM REV, V116, P9438, DOI 10.1021/acs.chemrev.6b00070; Mukherjee S., 2017, ORGANIC RADICAL POLY; Nguyen HVT, 2017, ACS CENTRAL SCI, V3, P800, DOI 10.1021/acscentsci.7b00253; Ostroverkhova O, 2016, CHEM REV, V116, P13279, DOI 10.1021/acs.chemrev.6b00127; Oyaizu K, 2010, MACROMOLECULES, V43, P10382, DOI 10.1021/ma1020159; Oyaizu K, 2009, ADV MATER, V21, P2339, DOI 10.1002/adma.200803554; Rostro L, 2015, MRS COMMUN, V5, P257, DOI 10.1557/mrc.2015.27; Rostro L, 2015, J POLYM SCI POL PHYS, V53, P311, DOI 10.1002/polb.23640; Rostro L, 2014, MACROMOLECULES, V47, P3713, DOI 10.1021/ma500626t; Rostro L, 2013, ACS APPL MATER INTER, V5, P9896, DOI 10.1021/am403223s; Salzmann I, 2016, ACCOUNTS CHEM RES, V49, P370, DOI 10.1021/acs.accounts.5b00438; Sasada Y, 2017, CHEM MATER, V29, P5942, DOI 10.1021/acs.chemmater.7b01476; Sato K, 2018, J AM CHEM SOC, V140, P1049, DOI 10.1021/jacs.7b11272; Sowers MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6460; Swager TM, 2017, MACROMOLECULES, V50, P4867, DOI 10.1021/acs.macromol.7b00582; Tokue H, 2017, CHEM LETT, V46, P647, DOI 10.1246/cl.170055; Tomlinson EP, 2015, ACS APPL MATER INTER, V7, P18195, DOI 10.1021/acsami.5b05860; Tomlinson EP, 2014, MACROMOLECULES, V47, P6145, DOI 10.1021/ma5014572; Wen YP, 2017, J POLYM SCI POL CHEM, V55, P1121, DOI 10.1002/pola.28482; Wingate AJ, 2016, J POLYM SCI POL CHEM, V54, P1875, DOI 10.1002/pola.28088; Zhang YR, 2018, J MATER CHEM C, V6, P111, DOI [10.1039/C7TC04645F, 10.1039/c7tc04645f]; Zhu ZY, 2017, SYNTHETIC MET, V225, P31, DOI 10.1016/j.synthmet.2016.11.011	29	138	146	20	313	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2018	359	6382			SI		1391	1394		10.1126/science.aao7287	http://dx.doi.org/10.1126/science.aao7287			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA0ZG	29567710				2022-12-28	WOS:000428043600043
J	Protasiewicz, JD				Protasiewicz, John D.			From rock-stable to reactive phosphorus	SCIENCE			English	Editorial Material									[Protasiewicz, John D.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA	Case Western Reserve University	Protasiewicz, JD (corresponding author), Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA.	protasiewicz@case.edu	Protasiewicz, John David/C-3484-2008	Protasiewicz, John David/0000-0002-3332-6985				Brummer J. R., PHOSPHORUS; Emsley J., 2001, SHOCKING HIST PHOSPH; Geeson MB, 2018, SCIENCE, V359, P1383, DOI 10.1126/science.aar6620	3	7	7	3	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2018	359	6382			SI		1333	1333		10.1126/science.aat1206	http://dx.doi.org/10.1126/science.aat1206			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA0ZG	29567694				2022-12-28	WOS:000428043600024
J	Stokstad, E				Stokstad, Erik			FUNDIG A research behemoth is born in Britain Expectations are high for the new 6 pound billion funder, UK Research and Innovation	SCIENCE			English	News Item									[Stokstad, Erik] No Og, Cambridge, England										0	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2018	359	6382			SI		1319	1319		10.1126/science.359.6382.1319	http://dx.doi.org/10.1126/science.359.6382.1319			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA0ZG	29567689				2022-12-28	WOS:000428043600019
J	Alibrahim, BK; Wharmby, G				Alibrahim, Bashaar K.; Wharmby, George			Ulnar-Artery Mycotic Aneurysm	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Alibrahim, Bashaar K.; Wharmby, George] Univ British Columbia, Vancouver, BC, Canada	University of British Columbia	Alibrahim, BK (corresponding author), Univ British Columbia, Vancouver, BC, Canada.	dr_bashare@hotmail.com							0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2018	378	12					E16	E16		10.1056/NEJMicm1603196	http://dx.doi.org/10.1056/NEJMicm1603196			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ9OV	29562157				2022-12-28	WOS:000427942300011
J	Hall, WJ				Hall, William J.			Review: In older adults, exercise alone and some combination interventions reduce injurious falls vs usual care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Hall, William J.] Univ Rochester, Sch Med & Dent, Rochester, NY 14627 USA	University of Rochester	Hall, WJ (corresponding author), Univ Rochester, Sch Med & Dent, Rochester, NY 14627 USA.							Bergen G, 2016, MMWR-MORBID MORTAL W, V65, P993, DOI 10.15585/mmwr.mm6537a2; Larson EB, 2017, JAMA-J AM MED ASSOC, V318, P1659, DOI 10.1001/jama.2017.15098	2	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2018	168	6					JC7	JC7		10.7326/ACPJC-2018-168-6-027	http://dx.doi.org/10.7326/ACPJC-2018-168-6-027			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ8AM	29554665				2022-12-28	WOS:000427827400004
J	Henrikson, NB; Morrison, CC; Blasi, PR; Nguyen, M; Shibuya, KC; Patnode, CD				Henrikson, Nora B.; Morrison, Caitlin C.; Blasi, Paula R.; Nguyen, Matt; Shibuya, Kendall C.; Patnode, Carrie D.			Behavioral Counseling for Skin Cancer Prevention Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED CONTROLLED-TRIAL; APPEARANCE-FOCUSED INTERVENTION; ULTRAVIOLET-RADIATION EXPOSURE; SUN PROTECTION BEHAVIORS; SELF-EXAMINATION; UNITED-STATES; PHYSICAL-ACTIVITY; MELANOMA PATIENTS; EXPERT-SYSTEMS; PROJECT SCAPE	IMPORTANCE Exposure to UV radiation, especially in childhood, increases skin cancer risk. OBJECTIVE To systematically review the evidence on the benefits and harms of behavioral counseling for skin cancer prevention to inform the US Preventive Services Task Force (USPSTF). DATA SOURCES Cochrane Central Register of Controlled Trials, MEDLINE, and PubMed were searched for studies published from January 2009 to March 31, 2016, for skin cancer prevention and from August 2005 to March 31, 2016, for skin self-examination. Surveillance in targeted publications was conducted through February 14, 2018. Studies included in previous USPSTF reports were reevaluated for inclusion. STUDY SELECTION Fair- and good-quality studies of primary care-relevant behavioral interventions focused on improving skin cancer outcomes, intermediate outcomes, or skin cancer prevention and self-examination behaviors. DATA EXTRACTION AND SYNTHESIS Two investigators independently reviewed abstracts and full-text articles and extracted data into evidence tables. Results were qualitatively summarized but not pooled because of heterogeneity of measures. MAIN OUTCOMES AND MEASURES Skin cancer, sunburn, precursor skin lesions, sun protection behaviors, and any harms from interventions. RESULTS Twenty-one trials in 27 publications were included (N = 20 561). No studies assessed skin cancer outcomes in pediatric populations; 1 adult trial (n = 1356) promoting skin self-examination found no significant difference in participants diagnosed with melanoma in the intervention group vs the control group at 12-month follow-up (0 vs 1 diagnosis). There was no consistent improvement in prevention of sunburn for children (3 trials [n 2508]) or adults (6 trials [n = 3959]). There were small to moderate increases in sun protection behavior in pediatric populations (6 trials [n 4252]) and adults (12 trials [n = 13 099]) and small increases in skin self-examination in adults (11 trials [n 7771]; odds ratios, 1.16-2.6). One of 3 trials of indoor tanning found an intervention effect; an appearance-focused intervention (n = 430) resulted in a smaller increase in mean indoor tanning sessions at 6 months in the intervention group vs the control group. Harms were rarely reported: 1 trial of skin self-examination (n = 1356) found an increase in skin procedures in the intervention group vs the control group at 6 months (8.0% vs 3.6%, P <.001) but not between 6 and 12 months (3.9% vs 3.3%, P =.50), and 1 trial (n = 217) found no between-group difference in skin cancer worry (28.9% vs 18.4%, P =.16). CONCLUSIONS AND RELEVANCE Behavioral interventions can increase sun protection behavior, but there is no consistent evidence that interventions are associated with a reduction in the frequency of sunburn in children or adults and minimal evidence on skin cancer outcomes. Intervention can increase skin self-examination in adults but may lead to increased skin procedures without detecting additional atypical nevi or skin cancers.	[Henrikson, Nora B.; Morrison, Caitlin C.; Blasi, Paula R.; Nguyen, Matt] Kaiser Permanente Washington Hlth Res Inst, Kaiser Permanente Res Affiliates Evidence Based P, Seattle, WA 98101 USA; [Shibuya, Kendall C.] Western Univ Hlth Sci COMP Northwest, Lebanon, OR USA; [Patnode, Carrie D.] Kaiser Permanente Ctr Hlth Res, Kaiser Permanente Res Affiliates Evidence Based P, Portland, OR USA	Kaiser Permanente; Kaiser Permanente	Henrikson, NB (corresponding author), Kaiser Permanente Washington Hlth Res Inst, 1730 Minor Ave, Seattle, WA 98101 USA.	Nora.B.Henrikson@kp.org		Blasi, Paula/0000-0002-7094-706X	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA290201500007I, 2]	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services	This research was funded under contract HHSA290201500007I, Task Order 2, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, under a contract to support the USPSTF.	Abar BW, 2010, HEALTH PSYCHOL, V29, P574, DOI 10.1037/a0021236; [Anonymous], 2015, BAS SQUAM CELL SKIN; [Anonymous], 2016, KEY STAT BAS SQUAM C; [Anonymous], SEER CANC STAT FACTS; Armstrong BK, 1992, CUTANEOUS MELANOMA; Baker J, 2016, PSYCHO-ONCOLOGY, V25, P28, DOI 10.1002/pon.4007; BERKMAN ND, 2014, AHRQ PUBLICATION, V10; Boniol M, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4757; Calonge N, 2009, ANN INTERN MED, V150, P188, DOI 10.7326/0003-4819-150-3-200902030-00020; Colantonio S, 2014, J AM ACAD DERMATOL, V70, P847, DOI 10.1016/j.jaad.2013.11.050; Community Preventive Services Task Force, 2016, Am J Prev Med, V51, P540, DOI 10.1016/j.amepre.2016.03.019; Community Preventive Services Task Force, 2014, CANC PREV CONTR SKIN; Crane LA, 2006, PREV MED, V42, P162, DOI 10.1016/j.ypmed.2005.11.007; Crane LA, 2012, AM J PREV MED, V43, P399, DOI 10.1016/j.amepre.2012.06.022; Cust AE, 2011, INT J CANCER, V128, P2425, DOI 10.1002/ijc.25576; Ferrucci LM, 2014, J AM ACAD DERMATOL, V71, P882, DOI 10.1016/j.jaad.2014.06.046; Fischer AH, 2016, JAMA DERMATOL, DOI 10.1001/jamadermato1.2016.3754; Geller AC, 2006, CANCER-AM CANCER SOC, V107, P806, DOI 10.1002/cncr.22050; Glanz K, 2015, CANCER EPIDEM BIOMAR, V24, P415, DOI 10.1158/1055-9965.EPI-14-0926; Glanz K, 2013, J HEALTH COMMUN, V18, P1368, DOI 10.1080/10810730.2013.778361; Glanz K, 2010, AM J PUBLIC HEALTH, V100, P735, DOI 10.2105/AJPH.2008.155705; Glasser A, 2010, AM J HEALTH BEHAV, V34, P500, DOI 10.5993/AJHB.34.4.11; Glazebrook C, 2006, PREV MED, V42, P449, DOI 10.1016/j.ypmed.2006.02.007; Green AC, 2011, J CLIN ONCOL, V29, P257, DOI 10.1200/JCO.2010.28.7078; Gritz ER, 2013, CANCER EPIDEM BIOMAR, V22, P1813, DOI 10.1158/1055-9965.EPI-13-0249; Guy GP, 2015, MMWR-MORBID MORTAL W, V64, P591; Heckman CJ, 2016, AM J PREV MED, V51, P1, DOI 10.1016/j.amepre.2015.11.008; Heckman CJ, 2016, PSYCHOL HEALTH MED, V21, P60, DOI 10.1080/13548506.2015.1051060; Heckman CJ, 2014, AM J HEALTH PROMOT, V28, P168, DOI 10.4278/ajhp.120912-QUAN-442; Henrikson NB, 2017, BEHAV COUNSELING SKI; Hillhouse J, 2008, CANCER-AM CANCER SOC, V113, P3257, DOI 10.1002/cncr.23922; Hillhouse J, 2010, ARCH DERMATOL, V146, P485, DOI 10.1001/archdermatol.2010.85; Howlader N., 2016, SEER CANC STAT REV 1; International Agency for Research on Cancer (IARC), 1992, IARC MON EV CARC RIS; Janda M, 2011, ARCH DERMATOL, V147, P799, DOI 10.1001/archdermatol.2011.48; Kohler BA, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv048; Koster B, 2010, SCAND J PUBLIC HEALT, V38, P548, DOI 10.1177/1403494810371250; Krist AH, 2015, AM J PREV MED, V49, pS138, DOI 10.1016/j.amepre.2015.05.009; Lazovich D, 2016, JAMA DERMATOL, V152, P268, DOI 10.1001/jamadermatol.2015.2938; Lin JS, 2011, BEHAV COUNSELING PRE; Lin SW, 2013, AM J EPIDEMIOL, V178, P521, DOI 10.1093/aje/kws589; Lin SW, 2012, INT J CANCER, V131, pE1015, DOI 10.1002/ijc.27619; Linos E, 2011, CANCER CAUSE CONTROL, V22, P1067, DOI 10.1007/s10552-011-9780-1; Linos E, 2009, J INVEST DERMATOL, V129, P1666, DOI 10.1038/jid.2008.423; Mahler HIM, 2007, HEALTH PSYCHOL, V26, P350, DOI 10.1037/0278-6133.26.3.350; Manne S, 2010, HEALTH PSYCHOL, V29, P583, DOI 10.1037/a0021387; Norman GJ, 2007, ARCH PEDIAT ADOL MED, V161, P146, DOI 10.1001/archpedi.161.2.146; Patrick K, 2006, ARCH PEDIAT ADOL MED, V160, P128, DOI 10.1001/archpedi.160.2.128; Petit A, 2014, CURR PHARM DESIGN, V20, P4070, DOI 10.2174/13816128113199990615; Prochaska JO, 2005, PREV MED, V41, P406, DOI 10.1016/j.ypmed.2004.09.050; Prochaska JO, 2004, HEALTH PSYCHOL, V23, P503, DOI 10.1037/0278-6133.23.5.503; Ransohoff KJ, 2016, CANCER CAUSE CONTROL, V27, P817, DOI 10.1007/s10552-016-0730-9; Rat C, 2014, ANN FAM MED, V12, P21, DOI 10.1370/afm.1600; Rosenberg DE, 2007, J ADOLESCENT HEALTH, V41, P472, DOI 10.1016/j.jadohealth.2007.05.018; U.S. Preventive Services Task Force, 2012, AM FAM PHYSICIAN, V86, P4; United Nations Development Programme, 2015, HUM DEV IND 2015 RAN; US Preventive Services Task Force, 2015, US PREV SERV TASK FO; US Preventive Services Task Force (USPSTF), 2012, FIN REC STAT SKIN CA; Veierod MB, 2014, INT J CANCER, V135, P413, DOI 10.1002/ijc.28657; Veierod MB, 2010, CANCER EPIDEM BIOMAR, V19, P111, DOI 10.1158/1055-9965.EPI-09-0567; Vuong K, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-137; Walls AC, 2013, AM J EPIDEMIOL, V177, P997, DOI 10.1093/aje/kws335; Walton AE, 2014, ARCH ENVIRON OCCUP H, V69, P214, DOI 10.1080/19338244.2013.771247; Wehner MR, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5909; WEINSTOCK MA, 1991, ARCH DERMATOL, V127, P1194, DOI 10.1001/archderm.127.8.1194; Weinstock MA, 2007, AM J PREV MED, V32, P517, DOI 10.1016/j.amepre.2007.02.024; Wernli KJ, 2016, JAMA-J AM MED ASSOC, V316, P436, DOI 10.1001/jama.2016.5415; Wolff T, 2009, ANN INTERN MED, V150, P194, DOI 10.7326/0003-4819-150-3-200902030-00009; Wu SW, 2016, AM J EPIDEMIOL, V183, P824, DOI 10.1093/aje/kwv282; Youl PH, 2015, PREV MED, V71, P50, DOI 10.1016/j.ypmed.2014.12.009	70	36	36	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2018	319	11					1143	1157		10.1001/jama.2017.21630	http://dx.doi.org/10.1001/jama.2017.21630			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ8LL	29558557	Bronze			2022-12-28	WOS:000427860200019
J	Uchino, K				Uchino, Ken			Review: Atraumatic lumbar puncture needles reduce postdural puncture headache compared with conventional needles	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Uchino, Ken] Cleveland Clin, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Uchino, K (corresponding author), Cleveland Clin, Cleveland, OH 44106 USA.		Uchino, Ken/ABC-1611-2021	Uchino, Ken/0000-0001-9468-4172					0	0	0	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2018	168	6					JC34	JC34		10.7326/ACPJC-2018-168-6-034	http://dx.doi.org/10.7326/ACPJC-2018-168-6-034			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ8AM	29554672				2022-12-28	WOS:000427827400011
J	Mozaffarian, D; Forouhi, NG				Mozaffarian, Dariush; Forouhi, Nita G.			Dietary guidelines and health-is nutrition science up to the task?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HORMONE REPLACEMENT THERAPY; CARDIOVASCULAR-DISEASE; HEART-DISEASE; RISK; METAANALYSIS; ASSOCIATION		[Mozaffarian, Dariush] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Forouhi, Nita G.] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England	Tufts University; University of Cambridge	Mozaffarian, D (corresponding author), Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA.	dariush.mozaffarian@tufts.edu	Mozaffarian, Dariush/ABC-2822-2020	Forouhi, Nita/0000-0002-5041-248X	EU; MRC [MC_UU_12015/5] Funding Source: UKRI	EU(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DM is a cardiologist and dean of the Friedman School of Nutrition Science and Policy at Tufts University. He has authored more than 300 scientific publications on the science of lifestyle and cardiometabolic health from a global perspective and on systems interventions and policies to most effectively reduce these burdens. NGF is programme leader of the nutritional epidemiology programme in the MRC Epidemiology Unit at the University of Cambridge. Her research focuses on identifying dietary risks for diabetes and related disorders. She is a principal investigator on the EU-FP6 funded EPIC-InterAct Study, the Fenland Study, The SABRE Study, and the EU-FP7 funded InterConnect Project and the EPIC-CVD study, and has co-authored over 200 scientific publications. Both authors conceived and drafted the manuscript, based on their experience and understanding of the scientific evidence and research methods. DM is the guarantor.	Anglemyer A, 2014, COCHRANE DB SYST REV; [Anonymous], 2017, OPT PROC EST DIET GU; [Anonymous], 2017, RED PROC EST DIET GU; Aveyard P, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2161; Bero L, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4845; Bes-Rastrollo M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001578; Boardman HMP, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002229.pub4; Centers for Disease Control and Prevention, 2014, CDCS GUID PRINC PUBL; Chartres N, 2016, JAMA INTERN MED, V176, P1769, DOI 10.1001/jamainternmed.2016.6721; COLDITZ GA, 1993, AM J OBSTET GYNECOL, V168, P1473, DOI 10.1016/S0002-9378(11)90784-4; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; DariushMozaffarian, 2017, JAMA-J AM MED ASSOC, V317, P1755, DOI 10.1001/jama.2017.3456; Davis C, 1999, AGR INFORM B, V750; Del Gobbo LC, 2016, JAMA INTERN MED, V176, P1155, DOI 10.1001/jamainternmed.2016.2925; Dietary Guidelines Advisory Committee, 2015, RAPP ACT 2015 REP PE; Forouhi NG, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002094; Frieden TR, 2017, NEW ENGL J MED, V377, P465, DOI 10.1056/NEJMra1614394; Friedman School of Nutrition Science & Policy, 2016, PUBL IMP IN; Grodstein F, 1997, NEW ENGL J MED, V336, P1769, DOI 10.1056/NEJM199706193362501; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Imamura F, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002087; IOANNIDIS JPA, 2013, BMJ-BRIT MED J, V347, DOI DOI 10.1136/BMJ.F669824231028; KJELSBERG MO, 1982, JAMA-J AM MED ASSOC, V248, P1465; Kones R, 2014, CURR MED RES OPIN, V30, P2009, DOI 10.1185/03007995.2014.925438; Kopel E, 2013, NEW ENGL J MED, V369, P672, DOI 10.1056/NEJMc1306659; Kuchler F, 2015, FEDERAL SUPPORT NUTR; Lundh A, 2017, COCHRANE DB SYST REV, V2; Mandrioli D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162198; Medical Research Council, 2017, MRC PRIOR NUTR RES; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Messina M, 2001, J AM DIET ASSOC, V101, P1416, DOI 10.1016/S0002-8223(01)00342-X; Micha R, 2017, JAMA-J AM MED ASSOC, V317, P912, DOI 10.1001/jama.2017.0947; Mohammed K, 2015, J CLIN ENDOCR METAB, V100, P4012, DOI 10.1210/jc.2015-2237; Mozaffarian D, 2015, BRAUNWALDS HEART DIS, P1001; Mozaffarian D, 2016, CIRCULATION, V133, P187, DOI 10.1161/CIRCULATIONAHA.115.018585; Mozaffarian D, 2015, JAMA-J AM MED ASSOC, V313, P2421, DOI 10.1001/jama.2015.5941; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Mozaffarian D, 2011, CIRCULATION, V123, P2870, DOI 10.1161/CIRCULATIONAHA.110.968735; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; Nelson HD, 2002, JAMA-J AM MED ASSOC, V288, P872, DOI 10.1001/jama.288.7.872; Nestle M, 2015, SODA POLITICS TAKING; Nissen SE, 2016, ANN INTERN MED, V164, P558, DOI 10.7326/M16-0035; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schillinger D, 2016, ANN INTERN MED, V165, P895, DOI 10.7326/L16-0534; UK Prevention Research Partnership, 2017, UKPRP PRINC WORK IND; Willett W., 2012, NUTR EPIDEMIOLOGY, DOI [10.1093/acprof:oso/9780199754038.001.0001, DOI 10.1093/ACPROF:OSO/9780199754038.001.0001]; Zhu LL, 2016, MENOPAUSE, V23, P461, DOI 10.1097/GME.0000000000000519	47	49	50	2	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2018	360								k822	10.1136/bmj.k822	http://dx.doi.org/10.1136/bmj.k822			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ9GG	29549076				2022-12-28	WOS:000427917400001
J	Glenn, DR; Bucher, DB; Lee, J; Lukin, MD; Park, H; Walsworth, RL				Glenn, David R.; Bucher, Dominik B.; Lee, Junghyun; Lukin, Mikhail D.; Park, Hongkun; Walsworth, Ronald L.			High-resolution magnetic resonance spectroscopy using a solid-state spin sensor	NATURE			English	Article							NMR-SPECTROSCOPY; PHYSICS	Quantum systems that consist of solid-state electronic spins can be sensitive detectors of nuclear magnetic resonance (NMR) signals, particularly from very small samples. For example, nitrogen-vacancy centres in diamond have been used to record NMR signals from nanometre-scale samples(1-3), with sensitivity sufficient to detect the magnetic field produced by a single protein(4). However, the best reported spectral resolution for NMR of molecules using nitrogen-vacancy centres is about 100 hertz(5). This is insufficient to resolve the key spectral identifiers of molecular structure that are critical to NMR applications in chemistry, structural biology and materials research, such as scalar couplings (which require a resolution of less than ten hertz(6)) and small chemical shifts (which require a resolution of around one part per million of the nuclear Larmor frequency). Conventional, inductively detected NMR can provide the necessary high spectral resolution, but its limited sensitivity typically requires millimetre-scale samples, precluding applications that involve smaller samples, such as picolitre-volume chemical analysis or correlated optical and NMR microscopy. Here we demonstrate a measurement technique that uses a solid-state spin sensor (a magnetometer) consisting of an ensemble of nitrogen-vacancy centres in combination with a narrowband synchronized readout protocol(7-9) to obtain NMR spectral resolution of about one hertz. We use this technique to observe NMR scalar couplings in a micrometre-scale sample volume of approximately ten picolitres. We also use the ensemble of nitrogen-vacancy centres to apply NMR to thermally polarized nuclear spins and resolve chemicalshift spectra from small molecules. Our technique enables analytical NMR spectroscopy at the scale of single cells.	[Glenn, David R.; Bucher, Dominik B.; Lukin, Mikhail D.; Park, Hongkun; Walsworth, Ronald L.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Bucher, Dominik B.; Walsworth, Ronald L.] Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA; [Lee, Junghyun] MIT, Dept Phys, Cambridge, MA 02139 USA; [Park, Hongkun] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Massachusetts Institute of Technology (MIT); Harvard University	Walsworth, RL (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.; Walsworth, RL (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	rwalsworth@cfa.harvard.edu	Park, Hongkun/R-9842-2019	Park, Hongkun/0000-0001-9576-8829; Bucher, Dominik Benjamin/0000-0003-2160-0235	US Army Research Laboratory; US Army Research Office [W911NF1510548]; German Research Foundation [BU 3257/1-1]; Gordon and Betty Moore foundation	US Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); US Army Research Office; German Research Foundation(German Research Foundation (DFG)); Gordon and Betty Moore foundation(Gordon and Betty Moore Foundation)	This material is based on work supported by, or supported in part by, the US Army Research Laboratory and the US Army Research Office under contract/grant number W911NF1510548. D.B.B. was partially supported by the German Research Foundation (BU 3257/1-1). M.D.L. acknowledges support from the Gordon and Betty Moore foundation. We thank R. Fu for assisting with acquisition of the electromagnet used to apply the bias field, M. Rosen for guidance on NMR techniques and S. DeVience for assisting with SpinDynamica calculations of NMR spectra at low B<INF>0</INF>.	Abrams D, 2014, NANO LETT, V14, P2471, DOI 10.1021/nl500147b; Aslam N, 2017, SCIENCE, V357, DOI 10.1126/science.aam8697; Babij NR, 2016, ORG PROCESS RES DEV, V20, P661, DOI 10.1021/acs.oprd.5b00417; Berger S., 2009, CLASSICS SPECTROSCOP; BLOEMBERGEN N, 1948, PHYS REV, V73, P679, DOI 10.1103/PhysRev.73.679; Boss JM, 2017, SCIENCE, V356, P837, DOI 10.1126/science.aam7009; Fessenden M, 2016, NATURE, V540, P153, DOI 10.1038/540153a; Fratila RM, 2011, ANNU REV ANAL CHEM, V4, P227, DOI 10.1146/annurev-anchem-061010-114024; Glenn DR, 2015, NAT METHODS, V12, P736, DOI [10.1038/NMETH.3449, 10.1038/nmeth.3449]; Grant SC, 2000, MAGNET RESON MED, V44, P19, DOI 10.1002/1522-2594(200007)44:1<19::AID-MRM4>3.0.CO;2-F; Grisi M, 2017, SCI REP-UK, V7, DOI 10.1038/srep44670; Herzog BE, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4892361; Liao SH, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3498895; Lovchinsky I, 2016, SCIENCE, V351, P836, DOI 10.1126/science.aad8022; Mamin HJ, 2013, SCIENCE, V339, P557, DOI 10.1126/science.1231540; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Meriles CA, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3483676; Mousoulis C, 2013, METHODS, V64, P119, DOI 10.1016/j.ymeth.2013.07.025; OLSON DL, 1995, SCIENCE, V270, P1967, DOI 10.1126/science.270.5244.1967; Rosskopf T, 2017, NPJ QUANTUM INFORM, V3, DOI 10.1038/s41534-017-0030-6; Ryan H, 2014, LAB CHIP, V14, P1678, DOI 10.1039/c3lc51431e; Schirhagl R, 2014, ANNU REV PHYS CHEM, V65, P83, DOI 10.1146/annurev-physchem-040513-103659; Schmitt S, 2017, SCIENCE, V356, P832, DOI 10.1126/science.aam5532; Staudacher T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9527; Staudacher T, 2013, SCIENCE, V339, P561, DOI 10.1126/science.1231675; Teschler JK, 2015, NAT REV MICROBIOL, V13, P255, DOI 10.1038/nrmicro3433; Waddington DEJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15118; Walsworth R. L., 2016, US patent, Patent No. [62/ 341,497, 62341497]; Walsworth R. L., 2017, International patent, Patent No. [PCT/ US17/ 34256, 1734256]; Zaiser S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12279	31	200	204	24	283	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2018	555	7696					351	+		10.1038/nature25781	http://dx.doi.org/10.1038/nature25781			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ3HG	29542693	Green Accepted, Green Submitted			2022-12-28	WOS:000427477100032
J	Dziadzko, V; Clavel, MA; Dziadzko, M; Medina-Inojosa, JR; Michelena, H; Maalouf, J; Nkomo, V; Thapa, P; Enriquez-Sarano, M				Dziadzko, Volha; Clavel, Marie-Annick; Dziadzko, Mikhail; Medina-Inojosa, Jose R.; Michelena, Hector; Maalouf, Joseph; Nkomo, Vuyisile; Thapa, Prabin; Enriquez-Sarano, Maurice			Outcome and undertreatment of mitral regurgitation: a community cohort study	LANCET			English	Article							VALVULAR HEART-DISEASE; AORTIC-VALVE-REPLACEMENT; REPAIR; DETERMINANTS; INTERVENTION; PREVALENCE; GUIDELINE; SOCIETY	Background Mitral regurgitation is the most common valve disease worldwide but whether the community-wide prevalence, poor patient outcomes, and low rates of surgical treatment justify costly development of new therapeutic interventions remains uncertain. Therefore, we did an observational cohort study to assess the clinical characteristics, outcomes, and degree of undertreatment of mitral regurgitation in a community setting. Methods We used data from Mayo Clinic electronic health records and the Rochester Epidemiology Project to identify all cases of moderate or severe isolated single-valvular mitral regurgitation (with no other severe left-sided valvular disease or previous mitral surgery) diagnosed during a 10-year period in the community setting in Olmsted County (MN, USA). We assessed clinical characteristics, mortality, heart failure incidence, and results of cardiac surgery post-diagnosis. Findings Between Jan 1, 2000, and Dec 31, 2010, 1294 community residents (median age at diagnosis 77 years [IQR 66-84]) were diagnosed with moderate or severe mitral regurgitation by Doppler echocardiography (prevalence 0.46% [95% CI 0.42-0.49] overall; 0.59% [0.54-0.64] in adults). Left-ventricular ejection fraction below 50% was frequent (recorded in 538 [42%] patients), and these patients had a slightly lower regurgitant volume than those with an ejection fraction of 50% or higher (mean 39 mL [SD 16] vs 45 mL [21], p<0.0001). Post-diagnosis mortality was mainly cardiovascular in nature (in 420 [51%] of 824 patients for whom the cause of death was available) and higher than expected for residents of the county for age or sex (risk ratio [RR] 2.23 [95% CI 2.06-2.41], p<0.0001). This excess mortality affected all subsets of patients, whether they had a left-ventricular ejection fraction lower than 50% (RR 3.17 [95% CI 2.84-3.53], p<0.0001) or of 50% or higher (1.71 [1.53-1.91], p<0.0001) and with primary mitral regurgitation (RR 1.73 [95% CI 1.53-1.96], p<0.0001) or secondary mitral regurgitation (2.72 [2.48-3.01], p<0.0001). Even patients with a low comorbidity burden combined with favourable characteristics such as left-ventricular ejection fraction of 50% or higher (RR 1.28 [95% CI 1.10-1.50], p<0.0017) or primary mitral regurgitation (1.29 [1.09-1.52], p=0.0030) incurred excess mortality. Heart failure was frequent (mean 64% [SE 1] at 5 years postdiagnosis), even in patients with left-ventricular ejection fraction of 50% or higher (49% [2] at 5 years postdiagnosis) or in those with primary mitral regurgitation (48% [2]). Mitral surgery was ultimately done in only 198 (15%) of 1294 patients, of which the predominant type of surgery was valve repair (in 149 [75%] patients). Mitral surgery was done in 28 (5%) of 538 patients with left-ventricular ejection fraction below 50% and in 170 (22%) of 756 patients with ejection fraction of 50% or higher, and in 34 (5%) of 723 with secondary mitral regurgitation versus 164 (29%) of 571 with primary regurgitation. All other types of cardiac surgery combined were performed in only 3% more patients (237 [18%] patients) than the number who underwent mitral surgery. Interpretation In the community, isolated mitral regurgitation is common and is associated with excess mortality and frequent heart failure postdiagnosis in all patient subsets, even in those with normal left-ventricular ejection fraction and low comorbidity. Despite these poor outcomes, only a minority of affected patients undergo mitral (or any type of cardiac) surgery even in a community with all means of diagnosis and treatment readily available and accessible. This suggests that in a wider population there might be a substantial unmet need for treatment for this disorder.	[Dziadzko, Volha; Clavel, Marie-Annick; Dziadzko, Mikhail; Medina-Inojosa, Jose R.; Michelena, Hector; Maalouf, Joseph; Nkomo, Vuyisile; Thapa, Prabin; Enriquez-Sarano, Maurice] Mayo Clin, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA	Mayo Clinic	Enriquez-Sarano, M (corresponding author), Mayo Clin, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA.	sarano.maurice@mayo.edu	Clavel, Marie-Annick/G-8453-2016; Dziadzko, Mikhail/AAC-4126-2022; Medina-Inojosa, Jose/Z-5609-2019; Medina, Jose/AAA-7327-2019	Clavel, Marie-Annick/0000-0002-8924-740X; Medina-Inojosa, Jose/0000-0001-8705-0462; Dziadzko, Mikhail/0000-0001-5116-2171; Enriquez-Sarano, Maurice/0000-0003-0910-5450	Mayo Clinic Foundation; NATIONAL INSTITUTE ON AGING [R01AG034676] Funding Source: NIH RePORTER	Mayo Clinic Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Mayo Clinic Foundation.	Acker MA, 2014, NEW ENGL J MED, V370, P23, DOI 10.1056/NEJMoa1312808; Al-Hasan MN, 2011, EPIDEMIOL INFECT, V139, P1750, DOI 10.1017/S095026881100001X; Avierinos JF, 2013, EUR HEART J, V34, P2600, DOI 10.1093/eurheartj/eht250; Avierinos JF, 2008, ANN INTERN MED, V149, P787, DOI 10.7326/0003-4819-149-11-200812020-00003; Avierinos JF, NATURAL HIST ASYMPTO; Bach DS, 2009, J AM COLL CARDIOL, V54, P860, DOI 10.1016/j.jacc.2009.03.079; Baumgartner H, 2017, EUR HEART J, V38, P2739, DOI 10.1093/eurheartj/ehx391; Bedogni F, 2013, CIRCULATION, V128, P2145, DOI 10.1161/CIRCULATIONAHA.113.001822; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chatterjee S, 2013, ANN THORAC SURG, V96, P1587, DOI 10.1016/j.athoracsur.2013.06.051; d'Arcy JL, 2016, EUR HEART J, V37, P3515, DOI 10.1093/eurheartj/ehw229; Enriquez-Sarano M, 2005, NEW ENGL J MED, V352, P875, DOI 10.1056/NEJMoa041451; Enriquez-Sarano M, 2009, LANCET, V373, P1382, DOI 10.1016/S0140-6736(09)60692-9; Grigioni F, 2001, CIRCULATION, V103, P1759, DOI 10.1161/01.CIR.103.13.1759; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Jones EC, 2001, AM J CARDIOL, V87, P298, DOI 10.1016/S0002-9149(00)01362-X; Liu Hongfang, 2013, AMIA Jt Summits Transl Sci Proc, V2013, P149; Lung B, 2007, CURR PROB CARDIOLOGY, V32, P609, DOI 10.1016/j.cpcardiol.2007.07.002; Mack MJ, 2011, JAMA-J AM MED ASSOC, V306, P2149, DOI 10.1001/jama.2011.1675; Maisano F, 2015, EUR HEART J, V36, P1651, DOI 10.1093/eurheartj/ehv123; Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277; Malouf J, 2012, J THORAC CARDIOV SUR, V144, P1421, DOI 10.1016/j.jtcvs.2011.09.075; Mantovani F, 2016, JACC-CARDIOVASC IMAG, V9, P388, DOI 10.1016/j.jcmg.2016.02.017; Michler RE, 2016, NEW ENGL J MED, V374, P1932, DOI 10.1056/NEJMoa1602003; Mirabel M, 2007, EUR HEART J, V28, P1358, DOI 10.1093/eurheartj/ehm001; Mohty D, 2001, CIRCULATION, V104, pI1; Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; Quinones MA, 2003, J AM SOC ECHOCARDIOG, V16, P379, DOI 10.1016/S0894-7317(03)00113-5; Rocca WA, 2012, MAYO CLIN PROC, V87, P1202, DOI 10.1016/j.mayocp.2012.08.012; Rosenhek R, 2006, CIRCULATION, V113, P2238, DOI 10.1161/CIRCULATIONAHA.105.599175; Singh JP, 1999, AM J CARDIOL, V83, P897, DOI 10.1016/S0002-9149(98)01064-9; St Sauver JL, 2012, MAYO CLIN PROC, V87, P151, DOI 10.1016/j.mayocp.2011.11.009; Stone GW, 2015, J AM COLL CARDIOL, V66, P308, DOI 10.1016/j.jacc.2015.05.049; Suri RM, 2008, J THORAC CARDIOV SUR, V136, P442, DOI 10.1016/j.jtcvs.2007.10.067; Suri RM, 2016, J AM COLL CARDIOL, V67, P488, DOI 10.1016/j.jacc.2015.10.098; Suri RM, 2014, SEMIN THORAC CARDIOV, V26, P95, DOI 10.1053/j.semtcvs.2014.07.004; Suri RM, 2013, JAMA-J AM MED ASSOC, V310, P609, DOI 10.1001/jama.2013.8643	39	156	160	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 10	2018	391	10124					960	969		10.1016/S0140-6736(18)30473-2	http://dx.doi.org/10.1016/S0140-6736(18)30473-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ1UN	29536860	Green Accepted			2022-12-28	WOS:000427363100029
J	Normile, D				Normile, Dennis			SPACE SCIENCE China hones plans for ambitious x-ray probe	SCIENCE			English	News Item																			0	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2018	359	6380					1085	1085		10.1126/science.359.6380.1085	http://dx.doi.org/10.1126/science.359.6380.1085			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4ZM	29590022				2022-12-28	WOS:000426835900017
J	Joye, S; Kleindienst, S; Pena-Montenegro, TD				Joye, Samantha; Kleindienst, Sara; Pena-Montenegro, Tito David			SnapShot: Microbial Hydrocarbon Bioremediation	CELL			English	Editorial Material									[Joye, Samantha; Pena-Montenegro, Tito David] Univ Georgia, Dept Marine Sci, Athens, GA 30605 USA; [Kleindienst, Sara] Eberhard Karls Univ Tubingen, Ctr Appl Geosci, D-72074 Tubingen, Germany	University System of Georgia; University of Georgia; Eberhard Karls University of Tubingen	Joye, S (corresponding author), Univ Georgia, Dept Marine Sci, Athens, GA 30605 USA.		Kleindienst, Sara/O-9908-2016	Kleindienst, Sara/0000-0001-8304-9149; Pena-Montenegro, Tito David/0000-0002-2646-4183	Gulf of Mexico Research Initiative's "Ecosystem Impacts of Oil and Gas to the Gulf" research consortium; Emmy-Noether fellowship from the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [326028733]; Fulbright Columbia Fellowship	Gulf of Mexico Research Initiative's "Ecosystem Impacts of Oil and Gas to the Gulf" research consortium; Emmy-Noether fellowship from the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); Fulbright Columbia Fellowship	S.B.J. is supported by the Gulf of Mexico Research Initiative's "Ecosystem Impacts of Oil and Gas to the Gulf" research consortium. S.K. is supported by an Emmy-Noether fellowship (grant #326028733) from the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG). TDPM is supported by a Fulbright Columbia Fellowship. This is ECOGIG contribution number 512. We thank Kai Ziervogel and Uta Passow for providing photographs of marine oil snow.	Joye SB, 2016, OCEANOGRAPHY, V29, P136, DOI 10.5670/oceanog.2016.78; Kleindienst S, 2016, ISME J, V10, P400, DOI 10.1038/ismej.2015.121; Krell T., 2017, CELLULAR ECOPHYSIOLO, P1; Mason OU, 2012, ISME J, V6, P1715, DOI 10.1038/ismej.2012.59; Ortega A., 2017, CELLULAR ECOPHYSIOLO, P1; Parales RE, 2017, CELLULAR ECOPHYSIOLO, P1; Passow U, 2016, DEEP-SEA RES PT II, V129, P232, DOI 10.1016/j.dsr2.2014.10.001; Perfumo A., 2017, CELLULAR ECOPHYSIOLO, P1, DOI DOI 10.1007/978-3-319-20796-4_35-1; Ziervogel K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034816	9	8	9	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 8	2018	172	6					1336	+		10.1016/j.cell.2018.02.059	http://dx.doi.org/10.1016/j.cell.2018.02.059			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FZ3IX	29522751	Bronze			2022-12-28	WOS:000427482100032
J	van Vugt, B; Dagnino, B; Vartak, D; Safaai, H; Panzeri, S; Dehaene, S; Roelfsema, PR				van Vugt, Bram; Dagnino, Bruno; Vartak, Devavrat; Safaai, Houman; Panzeri, Stefano; Dehaene, Stanislas; Roelfsema, Pieter R.			The threshold for conscious report: Signal loss and response bias in visual and frontal cortex	SCIENCE			English	Article							PERCEPTUAL AWARENESS; FLUCTUATIONS; ACCESS; FMRI	Why are some visual stimuli consciously detected, whereas others remain subliminal? We investigated the fate of weak visual stimuli in the visual and frontal cortex of awake monkeys trained to report stimulus presence. Reported stimuli were associated with strong sustained activity in the frontal cortex, and frontal activity was weaker and quickly decayed for unreported stimuli. Information about weak stimuli could be lost at successive stages en route from the visual to the frontal cortex, and these propagation failures were confirmed through microstimulation of area V1. Fluctuations in response bias and sensitivity during perception of identical stimuli were traced back to prestimulus brain-state markers. A model in which stimuli become consciously reportable when they elicit a nonlinear ignition process in higher cortical areas explained our results.	[van Vugt, Bram; Dagnino, Bruno; Vartak, Devavrat; Roelfsema, Pieter R.] Netherlands Inst Neurosci, Dept Vis & Cognit, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands; [Safaai, Houman] Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA; [Safaai, Houman; Panzeri, Stefano] Ist Italiano Tecnol, Neural Computat Lab, I-38068 Rovereto, Italy; [Dehaene, Stanislas] Univ Paris Sud, Cognit Neuroimaging Unit, Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant Inst Imagerie Biomed,INSERM,Neu, F-91191 Gif Sur Yvette, France; [Dehaene, Stanislas] Univ Paris Saclay, F-91191 Gif Sur Yvette, France; [Dehaene, Stanislas] Coll France, F-75005 Paris, France; [Roelfsema, Pieter R.] Vrije Univ Amsterdam, Dept Integrat Neurophysiol, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands; [Roelfsema, Pieter R.] Acad Med Ctr, Dept Psychiat, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Harvard University; Harvard Medical School; Istituto Italiano di Tecnologia - IIT; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; College de France; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Roelfsema, PR (corresponding author), Netherlands Inst Neurosci, Dept Vis & Cognit, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands.; Safaai, H (corresponding author), Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA.; Safaai, H (corresponding author), Ist Italiano Tecnol, Neural Computat Lab, I-38068 Rovereto, Italy.; Roelfsema, PR (corresponding author), Vrije Univ Amsterdam, Dept Integrat Neurophysiol, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands.; Roelfsema, PR (corresponding author), Acad Med Ctr, Dept Psychiat, Amsterdam, Netherlands.	houman_safaai@hms.harvard.edu; p.roelfsema@nin.knaw.nl	Roelfsema, Pieter/J-6903-2013; Panzeri, Stefano/L-5977-2013	Roelfsema, Pieter/0000-0002-1625-0034; Safaai, Houman/0000-0002-8609-7397; Panzeri, Stefano/0000-0003-1700-8909; van Vugt, Bram/0000-0003-3963-883X	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Brain and Cognition grant) [433-09-208]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (ALW grant) [823-02-010]; European Union [PITN-GA-2011-290011, 7202070]; European Union (European Research Council) [339490]; Fondation Bertarelli; Canadian Institute for Advanced Research	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Brain and Cognition grant); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (ALW grant)(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission); European Union (European Research Council)(European Research Council (ERC)European Commission); Fondation Bertarelli; Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR))	The work was supported by Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Brain and Cognition grant 433-09-208 and ALW grant 823-02-010) and the European Union Seventh Framework Program (Marie-Curie Action PITN-GA-2011-290011 "ABC," grant agreement 7202070 "Human Brain Project," and European Research Council grant agreement 339490 "Cortic_al_gorithms") awarded to P.R.R.; S.P. was supported by Fondation Bertarelli, and S.D. was supported by the Canadian Institute for Advanced Research.	Avidan G, 2002, J NEUROPHYSIOL, V87, P3102, DOI 10.1152/jn.2002.87.6.3102; Baars BJ, 2002, TRENDS COGN SCI, V6, P47, DOI 10.1016/S1364-6613(00)01819-2; Belopolsky AV, 2008, J COGNITIVE NEUROSCI, V20, P2285, DOI 10.1162/jocn.2008.20161; de Lafuente V, 2005, NAT NEUROSCI, V8, P1698, DOI 10.1038/nn1587; Dehaene S, 2005, PLOS BIOL, V3, P910, DOI 10.1371/journal.pbio.0030141; Fisch L, 2009, NEURON, V64, P562, DOI 10.1016/j.neuron.2009.11.001; Frasle S, 2014, J NEUROSCI, V34, P1738, DOI 10.1523/JNEUROSCI.4403-13.2014; Green DM, 1966, SIGNAL DETECTION THE; Herman WX, 2019, CEREB CORTEX, V29, P461, DOI 10.1093/cercor/bhx327; Iemi L, 2017, J NEUROSCI, V37, P807, DOI 10.1523/JNEUROSCI.1432-16.2016; King JR, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0204; Ko Y, 2012, PHILOS T R SOC B, V367, P1401, DOI 10.1098/rstb.2011.0380; Koch C, 2016, NAT REV NEUROSCI, V17, P307, DOI 10.1038/nrn.2016.22; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lee U, 2013, ANESTHESIOLOGY, V118, P1264, DOI 10.1097/ALN.0b013e31829103f5; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Maier A, 2008, NAT NEUROSCI, V11, P1193, DOI 10.1038/nn.2173; Palmer C, 2007, J NEUROSCI, V27, P8122, DOI 10.1523/JNEUROSCI.1940-07.2007; Panagiotaropoulos TI, 2012, NEURON, V74, P924, DOI 10.1016/j.neuron.2012.04.013; Pinto L, 2013, NAT NEUROSCI, V16, P1857, DOI 10.1038/nn.3552; Quiroga RQ, 2008, P NATL ACAD SCI USA, V105, P3599, DOI 10.1073/pnas.0707043105; Reimer J, 2014, NEURON, V84, P355, DOI 10.1016/j.neuron.2014.09.033; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Schmid MC, 2010, NATURE, V466, P373, DOI 10.1038/nature09179; Schmidt EM, 1996, BRAIN, V119, P507, DOI 10.1093/brain/119.2.507; Siclari F, 2017, NAT NEUROSCI, V20, P872, DOI 10.1038/nn.4545; Tsuchiya N, 2015, TRENDS COGN SCI, V19, P757, DOI 10.1016/j.tics.2015.10.002; Weiskrantz L., 1998, CONSCIOUSNESS LOST F; Wyart V, 2009, J NEUROSCI, V29, P8715, DOI 10.1523/JNEUROSCI.0962-09.2009	30	154	155	6	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2018	360	6388					537	542		10.1126/science.aar7186	http://dx.doi.org/10.1126/science.aar7186			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6PM	29567809				2022-12-28	WOS:000431351500047
J	Gostin, LO; Duranske, S				Gostin, Lawrence O.; Duranske, Sarah			The Second Amendment and a Well-Regulated Firearms Environment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RATES		[Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA; [Duranske, Sarah] Stanford Law Sch, Stanford, CA USA	Georgetown University; Stanford University	Gostin, LO (corresponding author), Georgetown Univ, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Dowd MD, FIR REL INJ AFF PED; Editorial Board, NY TIMES; Everytown for Gun Safety, GUNS VIOL WOM AM UN; Fox K., CNN; Grinshteyn E, 2016, AM J MED, V129, P266, DOI 10.1016/j.amjmed.2015.10.025; Hauser Christine., NY TIMES; Office of the Inspector General US Department of Justice, AUD HANDL FIR PURCH; Patel JK, NY TIMES; Siegel M, 2017, AM J PUBLIC HEALTH, V107, P1923, DOI 10.2105/AJPH.2017.304057	9	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2018	319	17					1763	1764		10.1001/jama.2018.4044	http://dx.doi.org/10.1001/jama.2018.4044			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GE3UQ	29570755				2022-12-28	WOS:000431138800010
J	Gupta, A; Das, SR; Pandey, A				Gupta, Arjun; Das, Sandeep R.; Pandey, Ambarish			beta-Blockers in Myocardial Infarction Issues With Standard Admission Order Sets	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ASSOCIATION TASK-FORCE; AMERICAN-COLLEGE; ST-ELEVATION; MEDICINE		[Gupta, Arjun; Das, Sandeep R.; Pandey, Ambarish] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX USA; [Das, Sandeep R.; Pandey, Ambarish] Univ Texas Southwestern Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Pandey, A (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Cardiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	ambarish.pandey@outlook.com			Roche Diagnostics	Roche Diagnostics	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Das reports receipt of a one-time consulting fee from Roche Diagnostics. Noother disclosures were reported.	Ansher C, 2014, MED DECIS MAKING, V34, P147, DOI 10.1177/0272989X13507339; Carayon P, 2010, STUD HEALTH TECHNOL, V153, P23, DOI 10.3233/978-1-60750-533-4-23; Center for Medicare & Medicaid Services (S. a, QUAL MEAS; Krumholz HM, 2011, J AM COLL CARDIOL, V57, P637, DOI 10.1016/j.jacc.2010.12.010; Krumholz HM, 2008, J AM COLL CARDIOL, V52, P2046, DOI 10.1016/j.jacc.2008.10.012; O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84; Olson Jordan, 2015, J Pathol Inform, V6, P16, DOI 10.4103/2153-3539.153916; Saver BG, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001902; Thiele H, 2012, NEW ENGL J MED, V367, P1287, DOI 10.1056/NEJMoa1208410	9	6	6	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2018	319	12					1269	1270		10.1001/jama.2018.0845	http://dx.doi.org/10.1001/jama.2018.0845			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GA5VW	29584845				2022-12-28	WOS:000428403000019
J	Voosen, P				Voosen, Paul			THE REALIST Vaclav Smil looks to history for the future of energy. What he sees is sobering	SCIENCE			English	Editorial Material																			0	2	2	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2018	359	6382			SI		1320	1324		10.1126/science.359.6382.1320	http://dx.doi.org/10.1126/science.359.6382.1320			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA0ZG	29567690				2022-12-28	WOS:000428043600020
J	Dobkin, C; Finkelstein, A; Kluender, R; Notowidigdo, MJ				Dobkin, Carlos; Finkelstein, Amy; Kluender, Raymond; Notowidigdo, Matthew J.			Myth and Measurement - The Case of Medical Bankruptcies	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dobkin, Carlos] Univ Calif Santa Cruz, Dept Econ, Santa Cruz, CA 95064 USA; [Finkelstein, Amy; Kluender, Raymond] MIT, Dept Econ, Cambridge, MA 02139 USA; [Notowidigdo, Matthew J.] Northwestern Univ, Dept Econ, Evanston, IL USA	University of California System; University of California Santa Cruz; Massachusetts Institute of Technology (MIT); Northwestern University	Dobkin, C (corresponding author), Univ Calif Santa Cruz, Dept Econ, Santa Cruz, CA 95064 USA.			Dobkin, Carlos/0000-0002-5171-8325	NIA NIH HHS [R37 AG032449, R01 AG032449, P01 AG005842] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG032449, P01AG005842] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Dobkin C, 2018, AM ECON REV, V108, P308, DOI 10.1257/aer.20161038; Dranove D, 2006, HEALTH AFFAIR, V25, pW74, DOI 10.1377/hlthaff.25.w74; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; Himmelstein DU, 2009, AM J MED, V122, P741, DOI 10.1016/j.amjmed.2009.04.012; HIMMELSTEIN DU, 2005, HEALTH AFFAIR, V24, P63, DOI DOI 10.1377/HLTHAFF.W5.63	5	22	23	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2018	378	12					1076	1078		10.1056/NEJMp1716604	http://dx.doi.org/10.1056/NEJMp1716604			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ9OV	29562153	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000427942300002
J	Franklin, D; Babl, FE; Schlapbach, LJ; Oakley, E; Craig, S; Neutze, J; Furyk, J; Fraser, JF; Jones, M; Whitty, JA; Dalziel, SR; Schibler, A				Franklin, Donna; Babl, Franz E.; Schlapbach, Luregn J.; Oakley, Ed; Craig, Simon; Neutze, Jocelyn; Furyk, Jeremy; Fraser, John F.; Jones, Mark; Whitty, Jennifer A.; Dalziel, Stuart R.; Schibler, Andreas			A Randomized Trial of High-Flow Oxygen Therapy in Infants with Bronchiolitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NASAL CANNULA THERAPY; NONINVASIVE VENTILATION; VIRAL BRONCHIOLITIS; CHILDREN; MANAGEMENT; DIAGNOSIS; TRENDS	BACKGROUND High-flow oxygen therapy through a nasal cannula has been increasingly used in infants with bronchiolitis, despite limited high-quality evidence of its efficacy. The efficacy of high-flow oxygen therapy through a nasal cannula in settings other than intensive care units (ICUs) is unclear. METHODS In this multicenter, randomized, controlled trial, we assigned infants younger than 12 months of age who had bronchiolitis and a need for supplemental oxygen therapy to receive either high-flow oxygen therapy (high-flow group) or standard oxygen therapy (standard-therapy group). Infants in the standard-therapy group could receive rescue high-flow oxygen therapy if their condition met criteria for treatment failure. The primary outcome was escalation of care due to treatment failure (defined as meeting >= 3 of 4 clinical criteria: persistent tachycardia, tachypnea, hypoxemia, and medical review triggered by a hospital early-warning tool). Secondary outcomes included duration of hospital stay, duration of oxygen therapy, and rates of transfer to a tertiary hospital, ICU admission, intubation, and adverse events. RESULTS The analyses included 1472 patients. The percentage of infants receiving escalation of care was 12% (87 of 739 infants) in the high-flow group, as compared with 23% (167 of 733) in the standard-therapy group (risk difference, -11 percentage points; 95% confidence interval, -15 to -7; P<0.001). No significant differences were observed in the duration of hospital stay or the duration of oxygen therapy. In each group, one case of pneumothorax (<1% of infants) occurred. Among the 167 infants in the standard-therapy group who had treatment failure, 102 (61%) had a response to high-flow rescue therapy. CONCLUSIONS Among infants with bronchiolitis who were treated outside an ICU, those who received high-flow oxygen therapy had significantly lower rates of escalation of care due to treatment failure than those in the group that received standard oxygen therapy.	[Franklin, Donna; Schlapbach, Luregn J.; Schibler, Andreas] Univ Queensland, Lady Cilento Childrens Hosp, Ctr Childrens Hlth Res, Pediat Crit Care Res Grp, Brisbane, Qld, Australia; [Franklin, Donna; Schlapbach, Luregn J.; Schibler, Andreas] Univ Queensland, Mater Res Inst, Brisbane, Qld, Australia; [Franklin, Donna; Schlapbach, Luregn J.; Fraser, John F.; Schibler, Andreas] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Jones, Mark] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Franklin, Donna; Fraser, John F.] Prince Charles Hosp, Adult Intens Care Serv, Crit Care Res Grp, Brisbane, Qld, Australia; [Franklin, Donna; Babl, Franz E.; Oakley, Ed; Craig, Simon; Neutze, Jocelyn; Furyk, Jeremy; Dalziel, Stuart R.; Schibler, Andreas] Paediat Res Emergency Dept Int Collaborat PREDICT, Parkville, Vic, Australia; [Babl, Franz E.; Oakley, Ed] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Emergency Dept, Melbourne, Vic, Australia; [Babl, Franz E.; Oakley, Ed] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Paediat, Melbourne, Vic, Australia; [Craig, Simon] Monash Univ, Sch Clin Sci, Dept Med, Clayton, Vic, Australia; [Craig, Simon] Monash Hlth, Monash Med Ctr, Paediat Emergency Dept, Clayton, Vic, Australia; [Furyk, Jeremy] James Cook Univ, Coll Med & Dent, Townsville, Qld, Australia; [Furyk, Jeremy] Townsville Hosp, Emergency Dept, Townsville, Qld, Australia; [Schlapbach, Luregn J.] Univ Bern, Bern Univ Hosp, Inselspital, Dept Pediat, Bern, Switzerland; [Neutze, Jocelyn] KidzFirst Middlemore Hosp, Auckland, New Zealand; [Neutze, Jocelyn] Univ Auckland, Auckland, New Zealand; [Dalziel, Stuart R.] Univ Auckland, Starship Childrens Hosp, Childrens Emergency Dept, Auckland, New Zealand; [Dalziel, Stuart R.] Univ Auckland, Liggins Inst, Auckland, New Zealand; [Whitty, Jennifer A.] Univ East Anglia, Norwich Med Sch, Hlth Econ Grp, Norwich, Norfolk, England	University of Queensland; Mater Research; University of Queensland; University of Queensland; University of Queensland; Prince Charles Hospital; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Melbourne; Monash University; Monash University; James Cook University; University of Bern; University Hospital of Bern; University of Auckland; Starship Children's Hospital; University of Auckland; University of Auckland; University of East Anglia	Schibler, A (corresponding author), Univ Queensland, Lady Cilento Childrens Hosp, Ctr Childrens Hlth Res, Precinct & Mater Res Inst, Level 7,62 Graham St, S Bank, Qld 4101, Australia.	a.schibler@uq.edu.au	Craig, Simon/H-9410-2019; Schlapbach, Luregn J/F-7465-2017; Whitty, Jennifer/N-6434-2013	Schlapbach, Luregn J/0000-0003-2281-2598; Schibler, Andreas/0000-0002-0791-5938; Whitty, Jennifer/0000-0002-5886-1933; Fraser, John/0000-0002-7012-2519	National Health and Medical Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Funded by the National Health and Medical Research Council and others. Australian and New Zealand Clinical Trials Registry number, ACTRN12613000388718.	[Anonymous], 2013, LANCET RESP MED, V1, P113, DOI 10.1016/S2213-2600(12)70053-X; Bressan S, 2013, EUR J PEDIATR, V172, P1649, DOI 10.1007/s00431-013-2094-4; Essouri S, 2006, PEDIATR CRIT CARE ME, V7, P329, DOI 10.1097/01.PCC.0000225089.21176.0B; Fernandes RM, 2014, JAMA-J AM MED ASSOC, V311, P87, DOI 10.1001/jama.2013.284921; Franklin D, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0501-x; Frat JP, 2015, NEW ENGL J MED, V372, P2185, DOI 10.1056/NEJMoa1503326; Green CA, 2016, ARCH DIS CHILD, V101, P140, DOI 10.1136/archdischild-2015-308723; Hasegawa K, 2013, PEDIATRICS, V132, P28, DOI 10.1542/peds.2012-3877; Javouhey E, 2008, INTENS CARE MED, V34, P1608, DOI 10.1007/s00134-008-1150-4; Kepreotes E, 2017, LANCET, V389, P930, DOI 10.1016/S0140-6736(17)30061-2; Lazner MR, 2012, PEDIATR PULM, V47, P909, DOI 10.1002/ppul.22513; Lee JH, 2013, INTENS CARE MED, V39, P247, DOI 10.1007/s00134-012-2743-5; Long E, 2016, EMERG MED J, V33, P386, DOI 10.1136/emermed-2015-204914; Manley BJ, 2013, NEW ENGL J MED, V369, P1425, DOI 10.1056/NEJMoa1300071; Mayfield S, 2014, J PAEDIATR CHILD H, V50, P373, DOI 10.1111/jpc.12509; Meissner HC, 2016, NEW ENGL J MED, V374, P62, DOI 10.1056/NEJMra1413456; Pham TMT, 2015, PEDIATR PULM, V50, P713, DOI 10.1002/ppul.23060; Ralston SL, 2014, PEDIATRICS, V134, pE1474, DOI 10.1542/peds.2014-2742; Schibler A, 2011, INTENS CARE MED, V37, P847, DOI 10.1007/s00134-011-2177-5; Schlapbach LJ, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01648-2016; Zorc JJ, 2010, PEDIATRICS, V125, P342, DOI 10.1542/peds.2009-2092	21	189	195	2	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2018	378	12					1121	1131		10.1056/NEJMoa1714855	http://dx.doi.org/10.1056/NEJMoa1714855			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ9OV	29562151	Green Published, Bronze			2022-12-28	WOS:000427942300008
J	Abrahami, D; Douros, A; Yin, H; Yu, OHY; Renoux, C; Bitton, A; Azoulay, L				Abrahami, Devin; Douros, Antonios; Yin, Hui; Yu, Oriana Hoi Yun; Renoux, Christel; Bitton, Alain; Azoulay, Laurent			Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRACTICE RESEARCH DATABASE; RISK-FACTORS; VALIDITY; BIAS; CD26; IV	OBJECTIVE To assess whether the use of dipeptidyl peptidase-4 inhibitors is associated with the incidence of inflammatory bowel disease in patients with type 2 diabetes. DESIGN Population based cohort study. SETTING More than 700 general practices contributing data to the United Kingdom Clinical Practice Research Datalink. PARTICIPANTS A cohort of 141 170 patients, at least 18 years of age, starting antidiabetic drugs between 1 January 2007 and 31 December 2016, with follow-up until 30 June 2017. MAIN OUTCOME MEASURES Adjusted hazard ratios for incident inflammatory bowel disease associated with use of dipeptidyl peptidase-4 inhibitors overall, by cumulative duration of use, and by time since initiation, estimated using time dependent Cox proportional hazards models. Use of dipeptidyl peptidase-4 inhibitors was modelled as a time varying variable and compared with use of other antidiabetic drugs, with exposures lagged by six months to account for latency and diagnostic delays. RESULTS During 552 413 person years of follow-up, 208 incident inflammatory bowel disease events occurred (crude incidence rate of 37.7 (95% confidence interval 32.7 to 43.1) per 100 000 person years). Overall, use of dipeptidyl peptidase-4 inhibitors was associated with an increased risk of inflammatory bowel disease (53.4 v 34.5 per 100 000 person years; hazard ratio 1.75, 95% confidence interval 1.22 to 2.49). Hazard ratios gradually increased with longer durations of use, reaching a peak after three to four years of use (hazard ratio 2.90, 1.31 to 6.41) and decreasing after more than four years of use (1.45, 0.44 to 4.76). A similar pattern was observed with time since starting dipeptidyl peptidase-4 inhibitors. These findings remained consistent in several sensitivity analyses. CONCLUSIONS In this first population based study, the use of dipeptidyl peptidase-4 inhibitors was associated with an increased risk of inflammatory bowel disease. Although these findings need to be replicated, physicians should be aware of this possible association.	[Abrahami, Devin; Douros, Antonios; Yin, Hui; Yu, Oriana Hoi Yun; Renoux, Christel; Azoulay, Laurent] Jewish Gen Hosp, Lady Davis Inst, Ctr Clin Epidemiol, Montreal, PQ H3T 1E2, Canada; [Abrahami, Devin; Douros, Antonios; Renoux, Christel; Azoulay, Laurent] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Douros, Antonios] Charite, Inst Clin Pharmacol & Toxicol, Berlin, Germany; [Yu, Oriana Hoi Yun] Jewish Gen Hosp, Div Endocrinol, Montreal, PQ, Canada; [Renoux, Christel] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Bitton, Alain] McGill Univ, Div Gastroenterol, Dept Med, Montreal, PQ, Canada; [Bitton, Alain] McGill Univ, Hlth Ctr, Montreal, PQ, Canada; [Azoulay, Laurent] McGill Univ, Gerald Bronfman Dept Oncol, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; McGill University; McGill University; McGill University; McGill University; McGill University	Azoulay, L (corresponding author), Jewish Gen Hosp, Lady Davis Inst, Ctr Clin Epidemiol, Montreal, PQ H3T 1E2, Canada.; Azoulay, L (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.; Azoulay, L (corresponding author), McGill Univ, Gerald Bronfman Dept Oncol, Montreal, PQ, Canada.	laurent.azoulay@mcgill.ca	Douros, Antonios/C-9751-2017; Azoulay, Laurent/Z-4421-2019	Douros, Antonios/0000-0002-6005-4006; 	Canadian Institutes of Health Research; German Research Foundation (Deutsche Forschungsgemeinschaft, DFG); Fonds de Recherche du Quebec Sante; McGill University	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); Fonds de Recherche du Quebec Sante(Fonds de la Recherche en Sante du Quebec); McGill University	This study was funded by a foundation scheme grant from the Canadian Institutes of Health Research. The sponsor had no influence on design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. AD is the recipient of a research fellowship from the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG). LA holds a ChercheurBoursier junior 2 award from the Fonds de Recherche du Quebec Sante and is the recipient of a William Dawson scholar award from McGill University.	Bahler C, 2017, EUR J GASTROEN HEPAT, V29, P916, DOI 10.1097/MEG.0000000000000891; Chen X, 2006, ADV EXP MED BIOL, V575, P27; Christensen DH, 2016, CLIN EPIDEMIOL, V8, P381, DOI 10.2147/CLEP.S113211; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hildebrandt M, 2001, SCAND J GASTROENTERO, V36, P1067, DOI 10.1080/003655201750422675; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; Jurjus A, 2016, BBA CLIN, V5, P16, DOI 10.1016/j.bbacli.2015.11.002; Kim SC, 2015, ANN RHEUM DIS, V74, P1968, DOI 10.1136/annrheumdis-2014-205216; Klemann C, 2016, CLIN EXP IMMUNOL, V185, P1, DOI 10.1111/cei.12781; Lawrenson R, 1999, J PUBLIC HEALTH MED, V21, P299, DOI 10.1093/pubmed/21.3.299; Lewis JD, 2002, PHARMACOEPIDEM DR S, V11, P211, DOI 10.1002/pds.698; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; Louis E, 2015, CURR OPIN GASTROEN, V31, P283, DOI 10.1097/MOG.0000000000000183; Magro DO, 2017, INTEST RES, V15, P352, DOI 10.5217/ir.2017.15.3.352; Mimura S, 2013, SCAND J GASTROENTERO, V48, P1152, DOI 10.3109/00365521.2013.832366; Moran GW, 2012, REGUL PEPTIDES, V177, P40, DOI 10.1016/j.regpep.2012.04.006; Nauck MA, 2009, DIABETES CARE, V32, pS223, DOI 10.2337/dc09-S315; Ohnuma K, 2011, ADV CLIN CHEM, V53, P51, DOI 10.1016/S0065-2423(11)53003-3; Public Health England, 2017, NHS BOW CANC SCREEN; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Rodriguez LAG, 2005, ALIMENT PHARM THER, V22, P309, DOI 10.1111/j.1365-2036.2005.02564.x; Ruigomez A, 2003, MATURITAS, V44, P133, DOI 10.1016/S0378-5122(02)00321-3; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Sharma M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010210; Son JW, 2015, DIABETES METAB J, V39, P373, DOI 10.4093/dmj.2015.39.5.373; Suissa D, 2012, J CLIN EPIDEMIOL, V65, P42, DOI 10.1016/j.jclinepi.2011.04.009; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; Thornberry NA, 2009, BEST PRACT RES CL EN, V23, P479, DOI 10.1016/j.beem.2009.03.004; U. S. National Library of Medicine, 2017, RCD RED COD SYN; Van Staa TP, 2003, GASTROENTEROLOGY, V125, P1591, DOI 10.1053/j.gastro.2003.09.027; Vavricka SR, 2012, INFLAMM BOWEL DIS, V18, P496, DOI 10.1002/ibd.21719; Yazbeck R, 2008, FRONT BIOSCI-LANDMRK, V13, P6850, DOI 10.2741/3193; Yazbeck R, 2009, TRENDS PHARMACOL SCI, V30, P600, DOI 10.1016/j.tips.2009.08.003; Zietek T, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00154	36	58	58	3	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 21	2018	360								k872	10.1136/bmj.k872	http://dx.doi.org/10.1136/bmj.k872			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB1LG	29563098	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000428811700028
J	Cline, CJ; Faul, UH; David, EC; Berry, AJ; Jackson, I				Cline, C. J., II; Faul, U. H.; David, E. C.; Berry, A. J.; Jackson, I.			Redox-influenced seismic properties of uppermantle olivine	NATURE			English	Article							PACIFIC UPPER-MANTLE; EARTHS UPPER-MANTLE; VISCOELASTIC RELAXATION; POLYCRYSTALLINE OLIVINE; WAVE ATTENUATION; SUBDUCTION ZONE; OXIDATION-STATE; HIGH-PRESSURE; WATER; CREEP	Lateral variations of seismic wave speeds and attenuation (dissipation of strain energy) in the Earth's upper mantle have the potential to map key characteristics such as temperature, major-element composition, melt fraction and water content(1-3). The inversion of these data into meaningful representations of physical properties requires a robust understanding of the micromechanical processes that affect the propagation of seismic waves(2,3). Structurally bound water (hydroxyl) is believed to affect seismic properties(2,3) but this has yet to be experimentally quantified. Here we present a comprehensive low-frequency forced-oscillation assessment of the seismic properties of olivine as a function of water content within the under-saturated regime that is relevant to the Earth's interior. Our results demonstrate that wave speeds and attenuation are in fact strikingly insensitive to water content. Rather, the redox conditions imposed by the choice of metal sleeving, and the associated defect chemistry, appear to have a substantial influence on the seismic properties. These findings suggest that elevated water contents are not responsible for low-velocity or high-attenuation structures in the upper mantle. Instead, the high attenuation observed in hydrous and oxidized regions of the upper mantle (such as above subduction zones) may reflect the prevailing oxygen fugacity. In addition, these data provide no support for the hypothesis whereby a sharp lithosphere-asthenosphere boundary is explained by enhanced grain boundary sliding in the presence of water.	[Cline, C. J., II; David, E. C.; Berry, A. J.; Jackson, I.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Faul, U. H.] MIT, Earth Atmospher & Planetary Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [David, E. C.] UCL, Dept Earth Sci, London, England	Australian National University; Massachusetts Institute of Technology (MIT); University of London; University College London	Cline, CJ (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia.	christopher.cline@anu.edu.au	jackson, ian/H-4739-2011; Berry, Andrew J/J-6725-2012	jackson, ian/0000-0001-5200-9734; Berry, Andrew/0000-0002-9952-6584; Faul, Ulrich/0000-0001-5036-4572; Cline II, Christopher/0000-0002-8719-3882	Australian Research Council [DP130103848]; NSF [EAR 1321889]; Australian National University International PhD Research Scholarship	Australian Research Council(Australian Research Council); NSF(National Science Foundation (NSF)); Australian National University International PhD Research Scholarship	We thank H. Kokkonen and H. Miller for technical support with sample preparation and operation of the Australian National University rock physics laboratory, H. Chen for assistance with electron backscatter diffraction, and S. Karato of Yale University for suggestions that improved the manuscript. This work was supported by grant DP130103848 from the Australian Research Council to I.J., A.J.B., U.H.F. and S. Karato. U.H.F. acknowledges support from NSF grant EAR 1321889. C.J.C. gratefully acknowledges funding by an Australian National University International PhD Research Scholarship.	Abers GA, 2014, GEOCHEM GEOPHY GEOSY, V15, P3521, DOI 10.1002/2014GC005444; Aizawa Y, 2008, J PETROL, V49, P841, DOI 10.1093/petrology/egn007; BAI Q, 1991, J GEOPHYS RES-SOLID, V96, P2441, DOI 10.1029/90JB01723; Berry AJ, 2005, GEOLOGY, V33, P869, DOI 10.1130/G21759.1; Brounce MN, 2014, J PETROL, V55, P2513, DOI 10.1093/petrology/egu065; De Hoog JCM, 2010, CHEM GEOL, V270, P196, DOI 10.1016/j.chemgeo.2009.11.017; Dohmen R, 2007, PHYS CHEM MINER, V34, P409, DOI 10.1007/s00269-007-0158-6; ENGI M, 1980, CONTRIB MINERAL PETR, V72, P415, DOI 10.1007/BF00371348; Farla RJM, 2012, SCIENCE, V336, P332, DOI 10.1126/science.1218318; Faul U. H., 2017, PHYS CHEM MINERAL; Faul UH, 2016, EARTH PLANET SC LETT, V452, P227, DOI 10.1016/j.epsl.2016.07.016; HEALD EF, 1967, T METALL SOC AIME, V239, P1337; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; Jackson I, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB001225; JACKSON I, 1993, PURE APPL GEOPHYS, V141, P445, DOI 10.1007/BF00998339; Jackson I., 2015, TREATISE GEOPHYS, P539; Jackson I, 2010, PHYS EARTH PLANET IN, V183, P151, DOI 10.1016/j.pepi.2010.09.005; Jackson I, 2009, PHYS EARTH PLANET IN, V172, P104, DOI 10.1016/j.pepi.2008.03.010; Jacobsen SD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034398; Karato S.-I., 2004, GEOPHYS MONOGR SER, V138, P135, DOI [10.1029/138GM08, DOI 10.1029/138GM08]; Karato SI, 2012, EARTH PLANET SC LETT, V321, P95, DOI 10.1016/j.epsl.2012.01.001; Karato SI, 2003, PHILOS MAG, V83, P401, DOI 10.1080/0141861021000025829; Kelley KA, 2009, SCIENCE, V325, P605, DOI 10.1126/science.1174156; Kessel R, 2001, AM MINERAL, V86, P1003; Kovacs I, 2010, AM MINERAL, V95, P292, DOI 10.2138/am.2010.3313; Lin PYP, 2016, NATURE, V535, P538, DOI 10.1038/nature18012; McCammon CA, 2004, PHYS EARTH PLANET IN, V143, P157, DOI 10.1016/j.pepi.2003.08.009; Mei S, 2000, J GEOPHYS RES-SOL EA, V105, P21457, DOI 10.1029/2000JB900179; NAKAMURA A, 1983, PHYS CHEM MINER, V10, P27, DOI 10.1007/BF01204323; Olugboji TM, 2013, GEOCHEM GEOPHY GEOSY, V14, P880, DOI 10.1002/ggge.20086; PATERSON MS, 1986, PHYS CHEM MINER, V13, P245, DOI 10.1007/BF00308276; Romanowicz B., 2015, TREATISE GEOPHYS, V1, P789, DOI [10.1016/B978-0-444-53802-4.00021-X, DOI 10.1016/B978-0-444-53802-4.00021-X]; RUBIE DC, 1993, PHYS CHEM MINER, V20, P315; Sarafian E, 2015, GEOCHEM GEOPHY GEOSY, V16, P1115, DOI 10.1002/2014GC005709; Shimizu K, 2016, GEOCHIM COSMOCHIM AC, V176, P44, DOI 10.1016/j.gca.2015.10.033; Stachnik JC, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003018; Tan BH, 2001, PHYS CHEM MINER, V28, P641, DOI 10.1007/s002690100189; Tenner TJ, 2012, CONTRIB MINERAL PETR, V163, P297, DOI 10.1007/s00410-011-0675-7; Walker AM, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004620	39	82	82	3	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2018	555	7696					355	+		10.1038/nature25764	http://dx.doi.org/10.1038/nature25764			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ3HG	29542688				2022-12-28	WOS:000427477100033
J	Cartwright, E				Cartwright, Emma			"What do you need to make things better?" Emma Cartwright talks about the importance of peer support in self management of chronic diseases	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												Emma.j.cartwright@gmail.com							0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 14	2018	360								k813	10.1136/bmj.k813	http://dx.doi.org/10.1136/bmj.k813			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ9FZ	29540350	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000427916700015
J	Hassager, C; Nagao, K; Hildick-Smith, D				Hassager, Christian; Nagao, Ken; Hildick-Smith, David			Out-of-hospital cardiac arrest: in-hospital intervention strategies	LANCET			English	Review							PERCUTANEOUS CORONARY INTERVENTION; TARGETED TEMPERATURE MANAGEMENT; ELEVATION MYOCARDIAL-INFARCTION; ST-SEGMENT ELEVATION; MILD THERAPEUTIC HYPOTHERMIA; CEREBRAL OXYGEN-SATURATION; 33 DEGREES-C; VENTRICULAR-FIBRILLATION; COMATOSE SURVIVORS; NEUROLOGICAL PROGNOSTICATION	The prognosis after out-of-hospital cardiac arrest (OHCA) has improved in the past few decades because of advances in interventions used outside and in hospital. About half of patients who have OHCA with initial ventricular tachycardia or ventricular fibrillation and who are admitted to hospital in coma after return of spontaneous circulation will survive to discharge with a reasonable neurological status. In this Series paper we discuss in-hospital management of patients with post-cardiac-arrest syndrome. In most patients, the most important in-hospital interventions other than routine intensive care are continuous active treatment (in non-comatose and comatose patients and including circulatory support in selected patients), cooling of core temperature to 32-36 degrees C by targeted temperature management for at least 24 h, immediate coronary angiography with or without percutaneous coronary intervention, and delay of final prognosis until at least 72 h after OHCA. Prognosis should be based on clinical observations and multimodal testing, with focus on no residual sedation.	[Hassager, Christian] Rigshosp, Dept Cardiol, Copenhagen, Denmark; [Hassager, Christian] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark; [Nagao, Ken] Nihon Univ Hosp, Cardiovasc Ctr, Tokyo, Japan; [Hildick-Smith, David] Brighton & Sussex Univ Hosp, Sussex Cardiac Ctr, Dept Cardiol, Brighton Hove, England	Rigshospitalet; University of Copenhagen; University of Copenhagen; Nihon University	Hassager, C (corresponding author), Univ Copenhagen, Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark.	hassager@dadlnet.dk		Hassager, Christian/0000-0002-1199-0981				ABRAMSON NS, 1986, NEW ENGL J MED, V314, P397; Argaud L, 2016, JAMA CARDIOL, V1, P557, DOI 10.1001/jamacardio.2016.1701; Batista LM, 2010, RESUSCITATION, V81, P398, DOI 10.1016/j.resuscitation.2009.12.016; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bernard SA, 2016, CIRCULATION, V134, P797, DOI 10.1161/CIRCULATIONAHA.116.021989; Bernard SA, 2012, CRIT CARE MED, V40, P747, DOI 10.1097/CCM.0b013e3182377038; Bernard SA, 2010, CIRCULATION, V122, P737, DOI 10.1161/CIRCULATIONAHA.109.906859; Bjelland TW, 2010, RESUSCITATION, V81, P1627, DOI 10.1016/j.resuscitation.2010.07.002; Brain Resuscitation Clinical Trial II Study Group, 1991, NEW ENGL J MED, V325, P1046; Bro-Jeppesen J, 2014, RESUSCITATION, V85, P1480, DOI 10.1016/j.resuscitation.2014.08.007; Bro-Jeppesen J, 2013, RESUSCITATION, V84, P1734, DOI 10.1016/j.resuscitation.2013.07.023; Bro-Jeppesen J, 2009, RESUSCITATION, V80, P171, DOI 10.1016/j.resuscitation.2008.09.009; Callaway CW, 2008, CRIT CARE MED, V36, P2607, DOI 10.1097/CCM.0b013e318184443b; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Camuglia AC, 2014, RESUSCITATION, V85, P1533, DOI 10.1016/j.resuscitation.2014.08.025; Cariou A, 2016, J AM COLL CARDIOL, V68, P40, DOI 10.1016/j.jacc.2016.04.040; Castren M, 2010, CIRCULATION, V122, P729, DOI 10.1161/CIRCULATIONAHA.109.931691; Cronberg T, 2015, JAMA NEUROL, V72, P634, DOI 10.1001/jamaneurol.2015.0169; Dae MW, 2002, AM J PHYSIOL-HEART C, V282, pH1584, DOI 10.1152/ajpheart.00980.2001; Debaty G, 2014, INTENS CARE MED, V40, P1832, DOI 10.1007/s00134-014-3519-x; Deye N, 2015, CIRCULATION, V132, P182, DOI 10.1161/CIRCULATIONAHA.114.012805; Dragancea I, 2017, RESUSCITATION, V117, P50, DOI 10.1016/j.resuscitation.2017.05.014; Dumas F, 2010, CIRC-CARDIOVASC INTE, V3, P200, DOI 10.1161/CIRCINTERVENTIONS.109.913665; Erlinge D, 2014, J AM COLL CARDIOL, V63, P1857, DOI 10.1016/j.jacc.2013.12.027; Garot P, 2007, CIRCULATION, V115, P1354, DOI 10.1161/CIRCULATIONAHA.106.657619; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hosmane VR, 2009, J AM COLL CARDIOL, V53, P409, DOI 10.1016/j.jacc.2008.08.076; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Ibrahim K, 2014, RESUSCITATION, V85, P649, DOI 10.1016/j.resuscitation.2014.02.004; Ito N, 2014, RESUSCITATION, V85, P778, DOI 10.1016/j.resuscitation.2014.02.012; Joffre J, 2014, RESUSCITATION, V85, P769, DOI 10.1016/j.resuscitation.2014.02.013; Kim F, 2014, JAMA-J AM MED ASSOC, V311, P45, DOI 10.1001/jama.2013.282173; Kirkegaard H, 2017, JAMA-J AM MED ASSOC, V318, P341, DOI 10.1001/jama.2017.8978; Knafelj R, 2007, RESUSCITATION, V74, P227, DOI 10.1016/j.resuscitation.2007.01.016; Laitio R, 2016, JAMA-J AM MED ASSOC, V315, P1120, DOI 10.1001/jama.2016.1933; Langkjaer S, 2015, RESUSCITATION, V92, P141, DOI 10.1016/j.resuscitation.2015.03.023; Larsen JM, 2012, RESUSCITATION, V83, P1427, DOI 10.1016/j.resuscitation.2012.08.337; Lettieri C, 2009, AM HEART J, V157, P569, DOI 10.1016/j.ahj.2008.10.018; Lilja G, 2015, CIRCULATION, V131, P1340, DOI 10.1161/CIRCULATIONAHA.114.014414; Longstreth WT, 2002, NEUROLOGY, V59, P506, DOI 10.1212/WNL.59.4.506; Lybeck A, 2018, RESUSCITATION, V126, P166, DOI 10.1016/j.resuscitation.2018.01.027; Mattsson N, 2017, ANN NEUROL, V82, P665, DOI 10.1002/ana.25067; Metter RB, 2011, RESUSCITATION, V82, P1180, DOI 10.1016/j.resuscitation.2011.04.001; Millin MG, 2016, RESUSCITATION, V108, P54, DOI 10.1016/j.resuscitation.2016.09.004; Mylotte D, 2013, JACC-CARDIOVASC INTE, V6, P115, DOI 10.1016/j.jcin.2012.10.006; Nagao K, 2016, CIRCULATION, V133, P1386, DOI 10.1161/CIRCULATIONAHA.115.018788; Nagao K, 2010, CIRC J, V74, P77, DOI 10.1253/circj.CJ-09-0502; Nichol G, 2010, CIRCULATION, V121, P709, DOI 10.1161/CIR.0b013e3181cdb7db; Nielsen N, 2009, ACTA ANAESTH SCAND, V53, P926, DOI 10.1111/j.1399-6576.2009.02021.x; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Nishiyama K, 2015, RESUSCITATION, V96, P135, DOI 10.1016/j.resuscitation.2015.07.049; Noc M, INVASIVE CORONARY TR; Nolan JP, 2015, RESUSCITATION, V95, P202, DOI 10.1016/j.resuscitation.2015.07.018; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Ortega-Deballon I, 2016, RESUSCITATION, V101, P12, DOI 10.1016/j.resuscitation.2016.01.018; Ouweneel DM, 2017, J AM COLL CARDIOL, V69, P278, DOI 10.1016/j.jacc.2016.10.022; Patel N, 2016, JAMA CARDIOL, V1, P890, DOI 10.1001/jamacardio.2016.2860; Peels HO, 2008, CATHETER CARDIO INTE, V71, P147, DOI 10.1002/ccd.21265; Penela D, 2013, J AM COLL CARDIOL, V61, P686, DOI 10.1016/j.jacc.2012.10.029; Rab T, 2015, J AM COLL CARDIOL, V66, P62, DOI 10.1016/j.jacc.2015.05.009; Radsel P, 2011, AM J CARDIOL, V108, P634, DOI 10.1016/j.amjcard.2011.04.008; Safar P, 1996, STROKE, V27, P105, DOI 10.1161/01.STR.27.1.105; Salam I, 2016, EUR HEART J-ACUTE CA, V5, P317, DOI 10.1177/2048872615585519; Shavelle DM, 2017, AM J CARDIOL, V120, P729, DOI 10.1016/j.amjcard.2017.06.010; Shinozaki K, 2017, CIRC J, V81, P1839, DOI 10.1253/circj.CJ-17-0335; Silva S, 2017, CRIT CARE MED, V45, pE763, DOI 10.1097/CCM.0000000000002379; Soholm H, 2013, RESUSCITATION, V84, P162, DOI 10.1016/j.resuscitation.2012.06.029; Spaulding CM, 1997, NEW ENGL J MED, V336, P1629, DOI 10.1056/NEJM199706053362302; Stammet P, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1729-7; Stammet P, 2015, J AM COLL CARDIOL, V65, P2104, DOI 10.1016/j.jacc.2015.03.538; Stub D, 2011, CIRCULATION, V123, P1428, DOI 10.1161/CIRCULATIONAHA.110.988725; Sunde K, 2007, RESUSCITATION, V73, P29, DOI 10.1016/j.resuscitation.2006.08.016; Thiele H, 2012, NEW ENGL J MED, V367, P1287, DOI 10.1056/NEJMoa1208410; Tranberg T, 2017, EUR HEART J, V38, P1645, DOI 10.1093/eurheartj/ehx104; Wanscher M, 2012, RESUSCITATION, V83, P1078, DOI 10.1016/j.resuscitation.2012.05.009; Westhall E, 2016, NEUROLOGY, V86, P1482, DOI 10.1212/WNL.0000000000002462; Wiberg S, 2016, CIRCULATION; Wissenberg M, 2013, JAMA-J AM MED ASSOC, V310, P1377, DOI 10.1001/jama.2013.278483; Wolfrum S, 2008, CRIT CARE MED, V36, P1780, DOI 10.1097/CCM.0b013e31817437ca; Wu O, 2009, RADIOLOGY, V252, P173, DOI 10.1148/radiol.2521081232; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yokoyama H, 2011, CIRC J, V75, P1063, DOI 10.1253/circj.CJ-11-0137; Youn CS, 2015, RESUSCITATION, V96, P1, DOI 10.1016/j.resuscitation.2015.06.029; Zeiner A, 2001, ARCH INTERN MED, V161, P2007, DOI 10.1001/archinte.161.16.2007	84	66	73	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 10	2018	391	10124					989	998		10.1016/S0140-6736(18)30315-5	http://dx.doi.org/10.1016/S0140-6736(18)30315-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ1UN	29536863				2022-12-28	WOS:000427363100032
J	Laufkotter, C; Gruber, N				Laufkotter, Charlotte; Gruber, Nicolas			Will marine productivity wane?	SCIENCE			English	Editorial Material							SOUTHERN-OCEAN; MODELS		[Laufkotter, Charlotte] Univ Bern, Phys Inst, Climate & Environm Phys, CH-3012 Bern, Switzerland; [Laufkotter, Charlotte] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland; [Gruber, Nicolas] ETH, Inst Biogeochem & Pollutant Dynam, Environm Phys, CH-8092 Zurich, Switzerland	University of Bern; University of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich	Laufkotter, C (corresponding author), Univ Bern, Phys Inst, Climate & Environm Phys, CH-3012 Bern, Switzerland.; Laufkotter, C (corresponding author), Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland.	laufkoetter@climate.unibe.ch	Gruber, Nicolas/B-7013-2009	Gruber, Nicolas/0000-0002-2085-2310; Laufkotter, Charlotte/0000-0001-5738-1121				Brzezinski MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014349; Gall MP, 2001, DEEP-SEA RES PT II, V48, P2571, DOI 10.1016/S0967-0645(01)00009-1; Heuze C, 2013, GEOPHYS RES LETT, V40, DOI 10.1002/grl.50287; John JG, 2015, GEOPHYS RES LETT, V42, P9836, DOI 10.1002/2015GL066160; Kwiatkowski L, 2017, NAT CLIM CHANGE, V7, P355, DOI [10.1038/nclimate3265, 10.1038/NCLIMATE3265]; Laufkotter C, 2015, BIOGEOSCIENCES, V12, P6955, DOI 10.5194/bg-12-6955-2015; Marinov I, 2006, NATURE, V441, P964, DOI 10.1038/nature04883; Moore JK, 2018, SCIENCE, V359, P1139, DOI 10.1126/science.aao6379; Sallee JB, 2013, J GEOPHYS RES-OCEANS, V118, P1845, DOI 10.1002/jgrc.20157; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; Tagliabue A, 2016, GLOBAL BIOGEOCHEM CY, V30, P149, DOI 10.1002/2015GB005289	11	10	10	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2018	359	6380					1103	1104		10.1126/science.aat0795	http://dx.doi.org/10.1126/science.aat0795			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY4ZM	29590030				2022-12-28	WOS:000426835900025
J	DeCamp, M; Lehmann, LS; Jaeel, P; Horwitch, C				DeCamp, Matthew; Lehmann, Lisa Soleymani; Jaeel, Pooja; Horwitch, Carrie		ACP Ethics Professionalism	Ethical Obligations Regarding Short-Term Global Health Clinical Experiences: An American College of Physicians Position Paper	ANNALS OF INTERNAL MEDICINE			English	Review							CANADIAN MEDICAL-STUDENTS; US; ELECTIVES; CHALLENGES; UNIVERSITY; MISSIONS; TRAINEES; ISSUES; ENGAGEMENT; CURRICULUM	This American College of Physicians position paper aims to inform ethical decision making surrounding participation in short-term global health clinical care experiences. Although the positions are primarily intended for practicing physicians, they may apply to other health care professionals and should inform how institutions, organizations, and others structure short-term global health experiences. The primary goal of short-term global health clinical care experiences is to improve the health and well-being of the individuals and communities where they occur. In addition, potential benefits for participants in global health include increased awareness of global health issues, new medical knowledge, enhanced physical diagnosis skills when practicing in low-technology settings, improved language skills, enhanced cultural sensitivity, a greater capacity for clinical problem solving, and an improved sense of self-satisfaction or professional satisfaction. However, these activities involve several ethical challenges. Addressing these challenges is critical to protecting patient welfare in all geographic locales, promoting fair and equitable care globally, and maintaining trust in the profession. This paper describes 5 core positions that focus on ethics and the clinical care context and provides case scenarios to illustrate them.	[DeCamp, Matthew] Johns Hopkins Univ, Baltimore, MD USA; [Lehmann, Lisa Soleymani] Vet Hlth Adm, Washington, DC USA; [Lehmann, Lisa Soleymani] Harvard Med Sch, Boston, MA USA; [Lehmann, Lisa Soleymani] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Jaeel, Pooja] Univ Calif San Diego, La Jolla, CA 92093 USA; [Horwitch, Carrie] Virginia Mason Med Ctr, 1100 9 Ave, Seattle, WA 98101 USA; [Lehmann, Lisa Soleymani] Amer Coll Physicians, Ctr Eth & Profess, 190 N Independence Mall West, Philadelphia, PA 19106 USA; [DeCamp, Matthew] Johns Hopkins Univ, Berman Inst Bioeth, 1809 Ashland Ave, Baltimore, MD 21205 USA; [Lehmann, Lisa Soleymani] Vet Hlth Adm, Natl Ctr Eth Hlth Care, 810 Vermont Ave, Washington, DC 20420 USA; [Jaeel, Pooja] Univ Calif San Diego, Sch Med, Internal Med Residency Training Program, 9500 Gilman Dr, La Jolla, CA 92093 USA	Johns Hopkins University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Diego; Virginia Mason Medical Center; American College of Physicians; Johns Hopkins University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Diego	Lehmann, LS (corresponding author), Amer Coll Physicians, Ctr Eth & Profess, 190 N Independence Mall West, Philadelphia, PA 19106 USA.; Lehmann, LS (corresponding author), Vet Hlth Adm, Natl Ctr Eth Hlth Care, 810 Vermont Ave, Washington, DC 20420 USA.	lsnyder@acponline.org			ACP	ACP	Financial support for the development of this paper comes exclusively from the ACP operating budget.	Abedini NC, 2012, ACAD MED, V87, P820, DOI 10.1097/ACM.0b013e31825396d8; Al-Samarrai T, 2011, HEALTH AFFAIR, V30, P525, DOI 10.1377/hlthaff.2010.0842; AmeriCares, 2013, LIT REV; Anderson KC, 2012, ACAD MED, V87, P206, DOI 10.1097/ACM.0b013e31823e23d4; [Anonymous], 2011, GUID MED DON; Arya AN., 2017, PREPARING INT HLTH E; Asgary R, 2013, J MED ETHICS, V39, P625, DOI 10.1136/medethics-2011-100488; Baker R, 2001, CAMB Q HEALTHC ETHIC, V10, P241, DOI 10.1017/S0963180101003048; Benatar SR, 2005, PLOS MED, V2, P587, DOI 10.1371/journal.pmed.0020143; Bender A, 2013, MED TEACH, V35, pE1027, DOI 10.3109/0142159X.2012.733449; Boston University, PRACT GUID GLOB HLTH; Caldron PH, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1929-x; Caldron PH, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0183-7; Caldron PH, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0980-3; Cantrell L, 2012, ARCH INTERN MED, V172, P1685, DOI 10.1001/archinternmed.2012.4501; Child Family Health International, 2017, CHOOS INT EL ROADM Y; Consortium of Universities for Global Health, GLOB HLTH TRAIN MOD; Creaton A, 2016, NEW ENGL J MED, V375, P1820, DOI 10.1056/NEJMp1608837; Crump JA, 2008, JAMA-J AM MED ASSOC, V300, P1456, DOI 10.1001/jama.300.12.1456; Crump JA, 2010, AM J TROP MED HYG, V83, P1178, DOI 10.4269/ajtmh.2010.10-0527; Decamp M, 2007, HASTINGS CENT REP, V37, P21, DOI 10.1353/hcr.2007.0096; DeCamp M, 2014, GLOB PUBLIC HEALTH, V9, P411, DOI 10.1080/17441692.2014.893368; DeCamp M, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-5; DeCamp M, 2011, HEC FORUM, V23, P91, DOI 10.1007/s10730-011-9152-y; Dell EM, 2014, INT J MED EDUC, V5, P63, DOI 10.5116/ijme.5334.8051; Dowell J, 2009, MED EDUC, V43, P121, DOI 10.1111/j.1365-2923.2008.03253.x; Einterz RM, 2007, ACAD MED, V82, P812, DOI 10.1097/ACM.0b013e3180cc29f1; Elansary M, 2015, MEDEDPORTAL PUBL, V11, P10232, DOI [10.15766/mep_2374-8265.10232, DOI 10.15766/MEP_2374-8265.10232]; Elit L, 2011, MED EDUC, V45, P704, DOI 10.1111/j.1365-2923.2011.03936.x; Evert J, 2014, DEV GLOBAL HLTH PROG; Farnan JM, 2013, ANN INTERN MED, V158, P620, DOI 10.7326/0003-4819-158-8-201304160-00100; Finklestein C., AM MED ASS STEPS FOR; Fisher QA, 2014, ANESTH ANALG, V118, P448, DOI 10.1213/ANE.0000000000000053; Greysen SR, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-19; Gupta AR, 1999, AM J TROP MED HYG, V61, P1019, DOI 10.4269/ajtmh.1999.61.1019; Hamric AB, 2014, J HOSP PALLIAT NURS, V16, P457, DOI 10.1097/NJH.0000000000000104; Harrison JD, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4030043; Hayward A., 2012, MED MISSIONS THERE I; Hunt MR, 2013, PREHOSP DISASTER MED, V28, P502, DOI 10.1017/S1049023X13008698; Imperato PJ, 1996, J COMMUN HEALTH, V21, P241, DOI 10.1007/BF01794876; International Medical Corps, 2016, INT MED CORPS COD CO; Jogerst K, 2015, ANN GLOB HEALTH, V81, P239, DOI 10.1016/j.aogh.2015.03.006; Khan OA, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-3; Koplan JP, 2009, LANCET, V373, P1993, DOI 10.1016/S0140-6736(09)60332-9; Kumwenda B, 2014, MED EDUC, V48, P593, DOI 10.1111/medu.12477; Kung TH, 2016, MED EDUC, V50, P1122, DOI 10.1111/medu.13106; Lahey T, 2012, ACAD MED, V87, P210, DOI 10.1097/ACM.0b013e31823f3fb1; Lasker JN, 2016, HOPING HELP PROMISES; Leppin AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111420; Logar T, 2015, J BIOETHIC INQ, V12, P69, DOI 10.1007/s11673-014-9603-7; Loh LC, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0135-7; Loh LC, 2015, J BIOETHIC INQ, V12, P129, DOI 10.1007/s11673-014-9591-7; Maki J, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-121; McKinley DW, 2008, ACAD MED, V83, pS53, DOI 10.1097/ACM.0b013e318183e351; Medical School Graduation Questionnaire, 2016, MED SCH GRAD QUEST 2; Medical Teams International, TEAM COD ETH COND; Melby MK, 2016, ACAD MED, V91, P633, DOI 10.1097/ACM.0000000000001009; Merson MH, 2014, NEW ENGL J MED, V370, P1676, DOI 10.1056/NEJMp1401124; Mitchell KB, 2012, S AFR J SURG, V50, P2; Montgomery L. M., 1993, MISSIOLOGY, V21, P333, DOI [10.1177/009182969302100305, DOI 10.1177/009182969302100305]; Mutchnick IS, 2003, ACAD MED, V78, pS1, DOI 10.1097/00001888-200310001-00002; Nelson Brett, 2012, J Grad Med Educ, V4, P184, DOI 10.4300/JGME-D-11-00214.1; Ott BB, 2011, HEC FORUM, V23, P105, DOI 10.1007/s10730-011-9154-9; Pinto AD, 2009, DEV WORLD BIOETH, V9, P1, DOI 10.1111/j.1471-8847.2007.00209.x; Provenzano AM, 2010, AM J TROP MED HYG, V83, P211, DOI 10.4269/ajtmh.2010.09-0692; Purkey E, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0675-4; Rahim A, 2016, MED TEACH, V38, P911, DOI 10.3109/0142159X.2015.1132832; Ramsey AH, 2004, FAM MED, V36, P412; Roberts M, 2006, JAMA-J AM MED ASSOC, V295, P1491, DOI 10.1001/jama.295.13.1491; Roche SD, 2017, INT J PUBLIC HEALTH, V62, P31, DOI 10.1007/s00038-016-0889-6; Shaywitz DA, 2002, AM J MED, V113, P354, DOI 10.1016/S0002-9343(02)01307-4; Snyder L, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-1-201201031-00001; Stone GS, 2016, MED CLIN N AM, V100, P237, DOI 10.1016/j.mcna.2015.09.001; Sykes KJ, 2014, AM J PUBLIC HEALTH, V104, pE38, DOI 10.2105/AJPH.2014.301983; Thompson MJ, 2003, ACAD MED, V78, P342, DOI 10.1097/00001888-200303000-00023; Unite for Sight, 2015, CERT GLOB HLTH; University of Minnesota, GLOB AMB PAT SAF TOO; Waal AE, 2012, ETHICS INT MED PRACT; White M, 2014, DEV WORLD BIOETH, V14, P111, DOI 10.1111/dewb.12000; Wilson JW, 2012, AM J MED, V125, P612, DOI 10.1016/j.amjmed.2012.01.008; Wolfberg AJ, 2006, NEW ENGL J MED, V354, P443, DOI 10.1056/NEJMp058220; World Medical Association, 2017, WMA STAT ETH CONS GL	82	34	34	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2018	168	9					651	+		10.7326/M17-3361	http://dx.doi.org/10.7326/M17-3361			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GI3BZ	29582076				2022-12-28	WOS:000434247300007
J	Ramaekers, JG				Ramaekers, Johannes G.			Driving Under the Influence of Cannabis An Increasing Public Health Concern	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PERFORMANCE; ALCOHOL		[Ramaekers, Johannes G.] Maastricht Univ, Fac Psychol & Neurosci, POB 616, NL-6200 MD Maastricht, Netherlands	Maastricht University	Ramaekers, JG (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, POB 616, NL-6200 MD Maastricht, Netherlands.	j.ramaekers@maastrichtuniversity.nl						Bosker WM, 2012, ADDICTION, V107, P1837, DOI 10.1111/j.1360-0443.2012.03928.x; Broyd SJ, 2016, BIOL PSYCHIAT, V79, P557, DOI 10.1016/j.biopsych.2015.12.002; Compton WM, 2017, JAMA PSYCHIAT, V74, P559, DOI 10.1001/jamapsychiatry.2017.0723; Gjerde H, 2016, ADDICTION, V111, P1492, DOI 10.1111/add.13435; Hartman RL, 2013, CLIN CHEM, V59, P478, DOI 10.1373/clinchem.2012.194381; Ramaekers JG, 2000, HUM PSYCHOPHARM CLIN, V15, P551, DOI 10.1002/1099-1077(200010)15:7<551::AID-HUP236>3.0.CO;2-P; Sewell RA, 2009, AM J ADDICTION, V18, P185, DOI 10.1080/10550490902786934; World Health Organization, 2016, DRUG US ROAD SAF POL	8	34	34	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 10	2018	319	14					1433	1434		10.1001/jama.2018.1334	http://dx.doi.org/10.1001/jama.2018.1334			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GC2CR	29582068				2022-12-28	WOS:000429590200010
J	Keene, DJ; Lamb, SE; Mistry, D; Tutton, E; Lall, R; Handley, R; Willett, K				Keene, David J.; Lamb, Sarah E.; Mistry, Dipesh; Tutton, Elizabeth; Lall, Ranjit; Handley, Robert; Willett, Keith		Ankle Injury Management AIM	Three-Year Follow-up of a Trial of Close Contact Casting vs Surgery for Initial Treatment of Unstable Ankle Fractures in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Keene, David J.; Lamb, Sarah E.; Willett, Keith] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Mistry, Dipesh; Lall, Ranjit] Univ Warwick, Warwick Clin Trials Unit, Coventry, W Midlands, England; [Tutton, Elizabeth] Univ Warwick, Warwick Res Nursing, Coventry, W Midlands, England; [Handley, Robert] Oxford Univ Hosp Natl Hlth Serv Fdn Trust, John Radcliffe Hosp, Oxford, England	University of Oxford; University of Warwick; University of Warwick; Oxford University Hospitals NHS Foundation Trust; University of Oxford	Keene, DJ (corresponding author), John Radcliffe Hosp, Kadoorie Ctr Crit Care Res & Educ, Level 3, Oxford OX3 9DU, England.	david.keene@ndorms.ox.ac.uk	Keene, David/P-9055-2019	Keene, David/0000-0001-7249-6496; Lall, Ranjit/0000-0003-1737-2866; Tutton, Elizabeth/0000-0003-3973-360X; Lamb, Sarah/0000-0003-4349-7195	Ankle Injury Management (AIM) - NIHR HTA program [07/37/61]; NIHR Biomedical Research Centre, Oxford; NIHR postdoctoral fellowship program [PDF-2016-09-056]; NIHR Collaboration for Leadership in Applied Health Research and Care Oxford at Oxford Health National Health Service (NHS) Foundation Trust	Ankle Injury Management (AIM) - NIHR HTA program; NIHR Biomedical Research Centre, Oxford(National Institute for Health Research (NIHR)); NIHR postdoctoral fellowship program; NIHR Collaboration for Leadership in Applied Health Research and Care Oxford at Oxford Health National Health Service (NHS) Foundation Trust	The Ankle Injury Management (AIM) trial was funded by the NIHR HTA program (project number 07/37/61). This article was supported by the NIHR Biomedical Research Centre, Oxford, and NIHR postdoctoral fellowship program (Dr Keene; PDF-2016-09-056). Dr Lamb receives funding from the NIHR Collaboration for Leadership in Applied Health Research and Care Oxford at Oxford Health National Health Service (NHS) Foundation Trust.	Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; OLERUD C, 1984, ARCH ORTHOP TRAUM SU, V103, P190, DOI 10.1007/BF00435553; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Sanders DW, 2016, JAMA-J AM MED ASSOC, V316, P1451, DOI 10.1001/jama.2016.14819; Willett K, 2016, JAMA-J AM MED ASSOC, V316, P1455, DOI 10.1001/jama.2016.14719	5	15	15	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2018	319	12					1274	1276		10.1001/jama.2018.0811	http://dx.doi.org/10.1001/jama.2018.0811			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GA5VW	29584832	Green Submitted, Green Published			2022-12-28	WOS:000428403000021
J	Rubin, R				Rubin, Rita			NIH Releases Data from Large Adolescent Brain Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item													Rubin, Rita/AAD-1259-2020						0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2018	319	12					1189	1189		10.1001/jama.2018.2352	http://dx.doi.org/10.1001/jama.2018.2352			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GA5VW	29584826				2022-12-28	WOS:000428403000003
J	June, CH; O'Connor, RS; Kawalekar, OU; Ghassemi, S; Milone, MC				June, Carl H.; O'Connor, Roddy S.; Kawalekar, Omkar U.; Ghassemi, Saba; Milone, Michael C.			CAR T cell immunotherapy for human cancer	SCIENCE			English	Review							CHIMERIC-ANTIGEN-RECEPTOR; CD19; REGRESSION; RECOGNITION; REMISSIONS; EXPRESSION; TOXICITY; THERAPY; PERSISTENCE; SENSITIVITY	Adoptive T cell transfer (ACT) is a new area of transfusion medicine involving the infusion of lymphocytes to mediate antitumor, antiviral, or anti-inflammatory effects. The field has rapidly advanced from a promising form of immuno-oncology in preclinical models to the recent commercial approvals of chimeric antigen receptor (CAR) T cells to treat leukemia and lymphoma. This Review describes opportunities and challenges for entering mainstream oncology that presently face the CAR T field, with a focus on the challenges that have emerged over the past several years.	[June, Carl H.; O'Connor, Roddy S.; Kawalekar, Omkar U.; Ghassemi, Saba; Milone, Michael C.] Perlman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA; [June, Carl H.; O'Connor, Roddy S.; Ghassemi, Saba] Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA; [June, Carl H.; Milone, Michael C.] Perlman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania	June, CH (corresponding author), Perlman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA.; June, CH (corresponding author), Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA.; June, CH (corresponding author), Perlman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	cjune@exchange.upenn.edu		Ghassemi, Saba/0000-0002-2415-3576; Milone, Michael/0000-0002-1580-9844	NIH [RO1CA226983, 5R01CA165206, 1P01CA214278]; NATIONAL CANCER INSTITUTE [P01CA214278, R01CA226983, R01CA165206] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants RO1CA226983 (C.H.J.), 5R01CA165206 (C.H.J.), and 1P01CA214278 (M.C.M.). We apologize that because of space constraints, we were unable to cite many studies.	Ahmed N, 2015, J CLIN ONCOL, V33, P1688, DOI 10.1200/JCO.2014.58.0225; Aleksic M, 2012, EUR J IMMUNOL, V42, P3174, DOI 10.1002/eji.201242606; Ali SA, 2016, BLOOD, V128, P1688, DOI 10.1182/blood-2016-04-711903; Barrett DM, 2014, CURR OPIN PEDIATR, V26, P43, DOI 10.1097/MOP.0000000000000043; Bhoj VG, 2016, BLOOD, V128, P360, DOI 10.1182/blood-2016-01-694356; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brown CE, 2016, NEW ENGL J MED, V375, P2561, DOI 10.1056/NEJMoa1610497; Cameron BJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006034; Caruso HG, 2015, CANCER RES, V75, P3505, DOI 10.1158/0008-5472.CAN-15-0139; Charlesworth CT, 2018, BIORXIV, DOI [10.1101/243345, DOI 10.1101/243345]; Chen Q, 2017, J CLIN ONCOL, V35, P166, DOI 10.1200/JCO.2016.68.2856; Chion-Sotinel I, 2015, BLOOD, V126, P116; Davenport AJ, 2015, CANCER IMMUNOL RES, V3, P483, DOI 10.1158/2326-6066.CIR-15-0048; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Fry TJ, 2018, NAT MED, V24, P20, DOI 10.1038/nm.4441; Garfall AL, 2015, NEW ENGL J MED, V373, P1040, DOI 10.1056/NEJMoa1504542; Garrido F, 2016, CURR OPIN IMMUNOL, V39, P44, DOI 10.1016/j.coi.2015.12.007; Gornalusse GG, 2017, NAT BIOTECHNOL, V35, P765, DOI 10.1038/nbt.3860; GROSS G, 1989, P NATL ACAD SCI USA, V86, P10024, DOI 10.1073/pnas.86.24.10024; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Gust J, 2017, CANCER DISCOV, V7, P1404, DOI 10.1158/2159-8290.CD-17-0698; Hettle R, 2017, HEALTH TECHNOL ASSES, V21, P1, DOI 10.3310/hta21070; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Joyce JA, 2015, SCIENCE, V348, P74, DOI 10.1126/science.aaa6204; June CH, 2017, NAT MED, V23, P540, DOI 10.1038/nm.4321; June CH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3643; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kloss CC, 2013, NAT BIOTECHNOL, V31, P71, DOI 10.1038/nbt.2459; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Kochenderfer JN, 2010, BLOOD, V116, P4099, DOI 10.1182/blood-2010-04-281931; KUWANA Y, 1987, BIOCHEM BIOPH RES CO, V149, P960, DOI 10.1016/0006-291X(87)90502-X; Lamers CHJ, 2013, MOL THER, V21, P904, DOI 10.1038/mt.2013.17; Levine BL, 2013, NATURE, V498, pS17, DOI 10.1038/498S17a; Lim WA, 2017, CELL, V168, P724, DOI 10.1016/j.cell.2017.01.016; Marotta M, 2017, SCI REP-UK, V7, DOI 10.1038/srep41921; Maude SL, 2018, NEW ENGL J MED, V378, P439, DOI 10.1056/NEJMoa1709866; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Morgan RA, 2013, J IMMUNOTHER, V36, P133, DOI 10.1097/CJI.0b013e3182829903; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Neumann PJ, 2015, NEW ENGL J MED, V373, P2595, DOI 10.1056/NEJMp1512009; O'Rourke DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaa0984; Porter DL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5415; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Postow MA, 2018, NEW ENGL J MED, V378, P158, DOI [10.1056/NEJMra1703481, 10.1056/NEJMc1801663]; Qasim W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj2013; Rapoport AP, 2015, NAT MED, V21, P914, DOI 10.1038/nm.3910; Richman SA, 2018, CANCER IMMUNOL RES, V6, P36, DOI 10.1158/2326-6066.CIR-17-0211; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Roybal KT, 2016, CELL, V164, P770, DOI 10.1016/j.cell.2016.01.011; Scholler J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003761; Sommermeyer D, 2017, LEUKEMIA, V31, P2191, DOI 10.1038/leu.2017.57; Sotillo E, 2015, CANCER DISCOV, V5, P1282, DOI 10.1158/2159-8290.CD-15-1020; Srivastava S, 2015, TRENDS IMMUNOL, V36, P494, DOI 10.1016/j.it.2015.06.004; Stone JD, 2012, ONCOIMMUNOLOGY, V1, P863, DOI 10.4161/onci.20592; Tan MP, 2015, CLIN EXP IMMUNOL, V180, P255, DOI 10.1111/cei.12570; Thistlethwaite FC, 2017, CANCER IMMUNOL IMMUN, V66, P1425, DOI 10.1007/s00262-017-2034-7; Torikai H, 2012, BLOOD, V119, P5697, DOI 10.1182/blood-2012-01-405365; van Zelm MC, 2006, NEW ENGL J MED, V354, P1901, DOI 10.1056/NEJMoa051568; Verdegaal EME, 2016, NATURE, V536, P91, DOI 10.1038/nature18945; Wang XL, 2016, BLOOD, V127, P2980, DOI 10.1182/blood-2015-12-686725; Zakrzewski JL, 2008, NAT BIOTECHNOL, V26, P453, DOI 10.1038/nbt1395	65	1263	1326	139	1072	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2018	359	6382			SI		1361	1365		10.1126/science.aar6711	http://dx.doi.org/10.1126/science.aar6711			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA0ZG	29567707				2022-12-28	WOS:000428043600038
J	Zitvogel, L; Ma, YT; Raoult, D; Kroemer, G; Gajewski, TF				Zitvogel, Laurence; Ma, Yuting; Raoult, Didier; Kroemer, Guido; Gajewski, Thomas F.			The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies	SCIENCE			English	Review							FUSOBACTERIUM-NUCLEATUM; COLORECTAL-CANCER; GUT MICROBIOTA; INTESTINAL MICROBIOTA; ENTEROCOCCUS-HIRAE; RESISTANCE; ANTITUMOR; IMMUNITY; BACTERIA; DISEASE	The fine line between human health and disease can be driven by the interplay between host and microbial factors. This "metagenome" regulates cancer initiation, progression, and response to therapies. Besides the capacity of distinct microbial species to modulate the pharmacodynamics of chemotherapeutic drugs, symbiosis between epithelial barriers and their microbial ecosystems has a major impact on the local and distant immune system, markedly influencing clinical outcome in cancer patients. Efficacy of cancer immunotherapy with immune checkpoint antibodies can be diminished with administration of antibiotics, and superior efficacy is observed with the presence of specific gut microbes. Future strategies of precision medicine will likely rely on novel diagnostic and therapeutic tools with which to identify and correct defects in the microbiome that compromise therapeutic efficacy.	[Zitvogel, Laurence] GRCC, Equipe Labellisee Ligue Natl Canc, Villejuif, France; [Zitvogel, Laurence] INSERM, U1015, Villejuif, France; [Zitvogel, Laurence] Univ Paris Sud, Univ Paris Saclay, Gustave Roussy, Villejuif, France; [Zitvogel, Laurence] Ctr Clin Invest Biotherapies Canc CICBT 1428, Villejuif, France; [Ma, Yuting] Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing 100005, Peoples R China; [Ma, Yuting] Peking Union Med Coll, Beijing 100005, Peoples R China; [Ma, Yuting] Suzhou Inst Syst Med, Suzhou 215123, Jiangsu, Peoples R China; [Raoult, Didier] Aix Marseille Univ, Unite Rech Malad Infect & Trop Emergentes, Inst Hosp Univ IHU Mediterranee Infect, UM63,CNRS 7278,IRD 198,INSERM 1095, 19-21 Blvd Jean Moulin, F-13005 Marseille, France; [Kroemer, Guido] Univ Paris 05, Univ Pierre & Marie Curie, Ctr Rech Cordeliers, Sorbonne Paris Cite, Paris, France; [Kroemer, Guido] GRCC, Metabol & Cell Biol Platforms, Villejuif, France; [Kroemer, Guido] Equipe 11 Labellisee Ligue Natl Canc, UMRS 1138, Paris, France; [Gajewski, Thomas F.] Univ Chicago, Dept Med, Dept Pathol, Chicago, IL 60615 USA; [Gajewski, Thomas F.] Univ Chicago, Ben May Dept Canc, Chicago, IL 60615 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of Chicago; University of Chicago	Zitvogel, L (corresponding author), GRCC, Equipe Labellisee Ligue Natl Canc, Villejuif, France.; Zitvogel, L (corresponding author), INSERM, U1015, Villejuif, France.; Zitvogel, L (corresponding author), Univ Paris Sud, Univ Paris Saclay, Gustave Roussy, Villejuif, France.; Zitvogel, L (corresponding author), Ctr Clin Invest Biotherapies Canc CICBT 1428, Villejuif, France.; Gajewski, TF (corresponding author), Univ Chicago, Dept Med, Dept Pathol, Chicago, IL 60615 USA.; Gajewski, TF (corresponding author), Univ Chicago, Ben May Dept Canc, Chicago, IL 60615 USA.	laurence.zitvogel@gustaveroussy.fr; tgajewsk@medicine.bsd.uchicago.edu	KROEMER, Guido/B-4263-2013; Kroemer, Guido/AAY-9859-2020; RAOULT, Didier/A-8434-2008	KROEMER, Guido/0000-0002-9334-4405; RAOULT, Didier/0000-0002-0633-5974; ZITVOGEL, laurence/0000-0003-1596-0998; Gajewski, Thomas/0000-0001-5727-3972	Ligue Contre le Cancer (Equipe Labelisee); Agence Nationale de la Recherche (ANR)-Projets blancs; ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases; Association pour la Recherche sur le Cancer (ARC); Canceropole Ile-de-France; Institut National du Cancer (INCa); Institut Universitaire de France; Fondation pour la Recherche Medicale (FRM); European Commission (ArtForce); European Research Council (ERC); LeDucq Foundation; LabEx Immuno-Oncology; Site de Recherche Integree sur le Cancer (SIRIC) Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); Recherche Hospitalo-Universitaire-LUMIERE; Seerave Foundation; Institut Suisse de Recherche Experimentale sur le Cancer (ISREC) Foundation; Swiss Foundation; Paris Alliance of Cancer Research Institutes (PACRI); Natural Science Foundation of China (NSFC) [81722037, 81671630]; China Ministry of Science and Technology (National key research and development program) [2017YFA0506200]; Natural Science Foundation of Jiangsu Province [BK20170006, BK20160379]; Chinese National Thousand Talents Program; Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine [CAMS-I2M, 2016-I2M-1-005]; Non-profit Central Research Institute Fund of CAMS [2016ZX310194, 2017NL31004, 2017RC31008]; French Ministery/IHU Mediterranee Infections; Team Science Award from the Melanoma Research Alliance [R35 CA210098]; American Cancer Society-Jules L. Plangere Jr. Family Foundation Professorship in Cancer Immunotherapy; University of Chicago Medicine Comprehensive Cancer Center; Institutional Training Grant [T32 CA009594]; Center for Research Informatics of The University of Chicago Biological Science Division; Roche-Genentech; BMS; Merck; Incyte; Seattle Genetics; Ono	Ligue Contre le Cancer (Equipe Labelisee)(Ligue nationale contre le cancer); Agence Nationale de la Recherche (ANR)-Projets blancs(French National Research Agency (ANR)); ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Canceropole Ile-de-France(Region Ile-de-France); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Institut Universitaire de France; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); European Commission (ArtForce)(European CommissionEuropean Commission Joint Research Centre); European Research Council (ERC)(European Research Council (ERC)); LeDucq Foundation(Leducq Foundation); LabEx Immuno-Oncology; Site de Recherche Integree sur le Cancer (SIRIC) Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); Recherche Hospitalo-Universitaire-LUMIERE; Seerave Foundation; Institut Suisse de Recherche Experimentale sur le Cancer (ISREC) Foundation; Swiss Foundation(Swiss National Science Foundation (SNSF)); Paris Alliance of Cancer Research Institutes (PACRI); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China Ministry of Science and Technology (National key research and development program); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Chinese National Thousand Talents Program; Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine; Non-profit Central Research Institute Fund of CAMS; French Ministery/IHU Mediterranee Infections; Team Science Award from the Melanoma Research Alliance; American Cancer Society-Jules L. Plangere Jr. Family Foundation Professorship in Cancer Immunotherapy; University of Chicago Medicine Comprehensive Cancer Center; Institutional Training Grant; Center for Research Informatics of The University of Chicago Biological Science Division; Roche-Genentech(Roche HoldingGenentech); BMS(Bristol-Myers Squibb); Merck(Merck & Company); Incyte; Seattle Genetics; Ono	L.Z. and G.K. were supported by the Ligue Contre le Cancer (Equipe Labelisee); Agence Nationale de la Recherche (ANR)-Projets blancs; ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases; Association pour la Recherche sur le Cancer (ARC); Canceropole Ile-de-France; Institut National du Cancer (INCa); Institut Universitaire de France; Fondation pour la Recherche Medicale (FRM); the European Commission (ArtForce); the European Research Council (ERC); the LeDucq Foundation; the LabEx Immuno-Oncology; the Site de Recherche Integree sur le Cancer (SIRIC) Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); the SIRIC Cancer Research and Personalized Medicine (CARPEM); Recherche Hospitalo-Universitaire-LUMIERE; the Seerave Foundation; Institut Suisse de Recherche Experimentale sur le Cancer (ISREC) Foundation; Swiss Foundation; the Paris Alliance of Cancer Research Institutes (PACRI); and philanthropy (from E. Badinter and N. Meyer). L.Z. is inventor on patent EP17305206 and European license 16306779.6 held by Institut Gustave Roussy that covers use of microbial modulators for anti-PD1/PD-L1/PD-L2 antibody-based treatments. Y.M. is supported by the Natural Science Foundation of China (NSFC, grants 81722037 and 81671630), China Ministry of Science and Technology (National key research and development program, grant 2017YFA0506200), Natural Science Foundation of Jiangsu Province (grants BK20170006 and BK20160379), Chinese National Thousand Talents Program, Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine (grants CAMS-I2M and 2016-I2M-1-005), and the Non-profit Central Research Institute Fund of CAMS (grants 2016ZX310194, 2017NL31004, and 2017RC31008). D.R. is supported by the French Ministery/IHU Mediterranee Infections. T.G. was supported by Team Science Award R35 CA210098 from the Melanoma Research Alliance, the American Cancer Society-Jules L. Plangere Jr. Family Foundation Professorship in Cancer Immunotherapy, and funds from the University of Chicago Medicine Comprehensive Cancer Center; by Institutional Training Grant T32 CA009594, and from The Center for Research Informatics of The University of Chicago Biological Science Division. T.F.G. is an advisory board member for Roche-Genentech, Merck, Abbvie, Bayer, Aduro, and Fog Pharma. T.F.G. receives research support from Roche-Genentech, BMS, Merck, Incyte, Seattle Genetics, and Ono. T.F.G. is a shareholder/cofounder of Jounce Therapeutics. L.Z., D.R., and G.K. are shareholders/founders of everImmune. The University of Chicago holds a licensing arrangement with Evelo. T.F.G. is an inventor on patent 15/170,284 submitted by the University of Chicago that covers the use of microbiota to improve cancer immunotherapy.	Alang N, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv004; Arthur JC, 2013, SCI REP-UK, V3, DOI 10.1038/srep02868; Balachandran VP, 2017, NATURE, V551, P512, DOI 10.1038/nature24462; Banna GL, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00603; Belkaid Y, 2013, NAT IMMUNOL, V14, P646, DOI 10.1038/ni.2604; Bindels LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131009; Blanton LV, 2016, SCIENCE, V351, DOI 10.1126/science.aad3311; Bullman S, 2017, SCIENCE, V358, P1443, DOI 10.1126/science.aal5240; Bultman SJ, 2016, SEMIN ONCOL, V43, P97, DOI 10.1053/j.seminoncol.2015.09.001; Caballero S, 2017, CELL HOST MICROBE, V21, P592, DOI 10.1016/j.chom.2017.04.002; Chaput N, 2017, ANN ONCOL, V28, P1368, DOI 10.1093/annonc/mdx108; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Daillere R, 2016, IMMUNITY, V45, P931, DOI 10.1016/j.immuni.2016.09.009; de Vos WM, 2012, NUTR REV, V70, pS45, DOI 10.1111/j.1753-4887.2012.00505.x; Dubin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10391; Dzutsev A, 2017, ANNU REV IMMUNOL, V35, P199, DOI 10.1146/annurev-immunol-051116-052133; Enache-Angoulvant A, 2005, CLIN INFECT DIS, V41, P1559, DOI 10.1086/497832; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Geller LT, 2017, SCIENCE, V357, P1156, DOI 10.1126/science.aah5043; Geva-Zatorsky N, 2017, CELL, V168, P928, DOI 10.1016/j.cell.2017.01.022; Gopalakrishnan V., 2017, SCIENCE, V358; Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010; Hanninen A, 2018, GUT, V67, P1445, DOI 10.1136/gutjnl-2017-314508; Huang HC, 2011, ARCH DERMATOL RES, V303, P527, DOI 10.1007/s00403-011-1135-y; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jenq RR, 2015, BIOL BLOOD MARROW TR, V21, P1373, DOI 10.1016/j.bbmt.2015.04.016; Joglekar P, 2017, CELL, V169, P378, DOI 10.1016/j.cell.2017.04.009; Kang CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076520; Lagier JC, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.203, 10.1038/nmicrobiol.2016.203]; Lee SM, 2013, NATURE, V501, P426, DOI 10.1038/nature12447; LI J, 2016, P NATL ACAD SCI USA, V1306, pE130; Liang XJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04985; Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290; Moayyedi P, 2017, MED J AUSTRALIA, V207, P166, DOI 10.5694/mja17.00295; Nanjundappa RH, 2017, CELL, V171, P655, DOI 10.1016/j.cell.2017.09.022; Odamaki T, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/567809; Ottman N, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.01014-17; Pahle J, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3123-x; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Peled JU, 2017, J CLIN ONCOL, V35, P1650, DOI 10.1200/JCO.2016.70.3348; Pietrocola F, 2016, CANCER CELL, V30, P147, DOI 10.1016/j.ccell.2016.05.016; PLOVIER H, 2017, NAT MED, V107, pU113; Pluzanska A, 1985, Pol Arch Med Wewn, V73, P351; Pustelny C, 2015, INFECT IMMUN, V83, P417, DOI 10.1128/IAI.02234-14; Roberts NJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008982; Rosshart SP, 2017, CELL, V171, P1015, DOI 10.1016/j.cell.2017.09.016; ROSZKOWSKI K, 1985, J CANCER RES CLIN, V109, P72, DOI 10.1007/BF01884258; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Sato J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12535-9; Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Shen Y, 2012, CELL HOST MICROBE, V12, P509, DOI 10.1016/j.chom.2012.08.004; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Stappenbeck TS, 2016, NATURE, V534, P191, DOI 10.1038/nature18285; Steed AL, 2017, SCIENCE, V357, P498, DOI 10.1126/science.aam5336; TAKADA H, 1995, INFECT IMMUN, V63, P57, DOI 10.1128/IAI.63.1.57-65.1995; Takagi A, 2001, CARCINOGENESIS, V22, P599, DOI 10.1093/carcin/22.4.599; Takahashi T, 2001, J UROLOGY, V166, P2506, DOI 10.1016/S0022-5347(05)65625-X; Thaiss CA, 2016, CELL, V167, P1495, DOI 10.1016/j.cell.2016.11.003; Thiemann S, 2017, CELL HOST MICROBE, V21, P682, DOI 10.1016/j.chom.2017.05.005; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Venugopalan V, 2010, EMERG INFECT DIS, V16, P1661, DOI 10.3201/eid1611.100574; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Wang Y, 2014, GUT MICROBES, V5, P552, DOI 10.4161/gmic.29797; Wong SH, 2017, GASTROENTEROLOGY, V153, P1621, DOI 10.1053/j.gastro.2017.08.022; Yang YZ, 2017, GASTROENTEROLOGY, V152, P851, DOI 10.1053/j.gastro.2016.11.018; Yissachar N, 2017, CELL, V168, P1135, DOI 10.1016/j.cell.2017.02.009; Yu TC, 2017, CELL, V170, P548, DOI 10.1016/j.cell.2017.07.008; Zhang JY, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00521-14; Zitvogel L, 2017, NAT REV MICROBIOL, V15, P465, DOI 10.1038/nrmicro.2017.44	73	344	364	8	274	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2018	359	6382			SI		1366	1370		10.1126/science.aar6918	http://dx.doi.org/10.1126/science.aar6918			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA0ZG	29567708	Green Submitted			2022-12-28	WOS:000428043600039
J	Ard, KL; Kelly, HR; Gandhi, RT; Louissaint, A				Ard, Kevin L.; Kelly, Hillary R.; Gandhi, Rajesh T.; Louissaint, Abner, Jr.			Case 9-2018: A 55-Year-Old Man with HIV Infection and a Mass on the Right Side of the Face	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	11th Annual Workshop on Advanced Clinical Care - AIDS (AWACC)	SEP 06-07, 2017	Durban, SOUTH AFRICA				ACQUIRED-IMMUNODEFICIENCY-SYNDROME; IMMUNE RECONSTITUTION SYNDROME; PAROTID-GLAND SARCOIDOSIS; B-CELL LYMPHOMAS; ANTIRETROVIRAL THERAPY; BURKITT-LYMPHOMA; INITIATION; CANCER; AIDS; SIALADENITIS		[Ard, Kevin L.; Gandhi, Rajesh T.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Kelly, Hillary R.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Louissaint, Abner, Jr.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA USA; [Ard, Kevin L.; Gandhi, Rajesh T.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Kelly, Hillary R.] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Louissaint, Abner, Jr.] Harvard Med Sch, Dept Pathol, Boston, MA USA; [Kelly, Hillary R.] Massachusetts Eye & Ear, Dept Radiol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary	Ard, KL (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Ard, KL (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.			Kelly, Hillary/0000-0002-6655-8723	Harvard University Center for AIDS Research [NIH P30 AI060354]; Centre for the AIDS Programme of Research in South Africa; University of KwaZulu-Natal; South African HIV Clinicians Society; KwaZulu-Natal Department of Health; Gilead Sciences; Merck; ViiV HealthCare; Theratechnologies; EMD Serono	Harvard University Center for AIDS Research; Centre for the AIDS Programme of Research in South Africa; University of KwaZulu-Natal; South African HIV Clinicians Society; KwaZulu-Natal Department of Health; Gilead Sciences(Gilead Sciences); Merck(Merck & Company); ViiV HealthCare; Theratechnologies; EMD Serono	This case was presented at the 11th Annual Workshop on Advanced Clinical Care-AIDS in Durban, South Africa, organized by Drs. Henry Sunpath and Mahomed-Yunus S. Moosa (Infectious Diseases Unit, Nelson R Mandela School of Medicine, University of KwaZulu-Natal) and Dr. Rajesh T. Gandhi (Massachusetts General Hospital and the Ragon Institute) and sponsored by the Harvard University Center for AIDS Research (NIH P30 AI060354), the Centre for the AIDS Programme of Research in South Africa, the University of KwaZulu-Natal, the South African HIV Clinicians Society, and the KwaZulu-Natal Department of Health.; Dr. Gandhi reports receiving grant support (paid to Massachusetts General Hospital) from Gilead Sciences, Merck, and ViiV HealthCare, and consulting fees from Theratechnologies and EMD Serono. No other potential conflict of interest relevant to this article was reported.	Benson CA, 2003, CLIN INFECT DIS, V37, P1234, DOI 10.1086/378807; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cote TR, 1997, INT J CANCER, V73, P645, DOI 10.1002/(SICI)1097-0215(19971127)73:5&lt;645::AID-IJC6&gt;3.0.CO;2-X; Del Bono V, 2000, CLIN INFECT DIS, V30, P947, DOI 10.1086/313813; Dunleavy K, 2016, HEMATOL ONCOL CLIN N, V30, P1333, DOI 10.1016/j.hoc.2016.07.009; Dunleavy K, 2013, NEW ENGL J MED, V369, P1915, DOI 10.1056/NEJMoa1308392; Dutertre M, 2017, JAIDS-J ACQ IMM DEF, V76, pE23, DOI 10.1097/QAI.0000000000001397; Ghrenassia E, 2015, J AUTOIMMUN, V59, P19, DOI 10.1016/j.jaut.2015.01.010; Gittinger FS, 2008, J MED MICROBIOL, V57, P536, DOI 10.1099/jmm.0.47698-0; Gopal S, 2014, CLIN INFECT DIS, V59, P279, DOI 10.1093/cid/ciu270; Grant PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011416; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Hernandez-Ramirez RU, 2017, LANCET HIV, V4, pE495, DOI 10.1016/S2352-3018(17)30125-X; Howlader N, 2016, CANCER EPIDEM BIOMAR, V25, P1289, DOI 10.1158/1055-9965.EPI-16-0273; Huhn GD, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-44; Hviid A, 2008, LANCET, V371, P932, DOI 10.1016/S0140-6736(08)60419-5; James DG, 2000, SARCOIDOSIS VASC DIF, V17, P27; Kemp JE, 1922, ARCH DERMATOL SYPH, V6, P57, DOI 10.1001/archderm.1922.02360010060010; Kranick SM, 2015, HAEMATOLOGICA, V100, pE21, DOI 10.3324/haematol.2014.114736; Li W, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0698-y; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Mehanna H, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6794; Phillips P, 2005, CLIN INFECT DIS, V41, P1483, DOI 10.1086/497269; Pienkowska-Grela B, 2011, MED ONCOL, V28, P1589, DOI 10.1007/s12032-010-9614-0; RAAD II, 1990, REV INFECT DIS, V12, P591; Rangel ALCA, 2005, J ORAL PATHOL MED, V34, P407, DOI 10.1111/j.1600-0714.2005.00331.x; Riedel DJ, 2015, LEUK LYMPHOMA; Rudek MA, 2011, LANCET ONCOL, V12, P905, DOI 10.1016/S1470-2045(11)70056-0; Salaverria I, 2014, BLOOD, V123, P1187, DOI 10.1182/blood-2013-06-507996; Swerdlow SH, 2016, WHO CLASSIFICATION T; Torres HA, 2014, CLIN INFECT DIS, V59, P106, DOI 10.1093/cid/ciu174; Ungprasert P, 2016, JAMA OTOLARYNGOL, V142, P503, DOI 10.1001/jamaoto.2016.0061; Vishnu Prakash, 2015, Clin Lymphoma Myeloma Leuk, V15, pe23, DOI 10.1016/j.clml.2014.09.009; Wilson WH, 2002, BLOOD, V99, P2685, DOI 10.1182/blood.V99.8.2685; Yanik EL, 2013, CLIN INFECT DIS, V57, P756, DOI 10.1093/cid/cit369	35	3	3	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2018	378	12					1143	1152		10.1056/NEJMcpc1800321	http://dx.doi.org/10.1056/NEJMcpc1800321			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	FZ9OV	29562158				2022-12-28	WOS:000427942300012
J	Bhashyam, AR; Weaver, MJ				Bhashyam, Abhiram R.; Weaver, Michael J.			SPOT DIAGNOSIS Knee pain after a fall	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DISLOCATION; PATELLA		[Bhashyam, Abhiram R.] Harvard Combined Orthopaed Residency Program, Boston, MA 02114 USA; [Weaver, Michael J.] Brigham & Womens Hosp, Dept Orthopaed Surg, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Bhashyam, AR (corresponding author), Harvard Combined Orthopaed Residency Program, Boston, MA 02114 USA.	abhashyam@partners.org						Feneley R C, 1968, J Bone Joint Surg Br, V50, P653; FRANGAKIS EK, 1974, J BONE JOINT SURG AM, VA 56, P423, DOI 10.2106/00004623-197456020-00025; Megson M., 2011, BMJ CASE REP; Moore BR, 2015, RECOGNITION INITIAL; MURAKAMI Y, 1982, CLIN ORTHOP RELAT R, P137; Yuguero M, 2003, ORTHOPEDICS, V26, P517	6	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2018	360								k775	10.1136/bmj.k775	http://dx.doi.org/10.1136/bmj.k775			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB1LO	29567767				2022-12-28	WOS:000428812500007
J	Reischauer, S; Stone, OA; Villasenor, A; Chi, N; Jin, SW; Martin, M; Lee, MT; Fukuda, N; Marass, M; Witty, A; Fiddes, I; Kuo, T; Chung, WS; Salek, S; Lerrigo, R; Alsio, J; Luo, S; Tworus, D; Augustine, SM; Mucenieks, S; Nystedt, B; Giraldez, AJ; Schroth, GP; Andersson, O; Stainier, DYR				Reischauer, Sven; Stone, Oliver A.; Villasenor, Alethia; Chi, Neil; Jin, Suk-Won; Martin, Marcel; Lee, Miler T.; Fukuda, Nana; Marass, Michele; Witty, Alec; Fiddes, Ian; Kuo, Taiyi; Chung, Won-Suk; Salek, Sherveen; Lerrigo, Robert; Alsio, Jessica; Luo, Shujun; Tworus, Dominika; Augustine, Sruthy M.; Mucenieks, Sophie; Nystedt, Bjorn; Giraldez, Antonio J.; Schroth, Gary P.; Andersson, Olov; Stainier, Didier Y. R.			Cloche is a bHLH-PAS transcription factor that drives haemato-vascular specification (vol 535, pg 294, 2016)	NATURE			English	Correction													Reischauer, Sven/AAO-8900-2020; Chung, Won-Suk/B-9011-2016	Chung, Won-Suk/0000-0003-1060-9007; Stainier, Didier/0000-0002-0382-0026				Reischauer S, 2016, NATURE, V535, P294, DOI 10.1038/nature18614	1	0	0	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2018	555	7697					543	543		10.1038/nature25991	http://dx.doi.org/10.1038/nature25991			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ9NF	29565360	Bronze			2022-12-28	WOS:000427937900058
J	Wang, CC; Schmid, CH; Fielding, RA; Harvey, WF; Reid, KF; Price, LL; Driban, JB; Kalish, R; Rones, R; McAlindon, T				Wang, Chenchen; Schmid, Christopher H.; Fielding, Roger A.; Harvey, William F.; Reid, Kieran F.; Price, Lori Lyn; Driban, Jeffrey B.; Kalish, Robert; Rones, Ramel; McAlindon, Timothy			Effect of tai chi versus aerobic exercise for fibromyalgia: comparative effectiveness randomized controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHRONIC OPIOID USE; SELF-EFFICACY; IMPACT QUESTIONNAIRE; LIMITED ELDERS; 6-MINUTE WALK; MUSCLE POWER; PAIN; MANAGEMENT; ARTHRITIS; SYMPTOMS	OBJECTIVES To determine the effectiveness of tai chi interventions compared with aerobic exercise, a current core standard treatment in patients with fibromyalgia, and to test whether the effectiveness of tai chi depends on its dosage or duration. DESIGN Prospective, randomized, 52 week, single blind comparative effectiveness trial. SETTING Urban tertiary care academic hospital in the United States between March 2012 and September 2016. PARTICIPANTS 226 adults with fibromyalgia (as defined by the American College of Rheumatology 1990 and 2010 criteria) were included in the intention to treat analyses: 151 were assigned to one of four tai chi groups and 75 to an aerobic exercise group. INTERVENTIONS Participants were randomly assigned to either supervised aerobic exercise (24 weeks, twice weekly) or one of four classic Yang style supervised tai chi interventions (12 or 24 weeks, once or twice weekly). Participants were followed for 52 weeks. Adherence was rigorously encouraged in person and by telephone. MAIN OUTCOME MEASURES The primary outcome was change in the revised fibromyalgia impact questionnaire (FIQR) scores at 24 weeks compared with baseline. Secondary outcomes included changes of scores in patient's global assessment, anxiety, depression, self efficacy, coping strategies, physical functional performance, functional limitation, sleep, and health related quality of life. RESULTS FIQR scores improved in all five treatment groups, but the combined tai chi groups improved statistically significantly more than the aerobic exercise group in FIQR scores at 24 weeks (difference between groups=5.5 points, 95% confidence interval 0.6 to 10.4,P=0.03) and several secondary outcomes (patient's global assessment=0.9 points, 0.3 to 1.4, P=0.005; anxiety=1.2 points, 0.3 to 2.1, P=0.006; self efficacy=1.0 points, 0.5 to 1.6, P=0.0004; and coping strategies, 2.6 points, 0.8 to 4.3, P=0.005). Tai chi treatment compared with aerobic exercise administered with the same intensity and duration (24 weeks, twice weekly) had greater benefit (between group difference in FIQR scores=16.2 points, 8.7 to 23.6, P<0.001). The groups who received tai chi for 24 weeks showed greater improvements than those who received it for 12 weeks (difference in FIQR scores=9.6 points, 2.6 to 16.6,P=0.007). There was no significant increase in benefit for groups who received tai chi twice weekly compared with once weekly. Participants attended the tai chi training sessions more often than participants attended aerobic exercise. The effects of tai chi were consistent across all instructors. No serious adverse events related to the interventions were reported. CONCLUSION Tai chi mind-body treatment results in similar or greater improvement in symptoms than aerobic exercise, the current most commonly prescribed non-drug treatment, for a variety of outcomes for patients with fibromyalgia. Longer duration of tai chi showed greater improvement. This mind-body approach may be considered a therapeutic option in the multidisciplinary management of fibromyalgia.	[Wang, Chenchen; Harvey, William F.; Driban, Jeffrey B.; McAlindon, Timothy] Tufts Univ, Sch Med, Tufts Med Ctr, Ctr Complementary & Integrat Med, Boston, MA 02111 USA; [Wang, Chenchen; Harvey, William F.; Driban, Jeffrey B.; McAlindon, Timothy] Tufts Univ, Sch Med, Tufts Med Ctr, Div Rheumatol, Boston, MA 02111 USA; [Schmid, Christopher H.] Brown Univ, Sch Publ Hlth, Dept Biostat, Providence, RI 02912 USA; [Schmid, Christopher H.] Brown Univ, Sch Publ Hlth, Ctr Evidence Synth Hlth, Providence, RI 02912 USA; [Fielding, Roger A.; Reid, Kieran F.] Tufts Univ, Sch Med, Nutr Exercise Physiol & Sarcopenia Lab, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Price, Lori Lyn] Tufts Univ, Inst Clin Res & Hlth Policy Studies, Tufts Med Ctr, Tufts Clin & Translat Sci Inst, Boston, MA 02111 USA; [Kalish, Robert] Tufts Univ, Sch Med, Div Rheumatol, Tufts Med Ctr, Boston, MA 02111 USA; [Rones, Ramel] Ctr Mind Body Therapies, Boston, MA USA	Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University; Brown University; Brown University; Tufts University; United States Department of Agriculture (USDA); Tufts Medical Center; Tufts Medical Center; Tufts University	Wang, CC (corresponding author), Tufts Univ, Sch Med, Tufts Med Ctr, Ctr Complementary & Integrat Med, Boston, MA 02111 USA.; Wang, CC (corresponding author), Tufts Univ, Sch Med, Tufts Med Ctr, Div Rheumatol, Boston, MA 02111 USA.	cwang2@tuftsmedicalcenter.org	Driban, Jeffrey/H-3486-2019; Schmid, Christopher H./J-2398-2014	Driban, Jeffrey/0000-0001-6098-4273; Schmid, Christopher H./0000-0002-0855-5313	National Center for Complementary and Integrative Health of the National Institutes of Health (NIH) [R01AT006367, K24AT007323]; National Center for Research Resources, NIH [UL1 RR025752]; National Center for Advancing Translational Sciences, NIH [UL1TR000073, UL1TR001064]; US Department of Agriculture [58-1950-4-003]; Boston Claude D Pepper Older Americans Independence Center [1P30AG031679]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001064, UL1TR000073] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT006367] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K24AT007323] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG031679] Funding Source: NIH RePORTER	National Center for Complementary and Integrative Health of the National Institutes of Health (NIH); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, NIH; US Department of Agriculture(United States Department of Agriculture (USDA)); Boston Claude D Pepper Older Americans Independence Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Center for Complementary and Integrative Health of the National Institutes of Health (NIH, R01AT006367 and K24AT007323), the National Center for Research Resources, NIH (UL1 RR025752) and the National Center for Advancing Translational Sciences, NIH (UL1TR000073 and UL1TR001064). RAF and KRF are supported in part by supported by the US Department of Agriculture, under agreement No 58-1950-4-003 and the Boston Claude D Pepper Older Americans Independence Center (1P30AG031679). The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Complementary and Integrative Health of the National Institutes of Health. The organizations mentioned here did not have any role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Bean JF, 2002, J GERONTOL A-BIOL, V57, pM751, DOI 10.1093/gerona/57.11.M751; Beck A.T., 1996, MANUAL BECK DEPRESSI; Bennett RM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2783; Bennett RM, 2009, J RHEUMATOL, V36, P1304, DOI 10.3899/jrheum.081090; Bidonde J, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012700; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Bruce B, 2005, CLIN EXP RHEUMATOL, V23, pS163; Bruce B, 2005, CLIN EXP RHEUMATOL, V23, pS14; Buckhardt C, 2005, GUIDELINE MANAGEMENT; BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728; Busch AJ, 2008, J RHEUMATOL, V35, P1130; Busch AJ, 2011, CURR PAIN HEADACHE R, V15, P358, DOI 10.1007/s11916-011-0214-2; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Callahan D, 2007, AGING CLIN EXP RES, V19, P194, DOI 10.1007/bf03324689; Carson JW, 2010, PAIN, V151, P530, DOI 10.1016/j.pain.2010.08.020; Carville SF, 2008, ANN RHEUM DIS, V67, P536, DOI 10.1136/ard.2007.071522; Clark M, 2008, NASM ESSENTIALS PERS; Cohen S, NATO ASI SERIES D, V24; CSUKA M, 1985, AM J MED, V78, P77, DOI 10.1016/0002-9343(85)90465-6; Fitzcharles MA, 2011, AM J MED, V124, P955, DOI 10.1016/j.amjmed.2011.05.031; Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fries JF, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3461; Fries JF, 2009, J RHEUMATOL, V36, P2061, DOI 10.3899/jrheum.090358; Fries JF, 2009, J CLIN EPIDEMIOL, V62, P779, DOI 10.1016/j.jclinepi.2008.12.001; George SZ, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0509-2; Goldenberg D., 2009, CLIN MANAGEMENT FIBR; Goldenberg D., 2016, CHRONIC WIDESPREAD P; Goldenberg DL, 2004, JAMA-J AM MED ASSOC, V292, P2388, DOI 10.1001/jama.292.19.2388; Goldenberg DL, 2016, MAYO CLIN PROC, V91, P640, DOI 10.1016/j.mayocp.2016.02.002; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; Hauser W, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3002; Jones KD, 2012, CLIN RHEUMATOL, V31, P1205, DOI 10.1007/s10067-012-1996-2; Jones KD, 2009, RHEUM DIS CLIN N AM, V35, P373, DOI 10.1016/j.rdc.2009.05.004; Khoury B, 2013, CLIN PSYCHOL REV, V33, P763, DOI 10.1016/j.cpr.2013.05.005; King S, 1999, J RHEUMATOL, V26, P2233; Lauche R, 2013, COMPLEMENT THER MED, V21, P396, DOI 10.1016/j.ctim.2013.06.001; Lauche R, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/610615; Lee MS, 2008, CLIN RHEUMATOL, V27, P211, DOI 10.1007/s10067-007-0700-4; Lindell L, 2000, SCAND J PRIM HEALTH, V18, P149; LORIG K, 1989, ARTHRITIS RHEUM, V32, P37, DOI 10.1002/anr.1780320107; NIAMS, 1999, FIBR RES CHALL OPP N; Painter JT, 2013, CLIN THER, V35, P303, DOI 10.1016/j.clinthera.2013.02.003; Painter JT, 2013, JCR-J CLIN RHEUMATOL, V19, P72, DOI 10.1097/RHU.0b013e3182863447; Peng XM, 2015, CLIN J PAIN, V31, P7, DOI 10.1097/AJP.0000000000000079; Phillips K, 2011, BEST PRACT RES CL RH, V25, P141, DOI 10.1016/j.berh.2011.02.005; Porter LS, 2002, PAIN, V98, P169, DOI 10.1016/S0304-3959(02)00042-8; Ramel J, 2009, CURR RHEUMATOL REV, V5, P188, DOI 10.2174/157339709790192459; Resnick B, 2000, J GERONTOL B-PSYCHOL, V55, pS352, DOI 10.1093/geronb/55.6.S352; Rooks DS, 2007, ARCH INTERN MED, V167, P2192, DOI 10.1001/archinte.167.20.2192; ROSENSTIEL AK, 1983, PAIN, V17, P33, DOI 10.1016/0304-3959(83)90125-2; Shelby RA, 2014, SUPPORT CARE CANCER, V22, P2851, DOI 10.1007/s00520-014-2269-1; Stewart AL, 2001, MED SCI SPORT EXER, V33, P1126, DOI 10.1097/00005768-200107000-00010; Suzuki T, 2001, J AM GERIATR SOC, V49, P1161, DOI 10.1046/j.1532-5415.2001.49232.x; Wang CC, 2004, ARCH INTERN MED, V164, P493, DOI 10.1001/archinte.164.5.493; Wang CC, 2016, ANN INTERN MED, V165, P77, DOI 10.7326/M15-2143; Wang CC, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0548-x; Wang CC, 2010, NEW ENGL J MED, V363, P743, DOI 10.1056/NEJMoa0912611; Wang Chenchen, 2008, V52, P218, DOI 10.1159/000134302; Ware JE, 2009, SF 36 PHYS MENTAL HL; Wayne PM, 2008, J ALTERN COMPLEM MED, V14, P95, DOI 10.1089/acm.2007.7170A; WOLFE F, 1995, ARTHRITIS RHEUM-US, V38, P19, DOI 10.1002/art.1780380104; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 1997, ARTHRITIS RHEUM, V40, P1560, DOI 10.1002/art.1780400904; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	66	86	90	5	56	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 21	2018	360								k851	10.1136/bmj.k851	http://dx.doi.org/10.1136/bmj.k851			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GB1LG	29563100	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000428811700027
J	Rodriguez-Gutierrez, R; Montori, VM				Rodriguez-Gutierrez, Ren; Montori, Victor M.			Review: Adding a DPP-4 inhibitor to an SGLT-2 inhibitor reduces genital, but not genitourinary, tract infection	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Rodriguez-Gutierrez, Ren; Montori, Victor M.] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Rodriguez-Gutierrez, R (corresponding author), Mayo Clin, Rochester, MN 55905 USA.							Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Mulvihill EE, 2014, ENDOCR REV, V35, P992, DOI 10.1210/er.2014-1035; Musso G, 2012, ANN MED, V44, P375, DOI 10.3109/07853890.2011.560181; Peters AL, 2015, DIABETES CARE, V38, P1687, DOI 10.2337/dc15-0843; Rodriguez-Gutierrez R, 2016, LANCET DIABETES ENDO, V4, P706, DOI 10.1016/S2213-8587(15)00468-4; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	6	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2018	168	6					JC33	JC33		10.7326/ACPJC-2018-168-6-033	http://dx.doi.org/10.7326/ACPJC-2018-168-6-033			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ8AM	29554671				2022-12-28	WOS:000427827400010
J	[Anonymous]				[Anonymous]			Use of E-Cigarettes Among Smokers Who Plan to Quit After a Hospitalization	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2018	168	9					I24	I24		10.7326/P18-0004	http://dx.doi.org/10.7326/P18-0004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3BZ	29582082				2022-12-28	WOS:000434247300001
J	Mazer-Amirshahi, M; Fox, ER				Mazer-Amirshahi, Maryann; Fox, Erin R.			Saline Shortages - Many Causes, No Simple Solution	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mazer-Amirshahi, Maryann] MedStar Washington Hosp Ctr, Dept Emergency Med, Washington, DC 20010 USA; [Mazer-Amirshahi, Maryann] Georgetown Univ, Sch Med, Washington, DC 20057 USA; [Fox, Erin R.] Univ Utah Hlth, Dept Pharm, Salt Lake City, UT USA	MedStar Washington Hospital Center; Georgetown University; Utah System of Higher Education; University of Utah	Mazer-Amirshahi, M (corresponding author), MedStar Washington Hosp Ctr, Dept Emergency Med, Washington, DC 20010 USA.; Mazer-Amirshahi, M (corresponding author), Georgetown Univ, Sch Med, Washington, DC 20057 USA.							American Society of Health-System Pharmacists, 2017, SMALL VOL PAR SOL SH; Hick JL, 2014, NEW ENGL J MED, V370, P1573, DOI 10.1056/NEJMp1401833; Langreth R, 2017, BLOOMBERG BUSINESSWE; Scott Gottlieb M. D., 2018, NEWS RELEASE FOOD DR; Woodcock J, 2013, CLIN PHARMACOL THER, V93, P170, DOI 10.1038/clpt.2012.220	5	40	40	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 19	2018	378	16					1472	1475		10.1056/NEJMp1800347	http://dx.doi.org/10.1056/NEJMp1800347			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GD2EI	29561694	Bronze			2022-12-28	WOS:000430312500002
J	Palaferri, D; Todorov, Y; Bigioli, A; Mottaghizadeh, A; Gacemi, D; Calabrese, A; Vasanelli, A; Li, LH; Davies, AG; Linfield, EH; Kapsalidis, F; Beck, M; Faist, J; Sirtori, C				Palaferri, Daniele; Todorov, Yanko; Bigioli, Azzurra; Mottaghizadeh, Alireza; Gacemi, Djamal; Calabrese, Allegra; Vasanelli, Angela; Li, Lianhe; Davies, A. Giles; Linfield, Edmund H.; Kapsalidis, Filippos; Beck, Mattias; Faist, Jerome; Sirtori, Carlo			Room-temperature nine-mu m-wavelength photodetectors and GHz-frequency heterodyne receivers	NATURE			English	Article							INTERSUBBAND ABSORPTION; QUANTUM; DETECTORS; GAALAS	Room-temperature operation is essential for any optoelectronics technology that aims to provide low-cost, compact systems for widespread applications. A recent technological advance in this direction is bolometric detection for thermal imaging(1), which has achieved relatively high sensitivity and video rates (about 60 hertz) at room temperature. However, owing to thermally induced dark current, room-temperature operation is still a great challenge for semiconductor photodetectors targeting the wavelength band between 8 and 12 micrometres(2), and all relevant applications, such as imaging, environmental remote sensing and laser-based free-space communication(3-5), have been realized at low temperatures. For these devices, high sensitivity and high speed have never been compatible with high-temperature operation(6,7). Here we show that a long-wavelength (nine micrometres) infrared quantum-well photodetector(8) fabricated from a metamaterial made of sub-wavelength metallic resonators(9-12) exhibits strongly enhanced performance with respect to the state of the art up to room temperature. This occurs because the photonic collection area of each resonator is much larger than its electrical area, thus substantially reducing the dark current of the device(13). Furthermore, we show that our photonic architecture overcomes intrinsic limitations of the material, such as the drop of the electronic drift velocity with temperature(14,15), which constrains conventional geometries at cryogenic operation(6). Finally, the reduced physical area of the device and its increased responsivity allow us to take advantage of the intrinsic high-frequency response of the quantum detector(7) at room temperature. By mixing the frequencies of two quantum-cascade lasers(16) on the detector, which acts as a heterodyne receiver, we have measured a high-frequency signal, above four gigahertz (GHz). Therefore, these wide-band uncooled detectors could benefit technologies such as high-speed (gigabits per second) multichannel coherent data transfer(17) and high-precision molecular spectroscopy(18).	[Palaferri, Daniele; Todorov, Yanko; Bigioli, Azzurra; Mottaghizadeh, Alireza; Gacemi, Djamal; Calabrese, Allegra; Vasanelli, Angela; Sirtori, Carlo] Univ Paris Diderot, CNRS, Lab Mat & Phenomenes Quant, Sorbonne Paris Cite,UMS 7162, F-75013 Paris, France; [Li, Lianhe; Davies, A. Giles; Linfield, Edmund H.] Univ Leeds, Sch Elect & Elect Engn, Leeds LS2 9JT, W Yorkshire, England; [Kapsalidis, Filippos; Beck, Mattias; Faist, Jerome] ETH, Inst Quantum Elect, Auguste Piccard Hof 1, CH-8093 Zurich, Switzerland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Leeds; Swiss Federal Institutes of Technology Domain; ETH Zurich	Sirtori, C (corresponding author), Univ Paris Diderot, CNRS, Lab Mat & Phenomenes Quant, Sorbonne Paris Cite,UMS 7162, F-75013 Paris, France.	carlo.sirtori@univ-paris-diderot.fr	Faist, Jerome/A-7339-2013; Beck, Mattias/A-7959-2013	Faist, Jerome/0000-0003-4429-7988; Beck, Mattias/0000-0002-0260-5797; Vasanelli, Angela/0000-0003-1945-2261; Gacemi, Djamal/0000-0003-0334-1815; Sirtori, Carlo/0000-0003-1817-4554; Li, Lianhe/0000-0003-4998-7259	FP7 ITN NOTEDEV project [607521]; ERC grant ADEQUATE; French National Research Agency [ANR-16-CE24-0020]; EPSRC (UK) [EP/J017671/1, EP/P021859/1]; Royal Society; Wolfson Foundation; EPSRC [EP/P021859/1] Funding Source: UKRI	FP7 ITN NOTEDEV project; ERC grant ADEQUATE; French National Research Agency(French National Research Agency (ANR)); EPSRC (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); Wolfson Foundation; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge financial support from the FP7 ITN NOTEDEV project (grant number 607521), the ERC grant ADEQUATE, the French National Research Agency (ANR-16-CE24-0020 Project "hoUDINi") and the EPSRC (UK) projects COTS and HYPERTERAHERTZ (EP/J017671/1, EP/P021859/1). E.H.L. and A.G.D. acknowledge support from the Royal Society and the Wolfson Foundation and thank L. Chen for support with device processing.	Argence B, 2015, NAT PHOTONICS, V9, P456, DOI [10.1038/nphoton.2015.93, 10.1038/NPHOTON.2015.93]; Chen YN, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4862750; Corrigan P, 2009, OPT EXPRESS, V17, P4355, DOI 10.1364/OE.17.004355; Faist J, 1997, APPL PHYS LETT, V70, P2670, DOI 10.1063/1.119208; Feuillet-Palma C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01361; Gensty T, 2005, OPT EXPRESS, V13, P2032, DOI 10.1364/OPEX.13.002032; Graf M, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2210088; Grant PD, 2006, IEEE PHOTONIC TECH L, V18, P2218, DOI 10.1109/LPT.2006.884267; Grundmann M, 2010, GRAD TEXTS PHYS, P1, DOI 10.1007/978-3-642-13884-3_1; Gunapala SD, 2000, SEMICONDUCT SEMIMET, V62, P197; HAVA S, 1993, J APPL PHYS, V73, P7431, DOI 10.1063/1.353985; Henini M., 2002, HDB INFRARED DETECTI; Hinds S, 2011, ADV MATER, V23, P5536, DOI 10.1002/adma.201103372; Hofstetter D, 2010, APPL PHYS B-LASERS O, V100, P313, DOI 10.1007/s00340-010-3965-2; HOWARTH DJ, 1953, PROC R SOC LON SER-A, V219, P53, DOI 10.1098/rspa.1953.0130; LEVINE BF, 1987, APPL PHYS LETT, V50, P1092, DOI 10.1063/1.97928; LIU HC, 1992, APPL PHYS LETT, V60, P1507, DOI 10.1063/1.107286; Martini R., 2005, J OPT FIBER COMMUN R, V2, P279, DOI DOI 10.1007/S10297-005-0052-2; Mizaikoff B, 2003, ANAL CHEM, V75, p258A, DOI 10.1021/ac031340g; Palaferri D, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4918983; Palaferri D, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/11/113016; PIOTROWSKI J, 1991, INFRARED PHYS, V31, P1, DOI 10.1016/0020-0891(91)90037-G; Rogalski A, 2003, PROG QUANT ELECTRON, V27, P59, DOI 10.1016/S0079-6727(02)00024-1; Schneider H, 1997, APPL PHYS LETT, V70, P1602, DOI 10.1063/1.118628; Schneider H., 2007, QUANTUM WELL INFRARE, P72; Stangier T, 2013, REMOTE SENS-BASEL, V5, P3397, DOI 10.3390/rs5073397; Sze S. M., 2011, PHYS SEMICONDUCTOR D; Theocharous E, 2005, INFRARED PHYS TECHN, V46, P309, DOI 10.1016/j.infrared.2004.05.002; Todorov Y, 2010, OPT EXPRESS, V18, P13886, DOI 10.1364/OE.18.013886; Villares G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6192; Vodopyanov KL, 1997, SEMICOND SCI TECH, V12, P708, DOI 10.1088/0268-1242/12/6/011; Wood RA, 2000, ELECTR MAT, V8, P149	32	153	153	17	283	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2018	556	7699					85	+		10.1038/nature25790	http://dx.doi.org/10.1038/nature25790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5KP	29579743	Green Accepted			2022-12-28	WOS:000429103300039
J	Faber, JA; Arrieta, AF; Studart, AR				Faber, Jakob A.; Arrieta, Andres F.; Studart, Andre R.			Bioinspired spring origami	SCIENCE			English	Article							ACTUATION	Origami enables folding of objects into a variety of shapes in arts, engineering, and biological systems. In contrast to well-known paper-folded objects, the wing of the earwig has an exquisite natural folding system that cannot be sufficiently described by current origami models. Such an unusual biological system displays incompatible folding patterns, remains open by a bistable locking mechanism during flight, and self-folds rapidly without muscular actuation. We show that these notable functionalities arise from the protein-rich joints of the earwig wing, which work as extensional and rotational springs between facets. Inspired by this biological wing, we establish a spring origami model that broadens the folding design space of traditional origami and allows for the fabrication of precisely tunable, four-dimensional-printed objects with programmable bioinspired morphing functionalities.	[Faber, Jakob A.; Studart, Andre R.] ETH, Dept Mat, Complex Mat, CH-8093 Zurich, Switzerland; [Arrieta, Andres F.] Purdue Univ, Sch Mech Engn, Programmable Struct Lab, W Lafayette, IN 47907 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Studart, AR (corresponding author), ETH, Dept Mat, Complex Mat, CH-8093 Zurich, Switzerland.; Arrieta, AF (corresponding author), Purdue Univ, Sch Mech Engn, Programmable Struct Lab, W Lafayette, IN 47907 USA.	aarrieta@purdue.edu; andre.studart@mat.ethz.ch		Arrieta, Andres/0000-0003-4641-5220; Faber, Jakob/0000-0002-9754-4826	ETH Zurich; Purdue University; European Office of Aerospace Research and Development [FA9550-16-1-0007]; Air Force Office of Scientific Research [FA9550-17-1-0074]	ETH Zurich(ETH Zurich); Purdue University; European Office of Aerospace Research and Development; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	We are grateful for financial support from ETH Zurich, Purdue University, European Office of Aerospace Research and Development (grant FA9550-16-1-0007), and the Air Force Office of Scientific Research (grant FA9550-17-1-0074).	Brunck V, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.033005; Burgert I, 2009, PHILOS T R SOC A, V367, P1541, DOI 10.1098/rsta.2009.0003; Daynes S, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/12/125011; Deiters J, 2016, BIOL OPEN, V5, P638, DOI 10.1242/bio.016527; Demaine ED, 2007, GEOMETRIC FOLDING ALGORITHMS: LINKAGES, ORIGAMI, POLYHEDRA, P292, DOI 10.1017/CBO9780511735172.022; Erb RM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2666; Felton S, 2014, SCIENCE, V345, P644, DOI 10.1126/science.1252610; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; Ge Q, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/9/094007; Ghadban A, 2016, CHEM COMMUN, V52, P697, DOI 10.1039/c5cc08617e; Haas F, 2000, ARTHROPOD STRUCT DEV, V29, P137, DOI 10.1016/S1467-8039(00)00025-6; Haas F., 1994, THESIS; Lebee Arthur, 2015, International Journal of Space Structures, V30, P55; Lechenault F, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.235501; Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M; Liu Y, 2012, SOFT MATTER, V8, P1764, DOI 10.1039/c1sm06564e; Mu JK, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500533; Papadopoulou A., 2015, ADDIT MANUF, V2, P106; Peraza-Hernandez EA, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/9/094001; Reis PM, 2015, P NATL ACAD SCI USA, V112, P12234, DOI 10.1073/pnas.1516974112; Shan SC, 2014, ADV FUNCT MATER, V24, P4935, DOI 10.1002/adfm.201400665; Silverberg JL, 2015, NAT MATER, V14, P389, DOI [10.1038/NMAT4232, 10.1038/nmat4232]; Silverberg JL, 2014, SCIENCE, V345, P647, DOI 10.1126/science.1252876; Tachi T, 2009, ORIGAMI4 4 INT C ORI, V4, P175; Tibbits S, 2012, ASSEMBLY AUTOM, V32, P216, DOI 10.1108/01445151211244348; Turner N, 2016, P I MECH ENG C-J MEC, V230, P2345, DOI 10.1177/0954406215597713; Vincent JFV, 2001, CISM COUR L, P37; Vincent O, 2011, P ROY SOC B-BIOL SCI, V278, P2909, DOI 10.1098/rspb.2010.2292; Waitukaitis S, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.055503; Zarzar LD, 2014, ACCOUNTS CHEM RES, V47, P530, DOI 10.1021/ar4001923	30	176	181	49	269	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2018	359	6382			SI		1386	+		10.1126/science.aap7753	http://dx.doi.org/10.1126/science.aap7753			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA0ZG	29567709				2022-12-28	WOS:000428043600042
J	Albright, R; Takeshita, Y; Koweek, DA; Ninokawa, A; Wolfe, K; Rivlin, T; Nebuchina, Y; Young, J; Caldeira, K				Albright, Rebecca; Takeshita, Yuichiro; Koweek, David A.; Ninokawa, Aaron; Wolfe, Kennedy; Rivlin, Tanya; Nebuchina, Yana; Young, Jordan; Caldeira, Ken			Carbon dioxide addition to coral reef waters suppresses net community calcification	NATURE			English	Article							OCEAN ACIDIFICATION; ALKALINITY CHANGES; SEAWATER; MARINE; CO2; DISSOCIATION; ACID; DISSOLUTION; ENRICHMENT; CONSTANTS	Coral reefs feed millions of people worldwide, provide coastal protection and generate billions of dollars annually in tourism revenue(1). The underlying architecture of a reef is a biogenic carbonate structure that accretes over many years of active biomineralizat ion by calcifying organisms, including corals and algae(2). Ocean acidification poses a chronic threat to coral reefs by reducing the saturation state of the aragonite mineral of which coral skeletons are primarily composed, and lowering the concentration of carbonate ions required to maintain the carbonate reef. Reduced calcification, coupled with increased bioerosion and dissolution(3), may drive reefs into a state of net loss this century(4). Our ability to predict changes in ecosystem function and associated services ultimately hinges on our understanding of community- and ecosystem-scale responses. Past research has primarily focused on the responses of individual species rather than evaluating more complex, community-level responses. Here we use an in situ carbon dioxide enrichment experiment to quantify the net calcification response of a coral reef flat to acidification. We present an estimate of community-scale calcification sensitivity to ocean acidification that is, to our knowledge, the first to be based on a controlled experiment in the natural environment. This estimate provides evidence that near-future reductions in the aragonite saturation state will compromise the ecosystem function of coral reefs.	[Albright, Rebecca; Takeshita, Yuichiro; Koweek, David A.; Nebuchina, Yana; Caldeira, Ken] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; [Albright, Rebecca] Calif Acad Sci, San Francisco, CA 94118 USA; [Takeshita, Yuichiro] Monterey Bay Aquariun Res Inst, Moss Landing, CA 95039 USA; [Ninokawa, Aaron; Young, Jordan] UC Davis Bodega Marine Lab, Bodega Bay, CA 94923 USA; [Wolfe, Kennedy] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia; [Rivlin, Tanya] Hebrew Univ Jerusalem, Interuniv Inst Marine Sci, H Steinitz Marine Biol Lab, IL-8810300 Coral Beach, Eilat, Israel; [Rivlin, Tanya] Hebrew Univ Jerusalem, Fredy & Nadine Herrman Inst Earth Sci, Edmond J Safra Campus, IL-9190401 Jerusalem, Israel	Carnegie Institution for Science; California Academy of Sciences; University of Sydney; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Albright, R (corresponding author), Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA.; Albright, R (corresponding author), Calif Acad Sci, San Francisco, CA 94118 USA.	ralbright@calacademy.org	Caldeira, Ken/E-7914-2011; Ninokawa, Aaron/AAC-6979-2022	Caldeira, Ken/0000-0002-4591-643X; Albright, Rebecca/0000-0003-3409-8766; Koweek, David/0000-0002-8846-6344; Wolfe, Kennedy/0000-0002-9502-6769; Ninokawa, Aaron/0000-0002-8259-0889	California Academy of Sciences; Fund for Innovative Climate and Energy Research; Great Barrier Reef Marine Park Authority [G14/36863.1]	California Academy of Sciences; Fund for Innovative Climate and Energy Research; Great Barrier Reef Marine Park Authority	We thank R. Dunbar for the use of his laboratory and D. Mucciarone for laboratory assistance; the Australian Institute of Marine Science for scientific and technical support; and the following people for their support in the field and/ or laboratory: M. Byrne, T. Hill, L. Caldeira, R. Johnson, D. Ross and the staff of the One Tree Island Research Station. Expedition and staff support was provided by the Carnegie Institution for Science. Additional support for staff, but not expedition expenses, was provided by the California Academy of Sciences and the Fund for Innovative Climate and Energy Research. This work was permitted by the Great Barrier Reef Marine Park Authority under permit G14/36863.1.	Albright R, 2016, NATURE, V531, P362, DOI 10.1038/nature17155; Andersson AJ, 2015, OCEANOGRAPHY, V28, P16; Andersson AJ, 2013, ANNU REV MAR SCI, V5, P321, DOI 10.1146/annurev-marine-121211-172241; Anthony KRN, 2016, ANNU REV ENV RESOUR, V41, P59, DOI 10.1146/annurev-environ-110615-085610; Arnold T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035107; Bates NR, 2014, OCEANOGRAPHY, V27, P126, DOI 10.5670/oceanog.2014.16; BERNER RA, 1970, LIMNOL OCEANOGR, V15, P544, DOI 10.4319/lo.1970.15.4.0544; Bresnahan Philip J.  Jr., 2014, Methods in Oceanography, V9, P44, DOI 10.1016/j.mio.2014.08.003; BREWER PG, 1976, LIMNOL OCEANOGR, V21, P108, DOI 10.4319/lo.1976.21.1.0108; Cao L, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035072; Carter BR, 2013, LIMNOL OCEANOGR-METH, V11, P16, DOI 10.4319/lom.2013.11.16; Chan NCS, 2013, GLOBAL CHANGE BIOL, V19, P282, DOI 10.1111/gcb.12011; Cooley SR, 2009, OCEANOGRAPHY, V22, P172, DOI 10.5670/oceanog.2009.106; Dickson A. G., 2007, PICES SPECIAL PUBLIC, V191; Dickson AG, 2003, MAR CHEM, V80, P185, DOI 10.1016/S0304-4203(02)00133-0; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; DICKSON AG, 1990, DEEP-SEA RES, V37, P755, DOI 10.1016/0198-0149(90)90004-F; Dove SG, 2013, P NATL ACAD SCI USA, V110, P15342, DOI 10.1073/pnas.1302701110; Enochs IC, 2015, NAT CLIM CHANGE, V5, P1083, DOI 10.1038/NCLIMATE2758; Eyre BD, 2014, NAT CLIM CHANGE, V4, P969, DOI 10.1038/NCLIMATE2380; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; GAINES AG, 1972, LIMNOL OCEANOGR, V17, P42, DOI 10.4319/lo.1972.17.1.0042; Gattuso JP, 1999, AM ZOOL, V39, P160; Grasshoff K, 1999, METHODS SEAWATER ANA; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Hughes TP, 2017, NATURE, V546, P82, DOI 10.1038/nature22901; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; Inoue S, 2013, NAT CLIM CHANGE, V3, P683, DOI [10.1038/nclimate1855, 10.1038/NCLIMATE1855]; KINSEY DW, 1978, LIMNOL OCEANOGR, V23, P989, DOI 10.4319/lo.1978.23.5.0989; Kline DI, 2012, SCI REP-UK, V2, DOI 10.1038/srep00413; Koop K, 2001, MAR POLLUT BULL, V42, P91, DOI 10.1016/S0025-326X(00)00181-8; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; Le Quere C, 2015, EARTH SYST SCI DATA, V7, P47, DOI 10.5194/essd-7-47-2015; Liu XW, 2011, ENVIRON SCI TECHNOL, V45, P4862, DOI 10.1021/es200665d; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Norby RJ, 2011, ANNU REV ECOL EVOL S, V42, P181, DOI 10.1146/annurev-ecolsys-102209-144647; Pascal N, 2016, ECOSYST SERV, V21, P72, DOI 10.1016/j.ecoser.2016.07.005; PENDLETON LH, 1995, OCEAN COAST MANAGE, V26, P119, DOI 10.1016/0964-5691(95)00007-O; Price NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043843; Ricke KL, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034003; Silverman J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036282; SMITH SV, 1975, LIMNOL OCEANOGR, V20, P493, DOI 10.4319/lo.1975.20.3.0493; Spalding M, 2017, MAR POLICY, V82, P104, DOI 10.1016/j.marpol.2017.05.014; Spalding MD, 2015, SCIENCE, V350, P769, DOI 10.1126/science.aad0349; Wilson Jr J. F., 1968, TECHNIQUES WATER RES	46	79	84	12	360	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2018	555	7697					516	+		10.1038/nature25968	http://dx.doi.org/10.1038/nature25968			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ9NF	29539634				2022-12-28	WOS:000427937900052
J	Kim, SJ; Fernandez-Martinez, J; Nudelman, I; Shi, Y; Zhang, WZ; Raveh, B; Herricks, T; Slaughter, BD; Hogan, JA; Upla, P; Chemmama, IE; Pellarin, R; Echeverria, I; Shivaraju, M; Chaudhury, AS; Wang, JJ; Williams, R; Unruh, JR; Greenberg, CH; Jacobs, EY; Yu, ZH; de la Cruz, MJ; Mironska, R; Stokes, DL; Aitchison, JD; Jarrold, MF; Gerton, JL; Ludtke, SJ; Akey, CW; Chait, BT; Sali, A; Rout, MP				Kim, Seung Joong; Fernandez-Martinez, Javier; Nudelman, Ilona; Shi, Yi; Zhang, Wenzhu; Raveh, Barak; Herricks, Thurston; Slaughter, Brian D.; Hogan, Joanna A.; Upla, Paula; Chemmama, Ilan E.; Pellarin, Riccardo; Echeverria, Ignacia; Shivaraju, Manjunatha; Chaudhury, Azraa S.; Wang, Junjie; Williams, Rosemary; Unruh, Jay R.; Greenberg, Charles H.; Jacobs, Erica Y.; Yu, Zhiheng; de la Cruz, M. Jason; Mironska, Roxana; Stokes, David L.; Aitchison, John D.; Jarrold, Martin F.; Gerton, Jennifer L.; Ludtke, Steven J.; Akey, Christopher W.; Chait, Brian T.; Sali, Andrej; Rout, Michael P.			Integrative structure and functional anatomy of a nuclear pore complex	NATURE			English	Article							MULTIPLEXED ABSOLUTE QUANTIFICATION; PROTEIN HOMOLOGY DETECTION; MOLECULAR ARCHITECTURE; TRANSPORT BARRIER; BASKET PROTEINS; ACCURATE MASS; INNER RING; IN-SITU; YEAST; NUCLEOPORINS	Nuclear pore complexes play central roles as gatekeepers of RNA and protein transport between the cytoplasm and nucleoplasm. However, their large size and dynamic nature have impeded a full structural and functional elucidation. Here we determined the structure of the entire 552-protein nuclear pore complex of the yeast Saccharomyces cerevisiae at sub-nanometre precision by satisfying a wide range of data relating to the molecular arrangement of its constituents. The nuclear pore complex incorporates sturdy diagonal columns and connector cables attached to these columns, imbuing the structure with strength and flexibility. These cables also tie together all other elements of the nuclear pore complex, including membrane-interacting regions, outer rings and RNA-processing platforms. Inwardly directed anchors create a high density of transport factor-docking Phe-Gly repeats in the central channel, organized into distinct functional units. This integrative structure enables us to rationalize the architecture, transport mechanism and evolutionary origins of the nuclear pore complex.	[Kim, Seung Joong; Raveh, Barak; Chemmama, Ilan E.; Pellarin, Riccardo; Echeverria, Ignacia; Greenberg, Charles H.; Sali, Andrej] Univ Calif San Francisco, Dept Pharmaceut Chem, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Kim, Seung Joong; Raveh, Barak; Chemmama, Ilan E.; Pellarin, Riccardo; Echeverria, Ignacia; Greenberg, Charles H.; Sali, Andrej] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Fernandez-Martinez, Javier; Nudelman, Ilona; Chaudhury, Azraa S.; Williams, Rosemary; Mironska, Roxana; Rout, Michael P.] Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10065 USA; [Shi, Yi; Zhang, Wenzhu; Wang, Junjie; Jacobs, Erica Y.; Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10065 USA; [Herricks, Thurston] Inst Syst Biol, 401 Terry Ave N, Seattle, WA 98109 USA; [Slaughter, Brian D.; Shivaraju, Manjunatha; Unruh, Jay R.; Gerton, Jennifer L.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Hogan, Joanna A.; Jarrold, Martin F.] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Upla, Paula; Stokes, David L.] NYU, Sch Med, Skirball Inst, New York, NY 10016 USA; [Upla, Paula; Stokes, David L.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Yu, Zhiheng; de la Cruz, M. Jason] Janelia Res Campus, Howard Hughes Med Inst, 19700 Helix Dr, Ashburn, VA 20148 USA; [Aitchison, John D.] Ctr Infect Dis Res, Seattle, WA 98109 USA; [Ludtke, Steven J.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA; [Akey, Christopher W.] Boston Univ, Sch Med, Dept Physiol & Biophys, 700 Albany St, Boston, MA 02118 USA; [Pellarin, Riccardo] Inst Pasteur, CNRS, UMR 3528, Struct Bioinformat Unit, Paris, France; [Shi, Yi] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA; [de la Cruz, M. Jason] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Rockefeller University; Rockefeller University; Institute for Systems Biology (ISB); Stowers Institute for Medical Research; Indiana University System; Indiana University Bloomington; New York University; New York University; Howard Hughes Medical Institute; Center for Infectious Disease Research; Walter Reed Army Institute of Research (WRAIR); Baylor College of Medicine; Boston University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Memorial Sloan Kettering Cancer Center	Sali, A (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA.; Sali, A (corresponding author), Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA.; Rout, MP (corresponding author), Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10065 USA.; Chait, BT (corresponding author), Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10065 USA.; Ludtke, SJ (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.; Akey, CW (corresponding author), Boston Univ, Sch Med, Dept Physiol & Biophys, 700 Albany St, Boston, MA 02118 USA.	sludtke@bcm.edu; cakey@bu.edu; chait@rockefeller.edu; sali@salilab.org; rout@rockefeller.edu	Fernandez-Martinez, Javier/HGC-9122-2022; Fernandez-Martinez, Javier/ABD-9112-2020; Rout, Michael/Y-7090-2018; Shi, Yi/P-7972-2018; Kim, Seung Joong/S-6970-2018; Echeverria, Ignacia/B-5466-2014; Ludtke, Steven/A-4478-2008	Fernandez-Martinez, Javier/0000-0003-0567-498X; Shi, Yi/0000-0002-2761-8324; Unruh, Jay/0000-0003-3077-4990; Chemmama, Ilan E./0000-0002-5657-3516; Chaudhury, Azraa/0000-0002-1977-8205; Akey, Christopher/0000-0002-3059-3121; Echeverria, Ignacia/0000-0003-4717-1467; de la Cruz, Michael Jason/0000-0002-8573-5406; Shivaraju, Manjunatha/0000-0001-6346-6279; Ludtke, Steven/0000-0002-1903-1574; Jarrold, Martin/0000-0001-7084-176X	NSF [GRF 1650113, CHE-1531823]; SIMR; NIH [R01 GM080477, U54 GM103511, R01 GM112108, P41 GM109824, P50 GM076547, R01 GM063834, R01 GM080139, P41 GM103314, R01 GM083960, U54 DK107981]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK107981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM109824, R01GM063834, P41GM103314, P50GM076547, R01GM080477, T32GM008284, U54GM103511, R01GM083960, R01GM112108, R01GM045377, R01GM080139] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021596] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); SIMR; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank B. Webb (UCSF) for help with the Integrative Modelling Platform, the Rockefeller University Outreach Program for support for A.S.C., the NYULMC OCS Microscopy Core, K. Uryu and the EMRC Resource Center (Rockefeller University) for assistance with negative-stain electron microscopy, F. Alber, M. C. Field, N. Ketaren, S. Obado, R. Hayama and D. Simon for feedback and critical reading of the manuscript, and L. Herlands for support and encouragement. The work was supported by a NSF GRF 1650113 (I.E.C.), a NSF grant CHE-1531823 (M.F.J.), the SIMR (J.L.G.), NIH grants R01 GM080477 (J.L.G.), U54 GM103511 (B.T.C., A. S., J.D.A. and M.P.R.), R01 GM112108 (M.P.R. and J.D.A.), P41 GM109824 (M.P.R., A. S., J. D. A. and B.T.C.), P50 GM076547 (J. D. A.), R01 GM063834 (C.W.A.), R01 GM080139 (S. J. L.), P41 GM103314 (B.T.C.), R01 GM083960 (A.S.) and U54 DK107981 (M.P.R. and J.D A.). We are grateful for the support provided by G. Blobel, who inspired the work presented here.	Adams RL, 2014, GENETICS, V197, P1213, DOI 10.1534/genetics.114.164012; Adams RL, 2013, CELL, V152, P1218, DOI 10.1016/j.cell.2013.02.042; AITCHISON JD, 1995, J CELL BIOL, V131, P1133, DOI 10.1083/jcb.131.5.1133; AKEY CW, 1989, J CELL BIOL, V109, P971, DOI 10.1083/jcb.109.3.971; Alber F, 2008, ANNU REV BIOCHEM, V77, P443, DOI 10.1146/annurev.biochem.77.060407.135530; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Alber Frank, 2008, V9, P99, DOI 10.1007/978-1-84800-125-1_6; Algret R, 2014, MOL CELL PROTEOMICS, V13, P2855, DOI 10.1074/mcp.M114.039388; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Beynon RJ, 2005, NAT METHODS, V2, P587, DOI 10.1038/NMETH774; Bharat TAM, 2016, NAT PROTOC, V11, P9, DOI 10.1038/nprot.2016.124; Bharat TAM, 2015, STRUCTURE, V23, P1743, DOI 10.1016/j.str.2015.06.026; Briggs JAG, 2013, CURR OPIN STRUC BIOL, V23, P261, DOI 10.1016/j.sbi.2013.02.003; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Bui KH, 2013, CELL, V155, P1233, DOI 10.1016/j.cell.2013.10.055; Cadene M, 2000, ANAL CHEM, V72, P5655, DOI 10.1021/ac000811l; Campelo F, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003556; Cevher MA, 2014, NAT STRUCT MOL BIOL, V21, P1028, DOI 10.1038/nsmb.2914; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Contino NC, 2013, J AM SOC MASS SPECTR, V24, P101, DOI 10.1007/s13361-012-0525-5; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Debler EW, 2008, MOL CELL, V32, P815, DOI 10.1016/j.molcel.2008.12.001; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Ding C, 2011, J PROTEOME RES, V10, P3652, DOI 10.1021/pr2002758; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Edelstein Arthur D, 2014, J Biol Methods, V1; Eibauer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8532; Elad N, 2015, J CELL SCI, V128, P589, DOI 10.1242/jcs.164384; ERMAK DL, 1978, J CHEM PHYS, V69, P1352, DOI 10.1063/1.436761; Erzberger JP, 2014, CELL, V158, P1123, DOI 10.1016/j.cell.2014.07.044; Faini M, 2013, TRENDS CELL BIOL, V23, P279, DOI 10.1016/j.tcb.2013.01.005; Fenyo David, 2007, J Vis Exp, P192, DOI 10.3791/192; Fernandez -Martinez J., 2016, CELL, V167; Fernandez-Martinez J, 2012, J CELL BIOL, V196, P419, DOI 10.1083/jcb.201109008; Field HI, 2002, PROTEOMICS, V2, P36, DOI 10.1002/1615-9861(200201)2:1<36::AID-PROT36>3.0.CO;2-W; Fischer J, 2015, NAT STRUCT MOL BIOL, V22, P774, DOI 10.1038/nsmb.3084; Folkmann AW, 2011, NUCLEUS-PHILA, V2, P540, DOI 10.4161/nucl.2.6.17881; Galaz-Montoya JG, 2016, J STRUCT BIOL, V194, P383, DOI 10.1016/j.jsb.2016.03.018; Galaz-Montoya JG, 2015, J STRUCT BIOL, V190, P279, DOI 10.1016/j.jsb.2015.04.016; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Hakhverdyan Z, 2015, NAT METHODS, V12, P553, DOI 10.1038/nmeth.3395; Hanot S., 2017, PREPRINT; Henderson R, 2012, STRUCTURE, V20, P205, DOI 10.1016/j.str.2011.12.014; Herricks T, 2017, G3-GENES GENOM GENET, V7, P279, DOI 10.1534/g3.116.037044; Hough LE, 2015, ELIFE, V4, DOI 10.7554/eLife.10027; Iwamoto M, 2017, J CELL SCI, V130, P1822, DOI 10.1242/jcs.199398; Iwanczyk J, 2006, J MOL BIOL, V363, P648, DOI 10.1016/j.jmb.2006.08.010; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jonic S, 2016, J STRUCT BIOL, V194, P423, DOI 10.1016/j.jsb.2016.04.007; Kawabata T, 2008, BIOPHYS J, V95, P4643, DOI 10.1529/biophysj.108.137125; Keifer DZ, 2016, RAPID COMMUN MASS SP, V30, P1957, DOI 10.1002/rcm.7673; Kim SJ, 2014, MOL CELL PROTEOMICS, V13, P2911, DOI 10.1074/mcp.M114.040915; Kito K, 2007, J PROTEOME RES, V6, P792, DOI 10.1021/pr060447s; Knockenhauer KE, 2016, CELL, V164, P1162, DOI 10.1016/j.cell.2016.01.034; Kosinski J, 2016, SCIENCE, V352, P363, DOI 10.1126/science.aaf0643; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kuzmanic A, 2010, BIOPHYS J, V98, P861, DOI 10.1016/j.bpj.2009.11.011; LaCava J., 2016, COLD SPRING HARB PRO; Leitner A, 2014, P NATL ACAD SCI USA, V111, P9455, DOI 10.1073/pnas.1320298111; Leitner A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014126; Lemke EA, 2016, J MOL BIOL, V428, P2011, DOI 10.1016/j.jmb.2016.01.002; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; Lin DH, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1015; LoPiccolo J, 2015, J BIOL CHEM, V290, P30390, DOI 10.1074/jbc.M115.689604; Ludtke SJ, 2016, METHOD ENZYMOL, V579, P159, DOI 10.1016/bs.mie.2016.05.001; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luo J, 2015, MOL CELL, V59, P794, DOI 10.1016/j.molcel.2015.07.016; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Marelli M, 2001, J CELL BIOL, V153, P709, DOI 10.1083/jcb.153.4.709; Marsden RL, 2002, PROTEIN SCI, V11, P2814, DOI 10.1110/ps.0209902; McCarroll D, 2016, SIMPLE STAT TESTS GE; McDonald J.H., 2014, HDB BIOL STAT; Meinema AC, 2011, SCIENCE, V333, P90, DOI 10.1126/science.1205741; Meseroll RA, 2016, J CELL PHYSIOL, V231, P2353, DOI 10.1002/jcp.25355; Meszaros N, 2015, DEV CELL, V33, P285, DOI 10.1016/j.devcel.2015.02.017; Milles S, 2015, CELL, V163, P734, DOI 10.1016/j.cell.2015.09.047; Montelione GT, 2013, STRUCTURE, V21, P1563, DOI 10.1016/j.str.2013.07.021; Niepel M, 2013, MOL BIOL CELL, V24, P3920, DOI 10.1091/mbc.E13-07-0412; Nofrini V, 2016, EUR J HUM GENET, V24, P1388, DOI 10.1038/ejhg.2016.25; Obado SO, 2017, NUCLEUS-PHILA, V8, P340, DOI 10.1080/19491034.2017.1313936; Obado SO, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002365; Oeffinger M, 2007, NAT METHODS, V4, P951, DOI 10.1038/NMETH1101; Paradise A, 2007, J MOL BIOL, V365, P50, DOI 10.1016/j.jmb.2006.09.089; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Pratt JM, 2006, NAT PROTOC, V1, P1029, DOI 10.1038/nprot.2006.129; Ptak C, 2014, CURR OPIN CELL BIOL, V28, P46, DOI 10.1016/j.ceb.2014.02.001; Raveh B, 2016, P NATL ACAD SCI USA, V113, pE2489, DOI 10.1073/pnas.1522663113; Read RJ, 2011, STRUCTURE, V19, P1395, DOI 10.1016/j.str.2011.08.006; Robinson PJ, 2015, ELIFE, V4, DOI 10.7554/eLife.08719; Rout MP, 2017, ANNU REV BIOCHEM, V86, P637, DOI 10.1146/annurev-biochem-061516-044643; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rout MP, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P143; ROUT MP, 1993, J CELL BIOL, V123, P771, DOI 10.1083/jcb.123.4.771; ROUT MP, 1990, J CELL BIOL, V111, P1913, DOI 10.1083/jcb.111.5.1913; Russel D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001244; Sakiyama Y, 2016, NAT NANOTECHNOL, V11, P719, DOI [10.1038/nnano.2016.62, 10.1038/NNANO.2016.62]; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sali A, 2015, STRUCTURE, V23, P1156, DOI 10.1016/j.str.2015.05.013; Sampathkumar P, 2013, STRUCTURE, V21, P560, DOI 10.1016/j.str.2013.02.005; Sampathkumar P, 2012, PROTEINS, V80, P2110, DOI 10.1002/prot.24102; Sampathkumar P, 2011, PROTEINS, V79, P1672, DOI 10.1002/prot.22973; Sampathkumar P, 2010, PROTEINS, V78, P1992, DOI 10.1002/prot.22707; Saroufim MA, 2015, J CELL BIOL, V211, P1131, DOI 10.1083/jcb.201503070; Schneidman-Duhovny D, 2014, CURR OPIN STRUC BIOL, V28, P96, DOI 10.1016/j.sbi.2014.08.001; Schneidman-Duhovny D, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-17; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Seo HS, 2009, P NATL ACAD SCI USA, V106, P14281, DOI 10.1073/pnas.0907453106; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shi Y, 2015, NAT METHODS, V12, P1135, DOI 10.1038/nmeth.3617; Shi Y, 2014, MOL CELL PROTEOMICS, V13, P2927, DOI 10.1074/mcp.M114.041673; Shivaraju M, 2012, CELL, V150, P304, DOI 10.1016/j.cell.2012.05.034; SIEGEL S., 1956, NONPARAMETRIC STAT B; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stanley GJ, 2017, SEMIN CELL DEV BIOL, V68, P42, DOI 10.1016/j.semcdb.2017.05.007; STRAMBIODECASTILLIA C, 1995, J CELL BIOL, V131, P19, DOI 10.1083/jcb.131.1.19; Sun JC, 2015, NAT STRUCT MOL BIOL, V22, P976, DOI 10.1038/nsmb.3113; Timney BL, 2016, J CELL BIOL, V215, P57, DOI 10.1083/jcb.201601004; Trewhella J, 2013, STRUCTURE, V21, P875, DOI 10.1016/j.str.2013.04.020; Trigg J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023519; Upla P, 2017, STRUCTURE, V25, P434, DOI 10.1016/j.str.2017.01.006; van der Maarel J. R. C., 2008, INTRO BIOPOLYMER PHY; Viswanath S, 2017, BIOPHYS J, V113, P2344, DOI 10.1016/j.bpj.2017.10.005; Vollmer B, 2012, EMBO J, V31, P4072, DOI 10.1038/emboj.2012.256; von Appen A, 2016, J MOL BIOL, V428, P2001, DOI 10.1016/j.jmb.2016.01.004; von Appen A, 2015, NATURE, V526, P140, DOI 10.1038/nature15381; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Webb B, 2014, METHODS MOL BIOL, V1091, P277, DOI 10.1007/978-1-62703-691-7_20; Yamada J, 2010, MOL CELL PROTEOMICS, V9, P2205, DOI 10.1074/mcp.M000035-MCP201; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007; Zheng SQ, 2007, J STRUCT BIOL, V157, P138, DOI 10.1016/j.jsb.2006.06.005	138	264	266	4	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2018	555	7697					475	+		10.1038/nature26003	http://dx.doi.org/10.1038/nature26003			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ9NF	29539637	Green Accepted			2022-12-28	WOS:000427937900044
J	Rimmer, A				Rimmer, Abi			Five medical schools are created in England in bid to increase home grown doctors	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Health Education England, 2018, NEW MED SCH OP TRAIN; Health Education England Higher Education Funding Council for England, 2017, EXP UND MED ED PLAC; Torjesen I, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5399	3	9	9	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 21	2018	360								k1328	10.1136/bmj.k1328	http://dx.doi.org/10.1136/bmj.k1328			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB1LG	29563094				2022-12-28	WOS:000428811700022
J	Adlington, K				Adlington, Kate			Pop a million happy pills? Antidepressants, nuance, and the media	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												kadlington@bmj.com	Adlington, Katherine/AAR-5656-2021	Adlington, Katherine/0000-0002-9296-4952				[Anonymous], 2018, EXP REACT LARG REV A; Boseley S., 2018, GUARDIAN; Cipriani A, 2018, LANCET; Donnelly L., 2018, TELEGRAPH; Ioannidis John P A, 2008, Philos Ethics Humanit Med, V3, P14, DOI 10.1186/1747-5341-3-14; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; McDermott N., 2018, SUN; Moncrieff J., 2018, CHALLENGING NEW HYPE; Naish J., 2018, DAILY MAIL; Prozac Boseley S., 2008, GUARDIAN; Rimmer A, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k847; Summerfield D., 2018, BMJ OPINION     0227	12	8	8	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2018	360								k1069	10.1136/bmj.k1069	http://dx.doi.org/10.1136/bmj.k1069			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ1ZU	29523579				2022-12-28	WOS:000427376900004
J	Auerbach, AD; Neinstein, A; Khanna, R				Auerbach, Andrew D.; Neinstein, Aaron; Khanna, Raman			Balancing Innovation and Safety When Integrating Digital Tools Into Health Care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SYSTEM		[Auerbach, Andrew D.; Neinstein, Aaron; Khanna, Raman] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Auerbach, AD (corresponding author), UCSF Div Hosp Med, UCSF Box 0131, San Francisco, CA 94143 USA.	andrew.auerbach@ucsf.edu	Neinstein, Aaron/X-6909-2019	Neinstein, Aaron/0000-0002-9774-7180; Auerbach, Andrew/0000-0001-8440-0527				Condie CK, 2008, AM J HEALTH-SYST PH, V65, P454, DOI 10.2146/ajhp070322; Lewis ZH, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1947-3; Mandl KD, 2009, NEW ENGL J MED, V360, P1278, DOI 10.1056/NEJMp0900411; Shuren J, 2016, JAMA-J AM MED ASSOC, V316, P1153, DOI 10.1001/jama.2016.8708; U. S. Food and Drug Administration, 2017, SOFTW PREC PROGR MOD	5	8	8	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2018	168	10					733	+		10.7326/M17-3108	http://dx.doi.org/10.7326/M17-3108			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3DE	29582072	Green Published			2022-12-28	WOS:000434250700019
J	Citron, I; Sonderman, K; Meara, JG				Citron, Isabelle; Sonderman, Kristin; Meara, John G.			Pathology and laboratory medicine in partnership with global surgery: working towards universal health coverage	LANCET			English	Editorial Material									[Citron, Isabelle; Sonderman, Kristin; Meara, John G.] Harvard Med Sch, Dept Global Hlth & Social Med, Program Global Surg & Social Change, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Meara, JG (corresponding author), Harvard Med Sch, Dept Global Hlth & Social Med, Program Global Surg & Social Change, Boston, MA 02115 USA.	john.meara@childrens.harvard.edu		Meara, John G./0000-0003-4369-3209; Citron, Isabelle/0000-0003-4702-4926				Berendes S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000433; Chu K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000078; Davison R, 2000, INFORM SYST J, V10, P3, DOI 10.1046/j.1365-2575.2000.00072.x; Horton S, 2018, LANCET, V391, P1953, DOI 10.1016/S0140-6736(18)30460-4; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Sayed S, 2018, LANCET, V391, P1939, DOI 10.1016/S0140-6736(18)30459-8; United Nations, 2016, SUST DEV GOALS REP; Wells KM, 2016, SURGERY, V160, P509, DOI 10.1016/j.surg.2016.04.001; Wilson ML, 2018, LANCET, V391, P1927, DOI [10.1016/S0140-6736(18)30458-6, 10.1016/S0140-6736]; World Health Organisation, 2007, TASK SHIFT RAT RED T; World Health Organization, STRENGTH EM ESS SURG	11	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2018	391	10133					1875	1877		10.1016/S0140-6736(18)30310-6	http://dx.doi.org/10.1016/S0140-6736(18)30310-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GF3NC	29550028				2022-12-28	WOS:000431861800009
J	Mehra, MR; Goldstein, DJ; Uriel, N; Cleveland, JC; Yuzefpolskaya, M; Salerno, C; Walsh, MN; Milano, CA; Patel, CB; Ewald, GA; Itoh, A; Dean, D; Krishnamoorthy, A; Cotts, WG; Tatooles, AJ; Jorde, UP; Bruckner, BA; Estep, JD; Jeevanandam, V; Sayer, G; Horstmanshof, D; Long, JW; Gulati, S; Skipper, ER; O'Connell, JB; Heatley, G; Sood, P; Naka, Y				Mehra, M. R.; Goldstein, D. J.; Uriel, N.; Cleveland, J. C.; Yuzefpolskaya, M.; Salerno, C.; Walsh, M. N.; Milano, C. A.; Patel, C. B.; Ewald, G. A.; Itoh, A.; Dean, D.; Krishnamoorthy, A.; Cotts, W. G.; Tatooles, A. J.; Jorde, U. P.; Bruckner, B. A.; Estep, J. D.; Jeevanandam, V.; Sayer, G.; Horstmanshof, D.; Long, J. W.; Gulati, S.; Skipper, E. R.; O'Connell, J. B.; Heatley, G.; Sood, P.; Naka, Y.		MOMENTUM 3 Investigators	Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VENTRICULAR ASSIST DEVICE; THROMBOSIS; SUPPORT; TRIAL; RISK	BACKGROUND In an early analysis of this trial, use of a magnetically levitated centrifugal continuous-flow circulatory pump was found to improve clinical outcomes, as compared with a mechanical-bearing axial continuous-flow pump, at 6 months in patients with advanced heart failure. METHODS In a randomized noninferiority and superiority trial, we compared the centrifugal-flow pump with the axial-flow pump in patients with advanced heart failure, irrespective of the intended goal of support (bridge to transplantation or destination therapy). The composite primary end point was survival at 2 years free of disabling stroke (with disabling stroke indicated by a modified Rankin score of >3; scores range from 0 to 6, with higher scores indicating more severe disability) or survival free of reoperation to replace or remove a malfunctioning device. The noninferiority margin for the risk difference (centrifugal-flow pump group minus axial-flow pump group) was -10 percentage points. RESULTS Of 366 patients, 190 were assigned to the centrifugal-flow pump group and 176 to the axial-flow pump group. In the intention-to-treat population, the primary end point occurred in 151 patients (79.5%) in the centrifugal-flow pump group, as compared with 106 (60.2%) in the axial-flow pump group (absolute difference, 19.2 percentage points; 95% lower confidence boundary, 9.8 percentage points [P<0.001 for noninferiority]; hazard ratio, 0.46; 95% confidence interval [CI], 0.31 to 0.69 [P<0.001 for superiority]). Reoperation for pump malfunction was less frequent in the centrifugal-flow pump group than in the axial-flow pump group (3 patients [1.6%] vs. 30 patients [17.0%]; hazard ratio, 0.08; 95% CI, 0.03 to 0.27; P<0.001). The rates of death and disabling stroke were similar in the two groups, but the overall rate of stroke was lower in the centrifugal-flow pump group than in the axial-flow pump group (10.1% vs. 19.2%; hazard ratio, 0.47; 95% CI, 0.27 to 0.84, P = 0.02). CONCLUSIONS In patients with advanced heart failure, a fully magnetically levitated centrifugal-flow pump was superior to a mechanical-bearing axial-flow pump with regard to survival free of disabling stroke or reoperation to replace or remove a malfunctioning device.	[Mehra, M. R.] Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA; [Mehra, M. R.] Harvard Med Sch, Boston, MA USA; [Goldstein, D. J.; Jorde, U. P.] Montefiore Einstein Ctr Heart & Vasc Care, New York, NY USA; [Yuzefpolskaya, M.; Naka, Y.] Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA; [Yuzefpolskaya, M.; Naka, Y.] New York Presbyterian Hosp, New York, NY USA; [Uriel, N.; Jeevanandam, V.; Sayer, G.] Univ Chicago, Sch Med, Chicago, IL 60637 USA; [Uriel, N.; Jeevanandam, V.; Sayer, G.] Univ Chicago, Med Ctr, Chicago, IL 60637 USA; [O'Connell, J. B.; Heatley, G.; Sood, P.] Abbott, Chicago, IL USA; [Cotts, W. G.; Tatooles, A. J.] Advocate Christ Med Ctr, Oak Lawn, IL USA; [Cleveland, J. C.] Univ Colorado, Sch Med, Aurora, CO USA; [Salerno, C.; Walsh, M. N.] St Vincent Heart Ctr, Indianapolis, IN USA; [Milano, C. A.; Patel, C. B.] Duke Univ, Duke Heart Ctr, Durham, NC 27706 USA; [Gulati, S.; Skipper, E. R.] Carolinas Med Ctr, Charlotte, NC 28203 USA; [Ewald, G. A.; Itoh, A.] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Dean, D.; Krishnamoorthy, A.] Piedmont Hosp, Atlanta, GA USA; [Bruckner, B. A.; Estep, J. D.] Houston Methodist Hosp, Houston, TX USA; [Horstmanshof, D.; Long, J. W.] Integris Baptist Med Ctr, Oklahoma City, OK USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Columbia University; NewYork-Presbyterian Hospital; University of Chicago; University of Chicago; University of Chicago Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; Duke University; Carolinas Medical Center; Washington University (WUSTL); The Methodist Hospital System; The Methodist Hospital - Houston	Mehra, MR (corresponding author), Brigham & Womens Hosp, Heart & Vasc Ctr, Cen Adv Heart Dis, 75 Francis St, Boston, MA 02115 USA.	mmehra@bwh.harvard.edu	Mehra, Mandeep R/G-3484-2013; Goldstein, Daniel J/I-5723-2019; Mehra, Mandeep R/O-7273-2019	Mehra, Mandeep R/0000-0001-8683-7044; Mehra, Mandeep R/0000-0001-8683-7044	Abbott	Abbott(Abbott Laboratories)	Funded by Abbott.	Eulert-Grehn JJ, 2018, J HEART LUNG TRANSPL, V37, P172, DOI 10.1016/j.healun.2017.07.025; Gruger T, 2018, J THORAC CARDIOV SUR, V155, pE33, DOI 10.1016/j.jtcvs.2017.08.022; Heatley G, 2016, J HEART LUNG TRANSPL, V35, P528, DOI 10.1016/j.healun.2016.01.021; Houston BA, 2017, J HEART LUNG TRANSPL, V36, P380, DOI 10.1016/j.healun.2016.12.016; Maltais S, 2017, J HEART LUNG TRANSPL, V36, P1, DOI 10.1016/j.healun.2016.10.001; Mehra MR, 2017, NEW ENGL J MED, V376, P440, DOI 10.1056/NEJMoa1610426; Mehra MR, 2017, EUR HEART J; Netuka I, 2018, J HEART LUNG TRANSPL, V37, P170, DOI 10.1016/j.healun.2017.11.002; Netuka I, 2016, J HEART LUNG TRANSPL, V35, P860, DOI 10.1016/j.healun.2016.05.019; Pinney SP, 2017, J AM COLL CARDIOL, V69, P2845, DOI 10.1016/j.jacc.2017.04.031; Roever L, 2016, STROKE, V47, P2677, DOI 10.1161/STROKEAHA.116.015036; Rogers JG, 2017, NEW ENGL J MED, V376, P451, DOI 10.1056/NEJMoa1602954; Schmitto JD, 2017, NEW ENGL J MED, V376, P1894, DOI 10.1056/NEJMc1703374; Schurr JW, 2017, J HEART LUNG TRANSPL, V36, P373, DOI 10.1016/j.healun.2017.01.1298; Shah P, 2017, J HEART LUNG TRANSPL, V36, P1164, DOI 10.1016/j.healun.2017.05.008; Teuteberg JJ, 2015, JACC-HEART FAIL, V3, P818, DOI 10.1016/j.jchf.2015.05.011; Uriel N, 2017, CIRCULATION, V135, P2003, DOI 10.1161/CIRCULATIONAHA.117.028303; Uriel N, 2010, J AM COLL CARDIOL, V56, P1207, DOI 10.1016/j.jacc.2010.05.016	18	424	430	3	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 12	2018	378	15					1386	1395		10.1056/NEJMoa1800866	http://dx.doi.org/10.1056/NEJMoa1800866			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GC3YA	29526139	Bronze			2022-12-28	WOS:000429718500005
J	Gostin, LO; Hodge, JG; Wetter, SA				Gostin, Lawrence O.; Hodge, James G., Jr.; Wetter, Sarah A.			Enforcing Federal Drug Laws in States Where Medical Marijuana Is Lawful	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA; [Hodge, James G., Jr.; Wetter, Sarah A.] Arizona State Univ, Sandra Day OConnor Coll Law, Phoenix, AZ USA	Georgetown University; Arizona State University; Arizona State University-Downtown Phoenix	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				[Anonymous], 2015, BEH HLTH TRENDS US R; [Anonymous], 2011, MEM US ATT GUID REG; [Anonymous], 2018, MEM ALL US ATT MAR E; De Pinto J, 2017, MARIJUANA LEGALIZATI; National Academies of Sciences Engineering and Medicine, 2017, HLTH EFF CANN CANN C; ProCon, 2016, NUMB LEG MED MAR PAT; Wang GS, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0971; Whiting PF, 2015, JAMA-J AM MED ASSOC, V313, P2456, DOI 10.1001/jama.2015.6358	8	5	5	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 10	2018	319	14					1435	1436		10.1001/jama.2018.1083	http://dx.doi.org/10.1001/jama.2018.1083			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GC2CR	29582074	Green Published			2022-12-28	WOS:000429590200011
J	Graham, BS; Mascola, JR; Fauci, AS				Graham, Barney S.; Mascola, John R.; Fauci, Anthony S.			Novel Vaccine Technologies Essential Components of an Adequate Response to Emerging Viral Diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Graham, Barney S.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Fauci, Anthony S.] NIAID, Off Director, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, Immunoregulat Lab, 31 Ctr Dr,MSC 2520,Bldg 31,Room 7A-03, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov	Mascola, John/AAI-7193-2021; Graham, Barney S./AAC-5898-2019	Graham, Barney S./0000-0001-8112-0853				Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137; Graham BS, 2018, NAT IMMUNOL, V19, P20, DOI 10.1038/s41590-017-0007-9; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Ulmer JB, 2016, CURR OPIN IMMUNOL, V41, P18, DOI 10.1016/j.coi.2016.05.008	4	49	49	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 10	2018	319	14					1431	1432		10.1001/jama.2018.0345	http://dx.doi.org/10.1001/jama.2018.0345			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GC2CR	29566112	Bronze			2022-12-28	WOS:000429590200009
J	Ioannidis, JPA				Ioannidis, John P. A.			The Proposal to Lower P Value Thresholds to .005	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ioannidis, John P. A.] Stanford Univ, Stanford Prevent Res Ctr, Metares Innovat Ctr Stanford, Dept Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Stanford Prevent Res Ctr, Metares Innovat Ctr Stanford, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Stanford Prevent Res Ctr, Metares Innovat Ctr Stanford, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Stanford Prevent Res Ctr, Metares Innovat Ctr Stanford, Dept Stat, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Ioannidis, JPA (corresponding author), Stanford Prevent Res Ctr, 1265 Welch Rd,Med Sch Off Bldg,Room X306, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011	Ioannidis, John P./0000-0003-3118-6859	Laura and John Arnold Foundation	Laura and John Arnold Foundation	The Meta-Research Innovation Center at Stanford has been supported by the Laura and John Arnold Foundation. The work of Dr Ioannidis is supported by an unrestricted gift from Sue and Bob O'Donnell.	Benjamin DJ, 2018, NAT HUM BEHAV, V2, P6, DOI 10.1038/s41562-017-0189-z; Chavalarias D, 2016, JAMA-J AM MED ASSOC, V315, P1141, DOI 10.1001/jama.2016.1952; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Li X, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2376; Prasad V, 2013, JAMA-J AM MED ASSOC, V309, P241, DOI 10.1001/jama.2012.96867; Resnick B., WHAT NERDY DEBATE P; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108	7	344	348	2	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 10	2018	319	14					1429	1430		10.1001/jama.2018.1536	http://dx.doi.org/10.1001/jama.2018.1536			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GC2CR	29566133				2022-12-28	WOS:000429590200008
J	Slomski, A				Slomski, Anita			Benefits of Moderate Physical Activity Despite Frailty	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2018	319	12					1190	1190		10.1001/jama.2018.2789	http://dx.doi.org/10.1001/jama.2018.2789			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HI0BD	29584840				2022-12-28	WOS:000456106200006
J	Slomski, A				Slomski, Anita			Brief Psychotherapy for PTSD	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2018	319	12					1190	1190		10.1001/jama.2018.2791	http://dx.doi.org/10.1001/jama.2018.2791			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HI0BD	29584841				2022-12-28	WOS:000456106200007
J	Lutkenhaus, J				Lutkenhaus, Jodie			A radical advance for conducting polymers	SCIENCE			English	Editorial Material							CHARGE-TRANSPORT; BATTERY		[Lutkenhaus, Jodie] Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX 77843 USA; [Lutkenhaus, Jodie] Texas A&M Univ, Dept Mat Sci & Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Lutkenhaus, J (corresponding author), Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX 77843 USA.; Lutkenhaus, J (corresponding author), Texas A&M Univ, Dept Mat Sci & Engn, College Stn, TX 77843 USA.	jodie.lutkenhaus@tamu.edu		Lutkenhaus, Jodie/0000-0002-2613-6016				Hall LM, 2012, J AM CHEM SOC, V134, P574, DOI 10.1021/ja209142b; Joo Y, 2018, SCIENCE, V359, P1391, DOI 10.1126/science.aao7287; Kemper TW, 2014, J PHYS CHEM C, V118, P17213, DOI 10.1021/jp501628z; KUROSAKI T, 1972, J POLYM SCI POL CHEM, V10, P3295, DOI 10.1002/pol.1972.170101116; Muench S, 2016, CHEM REV, V116, P9438, DOI 10.1021/acs.chemrev.6b00070; Nakahara K, 2011, CHEM LETT, V40, P222, DOI 10.1246/cl.2011.222; Nishide H, 2004, ELECTROCHIM ACTA, V50, P827, DOI 10.1016/j.electacta.2004.02.052; Rostro L, 2013, ACS APPL MATER INTER, V5, P9896, DOI 10.1021/am403223s; Sato K, 2018, J AM CHEM SOC, V140, P1049, DOI 10.1021/jacs.7b11272; Tomlinson EP, 2014, MACROMOLECULES, V47, P6145, DOI 10.1021/ma5014572; Zhang YR, 2018, J MATER CHEM C, V6, P111, DOI [10.1039/C7TC04645F, 10.1039/c7tc04645f]	11	30	31	4	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2018	359	6382			SI		1334	1335		10.1126/science.aat1298	http://dx.doi.org/10.1126/science.aat1298			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA0ZG	29567695				2022-12-28	WOS:000428043600025
J	Sahin, U; Tureci, O				Sahin, Ugur; Tureci, Ozlem			Personalized vaccines for cancer immunotherapy	SCIENCE			English	Review							CYTOLYTIC T-LYMPHOCYTES; EXOME ANALYSIS REVEALS; MASS-SPECTROMETRY; CTLA-4 BLOCKADE; PD-1 BLOCKADE; CELLS; IMMUNITY; MUTATIONS; VECTORS; TOOLS	Cancer is characterized by an accumulation of genetic alterations. Somatic mutations can generate cancer-specific neoepitopes that are recognized by autologous T cells as foreign and constitute ideal cancer vaccine targets. Every tumor has its own unique composition of mutations, with only a small fraction shared between patients. Technological advances in genomics, data science, and cancer immunotherapy now enable the rapid mapping of the mutations within a genome, rational selection of vaccine targets, and on-demand production of a therapy customized to a patient's individual tumor. First-in-human clinical trials of personalized cancer vaccines have shown the feasibility, safety, and immunotherapeutic activity of targeting individual tumor mutation signatures. With vaccination development being promoted by emerging innovations of the digital age, vaccinating a patient with individual tumor mutations may become the first truly personalized treatment for cancer.	[Sahin, Ugur] Biopharmaceut New Technol BioNTech Corp, D-55131 Mainz, Germany; [Sahin, Ugur] Johannes Gutenberg Univ gGmbH, Univ Med Ctr, TRON Translat Oncol, D-55131 Mainz, Germany; [Sahin, Ugur] Johannes Gutenberg Univ Mainz, Univ Med Ctr, D-55131 Mainz, Germany; [Tureci, Ozlem] CI3 Cluster Individualized Immunointervent eV, D-55131 Mainz, Germany	BioNTech SE; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Sahin, U (corresponding author), Biopharmaceut New Technol BioNTech Corp, D-55131 Mainz, Germany.; Sahin, U (corresponding author), Johannes Gutenberg Univ gGmbH, Univ Med Ctr, TRON Translat Oncol, D-55131 Mainz, Germany.; Sahin, U (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, D-55131 Mainz, Germany.	sahin@uni-mainz.de						Abelin JG, 2017, IMMUNITY, V46, P315, DOI 10.1016/j.immuni.2017.02.007; Balachandran VP, 2017, NATURE, V551, P512, DOI 10.1038/nature24462; Banchereau J, 2001, CELL, V106, P271, DOI 10.1016/S0092-8674(01)00448-2; Bassani-Sternberg M, 2015, MOL CELL PROTEOMICS, V14, P658, DOI 10.1074/mcp.M114.042812; Carreno BM, 2015, SCIENCE, V348, P803, DOI 10.1126/science.aaa3828; Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Coulie PG, 2014, NAT REV CANCER, V14, P135, DOI 10.1038/nrc3670; Duan F, 2014, J EXP MED, V211, P2231, DOI 10.1084/jem.20141308; DURSO CM, 1991, J CLIN INVEST, V87, P284, DOI 10.1172/JCI114984; Ehrlich P., 1909, NED TIJDSCHR GENEES, V5, P273; Ewer KJ, 2016, CURR OPIN IMMUNOL, V41, P47, DOI 10.1016/j.coi.2016.05.014; FOLEY EJ, 1953, CANCER RES, V13, P835; Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kreiter S, 2015, NATURE, V520, P692, DOI 10.1038/nature14426; Laidlaw BJ, 2016, NAT REV IMMUNOL, V16, P102, DOI 10.1038/nri.2015.10; Laumont CM, 2018, CELL MOL LIFE SCI, V75, P607, DOI 10.1007/s00018-017-2628-4; Lin IYC, 2015, VACCINES-BASEL, V3, P940, DOI 10.3390/vaccines3040940; Liu XS, 2017, CELL, V168, P600, DOI 10.1016/j.cell.2017.01.014; Luksza M, 2017, NATURE, V551, P517, DOI 10.1038/nature24473; Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Melief C. J. M., 2018, ONCOIMMUNOLOGY PRACT, P249; Ott PA, 2017, NATURE, V547, P217, DOI 10.1038/nature22991; Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243; Rice J, 2008, NAT REV CANCER, V8, P108, DOI 10.1038/nrc2326; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Sahin U, 2017, NATURE, V547, P222, DOI 10.1038/nature23003; Schumacher T, 2014, NATURE, V512, P324, DOI 10.1038/nature13387; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Tran E, 2015, SCIENCE, V350, P1387, DOI 10.1126/science.aad1253; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Tureci O, 2016, CLIN CANCER RES, V22, P1885, DOI 10.1158/1078-0432.CCR-15-1509; TYZZER EE, 1916, J CANCER RES, V1, P125; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010; Zitvogel L, 2018, SCIENCE, V359, P1366, DOI 10.1126/science.aar6918	50	454	477	38	345	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2018	359	6382			SI		1355	1360		10.1126/science.aar7112	http://dx.doi.org/10.1126/science.aar7112			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA0ZG	29567706				2022-12-28	WOS:000428043600037
J	Abdi-Jalebi, M; Andaji-Garmaroudi, Z; Cacovich, S; Stavrakas, C; Philippe, B; Richter, JM; Alsari, M; Booker, EP; Hutter, EM; Pearson, AJ; Lilliu, S; Savenije, TJ; Rensmo, H; Divitini, G; Ducati, C; Friend, RH; Stranks, SD				Abdi-Jalebi, Mojtaba; Andaji-Garmaroudi, Zahra; Cacovich, Stefania; Stavrakas, Camille; Philippe, Bertrand; Richter, Johannes M.; Alsari, Mejd; Booker, Edward P.; Hutter, Eline M.; Pearson, Andrew J.; Lilliu, Samuele; Savenije, Tom J.; Rensmo, Hakan; Divitini, Giorgio; Ducati, Caterina; Friend, Richard H.; Stranks, Samuel D.			Maximizing and stabilizing luminescence from halide perovskites with potassium passivation	NATURE			English	Article							LEAD IODIDE PEROVSKITE; SOLAR-CELLS; THIN-FILMS; PERFORMANCE; SEGREGATION; EFFICIENCY; ABSORBER; CARRIERS; DEFECTS	Metal halide perovskites are of great interest for various high-performance optoelectronic applications(1). The ability to tune the perovskite bandgap continuously by modifying the chemical composition opens up applications for perovskites as coloured emitters, in building-integrated photovoltaics, and as components of tandem photovoltaics to increase the power conversion efficiency(2-4). Nevertheless, performance is limited by non-radiative losses, with luminescence yields in state-of-the-art perovskite solar cells still far from 100 per cent under standard solar illumination conditions(5-7). Furthermore, in mixed halide perovskite systems designed for continuous bandgap tunability(2) (bandgaps of approximately 1.7 to 1.9 electronvolts), photoinduced ion segregation leads to bandgap instabilities(8,9). Here we demonstrate substantial mitigation of both non-radiative losses and photoinduced ion migration in perovskite films and interfaces by decorating the surfaces and grain boundaries with passivating potassium halide layers. We demonstrate external photoluminescence quantum yields of 66 per cent, which translate to internal yields that exceed 95 per cent. The high luminescence yields are achieved while maintaining high mobilities of more than 40 square centimetres per volt per second, providing the elusive combination of both high luminescence and excellent charge transport(10). When interfaced with electrodes in a solar cell device stack, the external luminescence yielda quantity that must be maximized to obtain high efficiencyremains as high as 15 per cent, indicating very clean interfaces. We also demonstrate the inhibition of transient photoinduced ion-migration processes across a wide range of mixed halide perovskite bandgaps in materials that exhibit bandgap instabilities when unpassivated. We validate these results in fully operating solar cells. Our work represents an important advance in the construction of tunable metal halide perovskite films and interfaces that can approach the efficiency limits in tandem solar cells, coloured-light-emitting diodes and other optoelectronic applications.	[Abdi-Jalebi, Mojtaba; Andaji-Garmaroudi, Zahra; Stavrakas, Camille; Richter, Johannes M.; Alsari, Mejd; Booker, Edward P.; Pearson, Andrew J.; Friend, Richard H.; Stranks, Samuel D.] Univ Cambridge, Dept Phys, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England; [Cacovich, Stefania; Divitini, Giorgio; Ducati, Caterina] Univ Cambridge, Dept Mat Sci & Met, 27 Charles Babbage Rd, Cambridge CB3 0FS, England; [Philippe, Bertrand; Rensmo, Hakan] Uppsala Univ, Dept Phys & Astron, Box 516, S-75120 Uppsala, Sweden; [Hutter, Eline M.; Savenije, Tom J.] Delft Univ Technol, Dept Chem Engn, van der Maasweg 9, NL-2629 HZ Delft, Netherlands; [Lilliu, Samuele] Univ Sheffield, Dept Phys & Astron, Sheffield S3 7RH, S Yorkshire, England; [Lilliu, Samuele] UAE Ctr Crystallog, Abu Dhabi, U Arab Emirates	University of Cambridge; University of Cambridge; Uppsala University; Delft University of Technology; University of Sheffield	Stranks, SD (corresponding author), Univ Cambridge, Dept Phys, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England.	sds65@cam.ac.uk	LILLIU, SAMUELE/H-4763-2019; Divitini, Giorgio/I-4007-2019; Hutter, Eline/AAB-5304-2022; Jalebi, Mojtaba Abdi/V-1405-2017; Alsari, Mejd/X-6865-2019; Stranks, Samuel D/M-7837-2015; Cacovich, Stefania/P-4134-2018	LILLIU, SAMUELE/0000-0002-8449-2211; Divitini, Giorgio/0000-0003-2775-610X; Jalebi, Mojtaba Abdi/0000-0002-9430-6371; Alsari, Mejd/0000-0001-6005-4906; Stranks, Samuel D/0000-0002-8303-7292; Africa, Josephine/0000-0002-8117-9211; Cacovich, Stefania/0000-0002-6402-4816; Friend, Richard Henry/0000-0001-6565-6308; Hutter, Eline/0000-0002-5537-6545	Nava Technology Limited; Nyak Technology Limited; Winton Studentship; ICON Studentship from Lloyd's Register Foundation; European Union [PIOF-GA-2013-622630]; European Research Council (ERC) under European Union [756962]; Royal Society; Tata Group [UF150033]; Engineering and Physical Sciences Research Council (EPSRC); EPSRC; ERC [25961976]; Ministry of Presidential Affairs; Swedish research council [20146019]; Swedish foundation for strategic research; Netherlands Organization for Scientific Research under Echo grant [712.014.007]	Nava Technology Limited; Nyak Technology Limited; Winton Studentship; ICON Studentship from Lloyd's Register Foundation; European Union(European Commission); European Research Council (ERC) under European Union(European Research Council (ERC)); Royal Society(Royal Society of London); Tata Group; Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ERC(European Research Council (ERC)European Commission); Ministry of Presidential Affairs; Swedish research council(Swedish Research CouncilEuropean Commission); Swedish foundation for strategic research(Swedish Foundation for Strategic Research); Netherlands Organization for Scientific Research under Echo grant	M.A.-J. thanks Nava Technology Limited and Nyak Technology Limited for their funding and technical support. Z.A.-G. acknowledges funding from a Winton Studentship, and ICON Studentship from the Lloyd's Register Foundation. This project has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement number PIOF-GA-2013-622630, the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement number 756962), and the Royal Society and Tata Group (UF150033). We thank the Engineering and Physical Sciences Research Council (EPSRC) for support. XMaS is a mid-range facility at the European Synchrotron Radiation Facility supported by the EPSRC and we are grateful to the XMaS beamline team staff for their support. We thank Diamond Light Source for access to beamline I09 and staff member T.-L. Lee as well as U. Cappel for assistance during the HAXPES measurements. S.C., C.D. and G.D. acknowledge funding from the ERC under grant number 25961976 PHOTO EM and financial support from the European Union under grant number 77 312483 ESTEEM2. M. A. thanks the president of the UAE's Distinguished Student Scholarship Program, granted by the Ministry of Presidential Affairs. H.R. and B.P. acknowledge support from the Swedish research council (20146019) and the Swedish foundation for strategic research. E.M.H. and T.J.S. were supported by the Netherlands Organization for Scientific Research under the Echo grant number 712.014.007.	Abdi-Jalebi M, 2016, J PHYS CHEM LETT, V7, P3264, DOI 10.1021/acs.jpclett.6b01617; Abdi-Jalebi M, 2016, ADV ENERGY MATER, V6, DOI 10.1002/aenm.201502472; Agiorgousis ML, 2014, J AM CHEM SOC, V136, P14570, DOI 10.1021/ja5079305; Barker AJ, 2017, ACS ENERGY LETT, V2, P1416, DOI 10.1021/acsenergylett.7b00282; Bush KA, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.9; Dar MI, 2015, ADV MATER, V27, P7221, DOI 10.1002/adma.201503124; deMello JC, 1997, ADV MATER, V9, P230, DOI 10.1002/adma.19970090308; Dequilettes DW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11683; Deschler F, 2014, J PHYS CHEM LETT, V5, P1421, DOI 10.1021/jz5005285; Eperon GE, 2016, SCIENCE, V354, P861, DOI 10.1126/science.aaf9717; Hoke ET, 2015, CHEM SCI, V6, P613, DOI 10.1039/c4sc03141e; Hutter EM, 2017, NAT MATER, V16, P115, DOI [10.1038/nmat4765, 10.1038/NMAT4765]; Hutter EM, 2015, J PHYS CHEM LETT, V6, P3082, DOI 10.1021/acs.jpclett.5b01361; Kim J, 2014, J PHYS CHEM LETT, V5, P1312, DOI 10.1021/jz500370k; Kubicki DJ, 2017, J AM CHEM SOC, V139, P14173, DOI 10.1021/jacs.7b07223; McMeekin DP, 2016, SCIENCE, V351, P151, DOI 10.1126/science.aad5845; Miller OD, 2012, IEEE J PHOTOVOLT, V2, P303, DOI 10.1109/JPHOTOV.2012.2198434; Momblona C, 2016, ENERG ENVIRON SCI, V9, P3456, DOI 10.1039/c6ee02100j; Nam JK, 2017, NANO LETT, V17, P2028, DOI 10.1021/acs.nanolett.7b00050; Park BW, 2015, J MATER CHEM A, V3, P21760, DOI 10.1039/c5ta05470b; Pauca VP, 2006, LINEAR ALGEBRA APPL, V416, P29, DOI 10.1016/j.laa.2005.06.025; Pazos-Outon LM, 2016, SCIENCE, V351, P1430, DOI 10.1126/science.aaf1168; Philippe B, 2017, CHEM MATER, V29, P3589, DOI 10.1021/acs.chemmater.7b00126; Reid OG, 2016, ACS ENERGY LETT, V1, P561, DOI 10.1021/acsenergylett.6b00288; Richter JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13941; Saliba M, 2016, SCIENCE, V354, P206, DOI 10.1126/science.aah5557; Saliba M, 2016, ENERG ENVIRON SCI, V9, P1989, DOI 10.1039/c5ee03874j; Stoddard RJ, 2017, J PHYS CHEM LETT, V8, P3289, DOI 10.1021/acs.jpclett.7b01185; Stranks SD, 2017, ACS ENERGY LETT, V2, P1515, DOI 10.1021/acsenergylett.7b00239; Stranks SD, 2015, NAT NANOTECHNOL, V10, P391, DOI [10.1038/NNANO.2015.90, 10.1038/nnano.2015.90]; Stranks SD, 2014, PHYS REV APPL, V2, DOI 10.1103/PhysRevApplied.2.034007; Stranks SD, 2013, SCIENCE, V342, P341, DOI 10.1126/science.1243982; Sutter-Fella CM, 2016, NANO LETT, V16, P800, DOI 10.1021/acs.nanolett.5b04884; Tang ZG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12436-x; Yablonovitch E., 2012, P C LAS EL OPT 2012; Zhao P, 2017, J MATER CHEM A, V5, P7905, DOI 10.1039/c7ta01203a	36	1015	1030	99	1455	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2018	555	7697					497	+		10.1038/nature25989	http://dx.doi.org/10.1038/nature25989			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ9NF	29565365	Green Submitted, Green Accepted			2022-12-28	WOS:000427937900048
J	Smith, EI; Jacobs, Z; Johnsen, R; Ren, M; Fisher, EC; Oestmo, S; Wilkins, J; Harris, JA; Karkanas, P; Fitch, S; Ciravolo, A; Keenan, D; Cleghorn, N; Lane, CS; Matthews, T; Marean, CW				Smith, Eugene I.; Jacobs, Zenobia; Johnsen, Racheal; Ren, Minghua; Fisher, Erich C.; Oestmo, Sinlen; Wilkins, Jayne; Harris, Jacob A.; Karkanas, Panagiotis; Fitch, Shelby; Ciravolo, Amber; Keenan, Deborah; Cleghorn, Naomi; Lane, Christine S.; Matthews, Thalassa; Marean, Curtis W.			Humans thrived in South Africa through the Toba eruption about 74,000 years ago	NATURE			English	Article							VOLCANIC WINTER; 40AR/39AR AGE; ROCK SHELTER; TEPHROCHRONOLOGY; CAVE; TUFF; SUPERERUPTION; CHRONOLOGIES; DEPOSITS; SINGLE	Approximately 74 thousand years ago (ka), the Toba caldera erupted in Sumatra. Since the magnitude of this eruption was first established, its effects on climate, environment and humans have been debated(1). Here we describe the discovery of microscopic glass shards characteristic of the Youngest Toba. Tuff-ashfall from the Toba eruption-in two archaeological sites on the south coast of South Africa, a region in which there is evidence for early human behavioural complexity. An independently derived dating model supports a date of approximately 74 ka for the sediments containing the Youngest Toba Tuff glass shards. By defining the input of shards at both sites, which are located nine kilometres apart, we are able to establish a close temporal correlation between them. Our high-resolution excavation and sampling technique enable exact comparisons between the input of Youngest Toba. Tuff glass shards and the evidence for human occupation. Humans in this region thrived through the Toba event and the ensuing full glacial conditions, perhaps as a combined result of the uniquely rich resource base of the region and fully evolved modern human adaptation.	[Smith, Eugene I.; Johnsen, Racheal; Ren, Minghua; Fitch, Shelby; Ciravolo, Amber] Univ Nevada, Dept Geosci, 4505 Maryland Pkwy, Las Vegas, NV 89154 USA; [Jacobs, Zenobia] Univ Wollongong, Sch Earth & Environm Sci, ARC Ctr Excellence Australian Biodivers & Heritag, Wollongong, NSW 2522, Australia; [Jacobs, Zenobia] Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia; [Fisher, Erich C.; Harris, Jacob A.; Marean, Curtis W.] Arizona State Univ, Sch Human Evolut & Social Change, Inst Human Origins, POB 872402, Tempe, AZ 85287 USA; [Fisher, Erich C.; Oestmo, Sinlen; Cleghorn, Naomi; Marean, Curtis W.] Nelson Mandela Univ, African Ctr Coastal Palaeosci, ZA-6031 Port Elizabeth, Eastern Cape, South Africa; [Wilkins, Jayne] Univ Cape Town, Dept Archaeol, Human Evolut Res Inst, Private Bag, ZA-7701 Rondebosch, South Africa; [Karkanas, Panagiotis] Amer Sch Class Studies, Malcolm H Wiener Lab Archaeol Sci, Soudias 54, Athens 10676, Greece; [Keenan, Deborah] Geosci Consultants LLC, Henderson, NV 89014 USA; [Cleghorn, Naomi] Univ Texas Arlington, Dept Sociol & Anthropol, 701 South Nedderman Dr, Arlington, TX 76019 USA; [Lane, Christine S.] Univ Cambridge, Dept Geog, Downing Pl, Cambridge CB2 3EN, England; [Matthews, Thalassa] Iziko Museums South Afr, Queen Victoria St,POB 61, ZA-8000 Cape Town, South Africa	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Wollongong; University of Wollongong; Arizona State University; Arizona State University-Tempe; Nelson Mandela University; University of Cape Town; University of Texas System; University of Texas Arlington; University of Cambridge	Smith, EI (corresponding author), Univ Nevada, Dept Geosci, 4505 Maryland Pkwy, Las Vegas, NV 89154 USA.; Marean, CW (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Inst Human Origins, POB 872402, Tempe, AZ 85287 USA.; Marean, CW (corresponding author), Nelson Mandela Univ, African Ctr Coastal Palaeosci, ZA-6031 Port Elizabeth, Eastern Cape, South Africa.	curtis.marean@asu.edu	CABAH, ARC/T-6419-2019; Smith, Eugene/J-5614-2016; Jacobs, Zenobia/B-2721-2012; Karkanas, Panagiotis/AAD-1227-2020; Fisher, Erich/ABA-9374-2020; Smith, Eugene/J-4907-2019; Wilkins, Jayne/ABF-9501-2020; Karkanas, Panagiotis/N-3168-2019; Oestmo, Simen/D-6331-2013	Jacobs, Zenobia/0000-0001-5424-5837; Fisher, Erich/0000-0002-9499-6093; Wilkins, Jayne/0000-0003-2586-107X; Karkanas, Panagiotis/0000-0002-7156-671X; Cleghorn, Naomi/0000-0002-0120-1205; Oestmo, Simen/0000-0002-9662-4904; Smith, Eugene/0000-0002-3851-7983	National Science Foundation [BCS-0524087, BCS-1138073, BCS-1460366]; Hyde Family Foundations; John Templeton Foundation; Institute of Human Origins at Arizona State University; Late Lessons from Early History program at ASU; ASU Strategic Initiative Fund; Australian Research Council [DP1092843]; Leverhulme Trust; American-Scandinavian Foundation; NORAM; AAAS-Pacific Division; Alan E. Leviton Student Research Award; UNLV Department of Geoscience; Direct For Social, Behav & Economic Scie [1460376, 1460366] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Hyde Family Foundations; John Templeton Foundation; Institute of Human Origins at Arizona State University; Late Lessons from Early History program at ASU; ASU Strategic Initiative Fund; Australian Research Council(Australian Research Council); Leverhulme Trust(Leverhulme Trust); American-Scandinavian Foundation; NORAM; AAAS-Pacific Division; Alan E. Leviton Student Research Award; UNLV Department of Geoscience; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research was partially funded by the National Science Foundation (BCS-0524087 and BCS-1138073, C.W.M. and BCS-1460366, E.I.S. and C.W.M.), the Hyde Family Foundations (C.W.M.), the John Templeton Foundation (C.W.M.), the Institute of Human Origins at Arizona State University (C.W.M.), the Late Lessons from Early History program at ASU (C.W.M.), the ASU Strategic Initiative Fund, the Australian Research Council Discovery Project grant DP1092843 (Z.J.) and a Leverhulme Trust Early Career Fellowship (C.L.). S.O. thanks the American-Scandinavian Foundation and NORAM. A.C. was partially funded by an AAAS-Pacific Division, Alan E. Leviton Student Research Award and grants from the UNLV Department of Geoscience. We thank the MAPCRM staff for their assistance, T. Lachlan and Y. Jafari for help with OSL dating, the Dias Museum for field facilities and SAHRA and HWC for permits. The staff at the National Lacustrine Core Facility at the University of Minnesota (LacCore) provided a sample of Lake Malawi core for shard processing and analysis. M. Storey provided samples of YTT from Bukit Sapi, Malaysia. The opinions expressed in this publication are those of the author(s) and do not necessarily reflect the views of the funding agencies.	AHLBRANDT TS, 1978, J SEDIMENT PETROL, V48, P839; Ambrose SH, 1998, J HUM EVOL, V34, P623, DOI 10.1006/jhev.1998.0219; Bernatchez J., 2011, SAA ARCHAEOL REC, V11, P16; Blockley SPE, 2005, QUATERNARY SCI REV, V24, P1952, DOI 10.1016/j.quascirev.2004.12.008; BOTTERJENSEN L, 1988, NUCL TRACKS RAD MEAS, V14, P187; Brown FH, 2013, J ARCHAEOL SCI, V40, P3233, DOI 10.1016/j.jas.2013.03.011; Brown FH, 2006, J GEOL SOC LONDON, V163, P185, DOI 10.1144/0016-764904-165; Brown KS, 2012, NATURE, V491, P590, DOI 10.1038/nature11660; Chesner CA, 2010, J VOLCANOL GEOTH RES, V197, P259, DOI 10.1016/j.jvolgeores.2010.06.001; Dunbar NW, 2011, QUATERNARY SCI REV, V30, P1602, DOI 10.1016/j.quascirev.2011.03.015; Feakins SJ, 2007, J AFR EARTH SCI, V48, P341, DOI 10.1016/j.jafrearsci.2007.05.004; Fisher EC, 2015, J ARCHAEOL SCI, V57, P380, DOI 10.1016/j.jas.2015.02.022; Fontijn K, 2010, J VOLCANOL GEOTH RES, V196, P91, DOI 10.1016/j.jvolgeores.2010.07.021; Gelman A., 2013, BAYESIAN DATA ANAL, DOI [10.1201/b16018, DOI 10.1201/B16018]; Guerin G, 2012, RADIAT MEAS, V47, P778, DOI 10.1016/j.radmeas.2012.04.004; Haileab B., 1995, THESIS; Hashim N. B., 2014, THESIS; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Hildreth W, 1999, REV GEOL CHILE, V26, P275; Jacobs Z, 2003, J HUM EVOL, V44, P599, DOI 10.1016/S0047-2484(03)00048-4; Jacobs Z, 2015, J ARCHAEOL SCI, V63, P175, DOI 10.1016/j.jas.2015.01.023; Jacobs Z, 2012, J HUM EVOL, V62, P377, DOI 10.1016/j.jhevol.2011.12.001; Jacobs Z, 2010, J HUM EVOL, V59, P289, DOI 10.1016/j.jhevol.2010.07.010; Jensen BJL, 2014, GEOLOGY, V42, P875, DOI 10.1130/G35945.1; Jochum KP, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001060; Karkanas P, 2015, J HUM EVOL, V85, P1, DOI 10.1016/j.jhevol.2015.04.006; Lane CS, 2014, J ARCHAEOL SCI, V42, P42, DOI 10.1016/j.jas.2013.10.033; Lane CS, 2013, P NATL ACAD SCI USA, V110, P8025, DOI 10.1073/pnas.1301474110; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Marean CW, 2015, ANNU REV ANTHROPOL, V44, P533, DOI 10.1146/annurev-anthro-102313-025954; Marean CW, 2014, FYNBOS: ECOLOGY, EVOLUTION, AND CONSERVATION OF A MEGADIVERSE REGION, P164; Marean CW, 2010, J HUM EVOL, V59, P425, DOI 10.1016/j.jhevol.2010.07.011; Mark DF, 2014, QUAT GEOCHRONOL, V21, P90, DOI 10.1016/j.quageo.2012.12.004; Mercier N., 2007, TECHNIQUE, V25, P1; Oestmo S., 2015, FIELD ARCHAEOLOGY WO, P5955; Oestmo S, 2014, QUATERN INT, V350, P147, DOI 10.1016/j.quaint.2014.07.043; PRESCOTT JR, 1988, NUCL TRACKS RAD MEAS, V14, P223; Rampino MR, 2000, GEOL S AM S, P71; Ramsey CB, 2001, RADIOCARBON, V43, P355; Ramsey CB, 2009, RADIOCARBON, V51, P1023, DOI 10.1017/S0033822200034093; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Rhodes E., 2007, ANCIENT TL, V25, P5; Rhodes EJ, 2003, QUATERNARY SCI REV, V22, P1231, DOI 10.1016/S0277-3791(03)00046-5; Roberts RG, 1999, ARCHAEOMETRY, V41, P365, DOI 10.1111/j.1475-4754.1999.tb00988.x; Robock A, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011652; Smith MA, 1997, QUATERNARY SCI REV, V16, P299, DOI 10.1016/S0277-3791(96)00085-6; Smith VC, 2011, QUATERN INT, V246, P97, DOI 10.1016/j.quaint.2011.05.012; Storey M, 2012, P NATL ACAD SCI USA, V109, P18684, DOI 10.1073/pnas.1208178109; Svensson A, 2013, CLIM PAST, V9, P749, DOI 10.5194/cp-9-749-2013; Visser M. P. E., 2012, THESIS; Weller DJ, 2015, B VOLCANOL, V77, DOI 10.1007/s00445-015-0991-2; Westgate JA, 2013, J QUATERNARY SCI, V28, P772, DOI 10.1002/jqs.2672; Williams M, 2012, QUATERN INT, V258, P19, DOI 10.1016/j.quaint.2011.08.025; ZINNER E, 1986, INT J MASS SPECTROM, V69, P17, DOI 10.1016/0168-1176(86)87039-2	54	43	43	11	64	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 22	2018	555	7697					511	+		10.1038/nature25967	http://dx.doi.org/10.1038/nature25967			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FZ9NF	29531318	Green Published, Green Submitted			2022-12-28	WOS:000427937900051
J	Hooper, R; Forbes, A; Hemming, K; Takeda, A; Beresford, L				Hooper, Richard; Forbes, Andrew; Hemming, Karla; Takeda, Andrea; Beresford, Lee			Analysis of cluster randomised trials with an assessment of outcome at baseline	BMJ-BRITISH MEDICAL JOURNAL			English	Article							STATISTICS NOTES; STEPPED WEDGE; COVARIANCE; DESIGN; CARE	In a cluster randomised clinical trial, all the participants who belong to the same cluster (eg, a local community, school, or general practice) are randomised to receive the same treatment. People from the same cluster tend to be more similar than those from different clusters, and the analysis must allow for this. A common enhancement is to add an assessment of participants' outcomes in a baseline period-that is, before randomisation. Even if different participants are assessed at baseline and follow-up, the fact that they are sampled from the same cluster allows some control for cluster differences. But the analysis of cluster randomised trials is more complex than for individually randomised trials, and it is not obvious how best to adjust for baseline assessments. A variety of methods of analysis have been suggested: in this article, we describe different approaches and their flaws, and make recommendations.	[Hooper, Richard; Beresford, Lee] Queen Mary Univ London, Ctr Primary Care & Publ Hlth, London E1 2AB, England; [Forbes, Andrew] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Hemming, Karla] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Takeda, Andrea] UCL, UCL Inst Hlth Informat, London, England	University of London; Queen Mary University London; Monash University; University of Birmingham; University of London; University College London	Hooper, R (corresponding author), Queen Mary Univ London, Ctr Primary Care & Publ Hlth, London E1 2AB, England.	r.l.hooper@qmul.ac.uk	Hemming, karla/AAB-3391-2021	Hemming, karla/0000-0002-2226-6550; Hooper, Richard/0000-0002-1063-0917; Forbes, Andrew/0000-0003-4269-914X				Coffman CJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013096; Costantini M, 2014, LANCET, V383, P226, DOI 10.1016/S0140-6736(13)61725-0; Coventry P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h638; Girling AJ, 2016, STAT MED, V35, P2149, DOI 10.1002/sim.6850; He FJ, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h770; Hemming K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h391; Hooper R, 2016, STAT MED, V35, P4718, DOI 10.1002/sim.7028; Hooper R, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2925; Hussey MA, 2007, CONTEMP CLIN TRIALS, V28, P182, DOI 10.1016/j.cct.2006.05.007; Kahan BC, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1571-2; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kerry SM, 1998, BRIT MED J, V316, P1455, DOI 10.1136/bmj.316.7142.1455; Klar N, 2004, STAT MED, V23, P2341, DOI 10.1002/sim.1858; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Martin J, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1532-9; Morton V, 2003, BRIT MED J, V326, P1083, DOI 10.1136/bmj.326.7398.1083; Senn S, 2006, STAT MED, V25, P4334, DOI 10.1002/sim.2682; Teerenstra S, 2012, STAT MED, V31, P2169, DOI 10.1002/sim.5352; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; White IR, 2005, STAT MED, V24, P993, DOI 10.1002/sim.1981	20	30	30	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2018	360								k1121	10.1136/bmj.k1121	http://dx.doi.org/10.1136/bmj.k1121			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB1KT	29559436	Green Submitted, Bronze			2022-12-28	WOS:000428810400001
J	Heath, A; Javois, A; Freudenthal, F				Heath, Alexandra; Javois, Alexander; Freudenthal, Franz			Weaving Indigenous Textile Art Into Cardiac Devices	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PATENT DUCTUS-ARTERIOSUS; HIGH-ALTITUDE; CLOSURE		[Heath, Alexandra; Freudenthal, Franz] Kardiozentrum, Calle 14,669, La Paz 11111, Bolivia; [Javois, Alexander] Univ Illinois, Chicago, IL USA; [Javois, Alexander] Advocate Childrens Hosp, Oak Lawn, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Freudenthal, F (corresponding author), Kardiozentrum, Calle 14,669, La Paz 11111, Bolivia.	ff@pfm.ag						Bulut MO, 2016, PEDIATR CARDIOL, V37, P1258, DOI 10.1007/s00246-016-1426-3; Freudenthal FP, 2012, CARDIOL YOUNG, V22, P128, DOI 10.1017/S1047951111000990; Heath A, 2012, CATHETER CARDIO INTE, V79, P399, DOI 10.1002/ccd.23302; MIAO CY, 1988, J AM COLL CARDIOL, V12, P224, DOI 10.1016/0735-1097(88)90378-6; Moore JW, 2014, JACC-CARDIOVASC INTE, V7, P1430, DOI 10.1016/j.jcin.2014.06.019; Peirone A, 2014, CATHETER CARDIO INTE, V84, P464, DOI 10.1002/ccd.25434	6	1	1	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2018	319	10					966	967		10.1001/jama.2018.0387	http://dx.doi.org/10.1001/jama.2018.0387			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ0HS	29536074				2022-12-28	WOS:000427249700001
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Cancer patients should not be shamed	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Major B, 2014, J EXP SOC PSYCHOL, V51, P74, DOI 10.1016/j.jesp.2013.11.009; Sutin AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070048	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2018	360								k1139	10.1136/bmj.k1139	http://dx.doi.org/10.1136/bmj.k1139			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ9FT	29530882	Bronze, Green Published			2022-12-28	WOS:000427916100001
J	Nickenig, G; Schueler, R				Nickenig, Georg; Schueler, Robert			Mitral meets mortality	LANCET			English	Editorial Material							TO-EDGE REPAIR; REGURGITATION		[Nickenig, Georg; Schueler, Robert] Univ Bonn, Ctr Heart, D-53105 Bonn, Germany	University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf	Nickenig, G (corresponding author), Univ Bonn, Ctr Heart, D-53105 Bonn, Germany.	georg.nickenig@ukbonn.de	Schueler, Robert/Z-1059-2019					Dziadzko V, 2018, LANCET, V391, P960, DOI 10.1016/S0140-6736(18)30473-2; Enriquez-Sarano M, 2009, LANCET, V373, P1382, DOI 10.1016/S0140-6736(09)60692-9; Feldman T, 2014, J AM COLL CARDIOL, V63, P2057, DOI 10.1016/j.jacc.2014.01.039; Feldman T, 2011, NEW ENGL J MED, V364, P1395, DOI 10.1056/NEJMoa1009355; Harold JG, 2014, J AM COLL CARDIOL, V63, pE57, DOI 10.1016/j.jacc.2014.02.536; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Maisano F, 2016, EUR HEART J, V37, P817, DOI 10.1093/eurheartj/ehv603; Nickenig G, 2016, JACC-CARDIOVASC INTE, V9, P2039, DOI 10.1016/j.jcin.2016.07.005; Nickenig G, 2014, J AM COLL CARDIOL, V64, P875, DOI 10.1016/j.jacc.2014.06.1166; Pleger ST, 2011, AM J CARDIOL, V108, P1478, DOI 10.1016/j.amjcard.2011.06.069; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109	11	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 10	2018	391	10124					916	918		10.1016/S0140-6736(18)30500-2	http://dx.doi.org/10.1016/S0140-6736(18)30500-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ1UN	29536844				2022-12-28	WOS:000427363100008
J	Eugenio, G; Tavares, J; Marques, M; Duarte, C; da Silva, JAP				Eugenio, Gisela; Tavares, Joao; Marques, Mary; Duarte, Catia; da Silva, J. A. P.			Just a painful swelling of the ankles?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SARCOIDOSIS; TUBERCULOSIS; DIAGNOSIS; PET/CT		[Eugenio, Gisela; Marques, Mary; Duarte, Catia; da Silva, J. A. P.] Ctr Hosp Univ Coimbra, Coimbra, Portugal; [Tavares, Joao] Hosp Sao Teotonio Viseu, Viseu, Portugal	Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC)	Eugenio, G (corresponding author), Ctr Hosp Univ Coimbra, Coimbra, Portugal.	giselaeugenio@gmail.com	Da Silva, Jose/K-9769-2018; Duarte, Catia/N-9827-2016	Da Silva, Jose/0000-0002-2782-6780; Duarte, Catia/0000-0001-9327-6935				Blake Tristan, 2014, Dermatol Online J, V20, P22376; Booker AL, 2008, THORAX, V63, pA115; Cardoso AV, 2017, REV PORT PNEUMOL, V23, P251, DOI 10.1016/j.rppnen.2017.05.004; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Koo HJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001095; LOFGREN S, 1952, ACTA MED SCAND, V142, P265; Mana J, 1999, AM J MED, V107, P240, DOI 10.1016/S0002-9343(99)00223-5; Mana J, 1992, Sarcoidosis, V9, P118; Requena Luis, 2002, Dermatol Online J, V8, P4; Thi Hong Nguyen C, 2017, J DERMATOL, V44, P789, DOI 10.1111/1346-8138.13792; Treglia G, 2014, ACAD RADIOL, V21, P675, DOI 10.1016/j.acra.2014.01.008; Valeyre D, 2014, LANCET, V383, P1155, DOI 10.1016/S0140-6736(13)60680-7; Wessendorf TE, 2015, CLIN REV ALLERG IMMU, V49, P54, DOI 10.1007/s12016-015-8475-x	13	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2018	360								k436	10.1136/bmj.k436	http://dx.doi.org/10.1136/bmj.k436			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ1ZU	29523539				2022-12-28	WOS:000427376900001
J	Iacobucci, G				Iacobucci, Gareth			How can the NHS become a millennial friendly employer?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												giacobucci@bmj.com							0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2018	360								k1095	10.1136/bmj.k1095	http://dx.doi.org/10.1136/bmj.k1095			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ1ZU	29523506				2022-12-28	WOS:000427376900006
J	Li, XH; Chavali, PL; Babu, MM				Li, Xiao-Han; Chavali, Pavithra L.; Babu, M. Madan			Capturing dynamic protein interactions	SCIENCE			English	Editorial Material							THERMAL SHIFT ASSAY; DRUG; STABILITY; NETWORK; CELLS		[Li, Xiao-Han; Chavali, Pavithra L.; Babu, M. Madan] MRC, Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Li, XH (corresponding author), MRC, Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.	xli@mrc-lmb.cam.ac.uk; madanm@mrc-lmb.cam.ac.uk	Mohan, Babu P./I-7362-2019	Lakshminarasimhan Chavali, Pavithra/0000-0002-7525-5230; Li, Xiaohan/0000-0002-6007-5149	Medical Research Council [MC_U105185859]; European Research Council [ERC-COG-2015-682414]; MRC [MC_U105185859] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank G. Slodkowicz and M. M. Solano for reading the manuscript and the Medical Research Council (MC_U105185859) and European Research Council (ERC-COG-2015-682414; IDR-Seq) for financial support.	Bhowmick A, 2016, J AM CHEM SOC, V138, P9730, DOI 10.1021/jacs.6b06543; Ghosh K, 2010, BIOPHYS J, V99, P3996, DOI 10.1016/j.bpj.2010.10.036; Huber KVM, 2015, NAT METHODS, V12, P1055, DOI [10.1038/NMETH.3590, 10.1038/nmeth.3590]; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138; Leuenberger P, 2017, SCIENCE, V355, DOI 10.1126/science.aai7825; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Sahni N, 2015, CELL, V161, P647, DOI 10.1016/j.cell.2015.04.013; Savitski MM, 2014, SCIENCE, V346, P55, DOI 10.1126/science.1255784; Tan CSH, 2018, SCIENCE, V359, P1170, DOI 10.1126/science.aan0346; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106	12	13	14	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2018	359	6380					1105	1106		10.1126/science.aat0576	http://dx.doi.org/10.1126/science.aat0576			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY4ZM	29590031				2022-12-28	WOS:000426835900026
J	Sharif, J; Koseki, H				Sharif, Jafar; Koseki, Haruhiko			Hemimethylation: DNA's lasting odd couple	SCIENCE			English	Editorial Material							METHYLATION; PROTEIN; DNMT3B		[Sharif, Jafar; Koseki, Haruhiko] RIKEN, Dev Genet Grp, Ctr Integrat Med Sci IMS, 1-7-22 Suehiro, Yokohama, Kanagawa 2300045, Japan	RIKEN	Sharif, J (corresponding author), RIKEN, Dev Genet Grp, Ctr Integrat Med Sci IMS, 1-7-22 Suehiro, Yokohama, Kanagawa 2300045, Japan.	jafarsharif@riken.jp; haruhiko.koseki@riken.jp						Baubec T, 2015, NATURE, V520, P243, DOI 10.1038/nature14176; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Sharif J, 2016, CELL STEM CELL, V19, P81, DOI 10.1016/j.stem.2016.03.013; Takeshima H, 2006, J BIOCHEM, V139, P503, DOI 10.1093/jb/mvj044; Xu CH, 2018, SCIENCE, V359, P1166, DOI 10.1126/science.aan5480; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028; Zhao L, 2014, GENOME RES, V24, P1296, DOI 10.1101/gr.163147.113	11	6	6	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2018	359	6380					1102	1103		10.1126/science.aat0789	http://dx.doi.org/10.1126/science.aat0789			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY4ZM	29590029				2022-12-28	WOS:000426835900024
J	Kleinert, S; Horton, R				Kleinert, Sabine; Horton, Richard			Pathology and laboratory medicine: the Cinderella of health systems	LANCET			English	Editorial Material							AFRICA		[Kleinert, Sabine; Horton, Richard] The Lancet, London EC2Y 5AS, England		Kleinert, S (corresponding author), The Lancet, London EC2Y 5AS, England.				US National Cancer Institute; National Institutes of Health	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We declare no competing interests. We are grateful to the US National Cancer Institute, National Institutes of Health, for financial support to the initial writing meeting and the peer-review meeting. We thank Kenneth Fleming for leading this Series and all authors and peer reviewers for drafting and refining the Series papers.	Allemani C, 2018, LANCET, V391, P1023, DOI 10.1016/S0140-6736(17)33326-3; Biccard BM, 2018, LANCET, V391, P1589, DOI [10.1016/S0140-6736(18)30001-1, 10.1016/s0140-6736(18)30001-1]; Citron I, 2018, LANCET, V391, P1875, DOI 10.1016/S0140-6736(18)30310-6; Horton S, 2018, LANCET, V391, P1953, DOI 10.1016/S0140-6736(18)30460-4; Jaffar S, 2017, LANCET DIABETES ENDO, V5, P574, DOI 10.1016/S2213-8587(17)30219-X; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Nkengasong JN, 2018, LANCET, DOI [10.1016/S0140-6736(18)30310-6, DOI 10.1016/S0140-6736(18)30310-6]; Royal College of Pathologists, 2018, DISC PATH WHAT IS PA; Sayed S, 2018, LANCET, V391, P1939, DOI 10.1016/S0140-6736(18)30459-8; Wilson ML, 2018, LANCET, V391, P1927, DOI [10.1016/S0140-6736(18)30458-6, 10.1016/S0140-6736]; Znaor A, 2018, LANCET ONCOL, V19, pE85, DOI 10.1016/S1470-2045(18)30019-6	11	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2018	391	10133					1872	1873		10.1016/S0140-6736(18)30457-4	http://dx.doi.org/10.1016/S0140-6736(18)30457-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GF3NC	29550026				2022-12-28	WOS:000431861800007
J	Kasivisvanathan, V; Rannikko, AS; Borghi, M; Panebianco, V; Mynderse, LA; Vaarala, MH; Briganti, A; Budaus, L; Hellawell, G; Hindley, RG; Roobol, MJ; Eggener, S; Ghei, M; Villers, A; Bladou, F; Villeirs, GM; Virdi, J; Boxler, S; Robert, G; Singh, PB; Venderink, W; Hadaschik, BA; Ruffion, A; Hu, JC; Margolis, D; Crouzet, S; Klotz, L; Taneja, SS; Pinto, P; Gill, I; Allen, C; Giganti, F; Freeman, A; Morris, S; Punwani, S; Williams, NR; Brew-Graves, C; Deeks, J; Takwoingi, Y; Emberton, M; Moore, CM				Kasivisvanathan, V; Rannikko, A. S.; Borghi, M.; Panebianco, V; Mynderse, L. A.; Vaarala, M. H.; Briganti, A.; Budaus, L.; Hellawell, G.; Hindley, R. G.; Roobol, M. J.; Eggener, S.; Ghei, M.; Villers, A.; Bladou, F.; Villeirs, G. M.; Virdi, J.; Boxler, S.; Robert, G.; Singh, P. B.; Venderink, W.; Hadaschik, B. A.; Ruffion, A.; Hu, J. C.; Margolis, D.; Crouzet, S.; Klotz, L.; Taneja, S. S.; Pinto, P.; Gill, I; Allen, C.; Giganti, F.; Freeman, A.; Morris, S.; Punwani, S.; Williams, N. R.; Brew-Graves, C.; Deeks, J.; Takwoingi, Y.; Emberton, M.; Moore, C. M.		PRECISION Study Grp Collaborators	MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ULTRASOUND-GUIDED BIOPSY; MAGNETIC-RESONANCE; ACTIVE SURVEILLANCE; COST-EFFECTIVENESS; MEN; OUTCOMES; FUSION	BACKGROUND Multiparametric magnetic resonance imaging (MRI), with or without targeted biopsy, is an alternative to standard transrectal ultrasonography-guided biopsy for prostate-cancer detection in men with a raised prostate-specific antigen level who have not undergone biopsy. However, comparative evidence is limited. METHODS In a multicenter, randomized, noninferiority trial, we assigned men with a clinical suspicion of prostate cancer who had not undergone biopsy previously to undergo MRI, with or without targeted biopsy, or standard transrectal ultrasonography-guided biopsy. Men in the MRI-targeted biopsy group underwent a targeted biopsy (without standard biopsy cores) if the MRI was suggestive of prostate cancer; men whose MRI results were not suggestive of prostate cancer were not offered biopsy. Standard biopsy was a 10-to-12-core, transrectal ultrasonography-guided biopsy. The primary outcome was the proportion of men who received a diagnosis of clinically significant cancer. Secondary outcomes included the proportion of men who received a diagnosis of clinically insignificant cancer. RESULTS A total of 500 men underwent randomization. In the MRI-targeted biopsy group, 71 of 252 men (28%) had MRI results that were not suggestive of prostate cancer, so they did not undergo biopsy. Clinically significant cancer was detected in 95 men (38%) in the MRI-targeted biopsy group, as compared with 64 of 248 (26%) in the standard-biopsy group (adjusted difference, 12 percentage points; 95% confidence interval [CI], 4 to 20; P=0.005). MRI, with or without targeted biopsy, was noninferior to standard biopsy, and the 95% confidence interval indicated the superiority of this strategy over standard biopsy. Fewer men in the MRI-targeted biopsy group than in the standard-biopsy group received a diagnosis of clinically insignificant cancer (adjusted difference, -13 percentage points; 95% CI, -19 to -7; P < 0.001). CONCLUSIONS The use of risk assessment with MRI before biopsy and MRI-targeted biopsy was superior to standard transrectal ultrasonography-guided biopsy in men at clinical risk for prostate cancer who had not undergone biopsy previously.	[Kasivisvanathan, V; Allen, C.; Giganti, F.; Freeman, A.; Morris, S.; Punwani, S.; Emberton, M.; Moore, C. M.] UCL, London, England; [Kasivisvanathan, V; Allen, C.; Giganti, F.; Freeman, A.; Morris, S.; Punwani, S.; Emberton, M.; Moore, C. M.] UCL Hosp NHS Fdn Trust, London, England; [Hellawell, G.] London North West Healthcare NHS Trust, London, England; [Ghei, M.] Whittington Hlth NHS Trust, London, England; [Singh, P. B.] Royal Free London NHS Fdn Trust, London, England; [Williams, N. R.; Brew-Graves, C.] UCL Surg & Intervent Trials Unit, London, England; [Hindley, R. G.] Hampshire Hosp NHS Fdn Trust, Basingstoke, Hants, England; [Virdi, J.] Princess Alexandra Hosp NHS Trust, Harlow, Essex, England; [Deeks, J.; Takwoingi, Y.] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Deeks, J.; Takwoingi, Y.] Univ Birmingham, NIHR Birmingham Biomed Res Ctr, Birmingham, W Midlands, England; [Rannikko, A. S.] Univ Helsinki, Helsinki, Finland; [Rannikko, A. S.] Helsinki Univ Hosp, Helsinki, Finland; [Vaarala, M. H.] Univ Oulu, Med Res Ctr Oulu, Oulu, Finland; [Vaarala, M. H.] Oulu Univ Hosp, Oulu, Finland; [Borghi, M.] Ctr Urol, Buenos Aires, DF, Argentina; [Panebianco, V] Sapienza Univ, Rome, Italy; [Briganti, A.] Osped San Raffaele, IRCCS, Milan, Italy; [Briganti, A.] Univ Vita Salute San Raffaele, Milan, Italy; [Mynderse, L. A.] Mayo Clin, Rochester, MN USA; [Budaus, L.] Martini Klin, Hamburg, Germany; [Hadaschik, B. A.] Univ Hosp Essen, Essen, Germany; [Hadaschik, B. A.] Univ Hosp Heidelberg, Heidelberg, Germany; [Roobol, M. J.] Erasmus Univ, Med Ctr, Rotterdam, Netherlands; [Venderink, W.] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands; [Eggener, S.] Univ Chicago, Chicago, IL 60637 USA; [Villers, A.] Univ Lille, Lille, France; [Villers, A.] CHU Lille, Lille, France; [Robert, G.] Univ Bordeaux, Bordeaux, France; [Robert, G.] Bordeaux Pellegrin Univ Hosp, Bordeaux, France; [Ruffion, A.] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Lyon, France; [Crouzet, S.] Hop Edouard Herriot, Hosp Civils Lyon, Lyon, France; [Bladou, F.] Jewish Gen Hosp, Montreal, PQ, Canada; [Klotz, L.] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Villeirs, G. M.] Ghent Univ Hosp, Ghent, Belgium; [Boxler, S.] Univ Hosp Bern, Bern, Switzerland; [Hu, J. C.; Margolis, D.] Weill Cornell Med, New York Presbyterian Hosp, New York, NY USA; [Taneja, S. S.] NYU, Langone Med Ctr, New York, NY 10016 USA; [Pinto, P.] NIH, Bldg 10, Bethesda, MD 20892 USA; [Gill, I] Univ Southern Calif, Keck Sch Med, Inst Urol, Los Angeles, CA 90033 USA	University of London; University College London; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; University of London; University College London; Princess Alexandra Hospital NHS Trust; University of Birmingham; University of Birmingham; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Oulu; University of Oulu; Sapienza University Rome; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Mayo Clinic; University of Duisburg Essen; Ruprecht Karls University Heidelberg; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; University of Chicago; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; CHU Lyon; CHU Lyon; McGill University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Ghent University; Ghent University Hospital; University of Bern; University Hospital of Bern; Cornell University; NewYork-Presbyterian Hospital; New York University; NYU Langone Medical Center; National Institutes of Health (NIH) - USA; University of Southern California	Kasivisvanathan, V (corresponding author), UCL, Div Surg & Intervent Sci, 3rd Fl,Charles Bell House,43-45 Foley St, London W1W 7TS, England.	veeru.kasi@ucl.ac.uk	Witjes, Wim PJ/L-4760-2015; SCIARRA, ALESSANDRO/AAC-8088-2021; Deeks, Jon/AAV-5745-2020; Briganti, Alberto/AAN-1965-2020; Fütterer, Jürgen J/A-1455-2014; WILLIAMS, Norman/C-2002-2008; Mulders, Peter F.A./H-8076-2014; Stabile, Armando/AAB-7639-2022; Grierson, Jack/P-4437-2019; Brembilla, Giorgio/AAS-2238-2020; Freeman, Alex/J-8344-2019; DE COBELLI, Francesco/AAC-6488-2022; Leyh-Bannurah, Sami-Ramzi/AGY-2359-2022; Rannikko, Antti/ABB-8453-2020; Vaarala, Markku/B-4116-2013; Moore, Caroline/T-2391-2017; Rouviere, Olivier/O-8150-2017; VILLERS, Arnauld/K-6629-2016	Witjes, Wim PJ/0000-0002-3600-7920; Deeks, Jon/0000-0002-8850-1971; WILLIAMS, Norman/0000-0001-6496-312X; Stabile, Armando/0000-0002-3700-0069; Grierson, Jack/0000-0003-3952-5640; Brembilla, Giorgio/0000-0002-9690-8624; DE COBELLI, Francesco/0000-0003-4014-3711; Leyh-Bannurah, Sami-Ramzi/0000-0002-6156-2117; Rannikko, Antti/0000-0002-4261-3484; Vaarala, Markku/0000-0003-4735-815X; Taneja, Samir/0000-0003-0887-8259; Moore, Caroline/0000-0003-0202-7912; Rouviere, Olivier/0000-0002-0030-478X; emara, Amr/0000-0002-9278-8354; Brew-Graves, Chris/0000-0002-0266-0315; Takwoingi, Yemisi/0000-0002-5828-9746; Ramachandran, Navin/0000-0001-7063-7064; Pendse, Douglas/0000-0002-6326-4658; Sciarra, Alessandro/0000-0002-7899-8056; Kenttamies, Anu/0000-0002-3937-5307; VILLERS, Arnauld/0000-0002-6298-7758; El Sheikh, Soha/0000-0003-4661-1563; Kasivisvanathan, Veeru/0000-0002-0832-382X; Shah, Taimur/0000-0003-1642-1208; Morris, Stephen/0000-0002-5828-3563; Hadaschik, Boris/0000-0002-1052-2692	NIHR [DRF-2014-07-146, PDF-2017-10-059]; EAURF [2015001]; UCL Hospitals-UCL NIHR Biomedical Research Centre; NIHR Birmingham Biomedical Research Centre; National Institute for Health Research [09/22/67, NF-SI-0514-10059, DRF-2014-07-146, PDF-2017-10-059, CL-2007-18-015] Funding Source: researchfish	NIHR(National Institute for Health Research (NIHR)); EAURF; UCL Hospitals-UCL NIHR Biomedical Research Centre; NIHR Birmingham Biomedical Research Centre; National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by the NIHR through a doctoral fellowship award (DRF-2014-07-146, to Dr. Kasivisvanathan) and by a grant (2015001) from the EAURF. This article presents independent research funded by the NIHR and EAURF. Dr. Deeks is a United Kingdom NIHR Senior Investigator Emeritus and has received support from the NIHR Birmingham Biomedical Research Centre. Dr. Takwoingi is supported by the NIHR through a postdoctoral fellowship award (PDF-2017-10-059). Dr. Emberton is a United Kingdom NIHR Senior Investigator and receives research support from UCL Hospitals-UCL NIHR Biomedical Research Centre.	Ahmed HU, 2017, LANCET, V389, P815, DOI 10.1016/S0140-6736(16)32401-1; Baco E, 2016, EUR UROL, V69, P149, DOI 10.1016/j.eururo.2015.03.041; Brimo F, 2010, J UROLOGY, V184, P126, DOI 10.1016/j.juro.2010.03.021; Cerantola Y, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2015.09.010; Chen RC, 2017, JAMA-J AM MED ASSOC, V317, P1141, DOI 10.1001/jama.2017.1652; de Rooij M, 2014, EUR UROL, V66, P430, DOI 10.1016/j.eururo.2013.12.012; Dickinson L, 2011, EUR UROL, V59, P477, DOI 10.1016/j.eururo.2010.12.009; Egger SJ, 2017, EUR UROL; Eldefrawy A, 2013, UROL ONCOL-SEMIN ORI, V31, P576, DOI 10.1016/j.urolonc.2011.04.005; Faria R, 2018, EUR UROL, V73, P23, DOI 10.1016/j.eururo.2017.08.018; Feng Y, 2018, HEALTH ECON, V27, P23, DOI 10.1002/hec.3560; Haffner J, 2011, BJU INT, V108, pE171, DOI 10.1111/j.1464-410X.2011.10112.x; Hamdy FC, 2016, NEW ENGL J MED, V375, P1415, DOI 10.1056/NEJMoa1606220; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Janssen MF, 2013, QUAL LIFE RES, V22, P1717, DOI 10.1007/s11136-012-0322-4; Kasivisvanathan V, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017863; Loudon K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2147; Maurice MJ, 2015, JAMA INTERN MED, V175, P1569, DOI 10.1001/jamainternmed.2015.2835; Moore CM, 2013, EUR UROL, V64, P544, DOI 10.1016/j.eururo.2013.03.030; Panebianco V, 2015, UROL ONCOL-SEMIN ORI, V33, DOI 10.1016/j.urolonc.2014.09.013; Porpiglia F, 2017, EUR UROL, V72, P282, DOI 10.1016/j.eururo.2016.08.041; Rhudd A, 2017, CURR OPIN UROL, V27, P488, DOI 10.1097/MOU.0000000000000415; Rosario DJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7894; Rosenkrantz AB, 2016, RADIOLOGY, V280, P793, DOI 10.1148/radiol.2016152542; Schoots IG, 2015, EUR UROL, V68, P438, DOI 10.1016/j.eururo.2014.11.037; Siddiqui MM, 2015, JAMA-J AM MED ASSOC, V313, P390, DOI 10.1001/jama.2014.17942; Tonttila PP, 2016, EUR UROL, V69, P419, DOI 10.1016/j.eururo.2015.05.024; Wegelin O, 2017, EUR UROL, V71, P517, DOI 10.1016/j.eururo.2016.07.041; Weinreb JC, 2016, EUR UROL, V69, P16, DOI 10.1016/j.eururo.2015.08.052; Wilt TJ, 2017, NEW ENGL J MED, V377, P132, DOI 10.1056/NEJMoa1615869; Wysock JS, 2014, EUR UROL, V66, P343, DOI 10.1016/j.eururo.2013.10.048	31	1456	1493	11	140	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2018	378	19					1767	1777		10.1056/NEJMoa1801993	http://dx.doi.org/10.1056/NEJMoa1801993			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF2MO	29552975	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000431774400004
J	Rosenberg, AB; Roco, CM; Muscat, RA; Kuchina, A; Sample, P; Yao, ZZ; Graybuck, LT; Peeler, DJ; Mukherjee, S; Chen, W; Pun, SH; Sellers, DL; Tasic, B; Seelig, G				Rosenberg, Alexander B.; Roco, Charles M.; Muscat, Richard A.; Kuchina, Anna; Sample, Paul; Yao, Zizhen; Graybuck, Lucas T.; Peeler, David J.; Mukherjee, Sumit; Chen, Wei; Pun, Suzie H.; Sellers, Drew L.; Tasic, Bosiljka; Seelig, Georg			Single-cell profiling of the developing mouse brain and spinal cord with split-pool barcoding	SCIENCE			English	Article							RNA-SEQ; CEREBELLAR CORTEX; MOTOR-NEURONS; EXPRESSION; TRANSCRIPTOMICS; HIPPOCAMPUS; DIVERSITY; INTERNEURONS; PRECURSORS; SUBTYPES	To facilitate scalable profiling of single cells, we developed split-pool ligation-based transcriptome sequencing (SPLiT-seq), a single-cell RNA-seq (scRNA-seq) method that labels the cellular origin of RNA through combinatorial barcoding. SPLiT-seq is compatible with fixed cells or nuclei, allows efficient sample multiplexing, and requires no customized equipment. We used SPLiT-seq to analyze 156,049 single-nucleus transcriptomes from postnatal day 2 and 11 mouse brains and spinal cords. More than 100 cell types were identified, with gene expression patterns corresponding to cellular function, regional specificity, and stage of differentiation. Pseudotime analysis revealed transcriptional programs driving four developmental lineages, providing a snapshot of early postnatal development in the murine central nervous system. SPLiT-seq provides a path toward comprehensive single-cell transcriptomic analysis of other similarly complex multicellular systems.	[Rosenberg, Alexander B.; Muscat, Richard A.; Kuchina, Anna; Sample, Paul; Mukherjee, Sumit; Seelig, Georg] Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA; [Roco, Charles M.; Peeler, David J.; Pun, Suzie H.; Sellers, Drew L.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Yao, Zizhen; Graybuck, Lucas T.; Tasic, Bosiljka] Allen Inst Brain Sci, Seattle, WA USA; [Chen, Wei; Seelig, Georg] Univ Washington, Mol Engn & Sci Inst, Seattle, WA 98195 USA; [Sellers, Drew L.] Inst Stem Cell & Regenerat Med, Seattle, WA USA; [Seelig, Georg] Univ Washington, Paul G Allen Sch Comp Sci & Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Allen Institute for Brain Science; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rosenberg, AB (corresponding author), Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA.; Seelig, G (corresponding author), Univ Washington, Mol Engn & Sci Inst, Seattle, WA 98195 USA.; Seelig, G (corresponding author), Univ Washington, Paul G Allen Sch Comp Sci & Engn, Seattle, WA 98195 USA.	alex.b.rosenberg@gmail.com; gseelig@uw.edu	Peeler, David J/M-2673-2014	Peeler, David J/0000-0003-2441-6409; Rosenberg, Alexander/0000-0003-2276-2412; Yao, Zizhen/0000-0002-9361-5607; Roco, Charles/0000-0002-6493-000X; Muscat, Richard/0000-0003-1509-5674; Graybuck, Lucas/0000-0002-8814-6818; Sample, Paul/0000-0001-6092-4449; Mukherjee, Sumit/0000-0001-6532-3343	NIH [R01CA207029, R01NS064404, R21NS086500]; NSF [CCF-1317653]; Allen Institute for Brain Science; National Center for Advancing Translational Sciences of the National Institutes of Health [TL1 TR002318]; NATIONAL CANCER INSTITUTE [R01CA207029] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR002318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS086500, R01NS064404] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Allen Institute for Brain Science; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH R01CA207029 and NSF CCF-1317653 to G.S. and NIH R01NS064404 and R21NS086500 to S.H.P. Z.Y., L.T.G., and B.T. were supported by the Allen Institute for Brain Science. C.M.R. was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number TL1 TR002318.	Allen Institute for Brain Science, 2008, DEV MOUS BRAIN ATL; Allen Institute for Brain Science, 2008, ALL MOUS SPIN CORD A; ALTMAN J, 1987, J COMP NEUROL, V257, P477, DOI 10.1002/cne.902570402; Bonnet F, 1996, J BIOL CHEM, V271, P4373; Chang JC, 2015, J NEUROPATH EXP NEUR, V74, P261, DOI 10.1097/NEN.0000000000000171; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Enjin A, 2010, J COMP NEUROL, V518, P2284, DOI 10.1002/cne.22332; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Herculano-Houzel S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.031.2009; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Iwano T, 2012, DEVELOPMENT, V139, P3051, DOI 10.1242/dev.080002; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Lacar B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11022; Lake BB, 2016, SCIENCE, V352, P1586, DOI 10.1126/science.aaf1204; Lalancette-Hebert M, 2016, P NATL ACAD SCI USA, V113, pE8316, DOI 10.1073/pnas.1605210113; Lavado A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000460; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Maricich SM, 1999, J NEUROBIOL, V41, P281, DOI 10.1002/(SICI)1097-4695(19991105)41:2<281::AID-NEU10>3.0.CO;2-5; Marques S, 2016, SCIENCE, V352, P1326, DOI 10.1126/science.aaf6463; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Moignard V, 2015, NAT BIOTECHNOL, V33, P269, DOI 10.1038/nbt.3154; Nakashima K, 2015, DEV DYNAM, V244, P748, DOI 10.1002/dvdy.24276; Petracca YL, 2016, DEVELOPMENT, V143, P880, DOI 10.1242/dev.129254; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Schilling K, 2008, HISTOCHEM CELL BIOL, V130, P601, DOI 10.1007/s00418-008-0483-y; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Sudarov A, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-26; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Thomsen ER, 2016, NAT METHODS, V13, P87, DOI [10.1038/NMETH.3629, 10.1038/nmeth.3629]; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Venteicher AS, 2017, SCIENCE, V355, DOI 10.1126/science.aai8478; Weisheit G, 2006, EUR J NEUROSCI, V24, P466, DOI 10.1111/j.1460-9568.2006.04915.x; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	42	494	529	24	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2018	360	6385					176	+		10.1126/science.aam8999	http://dx.doi.org/10.1126/science.aam8999			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC5DK	29545511	Green Accepted, Green Submitted			2022-12-28	WOS:000429805400040
J	Bedrosian, TA; Quayle, C; Novaresi, N; Gage, FH				Bedrosian, Tracy A.; Quayle, Carolina; Novaresi, Nicole; Gage, Fred. H.			Early life experience drives structural variation of neural genomes in mice	SCIENCE			English	Article							L1 RETROTRANSPOSITION; MATERNAL SEPARATION; SOMATIC MOSAICISM; FEAR RESPONSES; C57BL/6 MICE; HUMAN BRAIN; ANXIETY; CARE; RAT; ENVIRONMENT	The brain is a genomic mosaic owing to somatic mutations that arise throughout development. Mobile genetic elements, including retrotransposons, are one source of somatic mosaicism in the brain. Retrotransposition may represent a form of plasticity in response to experience. Here, we use droplet digital polymerase chain reaction to show that natural variations in maternal care mediate the mobilization of long interspersed nuclear element-1 (LINE-1 or L1) retrotransposons in the hippocampus of the mouse brain. Increasing the amount of maternal care blocks the accumulation of L1. Maternal care also alters DNA methylation at YY1 binding sites implicated in L1 activation and affects expression of the de novo methyltransferase DNMT3a. Our observations indicate that early life experience drives somatic variation in the genome via L1 retrotransposons.	[Bedrosian, Tracy A.; Quayle, Carolina; Novaresi, Nicole; Gage, Fred. H.] Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	Salk Institute	Bedrosian, TA; Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	tbedrosian@salk.edu; gage@salk.edu		Gage, Fred/0000-0002-0938-4106	NIH [R01 MH095741, U01 MH106882, F32 MH102983]; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED00]; Engman Foundation; Annette C. Merle-Smith, Takeda Pharmaceutical International; The JPB Foundation; National Alliance for Research on Schizophrenia and Depression Young Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH106882, R01MH095741, F32MH102983] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Engman Foundation; Annette C. Merle-Smith, Takeda Pharmaceutical International; The JPB Foundation; National Alliance for Research on Schizophrenia and Depression Young Investigator Award(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH R01 MH095741, NIH U01 MH106882, The G. Harold and Leila Y. Mathers Charitable Foundation, The Leona M. and Harry B. Helmsley Charitable Trust grant 2012-PG-MED00, The Engman Foundation, Annette C. Merle-Smith, Takeda Pharmaceutical International, The JPB Foundation, NIH F32 MH102983 (T.A.B), and a National Alliance for Research on Schizophrenia and Depression Young Investigator Award (T.A.B.).	Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; BAYER SA, 1980, J COMP NEUROL, V190, P87, DOI 10.1002/cne.901900107; Bedrosian TA, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0317-9; Brown SE, 2008, NEUROSCI LETT, V440, P49, DOI 10.1016/j.neulet.2008.05.028; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Erwin JA, 2014, NAT REV NEUROSCI, V15, P497, DOI 10.1038/nrn3730; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Lee SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011353; Macri S, 2004, EUR J NEUROSCI, V20, P1017, DOI 10.1111/j.1460-9568.2004.03541.x; Macri S, 2006, HORM BEHAV, V50, P667, DOI 10.1016/j.yhbeh.2006.06.015; Millstein RA, 2007, NEUROSCI BIOBEHAV R, V31, P3, DOI 10.1016/j.neubiorev.2006.05.003; Misiak B, 2015, EPIGENOMICS-UK, V7, P1275, DOI 10.2217/epi.15.68; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Natt D, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0123-z; Own LS, 2013, HORM BEHAV, V63, P411, DOI 10.1016/j.yhbeh.2012.11.010; Romeo RD, 2003, HORM BEHAV, V43, P561, DOI 10.1016/S0018-506X(03)00063-1; Sookdeo A, 2013, MOBILE DNA-UK, V4, DOI 10.1186/1759-8753-4-3; Upton KR, 2015, CELL, V161, P228, DOI 10.1016/j.cell.2015.03.026; Weaver ICG, 2006, P NATL ACAD SCI USA, V103, P3480, DOI 10.1073/pnas.0507526103; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276	22	78	77	3	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2018	359	6382			SI		1395	+		10.1126/science.aah3378	http://dx.doi.org/10.1126/science.aah3378			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA0ZG	29567711				2022-12-28	WOS:000428043600044
J	Gao, L; Wu, KL; Liu, ZB; Yao, XL; Yuan, SL; Tao, WR; Yi, LZ; Yu, GL; Hou, ZZ; Fan, DD; Tian, Y; Liu, JQ; Chen, ZJ; Liu, J				Gao, Lei; Wu, Keliang; Liu, Zhenbo; Yao, Xuelong; Yuan, Shenli; Tao, Wenrong; Yi, Lizhi; Yu, Guanling; Hou, Zhenzhen; Fan, Dongdong; Tian, Yong; Liu, Jianqiao; Chen, Zi-Jiang; Liu, Jiang			Chromatin Accessibility Landscape in Human Early Embryos and Its Association with Evolution	CELL			English	Article							HUMAN PREIMPLANTATION EMBRYOS; PARENTAL DNA METHYLOMES; MOUSE EARLY EMBRYOS; TRANSPOSABLE ELEMENTS; METHYLATION; REVEALS; H3K4ME3; RETROTRANSPOSONS; INHERITANCE; EXPRESSION	The dynamics of the chromatin regulatory landscape during human early embryogenesis remains unknown. Using DNase I hypersensitive site (DHS) sequencing, we report that the chromatin accessibility landscape is gradually established during human early embryogenesis. Interestingly, the DHSs with OCT4 binding motifs are enriched at the timing of zygotic genome activation (ZGA) in humans, but not in mice. Consistently, OCT4 contributes to ZGA in humans, but not in mice. We further find that lower CpG promoters usually establish DHSs at later stages. Similarly, younger genes tend to establish promoter DHSs and are expressed at later embryonic stages, while older genes exhibit these features at earlier stages. Moreover, our data show that human active transposons SVA and HERV-K harbor DHSs and are highly expressed in early embryos, but not in differentiated tissues. In summary, our data provide an evolutionary developmental view for understanding the regulation of gene and transposon expression.	[Gao, Lei; Liu, Zhenbo; Yao, Xuelong; Yuan, Shenli; Yi, Lizhi; Liu, Jiang] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing 100101, Peoples R China; [Wu, Keliang; Tao, Wenrong; Yu, Guanling; Hou, Zhenzhen; Chen, Zi-Jiang] Shandong Univ, Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Key Lab Reprod Endocrinol, Ctr Reprod Med,Minist Educ, Jinan 250001, Shandong, Peoples R China; [Yao, Xuelong; Yuan, Shenli; Yi, Lizhi] Univ Chinese Acad Sci, CAS Ctr Excellence Anim Evolut & Genet, Beijing 100049, Peoples R China; [Fan, Dongdong; Tian, Yong] Univ Chinese Acad Sci, Chinese Acad Sci, Inst Biophys, Key Lab RNA Biol CAS, Beijing 100101, Peoples R China; [Liu, Jianqiao] Guangzhou Med Univ, Affiliated Hosp 3, Ctr Reprod Med, Guangzhou 510150, Guangdong, Peoples R China; [Liu, Jiang] Univ Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Shandong University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Chinese Academy of Sciences, CAS; Guangzhou Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, J (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing 100101, Peoples R China.; Chen, ZJ (corresponding author), Shandong Univ, Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Key Lab Reprod Endocrinol, Ctr Reprod Med,Minist Educ, Jinan 250001, Shandong, Peoples R China.; Liu, JQ (corresponding author), Guangzhou Med Univ, Affiliated Hosp 3, Ctr Reprod Med, Guangzhou 510150, Guangdong, Peoples R China.; Liu, J (corresponding author), Univ Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Beijing 100049, Peoples R China.	ljq88gz@163.com; chenzijiang@hotmail.com; liuj@big.ac.cn	TIAN, YONG/ABF-4406-2021; Wu, Ke/HCQ-3503-2022; Gao, Lei/X-4824-2018; TIAN, YONG/L-2414-2019; Yan, Junhao/AAH-8310-2019; Li, Yuan/GXV-1310-2022; Chen, Zi-Jiang/GOE-6119-2022	Gao, Lei/0000-0002-0882-7518; TIAN, YONG/0000-0002-8790-1148; Liu, Jiang/0000-0002-5687-5047; Chen, Zi-Jiang/0000-0001-6637-6631	Chinese Academy of Sciences [XDB13040200]; National Key RD Program [2015CB856200]; National Natural Science Foundation of China [91731312, 31425015, 31601052, 31561130152, 81601256]; CAS [QYZDY-SSW-SMC016]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Key RD Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS(Chinese Academy of Sciences)	This work was supported by the grants from the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB13040200), The National Key R&D Program (2015CB856200), National Natural Science Foundation of China (91731312, 31425015, 31601052, 31561130152, and 81601256), and CAS (QYZDY-SSW-SMC016). We thank Li Lan for the language editing.	Baczkowski Tomasz, 2004, Reprod Biol, V4, P5; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Bennett EA, 2008, GENOME RES, V18, P1875, DOI 10.1101/gr.081737.108; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Burns KH, 2012, CELL, V149, P740, DOI 10.1016/j.cell.2012.04.019; Ci WM, 2015, PHYSIOLOGY, V30, P63, DOI 10.1152/physiol.00037.2014; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; Dahl JA, 2016, NATURE, V537, P548, DOI 10.1038/nature19360; Dang YJ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0991-3; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Domazet-Loso T, 2008, MOL BIOL EVOL, V25, P2699, DOI 10.1093/molbev/msn214; Domazet-Loso T, 2010, NATURE, V468, P815, DOI 10.1038/nature09632; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ferrier DEK, 2001, NAT REV GENET, V2, P33, DOI 10.1038/35047605; Fogarty NME, 2017, NATURE, V550, P67, DOI 10.1038/nature24033; Friedli M, 2015, ANNU REV CELL DEV BI, V31, P429, DOI 10.1146/annurev-cellbio-100814-125514; Grow EJ, 2015, NATURE, V522, P221, DOI 10.1038/nature14308; Guo F, 2017, CELL RES, V27, P967, DOI 10.1038/cr.2017.82; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ishibashi R, 2016, J BIOL CHEM, V291, P3333, DOI 10.1074/jbc.M115.679563; Jin WF, 2015, NATURE, V528, P142, DOI 10.1038/nature15740; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Bin GC, 2014, DEVELOPMENT, V141, P1001, DOI 10.1242/dev.096875; Li GQ, 2017, J GENET GENOMICS, V44, P475, DOI 10.1016/j.jgg.2017.09.001; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu XY, 2016, NATURE, V537, P558, DOI 10.1038/nature19362; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu FL, 2016, CELL, V165, P1375, DOI 10.1016/j.cell.2016.05.050; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mills RE, 2007, TRENDS GENET, V23, P183, DOI 10.1016/j.tig.2007.02.006; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Neme R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-117; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rossant J, 2017, CELL STEM CELL, V20, P18, DOI 10.1016/j.stem.2016.12.004; Roy TK, 2014, FERTIL STERIL, V101, P1294, DOI 10.1016/j.fertnstert.2014.01.046; Santoni FA, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-111; Shirasawa H, 2013, J ASSIST REPROD GEN, V30, P1227, DOI 10.1007/s10815-013-0040-z; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Subramanian RP, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-90; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Than NG, 2009, P NATL ACAD SCI USA, V106, P9731, DOI 10.1073/pnas.0903568106; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vierstra J, 2014, SCIENCE, V346, P1007, DOI 10.1126/science.1246426; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Zhang BJ, 2016, NATURE, V537, P553, DOI 10.1038/nature19361	67	101	108	2	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 22	2018	173	1					248	+		10.1016/j.cell.2018.02.028	http://dx.doi.org/10.1016/j.cell.2018.02.028			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GA3MT	29526463	Bronze			2022-12-28	WOS:000428234200022
J	van Berlo, JH; Kanisicak, O; Maillet, M; Vagnozzi, RJ; Karch, J; Lin, SCJ; Middleton, RC; Marban, E; Molkentin, JD				van Berlo, Jop H.; Kanisicak, Onur; Maillet, Marjorie; Vagnozzi, Ronald J.; Karch, Jason; Lin, Suh-Chin J.; Middleton, Ryan C.; Marban, Eduardo; Molkentin, Jeffery D.			Kit(cre) knock-in mice fail to fate-map cardiac stem cells reply	NATURE			English	Letter							C-KIT(+) CELLS; REGENERATION; MULTIPOTENT; SUFFICIENT		[van Berlo, Jop H.] Univ Minnesota, Dept Med, Div Cardiol, Lillehei Heart Inst, Box 736 UMHC, Minneapolis, MN 55455 USA; [Kanisicak, Onur; Maillet, Marjorie; Vagnozzi, Ronald J.; Karch, Jason; Lin, Suh-Chin J.; Molkentin, Jeffery D.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Middleton, Ryan C.; Marban, Eduardo] Cedars Sinai Heart Inst, 8700 Beverly Blvd, Los Angeles, CA USA; [Molkentin, Jeffery D.] Cincinnati Childrens Hosp Med Ctr, Howard Hughes Med Inst, Cincinnati, OH 45229 USA	University of Minnesota System; University of Minnesota Twin Cities; Cincinnati Children's Hospital Medical Center; Cedars Sinai Medical Center; Cincinnati Children's Hospital Medical Center; Howard Hughes Medical Institute	Molkentin, JD (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA.; Molkentin, JD (corresponding author), Cincinnati Childrens Hosp Med Ctr, Howard Hughes Med Inst, Cincinnati, OH 45229 USA.	Jeff.Molkentin@cchmc.org	Marban, Eduardo/GWC-8514-2022; Vagnozzi, Ronald/AAR-6891-2020; Kanisicak, Onur/AAU-4586-2020	Vagnozzi, Ronald/0000-0002-8027-1809; Kanisicak, Onur/0000-0002-8393-4874; Molkentin, Jeffery/0000-0002-3558-6529; van Berlo, Jop/0000-0001-9229-4429	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130072] Funding Source: NIH RePORTER; American Heart Association-American Stroke Association [15POST25480009] Funding Source: Medline; NHLBI NIH HHS [R01 HL130072] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association-American Stroke Association(American Heart Association); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039; Eschenhagen T, 2017, CIRCULATION, V136, P680, DOI 10.1161/CIRCULATIONAHA.117.029343; Kanisicak O, 2017, CIRC RES, V121, P1130, DOI 10.1161/CIRCRESAHA.117.311921; Liu QZ, 2016, CELL RES, V26, P119, DOI 10.1038/cr.2015.143; Molkentin JD, 2014, CIRC RES, V115, pE21, DOI 10.1161/CIRCRESAHA.114.305011; Sultana N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9701; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; Vicinanza C, 2018, NATURE, V555, pE1, DOI 10.1038/nature25771; Vicinanza C, 2017, CELL DEATH DIFFER, V24, P2101, DOI 10.1038/cdd.2017.130	10	5	5	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2018	555	7697					E18	E18		10.1038/nature25772	http://dx.doi.org/10.1038/nature25772			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ9NF	29565361				2022-12-28	WOS:000427937900002
J	Daniels, JP				Daniels, Joe Parkin			Frontline: a Safe Hospital on the border with Haiti	LANCET			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2018	391	10125					1012	1012		10.1016/S0140-6736(18)30661-5	http://dx.doi.org/10.1016/S0140-6736(18)30661-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ4TP	29565008				2022-12-28	WOS:000427585100012
J	Horton, R				Horton, Richard			Offline: Owning up on gender equality	LANCET			English	Editorial Material												richard.horton@lancet.com							0	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2018	391	10125					1008	1008		10.1016/S0140-6736(18)30663-9	http://dx.doi.org/10.1016/S0140-6736(18)30663-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ4TP	29565006				2022-12-28	WOS:000427585100010
J	Peterson, CW; Benalcazar, WA; Hughes, TL; Bahl, G				Peterson, Christopher W.; Benalcazar, Wladimir A.; Hughes, Taylor L.; Bahl, Gaurav			A quantized microwave quadrupole insulator with topologically protected corner states	NATURE			English	Article							EDGE STATES; POLARIZATION; PHASE	The theory of electric polarization in crystals defines the dipole moment of an insulator in terms of a Berry phase (geometric phase) associated with its electronic ground state(1,2). This concept not only solves the long-standing puzzle of how to calculate dipole moments in crystals, but also explains topological band structures in insulators and superconductors, including the quantum anomalous Hall insulator(3,4) and the quantum spin Hall insulator(5-7), as well as quantized adiabatic pumping processes(8-10). A recent theoretical study has extended the Berry phase framework to also account for higher electric multipole moments(11), revealing the existence of higher-order topological phases that have not previously been observed. Here we demonstrate experimentally a member of this predicted class of materials-a quantized quadrupole topological insulator-produced using a gigahertz-frequency reconfigurable microwave circuit. We confirm the non-trivial topological phase using spectroscopic measurements and by identifying corner states that result from the bulk topology. In addition, we test the critical prediction that these corner states are protected by the topology of the bulk, and are not due to surface artefacts, by deforming the edges of the crystal lattice from the topological to the trivial regime. Our results provide conclusive evidence of a unique form of robustness against disorder and deformation, which is characteristic of higher-order topological insulators.	[Peterson, Christopher W.] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA; [Benalcazar, Wladimir A.; Hughes, Taylor L.] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Bahl, Gaurav] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Bahl, G (corresponding author), Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA.	bahl@illinois.edu		Peterson, Christopher/0000-0003-2538-3143	US National Science Foundation (NSF) through the Emerging Frontiers in Research and Innovation (EFRI) grant [EFMA-1627184]; NSF Graduate Research Fellowship; US Office of Naval Research (ONR); US NSF [DMR-1351895]	US National Science Foundation (NSF) through the Emerging Frontiers in Research and Innovation (EFRI) grant(National Science Foundation (NSF)); NSF Graduate Research Fellowship(National Science Foundation (NSF)); US Office of Naval Research (ONR)(Office of Naval Research); US NSF(National Science Foundation (NSF))	We would like to thank J. T. Bernhard for access to the resources at the UIUC Electromagnetics Laboratory. This project was supported by the US National Science Foundation (NSF) through the Emerging Frontiers in Research and Innovation (EFRI) grant EFMA-1627184. C.W.P. acknowledges support from an NSF Graduate Research Fellowship. G.B. acknowledges support from the US Office of Naval Research (ONR) through a Director for Research Early Career Grant. W.A.B. and T.L.H. thank the US NSF for grant DMR-1351895.	Benalcazar WA, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.245115; Benalcazar WA, 2017, SCIENCE, V357, P61, DOI 10.1126/science.aah6442; Benalcazar WA, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.224503; Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Blanco-Redondo A, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.163901; Chang CZ, 2013, SCIENCE, V340, P167, DOI 10.1126/science.1234414; Chaunsali R, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.024301; Fu L, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.195312; Hafezi M, 2013, NAT PHOTONICS, V7, P1001, DOI [10.1038/NPHOTON.2013.274, 10.1038/nphoton.2013.274]; Hughes TL, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.245132; Imhof S., 2017, PREPRINT; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; KINGSMITH RD, 1993, PHYS REV B, V47, P1651, DOI 10.1103/PhysRevB.47.1651; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Kraus YE, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.106402; Leder M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13112; Meier EJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13986; Nash LM, 2015, P NATL ACAD SCI USA, V112, P14495, DOI 10.1073/pnas.1507413112; Ningyuan J, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.021031; Rechtsman MC, 2013, NATURE, V496, P196, DOI 10.1038/nature12066; Schindler F., 2017, PREPRINT; Serra-Garcia M, 2018, NATURE, V555, P342, DOI 10.1038/nature25156; Slobozhanyuk AP, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.123901; SU WP, 1979, PHYS REV LETT, V42, P1698, DOI 10.1103/PhysRevLett.42.1698; Susstrunk R, 2015, SCIENCE, V349, P47, DOI 10.1126/science.aab0239; Teo JCY, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.047006; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; THOULESS DJ, 1983, PHYS REV B, V27, P6083, DOI 10.1103/PhysRevB.27.6083; Turner AM, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.075102; VANDERBILT D, 1993, PHYS REV B, V48, P4442, DOI 10.1103/PhysRevB.48.4442; Wang Z, 2009, NATURE, V461, P772, DOI 10.1038/nature08293; ZAK J, 1989, PHYS REV LETT, V62, P2747, DOI 10.1103/PhysRevLett.62.2747	32	422	425	18	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2018	555	7696					346	+		10.1038/nature25777	http://dx.doi.org/10.1038/nature25777			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ3HG	29542690	Green Submitted			2022-12-28	WOS:000427477100031
J	Nkengasong, JN; Yao, K; Onyebujoh, P				Nkengasong, John N.; Yao, Katy; Onyebujoh, Philip			Laboratory medicine in low-income and middle-income countries: progress and challenges	LANCET			English	Editorial Material							SYSTEMS		[Nkengasong, John N.; Onyebujoh, Philip] African Union, Africa Ctr Dis Control & Prevent, W21K19, Addis Ababa, Ethiopia; [Yao, Katy] US Ctr Dis Control & Prevent, Atlanta, GA USA	African Union (AU); Centers for Disease Control & Prevention - USA	Nkengasong, JN (corresponding author), African Union, Africa Ctr Dis Control & Prevent, W21K19, Addis Ababa, Ethiopia.	nkengasongj@africa-union.org			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Amukele T, 2017, AFR J LAB MED, V6, DOI [10.4102/ajlm, 10.4102/ajlm.v6i1.638]; Fonjungo PN, 2017, CLIN INFECT DIS, V64, P796, DOI 10.1093/cid/ciw817; Horton S, 2018, LANCET, V391, P1953, DOI 10.1016/S0140-6736(18)30460-4; Institute of Medicine of the National Academies, 2013, EV PEPFAR; Justman JE, 2009, JAIDS-J ACQ IMM DEF, V52, pS30, DOI 10.1097/QAI.0b013e3181bbc9f5; Nkengasong JN, 2010, AM J CLIN PATHOL, V134, P368, DOI 10.1309/AJCPMPSINQ9BRMU6; Sayed S, 2018, LANCET, V391, P1939, DOI 10.1016/S0140-6736(18)30459-8; Shrivastava R, 2016, J INFECT DIS, V213, pS35, DOI 10.1093/infdis/jiv574; US Centers for Disease Control and Prevention, 2017, FIELD EP TRAIN PROGR; Wilson ML, 2018, LANCET, V391, P1927, DOI [10.1016/S0140-6736(18)30458-6, 10.1016/S0140-6736]; Yao K, 2010, AM J CLIN PATHOL, V134, P401, DOI 10.1309/AJCPNBBL53FWUIQJ	11	37	37	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2018	391	10133					1873	1875		10.1016/S0140-6736(18)30308-8	http://dx.doi.org/10.1016/S0140-6736(18)30308-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GF3NC	29550031	Green Accepted			2022-12-28	WOS:000431861800008
J	Blattler, CL; Claire, MW; Prave, AR; Kirsimae, K; Higgins, JA; Medvedev, PV; Romashkin, AE; Rychanchik, DV; Zerkle, AL; Paiste, K; Kreitsmann, T; Millar, IL; Hayles, JA; Bao, H; Turchyn, AV; Warke, MR; Lepland, A				Blattler, C. L.; Claire, M. W.; Prave, A. R.; Kirsimae, K.; Higgins, J. A.; Medvedev, P. V.; Romashkin, A. E.; Rychanchik, D. V.; Zerkle, A. L.; Paiste, K.; Kreitsmann, T.; Millar, I. L.; Hayles, J. A.; Bao, H.; Turchyn, A. V.; Warke, M. R.; Lepland, A.			Two-billion-year-old evaporites capture Earth's great oxidation	SCIENCE			English	Article							MASS-INDEPENDENT FRACTIONATION; ATMOSPHERIC OXYGEN; SEAWATER SULFATE; SULFUR; RECORD; RISE; ISOTOPES; CONSTRAINTS; OCEAN; BASIN	Major changes in atmospheric and ocean chemistry occurred in the Paleoproterozoic era (2.5 to 1.6 billion years ago). Increasing oxidation dramatically changed Earth's surface, but few quantitative constraints exist on this important transition. This study describes the sedimentology, mineralogy, and geochemistry of a 2-billion-year-old, similar to 800-meter-thick evaporite succession from the Onega Basin in Russian Karelia. The deposit consists of a basal unit dominated by halite (similar to 100 meters) followed by units dominated by anhydrite-magnesite (similar to 500 meters) and dolomite-magnesite (similar to 200 meters). The evaporite minerals robustly constrain marine sulfate concentrations to at least 10 millimoles per kilogram of water, representing an oxidant reservoir equivalent to more than 20% of the modern ocean-atmosphere oxidizing capacity. These results show that substantial amounts of surface oxidant accumulated during this critical transition in Earth's oxygenation.	[Blattler, C. L.; Higgins, J. A.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Claire, M. W.; Prave, A. R.; Zerkle, A. L.; Warke, M. R.] Univ St Andrews, Sch Earth & Environm Sci, St Andrews KY16 9AL, Fife, Scotland; [Claire, M. W.; Zerkle, A. L.] Univ St Andrews, Ctr Exoplanet Sci, St Andrews KY16 9AL, Fife, Scotland; [Claire, M. W.] Blue Marble Space Inst Sci, 1001 4th Ave,Suite 3201, Seattle, WA 98154 USA; [Kirsimae, K.; Kreitsmann, T.; Lepland, A.] Univ Tartu, Dept Geol, EE-50411 Tartu, Estonia; [Medvedev, P. V.; Romashkin, A. E.; Rychanchik, D. V.] Karelian Res Ctr, Inst Geol, Pushkinskaya 11, Petrozavodsk 185610, Russia; [Paiste, K.; Lepland, A.] UiT Arctic Univ Norway, Dept Geosci, Ctr Arctic Gas Hydrate Environm & Climate, N-9037 Tromso, Norway; [Millar, I. L.] British Geol Survey, NERC, Isotope Geosci Lab, Keyworth NG12 5GG, Notts, England; [Hayles, J. A.] Rice Univ, Dept Earth Sci, 6100 Main St, Houston, TX 77005 USA; [Bao, H.] Louisiana State Univ, Dept Geol & Geophys, E235 Howe Russell Geosci Complex, Baton Rouge, LA 70803 USA; [Turchyn, A. V.] Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England; [Lepland, A.] Geol Survey Norway, N-7491 Trondheim, Norway; [Lepland, A.] Tallinn Univ Technol, Inst Geol, EE-19086 Tallinn, Estonia	Princeton University; University of St Andrews; University of St Andrews; University of Tartu; Russian Academy of Sciences; Karelian Research Centre of the Russian Academy of Sciences; Institute of Geology of the Karelian Research Centre (IG KarRC); UiT The Arctic University of Tromso; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; Rice University; Louisiana State University System; Louisiana State University; University of Cambridge; Geological Survey of Norway; Tallinn University of Technology	Blattler, CL (corresponding author), Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA.	blattler@princeton.edu	Warke, Matthew/AAF-3947-2019; Paiste, Kärt/AAF-4929-2020; Medvedev, Pavel Vladimirovich/AAB-9755-2022; Kirsimäe, Kalle/H-9610-2018; Millar, Ian L/F-1541-2010; Claire, Mark/G-4989-2017	Warke, Matthew/0000-0001-9830-0383; Paiste, Kärt/0000-0002-0997-8860; Medvedev, Pavel Vladimirovich/0000-0002-4098-5321; Kirsimäe, Kalle/0000-0002-1221-3623; Claire, Mark/0000-0001-9518-089X; Blattler, Clara/0000-0003-4843-3625; Rychanchik, Dmitrii/0000-0002-5938-9570; Prave, Tony/0000-0002-4614-3774; Lepland, Aivo/0000-0002-0248-1405; Kreitsmann, Timmu/0000-0001-8516-3535; Zerkle, Aubrey/0000-0003-2324-1619	Simons Foundation [SCOL 339006]; European Research Council (ERC) [678812]; Research Council of Norway (RCN Centres of Excellence funding scheme project) [223259]; Estonian Science Agency [PUT696]; Princeton University; Natural Environment Research Council [NE/J017930/1] Funding Source: researchfish; NERC [nigl010001, NE/J017930/1] Funding Source: UKRI	Simons Foundation; European Research Council (ERC)(European Research Council (ERC)European Commission); Research Council of Norway (RCN Centres of Excellence funding scheme project)(Research Council of Norway); Estonian Science Agency(Estonian Research Council); Princeton University(Princeton University); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Thanks to T. H. Bui for assistance with sulfur isotope analyses and B. A. Wing for helpful discussions. This work was supported by a grant from the Simons Foundation (SCOL 339006 to C.L.B.) and by the European Research Council (ERC Horizon 2020 grant 678812 to M.C.), the Research Council of Norway (RCN Centres of Excellence funding scheme project 223259 to K.P. and A.L.), the Estonian Science Agency (PUT696 to K.K., A.L., K.P., and T.K.), and Princeton University (to J.A.H.). Core material from the OPH is maintained by the Institute of Geology, Karelian Research Centre, Petrozavodsk, Russia. Data presented in this study are available in the supplementary materials.	[Anonymous], 2006, GEOBIOLOGY, DOI [DOI 10.1111/J.1472-4669.2006.00085.X, DOI 10.1111/j.1472-4669.2006.00085.x]; Bachan A, 2015, P NATL ACAD SCI USA, V112, P6562, DOI 10.1073/pnas.1422319112; Bao HM, 2008, NATURE, V453, P504, DOI 10.1038/nature06959; Bekker A, 2012, EARTH PLANET SC LETT, V317, P295, DOI 10.1016/j.epsl.2011.12.012; BERNER RA, 1989, AM J SCI, V289, P333, DOI 10.2475/ajs.289.4.333; Blattler CL, 2014, GEOLOGY, V42, P711, DOI 10.1130/G35721.1; Brasier AT, 2011, PRECAMBRIAN RES, V189, P193, DOI 10.1016/j.precamres.2011.05.011; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Cao XB, 2013, P NATL ACAD SCI USA, V110, P14546, DOI 10.1073/pnas.1302972110; CLAYPOOL GE, 1980, CHEM GEOL, V28, P199, DOI 10.1016/0009-2541(80)90047-9; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; GROTZINGER JP, 1993, J GEOL, V101, P235, DOI 10.1086/648218; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; Holland H., 1994, EARLY LIFE EARTH NOB; Horita J, 2002, GEOCHIM COSMOCHIM AC, V66, P3733, DOI 10.1016/S0016-7037(01)00884-5; Kah LC, 2001, PRECAMBRIAN RES, V111, P203, DOI 10.1016/S0301-9268(01)00161-9; Krupenik V. A., 2011, PALAEOPROTEROZOIC ON, P250; Krupenik V. A., 2011, ONEGA PALAEOPROTEROZ, P190; LINDSAY JF, 1987, GEOL SOC AM BULL, V99, P852, DOI 10.1130/0016-7606(1987)99<852:UPEITA>2.0.CO;2; Lowenstein TK, 2001, SCIENCE, V294, P1086, DOI 10.1126/science.1064280; Luo GM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600134; Lyons TW, 2014, NATURE, V506, P307, DOI 10.1038/nature13068; Melezhik VA, 2005, TERRA NOVA, V17, P141, DOI 10.1111/j.1365-3121.2005.00600.x; Morozov AF, 2010, DOKL EARTH SCI, V435, P1483, DOI 10.1134/S1028334X10110164; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; Planavsky NJ, 2012, P NATL ACAD SCI USA, V109, P18300, DOI 10.1073/pnas.1120387109; Pope MC, 2003, J SEDIMENT RES, V73, P280, DOI 10.1306/091302730280; Reuschel M, 2012, PRECAMBRIAN RES, V192-95, P78, DOI 10.1016/j.precamres.2011.10.013; Schroeder S, 2008, TERRA NOVA, V20, P108, DOI 10.1111/j.1365-3121.2008.00795.x; Spear N, 2014, GEOLOGY, V42, P103, DOI 10.1130/G34913.1	30	85	85	5	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2018	360	6386					320	+		10.1126/science.aar2687	http://dx.doi.org/10.1126/science.aar2687			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD3IC	29567810	Green Submitted, Green Accepted			2022-12-28	WOS:000430396600045
J	Desai, SV; Asch, DA; Bellini, LM; Chaiyachati, KH; Liu, M; Sternberg, AL; Tonascia, J; Yeager, AM; Asch, JM; Katz, JT; Basner, M; Bates, DW; Bilimoria, KY; Dinges, DF; Even-Shoshan, O; Shade, DM; Silber, JH; Small, DS; Volpp, KG; Shea, JA				Desai, S. V.; Asch, D. A.; Bellini, L. M.; Chaiyachati, K. H.; Liu, M.; Sternberg, A. L.; Tonascia, J.; Yeager, A. M.; Asch, J. M.; Katz, J. T.; Basner, M.; Bates, D. W.; Bilimoria, K. Y.; Dinges, D. F.; Even-Shoshan, O.; Shade, D. M.; Silber, J. H.; Small, D. S.; Volpp, K. G.; Shea, J. A.		iCOMPARE Res Grp	Education Outcomes in a Duty-Hour Flexibility Trial in Internal Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROGRAM DIRECTORS; BURNOUT; MORTALITY; REFORM; TIME; ASSOCIATION; PERFORMANCE; RESIDENTS; SPEND; WORK	BACKGROUND Concern persists that inflexible duty-hour rules in medical residency programs may adversely affect the training of physicians. METHODS We randomly assigned 63 internal medicine residency programs in the United States to be governed by standard duty-hour policies of the 2011 Accreditation Council for Graduate Medical Education (ACGME) or by more flexible policies that did not specify limits on shift length or mandatory time off between shifts. Measures of educational experience included observations of the activities of interns (first-year residents), surveys of trainees (both interns and residents) and faculty, and intern examination scores. RESULTS There were no significant between-group differences in the mean percentages of time that interns spent in direct patient care and education nor in trainees' perceptions of an appropriate balance between clinical demands and education (primary outcome for trainee satisfaction with education; response rate, 91%) or in the assessments by program directors and faculty of whether trainees' workload exceeded their capacity (primary outcome for faculty satisfaction with education; response rate, 90%). Another survey of interns (response rate, 49%) revealed that those in flexible programs were more likely to report dissatisfaction with multiple aspects of training, including educational quality (odds ratio, 1.67; 95% confidence interval [CI], 1.02 to 2.73) and overall well-being (odds ratio, 2.47; 95% CI, 1.67 to 3.65). In contrast, directors of flexible programs were less likely to report dissatisfaction with multiple educational processes, including time for bedside teaching (response rate, 98%; odds ratio, 0.13; 95% CI, 0.03 to 0.49). Average scores (percent correct answers) on in-training examinations were 68.9% in flexible programs and 69.4% in standard programs; the difference did not meet the noninferiority margin of 2 percentage points (difference, -0.43; 95% CI, -2.38 to 1.52; P = 0.06 for noninferiority). CONCLUSIONS There was no significant difference in the proportion of time that medical interns spent on direct patient care and education between programs with standard dutyhour policies and programs with more flexible policies. Interns in flexible programs were less satisfied with their educational experience than were their peers in standard programs, but program directors were more satisfied. (Funded by the National Heart, Lung, and Blood Institute and the ACGME; iCOMPARE ClinicalTrials. gov number, NCT02274818.)	[Desai, S. V.] Johns Hopkins Univ, Dept Med, Baltimore, MD 21218 USA; [Sternberg, A. L.; Tonascia, J.; Shade, D. M.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Tonascia, J.] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; [Asch, D. A.; Bellini, L. M.; Chaiyachati, K. H.; Liu, M.; Yeager, A. M.; Asch, J. M.; Shea, J. A.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Basner, M.; Dinges, D. F.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Volpp, K. G.] Univ Penn, Dept Med Eth & Policy, Philadelphia, PA 19104 USA; [Small, D. S.] Univ Penn, Wharton Sch, Dept Stat, Philadelphia, PA 19104 USA; [Asch, D. A.; Chaiyachati, K. H.; Volpp, K. G.] Corporal Michael J Crescenz Vet Affairs Med Ctr, Philadelphia, PA USA; [Even-Shoshan, O.; Silber, J. H.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Katz, J. T.; Bates, D. W.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Bilimoria, K. Y.] Northwestern Univ, Dept Surg, Chicago, IL 60611 USA; [Bilimoria, K. Y.] Northwestern Univ, Ctr Healthcare Studies, Chicago, IL 60611 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Brigham & Women's Hospital; Northwestern University; Northwestern University	Desai, SV (corresponding author), Johns Hopkins Univ, Sch Med, Rm 9029,1830 E Monument St, Baltimore, MD 21205 USA.	sanjayvdesai@jhmi.edu	Dinges, David/P-7183-2019; Bates, David/AAE-7283-2019; Vyas, Jatin/Q-1627-2016	Vyas, Jatin/0000-0002-9985-9565; Asch, David/0000-0002-7970-286X; Patton, Jill/0000-0003-2904-4106	National Heart, Lung, and Blood Institute [U01HL125388, U01HL126088]; Accreditation Council for Graduate Medical Education; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL125388, U01HL126088] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Accreditation Council for Graduate Medical Education; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants (U01HL125388, to Dr. Asch; and U01HL126088, to Dr. Tonascia) from the National Heart, Lung, and Blood Institute; and by a grant from the Accreditation Council for Graduate Medical Education to Dr. Shea.	Bilimoria KY, 2016, NEW ENGL J MED, V374, P713, DOI 10.1056/NEJMoa1515724; Block L, 2013, J GEN INTERN MED, V28, P1042, DOI 10.1007/s11606-013-2376-6; Bolster Lauren, 2015, J Grad Med Educ, V7, P349, DOI 10.4300/JGME-D-14-00612.1; Cunningham CT, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0016-z; Drolet BC, 2013, NEW ENGL J MED, V368, P694, DOI 10.1056/NEJMp1214483; Eckleberry-Hunt J, 2018, ACAD MED, V93, P367, DOI 10.1097/ACM.0000000000001890; Elmore LC, 2016, J AM COLL SURGEONS, V223, P440, DOI 10.1016/j.jamcollsurg.2016.05.014; Fletcher KE, 2012, J GEN INTERN MED, V27, P1432, DOI 10.1007/s11606-012-2120-7; Garg M, 2014, J GEN INTERN MED, V29, P1349, DOI 10.1007/s11606-014-2912-z; GUARISCO S, 1994, J GEN INTERN MED, V9, P272, DOI 10.1007/BF02599655; Lackritz JR, 2004, TEACH TEACH EDUC, V20, P713, DOI 10.1016/j.tate.2004.07.002; Lin H, 2016, ACAD MED, V91, P140, DOI 10.1097/ACM.0000000000000937; Mamykina L, 2016, ACAD MED, V91, P827, DOI 10.1097/ACM.0000000000001148; Nasca TJ, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMsb1005800; Patel MS, 2014, JAMA-J AM MED ASSOC, V312, P2364, DOI 10.1001/jama.2014.15273; Rajaram R, 2014, JAMA-J AM MED ASSOC, V312, P2374, DOI 10.1001/jama.2014.15277; Schaufeli W.B., 1996, MASLACH BURNOUT INVE, V3rd, P22; Shea JA, 2012, ACAD MED, V87, P895, DOI 10.1097/ACM.0b013e3182584118; Takayesu JK, 2014, ACAD EMERG MED, V21, P1031, DOI 10.1111/acem.12464; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P984, DOI 10.1001/jama.298.9.984; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975	21	97	97	3	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 19	2018	378	16					1494	1508		10.1056/NEJMoa1800965	http://dx.doi.org/10.1056/NEJMoa1800965			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD2EI	29557719	Green Accepted, Bronze			2022-12-28	WOS:000430312500005
J	Sack, LM; Davoli, T; Li, MZ; Li, YY; Xu, QK; Naxerova, K; Wooten, EC; Bernardi, RJ; Martin, TD; Chen, T; Leng, YM; Liang, AC; Scorsone, KA; Westbrook, TF; Wong, KK; Elledge, SJ				Sack, Laura Magill; Davoli, Teresa; Li, Mamie Z.; Li, Yuyang; Xu, Qikai; Naxerova, Kamila; Wooten, Eric C.; Bernardi, Ronald J.; Martin, Timothy D.; Chen, Ting; Leng, Yumei; Liang, Anthony C.; Scorsone, Kathleen A.; Westbrook, Thomas F.; Wong, Kwok-Kin; Elledge, Stephen J.			Profound Tissue Specificity in Proliferation Control Underlies Cancer Drivers and Aneuploidy Patterns	CELL			English	Article							COPY-NUMBER ALTERATION; PANCREATIC-CANCER; GENES; GENOME; REGULATOR; DISCOVERY; PACKAGE; CENSUS	Genomics has provided a detailed structural description of the cancer genome. Identifying oncogenic drivers that work primarily through dosage changes is a current challenge. Unrestrained proliferation is a critical hallmark of cancer. We constructed modular, barcoded libraries of human open reading frames (ORFs) and performed screens for proliferation regulators in multiple cell types. Approximately 10% of genes regulate proliferation, with most performing in an unexpectedly highly tissue-specific manner. Proliferation drivers in a given cell type showed specific enrichment in somatic copy number changes (SCNAs) from cognate tumors and helped predict aneuploidy patterns in those tumors, implying that tissue-type-specific genetic network architectures underlie SCNA and driver selection in different cancers. In vivo screening confirmed these results. We report a substantial contribution to the catalog of SCNA-associated cancer drivers, identifying 147 amplified and 107 deleted genes as potential drivers, and derive insights about the genetic network architecture of aneuploidy in tumors.	[Sack, Laura Magill; Davoli, Teresa; Li, Mamie Z.; Xu, Qikai; Naxerova, Kamila; Wooten, Eric C.; Martin, Timothy D.; Leng, Yumei; Liang, Anthony C.; Elledge, Stephen J.] Harvard Med Sch, Dept Genet, Howard Hughes Med Inst, Div Genet,Brigham & Womens Hosp, 77 Ave Louis Pasteur, Boston, MA 02115 USA; [Li, Yuyang; Chen, Ting; Wong, Kwok-Kin] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Li, Yuyang] Shandong Univ, Shandong Prov Hosp, Jinan 250021, Shandong, Peoples R China; [Bernardi, Ronald J.; Scorsone, Kathleen A.; Westbrook, Thomas F.] Baylor Coll Med, Dan L Duncan Canc Ctr, Verna & Marrs McLean Dept Biochem & Mol Biol, Dept Mol & Human Genet, Houston, TX 77030 USA; [Chen, Ting; Wong, Kwok-Kin] NYU, Langone Med Ctr, Laura & Isaac Perlmutter Canc Ctr, New York, NY USA; [Davoli, Teresa] NYU Langone Hlth, Dept Biochem & Mol Pharmacol, Inst Syst Genet, 430 East 29th St, New York, NY 10016 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Baylor College of Medicine; New York University; NYU Langone Medical Center; NYU Langone Medical Center	Elledge, SJ (corresponding author), Harvard Med Sch, Dept Genet, Howard Hughes Med Inst, Div Genet,Brigham & Womens Hosp, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu		Wooten, Eric/0000-0002-8403-8668; Sack, Laura/0000-0003-1186-1335; chen, ting/0000-0001-8414-6346; Chen, Ting/0000-0003-1725-7956; Naxerova, Kamila/0000-0001-7744-5110; Davoli, Teresa/0000-0003-4116-9745; wong, kwok kin/0000-0001-6323-235X	Alex's Lemonade Stand Foundation-Center of Excellence; Damon Runyon fellowship; NIH; DOD Breast Cancer Research Program; Ludwig grant; CPRIT [RP120583]; NIH/NCI [1R01CA178039-01, NCI-P30CA125123]; DOD Breast Cancer Research Program [BC120604]; Adrienne Helis Melvin Medical Research Foundation;  [1K99CA212621-01]; NATIONAL CANCER INSTITUTE [P30CA125123, K99CA212621, R01CA178039, R00CA212621] Funding Source: NIH RePORTER	Alex's Lemonade Stand Foundation-Center of Excellence; Damon Runyon fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD Breast Cancer Research Program(United States Department of Defense); Ludwig grant; CPRIT; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DOD Breast Cancer Research Program(United States Department of Defense); Adrienne Helis Melvin Medical Research Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank K. Polyak, P. Campbell, M. Vidal, K. Mengwasser, and R. Patel for reagents. T.D. was supported by 1K99CA212621-01. R.J.B. was supported by an Alex's Lemonade Stand Foundation-Center of Excellence. T.D.M. is supported by a Damon Runyon fellowship. This work was supported by NIH grants to S.J.E. and K.-K.W., and a DOD Breast Cancer Research Program and Ludwig grant to S.J.E. T.F.W. was supported by CPRIT (RP120583), the NIH/NCI (1R01CA178039-01 and NCI-P30CA125123), the DOD Breast Cancer Research Program (BC120604), and Adrienne Helis Melvin Medical Research Foundation. S.J.E. is an investigator with the Howard Hughes Medical Institute.	Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dai Zhiyin, 2014, F1000Res, V3, P95, DOI 10.12688/f1000research.3928.2; Davoli T, 2017, SCIENCE, V355, DOI 10.1126/science.aaf8399; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Eser S, 2014, BRIT J CANCER, V111, P817, DOI 10.1038/bjc.2014.215; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkz1031, 10.1093/nar/gkx1132]; Fisher R.A., 1948, AM STAT, V2, P30, DOI DOI 10.2307/2681650; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Ho H, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12058; Kim C, 2016, J CANCER, V7, P1550, DOI 10.7150/jca.15578; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Martin TD, 2017, CELL REP, V20, P427, DOI 10.1016/j.celrep.2017.06.061; McDonald ER, 2017, CELL, V170, P577, DOI 10.1016/j.cell.2017.07.005; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Milacic Marija, 2012, Cancers (Basel), V4, P1180, DOI 10.3390/cancers4041180; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Reader J, 2011, CANCER METAST REV, V30, P449, DOI 10.1007/s10555-011-9303-2; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sack LM, 2016, G3-GENES GENOM GENET, V6, P2781, DOI 10.1534/g3.116.030973; Sanchez-Garcia F, 2014, CELL, V159, P1461, DOI 10.1016/j.cell.2014.10.048; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Waclaw B, 2015, NATURE, V525, P261, DOI 10.1038/nature14971; Wang YF, 2016, GENE DEV, V30, P293, DOI 10.1101/gad.271445.115; Wu DD, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-241; Youssef J, 2011, BRIT J PHARMACOL, V164, P68, DOI 10.1111/j.1476-5381.2011.01383.x; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	48	86	90	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 5	2018	173	2					499	+	514.e1	10.1016/j.cell.2018.02.037	http://dx.doi.org/10.1016/j.cell.2018.02.037			39	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GB8IS	29576454	Green Accepted, Bronze			2022-12-28	WOS:000429320200021
J	Howe, JL; Adams, KT; Hettinger, AZ; Ratwani, RM				Howe, Jessica L.; Adams, Katharine T.; Hettinger, A. Zachary; Ratwani, Raj M.			Electronic Health Record Usability Issues and Potential Contribution to Patient Harm	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Howe, Jessica L.; Adams, Katharine T.; Hettinger, A. Zachary; Ratwani, Raj M.] MedStar Hlth, Natl Ctr Human Factors Healthcare, 3007 Tilden St NW,Ste 7L, Washington, DC 20036 USA		Ratwani, RM (corresponding author), MedStar Hlth, Natl Ctr Human Factors Healthcare, 3007 Tilden St NW,Ste 7L, Washington, DC 20036 USA.	raj.m.ratwani@medstar.net		Hettinger, Aaron/0000-0003-0483-5788	Agency for Healthcare Research and Quality (AHRQ) of the US Department of Health and Human Services [R01 HS023701-02]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS023701] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality (AHRQ) of the US Department of Health and Human Services; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This project was funded by grant R01 HS023701-02 from the Agency for Healthcare Research and Quality (AHRQ) of the US Department of Health and Human Services (Dr Ratwani).	CULLEN DJ, 1995, JOINT COMM J QUAL IM, V21, P541, DOI 10.1016/S1070-3241(16)30180-8; Ellsworth MA, 2017, J AM MED INFORM ASSN, V24, P218, DOI 10.1093/jamia/ocw046; Institute of Medicine, HLTH IT PAT SAF BUIL; International organization for standardization, 250102011 ISOIEC; Ratwani RM, 2015, JAMA-J AM MED ASSOC, V314, P1070, DOI 10.1001/jama.2015.8372; The Office of the National Coordinator for Health Information Technology, CERT HLTH IT DEV ED	6	117	117	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2018	319	12					1276	1278		10.1001/jama.2018.1171	http://dx.doi.org/10.1001/jama.2018.1171			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GA5VW	29584833	Green Published			2022-12-28	WOS:000428403000022
J	Murphy, KM; Hughes, LS; Conway, P				Murphy, Karen M.; Hughes, Lauren S.; Conway, Patrick			A Path to Sustain Rural Hospitals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Murphy, Karen M.] Geisinger, 100 N Acad Ave, Danville, PA 17822 USA; [Hughes, Lauren S.] Commonwealth Penn, Dept Hlth, Harrisburg, PA USA; [Conway, Patrick] Blue Cross Blue Shield North Carolina, Durham, NC USA		Murphy, KM (corresponding author), Geisinger, 100 N Acad Ave, Danville, PA 17822 USA.	Kmurphy2@Geisinger.edu						Garcia MC, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6602a1; Gugliotta G., 2015, WASHINGTON POST; Morse S., 2016, HEALTHCARE FINANCE; Pennsylvania Health Care Cost Containment Council, 2017, FIN AN 2016 GEN AC C; Rajkumar R, 2014, NEW ENGL J MED, V370, P493, DOI 10.1056/NEJMp1314868; The Cecil G. Sheps Center for Health Services Research University of North Carolina at Chapel Hill, 83 RUR HOSP CLOS JAN; US Census Bureau, 2010 CENS URB RUR CL	7	14	14	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2018	319	12					1193	1194		10.1001/jama.2018.2967	http://dx.doi.org/10.1001/jama.2018.2967			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GA5VW	29584850				2022-12-28	WOS:000428403000006
J	Rubin, R				Rubin, Rita			CMS to Improve Drug Programs and Opioid Overuse Oversight	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item													Rubin, Rita/AAD-1259-2020						0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2018	319	12					1189	1189		10.1001/jama.2018.2785	http://dx.doi.org/10.1001/jama.2018.2785			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HI0BD	29584828				2022-12-28	WOS:000456106200003
J	Albaladejo, A				Albaladejo, Angelika			Contraceptive shortages mean Venezuela's people face a sexual health emergency	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												angelikaalbaladejo@gmail.com						255 casos de Guillain Barre confirmo el Ministerio de Salud, 2016, EL NACIONAL     1206; Albaladejo AA, 2016, WORLD POLICY J; Allen G., 2017, NPR; [Anonymous], 2017, CACTUS24; Barbarani S., 2016, WASHINGTON POST; Guttmacher Institute, 2017, AB LAT AM CAR FACT S; Guttmacher Institute, 2016, ADD IT COSTS BEN M C; Krygier R., 2018, WASHINGTON POST; Nolen S., 2017, GLOBE MAIL; Pan American Health Organisation, 2017, BROT VIR ZIK CONT AN; Polanco A, 2017, REUTERS; Santos T., 2016, MEDSCAPE; UNAIDS, VEN COUNTR DAT; UNFPA, 2017, WORLDS AP REPR HLTH; Unicef, VEN CHILD MORT EST; Urdaneta D., 2016, VICE NEWS       0322; Vielma O., 2017, EL NUEVO HERALD; Watts J, 2016, GUARDIAN; World Health Organization, MAT MORT 1990 2015; World Health Organization, 2018, AD PREGN FACT SHEET	20	5	6	1	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2018	360								k1197	10.1136/bmj.k1197	http://dx.doi.org/10.1136/bmj.k1197			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB1LW	29572318				2022-12-28	WOS:000428813300003
J	Dye, C				Dye, Christopher			Expanded health systems for sustainable development	SCIENCE			English	Editorial Material									[Dye, Christopher] WHO, Geneva, Switzerland	World Health Organization	Dye, C (corresponding author), WHO, Geneva, Switzerland.	chrisdye56@gmail.com	Dye, Christopher/AIC-4659-2022					Dye C, 2013, NATURE, V502, pS13, DOI 10.1038/502S13a; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Hafner T, 2013, HEALTH POLICY PLANN, V28, P41, DOI 10.1093/heapol/czs023; Haldane V, 2018, AIDS CARE, V30, P103, DOI 10.1080/09540121.2017.1344350; Kuruvilla S, 2014, B WORLD HEALTH ORGAN, V92, P533, DOI 10.2471/BLT.14.138131; Ruducha J, 2017, LANCET GLOB HEALTH, V5, pE1142, DOI 10.1016/S2214-109X(17)30331-5; Shindell D, 2017, SCIENCE, V356, P493, DOI 10.1126/science.aak9521; Stenberg K, 2017, LANCET GLOB HEALTH, V5, pE875, DOI [10.1016/S2214-109X(17)30263-2, 10.1016/s2214-109x(17)30263-2]; Tobias M, 2017, LANCET, V389, P1172, DOI 10.1016/S0140-6736(17)30191-5; WHO, 2017, NEW PERSP GLOB HLTH; World Health Organization, 2016, STAT IN CHILDH IMM; World Health Organization (WHO), 2017, WORLD HLTH STAT; [No title captured]; [No title captured]; [No title captured]	15	14	14	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2018	359	6382			SI		1337	1339		10.1126/science.aaq1081	http://dx.doi.org/10.1126/science.aaq1081			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA0ZG	29567697	Green Submitted			2022-12-28	WOS:000428043600027
J	Kremling, KAG; Chen, SY; Su, MH; Lepak, NK; Romay, MC; Swarts, KL; Lu, F; Lorant, A; Bradbury, PJ; Buckler, ES				Kremling, Karl A. G.; Chen, Shu-Yun; Su, Mei-Hsiu; Lepak, Nicholas K.; Romay, M. Cinta; Swarts, Kelly L.; Lu, Fei; Lorant, Anne; Bradbury, Peter J.; Buckler, Edward S.			Dysregulation of expression correlates with rare-allele burden and fitness loss in maize	NATURE			English	Article							MUTATION LOAD; HAPLOTYPE MAP; YIELD; POPULATION; HETEROSIS; RNA	Here we report a multi-tissue gene expression resource that represents the genotypic and phenotypic diversity of modern inbred maize, and includes transcriptomes in an average of 255 lines in seven tissues. We mapped expression quantitative trait loci and characterized the contribution of rare genetic variants to extremes in gene expression. Some of the new mutations that arise in the maize genome can be deleterious; although selection acts to keep deleterious variants rare, their complete removal is impeded by genetic linkage to favourable loci and by finite population size(1-4). Modern maize breeders have systematically reduced the effects of this constant mutational pressure through artificial selection and self-fertilization, which have exposed rare recessive variants in elite inbred lines(5). However, the ongoing effect of these rare alleles on modern inbred maize is unknown. By analysing this gene expression resource and exploiting the extreme diversity and rapid linkage disequilibrium decay of maize(6), we characterize the effect of rare alleles and evolutionary history on the regulation of expression. Rare alleles are associated with the dysregulation of expression, and we correlate this dysregulation to seed-weight fitness. We find enrichment of ancestral rare variants among expression quantitative trait loci mapped in modern inbred lines, which suggests that historic bottlenecks have shaped regulation. Our results suggest that one path for further genetic improvement in agricultural species lies in purging the rare deleterious variants that have been associated with crop fitness.	[Kremling, Karl A. G.; Swarts, Kelly L.; Buckler, Edward S.] Cornell Univ, Sect Plant Breeding & Genet, 175 Biotechnol Bldg, Ithaca, NY 14853 USA; [Chen, Shu-Yun; Su, Mei-Hsiu; Romay, M. Cinta; Lu, Fei; Buckler, Edward S.] Cornell Univ, Inst Genom Div, 175 Biotechnol Bldg, Ithaca, NY 14853 USA; [Chen, Shu-Yun] Acad Sinica, Inst Plant & Microbial Biol, 128,Sec 2nd,Acad Rd, Taipei 11529, Taiwan; [Lepak, Nicholas K.; Bradbury, Peter J.; Buckler, Edward S.] Cornell Univ, USDA ARS, RW Holley Ctr, Ithaca, NY 14853 USA; [Swarts, Kelly L.] Max Planck Inst Dev Biol, Dept Mol Biol, Res Grp Ancient Genom & Evolut, Spemannstr 35, D-72076 Tubingen, Germany; [Lu, Fei] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing 100101, Peoples R China; [Lorant, Anne] Univ Calif Davis, Dept Plant Sci, Davis, CA 95618 USA	Cornell University; Cornell University; Academia Sinica - Taiwan; Cornell University; United States Department of Agriculture (USDA); Max Planck Society; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; University of California System; University of California Davis	Kremling, KAG; Buckler, ES (corresponding author), Cornell Univ, Sect Plant Breeding & Genet, 175 Biotechnol Bldg, Ithaca, NY 14853 USA.; Buckler, ES (corresponding author), Cornell Univ, Inst Genom Div, 175 Biotechnol Bldg, Ithaca, NY 14853 USA.; Buckler, ES (corresponding author), Cornell Univ, USDA ARS, RW Holley Ctr, Ithaca, NY 14853 USA.	kak268@cornell.edu; esb33@cornell.edu	Romay, Cinta/ABE-8340-2020; Lu, Fei/ABC-6704-2021; Buckler, Edward/L-7651-2019; Buckler, Edward/GPS-4932-2022	Romay, Cinta/0000-0001-9309-1586; Lu, Fei/0000-0002-3596-1712; Buckler, Edward/0000-0002-3100-371X; Swarts, Kelly/0000-0002-0578-7426; Chen, Shu-Yun/0000-0001-6116-0874	US Department of Agriculture-Agricultural Research Service; National Science Foundation [IOS-0922493, IOS-1238014]; National Science Foundation Graduate Research Fellowship Program [DGE-1650441]; Section of Plant Breeding and Genetics at Cornell University; Taiwanese Ministry of Science and Technology Overseas Project [104-2917-I-564-015]; Direct For Biological Sciences [1238014] Funding Source: National Science Foundation	US Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Science Foundation(National Science Foundation (NSF)); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Section of Plant Breeding and Genetics at Cornell University; Taiwanese Ministry of Science and Technology Overseas Project; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank J. Pardo, J. Wallace, R. Punna, K. Shirasawa and S. Miller for assistance with tissue collection; J. Budka and G. Inzinna for field and greenhouse assistance; R. Bukowski for running the maize HapMap genotyping pipeline; L. Johnson and Z. Miller for database curation; G. Gibson, M. Wolfe, J.-L. Jannink, M. Hufford and J. Ross-Ibarra for discussions; P. Schweitzer, J. Mosher, A. Tate, J. Mattison, M. Magallanes-Lundback, I. Hollander and D. Daujotyte for guidance on RNA extraction, library preparation automation and sequencing; and S. Miller for copy-editing. This work was supported by the US Department of Agriculture-Agricultural Research Service and the National Science Foundation grants IOS-0922493 and IOS-1238014 to E.S.B. The National Science Foundation Graduate Research Fellowship Program grant DGE-1650441 and the Section of Plant Breeding and Genetics at Cornell University provided support to K. A. G. K. The Taiwanese Ministry of Science and Technology Overseas Project for Post Graduate Research grant 104-2917-I-564-015 supported S.-Y.C.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Beissinger TM, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.84, 10.1038/nplants.2016.84]; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Bukowski R, 2017, GIGASCIENCE, V7, DOI 10.1093/gigascience/gix134; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duvick DN, 2005, ADV AGRON, V86, P83, DOI 10.1016/S0065-2113(05)86002-X; Eveland AL, 2008, PLANT PHYSIOL, V146, P32, DOI 10.1104/pp.107.108597; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Gout JF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000944; Henn BM, 2015, NAT REV GENET, V16, P333, DOI 10.1038/nrg3931; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Hung HY, 2012, HEREDITY, V108, P490, DOI 10.1038/hdy.2011.103; Jiao YP, 2012, NAT GENET, V44, P812, DOI 10.1038/ng.2312; Josephs EB, 2015, P NATL ACAD SCI USA, V112, P15390, DOI 10.1073/pnas.1503027112; KIMURA M, 1963, GENETICS, V48, P1303; Kisselbach TA, 1999, STRUCTURE REPROD COR; Kono TJY, 2016, MOL BIOL EVOL, V33, P2307, DOI 10.1093/molbev/msw102; Li X, 2014, AM J HUM GENET, V95, P245, DOI 10.1016/j.ajhg.2014.08.004; Lohman BK, 2016, MOL ECOL RESOUR, V16, P1315, DOI 10.1111/1755-0998.12529; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; Money D, 2015, G3-GENES GENOM GENET, V5, P2383, DOI 10.1534/g3.115.021667; Ramu P, 2017, NAT GENET, V49, P959, DOI 10.1038/ng.3845; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Rodgers-Melnick E, 2015, P NATL ACAD SCI USA, V112, P3823, DOI 10.1073/pnas.1413864112; Romay MC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r55; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Swarts K, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2014.05.0023; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Troyer AF, 2009, CROP SCI, V49, P1969, DOI 10.2135/cropsci2009.04.0170; TROYER AF, 1990, J HERED, V81, P17, DOI 10.1093/oxfordjournals.jhered.a110920; Vigouroux Y, 2002, MOL BIOL EVOL, V19, P1251, DOI 10.1093/oxfordjournals.molbev.a004186; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Yao H, 2013, P NATL ACAD SCI USA, V110, P2665, DOI 10.1073/pnas.1221966110; Zhao J, 2016, AM J HUM GENET, V98, P299, DOI 10.1016/j.ajhg.2015.12.023	41	107	109	2	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2018	555	7697					520	+		10.1038/nature25966	http://dx.doi.org/10.1038/nature25966			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ9NF	29539638				2022-12-28	WOS:000427937900053
J	Perez-Garcia, V; Fineberg, E; Wilson, R; Murray, A; Mazzeo, CI; Tudor, C; Sienerth, A; White, JK; Tuck, E; Ryder, EJ; Gleeson, D; Siragher, E; Wardle-Jones, H; Staudt, N; Wali, N; Collins, J; Geyer, S; Busch-Nentwich, EM; Galli, A; Smith, JC; Robertson, E; Adams, DJ; Weninger, WJ; Mohun, T; Hemberger, M				Perez-Garcia, Vicente; Fineberg, Elena; Wilson, Robert; Murray, Alexander; Mazzeo, Cecilia Icoresi; Tudor, Catherine; Sienerth, Arnold; White, Jacqueline K.; Tuck, Elizabeth; Ryder, Edward J.; Gleeson, Diane; Siragher, Emma; Wardle-Jones, Hannah; Staudt, Nicole; Wali, Neha; Collins, John; Geyer, Stefan; Busch-Nentwich, Elisabeth M.; Galli, Antonella; Smith, James C.; Robertson, Elizabeth; Adams, David J.; Weninger, Wolfgang J.; Mohun, Timothy; Hemberger, Myriam			Placentation defects are highly prevalent in embryonic lethal mouse mutants	NATURE			English	Article							MAMMALIAN GENE-FUNCTION; C-MYC; TRANSCRIPTION FACTOR; MICE; ABNORMALITIES; VASCULARIZATION; REQUIREMENT; MECHANISMS; EXPRESSION; DEFICIENT	Large-scale phenotyping efforts have demonstrated that approximately 25-30% of mouse gene knockouts cause intrauterine lethality. Analysis of these mutants has largely focused on the embryo and not the placenta, despite the crucial role of this extraembryonic organ for developmental progression. Here we screened 103 embryonic lethal and sub-viable mouse knockout lines from the Deciphering the Mechanisms of Developmental Disorders program for placental phenotypes. We found that 68% of knockout lines that are lethal at or after mid-gestation exhibited placental dysmorphologies. Early lethality (embryonic days 9.5-14.5) is almost always associated with severe placental malformations. Placental defects correlate strongly with abnormal brain, heart and vascular development. Analysis of mutant trophoblast stem cells and conditional knockouts suggests that a considerable number of factors that cause embryonic lethality when ablated have primary gene function in trophoblast cells. Our data highlight the hugely under-appreciated importance of placental defects in contributing to abnormal embryo development and suggest key molecular nodes that govern placenta formation.	[Perez-Garcia, Vicente; Fineberg, Elena; Murray, Alexander; Sienerth, Arnold; Hemberger, Myriam] Babraham Inst, Babraham Res Campus, Cambridge CB22 3AT, England; [Perez-Garcia, Vicente; Fineberg, Elena; Murray, Alexander; Sienerth, Arnold; Hemberger, Myriam] Univ Cambridge, Ctr Trophoblast Res, Downing St, Cambridge CB2 3EG, England; [Wilson, Robert; Smith, James C.; Mohun, Timothy] Francis Crick Inst, 1 Midland Rd, London NW1 1AT, England; [Mazzeo, Cecilia Icoresi; Tudor, Catherine; White, Jacqueline K.; Tuck, Elizabeth; Ryder, Edward J.; Gleeson, Diane; Siragher, Emma; Wardle-Jones, Hannah; Staudt, Nicole; Wali, Neha; Collins, John; Busch-Nentwich, Elisabeth M.; Galli, Antonella; Adams, David J.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Geyer, Stefan; Weninger, Wolfgang J.] Med Univ Vienna, Ctr Anat & Cell Biol, Div Anat, Waehringerstr 13, A-1090 Vienna, Austria; [Busch-Nentwich, Elisabeth M.] Univ Cambridge, Dept Med, Cambridge CB2 0QQ, England; [Robertson, Elizabeth] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; Francis Crick Institute; Wellcome Trust Sanger Institute; Medical University of Vienna; University of Cambridge; University of Oxford	Hemberger, M (corresponding author), Babraham Inst, Babraham Res Campus, Cambridge CB22 3AT, England.; Hemberger, M (corresponding author), Univ Cambridge, Ctr Trophoblast Res, Downing St, Cambridge CB2 3EG, England.	myriam.hemberger@babraham.ac.uk	Ryder, Edward/AAK-1243-2021; Perez-Garcia, Vicente/B-6910-2019; Perez-Garcia, Vicente/ABB-8792-2021	Ryder, Edward/0000-0002-1799-9899; Perez-Garcia, Vicente/0000-0001-5594-1607; Perez-Garcia, Vicente/0000-0001-5594-1607; Smith, Jim/0000-0003-2413-9392; Wilson, Robert/0000-0002-9407-5526; Weninger, Wolfgang J/0000-0003-0575-0073; Geyer, Stefan/0000-0003-2283-4439; Icoresi Mazzeo, Cecilia/0000-0003-4728-3194; Adams, David/0000-0001-9490-0306; Hemberger, Myriam/0000-0003-3332-6958	Wellcome Trust [WT100160MA]; BBSRC [BBS/E/B/000C0424] Funding Source: UKRI; MRC [MC_U117597140] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank N. Karp for expert advice on statistical analyses, I. Sealy for help with PCA analyses, the Flow Cytometry Facility at the Babraham Institute, as well as all contributors to the DMDD programme. This work was supported by Wellcome Trust Strategic Award WT100160MA.	Acuna-Hidalgo R, 2014, AM J HUM GENET, V95, P285, DOI 10.1016/j.ajhg.2014.07.012; Adams D, 2013, DIS MODEL MECH, V6, P571, DOI 10.1242/dmm.011833; Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Adelman DM, 2000, GENE DEV, V14, P3191, DOI 10.1101/gad.853700; Ayadi A, 2012, MAMM GENOME, V23, P600, DOI 10.1007/s00335-012-9418-y; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259; Bradley A, 2012, MAMM GENOME, V23, P580, DOI 10.1007/s00335-012-9422-2; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; COPP AJ, 1995, TRENDS GENET, V11, P87, DOI 10.1016/S0168-9525(00)89008-3; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; de Angelis MH, 2015, NAT GENET, V47, P969, DOI 10.1038/ng.3360; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Dubois NC, 2008, DEVELOPMENT, V135, P2455, DOI 10.1242/dev.022707; Fu JH, 2015, TAIWAN J OBSTET GYNE, V54, P19, DOI 10.1016/j.tjog.2014.11.002; Geyer SH, 2017, J ANAT, V230, P710, DOI 10.1111/joa.12590; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; Haider S, 2009, PLACENTA, V30, P111, DOI 10.1016/j.placenta.2008.10.012; Hartley SW, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0670-5; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Hemberger M, 2003, DEV DYNAM, V227, P185, DOI 10.1002/dvdy.10291; Karp NA, 2017, GENETICS, V205, P491, DOI 10.1534/genetics.116.195388; Kozak KR, 1997, DEV BIOL, V191, P297, DOI 10.1006/dbio.1997.8758; Latos PA, 2015, GENE DEV, V29, P2435, DOI 10.1101/gad.268821.115; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Linask KK, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00390; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo JM, 1997, NATURE, V388, P778, DOI 10.1038/42022; Maruyama EO, 2016, SCI REP-UK, V6, DOI 10.1038/srep20999; Matthiesen NB, 2016, CIRCULATION, V134, P1546, DOI 10.1161/CIRCULATIONAHA.116.021793; Mohun T, 2013, DIS MODEL MECH, V6, P562, DOI 10.1242/dmm.011957; Murray A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25112; Raffel GD, 2009, MOL CELL BIOL, V29, P333, DOI 10.1128/MCB.00370-08; Riley P, 1998, NAT GENET, V18, P271, DOI 10.1038/ng0398-271; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Rossant Janet, 1995, Seminars in Developmental Biology, V6, P237, DOI 10.1016/S1044-5781(06)80049-6; Schreiber M, 2000, DEVELOPMENT, V127, P4937; Shi W, 2004, DEV BIOL, V272, P53, DOI 10.1016/j.ydbio.2004.04.016; Srivastava A, 2016, HUM MOL GENET, V25, P597, DOI 10.1093/hmg/ddv499; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Wang JB, 2002, MAMM GENOME, V13, P493, DOI 10.1007/s00335-002-2182-7; Weninger WJ, 2014, DIS MODEL MECH, V7, P1143, DOI 10.1242/dmm.016337; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Wilson R, 2016, NUCLEIC ACIDS RES, V44, pD855, DOI 10.1093/nar/gkv1138; Wu LZ, 2003, NATURE, V421, P942, DOI 10.1038/nature01417; Xiao ZJ, 2011, DEV DYNAM, V240, P2646, DOI 10.1002/dvdy.22778; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315	48	171	173	3	31	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 22	2018	555	7697					463	+		10.1038/nature26002	http://dx.doi.org/10.1038/nature26002			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ9NF	29539633	Green Submitted, Green Accepted			2022-12-28	WOS:000427937900042
J	Voelker, R				Voelker, Rebecca			New Treatment Option for Pneumonia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2018	319	11					1086	1086		10.1001/jama.2018.1812	http://dx.doi.org/10.1001/jama.2018.1812			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HI0BJ	29558541				2022-12-28	WOS:000456106800006
J	Campos, CA; Bowen, AJ; Roman, CW; Palmiter, RD				Campos, Carlos A.; Bowen, Anna J.; Roman, Carolyn W.; Palmiter, Richard D.			Encoding of danger by parabrachial CGRP neurons	NATURE			English	Article							CONDITIONED TASTE-AVERSION; NEURAL CIRCUIT; ELECTROPHYSIOLOGICAL EVIDENCE; NUCLEUS; RAT; AMYGDALA; BEHAVIOR; MEDIATE; PAIN; MICE	Animals must respond to various threats to survive. Neurons that express calcitonin gene-related peptide in the parabrachial nucleus (CGRP(PBN) neurons) relay sensory signals that contribute to satiation and pain-induced fear behaviour, but it is unclear how they encode these distinct processes. Here, by recording calcium transients in vivo from individual neurons in mice, we show that most CGRP(PBN) neurons are activated by noxious cutaneous (shock, heat, itch) and visceral stimuli (lipopolysaccharide). The same neurons are inhibited during feeding, but become activated during satiation, consistent with evidence that CGRP(PBN) neurons prevent overeating. CGRP(PBN) neurons are also activated during consumption of novel foods or by an auditory cue that has previously been paired with electrical footshocks. Correspondingly, silencing of CGRP(PBN) neurons attenuates the expression of food neophobia and conditioned fear responses. Therefore, in addition to transducing primary sensory danger signals, CGRP(PBN) neurons promote affective-behavioural states that limit harm in response to potential threats.	[Campos, Carlos A.; Bowen, Anna J.; Roman, Carolyn W.; Palmiter, Richard D.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Campos, Carlos A.; Bowen, Anna J.; Roman, Carolyn W.; Palmiter, Richard D.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Campos, CA; Palmiter, RD (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.; Campos, CA; Palmiter, RD (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	camposca@uw.edu; palmiter@uw.edu		Campos, Carlos A/0000-0002-5510-091X; Bowen, Anna/0000-0002-8911-2572	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047, T32DK007247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024908] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA024908] Funding Source: Medline; NIDDK NIH HHS [P30 DK017047, T32 DK007247] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERNARD JF, 1994, J NEUROPHYSIOL, V71, P1646, DOI 10.1152/jn.1994.71.5.1646; BERNARD JF, 1990, J NEUROPHYSIOL, V63, P473, DOI 10.1152/jn.1990.63.3.473; Betley JN, 2015, NATURE, V521, P180, DOI 10.1038/nature14416; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; Braz J, 2014, NEURON, V82, P522, DOI 10.1016/j.neuron.2014.01.018; Cai HJ, 2014, NAT NEUROSCI, V17, P1240, DOI 10.1038/nn.3767; Campos CA, 2017, NAT NEUROSCI, V20, P934, DOI 10.1038/nn.4574; Campos CA, 2016, CELL METAB, V23, P811, DOI 10.1016/j.cmet.2016.04.006; Carter ME, 2015, J NEUROSCI, V35, P4582, DOI 10.1523/JNEUROSCI.3729-14.2015; Carter ME, 2013, NATURE, V503, P111, DOI 10.1038/nature12596; Chen YM, 2015, CELL, V160, P829, DOI 10.1016/j.cell.2015.01.033; Day HEW, 2004, BRAIN RES, V1025, P139, DOI 10.1016/j.brainres.2004.07.079; Flusberg BA, 2008, NAT METHODS, V5, P935, DOI 10.1038/nmeth.1256; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Han S, 2015, CELL, V162, P363, DOI 10.1016/j.cell.2015.05.057; Illing RB, 2002, EXP NEUROL, V175, P226, DOI 10.1006/exnr.2002.7895; Kaur S, 2013, J NEUROSCI, V33, P7627, DOI 10.1523/JNEUROSCI.0173-13.2013; Kim J, 2017, NEURON, V93, P1464, DOI 10.1016/j.neuron.2017.02.034; Kim JC, 2009, NEURON, V63, P305, DOI 10.1016/j.neuron.2009.07.010; Kim SY, 2013, NATURE, V496, P219, DOI 10.1038/nature12018; Lebow MA, 2016, MOL PSYCHIATR, V21, P450, DOI 10.1038/mp.2016.1; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Mu D, 2017, SCIENCE, V357, P695, DOI 10.1126/science.aaf4918; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Padilla SL, 2016, NAT NEUROSCI, V19, P734, DOI 10.1038/nn.4274; Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980; Reilly S, 2001, BRAIN RES BULL, V55, P359, DOI 10.1016/S0361-9230(01)00517-2; Resendez SL, 2016, NAT PROTOC, V11, P566, DOI 10.1038/nprot.2016.021; RICARDO JA, 1978, BRAIN RES, V153, P1, DOI 10.1016/0006-8993(78)91125-3; Ritter RC, 2004, PHYSIOL BEHAV, V81, P249, DOI 10.1016/j.physbeh.2004.02.012; Roman CW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11905; Ryan PJ, 2017, NAT NEUROSCI, V20, P1722, DOI 10.1038/s41593-017-0014-z; SAPER CB, 1980, BRAIN RES, V197, P291, DOI 10.1016/0006-8993(80)91117-8; Saper CB, 2016, CELL METAB, V23, P754, DOI 10.1016/j.cmet.2016.04.021; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Steculorum SM, 2016, CELL, V165, P125, DOI 10.1016/j.cell.2016.02.044; Suzuki T, 2012, AM J PHYSIOL-REG I, V302, pR965, DOI 10.1152/ajpregu.00680.2011; Tokita K, 2009, NEUROSCIENCE, V161, P475, DOI 10.1016/j.neuroscience.2009.03.046; Tovote P, 2015, NAT REV NEUROSCI, V16, P317, DOI 10.1038/nrn3945; Zhou P, ELIFE IN PRESS; Zseli G, 2016, J COMP NEUROL, V524, P2803, DOI 10.1002/cne.23992	41	122	128	5	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2018	555	7698					617	+		10.1038/nature25511	http://dx.doi.org/10.1038/nature25511			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8UX	29562230	Green Accepted			2022-12-28	WOS:000428617600041
J	Ye, LD; Kang, MG; Liu, JW; von Cube, F; Wicker, CR; Suzuki, T; Jozwiak, C; Bostwick, A; Rotenberg, E; Bell, DC; Fu, L; Comin, R; Checkelsky, JG				Ye, Linda; Kang, Mingu; Liu, Junwei; von Cube, Felix; Wicker, Christina R.; Suzuki, Takehito; Jozwiak, Chris; Bostwick, Aaron; Rotenberg, Eli; Bell, David C.; Fu, Liang; Comin, Riccardo; Checkelsky, Joseph G.			Massive Dirac fermions in a ferromagnetic kagome metal	NATURE			English	Article							LATTICE; ANTIFERROMAGNET; GRAPHENE	The kagome lattice is a two-dimensional network of corner-sharing triangles(1) that is known to host exotic quantum magnetic states(2-4). Theoretical work has predicted that kagome lattices may also host Dirac electronic states(5) that could lead to topological(6) and Chern(7) insulating phases, but these states have so far not been detected in experiments. Here we study the d-electron kagome metal Fe3Sn2, which is designed to support bulk massive Dirac fermions in the presence of ferromagnetic order. We observe a temperature-independent intrinsic anomalous Hall conductivity that persists above room temperature, which is suggestive of prominent Berry curvature from the time-reversal-symmetry-breaking electronic bands of the kagome plane. Using angle-resolved photoemission spectroscopy, we observe a pair of quasi-two-dimensional Dirac cones near the Fermi level with a mass gap of 30 millielectronvolts, which correspond to massive Dirac fermions that generate Berry-curvature-induced Hall conductivity. We show that this behaviour is a consequence of the underlying symmetry properties of the bilayer kagome lattice in the ferromagnetic state and the atomic spin-orbit coupling. This work provides evidence for a ferromagnetic kagome metal and an example of emergent topological electronic properties in a correlated electron system. Our results provide insight into the recent discoveries of exotic electronic behaviour in kagome-lattice antiferromagnets(8-10) and may enable lattice-model realizations of fractional topological quantum states(11,12).	[Ye, Linda; Kang, Mingu; Liu, Junwei; Wicker, Christina R.; Suzuki, Takehito; Fu, Liang; Comin, Riccardo; Checkelsky, Joseph G.] MIT, Dept Phys, Cambridge, MA 02139 USA; [von Cube, Felix; Bell, David C.] Harvard Univ, Harvard John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Jozwiak, Chris; Bostwick, Aaron; Rotenberg, Eli] EO Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Bell, David C.] Harvard Univ, Ctr Nanoscale Syst, Cambridge, MA 02138 USA; [Liu, Junwei] Hong Kong UST, Dept Phys, Clear Water Bay, Hong Kong, Peoples R China; [von Cube, Felix] Hitachi High Technol Europe GmbH, Krefeld, Germany	Massachusetts Institute of Technology (MIT); Harvard University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Harvard University; Hong Kong University of Science & Technology; Hitachi Limited	Comin, R; Checkelsky, JG (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	rcomin@mit.edu; checkelsky@mit.edu	Suzuki, Takehito/B-3038-2013; LIU, Junwei/B-1468-2010; Rotenberg, Eli/B-3700-2009; Comin, Riccardo/H-7731-2016; Bostwick, Aaron/E-8549-2010	Suzuki, Takehito/0000-0002-5670-2103; LIU, Junwei/0000-0001-8051-7349; Rotenberg, Eli/0000-0002-3979-8844; Comin, Riccardo/0000-0002-1069-9973; Bell, David/0000-0002-8215-127X; Jozwiak, Chris/0000-0002-0980-3753; Bostwick, Aaron/0000-0002-9008-2980; Kang, Min Gu/0000-0001-6991-0481; /0000-0001-7949-1356				Balog R, 2010, NAT MATER, V9, P315, DOI [10.1038/nmat2710, 10.1038/NMAT2710]; Bergholtz EJ, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.016806; Bostwick A, 2007, NAT PHYS, V3, P36, DOI 10.1038/nphys477; Chang CZ, 2013, SCIENCE, V340, P167, DOI 10.1126/science.1234414; Chen YL, 2010, SCIENCE, V329, P659, DOI 10.1126/science.1189924; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; DRIJVER JW, 1976, J PHYS F MET PHYS, V6, P2165, DOI 10.1088/0305-4608/6/11/015; Fang Z, 2003, SCIENCE, V302, P92, DOI 10.1126/science.1089408; Fenner LA, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/45/452202; Giefers H, 2006, J ALLOY COMPD, V422, P132, DOI 10.1016/j.jallcom.2005.11.061; Guo HM, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.113102; Haldane FDM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.206602; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; Han TH, 2012, NATURE, V492, P406, DOI 10.1038/nature11659; Hiroi Z, 2001, J PHYS SOC JPN, V70, P3377, DOI 10.1143/JPSJ.70.3377; Hou ZP, 2017, ADV MATER, V29, DOI 10.1002/adma.201701144; Inami T, 2000, PHYS REV B, V61, P12181, DOI 10.1103/PhysRevB.61.12181; Ishii Y, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.023705; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Kida T, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/11/112205; Kim KS, 2013, NAT MATER, V12, P887, DOI [10.1038/NMAT3717, 10.1038/nmat3717]; Kuroda K, 2017, NAT MATER, V16, P1090, DOI [10.1038/NMAT4987, 10.1038/nmat4987]; LECAER G, 1978, J PHYS F MET PHYS, V8, P323, DOI 10.1088/0305-4608/8/2/018; Mazin II, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5261; Nakatsuji S, 2015, NATURE, V527, P212, DOI 10.1038/nature15723; Nayak AK, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501870; Nevius MS, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.136802; O'Keeffe M., 1996, CRYST STRUCT, VI; Onose Y, 2010, SCIENCE, V329, P297, DOI 10.1126/science.1188260; Qi XL, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.085308; Raquet B, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.024433; Richard P, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.137001; SACHDEV S, 1992, PHYS REV B, V45, P12377, DOI 10.1103/PhysRevB.45.12377; Sales BC, 2014, SCI REP-UK, V4, DOI 10.1038/srep07024; Shitade A, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.083704; Sinitsyn NA, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.045315; Tan SY, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.104513; Tang E, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.236802; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; Tian Y, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.087206; WALLACE PR, 1947, PHYS REV, V71, P622, DOI 10.1103/PhysRev.71.622; Wang Q, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.075135; Xu G, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.186802; Xu SY, 2012, NAT PHYS, V8, P616, DOI [10.1038/nphys2351, 10.1038/NPHYS2351]; Zhou Y, 2017, REV MOD PHYS, V89, DOI 10.1103/RevModPhys.89.025003	47	339	340	51	452	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 29	2018	555	7698					638	+		10.1038/nature25987	http://dx.doi.org/10.1038/nature25987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8UX	29555992	Green Submitted			2022-12-28	WOS:000428617600045
J	Chen, YE; Fischbach, MA; Belkaid, Y				Chen, Y. Erin; Fischbach, Michael A.; Belkaid, Yasmine			Skin microbiota-host interactions (vol 553, pg 427, 2018)	NATURE			English	Correction																		Chen YE, 2018, NATURE, V553, P427, DOI 10.1038/nature25177	1	7	7	10	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2018	555	7697								10.1038/nature25994	http://dx.doi.org/10.1038/nature25994			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ9NF	29565366	Bronze			2022-12-28	WOS:000427937900059
J	Hornyak, T				Hornyak, Tim			FACING DOWN DISASTER	NATURE			English	Editorial Material																			0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2018	555	7697					S66	S66		10.1038/d41586-018-02900-7	http://dx.doi.org/10.1038/d41586-018-02900-7			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FZ9NF	29565383	Bronze			2022-12-28	WOS:000427937900010
J	Baxi, S; Yang, A; Gennarelli, RL; Khan, N; Wang, ZW; Boyce, L; Korenstein, D				Baxi, Shrujal; Yang, Annie; Gennarelli, Renee L.; Khan, Niloufer; Wang, Ziwei; Boyce, Lindsay; Korenstein, Deborah			Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CELL LUNG-CANCER; CHECKPOINT INHIBITORS; OPEN-LABEL; ADVANCED MELANOMA; NIVOLUMAB; RISK; PEMBROLIZUMAB; DOCETAXEL; CHEMOTHERAPY; ARTHRITIS	OBJECTIVE To evaluate rates of serious organ specific immune-related adverse events, general adverse events related to immune activation, and adverse events consistent with musculoskeletal problems for anti-programmed cell death 1 (PD-1) drugs overall and compared with control treatments. DESIGN Systematic review and meta-analysis. DATA SOURCES Medline, Embase, Cochrane Library, Web of Science, and Scopus searched to 16 March 2017 and combined with data from ClinicalTrials. gov. STUDY SELECTION Eligible studies included primary clinical trial data on patients with cancer with recurrent or metastatic disease. DATA EXTRACTION Three independent investigators extracted data on adverse events from ClinicalTrials. gov and the published studies. Risk of bias was assessed using the Cochrane tool by three independent investigators. RESULTS 13 relevant studies were included; adverse event data were available on ClinicalTrials. gov for eight. Studies compared nivolumab (n=6), pembrolizumab (5), or atezolizumab (2) with chemotherapy (11), targeted drugs (1), or both (1). Serious organ specific immune-related adverse events were rare, but compared with standard treatment, rates of hypothyroidism (odds ratio 7.56, 95% confidence interval 4.53 to 12.61), pneumonitis (5.37, 2.73 to 10.56), colitis (2.88, 1.30 to 6.37), and hypophysitis (3.38, 1.02 to 11.08) were increased with anti-PD-1 drugs. Of the general adverse events related to immune activation, only the rate of rash (2.34, 2.73 to 10.56) increased. Incidence of fatigue (32%) and diarrhea (19%) were high but similar to control. Reporting of adverse events consistent with musculoskeletal problems was inconsistent; rates varied but were over 20% in some studies for arthraligia and back pain. CONCLUSIONS Organ specific immune-related adverse events are uncommon with anti-PD-1 drugs but the risk is increased compared with control treatments. General adverse events related to immune activation are largely similar. Adverse events consistent with musculoskeletal problems are inconsistently reported but adverse events may be common.	[Baxi, Shrujal; Khan, Niloufer; Korenstein, Deborah] Mem Sloan Kettering Canc Ctr, Dept Med, 485 Lexington Ave,2nd Floor, New York, NY 10021 USA; [Baxi, Shrujal; Yang, Annie; Gennarelli, Renee L.; Korenstein, Deborah] Mem Sloan Kettering Canc Ctr, Ctr Hlth Policy & Outcomes, 1275 York Ave, New York, NY 10021 USA; [Baxi, Shrujal] Weill Cornell Med, Dept Med, New York, NY USA; [Wang, Ziwei] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Boyce, Lindsay] Mem Sloan Kettering Canc Ctr, Med Lib, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; University of California System; University of California Los Angeles; Memorial Sloan Kettering Cancer Center	Korenstein, D (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 485 Lexington Ave,2nd Floor, New York, NY 10021 USA.; Korenstein, D (corresponding author), Mem Sloan Kettering Canc Ctr, Ctr Hlth Policy & Outcomes, 1275 York Ave, New York, NY 10021 USA.	korenstd@mskcc.org	Wang, Zhiquan/HHS-6768-2022	Khan, Niloufer/0000-0002-8631-5710; Boyce, Lindsay/0000-0002-1003-7275	National Institutes of Health; National Cancer Institute Cancer Center Support Grant [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the National Institutes of Health and National Cancer Institute Cancer Center Support Grant (P30 CA008748). The funder had no role in the design of the study; the collection, analysis, and interpretation of the data; or approval of the finished manuscript.	Abdel-Rahman O, 2016, CLIN ONCOL-UK, V28, pE127, DOI 10.1016/j.clon.2016.06.008; Abdel-Rahman O, 2016, THER ADV RESPIR DIS, V10, P183, DOI 10.1177/1753465816636557; Abdel-Rahman O, 2016, IMMUNOTHERAPY-UK, V8, P665, DOI 10.2217/imt-2015-0020; Abdel-Rahman O, 2015, IMMUNOTHERAPY-UK, V7, P1213, DOI 10.2217/imt.15.87; Abdel-Rahman O, 2015, EXPERT OPIN DRUG SAF, V14, P1507, DOI 10.1517/14740338.2015.1085969; Abdel-Wahab N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160221; Anvik Tor, 2006, BMC Fam Pract, V7, P19, DOI 10.1186/1471-2296-7-19; Belkhir R, 2017, ANN RHEUM DIS, V76, P1747, DOI 10.1136/annrheumdis-2017-211216; Bellmunt J, 2017, NEW ENGL J MED, V376, P1015, DOI 10.1056/NEJMoa1613683; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Bramer WM, 2016, J MED LIBR ASSOC, V104, P240, DOI 10.3163/1536-5050.104.3.014; Brzezianska E, 2006, MUTAT RES-FUND MOL M, V599, P26, DOI 10.1016/j.mrfmmm.2005.12.013; Cappelli LC, 2017, ARTHRIT CARE RES, V69, P1751, DOI 10.1002/acr.23177; Cappelli LC, 2016, RMD OPEN, V2, DOI 10.1136/rmdopen-2016-000321; Cappelli LC, 2017, ANN RHEUM DIS, V76, P43, DOI 10.1136/annrheumdis-2016-209595; Cappelli LC, 2017, RHEUM DIS CLIN N AM, V43, P65, DOI 10.1016/j.rdc.2016.09.007; Christ LA, 2017, ANN RHEUM DIS, V76, P718, DOI 10.1136/annrheumdis-2017-eular.6532; De Velasco G, 2017, CANCER IMMUNOL RES, V5, P312, DOI 10.1158/2326-6066.CIR-16-0237; Ferris RL, 2016, NEW ENGL J MED, V375, P1856, DOI 10.1056/NEJMoa1602252; Gladman DD, 2009, DERMATOL THER, V22, P40, DOI 10.1111/j.1529-8019.2008.01215.x; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; IMS Institute for Healthcare Informatics, 2017, GLOB US MED OUTL 201; Johnson DB, 2016, NEW ENGL J MED, V375, P1749, DOI 10.1056/NEJMoa1609214; Komaki Y, 2018, CLIN PHARMACOL THER, V103, P318, DOI 10.1002/cpt.633; Kostine M, 2018, ANN RHEUM DIS, V77, P393, DOI 10.1136/annrheumdis-2017-212257; Laubli H, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0057-1; Langer CJ, 2016, LANCET ONCOL, V17, P1497, DOI 10.1016/S1470-2045(16)30498-3; Larkin J, 2017, ONCOLOGIST, V22, P709, DOI 10.1634/theoncologist.2016-0487; Linardou H, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.07.10; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Ohe Y, 2008, CLIN CANCER RES, V14, P4206, DOI 10.1158/1078-0432.CCR-07-5143; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Ribas A, 2015, LANCET ONCOL, V16, P908, DOI 10.1016/S1470-2045(15)00083-2; Richtel Matt, 2016, NY TIMES; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Saini P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6501; Schuette W, 2005, J CLIN ONCOL, V23, P8389, DOI 10.1200/JCO.2005.02.3739; Umscheid CA, 2011, POSTGRAD MED, V123, P194, DOI 10.3810/pgm.2011.09.2475; Uyl-de Groot CA, 2015, LANCET ONCOL, V16, P1226, DOI 10.1016/S1470-2045(15)00294-6; Weber JS, 2016, ONCOLOGIST, V21, P1230, DOI 10.1634/theoncologist.2016-0055; Weber JS, 2015, J CLIN ONCOL, V33, P2092, DOI 10.1200/JCO.2014.60.0379; Weber JS, 2015, LANCET ONCOL, V16, P375, DOI 10.1016/S1470-2045(15)70076-8; Zimmer L, 2016, EUR J CANCER, V60, P210, DOI 10.1016/j.ejca.2016.02.024	45	296	311	3	46	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 14	2018	360								k793	10.1136/bmj.k793	http://dx.doi.org/10.1136/bmj.k793			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ9FZ	29540345	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000427916700014
J	McNeish, H				McNeish, Hannah			Global watchdog to counter big tobacco	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												hannahmcneish1@gmail.com						Bloomberg Philanthropies, STOPP TOB ORG PROD S; US Surgeon General, 2016, E CIG US YOUTH YOUNG	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 14	2018	360								k1172	10.1136/bmj.k1172	http://dx.doi.org/10.1136/bmj.k1172			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ9FZ	29540342				2022-12-28	WOS:000427916700007
J	Cotts, KG; Cifu, AS				Cotts, Kamala Gullapalli; Cifu, Adam S.			Treatment of Osteoporosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PREVENT FRACTURES; AMERICAN-COLLEGE; WOMEN; ALENDRONATE; EXTENSION; FLEX		[Cotts, Kamala Gullapalli; Cifu, Adam S.] Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA	University of Chicago	Cifu, AS (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						Altkorn D, 2015, JAMA-J AM MED ASSOC, V313, P1467, DOI 10.1001/jama.2015.1064; Black DM, 2012, J BONE MINER RES, V27, P243, DOI 10.1002/jbmr.1494; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Crandall CJ, 2014, ANN INTERN MED, V161, P711, DOI 10.7326/M14-0317; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; National Osteoporosis Foundation, WHAT IS OST WHAT CAU; Qaseem A, 2017, ANN INTERN MED, V166, P818, DOI 10.7326/M15-1361; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; Schwartz AV, 2010, J BONE MINER RES, V25, P976, DOI 10.1002/jbmr.11; Siris ES, 2008, OSTEOPOROSIS INT, V19, P681, DOI 10.1007/s00198-007-0493-y	10	53	60	3	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2018	319	10					1040	1041		10.1001/jama.2017.21995	http://dx.doi.org/10.1001/jama.2017.21995			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ0HS	29536084				2022-12-28	WOS:000427249700020
J	Jansen, IGH; Mulder, MJHL; Goldhoorn, RJB; Emmer, BJ; van Es, ACGM; Roozenbeek, B; Schonewille, WJ; van den Berg, R; Coutinho, JM; Staals, J; Postma, AA; Lycklama, GJ; Hofmeijer, J; Martens, JM; den Hertog, HM; Sturm, FJC; van der Worp, HB; Lo, RH; Heijboer, RJJ; Keizer, K; Uyttenboogaart, M; Eshghi, O; Wermer, MJH; van Walderveen, MAA; van Dijk, EJ; Boogaarts, HD; de Bruijn, SF; van Dijk, LC; van den Berg, JSP; van Hasselt, BAAM; de Kort, PLM; Peluso, JPP; Schreuder, THCML; Aerden, LAM; Dallinga, RJ; Sprengers, MES; Yo, LSF; Jenniskens, SFM; Roosendaal, SD; van der Kallen, BFW; van den Wijngaard, IR; Bot, JCJ; van Doormaal, PJ; Flach, HZ; Venema, E; Lingsma, HF; Beenen, LFM; Yoo, AJ; Boiten, J; Vos, JA; Roos, YBWEM; van Oostenbrugge, RJ; van der Lugt, A; van Zwam, WH; Dippel, DWJ; Majoie, CBLM				Jansen, Ivo G. H.; Mulder, Maxim J. H. L.; Goldhoorn, Robert-Jan B.; Emmer, Bart J.; van Es, Adriaan C. G. M.; Roozenbeek, Bob; Schonewille, Wouter J.; van den Berg, Rene; Coutinho, Jonathan M.; Staals, Julie; Postma, Alida A.; Lycklama, Geert J.; Hofmeijer, Jeannette; Martens, Jasper M.; den Hertog, Heleen M.; Sturm, Fmiel J. C.; van der Worp, H. Bart; Lo, Rob H.; Heijboer, Roel J. J.; Keizer, Koos; Uyttenboogaart, Maarten; Eshghi, Omid; Wermer, Marieke J. H.; van Walderveen, Marianne A. A.; van Dijk, Ewoud J.; Boogaarts, Hieronymus D.; de Bruijn, Sebastiaan F.; van Dijk, Lukas C.; van den Berg, Jan S. P.; van Hasselt, Boudewijn A. A. M.; de Kort, Paul L. M.; Peluso, Jo P. P.; Schreuder, Tobien H. C. M. L.; Aerden, Leo A. M.; Dallinga, Rene J.; Sprengers, Marieke E. S.; Yo, Lonneke S. F.; Jenniskens, Sjoerd F. M.; Roosendaal, Stefan D.; van der Kallen, Bas F. W.; van den Wijngaard, Ido R.; Bot, Joost C. J.; van Doormaal, Pieter J.; Flach, H. Zwenneke; Venema, Esmee; Lingsma, Hester F.; Beenen, Ludo F. M.; Yoo, Albert J.; Boiten, Jelis; Vos, Jan A.; Roos, Yvo B. W. E. M.; van Oostenbrugge, Robert J.; van der Lugt, Aad; van Zwam, Wim H.; Dippel, Diederik W. J.; Majoie, Charles B. L. M.		M R Clean Registry Investigators	Endovascular treatment for acute ischaemic stroke in routine clinical practice: prospective, observational cohort study (MR CLEAN Registry)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; CLOT BURDEN SCORE; MECHANICAL THROMBECTOMY; THROMBOLYTIC THERAPY; METAANALYSIS; VALIDITY; INFARCT	OBJECTIVE To determine outcomes and safety of endovascular treatment for acute ischaemic stroke, due to proximal intracranial vessel occlusion in the anterior circulation, in routine clinical practice. DESIGN Ongoing, prospective, observational cohort study. SETTING 16 centres that perform endovascular treatment in the Netherlands. PARTICIPANTS 1488 patients included in the Multicentre Randomised Controlled Trial of Endovascular Treatment for Acute Ischaemic Stroke in the Netherlands (MR CLEAN) Registry who had received endovascular treatment, including stent retriever thrombectomy, aspiration, and all alternative methods for acute ischaemic stroke within 6.5 hours from onset of symptoms between March 2014 and June 2016. MAIN OUTCOME MEASURES The primary outcome was the modified Rankin Scale (mRS) score, ranging from 0 (no symptoms) to 6 (death) at 90 days after the onset of symptoms. Secondary outcomes were excellent functional outcome (mRS score 0-1), good functional outcome (mRS score 0-2), and favourable functional outcome (mRS score 0-3) at 90 days; score on the extended thrombolysis in cerebral infarction scale at the end of the intervention procedure; National Institutes of Health Stroke Scale score 24-48 hours after intervention; and complications that occurred during intervention, hospital admission, or three months' follow up period. Outcomes and safety variables in the MR CLEAN Registry were compared with the MR CLEAN trial intervention and control arms. RESULTS A statistically significant shift was observed towards better functional outcome in patients in the MR CLEAN Registry compared with the MR CLEAN trial intervention arm (adjusted common odds ratio 1.30, 95% confidence interval 1.02 to 1.67) and the MR CLEAN trial control arm (1.85, 1.46 to 2.34). The reperfusion rate, with successful reperfusion defined as a score of 2B-3 on the extended thrombolysis in cerebral infarction score, was 58.7%, the same as for patients in the MR CLEAN trial. Duration from onset of stroke to start of endovascular treatment and from onset of stroke to successful reperfusion or last contrast bolus was one hour shorter for patients in the MR CLEAN Registry. Symptomatic intracranial haemorrhage occurred in 5.8% of patients in the MR CLEAN Registry compared with 7.7% in the MR CLEAN trial intervention arm and 6.4% in the MR CLEAN trial control arm. CONCLUSION In routine clinical practice, endovascular treatment for patients with acute ischaemic stroke is at least as effective and safe as in the setting of a randomised controlled trial.				i.g.jansen@amc.nl	Emmer, Bart/AAA-2817-2021; van Dijk, Ewoud J/J-7951-2012; Jacobi-Postma, linda (Alida) A/ABG-1756-2021; Roos, Yvo BWEM/B-9843-2013; Dippel, Diederik/AAJ-2192-2020; Coutinho, Jonathan/AAN-4546-2020; Boogaarts, Jeroen/L-4216-2015; Beenen, Ludo F/AAA-3114-2021; Jenniskens, S.F.M./L-4415-2015; van den Wijngaard, Ido/N-2331-2019	Jacobi-Postma, linda (Alida) A/0000-0002-1116-054X; Dippel, Diederik/0000-0002-9234-3515; Coutinho, Jonathan/0000-0002-8284-982X; Boogaarts, Jeroen/0000-0001-5855-2447; Beenen, Ludo F/0000-0001-9204-1026; van den Wijngaard, Ido/0000-0002-3734-6086; Emmer, Bart/0000-0001-8462-4037; Venema, Esmee/0000-0003-1631-6635	Erasmus University Medical Centre; Academic Medical Centre Amsterdam; Maastricht University Medical Centre; Applied Scientific Institute for Neuromodulation (Toegepast Wetenschappelijk Instituut voor Neuromodulatie)	Erasmus University Medical Centre; Academic Medical Centre Amsterdam; Maastricht University Medical Centre; Applied Scientific Institute for Neuromodulation (Toegepast Wetenschappelijk Instituut voor Neuromodulatie)	This study was funded and carried out by the Erasmus University Medical Centre, the Academic Medical Centre Amsterdam, and the Maastricht University Medical Centre. The study was additionally funded by the Applied Scientific Institute for Neuromodulation (Toegepast Wetenschappelijk Instituut voor Neuromodulatie), which played no role in trial design and patient enrolment, nor in data collection, analysis, or writing of the manuscript. The corresponding author had full access to all the data. The executive committee had responsibility for the decision to submit for publication.	Badhiwala JH, 2015, JAMA-J AM MED ASSOC, V314, P1832, DOI 10.1001/jama.2015.13767; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Bracard S, 2016, LANCET NEUROL, V15, P1138, DOI 10.1016/S1474-4422(16)30177-6; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Carvalho A, 2017, J STROKE CEREBROVASC, V26, P589, DOI 10.1016/j.jstrokecerebrovasdis.2016.11.116; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Fransen PSS, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-343; Frieden TR, 2017, NEW ENGL J MED, V377, P465, DOI 10.1056/NEJMra1614394; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Mueller-Kronast NH, 2017, STROKE, V48, P2760, DOI 10.1161/STROKEAHA.117.016456; Muir KW, 2017, J NEUROL NEUROSUR PS, V88, P38, DOI 10.1136/jnnp-2016-314117; Noser EA, 2005, STROKE, V36, P292, DOI 10.1161/01.STR.0000152331.93770.18; Puetz V, 2008, INT J STROKE, V3, P230, DOI 10.1111/j.1747-4949.2008.00221.x; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Senn S, 2009, STAT MED, V28, P3189, DOI 10.1002/sim.3603; Tan IYL, 2009, AM J NEURORADIOL, V30, P525, DOI 10.3174/ajnr.A1408; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; VENEMA E, 2017, BMJ-BRIT MED J, V357, DOI DOI 10.1136/BMJ.J1710; von Kummer R, 2015, STROKE, V46, P2981, DOI 10.1161/STROKEAHA.115.010049	23	169	169	1	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2018	360								k949	10.1136/bmj.k949	http://dx.doi.org/10.1136/bmj.k949			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ1ZU	29523557	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000427376900003
J	Boto, E; Holmes, N; Leggett, J; Roberts, G; Shah, V; Meyer, SS; Munoz, LD; Mullinger, KJ; Tierney, TM; Bestmann, S; Barnes, GR; Bowtell, R; Brookes, MJ				Boto, Elena; Holmes, Niall; Leggett, James; Roberts, Gillian; Shah, Vishal; Meyer, Sofie S.; Munoz, Leonardo Duque; Mullinger, Karen J.; Tierney, Tim M.; Bestmann, Sven; Barnes, Gareth R.; Bowtell, Richard; Brookes, Matthew J.			Moving magnetoencephalography towards real-world applications with a wearable system	NATURE			English	Article							MULTICHANNEL ATOMIC MAGNETOMETER; OPTICALLY-PUMPED MAGNETOMETERS; NEURAL OSCILLATIONS; ELECTRICAL-ACTIVITY; GRADIENT COILS; MEG; DESIGN; BRAIN; SCHIZOPHRENIA	Imaging human brain function with techniques such as magnetoencephalography(1) typically requires a subject to perform tasks while their head remains still within a restrictive scanner. This artificial environment makes the technique inaccessible to many people, and limits the experimental questions that can be addressed. For example, it has been difficult to apply neuroimaging to investigation of the neural substrates of cognitive development in babies and children, or to study processes in adults that require unconstrained head movement (such as spatial navigation). Here we describe a magnetoencephalography system that can be worn like a helmet, allowing free and natural movement during scanning. This is possible owing to the integration of quantum sensors(2,3), which do not rely on superconducting technology, with a system for nulling background magnetic fields. We demonstrate human electrophysiological measurement at millisecond resolution while subjects make natural movements, including head nodding, stretching, drinking and playing a ball game. Our results compare well to those of the current state-of-the-art, even when subjects make large head movements. The system opens up new possibilities for scanning any subject or patient group, with myriad applications such as characterization of the neurodevelopmental connectome, imaging subjects moving naturally in a virtual environment and investigating the pathophysiology of movement disorders.	[Boto, Elena; Holmes, Niall; Leggett, James; Roberts, Gillian; Mullinger, Karen J.; Bowtell, Richard; Brookes, Matthew J.] Univ Nottingham, Sch Phys & Astron, Sir Peter Mansfield Imaging Ctr, Univ Pk, Nottingham NG7 2RD, England; [Shah, Vishal] QuSpin Inc, 331 South 04th St,Suite 130, Louisville, CO 80027 USA; [Meyer, Sofie S.; Munoz, Leonardo Duque; Tierney, Tim M.; Bestmann, Sven; Barnes, Gareth R.] UCL, UCL Inst Neurol, Wellcome Ctr Human Neuroimaging, 12 Queen Sq, London WC1N 3BG, England; [Meyer, Sofie S.] UCL, Inst Cognit Neurosci, 17-19 Queen Sq, London WC1N 3AZ, England; [Mullinger, Karen J.] Univ Birmingham, Sch Psychol, Ctr Human Brain Hlth, Birmingham B15 2TT, W Midlands, England; [Bestmann, Sven] UCL, UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, Queen Sq House,Queen Sq, London WC1N 3BG, England	University of Nottingham; University of London; University College London; University of London; University College London; University of Birmingham; University of London; University College London	Brookes, MJ (corresponding author), Univ Nottingham, Sch Phys & Astron, Sir Peter Mansfield Imaging Ctr, Univ Pk, Nottingham NG7 2RD, England.	matthew.brookes@nottingham.ac.uk	Barnes, Gareth/ABB-7650-2020; Mullinger, Karen/ABG-4896-2021; Muñoz, Leonardo Duque/P-7539-2018	Barnes, Gareth/0000-0002-5396-7712; Mullinger, Karen/0000-0002-8164-0274; Muñoz, Leonardo Duque/0000-0001-7115-3870; Holmes, Niall/0000-0002-0561-8366; Bestmann, Sven/0000-0002-6867-9545; Boto, Elena/0000-0002-0347-280X; Brookes, Matthew/0000-0002-8687-8185	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R44HD074495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R44MH110288] Funding Source: NIH RePORTER; EPSRC [EP/M013294/1] Funding Source: UKRI; Medical Research Council Funding Source: Medline; NICHD NIH HHS [R44 HD074495] Funding Source: Medline; NIMH NIH HHS [R44 MH110288] Funding Source: Medline; Wellcome Trust [203257BARNES] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome Trust)		Alem O, 2017, OPT EXPRESS, V25, P7849, DOI 10.1364/OE.25.007849; Alem O, 2014, J NEUROSCI, V34, P14324, DOI 10.1523/JNEUROSCI.3495-14.2014; Allred JC, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.130801; BACKUS G, 1968, GEOPHYS J ROY ASTR S, V16, P169, DOI 10.1111/j.1365-246X.1968.tb00216.x; Baillet S, 2017, NAT NEUROSCI, V20, P327, DOI 10.1038/nn.4504; Barratt EL, 2017, HUM BRAIN MAPP, V38, P2441, DOI 10.1002/hbm.23531; Borna A, 2017, PHYS MED BIOL, V62, P8909, DOI 10.1088/1361-6560/aa93d1; Boto E, 2017, NEUROIMAGE, V149, P404, DOI 10.1016/j.neuroimage.2017.01.034; Brookes MJ, 2008, NEUROIMAGE, V39, P1788, DOI 10.1016/j.neuroimage.2007.09.050; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; CARLSON JW, 1992, MAGNET RESON MED, V26, P191, DOI 10.1002/mrm.1910260202; COHEN D, 1972, SCIENCE, V175, P664, DOI 10.1126/science.175.4022.664; DUPONTRO.J, 1969, PHYS LETT A, VA 28, P638, DOI 10.1016/0375-9601(69)90480-0; Gaetz W, 2010, NEUROIMAGE, V51, P792, DOI 10.1016/j.neuroimage.2010.01.077; Gross J, 2013, NEUROIMAGE, V65, P349, DOI 10.1016/j.neuroimage.2012.10.001; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Jerbi K, 2007, P NATL ACAD SCI USA, V104, P7676, DOI 10.1073/pnas.0609632104; Johnson C, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3522648; Johnson CN, 2013, PHYS MED BIOL, V58, P6065, DOI 10.1088/0031-9155/58/17/6065; Kameda K, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.026601; Kim K, 2014, NEUROIMAGE, V89, P143, DOI 10.1016/j.neuroimage.2013.10.040; Kominis IK, 2003, NATURE, V422, P596, DOI 10.1038/nature01484; Mary A, 2015, NEUROIMAGE, V104, P59, DOI 10.1016/j.neuroimage.2014.10.010; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Poole M, 2007, CONCEPT MAGN RESON B, V31B, P162, DOI 10.1002/cmr.b.20091; Robinson S., 1998, RECENT ADV BIOMAGNET, P302; Robson SE, 2016, NEUROIMAGE-CLIN, V12, P869, DOI 10.1016/j.nicl.2015.08.005; SARVAS J, 1987, PHYS MED BIOL, V32, P11, DOI 10.1088/0031-9155/32/1/004; Shah V, 2007, NAT PHOTONICS, V1, P649, DOI 10.1038/nphoton.2007.201; Shah VK, 2013, PHYS MED BIOL, V58, P8153, DOI 10.1088/0031-9155/58/22/8153; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238; YODA K, 1990, J APPL PHYS, V67, P4349, DOI 10.1063/1.344953	35	439	466	41	353	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2018	555	7698					657	+		10.1038/nature26147	http://dx.doi.org/10.1038/nature26147			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8UX	29562238	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000428617600049
J	[Anonymous]				[Anonymous]			VA Announces Plan to Improve Worst-Performing Medical Centers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2018	319	12					1189	1189		10.1001/jama.2018.2784	http://dx.doi.org/10.1001/jama.2018.2784			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HI0BD	29584827				2022-12-28	WOS:000456106200002
J	Marshall, M; Shah, R; Stokes-Lampard, H				Marshall, Martin; Shah, Robina; Stokes-Lampard, Helen			Online consulting in general practice: making the move from disruptive innovation to mainstream service	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY-CARE; HEALTH; IMPROVEMENT; SYSTEMS		[Marshall, Martin] UCL, Dept Primary Care & Populat Hlth, UCL Med Sch, Upper 3rd Floor,Royal Free Campus,Rowland Hill St, London NW3 2PF, England; [Marshall, Martin; Shah, Robina; Stokes-Lampard, Helen] Royal Coll Gen Practitioners, London, England	University of London; University College London	Marshall, M (corresponding author), UCL, Dept Primary Care & Populat Hlth, UCL Med Sch, Upper 3rd Floor,Royal Free Campus,Rowland Hill St, London NW3 2PF, England.; Marshall, M (corresponding author), Royal Coll Gen Practitioners, London, England.	martin.marshall@ucl.ac.uk						ARMSTRONG S, 2018, BMJ-BRIT MED J, V360, DOI DOI 10.1136/BMJ.K156; Balasubramanian BA, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0219-z; Banks J, 2018, BRIT J GEN PRACT, V68, pE1, DOI 10.3399/bjgp17X693509; Brant H, 2016, BRIT J GEN PRACT, V66, pE460, DOI 10.3399/bjgp16X685597; Casey M, 2017, BRIT J GEN PRACT, V67, pE736, DOI 10.3399/bjgp17X693137; DUGGAL R, 2018, BMJ-BRIT MED J, V360, DOI DOI 10.1136/BMJ.K6; Edwards HB, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016901; HENDERSON C, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.F1035; HM Government, 2017, IND STRAT; Madsen M, 2017, PULSE; Marshall M, 2017, BMJ QUAL SAF, V26, P578, DOI 10.1136/bmjqs-2016-006143; Mehrotra A, 2013, JAMA INTERN MED, V173, P72, DOI 10.1001/2013.jamainternmed.305; Oliver D, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5108; Parry GJ, 2013, ACAD PEDIATR, V13, pS23, DOI 10.1016/j.acap.2013.04.007; Peters L, 2018, J ROY SOC MED; SALISBURY C, 2002, NATL EVALUATION NHS; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x	17	23	23	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2018	360								k1195	10.1136/bmj.k1195	http://dx.doi.org/10.1136/bmj.k1195			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB5MP	29581174	Green Submitted			2022-12-28	WOS:000429109200001
J	Longchamp, A; Mirabella, T; Arduini, A; MacArthur, MR; Das, A; Trevino-Villarreal, JH; Hine, C; Ben-Sahra, I; Knudsen, NH; Brace, LE; Reynolds, J; Mejia, P; Tao, M; Sharma, G; Wang, R; Corpataux, JM; Haefliger, JA; Ahn, KH; Lee, CH; Manning, BD; Sinclair, DA; Chen, CS; Ozaki, CK; Mitchell, JR				Longchamp, Alban; Mirabella, Teodelinda; Arduini, Alessandro; MacArthur, Michael R.; Das, Abhirup; Trevino-Villarreal, J. Humberto; Hine, Christopher; Ben-Sahra, Issam; Knudsen, Nelson H.; Brace, Lear E.; Reynolds, Justin; Mejia, Pedro; Tao, Ming; Sharma, Gaurav; Wang, Rui; Corpataux, Jean-Marc; Haefliger, Jacques-Antoine; Ahn, Kyo Han; Lee, Chih-Hao; Manning, Brendan D.; Sinclair, David A.; Chen, Christopher S.; Ozaki, C. Keith; Mitchell, James R.			Amino Acid Restriction Triggers Angiogenesis via GCN2/ATF4 Regulation of VEGF and H2S Production	CELL			English	Article							CYSTATHIONINE-BETA-SYNTHASE; HYDROGEN-SULFIDE PRODUCTION; CYTOCHROME-C OXIDASE; NITRIC-OXIDE; LIFE-SPAN; CALORIC RESTRICTION; GENE-EXPRESSION; PROTEIN-KINASE; CELLS RESPOND; TRANSFER-RNA	Angiogenesis, the formation of new blood vessels by endothelial cells (ECs), is an adaptive response to oxygen/nutrient deprivation orchestrated by vascular endothelial growth factor (VEGF) upon ischemia or exercise. Hypoxia is the best-understood trigger of VEGF expression via the transcription factor HIF1 alpha. Nutrient deprivation is inseparable from hypoxia during ischemia, yet its role in angiogenesis is poorly characterized. Here, we identified sulfur amino acid restriction as a proangiogenic trigger, promoting increased VEGF expression, migration and sprouting in ECs in vitro, and increased capillary density in mouse skeletal muscle in vivo via the GCN2/ATF4 amino acid starvation response pathway independent of hypoxia or HIF1 alpha. We also identified a requirement for cystathionine-gamma-lyase in VEGF-dependent angiogenesis via increased hydrogen sulfide (H2S) production. H2S mediated its proangiogenic effects in part by inhibiting mitochondrial electron transport and oxidative phosphorylation, resulting in increased glucose uptake and glycolytic ATP production.	[Longchamp, Alban; Arduini, Alessandro; MacArthur, Michael R.; Trevino-Villarreal, J. Humberto; Hine, Christopher; Ben-Sahra, Issam; Knudsen, Nelson H.; Brace, Lear E.; Reynolds, Justin; Mejia, Pedro; Lee, Chih-Hao; Manning, Brendan D.; Mitchell, James R.] Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA USA; [Longchamp, Alban; Tao, Ming; Sharma, Gaurav; Ozaki, C. Keith] Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA; [Longchamp, Alban; Tao, Ming; Sharma, Gaurav; Ozaki, C. Keith] Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA; [Longchamp, Alban; Tao, Ming; Sharma, Gaurav; Ozaki, C. Keith] Harvard Med Sch, Boston, MA USA; [Mirabella, Teodelinda; Chen, Christopher S.] Boston Univ, Dept Biomed Engn, Tissue Microfabricat Lab, Boston, MA 02215 USA; [Mirabella, Teodelinda; Chen, Christopher S.] Wyss Inst Biol Inspired Engn, Boston, MA USA; [Das, Abhirup; Sinclair, David A.] Harvard Med Sch, Dept Genet, Glenn Ctr Biol Mech Aging, Boston, MA 02115 USA; [Das, Abhirup; Sinclair, David A.] Univ New South Wales, Sch Med Sci, Dept Pharmacol, Lab Ageing Res, Sydney, NSW 2052, Australia; [Wang, Rui] Laurentian Univ, Cardiovasc & Metab Res Unit, Sudbury, ON, Canada; [Corpataux, Jean-Marc; Haefliger, Jacques-Antoine] CHU Vaudois, Lab Expt Med, Dept Vasc Surg, Lausanne, Switzerland; [Ahn, Kyo Han] Postech, Dept Chem, 77 Cheongam Ro, Pohang 37673, South Korea	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University; Harvard University; Harvard Medical School; University of New South Wales Sydney; Laurentian University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Pohang University of Science & Technology (POSTECH)	Mitchell, JR (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA USA.	jmitchel@hsph.harvard.edu	Wang, Rui/C-7824-2012; MacArthur, Michael Robert/AAA-3173-2022; Das, Abhirup/AAF-5129-2019; Chen, Christopher S./ABD-8499-2021; Manning, Brendan/ABD-6528-2021	Wang, Rui/0000-0003-3825-3620; MacArthur, Michael Robert/0000-0003-3593-6995; Chen, Christopher S./0000-0003-2445-8449; Manning, Brendan/0000-0003-3895-5956; Hine, Christopher/0000-0003-1926-7939; Das, Abhirup/0000-0003-1866-457X; Sinclair, David/0000-0002-9936-436X	Swiss National Science Foundation [P1LAP3_158895]; National Science Foundation [NSF-DGE1144152]; Canadian Institutes of Health Sciences; NIH [EB00262, AG036712, DK090629]; American Heart Association [12GRNT9510001, 12GRNT1207025]; Lea Carpenter du Pont Vascular Surgery Fund; Carl and Ruth Shapiro Family Foundation; Charoen Pokphand Group; NATIONAL CANCER INSTITUTE [R35CA197459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100263, R01DK090629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG036712, R37AG028730, R01AG028730, R01AG019719, R01AG036712, DP1AG058605] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Science Foundation(National Science Foundation (NSF)); Canadian Institutes of Health Sciences(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Lea Carpenter du Pont Vascular Surgery Fund; Carl and Ruth Shapiro Family Foundation; Charoen Pokphand Group; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Florent Allagnat for critical discussions and reading the manuscript; Andrew Thompson, Nandan Nurukar, and Rohan Kulkarni for technical assistance; Gokhan Hotamisligil for the use of the Seahorse; John Asara for assistance with metabolomics; Frederick Bowman for the use of the laser Doppler imager; and Constance Cepko for the use of the two-photon microscope. This work was supported by grants from the Swiss National Science Foundation (P1LAP3_158895) to A.L.; the National Science Foundation (NSF-DGE1144152) to L.E.B.; the Canadian Institutes of Health Sciences to R.W.; the NIH (EB00262) to C.S.C.; the American Heart Association (12GRNT9510001 and 12GRNT1207025), the Lea Carpenter du Pont Vascular Surgery Fund, and the Carl and Ruth Shapiro Family Foundation to C.K.O.; and the NIH (AG036712 and DK090629) and the Charoen Pokphand Group to J.R.M.	Abcouwer SF, 2002, INVEST OPHTH VIS SCI, V43, P2791; Alonso F, 2010, CARDIOVASC RES, V87, P166, DOI 10.1093/cvr/cvq031; Altaany Z, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005478; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Bhattacharyya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079167; Bierhansl L, 2017, PHYSIOLOGY, V32, P126, DOI 10.1152/physiol.00031.2016; Borradaile NM, 2009, AGING CELL, V8, P100, DOI 10.1111/j.1474-9726.2009.00453.x; Cai WJ, 2007, CARDIOVASC RES, V76, P29, DOI 10.1016/j.cardiores.2007.05.026; Canto C, 2009, TRENDS ENDOCRIN MET, V20, P325, DOI 10.1016/j.tem.2009.03.008; Castranova D, 2016, ARTERIOSCL THROM VAS, V36, P655, DOI 10.1161/ATVBAHA.115.307087; Coletta C, 2012, P NATL ACAD SCI USA, V109, P9161, DOI 10.1073/pnas.1202916109; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Cooper CE, 2008, J BIOENERG BIOMEMBR, V40, P533, DOI 10.1007/s10863-008-9166-6; Das A, 2018, CELL, V173, P74, DOI 10.1016/j.cell.2018.02.008; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; Dickhout JG, 2012, J BIOL CHEM, V287, P7603, DOI 10.1074/jbc.M111.304576; Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Gao XH, 2015, ELIFE, V4, DOI 10.7554/eLife.10067; Goubern M, 2007, FASEB J, V21, P1699, DOI 10.1096/fj.06-7407com; Hine C, 2017, CELL METAB, V25, P1320, DOI 10.1016/j.cmet.2017.05.003; Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048; Katsouda A, 2016, PHARMACOL RES, V113, P175, DOI 10.1016/j.phrs.2016.08.026; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; Kolluru GK, 2015, CARDIOVASC RES, V107, P590, DOI 10.1093/cvr/cvv198; Kondo M, 2009, J BIOL CHEM, V284, P1718, DOI 10.1074/jbc.M805301200; Lee HJ, 2012, J BIOL CHEM, V287, P4451, DOI 10.1074/jbc.M111.278325; Lee JI, 2008, PHYSIOL GENOMICS, V33, P218, DOI 10.1152/physiolgenomics.00263.2007; Leschelle X, 2005, BBA-GEN SUBJECTS, V1725, P201, DOI 10.1016/j.bbagen.2005.06.002; Li L, 2013, CELL SIGNAL, V25, P50, DOI 10.1016/j.cellsig.2012.09.020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longchamp A, 2014, BIOMATERIALS, V35, P2588, DOI 10.1016/j.biomaterials.2013.12.041; Ma J, 2008, MOL CANCER THER, V7, P79, DOI 10.1158/1535-7163.MCT-07-0584; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Mishanina AV, 2015, NAT CHEM BIOL, V11, P457, DOI 10.1038/nchembio.1834; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; NICHOLLS P, 1982, CAN J BIOCHEM CELL B, V60, P613, DOI 10.1139/o82-076; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Omodei D, 2011, FEBS LETT, V585, P1537, DOI 10.1016/j.febslet.2011.03.015; ORENTREICH N, 1993, J NUTR, V123, P269; Papapetropoulos A, 2009, P NATL ACAD SCI USA, V106, P21972, DOI 10.1073/pnas.0908047106; Peng Wei, 2012, Sci Transl Med, V4, p118ra11, DOI 10.1126/scitranslmed.3002629; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Ruckenstuhl C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004347; Salabei JK, 2014, NAT PROTOC, V9, P421, DOI 10.1038/nprot.2014.018; Schoors S, 2014, CELL METAB, V19, P37, DOI 10.1016/j.cmet.2013.11.008; Sen S, 2015, FREE RADICAL BIO MED, V86, P228, DOI 10.1016/j.freeradbiomed.2015.05.024; Singha S, 2015, ANAL CHEM, V87, P1188, DOI 10.1021/ac503806w; SMITH L, 1977, BIOCHEM PHARMACOL, V26, P2247, DOI 10.1016/0006-2952(77)90287-8; Sonke E, 2015, NITRIC OXIDE-BIOL CH, V49, P26, DOI 10.1016/j.niox.2015.06.001; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Szabo C, 2013, P NATL ACAD SCI USA, V110, P12474, DOI 10.1073/pnas.1306241110; Teodelinda M, 2011, BIOMATERIALS, V32, P3689, DOI 10.1016/j.biomaterials.2011.01.071; Vizan P, 2009, CARCINOGENESIS, V30, P946, DOI 10.1093/carcin/bgp083; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wang Y, 2014, DIABETES METAB J, V38, P321, DOI 10.4093/dmj.2014.38.5.321; Wang YG, 2013, NEOPLASIA, V15, P989, DOI 10.1593/neo.13262; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Whiteman M, 2005, BIOCHEM BIOPH RES CO, V326, P794, DOI 10.1016/j.bbrc.2004.11.110; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Yadav V, 2017, J BIOL CHEM, V292, P13143, DOI 10.1074/jbc.M117.778654; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yong R, 2001, COMP BIOCHEM PHYS B, V129, P129, DOI 10.1016/S1096-4959(01)00309-8	67	162	166	5	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 22	2018	173	1					117	+		10.1016/j.cell.2018.03.001	http://dx.doi.org/10.1016/j.cell.2018.03.001			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GA3MT	29570992	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000428234200012
J	Chernew, ME; Landrum, MB				Chernew, Michael E.; Landrum, Mary Beth			Targeted Supplemental Data Collection - Addressing the Quality-Measurement Conundrum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chernew, Michael E.; Landrum, Mary Beth] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Chernew, ME (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA.							Casalino LP, 2016, HEALTH AFFAIR, V35, P401, DOI 10.1377/hlthaff.2015.1258; Meyer GS, 2012, BMJ QUAL SAF, V21, P964, DOI 10.1136/bmjqs-2012-001081; Penso J, 2017, STAT NEWS       1213; Roberts ET, 2018, ANN INTERN MED, V168, P255, DOI 10.7326/M17-1740	4	4	4	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2018	378	11					979	981		10.1056/NEJMp1713834	http://dx.doi.org/10.1056/NEJMp1713834			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ2HT	29539286				2022-12-28	WOS:000427399000002
J	Raven, A; Lu, WY; Man, TY; Ferreira-Gonzalez, S; O'Duibhir, E; Dwyer, BJ; Thomson, JP; Eehan, RRM; Bogorad, R; Koteliansky, V; Kotelevtsev, Y; Ffrench-Constant, C; Boulter, L; Forbes, SJ				Raven, Alexander; Lu, Wei-Yu; Man, Tak Yung; Ferreira-Gonzalez, Sofia; O'Duibhir, Eoghan; Dwyer, Benjamin J.; Thomson, John P.; Eehan, Richard R. M.; Bogorad, Roman; Koteliansky, Victor; Kotelevtsev, Yuri; Ffrench-Constant, Charles; Boulter, Luke; Forbes, Stuart J.			Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration (vol 547, pg 350, 2017)	NATURE			English	Correction													Ferreira-Gonzalez, Sofia/AAL-9189-2021; Kotelevtsev, Yuri V/R-1772-2016	Ferreira-Gonzalez, Sofia/0000-0001-7776-287X; Forbes, Stuart/0000-0003-3715-2561				Choi TY, 2014, GASTROENTEROLOGY, V146, P776, DOI 10.1053/j.gastro.2013.10.019; Raven A, 2017, NATURE, V547, P350, DOI 10.1038/nature23015	2	2	3	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2018	555	7696								10.1038/nature25996	http://dx.doi.org/10.1038/nature25996			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ3HG	29542689	Bronze			2022-12-28	WOS:000427477100044
J	Butler, SM				Butler, Stuart M.			Don't Let Budget Cuts Wreck Medicare Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Butler, Stuart M.] Brookings Inst, Econ Studies, Washington, DC 20036 USA	Brookings Institution	Butler, SM (corresponding author), Brookings Inst, Econ Studies, Washington, DC 20036 USA.	smbutler@brookings.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2018	319	10					970	971		10.1001/jama.2018.1439	http://dx.doi.org/10.1001/jama.2018.1439			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ0HS	29536086	Bronze			2022-12-28	WOS:000427249700003
J	Vogel, G				Vogel, Gretchen			FEVER DILEMMA	SCIENCE			English	Editorial Material																			0	2	2	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2018	359	6380					1090	1092		10.1126/science.359.6380.1090	http://dx.doi.org/10.1126/science.359.6380.1090			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY4ZM	29590024				2022-12-28	WOS:000426835900019
J	[Anonymous]				[Anonymous]			Libya: war and migration strain a broken health system (vol 391, pg 824, 2018)	LANCET			English	Correction																		Zarocostas J, 2018, LANCET, V391, P824, DOI 10.1016/S0140-6736(18)30505-1	1	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2018	391	10128					1356	1356		10.1016/S0140-6736(18)30618-4	http://dx.doi.org/10.1016/S0140-6736(18)30618-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB8RK	29636271	Bronze			2022-12-28	WOS:000429342800023
